data_1bt7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bt7 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.499 1.978 0 CA-C-O 120.947 0.403 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 59.92 79.64 0.23 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.173 -0.954 . . . . 0.0 109.831 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.03 -89.72 0.08 OUTLIER Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -171.15 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.633 -0.922 . . . . 0.0 110.762 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.34 158.8 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.59 0.71 . . . . 0.0 111.705 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -142.35 140.2 32.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.412 ' CG1' ' HB2' ' A' ' 109' ' ' ARG . 27.7 m -106.22 173.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.967 0.889 . . . . 0.0 112.233 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.446 HG12 ' CH2' ' A' ' 85' ' ' TRP . 33.6 m -129.68 179.75 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.5 p -152.95 139.4 18.62 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.147 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.0 p -146.09 -178.92 6.38 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -71.42 75.34 0.76 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.762 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 39' ' ' ALA . 1.3 m 178.7 -58.32 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -179.72 -156.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.391 -0.818 . . . . 0.0 109.717 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 p -128.34 139.35 52.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.548 -0.72 . . . . 0.0 109.962 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 67.9 m-85 -99.67 -178.71 3.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.477 -0.764 . . . . 0.0 110.284 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.447 HD23 ' HA2' ' A' ' 141' ' ' GLY . 6.8 tt -116.48 146.76 42.33 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.217 -0.927 . . . . 0.0 108.883 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.431 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -148.96 137.51 21.12 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.909 -1.119 . . . . 0.0 110.714 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.405 ' CG2' HG23 ' A' ' 153' ' ' ILE . 14.8 t -106.39 129.89 54.3 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.283 -0.886 . . . . 0.0 113.381 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.2 t -75.46 87.85 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 109.883 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.33 135.01 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m120 57.8 18.97 5.26 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.346 -0.846 . . . . 0.0 110.137 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.19 20.36 52.91 Favored Glycine 0 N--CA 1.498 2.775 0 O-C-N 121.215 -0.928 . . . . 0.0 111.015 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.0 t -137.91 107.78 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.211 -1.17 . . . . 0.0 110.119 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.0 p -60.17 107.38 0.63 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.528 -0.733 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.465 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 96.2 m95 -88.19 146.68 25.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.032 -1.042 . . . . 0.0 111.956 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.6 t -162.76 171.25 17.05 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.442 HG12 ' CE1' ' A' ' 57' ' ' HIS . 16.3 t -94.5 151.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.451 -0.78 . . . . 0.0 109.655 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -76.93 4.46 9.88 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.178 -0.951 . . . . 0.0 111.709 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.442 ' CE1' HG12 ' A' ' 55' ' ' VAL . 26.3 m170 -40.72 -39.45 1.09 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.379 -0.826 . . . . 0.0 112.392 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.34 40.74 0.24 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.91 -5.6 59.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.445 -1.032 . . . . 0.0 110.864 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.49 133.58 3.07 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -92.32 -20.96 20.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.556 -0.967 . . . . 0.0 110.364 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.0 mtpp -77.7 -165.59 0.65 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.775 . . . . 0.0 110.374 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -64.93 100.09 0.39 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.594 -0.691 . . . . 0.0 111.147 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.24 171.39 0.05 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.626 -0.671 . . . . 0.0 110.261 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.37 142.89 46.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.269 -0.895 . . . . 0.0 111.312 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.99 -179.02 17.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -64.88 -23.0 62.62 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 O-C-N 123.9 1.474 . . . . 0.0 110.752 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -152.27 41.45 0.64 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.356 -0.84 . . . . 0.0 110.062 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.69 156.1 7.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -61.52 158.71 35.2 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.778 1.409 . . . . 0.0 110.112 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 80.5 mt -99.3 118.57 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.514 -0.741 . . . . 0.0 109.563 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 m -59.22 124.64 20.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.772 -0.58 . . . . 0.0 110.41 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -73.59 136.02 43.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.656 -0.653 . . . . 0.0 110.072 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.402 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -135.1 -44.9 0.71 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.631 -0.668 . . . . 0.0 110.304 -179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.429 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 14.8 m-85 -130.6 118.44 21.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.599 -0.688 . . . . 0.0 110.055 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 11.7 m -158.27 108.91 2.13 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.558 -0.714 . . . . 0.0 111.196 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -138.67 76.65 1.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.021 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.2 m 11.77 -133.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.88 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.49 177.99 8.62 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.733 -1.23 . . . . 0.0 110.106 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 52.31 23.08 2.25 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.523 -0.736 . . . . 0.0 110.871 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -163.59 -114.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 109.081 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.43 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 3.0 tp 173.47 176.53 0.12 Allowed 'General case' 0 N--CA 1.516 2.847 0 CA-C-N 120.908 1.686 . . . . 0.0 111.319 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 13.3 t -144.8 104.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -123.06 109.87 1.43 Allowed Glycine 0 N--CA 1.487 2.049 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.879 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.446 ' CH2' HG12 ' A' ' 36' ' ' VAL . 1.7 m0 -86.72 171.19 11.13 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -83.11 131.73 35.13 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.338 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -108.0 85.38 2.55 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.144 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.551 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -95.55 -10.71 1.0 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.745 1.392 . . . . 0.0 113.218 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 47.7 Cg_endo -72.32 73.57 2.69 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 115.715 -2.39 . . . . 0.0 110.767 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 51.87 25.8 16.82 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.56 138.73 56.71 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.458 -1.025 . . . . 0.0 110.963 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -84.18 120.4 26.15 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.3 p -93.17 119.73 32.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.632 -0.667 . . . . 0.0 110.7 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mt -77.66 -147.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.2 -174.7 0.45 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 109.084 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -80.22 149.24 19.46 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 O-C-N 123.339 1.178 . . . . 0.0 111.138 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 151' ' ' VAL . 1.8 t -68.15 156.23 37.94 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.158 0.98 . . . . 0.0 110.65 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -170.98 38.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 11.8 m -82.33 -172.56 4.07 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.625 0.726 . . . . 0.0 110.842 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -110.59 -32.76 2.62 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 m -99.02 -155.38 0.5 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.537 -0.978 . . . . 0.0 109.858 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.76 19.92 0.91 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.383 -0.823 . . . . 0.0 111.094 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -78.85 106.82 11.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.54 -178.39 3.61 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.778 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -141.49 92.97 2.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.686 -0.634 . . . . 0.0 109.32 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 tp -51.33 100.45 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.412 -0.805 . . . . 0.0 110.201 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.2 t -82.79 124.64 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.106 -1.037 . . . . 0.0 110.858 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.415 ' HB ' ' NE2' ' A' ' 110' ' ' HIS . 47.6 p -89.91 179.73 5.91 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.412 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -96.38 52.99 1.28 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.047 -1.033 . . . . 0.0 111.404 -178.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.415 ' NE2' ' HB ' ' A' ' 108' ' ' THR . 4.9 p80 -177.09 44.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.44 -0.788 . . . . 0.0 109.996 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.57 65.11 1.61 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.643 -0.661 . . . . 0.0 111.237 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.58 96.56 1.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -109.26 150.71 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.607 -0.683 . . . . 0.0 110.948 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.8 pt -133.22 134.61 24.34 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.379 -0.825 . . . . 0.0 109.797 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.93 142.3 92.55 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 123.831 1.437 . . . . 0.0 112.13 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.45 152.89 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.763 -0.586 . . . . 0.0 109.683 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.89 110.84 18.24 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -48.35 127.12 12.46 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.354 -0.841 . . . . 0.0 110.725 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -111.88 -24.7 9.83 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.384 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.44 -169.66 36.75 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -63.31 128.33 35.33 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.843 0.83 . . . . 0.0 109.96 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.78 46.86 24.93 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.139 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.46 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 1.2 ttp180 -166.44 151.16 7.81 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.493 -0.754 . . . . 0.0 110.649 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.84 -178.34 18.65 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.64 134.45 53.77 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 122.008 -0.701 . . . . 0.0 111.88 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.98 133.47 40.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.608 -0.683 . . . . 0.0 109.194 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 33.2 mt -107.27 54.16 0.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.001 0.905 . . . . 0.0 108.642 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.34 126.6 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.175 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -58.35 110.12 0.6 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 O-C-N 123.568 1.299 . . . . 0.0 110.33 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -123.03 137.77 28.71 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.58 131.69 26.86 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.854 1.45 . . . . 0.0 110.505 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.8 p -60.14 -36.83 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.658 -0.651 . . . . 0.0 109.674 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 t -49.39 -36.51 22.07 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 122.035 0.922 . . . . 0.0 110.654 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -66.68 -37.49 84.86 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 13.3 mt -66.46 -36.23 82.24 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -61.18 121.62 13.0 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.746 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 113.82 -31.99 6.26 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.5 m -91.39 13.2 18.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.975 . . . . 0.0 110.881 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 p -51.52 128.74 23.82 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.174 -0.954 . . . . 0.0 110.379 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 116.26 -13.75 16.13 Favored Glycine 0 CA--C 1.542 1.772 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.447 ' HA2' HD23 ' A' ' 44' ' ' LEU . . . -46.28 110.22 0.47 Allowed Glycine 0 N--CA 1.504 3.21 0 O-C-N 121.504 -0.997 . . . . 0.0 111.174 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -67.84 126.97 15.38 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 124.066 1.561 . . . . 0.0 110.927 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.431 HD21 ' CG ' ' A' ' 169' ' ' PHE . 6.2 mp -80.24 130.87 35.51 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.64 120.37 22.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 109.472 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.566 ' CB ' ' HD3' ' A' ' 146' ' ' PRO . 43.1 m -49.9 -92.17 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.653 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 145' ' ' CYS . 49.3 Cg_endo -92.3 -81.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 114.764 -3.024 . . . . 0.0 111.15 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.7 t -136.95 78.96 1.73 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.19 -0.944 . . . . 0.0 109.714 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 127.09 -166.53 19.85 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.9 m170 54.46 98.53 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.266 -1.138 . . . . 0.0 110.382 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.68 141.33 49.87 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.206 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 97' ' ' CYS . 33.4 t -107.04 -43.39 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.81 179.33 46.24 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.426 HG13 HG11 ' A' ' 170' ' ' VAL . 1.4 pt -111.8 170.47 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 CA-C-N 119.589 1.695 . . . . 0.0 111.212 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 10.3 t80 -83.71 89.17 7.1 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.089 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -74.75 -41.04 60.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.503 -0.748 . . . . 0.0 109.153 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.405 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -159.74 -179.46 7.88 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -137.98 113.91 9.91 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.452 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.5 t -60.21 101.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.9 p -123.01 156.94 33.77 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.363 1.078 . . . . 0.0 113.603 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 162' ' ' GLY . 6.1 p -96.38 -171.79 2.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -46.0 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.396 -0.815 . . . . 0.0 111.905 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 73.01 -19.24 1.28 Allowed Glycine 0 N--CA 1.499 2.865 0 O-C-N 121.168 -0.958 . . . . 0.0 112.795 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.8 t -101.98 136.05 35.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 119.39 1.595 . . . . 0.0 109.199 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -94.53 135.59 35.8 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.063 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -116.23 -38.48 3.57 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.611 -0.681 . . . . 0.0 111.047 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -129.36 178.78 6.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.496 -0.753 . . . . 0.0 109.685 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.2 t -121.11 144.82 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.671 0.748 . . . . 0.0 111.595 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.6 97.34 7.09 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.46 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 0.2 OUTLIER -126.97 142.91 51.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.881 -1.128 . . . . 0.0 112.468 -175.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.426 HG11 HG13 ' A' ' 153' ' ' ILE . 3.7 p -98.19 130.43 28.5 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 50.5 Cg_endo -58.68 152.69 54.46 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.667 1.351 . . . . 0.0 111.484 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.464 ' HA ' ' HG3' ' A' ' 175' ' ' MET . 17.8 m -77.57 -2.53 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.417 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -85.32 -38.67 18.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 109.032 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.4 m -60.68 -36.42 78.7 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.464 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 3.3 mtt -49.25 -37.13 22.38 Favored 'General case' 0 N--CA 1.515 2.796 0 CA-C-O 121.715 0.769 . . . . 0.0 109.075 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -61.0 -40.53 93.87 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.7 m -65.55 -39.74 92.06 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.718 0.771 . . . . 0.0 109.205 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -50.62 -41.22 54.76 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.819 -0.551 . . . . 0.0 110.798 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.465 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -53.88 -41.45 67.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.943 -1.098 . . . . 0.0 111.193 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -53.39 -36.7 61.73 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.301 -0.874 . . . . 0.0 109.61 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -67.82 -43.54 79.35 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.449 -0.782 . . . . 0.0 110.656 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 9.4 p . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.329 0.585 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -170.82 81.04 0.08 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.72 169.53 11.77 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -98.4 -6.12 31.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.587 -0.949 . . . . 0.0 111.308 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.0 t -120.23 142.38 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.122 -0.986 . . . . 0.0 110.749 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -135.47 144.81 46.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.826 -0.546 . . . . 0.0 109.873 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.8 174.01 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.38 -0.825 . . . . 0.0 110.815 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.465 HG13 ' CH2' ' A' ' 85' ' ' TRP . 36.0 m -128.57 -179.07 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -138.66 133.97 33.06 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.731 -1.187 . . . . 0.0 112.296 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.3 p -126.48 -177.81 4.12 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.18 96.69 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.164 -0.96 . . . . 0.0 111.145 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 m 59.54 47.55 10.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.644 -0.66 . . . . 0.0 110.622 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -165.13 169.31 16.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.248 -0.907 . . . . 0.0 110.984 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.5 p -158.45 132.99 8.14 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -99.65 -178.94 4.04 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.111 -0.993 . . . . 0.0 111.235 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.1 152.49 29.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -162.18 159.39 25.82 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.596 -0.69 . . . . 0.0 110.368 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.2 t -138.05 128.83 26.86 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.457 -0.777 . . . . 0.0 111.612 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 79.5 m -77.97 82.22 4.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.551 -0.718 . . . . 0.0 109.727 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.417 ' HB ' ' CD1' ' A' ' 53' ' ' TRP . 57.9 t -97.95 137.84 24.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 57.18 21.0 6.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.801 -0.562 . . . . 0.0 110.248 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.63 23.62 38.79 Favored Glycine 0 N--CA 1.494 2.524 0 O-C-N 121.414 -0.804 . . . . 0.0 111.822 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -143.3 116.18 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-N 118.939 1.37 . . . . 0.0 110.388 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.1 t -64.29 105.64 0.95 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.526 ' CZ3' HG23 ' A' ' 178' ' ' THR . 98.3 m95 -86.41 149.84 24.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.388 -0.82 . . . . 0.0 112.146 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.5 t -164.45 171.93 14.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.584 -0.698 . . . . 0.0 110.519 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -92.98 150.05 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.604 -0.685 . . . . 0.0 109.922 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.533 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 27.0 t80 -82.95 -2.43 55.08 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.219 -0.926 . . . . 0.0 112.112 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -67.47 -10.72 54.19 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.206 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.12 -50.58 0.02 OUTLIER Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.833 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.08 112.63 19.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.012 -1.287 . . . . 0.0 109.899 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.27 10.45 27.61 Favored Glycine 0 N--CA 1.499 2.847 0 O-C-N 121.169 -0.957 . . . . 0.0 110.85 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.4 t -103.66 -38.57 7.05 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.86 -1.377 . . . . 0.0 110.193 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.53 -165.17 1.09 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.494 -0.754 . . . . 0.0 110.577 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -72.05 90.57 1.18 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.669 -0.645 . . . . 0.0 109.855 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.423 ' CD1' ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -56.22 177.77 0.06 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.869 -0.519 . . . . 0.0 110.414 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.3 126.82 32.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -127.99 -178.63 15.43 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.78 -18.04 52.69 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 124.036 1.545 . . . . 0.0 109.649 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -122.89 25.55 8.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 111.008 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 66' ' ' GLY . . . 108.7 -157.71 15.07 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -55.49 145.81 66.82 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.692 1.364 . . . . 0.0 111.523 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.1 mt -93.14 16.57 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.519 -0.738 . . . . 0.0 110.506 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 p 43.17 -153.8 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.302 -0.874 . . . . 0.0 111.501 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.66 118.75 2.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.68 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -30.49 9.98 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.374 -0.828 . . . . 0.0 109.967 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.433 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 15.5 m-85 -129.58 121.71 27.66 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.533 ' CG2' ' CD1' ' A' ' 56' ' ' TYR . 3.7 m -160.44 113.52 2.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.287 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.408 ' HB3' ' CB ' ' A' ' 81' ' ' ASP . 6.3 t-20 -143.59 73.15 1.38 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.504 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 14.2 m 36.01 -162.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.93 -31.61 34.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -52.2 -30.6 27.9 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.682 0.753 . . . . 0.0 109.255 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.408 ' CB ' ' HB3' ' A' ' 77' ' ' ASN . 0.5 OUTLIER -126.97 -102.26 0.35 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.484 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.45 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 0.8 OUTLIER 179.22 168.42 1.01 Allowed 'General case' 0 N--CA 1.512 2.628 0 O-C-N 120.299 -1.501 . . . . 0.0 112.27 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 20.0 t -128.5 150.54 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.38 111.31 0.47 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.319 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.465 ' CH2' HG13 ' A' ' 36' ' ' VAL . 1.1 m-90 -87.04 172.58 9.87 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -87.31 131.33 34.29 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.688 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.66 167.73 1.7 Allowed Pre-proline 0 N--CA 1.494 1.773 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.533 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 33.2 Cg_endo -67.29 -79.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.555 1.546 0 O-C-N 123.879 1.463 . . . . 0.0 110.581 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 88' ' ' PRO . 56.0 Cg_endo -97.65 36.04 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 115.731 -2.379 . . . . 0.0 108.606 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.28 -10.34 73.53 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.433 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . . . 50.15 -178.39 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.207 -1.173 . . . . 0.0 111.855 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -73.19 72.43 1.22 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 t -41.74 95.88 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.755 -0.591 . . . . 0.0 111.968 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.88 -157.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.29 175.14 3.16 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 121.245 -0.91 . . . . 0.0 111.179 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.62 163.95 26.26 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 O-C-N 123.845 1.445 . . . . 0.0 111.545 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 151' ' ' VAL . 18.5 t -79.56 -72.78 0.38 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.705 -0.622 . . . . 0.0 109.811 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.0 m 49.77 74.48 0.2 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.419 -0.801 . . . . 0.0 110.612 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 77.2 m -138.14 -64.92 0.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.261 -0.899 . . . . 0.0 110.601 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 116.33 33.69 1.43 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.4 m -134.32 -163.84 1.42 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.655 -0.909 . . . . 0.0 109.725 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.6 p -135.64 -151.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.578 -0.701 . . . . 0.0 109.546 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.2 t70 62.23 109.79 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.331 -0.856 . . . . 0.0 109.893 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.423 ' CD2' HG22 ' A' ' 151' ' ' VAL . 1.1 mt -128.2 -171.4 2.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.545 -0.722 . . . . 0.0 109.434 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -139.5 90.5 2.41 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.6 tp -59.44 93.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.6 t -82.56 101.57 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.356 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.5 p -65.66 168.48 7.57 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -93.35 24.03 4.15 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.728 -1.232 . . . . 0.0 110.727 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.96 31.27 5.88 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 56.46 71.73 0.55 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.63 0.729 . . . . 0.0 110.516 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -171.99 91.88 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 m -94.57 151.24 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.9 pt -129.96 142.43 45.34 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.29 -0.881 . . . . 0.0 109.031 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.58 132.85 24.5 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.811 1.427 . . . . 0.0 112.09 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.4 t -121.45 153.71 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -116.06 111.85 20.9 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.92 124.13 8.15 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.626 -0.672 . . . . 0.0 110.15 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.422 ' HG3' ' HB2' ' A' ' 125' ' ' SER . 1.6 mmm180 -104.97 -49.45 3.48 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.842 -0.536 . . . . 0.0 110.701 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -151.93 -158.43 8.41 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.712 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -70.58 125.05 25.73 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.147 0.975 . . . . 0.0 109.262 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.83 50.13 16.36 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.042 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.521 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 19.2 ttm180 -166.12 156.53 12.64 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.589 -0.694 . . . . 0.0 110.787 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.95 -178.61 23.28 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.422 ' HB2' ' HG3' ' A' ' 119' ' ' ARG . 1.4 t -135.37 100.84 4.64 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.086 -0.655 . . . . 0.0 111.559 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 pp -48.19 162.64 0.08 Allowed 'General case' 0 N--CA 1.51 2.552 0 O-C-N 121.466 -0.771 . . . . 0.0 110.713 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.7 mt -127.41 67.51 1.3 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 164.3 134.96 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.058 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.691 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.0 100.49 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.803 1.423 . . . . 0.0 109.566 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.36 128.21 25.74 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.539 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -56.0 127.13 24.81 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.917 1.483 . . . . 0.0 110.85 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.61 -36.56 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.44 -37.03 24.29 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.546 -0.722 . . . . 0.0 110.807 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.407 ' CD2' HD22 ' A' ' 135' ' ' LEU . 17.0 t80 -67.8 -39.49 84.01 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.3 mt -63.05 -34.8 78.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 123.81 17.1 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.651 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.31 -31.22 8.88 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.6 m -79.34 -0.62 33.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.915 -0.756 . . . . 0.0 111.104 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 m -57.53 119.84 7.24 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 120.9 -1.125 . . . . 0.0 109.738 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 122.8 -17.24 8.22 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.4 137.88 49.71 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -85.16 129.12 3.78 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 O-C-N 123.522 1.275 . . . . 0.0 113.476 -177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.426 HD23 ' CD2' ' A' ' 169' ' ' PHE . 4.4 mp -81.6 130.79 35.18 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mt -129.92 123.74 31.46 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 119.778 1.172 . . . . 0.0 112.474 -178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 4.2 p -67.44 -173.6 0.16 Allowed Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.94 169.25 15.24 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.674 1.355 . . . . 0.0 110.214 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m 53.35 29.89 9.4 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.638 -0.664 . . . . 0.0 111.43 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 73.63 -134.01 18.43 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 59.61 106.19 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.26 -1.141 . . . . 0.0 110.278 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.81 143.94 57.17 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.69 -0.631 . . . . 0.0 110.798 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 2.1 t -107.01 -42.94 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.759 -0.588 . . . . 0.0 110.326 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.454 ' N ' HG12 ' A' ' 172' ' ' VAL . . . 177.71 -178.62 48.42 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.449 HG13 HG12 ' A' ' 170' ' ' VAL . 1.0 OUTLIER -116.72 153.48 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 118.59 1.195 . . . . 0.0 111.718 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 7.4 t80 -65.38 117.24 7.62 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.505 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -107.26 -35.01 6.93 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.234 -0.916 . . . . 0.0 109.171 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -159.17 169.83 23.28 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -129.84 116.89 19.36 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.41 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.0 t -63.39 100.55 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.431 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 27.8 p -129.03 167.29 17.71 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.512 1.148 . . . . 0.0 113.971 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 162' ' ' GLY . 14.9 p -105.47 -173.51 2.32 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.12 82.9 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 86.09 -27.25 5.63 Favored Glycine 0 N--CA 1.501 2.968 0 O-C-N 121.098 -1.001 . . . . 0.0 112.52 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.27 139.73 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-N 119.188 1.494 . . . . 0.0 108.288 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.431 ' HA ' ' CB ' ' A' ' 159' ' ' CYS . . . -99.52 139.32 35.35 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.371 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -112.98 -31.36 6.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.697 -0.627 . . . . 0.0 110.62 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -141.58 178.65 7.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.888 . . . . 0.0 110.324 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.418 HG11 ' CE1' ' A' ' 154' ' ' PHE . 1.5 t -118.34 150.4 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.662 0.744 . . . . 0.0 110.857 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.92 103.24 9.16 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.521 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 1.7 p90 -128.44 174.32 9.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 118.966 -1.094 . . . . 0.0 112.23 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.449 HG12 HG13 ' A' ' 153' ' ' ILE . 1.4 p -125.96 122.26 24.35 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 41.1 Cg_endo -47.92 152.84 2.89 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 O-C-N 123.651 1.343 . . . . 0.0 113.11 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.475 ' HA ' ' HG2' ' A' ' 175' ' ' MET . 18.2 m -82.38 -1.85 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.343 -0.848 . . . . 0.0 109.832 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -87.42 -43.69 11.9 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.547 -0.72 . . . . 0.0 109.187 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.7 t -60.7 -42.74 97.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.737 -0.602 . . . . 0.0 109.716 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.475 ' HG2' ' HA ' ' A' ' 172' ' ' VAL . 8.2 ptp -58.9 -36.54 74.85 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.914 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.85 -38.05 69.57 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.387 -1.445 . . . . 0.0 108.822 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.7 m -63.62 -36.89 85.3 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.325 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.526 HG23 ' CZ3' ' A' ' 53' ' ' TRP . 3.1 t -48.71 -35.5 14.15 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.12 -0.987 . . . . 0.0 111.645 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.471 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -58.19 -41.25 83.51 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.866 -1.146 . . . . 0.0 110.447 179.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -48.61 -36.68 16.27 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.967 0.889 . . . . 0.0 110.604 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -91.3 -42.74 10.2 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.502 2.155 0 O-C-N 121.296 -0.877 . . . . 0.0 110.962 179.705 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.049 0.452 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 58.51 79.07 0.22 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.333 -0.855 . . . . 0.0 109.869 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.0 -108.92 0.21 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -168.43 -35.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.549 -0.971 . . . . 0.0 111.437 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.42 HG21 HG22 ' A' ' 46' ' ' THR . 54.1 t -131.32 140.6 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.119 -0.988 . . . . 0.0 111.723 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.84 156.41 48.95 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.27 174.87 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.307 -0.87 . . . . 0.0 111.885 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.471 ' CG1' ' CZ ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -144.6 163.73 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.3 p -119.91 142.89 48.29 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.387 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 p -123.85 -176.87 3.58 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.27 98.36 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.395 -0.815 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 p 51.92 31.98 9.27 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.828 -0.545 . . . . 0.0 110.794 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -146.87 154.99 41.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.552 -0.717 . . . . 0.0 110.449 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.2 t -150.0 165.72 31.83 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.568 -0.707 . . . . 0.0 109.318 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.471 ' CZ ' ' CG1' ' A' ' 36' ' ' VAL . 11.0 p90 -153.6 -177.38 6.33 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.254 -0.904 . . . . 0.0 110.598 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.441 ' HB2' ' CG ' ' A' ' 109' ' ' ARG . 7.0 tt -110.43 146.1 36.46 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -146.12 128.86 16.23 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.681 -1.262 . . . . 0.0 110.287 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.42 HG22 HG21 ' A' ' 33' ' ' VAL . 99.9 m -110.31 128.13 55.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.435 -0.791 . . . . 0.0 111.479 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 79.2 m -78.07 85.95 4.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.806 -0.559 . . . . 0.0 109.816 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.26 136.44 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.99 19.3 5.78 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.397 -0.815 . . . . 0.0 109.993 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.98 24.35 45.31 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -139.85 105.44 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 121.261 -1.141 . . . . 0.0 110.378 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.6 OUTLIER -58.04 97.34 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.464 -0.772 . . . . 0.0 109.942 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.478 ' CE3' ' CD2' ' A' ' 82' ' ' LEU . 81.2 m95 -78.53 141.35 38.23 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.341 -0.849 . . . . 0.0 110.668 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.434 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 10.2 t -163.33 126.77 2.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.564 -0.71 . . . . 0.0 109.707 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 m -49.3 143.7 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 O-C-N 121.274 -0.891 . . . . 0.0 110.902 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CB ' ' HB ' ' A' ' 78' ' ' VAL . 4.8 t80 -74.62 -1.72 22.85 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.123 -0.986 . . . . 0.0 110.902 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -48.79 -27.31 2.89 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.26 -0.9 . . . . 0.0 110.689 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.03 76.7 0.09 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 43' ' ' PHE . . . -105.09 -51.16 3.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.447 -1.031 . . . . 0.0 110.101 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 151.08 -40.6 0.79 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 p 51.68 23.94 2.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.551 -0.97 . . . . 0.0 111.201 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.24 -158.47 0.91 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.426 -0.797 . . . . 0.0 110.509 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.4 m -60.3 91.02 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.573 -0.704 . . . . 0.0 110.534 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.16 164.82 25.72 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.675 -0.641 . . . . 0.0 110.233 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.31 135.48 55.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.205 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.23 -179.02 19.87 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.3 -29.19 88.37 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.872 1.459 . . . . 0.0 111.098 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -147.32 38.6 0.96 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.407 -0.808 . . . . 0.0 110.096 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.06 158.08 8.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -63.63 163.7 23.52 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 O-C-N 123.92 1.484 . . . . 0.0 110.493 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.416 HG23 ' CE3' ' A' ' 85' ' ' TRP . 93.4 mt -106.81 108.75 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.653 -0.654 . . . . 0.0 109.494 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -62.0 137.09 58.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.717 -0.615 . . . . 0.0 110.51 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -73.55 163.47 27.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.566 -0.708 . . . . 0.0 109.806 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -43.81 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.448 -0.783 . . . . 0.0 110.486 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.458 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 14.3 m-85 -126.68 124.36 39.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.492 -0.755 . . . . 0.0 110.075 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.427 HG22 ' CG1' ' A' ' 83' ' ' VAL . 6.3 m -158.85 106.41 1.84 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.705 -0.622 . . . . 0.0 111.009 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -152.44 76.57 1.16 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.554 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.446 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.5 p -72.31 -21.26 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.641 -0.662 . . . . 0.0 110.828 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.73 -32.17 29.32 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.045 -1.034 . . . . 0.0 110.401 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -173.85 34.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.595 -0.691 . . . . 0.0 110.337 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -153.95 -99.92 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.313 -0.867 . . . . 0.0 111.811 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.478 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 6.2 tp 178.19 176.35 0.47 Allowed 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.548 -1.345 . . . . 0.0 110.274 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 54' ' ' THR . 16.1 t -132.83 115.57 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.31 110.79 0.82 Allowed Glycine 0 N--CA 1.485 1.908 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.42 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.416 ' CE3' HG23 ' A' ' 71' ' ' ILE . 1.9 m0 -79.38 166.43 22.07 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -86.39 130.29 34.56 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.304 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -108.17 92.13 9.04 Favored Pre-proline 0 C--N 1.294 -1.846 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.344 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.578 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.8 Cg_endo -104.48 -3.5 0.2 Allowed 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.747 1.393 . . . . 0.0 112.967 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 52.4 Cg_endo -72.94 72.29 3.28 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 115.714 -2.391 . . . . 0.0 109.683 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 57.21 24.24 50.58 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.39 138.56 43.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.546 -0.973 . . . . 0.0 110.732 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.0 135.95 43.16 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.474 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.3 p -104.59 97.93 7.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.563 -0.71 . . . . 0.0 109.563 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.49 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.543 -0.723 . . . . 0.0 109.161 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.6 p -155.48 173.77 4.56 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.573 -0.705 . . . . 0.0 110.339 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.34 177.61 8.55 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.839 1.441 . . . . 0.0 110.198 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 t -98.69 -77.3 0.52 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.539 -0.725 . . . . 0.0 110.119 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m 55.11 49.81 16.64 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.223 -0.923 . . . . 0.0 110.008 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 78.3 m -112.5 -46.69 3.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.671 -0.643 . . . . 0.0 110.302 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.98 28.8 6.38 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.31 -164.56 1.22 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.609 -0.936 . . . . 0.0 109.987 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.2 p -140.88 -150.33 0.31 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.369 -0.832 . . . . 0.0 110.541 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.73 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.137 -0.977 . . . . 0.0 109.973 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.94 -178.8 3.58 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.503 -0.748 . . . . 0.0 110.097 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -133.56 84.74 2.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.669 -0.644 . . . . 0.0 109.618 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.5 tp -60.87 106.38 0.57 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.629 -0.669 . . . . 0.0 109.39 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.409 ' HB ' ' HD2' ' A' ' 142' ' ' PRO . 25.1 t -84.43 133.65 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.657 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.3 p -89.34 -177.86 5.47 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.441 ' CG ' ' HB2' ' A' ' 44' ' ' LEU . 14.5 mtm180 -87.73 18.9 3.73 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.0 -1.063 . . . . 0.0 110.505 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.48 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.9 OUTLIER -151.19 47.49 0.83 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.051 -1.03 . . . . 0.0 111.99 -177.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.06 73.03 0.44 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.294 -0.879 . . . . 0.0 111.457 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.82 90.16 0.69 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.791 -0.568 . . . . 0.0 109.818 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.3 m -94.78 149.55 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 110.252 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 34.1 pt -131.48 141.77 42.94 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.512 -0.742 . . . . 0.0 109.723 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.33 137.38 36.55 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.918 1.483 . . . . 0.0 111.772 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.9 t -130.97 140.31 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.04 118.26 36.16 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -48.75 127.3 13.51 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.401 -0.812 . . . . 0.0 110.203 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -107.13 -25.23 11.64 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.257 -177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 121' ' ' ASP . . . 173.04 56.52 0.05 OUTLIER Glycine 0 N--CA 1.498 2.773 0 C-N-CA 118.834 -1.65 . . . . 0.0 110.59 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 120' ' ' GLY . 0.6 OUTLIER 59.23 142.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.831 -0.806 . . . . 0.0 110.132 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.5 p 45.57 27.78 0.45 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.544 0.688 . . . . 0.0 111.554 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.494 ' N ' ' CD2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -166.88 148.05 5.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.522 -0.736 . . . . 0.0 109.427 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.37 -178.09 18.04 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.6 t -124.31 122.25 37.22 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.245 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.4 149.53 33.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.743 -0.598 . . . . 0.0 109.582 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 128' ' ' SER . 90.2 mt -126.01 69.4 1.2 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER 158.16 123.05 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.368 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -58.95 106.81 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 O-C-N 123.588 1.31 . . . . 0.0 109.745 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -122.39 151.18 59.0 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.95 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.3 130.02 12.6 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.178 1.62 . . . . 0.0 109.807 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.7 p -57.92 -36.53 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.73 -0.606 . . . . 0.0 110.093 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 t -49.58 -36.55 24.35 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 122.127 0.965 . . . . 0.0 110.227 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -60.85 -38.04 84.18 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 11.5 mt -69.21 -35.28 76.05 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.712 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -56.95 117.07 3.6 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.746 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 108.29 -24.47 22.57 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.43 4.29 40.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.506 -0.997 . . . . 0.0 111.273 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 80.1 p -51.93 128.85 25.4 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.964 -1.085 . . . . 0.0 109.609 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 114.96 -18.28 16.64 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.28 117.46 3.79 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 53.7 Cg_endo -74.11 124.71 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 124.022 1.538 . . . . 0.0 111.343 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.461 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 6.0 mp -82.9 105.07 13.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 176.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.5 mt -105.24 119.72 39.75 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.131 -0.981 . . . . 0.0 112.385 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.41 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 0.9 OUTLIER -59.63 -167.34 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 41.2 Cg_endo -69.4 167.06 25.06 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 117.092 -1.472 . . . . 0.0 109.472 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.2 t 56.77 -155.04 0.32 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.27 -0.894 . . . . 0.0 110.115 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 149' ' ' HIS . . . -102.76 100.53 1.97 Allowed Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.426 ' CG ' ' O ' ' A' ' 148' ' ' GLY . 1.1 m170 -170.65 95.95 0.22 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.692 -0.887 . . . . 0.0 109.853 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.23 142.32 58.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.573 -0.704 . . . . 0.0 109.256 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 0.9 OUTLIER -103.39 -36.99 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.451 -0.781 . . . . 0.0 109.575 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.419 ' HA2' ' CG2' ' A' ' 172' ' ' VAL . . . 176.15 -178.89 47.49 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.438 HG13 HG11 ' A' ' 170' ' ' VAL . 1.1 pp -114.7 168.75 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-N 118.906 1.353 . . . . 0.0 111.392 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 5.9 t80 -76.96 114.57 15.89 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.29 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 26.5 ttt-85 -100.97 -38.97 7.97 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -159.89 173.61 15.68 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -129.69 119.84 24.16 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.772 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.95 100.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.6 p -127.3 158.07 38.19 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 122.253 1.025 . . . . 0.0 113.354 -175.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' GLY . 16.5 p -91.25 -175.01 4.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.92 85.65 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 86.51 -25.0 7.62 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 121.063 -1.023 . . . . 0.0 112.214 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -101.7 140.61 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 119.177 1.489 . . . . 0.0 109.214 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -103.26 129.63 50.29 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.047 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt -111.51 -33.79 6.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.652 -0.655 . . . . 0.0 110.548 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -129.6 -179.7 5.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.275 -0.891 . . . . 0.0 110.219 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -126.89 147.47 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.615 0.722 . . . . 0.0 111.683 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.45 96.33 6.04 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.494 ' CD2' ' N ' ' A' ' 123' ' ' ARG . 0.3 OUTLIER -124.13 160.42 27.83 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.252 -0.979 . . . . 0.0 112.694 -175.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.438 HG11 HG13 ' A' ' 153' ' ' ILE . 2.7 p -116.21 126.22 27.82 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 47.0 Cg_endo -56.53 156.36 22.46 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 O-C-N 123.872 1.459 . . . . 0.0 112.311 -177.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.448 ' HA ' ' HG3' ' A' ' 175' ' ' MET . 57.5 t -80.76 -2.96 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.05 -37.78 28.5 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.9 t -72.42 -36.01 68.49 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.448 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 36.7 mtt -48.24 -39.07 20.13 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.621 -0.674 . . . . 0.0 110.426 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -54.82 -37.27 65.93 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.883 0.849 . . . . 0.0 109.283 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.7 m -52.9 -41.71 64.65 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.236 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.461 HG23 ' CZ3' ' A' ' 53' ' ' TRP . 14.6 t -56.56 -36.47 69.34 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.94 -1.1 . . . . 0.0 111.635 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.458 ' CG ' ' CZ ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -56.2 -44.2 79.23 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.645 -1.284 . . . . 0.0 110.56 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -51.45 -37.91 51.07 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.944 0.878 . . . . 0.0 110.054 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -74.11 -48.47 29.39 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.697 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.503 2.22 0 O-C-N 121.509 -0.744 . . . . 0.0 110.992 179.701 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 30' ' ' GLU . 3.5 p . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 121.401 0.62 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' N ' HG23 ' A' ' 29' ' ' VAL . 2.6 mm-40 -156.06 79.38 0.98 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.32 -26.39 3.4 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.39 -79.72 0.07 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.508 -0.995 . . . . 0.0 109.243 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.6 p -150.43 148.71 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 111.385 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -131.84 150.2 52.22 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.6 m -108.98 164.09 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.218 -0.926 . . . . 0.0 112.311 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 m -122.53 179.7 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -149.93 137.87 20.23 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.447 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.4 p -144.65 -178.67 6.12 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.87 76.74 0.31 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.027 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 175.51 -59.51 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.584 -0.697 . . . . 0.0 109.323 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 178.21 -171.3 0.11 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.538 -0.726 . . . . 0.0 109.075 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.3 p -112.68 138.06 50.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.513 -0.742 . . . . 0.0 109.923 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.485 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 43.9 m-85 -106.3 173.07 6.48 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.537 -0.727 . . . . 0.0 110.607 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 12.7 mt -100.67 159.85 14.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.521 -0.737 . . . . 0.0 110.713 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.45 126.71 5.3 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.073 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.6 t -104.95 127.43 52.79 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.375 -0.828 . . . . 0.0 112.288 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 97.2 m -80.15 85.41 5.71 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.762 -0.586 . . . . 0.0 109.951 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.7 t -105.13 139.43 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.41 17.97 5.23 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.246 -0.909 . . . . 0.0 110.259 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.23 43.12 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.4 t -141.59 112.04 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.313 -1.11 . . . . 0.0 110.546 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.8 t -67.38 105.65 1.85 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.459 ' CE3' ' CD2' ' A' ' 82' ' ' LEU . 82.2 m95 -87.3 145.54 26.31 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.235 -0.916 . . . . 0.0 111.097 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 t -162.2 178.35 8.83 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.269 -0.894 . . . . 0.0 110.293 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.4 m -101.35 143.12 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.636 -0.665 . . . . 0.0 109.948 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.477 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 36.9 t80 -78.25 2.53 18.03 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.063 -1.023 . . . . 0.0 111.923 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -48.73 -26.77 2.51 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.178 -0.951 . . . . 0.0 110.868 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.424 ' HA3' ' CZ ' ' A' ' 43' ' ' PHE . . . -177.75 35.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.29 0.39 37.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.188 -1.184 . . . . 0.0 111.194 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.05 -171.28 22.37 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.0 t -160.65 -43.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.677 -0.896 . . . . 0.0 110.033 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -165.99 0.06 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.726 -0.608 . . . . 0.0 110.513 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -59.7 97.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.663 -0.648 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.473 HD12 ' CE2' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -60.46 176.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.668 -0.645 . . . . 0.0 109.928 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -118.18 135.68 54.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.417 -0.802 . . . . 0.0 110.669 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.3 179.61 23.81 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -63.57 -23.15 70.54 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.876 1.461 . . . . 0.0 110.483 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -153.28 40.47 0.53 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.326 -0.859 . . . . 0.0 110.425 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 150.11 170.07 16.99 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -64.74 147.7 89.85 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.892 1.469 . . . . 0.0 110.333 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 91.4 mt -79.22 168.87 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.581 -0.699 . . . . 0.0 109.369 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.2 m -80.75 -45.58 16.82 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.21 -0.931 . . . . 0.0 111.608 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 55.5 90.05 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.457 -0.777 . . . . 0.0 109.775 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.6 ttt -126.81 -10.02 6.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.546 -0.722 . . . . 0.0 111.444 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.407 ' CD2' ' HE3' ' A' ' 179' ' ' MET . 15.5 m-85 -128.25 113.65 15.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.091 -1.006 . . . . 0.0 109.655 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.443 HG21 ' HB ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -151.06 112.51 4.4 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.888 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -159.8 74.63 0.6 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 6.6 p -68.05 -10.8 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.361 -0.837 . . . . 0.0 111.302 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.79 85.75 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.349 -0.844 . . . . 0.0 108.976 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 78' ' ' VAL . 3.9 tt0 60.1 39.09 20.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.544 -0.723 . . . . 0.0 109.653 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.79 -93.89 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.969 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.459 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 10.2 tp 177.68 168.61 0.68 Allowed 'General case' 0 N--CA 1.508 2.425 0 O-C-N 120.329 -1.482 . . . . 0.0 110.943 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 9.8 m -141.98 122.67 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.69 142.83 10.29 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.473 ' CE2' HD12 ' A' ' 64' ' ' LEU . 2.4 m-90 -99.08 169.52 9.35 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.32 140.31 31.7 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.727 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.81 94.73 5.52 Favored Pre-proline 0 C--N 1.3 -1.553 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.041 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.576 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.5 Cg_endo -101.39 -12.3 0.17 Allowed 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.644 1.339 . . . . 0.0 113.321 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 49.5 Cg_endo -72.03 69.1 3.14 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 116.175 -2.083 . . . . 0.0 111.203 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.12 14.48 25.31 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.404 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . . . -57.01 131.7 50.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.107 -1.231 . . . . 0.0 110.73 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -85.16 97.73 10.06 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.5 m -52.17 112.95 0.89 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.737 -0.602 . . . . 0.0 111.394 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -152.62 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.52 -0.737 . . . . 0.0 109.133 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p -152.67 179.44 1.27 Allowed Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.346 -0.846 . . . . 0.0 111.303 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.401 ' HA ' HG22 ' A' ' 172' ' ' VAL . 42.7 Cg_endo -86.03 164.19 10.14 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 O-C-N 123.916 1.482 . . . . 0.0 111.535 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 149' ' ' HIS . 0.8 OUTLIER -96.76 86.58 4.09 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.592 -0.693 . . . . 0.0 110.605 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.1 p -61.11 -39.07 88.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.421 -0.799 . . . . 0.0 109.647 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.3 p -64.6 -37.91 89.18 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.48 -0.763 . . . . 0.0 109.764 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 48.2 29.29 6.76 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.86 159.02 14.68 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.498 -1.001 . . . . 0.0 110.281 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.1 t -66.02 -170.1 0.08 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.524 -0.735 . . . . 0.0 110.049 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.77 100.66 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.507 -0.745 . . . . 0.0 110.34 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 mt -117.33 -173.59 2.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.398 -0.814 . . . . 0.0 109.936 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -140.7 84.98 1.97 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.817 -0.552 . . . . 0.0 109.699 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.5 tp -71.89 100.96 2.54 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.2 t -90.72 123.21 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.123 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.9 p -88.37 145.84 25.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -15.14 39.46 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.837 -1.165 . . . . 0.0 109.744 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.423 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 13.4 m170 -55.23 -79.29 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 169.72 47.83 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.25 -0.906 . . . . 0.0 110.305 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -169.56 127.15 0.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.734 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 m -95.6 156.49 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.3 pt -131.68 127.76 21.51 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.442 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -66.04 145.9 80.72 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.876 1.461 . . . . 0.0 110.786 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.8 t -137.74 152.22 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.24 107.5 18.35 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.57 122.76 5.83 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.584 -0.697 . . . . 0.0 110.566 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.18 -24.33 9.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.824 -0.547 . . . . 0.0 110.188 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.96 177.92 36.24 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -61.42 -22.8 65.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.959 -0.73 . . . . 0.0 110.204 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.3 p -135.76 41.09 2.73 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.834 -0.541 . . . . 0.0 111.463 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.499 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -169.8 151.88 4.34 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.174 -0.954 . . . . 0.0 111.397 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.86 -178.73 22.42 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.09 116.08 19.43 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.896 -0.767 . . . . 0.0 111.773 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.66 142.71 17.71 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.43 -0.794 . . . . 0.0 110.514 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.9 mt -111.03 54.27 0.68 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 164.38 125.28 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.252 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -56.82 115.94 2.85 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 O-C-N 123.543 1.286 . . . . 0.0 110.72 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -122.31 141.63 35.09 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.752 . . . . 0.0 109.27 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -64.52 128.19 20.68 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.813 1.428 . . . . 0.0 110.383 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 p -62.84 -35.06 69.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.157 0.503 . . . . 0.0 110.061 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 m -48.71 -37.24 18.13 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.122 -0.986 . . . . 0.0 110.487 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -67.26 -38.34 84.97 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.9 mt -64.99 -36.13 83.4 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -63.85 123.18 18.28 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.97 -26.01 24.52 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.9 m -92.38 14.41 16.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.481 -1.011 . . . . 0.0 110.694 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.59 127.67 32.38 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.102 -0.999 . . . . 0.0 109.63 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.51 -7.12 26.38 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.45 136.2 50.81 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.07 123.59 5.72 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.745 1.392 . . . . 0.0 112.698 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.458 HD23 ' CD1' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -82.74 124.69 30.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.179 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.3 mt -124.34 116.19 22.2 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.955 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.419 ' HB2' ' CD ' ' A' ' 146' ' ' PRO . 19.9 p -73.41 177.76 1.85 Allowed Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.419 ' CD ' ' HB2' ' A' ' 145' ' ' CYS . 48.7 Cg_endo -62.36 179.73 0.6 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.297 1.156 . . . . 0.0 109.952 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.5 m 56.01 29.1 13.78 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.312 -0.867 . . . . 0.0 110.789 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 60.5 -145.09 47.43 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 21.1 m170 61.68 127.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.895 -0.768 . . . . 0.0 110.44 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.34 140.89 41.64 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.347 -0.846 . . . . 0.0 110.461 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 1.1 t -97.14 -43.41 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.407 ' HA2' ' CG1' ' A' ' 172' ' ' VAL . . . 178.53 -178.56 48.69 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.3 pp -116.93 150.31 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.063 -1.257 . . . . 0.0 111.397 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 5.3 t80 -63.0 115.13 4.14 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.014 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -102.05 -38.58 7.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -160.74 176.13 11.84 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -133.17 117.06 17.0 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.473 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.4 t -65.9 97.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.6 p -120.93 159.51 25.41 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 122.399 1.095 . . . . 0.0 113.888 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 162' ' ' GLY . 2.1 m -95.5 -173.78 2.99 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.65 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.438 -0.789 . . . . 0.0 112.567 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 82.8 -31.83 3.0 Favored Glycine 0 N--CA 1.499 2.888 0 O-C-N 121.205 -0.934 . . . . 0.0 111.748 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.25 131.64 39.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 119.144 1.472 . . . . 0.0 109.328 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -92.13 135.14 34.22 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.035 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -113.31 -44.19 3.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.555 -0.716 . . . . 0.0 111.135 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -121.84 179.45 4.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.129 -0.982 . . . . 0.0 109.868 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.58 151.17 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.421 -0.799 . . . . 0.0 110.818 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.68 91.04 3.45 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.499 ' CE1' ' N ' ' A' ' 123' ' ' ARG . 3.1 p90 -127.42 160.24 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.862 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.63 130.3 23.01 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.2 Cg_endo -60.67 154.05 57.59 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 124.14 1.6 . . . . 0.0 111.394 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.427 ' HA ' ' HG3' ' A' ' 175' ' ' MET . 25.2 m -79.47 1.05 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.6 -0.688 . . . . 0.0 110.789 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.22 -37.46 14.12 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 35.4 t -72.07 -36.25 69.49 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.119 0.485 . . . . 0.0 110.272 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.427 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 32.3 mtt -47.32 -36.94 10.07 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.69 -0.631 . . . . 0.0 111.08 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -48.02 -36.59 13.13 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.694 -0.629 . . . . 0.0 111.915 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.0 t -48.64 -39.07 22.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.542 -0.724 . . . . 0.0 112.841 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.426 HG23 ' CZ3' ' A' ' 53' ' ' TRP . 6.4 t -56.92 -38.49 72.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.116 -0.99 . . . . 0.0 112.213 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.443 ' HE2' ' CH2' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -57.5 -40.07 77.88 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.596 -1.315 . . . . 0.0 110.362 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -38.4 91.01 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.956 0.884 . . . . 0.0 108.905 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.76 66.1 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.909 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.518 -0.739 . . . . 0.0 109.913 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -168.73 78.84 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.8 . . . . 0.0 109.375 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.55 -68.77 0.07 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.467 ' C ' ' CG2' ' A' ' 33' ' ' VAL . 3.5 pt-20 -164.92 -48.78 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.963 . . . . 0.0 110.832 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.578 ' CG2' ' HA ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -164.09 -161.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.929 -1.107 . . . . 0.0 112.738 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -143.08 167.1 22.89 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.462 0.649 . . . . 0.0 110.117 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.98 147.03 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.415 ' CG1' HD23 ' A' ' 64' ' ' LEU . 28.0 m -98.48 -179.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 m -134.69 138.88 44.8 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.968 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 p -132.99 -175.99 3.97 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.1 102.99 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.357 -0.84 . . . . 0.0 110.551 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.5 p 47.47 43.76 16.04 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.202 0.525 . . . . 0.0 111.554 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.47 153.13 21.01 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.709 -0.619 . . . . 0.0 111.128 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 p -139.85 139.48 36.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.504 -0.748 . . . . 0.0 109.25 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 37.2 m-85 -105.02 -179.26 3.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.164 -0.96 . . . . 0.0 111.802 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.34 140.64 50.98 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.605 -0.684 . . . . 0.0 110.445 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.464 ' C ' HG13 ' A' ' 33' ' ' VAL . . . -119.45 -177.56 3.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.41 -0.806 . . . . 0.0 109.747 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.578 ' HA ' ' CG2' ' A' ' 33' ' ' VAL . 3.4 t -157.85 113.91 2.82 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.185 -0.947 . . . . 0.0 111.513 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.436 ' N ' HG12 ' A' ' 33' ' ' VAL . 24.3 p -70.62 105.73 3.24 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.947 -1.095 . . . . 0.0 111.434 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.44 ' HB ' ' CD1' ' A' ' 53' ' ' TRP . 17.6 t -124.39 127.93 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t30 60.48 17.83 7.66 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.365 -0.834 . . . . 0.0 109.722 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.05 19.79 52.05 Favored Glycine 0 N--CA 1.499 2.894 0 O-C-N 121.109 -0.994 . . . . 0.0 111.088 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.406 ' O ' ' CD1' ' A' ' 53' ' ' TRP . 47.3 t -136.18 105.84 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.114 -1.227 . . . . 0.0 109.638 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.4 p -59.75 103.37 0.2 Allowed 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.309 -0.87 . . . . 0.0 109.794 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.494 ' CH2' ' HE3' ' A' ' 179' ' ' MET . 95.9 m95 -82.75 150.96 26.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.998 -1.064 . . . . 0.0 111.416 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.422 ' CG2' ' CZ2' ' A' ' 85' ' ' TRP . 7.7 t -158.61 155.23 27.87 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.41 HG13 ' CG ' ' A' ' 57' ' ' HIS . 20.7 t -80.83 144.57 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.232 -0.917 . . . . 0.0 109.676 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 28.8 t80 -78.08 4.75 11.58 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.049 -1.032 . . . . 0.0 112.134 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.41 ' CG ' HG13 ' A' ' 55' ' ' VAL . 16.2 m170 -45.51 -39.63 7.59 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.292 -0.88 . . . . 0.0 111.54 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.416 ' HA3' ' CZ ' ' A' ' 43' ' ' PHE . . . -167.68 28.18 0.16 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.57 -166.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.262 -1.14 . . . . 0.0 109.632 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.22 90.77 0.81 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.6 p -71.2 -10.09 59.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.497 -1.002 . . . . 0.0 110.082 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -118.79 -153.39 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 110.506 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.5 t -59.69 90.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.477 -0.764 . . . . 0.0 110.937 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.415 HD23 ' CG1' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.21 173.15 0.9 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.322 -0.861 . . . . 0.0 109.392 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.43 132.21 55.16 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.206 -0.934 . . . . 0.0 110.314 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.88 -178.82 24.26 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -57.9 -20.38 44.09 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.78 1.41 . . . . 0.0 110.507 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 24.71 12.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.534 -0.729 . . . . 0.0 109.809 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.6 -106.51 2.43 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -76.35 120.39 5.62 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.753 1.396 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.407 ' CD1' HD21 ' A' ' 64' ' ' LEU . 75.5 mt -75.19 146.15 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 m -90.64 92.95 9.06 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.442 -0.786 . . . . 0.0 111.06 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -61.63 107.92 0.89 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.675 -0.641 . . . . 0.0 109.406 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 mmt -113.9 -26.81 7.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.576 -0.702 . . . . 0.0 111.042 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CD2' ' CE ' ' A' ' 179' ' ' MET . 7.5 m-85 -122.57 118.31 27.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.417 -0.802 . . . . 0.0 109.738 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.475 ' CG2' ' CD1' ' A' ' 56' ' ' TYR . 5.4 m -155.29 122.99 5.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.635 -0.666 . . . . 0.0 110.779 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -142.11 76.65 1.55 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.28 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.43 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.4 p -49.5 -32.62 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.595 -0.691 . . . . 0.0 109.69 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.59 -47.72 73.01 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.7 -0.625 . . . . 0.0 109.671 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -93.06 17.27 11.11 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.981 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 52.29 52.47 14.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.214 -0.929 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.476 ' CD1' ' HG2' ' A' ' 175' ' ' MET . 1.5 mt -161.44 151.69 17.42 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.031 0.919 . . . . 0.0 112.343 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 53' ' ' TRP . 58.1 t -156.76 146.03 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -142.45 115.28 0.94 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.008 -1.568 . . . . 0.0 112.18 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.422 ' CZ2' ' CG2' ' A' ' 54' ' ' THR . 1.5 m0 -97.98 167.2 11.05 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -81.22 134.71 35.66 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.387 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.05 91.17 3.5 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.214 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 53.5 Cg_endo -101.9 -10.24 0.2 Allowed 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.595 1.313 . . . . 0.0 112.726 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 46.5 Cg_endo -72.84 67.52 3.92 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 115.735 -2.377 . . . . 0.0 110.678 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 53.79 23.24 21.24 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.4 135.79 44.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -1.005 . . . . 0.0 110.736 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -61.35 -168.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.771 -0.581 . . . . 0.0 109.68 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 t -147.0 103.97 3.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.54 -0.725 . . . . 0.0 109.386 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 mt -79.66 -160.77 0.28 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.618 -0.676 . . . . 0.0 109.907 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.416 HG22 ' CD2' ' A' ' 149' ' ' HIS . 5.2 t -161.01 153.46 17.16 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.754 -0.591 . . . . 0.0 109.452 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.79 143.43 73.71 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 O-C-N 123.517 1.272 . . . . 0.0 111.727 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 25.0 t -64.94 159.45 22.86 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.432 0.634 . . . . 0.0 110.416 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 t -159.19 33.95 0.2 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.448 0.642 . . . . 0.0 109.339 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.2 p -117.85 -167.73 1.39 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.664 -0.648 . . . . 0.0 110.336 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -124.49 29.88 4.87 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.3 m -91.94 171.87 8.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.587 -0.949 . . . . 0.0 109.998 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.8 m -127.4 -35.2 2.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.51 -0.743 . . . . 0.0 111.634 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.85 119.07 9.3 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.347 -0.846 . . . . 0.0 110.593 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 mt -115.37 -174.46 2.51 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.211 -0.931 . . . . 0.0 110.42 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -139.85 87.25 2.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.0 tp -64.62 99.39 0.31 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.47 114.48 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.833 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.3 p -71.86 -179.82 2.86 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.33 16.28 13.69 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.072 -1.017 . . . . 0.0 110.67 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -124.78 41.4 3.52 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.216 -0.927 . . . . 0.0 109.754 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.62 68.15 0.9 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.486 -0.758 . . . . 0.0 111.499 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -155.1 109.17 2.9 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.654 -0.654 . . . . 0.0 110.589 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.4 t -106.14 137.52 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.772 -0.58 . . . . 0.0 109.69 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.3 pt -131.74 131.15 22.56 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 109.126 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.07 140.51 60.1 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.835 1.439 . . . . 0.0 111.779 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.0 t -136.03 144.59 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.12 119.43 38.73 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -49.73 126.96 14.95 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.263 -0.898 . . . . 0.0 110.032 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.96 -33.14 7.0 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.013 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -169.08 58.52 0.2 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.415 -1.374 . . . . 0.0 110.414 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.1 OUTLIER 64.35 -72.82 0.06 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.728 -0.866 . . . . 0.0 110.056 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 120' ' ' GLY . 3.8 p -92.44 40.02 1.04 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 121.162 0.506 . . . . 0.0 110.39 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.435 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 13.8 ttm180 -168.33 154.79 7.34 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.42 -0.8 . . . . 0.0 110.252 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.49 -178.62 23.76 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.55 118.33 22.82 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 122.048 -0.678 . . . . 0.0 111.819 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 145.31 52.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.695 -0.628 . . . . 0.0 109.794 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.2 mt -115.38 55.23 0.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 170.32 125.33 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -63.67 103.49 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.757 1.399 . . . . 0.0 109.843 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.91 149.59 42.71 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.407 -0.808 . . . . 0.0 109.207 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.07 127.33 15.79 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.819 1.431 . . . . 0.0 110.604 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.01 -37.08 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.829 -0.544 . . . . 0.0 110.166 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.33 -35.73 19.23 Favored 'General case' 0 N--CA 1.506 2.36 0 CA-C-O 122.082 0.944 . . . . 0.0 110.535 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.425 ' CD2' HD22 ' A' ' 135' ' ' LEU . 21.2 t80 -67.66 -38.93 84.47 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.425 HD22 ' CD2' ' A' ' 134' ' ' TYR . 14.3 mt -64.02 -35.79 81.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -57.9 131.31 50.01 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.71 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.8 -25.74 26.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.9 m -90.0 4.17 50.96 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -1.081 . . . . 0.0 111.486 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.5 p -56.87 121.91 10.99 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.967 -1.083 . . . . 0.0 111.025 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.83 -15.15 9.02 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.27 139.22 48.31 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.714 -1.755 . . . . 0.0 108.714 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.87 123.14 6.65 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.921 1.485 . . . . 0.0 113.691 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.41 HD23 ' CD1' ' A' ' 169' ' ' PHE . 1.7 mp -79.03 116.91 19.62 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.35 117.75 33.34 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.82 -1.152 . . . . 0.0 113.081 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.0 p -56.99 173.69 0.31 Allowed Pre-proline 0 N--CA 1.5 2.064 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.809 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -76.66 72.44 5.64 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.714 1.376 . . . . 0.0 109.907 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.37 -46.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.62 -0.675 . . . . 0.0 110.26 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 135.36 -28.27 3.03 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.416 ' CD2' HG22 ' A' ' 95' ' ' THR . 0.3 OUTLIER -74.99 129.61 37.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.523 -0.986 . . . . 0.0 110.194 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -59.07 138.75 57.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.669 -0.644 . . . . 0.0 110.112 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.457 HG13 ' CE2' ' A' ' 169' ' ' PHE . 0.9 OUTLIER -99.61 -33.1 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.462 ' HA2' ' N ' ' A' ' 172' ' ' VAL . . . 176.92 -178.44 48.13 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.19 139.93 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.354 -1.086 . . . . 0.0 111.016 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 5.3 t80 -53.34 118.58 3.93 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.92 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -107.59 -41.06 5.14 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.439 -0.788 . . . . 0.0 109.6 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -154.08 167.59 29.3 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -124.95 116.46 22.22 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.659 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.56 100.75 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.5 p -125.25 154.91 40.93 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.648 1.213 . . . . 0.0 114.119 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.479 ' N ' ' O ' ' A' ' 163' ' ' VAL . 2.0 m -92.2 -172.3 3.08 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -45.94 88.91 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.402 -0.811 . . . . 0.0 111.727 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 72.63 -15.08 2.28 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.101 -1.0 . . . . 0.0 112.509 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.7 t -101.14 135.85 35.55 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.351 0 CA-C-N 118.948 1.374 . . . . 0.0 109.286 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -97.59 124.78 41.99 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.747 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -108.2 -41.28 4.94 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.607 -0.683 . . . . 0.0 110.545 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -126.48 166.78 16.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 109.358 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.42 162.01 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.839 0.828 . . . . 0.0 111.28 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.65 99.28 4.91 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.457 ' CE2' HG13 ' A' ' 151' ' ' VAL . 5.1 p90 -135.9 159.63 41.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.007 -1.058 . . . . 0.0 111.567 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 82' ' ' LEU . 1.2 m -103.75 144.68 29.16 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 37.1 Cg_endo -61.9 155.17 56.52 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.092 1.575 . . . . 0.0 111.917 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.462 ' N ' ' HA2' ' A' ' 152' ' ' GLY . 4.3 t -82.75 -2.11 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.504 -0.747 . . . . 0.0 109.709 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -81.96 -38.43 25.19 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.6 t -57.64 -36.79 72.32 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.806 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.476 ' HG2' ' CD1' ' A' ' 82' ' ' LEU . 8.4 mtt -49.93 -39.2 39.46 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.563 -0.71 . . . . 0.0 109.348 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 179' ' ' MET . 2.0 mt-10 -66.18 -38.11 87.27 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.8 m -64.98 -38.75 91.99 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -37.08 81.36 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.494 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 34.5 tpp -61.79 -53.44 55.87 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.723 -0.611 . . . . 0.0 110.329 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.12 -38.77 62.92 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.366 -0.834 . . . . 0.0 110.915 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -55.94 -38.11 69.87 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.431 -0.793 . . . . 0.0 110.926 -179.754 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 120.992 0.425 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.92 78.41 0.29 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.248 -0.907 . . . . 0.0 109.384 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.59 14.29 0.05 OUTLIER Glycine 0 N--CA 1.498 2.805 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.427 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 55.98 6.73 0.24 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.858 -1.378 . . . . 0.0 113.433 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -152.23 151.98 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 120.455 -1.403 . . . . 0.0 110.151 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -150.44 143.26 24.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.734 -0.604 . . . . 0.0 110.05 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.15 174.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.482 0.658 . . . . 0.0 110.712 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.9 m -131.76 -178.18 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -147.84 136.05 21.37 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.0 p -143.78 -179.11 6.26 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.67 76.11 0.6 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.911 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m 177.31 -61.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -179.39 -159.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.612 -0.68 . . . . 0.0 109.262 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.3 t -117.58 139.72 50.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.503 -0.748 . . . . 0.0 109.928 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -102.18 -178.54 3.73 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.569 -0.707 . . . . 0.0 111.617 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.401 ' CD2' ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -111.69 151.7 28.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.608 -0.683 . . . . 0.0 111.351 -178.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -159.55 145.01 15.74 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.654 -0.654 . . . . 0.0 109.351 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.2 t -117.86 127.38 53.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.162 -0.961 . . . . 0.0 112.036 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 87.4 m -78.77 82.78 4.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.531 -0.73 . . . . 0.0 110.467 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.8 t -98.59 139.2 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 56.12 20.41 4.41 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.343 -0.848 . . . . 0.0 110.027 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.6 24.49 53.43 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.9 t -138.81 103.97 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -1.212 . . . . 0.0 110.612 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.7 t -58.2 96.61 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.538 -0.726 . . . . 0.0 110.022 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.475 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 79.5 m95 -76.07 145.34 40.17 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.325 -0.859 . . . . 0.0 110.331 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.409 HG22 HG21 ' A' ' 83' ' ' VAL . 2.7 t -163.08 176.43 10.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.574 -0.704 . . . . 0.0 109.787 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.431 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 13.6 m -104.42 138.19 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.563 -0.711 . . . . 0.0 109.986 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.465 ' CB ' ' HB ' ' A' ' 78' ' ' VAL . 1.6 t80 -73.79 -12.07 60.58 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.007 -1.058 . . . . 0.0 111.357 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.431 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 4.7 p-80 -83.63 -0.95 52.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.151 -0.968 . . . . 0.0 110.229 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.53 74.84 0.21 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.35 -72.1 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.466 -1.02 . . . . 0.0 110.123 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.85 -161.96 32.25 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.4 p -167.15 -163.52 0.54 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.725 -0.867 . . . . 0.0 109.702 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt 51.5 -164.2 0.06 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.421 -0.8 . . . . 0.0 110.72 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -56.7 90.35 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.512 -0.742 . . . . 0.0 110.615 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.408 ' CD1' ' CZ2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -63.9 162.26 14.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.705 -0.622 . . . . 0.0 110.295 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.23 142.74 48.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.632 -0.667 . . . . 0.0 110.313 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -124.83 -179.4 15.7 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.84 -6.91 20.19 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.972 1.512 . . . . 0.0 111.493 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.66 29.57 1.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.045 . . . . 0.0 110.382 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.61 176.51 14.44 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.25 155.79 68.15 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.852 1.449 . . . . 0.0 109.9 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.8 mt -100.79 119.54 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.558 -0.714 . . . . 0.0 109.786 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -61.4 135.14 57.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.609 -0.682 . . . . 0.0 110.703 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -94.51 115.11 27.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 109.415 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.3 mmm -124.81 -34.88 2.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.525 -0.735 . . . . 0.0 110.866 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.468 ' CD2' ' CE ' ' A' ' 179' ' ' MET . 15.5 m-85 -118.35 108.45 15.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.389 -0.819 . . . . 0.0 109.661 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 1.6 m -149.1 114.46 5.54 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.544 -0.862 . . . . 0.0 112.407 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -148.03 75.66 1.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.872 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.465 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 8.2 p -54.97 -22.48 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.465 -0.772 . . . . 0.0 111.098 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -60.67 83.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.732 -0.605 . . . . 0.0 110.962 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 49.45 26.39 1.65 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.515 -0.741 . . . . 0.0 111.461 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.12 -95.32 0.45 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.937 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.467 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 8.4 tp 177.72 164.21 0.62 Allowed 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.548 -1.345 . . . . 0.0 110.824 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 16.4 m -135.02 122.99 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.12 133.93 4.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.408 ' CZ2' ' CD1' ' A' ' 64' ' ' LEU . 1.3 m-90 -100.55 168.91 9.42 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -80.23 136.52 36.48 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.586 -0.845 . . . . 0.0 109.844 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -108.94 92.94 11.52 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.874 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.568 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.5 Cg_endo -102.35 -11.69 0.16 Allowed 'Trans proline' 0 CA--C 1.551 1.354 0 O-C-N 123.911 1.48 . . . . 0.0 112.847 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 51.2 Cg_endo -71.2 75.8 1.79 Allowed 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 116.058 -2.162 . . . . 0.0 111.104 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.83 25.13 21.95 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.71 139.44 43.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.942 . . . . 0.0 110.574 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.3 tpt85 -75.34 140.3 42.97 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.7 p -104.66 103.15 12.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.348 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -158.37 0.25 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.55 -169.44 0.22 Allowed Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.567 -0.708 . . . . 0.0 109.878 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -93.81 159.48 2.28 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 O-C-N 123.69 1.363 . . . . 0.0 111.521 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 0.5 OUTLIER -108.65 133.51 52.66 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.667 -0.646 . . . . 0.0 109.94 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 m -139.56 91.33 2.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.612 -0.68 . . . . 0.0 109.953 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 29.7 m -132.95 -162.28 1.22 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.47 -0.769 . . . . 0.0 109.927 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.73 31.42 2.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.88 -151.1 0.47 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.685 -0.891 . . . . 0.0 110.168 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.8 p -149.78 -147.97 0.25 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 0.0 109.881 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.6 t0 58.06 105.24 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.126 -0.984 . . . . 0.0 110.794 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.18 -168.45 1.77 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.407 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 79.7 m-85 -142.3 93.04 2.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.492 -0.755 . . . . 0.0 110.728 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.4 ' CD1' ' CD1' ' A' ' 143' ' ' LEU . 7.0 tp -60.09 92.59 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.7 t -84.5 101.95 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.331 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.415 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 21.8 p -67.4 155.86 37.95 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.401 ' CB ' ' CD2' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -78.18 3.9 13.99 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.028 -1.045 . . . . 0.0 111.126 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.447 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -101.91 31.52 3.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.972 -1.08 . . . . 0.0 109.055 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 61.42 74.55 0.44 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.519 -0.738 . . . . 0.0 110.67 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.61 119.47 0.88 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.606 -0.684 . . . . 0.0 110.528 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.407 ' CG1' ' HB3' ' A' ' 105' ' ' TYR . 71.5 t -98.13 143.34 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.537 -0.727 . . . . 0.0 109.768 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 114' ' ' ILE . 14.4 mt -130.68 109.89 15.93 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -58.05 134.16 60.31 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 O-C-N 123.655 1.345 . . . . 0.0 111.929 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.1 t -127.78 142.98 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.644 -0.66 . . . . 0.0 109.525 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.58 121.29 43.21 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -48.68 130.41 17.41 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.38 -0.825 . . . . 0.0 110.917 -178.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -102.95 -49.43 3.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.804 -0.56 . . . . 0.0 110.654 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.84 60.23 0.11 Allowed Glycine 0 N--CA 1.498 2.796 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.757 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.37 145.35 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.787 -0.831 . . . . 0.0 109.222 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.406 ' CA ' ' O ' ' A' ' 169' ' ' PHE . 17.5 p 44.63 27.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.737 -0.602 . . . . 0.0 112.122 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.47 ' N ' ' CD2' ' A' ' 169' ' ' PHE . 0.4 OUTLIER -170.37 144.26 2.47 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.125 -0.984 . . . . 0.0 110.219 178.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.26 -177.79 16.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.21 123.14 40.12 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 122.045 -0.679 . . . . 0.0 111.743 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.09 130.7 45.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.565 -0.709 . . . . 0.0 109.492 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.5 mt -101.06 53.62 0.84 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.86 118.45 0.14 Allowed Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.333 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -60.31 106.86 0.37 Allowed 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.61 1.321 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.6 mtt-85 -125.75 146.41 54.99 Favored Pre-proline 0 N--CA 1.49 1.54 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.089 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.24 129.31 23.8 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 124.098 1.578 . . . . 0.0 110.604 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 p -56.96 -36.01 49.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.848 -0.532 . . . . 0.0 110.163 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -49.14 -36.85 20.27 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.232 -0.918 . . . . 0.0 110.603 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.46 ' CD2' HD22 ' A' ' 135' ' ' LEU . 7.4 t80 -64.43 -38.9 92.65 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.46 HD22 ' CD2' ' A' ' 134' ' ' TYR . 8.7 mt -67.4 -35.92 80.26 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -56.39 111.87 1.1 Allowed 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.939 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.27 -34.37 4.73 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.7 m -79.86 -2.72 44.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.676 -0.896 . . . . 0.0 110.808 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.1 m -57.37 126.6 28.02 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.181 -0.95 . . . . 0.0 110.447 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.12 -9.22 31.37 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.88 -175.98 0.31 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -114.57 124.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.489 1.258 . . . . 0.0 112.527 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.443 HD23 ' CD2' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -83.34 126.35 32.61 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 176.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.16 121.06 31.74 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.709 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 14.7 p -69.29 -173.27 0.2 Allowed Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.424 ' CD ' ' HB2' ' A' ' 145' ' ' CYS . 49.9 Cg_endo -71.65 66.92 3.01 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.562 1.296 . . . . 0.0 110.422 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.86 -165.7 0.38 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.551 -0.718 . . . . 0.0 110.123 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -110.24 48.57 0.92 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -136.41 128.69 30.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.606 -0.937 . . . . 0.0 109.927 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.34 121.83 16.15 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.496 -0.752 . . . . 0.0 109.918 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 0.9 OUTLIER -78.24 -44.5 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.415 ' N ' HG22 ' A' ' 172' ' ' VAL . . . -179.6 -178.31 48.34 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.406 HG12 ' CE ' ' A' ' 175' ' ' MET . 1.0 OUTLIER -111.73 154.79 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-N 118.838 1.319 . . . . 0.0 111.988 179.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 7.6 t80 -69.17 83.3 0.35 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.8 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -64.06 -49.91 70.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.618 -0.676 . . . . 0.0 109.595 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -155.78 -179.19 7.88 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.04 121.82 22.1 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.874 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.69 104.49 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.416 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 27.3 p -129.43 142.58 50.76 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -175.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 162' ' ' GLY . 5.9 t -76.26 -174.58 2.85 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.54 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.325 -0.859 . . . . 0.0 112.937 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 85.99 -27.32 5.54 Favored Glycine 0 N--CA 1.498 2.771 0 O-C-N 121.204 -0.935 . . . . 0.0 112.316 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.0 OUTLIER -96.55 136.91 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 119.108 1.454 . . . . 0.0 109.82 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.416 ' HA ' ' CB ' ' A' ' 159' ' ' CYS . . . -103.57 125.65 50.23 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.604 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -111.62 -34.37 6.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.654 -0.653 . . . . 0.0 111.224 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.8 176.77 6.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.077 -1.014 . . . . 0.0 110.946 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.407 HG11 ' CE1' ' A' ' 154' ' ' PHE . 0.6 OUTLIER -123.52 140.92 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 111.596 -178.575 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -106.48 100.24 9.77 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.47 ' CD2' ' N ' ' A' ' 123' ' ' ARG . 0.5 OUTLIER -129.8 157.87 41.02 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.071 -1.052 . . . . 0.0 113.748 -176.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.9 p -111.87 128.09 25.93 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 45.0 Cg_endo -57.68 156.37 27.72 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 O-C-N 123.775 1.408 . . . . 0.0 111.752 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.479 ' HA ' ' HE1' ' A' ' 175' ' ' MET . 97.9 t -79.37 -1.66 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.611 -0.681 . . . . 0.0 110.08 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -86.08 -37.66 18.61 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.1 m -72.08 -38.61 69.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.861 -0.525 . . . . 0.0 110.021 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.479 ' HE1' ' HA ' ' A' ' 172' ' ' VAL . 14.8 mtt -50.93 -38.79 52.37 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.542 -0.724 . . . . 0.0 109.711 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -62.87 -39.99 96.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 35.1 m -57.86 -38.51 75.84 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.31 -35.01 35.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.844 -0.535 . . . . 0.0 109.739 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.475 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 9.5 mmt -48.04 -53.63 15.69 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.46 -0.775 . . . . 0.0 110.847 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.02 -37.45 45.32 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.989 0.899 . . . . 0.0 109.846 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.77 95.11 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.013 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.47 -179.809 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -154.6 76.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.636 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 44.58 66.56 1.37 Allowed Glycine 0 N--CA 1.5 2.911 0 O-C-N 121.933 -0.48 . . . . 0.0 111.911 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.08 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.418 -1.048 . . . . 0.0 111.432 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.1 t -150.91 153.83 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.227 -0.92 . . . . 0.0 111.724 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -144.84 136.37 25.41 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -98.81 168.68 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.82 0.819 . . . . 0.0 111.632 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.493 HG13 ' CH2' ' A' ' 85' ' ' TRP . 28.2 m -125.91 -179.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -145.43 135.99 24.27 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.251 -0.905 . . . . 0.0 110.95 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.5 p -142.74 177.79 8.08 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.42 75.87 0.55 Allowed 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.254 -0.979 . . . . 0.0 108.684 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 173.69 -57.16 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.57 -170.13 0.1 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.42 -0.8 . . . . 0.0 109.65 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 86.0 p -111.22 140.75 45.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.706 -0.621 . . . . 0.0 110.431 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 27.4 m-85 -102.08 175.51 5.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.467 -0.771 . . . . 0.0 109.944 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.422 ' CG ' ' HB3' ' A' ' 109' ' ' ARG . 5.5 tt -109.96 143.92 39.21 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.42 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -147.21 131.53 17.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.927 -1.108 . . . . 0.0 110.311 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.4 t -100.02 127.81 46.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.254 -0.904 . . . . 0.0 112.462 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 85.8 m -82.89 95.07 7.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.375 -0.828 . . . . 0.0 110.747 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.5 t -103.86 133.09 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t30 62.22 11.4 4.41 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.422 -0.799 . . . . 0.0 110.681 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.62 30.61 8.91 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.023 -1.048 . . . . 0.0 111.167 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.4 t -147.2 105.81 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -1.187 . . . . 0.0 109.257 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.17 109.56 0.61 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.498 -0.751 . . . . 0.0 109.485 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.472 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 92.7 m95 -91.23 141.8 28.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.671 -0.643 . . . . 0.0 110.435 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.449 HG23 ' CH2' ' A' ' 85' ' ' TRP . 5.2 t -161.27 -179.78 7.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.457 -0.777 . . . . 0.0 110.319 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 m -102.18 145.12 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.596 -0.69 . . . . 0.0 110.497 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.432 ' N ' HG22 ' A' ' 83' ' ' VAL . 42.9 t80 -78.02 1.72 20.01 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.113 -0.992 . . . . 0.0 112.301 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -49.78 -24.85 2.59 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 121.163 -0.961 . . . . 0.0 110.684 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.448 ' O ' ' CE1' ' A' ' 43' ' ' PHE . . . -177.89 39.83 0.09 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.41 25.96 4.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.331 -1.099 . . . . 0.0 111.009 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.56 -164.39 41.47 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.1 t -136.84 -80.38 0.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.762 -0.846 . . . . 0.0 110.074 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -118.47 -33.46 4.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.198 -0.939 . . . . 0.0 111.305 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -93.31 89.57 6.43 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.116 0.484 . . . . 0.0 111.721 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.4 HD12 ' CE2' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -101.28 172.8 6.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.51 -0.744 . . . . 0.0 109.751 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.6 130.97 57.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.681 -0.637 . . . . 0.0 110.136 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.59 179.24 16.73 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -55.17 103.82 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 O-C-N 123.652 1.343 . . . . 0.0 110.628 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.1 tttp 54.37 30.05 11.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.505 -0.747 . . . . 0.0 111.22 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.43 134.87 2.1 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -58.85 169.8 3.16 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 O-C-N 123.729 1.383 . . . . 0.0 110.82 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.2 mt -106.93 134.5 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.395 -0.816 . . . . 0.0 108.976 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.5 p -74.69 -174.61 2.18 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.278 -0.889 . . . . 0.0 111.032 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -123.15 166.43 15.21 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.606 -0.684 . . . . 0.0 109.973 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.435 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 6.4 tpt -169.54 -37.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.156 -0.965 . . . . 0.0 111.453 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 74' ' ' MET . 14.4 m-85 -131.84 111.53 11.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.472 -0.768 . . . . 0.0 109.103 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.49 114.2 4.34 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.035 -1.066 . . . . 0.0 113.013 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -160.54 76.52 0.59 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.729 -0.607 . . . . 0.0 110.45 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.422 ' CG1' ' HB3' ' A' ' 56' ' ' TYR . 7.3 p -74.74 -17.3 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.1 -1.0 . . . . 0.0 111.128 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.73 -25.17 17.45 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.129 -0.982 . . . . 0.0 110.244 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -176.11 34.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.748 -0.595 . . . . 0.0 110.144 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -156.03 -89.44 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.997 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.465 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 6.8 tp 179.14 177.29 0.53 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.718 -1.239 . . . . 0.0 110.125 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.432 HG22 ' N ' ' A' ' 56' ' ' TYR . 21.6 m -146.58 121.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -154.09 144.08 10.82 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.493 ' CH2' HG13 ' A' ' 36' ' ' VAL . 1.1 m-90 -108.2 167.83 9.73 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -69.5 137.52 52.62 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.879 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.55 97.0 15.26 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.721 -0.612 . . . . 0.0 111.144 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.7 Cg_endo -111.21 10.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 117.178 -1.415 . . . . 0.0 113.061 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 55.7 Cg_endo -67.58 -108.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 116.587 -1.809 . . . . 0.0 107.75 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.79 32.47 7.39 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 106.559 -2.616 . . . . 0.0 106.559 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.62 152.69 45.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.383 -1.069 . . . . 0.0 111.058 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -125.14 17.16 8.43 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.784 -0.572 . . . . 0.0 110.735 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.8 t 49.98 97.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.288 -0.883 . . . . 0.0 112.536 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.19 -143.16 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.555 -0.715 . . . . 0.0 110.13 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 t -169.61 153.3 5.04 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 120.897 -1.127 . . . . 0.0 110.657 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.45 160.37 46.95 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.741 1.39 . . . . 0.0 111.173 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.9 t -95.6 112.12 23.9 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.1 p -75.1 -44.05 49.53 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.4 p -65.48 149.42 50.07 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.325 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -111.2 40.43 2.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.99 146.13 51.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.687 -0.89 . . . . 0.0 109.703 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 m -77.69 -159.17 0.14 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.664 -0.648 . . . . 0.0 110.929 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.7 t70 52.43 95.08 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.652 -0.655 . . . . 0.0 111.171 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.6 168.81 9.45 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.371 -0.83 . . . . 0.0 110.025 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -117.4 86.43 2.51 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.644 -0.66 . . . . 0.0 109.571 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.435 ' CD1' ' CD1' ' A' ' 143' ' ' LEU . 9.5 tp -54.45 98.85 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.445 -0.785 . . . . 0.0 109.838 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 37.4 t -81.68 109.65 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.239 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.44 ' HB ' ' NE2' ' A' ' 110' ' ' HIS . 18.7 p -74.58 177.52 6.0 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HB3' ' CG ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -95.06 28.1 2.93 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.913 -1.117 . . . . 0.0 110.819 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.463 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 1.4 p80 -150.31 46.17 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.916 0.865 . . . . 0.0 109.537 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 49.08 63.47 2.12 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.425 0.631 . . . . 0.0 111.674 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.46 92.37 2.08 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.1 t -81.0 144.04 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.176 -0.952 . . . . 0.0 110.123 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.2 mt -128.97 114.99 18.89 Favored Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -59.35 134.42 58.63 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.781 1.411 . . . . 0.0 111.516 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.5 149.33 30.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -114.25 111.7 21.94 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -48.12 121.61 4.44 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.749 0.785 . . . . 0.0 110.276 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.9 -37.51 5.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.963 -0.46 . . . . 0.0 110.406 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.81 -170.07 26.03 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -62.56 140.9 58.65 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.831 -0.806 . . . . 0.0 109.568 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.0 p 44.46 42.55 5.57 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.275 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.441 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 3.9 ttp85 -164.32 153.75 13.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.337 -0.852 . . . . 0.0 111.392 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.88 -179.58 21.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.39 130.9 55.54 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 122.072 -0.663 . . . . 0.0 111.116 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.75 128.9 36.9 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.355 -0.84 . . . . 0.0 109.383 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 mt -103.71 54.57 0.74 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 p 174.95 107.09 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -57.56 103.63 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 O-C-N 123.598 1.315 . . . . 0.0 109.168 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -124.63 159.03 59.94 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.986 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.413 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 50.1 Cg_endo -72.54 129.58 14.89 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 124.077 1.567 . . . . 0.0 109.255 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 162' ' ' GLY . 10.1 p -55.7 -35.71 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.387 -0.82 . . . . 0.0 109.879 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.3 t -48.85 -36.67 17.47 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.401 -0.812 . . . . 0.0 110.504 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.42 ' CD2' HD22 ' A' ' 135' ' ' LEU . 19.8 t80 -63.4 -39.24 93.98 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 154' ' ' PHE . 15.9 mt -66.2 -34.78 78.81 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.58 126.3 24.73 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.858 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.26 -31.8 8.31 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.1 m -84.04 3.14 35.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.822 -0.811 . . . . 0.0 110.525 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.2 m -49.77 127.04 15.19 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.289 -0.882 . . . . 0.0 109.731 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 116.22 -17.24 14.75 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 107.031 -2.428 . . . . 0.0 107.031 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.4 ' HA2' HD23 ' A' ' 44' ' ' LEU . . . -45.66 110.24 0.43 Allowed Glycine 0 N--CA 1.501 2.987 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.16 126.62 14.64 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.933 1.491 . . . . 0.0 111.9 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.435 ' CD1' ' CD1' ' A' ' 106' ' ' LEU . 9.0 mp -80.56 135.43 36.08 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.89 111.91 11.99 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.389 -0.924 . . . . 0.0 112.172 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.441 ' HB3' HG23 ' A' ' 151' ' ' VAL . 27.7 p -69.9 163.53 59.78 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.933 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 46.9 Cg_endo -62.72 86.31 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.769 1.405 . . . . 0.0 110.136 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.9 -48.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.637 -0.664 . . . . 0.0 109.47 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.04 23.43 3.27 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -131.44 147.09 52.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.401 -1.058 . . . . 0.0 109.554 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.43 122.14 16.87 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.497 -0.752 . . . . 0.0 110.723 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 145' ' ' CYS . 2.1 t -84.47 -37.88 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 169' ' ' PHE . . . 178.43 -179.09 48.72 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.5 pt -117.12 156.77 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 CA-C-N 118.923 1.362 . . . . 0.0 111.841 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 135' ' ' LEU . 9.9 t80 -75.56 85.78 2.64 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.602 0.715 . . . . 0.0 111.203 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -70.91 -49.29 47.35 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -147.78 177.65 9.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -131.67 119.86 21.97 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.967 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.4 99.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.403 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 28.7 p -126.08 140.57 52.48 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.9 OUTLIER -74.34 -174.77 2.1 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.78 82.93 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 86.01 -26.95 5.73 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.033 -1.042 . . . . 0.0 110.91 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -93.83 135.99 26.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 118.981 1.391 . . . . 0.0 108.631 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.403 ' HA ' ' CB ' ' A' ' 159' ' ' CYS . . . -97.53 129.78 44.65 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.876 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -113.09 -44.87 3.22 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.452 -0.78 . . . . 0.0 111.174 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -123.82 -178.95 4.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.451 -0.78 . . . . 0.0 109.766 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' ' 154' ' ' PHE . 1.3 t -120.32 164.07 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.45 -0.781 . . . . 0.0 110.647 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -128.69 94.8 3.94 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.441 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 0.7 OUTLIER -126.53 146.1 50.26 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.718 -174.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.458 HG12 ' CD1' ' A' ' 82' ' ' LEU . 2.7 p -99.81 131.69 24.16 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 42.9 Cg_endo -56.42 154.98 27.23 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 O-C-N 123.756 1.398 . . . . 0.0 111.412 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.406 HG22 ' N ' ' A' ' 152' ' ' GLY . 42.6 t -84.44 2.78 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.366 -0.833 . . . . 0.0 109.748 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -91.75 -39.06 12.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.592 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.6 t -72.13 -44.33 63.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.809 -0.557 . . . . 0.0 110.75 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.436 ' HB3' HD23 ' A' ' 82' ' ' LEU . 2.8 ptp -53.76 -37.86 63.84 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.233 -0.917 . . . . 0.0 110.536 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -56.39 -37.84 70.69 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.999 0.904 . . . . 0.0 108.961 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.4 m -62.37 -35.01 77.81 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.96 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.468 HG23 ' CZ3' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -47.22 -37.52 10.5 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.41 -0.806 . . . . 0.0 111.455 -178.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.472 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -51.83 -46.12 64.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.234 -0.916 . . . . 0.0 110.323 178.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.45 -38.22 58.76 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.096 0.95 . . . . 0.0 110.018 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.87 65.38 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.087 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.7 t . . . . . 0 N--CA 1.5 2.065 0 O-C-N 121.517 -0.74 . . . . 0.0 111.166 179.492 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.5 m . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 121.554 0.693 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 174.1 77.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 25.68 53.19 0.06 OUTLIER Glycine 0 N--CA 1.51 3.589 0 C-N-CA 123.548 0.594 . . . . 0.0 113.529 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -164.21 -67.36 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.485 1.143 . . . . 0.0 112.669 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.4 t -138.04 158.77 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 122.25 1.024 . . . . 0.0 112.971 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -143.93 137.85 28.09 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.435 ' CG1' ' CD ' ' A' ' 109' ' ' ARG . 32.6 m -108.41 -179.78 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 122.152 0.977 . . . . 0.0 112.664 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.3 m -139.29 -179.36 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.2 p -149.91 138.09 20.43 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.541 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.2 p -139.45 179.16 6.71 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.471 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -73.43 72.42 1.34 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.815 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 39' ' ' ALA . 72.1 m -175.4 -59.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 179.77 -163.22 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.72 -0.612 . . . . 0.0 109.525 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 p -117.99 143.66 46.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.258 -0.901 . . . . 0.0 110.151 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.462 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 42.7 m-85 -99.81 -178.47 3.87 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.268 -0.895 . . . . 0.0 110.855 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.415 HD23 ' HA2' ' A' ' 141' ' ' GLY . 5.5 tt -114.32 142.44 46.31 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.409 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -147.45 131.22 16.99 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.804 -1.185 . . . . 0.0 110.805 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 t -97.84 123.48 41.82 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.34 -0.85 . . . . 0.0 111.865 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 26.4 p -78.98 83.63 5.06 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.796 0.808 . . . . 0.0 110.368 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.3 t -102.02 145.65 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 54.56 23.69 4.81 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.76 31.1 56.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.2 t -147.02 111.38 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.176 -1.191 . . . . 0.0 110.483 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 49.3 m -60.83 115.62 3.82 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.474 -0.766 . . . . 0.0 109.294 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.463 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 76.2 m95 -94.49 140.82 29.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.354 -0.841 . . . . 0.0 111.206 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.424 HG23 ' CH2' ' A' ' 85' ' ' TRP . 4.5 t -161.95 -178.58 6.54 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.465 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 12.5 t -104.0 144.82 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.426 -0.796 . . . . 0.0 109.671 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -74.34 -1.0 18.93 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.882 -1.137 . . . . 0.0 112.597 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.465 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 1.5 p-80 -70.08 -8.69 51.48 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.912 -1.118 . . . . 0.0 111.169 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.429 ' HA3' ' CE2' ' A' ' 43' ' ' PHE . . . -137.63 -134.08 3.2 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 54.51 174.6 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.481 -1.011 . . . . 0.0 111.01 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.09 112.4 4.46 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.0 p -56.09 173.28 0.16 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.442 -1.034 . . . . 0.0 110.388 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 tttp 58.17 -161.5 0.24 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.317 -0.864 . . . . 0.0 110.482 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -55.24 97.3 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.506 -0.747 . . . . 0.0 110.954 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.99 174.65 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.724 -0.61 . . . . 0.0 110.613 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.2 137.29 54.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.49 -0.756 . . . . 0.0 110.613 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.12 179.38 20.47 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.0 -21.82 73.09 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.815 1.429 . . . . 0.0 110.957 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -154.31 36.57 0.43 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.361 -0.837 . . . . 0.0 109.937 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 156.62 150.4 5.65 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.1 158.43 51.97 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.889 1.468 . . . . 0.0 110.483 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.6 mt -99.94 117.51 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.705 -0.622 . . . . 0.0 109.392 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 t -59.95 119.83 8.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.5 -0.75 . . . . 0.0 110.372 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 140.97 54.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.65 -0.656 . . . . 0.0 109.973 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.408 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 6.5 tpt -131.01 -41.16 1.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.641 -0.662 . . . . 0.0 110.395 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.44 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 20.7 m-85 -133.15 126.42 31.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.569 -0.707 . . . . 0.0 110.126 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 m -151.2 113.92 4.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.717 . . . . 0.0 110.407 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.9 76.92 1.53 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.479 -0.889 . . . . 0.0 111.018 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.42 -26.86 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -42.6 80.28 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -96.18 20.15 10.73 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.34 46.88 24.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.406 -0.809 . . . . 0.0 111.842 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.421 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 1.9 tp -161.87 141.68 10.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.359 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.4 m -143.58 111.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -105.69 102.53 1.99 Allowed Glycine 0 N--CA 1.486 2.014 0 C-N-CA 119.613 -1.279 . . . . 0.0 111.431 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.424 ' CH2' HG23 ' A' ' 54' ' ' THR . 1.8 m-90 -82.0 167.01 19.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.4 ' O ' ' CD ' ' A' ' 88' ' ' PRO . 8.0 mt-30 -80.58 140.45 35.76 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.441 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.75 89.94 2.05 Favored Pre-proline 0 C--N 1.301 -1.539 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.545 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.588 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 46.5 Cg_endo -96.62 -14.83 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.731 1.385 . . . . 0.0 112.618 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 46.9 Cg_endo -71.29 87.97 0.74 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 116.216 -2.056 . . . . 0.0 111.281 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 49.07 21.44 2.53 Favored Glycine 0 N--CA 1.5 2.944 0 O-C-N 121.402 -0.812 . . . . 0.0 111.368 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.52 148.3 49.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.304 -1.115 . . . . 0.0 109.734 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -106.48 12.07 30.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.454 -0.779 . . . . 0.0 111.576 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 t 46.7 103.58 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.486 -0.759 . . . . 0.0 112.906 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.56 -150.21 0.15 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.267 -0.896 . . . . 0.0 109.855 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 p -156.06 177.91 1.88 Allowed Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.206 -0.934 . . . . 0.0 110.897 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -90.6 169.77 3.79 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 O-C-N 123.79 1.416 . . . . 0.0 111.014 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.443 ' CB ' ' HA ' ' A' ' 151' ' ' VAL . 39.3 t -93.06 -73.64 0.55 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.69 -0.631 . . . . 0.0 110.023 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m 56.1 42.82 27.88 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.385 -0.822 . . . . 0.0 109.071 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.0 p -126.42 -163.55 1.24 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.899 -0.5 . . . . 0.0 110.596 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.97 70.13 0.39 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t -128.37 -8.11 5.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.541 -0.976 . . . . 0.0 111.677 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.6 m 53.78 -162.68 0.11 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.012 -1.055 . . . . 0.0 111.029 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.79 100.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.617 -0.677 . . . . 0.0 110.605 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mt -115.86 153.99 30.52 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.02 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -105.17 94.35 5.19 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.401 HD13 ' CD1' ' A' ' 143' ' ' LEU . 8.8 tp -62.98 93.66 0.06 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.4 t -80.94 112.8 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.892 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.404 HG23 ' CE1' ' A' ' 110' ' ' HIS . 8.7 m -78.38 172.89 12.96 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.435 ' CD ' ' CG1' ' A' ' 35' ' ' VAL . 19.1 tpt180 -85.51 -8.85 58.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 111.021 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.493 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -107.55 41.42 1.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 110.046 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.48 71.44 0.52 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.376 -0.827 . . . . 0.0 110.676 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -156.4 98.37 1.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.777 -0.577 . . . . 0.0 110.284 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.6 t -99.71 135.57 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.489 -0.757 . . . . 0.0 110.121 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.4 pt -127.07 140.52 38.06 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.85 142.3 51.68 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 O-C-N 123.687 1.362 . . . . 0.0 112.044 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.26 151.36 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -106.2 105.6 15.71 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -48.89 123.02 6.36 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 122.036 0.922 . . . . 0.0 111.81 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -115.72 -26.79 7.29 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.72 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.21 161.06 32.7 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -51.49 -26.87 9.07 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.311 -1.111 . . . . 0.0 110.776 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -124.41 38.81 4.11 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.046 0.45 . . . . 0.0 110.364 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.468 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 4.1 ttt180 -166.82 156.82 11.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.343 -0.848 . . . . 0.0 110.528 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.47 -178.43 28.82 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.96 113.68 18.14 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.857 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.92 130.99 49.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.535 -0.728 . . . . 0.0 109.463 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.6 mt -105.6 54.66 0.7 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.7 t 177.83 114.03 0.16 Allowed Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.095 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -58.27 102.98 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.731 0 O-C-N 123.478 1.251 . . . . 0.0 109.979 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 mtt-85 -119.01 160.73 39.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.233 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 43.3 Cg_endo -73.93 127.66 11.66 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 124.058 1.557 . . . . 0.0 109.956 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.82 -37.5 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.806 -0.559 . . . . 0.0 110.571 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -48.87 -36.46 17.08 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 122.038 0.923 . . . . 0.0 110.783 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 25.3 t80 -66.13 -38.41 88.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 13.0 mt -65.34 -35.96 82.57 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -63.67 -21.4 66.36 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.559 -0.856 . . . . 0.0 110.649 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.04 30.37 10.23 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 85.2 p -150.7 21.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.566 -0.961 . . . . 0.0 111.453 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.7 p -56.07 132.91 51.42 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.152 -0.968 . . . . 0.0 109.04 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.9 -19.2 28.22 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 44' ' ' LEU . . . -43.85 100.79 0.02 OUTLIER Glycine 0 N--CA 1.504 3.207 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 153' ' ' ILE . 44.2 Cg_endo -63.76 128.23 21.61 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.996 1.524 . . . . 0.0 112.243 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.445 ' CD2' ' CD1' ' A' ' 169' ' ' PHE . 9.8 mp -84.26 119.76 25.43 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.5 130.26 56.82 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.686 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 31.6 p -74.05 168.27 27.78 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.235 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.63 76.66 1.07 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 O-C-N 123.739 1.389 . . . . 0.0 110.751 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.6 t -173.4 -57.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.326 -0.858 . . . . 0.0 110.345 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.57 -42.75 0.63 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.432 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER -59.27 123.5 16.94 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.729 -0.865 . . . . 0.0 110.083 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.34 145.33 55.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.66 . . . . 0.0 110.064 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 2.4 t -94.8 -37.23 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.644 -0.66 . . . . 0.0 109.478 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.13 -178.08 48.24 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 142' ' ' PRO . 1.8 pp -117.06 157.15 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.363 -1.081 . . . . 0.0 110.983 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 6.1 t80 -68.85 119.26 12.92 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.73 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -107.01 -41.13 5.26 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.406 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -161.28 179.98 7.89 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . . . -141.65 128.29 20.29 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.492 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.32 99.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 72.8 m -115.9 159.86 20.98 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.461 1.124 . . . . 0.0 113.351 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 162' ' ' GLY . 1.8 m -98.3 -174.83 2.94 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.405 ' O ' ' CG ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -47.88 83.8 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.456 -0.778 . . . . 0.0 112.708 -179.138 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 83.06 -32.31 3.02 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.846 -1.159 . . . . 0.0 111.443 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.97 131.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 119.098 1.449 . . . . 0.0 108.944 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.41 ' CB ' ' CD1' ' A' ' 135' ' ' LEU . . . -91.68 132.71 36.17 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.713 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -113.86 -46.78 3.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.649 -0.657 . . . . 0.0 111.045 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.46 179.08 4.16 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.259 -0.901 . . . . 0.0 110.405 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 t -115.47 162.24 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.464 -0.772 . . . . 0.0 110.599 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.27 84.45 2.08 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.468 ' CE1' ' N ' ' A' ' 123' ' ' ARG . 2.6 p90 -119.97 163.19 17.97 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.054 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.6 p -111.14 130.52 22.91 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 40.5 Cg_endo -60.57 159.41 28.06 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 124.063 1.559 . . . . 0.0 111.468 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.44 ' HA ' ' HG3' ' A' ' 175' ' ' MET . 96.3 t -77.36 -3.88 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -84.57 -37.75 20.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 0.0 108.692 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.9 t -70.3 -38.12 74.92 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.76 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.44 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 19.4 mtt -49.91 -38.83 37.76 Favored 'General case' 0 N--CA 1.516 2.866 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -52.94 -38.73 62.26 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.497 0.665 . . . . 0.0 109.854 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.2 m -51.82 -38.07 54.29 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.405 0.621 . . . . 0.0 109.767 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.09 -42.37 80.6 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.65 -0.656 . . . . 0.0 110.02 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.463 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -56.19 -49.69 73.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.458 -0.776 . . . . 0.0 110.585 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -37.35 61.72 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.93 0.871 . . . . 0.0 109.804 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -78.54 -39.65 37.26 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.919 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.218 0 O-C-N 121.35 -0.844 . . . . 0.0 110.647 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.452 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 7.7 p . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -161.65 78.58 0.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.124 0.964 . . . . 0.0 110.618 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 45.46 -93.66 0.01 OUTLIER Glycine 0 N--CA 1.496 2.685 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.363 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -90.42 -29.8 17.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.73 -0.865 . . . . 0.0 112.729 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.3 t -125.97 162.38 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 120.942 -1.099 . . . . 0.0 112.554 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -153.46 135.67 14.87 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.418 ' CG1' ' HB2' ' A' ' 109' ' ' ARG . 11.2 m -91.89 177.7 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 120.932 -1.105 . . . . 0.0 112.53 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.471 HG23 ' CD2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -135.97 172.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.55 -179.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -160.7 138.36 9.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.453 -0.779 . . . . 0.0 111.008 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 40' ' ' THR . 6.2 t -153.42 179.55 8.68 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.466 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -71.01 72.72 0.59 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.815 -1.154 . . . . 0.0 108.772 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 39' ' ' ALA . 23.3 m -175.24 -61.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -177.24 -168.16 0.19 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.839 -0.538 . . . . 0.0 109.867 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.5 p -125.05 128.01 47.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.658 -0.651 . . . . 0.0 109.251 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -108.12 -177.43 3.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.143 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 45' ' ' ALA . 6.1 tt -107.9 149.94 27.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.343 -0.848 . . . . 0.0 109.687 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.452 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -139.77 136.01 33.66 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.217 -0.927 . . . . 0.0 109.391 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 46' ' ' THR . 4.6 t -107.29 116.7 32.39 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.3 -0.875 . . . . 0.0 112.522 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 84.3 m -72.11 83.0 0.99 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.319 -0.863 . . . . 0.0 110.175 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.5 t -107.28 139.5 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.0 t30 57.44 19.96 5.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.575 -0.703 . . . . 0.0 109.811 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.76 54.68 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.0 t -144.52 109.67 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.424 -1.045 . . . . 0.0 110.089 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.0 p -61.4 97.03 0.06 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.702 -0.624 . . . . 0.0 110.136 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.486 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 98.4 m95 -76.43 150.29 36.76 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.089 -1.007 . . . . 0.0 110.302 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.439 HG23 ' CH2' ' A' ' 85' ' ' TRP . 7.9 t -164.03 -178.59 5.7 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.972 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.0 m -97.25 139.16 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.562 -0.712 . . . . 0.0 110.076 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.455 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 31.9 t80 -76.33 0.05 20.82 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.306 -0.871 . . . . 0.0 111.313 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -49.2 -33.33 12.19 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.415 -0.803 . . . . 0.0 110.871 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.81 -14.0 1.93 Allowed Glycine 0 N--CA 1.496 2.667 0 C-N-CA 119.754 -1.213 . . . . 0.0 111.875 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 43' ' ' PHE . . . -52.32 -34.38 46.75 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.787 -1.42 . . . . 0.0 110.983 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.84 168.81 4.41 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.6 t -96.94 -19.65 18.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.521 -0.987 . . . . 0.0 110.19 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -57.33 179.0 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.56 0.695 . . . . 0.0 110.768 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.47 103.91 2.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.678 -0.639 . . . . 0.0 110.094 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.442 HD12 ' CZ2' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -53.43 160.98 1.07 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.694 -0.629 . . . . 0.0 110.192 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.1 133.09 50.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.804 . . . . 0.0 110.602 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.87 -177.5 14.9 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -59.05 96.17 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 O-C-N 123.77 1.405 . . . . 0.0 110.279 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.63 37.86 29.13 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.367 -0.833 . . . . 0.0 110.443 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.97 136.5 2.44 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.035 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.58 153.22 78.77 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 124.081 1.569 . . . . 0.0 109.685 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.7 mt -100.45 116.76 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.336 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -59.92 126.79 28.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.565 -0.709 . . . . 0.0 111.034 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -79.76 105.24 10.91 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 tpt -101.56 -32.17 10.5 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.23 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.407 ' CZ ' ' HG3' ' A' ' 179' ' ' MET . 14.2 m-85 -130.15 115.63 17.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.696 -0.628 . . . . 0.0 110.084 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.455 ' CG2' ' CD1' ' A' ' 56' ' ' TYR . 18.4 m -161.06 107.5 1.43 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.146 -0.971 . . . . 0.0 112.839 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 5.0 m-80 -163.84 78.17 0.4 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.694 . . . . 0.0 109.917 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.404 ' CG1' ' CB ' ' A' ' 56' ' ' TYR . 34.9 m -51.39 -21.92 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.731 -1.231 . . . . 0.0 111.852 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.85 78.69 0.63 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.052 -1.03 . . . . 0.0 108.721 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 60.32 46.57 9.94 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.644 -0.66 . . . . 0.0 110.753 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -156.33 -33.21 0.09 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.217 -0.927 . . . . 0.0 111.859 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 175' ' ' MET . 5.7 tp 72.75 165.62 0.3 Allowed 'General case' 0 N--CA 1.526 3.343 0 CA-C-N 120.217 1.371 . . . . 0.0 111.075 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 1.4 m -122.21 147.79 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.94 110.04 0.42 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.442 ' CZ2' HD12 ' A' ' 64' ' ' LEU . 1.2 m-90 -86.6 169.62 12.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -81.98 138.45 34.92 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.482 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -107.0 82.52 1.12 Allowed Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.401 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.566 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 48.0 Cg_endo -98.81 -6.8 0.63 Allowed 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.575 1.303 . . . . 0.0 112.977 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 40.4 Cg_endo -73.24 63.23 4.32 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 115.592 -2.472 . . . . 0.0 111.269 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.96 52.91 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.452 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . . . -72.19 129.48 38.57 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.247 -1.149 . . . . 0.0 111.206 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -68.46 136.15 52.79 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.223 -0.991 . . . . 0.0 108.619 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -103.21 115.43 30.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.49 -0.757 . . . . 0.0 110.292 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mp -85.92 -164.1 0.98 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.495 0.664 . . . . 0.0 110.513 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.64 173.83 4.13 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.778 -0.576 . . . . 0.0 110.343 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.91 166.16 30.8 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 O-C-N 123.657 1.346 . . . . 0.0 110.551 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 6.8 t -84.68 -49.99 8.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.727 -0.608 . . . . 0.0 109.656 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.8 p 45.06 37.33 2.45 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.813 -0.554 . . . . 0.0 111.041 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.6 p -122.78 -162.03 0.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.492 -0.755 . . . . 0.0 110.172 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.27 74.55 0.37 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m -150.72 165.11 34.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.719 -0.871 . . . . 0.0 110.184 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.8 t -112.31 -154.89 0.55 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.52 -0.737 . . . . 0.0 110.588 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 57.86 99.35 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.207 -0.933 . . . . 0.0 110.508 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.424 ' HB2' ' HB ' ' A' ' 116' ' ' VAL . 2.3 mt -116.11 -176.27 2.91 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.301 -0.874 . . . . 0.0 109.963 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -131.53 85.06 2.22 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.2 tp -61.13 89.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.457 -0.777 . . . . 0.0 109.039 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.41 101.37 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.186 -1.006 . . . . 0.0 109.638 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.421 HG22 ' HB2' ' A' ' 110' ' ' HIS . 7.4 t -75.73 179.7 5.27 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.43 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 16.4 ptt85 -95.3 17.07 15.11 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.12 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.483 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 6.3 m170 -103.36 21.17 16.43 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 59.12 56.36 3.95 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.363 -0.836 . . . . 0.0 109.816 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.41 ' O ' ' CG2' ' A' ' 108' ' ' THR . 11.6 t70 -166.86 121.88 1.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.688 -0.632 . . . . 0.0 109.881 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.4 m -104.1 145.36 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.993 -1.067 . . . . 0.0 109.608 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.0 pt -125.98 138.6 32.41 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.077 -1.015 . . . . 0.0 110.091 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -66.18 141.47 63.31 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 O-C-N 123.796 1.419 . . . . 0.0 112.201 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 58.4 t -132.59 138.47 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.679 -0.638 . . . . 0.0 109.65 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.58 117.71 35.26 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 -48.96 129.5 17.4 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.488 -0.757 . . . . 0.0 110.702 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.401 ' CG ' ' HB2' ' A' ' 125' ' ' SER . 5.5 mmm180 -109.8 -27.26 9.39 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.736 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.19 -150.05 7.43 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -77.16 127.58 32.88 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.734 -0.862 . . . . 0.0 108.822 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.38 45.39 28.6 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.127 0.489 . . . . 0.0 111.217 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.485 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -160.89 151.59 18.33 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.332 -0.855 . . . . 0.0 110.754 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.0 -177.05 17.64 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.0 OUTLIER -129.46 120.65 25.81 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.803 -0.822 . . . . 0.0 112.041 -178.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.48 141.25 52.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.436 -0.79 . . . . 0.0 109.001 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.7 mt -108.44 52.99 0.7 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.3 p 166.19 136.79 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.2 113.96 2.84 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.802 1.422 . . . . 0.0 109.81 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.66 147.32 47.76 Favored Pre-proline 0 N--CA 1.49 1.531 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.68 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.15 125.11 12.54 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 124.14 1.6 . . . . 0.0 110.055 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 p -58.86 -36.84 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.624 0.726 . . . . 0.0 109.684 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.1 m -49.13 -35.63 16.97 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 122.031 0.919 . . . . 0.0 110.936 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -70.07 -36.93 75.31 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 13.9 mt -63.58 -37.2 86.41 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -57.83 122.93 14.09 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.576 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.45 -31.64 8.48 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.9 m -79.96 0.19 32.54 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.487 -1.008 . . . . 0.0 111.152 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.8 p -48.42 134.04 15.55 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.225 -0.922 . . . . 0.0 110.714 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.74 -20.59 24.48 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 107.376 -2.29 . . . . 0.0 107.376 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.441 ' HA2' HD23 ' A' ' 44' ' ' LEU . . . -47.09 113.66 1.31 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.41 122.62 9.64 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 124.05 1.552 . . . . 0.0 111.726 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.468 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 6.4 mp -79.11 114.08 17.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 mt -110.15 121.85 46.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 111.492 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.445 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 29.5 p -60.81 178.32 0.27 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.93 -0.481 . . . . 0.0 109.932 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 55.1 Cg_endo -83.63 51.01 3.37 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.514 1.271 . . . . 0.0 111.227 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.84 43.75 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.182 -0.949 . . . . 0.0 110.456 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 61.14 -167.01 12.53 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.4 m170 56.48 106.02 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.567 -0.96 . . . . 0.0 110.671 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.44 153.63 12.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.192 -0.943 . . . . 0.0 109.982 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -105.07 -30.72 2.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.426 ' HA2' HG21 ' A' ' 172' ' ' VAL . . . 173.55 -177.15 46.03 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.424 HG13 ' CG1' ' A' ' 170' ' ' VAL . 1.2 pt -121.59 164.22 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 CA-C-N 119.24 1.52 . . . . 0.0 111.541 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 5.5 t80 -75.41 99.83 4.28 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.447 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -37.9 15.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -161.35 176.63 10.95 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -135.37 120.75 19.14 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.371 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.1 t -68.61 103.62 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 30.0 p -124.02 162.92 22.46 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.733 1.254 . . . . 0.0 114.06 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 162' ' ' GLY . 1.3 m -103.67 -172.56 2.13 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -46.38 90.07 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.677 0 O-C-N 121.396 -0.815 . . . . 0.0 111.623 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 72.25 -18.2 1.27 Allowed Glycine 0 N--CA 1.499 2.889 0 O-C-N 121.245 -0.91 . . . . 0.0 112.984 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.12 127.87 60.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 119.484 1.642 . . . . 0.0 109.527 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -89.66 137.82 32.0 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.052 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -117.94 -43.74 2.75 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.461 -0.775 . . . . 0.0 110.77 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 125' ' ' SER . . . -119.4 171.84 8.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.411 -0.806 . . . . 0.0 109.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.8 t -118.24 145.83 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.543 0.687 . . . . 0.0 110.865 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.94 100.28 9.27 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 177.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.485 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 0.4 OUTLIER -131.89 142.97 49.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.803 -1.159 . . . . 0.0 113.194 -175.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.424 ' CG1' HG13 ' A' ' 153' ' ' ILE . 2.9 p -94.09 133.45 27.46 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 49.4 Cg_endo -61.17 160.74 25.34 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.812 1.427 . . . . 0.0 110.859 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.426 HG21 ' HA2' ' A' ' 152' ' ' GLY . 40.1 t -82.41 1.56 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.294 -0.879 . . . . 0.0 109.602 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -93.08 -39.38 11.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.046 -1.034 . . . . 0.0 110.228 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.9 t -75.33 -40.05 58.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.72 -0.613 . . . . 0.0 110.305 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.478 ' HB2' HD21 ' A' ' 82' ' ' LEU . 4.0 ptp -55.75 -36.32 67.16 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.315 -0.866 . . . . 0.0 110.349 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -37.95 65.41 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.219 -0.926 . . . . 0.0 109.862 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.4 m -48.92 -38.96 24.35 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 175' ' ' MET . 7.6 t -49.91 -38.73 37.28 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 120.752 -1.217 . . . . 0.0 112.267 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.486 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -57.69 -35.14 70.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.814 -1.179 . . . . 0.0 111.462 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -47.41 -37.28 11.13 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.272 -0.892 . . . . 0.0 110.634 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.85 -45.55 10.2 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.103 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.504 2.247 0 O-C-N 121.096 -1.002 . . . . 0.0 111.176 179.515 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.501 2.099 0 CA-C-O 120.641 0.258 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 62.69 80.06 0.24 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.984 -1.072 . . . . 0.0 109.364 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.58 164.61 29.73 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -90.9 -28.1 18.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.669 -0.901 . . . . 0.0 110.94 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.5 143.86 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.476 -0.765 . . . . 0.0 111.248 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -137.13 175.74 9.34 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -148.56 177.96 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.23 -0.919 . . . . 0.0 111.173 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.75 -179.4 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 p -136.88 133.75 36.11 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.48 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.3 p -128.46 -176.42 3.82 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.94 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.201 -0.937 . . . . 0.0 110.959 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.0 p 49.1 39.95 16.3 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.842 -0.536 . . . . 0.0 111.005 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -155.03 137.87 15.36 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.661 -0.649 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.9 t -130.71 135.03 47.42 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.464 -0.773 . . . . 0.0 109.098 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -100.9 178.29 4.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.261 -0.899 . . . . 0.0 110.824 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.13 149.39 33.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.427 -0.796 . . . . 0.0 109.729 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.07 152.52 24.63 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.55 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.411 HG21 ' O ' ' A' ' 46' ' ' THR . 11.8 t -125.55 127.19 46.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.327 -0.858 . . . . 0.0 111.155 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.4 m -78.27 80.89 4.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.333 -0.854 . . . . 0.0 110.325 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.3 t -100.04 139.17 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.75 20.31 6.35 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.327 -0.858 . . . . 0.0 108.945 -177.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 23.13 60.07 Favored Glycine 0 N--CA 1.491 2.332 0 O-C-N 121.392 -0.817 . . . . 0.0 111.361 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -136.88 105.12 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 118.79 1.295 . . . . 0.0 110.557 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.5 t -58.4 101.44 0.08 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.68 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.46 ' CZ2' ' CE ' ' A' ' 179' ' ' MET . 52.8 m95 -82.19 144.98 30.33 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.479 -0.763 . . . . 0.0 112.177 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.444 ' CG2' ' CH2' ' A' ' 85' ' ' TRP . 3.4 t -165.23 128.66 2.28 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.4 m -49.61 153.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 O-C-N 121.26 -0.9 . . . . 0.0 111.349 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.465 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 57.1 t80 -76.4 1.31 16.72 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.159 -0.963 . . . . 0.0 111.643 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -49.24 -25.12 2.1 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.129 -0.982 . . . . 0.0 110.883 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.95 73.1 0.06 OUTLIER Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -156.01 -54.45 0.09 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.592 -0.946 . . . . 0.0 110.264 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.68 -1.6 90.24 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 p -74.16 144.88 44.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.191 -1.182 . . . . 0.0 110.242 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.0 tttm 55.04 -171.6 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.477 -0.765 . . . . 0.0 110.65 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m -86.92 101.95 13.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.611 -0.68 . . . . 0.0 110.287 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.46 HD12 ' CZ2' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -55.46 156.13 4.79 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.625 -0.672 . . . . 0.0 110.646 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.21 141.4 47.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.673 -0.642 . . . . 0.0 110.465 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.97 -178.44 15.41 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -56.14 95.76 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.766 1.403 . . . . 0.0 110.59 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.9 tttt 56.66 33.44 22.83 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.535 -0.728 . . . . 0.0 110.503 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.35 137.33 3.42 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.98 162.21 42.62 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 O-C-N 123.836 1.44 . . . . 0.0 109.769 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 73.6 mt -118.9 93.54 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.375 -0.828 . . . . 0.0 110.098 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 m -110.02 141.19 43.17 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.222 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -146.87 -144.92 0.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.794 -0.566 . . . . 0.0 109.799 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.8 ttp -145.65 22.82 1.45 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.985 -1.072 . . . . 0.0 111.179 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.434 ' CD1' ' HG3' ' A' ' 179' ' ' MET . 11.3 m-30 -115.85 101.85 9.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.328 -0.857 . . . . 0.0 110.139 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.465 ' CG2' ' CD1' ' A' ' 56' ' ' TYR . 3.0 m -150.88 121.33 7.37 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -142.83 78.09 1.6 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.344 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.432 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.7 p -52.76 -29.36 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.352 -0.842 . . . . 0.0 110.03 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.03 -50.65 69.85 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -86.59 5.98 33.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.772 -0.58 . . . . 0.0 109.786 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 56.72 54.17 7.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.254 -0.904 . . . . 0.0 112.601 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.401 ' CD1' HG12 ' A' ' 170' ' ' VAL . 1.2 tp -160.87 138.02 9.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.922 -1.112 . . . . 0.0 112.559 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.405 HG12 ' CB ' ' A' ' 76' ' ' THR . 21.9 t -143.67 139.26 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -145.09 123.61 1.96 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 118.14 -1.981 . . . . 0.0 112.585 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.46 ' CZ2' HD12 ' A' ' 64' ' ' LEU . 1.2 m-90 -99.75 137.51 38.12 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -58.45 131.3 50.31 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.69 0.757 . . . . 0.0 111.757 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.65 93.28 5.86 Favored Pre-proline 0 C--N 1.296 -1.753 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.09 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.2 Cg_endo -99.89 -14.95 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.863 1.454 . . . . 0.0 112.473 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 47.9 Cg_endo -69.42 78.7 0.88 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 116.235 -2.043 . . . . 0.0 111.062 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 50.09 26.47 8.96 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.08 138.46 37.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.618 -0.931 . . . . 0.0 110.229 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -68.93 145.58 53.52 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.412 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -111.67 92.62 4.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.611 -0.681 . . . . 0.0 109.513 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.14 -161.37 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.593 -0.692 . . . . 0.0 109.621 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.96 -176.28 0.57 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.718 -0.614 . . . . 0.0 109.959 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -85.61 158.12 10.64 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 O-C-N 123.814 1.429 . . . . 0.0 109.944 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.876 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 0.1 OUTLIER -109.81 86.71 2.35 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.509 -0.745 . . . . 0.0 110.709 -179.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.1 p -91.85 79.59 5.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.41 -0.806 . . . . 0.0 109.549 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 31.1 p -138.2 -151.51 0.39 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.64 -128.98 3.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m 54.67 -164.16 0.11 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.252 -1.146 . . . . 0.0 110.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.9 m -160.19 -35.3 0.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.355 -0.84 . . . . 0.0 111.779 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -60.68 134.31 56.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.21 -0.931 . . . . 0.0 110.787 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.08 -166.87 1.68 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.03 -1.043 . . . . 0.0 109.884 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -144.74 85.59 1.77 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.0 tp -65.84 109.66 2.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.315 -0.866 . . . . 0.0 109.279 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.1 t -100.69 128.27 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 111.582 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 33.2 p -94.55 166.49 12.01 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 109' ' ' ARG . 27.2 tpt85 -79.97 -7.52 58.84 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.199 -0.938 . . . . 0.0 110.724 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.39 41.53 1.3 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.979 -1.075 . . . . 0.0 110.037 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 50.63 63.52 2.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.558 -0.714 . . . . 0.0 111.329 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.36 82.61 1.42 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.643 -0.66 . . . . 0.0 110.021 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.7 p -92.94 149.96 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.493 -0.754 . . . . 0.0 110.93 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.6 pt -145.16 144.72 24.41 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.226 -0.921 . . . . 0.0 110.018 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -78.07 135.41 13.82 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.805 1.424 . . . . 0.0 110.909 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.415 ' CG1' ' HA3' ' A' ' 124' ' ' GLY . 46.4 t -122.01 146.28 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.552 -0.718 . . . . 0.0 109.38 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.17 115.05 29.72 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.01 129.21 17.27 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.505 -0.747 . . . . 0.0 111.047 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -114.73 -25.85 8.09 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.51 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -171.03 61.22 0.17 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.825 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.456 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.4 OUTLIER 60.13 -75.17 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.663 -0.904 . . . . 0.0 111.66 179.051 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 120' ' ' GLY . 9.4 p -91.97 39.82 1.03 Allowed 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.283 0.563 . . . . 0.0 111.579 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.05 151.22 2.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.415 ' HA3' ' CG1' ' A' ' 116' ' ' VAL . . . -143.25 -177.2 18.0 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -125.04 118.39 26.08 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.917 -178.328 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.35 141.78 34.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.591 -0.693 . . . . 0.0 110.112 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.2 mt -109.75 53.94 0.68 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 168.08 128.82 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.05 112.45 2.05 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.775 1.408 . . . . 0.0 110.022 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -125.72 143.81 46.26 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.254 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.49 128.46 23.64 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.987 1.52 . . . . 0.0 110.907 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.28 -36.73 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.482 0.658 . . . . 0.0 109.499 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.8 m -48.44 -36.53 15.08 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.372 -0.83 . . . . 0.0 110.979 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.512 ' CD2' HD22 ' A' ' 135' ' ' LEU . 0.1 OUTLIER -65.87 -38.58 89.19 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.512 HD22 ' CD2' ' A' ' 134' ' ' TYR . 14.8 mt -63.91 -35.49 80.82 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.08 121.7 10.63 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.584 -0.847 . . . . 0.0 109.788 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.34 -30.83 9.42 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.9 m -80.83 2.23 27.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.533 -0.981 . . . . 0.0 111.263 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 p -52.96 122.84 10.1 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.133 -0.979 . . . . 0.0 110.618 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 115.37 -9.71 19.98 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -59.86 152.35 35.9 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -93.82 129.64 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.697 1.367 . . . . 0.0 112.784 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.444 HD21 ' CD1' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -88.05 123.35 32.65 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 176.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.61 123.87 42.17 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.673 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.876 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 31.3 p -58.54 -170.95 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 48.6 Cg_endo -81.13 57.51 6.54 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 117.699 -1.068 . . . . 0.0 111.149 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.2 p -175.7 -158.13 0.06 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 149' ' ' HIS . . . -83.32 -160.18 29.12 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 148' ' ' GLY . 27.2 m170 57.73 133.17 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 117.789 0.795 . . . . 0.0 112.034 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.85 137.5 36.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.101 -0.999 . . . . 0.0 109.811 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.442 HG13 ' CE2' ' A' ' 169' ' ' PHE . 0.9 OUTLIER -81.83 -38.51 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.428 ' N ' HG22 ' A' ' 172' ' ' VAL . . . 177.16 -178.29 48.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.437 HG13 HG11 ' A' ' 170' ' ' VAL . 1.7 pp -118.76 150.8 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 118.67 1.235 . . . . 0.0 111.346 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 5.9 t80 -60.63 112.33 1.96 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.39 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -46.75 5.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -149.32 172.99 14.0 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -128.73 115.6 18.23 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.555 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.4 t -67.67 94.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.2 p -123.87 148.68 46.59 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.876 0.846 . . . . 0.0 113.279 -175.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 162' ' ' GLY . 2.3 m -88.59 -173.49 4.17 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.409 ' O ' ' CG ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -46.56 85.99 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.99 0.9 . . . . 0.0 112.829 -178.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 80.42 -26.1 3.12 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.994 -1.066 . . . . 0.0 112.321 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.35 129.91 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.088 1.444 . . . . 0.0 109.271 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.98 126.69 37.16 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.961 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -109.0 -35.87 6.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.483 -0.761 . . . . 0.0 110.638 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 125' ' ' SER . . . -134.3 176.36 8.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.816 . . . . 0.0 109.921 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.01 153.11 26.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-O 121.663 0.745 . . . . 0.0 110.85 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -120.53 93.93 4.2 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.456 ' CZ ' ' O ' ' A' ' 121' ' ' ASP . 3.5 p90 -124.85 156.38 37.94 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.954 -1.098 . . . . 0.0 113.099 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.437 HG11 HG13 ' A' ' 153' ' ' ILE . 4.7 p -100.15 130.62 25.69 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 39.2 Cg_endo -62.06 159.59 33.67 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.778 1.41 . . . . 0.0 110.97 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.478 ' HA ' ' HG3' ' A' ' 175' ' ' MET . 92.6 t -78.37 0.32 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.458 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -87.48 -37.65 16.77 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.838 0.828 . . . . 0.0 108.789 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 t -70.31 -37.21 74.71 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.28 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.478 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 14.9 mtt -49.12 -38.3 24.57 Favored 'General case' 0 N--CA 1.516 2.844 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -53.15 -38.34 62.63 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.29 -0.881 . . . . 0.0 108.968 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 m -55.47 -35.14 65.19 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.525 0.678 . . . . 0.0 109.452 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.403 ' CB ' ' O ' ' A' ' 175' ' ' MET . 31.0 m -48.02 -61.02 2.18 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.859 -0.526 . . . . 0.0 110.535 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.46 ' CE ' ' CZ2' ' A' ' 53' ' ' TRP . 0.8 OUTLIER -55.04 -38.13 67.57 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.628 -0.67 . . . . 0.0 110.763 179.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -48.94 -37.04 18.82 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.982 0.896 . . . . 0.0 110.337 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.03 36.76 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.239 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.503 2.177 0 O-C-N 121.218 -0.926 . . . . 0.0 110.649 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 121.382 0.611 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.84 79.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.91 53.82 4.7 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -164.47 -82.1 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.516 -0.99 . . . . 0.0 109.764 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 72.2 t -129.5 147.38 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.322 -0.861 . . . . 0.0 110.726 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -134.56 178.85 6.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.68 -0.637 . . . . 0.0 110.033 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -159.89 144.64 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.861 0.839 . . . . 0.0 110.01 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.8 m -116.74 -178.96 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.1 m -146.37 137.54 24.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.38 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.9 p -136.65 -178.88 5.37 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.53 74.27 0.77 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.68 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 m 174.55 -63.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -173.15 -173.64 0.95 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.507 -0.746 . . . . 0.0 110.564 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.5 p -107.61 146.34 32.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.713 -0.617 . . . . 0.0 110.302 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.506 ' CE1' ' CA ' ' A' ' 58' ' ' GLY . 93.1 m-85 -105.85 -177.48 3.37 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.316 -0.865 . . . . 0.0 111.855 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.411 ' CD2' ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -114.19 146.88 39.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.616 -0.678 . . . . 0.0 110.382 -178.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.33 166.73 30.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.58 -0.7 . . . . 0.0 110.685 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.45 HG23 ' CG2' ' A' ' 153' ' ' ILE . 8.8 t -141.93 115.34 8.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.722 . . . . 0.0 111.685 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 81.8 m -66.88 85.5 0.12 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.361 -0.837 . . . . 0.0 110.247 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.3 t -104.35 139.75 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 55.39 20.2 3.49 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.485 -0.76 . . . . 0.0 110.331 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.13 26.63 43.61 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.2 t -146.9 106.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.448 -1.031 . . . . 0.0 109.865 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.9 OUTLIER -61.8 119.98 9.81 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.484 -0.76 . . . . 0.0 109.259 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.471 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 95.7 m95 -99.75 153.62 18.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.44 -0.788 . . . . 0.0 111.807 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.9 t -162.89 -176.53 4.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.433 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 15.5 m -104.96 139.13 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.5 ' CB ' ' HB ' ' A' ' 78' ' ' VAL . 13.1 t80 -65.99 -7.14 15.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.182 -0.948 . . . . 0.0 113.022 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.433 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 14.6 p-80 -95.84 36.36 1.3 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.024 -1.048 . . . . 0.0 110.161 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.506 ' CA ' ' CE1' ' A' ' 43' ' ' PHE . . . -173.93 -81.41 0.05 OUTLIER Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.43 116.48 26.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.585 -0.95 . . . . 0.0 109.13 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.93 -60.22 0.49 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.8 t -55.16 170.69 0.19 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.232 -1.158 . . . . 0.0 110.597 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 58.91 168.74 0.06 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.479 -0.763 . . . . 0.0 110.053 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.418 ' O ' ' CG2' ' A' ' 63' ' ' THR . 9.0 t -78.03 101.06 6.75 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.699 0.762 . . . . 0.0 110.759 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.479 ' CD1' ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -61.91 168.49 3.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.362 -0.836 . . . . 0.0 109.496 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.69 130.16 50.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.46 -0.775 . . . . 0.0 110.739 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.88 179.86 19.29 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.12 -26.83 65.17 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.982 1.517 . . . . 0.0 110.994 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -143.48 27.49 1.54 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.386 -0.821 . . . . 0.0 111.082 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.23 154.85 8.03 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -64.23 168.64 12.18 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.957 1.504 . . . . 0.0 110.186 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.5 mt -127.25 98.27 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 O-C-N 121.392 -0.817 . . . . 0.0 110.371 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 m -161.86 51.52 0.22 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.264 -0.898 . . . . 0.0 111.064 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -168.18 66.66 0.07 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.047 -1.033 . . . . 0.0 111.473 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -143.03 -72.82 0.3 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.225 -0.922 . . . . 0.0 109.799 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.463 ' CE1' ' CG ' ' A' ' 179' ' ' MET . 22.5 m-85 -137.77 119.83 15.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.564 -0.71 . . . . 0.0 109.479 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 0.6 OUTLIER -151.87 112.58 4.19 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.375 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.441 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 41.4 t-20 -147.29 75.63 1.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.637 0.732 . . . . 0.0 110.018 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.5 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.3 p -44.99 168.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.497 -0.752 . . . . 0.0 112.166 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 57.51 114.48 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.679 0.752 . . . . 0.0 111.336 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 66.33 -66.73 0.17 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.593 -0.692 . . . . 0.0 111.999 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 77' ' ' ASN . 21.1 m-20 -63.99 -114.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 111.689 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.451 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 4.5 tp 176.94 174.09 0.42 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.182 -1.574 . . . . 0.0 111.286 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 56' ' ' TYR . 27.5 m -135.54 133.78 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.6 131.63 2.69 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.302 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.479 ' CZ2' ' CD1' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -95.42 161.2 14.18 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -79.52 135.27 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.812 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.55 93.38 4.93 Favored Pre-proline 0 C--N 1.298 -1.672 0 O-C-N 122.003 -0.436 . . . . 0.0 110.404 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.527 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 52.1 Cg_endo -92.44 -12.82 1.65 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 123.779 1.41 . . . . 0.0 113.782 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 43.0 Cg_endo -68.83 80.51 0.64 Allowed 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 115.931 -2.246 . . . . 0.0 111.738 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 49.49 24.6 5.6 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -53.63 133.32 41.59 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.315 -1.109 . . . . 0.0 110.133 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -94.87 -5.28 45.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.632 -0.668 . . . . 0.0 112.056 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 t 59.68 129.42 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 121.708 0.766 . . . . 0.0 110.813 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.412 ' CD2' HD23 ' A' ' 144' ' ' LEU . 12.7 tp -95.54 14.92 21.24 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.302 -0.874 . . . . 0.0 111.05 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.4 p 44.35 -169.26 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.853 -0.53 . . . . 0.0 112.176 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -112.86 -164.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 O-C-N 123.439 1.231 . . . . 0.0 111.179 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 1.268 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 43.4 t -110.66 -50.37 2.96 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.446 -0.784 . . . . 0.0 110.083 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 97' ' ' CYS . 9.6 t 38.45 30.46 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 1.268 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 28.0 p -116.32 -177.73 3.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 109.642 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.27 -18.93 27.28 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.6 t -51.18 138.99 19.32 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.221 -1.164 . . . . 0.0 111.363 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.3 m -109.78 -11.11 14.75 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.436 -0.79 . . . . 0.0 111.403 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.28 112.77 2.28 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.875 -1.141 . . . . 0.0 109.072 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.475 ' HB2' ' HB ' ' A' ' 116' ' ' VAL . 33.9 mt -112.31 170.29 8.27 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.558 0.694 . . . . 0.0 111.427 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -148.23 89.45 1.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 tp -59.56 111.46 1.42 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.487 -0.758 . . . . 0.0 109.123 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.8 t -92.99 97.1 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.551 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.425 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 80.6 p -65.59 152.38 44.25 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.411 ' CB ' ' CD2' ' A' ' 44' ' ' LEU . 1.6 tpm_? -74.25 -2.0 23.05 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.17 -0.956 . . . . 0.0 111.037 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.441 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -103.62 34.76 2.84 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.027 -1.046 . . . . 0.0 109.252 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.71 75.35 0.3 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.446 -0.783 . . . . 0.0 110.746 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.3 102.96 0.96 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.887 -0.508 . . . . 0.0 110.406 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.38 139.05 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.7 pt -129.55 131.4 23.56 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.01 137.19 43.67 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 O-C-N 123.581 1.306 . . . . 0.0 112.436 -177.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 62.1 t -127.14 148.25 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -113.72 120.91 42.45 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -48.7 128.27 15.05 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.676 -0.64 . . . . 0.0 110.429 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -109.02 -29.08 8.74 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.8 -0.562 . . . . 0.0 110.221 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.39 -159.45 22.96 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.36 127.81 33.72 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.701 -0.882 . . . . 0.0 109.373 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.411 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 0.0 OUTLIER 49.94 55.95 8.64 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 121.221 0.534 . . . . 0.0 111.492 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -172.84 149.75 2.0 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.438 -0.789 . . . . 0.0 111.061 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.95 -178.24 17.85 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.27 104.7 5.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.729 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 pp -49.37 151.32 1.54 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.817 -0.552 . . . . 0.0 110.319 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.8 mt -110.91 54.2 0.68 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.53 106.51 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -55.71 106.76 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 O-C-N 123.396 1.208 . . . . 0.0 110.283 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -109.76 175.61 1.87 Allowed Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.781 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 51.5 Cg_endo -79.9 124.99 5.8 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 124.139 1.599 . . . . 0.0 109.294 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 162' ' ' GLY . 7.2 p -62.39 -35.41 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.558 -0.714 . . . . 0.0 109.4 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.75 -36.77 17.16 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 122.111 0.958 . . . . 0.0 110.27 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.408 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 21.9 t80 -66.34 -38.73 88.31 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 17.9 mt -64.88 -35.84 82.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.37 119.2 4.86 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.704 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.5 -32.98 6.37 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.6 m -78.72 -4.68 50.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.625 -0.926 . . . . 0.0 111.454 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 2.4 m -50.39 125.28 12.31 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.003 -1.061 . . . . 0.0 111.045 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 113.83 -15.69 21.37 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.407 ' HA2' HD11 ' A' ' 44' ' ' LEU . . . -58.69 135.09 52.21 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -79.75 131.18 9.06 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.8 1.421 . . . . 0.0 113.011 -177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.1 mp -79.11 138.13 37.8 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -129.81 128.06 41.58 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.003 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 1.076 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 1.1 p -58.58 -109.25 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.104 0 CA-C-O 117.337 -1.316 . . . . 0.0 110.907 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 145' ' ' CYS . 47.2 Cg_endo -68.99 -84.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 114.35 -3.3 . . . . 0.0 110.307 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.9 m -153.79 99.86 2.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.797 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.1 -61.34 0.65 Allowed Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -58.9 124.41 19.76 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.699 -0.883 . . . . 0.0 111.24 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.27 140.88 38.84 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 2.5 t -108.62 -37.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.522 -0.736 . . . . 0.0 109.54 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.432 ' N ' HG12 ' A' ' 172' ' ' VAL . . . 174.19 -177.91 46.23 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.45 ' CG2' HG23 ' A' ' 46' ' ' THR . 3.2 pt -112.76 156.07 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 120.96 -1.318 . . . . 0.0 111.428 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 9.8 t80 -73.58 84.5 1.56 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.219 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -66.05 -52.25 50.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.584 -0.698 . . . . 0.0 109.901 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -150.13 178.81 8.62 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -131.01 115.91 17.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.136 -0.978 . . . . 0.0 110.313 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.2 t -63.46 101.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.403 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 26.3 p -129.57 139.53 51.46 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.6 OUTLIER -73.83 -173.79 1.63 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 176.143 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.57 84.16 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.333 -0.854 . . . . 0.0 112.801 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 87.42 -28.27 5.86 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 120.809 -1.182 . . . . 0.0 111.447 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.0 OUTLIER -92.49 133.92 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.86 -1.377 . . . . 0.0 110.022 -179.245 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.403 ' HA ' ' CB ' ' A' ' 159' ' ' CYS . . . -92.8 129.2 38.79 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.221 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -114.09 -21.5 10.5 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.474 -0.766 . . . . 0.0 111.318 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -151.27 -178.47 6.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.878 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.23 144.29 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 111.59 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.98 101.28 10.11 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.409 ' CE1' ' HA3' ' A' ' 152' ' ' GLY . 0.6 OUTLIER -130.63 148.15 52.39 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.33 -0.948 . . . . 0.0 113.019 -175.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.439 HG12 ' CD1' ' A' ' 82' ' ' LEU . 3.0 p -103.17 132.98 20.59 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 54.7 Cg_endo -60.38 153.66 58.56 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.796 1.419 . . . . 0.0 111.357 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 152' ' ' GLY . 35.9 m -80.3 0.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.452 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -89.9 -38.93 13.36 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.311 -0.868 . . . . 0.0 108.776 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 88.3 p -61.12 -36.37 79.54 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.45 ' SD ' ' CG ' ' A' ' 53' ' ' TRP . 19.7 mtt -48.13 -38.18 17.25 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-O 121.519 0.676 . . . . 0.0 109.649 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -56.11 -38.09 70.29 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -67.5 -39.73 85.18 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.738 0.78 . . . . 0.0 109.031 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.31 -41.5 63.01 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.807 -0.558 . . . . 0.0 110.543 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.471 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -49.56 -41.6 42.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.206 -0.934 . . . . 0.0 111.167 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -38.71 72.99 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.133 0.968 . . . . 0.0 109.322 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.37 82.98 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.512 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.333 -0.854 . . . . 0.0 111.142 179.664 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.259 0.552 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 62.37 78.58 0.29 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.063 -1.023 . . . . 0.0 108.859 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.95 -95.81 0.11 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -173.12 -36.01 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.275 -1.133 . . . . 0.0 111.629 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.0 t -113.52 155.34 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.187 -0.946 . . . . 0.0 110.92 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -141.16 148.78 40.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.592 -0.693 . . . . 0.0 110.231 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.404 ' CG1' ' HB2' ' A' ' 109' ' ' ARG . 31.4 m -106.78 -179.3 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.42 -0.8 . . . . 0.0 112.034 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.481 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 27.6 m -139.1 -178.33 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.5 p -156.2 136.62 13.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.582 -0.699 . . . . 0.0 110.054 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 40' ' ' THR . 8.0 t -152.83 -178.7 7.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.41 76.85 0.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.349 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER 174.03 -58.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 175.4 -176.41 0.1 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.269 -0.894 . . . . 0.0 109.948 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.8 t -112.49 127.87 56.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 109.358 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -107.37 -176.26 3.02 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.144 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 45' ' ' ALA . 6.6 tt -103.85 154.47 19.57 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.668 -0.645 . . . . 0.0 109.738 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.419 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -150.77 129.13 12.05 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.261 -0.899 . . . . 0.0 109.689 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.6 t -97.58 124.74 41.95 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.241 -0.912 . . . . 0.0 112.004 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.3 t -75.22 90.71 2.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.65 -0.656 . . . . 0.0 109.793 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.1 t -104.14 133.43 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.4 t30 57.34 20.61 6.01 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.471 -0.768 . . . . 0.0 110.032 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.97 25.08 38.85 Favored Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.225 -0.922 . . . . 0.0 110.887 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.443 ' O ' ' CD1' ' A' ' 53' ' ' TRP . 94.3 t -139.44 106.69 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.54 -0.977 . . . . 0.0 110.06 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.4 m -62.51 114.67 3.67 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.262 -0.899 . . . . 0.0 108.854 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.51 ' CZ3' HG23 ' A' ' 178' ' ' THR . 98.8 m95 -96.8 146.89 24.49 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.409 -0.807 . . . . 0.0 112.682 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.473 ' CG2' ' CH2' ' A' ' 85' ' ' TRP . 4.5 t -164.31 141.71 6.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 m -57.71 148.12 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.029 -1.045 . . . . 0.0 109.812 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 47.3 t80 -72.99 -1.07 15.64 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.008 -1.057 . . . . 0.0 111.715 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -49.8 -28.1 5.87 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.209 -0.932 . . . . 0.0 110.397 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.31 -46.83 0.16 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' CE1' ' A' ' 56' ' ' TYR . . . -49.49 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.404 -1.057 . . . . 0.0 110.831 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.66 175.36 22.25 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.2 p -93.57 -7.51 43.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.702 -0.881 . . . . 0.0 110.783 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -59.53 -167.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.152 -0.967 . . . . 0.0 110.856 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.3 m -83.97 101.77 11.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.742 -0.598 . . . . 0.0 109.705 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.428 HD11 ' CE2' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -57.72 173.51 0.29 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.579 -0.701 . . . . 0.0 110.139 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.94 132.75 53.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.524 -0.735 . . . . 0.0 110.876 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.03 -179.46 37.2 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.15 -18.39 64.76 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.767 1.404 . . . . 0.0 110.797 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -159.86 31.47 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 110.235 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.01 161.43 12.35 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.53 159.37 36.71 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.957 1.504 . . . . 0.0 110.403 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.1 mt -91.54 153.96 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 110.351 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.5 p -89.45 167.29 13.12 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.497 -0.752 . . . . 0.0 110.698 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 53.0 -179.21 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.381 -0.824 . . . . 0.0 110.359 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.6 ttp -176.37 51.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.332 -0.855 . . . . 0.0 109.902 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -55.9 131.7 47.77 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.267 -0.896 . . . . 0.0 109.108 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.432 ' CG2' ' CD1' ' A' ' 56' ' ' TYR . 3.7 m -156.91 118.13 3.72 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.458 -0.897 . . . . 0.0 112.323 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 49.3 m-20 -145.64 76.66 1.48 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.829 0.823 . . . . 0.0 109.076 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.416 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.9 p -48.67 152.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.485 0.66 . . . . 0.0 111.372 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 t70 61.61 127.01 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.887 0.851 . . . . 0.0 112.446 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 46.56 24.48 0.32 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 3.2 m-20 -156.2 -126.71 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -0.987 . . . . 0.0 109.777 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 53' ' ' TRP . 1.7 tp -178.65 174.98 1.13 Allowed 'General case' 0 N--CA 1.511 2.615 0 CA-C-N 121.089 1.768 . . . . 0.0 112.739 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 13.6 t -134.03 138.55 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.25 117.57 0.78 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 118.738 -1.696 . . . . 0.0 110.596 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.473 ' CH2' ' CG2' ' A' ' 54' ' ' THR . 0.1 OUTLIER -95.42 135.81 36.58 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -57.55 133.89 55.65 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.835 0.826 . . . . 0.0 111.482 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -112.85 98.29 44.56 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.135 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.58 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 46.6 Cg_endo -113.95 8.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.781 1.411 . . . . 0.0 113.264 178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 55.2 Cg_endo -68.46 -106.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 115.832 -2.312 . . . . 0.0 108.083 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.91 39.46 2.85 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 105.535 -3.026 . . . . 0.0 105.535 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.85 140.4 34.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.582 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -92.6 100.42 12.95 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.8 t -55.41 104.04 0.11 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.366 -0.834 . . . . 0.0 110.832 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.77 -156.03 0.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.687 -0.633 . . . . 0.0 109.603 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.96 -171.03 0.26 Allowed Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.489 -0.757 . . . . 0.0 110.612 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -92.97 170.72 2.25 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 O-C-N 123.567 1.299 . . . . 0.0 111.137 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 18.2 t -90.4 148.76 22.6 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.526 -0.734 . . . . 0.0 109.742 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 t -146.33 43.64 1.21 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 1.304 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 26.3 p -125.74 174.1 8.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.677 -0.64 . . . . 0.0 110.618 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -113.57 33.95 5.26 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 p -108.2 -179.35 3.86 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.534 -0.98 . . . . 0.0 110.403 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.5 p -136.26 19.71 3.18 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.585 -0.697 . . . . 0.0 110.809 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -81.65 90.52 6.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.369 -0.832 . . . . 0.0 109.564 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 116' ' ' VAL . 88.5 mt -97.09 156.63 16.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -0.825 . . . . 0.0 111.402 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -132.12 84.49 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.959 -0.463 . . . . 0.0 109.797 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.4 tp -55.36 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.328 -0.857 . . . . 0.0 109.539 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.4 t -80.29 119.57 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.008 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.434 ' HB ' ' NE2' ' A' ' 110' ' ' HIS . 37.9 p -82.15 -179.88 7.56 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.412 ' N ' HD11 ' A' ' 44' ' ' LEU . 51.9 ptt85 -99.96 51.41 0.91 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.026 -1.046 . . . . 0.0 110.447 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.434 ' NE2' ' HB ' ' A' ' 108' ' ' THR . 3.9 p80 -175.17 44.06 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.532 0.682 . . . . 0.0 110.024 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.62 67.2 1.04 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.524 -0.735 . . . . 0.0 111.005 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.99 83.65 0.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.619 -0.676 . . . . 0.0 110.08 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 53.9 t -77.91 154.44 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.573 -0.705 . . . . 0.0 109.534 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.8 mt -136.79 107.88 9.08 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -53.4 141.51 61.07 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 O-C-N 123.63 1.332 . . . . 0.0 112.695 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 21.7 t -133.97 150.23 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -111.81 118.56 35.9 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -47.88 127.85 12.55 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.374 -0.829 . . . . 0.0 110.207 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -107.79 -36.85 6.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.598 -0.689 . . . . 0.0 111.603 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.95 64.03 0.06 OUTLIER Glycine 0 N--CA 1.497 2.738 0 C-N-CA 118.892 -1.623 . . . . 0.0 110.604 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.81 140.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.89 0.852 . . . . 0.0 110.242 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.404 ' CA ' ' O ' ' A' ' 169' ' ' PHE . 69.1 p 44.12 28.56 0.28 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.792 -0.567 . . . . 0.0 112.278 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.502 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 8.4 ttm180 -165.36 151.5 9.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.274 -0.891 . . . . 0.0 110.457 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.16 -177.99 22.12 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.43 127.63 51.33 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.696 -178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.56 132.14 43.4 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.3 mt -103.09 53.55 0.77 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.2 t 175.47 133.5 0.16 Allowed Pre-proline 0 N--CA 1.5 2.044 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.829 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -62.64 104.94 0.39 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 O-C-N 123.721 1.38 . . . . 0.0 108.813 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.61 128.24 25.49 Favored Pre-proline 0 N--CA 1.488 1.458 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.632 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -60.76 131.18 36.29 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.982 1.517 . . . . 0.0 110.129 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 162' ' ' GLY . 11.7 p -57.63 -36.84 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.728 -0.608 . . . . 0.0 110.266 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.401 ' N ' HG11 ' A' ' 132' ' ' VAL . 5.8 t -49.09 -36.59 19.04 Favored 'General case' 0 N--CA 1.507 2.393 0 CA-C-O 122.064 0.935 . . . . 0.0 110.728 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -69.09 -38.21 78.84 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 13.7 mt -65.5 -35.37 80.68 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.153 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -57.14 -21.03 29.57 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.001 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -97.87 30.2 9.79 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 99.0 p -150.89 23.39 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.516 -0.99 . . . . 0.0 110.734 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.36 126.94 29.69 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.256 -0.902 . . . . 0.0 108.691 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 108.43 -13.38 36.26 Favored Glycine 0 CA--C 1.541 1.663 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.401 ' HA2' HD23 ' A' ' 44' ' ' LEU . . . -46.34 109.06 0.31 Allowed Glycine 0 N--CA 1.503 3.166 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.81 125.67 12.39 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.997 1.525 . . . . 0.0 111.753 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.433 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 6.3 mp -82.52 116.28 21.88 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mt -114.36 119.01 35.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.108 -0.995 . . . . 0.0 111.194 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 1.304 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER -60.4 -20.68 0.65 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.839 -0.538 . . . . 0.0 110.507 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 145' ' ' CYS . 40.7 Cg_endo -137.44 -77.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.322 -0.833 0 O-C-N 123.535 1.282 . . . . 0.0 110.326 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.1 p -164.18 -54.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.406 -0.809 . . . . 0.0 110.0 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.68 -51.39 3.45 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -66.98 117.37 8.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.599 -0.942 . . . . 0.0 110.297 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.99 150.58 22.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 110.075 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -107.3 -31.77 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.603 -0.685 . . . . 0.0 109.913 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.425 ' HA3' ' CD1' ' A' ' 169' ' ' PHE . . . 177.28 -179.67 47.97 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.1 pt -117.2 162.71 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.317 -1.107 . . . . 0.0 110.858 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 6.5 t80 -79.91 98.58 7.19 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.585 0.707 . . . . 0.0 110.9 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -82.69 -42.91 17.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.409 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -160.69 -179.68 7.82 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.42 120.96 20.46 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.569 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.3 t -65.82 102.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.404 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 27.2 p -129.18 142.88 50.74 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -175.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 162' ' ' GLY . 1.9 m -75.74 -174.25 2.5 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.85 86.07 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.734 0.778 . . . . 0.0 112.884 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 82.53 -25.25 4.54 Favored Glycine 0 N--CA 1.499 2.896 0 O-C-N 120.879 -1.138 . . . . 0.0 112.186 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -95.48 133.54 36.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 119.217 1.508 . . . . 0.0 109.345 -179.48 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.415 ' CB ' ' CD1' ' A' ' 135' ' ' LEU . . . -100.35 132.82 45.51 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.1 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -117.71 -37.27 3.48 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.571 -0.706 . . . . 0.0 110.775 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -122.27 -179.36 4.15 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.202 -0.936 . . . . 0.0 109.994 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -125.6 145.85 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.46 -0.775 . . . . 0.0 111.878 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.3 101.46 10.46 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.502 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 0.2 OUTLIER -132.56 154.42 50.02 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.891 -175.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.12 144.46 29.46 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.4 Cg_endo -64.39 148.59 90.84 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.916 1.482 . . . . 0.0 110.675 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.444 ' HA ' ' HG2' ' A' ' 175' ' ' MET . 18.1 m -82.21 2.95 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.068 -1.02 . . . . 0.0 110.618 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -83.55 -38.15 22.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.0 t -74.02 -40.18 63.08 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.69 -0.631 . . . . 0.0 110.872 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.444 ' HG2' ' HA ' ' A' ' 172' ' ' VAL . 12.4 ptp -51.07 -36.18 38.66 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.307 -0.871 . . . . 0.0 110.012 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' A' ' 175' ' ' MET . 19.0 tt0 -58.1 -36.33 72.72 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.194 -0.941 . . . . 0.0 108.847 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.7 m -70.6 -36.07 73.32 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.418 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.51 HG23 ' CZ3' ' A' ' 53' ' ' TRP . 2.8 t -48.44 -37.52 17.42 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.095 -1.003 . . . . 0.0 112.699 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.452 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 2.3 ptp -63.22 -39.65 95.22 Favored 'General case' 0 N--CA 1.513 2.678 0 O-C-N 120.418 -1.426 . . . . 0.0 110.253 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -38.25 41.0 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.769 0.795 . . . . 0.0 110.512 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -79.81 -44.65 20.19 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.47 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.506 2.343 0 O-C-N 121.6 -0.688 . . . . 0.0 111.678 179.51 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -171.95 80.72 0.06 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.395 -0.815 . . . . 0.0 110.417 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.11 -68.15 0.1 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -172.63 -46.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.947 . . . . 0.0 110.091 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.584 ' CG2' ' HA ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -158.78 -163.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 122.318 1.056 . . . . 0.0 112.337 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -148.99 171.89 15.62 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.402 ' CG1' HD23 ' A' ' 44' ' ' LEU . 34.0 m -108.96 169.56 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.722 -0.611 . . . . 0.0 109.969 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.93 -179.16 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -149.79 138.92 21.21 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.655 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.0 p -146.72 -179.76 7.01 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.41 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -71.81 75.45 0.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.651 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 39' ' ' ALA . 1.2 m 175.84 -61.22 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.74 -171.04 0.29 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.468 -0.77 . . . . 0.0 109.655 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.7 p -110.74 142.25 42.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.34 -0.85 . . . . 0.0 110.146 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.43 ' CE2' ' HA3' ' A' ' 58' ' ' GLY . 80.2 m-85 -105.53 -178.39 3.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.473 -0.767 . . . . 0.0 111.201 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -118.49 141.27 48.73 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.547 -0.721 . . . . 0.0 111.173 -178.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.417 ' C ' HG13 ' A' ' 33' ' ' VAL . . . -121.93 -177.71 3.65 Favored 'General case' 0 N--CA 1.507 2.417 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.525 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.584 ' HA ' ' CG2' ' A' ' 33' ' ' VAL . 4.6 t -154.94 109.19 2.94 Favored 'General case' 0 N--CA 1.51 2.537 0 O-C-N 121.102 -0.999 . . . . 0.0 112.449 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.49 85.89 0.44 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.319 -0.863 . . . . 0.0 110.18 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.4 t -108.57 128.17 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.6 t30 64.4 12.74 7.55 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.396 -0.815 . . . . 0.0 110.558 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.07 14.55 48.39 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.161 -0.962 . . . . 0.0 111.88 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.3 t -137.46 109.54 6.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.212 -1.169 . . . . 0.0 109.428 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 12.8 m -58.6 99.71 0.05 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.806 -0.559 . . . . 0.0 110.148 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.478 ' CZ3' HG23 ' A' ' 178' ' ' THR . 97.7 m95 -80.47 144.87 32.22 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.197 -0.939 . . . . 0.0 110.588 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.455 ' CG2' ' CZ2' ' A' ' 85' ' ' TRP . 7.2 t -162.64 131.89 4.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.795 -0.565 . . . . 0.0 110.204 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.434 HG22 ' CE1' ' A' ' 57' ' ' HIS . 9.8 m -48.69 154.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.646 0 O-C-N 121.349 -0.844 . . . . 0.0 111.384 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.472 ' CD1' HG23 ' A' ' 83' ' ' VAL . 2.6 t80 -99.97 -12.61 19.62 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.096 -1.003 . . . . 0.0 111.933 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.434 ' CE1' HG22 ' A' ' 55' ' ' VAL . 2.4 p-80 -57.82 -20.37 35.46 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.936 -1.103 . . . . 0.0 110.05 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.43 ' HA3' ' CE2' ' A' ' 43' ' ' PHE . . . -128.46 -137.2 4.33 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 52.26 -172.18 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.243 -1.151 . . . . 0.0 110.811 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.89 122.32 5.98 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 89.8 p -79.9 -13.26 59.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.639 -0.919 . . . . 0.0 111.022 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -148.09 -58.96 0.25 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.234 -0.916 . . . . 0.0 110.439 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -96.61 95.29 7.86 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.113 0.482 . . . . 0.0 111.192 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.446 ' CD1' ' CZ2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -101.45 172.99 6.64 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.499 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.79 129.67 56.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.287 -0.883 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.72 -178.24 15.52 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -53.39 93.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 O-C-N 123.776 1.409 . . . . 0.0 111.128 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.6 tttp 52.65 42.36 31.56 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.475 -0.766 . . . . 0.0 110.947 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.98 131.93 1.5 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -60.65 156.44 42.5 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 O-C-N 123.779 1.41 . . . . 0.0 110.931 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.7 mt -102.12 127.06 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.565 -0.71 . . . . 0.0 110.106 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 m -119.49 -61.37 1.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.429 -0.794 . . . . 0.0 109.721 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 54.43 -159.02 0.18 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.348 -0.845 . . . . 0.0 111.015 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.8 ttm -149.49 22.97 0.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.147 -0.971 . . . . 0.0 111.139 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 -115.25 103.67 11.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.461 -0.774 . . . . 0.0 109.216 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.464 ' CG2' ' CD1' ' A' ' 56' ' ' TYR . 2.3 m -152.7 133.89 14.25 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.735 -0.603 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.63 78.01 1.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.639 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 p -48.46 -28.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.49 -0.756 . . . . 0.0 110.387 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -51.2 60.26 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -83.93 2.52 38.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.998 -0.439 . . . . 0.0 109.969 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 57.09 52.15 9.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.879 . . . . 0.0 111.228 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.408 HD22 ' CG ' ' A' ' 175' ' ' MET . 1.4 tp -158.0 143.75 17.1 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.424 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 56' ' ' TYR . 22.0 t -145.4 119.38 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -99.79 97.1 1.73 Allowed Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.514 -1.327 . . . . 0.0 112.213 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.455 ' CZ2' ' CG2' ' A' ' 54' ' ' THR . 24.1 m0 -76.8 172.92 12.33 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.52 134.46 38.34 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.907 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -109.79 87.67 5.83 Favored Pre-proline 0 C--N 1.295 -1.771 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.803 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.558 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -100.24 -8.59 0.36 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.844 1.444 . . . . 0.0 113.401 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 46.5 Cg_endo -73.16 65.11 4.3 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 115.982 -2.212 . . . . 0.0 110.689 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.46 24.94 18.88 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.13 136.18 55.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.692 -0.887 . . . . 0.0 110.962 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -75.85 129.25 36.7 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 p -98.65 103.94 15.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.544 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.33 -156.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.635 -0.666 . . . . 0.0 109.562 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -154.3 175.41 3.08 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.575 -0.703 . . . . 0.0 110.538 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -74.98 151.53 39.74 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 O-C-N 123.815 1.429 . . . . 0.0 110.604 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.652 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 1.6 t -106.3 85.99 2.28 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.424 -0.798 . . . . 0.0 110.211 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -66.62 -32.46 73.81 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.044 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.652 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 11.9 p -60.53 111.88 1.76 Allowed 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.268 0.556 . . . . 0.0 110.459 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.99 80.03 1.4 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.7 m -122.76 139.92 53.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.587 -0.949 . . . . 0.0 109.955 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -76.2 -165.86 0.54 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.545 -0.722 . . . . 0.0 110.437 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 t70 57.93 102.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.501 -0.75 . . . . 0.0 110.008 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 mt -116.01 -167.53 1.28 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.565 -0.709 . . . . 0.0 110.004 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -140.26 92.21 2.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.814 -0.554 . . . . 0.0 109.576 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.0 tp -77.53 95.17 4.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.1 t -89.93 111.6 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.377 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.429 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 20.7 p -69.42 178.83 2.26 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HB2' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.72 29.51 5.29 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.766 -1.209 . . . . 0.0 110.348 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -133.4 34.46 3.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.451 -0.78 . . . . 0.0 109.214 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.48 68.35 0.84 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.838 -0.539 . . . . 0.0 111.257 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -167.57 90.8 0.34 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.781 -0.575 . . . . 0.0 109.678 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.5 p -77.52 152.62 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.491 -0.756 . . . . 0.0 110.686 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 22.5 mt -131.58 111.5 15.01 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -62.35 133.4 43.06 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 O-C-N 123.604 1.318 . . . . 0.0 111.239 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.0 t -124.05 151.1 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.624 -0.672 . . . . 0.0 109.362 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -111.85 114.81 27.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -48.67 124.54 8.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.575 -0.703 . . . . 0.0 111.022 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -109.53 -48.9 3.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.791 -0.568 . . . . 0.0 110.096 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.23 -169.71 16.06 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.5 135.45 54.23 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 169' ' ' PHE . 10.4 p 53.52 43.31 31.42 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.439 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.497 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 2.2 ttp180 -167.43 151.15 6.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.417 -0.802 . . . . 0.0 110.889 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.9 -178.83 19.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.23 120.41 34.06 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 122.019 -0.695 . . . . 0.0 111.688 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.72 132.93 52.54 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.4 mt -106.13 54.37 0.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.074 0.94 . . . . 0.0 108.502 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.9 t 176.1 116.46 0.13 Allowed Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -57.72 100.24 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.502 1.264 . . . . 0.0 109.467 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 -118.32 147.07 40.93 Favored Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.29 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -65.9 127.42 17.74 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 124.018 1.536 . . . . 0.0 109.838 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 p -55.29 -36.14 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.78 -0.575 . . . . 0.0 110.4 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -48.35 -36.37 14.33 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.28 -0.888 . . . . 0.0 110.789 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.434 ' CD2' HD22 ' A' ' 135' ' ' LEU . 9.1 t80 -65.39 -38.5 90.19 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 11.8 mt -66.62 -35.93 81.37 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.87 120.59 9.31 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.56 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.11 -33.39 6.17 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.9 m -82.06 3.1 28.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.642 -0.917 . . . . 0.0 111.208 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 28.4 p -57.67 127.47 32.2 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.136 -0.978 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.12 -8.83 29.16 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.71 -177.28 0.36 Allowed Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -112.99 121.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.103 0 O-C-N 123.494 1.26 . . . . 0.0 113.276 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.446 HD21 ' CD2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -86.53 110.39 19.75 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 175.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -113.26 123.94 51.34 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.117 -0.989 . . . . 0.0 111.651 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.426 ' HB2' ' CD ' ' A' ' 146' ' ' PRO . 16.4 p -78.13 177.97 2.46 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 145' ' ' CYS . 47.2 Cg_endo -62.0 173.98 2.76 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 O-C-N 123.516 1.272 . . . . 0.0 110.326 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 59.23 24.77 13.25 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.396 -0.815 . . . . 0.0 110.5 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 68.1 -144.38 42.92 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.6 m170 58.03 111.15 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.85 -0.794 . . . . 0.0 111.333 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.92 142.24 57.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.545 -0.722 . . . . 0.0 109.305 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 1.0 OUTLIER -100.58 -41.07 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.665 -0.647 . . . . 0.0 109.723 -179.385 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.401 ' N ' HG12 ' A' ' 172' ' ' VAL . . . -179.62 -177.58 47.93 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.432 HG12 ' CE ' ' A' ' 175' ' ' MET . 1.2 pt -117.23 157.12 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.14 -1.212 . . . . 0.0 111.329 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 7.7 t80 -69.26 109.4 4.09 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.314 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -44.73 6.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.383 -0.823 . . . . 0.0 109.717 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' A' ' 168' ' ' ASP . . . -149.42 170.59 18.21 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -128.23 117.15 21.0 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.887 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.73 99.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.5 p -127.21 143.65 51.21 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 162' ' ' GLY . 2.2 p -77.37 -173.51 2.91 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -48.21 85.21 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 121.667 0.746 . . . . 0.0 112.912 -178.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 84.01 -28.48 4.1 Favored Glycine 0 N--CA 1.5 2.94 0 O-C-N 120.803 -1.186 . . . . 0.0 112.038 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.5 t -94.62 137.93 21.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 119.264 1.532 . . . . 0.0 109.086 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.26 127.36 47.89 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.016 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -109.72 -42.27 4.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.706 -0.621 . . . . 0.0 110.688 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -121.2 176.54 5.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.16 -0.962 . . . . 0.0 110.221 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.76 154.26 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-O 121.786 0.803 . . . . 0.0 111.095 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.405 ' HB3' ' CB ' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -118.76 102.16 8.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 177.137 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.497 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 1.1 p90 -132.87 150.4 52.16 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.823 -1.151 . . . . 0.0 112.435 -175.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.2 p -101.25 133.56 20.86 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 47.2 Cg_endo -60.88 158.42 33.63 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.91 1.479 . . . . 0.0 111.469 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 152' ' ' GLY . 31.3 m -82.55 3.43 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.381 -0.824 . . . . 0.0 110.688 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -90.54 -37.78 13.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 108.731 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.9 t -63.85 -36.45 83.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.935 -0.478 . . . . 0.0 110.05 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.432 ' CE ' HG12 ' A' ' 153' ' ' ILE . 0.5 OUTLIER -48.75 -39.55 25.38 Favored 'General case' 0 N--CA 1.518 2.954 0 CA-C-O 121.643 0.735 . . . . 0.0 109.375 -179.428 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -53.14 -38.06 62.37 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.882 0.848 . . . . 0.0 109.711 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 m -54.22 -39.0 66.31 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.606 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.478 HG23 ' CZ3' ' A' ' 53' ' ' TRP . 9.6 t -59.0 -35.94 74.09 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.093 -1.004 . . . . 0.0 111.644 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.44 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -53.14 -39.63 63.66 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.707 -1.246 . . . . 0.0 110.716 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -38.46 83.43 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.076 0.941 . . . . 0.0 109.179 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -71.47 -39.14 71.11 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.737 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 94.4 p . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.525 -0.734 . . . . 0.0 110.357 -179.834 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 57.05 78.82 0.21 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.31 -0.869 . . . . 0.0 109.652 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -161.27 -121.46 0.58 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -150.98 -39.74 0.12 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.668 -0.901 . . . . 0.0 110.681 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.7 t -111.58 156.28 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.45 -0.781 . . . . 0.0 110.49 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.67 174.0 10.98 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.427 ' CG1' ' HD2' ' A' ' 109' ' ' ARG . 5.2 p -161.93 150.48 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.353 -0.842 . . . . 0.0 110.487 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.484 ' CG1' ' CH2' ' A' ' 85' ' ' TRP . 0.9 OUTLIER -131.6 175.08 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.2 p -127.61 143.55 51.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.613 -0.679 . . . . 0.0 110.337 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 40' ' ' THR . 7.6 t -142.58 -179.7 6.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.634 -0.666 . . . . 0.0 109.349 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.65 76.8 0.29 Allowed 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.106 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.1 m 174.72 -61.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 174.71 -165.44 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.0 p -108.58 143.49 37.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.409 -0.807 . . . . 0.0 109.369 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 59' ' ' ALA . 11.9 p90 -115.01 -177.42 3.12 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.379 -0.826 . . . . 0.0 111.637 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.413 ' CD2' ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -101.69 147.11 26.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.0 110.919 -178.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.24 152.97 36.87 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.791 -0.568 . . . . 0.0 109.996 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 46' ' ' THR . 14.2 t -134.47 117.47 16.29 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.273 1.035 . . . . 0.0 111.966 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 21.4 p -66.83 81.71 0.11 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.719 -0.613 . . . . 0.0 110.785 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.4 t -97.11 133.45 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.835 -1.166 . . . . 0.0 109.096 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.63 23.55 6.23 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.49 -0.756 . . . . 0.0 110.151 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.0 23.28 49.86 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.1 t -139.41 114.84 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.374 -1.074 . . . . 0.0 109.69 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.514 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 57.0 m -69.79 105.46 2.77 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.612 -0.68 . . . . 0.0 109.876 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.459 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 97.0 m95 -88.21 137.1 32.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.267 -0.896 . . . . 0.0 112.152 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.45 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 2.0 t -162.82 130.33 3.69 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.208 0.527 . . . . 0.0 109.76 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.416 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 8.4 m -48.54 145.66 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 O-C-N 121.417 -0.802 . . . . 0.0 111.547 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -78.54 -15.9 58.06 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.338 -0.851 . . . . 0.0 111.118 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.416 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 6.1 p-80 -77.33 -23.0 50.99 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.219 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.6 -23.18 7.32 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.478 ' HA ' ' CE1' ' A' ' 43' ' ' PHE . . . -69.34 -81.0 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.309 -1.112 . . . . 0.0 109.957 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.0 -144.22 15.93 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.8 -148.69 0.26 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.425 -1.044 . . . . 0.0 110.358 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.77 -178.99 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.287 -0.883 . . . . 0.0 110.842 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.86 97.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.734 -0.604 . . . . 0.0 109.94 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.408 ' HG ' HG23 ' A' ' 36' ' ' VAL . 3.4 tt -53.84 153.71 4.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.726 -0.609 . . . . 0.0 110.839 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.76 145.95 39.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.766 -0.584 . . . . 0.0 109.752 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.87 -179.07 16.14 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.65 -16.89 57.61 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.938 1.494 . . . . 0.0 110.73 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -120.4 23.22 10.98 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.117 -0.989 . . . . 0.0 111.439 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.71 -166.31 12.25 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -65.6 135.5 42.33 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.96 1.505 . . . . 0.0 110.786 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.6 mt -95.72 157.81 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.62 -0.675 . . . . 0.0 109.945 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 p -105.11 104.98 14.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.401 -0.812 . . . . 0.0 109.998 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -56.33 151.64 12.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.732 -0.605 . . . . 0.0 111.166 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 tpt -138.11 -38.88 0.55 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.66 -0.65 . . . . 0.0 110.329 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -126.22 122.86 36.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.287 -0.883 . . . . 0.0 110.032 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.414 ' HA ' HG11 ' A' ' 83' ' ' VAL . 2.5 m -146.88 121.81 10.01 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.456 -0.777 . . . . 0.0 109.589 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -146.31 77.79 1.49 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.259 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -49.97 -28.95 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.628 -0.67 . . . . 0.0 110.433 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.33 -45.19 92.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.43 -0.794 . . . . 0.0 109.485 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.83 14.17 26.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.599 -0.688 . . . . 0.0 109.694 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 52.22 56.28 7.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.283 -0.885 . . . . 0.0 111.951 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' CD1' HG13 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -159.29 137.54 10.52 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.215 -0.928 . . . . 0.0 111.651 178.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.414 HG11 ' HA ' ' A' ' 76' ' ' THR . 39.6 t -144.14 103.0 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 52' ' ' CYS . . . -102.83 94.29 1.13 Allowed Glycine 0 N--CA 1.483 1.797 0 C-N-CA 119.928 -1.13 . . . . 0.0 111.216 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.514 ' CE2' ' HB2' ' A' ' 52' ' ' CYS . 4.8 p90 -81.43 178.57 8.29 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -92.26 125.08 36.78 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.042 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.06 156.15 21.46 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.424 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.489 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 30.2 Cg_endo -62.28 -77.43 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.353 0 O-C-N 123.991 1.522 . . . . 0.0 111.822 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 88' ' ' PRO . 59.3 Cg_endo -94.16 28.54 0.28 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 115.874 -2.284 . . . . 0.0 109.287 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.52 -16.91 59.61 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 50.49 22.04 0.97 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.039 -1.271 . . . . 0.0 111.31 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 64.7 69.56 0.5 Allowed 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 m -43.27 128.68 4.78 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.04 -157.9 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 p -144.08 -179.25 0.91 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.554 -0.716 . . . . 0.0 110.263 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -86.51 170.18 7.93 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 O-C-N 123.841 1.443 . . . . 0.0 110.318 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 9.4 t -82.81 -91.35 0.07 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.611 -0.681 . . . . 0.0 109.694 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.2 m 51.83 21.42 1.42 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.909 -1.12 . . . . 0.0 111.348 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 13.3 p -141.42 -25.5 0.71 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.284 -0.885 . . . . 0.0 112.482 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -102.06 128.71 9.64 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.0 p -66.63 -46.88 74.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.753 -0.851 . . . . 0.0 110.058 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 t -162.57 -156.45 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.576 -0.702 . . . . 0.0 110.504 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 55.41 100.69 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.549 -0.719 . . . . 0.0 110.493 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.22 -170.18 1.98 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.36 -0.837 . . . . 0.0 110.124 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 105' ' ' TYR . 11.7 p90 -160.88 98.02 1.18 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 pp -67.29 123.3 19.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.843 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.23 99.63 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.452 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.9 p -61.92 155.38 23.68 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HD2' ' CG1' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -78.95 0.56 26.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.301 -0.875 . . . . 0.0 110.764 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.1 OUTLIER -114.87 35.76 4.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.096 -1.003 . . . . 0.0 109.678 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.35 76.74 0.32 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.52 -0.738 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -167.46 97.25 0.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.534 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.72 145.05 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.425 HD13 ' CZ ' ' A' ' 134' ' ' TYR . 39.7 mt -133.21 111.39 12.96 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -58.47 145.27 95.1 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.655 1.345 . . . . 0.0 111.396 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.1 t -140.46 150.8 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.609 -0.682 . . . . 0.0 109.886 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -109.34 116.14 31.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -48.68 125.35 9.88 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.363 -0.836 . . . . 0.0 111.015 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -108.32 -44.22 4.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.95 -0.469 . . . . 0.0 110.479 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -159.2 63.93 0.3 Allowed Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.947 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.457 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER 60.9 -75.56 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.625 -0.927 . . . . 0.0 111.109 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 120' ' ' GLY . 41.2 p -89.69 38.24 0.91 Allowed 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.85 -0.531 . . . . 0.0 110.3 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.466 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 18.6 ttm180 -168.43 149.12 4.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.371 -0.83 . . . . 0.0 110.312 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.17 -179.26 19.7 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.16 117.21 24.12 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 122.097 -0.649 . . . . 0.0 111.415 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.29 142.22 32.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.637 -0.664 . . . . 0.0 110.158 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.5 mt -112.42 55.21 0.69 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.57 118.8 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.027 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.254 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -59.79 101.01 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 O-C-N 123.483 1.254 . . . . 0.0 109.568 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -120.51 169.26 8.98 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.22 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -85.73 129.3 3.52 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 124.148 1.604 . . . . 0.0 110.303 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.68 -35.35 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.796 -0.565 . . . . 0.0 110.076 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.9 m -48.94 -36.34 17.15 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.299 -0.876 . . . . 0.0 110.41 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.425 ' CZ ' HD13 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -66.03 -38.25 87.92 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 17.5 mt -70.21 -37.04 74.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -55.57 124.82 18.59 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.022 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.33 -29.62 12.11 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.2 m -82.71 1.11 40.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.694 -0.886 . . . . 0.0 111.028 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.41 123.95 14.55 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.922 -1.111 . . . . 0.0 110.394 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.58 -11.85 12.31 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.41 140.07 46.08 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -82.85 124.27 3.88 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.594 1.312 . . . . 0.0 113.171 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.463 HD23 ' CD1' ' A' ' 169' ' ' PHE . 1.2 mp -76.0 141.3 42.2 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.416 ' O ' ' CE1' ' A' ' 105' ' ' TYR . 0.9 OUTLIER -137.57 136.58 37.71 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 120.009 1.277 . . . . 0.0 112.355 -177.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.434 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 15.2 p -84.16 -174.16 0.5 Allowed Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 49.6 Cg_endo -60.1 164.84 11.61 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 117.328 -1.314 . . . . 0.0 110.08 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.36 163.15 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.344 -0.847 . . . . 0.0 109.588 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 149' ' ' HIS . . . -69.59 102.81 1.01 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.41 ' CG ' ' O ' ' A' ' 148' ' ' GLY . 1.5 m170 -166.46 106.84 0.66 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.588 -0.948 . . . . 0.0 110.38 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.17 142.36 54.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.642 . . . . 0.0 110.448 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.452 HG13 ' CE2' ' A' ' 169' ' ' PHE . 3.4 t -107.88 -44.38 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.414 ' N ' HG12 ' A' ' 172' ' ' VAL . . . -178.86 -178.33 48.07 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.431 HG12 ' CE ' ' A' ' 175' ' ' MET . 1.1 pt -116.44 143.77 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.129 -1.218 . . . . 0.0 111.21 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 5.8 t80 -60.53 116.55 4.42 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.048 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -103.68 -44.62 5.04 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.371 -0.83 . . . . 0.0 109.062 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.5 169.92 21.42 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.58 115.58 19.72 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.066 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.41 100.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.4 p -128.88 142.48 50.94 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -174.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 162' ' ' GLY . 69.9 p -73.79 -174.61 1.84 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.9 84.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 86.89 -27.77 5.81 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 121.146 -0.971 . . . . 0.0 111.92 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -94.07 137.16 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.026 1.413 . . . . 0.0 109.089 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.03 126.08 47.69 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.843 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -110.35 -38.68 5.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.78 -0.575 . . . . 0.0 110.384 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -126.32 170.56 11.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 110.164 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.2 153.85 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.642 0.734 . . . . 0.0 111.261 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.03 96.49 5.12 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CE1' ' N ' ' A' ' 123' ' ' ARG . 3.7 p90 -130.41 161.39 31.46 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.596 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.405 HG13 ' CD1' ' A' ' 82' ' ' LEU . 1.1 p -111.28 123.21 35.64 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.1 Cg_endo -50.56 157.13 3.64 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.861 1.453 . . . . 0.0 112.359 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 152' ' ' GLY . 27.8 m -83.22 3.08 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.799 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -87.79 -36.32 17.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -36.05 78.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 110.592 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.436 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -47.3 -39.18 14.1 Favored 'General case' 0 N--CA 1.524 3.27 0 CA-C-O 121.789 0.804 . . . . 0.0 109.302 -179.159 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -53.78 -38.46 64.51 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.915 0.864 . . . . 0.0 109.197 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.1 m -55.81 -39.6 71.56 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.374 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -58.11 -42.64 86.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.522 -0.736 . . . . 0.0 110.32 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.459 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -54.79 -40.16 69.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.405 -0.809 . . . . 0.0 111.056 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -51.28 -38.22 51.62 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.94 0.876 . . . . 0.0 110.408 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -80.84 -41.18 23.66 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.5 2.056 0 O-C-N 121.626 -0.671 . . . . 0.0 110.595 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -156.28 76.84 0.92 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.64 0.733 . . . . 0.0 109.565 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.35 57.45 8.17 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -154.83 -85.26 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.57 -0.959 . . . . 0.0 111.795 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.9 t -149.8 152.11 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.964 -1.085 . . . . 0.0 111.581 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.22 144.11 48.24 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.413 ' CG1' ' HB2' ' A' ' 109' ' ' ARG . 34.5 m -103.57 178.81 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.207 -0.933 . . . . 0.0 111.934 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.407 HG12 ' CH2' ' A' ' 85' ' ' TRP . 33.1 m -136.31 -179.4 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.0 m -157.5 135.59 10.96 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.634 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 p -141.36 -179.07 5.92 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.09 75.44 0.67 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.949 -1.101 . . . . 0.0 108.621 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m 179.25 -63.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.7 -163.36 0.14 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.664 -0.647 . . . . 0.0 109.342 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -120.63 136.5 54.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.435 -0.791 . . . . 0.0 109.902 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 52.4 m-85 -101.87 -177.55 3.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.609 -0.682 . . . . 0.0 110.518 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.426 ' CG ' ' HB3' ' A' ' 109' ' ' ARG . 7.6 tt -113.37 153.72 28.07 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.363 -0.836 . . . . 0.0 109.37 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.413 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -156.85 130.94 8.42 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.029 -1.044 . . . . 0.0 109.973 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -97.84 129.98 44.78 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.201 -0.937 . . . . 0.0 111.883 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 80.1 m -80.81 84.39 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.292 -0.88 . . . . 0.0 110.289 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.451 ' HB ' ' CD1' ' A' ' 53' ' ' TRP . 54.7 t -98.4 138.01 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 58.26 19.61 6.4 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.207 -0.933 . . . . 0.0 109.818 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.28 24.33 54.68 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -138.24 106.85 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.38 -1.071 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.94 115.57 2.94 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.62 -0.675 . . . . 0.0 109.182 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.47 ' CH2' ' HE2' ' A' ' 179' ' ' MET . 97.7 m95 -96.49 142.44 28.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 111.326 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.8 t -161.42 -177.59 6.08 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 m -109.8 150.27 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.449 -0.782 . . . . 0.0 110.457 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.412 ' CB ' ' HB ' ' A' ' 78' ' ' VAL . 33.7 t80 -71.2 -0.91 10.88 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.826 -1.171 . . . . 0.0 112.073 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -48.44 -27.65 2.78 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.171 -0.956 . . . . 0.0 110.608 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.9 41.27 0.11 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -156.95 113.73 3.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.661 -0.905 . . . . 0.0 110.328 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.07 -49.0 0.89 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.09 178.28 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.546 -0.973 . . . . 0.0 110.514 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 50.7 -170.93 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.39 -0.819 . . . . 0.0 110.889 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.63 106.88 19.26 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.652 0.739 . . . . 0.0 109.768 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 169.98 2.32 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.502 0.667 . . . . 0.0 111.275 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -115.99 136.3 53.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.869 -0.519 . . . . 0.0 109.691 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.18 -178.48 15.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -53.46 96.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.826 0 O-C-N 123.653 1.344 . . . . 0.0 110.855 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt 54.2 28.28 8.9 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.445 -0.784 . . . . 0.0 110.629 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.07 139.09 5.0 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.14 163.06 24.07 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.861 1.453 . . . . 0.0 110.3 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.9 mt -97.94 99.2 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.569 -0.707 . . . . 0.0 109.684 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.2 t -55.81 123.47 14.3 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.623 -0.673 . . . . 0.0 110.874 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -55.4 130.73 43.73 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.631 -0.668 . . . . 0.0 111.007 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.2 mmt -128.75 -50.07 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.494 -0.753 . . . . 0.0 109.82 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.426 ' CE1' ' HB2' ' A' ' 179' ' ' MET . 10.7 m-85 -125.93 111.67 15.05 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.538 -0.726 . . . . 0.0 110.014 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.4 HG21 ' CG1' ' A' ' 83' ' ' VAL . 12.8 m -144.67 112.36 6.22 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.601 -0.687 . . . . 0.0 110.723 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -139.53 76.01 1.54 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.921 -1.112 . . . . 0.0 111.886 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.412 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.4 p -52.35 -25.18 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.36 -0.838 . . . . 0.0 109.512 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -32.82 73.61 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -96.75 22.48 8.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.76 41.9 31.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.498 -0.751 . . . . 0.0 111.469 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 175' ' ' MET . 0.3 OUTLIER -169.09 153.23 5.42 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.061 -1.055 . . . . 0.0 113.158 178.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.4 ' CG1' HG21 ' A' ' 76' ' ' THR . 35.0 m -155.34 130.48 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.45 148.71 20.32 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.615 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.407 ' CH2' HG12 ' A' ' 36' ' ' VAL . 1.1 m-90 -116.32 172.02 7.45 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -75.11 141.94 43.69 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.126 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -111.2 101.69 50.99 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.111 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.4 Cg_endo -115.63 10.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.11 0 O-C-N 123.75 1.395 . . . . 0.0 112.768 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 52.1 Cg_endo -63.7 -100.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 116.702 -1.732 . . . . 0.0 108.686 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.44 34.21 5.83 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 105.49 -3.044 . . . . 0.0 105.49 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.61 157.97 37.01 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.945 -0.738 . . . . 0.0 111.214 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.19 20.48 6.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.846 -0.534 . . . . 0.0 109.926 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.9 p 45.63 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.628 -0.67 . . . . 0.0 112.431 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.7 -151.52 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 109.763 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -161.04 171.23 7.26 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.394 -0.816 . . . . 0.0 110.611 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 172' ' ' VAL . 49.1 Cg_endo -83.12 159.46 15.44 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 O-C-N 123.935 1.492 . . . . 0.0 110.575 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.1 t -92.99 136.77 32.96 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.561 -0.712 . . . . 0.0 109.555 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.9 m -108.05 -37.12 6.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.603 -0.685 . . . . 0.0 110.121 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.473 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 26.6 p -64.67 -22.31 66.95 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.675 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.87 -94.57 0.04 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.6 t 51.82 -174.5 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.389 -1.065 . . . . 0.0 110.436 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.2 p -107.23 -162.0 0.82 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.433 -0.792 . . . . 0.0 110.33 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 55.36 97.21 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.529 -0.732 . . . . 0.0 110.467 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 116' ' ' VAL . 3.0 mt -114.18 -176.38 2.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.598 -0.689 . . . . 0.0 110.159 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -132.08 84.77 2.18 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.9 tp -67.52 97.0 0.56 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.6 t -82.96 113.9 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.616 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.432 ' HB ' ' NE2' ' A' ' 110' ' ' HIS . 67.3 p -70.21 178.5 2.79 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.426 ' HB3' ' CG ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -99.73 42.44 1.11 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.008 -1.058 . . . . 0.0 110.64 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.432 ' NE2' ' HB ' ' A' ' 108' ' ' THR . 2.8 p80 -164.97 46.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.717 0.77 . . . . 0.0 109.703 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.29 70.0 0.61 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.353 0.597 . . . . 0.0 111.206 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.49 78.18 0.29 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.479 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.7 p -68.1 152.72 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.615 -0.678 . . . . 0.0 110.209 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 114' ' ' ILE . 46.9 mt -131.37 111.63 15.31 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.353 -0.842 . . . . 0.0 108.783 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -56.89 141.6 93.18 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 O-C-N 123.66 1.348 . . . . 0.0 111.913 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 41.9 t -135.95 148.72 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.525 -0.735 . . . . 0.0 109.767 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.2 115.96 29.05 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -49.3 125.24 10.56 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.299 -0.875 . . . . 0.0 110.882 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.402 ' HG2' ' HB2' ' A' ' 125' ' ' SER . 0.0 OUTLIER -104.75 -47.34 4.07 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.278 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.73 -164.91 13.1 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.12 137.66 57.2 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.457 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 58.1 p 46.03 47.71 12.69 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.062 0.458 . . . . 0.0 111.892 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.441 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.4 OUTLIER -168.59 144.81 3.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.41 -0.806 . . . . 0.0 110.779 179.279 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -137.98 -178.44 16.1 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.402 ' HB2' ' HG2' ' A' ' 119' ' ' ARG . 0.3 OUTLIER -130.3 102.93 6.41 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.004 -178.242 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 pp -49.63 146.91 3.88 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.597 -0.69 . . . . 0.0 110.404 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.8 mt -109.08 54.74 0.65 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.02 0.914 . . . . 0.0 108.841 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.5 117.77 0.17 Allowed Pre-proline 0 N--CA 1.497 1.902 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -59.12 99.13 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 O-C-N 123.742 1.391 . . . . 0.0 109.447 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -114.46 144.9 32.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.019 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 44.3 Cg_endo -62.25 123.84 13.23 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 124.042 1.549 . . . . 0.0 109.993 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 p -51.0 -36.57 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.593 -0.692 . . . . 0.0 110.901 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.4 t -49.56 -35.36 20.23 Favored 'General case' 0 N--CA 1.506 2.353 0 CA-C-O 122.042 0.925 . . . . 0.0 110.099 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 34.8 t80 -63.38 -38.56 91.62 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 10.7 mt -68.8 -35.9 77.6 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.113 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -59.99 121.85 12.85 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.555 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 112.66 -30.21 7.66 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.3 m -88.78 10.53 20.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.74 -0.859 . . . . 0.0 111.12 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.5 p -51.46 127.6 20.47 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.049 -1.032 . . . . 0.0 109.755 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 115.71 -11.91 18.27 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -44.51 114.99 1.18 Allowed Glycine 0 N--CA 1.504 3.225 0 O-C-N 121.556 -0.967 . . . . 0.0 111.454 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.62 119.87 6.84 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.927 1.488 . . . . 0.0 111.356 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.402 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 4.0 mp -87.6 90.94 8.56 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.31 124.1 34.63 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.304 -0.872 . . . . 0.0 111.395 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.473 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 26.6 p -74.86 172.31 9.34 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.776 -0.578 . . . . 0.0 109.892 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 49.3 Cg_endo -71.05 90.43 0.65 Allowed 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.637 1.335 . . . . 0.0 110.973 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.72 -41.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.431 -0.793 . . . . 0.0 110.149 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.97 28.9 1.6 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -141.29 143.27 33.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.377 -1.072 . . . . 0.0 109.469 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.51 131.95 46.14 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.54 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 0.8 OUTLIER -94.14 -27.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.451 ' HA2' ' CG1' ' A' ' 172' ' ' VAL . . . 177.91 -177.85 48.4 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.408 ' CD1' HD13 ' A' ' 82' ' ' LEU . 1.8 pp -128.51 153.69 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 CA-C-N 119.013 1.406 . . . . 0.0 111.828 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 4.2 t80 -64.26 103.52 0.64 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.777 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -90.95 -42.66 10.44 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -154.46 177.88 10.68 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -133.35 118.56 18.62 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.657 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.99 102.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.424 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 28.0 p -129.1 153.25 47.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 122.162 0.982 . . . . 0.0 113.618 -174.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -86.77 -174.84 5.16 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.61 85.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.657 -0.652 . . . . 0.0 112.442 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 85.15 -23.59 7.93 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.23 -0.919 . . . . 0.0 111.718 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -98.41 142.42 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 119.125 1.462 . . . . 0.0 109.123 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.424 ' HA ' ' CB ' ' A' ' 159' ' ' CYS . . . -102.05 133.09 47.43 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.151 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.6 mtpt -114.17 -36.13 4.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.562 -0.711 . . . . 0.0 110.965 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.37 172.75 12.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.402 -0.811 . . . . 0.0 109.979 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.431 HG11 ' CE1' ' A' ' 154' ' ' PHE . 0.7 OUTLIER -115.19 152.62 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 111.178 -178.557 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.03 93.21 4.1 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.441 ' CE1' ' N ' ' A' ' 123' ' ' ARG . 2.6 p90 -128.35 148.65 50.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.408 -0.808 . . . . 0.0 110.838 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.412 ' CG2' ' SD ' ' A' ' 175' ' ' MET . 1.0 OUTLIER -103.51 148.78 36.27 Favored Pre-proline 0 N--CA 1.497 1.916 0 C-N-CA 118.621 -1.232 . . . . 0.0 108.596 179.054 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 175' ' ' MET . 47.0 Cg_endo -63.03 137.91 64.7 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.103 1.581 . . . . 0.0 110.496 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.451 ' CG1' ' HA2' ' A' ' 152' ' ' GLY . 25.6 m -75.94 -0.99 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -77.27 -37.01 53.8 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.1 m -84.13 -38.42 20.74 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.781 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.511 ' HG3' ' O ' ' A' ' 171' ' ' PRO . 11.3 mtm -49.54 -41.05 40.22 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.313 -0.867 . . . . 0.0 110.039 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.446 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 44.8 mm-40 -54.15 -39.49 66.57 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.569 0.7 . . . . 0.0 110.323 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.4 m -50.26 -35.75 28.35 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.933 -0.479 . . . . 0.0 112.266 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.3 t -48.69 -40.81 29.53 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.213 -0.93 . . . . 0.0 113.174 -177.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.47 ' HE2' ' CH2' ' A' ' 53' ' ' TRP . 3.3 ptp -61.0 -38.59 86.57 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.611 -1.306 . . . . 0.0 110.003 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.34 -38.55 53.69 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.871 0.843 . . . . 0.0 109.903 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -78.53 -39.7 37.18 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.502 2.128 0 O-C-N 121.382 -0.824 . . . . 0.0 111.042 179.72 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.249 0.547 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.83 79.37 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.625 -0.672 . . . . 0.0 109.22 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.89 -86.75 0.12 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.67 -35.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.495 -1.003 . . . . 0.0 111.008 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.56 153.29 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.32 -0.862 . . . . 0.0 110.303 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -139.3 135.33 33.7 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.411 -0.806 . . . . 0.0 110.438 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -108.97 161.58 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.544 -0.723 . . . . 0.0 111.583 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.0 p -144.87 145.28 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 p -117.7 143.54 46.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.748 . . . . 0.0 111.03 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.418 HG23 ' CE1' ' A' ' 43' ' ' PHE . 7.4 t -128.74 -179.61 5.17 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.06 76.63 0.23 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.354 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.2 m 177.9 -59.76 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -175.95 -166.38 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.677 -0.64 . . . . 0.0 109.443 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.7 p -119.83 137.91 53.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.354 -0.842 . . . . 0.0 110.436 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -108.96 -176.2 2.97 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.462 ' HG ' ' HG3' ' A' ' 109' ' ' ARG . 8.3 tt -125.74 147.86 49.24 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.92 135.98 19.97 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.858 -1.151 . . . . 0.0 111.467 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 46' ' ' THR . 7.3 t -106.32 126.37 52.15 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.471 -0.768 . . . . 0.0 111.88 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.6 t -76.34 85.01 3.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.475 -0.766 . . . . 0.0 109.766 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.8 t -102.14 138.03 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.4 t30 58.18 18.83 5.62 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.434 -0.791 . . . . 0.0 110.143 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.97 23.97 43.25 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.1 t -143.0 112.62 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -1.117 . . . . 0.0 110.358 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.7 p -61.56 126.37 27.11 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.47 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 85.2 m95 -105.5 139.46 40.08 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.233 -0.917 . . . . 0.0 112.621 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.4 HG23 ' CZ2' ' A' ' 85' ' ' TRP . 5.7 t -160.73 150.81 17.73 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.598 -0.688 . . . . 0.0 110.235 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.417 ' HB ' ' CD2' ' A' ' 57' ' ' HIS . 16.0 t -72.67 149.45 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 121.242 -0.911 . . . . 0.0 109.888 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.433 ' CD1' HG22 ' A' ' 76' ' ' THR . 9.0 t80 -82.44 5.26 21.11 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.856 -1.153 . . . . 0.0 112.328 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.417 ' CD2' ' HB ' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -76.68 5.91 6.82 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.059 -1.025 . . . . 0.0 112.013 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.57 -43.21 0.03 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HB3' ' CD2' ' A' ' 43' ' ' PHE . . . -91.55 146.19 23.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.593 -0.945 . . . . 0.0 110.147 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.44 -45.8 1.42 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.5 t -60.19 174.36 0.53 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.519 -0.989 . . . . 0.0 109.803 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.32 -176.24 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.304 -0.873 . . . . 0.0 110.489 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 m -88.87 94.72 10.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.539 -0.725 . . . . 0.0 110.18 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.448 ' CD1' ' CH2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -61.23 174.78 0.63 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.637 -0.664 . . . . 0.0 110.046 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.53 137.14 41.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.46 -0.775 . . . . 0.0 110.68 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.96 -179.46 16.04 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.4 -8.48 23.71 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.914 1.481 . . . . 0.0 111.035 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -139.01 30.87 2.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.034 -1.041 . . . . 0.0 110.999 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.67 175.13 13.98 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.73 148.02 76.66 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 124.016 1.535 . . . . 0.0 110.13 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.444 HG23 ' CG ' ' A' ' 85' ' ' TRP . 84.1 mt -91.62 151.06 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 110.04 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.2 m -159.49 -62.81 0.07 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.479 -0.763 . . . . 0.0 110.401 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.19 -156.48 0.24 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.409 -0.807 . . . . 0.0 110.183 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.3 ttt -142.7 28.04 1.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.764 . . . . 0.0 110.164 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CE1' ' CB ' ' A' ' 179' ' ' MET . 13.4 m-30 -106.94 100.32 9.83 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.433 HG22 ' CD1' ' A' ' 56' ' ' TYR . 66.3 m -159.93 137.36 9.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 110.742 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -159.95 79.66 0.7 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.561 -0.856 . . . . 0.0 112.142 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.9 m -44.63 -26.44 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.437 -0.79 . . . . 0.0 111.812 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -55.65 -62.66 1.54 Allowed 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.004 -1.06 . . . . 0.0 108.596 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -81.48 -1.19 45.02 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.143 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.447 ' HB3' ' HG3' ' A' ' 155' ' ' ARG . 1.0 OUTLIER 60.77 66.49 0.91 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.563 -0.711 . . . . 0.0 111.076 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.496 ' CD2' ' CB ' ' A' ' 175' ' ' MET . 0.2 OUTLIER -164.44 145.9 8.35 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.254 -0.978 . . . . 0.0 112.868 178.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 m -142.81 159.39 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.1 101.83 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 118.486 -1.816 . . . . 0.0 111.782 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.448 ' CH2' ' CD1' ' A' ' 64' ' ' LEU . 0.6 OUTLIER -85.62 166.28 16.34 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 177.382 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -90.44 131.13 36.38 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.904 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.71 139.17 80.34 Favored Pre-proline 0 C--N 1.297 -1.686 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.829 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.453 ' CD ' ' CD ' ' A' ' 89' ' ' PRO . 36.3 Cg_endo -115.23 -41.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 117.389 -1.274 . . . . 0.0 115.116 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.453 ' CD ' ' CD ' ' A' ' 88' ' ' PRO . 55.8 Cg_endo -63.27 -152.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 116.994 -1.537 . . . . 0.0 109.454 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.79 34.11 2.56 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.25 126.85 26.63 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.059 -1.26 . . . . 0.0 111.014 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.81 154.7 41.53 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.3 p -112.91 117.94 33.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.363 -0.836 . . . . 0.0 110.619 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.7 mt -86.71 -164.39 1.06 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.623 -0.673 . . . . 0.0 109.288 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.52 -170.04 0.23 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.631 -0.668 . . . . 0.0 109.48 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -89.19 156.71 5.64 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 O-C-N 123.528 1.278 . . . . 0.0 111.308 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -105.14 143.44 33.31 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.568 -0.708 . . . . 0.0 110.204 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 m -156.81 37.18 0.31 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.622 -0.674 . . . . 0.0 110.439 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 31.6 p -93.57 -171.27 2.57 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.28 -0.888 . . . . 0.0 110.579 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.79 94.81 0.87 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.7 p -165.47 -164.09 0.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.963 . . . . 0.0 109.893 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.07 -40.32 0.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.432 -0.793 . . . . 0.0 110.789 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -64.5 123.49 19.36 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.414 -0.803 . . . . 0.0 110.087 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mt -115.85 179.15 4.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.453 -0.78 . . . . 0.0 109.97 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -132.92 79.49 1.84 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.427 ' HB3' ' HB ' ' A' ' 114' ' ' ILE . 1.4 tp -58.79 101.81 0.1 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.6 t -90.55 114.89 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.563 -0.711 . . . . 0.0 111.727 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.2 p -74.71 178.71 5.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.462 ' HG3' ' HG ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -98.31 29.51 3.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.857 -1.152 . . . . 0.0 110.288 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -128.58 33.41 4.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.51 69.31 0.74 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.455 -0.778 . . . . 0.0 110.908 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -172.06 108.64 0.23 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.594 -0.691 . . . . 0.0 110.256 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.3 m -84.81 158.39 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.929 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 106' ' ' LEU . 28.3 mm -127.98 111.56 20.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -60.88 133.12 45.84 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 O-C-N 123.752 1.396 . . . . 0.0 111.259 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.2 t -135.09 149.08 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.643 -0.66 . . . . 0.0 109.841 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -104.29 111.15 23.66 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -48.71 122.54 5.72 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.641 0.734 . . . . 0.0 111.351 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.85 -36.95 5.77 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.31 171.82 32.21 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.04 -21.95 35.18 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.502 -0.999 . . . . 0.0 110.703 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.6 p -130.91 40.02 3.52 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.807 -0.558 . . . . 0.0 111.104 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.487 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -171.05 153.5 3.8 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.142 -0.974 . . . . 0.0 111.021 179.08 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.39 -178.39 25.23 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.38 115.75 18.0 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.912 -0.758 . . . . 0.0 111.907 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.43 148.08 12.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.328 -0.857 . . . . 0.0 109.881 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.6 mt -112.27 54.02 0.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 164.5 142.73 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.311 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.31 112.15 2.02 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.79 1.416 . . . . 0.0 109.576 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.08 127.99 25.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.474 -0.766 . . . . 0.0 108.945 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -54.72 131.11 44.02 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.775 1.408 . . . . 0.0 111.467 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.79 -36.03 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 121.253 0.549 . . . . 0.0 109.999 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -48.74 -36.54 16.61 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.08 -1.013 . . . . 0.0 110.611 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.405 ' CD2' HD22 ' A' ' 135' ' ' LEU . 26.8 t80 -65.8 -38.62 89.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.1 mt -65.09 -36.01 82.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -63.08 124.78 22.0 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.704 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.52 -25.55 27.21 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.3 m -90.32 6.79 41.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.994 . . . . 0.0 111.283 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 p -53.15 121.4 7.4 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.021 -1.049 . . . . 0.0 109.747 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 120.91 -10.33 10.27 Favored Glycine 0 CA--C 1.542 1.725 0 N-CA-C 107.664 -2.174 . . . . 0.0 107.664 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -54.97 116.41 6.72 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.41 118.82 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.813 1.428 . . . . 0.0 111.805 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.44 HD21 ' CD1' ' A' ' 169' ' ' PHE . 2.7 mp -74.87 138.58 42.57 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 176.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mt -134.8 120.57 19.53 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.845 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 16.9 p -71.81 -178.3 0.59 Allowed Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.1 Cg_endo -60.62 -179.57 0.28 Allowed 'Trans proline' 0 N--CA 1.491 1.343 0 O-C-N 123.288 1.151 . . . . 0.0 110.833 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.01 -79.16 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.449 -0.782 . . . . 0.0 110.286 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 177.46 -142.28 5.64 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 62.4 m170 57.99 118.14 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.839 -0.801 . . . . 0.0 111.308 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.02 137.68 58.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.489 -0.757 . . . . 0.0 109.913 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 145' ' ' CYS . 3.1 t -92.04 -44.92 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.42 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -173.62 -177.78 43.09 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.0 142.06 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.515 -0.991 . . . . 0.0 110.541 178.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 10.1 t80 -58.2 116.58 3.66 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.447 ' HG3' ' HB3' ' A' ' 81' ' ' ASP . 5.4 ttt180 -103.37 -43.06 5.53 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.406 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -160.4 179.6 8.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.413 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -141.67 128.9 21.02 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.036 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.66 102.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 76.7 m -120.9 172.42 7.93 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.587 1.184 . . . . 0.0 113.401 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.4 OUTLIER -110.92 -174.42 2.47 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.422 ' O ' ' CG ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -49.47 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.37 -0.831 . . . . 0.0 112.798 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 84.4 -25.21 5.76 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.668 -1.27 . . . . 0.0 111.896 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.18 136.1 31.62 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.222 0 O-C-N 120.756 -1.438 . . . . 0.0 109.256 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -96.57 139.62 32.4 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.732 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -114.61 -47.84 2.89 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.529 -0.732 . . . . 0.0 110.887 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -123.05 -178.93 4.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.788 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.59 162.38 12.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.501 0.667 . . . . 0.0 110.104 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.97 88.26 2.38 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.487 ' CE1' ' N ' ' A' ' 123' ' ' ARG . 4.7 p90 -128.42 166.59 18.42 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.006 -1.078 . . . . 0.0 112.694 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -112.82 131.03 22.93 Favored Pre-proline 0 N--CA 1.491 1.58 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -60.27 157.15 36.7 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.985 1.519 . . . . 0.0 111.02 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.418 ' N ' ' HA2' ' A' ' 152' ' ' GLY . 26.8 m -82.05 5.05 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.381 -0.825 . . . . 0.0 110.744 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -85.87 -37.08 19.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.32 -38.74 49.81 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.765 -0.584 . . . . 0.0 111.024 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.496 ' CB ' ' CD2' ' A' ' 82' ' ' LEU . 9.2 ptp -49.91 -36.47 27.63 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.141 -0.974 . . . . 0.0 110.184 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.462 ' N ' ' HG3' ' A' ' 175' ' ' MET . 27.4 mm-40 -57.23 -37.86 72.91 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.485 -0.76 . . . . 0.0 109.731 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.5 m -60.3 -36.03 76.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.245 0.545 . . . . 0.0 110.343 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -49.56 -52.83 27.24 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.581 -0.699 . . . . 0.0 112.421 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.47 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 3.9 ptp -65.03 -40.94 95.57 Favored 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.041 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -54.94 -38.13 67.31 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 122.053 0.93 . . . . 0.0 109.25 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.5 -38.98 67.99 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.369 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.495 1.797 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.083 179.829 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 121.191 0.519 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -170.96 79.28 0.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.368 0.604 . . . . 0.0 109.502 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.74 -19.17 58.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -79.54 -68.92 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.353 -1.087 . . . . 0.0 110.685 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.6 t -137.5 146.62 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.031 0.919 . . . . 0.0 111.497 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.97 173.94 11.16 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.1 m -143.03 161.43 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 118.963 -1.095 . . . . 0.0 111.613 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.488 ' CG2' ' CD2' ' A' ' 43' ' ' PHE . 26.4 m -120.94 -178.42 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 m -153.84 139.83 18.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.296 -0.878 . . . . 0.0 111.422 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -139.24 -178.38 5.34 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.411 ' O ' ' CG2' ' A' ' 40' ' ' THR . . . -69.19 75.67 0.35 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.131 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER 170.75 -61.24 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -174.73 -170.48 0.49 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.322 -0.861 . . . . 0.0 111.083 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.7 p -116.6 145.37 43.43 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.625 -0.672 . . . . 0.0 110.425 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.493 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -106.74 -172.85 2.16 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.173 -0.955 . . . . 0.0 109.766 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 45' ' ' ALA 0.25 5.7 tt -111.1 149.1 31.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.466 -0.771 . . . . 0.0 109.937 -178.001 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.412 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -155.35 137.35 14.58 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.974 -1.079 . . . . 0.0 110.809 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 t -105.49 125.0 50.48 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.995 -1.066 . . . . 0.0 113.137 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 89.9 m -77.18 86.06 3.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.44 -0.787 . . . . 0.0 110.458 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -107.15 141.84 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.338 -0.851 . . . . 0.0 108.731 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 57.3 19.04 4.69 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.363 -0.835 . . . . 0.0 110.082 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.59 23.71 49.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.1 t -142.42 113.84 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.268 -1.137 . . . . 0.0 110.493 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.31 114.04 4.47 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.483 ' CZ3' HG23 ' A' ' 178' ' ' THR . 96.0 m95 -97.83 140.53 32.07 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.588 -0.695 . . . . 0.0 111.614 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.405 HG21 HG21 ' A' ' 83' ' ' VAL . 4.3 t -161.64 177.8 9.63 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.421 HG12 ' CE1' ' A' ' 57' ' ' HIS . 21.2 t -97.86 146.87 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.274 -0.891 . . . . 0.0 109.927 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.44 ' CE1' ' O ' ' A' ' 59' ' ' ALA . 37.1 t80 -63.33 -4.52 2.67 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.659 -1.276 . . . . 0.0 112.08 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.421 ' CE1' HG12 ' A' ' 55' ' ' VAL . 30.3 m170 -39.64 -39.89 0.82 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.313 -0.867 . . . . 0.0 111.816 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.86 -44.79 0.44 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.486 ' N ' ' CE2' ' A' ' 43' ' ' PHE . . . -51.51 97.75 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.433 -1.04 . . . . 0.0 109.818 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.67 25.42 21.28 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.67 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.15 28.34 5.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.244 -1.151 . . . . 0.0 110.891 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -98.1 -156.41 0.54 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.49 -0.756 . . . . 0.0 109.881 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 m -59.21 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.336 -0.853 . . . . 0.0 110.386 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.34 136.35 42.52 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.2 143.19 49.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.432 -0.792 . . . . 0.0 110.789 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.97 -179.44 17.06 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.82 -11.56 31.34 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.92 1.484 . . . . 0.0 110.844 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -114.55 19.63 15.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.982 -1.074 . . . . 0.0 110.858 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.25 -152.64 17.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.14 143.7 54.74 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 124.064 1.56 . . . . 0.0 111.216 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.3 mt -107.28 105.09 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -55.16 149.65 12.03 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.306 -0.871 . . . . 0.0 110.892 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.59 165.36 19.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 0.0 110.087 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -166.21 -47.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.359 -0.838 . . . . 0.0 111.338 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.452 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 19.1 m-85 -123.27 126.54 47.1 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.2 m -158.29 111.76 2.43 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.293 -0.879 . . . . 0.0 112.333 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -137.46 75.18 1.51 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 111.117 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.414 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.5 p -55.56 -21.97 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.433 -0.792 . . . . 0.0 111.012 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.2 77.97 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.467 -0.77 . . . . 0.0 111.324 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 49.24 25.23 1.16 Allowed 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.277 -0.889 . . . . 0.0 111.238 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.96 -95.36 0.49 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.403 -0.811 . . . . 0.0 110.943 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 175' ' ' MET . 5.1 tp -179.13 163.19 1.28 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.518 -1.364 . . . . 0.0 111.021 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 56' ' ' TYR . 26.9 m -139.82 137.61 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.42 137.93 5.26 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.019 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.437 ' CH2' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -98.32 150.36 21.65 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -64.78 141.16 58.87 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.22 89.95 4.28 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.834 -0.541 . . . . 0.0 110.769 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.567 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -97.46 0.65 1.56 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 O-C-N 123.679 1.358 . . . . 0.0 113.455 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 49.8 Cg_endo -74.73 74.76 3.76 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 115.75 -2.367 . . . . 0.0 109.915 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.64 25.8 22.57 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.32 140.3 39.92 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.471 -1.017 . . . . 0.0 110.63 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -84.93 3.88 36.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.352 -0.842 . . . . 0.0 111.437 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.5 t 45.36 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.415 -0.803 . . . . 0.0 112.558 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -161.39 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.7 p -148.74 177.92 1.64 Allowed Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.662 -0.649 . . . . 0.0 110.956 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -86.51 155.36 9.17 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.95 1.5 . . . . 0.0 110.262 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.98 114.63 21.84 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.313 -0.867 . . . . 0.0 110.016 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 66.9 p -75.11 -28.51 60.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.636 -0.665 . . . . 0.0 110.095 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.1 p -100.41 109.84 22.02 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.62 0.724 . . . . 0.0 110.253 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.7 63.39 2.32 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 m -91.51 157.94 16.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.518 -0.99 . . . . 0.0 109.563 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.5 p -85.54 -157.98 0.35 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.444 -0.785 . . . . 0.0 110.809 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 t70 52.84 83.89 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.466 -0.771 . . . . 0.0 110.761 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.88 -174.51 2.53 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.4 -0.813 . . . . 0.0 109.39 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -134.05 91.51 2.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.757 -0.59 . . . . 0.0 109.837 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.414 ' CD1' ' CD1' ' A' ' 143' ' ' LEU . 8.8 tp -56.36 98.89 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.413 -0.804 . . . . 0.0 110.268 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.6 t -74.07 118.99 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.587 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.7 p -86.53 166.98 15.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.557 -0.714 . . . . 0.0 109.418 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.408 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 34.5 ttp180 -77.16 -1.35 28.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.611 -0.681 . . . . 0.0 111.098 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.485 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -120.7 40.77 3.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.221 -0.925 . . . . 0.0 109.993 -178.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.39 64.4 1.86 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.543 -0.723 . . . . 0.0 111.56 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -152.62 89.96 1.45 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.1 m -87.83 136.0 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.457 -0.777 . . . . 0.0 110.071 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.3 pt -124.36 146.76 53.0 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.527 -0.733 . . . . 0.0 109.59 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.65 148.13 82.69 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 124.066 1.561 . . . . 0.0 111.746 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.7 t -138.63 141.11 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -106.7 113.46 26.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -48.93 124.29 8.43 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.613 -0.679 . . . . 0.0 110.307 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -110.66 -25.78 9.77 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.539 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -173.14 -176.11 41.43 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.94 122.74 15.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.758 -0.848 . . . . 0.0 109.515 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 169' ' ' PHE . 0.9 OUTLIER 60.95 44.32 10.66 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.214 0.53 . . . . 0.0 110.721 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.498 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 8.7 ttm180 -162.65 151.83 15.26 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.413 -0.805 . . . . 0.0 110.228 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.54 -178.42 21.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.34 130.82 53.27 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.948 -0.737 . . . . 0.0 111.308 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.37 123.24 25.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.655 -0.653 . . . . 0.0 109.475 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mt -100.01 53.84 0.91 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 177.41 91.55 0.13 Allowed Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -52.87 108.69 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 O-C-N 123.588 1.31 . . . . 0.0 110.626 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -130.64 162.18 56.51 Favored Pre-proline 0 N--CA 1.493 1.696 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.028 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.37 130.9 28.19 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.939 1.494 . . . . 0.0 111.274 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 p -59.84 -35.23 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.487 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.96 -34.81 9.75 Favored 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 122.139 0.971 . . . . 0.0 110.535 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -64.66 -38.51 91.24 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 13.4 mt -65.33 -36.24 83.44 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -62.55 129.51 40.91 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.489 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.59 -28.01 17.89 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.8 m -93.45 16.18 14.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.556 -0.967 . . . . 0.0 110.566 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 56.3 m -62.0 122.32 15.2 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.3 -0.875 . . . . 0.0 109.003 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 122.12 -10.77 9.37 Favored Glycine 0 CA--C 1.543 1.781 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.409 ' HA2' HD23 ' A' ' 44' ' ' LEU . . . -55.72 108.82 1.17 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 153' ' ' ILE . 43.1 Cg_endo -66.25 126.38 15.59 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.074 1.565 . . . . 0.0 112.458 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.414 ' CD1' ' CD1' ' A' ' 106' ' ' LEU . 6.6 mp -79.6 128.83 33.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 176.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -124.21 123.61 40.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 111.662 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 32.0 p -77.82 162.63 67.08 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.798 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -62.89 87.07 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 O-C-N 123.763 1.401 . . . . 0.0 110.726 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t -172.73 -40.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.62 -0.675 . . . . 0.0 110.18 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.03 -30.57 4.77 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -73.21 154.93 40.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.638 -0.919 . . . . 0.0 109.915 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -85.39 141.32 30.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.098 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 2.1 t -97.65 -36.62 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.823 -0.548 . . . . 0.0 109.743 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.443 ' HA2' ' N ' ' A' ' 172' ' ' VAL . . . 176.49 -178.91 47.76 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.431 HG13 ' CG1' ' A' ' 170' ' ' VAL . 1.2 pt -116.8 158.19 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 118.504 1.152 . . . . 0.0 110.953 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 12.2 t80 -75.99 103.41 6.04 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.701 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -92.0 -39.1 11.85 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.413 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -159.39 -179.66 8.14 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.401 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -140.76 125.98 18.58 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.762 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.67 102.08 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 71.0 m -115.67 159.4 21.4 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 122.451 1.119 . . . . 0.0 113.722 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.8 OUTLIER -97.63 -174.06 2.8 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.75 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 O-C-N 121.314 -0.866 . . . . 0.0 112.69 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 82.83 -35.59 2.7 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.014 -1.053 . . . . 0.0 111.382 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.75 134.47 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 120.713 -1.463 . . . . 0.0 109.145 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.4 140.64 29.57 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.336 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -120.9 -44.25 2.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.468 -0.77 . . . . 0.0 110.866 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.94 -179.77 4.12 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.311 -0.868 . . . . 0.0 110.612 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -119.42 151.46 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.8 0.81 . . . . 0.0 111.022 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.16 94.25 4.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.498 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 1.1 p90 -127.89 148.52 50.49 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.922 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.431 ' CG1' HG13 ' A' ' 153' ' ' ILE . 3.9 p -98.9 136.55 20.59 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 52.2 Cg_endo -64.91 152.91 80.58 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.814 1.428 . . . . 0.0 110.476 -178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.448 ' HA ' ' HG2' ' A' ' 175' ' ' MET . 30.6 m -79.8 1.04 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.395 -0.816 . . . . 0.0 110.597 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -89.14 -38.56 14.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.314 -0.866 . . . . 0.0 109.8 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.6 t -74.14 -40.73 62.42 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.603 -0.686 . . . . 0.0 110.791 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.473 ' HB3' HD23 ' A' ' 82' ' ' LEU . 8.3 ptp -51.78 -36.2 46.7 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.096 -1.003 . . . . 0.0 110.48 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.98 -38.02 69.85 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.192 -0.943 . . . . 0.0 109.068 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.6 m -57.53 -37.47 73.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.945 -0.472 . . . . 0.0 110.64 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.483 HG23 ' CZ3' ' A' ' 53' ' ' TRP . 1.4 t -48.54 -36.42 15.39 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.431 -0.793 . . . . 0.0 111.96 -178.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.471 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -51.08 -39.49 56.16 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.815 -1.178 . . . . 0.0 110.685 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.7 ttt85 -52.2 -37.43 54.83 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.916 0.865 . . . . 0.0 110.194 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -81.25 -44.31 17.94 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.891 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.504 2.258 0 O-C-N 121.072 -1.018 . . . . 0.0 110.439 -179.344 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.472 0.653 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -167.8 79.29 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.02 -170.98 38.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -117.89 22.98 11.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.501 -1.0 . . . . 0.0 110.531 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 44.6 t -145.15 143.58 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.734 . . . . 0.0 110.431 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -138.97 140.62 38.28 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.465 -0.772 . . . . 0.0 109.718 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.1 p -108.97 150.37 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.448 -0.783 . . . . 0.0 111.481 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.453 HG11 ' CE2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -131.33 124.38 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.589 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 p -101.16 143.85 30.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.369 -0.832 . . . . 0.0 109.455 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 40' ' ' THR . 5.6 t -149.61 -178.84 6.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.556 -0.715 . . . . 0.0 109.083 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.418 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -69.21 75.53 0.35 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.062 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 39' ' ' ALA . 2.3 m -177.44 -61.14 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.77 -163.95 0.05 Allowed 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 t -122.06 119.46 31.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.292 -0.88 . . . . 0.0 109.297 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.453 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -111.52 166.46 11.12 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.614 -0.679 . . . . 0.0 109.718 -179.488 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 109' ' ' ARG . 13.3 mt -105.31 174.31 5.93 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.174 -0.954 . . . . 0.0 111.133 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -157.08 128.74 7.05 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.981 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -103.1 118.89 37.82 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.966 0.888 . . . . 0.0 111.643 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.2 t -70.2 89.63 0.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.821 -0.549 . . . . 0.0 110.161 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.7 t -109.16 136.27 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.8 19.18 6.69 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.404 -0.81 . . . . 0.0 110.18 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.85 24.88 40.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.9 t -145.98 108.82 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -1.136 . . . . 0.0 110.668 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.1 p -61.57 129.11 39.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.248 -0.907 . . . . 0.0 109.304 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.476 ' CZ2' ' HE3' ' A' ' 179' ' ' MET . 56.1 m95 -108.13 139.25 43.06 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.502 -0.749 . . . . 0.0 111.66 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.451 ' O ' HG21 ' A' ' 83' ' ' VAL . 7.6 t -161.13 128.08 4.06 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.64 0.734 . . . . 0.0 110.315 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 57' ' ' HIS . 28.3 m -48.92 141.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.47 0 O-C-N 120.855 -1.153 . . . . 0.0 112.16 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -83.08 -13.65 55.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.062 -1.024 . . . . 0.0 111.357 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.461 ' CE1' ' CG2' ' A' ' 55' ' ' VAL . 2.1 p-80 -63.23 -22.9 67.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.957 . . . . 0.0 110.061 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.45 ' N ' ' CD2' ' A' ' 57' ' ' HIS . . . -119.03 -30.27 1.64 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HA ' ' CE2' ' A' ' 43' ' ' PHE . . . -55.34 174.75 0.08 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.357 -1.084 . . . . 0.0 111.203 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.97 150.62 19.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 m -101.79 -32.25 10.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.794 -0.827 . . . . 0.0 109.635 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -59.31 -169.49 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.639 -0.663 . . . . 0.0 109.933 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.8 m -68.24 97.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.543 -0.723 . . . . 0.0 109.424 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.412 ' CG ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -55.21 165.9 0.65 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.663 -0.648 . . . . 0.0 110.962 -179.446 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.82 145.37 50.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.836 -0.54 . . . . 0.0 110.491 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -140.29 177.18 20.88 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.49 -12.66 36.5 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 O-C-N 123.915 1.482 . . . . 0.0 111.278 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.63 21.36 11.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 111.044 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.88 -168.3 13.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.51 144.14 65.77 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 124.033 1.544 . . . . 0.0 110.511 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.41 HD11 HD21 ' A' ' 64' ' ' LEU . 56.0 mt -92.88 101.93 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -63.0 117.53 6.56 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.964 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -59.02 102.5 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.299 0.571 . . . . 0.0 110.31 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpt -87.46 -42.0 13.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.777 . . . . 0.0 109.468 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.409 ' CD1' ' HG3' ' A' ' 179' ' ' MET . 23.5 m-85 -125.7 130.51 51.69 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m -149.77 126.56 11.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.533 -0.729 . . . . 0.0 110.435 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.12 77.82 1.37 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.518 -0.739 . . . . 0.0 110.845 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -56.15 -18.62 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.407 -0.808 . . . . 0.0 109.947 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.54 -58.14 7.13 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.096 -1.002 . . . . 0.0 109.482 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.09 23.77 8.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 52.83 69.51 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.826 -0.546 . . . . 0.0 112.088 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.404 ' CD1' HG12 ' A' ' 170' ' ' VAL . 1.4 tp -162.43 141.91 9.41 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.01 -1.056 . . . . 0.0 112.638 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 54' ' ' THR . 9.4 m -145.13 125.39 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -110.94 99.99 1.19 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.931 -1.128 . . . . 0.0 111.874 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.45 ' CE2' HG22 ' A' ' 83' ' ' VAL . 1.6 m0 -90.18 169.14 11.39 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 176.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -89.24 128.9 35.87 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.041 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.76 139.24 93.39 Favored Pre-proline 0 N--CA 1.494 1.769 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.702 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.507 ' CD ' ' HD3' ' A' ' 89' ' ' PRO . 33.7 Cg_endo -105.54 -54.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 117.266 -1.356 . . . . 0.0 115.081 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.507 ' HD3' ' CD ' ' A' ' 88' ' ' PRO . 56.6 Cg_endo -66.37 -150.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.859 0 C-N-CA 116.923 -1.585 . . . . 0.0 108.822 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.85 34.19 3.21 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 107.734 -2.147 . . . . 0.0 107.734 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -48.64 130.73 17.58 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.105 -1.232 . . . . 0.0 110.923 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.6 142.21 58.5 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.76 -0.588 . . . . 0.0 110.44 -179.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 m -112.82 110.52 20.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 110.628 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 mt -93.3 -158.74 0.63 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.623 -0.673 . . . . 0.0 109.669 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.68 176.5 2.23 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.784 -0.573 . . . . 0.0 109.676 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.52 162.28 42.58 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 O-C-N 123.671 1.353 . . . . 0.0 111.18 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 1.093 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 43.6 t -81.95 -76.35 0.26 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.67 -0.644 . . . . 0.0 110.491 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.2 m 55.31 52.81 10.84 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.34 -0.85 . . . . 0.0 110.198 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 1.093 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 30.6 p -139.34 -149.59 0.29 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.488 -0.757 . . . . 0.0 110.304 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.33 -128.94 4.49 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.9 m 49.75 -157.59 0.08 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.371 -1.076 . . . . 0.0 111.031 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 p -171.4 -34.71 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.538 -0.726 . . . . 0.0 110.684 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.8 128.09 35.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.563 -0.711 . . . . 0.0 110.314 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.84 -168.01 1.58 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.416 -0.803 . . . . 0.0 109.345 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -141.11 87.15 2.07 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.433 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 12.3 tp -56.98 96.66 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.155 -0.966 . . . . 0.0 108.494 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.7 t -89.77 101.94 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.662 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.38 179.99 0.69 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.428 ' HB2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -100.92 29.16 4.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.015 -1.053 . . . . 0.0 109.464 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.83 30.17 4.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.338 -0.851 . . . . 0.0 109.679 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 59.36 70.6 0.63 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.46 -0.775 . . . . 0.0 110.551 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -171.56 93.88 0.16 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.344 0.593 . . . . 0.0 109.874 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.7 m -98.87 149.0 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.424 -0.797 . . . . 0.0 110.593 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.433 ' CG1' ' HB3' ' A' ' 106' ' ' LEU . 33.2 pt -131.33 147.55 66.61 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.631 -0.668 . . . . 0.0 109.316 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.88 138.67 29.04 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 O-C-N 123.909 1.479 . . . . 0.0 112.222 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.5 t -129.59 137.94 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.8 mmm-85 -102.64 121.28 42.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.862 . . . . 0.0 108.979 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -49.15 126.82 13.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.395 -0.816 . . . . 0.0 110.994 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -103.97 -55.0 2.45 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.53 -166.71 13.1 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -62.64 127.67 32.38 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.735 -0.862 . . . . 0.0 109.908 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.02 50.81 15.86 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.491 0.663 . . . . 0.0 109.901 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.463 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -166.77 151.37 7.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.767 -0.583 . . . . 0.0 110.391 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.62 -177.73 18.8 Favored Glycine 0 N--CA 1.498 2.828 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.27 103.94 6.23 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.769 -0.842 . . . . 0.0 112.291 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 165' ' ' LYS . 2.7 pp -50.91 150.91 2.74 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.361 -0.837 . . . . 0.0 110.537 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.4 mt -114.88 54.47 0.78 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.27 99.06 0.1 Allowed Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -52.38 99.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.805 0 O-C-N 123.417 1.219 . . . . 0.0 110.92 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -116.03 164.59 17.27 Favored Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.006 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.79 124.41 12.28 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.99 1.521 . . . . 0.0 111.064 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.4 p -57.82 -34.15 47.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.501 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -48.53 -36.21 14.89 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.245 -0.909 . . . . 0.0 110.256 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -62.24 -39.14 91.86 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.0 mt -67.39 -36.61 81.67 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 126.36 27.09 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.615 -0.834 . . . . 0.0 108.884 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.47 -20.64 49.51 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.0 m -93.91 11.6 28.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -1.09 . . . . 0.0 110.847 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.7 p -54.85 143.51 25.62 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.848 -1.158 . . . . 0.0 110.255 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.9 -14.32 58.77 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.54 115.6 4.99 Favored Glycine 0 N--CA 1.503 3.13 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.35 128.37 16.3 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 O-C-N 123.707 1.372 . . . . 0.0 112.683 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.56 120.26 25.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.77 124.91 50.75 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.693 -177.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.473 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 31.1 p -68.59 172.14 5.08 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.8 Cg_endo -64.73 165.52 20.65 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 O-C-N 123.38 1.2 . . . . 0.0 110.116 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.72 39.46 20.92 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.165 -0.959 . . . . 0.0 110.479 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.12 -138.02 30.48 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.7 m170 56.44 111.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.718 -0.872 . . . . 0.0 111.446 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.3 147.55 42.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 109.053 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 1.4 t -108.48 -34.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.636 -0.665 . . . . 0.0 109.638 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.439 ' HA2' HG21 ' A' ' 172' ' ' VAL . . . 174.1 179.22 44.58 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.409 HG12 ' CE ' ' A' ' 175' ' ' MET . 0.9 OUTLIER -115.05 163.32 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 CA-C-N 118.871 1.336 . . . . 0.0 110.903 178.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 3.2 t80 -70.76 114.82 9.23 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.017 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -101.18 -45.71 5.28 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 168' ' ' ASP . . . -153.44 168.36 26.38 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -124.02 116.59 23.07 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.985 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.3 t -68.63 103.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.5 p -127.32 158.41 37.32 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.121 0.963 . . . . 0.0 113.51 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 162' ' ' GLY . 24.0 p -95.13 -173.54 2.97 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 175.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.22 82.53 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 86.02 -25.56 6.76 Favored Glycine 0 N--CA 1.502 3.063 0 O-C-N 120.7 -1.25 . . . . 0.0 111.916 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.45 140.69 17.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 120.962 -1.317 . . . . 0.0 108.949 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -93.46 138.21 31.98 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.962 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.411 ' HA ' HD12 ' A' ' 126' ' ' LEU . 0.7 OUTLIER -119.16 -28.26 5.49 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.635 -0.665 . . . . 0.0 110.38 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -144.01 178.14 8.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.875 . . . . 0.0 109.444 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.03 154.54 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.878 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.411 ' HB3' ' CB ' ' A' ' 156' ' ' ALA . 1.7 t70 -119.94 99.62 6.73 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.463 ' CE1' ' N ' ' A' ' 123' ' ' ARG . 1.6 p90 -130.38 153.88 48.26 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.83 -1.148 . . . . 0.0 112.798 -175.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.404 HG12 ' CD1' ' A' ' 82' ' ' LEU . 2.7 p -103.0 127.47 29.81 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 45.9 Cg_endo -56.56 163.69 6.58 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 124.024 1.539 . . . . 0.0 111.636 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.439 HG21 ' HA2' ' A' ' 152' ' ' GLY . 70.8 t -81.24 1.14 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.378 -0.827 . . . . 0.0 110.039 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -92.92 -37.69 12.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.844 . . . . 0.0 108.95 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.3 t -63.93 -38.14 90.0 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.434 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 7.9 mtt -48.14 -35.28 11.26 Favored 'General case' 0 N--CA 1.518 2.941 0 O-C-N 121.853 -0.529 . . . . 0.0 109.871 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -48.22 -38.34 18.21 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.131 -0.98 . . . . 0.0 111.177 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.6 t -54.21 -34.67 61.16 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.213 -0.93 . . . . 0.0 109.529 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.404 ' CB ' ' O ' ' A' ' 175' ' ' MET . 32.1 m -48.12 -61.94 1.73 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.898 -0.501 . . . . 0.0 110.949 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.476 ' HE3' ' CZ2' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -54.57 -51.3 65.68 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.385 -0.822 . . . . 0.0 110.887 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -52.87 -37.68 60.71 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.154 -0.966 . . . . 0.0 109.994 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -73.33 -39.23 65.4 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.993 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.635 179.627 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.503 2.205 0 CA-C-O 121.608 0.718 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 54.89 80.2 0.13 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.408 0.623 . . . . 0.0 110.98 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.22 63.9 1.34 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -175.35 -73.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.438 ' CG1' ' CD1' ' A' ' 44' ' ' LEU . 62.4 t -124.62 138.26 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.63 -0.669 . . . . 0.0 110.263 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -125.05 178.94 5.26 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.414 ' CG2' ' O ' ' A' ' 43' ' ' PHE . 2.9 p -154.46 143.19 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.542 -0.724 . . . . 0.0 109.533 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.457 ' CG1' ' CH2' ' A' ' 85' ' ' TRP . 33.9 m -104.18 176.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.7 p -131.28 137.71 48.96 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.566 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.3 p -131.49 -176.42 4.02 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.57 103.09 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.206 -0.934 . . . . 0.0 110.389 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 62.1 p 47.0 53.71 10.21 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.275 0.559 . . . . 0.0 111.473 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.79 164.39 16.5 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.507 0.67 . . . . 0.0 110.554 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.6 p -155.51 132.8 10.92 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.414 ' O ' ' CG2' ' A' ' 35' ' ' VAL . 92.8 m-85 -105.76 175.03 5.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.193 -0.942 . . . . 0.0 111.612 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.438 ' CD1' ' CG1' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -101.89 152.76 20.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 0.0 111.899 -177.794 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.43 161.24 32.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.896 -0.503 . . . . 0.0 110.283 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.411 HG21 ' O ' ' A' ' 46' ' ' THR . 14.6 t -137.82 125.18 21.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.098 -1.001 . . . . 0.0 111.981 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.8 m -74.04 79.24 1.71 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.378 -0.826 . . . . 0.0 109.408 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.89 138.1 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.965 -1.084 . . . . 0.0 108.586 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.53 18.46 3.58 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.307 -0.871 . . . . 0.0 110.219 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.405 ' N ' ' CB ' ' A' ' 93' ' ' SER . . . 85.6 27.33 32.75 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.2 t -143.12 116.16 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.41 -1.053 . . . . 0.0 110.506 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 58.8 m -66.59 117.15 8.38 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.474 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 21.4 m95 -102.29 137.1 40.99 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 121.042 -1.036 . . . . 0.0 112.442 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.447 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 1.0 OUTLIER -162.74 131.51 4.07 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.518 -0.739 . . . . 0.0 110.443 177.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.469 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 30.4 m -52.91 147.98 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.334 -0.854 . . . . 0.0 111.497 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.452 ' CD1' HG12 ' A' ' 83' ' ' VAL . 19.9 t80 -68.26 -11.06 58.77 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.118 -0.988 . . . . 0.0 112.052 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.469 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 12.9 p-80 -94.99 36.97 1.16 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.981 -1.074 . . . . 0.0 109.952 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.414 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . -149.95 -67.16 0.01 OUTLIER Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.029 -2.029 . . . . 0.0 108.029 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.37 141.85 40.4 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.476 -1.014 . . . . 0.0 109.885 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.7 -5.23 73.38 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 120.266 -0.968 . . . . 0.0 111.029 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 p 51.76 178.72 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.171 -1.194 . . . . 0.0 111.6 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.3 mttp 53.74 -94.43 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 111.338 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m -85.06 90.41 7.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 110.541 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.424 HD12 ' CZ3' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -103.41 143.61 32.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.637 -0.664 . . . . 0.0 109.903 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.64 149.54 25.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.49 -0.756 . . . . 0.0 110.022 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.1 -179.46 15.88 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.87 -5.19 16.57 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 O-C-N 124.044 1.549 . . . . 0.0 111.268 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -139.59 22.27 2.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.072 -1.017 . . . . 0.0 110.582 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.5 -178.92 17.29 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.51 149.78 87.4 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.07 1.563 . . . . 0.0 111.143 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.407 HG22 ' CD1' ' A' ' 85' ' ' TRP . 59.1 mt -108.33 165.09 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.2 t -102.11 -166.7 1.32 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.435 -0.79 . . . . 0.0 110.057 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -119.62 120.07 35.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.557 -0.714 . . . . 0.0 110.147 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.413 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 3.6 mmt -116.03 -36.68 4.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 110.308 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.447 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 24.6 m-85 -133.44 129.93 37.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.497 -0.752 . . . . 0.0 110.367 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -152.69 115.37 4.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.385 -0.822 . . . . 0.0 110.464 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -145.93 75.15 1.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.853 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.43 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.4 p -54.0 -25.96 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.36 -41.83 76.78 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.392 -0.817 . . . . 0.0 109.347 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -97.48 22.5 8.79 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 53.95 52.34 13.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.512 -0.743 . . . . 0.0 111.667 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.415 ' CD2' ' HB3' ' A' ' 175' ' ' MET . 1.3 tp -166.43 136.12 3.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.089 -1.007 . . . . 0.0 112.596 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.452 HG12 ' CD1' ' A' ' 56' ' ' TYR . 30.0 m -148.23 140.39 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 176.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.28 176.17 36.98 Favored Glycine 0 C--N 1.298 -1.566 0 C-N-CA 118.426 -1.845 . . . . 0.0 111.663 -178.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.457 ' CH2' ' CG1' ' A' ' 36' ' ' VAL . 37.1 p90 -130.07 134.78 47.6 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -51.26 139.46 18.82 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.484 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.3 88.18 1.58 Allowed Pre-proline 0 C--N 1.297 -1.702 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.263 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.54 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.1 Cg_endo -94.79 -12.97 0.86 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.867 1.456 . . . . 0.0 112.271 177.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 43.1 Cg_endo -70.93 71.95 2.06 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 115.738 -2.374 . . . . 0.0 111.046 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.75 24.91 20.66 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.48 125.43 30.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.488 -1.007 . . . . 0.0 110.488 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -66.31 154.32 40.3 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.405 ' CB ' ' N ' ' A' ' 50' ' ' GLY . 4.9 p -113.69 103.91 11.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.625 -0.672 . . . . 0.0 110.351 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.44 -162.08 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.535 -0.728 . . . . 0.0 109.475 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 96' ' ' PRO . 0.6 OUTLIER -145.6 -172.06 0.3 Allowed Pre-proline 0 C--N 1.299 -1.589 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.333 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.41 ' N ' HG22 ' A' ' 95' ' ' THR . 51.2 Cg_endo -90.93 162.68 3.97 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.772 1.406 . . . . 0.0 110.991 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 80.29 1.29 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.377 -0.827 . . . . 0.0 110.845 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.2 p -77.46 62.63 2.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.437 -0.789 . . . . 0.0 109.234 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 27.2 p -129.9 169.14 15.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.48 -0.762 . . . . 0.0 111.191 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.51 -156.17 26.64 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.82 -158.45 0.2 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.448 -1.031 . . . . 0.0 110.434 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.01 -88.76 0.39 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.547 -0.721 . . . . 0.0 110.121 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 44.81 55.13 6.23 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.167 -0.958 . . . . 0.0 111.769 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.441 ' CB ' ' HB ' ' A' ' 116' ' ' VAL . 16.8 mt -88.85 168.65 12.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -149.79 86.87 1.46 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.405 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 40.6 tp -58.48 103.21 0.14 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.632 -0.667 . . . . 0.0 109.237 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.44 101.06 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.326 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 48.7 p -66.4 158.45 29.31 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.417 ' CB ' ' CD2' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -80.56 2.14 26.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.001 -1.062 . . . . 0.0 110.974 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.435 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -97.73 30.09 3.11 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.054 -1.029 . . . . 0.0 109.465 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.73 62.42 1.93 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.458 -0.776 . . . . 0.0 110.805 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.34 104.1 0.45 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.225 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.4 m -102.32 155.34 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.519 -0.738 . . . . 0.0 110.751 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.405 ' CG1' ' HB3' ' A' ' 106' ' ' LEU . 42.2 pt -133.09 140.19 36.7 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.477 -0.765 . . . . 0.0 109.636 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.1 129.04 16.57 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.861 1.453 . . . . 0.0 111.988 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 104' ' ' LEU . 63.9 t -116.95 158.69 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.57 109.42 18.23 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -46.6 129.31 11.04 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.494 -0.754 . . . . 0.0 111.418 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.7 -46.37 3.38 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.943 -0.473 . . . . 0.0 111.482 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -155.35 57.88 0.39 Allowed Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.27 -1.443 . . . . 0.0 111.1 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.419 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.5 OUTLIER 65.48 -66.72 0.14 Allowed 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.486 -1.008 . . . . 0.0 111.06 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 120' ' ' GLY . 25.8 p -98.96 41.68 1.13 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 121.467 0.651 . . . . 0.0 110.019 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.459 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 13.7 ttm180 -171.65 150.02 2.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 109.689 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.37 -178.99 18.18 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.65 113.34 16.58 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 122.181 -0.6 . . . . 0.0 111.161 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.38 133.15 45.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.623 -0.673 . . . . 0.0 109.705 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.3 mt -106.91 54.35 0.67 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.107 0.956 . . . . 0.0 108.587 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 170.44 123.52 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.15 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -56.02 112.11 0.97 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 O-C-N 123.495 1.261 . . . . 0.0 110.043 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -127.72 150.58 73.57 Favored Pre-proline 0 N--CA 1.487 1.375 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.646 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.14 130.18 18.44 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 124.107 1.583 . . . . 0.0 110.342 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.91 -35.98 73.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.416 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -49.23 -37.82 24.36 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -61.84 -38.24 87.47 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.1 mt -69.54 -36.65 76.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.6 103.64 0.7 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.461 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.36 -33.48 3.45 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.7 p -83.65 5.35 24.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.654 -0.909 . . . . 0.0 110.955 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.4 m -54.3 124.32 15.55 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.134 -0.979 . . . . 0.0 110.797 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.05 -13.67 12.67 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.64 134.44 44.39 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -79.23 132.56 10.36 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.717 1.377 . . . . 0.0 113.254 -177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.435 HD23 ' CD1' ' A' ' 169' ' ' PHE . 4.6 mp -82.53 139.22 34.0 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 175.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.67 121.81 19.08 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 120.099 1.318 . . . . 0.0 111.593 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -69.56 -21.18 0.55 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.862 -0.524 . . . . 0.0 110.255 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 145' ' ' CYS . 46.0 Cg_endo -140.9 -162.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.876 0 O-C-N 123.461 1.243 . . . . 0.0 110.438 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.45 -55.59 29.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.387 -0.821 . . . . 0.0 110.185 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -107.7 -158.55 20.41 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.4 m170 53.06 100.7 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.395 -1.062 . . . . 0.0 111.095 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.42 154.64 36.98 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.512 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 2.1 t -103.9 -35.32 3.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 171' ' ' PRO . . . 176.23 -178.36 47.64 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.436 ' CG1' ' CE ' ' A' ' 175' ' ' MET . 1.6 pp -118.61 146.45 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 CA-C-N 118.837 1.319 . . . . 0.0 110.98 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 6.6 t80 -59.01 113.55 2.15 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.632 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.4 -46.94 5.33 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -150.45 171.39 17.12 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.67 116.66 21.33 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.019 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.402 ' HB ' ' CB ' ' A' ' 166' ' ' ALA . 7.0 t -67.34 99.73 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 177.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.1 p -127.73 165.04 20.81 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.555 1.169 . . . . 0.0 113.78 -175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.6 OUTLIER -105.31 -174.18 2.47 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.398 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.427 ' O ' ' CG ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -48.77 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.087 0.946 . . . . 0.0 112.544 -179.31 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 82.17 -26.69 3.78 Favored Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.644 -1.285 . . . . 0.0 112.43 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.5 t -100.58 134.82 39.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 119.223 1.512 . . . . 0.0 110.025 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -95.75 131.15 42.33 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.421 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -109.12 -43.21 4.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.746 . . . . 0.0 110.344 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.402 ' CB ' ' HB ' ' A' ' 158' ' ' VAL . . . -128.43 163.86 23.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.49 -0.756 . . . . 0.0 110.088 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.55 154.28 9.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.533 0.683 . . . . 0.0 110.26 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.01 101.62 7.33 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.459 ' CE1' ' N ' ' A' ' 123' ' ' ARG . 4.9 p90 -135.22 164.34 27.92 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.676 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.402 HG11 HG13 ' A' ' 153' ' ' ILE . 3.2 p -108.57 132.39 21.16 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 40.6 Cg_endo -61.73 161.52 24.72 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.794 1.418 . . . . 0.0 111.364 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.439 ' HA ' ' HG3' ' A' ' 175' ' ' MET . 19.0 m -83.93 3.54 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 121.238 -0.914 . . . . 0.0 111.341 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.67 -38.15 13.28 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.6 t -72.69 -37.2 67.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.933 -0.48 . . . . 0.0 110.642 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.439 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 28.5 mtt -48.89 -38.74 23.51 Favored 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.429 -0.795 . . . . 0.0 109.252 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -55.87 -39.13 71.08 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.629 0.728 . . . . 0.0 109.695 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.1 m -54.62 -38.1 66.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.774 -0.579 . . . . 0.0 110.472 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.65 -41.01 63.4 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.444 -0.785 . . . . 0.0 110.548 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.474 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -52.34 -40.47 61.98 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.19 -0.944 . . . . 0.0 111.629 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.13 -37.62 64.55 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.246 -0.909 . . . . 0.0 110.149 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.28 -39.19 54.91 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.37 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 O-C-N 121.459 -0.776 . . . . 0.0 111.301 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.19 0.519 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -173.92 79.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.371 -0.831 . . . . 0.0 109.766 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.65 151.5 5.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -67.98 -14.6 63.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.705 -0.879 . . . . 0.0 110.771 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.4 t -111.78 141.82 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 0.0 110.188 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -125.33 171.22 10.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.703 -0.623 . . . . 0.0 109.351 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.5 m -143.63 177.28 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.774 . . . . 0.0 110.748 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.07 179.48 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 p -137.09 135.88 37.85 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.073 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.2 p -132.52 -177.45 4.48 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.76 95.66 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.459 -0.776 . . . . 0.0 110.986 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.6 m 58.25 44.95 17.97 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.483 -0.761 . . . . 0.0 110.994 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -164.92 156.95 15.64 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.204 -0.935 . . . . 0.0 111.262 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 p -146.5 132.61 19.33 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.476 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 46.9 m-85 -100.59 -179.29 4.05 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.199 -0.938 . . . . 0.0 110.401 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.487 ' CD1' ' HA ' ' A' ' 138' ' ' SER . 0.0 OUTLIER -111.97 152.47 28.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 0.0 110.881 -178.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.0 136.56 9.01 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.554 -0.717 . . . . 0.0 109.609 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.413 HG23 ' CG2' ' A' ' 153' ' ' ILE . 13.6 t -110.52 119.22 38.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.222 -0.924 . . . . 0.0 112.636 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 52.5 t -71.38 83.36 0.79 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.4 t -102.63 138.43 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 t30 56.07 21.35 5.02 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.405 -0.809 . . . . 0.0 110.208 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.13 24.94 53.64 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.432 ' O ' ' CD1' ' A' ' 53' ' ' TRP . 61.6 t -141.44 106.34 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.37 -1.077 . . . . 0.0 109.875 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.9 OUTLIER -64.24 108.86 1.69 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.291 -0.88 . . . . 0.0 109.913 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.459 ' CZ2' ' CE ' ' A' ' 179' ' ' MET . 97.7 m95 -93.79 148.54 22.03 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.486 -0.759 . . . . 0.0 111.157 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.6 t -161.26 179.91 7.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.845 -0.535 . . . . 0.0 109.725 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -94.85 143.57 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.581 -0.699 . . . . 0.0 110.54 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.441 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 45.7 t80 -76.05 -0.92 23.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.098 -1.001 . . . . 0.0 111.889 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -51.76 -30.63 23.55 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.073 -1.017 . . . . 0.0 109.648 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.86 -147.8 5.25 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.41 ' HB1' ' CG ' ' A' ' 43' ' ' PHE . . . 53.0 22.07 2.31 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.12 -1.223 . . . . 0.0 111.406 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.98 -136.39 2.16 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.92 20.67 4.35 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.505 -0.997 . . . . 0.0 110.964 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -171.61 -161.18 0.19 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.21 -0.931 . . . . 0.0 110.65 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -78.2 96.31 5.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.715 -0.616 . . . . 0.0 110.397 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.464 ' CD1' ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -64.78 177.56 0.93 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.714 -0.616 . . . . 0.0 110.234 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.88 136.34 48.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.59 -0.694 . . . . 0.0 110.108 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.46 178.76 17.87 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -64.71 -16.97 58.03 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.997 1.525 . . . . 0.0 110.673 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -147.45 42.26 1.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.224 -0.923 . . . . 0.0 110.082 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.74 164.16 11.19 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -57.3 157.88 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 O-C-N 123.747 1.393 . . . . 0.0 110.877 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 92.0 mt -98.5 162.49 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.557 -0.715 . . . . 0.0 110.297 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 p -97.11 -169.68 1.9 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.565 -0.71 . . . . 0.0 110.495 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -141.56 116.4 9.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.696 . . . . 0.0 110.021 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 tpt -113.96 -31.84 6.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.559 -0.713 . . . . 0.0 110.331 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.416 ' CD1' ' HA ' ' A' ' 179' ' ' MET . 15.8 m-85 -129.47 104.34 7.41 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.582 -0.699 . . . . 0.0 109.658 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.75 109.69 4.68 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.349 -0.941 . . . . 0.0 112.117 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -161.82 74.86 0.46 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.36 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 5.9 p -67.77 -23.18 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.229 -0.919 . . . . 0.0 110.224 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -50.95 -26.35 5.83 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.301 -0.874 . . . . 0.0 110.653 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -172.68 36.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.585 -0.697 . . . . 0.0 110.511 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.82 -86.19 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.138 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.409 ' CD1' ' CG2' ' A' ' 170' ' ' VAL . 0.2 OUTLIER 175.55 175.97 0.23 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.58 -1.325 . . . . 0.0 110.343 -178.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 83' ' ' VAL . 27.7 m -143.56 121.6 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.648 0.737 . . . . 0.0 109.354 177.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.19 149.34 18.7 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.464 ' CZ2' ' CD1' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -110.46 151.37 27.61 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -63.55 137.19 58.02 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.168 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 135.8 34.62 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.736 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.458 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 38.0 Cg_endo -114.46 -38.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.463 0 O-C-N 123.56 1.295 . . . . 0.0 114.911 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 54.9 Cg_endo -61.34 -155.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 117.063 -1.492 . . . . 0.0 109.966 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -78.63 32.45 1.89 Allowed Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 89' ' ' PRO . . . -58.33 126.52 27.89 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.021 -1.282 . . . . 0.0 110.549 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 147.68 52.29 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.62 116.83 32.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.456 -0.778 . . . . 0.0 110.895 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -159.23 0.61 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.73 -0.607 . . . . 0.0 109.528 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.06 -173.64 0.39 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.601 -0.687 . . . . 0.0 109.742 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -87.97 156.16 7.21 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 O-C-N 123.77 1.405 . . . . 0.0 110.311 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.46 -67.81 0.82 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.443 -0.785 . . . . 0.0 110.275 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.1 m 50.57 26.79 2.58 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.193 -0.942 . . . . 0.0 110.721 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -147.06 174.28 11.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.513 -0.742 . . . . 0.0 110.86 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.46 -167.1 48.41 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.9 m -121.11 -55.41 1.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.726 -0.867 . . . . 0.0 109.772 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.62 -152.84 0.21 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.713 -0.617 . . . . 0.0 109.944 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 t0 57.3 101.87 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.335 -0.853 . . . . 0.0 110.266 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.4 mt -120.3 -168.99 1.72 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.505 -0.747 . . . . 0.0 109.751 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -140.45 83.68 1.92 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 24.6 tp -60.01 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.67 102.88 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.063 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.3 p -65.14 170.17 4.8 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.454 ' HB2' ' CG ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -95.55 25.8 4.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.911 -1.118 . . . . 0.0 110.363 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.463 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -124.62 29.83 6.15 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 62.08 70.68 0.57 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.543 -0.723 . . . . 0.0 111.088 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -175.0 102.69 0.09 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.645 -0.659 . . . . 0.0 110.223 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.8 m -101.79 153.81 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.446 -0.784 . . . . 0.0 110.222 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.2 pt -135.94 139.34 30.17 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.474 -0.766 . . . . 0.0 109.559 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.85 145.48 74.84 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 123.929 1.489 . . . . 0.0 111.503 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.33 142.9 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.93 117.32 34.35 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.84 128.52 15.79 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.527 -0.733 . . . . 0.0 110.119 -178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -112.97 -25.41 8.99 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.173 -177.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -172.93 53.35 0.16 Allowed Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.57 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.411 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER 65.9 -70.19 0.1 Allowed 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.633 -0.922 . . . . 0.0 110.06 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 120' ' ' GLY . 77.7 p -92.94 35.7 1.05 Allowed 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.342 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.456 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -167.91 150.75 5.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.336 -0.852 . . . . 0.0 110.216 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.42 -178.21 20.78 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.1 t -127.86 117.0 21.01 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.607 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.53 139.27 55.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.45 -0.782 . . . . 0.0 109.475 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.7 mt -105.26 53.92 0.71 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.237 1.018 . . . . 0.0 108.267 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 167.48 152.64 0.1 Allowed Pre-proline 0 N--CA 1.503 2.184 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.19 115.65 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.782 1.412 . . . . 0.0 110.044 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.62 131.8 24.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.488 -0.758 . . . . 0.0 109.035 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -58.2 130.84 39.85 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.793 1.418 . . . . 0.0 110.898 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.79 -37.3 79.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.584 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -49.97 -37.08 30.74 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 122.042 0.925 . . . . 0.0 110.458 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.46 ' CD2' HD22 ' A' ' 135' ' ' LEU . 15.5 t80 -66.91 -38.37 86.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.46 HD22 ' CD2' ' A' ' 134' ' ' TYR . 15.4 mt -66.95 -36.43 82.21 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -61.02 123.29 17.19 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.949 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.17 -25.89 26.56 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.487 ' HA ' ' CD1' ' A' ' 44' ' ' LEU . 7.4 m -81.09 0.96 33.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.547 -0.972 . . . . 0.0 111.427 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 60.1 m -55.83 126.2 24.61 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.216 -0.928 . . . . 0.0 111.569 -178.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 123.66 -22.66 6.86 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.42 ' CA ' ' CD2' ' A' ' 44' ' ' LEU . . . -53.75 126.37 35.02 Favored Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.33 125.67 9.85 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.763 1.402 . . . . 0.0 112.977 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.446 HD23 ' CG ' ' A' ' 169' ' ' PHE . 1.1 mp -76.86 135.22 38.86 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 175.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mt -132.91 127.73 34.98 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 118.924 -1.11 . . . . 0.0 111.962 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.415 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 14.2 p -74.98 -174.72 0.39 Allowed Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.1 Cg_endo -71.1 68.21 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.419 1.22 . . . . 0.0 110.643 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.78 -175.28 1.76 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.559 -0.713 . . . . 0.0 109.75 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.42 27.11 20.98 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -116.81 135.97 53.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.535 -0.979 . . . . 0.0 109.753 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.05 141.01 49.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.662 -0.649 . . . . 0.0 110.241 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 1.4 t -96.85 -37.64 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.419 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . 177.29 -177.9 48.28 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.422 ' O ' ' HB2' ' A' ' 169' ' ' PHE . 1.1 pt -117.02 140.32 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.112 -1.228 . . . . 0.0 110.435 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 9.1 t80 -58.44 115.94 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.268 0.556 . . . . 0.0 110.541 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.68 -46.09 4.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.662 -0.649 . . . . 0.0 109.662 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.29 171.99 16.59 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -132.09 118.11 19.2 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.674 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.96 102.44 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.403 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 27.9 p -128.08 159.55 34.73 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.301 1.048 . . . . 0.0 113.642 -175.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 162' ' ' GLY . 1.6 m -94.05 -174.17 3.32 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.421 ' O ' ' CG ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -48.85 84.96 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 121.74 0.781 . . . . 0.0 112.76 -178.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 84.78 -27.59 4.79 Favored Glycine 0 N--CA 1.5 2.967 0 O-C-N 120.713 -1.242 . . . . 0.0 111.775 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -96.21 131.75 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.773 -1.428 . . . . 0.0 109.604 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.403 ' HA ' ' CB ' ' A' ' 159' ' ' CYS . . . -95.62 134.47 38.47 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.772 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -115.24 -39.98 3.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.729 -0.607 . . . . 0.0 110.961 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.61 177.95 5.68 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.255 -0.903 . . . . 0.0 109.841 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.33 155.55 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.608 0.718 . . . . 0.0 110.685 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.28 96.02 4.46 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.456 ' CE1' ' N ' ' A' ' 123' ' ' ARG . 3.7 p90 -132.54 165.86 23.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.824 -1.173 . . . . 0.0 112.946 -176.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.409 ' CG2' ' CD1' ' A' ' 82' ' ' LEU . 1.3 p -108.81 127.46 27.32 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 44.2 Cg_endo -59.05 160.58 18.26 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.963 1.507 . . . . 0.0 111.954 -177.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 152' ' ' GLY . 40.0 t -84.23 2.98 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.515 -0.741 . . . . 0.0 109.798 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.41 -37.17 21.8 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -36.34 83.92 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.585 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.451 ' O ' ' HB ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -49.89 -36.37 27.09 Favored 'General case' 0 N--CA 1.521 3.09 0 O-C-N 121.426 -0.796 . . . . 0.0 108.885 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -57.77 -37.48 73.74 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.121 -0.987 . . . . 0.0 108.708 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.1 m -76.27 -36.84 58.22 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.633 0.73 . . . . 0.0 109.42 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 175' ' ' MET . 1.3 m -48.82 -52.99 21.12 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.673 -0.642 . . . . 0.0 111.193 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.459 ' CE ' ' CZ2' ' A' ' 53' ' ' TRP . 2.2 ptp -59.85 -40.85 89.92 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.066 -1.021 . . . . 0.0 109.94 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -57.67 -38.36 74.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.038 0.923 . . . . 0.0 109.449 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.58 78.22 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.624 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.59 -0.693 . . . . 0.0 110.714 -179.738 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.11 0.481 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.85 78.88 0.16 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.2 71.69 0.96 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.539 -0.977 . . . . 0.0 109.495 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -72.71 141.03 48.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.766 -0.584 . . . . 0.0 110.211 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.99 90.91 1.99 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.586 -0.696 . . . . 0.0 110.398 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -84.87 -177.33 6.55 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -153.43 77.84 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.41 0.624 . . . . 0.0 110.184 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.2 m -64.14 -158.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.749 -0.594 . . . . 0.0 110.278 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 59.92 79.64 0.23 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.173 -0.954 . . . . 0.0 109.831 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.03 -89.72 0.08 OUTLIER Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -171.15 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.633 -0.922 . . . . 0.0 110.762 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.34 158.8 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.59 0.71 . . . . 0.0 111.705 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -142.35 140.2 32.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.412 ' CG1' ' HB2' ' A' ' 109' ' ' ARG . 27.7 m -106.22 173.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.967 0.889 . . . . 0.0 112.233 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.446 HG12 ' CH2' ' A' ' 85' ' ' TRP . 33.6 m -129.68 179.75 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.5 p -152.95 139.4 18.62 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.147 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.0 p -146.09 -178.92 6.38 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -71.42 75.34 0.76 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.762 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 39' ' ' ALA . 1.3 m 178.7 -58.32 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -179.72 -156.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.391 -0.818 . . . . 0.0 109.717 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 p -128.34 139.35 52.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.548 -0.72 . . . . 0.0 109.962 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 67.9 m-85 -99.67 -178.71 3.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.477 -0.764 . . . . 0.0 110.284 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.447 HD23 ' HA2' ' A' ' 141' ' ' GLY . 6.8 tt -116.48 146.76 42.33 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.217 -0.927 . . . . 0.0 108.883 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.431 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -148.96 137.51 21.12 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.909 -1.119 . . . . 0.0 110.714 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.405 ' CG2' HG23 ' A' ' 153' ' ' ILE . 14.8 t -106.39 129.89 54.3 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.283 -0.886 . . . . 0.0 113.381 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.2 t -75.46 87.85 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 109.883 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.33 135.01 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m120 57.8 18.97 5.26 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.346 -0.846 . . . . 0.0 110.137 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.19 20.36 52.91 Favored Glycine 0 N--CA 1.498 2.775 0 O-C-N 121.215 -0.928 . . . . 0.0 111.015 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.0 t -137.91 107.78 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.211 -1.17 . . . . 0.0 110.119 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.0 p -60.17 107.38 0.63 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.528 -0.733 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.465 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 96.2 m95 -88.19 146.68 25.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.032 -1.042 . . . . 0.0 111.956 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.6 t -162.76 171.25 17.05 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.442 HG12 ' CE1' ' A' ' 57' ' ' HIS . 16.3 t -94.5 151.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.451 -0.78 . . . . 0.0 109.655 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -76.93 4.46 9.88 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.178 -0.951 . . . . 0.0 111.709 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.442 ' CE1' HG12 ' A' ' 55' ' ' VAL . 26.3 m170 -40.72 -39.45 1.09 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.379 -0.826 . . . . 0.0 112.392 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.34 40.74 0.24 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.91 -5.6 59.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.445 -1.032 . . . . 0.0 110.864 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.49 133.58 3.07 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -92.32 -20.96 20.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.556 -0.967 . . . . 0.0 110.364 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.0 mtpp -77.7 -165.59 0.65 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.775 . . . . 0.0 110.374 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -64.93 100.09 0.39 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.594 -0.691 . . . . 0.0 111.147 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.24 171.39 0.05 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.626 -0.671 . . . . 0.0 110.261 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.37 142.89 46.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.269 -0.895 . . . . 0.0 111.312 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.99 -179.02 17.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -64.88 -23.0 62.62 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 O-C-N 123.9 1.474 . . . . 0.0 110.752 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -152.27 41.45 0.64 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.356 -0.84 . . . . 0.0 110.062 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.69 156.1 7.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -61.52 158.71 35.2 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.778 1.409 . . . . 0.0 110.112 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 80.5 mt -99.3 118.57 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.514 -0.741 . . . . 0.0 109.563 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 m -59.22 124.64 20.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.772 -0.58 . . . . 0.0 110.41 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -73.59 136.02 43.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.656 -0.653 . . . . 0.0 110.072 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.402 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -135.1 -44.9 0.71 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.631 -0.668 . . . . 0.0 110.304 -179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.429 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 14.8 m-85 -130.6 118.44 21.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.599 -0.688 . . . . 0.0 110.055 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 11.7 m -158.27 108.91 2.13 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.558 -0.714 . . . . 0.0 111.196 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -138.67 76.65 1.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.021 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.2 m 11.77 -133.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.88 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.49 177.99 8.62 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.733 -1.23 . . . . 0.0 110.106 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 52.31 23.08 2.25 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.523 -0.736 . . . . 0.0 110.871 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -163.59 -114.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 109.081 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.43 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 3.0 tp 173.47 176.53 0.12 Allowed 'General case' 0 N--CA 1.516 2.847 0 CA-C-N 120.908 1.686 . . . . 0.0 111.319 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 13.3 t -144.8 104.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -123.06 109.87 1.43 Allowed Glycine 0 N--CA 1.487 2.049 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.879 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.446 ' CH2' HG12 ' A' ' 36' ' ' VAL . 1.7 m0 -86.72 171.19 11.13 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -83.11 131.73 35.13 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.338 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -108.0 85.38 2.55 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.144 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.551 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -95.55 -10.71 1.0 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.745 1.392 . . . . 0.0 113.218 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 47.7 Cg_endo -72.32 73.57 2.69 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 115.715 -2.39 . . . . 0.0 110.767 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 51.87 25.8 16.82 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.56 138.73 56.71 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.458 -1.025 . . . . 0.0 110.963 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -84.18 120.4 26.15 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.3 p -93.17 119.73 32.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.632 -0.667 . . . . 0.0 110.7 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mt -77.66 -147.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.2 -174.7 0.45 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 109.084 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -80.22 149.24 19.46 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 O-C-N 123.339 1.178 . . . . 0.0 111.138 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 151' ' ' VAL . 1.8 t -68.15 156.23 37.94 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.158 0.98 . . . . 0.0 110.65 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -170.98 38.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 11.8 m -82.33 -172.56 4.07 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.625 0.726 . . . . 0.0 110.842 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -110.59 -32.76 2.62 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 m -99.02 -155.38 0.5 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.537 -0.978 . . . . 0.0 109.858 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.76 19.92 0.91 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.383 -0.823 . . . . 0.0 111.094 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -78.85 106.82 11.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.54 -178.39 3.61 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.778 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -141.49 92.97 2.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.686 -0.634 . . . . 0.0 109.32 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 tp -51.33 100.45 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.412 -0.805 . . . . 0.0 110.201 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.2 t -82.79 124.64 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.106 -1.037 . . . . 0.0 110.858 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.415 ' HB ' ' NE2' ' A' ' 110' ' ' HIS . 47.6 p -89.91 179.73 5.91 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.412 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -96.38 52.99 1.28 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.047 -1.033 . . . . 0.0 111.404 -178.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.415 ' NE2' ' HB ' ' A' ' 108' ' ' THR . 4.9 p80 -177.09 44.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.44 -0.788 . . . . 0.0 109.996 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.57 65.11 1.61 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.643 -0.661 . . . . 0.0 111.237 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.58 96.56 1.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -109.26 150.71 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.607 -0.683 . . . . 0.0 110.948 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.8 pt -133.22 134.61 24.34 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.379 -0.825 . . . . 0.0 109.797 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.93 142.3 92.55 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 123.831 1.437 . . . . 0.0 112.13 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.45 152.89 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.763 -0.586 . . . . 0.0 109.683 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.89 110.84 18.24 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -48.35 127.12 12.46 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.354 -0.841 . . . . 0.0 110.725 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -111.88 -24.7 9.83 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.384 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.44 -169.66 36.75 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -63.31 128.33 35.33 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.843 0.83 . . . . 0.0 109.96 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.78 46.86 24.93 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.139 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.46 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 1.2 ttp180 -166.44 151.16 7.81 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.493 -0.754 . . . . 0.0 110.649 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.84 -178.34 18.65 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.64 134.45 53.77 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 122.008 -0.701 . . . . 0.0 111.88 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.98 133.47 40.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.608 -0.683 . . . . 0.0 109.194 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 33.2 mt -107.27 54.16 0.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.001 0.905 . . . . 0.0 108.642 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.34 126.6 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.175 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -58.35 110.12 0.6 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 O-C-N 123.568 1.299 . . . . 0.0 110.33 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -123.03 137.77 28.71 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.58 131.69 26.86 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.854 1.45 . . . . 0.0 110.505 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.8 p -60.14 -36.83 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.658 -0.651 . . . . 0.0 109.674 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 t -49.39 -36.51 22.07 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 122.035 0.922 . . . . 0.0 110.654 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -66.68 -37.49 84.86 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 13.3 mt -66.46 -36.23 82.24 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -61.18 121.62 13.0 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.746 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 113.82 -31.99 6.26 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.5 m -91.39 13.2 18.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.975 . . . . 0.0 110.881 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 p -51.52 128.74 23.82 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.174 -0.954 . . . . 0.0 110.379 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 116.26 -13.75 16.13 Favored Glycine 0 CA--C 1.542 1.772 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.447 ' HA2' HD23 ' A' ' 44' ' ' LEU . . . -46.28 110.22 0.47 Allowed Glycine 0 N--CA 1.504 3.21 0 O-C-N 121.504 -0.997 . . . . 0.0 111.174 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -67.84 126.97 15.38 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 124.066 1.561 . . . . 0.0 110.927 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.431 HD21 ' CG ' ' A' ' 169' ' ' PHE . 6.2 mp -80.24 130.87 35.51 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.64 120.37 22.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 109.472 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.566 ' CB ' ' HD3' ' A' ' 146' ' ' PRO . 43.1 m -49.9 -92.17 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.653 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 145' ' ' CYS . 49.3 Cg_endo -92.3 -81.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 114.764 -3.024 . . . . 0.0 111.15 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.7 t -136.95 78.96 1.73 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.19 -0.944 . . . . 0.0 109.714 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 127.09 -166.53 19.85 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.9 m170 54.46 98.53 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.266 -1.138 . . . . 0.0 110.382 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.68 141.33 49.87 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.206 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 97' ' ' CYS . 33.4 t -107.04 -43.39 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.81 179.33 46.24 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.426 HG13 HG11 ' A' ' 170' ' ' VAL . 1.4 pt -111.8 170.47 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 CA-C-N 119.589 1.695 . . . . 0.0 111.212 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 10.3 t80 -83.71 89.17 7.1 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.089 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -74.75 -41.04 60.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.503 -0.748 . . . . 0.0 109.153 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.405 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -159.74 -179.46 7.88 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -137.98 113.91 9.91 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.452 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.5 t -60.21 101.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.9 p -123.01 156.94 33.77 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.363 1.078 . . . . 0.0 113.603 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 162' ' ' GLY . 6.1 p -96.38 -171.79 2.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -46.0 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.396 -0.815 . . . . 0.0 111.905 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 73.01 -19.24 1.28 Allowed Glycine 0 N--CA 1.499 2.865 0 O-C-N 121.168 -0.958 . . . . 0.0 112.795 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.8 t -101.98 136.05 35.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 119.39 1.595 . . . . 0.0 109.199 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -94.53 135.59 35.8 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.063 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -116.23 -38.48 3.57 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.611 -0.681 . . . . 0.0 111.047 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -129.36 178.78 6.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.496 -0.753 . . . . 0.0 109.685 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.2 t -121.11 144.82 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.671 0.748 . . . . 0.0 111.595 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.6 97.34 7.09 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.46 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 0.2 OUTLIER -126.97 142.91 51.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.881 -1.128 . . . . 0.0 112.468 -175.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.426 HG11 HG13 ' A' ' 153' ' ' ILE . 3.7 p -98.19 130.43 28.5 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 50.5 Cg_endo -58.68 152.69 54.46 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.667 1.351 . . . . 0.0 111.484 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.464 ' HA ' ' HG3' ' A' ' 175' ' ' MET . 17.8 m -77.57 -2.53 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.417 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -85.32 -38.67 18.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 109.032 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.4 m -60.68 -36.42 78.7 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.464 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 3.3 mtt -49.25 -37.13 22.38 Favored 'General case' 0 N--CA 1.515 2.796 0 CA-C-O 121.715 0.769 . . . . 0.0 109.075 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -61.0 -40.53 93.87 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.7 m -65.55 -39.74 92.06 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.718 0.771 . . . . 0.0 109.205 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -50.62 -41.22 54.76 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.819 -0.551 . . . . 0.0 110.798 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.465 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -53.88 -41.45 67.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.943 -1.098 . . . . 0.0 111.193 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -53.39 -36.7 61.73 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.301 -0.874 . . . . 0.0 109.61 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -67.82 -43.54 79.35 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 t -100.93 107.45 18.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.449 -0.782 . . . . 0.0 110.656 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -118.75 -62.17 1.56 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.436 -0.79 . . . . 0.0 110.326 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt 52.96 26.07 4.45 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.393 -0.817 . . . . 0.0 110.743 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -86.7 -80.93 0.23 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.57 -0.706 . . . . 0.0 110.019 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.183 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.953 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.261 0.553 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -151.99 -105.46 0.29 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 57.74 107.18 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.55 -0.971 . . . . 0.0 111.154 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.4 t0 55.69 40.3 30.88 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.466 -0.772 . . . . 0.0 110.201 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.79 21.44 4.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.516 -0.74 . . . . 0.0 111.195 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -108.21 -179.49 3.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 110.011 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.73 80.09 0.64 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 9.4 p -52.27 115.87 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.642 -0.661 . . . . 0.0 111.239 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -170.82 81.04 0.08 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.72 169.53 11.77 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -98.4 -6.12 31.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.587 -0.949 . . . . 0.0 111.308 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.0 t -120.23 142.38 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.122 -0.986 . . . . 0.0 110.749 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -135.47 144.81 46.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.826 -0.546 . . . . 0.0 109.873 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.8 174.01 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.38 -0.825 . . . . 0.0 110.815 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.465 HG13 ' CH2' ' A' ' 85' ' ' TRP . 36.0 m -128.57 -179.07 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -138.66 133.97 33.06 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.731 -1.187 . . . . 0.0 112.296 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.3 p -126.48 -177.81 4.12 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.18 96.69 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.164 -0.96 . . . . 0.0 111.145 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 m 59.54 47.55 10.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.644 -0.66 . . . . 0.0 110.622 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -165.13 169.31 16.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.248 -0.907 . . . . 0.0 110.984 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.5 p -158.45 132.99 8.14 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -99.65 -178.94 4.04 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.111 -0.993 . . . . 0.0 111.235 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.1 152.49 29.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -162.18 159.39 25.82 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.596 -0.69 . . . . 0.0 110.368 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.2 t -138.05 128.83 26.86 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.457 -0.777 . . . . 0.0 111.612 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 79.5 m -77.97 82.22 4.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.551 -0.718 . . . . 0.0 109.727 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.417 ' HB ' ' CD1' ' A' ' 53' ' ' TRP . 57.9 t -97.95 137.84 24.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 57.18 21.0 6.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.801 -0.562 . . . . 0.0 110.248 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.63 23.62 38.79 Favored Glycine 0 N--CA 1.494 2.524 0 O-C-N 121.414 -0.804 . . . . 0.0 111.822 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -143.3 116.18 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-N 118.939 1.37 . . . . 0.0 110.388 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.1 t -64.29 105.64 0.95 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.526 ' CZ3' HG23 ' A' ' 178' ' ' THR . 98.3 m95 -86.41 149.84 24.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.388 -0.82 . . . . 0.0 112.146 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.5 t -164.45 171.93 14.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.584 -0.698 . . . . 0.0 110.519 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -92.98 150.05 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.604 -0.685 . . . . 0.0 109.922 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.533 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 27.0 t80 -82.95 -2.43 55.08 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.219 -0.926 . . . . 0.0 112.112 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -67.47 -10.72 54.19 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.206 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.12 -50.58 0.02 OUTLIER Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.833 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.08 112.63 19.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.012 -1.287 . . . . 0.0 109.899 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.27 10.45 27.61 Favored Glycine 0 N--CA 1.499 2.847 0 O-C-N 121.169 -0.957 . . . . 0.0 110.85 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.4 t -103.66 -38.57 7.05 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.86 -1.377 . . . . 0.0 110.193 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.53 -165.17 1.09 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.494 -0.754 . . . . 0.0 110.577 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -72.05 90.57 1.18 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.669 -0.645 . . . . 0.0 109.855 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.423 ' CD1' ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -56.22 177.77 0.06 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.869 -0.519 . . . . 0.0 110.414 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.3 126.82 32.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -127.99 -178.63 15.43 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.78 -18.04 52.69 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 124.036 1.545 . . . . 0.0 109.649 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -122.89 25.55 8.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 111.008 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 66' ' ' GLY . . . 108.7 -157.71 15.07 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -55.49 145.81 66.82 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.692 1.364 . . . . 0.0 111.523 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.1 mt -93.14 16.57 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.519 -0.738 . . . . 0.0 110.506 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 p 43.17 -153.8 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.302 -0.874 . . . . 0.0 111.501 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.66 118.75 2.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.68 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -30.49 9.98 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.374 -0.828 . . . . 0.0 109.967 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.433 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 15.5 m-85 -129.58 121.71 27.66 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.533 ' CG2' ' CD1' ' A' ' 56' ' ' TYR . 3.7 m -160.44 113.52 2.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.287 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.408 ' HB3' ' CB ' ' A' ' 81' ' ' ASP . 6.3 t-20 -143.59 73.15 1.38 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.504 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 14.2 m 36.01 -162.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.93 -31.61 34.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -52.2 -30.6 27.9 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.682 0.753 . . . . 0.0 109.255 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.408 ' CB ' ' HB3' ' A' ' 77' ' ' ASN . 0.5 OUTLIER -126.97 -102.26 0.35 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.484 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.45 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 0.8 OUTLIER 179.22 168.42 1.01 Allowed 'General case' 0 N--CA 1.512 2.628 0 O-C-N 120.299 -1.501 . . . . 0.0 112.27 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 20.0 t -128.5 150.54 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.38 111.31 0.47 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.319 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.465 ' CH2' HG13 ' A' ' 36' ' ' VAL . 1.1 m-90 -87.04 172.58 9.87 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -87.31 131.33 34.29 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.688 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.66 167.73 1.7 Allowed Pre-proline 0 N--CA 1.494 1.773 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.533 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 33.2 Cg_endo -67.29 -79.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.555 1.546 0 O-C-N 123.879 1.463 . . . . 0.0 110.581 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 88' ' ' PRO . 56.0 Cg_endo -97.65 36.04 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 115.731 -2.379 . . . . 0.0 108.606 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.28 -10.34 73.53 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.433 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . . . 50.15 -178.39 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.207 -1.173 . . . . 0.0 111.855 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -73.19 72.43 1.22 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 t -41.74 95.88 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.755 -0.591 . . . . 0.0 111.968 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.88 -157.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.29 175.14 3.16 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 121.245 -0.91 . . . . 0.0 111.179 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.62 163.95 26.26 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 O-C-N 123.845 1.445 . . . . 0.0 111.545 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 151' ' ' VAL . 18.5 t -79.56 -72.78 0.38 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.705 -0.622 . . . . 0.0 109.811 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.0 m 49.77 74.48 0.2 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.419 -0.801 . . . . 0.0 110.612 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 77.2 m -138.14 -64.92 0.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.261 -0.899 . . . . 0.0 110.601 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 116.33 33.69 1.43 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.4 m -134.32 -163.84 1.42 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.655 -0.909 . . . . 0.0 109.725 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.6 p -135.64 -151.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.578 -0.701 . . . . 0.0 109.546 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.2 t70 62.23 109.79 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.331 -0.856 . . . . 0.0 109.893 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.423 ' CD2' HG22 ' A' ' 151' ' ' VAL . 1.1 mt -128.2 -171.4 2.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.545 -0.722 . . . . 0.0 109.434 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -139.5 90.5 2.41 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.6 tp -59.44 93.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.6 t -82.56 101.57 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.356 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.5 p -65.66 168.48 7.57 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -93.35 24.03 4.15 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.728 -1.232 . . . . 0.0 110.727 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.96 31.27 5.88 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 56.46 71.73 0.55 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.63 0.729 . . . . 0.0 110.516 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -171.99 91.88 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 m -94.57 151.24 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.9 pt -129.96 142.43 45.34 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.29 -0.881 . . . . 0.0 109.031 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.58 132.85 24.5 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.811 1.427 . . . . 0.0 112.09 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.4 t -121.45 153.71 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -116.06 111.85 20.9 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.92 124.13 8.15 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.626 -0.672 . . . . 0.0 110.15 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.422 ' HG3' ' HB2' ' A' ' 125' ' ' SER . 1.6 mmm180 -104.97 -49.45 3.48 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.842 -0.536 . . . . 0.0 110.701 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -151.93 -158.43 8.41 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.712 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -70.58 125.05 25.73 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.147 0.975 . . . . 0.0 109.262 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.83 50.13 16.36 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.042 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.521 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 19.2 ttm180 -166.12 156.53 12.64 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.589 -0.694 . . . . 0.0 110.787 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.95 -178.61 23.28 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.422 ' HB2' ' HG3' ' A' ' 119' ' ' ARG . 1.4 t -135.37 100.84 4.64 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.086 -0.655 . . . . 0.0 111.559 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 pp -48.19 162.64 0.08 Allowed 'General case' 0 N--CA 1.51 2.552 0 O-C-N 121.466 -0.771 . . . . 0.0 110.713 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.7 mt -127.41 67.51 1.3 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 164.3 134.96 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.058 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.691 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.0 100.49 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.803 1.423 . . . . 0.0 109.566 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.36 128.21 25.74 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.539 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -56.0 127.13 24.81 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.917 1.483 . . . . 0.0 110.85 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.61 -36.56 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.44 -37.03 24.29 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.546 -0.722 . . . . 0.0 110.807 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.407 ' CD2' HD22 ' A' ' 135' ' ' LEU . 17.0 t80 -67.8 -39.49 84.01 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.3 mt -63.05 -34.8 78.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 123.81 17.1 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.651 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.31 -31.22 8.88 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.6 m -79.34 -0.62 33.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.915 -0.756 . . . . 0.0 111.104 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 m -57.53 119.84 7.24 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 120.9 -1.125 . . . . 0.0 109.738 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 122.8 -17.24 8.22 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.4 137.88 49.71 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -85.16 129.12 3.78 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 O-C-N 123.522 1.275 . . . . 0.0 113.476 -177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.426 HD23 ' CD2' ' A' ' 169' ' ' PHE . 4.4 mp -81.6 130.79 35.18 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mt -129.92 123.74 31.46 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 119.778 1.172 . . . . 0.0 112.474 -178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 4.2 p -67.44 -173.6 0.16 Allowed Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.94 169.25 15.24 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.674 1.355 . . . . 0.0 110.214 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m 53.35 29.89 9.4 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.638 -0.664 . . . . 0.0 111.43 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 73.63 -134.01 18.43 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 59.61 106.19 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.26 -1.141 . . . . 0.0 110.278 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.81 143.94 57.17 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.69 -0.631 . . . . 0.0 110.798 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 2.1 t -107.01 -42.94 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.759 -0.588 . . . . 0.0 110.326 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.454 ' N ' HG12 ' A' ' 172' ' ' VAL . . . 177.71 -178.62 48.42 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.449 HG13 HG12 ' A' ' 170' ' ' VAL . 1.0 OUTLIER -116.72 153.48 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 118.59 1.195 . . . . 0.0 111.718 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 7.4 t80 -65.38 117.24 7.62 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.505 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -107.26 -35.01 6.93 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.234 -0.916 . . . . 0.0 109.171 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -159.17 169.83 23.28 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -129.84 116.89 19.36 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.41 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.0 t -63.39 100.55 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.431 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 27.8 p -129.03 167.29 17.71 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.512 1.148 . . . . 0.0 113.971 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 162' ' ' GLY . 14.9 p -105.47 -173.51 2.32 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.12 82.9 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 86.09 -27.25 5.63 Favored Glycine 0 N--CA 1.501 2.968 0 O-C-N 121.098 -1.001 . . . . 0.0 112.52 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.27 139.73 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-N 119.188 1.494 . . . . 0.0 108.288 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.431 ' HA ' ' CB ' ' A' ' 159' ' ' CYS . . . -99.52 139.32 35.35 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.371 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -112.98 -31.36 6.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.697 -0.627 . . . . 0.0 110.62 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -141.58 178.65 7.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.888 . . . . 0.0 110.324 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.418 HG11 ' CE1' ' A' ' 154' ' ' PHE . 1.5 t -118.34 150.4 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.662 0.744 . . . . 0.0 110.857 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.92 103.24 9.16 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.521 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 1.7 p90 -128.44 174.32 9.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 118.966 -1.094 . . . . 0.0 112.23 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.449 HG12 HG13 ' A' ' 153' ' ' ILE . 1.4 p -125.96 122.26 24.35 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 41.1 Cg_endo -47.92 152.84 2.89 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 O-C-N 123.651 1.343 . . . . 0.0 113.11 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.475 ' HA ' ' HG2' ' A' ' 175' ' ' MET . 18.2 m -82.38 -1.85 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.343 -0.848 . . . . 0.0 109.832 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -87.42 -43.69 11.9 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.547 -0.72 . . . . 0.0 109.187 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.7 t -60.7 -42.74 97.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.737 -0.602 . . . . 0.0 109.716 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.475 ' HG2' ' HA ' ' A' ' 172' ' ' VAL . 8.2 ptp -58.9 -36.54 74.85 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.914 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.85 -38.05 69.57 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.387 -1.445 . . . . 0.0 108.822 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.7 m -63.62 -36.89 85.3 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.325 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.526 HG23 ' CZ3' ' A' ' 53' ' ' TRP . 3.1 t -48.71 -35.5 14.15 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.12 -0.987 . . . . 0.0 111.645 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.471 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -58.19 -41.25 83.51 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.866 -1.146 . . . . 0.0 110.447 179.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -48.61 -36.68 16.27 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.967 0.889 . . . . 0.0 110.604 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -91.3 -42.74 10.2 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.2 t 51.72 -176.57 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.296 -0.877 . . . . 0.0 110.962 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt -101.62 -67.64 0.86 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.741 0.781 . . . . 0.0 109.941 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.63 144.53 30.24 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.778 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -149.04 53.44 0.97 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.526 -0.734 . . . . 0.0 110.46 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.29 179.721 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.181 0.515 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.11 71.32 0.6 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -124.0 54.76 1.31 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.604 -0.939 . . . . 0.0 109.331 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -147.27 42.3 1.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.633 -0.667 . . . . 0.0 110.453 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -91.47 52.54 2.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.47 -0.769 . . . . 0.0 110.489 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -65.22 86.82 0.07 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.534 -0.729 . . . . 0.0 109.305 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.85 77.94 0.76 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.543 -0.723 . . . . 0.0 109.592 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.6 m -100.31 -164.48 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.816 -0.553 . . . . 0.0 109.91 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 58.51 79.07 0.22 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.333 -0.855 . . . . 0.0 109.869 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.0 -108.92 0.21 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -168.43 -35.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.549 -0.971 . . . . 0.0 111.437 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.42 HG21 HG22 ' A' ' 46' ' ' THR . 54.1 t -131.32 140.6 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.119 -0.988 . . . . 0.0 111.723 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.84 156.41 48.95 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.27 174.87 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.307 -0.87 . . . . 0.0 111.885 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.471 ' CG1' ' CZ ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -144.6 163.73 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.3 p -119.91 142.89 48.29 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.387 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 p -123.85 -176.87 3.58 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.27 98.36 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.395 -0.815 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 p 51.92 31.98 9.27 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.828 -0.545 . . . . 0.0 110.794 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -146.87 154.99 41.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.552 -0.717 . . . . 0.0 110.449 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.2 t -150.0 165.72 31.83 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.568 -0.707 . . . . 0.0 109.318 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.471 ' CZ ' ' CG1' ' A' ' 36' ' ' VAL . 11.0 p90 -153.6 -177.38 6.33 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.254 -0.904 . . . . 0.0 110.598 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.441 ' HB2' ' CG ' ' A' ' 109' ' ' ARG . 7.0 tt -110.43 146.1 36.46 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -146.12 128.86 16.23 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.681 -1.262 . . . . 0.0 110.287 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.42 HG22 HG21 ' A' ' 33' ' ' VAL . 99.9 m -110.31 128.13 55.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.435 -0.791 . . . . 0.0 111.479 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 79.2 m -78.07 85.95 4.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.806 -0.559 . . . . 0.0 109.816 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.26 136.44 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.99 19.3 5.78 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.397 -0.815 . . . . 0.0 109.993 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.98 24.35 45.31 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -139.85 105.44 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 121.261 -1.141 . . . . 0.0 110.378 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.6 OUTLIER -58.04 97.34 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.464 -0.772 . . . . 0.0 109.942 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.478 ' CE3' ' CD2' ' A' ' 82' ' ' LEU . 81.2 m95 -78.53 141.35 38.23 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.341 -0.849 . . . . 0.0 110.668 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.434 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 10.2 t -163.33 126.77 2.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.564 -0.71 . . . . 0.0 109.707 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 m -49.3 143.7 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 O-C-N 121.274 -0.891 . . . . 0.0 110.902 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CB ' ' HB ' ' A' ' 78' ' ' VAL . 4.8 t80 -74.62 -1.72 22.85 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.123 -0.986 . . . . 0.0 110.902 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -48.79 -27.31 2.89 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.26 -0.9 . . . . 0.0 110.689 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.03 76.7 0.09 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 43' ' ' PHE . . . -105.09 -51.16 3.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.447 -1.031 . . . . 0.0 110.101 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 151.08 -40.6 0.79 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 p 51.68 23.94 2.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.551 -0.97 . . . . 0.0 111.201 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.24 -158.47 0.91 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.426 -0.797 . . . . 0.0 110.509 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.4 m -60.3 91.02 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.573 -0.704 . . . . 0.0 110.534 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.16 164.82 25.72 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.675 -0.641 . . . . 0.0 110.233 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.31 135.48 55.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.205 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.23 -179.02 19.87 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.3 -29.19 88.37 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.872 1.459 . . . . 0.0 111.098 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -147.32 38.6 0.96 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.407 -0.808 . . . . 0.0 110.096 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.06 158.08 8.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -63.63 163.7 23.52 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 O-C-N 123.92 1.484 . . . . 0.0 110.493 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.416 HG23 ' CE3' ' A' ' 85' ' ' TRP . 93.4 mt -106.81 108.75 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.653 -0.654 . . . . 0.0 109.494 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -62.0 137.09 58.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.717 -0.615 . . . . 0.0 110.51 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -73.55 163.47 27.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.566 -0.708 . . . . 0.0 109.806 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -43.81 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.448 -0.783 . . . . 0.0 110.486 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.458 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 14.3 m-85 -126.68 124.36 39.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.492 -0.755 . . . . 0.0 110.075 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.427 HG22 ' CG1' ' A' ' 83' ' ' VAL . 6.3 m -158.85 106.41 1.84 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.705 -0.622 . . . . 0.0 111.009 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -152.44 76.57 1.16 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.554 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.446 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.5 p -72.31 -21.26 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.641 -0.662 . . . . 0.0 110.828 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.73 -32.17 29.32 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.045 -1.034 . . . . 0.0 110.401 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -173.85 34.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.595 -0.691 . . . . 0.0 110.337 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -153.95 -99.92 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.313 -0.867 . . . . 0.0 111.811 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.478 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 6.2 tp 178.19 176.35 0.47 Allowed 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.548 -1.345 . . . . 0.0 110.274 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 54' ' ' THR . 16.1 t -132.83 115.57 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.31 110.79 0.82 Allowed Glycine 0 N--CA 1.485 1.908 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.42 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.416 ' CE3' HG23 ' A' ' 71' ' ' ILE . 1.9 m0 -79.38 166.43 22.07 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -86.39 130.29 34.56 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.304 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -108.17 92.13 9.04 Favored Pre-proline 0 C--N 1.294 -1.846 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.344 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.578 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.8 Cg_endo -104.48 -3.5 0.2 Allowed 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.747 1.393 . . . . 0.0 112.967 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 52.4 Cg_endo -72.94 72.29 3.28 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 115.714 -2.391 . . . . 0.0 109.683 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 57.21 24.24 50.58 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.39 138.56 43.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.546 -0.973 . . . . 0.0 110.732 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.0 135.95 43.16 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.474 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.3 p -104.59 97.93 7.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.563 -0.71 . . . . 0.0 109.563 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.49 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.543 -0.723 . . . . 0.0 109.161 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.6 p -155.48 173.77 4.56 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.573 -0.705 . . . . 0.0 110.339 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.34 177.61 8.55 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.839 1.441 . . . . 0.0 110.198 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 t -98.69 -77.3 0.52 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.539 -0.725 . . . . 0.0 110.119 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m 55.11 49.81 16.64 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.223 -0.923 . . . . 0.0 110.008 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 78.3 m -112.5 -46.69 3.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.671 -0.643 . . . . 0.0 110.302 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.98 28.8 6.38 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.31 -164.56 1.22 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.609 -0.936 . . . . 0.0 109.987 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.2 p -140.88 -150.33 0.31 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.369 -0.832 . . . . 0.0 110.541 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.73 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.137 -0.977 . . . . 0.0 109.973 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.94 -178.8 3.58 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.503 -0.748 . . . . 0.0 110.097 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -133.56 84.74 2.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.669 -0.644 . . . . 0.0 109.618 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.5 tp -60.87 106.38 0.57 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.629 -0.669 . . . . 0.0 109.39 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.409 ' HB ' ' HD2' ' A' ' 142' ' ' PRO . 25.1 t -84.43 133.65 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.657 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.3 p -89.34 -177.86 5.47 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.441 ' CG ' ' HB2' ' A' ' 44' ' ' LEU . 14.5 mtm180 -87.73 18.9 3.73 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.0 -1.063 . . . . 0.0 110.505 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.48 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.9 OUTLIER -151.19 47.49 0.83 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.051 -1.03 . . . . 0.0 111.99 -177.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.06 73.03 0.44 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.294 -0.879 . . . . 0.0 111.457 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.82 90.16 0.69 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.791 -0.568 . . . . 0.0 109.818 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.3 m -94.78 149.55 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 110.252 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 34.1 pt -131.48 141.77 42.94 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.512 -0.742 . . . . 0.0 109.723 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.33 137.38 36.55 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.918 1.483 . . . . 0.0 111.772 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.9 t -130.97 140.31 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.04 118.26 36.16 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -48.75 127.3 13.51 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.401 -0.812 . . . . 0.0 110.203 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -107.13 -25.23 11.64 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.257 -177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 121' ' ' ASP . . . 173.04 56.52 0.05 OUTLIER Glycine 0 N--CA 1.498 2.773 0 C-N-CA 118.834 -1.65 . . . . 0.0 110.59 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 120' ' ' GLY . 0.6 OUTLIER 59.23 142.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.831 -0.806 . . . . 0.0 110.132 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.5 p 45.57 27.78 0.45 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.544 0.688 . . . . 0.0 111.554 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.494 ' N ' ' CD2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -166.88 148.05 5.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.522 -0.736 . . . . 0.0 109.427 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.37 -178.09 18.04 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.6 t -124.31 122.25 37.22 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.245 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.4 149.53 33.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.743 -0.598 . . . . 0.0 109.582 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 128' ' ' SER . 90.2 mt -126.01 69.4 1.2 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER 158.16 123.05 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.368 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -58.95 106.81 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 O-C-N 123.588 1.31 . . . . 0.0 109.745 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -122.39 151.18 59.0 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.95 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.3 130.02 12.6 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.178 1.62 . . . . 0.0 109.807 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.7 p -57.92 -36.53 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.73 -0.606 . . . . 0.0 110.093 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 t -49.58 -36.55 24.35 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 122.127 0.965 . . . . 0.0 110.227 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -60.85 -38.04 84.18 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 11.5 mt -69.21 -35.28 76.05 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.712 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -56.95 117.07 3.6 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.746 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 108.29 -24.47 22.57 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.43 4.29 40.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.506 -0.997 . . . . 0.0 111.273 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 80.1 p -51.93 128.85 25.4 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.964 -1.085 . . . . 0.0 109.609 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 114.96 -18.28 16.64 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.28 117.46 3.79 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 53.7 Cg_endo -74.11 124.71 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 124.022 1.538 . . . . 0.0 111.343 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.461 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 6.0 mp -82.9 105.07 13.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 176.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.5 mt -105.24 119.72 39.75 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.131 -0.981 . . . . 0.0 112.385 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.41 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 0.9 OUTLIER -59.63 -167.34 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 41.2 Cg_endo -69.4 167.06 25.06 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 117.092 -1.472 . . . . 0.0 109.472 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.2 t 56.77 -155.04 0.32 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.27 -0.894 . . . . 0.0 110.115 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 149' ' ' HIS . . . -102.76 100.53 1.97 Allowed Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.426 ' CG ' ' O ' ' A' ' 148' ' ' GLY . 1.1 m170 -170.65 95.95 0.22 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.692 -0.887 . . . . 0.0 109.853 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.23 142.32 58.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.573 -0.704 . . . . 0.0 109.256 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 0.9 OUTLIER -103.39 -36.99 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.451 -0.781 . . . . 0.0 109.575 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.419 ' HA2' ' CG2' ' A' ' 172' ' ' VAL . . . 176.15 -178.89 47.49 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.438 HG13 HG11 ' A' ' 170' ' ' VAL . 1.1 pp -114.7 168.75 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-N 118.906 1.353 . . . . 0.0 111.392 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 5.9 t80 -76.96 114.57 15.89 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.29 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 26.5 ttt-85 -100.97 -38.97 7.97 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -159.89 173.61 15.68 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -129.69 119.84 24.16 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.772 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.95 100.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.6 p -127.3 158.07 38.19 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 122.253 1.025 . . . . 0.0 113.354 -175.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' GLY . 16.5 p -91.25 -175.01 4.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.92 85.65 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 86.51 -25.0 7.62 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 121.063 -1.023 . . . . 0.0 112.214 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -101.7 140.61 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 119.177 1.489 . . . . 0.0 109.214 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -103.26 129.63 50.29 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.047 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt -111.51 -33.79 6.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.652 -0.655 . . . . 0.0 110.548 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -129.6 -179.7 5.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.275 -0.891 . . . . 0.0 110.219 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -126.89 147.47 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.615 0.722 . . . . 0.0 111.683 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.45 96.33 6.04 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.494 ' CD2' ' N ' ' A' ' 123' ' ' ARG . 0.3 OUTLIER -124.13 160.42 27.83 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.252 -0.979 . . . . 0.0 112.694 -175.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.438 HG11 HG13 ' A' ' 153' ' ' ILE . 2.7 p -116.21 126.22 27.82 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 47.0 Cg_endo -56.53 156.36 22.46 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 O-C-N 123.872 1.459 . . . . 0.0 112.311 -177.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.448 ' HA ' ' HG3' ' A' ' 175' ' ' MET . 57.5 t -80.76 -2.96 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.05 -37.78 28.5 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.9 t -72.42 -36.01 68.49 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.448 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 36.7 mtt -48.24 -39.07 20.13 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.621 -0.674 . . . . 0.0 110.426 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -54.82 -37.27 65.93 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.883 0.849 . . . . 0.0 109.283 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.7 m -52.9 -41.71 64.65 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.236 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.461 HG23 ' CZ3' ' A' ' 53' ' ' TRP . 14.6 t -56.56 -36.47 69.34 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.94 -1.1 . . . . 0.0 111.635 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.458 ' CG ' ' CZ ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -56.2 -44.2 79.23 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.645 -1.284 . . . . 0.0 110.56 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -51.45 -37.91 51.07 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.944 0.878 . . . . 0.0 110.054 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -74.11 -48.47 29.39 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.697 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.3 t 49.88 41.45 22.68 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.509 -0.744 . . . . 0.0 110.992 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt 54.22 -177.19 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.471 -0.768 . . . . 0.0 110.784 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -67.01 151.54 47.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.579 -0.701 . . . . 0.0 109.916 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -154.68 29.07 0.43 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.561 -0.712 . . . . 0.0 110.518 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.7 tptt . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.289 179.957 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.204 0.526 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.13 -37.46 0.07 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.18 85.39 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.385 -1.068 . . . . 0.0 110.508 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -125.13 45.75 2.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.732 -0.605 . . . . 0.0 110.304 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -95.01 47.37 1.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.633 -0.667 . . . . 0.0 110.454 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -62.58 83.91 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.629 -0.669 . . . . 0.0 110.155 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -160.84 77.81 0.59 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.639 -0.663 . . . . 0.0 109.351 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 30' ' ' GLU . 3.5 p -51.36 162.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.468 -0.77 . . . . 0.0 110.476 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' N ' HG23 ' A' ' 29' ' ' VAL . 2.6 mm-40 -156.06 79.38 0.98 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.32 -26.39 3.4 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.39 -79.72 0.07 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.508 -0.995 . . . . 0.0 109.243 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.6 p -150.43 148.71 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 111.385 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -131.84 150.2 52.22 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.6 m -108.98 164.09 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.218 -0.926 . . . . 0.0 112.311 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 m -122.53 179.7 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -149.93 137.87 20.23 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.447 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.4 p -144.65 -178.67 6.12 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.87 76.74 0.31 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.027 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 175.51 -59.51 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.584 -0.697 . . . . 0.0 109.323 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 178.21 -171.3 0.11 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.538 -0.726 . . . . 0.0 109.075 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.3 p -112.68 138.06 50.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.513 -0.742 . . . . 0.0 109.923 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.485 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 43.9 m-85 -106.3 173.07 6.48 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.537 -0.727 . . . . 0.0 110.607 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 12.7 mt -100.67 159.85 14.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.521 -0.737 . . . . 0.0 110.713 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.45 126.71 5.3 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.073 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.6 t -104.95 127.43 52.79 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.375 -0.828 . . . . 0.0 112.288 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 97.2 m -80.15 85.41 5.71 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.762 -0.586 . . . . 0.0 109.951 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.7 t -105.13 139.43 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.41 17.97 5.23 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.246 -0.909 . . . . 0.0 110.259 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.23 43.12 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.4 t -141.59 112.04 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.313 -1.11 . . . . 0.0 110.546 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.8 t -67.38 105.65 1.85 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.459 ' CE3' ' CD2' ' A' ' 82' ' ' LEU . 82.2 m95 -87.3 145.54 26.31 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.235 -0.916 . . . . 0.0 111.097 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 t -162.2 178.35 8.83 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.269 -0.894 . . . . 0.0 110.293 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.4 m -101.35 143.12 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.636 -0.665 . . . . 0.0 109.948 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.477 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 36.9 t80 -78.25 2.53 18.03 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.063 -1.023 . . . . 0.0 111.923 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -48.73 -26.77 2.51 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.178 -0.951 . . . . 0.0 110.868 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.424 ' HA3' ' CZ ' ' A' ' 43' ' ' PHE . . . -177.75 35.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.29 0.39 37.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.188 -1.184 . . . . 0.0 111.194 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.05 -171.28 22.37 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.0 t -160.65 -43.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.677 -0.896 . . . . 0.0 110.033 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -165.99 0.06 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.726 -0.608 . . . . 0.0 110.513 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -59.7 97.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.663 -0.648 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.473 HD12 ' CE2' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -60.46 176.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.668 -0.645 . . . . 0.0 109.928 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -118.18 135.68 54.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.417 -0.802 . . . . 0.0 110.669 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.3 179.61 23.81 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -63.57 -23.15 70.54 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.876 1.461 . . . . 0.0 110.483 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -153.28 40.47 0.53 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.326 -0.859 . . . . 0.0 110.425 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 150.11 170.07 16.99 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -64.74 147.7 89.85 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.892 1.469 . . . . 0.0 110.333 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 91.4 mt -79.22 168.87 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.581 -0.699 . . . . 0.0 109.369 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.2 m -80.75 -45.58 16.82 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.21 -0.931 . . . . 0.0 111.608 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 55.5 90.05 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.457 -0.777 . . . . 0.0 109.775 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.6 ttt -126.81 -10.02 6.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.546 -0.722 . . . . 0.0 111.444 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.407 ' CD2' ' HE3' ' A' ' 179' ' ' MET . 15.5 m-85 -128.25 113.65 15.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.091 -1.006 . . . . 0.0 109.655 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.443 HG21 ' HB ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -151.06 112.51 4.4 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.888 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -159.8 74.63 0.6 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 6.6 p -68.05 -10.8 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.361 -0.837 . . . . 0.0 111.302 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.79 85.75 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.349 -0.844 . . . . 0.0 108.976 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 78' ' ' VAL . 3.9 tt0 60.1 39.09 20.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.544 -0.723 . . . . 0.0 109.653 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.79 -93.89 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.969 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.459 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 10.2 tp 177.68 168.61 0.68 Allowed 'General case' 0 N--CA 1.508 2.425 0 O-C-N 120.329 -1.482 . . . . 0.0 110.943 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 9.8 m -141.98 122.67 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.69 142.83 10.29 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.473 ' CE2' HD12 ' A' ' 64' ' ' LEU . 2.4 m-90 -99.08 169.52 9.35 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.32 140.31 31.7 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.727 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.81 94.73 5.52 Favored Pre-proline 0 C--N 1.3 -1.553 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.041 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.576 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.5 Cg_endo -101.39 -12.3 0.17 Allowed 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.644 1.339 . . . . 0.0 113.321 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 49.5 Cg_endo -72.03 69.1 3.14 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 116.175 -2.083 . . . . 0.0 111.203 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.12 14.48 25.31 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.404 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . . . -57.01 131.7 50.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.107 -1.231 . . . . 0.0 110.73 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -85.16 97.73 10.06 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.5 m -52.17 112.95 0.89 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.737 -0.602 . . . . 0.0 111.394 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -152.62 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.52 -0.737 . . . . 0.0 109.133 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p -152.67 179.44 1.27 Allowed Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.346 -0.846 . . . . 0.0 111.303 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.401 ' HA ' HG22 ' A' ' 172' ' ' VAL . 42.7 Cg_endo -86.03 164.19 10.14 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 O-C-N 123.916 1.482 . . . . 0.0 111.535 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 149' ' ' HIS . 0.8 OUTLIER -96.76 86.58 4.09 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.592 -0.693 . . . . 0.0 110.605 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.1 p -61.11 -39.07 88.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.421 -0.799 . . . . 0.0 109.647 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.3 p -64.6 -37.91 89.18 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.48 -0.763 . . . . 0.0 109.764 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 48.2 29.29 6.76 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.86 159.02 14.68 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.498 -1.001 . . . . 0.0 110.281 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.1 t -66.02 -170.1 0.08 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.524 -0.735 . . . . 0.0 110.049 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.77 100.66 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.507 -0.745 . . . . 0.0 110.34 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 mt -117.33 -173.59 2.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.398 -0.814 . . . . 0.0 109.936 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -140.7 84.98 1.97 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.817 -0.552 . . . . 0.0 109.699 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.5 tp -71.89 100.96 2.54 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.2 t -90.72 123.21 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.123 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.9 p -88.37 145.84 25.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -15.14 39.46 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.837 -1.165 . . . . 0.0 109.744 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.423 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 13.4 m170 -55.23 -79.29 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 169.72 47.83 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.25 -0.906 . . . . 0.0 110.305 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -169.56 127.15 0.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.734 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 m -95.6 156.49 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.3 pt -131.68 127.76 21.51 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.442 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -66.04 145.9 80.72 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.876 1.461 . . . . 0.0 110.786 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.8 t -137.74 152.22 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.24 107.5 18.35 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.57 122.76 5.83 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.584 -0.697 . . . . 0.0 110.566 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.18 -24.33 9.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.824 -0.547 . . . . 0.0 110.188 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.96 177.92 36.24 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -61.42 -22.8 65.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.959 -0.73 . . . . 0.0 110.204 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.3 p -135.76 41.09 2.73 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.834 -0.541 . . . . 0.0 111.463 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.499 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -169.8 151.88 4.34 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.174 -0.954 . . . . 0.0 111.397 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.86 -178.73 22.42 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.09 116.08 19.43 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.896 -0.767 . . . . 0.0 111.773 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.66 142.71 17.71 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.43 -0.794 . . . . 0.0 110.514 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.9 mt -111.03 54.27 0.68 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 164.38 125.28 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.252 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -56.82 115.94 2.85 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 O-C-N 123.543 1.286 . . . . 0.0 110.72 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -122.31 141.63 35.09 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.752 . . . . 0.0 109.27 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -64.52 128.19 20.68 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.813 1.428 . . . . 0.0 110.383 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 p -62.84 -35.06 69.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.157 0.503 . . . . 0.0 110.061 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 m -48.71 -37.24 18.13 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.122 -0.986 . . . . 0.0 110.487 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -67.26 -38.34 84.97 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.9 mt -64.99 -36.13 83.4 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -63.85 123.18 18.28 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.97 -26.01 24.52 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.9 m -92.38 14.41 16.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.481 -1.011 . . . . 0.0 110.694 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.59 127.67 32.38 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.102 -0.999 . . . . 0.0 109.63 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.51 -7.12 26.38 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.45 136.2 50.81 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.07 123.59 5.72 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.745 1.392 . . . . 0.0 112.698 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.458 HD23 ' CD1' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -82.74 124.69 30.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.179 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.3 mt -124.34 116.19 22.2 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.955 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.419 ' HB2' ' CD ' ' A' ' 146' ' ' PRO . 19.9 p -73.41 177.76 1.85 Allowed Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.419 ' CD ' ' HB2' ' A' ' 145' ' ' CYS . 48.7 Cg_endo -62.36 179.73 0.6 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.297 1.156 . . . . 0.0 109.952 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.5 m 56.01 29.1 13.78 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.312 -0.867 . . . . 0.0 110.789 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 60.5 -145.09 47.43 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 21.1 m170 61.68 127.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.895 -0.768 . . . . 0.0 110.44 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.34 140.89 41.64 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.347 -0.846 . . . . 0.0 110.461 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 1.1 t -97.14 -43.41 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.407 ' HA2' ' CG1' ' A' ' 172' ' ' VAL . . . 178.53 -178.56 48.69 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.3 pp -116.93 150.31 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.063 -1.257 . . . . 0.0 111.397 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 5.3 t80 -63.0 115.13 4.14 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.014 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -102.05 -38.58 7.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -160.74 176.13 11.84 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -133.17 117.06 17.0 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.473 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.4 t -65.9 97.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.6 p -120.93 159.51 25.41 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 122.399 1.095 . . . . 0.0 113.888 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 162' ' ' GLY . 2.1 m -95.5 -173.78 2.99 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.65 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.438 -0.789 . . . . 0.0 112.567 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 82.8 -31.83 3.0 Favored Glycine 0 N--CA 1.499 2.888 0 O-C-N 121.205 -0.934 . . . . 0.0 111.748 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.25 131.64 39.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 119.144 1.472 . . . . 0.0 109.328 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -92.13 135.14 34.22 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.035 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -113.31 -44.19 3.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.555 -0.716 . . . . 0.0 111.135 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -121.84 179.45 4.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.129 -0.982 . . . . 0.0 109.868 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.58 151.17 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.421 -0.799 . . . . 0.0 110.818 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.68 91.04 3.45 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.499 ' CE1' ' N ' ' A' ' 123' ' ' ARG . 3.1 p90 -127.42 160.24 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.862 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.63 130.3 23.01 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.2 Cg_endo -60.67 154.05 57.59 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 124.14 1.6 . . . . 0.0 111.394 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.427 ' HA ' ' HG3' ' A' ' 175' ' ' MET . 25.2 m -79.47 1.05 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.6 -0.688 . . . . 0.0 110.789 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.22 -37.46 14.12 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 35.4 t -72.07 -36.25 69.49 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.119 0.485 . . . . 0.0 110.272 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.427 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 32.3 mtt -47.32 -36.94 10.07 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.69 -0.631 . . . . 0.0 111.08 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -48.02 -36.59 13.13 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.694 -0.629 . . . . 0.0 111.915 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.0 t -48.64 -39.07 22.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.542 -0.724 . . . . 0.0 112.841 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.426 HG23 ' CZ3' ' A' ' 53' ' ' TRP . 6.4 t -56.92 -38.49 72.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.116 -0.99 . . . . 0.0 112.213 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.443 ' HE2' ' CH2' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -57.5 -40.07 77.88 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.596 -1.315 . . . . 0.0 110.362 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -38.4 91.01 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.956 0.884 . . . . 0.0 108.905 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.76 66.1 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.909 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.5 m -77.64 103.04 7.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.518 -0.739 . . . . 0.0 109.913 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -121.04 63.98 0.87 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.463 -0.773 . . . . 0.0 110.749 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -87.82 66.12 8.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.402 -0.811 . . . . 0.0 109.45 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -65.31 152.35 44.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.703 -0.623 . . . . 0.0 109.94 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.644 -179.704 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.057 0.456 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -129.9 35.93 2.44 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -86.83 95.7 9.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.601 -0.941 . . . . 0.0 110.152 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.54 -45.7 3.1 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -145.67 86.88 1.75 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.328 0.585 . . . . 0.0 109.979 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -80.01 -178.14 6.36 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.702 -0.624 . . . . 0.0 109.425 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -160.71 78.61 0.62 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.248 0.547 . . . . 0.0 110.159 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.53 163.41 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -168.73 78.84 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.8 . . . . 0.0 109.375 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.55 -68.77 0.07 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.467 ' C ' ' CG2' ' A' ' 33' ' ' VAL . 3.5 pt-20 -164.92 -48.78 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.963 . . . . 0.0 110.832 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.578 ' CG2' ' HA ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -164.09 -161.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.929 -1.107 . . . . 0.0 112.738 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -143.08 167.1 22.89 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.462 0.649 . . . . 0.0 110.117 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.98 147.03 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.415 ' CG1' HD23 ' A' ' 64' ' ' LEU . 28.0 m -98.48 -179.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 m -134.69 138.88 44.8 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.968 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 p -132.99 -175.99 3.97 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.1 102.99 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.357 -0.84 . . . . 0.0 110.551 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.5 p 47.47 43.76 16.04 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.202 0.525 . . . . 0.0 111.554 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.47 153.13 21.01 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.709 -0.619 . . . . 0.0 111.128 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 p -139.85 139.48 36.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.504 -0.748 . . . . 0.0 109.25 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 37.2 m-85 -105.02 -179.26 3.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.164 -0.96 . . . . 0.0 111.802 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.34 140.64 50.98 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.605 -0.684 . . . . 0.0 110.445 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.464 ' C ' HG13 ' A' ' 33' ' ' VAL . . . -119.45 -177.56 3.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.41 -0.806 . . . . 0.0 109.747 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.578 ' HA ' ' CG2' ' A' ' 33' ' ' VAL . 3.4 t -157.85 113.91 2.82 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.185 -0.947 . . . . 0.0 111.513 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.436 ' N ' HG12 ' A' ' 33' ' ' VAL . 24.3 p -70.62 105.73 3.24 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.947 -1.095 . . . . 0.0 111.434 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.44 ' HB ' ' CD1' ' A' ' 53' ' ' TRP . 17.6 t -124.39 127.93 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t30 60.48 17.83 7.66 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.365 -0.834 . . . . 0.0 109.722 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.05 19.79 52.05 Favored Glycine 0 N--CA 1.499 2.894 0 O-C-N 121.109 -0.994 . . . . 0.0 111.088 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.406 ' O ' ' CD1' ' A' ' 53' ' ' TRP . 47.3 t -136.18 105.84 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.114 -1.227 . . . . 0.0 109.638 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.4 p -59.75 103.37 0.2 Allowed 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.309 -0.87 . . . . 0.0 109.794 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.494 ' CH2' ' HE3' ' A' ' 179' ' ' MET . 95.9 m95 -82.75 150.96 26.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.998 -1.064 . . . . 0.0 111.416 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.422 ' CG2' ' CZ2' ' A' ' 85' ' ' TRP . 7.7 t -158.61 155.23 27.87 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.41 HG13 ' CG ' ' A' ' 57' ' ' HIS . 20.7 t -80.83 144.57 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.232 -0.917 . . . . 0.0 109.676 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 28.8 t80 -78.08 4.75 11.58 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.049 -1.032 . . . . 0.0 112.134 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.41 ' CG ' HG13 ' A' ' 55' ' ' VAL . 16.2 m170 -45.51 -39.63 7.59 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.292 -0.88 . . . . 0.0 111.54 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.416 ' HA3' ' CZ ' ' A' ' 43' ' ' PHE . . . -167.68 28.18 0.16 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.57 -166.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.262 -1.14 . . . . 0.0 109.632 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.22 90.77 0.81 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.6 p -71.2 -10.09 59.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.497 -1.002 . . . . 0.0 110.082 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -118.79 -153.39 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 110.506 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.5 t -59.69 90.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.477 -0.764 . . . . 0.0 110.937 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.415 HD23 ' CG1' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.21 173.15 0.9 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.322 -0.861 . . . . 0.0 109.392 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.43 132.21 55.16 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.206 -0.934 . . . . 0.0 110.314 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.88 -178.82 24.26 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -57.9 -20.38 44.09 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.78 1.41 . . . . 0.0 110.507 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 24.71 12.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.534 -0.729 . . . . 0.0 109.809 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.6 -106.51 2.43 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -76.35 120.39 5.62 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.753 1.396 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.407 ' CD1' HD21 ' A' ' 64' ' ' LEU . 75.5 mt -75.19 146.15 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 m -90.64 92.95 9.06 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.442 -0.786 . . . . 0.0 111.06 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -61.63 107.92 0.89 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.675 -0.641 . . . . 0.0 109.406 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 mmt -113.9 -26.81 7.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.576 -0.702 . . . . 0.0 111.042 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CD2' ' CE ' ' A' ' 179' ' ' MET . 7.5 m-85 -122.57 118.31 27.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.417 -0.802 . . . . 0.0 109.738 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.475 ' CG2' ' CD1' ' A' ' 56' ' ' TYR . 5.4 m -155.29 122.99 5.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.635 -0.666 . . . . 0.0 110.779 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -142.11 76.65 1.55 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.28 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.43 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.4 p -49.5 -32.62 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.595 -0.691 . . . . 0.0 109.69 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.59 -47.72 73.01 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.7 -0.625 . . . . 0.0 109.671 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -93.06 17.27 11.11 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.981 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 52.29 52.47 14.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.214 -0.929 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.476 ' CD1' ' HG2' ' A' ' 175' ' ' MET . 1.5 mt -161.44 151.69 17.42 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.031 0.919 . . . . 0.0 112.343 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 53' ' ' TRP . 58.1 t -156.76 146.03 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -142.45 115.28 0.94 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.008 -1.568 . . . . 0.0 112.18 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.422 ' CZ2' ' CG2' ' A' ' 54' ' ' THR . 1.5 m0 -97.98 167.2 11.05 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -81.22 134.71 35.66 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.387 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.05 91.17 3.5 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.214 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 53.5 Cg_endo -101.9 -10.24 0.2 Allowed 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.595 1.313 . . . . 0.0 112.726 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 46.5 Cg_endo -72.84 67.52 3.92 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 115.735 -2.377 . . . . 0.0 110.678 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 53.79 23.24 21.24 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.4 135.79 44.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -1.005 . . . . 0.0 110.736 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -61.35 -168.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.771 -0.581 . . . . 0.0 109.68 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 t -147.0 103.97 3.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.54 -0.725 . . . . 0.0 109.386 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 mt -79.66 -160.77 0.28 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.618 -0.676 . . . . 0.0 109.907 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.416 HG22 ' CD2' ' A' ' 149' ' ' HIS . 5.2 t -161.01 153.46 17.16 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.754 -0.591 . . . . 0.0 109.452 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.79 143.43 73.71 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 O-C-N 123.517 1.272 . . . . 0.0 111.727 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 25.0 t -64.94 159.45 22.86 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.432 0.634 . . . . 0.0 110.416 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 t -159.19 33.95 0.2 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.448 0.642 . . . . 0.0 109.339 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.2 p -117.85 -167.73 1.39 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.664 -0.648 . . . . 0.0 110.336 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -124.49 29.88 4.87 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.3 m -91.94 171.87 8.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.587 -0.949 . . . . 0.0 109.998 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.8 m -127.4 -35.2 2.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.51 -0.743 . . . . 0.0 111.634 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.85 119.07 9.3 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.347 -0.846 . . . . 0.0 110.593 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 mt -115.37 -174.46 2.51 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.211 -0.931 . . . . 0.0 110.42 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -139.85 87.25 2.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.0 tp -64.62 99.39 0.31 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.47 114.48 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.833 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.3 p -71.86 -179.82 2.86 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.33 16.28 13.69 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.072 -1.017 . . . . 0.0 110.67 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -124.78 41.4 3.52 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.216 -0.927 . . . . 0.0 109.754 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.62 68.15 0.9 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.486 -0.758 . . . . 0.0 111.499 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -155.1 109.17 2.9 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.654 -0.654 . . . . 0.0 110.589 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.4 t -106.14 137.52 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.772 -0.58 . . . . 0.0 109.69 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.3 pt -131.74 131.15 22.56 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 109.126 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.07 140.51 60.1 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.835 1.439 . . . . 0.0 111.779 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.0 t -136.03 144.59 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.12 119.43 38.73 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -49.73 126.96 14.95 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.263 -0.898 . . . . 0.0 110.032 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.96 -33.14 7.0 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.013 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -169.08 58.52 0.2 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.415 -1.374 . . . . 0.0 110.414 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.1 OUTLIER 64.35 -72.82 0.06 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.728 -0.866 . . . . 0.0 110.056 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 120' ' ' GLY . 3.8 p -92.44 40.02 1.04 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 121.162 0.506 . . . . 0.0 110.39 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.435 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 13.8 ttm180 -168.33 154.79 7.34 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.42 -0.8 . . . . 0.0 110.252 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.49 -178.62 23.76 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.55 118.33 22.82 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 122.048 -0.678 . . . . 0.0 111.819 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 145.31 52.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.695 -0.628 . . . . 0.0 109.794 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.2 mt -115.38 55.23 0.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 170.32 125.33 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -63.67 103.49 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.757 1.399 . . . . 0.0 109.843 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.91 149.59 42.71 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.407 -0.808 . . . . 0.0 109.207 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.07 127.33 15.79 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.819 1.431 . . . . 0.0 110.604 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.01 -37.08 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.829 -0.544 . . . . 0.0 110.166 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.33 -35.73 19.23 Favored 'General case' 0 N--CA 1.506 2.36 0 CA-C-O 122.082 0.944 . . . . 0.0 110.535 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.425 ' CD2' HD22 ' A' ' 135' ' ' LEU . 21.2 t80 -67.66 -38.93 84.47 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.425 HD22 ' CD2' ' A' ' 134' ' ' TYR . 14.3 mt -64.02 -35.79 81.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -57.9 131.31 50.01 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.71 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.8 -25.74 26.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.9 m -90.0 4.17 50.96 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -1.081 . . . . 0.0 111.486 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.5 p -56.87 121.91 10.99 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.967 -1.083 . . . . 0.0 111.025 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.83 -15.15 9.02 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.27 139.22 48.31 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.714 -1.755 . . . . 0.0 108.714 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.87 123.14 6.65 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.921 1.485 . . . . 0.0 113.691 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.41 HD23 ' CD1' ' A' ' 169' ' ' PHE . 1.7 mp -79.03 116.91 19.62 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.35 117.75 33.34 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.82 -1.152 . . . . 0.0 113.081 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.0 p -56.99 173.69 0.31 Allowed Pre-proline 0 N--CA 1.5 2.064 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.809 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -76.66 72.44 5.64 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.714 1.376 . . . . 0.0 109.907 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.37 -46.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.62 -0.675 . . . . 0.0 110.26 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 135.36 -28.27 3.03 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.416 ' CD2' HG22 ' A' ' 95' ' ' THR . 0.3 OUTLIER -74.99 129.61 37.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.523 -0.986 . . . . 0.0 110.194 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -59.07 138.75 57.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.669 -0.644 . . . . 0.0 110.112 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.457 HG13 ' CE2' ' A' ' 169' ' ' PHE . 0.9 OUTLIER -99.61 -33.1 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.462 ' HA2' ' N ' ' A' ' 172' ' ' VAL . . . 176.92 -178.44 48.13 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.19 139.93 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.354 -1.086 . . . . 0.0 111.016 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 5.3 t80 -53.34 118.58 3.93 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.92 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -107.59 -41.06 5.14 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.439 -0.788 . . . . 0.0 109.6 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -154.08 167.59 29.3 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -124.95 116.46 22.22 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.659 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.56 100.75 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.5 p -125.25 154.91 40.93 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.648 1.213 . . . . 0.0 114.119 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.479 ' N ' ' O ' ' A' ' 163' ' ' VAL . 2.0 m -92.2 -172.3 3.08 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -45.94 88.91 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.402 -0.811 . . . . 0.0 111.727 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 72.63 -15.08 2.28 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.101 -1.0 . . . . 0.0 112.509 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.7 t -101.14 135.85 35.55 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.351 0 CA-C-N 118.948 1.374 . . . . 0.0 109.286 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -97.59 124.78 41.99 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.747 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -108.2 -41.28 4.94 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.607 -0.683 . . . . 0.0 110.545 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -126.48 166.78 16.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 109.358 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.42 162.01 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.839 0.828 . . . . 0.0 111.28 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.65 99.28 4.91 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.457 ' CE2' HG13 ' A' ' 151' ' ' VAL . 5.1 p90 -135.9 159.63 41.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.007 -1.058 . . . . 0.0 111.567 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 82' ' ' LEU . 1.2 m -103.75 144.68 29.16 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 37.1 Cg_endo -61.9 155.17 56.52 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.092 1.575 . . . . 0.0 111.917 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.462 ' N ' ' HA2' ' A' ' 152' ' ' GLY . 4.3 t -82.75 -2.11 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.504 -0.747 . . . . 0.0 109.709 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -81.96 -38.43 25.19 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.6 t -57.64 -36.79 72.32 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.806 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.476 ' HG2' ' CD1' ' A' ' 82' ' ' LEU . 8.4 mtt -49.93 -39.2 39.46 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.563 -0.71 . . . . 0.0 109.348 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 179' ' ' MET . 2.0 mt-10 -66.18 -38.11 87.27 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.8 m -64.98 -38.75 91.99 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -37.08 81.36 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.494 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 34.5 tpp -61.79 -53.44 55.87 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.723 -0.611 . . . . 0.0 110.329 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.12 -38.77 62.92 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.366 -0.834 . . . . 0.0 110.915 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -55.94 -38.11 69.87 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 59.7 p -75.17 112.1 11.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.431 -0.793 . . . . 0.0 110.926 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -98.01 141.85 30.45 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.494 -0.754 . . . . 0.0 110.34 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -66.34 115.28 6.11 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.513 -0.742 . . . . 0.0 110.392 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -111.53 -76.03 0.61 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.352 -0.843 . . . . 0.0 110.334 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 11.5 mptt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.132 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.166 0.507 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.65 -111.75 1.98 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 57.66 -85.74 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.538 -0.978 . . . . 0.0 110.872 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.5 96.14 1.48 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.532 -0.73 . . . . 0.0 110.281 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 94.91 8.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.484 -0.76 . . . . 0.0 109.792 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -66.01 84.15 0.08 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.599 -0.688 . . . . 0.0 110.497 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.63 77.62 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.633 -0.667 . . . . 0.0 109.254 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.38 -158.72 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.737 -0.602 . . . . 0.0 109.886 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.92 78.41 0.29 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.248 -0.907 . . . . 0.0 109.384 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.59 14.29 0.05 OUTLIER Glycine 0 N--CA 1.498 2.805 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.427 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 55.98 6.73 0.24 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.858 -1.378 . . . . 0.0 113.433 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -152.23 151.98 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 120.455 -1.403 . . . . 0.0 110.151 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -150.44 143.26 24.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.734 -0.604 . . . . 0.0 110.05 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.15 174.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.482 0.658 . . . . 0.0 110.712 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.9 m -131.76 -178.18 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -147.84 136.05 21.37 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.0 p -143.78 -179.11 6.26 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.67 76.11 0.6 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.911 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m 177.31 -61.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -179.39 -159.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.612 -0.68 . . . . 0.0 109.262 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.3 t -117.58 139.72 50.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.503 -0.748 . . . . 0.0 109.928 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -102.18 -178.54 3.73 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.569 -0.707 . . . . 0.0 111.617 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.401 ' CD2' ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -111.69 151.7 28.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.608 -0.683 . . . . 0.0 111.351 -178.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -159.55 145.01 15.74 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.654 -0.654 . . . . 0.0 109.351 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.2 t -117.86 127.38 53.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.162 -0.961 . . . . 0.0 112.036 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 87.4 m -78.77 82.78 4.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.531 -0.73 . . . . 0.0 110.467 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.8 t -98.59 139.2 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 56.12 20.41 4.41 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.343 -0.848 . . . . 0.0 110.027 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.6 24.49 53.43 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.9 t -138.81 103.97 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -1.212 . . . . 0.0 110.612 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.7 t -58.2 96.61 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.538 -0.726 . . . . 0.0 110.022 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.475 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 79.5 m95 -76.07 145.34 40.17 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.325 -0.859 . . . . 0.0 110.331 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.409 HG22 HG21 ' A' ' 83' ' ' VAL . 2.7 t -163.08 176.43 10.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.574 -0.704 . . . . 0.0 109.787 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.431 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 13.6 m -104.42 138.19 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.563 -0.711 . . . . 0.0 109.986 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.465 ' CB ' ' HB ' ' A' ' 78' ' ' VAL . 1.6 t80 -73.79 -12.07 60.58 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.007 -1.058 . . . . 0.0 111.357 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.431 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 4.7 p-80 -83.63 -0.95 52.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.151 -0.968 . . . . 0.0 110.229 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.53 74.84 0.21 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.35 -72.1 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.466 -1.02 . . . . 0.0 110.123 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.85 -161.96 32.25 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.4 p -167.15 -163.52 0.54 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.725 -0.867 . . . . 0.0 109.702 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt 51.5 -164.2 0.06 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.421 -0.8 . . . . 0.0 110.72 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -56.7 90.35 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.512 -0.742 . . . . 0.0 110.615 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.408 ' CD1' ' CZ2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -63.9 162.26 14.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.705 -0.622 . . . . 0.0 110.295 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.23 142.74 48.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.632 -0.667 . . . . 0.0 110.313 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -124.83 -179.4 15.7 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.84 -6.91 20.19 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.972 1.512 . . . . 0.0 111.493 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.66 29.57 1.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.045 . . . . 0.0 110.382 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.61 176.51 14.44 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.25 155.79 68.15 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.852 1.449 . . . . 0.0 109.9 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.8 mt -100.79 119.54 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.558 -0.714 . . . . 0.0 109.786 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -61.4 135.14 57.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.609 -0.682 . . . . 0.0 110.703 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -94.51 115.11 27.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 109.415 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.3 mmm -124.81 -34.88 2.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.525 -0.735 . . . . 0.0 110.866 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.468 ' CD2' ' CE ' ' A' ' 179' ' ' MET . 15.5 m-85 -118.35 108.45 15.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.389 -0.819 . . . . 0.0 109.661 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 1.6 m -149.1 114.46 5.54 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.544 -0.862 . . . . 0.0 112.407 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -148.03 75.66 1.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.872 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.465 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 8.2 p -54.97 -22.48 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.465 -0.772 . . . . 0.0 111.098 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -60.67 83.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.732 -0.605 . . . . 0.0 110.962 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 49.45 26.39 1.65 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.515 -0.741 . . . . 0.0 111.461 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.12 -95.32 0.45 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.937 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.467 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 8.4 tp 177.72 164.21 0.62 Allowed 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.548 -1.345 . . . . 0.0 110.824 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 16.4 m -135.02 122.99 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.12 133.93 4.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.408 ' CZ2' ' CD1' ' A' ' 64' ' ' LEU . 1.3 m-90 -100.55 168.91 9.42 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -80.23 136.52 36.48 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.586 -0.845 . . . . 0.0 109.844 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -108.94 92.94 11.52 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.874 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.568 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.5 Cg_endo -102.35 -11.69 0.16 Allowed 'Trans proline' 0 CA--C 1.551 1.354 0 O-C-N 123.911 1.48 . . . . 0.0 112.847 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 51.2 Cg_endo -71.2 75.8 1.79 Allowed 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 116.058 -2.162 . . . . 0.0 111.104 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.83 25.13 21.95 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.71 139.44 43.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.942 . . . . 0.0 110.574 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.3 tpt85 -75.34 140.3 42.97 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.7 p -104.66 103.15 12.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.348 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -158.37 0.25 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.55 -169.44 0.22 Allowed Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.567 -0.708 . . . . 0.0 109.878 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -93.81 159.48 2.28 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 O-C-N 123.69 1.363 . . . . 0.0 111.521 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.65 133.51 52.66 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.667 -0.646 . . . . 0.0 109.94 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 m -139.56 91.33 2.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.612 -0.68 . . . . 0.0 109.953 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 29.7 m -132.95 -162.28 1.22 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.47 -0.769 . . . . 0.0 109.927 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.73 31.42 2.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.88 -151.1 0.47 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.685 -0.891 . . . . 0.0 110.168 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.8 p -149.78 -147.97 0.25 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 0.0 109.881 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.6 t0 58.06 105.24 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.126 -0.984 . . . . 0.0 110.794 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.18 -168.45 1.77 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.407 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 79.7 m-85 -142.3 93.04 2.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.492 -0.755 . . . . 0.0 110.728 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.4 ' CD1' ' CD1' ' A' ' 143' ' ' LEU . 7.0 tp -60.09 92.59 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.7 t -84.5 101.95 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.331 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.415 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 21.8 p -67.4 155.86 37.95 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.401 ' CB ' ' CD2' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -78.18 3.9 13.99 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.028 -1.045 . . . . 0.0 111.126 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.447 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -101.91 31.52 3.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.972 -1.08 . . . . 0.0 109.055 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 61.42 74.55 0.44 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.519 -0.738 . . . . 0.0 110.67 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.61 119.47 0.88 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.606 -0.684 . . . . 0.0 110.528 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.407 ' CG1' ' HB3' ' A' ' 105' ' ' TYR . 71.5 t -98.13 143.34 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.537 -0.727 . . . . 0.0 109.768 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 114' ' ' ILE . 14.4 mt -130.68 109.89 15.93 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -58.05 134.16 60.31 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 O-C-N 123.655 1.345 . . . . 0.0 111.929 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.1 t -127.78 142.98 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.644 -0.66 . . . . 0.0 109.525 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.58 121.29 43.21 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -48.68 130.41 17.41 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.38 -0.825 . . . . 0.0 110.917 -178.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -102.95 -49.43 3.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.804 -0.56 . . . . 0.0 110.654 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.84 60.23 0.11 Allowed Glycine 0 N--CA 1.498 2.796 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.757 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.37 145.35 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.787 -0.831 . . . . 0.0 109.222 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.406 ' CA ' ' O ' ' A' ' 169' ' ' PHE . 17.5 p 44.63 27.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.737 -0.602 . . . . 0.0 112.122 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.47 ' N ' ' CD2' ' A' ' 169' ' ' PHE . 0.4 OUTLIER -170.37 144.26 2.47 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.125 -0.984 . . . . 0.0 110.219 178.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.26 -177.79 16.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.21 123.14 40.12 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 122.045 -0.679 . . . . 0.0 111.743 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.09 130.7 45.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.565 -0.709 . . . . 0.0 109.492 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.5 mt -101.06 53.62 0.84 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.86 118.45 0.14 Allowed Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.333 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -60.31 106.86 0.37 Allowed 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.61 1.321 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.6 mtt-85 -125.75 146.41 54.99 Favored Pre-proline 0 N--CA 1.49 1.54 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.089 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.24 129.31 23.8 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 124.098 1.578 . . . . 0.0 110.604 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 p -56.96 -36.01 49.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.848 -0.532 . . . . 0.0 110.163 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -49.14 -36.85 20.27 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.232 -0.918 . . . . 0.0 110.603 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.46 ' CD2' HD22 ' A' ' 135' ' ' LEU . 7.4 t80 -64.43 -38.9 92.65 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.46 HD22 ' CD2' ' A' ' 134' ' ' TYR . 8.7 mt -67.4 -35.92 80.26 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -56.39 111.87 1.1 Allowed 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.939 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.27 -34.37 4.73 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.7 m -79.86 -2.72 44.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.676 -0.896 . . . . 0.0 110.808 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.1 m -57.37 126.6 28.02 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.181 -0.95 . . . . 0.0 110.447 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.12 -9.22 31.37 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.88 -175.98 0.31 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -114.57 124.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.489 1.258 . . . . 0.0 112.527 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.443 HD23 ' CD2' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -83.34 126.35 32.61 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 176.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.16 121.06 31.74 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.709 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.424 ' HB2' ' CD ' ' A' ' 146' ' ' PRO . 14.7 p -69.29 -173.27 0.2 Allowed Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.424 ' CD ' ' HB2' ' A' ' 145' ' ' CYS . 49.9 Cg_endo -71.65 66.92 3.01 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.562 1.296 . . . . 0.0 110.422 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.86 -165.7 0.38 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.551 -0.718 . . . . 0.0 110.123 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -110.24 48.57 0.92 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -136.41 128.69 30.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.606 -0.937 . . . . 0.0 109.927 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.34 121.83 16.15 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.496 -0.752 . . . . 0.0 109.918 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 0.9 OUTLIER -78.24 -44.5 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.415 ' N ' HG22 ' A' ' 172' ' ' VAL . . . -179.6 -178.31 48.34 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.406 HG12 ' CE ' ' A' ' 175' ' ' MET . 1.0 OUTLIER -111.73 154.79 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-N 118.838 1.319 . . . . 0.0 111.988 179.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 7.6 t80 -69.17 83.3 0.35 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.8 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -64.06 -49.91 70.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.618 -0.676 . . . . 0.0 109.595 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -155.78 -179.19 7.88 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.04 121.82 22.1 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.874 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.69 104.49 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.416 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 27.3 p -129.43 142.58 50.76 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -175.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 162' ' ' GLY . 5.9 t -76.26 -174.58 2.85 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.54 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.325 -0.859 . . . . 0.0 112.937 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 85.99 -27.32 5.54 Favored Glycine 0 N--CA 1.498 2.771 0 O-C-N 121.204 -0.935 . . . . 0.0 112.316 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.0 OUTLIER -96.55 136.91 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 119.108 1.454 . . . . 0.0 109.82 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.416 ' HA ' ' CB ' ' A' ' 159' ' ' CYS . . . -103.57 125.65 50.23 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.604 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -111.62 -34.37 6.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.654 -0.653 . . . . 0.0 111.224 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.8 176.77 6.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.077 -1.014 . . . . 0.0 110.946 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.407 HG11 ' CE1' ' A' ' 154' ' ' PHE . 0.6 OUTLIER -123.52 140.92 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 111.596 -178.575 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -106.48 100.24 9.77 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.47 ' CD2' ' N ' ' A' ' 123' ' ' ARG . 0.5 OUTLIER -129.8 157.87 41.02 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.071 -1.052 . . . . 0.0 113.748 -176.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.9 p -111.87 128.09 25.93 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 45.0 Cg_endo -57.68 156.37 27.72 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 O-C-N 123.775 1.408 . . . . 0.0 111.752 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.479 ' HA ' ' HE1' ' A' ' 175' ' ' MET . 97.9 t -79.37 -1.66 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.611 -0.681 . . . . 0.0 110.08 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -86.08 -37.66 18.61 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.1 m -72.08 -38.61 69.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.861 -0.525 . . . . 0.0 110.021 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.479 ' HE1' ' HA ' ' A' ' 172' ' ' VAL . 14.8 mtt -50.93 -38.79 52.37 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.542 -0.724 . . . . 0.0 109.711 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -62.87 -39.99 96.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 35.1 m -57.86 -38.51 75.84 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.31 -35.01 35.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.844 -0.535 . . . . 0.0 109.739 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.475 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 9.5 mmt -48.04 -53.63 15.69 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.46 -0.775 . . . . 0.0 110.847 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.02 -37.45 45.32 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.989 0.899 . . . . 0.0 109.846 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.77 95.11 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.013 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.8 m -91.57 74.82 5.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.47 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -135.6 47.8 2.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.667 -0.646 . . . . 0.0 109.547 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -108.83 32.23 5.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.728 . . . . 0.0 110.861 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.2 ttmt -148.77 82.78 1.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.548 -0.72 . . . . 0.0 110.276 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.035 179.85 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.324 0.583 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.67 -39.54 1.27 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -91.31 96.1 10.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.938 -0.742 . . . . 0.0 110.491 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -155.44 -160.36 1.03 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.596 -0.69 . . . . 0.0 110.537 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -100.21 93.67 5.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.665 -0.647 . . . . 0.0 111.071 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.44 -179.14 6.64 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.401 -0.812 . . . . 0.0 109.308 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -161.64 77.96 0.54 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.247 0.546 . . . . 0.0 110.304 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.25 176.73 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -154.6 76.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.636 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 44.58 66.56 1.37 Allowed Glycine 0 N--CA 1.5 2.911 0 O-C-N 121.933 -0.48 . . . . 0.0 111.911 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.08 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.418 -1.048 . . . . 0.0 111.432 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.1 t -150.91 153.83 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.227 -0.92 . . . . 0.0 111.724 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -144.84 136.37 25.41 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -98.81 168.68 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.82 0.819 . . . . 0.0 111.632 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.493 HG13 ' CH2' ' A' ' 85' ' ' TRP . 28.2 m -125.91 -179.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -145.43 135.99 24.27 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.251 -0.905 . . . . 0.0 110.95 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.5 p -142.74 177.79 8.08 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.42 75.87 0.55 Allowed 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.254 -0.979 . . . . 0.0 108.684 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 173.69 -57.16 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.57 -170.13 0.1 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.42 -0.8 . . . . 0.0 109.65 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 86.0 p -111.22 140.75 45.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.706 -0.621 . . . . 0.0 110.431 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 27.4 m-85 -102.08 175.51 5.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.467 -0.771 . . . . 0.0 109.944 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.422 ' CG ' ' HB3' ' A' ' 109' ' ' ARG . 5.5 tt -109.96 143.92 39.21 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.42 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -147.21 131.53 17.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.927 -1.108 . . . . 0.0 110.311 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.4 t -100.02 127.81 46.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.254 -0.904 . . . . 0.0 112.462 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 85.8 m -82.89 95.07 7.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.375 -0.828 . . . . 0.0 110.747 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.5 t -103.86 133.09 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t30 62.22 11.4 4.41 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.422 -0.799 . . . . 0.0 110.681 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.62 30.61 8.91 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.023 -1.048 . . . . 0.0 111.167 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.4 t -147.2 105.81 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -1.187 . . . . 0.0 109.257 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.17 109.56 0.61 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.498 -0.751 . . . . 0.0 109.485 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.472 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 92.7 m95 -91.23 141.8 28.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.671 -0.643 . . . . 0.0 110.435 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.449 HG23 ' CH2' ' A' ' 85' ' ' TRP . 5.2 t -161.27 -179.78 7.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.457 -0.777 . . . . 0.0 110.319 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 m -102.18 145.12 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.596 -0.69 . . . . 0.0 110.497 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.432 ' N ' HG22 ' A' ' 83' ' ' VAL . 42.9 t80 -78.02 1.72 20.01 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.113 -0.992 . . . . 0.0 112.301 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -49.78 -24.85 2.59 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 121.163 -0.961 . . . . 0.0 110.684 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.448 ' O ' ' CE1' ' A' ' 43' ' ' PHE . . . -177.89 39.83 0.09 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.41 25.96 4.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.331 -1.099 . . . . 0.0 111.009 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.56 -164.39 41.47 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.1 t -136.84 -80.38 0.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.762 -0.846 . . . . 0.0 110.074 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -118.47 -33.46 4.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.198 -0.939 . . . . 0.0 111.305 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -93.31 89.57 6.43 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.116 0.484 . . . . 0.0 111.721 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.4 HD12 ' CE2' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -101.28 172.8 6.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.51 -0.744 . . . . 0.0 109.751 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.6 130.97 57.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.681 -0.637 . . . . 0.0 110.136 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.59 179.24 16.73 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -55.17 103.82 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 O-C-N 123.652 1.343 . . . . 0.0 110.628 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.1 tttp 54.37 30.05 11.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.505 -0.747 . . . . 0.0 111.22 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.43 134.87 2.1 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -58.85 169.8 3.16 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 O-C-N 123.729 1.383 . . . . 0.0 110.82 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.2 mt -106.93 134.5 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.395 -0.816 . . . . 0.0 108.976 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.5 p -74.69 -174.61 2.18 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.278 -0.889 . . . . 0.0 111.032 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -123.15 166.43 15.21 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.606 -0.684 . . . . 0.0 109.973 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.435 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 6.4 tpt -169.54 -37.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.156 -0.965 . . . . 0.0 111.453 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 74' ' ' MET . 14.4 m-85 -131.84 111.53 11.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.472 -0.768 . . . . 0.0 109.103 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.49 114.2 4.34 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.035 -1.066 . . . . 0.0 113.013 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -160.54 76.52 0.59 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.729 -0.607 . . . . 0.0 110.45 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.422 ' CG1' ' HB3' ' A' ' 56' ' ' TYR . 7.3 p -74.74 -17.3 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.1 -1.0 . . . . 0.0 111.128 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.73 -25.17 17.45 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.129 -0.982 . . . . 0.0 110.244 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -176.11 34.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.748 -0.595 . . . . 0.0 110.144 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -156.03 -89.44 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.997 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.465 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 6.8 tp 179.14 177.29 0.53 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.718 -1.239 . . . . 0.0 110.125 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.432 HG22 ' N ' ' A' ' 56' ' ' TYR . 21.6 m -146.58 121.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -154.09 144.08 10.82 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.493 ' CH2' HG13 ' A' ' 36' ' ' VAL . 1.1 m-90 -108.2 167.83 9.73 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -69.5 137.52 52.62 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.879 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.55 97.0 15.26 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.721 -0.612 . . . . 0.0 111.144 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.7 Cg_endo -111.21 10.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 117.178 -1.415 . . . . 0.0 113.061 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 55.7 Cg_endo -67.58 -108.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 116.587 -1.809 . . . . 0.0 107.75 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.79 32.47 7.39 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 106.559 -2.616 . . . . 0.0 106.559 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.62 152.69 45.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.383 -1.069 . . . . 0.0 111.058 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -125.14 17.16 8.43 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.784 -0.572 . . . . 0.0 110.735 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.8 t 49.98 97.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.288 -0.883 . . . . 0.0 112.536 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.19 -143.16 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.555 -0.715 . . . . 0.0 110.13 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 t -169.61 153.3 5.04 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 120.897 -1.127 . . . . 0.0 110.657 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.45 160.37 46.95 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.741 1.39 . . . . 0.0 111.173 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.9 t -95.6 112.12 23.9 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.1 p -75.1 -44.05 49.53 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.4 p -65.48 149.42 50.07 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.325 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -111.2 40.43 2.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.99 146.13 51.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.687 -0.89 . . . . 0.0 109.703 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 m -77.69 -159.17 0.14 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.664 -0.648 . . . . 0.0 110.929 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.7 t70 52.43 95.08 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.652 -0.655 . . . . 0.0 111.171 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.6 168.81 9.45 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.371 -0.83 . . . . 0.0 110.025 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -117.4 86.43 2.51 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.644 -0.66 . . . . 0.0 109.571 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.435 ' CD1' ' CD1' ' A' ' 143' ' ' LEU . 9.5 tp -54.45 98.85 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.445 -0.785 . . . . 0.0 109.838 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 37.4 t -81.68 109.65 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.239 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.44 ' HB ' ' NE2' ' A' ' 110' ' ' HIS . 18.7 p -74.58 177.52 6.0 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HB3' ' CG ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -95.06 28.1 2.93 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.913 -1.117 . . . . 0.0 110.819 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.463 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 1.4 p80 -150.31 46.17 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.916 0.865 . . . . 0.0 109.537 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 49.08 63.47 2.12 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.425 0.631 . . . . 0.0 111.674 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.46 92.37 2.08 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.1 t -81.0 144.04 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.176 -0.952 . . . . 0.0 110.123 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.2 mt -128.97 114.99 18.89 Favored Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -59.35 134.42 58.63 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.781 1.411 . . . . 0.0 111.516 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.5 149.33 30.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -114.25 111.7 21.94 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -48.12 121.61 4.44 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.749 0.785 . . . . 0.0 110.276 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.9 -37.51 5.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.963 -0.46 . . . . 0.0 110.406 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.81 -170.07 26.03 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -62.56 140.9 58.65 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.831 -0.806 . . . . 0.0 109.568 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.0 p 44.46 42.55 5.57 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.275 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.441 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 3.9 ttp85 -164.32 153.75 13.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.337 -0.852 . . . . 0.0 111.392 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.88 -179.58 21.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.39 130.9 55.54 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 122.072 -0.663 . . . . 0.0 111.116 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.75 128.9 36.9 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.355 -0.84 . . . . 0.0 109.383 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 mt -103.71 54.57 0.74 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 p 174.95 107.09 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -57.56 103.63 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 O-C-N 123.598 1.315 . . . . 0.0 109.168 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -124.63 159.03 59.94 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.986 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.413 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 50.1 Cg_endo -72.54 129.58 14.89 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 124.077 1.567 . . . . 0.0 109.255 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 162' ' ' GLY . 10.1 p -55.7 -35.71 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.387 -0.82 . . . . 0.0 109.879 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.3 t -48.85 -36.67 17.47 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.401 -0.812 . . . . 0.0 110.504 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.42 ' CD2' HD22 ' A' ' 135' ' ' LEU . 19.8 t80 -63.4 -39.24 93.98 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 154' ' ' PHE . 15.9 mt -66.2 -34.78 78.81 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.58 126.3 24.73 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.858 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.26 -31.8 8.31 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.1 m -84.04 3.14 35.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.822 -0.811 . . . . 0.0 110.525 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.2 m -49.77 127.04 15.19 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.289 -0.882 . . . . 0.0 109.731 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 116.22 -17.24 14.75 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 107.031 -2.428 . . . . 0.0 107.031 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.4 ' HA2' HD23 ' A' ' 44' ' ' LEU . . . -45.66 110.24 0.43 Allowed Glycine 0 N--CA 1.501 2.987 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.16 126.62 14.64 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.933 1.491 . . . . 0.0 111.9 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.435 ' CD1' ' CD1' ' A' ' 106' ' ' LEU . 9.0 mp -80.56 135.43 36.08 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.89 111.91 11.99 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.389 -0.924 . . . . 0.0 112.172 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.441 ' HB3' HG23 ' A' ' 151' ' ' VAL . 27.7 p -69.9 163.53 59.78 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.933 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 46.9 Cg_endo -62.72 86.31 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.769 1.405 . . . . 0.0 110.136 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.9 -48.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.637 -0.664 . . . . 0.0 109.47 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.04 23.43 3.27 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -131.44 147.09 52.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.401 -1.058 . . . . 0.0 109.554 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.43 122.14 16.87 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.497 -0.752 . . . . 0.0 110.723 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 145' ' ' CYS . 2.1 t -84.47 -37.88 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 169' ' ' PHE . . . 178.43 -179.09 48.72 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.5 pt -117.12 156.77 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 CA-C-N 118.923 1.362 . . . . 0.0 111.841 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 135' ' ' LEU . 9.9 t80 -75.56 85.78 2.64 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.602 0.715 . . . . 0.0 111.203 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -70.91 -49.29 47.35 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -147.78 177.65 9.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -131.67 119.86 21.97 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.967 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.4 99.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.403 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 28.7 p -126.08 140.57 52.48 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.9 OUTLIER -74.34 -174.77 2.1 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.78 82.93 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 86.01 -26.95 5.73 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.033 -1.042 . . . . 0.0 110.91 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -93.83 135.99 26.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 118.981 1.391 . . . . 0.0 108.631 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.403 ' HA ' ' CB ' ' A' ' 159' ' ' CYS . . . -97.53 129.78 44.65 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.876 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -113.09 -44.87 3.22 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.452 -0.78 . . . . 0.0 111.174 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -123.82 -178.95 4.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.451 -0.78 . . . . 0.0 109.766 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' ' 154' ' ' PHE . 1.3 t -120.32 164.07 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.45 -0.781 . . . . 0.0 110.647 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -128.69 94.8 3.94 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.441 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 0.7 OUTLIER -126.53 146.1 50.26 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.718 -174.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.458 HG12 ' CD1' ' A' ' 82' ' ' LEU . 2.7 p -99.81 131.69 24.16 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 42.9 Cg_endo -56.42 154.98 27.23 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 O-C-N 123.756 1.398 . . . . 0.0 111.412 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.406 HG22 ' N ' ' A' ' 152' ' ' GLY . 42.6 t -84.44 2.78 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.366 -0.833 . . . . 0.0 109.748 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -91.75 -39.06 12.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.592 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.6 t -72.13 -44.33 63.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.809 -0.557 . . . . 0.0 110.75 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.436 ' HB3' HD23 ' A' ' 82' ' ' LEU . 2.8 ptp -53.76 -37.86 63.84 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.233 -0.917 . . . . 0.0 110.536 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -56.39 -37.84 70.69 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.999 0.904 . . . . 0.0 108.961 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.4 m -62.37 -35.01 77.81 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.96 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.468 HG23 ' CZ3' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -47.22 -37.52 10.5 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.41 -0.806 . . . . 0.0 111.455 -178.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.472 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -51.83 -46.12 64.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.234 -0.916 . . . . 0.0 110.323 178.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.45 -38.22 58.76 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.096 0.95 . . . . 0.0 110.018 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.87 65.38 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.087 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.7 t -75.64 -2.96 31.83 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.517 -0.74 . . . . 0.0 111.166 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.45 160.2 24.06 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.141 -0.974 . . . . 0.0 110.64 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 2.1 ptmt -68.78 80.83 0.29 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.302 -0.874 . . . . 0.0 109.917 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.35 100.1 11.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.288 -0.883 . . . . 0.0 109.619 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.4 mttt . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.652 -179.492 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.057 0.456 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.35 115.38 4.0 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.11 79.86 0.11 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.378 -1.072 . . . . 0.0 110.645 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -107.88 2.87 23.73 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.595 -0.691 . . . . 0.0 111.11 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 53.13 95.18 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.07 -1.019 . . . . 0.0 111.104 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -96.14 -177.7 4.08 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.639 -0.663 . . . . 0.0 109.303 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -148.12 77.32 1.4 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.554 0.692 . . . . 0.0 109.287 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.5 m -58.66 175.66 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 121.554 0.693 . . . . 0.0 110.474 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 174.1 77.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 25.68 53.19 0.06 OUTLIER Glycine 0 N--CA 1.51 3.589 0 C-N-CA 123.548 0.594 . . . . 0.0 113.529 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -164.21 -67.36 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.485 1.143 . . . . 0.0 112.669 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.4 t -138.04 158.77 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 122.25 1.024 . . . . 0.0 112.971 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -143.93 137.85 28.09 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.435 ' CG1' ' CD ' ' A' ' 109' ' ' ARG . 32.6 m -108.41 -179.78 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 122.152 0.977 . . . . 0.0 112.664 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.3 m -139.29 -179.36 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.2 p -149.91 138.09 20.43 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.541 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.2 p -139.45 179.16 6.71 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.471 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -73.43 72.42 1.34 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.815 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 39' ' ' ALA . 72.1 m -175.4 -59.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 179.77 -163.22 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.72 -0.612 . . . . 0.0 109.525 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 p -117.99 143.66 46.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.258 -0.901 . . . . 0.0 110.151 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.462 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 42.7 m-85 -99.81 -178.47 3.87 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.268 -0.895 . . . . 0.0 110.855 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.415 HD23 ' HA2' ' A' ' 141' ' ' GLY . 5.5 tt -114.32 142.44 46.31 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.409 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -147.45 131.22 16.99 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.804 -1.185 . . . . 0.0 110.805 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 t -97.84 123.48 41.82 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.34 -0.85 . . . . 0.0 111.865 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 26.4 p -78.98 83.63 5.06 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.796 0.808 . . . . 0.0 110.368 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.3 t -102.02 145.65 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 54.56 23.69 4.81 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.76 31.1 56.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.2 t -147.02 111.38 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.176 -1.191 . . . . 0.0 110.483 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 49.3 m -60.83 115.62 3.82 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.474 -0.766 . . . . 0.0 109.294 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.463 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 76.2 m95 -94.49 140.82 29.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.354 -0.841 . . . . 0.0 111.206 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.424 HG23 ' CH2' ' A' ' 85' ' ' TRP . 4.5 t -161.95 -178.58 6.54 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.465 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 12.5 t -104.0 144.82 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.426 -0.796 . . . . 0.0 109.671 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -74.34 -1.0 18.93 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.882 -1.137 . . . . 0.0 112.597 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.465 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 1.5 p-80 -70.08 -8.69 51.48 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.912 -1.118 . . . . 0.0 111.169 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.429 ' HA3' ' CE2' ' A' ' 43' ' ' PHE . . . -137.63 -134.08 3.2 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 54.51 174.6 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.481 -1.011 . . . . 0.0 111.01 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.09 112.4 4.46 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.0 p -56.09 173.28 0.16 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.442 -1.034 . . . . 0.0 110.388 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 tttp 58.17 -161.5 0.24 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.317 -0.864 . . . . 0.0 110.482 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -55.24 97.3 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.506 -0.747 . . . . 0.0 110.954 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.99 174.65 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.724 -0.61 . . . . 0.0 110.613 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.2 137.29 54.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.49 -0.756 . . . . 0.0 110.613 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.12 179.38 20.47 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.0 -21.82 73.09 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.815 1.429 . . . . 0.0 110.957 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -154.31 36.57 0.43 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.361 -0.837 . . . . 0.0 109.937 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 156.62 150.4 5.65 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.1 158.43 51.97 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.889 1.468 . . . . 0.0 110.483 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.6 mt -99.94 117.51 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.705 -0.622 . . . . 0.0 109.392 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 t -59.95 119.83 8.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.5 -0.75 . . . . 0.0 110.372 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 140.97 54.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.65 -0.656 . . . . 0.0 109.973 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.408 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 6.5 tpt -131.01 -41.16 1.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.641 -0.662 . . . . 0.0 110.395 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.44 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 20.7 m-85 -133.15 126.42 31.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.569 -0.707 . . . . 0.0 110.126 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 m -151.2 113.92 4.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.717 . . . . 0.0 110.407 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.9 76.92 1.53 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.479 -0.889 . . . . 0.0 111.018 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.42 -26.86 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -42.6 80.28 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -96.18 20.15 10.73 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.34 46.88 24.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.406 -0.809 . . . . 0.0 111.842 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.421 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 1.9 tp -161.87 141.68 10.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.359 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.4 m -143.58 111.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -105.69 102.53 1.99 Allowed Glycine 0 N--CA 1.486 2.014 0 C-N-CA 119.613 -1.279 . . . . 0.0 111.431 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.424 ' CH2' HG23 ' A' ' 54' ' ' THR . 1.8 m-90 -82.0 167.01 19.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.4 ' O ' ' CD ' ' A' ' 88' ' ' PRO . 8.0 mt-30 -80.58 140.45 35.76 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.441 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.75 89.94 2.05 Favored Pre-proline 0 C--N 1.301 -1.539 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.545 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.588 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 46.5 Cg_endo -96.62 -14.83 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.731 1.385 . . . . 0.0 112.618 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 46.9 Cg_endo -71.29 87.97 0.74 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 116.216 -2.056 . . . . 0.0 111.281 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 49.07 21.44 2.53 Favored Glycine 0 N--CA 1.5 2.944 0 O-C-N 121.402 -0.812 . . . . 0.0 111.368 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.52 148.3 49.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.304 -1.115 . . . . 0.0 109.734 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -106.48 12.07 30.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.454 -0.779 . . . . 0.0 111.576 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 t 46.7 103.58 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.486 -0.759 . . . . 0.0 112.906 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.56 -150.21 0.15 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.267 -0.896 . . . . 0.0 109.855 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 p -156.06 177.91 1.88 Allowed Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.206 -0.934 . . . . 0.0 110.897 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -90.6 169.77 3.79 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 O-C-N 123.79 1.416 . . . . 0.0 111.014 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.443 ' CB ' ' HA ' ' A' ' 151' ' ' VAL . 39.3 t -93.06 -73.64 0.55 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.69 -0.631 . . . . 0.0 110.023 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m 56.1 42.82 27.88 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.385 -0.822 . . . . 0.0 109.071 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.0 p -126.42 -163.55 1.24 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.899 -0.5 . . . . 0.0 110.596 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.97 70.13 0.39 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t -128.37 -8.11 5.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.541 -0.976 . . . . 0.0 111.677 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.6 m 53.78 -162.68 0.11 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.012 -1.055 . . . . 0.0 111.029 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.79 100.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.617 -0.677 . . . . 0.0 110.605 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mt -115.86 153.99 30.52 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.02 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -105.17 94.35 5.19 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.401 HD13 ' CD1' ' A' ' 143' ' ' LEU . 8.8 tp -62.98 93.66 0.06 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.4 t -80.94 112.8 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.892 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.404 HG23 ' CE1' ' A' ' 110' ' ' HIS . 8.7 m -78.38 172.89 12.96 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.435 ' CD ' ' CG1' ' A' ' 35' ' ' VAL . 19.1 tpt180 -85.51 -8.85 58.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 111.021 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.493 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -107.55 41.42 1.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 110.046 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.48 71.44 0.52 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.376 -0.827 . . . . 0.0 110.676 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -156.4 98.37 1.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.777 -0.577 . . . . 0.0 110.284 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.6 t -99.71 135.57 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.489 -0.757 . . . . 0.0 110.121 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.4 pt -127.07 140.52 38.06 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.85 142.3 51.68 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 O-C-N 123.687 1.362 . . . . 0.0 112.044 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.26 151.36 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -106.2 105.6 15.71 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -48.89 123.02 6.36 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 122.036 0.922 . . . . 0.0 111.81 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -115.72 -26.79 7.29 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.72 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.21 161.06 32.7 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -51.49 -26.87 9.07 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.311 -1.111 . . . . 0.0 110.776 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -124.41 38.81 4.11 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.046 0.45 . . . . 0.0 110.364 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.468 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 4.1 ttt180 -166.82 156.82 11.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.343 -0.848 . . . . 0.0 110.528 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.47 -178.43 28.82 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.96 113.68 18.14 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.857 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.92 130.99 49.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.535 -0.728 . . . . 0.0 109.463 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.6 mt -105.6 54.66 0.7 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.7 t 177.83 114.03 0.16 Allowed Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.095 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -58.27 102.98 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.731 0 O-C-N 123.478 1.251 . . . . 0.0 109.979 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 mtt-85 -119.01 160.73 39.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.233 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 43.3 Cg_endo -73.93 127.66 11.66 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 124.058 1.557 . . . . 0.0 109.956 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.82 -37.5 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.806 -0.559 . . . . 0.0 110.571 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -48.87 -36.46 17.08 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 122.038 0.923 . . . . 0.0 110.783 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 25.3 t80 -66.13 -38.41 88.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 13.0 mt -65.34 -35.96 82.57 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -63.67 -21.4 66.36 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.559 -0.856 . . . . 0.0 110.649 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.04 30.37 10.23 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 85.2 p -150.7 21.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.566 -0.961 . . . . 0.0 111.453 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.7 p -56.07 132.91 51.42 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.152 -0.968 . . . . 0.0 109.04 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.9 -19.2 28.22 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 44' ' ' LEU . . . -43.85 100.79 0.02 OUTLIER Glycine 0 N--CA 1.504 3.207 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 153' ' ' ILE . 44.2 Cg_endo -63.76 128.23 21.61 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.996 1.524 . . . . 0.0 112.243 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.445 ' CD2' ' CD1' ' A' ' 169' ' ' PHE . 9.8 mp -84.26 119.76 25.43 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.5 130.26 56.82 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.686 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 31.6 p -74.05 168.27 27.78 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.235 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.63 76.66 1.07 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 O-C-N 123.739 1.389 . . . . 0.0 110.751 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.6 t -173.4 -57.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.326 -0.858 . . . . 0.0 110.345 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.57 -42.75 0.63 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.432 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER -59.27 123.5 16.94 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.729 -0.865 . . . . 0.0 110.083 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.34 145.33 55.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.66 . . . . 0.0 110.064 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 2.4 t -94.8 -37.23 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.644 -0.66 . . . . 0.0 109.478 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.13 -178.08 48.24 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 142' ' ' PRO . 1.8 pp -117.06 157.15 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.363 -1.081 . . . . 0.0 110.983 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 6.1 t80 -68.85 119.26 12.92 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.73 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -107.01 -41.13 5.26 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.406 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -161.28 179.98 7.89 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . . . -141.65 128.29 20.29 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.492 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.32 99.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 72.8 m -115.9 159.86 20.98 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.461 1.124 . . . . 0.0 113.351 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 162' ' ' GLY . 1.8 m -98.3 -174.83 2.94 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.405 ' O ' ' CG ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -47.88 83.8 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.456 -0.778 . . . . 0.0 112.708 -179.138 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 83.06 -32.31 3.02 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.846 -1.159 . . . . 0.0 111.443 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.97 131.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 119.098 1.449 . . . . 0.0 108.944 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.41 ' CB ' ' CD1' ' A' ' 135' ' ' LEU . . . -91.68 132.71 36.17 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.713 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -113.86 -46.78 3.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.649 -0.657 . . . . 0.0 111.045 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.46 179.08 4.16 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.259 -0.901 . . . . 0.0 110.405 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 t -115.47 162.24 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.464 -0.772 . . . . 0.0 110.599 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.27 84.45 2.08 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.468 ' CE1' ' N ' ' A' ' 123' ' ' ARG . 2.6 p90 -119.97 163.19 17.97 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.054 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.6 p -111.14 130.52 22.91 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 40.5 Cg_endo -60.57 159.41 28.06 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 124.063 1.559 . . . . 0.0 111.468 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.44 ' HA ' ' HG3' ' A' ' 175' ' ' MET . 96.3 t -77.36 -3.88 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -84.57 -37.75 20.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 0.0 108.692 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.9 t -70.3 -38.12 74.92 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.76 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.44 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 19.4 mtt -49.91 -38.83 37.76 Favored 'General case' 0 N--CA 1.516 2.866 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -52.94 -38.73 62.26 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.497 0.665 . . . . 0.0 109.854 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.2 m -51.82 -38.07 54.29 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.405 0.621 . . . . 0.0 109.767 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.09 -42.37 80.6 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.65 -0.656 . . . . 0.0 110.02 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.463 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -56.19 -49.69 73.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.458 -0.776 . . . . 0.0 110.585 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -37.35 61.72 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.93 0.871 . . . . 0.0 109.804 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -78.54 -39.65 37.26 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.919 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.7 -172.06 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.35 -0.844 . . . . 0.0 110.647 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.86 71.06 0.51 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.488 -0.758 . . . . 0.0 109.906 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.29 127.68 33.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.696 -0.627 . . . . 0.0 110.593 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -88.4 152.3 22.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.541 -0.724 . . . . 0.0 109.852 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 2.4 tptp . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.247 -179.873 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.33 0.586 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.38 -83.18 0.05 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -95.59 28.89 2.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.503 -0.998 . . . . 0.0 110.783 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -65.39 -175.59 0.26 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.411 -0.806 . . . . 0.0 109.091 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.3 44.32 2.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.622 -0.674 . . . . 0.0 110.317 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 p-10 -157.37 117.22 3.41 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.482 -0.761 . . . . 0.0 110.656 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.11 76.87 1.3 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.542 -0.724 . . . . 0.0 109.198 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.452 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 7.7 p -160.47 154.98 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.712 -0.617 . . . . 0.0 109.626 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -161.65 78.58 0.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.124 0.964 . . . . 0.0 110.618 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 45.46 -93.66 0.01 OUTLIER Glycine 0 N--CA 1.496 2.685 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.363 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -90.42 -29.8 17.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.73 -0.865 . . . . 0.0 112.729 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.3 t -125.97 162.38 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 120.942 -1.099 . . . . 0.0 112.554 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -153.46 135.67 14.87 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.418 ' CG1' ' HB2' ' A' ' 109' ' ' ARG . 11.2 m -91.89 177.7 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 120.932 -1.105 . . . . 0.0 112.53 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.471 HG23 ' CD2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -135.97 172.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.55 -179.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -160.7 138.36 9.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.453 -0.779 . . . . 0.0 111.008 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 40' ' ' THR . 6.2 t -153.42 179.55 8.68 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.466 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -71.01 72.72 0.59 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.815 -1.154 . . . . 0.0 108.772 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 39' ' ' ALA . 23.3 m -175.24 -61.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -177.24 -168.16 0.19 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.839 -0.538 . . . . 0.0 109.867 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.5 p -125.05 128.01 47.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.658 -0.651 . . . . 0.0 109.251 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -108.12 -177.43 3.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.143 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 45' ' ' ALA . 6.1 tt -107.9 149.94 27.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.343 -0.848 . . . . 0.0 109.687 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -139.77 136.01 33.66 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.217 -0.927 . . . . 0.0 109.391 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 46' ' ' THR . 4.6 t -107.29 116.7 32.39 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.3 -0.875 . . . . 0.0 112.522 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 84.3 m -72.11 83.0 0.99 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.319 -0.863 . . . . 0.0 110.175 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.5 t -107.28 139.5 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.0 t30 57.44 19.96 5.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.575 -0.703 . . . . 0.0 109.811 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.76 54.68 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.0 t -144.52 109.67 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.424 -1.045 . . . . 0.0 110.089 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.0 p -61.4 97.03 0.06 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.702 -0.624 . . . . 0.0 110.136 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.486 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 98.4 m95 -76.43 150.29 36.76 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.089 -1.007 . . . . 0.0 110.302 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.439 HG23 ' CH2' ' A' ' 85' ' ' TRP . 7.9 t -164.03 -178.59 5.7 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.972 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.0 m -97.25 139.16 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.562 -0.712 . . . . 0.0 110.076 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.455 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 31.9 t80 -76.33 0.05 20.82 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.306 -0.871 . . . . 0.0 111.313 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -49.2 -33.33 12.19 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.415 -0.803 . . . . 0.0 110.871 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.81 -14.0 1.93 Allowed Glycine 0 N--CA 1.496 2.667 0 C-N-CA 119.754 -1.213 . . . . 0.0 111.875 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 43' ' ' PHE . . . -52.32 -34.38 46.75 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.787 -1.42 . . . . 0.0 110.983 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.84 168.81 4.41 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.6 t -96.94 -19.65 18.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.521 -0.987 . . . . 0.0 110.19 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -57.33 179.0 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.56 0.695 . . . . 0.0 110.768 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.47 103.91 2.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.678 -0.639 . . . . 0.0 110.094 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.442 HD12 ' CZ2' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -53.43 160.98 1.07 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.694 -0.629 . . . . 0.0 110.192 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.1 133.09 50.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.804 . . . . 0.0 110.602 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.87 -177.5 14.9 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -59.05 96.17 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 O-C-N 123.77 1.405 . . . . 0.0 110.279 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.63 37.86 29.13 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.367 -0.833 . . . . 0.0 110.443 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.97 136.5 2.44 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.035 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.58 153.22 78.77 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 124.081 1.569 . . . . 0.0 109.685 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.7 mt -100.45 116.76 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.336 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -59.92 126.79 28.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.565 -0.709 . . . . 0.0 111.034 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -79.76 105.24 10.91 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 tpt -101.56 -32.17 10.5 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.23 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.407 ' CZ ' ' HG3' ' A' ' 179' ' ' MET . 14.2 m-85 -130.15 115.63 17.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.696 -0.628 . . . . 0.0 110.084 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.455 ' CG2' ' CD1' ' A' ' 56' ' ' TYR . 18.4 m -161.06 107.5 1.43 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.146 -0.971 . . . . 0.0 112.839 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 5.0 m-80 -163.84 78.17 0.4 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.694 . . . . 0.0 109.917 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.404 ' CG1' ' CB ' ' A' ' 56' ' ' TYR . 34.9 m -51.39 -21.92 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.731 -1.231 . . . . 0.0 111.852 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.85 78.69 0.63 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.052 -1.03 . . . . 0.0 108.721 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 60.32 46.57 9.94 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.644 -0.66 . . . . 0.0 110.753 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -156.33 -33.21 0.09 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.217 -0.927 . . . . 0.0 111.859 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 175' ' ' MET . 5.7 tp 72.75 165.62 0.3 Allowed 'General case' 0 N--CA 1.526 3.343 0 CA-C-N 120.217 1.371 . . . . 0.0 111.075 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 1.4 m -122.21 147.79 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.94 110.04 0.42 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.442 ' CZ2' HD12 ' A' ' 64' ' ' LEU . 1.2 m-90 -86.6 169.62 12.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -81.98 138.45 34.92 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.482 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -107.0 82.52 1.12 Allowed Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.401 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.566 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 48.0 Cg_endo -98.81 -6.8 0.63 Allowed 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.575 1.303 . . . . 0.0 112.977 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 40.4 Cg_endo -73.24 63.23 4.32 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 115.592 -2.472 . . . . 0.0 111.269 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.96 52.91 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.452 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . . . -72.19 129.48 38.57 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.247 -1.149 . . . . 0.0 111.206 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -68.46 136.15 52.79 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.223 -0.991 . . . . 0.0 108.619 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -103.21 115.43 30.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.49 -0.757 . . . . 0.0 110.292 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mp -85.92 -164.1 0.98 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.495 0.664 . . . . 0.0 110.513 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.64 173.83 4.13 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.778 -0.576 . . . . 0.0 110.343 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.91 166.16 30.8 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 O-C-N 123.657 1.346 . . . . 0.0 110.551 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 6.8 t -84.68 -49.99 8.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.727 -0.608 . . . . 0.0 109.656 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.8 p 45.06 37.33 2.45 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.813 -0.554 . . . . 0.0 111.041 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.6 p -122.78 -162.03 0.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.492 -0.755 . . . . 0.0 110.172 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.27 74.55 0.37 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m -150.72 165.11 34.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.719 -0.871 . . . . 0.0 110.184 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.8 t -112.31 -154.89 0.55 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.52 -0.737 . . . . 0.0 110.588 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 57.86 99.35 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.207 -0.933 . . . . 0.0 110.508 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.424 ' HB2' ' HB ' ' A' ' 116' ' ' VAL . 2.3 mt -116.11 -176.27 2.91 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.301 -0.874 . . . . 0.0 109.963 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -131.53 85.06 2.22 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.2 tp -61.13 89.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.457 -0.777 . . . . 0.0 109.039 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.41 101.37 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.186 -1.006 . . . . 0.0 109.638 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.421 HG22 ' HB2' ' A' ' 110' ' ' HIS . 7.4 t -75.73 179.7 5.27 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.43 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 16.4 ptt85 -95.3 17.07 15.11 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.12 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.483 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 6.3 m170 -103.36 21.17 16.43 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 59.12 56.36 3.95 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.363 -0.836 . . . . 0.0 109.816 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.41 ' O ' ' CG2' ' A' ' 108' ' ' THR . 11.6 t70 -166.86 121.88 1.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.688 -0.632 . . . . 0.0 109.881 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.4 m -104.1 145.36 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.993 -1.067 . . . . 0.0 109.608 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.0 pt -125.98 138.6 32.41 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.077 -1.015 . . . . 0.0 110.091 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -66.18 141.47 63.31 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 O-C-N 123.796 1.419 . . . . 0.0 112.201 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 58.4 t -132.59 138.47 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.679 -0.638 . . . . 0.0 109.65 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.58 117.71 35.26 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 -48.96 129.5 17.4 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.488 -0.757 . . . . 0.0 110.702 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.401 ' CG ' ' HB2' ' A' ' 125' ' ' SER . 5.5 mmm180 -109.8 -27.26 9.39 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.736 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.19 -150.05 7.43 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -77.16 127.58 32.88 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.734 -0.862 . . . . 0.0 108.822 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.38 45.39 28.6 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.127 0.489 . . . . 0.0 111.217 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.485 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -160.89 151.59 18.33 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.332 -0.855 . . . . 0.0 110.754 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.0 -177.05 17.64 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.0 OUTLIER -129.46 120.65 25.81 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.803 -0.822 . . . . 0.0 112.041 -178.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.48 141.25 52.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.436 -0.79 . . . . 0.0 109.001 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.7 mt -108.44 52.99 0.7 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.3 p 166.19 136.79 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.2 113.96 2.84 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.802 1.422 . . . . 0.0 109.81 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.66 147.32 47.76 Favored Pre-proline 0 N--CA 1.49 1.531 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.68 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.15 125.11 12.54 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 124.14 1.6 . . . . 0.0 110.055 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 p -58.86 -36.84 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.624 0.726 . . . . 0.0 109.684 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.1 m -49.13 -35.63 16.97 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 122.031 0.919 . . . . 0.0 110.936 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -70.07 -36.93 75.31 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 13.9 mt -63.58 -37.2 86.41 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -57.83 122.93 14.09 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.576 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.45 -31.64 8.48 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.9 m -79.96 0.19 32.54 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.487 -1.008 . . . . 0.0 111.152 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.8 p -48.42 134.04 15.55 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.225 -0.922 . . . . 0.0 110.714 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.74 -20.59 24.48 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 107.376 -2.29 . . . . 0.0 107.376 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.441 ' HA2' HD23 ' A' ' 44' ' ' LEU . . . -47.09 113.66 1.31 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.41 122.62 9.64 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 124.05 1.552 . . . . 0.0 111.726 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.468 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 6.4 mp -79.11 114.08 17.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 mt -110.15 121.85 46.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 111.492 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.445 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 29.5 p -60.81 178.32 0.27 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.93 -0.481 . . . . 0.0 109.932 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 55.1 Cg_endo -83.63 51.01 3.37 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.514 1.271 . . . . 0.0 111.227 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.84 43.75 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.182 -0.949 . . . . 0.0 110.456 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 61.14 -167.01 12.53 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.4 m170 56.48 106.02 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.567 -0.96 . . . . 0.0 110.671 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.44 153.63 12.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.192 -0.943 . . . . 0.0 109.982 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -105.07 -30.72 2.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.426 ' HA2' HG21 ' A' ' 172' ' ' VAL . . . 173.55 -177.15 46.03 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.424 HG13 ' CG1' ' A' ' 170' ' ' VAL . 1.2 pt -121.59 164.22 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 CA-C-N 119.24 1.52 . . . . 0.0 111.541 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 5.5 t80 -75.41 99.83 4.28 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.447 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -37.9 15.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -161.35 176.63 10.95 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -135.37 120.75 19.14 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.371 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.1 t -68.61 103.62 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 30.0 p -124.02 162.92 22.46 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.733 1.254 . . . . 0.0 114.06 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 162' ' ' GLY . 1.3 m -103.67 -172.56 2.13 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -46.38 90.07 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.677 0 O-C-N 121.396 -0.815 . . . . 0.0 111.623 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 72.25 -18.2 1.27 Allowed Glycine 0 N--CA 1.499 2.889 0 O-C-N 121.245 -0.91 . . . . 0.0 112.984 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.12 127.87 60.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 119.484 1.642 . . . . 0.0 109.527 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -89.66 137.82 32.0 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.052 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -117.94 -43.74 2.75 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.461 -0.775 . . . . 0.0 110.77 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 125' ' ' SER . . . -119.4 171.84 8.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.411 -0.806 . . . . 0.0 109.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.8 t -118.24 145.83 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.543 0.687 . . . . 0.0 110.865 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.94 100.28 9.27 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 177.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.485 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 0.4 OUTLIER -131.89 142.97 49.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.803 -1.159 . . . . 0.0 113.194 -175.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.424 ' CG1' HG13 ' A' ' 153' ' ' ILE . 2.9 p -94.09 133.45 27.46 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 49.4 Cg_endo -61.17 160.74 25.34 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.812 1.427 . . . . 0.0 110.859 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.426 HG21 ' HA2' ' A' ' 152' ' ' GLY . 40.1 t -82.41 1.56 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.294 -0.879 . . . . 0.0 109.602 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -93.08 -39.38 11.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.046 -1.034 . . . . 0.0 110.228 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.9 t -75.33 -40.05 58.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.72 -0.613 . . . . 0.0 110.305 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.478 ' HB2' HD21 ' A' ' 82' ' ' LEU . 4.0 ptp -55.75 -36.32 67.16 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.315 -0.866 . . . . 0.0 110.349 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -37.95 65.41 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.219 -0.926 . . . . 0.0 109.862 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.4 m -48.92 -38.96 24.35 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 175' ' ' MET . 7.6 t -49.91 -38.73 37.28 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 120.752 -1.217 . . . . 0.0 112.267 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.486 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -57.69 -35.14 70.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.814 -1.179 . . . . 0.0 111.462 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -47.41 -37.28 11.13 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.272 -0.892 . . . . 0.0 110.634 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.85 -45.55 10.2 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.103 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.3 t 50.28 31.56 5.36 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.096 -1.002 . . . . 0.0 111.176 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 43.8 mttt 52.97 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.22 -0.925 . . . . 0.0 110.661 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -139.1 -40.95 0.47 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.409 -0.807 . . . . 0.0 111.127 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -64.95 153.33 40.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.406 -0.809 . . . . 0.0 110.11 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.061 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.978 0.418 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.25 -74.26 0.28 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.95 -88.79 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.658 -0.907 . . . . 0.0 111.295 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t0 57.49 -167.22 0.13 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.148 -0.97 . . . . 0.0 109.924 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -144.78 -162.81 1.56 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.472 -0.767 . . . . 0.0 110.055 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -99.24 109.46 22.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.814 -0.554 . . . . 0.0 109.895 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.2 77.71 1.41 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.387 0.613 . . . . 0.0 110.03 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.9 m -99.72 -148.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.658 -0.651 . . . . 0.0 110.402 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 62.69 80.06 0.24 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.984 -1.072 . . . . 0.0 109.364 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.58 164.61 29.73 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -90.9 -28.1 18.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.669 -0.901 . . . . 0.0 110.94 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.5 143.86 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.476 -0.765 . . . . 0.0 111.248 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -137.13 175.74 9.34 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -148.56 177.96 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.23 -0.919 . . . . 0.0 111.173 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.75 -179.4 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 p -136.88 133.75 36.11 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.48 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.3 p -128.46 -176.42 3.82 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.94 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.201 -0.937 . . . . 0.0 110.959 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.0 p 49.1 39.95 16.3 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.842 -0.536 . . . . 0.0 111.005 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -155.03 137.87 15.36 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.661 -0.649 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.9 t -130.71 135.03 47.42 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.464 -0.773 . . . . 0.0 109.098 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -100.9 178.29 4.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.261 -0.899 . . . . 0.0 110.824 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.13 149.39 33.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.427 -0.796 . . . . 0.0 109.729 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.07 152.52 24.63 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.55 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.411 HG21 ' O ' ' A' ' 46' ' ' THR . 11.8 t -125.55 127.19 46.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.327 -0.858 . . . . 0.0 111.155 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.4 m -78.27 80.89 4.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.333 -0.854 . . . . 0.0 110.325 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.3 t -100.04 139.17 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.75 20.31 6.35 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.327 -0.858 . . . . 0.0 108.945 -177.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 23.13 60.07 Favored Glycine 0 N--CA 1.491 2.332 0 O-C-N 121.392 -0.817 . . . . 0.0 111.361 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -136.88 105.12 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 118.79 1.295 . . . . 0.0 110.557 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.5 t -58.4 101.44 0.08 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.68 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.46 ' CZ2' ' CE ' ' A' ' 179' ' ' MET . 52.8 m95 -82.19 144.98 30.33 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.479 -0.763 . . . . 0.0 112.177 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.444 ' CG2' ' CH2' ' A' ' 85' ' ' TRP . 3.4 t -165.23 128.66 2.28 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.4 m -49.61 153.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 O-C-N 121.26 -0.9 . . . . 0.0 111.349 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.465 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 57.1 t80 -76.4 1.31 16.72 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.159 -0.963 . . . . 0.0 111.643 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -49.24 -25.12 2.1 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.129 -0.982 . . . . 0.0 110.883 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.95 73.1 0.06 OUTLIER Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -156.01 -54.45 0.09 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.592 -0.946 . . . . 0.0 110.264 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.68 -1.6 90.24 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 p -74.16 144.88 44.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.191 -1.182 . . . . 0.0 110.242 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.0 tttm 55.04 -171.6 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.477 -0.765 . . . . 0.0 110.65 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m -86.92 101.95 13.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.611 -0.68 . . . . 0.0 110.287 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.46 HD12 ' CZ2' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -55.46 156.13 4.79 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.625 -0.672 . . . . 0.0 110.646 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.21 141.4 47.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.673 -0.642 . . . . 0.0 110.465 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.97 -178.44 15.41 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -56.14 95.76 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.766 1.403 . . . . 0.0 110.59 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.9 tttt 56.66 33.44 22.83 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.535 -0.728 . . . . 0.0 110.503 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.35 137.33 3.42 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.98 162.21 42.62 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 O-C-N 123.836 1.44 . . . . 0.0 109.769 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 73.6 mt -118.9 93.54 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.375 -0.828 . . . . 0.0 110.098 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 m -110.02 141.19 43.17 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.222 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -146.87 -144.92 0.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.794 -0.566 . . . . 0.0 109.799 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.8 ttp -145.65 22.82 1.45 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.985 -1.072 . . . . 0.0 111.179 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.434 ' CD1' ' HG3' ' A' ' 179' ' ' MET . 11.3 m-30 -115.85 101.85 9.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.328 -0.857 . . . . 0.0 110.139 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.465 ' CG2' ' CD1' ' A' ' 56' ' ' TYR . 3.0 m -150.88 121.33 7.37 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -142.83 78.09 1.6 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.344 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.432 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.7 p -52.76 -29.36 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.352 -0.842 . . . . 0.0 110.03 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.03 -50.65 69.85 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -86.59 5.98 33.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.772 -0.58 . . . . 0.0 109.786 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 56.72 54.17 7.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.254 -0.904 . . . . 0.0 112.601 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.401 ' CD1' HG12 ' A' ' 170' ' ' VAL . 1.2 tp -160.87 138.02 9.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.922 -1.112 . . . . 0.0 112.559 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.405 HG12 ' CB ' ' A' ' 76' ' ' THR . 21.9 t -143.67 139.26 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -145.09 123.61 1.96 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 118.14 -1.981 . . . . 0.0 112.585 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.46 ' CZ2' HD12 ' A' ' 64' ' ' LEU . 1.2 m-90 -99.75 137.51 38.12 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -58.45 131.3 50.31 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.69 0.757 . . . . 0.0 111.757 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.65 93.28 5.86 Favored Pre-proline 0 C--N 1.296 -1.753 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.09 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.2 Cg_endo -99.89 -14.95 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.863 1.454 . . . . 0.0 112.473 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 47.9 Cg_endo -69.42 78.7 0.88 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 116.235 -2.043 . . . . 0.0 111.062 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 50.09 26.47 8.96 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.08 138.46 37.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.618 -0.931 . . . . 0.0 110.229 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -68.93 145.58 53.52 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.412 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -111.67 92.62 4.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.611 -0.681 . . . . 0.0 109.513 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.14 -161.37 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.593 -0.692 . . . . 0.0 109.621 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.96 -176.28 0.57 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.718 -0.614 . . . . 0.0 109.959 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -85.61 158.12 10.64 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 O-C-N 123.814 1.429 . . . . 0.0 109.944 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.81 86.71 2.35 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.509 -0.745 . . . . 0.0 110.709 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.1 p -91.85 79.59 5.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.41 -0.806 . . . . 0.0 109.549 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 31.1 p -138.2 -151.51 0.39 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.64 -128.98 3.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m 54.67 -164.16 0.11 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.252 -1.146 . . . . 0.0 110.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.9 m -160.19 -35.3 0.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.355 -0.84 . . . . 0.0 111.779 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -60.68 134.31 56.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.21 -0.931 . . . . 0.0 110.787 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.08 -166.87 1.68 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.03 -1.043 . . . . 0.0 109.884 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -144.74 85.59 1.77 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.0 tp -65.84 109.66 2.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.315 -0.866 . . . . 0.0 109.279 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.1 t -100.69 128.27 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 111.582 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 33.2 p -94.55 166.49 12.01 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 109' ' ' ARG . 27.2 tpt85 -79.97 -7.52 58.84 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.199 -0.938 . . . . 0.0 110.724 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.39 41.53 1.3 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.979 -1.075 . . . . 0.0 110.037 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 50.63 63.52 2.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.558 -0.714 . . . . 0.0 111.329 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.36 82.61 1.42 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.643 -0.66 . . . . 0.0 110.021 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.7 p -92.94 149.96 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.493 -0.754 . . . . 0.0 110.93 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.6 pt -145.16 144.72 24.41 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.226 -0.921 . . . . 0.0 110.018 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -78.07 135.41 13.82 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.805 1.424 . . . . 0.0 110.909 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.415 ' CG1' ' HA3' ' A' ' 124' ' ' GLY . 46.4 t -122.01 146.28 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.552 -0.718 . . . . 0.0 109.38 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.17 115.05 29.72 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.01 129.21 17.27 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.505 -0.747 . . . . 0.0 111.047 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -114.73 -25.85 8.09 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.51 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -171.03 61.22 0.17 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.825 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.456 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.4 OUTLIER 60.13 -75.17 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.663 -0.904 . . . . 0.0 111.66 179.051 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 120' ' ' GLY . 9.4 p -91.97 39.82 1.03 Allowed 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.283 0.563 . . . . 0.0 111.579 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.05 151.22 2.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.415 ' HA3' ' CG1' ' A' ' 116' ' ' VAL . . . -143.25 -177.2 18.0 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -125.04 118.39 26.08 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.917 -178.328 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.35 141.78 34.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.591 -0.693 . . . . 0.0 110.112 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.2 mt -109.75 53.94 0.68 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 168.08 128.82 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.05 112.45 2.05 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.775 1.408 . . . . 0.0 110.022 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -125.72 143.81 46.26 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.254 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.49 128.46 23.64 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.987 1.52 . . . . 0.0 110.907 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.28 -36.73 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.482 0.658 . . . . 0.0 109.499 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.8 m -48.44 -36.53 15.08 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.372 -0.83 . . . . 0.0 110.979 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.512 ' CD2' HD22 ' A' ' 135' ' ' LEU . 0.1 OUTLIER -65.87 -38.58 89.19 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.512 HD22 ' CD2' ' A' ' 134' ' ' TYR . 14.8 mt -63.91 -35.49 80.82 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.08 121.7 10.63 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.584 -0.847 . . . . 0.0 109.788 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.34 -30.83 9.42 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.9 m -80.83 2.23 27.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.533 -0.981 . . . . 0.0 111.263 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 p -52.96 122.84 10.1 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.133 -0.979 . . . . 0.0 110.618 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 115.37 -9.71 19.98 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -59.86 152.35 35.9 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -93.82 129.64 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.697 1.367 . . . . 0.0 112.784 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.444 HD21 ' CD1' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -88.05 123.35 32.65 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 176.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.61 123.87 42.17 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.673 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.486 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 31.3 p -58.54 -170.95 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 48.6 Cg_endo -81.13 57.51 6.54 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 117.699 -1.068 . . . . 0.0 111.149 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.2 p -175.7 -158.13 0.06 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 149' ' ' HIS . . . -83.32 -160.18 29.12 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 148' ' ' GLY . 27.2 m170 57.73 133.17 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 117.789 0.795 . . . . 0.0 112.034 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.85 137.5 36.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.101 -0.999 . . . . 0.0 109.811 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.442 HG13 ' CE2' ' A' ' 169' ' ' PHE . 0.9 OUTLIER -81.83 -38.51 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.428 ' N ' HG22 ' A' ' 172' ' ' VAL . . . 177.16 -178.29 48.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.437 HG13 HG11 ' A' ' 170' ' ' VAL . 1.7 pp -118.76 150.8 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 118.67 1.235 . . . . 0.0 111.346 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 5.9 t80 -60.63 112.33 1.96 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.39 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -46.75 5.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -149.32 172.99 14.0 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -128.73 115.6 18.23 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.555 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.4 t -67.67 94.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.2 p -123.87 148.68 46.59 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.876 0.846 . . . . 0.0 113.279 -175.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 162' ' ' GLY . 2.3 m -88.59 -173.49 4.17 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.409 ' O ' ' CG ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -46.56 85.99 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.99 0.9 . . . . 0.0 112.829 -178.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 80.42 -26.1 3.12 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.994 -1.066 . . . . 0.0 112.321 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.35 129.91 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.088 1.444 . . . . 0.0 109.271 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.98 126.69 37.16 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.961 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -109.0 -35.87 6.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.483 -0.761 . . . . 0.0 110.638 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 125' ' ' SER . . . -134.3 176.36 8.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.816 . . . . 0.0 109.921 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.01 153.11 26.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-O 121.663 0.745 . . . . 0.0 110.85 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -120.53 93.93 4.2 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.456 ' CZ ' ' O ' ' A' ' 121' ' ' ASP . 3.5 p90 -124.85 156.38 37.94 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.954 -1.098 . . . . 0.0 113.099 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.437 HG11 HG13 ' A' ' 153' ' ' ILE . 4.7 p -100.15 130.62 25.69 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 39.2 Cg_endo -62.06 159.59 33.67 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.778 1.41 . . . . 0.0 110.97 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.478 ' HA ' ' HG3' ' A' ' 175' ' ' MET . 92.6 t -78.37 0.32 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.458 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -87.48 -37.65 16.77 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.838 0.828 . . . . 0.0 108.789 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 t -70.31 -37.21 74.71 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.28 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.478 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 14.9 mtt -49.12 -38.3 24.57 Favored 'General case' 0 N--CA 1.516 2.844 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -53.15 -38.34 62.63 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.29 -0.881 . . . . 0.0 108.968 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 m -55.47 -35.14 65.19 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.525 0.678 . . . . 0.0 109.452 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.403 ' CB ' ' O ' ' A' ' 175' ' ' MET . 31.0 m -48.02 -61.02 2.18 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.859 -0.526 . . . . 0.0 110.535 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.46 ' CE ' ' CZ2' ' A' ' 53' ' ' TRP . 0.8 OUTLIER -55.04 -38.13 67.57 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.628 -0.67 . . . . 0.0 110.763 179.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -48.94 -37.04 18.82 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.982 0.896 . . . . 0.0 110.337 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.03 36.76 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.239 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.28 30.27 7.75 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.218 -0.926 . . . . 0.0 110.649 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -51.92 118.81 3.7 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.488 -0.757 . . . . 0.0 111.271 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -81.96 178.88 8.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.595 -0.69 . . . . 0.0 110.267 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -119.07 45.42 2.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.538 -0.726 . . . . 0.0 110.713 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.181 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.257 0.551 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.49 -94.64 0.48 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -86.47 92.45 8.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.493 -1.004 . . . . 0.0 109.76 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.38 175.45 0.76 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.636 -0.665 . . . . 0.0 110.692 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -124.23 -142.53 0.31 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.604 -0.685 . . . . 0.0 109.393 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -65.42 99.57 0.42 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.739 -1.226 . . . . 0.0 110.245 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -159.62 78.91 0.71 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.4 m -57.58 -176.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.382 0.611 . . . . 0.0 111.012 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.84 79.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.91 53.82 4.7 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -164.47 -82.1 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.516 -0.99 . . . . 0.0 109.764 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 72.2 t -129.5 147.38 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.322 -0.861 . . . . 0.0 110.726 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -134.56 178.85 6.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.68 -0.637 . . . . 0.0 110.033 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -159.89 144.64 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.861 0.839 . . . . 0.0 110.01 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.8 m -116.74 -178.96 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.1 m -146.37 137.54 24.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.38 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.9 p -136.65 -178.88 5.37 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.53 74.27 0.77 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.68 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 m 174.55 -63.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -173.15 -173.64 0.95 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.507 -0.746 . . . . 0.0 110.564 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.5 p -107.61 146.34 32.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.713 -0.617 . . . . 0.0 110.302 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.506 ' CE1' ' CA ' ' A' ' 58' ' ' GLY . 93.1 m-85 -105.85 -177.48 3.37 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.316 -0.865 . . . . 0.0 111.855 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.411 ' CD2' ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -114.19 146.88 39.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.616 -0.678 . . . . 0.0 110.382 -178.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.33 166.73 30.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.58 -0.7 . . . . 0.0 110.685 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.45 HG23 ' CG2' ' A' ' 153' ' ' ILE . 8.8 t -141.93 115.34 8.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.722 . . . . 0.0 111.685 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 81.8 m -66.88 85.5 0.12 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.361 -0.837 . . . . 0.0 110.247 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.3 t -104.35 139.75 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 55.39 20.2 3.49 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.485 -0.76 . . . . 0.0 110.331 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.13 26.63 43.61 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.2 t -146.9 106.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.448 -1.031 . . . . 0.0 109.865 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.9 OUTLIER -61.8 119.98 9.81 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.484 -0.76 . . . . 0.0 109.259 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.471 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 95.7 m95 -99.75 153.62 18.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.44 -0.788 . . . . 0.0 111.807 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.9 t -162.89 -176.53 4.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.433 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 15.5 m -104.96 139.13 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.5 ' CB ' ' HB ' ' A' ' 78' ' ' VAL . 13.1 t80 -65.99 -7.14 15.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.182 -0.948 . . . . 0.0 113.022 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.433 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 14.6 p-80 -95.84 36.36 1.3 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.024 -1.048 . . . . 0.0 110.161 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.506 ' CA ' ' CE1' ' A' ' 43' ' ' PHE . . . -173.93 -81.41 0.05 OUTLIER Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.43 116.48 26.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.585 -0.95 . . . . 0.0 109.13 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.93 -60.22 0.49 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.8 t -55.16 170.69 0.19 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.232 -1.158 . . . . 0.0 110.597 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 58.91 168.74 0.06 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.479 -0.763 . . . . 0.0 110.053 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.418 ' O ' ' CG2' ' A' ' 63' ' ' THR . 9.0 t -78.03 101.06 6.75 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.699 0.762 . . . . 0.0 110.759 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.479 ' CD1' ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -61.91 168.49 3.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.362 -0.836 . . . . 0.0 109.496 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.69 130.16 50.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.46 -0.775 . . . . 0.0 110.739 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.88 179.86 19.29 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.12 -26.83 65.17 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.982 1.517 . . . . 0.0 110.994 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -143.48 27.49 1.54 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.386 -0.821 . . . . 0.0 111.082 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.23 154.85 8.03 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -64.23 168.64 12.18 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.957 1.504 . . . . 0.0 110.186 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.5 mt -127.25 98.27 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 O-C-N 121.392 -0.817 . . . . 0.0 110.371 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 m -161.86 51.52 0.22 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.264 -0.898 . . . . 0.0 111.064 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -168.18 66.66 0.07 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.047 -1.033 . . . . 0.0 111.473 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -143.03 -72.82 0.3 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.225 -0.922 . . . . 0.0 109.799 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.463 ' CE1' ' CG ' ' A' ' 179' ' ' MET . 22.5 m-85 -137.77 119.83 15.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.564 -0.71 . . . . 0.0 109.479 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 0.6 OUTLIER -151.87 112.58 4.19 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.375 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.441 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 41.4 t-20 -147.29 75.63 1.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.637 0.732 . . . . 0.0 110.018 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.5 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.3 p -44.99 168.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.497 -0.752 . . . . 0.0 112.166 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 57.51 114.48 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.679 0.752 . . . . 0.0 111.336 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 66.33 -66.73 0.17 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.593 -0.692 . . . . 0.0 111.999 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 77' ' ' ASN . 21.1 m-20 -63.99 -114.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 111.689 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.451 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 4.5 tp 176.94 174.09 0.42 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.182 -1.574 . . . . 0.0 111.286 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 56' ' ' TYR . 27.5 m -135.54 133.78 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.6 131.63 2.69 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.302 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.479 ' CZ2' ' CD1' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -95.42 161.2 14.18 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -79.52 135.27 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.812 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.55 93.38 4.93 Favored Pre-proline 0 C--N 1.298 -1.672 0 O-C-N 122.003 -0.436 . . . . 0.0 110.404 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.527 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 52.1 Cg_endo -92.44 -12.82 1.65 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 123.779 1.41 . . . . 0.0 113.782 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 43.0 Cg_endo -68.83 80.51 0.64 Allowed 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 115.931 -2.246 . . . . 0.0 111.738 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 49.49 24.6 5.6 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -53.63 133.32 41.59 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.315 -1.109 . . . . 0.0 110.133 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -94.87 -5.28 45.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.632 -0.668 . . . . 0.0 112.056 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 t 59.68 129.42 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 121.708 0.766 . . . . 0.0 110.813 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.412 ' CD2' HD23 ' A' ' 144' ' ' LEU . 12.7 tp -95.54 14.92 21.24 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.302 -0.874 . . . . 0.0 111.05 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.4 p 44.35 -169.26 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.853 -0.53 . . . . 0.0 112.176 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -112.86 -164.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 O-C-N 123.439 1.231 . . . . 0.0 111.179 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.404 ' O ' ' CG2' ' A' ' 98' ' ' THR . 43.4 t -110.66 -50.37 2.96 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.446 -0.784 . . . . 0.0 110.083 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 97' ' ' CYS . 9.6 t 38.45 30.46 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.0 p -116.32 -177.73 3.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 109.642 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.27 -18.93 27.28 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.6 t -51.18 138.99 19.32 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.221 -1.164 . . . . 0.0 111.363 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.3 m -109.78 -11.11 14.75 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.436 -0.79 . . . . 0.0 111.403 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.28 112.77 2.28 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.875 -1.141 . . . . 0.0 109.072 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.475 ' HB2' ' HB ' ' A' ' 116' ' ' VAL . 33.9 mt -112.31 170.29 8.27 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.558 0.694 . . . . 0.0 111.427 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -148.23 89.45 1.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 tp -59.56 111.46 1.42 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.487 -0.758 . . . . 0.0 109.123 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.8 t -92.99 97.1 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.551 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.425 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 80.6 p -65.59 152.38 44.25 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.411 ' CB ' ' CD2' ' A' ' 44' ' ' LEU . 1.6 tpm_? -74.25 -2.0 23.05 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.17 -0.956 . . . . 0.0 111.037 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.441 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -103.62 34.76 2.84 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.027 -1.046 . . . . 0.0 109.252 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.71 75.35 0.3 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.446 -0.783 . . . . 0.0 110.746 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.3 102.96 0.96 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.887 -0.508 . . . . 0.0 110.406 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.38 139.05 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.7 pt -129.55 131.4 23.56 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.01 137.19 43.67 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 O-C-N 123.581 1.306 . . . . 0.0 112.436 -177.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 62.1 t -127.14 148.25 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -113.72 120.91 42.45 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -48.7 128.27 15.05 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.676 -0.64 . . . . 0.0 110.429 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -109.02 -29.08 8.74 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.8 -0.562 . . . . 0.0 110.221 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.39 -159.45 22.96 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.36 127.81 33.72 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.701 -0.882 . . . . 0.0 109.373 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.411 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 0.0 OUTLIER 49.94 55.95 8.64 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 121.221 0.534 . . . . 0.0 111.492 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -172.84 149.75 2.0 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.438 -0.789 . . . . 0.0 111.061 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.95 -178.24 17.85 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.27 104.7 5.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.729 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 pp -49.37 151.32 1.54 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.817 -0.552 . . . . 0.0 110.319 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.8 mt -110.91 54.2 0.68 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.53 106.51 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -55.71 106.76 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 O-C-N 123.396 1.208 . . . . 0.0 110.283 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -109.76 175.61 1.87 Allowed Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.781 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 51.5 Cg_endo -79.9 124.99 5.8 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 124.139 1.599 . . . . 0.0 109.294 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 162' ' ' GLY . 7.2 p -62.39 -35.41 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.558 -0.714 . . . . 0.0 109.4 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.75 -36.77 17.16 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 122.111 0.958 . . . . 0.0 110.27 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.408 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 21.9 t80 -66.34 -38.73 88.31 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 17.9 mt -64.88 -35.84 82.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.37 119.2 4.86 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.704 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.5 -32.98 6.37 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.6 m -78.72 -4.68 50.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.625 -0.926 . . . . 0.0 111.454 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 2.4 m -50.39 125.28 12.31 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.003 -1.061 . . . . 0.0 111.045 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 113.83 -15.69 21.37 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.407 ' HA2' HD11 ' A' ' 44' ' ' LEU . . . -58.69 135.09 52.21 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -79.75 131.18 9.06 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.8 1.421 . . . . 0.0 113.011 -177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.1 mp -79.11 138.13 37.8 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -129.81 128.06 41.58 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.003 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.479 ' HB2' ' HD3' ' A' ' 146' ' ' PRO . 1.1 p -58.58 -109.25 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.104 0 CA-C-O 117.337 -1.316 . . . . 0.0 110.907 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 145' ' ' CYS . 47.2 Cg_endo -68.99 -84.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 114.35 -3.3 . . . . 0.0 110.307 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.9 m -153.79 99.86 2.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.797 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.1 -61.34 0.65 Allowed Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -58.9 124.41 19.76 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.699 -0.883 . . . . 0.0 111.24 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.27 140.88 38.84 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 2.5 t -108.62 -37.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.522 -0.736 . . . . 0.0 109.54 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.432 ' N ' HG12 ' A' ' 172' ' ' VAL . . . 174.19 -177.91 46.23 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.45 ' CG2' HG23 ' A' ' 46' ' ' THR . 3.2 pt -112.76 156.07 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 120.96 -1.318 . . . . 0.0 111.428 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 9.8 t80 -73.58 84.5 1.56 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.219 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -66.05 -52.25 50.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.584 -0.698 . . . . 0.0 109.901 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -150.13 178.81 8.62 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -131.01 115.91 17.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.136 -0.978 . . . . 0.0 110.313 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.2 t -63.46 101.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.403 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 26.3 p -129.57 139.53 51.46 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.6 OUTLIER -73.83 -173.79 1.63 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 176.143 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.57 84.16 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.333 -0.854 . . . . 0.0 112.801 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 87.42 -28.27 5.86 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 120.809 -1.182 . . . . 0.0 111.447 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.0 OUTLIER -92.49 133.92 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.86 -1.377 . . . . 0.0 110.022 -179.245 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.403 ' HA ' ' CB ' ' A' ' 159' ' ' CYS . . . -92.8 129.2 38.79 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.221 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -114.09 -21.5 10.5 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.474 -0.766 . . . . 0.0 111.318 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -151.27 -178.47 6.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.878 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.23 144.29 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 111.59 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.98 101.28 10.11 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.409 ' CE1' ' HA3' ' A' ' 152' ' ' GLY . 0.6 OUTLIER -130.63 148.15 52.39 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.33 -0.948 . . . . 0.0 113.019 -175.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.439 HG12 ' CD1' ' A' ' 82' ' ' LEU . 3.0 p -103.17 132.98 20.59 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 54.7 Cg_endo -60.38 153.66 58.56 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.796 1.419 . . . . 0.0 111.357 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 152' ' ' GLY . 35.9 m -80.3 0.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.452 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -89.9 -38.93 13.36 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.311 -0.868 . . . . 0.0 108.776 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 88.3 p -61.12 -36.37 79.54 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.45 ' SD ' ' CG ' ' A' ' 53' ' ' TRP . 19.7 mtt -48.13 -38.18 17.25 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-O 121.519 0.676 . . . . 0.0 109.649 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -56.11 -38.09 70.29 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -67.5 -39.73 85.18 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.738 0.78 . . . . 0.0 109.031 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.31 -41.5 63.01 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.807 -0.558 . . . . 0.0 110.543 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.471 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -49.56 -41.6 42.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.206 -0.934 . . . . 0.0 111.167 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -38.71 72.99 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.133 0.968 . . . . 0.0 109.322 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.37 82.98 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.512 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.8 t -77.69 -8.09 57.43 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.333 -0.854 . . . . 0.0 111.142 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -102.41 99.54 9.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.943 -1.098 . . . . 0.0 110.104 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -100.04 32.54 2.91 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.528 -0.733 . . . . 0.0 110.862 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -91.31 98.39 11.68 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.447 -0.783 . . . . 0.0 109.606 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 18.9 mttp . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.594 -179.673 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.8 m . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.19 0.519 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.53 71.33 0.12 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.27 91.35 3.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.64 -0.918 . . . . 0.0 110.097 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.59 135.82 42.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.672 -0.642 . . . . 0.0 109.826 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.86 85.32 7.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.561 -0.712 . . . . 0.0 109.758 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -81.25 -178.21 6.81 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.621 0.724 . . . . 0.0 109.529 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -149.79 77.79 1.34 Allowed 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -59.93 -157.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.259 0.552 . . . . 0.0 110.727 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 62.37 78.58 0.29 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.063 -1.023 . . . . 0.0 108.859 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.95 -95.81 0.11 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -173.12 -36.01 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.275 -1.133 . . . . 0.0 111.629 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.0 t -113.52 155.34 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.187 -0.946 . . . . 0.0 110.92 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -141.16 148.78 40.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.592 -0.693 . . . . 0.0 110.231 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.404 ' CG1' ' HB2' ' A' ' 109' ' ' ARG . 31.4 m -106.78 -179.3 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.42 -0.8 . . . . 0.0 112.034 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.481 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 27.6 m -139.1 -178.33 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.5 p -156.2 136.62 13.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.582 -0.699 . . . . 0.0 110.054 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 40' ' ' THR . 8.0 t -152.83 -178.7 7.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.41 76.85 0.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.349 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER 174.03 -58.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 175.4 -176.41 0.1 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.269 -0.894 . . . . 0.0 109.948 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.8 t -112.49 127.87 56.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 109.358 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -107.37 -176.26 3.02 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.144 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 45' ' ' ALA . 6.6 tt -103.85 154.47 19.57 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.668 -0.645 . . . . 0.0 109.738 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.419 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -150.77 129.13 12.05 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.261 -0.899 . . . . 0.0 109.689 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.6 t -97.58 124.74 41.95 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.241 -0.912 . . . . 0.0 112.004 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.3 t -75.22 90.71 2.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.65 -0.656 . . . . 0.0 109.793 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.1 t -104.14 133.43 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.4 t30 57.34 20.61 6.01 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.471 -0.768 . . . . 0.0 110.032 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.97 25.08 38.85 Favored Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.225 -0.922 . . . . 0.0 110.887 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.443 ' O ' ' CD1' ' A' ' 53' ' ' TRP . 94.3 t -139.44 106.69 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.54 -0.977 . . . . 0.0 110.06 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.4 m -62.51 114.67 3.67 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.262 -0.899 . . . . 0.0 108.854 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.51 ' CZ3' HG23 ' A' ' 178' ' ' THR . 98.8 m95 -96.8 146.89 24.49 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.409 -0.807 . . . . 0.0 112.682 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.473 ' CG2' ' CH2' ' A' ' 85' ' ' TRP . 4.5 t -164.31 141.71 6.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 m -57.71 148.12 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.029 -1.045 . . . . 0.0 109.812 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 47.3 t80 -72.99 -1.07 15.64 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.008 -1.057 . . . . 0.0 111.715 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -49.8 -28.1 5.87 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.209 -0.932 . . . . 0.0 110.397 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.31 -46.83 0.16 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' CE1' ' A' ' 56' ' ' TYR . . . -49.49 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.404 -1.057 . . . . 0.0 110.831 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.66 175.36 22.25 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.2 p -93.57 -7.51 43.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.702 -0.881 . . . . 0.0 110.783 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -59.53 -167.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.152 -0.967 . . . . 0.0 110.856 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.3 m -83.97 101.77 11.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.742 -0.598 . . . . 0.0 109.705 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.428 HD11 ' CE2' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -57.72 173.51 0.29 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.579 -0.701 . . . . 0.0 110.139 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.94 132.75 53.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.524 -0.735 . . . . 0.0 110.876 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.03 -179.46 37.2 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.15 -18.39 64.76 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.767 1.404 . . . . 0.0 110.797 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -159.86 31.47 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 110.235 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.01 161.43 12.35 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.53 159.37 36.71 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.957 1.504 . . . . 0.0 110.403 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.1 mt -91.54 153.96 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 110.351 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.5 p -89.45 167.29 13.12 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.497 -0.752 . . . . 0.0 110.698 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 53.0 -179.21 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.381 -0.824 . . . . 0.0 110.359 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.6 ttp -176.37 51.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.332 -0.855 . . . . 0.0 109.902 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -55.9 131.7 47.77 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.267 -0.896 . . . . 0.0 109.108 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.432 ' CG2' ' CD1' ' A' ' 56' ' ' TYR . 3.7 m -156.91 118.13 3.72 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.458 -0.897 . . . . 0.0 112.323 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 49.3 m-20 -145.64 76.66 1.48 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.829 0.823 . . . . 0.0 109.076 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.416 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.9 p -48.67 152.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.485 0.66 . . . . 0.0 111.372 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 t70 61.61 127.01 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.887 0.851 . . . . 0.0 112.446 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 46.56 24.48 0.32 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 3.2 m-20 -156.2 -126.71 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -0.987 . . . . 0.0 109.777 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 53' ' ' TRP . 1.7 tp -178.65 174.98 1.13 Allowed 'General case' 0 N--CA 1.511 2.615 0 CA-C-N 121.089 1.768 . . . . 0.0 112.739 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 13.6 t -134.03 138.55 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.25 117.57 0.78 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 118.738 -1.696 . . . . 0.0 110.596 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.473 ' CH2' ' CG2' ' A' ' 54' ' ' THR . 0.1 OUTLIER -95.42 135.81 36.58 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -57.55 133.89 55.65 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.835 0.826 . . . . 0.0 111.482 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -112.85 98.29 44.56 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.135 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.58 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 46.6 Cg_endo -113.95 8.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.781 1.411 . . . . 0.0 113.264 178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 55.2 Cg_endo -68.46 -106.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 115.832 -2.312 . . . . 0.0 108.083 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.91 39.46 2.85 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 105.535 -3.026 . . . . 0.0 105.535 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.85 140.4 34.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.582 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -92.6 100.42 12.95 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.8 t -55.41 104.04 0.11 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.366 -0.834 . . . . 0.0 110.832 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.77 -156.03 0.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.687 -0.633 . . . . 0.0 109.603 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.96 -171.03 0.26 Allowed Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.489 -0.757 . . . . 0.0 110.612 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -92.97 170.72 2.25 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 O-C-N 123.567 1.299 . . . . 0.0 111.137 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 18.2 t -90.4 148.76 22.6 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.526 -0.734 . . . . 0.0 109.742 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 t -146.33 43.64 1.21 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -125.74 174.1 8.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.677 -0.64 . . . . 0.0 110.618 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -113.57 33.95 5.26 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 p -108.2 -179.35 3.86 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.534 -0.98 . . . . 0.0 110.403 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.5 p -136.26 19.71 3.18 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.585 -0.697 . . . . 0.0 110.809 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -81.65 90.52 6.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.369 -0.832 . . . . 0.0 109.564 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 116' ' ' VAL . 88.5 mt -97.09 156.63 16.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -0.825 . . . . 0.0 111.402 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -132.12 84.49 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.959 -0.463 . . . . 0.0 109.797 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.4 tp -55.36 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.328 -0.857 . . . . 0.0 109.539 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.4 t -80.29 119.57 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.008 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.434 ' HB ' ' NE2' ' A' ' 110' ' ' HIS . 37.9 p -82.15 -179.88 7.56 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.412 ' N ' HD11 ' A' ' 44' ' ' LEU . 51.9 ptt85 -99.96 51.41 0.91 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.026 -1.046 . . . . 0.0 110.447 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.434 ' NE2' ' HB ' ' A' ' 108' ' ' THR . 3.9 p80 -175.17 44.06 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.532 0.682 . . . . 0.0 110.024 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.62 67.2 1.04 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.524 -0.735 . . . . 0.0 111.005 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.99 83.65 0.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.619 -0.676 . . . . 0.0 110.08 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 53.9 t -77.91 154.44 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.573 -0.705 . . . . 0.0 109.534 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.8 mt -136.79 107.88 9.08 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -53.4 141.51 61.07 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 O-C-N 123.63 1.332 . . . . 0.0 112.695 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 21.7 t -133.97 150.23 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -111.81 118.56 35.9 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -47.88 127.85 12.55 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.374 -0.829 . . . . 0.0 110.207 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -107.79 -36.85 6.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.598 -0.689 . . . . 0.0 111.603 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.95 64.03 0.06 OUTLIER Glycine 0 N--CA 1.497 2.738 0 C-N-CA 118.892 -1.623 . . . . 0.0 110.604 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.81 140.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.89 0.852 . . . . 0.0 110.242 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.404 ' CA ' ' O ' ' A' ' 169' ' ' PHE . 69.1 p 44.12 28.56 0.28 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.792 -0.567 . . . . 0.0 112.278 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.502 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 8.4 ttm180 -165.36 151.5 9.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.274 -0.891 . . . . 0.0 110.457 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.16 -177.99 22.12 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.43 127.63 51.33 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.696 -178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.56 132.14 43.4 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.3 mt -103.09 53.55 0.77 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.2 t 175.47 133.5 0.16 Allowed Pre-proline 0 N--CA 1.5 2.044 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.829 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -62.64 104.94 0.39 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 O-C-N 123.721 1.38 . . . . 0.0 108.813 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.61 128.24 25.49 Favored Pre-proline 0 N--CA 1.488 1.458 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.632 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -60.76 131.18 36.29 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.982 1.517 . . . . 0.0 110.129 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 162' ' ' GLY . 11.7 p -57.63 -36.84 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.728 -0.608 . . . . 0.0 110.266 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.401 ' N ' HG11 ' A' ' 132' ' ' VAL . 5.8 t -49.09 -36.59 19.04 Favored 'General case' 0 N--CA 1.507 2.393 0 CA-C-O 122.064 0.935 . . . . 0.0 110.728 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -69.09 -38.21 78.84 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 13.7 mt -65.5 -35.37 80.68 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.153 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -57.14 -21.03 29.57 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.001 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -97.87 30.2 9.79 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 99.0 p -150.89 23.39 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.516 -0.99 . . . . 0.0 110.734 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.36 126.94 29.69 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.256 -0.902 . . . . 0.0 108.691 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 108.43 -13.38 36.26 Favored Glycine 0 CA--C 1.541 1.663 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.401 ' HA2' HD23 ' A' ' 44' ' ' LEU . . . -46.34 109.06 0.31 Allowed Glycine 0 N--CA 1.503 3.166 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.81 125.67 12.39 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.997 1.525 . . . . 0.0 111.753 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.433 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 6.3 mp -82.52 116.28 21.88 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mt -114.36 119.01 35.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.108 -0.995 . . . . 0.0 111.194 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.442 ' N ' ' CD ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -60.4 -20.68 0.65 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.839 -0.538 . . . . 0.0 110.507 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 145' ' ' CYS . 40.7 Cg_endo -137.44 -77.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.322 -0.833 0 O-C-N 123.535 1.282 . . . . 0.0 110.326 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.1 p -164.18 -54.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.406 -0.809 . . . . 0.0 110.0 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.68 -51.39 3.45 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -66.98 117.37 8.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.599 -0.942 . . . . 0.0 110.297 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.99 150.58 22.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 110.075 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -107.3 -31.77 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.603 -0.685 . . . . 0.0 109.913 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.425 ' HA3' ' CD1' ' A' ' 169' ' ' PHE . . . 177.28 -179.67 47.97 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.1 pt -117.2 162.71 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.317 -1.107 . . . . 0.0 110.858 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 6.5 t80 -79.91 98.58 7.19 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.585 0.707 . . . . 0.0 110.9 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -82.69 -42.91 17.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.409 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -160.69 -179.68 7.82 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.42 120.96 20.46 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.569 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.3 t -65.82 102.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.404 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 27.2 p -129.18 142.88 50.74 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -175.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 162' ' ' GLY . 1.9 m -75.74 -174.25 2.5 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.85 86.07 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.734 0.778 . . . . 0.0 112.884 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 82.53 -25.25 4.54 Favored Glycine 0 N--CA 1.499 2.896 0 O-C-N 120.879 -1.138 . . . . 0.0 112.186 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -95.48 133.54 36.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 119.217 1.508 . . . . 0.0 109.345 -179.48 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.415 ' CB ' ' CD1' ' A' ' 135' ' ' LEU . . . -100.35 132.82 45.51 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.1 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -117.71 -37.27 3.48 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.571 -0.706 . . . . 0.0 110.775 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -122.27 -179.36 4.15 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.202 -0.936 . . . . 0.0 109.994 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -125.6 145.85 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.46 -0.775 . . . . 0.0 111.878 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.3 101.46 10.46 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.502 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 0.2 OUTLIER -132.56 154.42 50.02 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.891 -175.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.12 144.46 29.46 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.4 Cg_endo -64.39 148.59 90.84 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.916 1.482 . . . . 0.0 110.675 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.444 ' HA ' ' HG2' ' A' ' 175' ' ' MET . 18.1 m -82.21 2.95 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.068 -1.02 . . . . 0.0 110.618 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -83.55 -38.15 22.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.0 t -74.02 -40.18 63.08 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.69 -0.631 . . . . 0.0 110.872 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.444 ' HG2' ' HA ' ' A' ' 172' ' ' VAL . 12.4 ptp -51.07 -36.18 38.66 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.307 -0.871 . . . . 0.0 110.012 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' A' ' 175' ' ' MET . 19.0 tt0 -58.1 -36.33 72.72 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.194 -0.941 . . . . 0.0 108.847 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.7 m -70.6 -36.07 73.32 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.418 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.51 HG23 ' CZ3' ' A' ' 53' ' ' TRP . 2.8 t -48.44 -37.52 17.42 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.095 -1.003 . . . . 0.0 112.699 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.452 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 2.3 ptp -63.22 -39.65 95.22 Favored 'General case' 0 N--CA 1.513 2.678 0 O-C-N 120.418 -1.426 . . . . 0.0 110.253 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -38.25 41.0 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.769 0.795 . . . . 0.0 110.512 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -79.81 -44.65 20.19 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.47 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.2 p 46.16 29.21 0.77 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.6 -0.688 . . . . 0.0 111.678 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -80.57 130.79 35.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.528 -0.733 . . . . 0.0 110.548 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -133.76 -39.0 0.89 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.615 -0.678 . . . . 0.0 110.534 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.31 113.45 19.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.286 -0.883 . . . . 0.0 110.13 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 69.5 tttt . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.297 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.144 0.497 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.89 99.13 1.98 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -82.05 97.57 8.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.965 . . . . 0.0 109.949 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -95.23 -17.07 22.02 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.643 -0.66 . . . . 0.0 110.761 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -98.44 28.32 4.22 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.264 -0.898 . . . . 0.0 110.045 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -93.17 89.92 6.64 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.726 -0.609 . . . . 0.0 109.935 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -161.91 78.09 0.52 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.296 -0.877 . . . . 0.0 110.215 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -98.0 166.59 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -171.95 80.72 0.06 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.395 -0.815 . . . . 0.0 110.417 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.11 -68.15 0.1 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -172.63 -46.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.947 . . . . 0.0 110.091 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.584 ' CG2' ' HA ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -158.78 -163.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 122.318 1.056 . . . . 0.0 112.337 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -148.99 171.89 15.62 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.402 ' CG1' HD23 ' A' ' 44' ' ' LEU . 34.0 m -108.96 169.56 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.722 -0.611 . . . . 0.0 109.969 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.93 -179.16 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -149.79 138.92 21.21 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.655 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.0 p -146.72 -179.76 7.01 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.41 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -71.81 75.45 0.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.651 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 39' ' ' ALA . 1.2 m 175.84 -61.22 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.74 -171.04 0.29 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.468 -0.77 . . . . 0.0 109.655 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.7 p -110.74 142.25 42.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.34 -0.85 . . . . 0.0 110.146 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.43 ' CE2' ' HA3' ' A' ' 58' ' ' GLY . 80.2 m-85 -105.53 -178.39 3.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.473 -0.767 . . . . 0.0 111.201 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -118.49 141.27 48.73 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.547 -0.721 . . . . 0.0 111.173 -178.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.417 ' C ' HG13 ' A' ' 33' ' ' VAL . . . -121.93 -177.71 3.65 Favored 'General case' 0 N--CA 1.507 2.417 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.525 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.584 ' HA ' ' CG2' ' A' ' 33' ' ' VAL . 4.6 t -154.94 109.19 2.94 Favored 'General case' 0 N--CA 1.51 2.537 0 O-C-N 121.102 -0.999 . . . . 0.0 112.449 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.49 85.89 0.44 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.319 -0.863 . . . . 0.0 110.18 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.4 t -108.57 128.17 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.6 t30 64.4 12.74 7.55 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.396 -0.815 . . . . 0.0 110.558 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.07 14.55 48.39 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.161 -0.962 . . . . 0.0 111.88 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.3 t -137.46 109.54 6.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.212 -1.169 . . . . 0.0 109.428 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 12.8 m -58.6 99.71 0.05 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.806 -0.559 . . . . 0.0 110.148 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.478 ' CZ3' HG23 ' A' ' 178' ' ' THR . 97.7 m95 -80.47 144.87 32.22 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.197 -0.939 . . . . 0.0 110.588 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.455 ' CG2' ' CZ2' ' A' ' 85' ' ' TRP . 7.2 t -162.64 131.89 4.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.795 -0.565 . . . . 0.0 110.204 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.434 HG22 ' CE1' ' A' ' 57' ' ' HIS . 9.8 m -48.69 154.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.646 0 O-C-N 121.349 -0.844 . . . . 0.0 111.384 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.472 ' CD1' HG23 ' A' ' 83' ' ' VAL . 2.6 t80 -99.97 -12.61 19.62 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.096 -1.003 . . . . 0.0 111.933 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.434 ' CE1' HG22 ' A' ' 55' ' ' VAL . 2.4 p-80 -57.82 -20.37 35.46 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.936 -1.103 . . . . 0.0 110.05 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.43 ' HA3' ' CE2' ' A' ' 43' ' ' PHE . . . -128.46 -137.2 4.33 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 52.26 -172.18 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.243 -1.151 . . . . 0.0 110.811 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.89 122.32 5.98 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 89.8 p -79.9 -13.26 59.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.639 -0.919 . . . . 0.0 111.022 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -148.09 -58.96 0.25 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.234 -0.916 . . . . 0.0 110.439 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -96.61 95.29 7.86 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.113 0.482 . . . . 0.0 111.192 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.446 ' CD1' ' CZ2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -101.45 172.99 6.64 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.499 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.79 129.67 56.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.287 -0.883 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.72 -178.24 15.52 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -53.39 93.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 O-C-N 123.776 1.409 . . . . 0.0 111.128 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.6 tttp 52.65 42.36 31.56 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.475 -0.766 . . . . 0.0 110.947 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.98 131.93 1.5 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -60.65 156.44 42.5 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 O-C-N 123.779 1.41 . . . . 0.0 110.931 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.7 mt -102.12 127.06 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.565 -0.71 . . . . 0.0 110.106 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 m -119.49 -61.37 1.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.429 -0.794 . . . . 0.0 109.721 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 54.43 -159.02 0.18 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.348 -0.845 . . . . 0.0 111.015 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.8 ttm -149.49 22.97 0.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.147 -0.971 . . . . 0.0 111.139 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 -115.25 103.67 11.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.461 -0.774 . . . . 0.0 109.216 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.464 ' CG2' ' CD1' ' A' ' 56' ' ' TYR . 2.3 m -152.7 133.89 14.25 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.735 -0.603 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.63 78.01 1.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.639 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 p -48.46 -28.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.49 -0.756 . . . . 0.0 110.387 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -51.2 60.26 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -83.93 2.52 38.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.998 -0.439 . . . . 0.0 109.969 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 57.09 52.15 9.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.879 . . . . 0.0 111.228 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.408 HD22 ' CG ' ' A' ' 175' ' ' MET . 1.4 tp -158.0 143.75 17.1 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.424 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 56' ' ' TYR . 22.0 t -145.4 119.38 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -99.79 97.1 1.73 Allowed Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.514 -1.327 . . . . 0.0 112.213 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.455 ' CZ2' ' CG2' ' A' ' 54' ' ' THR . 24.1 m0 -76.8 172.92 12.33 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.52 134.46 38.34 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.907 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -109.79 87.67 5.83 Favored Pre-proline 0 C--N 1.295 -1.771 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.803 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.558 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -100.24 -8.59 0.36 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.844 1.444 . . . . 0.0 113.401 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 46.5 Cg_endo -73.16 65.11 4.3 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 115.982 -2.212 . . . . 0.0 110.689 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.46 24.94 18.88 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.13 136.18 55.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.692 -0.887 . . . . 0.0 110.962 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -75.85 129.25 36.7 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 p -98.65 103.94 15.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.544 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.33 -156.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.635 -0.666 . . . . 0.0 109.562 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -154.3 175.41 3.08 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.575 -0.703 . . . . 0.0 110.538 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -74.98 151.53 39.74 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 O-C-N 123.815 1.429 . . . . 0.0 110.604 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.6 t -106.3 85.99 2.28 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.424 -0.798 . . . . 0.0 110.211 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -66.62 -32.46 73.81 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.044 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 11.9 p -60.53 111.88 1.76 Allowed 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.268 0.556 . . . . 0.0 110.459 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.99 80.03 1.4 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.7 m -122.76 139.92 53.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.587 -0.949 . . . . 0.0 109.955 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -76.2 -165.86 0.54 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.545 -0.722 . . . . 0.0 110.437 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 t70 57.93 102.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.501 -0.75 . . . . 0.0 110.008 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 mt -116.01 -167.53 1.28 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.565 -0.709 . . . . 0.0 110.004 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -140.26 92.21 2.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.814 -0.554 . . . . 0.0 109.576 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.0 tp -77.53 95.17 4.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.1 t -89.93 111.6 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.377 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.429 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 20.7 p -69.42 178.83 2.26 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HB2' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.72 29.51 5.29 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.766 -1.209 . . . . 0.0 110.348 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -133.4 34.46 3.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.451 -0.78 . . . . 0.0 109.214 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.48 68.35 0.84 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.838 -0.539 . . . . 0.0 111.257 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -167.57 90.8 0.34 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.781 -0.575 . . . . 0.0 109.678 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.5 p -77.52 152.62 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.491 -0.756 . . . . 0.0 110.686 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 22.5 mt -131.58 111.5 15.01 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -62.35 133.4 43.06 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 O-C-N 123.604 1.318 . . . . 0.0 111.239 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.0 t -124.05 151.1 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.624 -0.672 . . . . 0.0 109.362 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -111.85 114.81 27.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -48.67 124.54 8.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.575 -0.703 . . . . 0.0 111.022 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -109.53 -48.9 3.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.791 -0.568 . . . . 0.0 110.096 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.23 -169.71 16.06 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.5 135.45 54.23 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 169' ' ' PHE . 10.4 p 53.52 43.31 31.42 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.439 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.497 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 2.2 ttp180 -167.43 151.15 6.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.417 -0.802 . . . . 0.0 110.889 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.9 -178.83 19.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.23 120.41 34.06 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 122.019 -0.695 . . . . 0.0 111.688 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.72 132.93 52.54 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.4 mt -106.13 54.37 0.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.074 0.94 . . . . 0.0 108.502 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.9 t 176.1 116.46 0.13 Allowed Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -57.72 100.24 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.502 1.264 . . . . 0.0 109.467 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 -118.32 147.07 40.93 Favored Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.29 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -65.9 127.42 17.74 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 124.018 1.536 . . . . 0.0 109.838 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 p -55.29 -36.14 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.78 -0.575 . . . . 0.0 110.4 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -48.35 -36.37 14.33 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.28 -0.888 . . . . 0.0 110.789 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.434 ' CD2' HD22 ' A' ' 135' ' ' LEU . 9.1 t80 -65.39 -38.5 90.19 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 11.8 mt -66.62 -35.93 81.37 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.87 120.59 9.31 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.56 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.11 -33.39 6.17 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.9 m -82.06 3.1 28.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.642 -0.917 . . . . 0.0 111.208 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 28.4 p -57.67 127.47 32.2 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.136 -0.978 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.12 -8.83 29.16 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.71 -177.28 0.36 Allowed Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -112.99 121.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.103 0 O-C-N 123.494 1.26 . . . . 0.0 113.276 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.446 HD21 ' CD2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -86.53 110.39 19.75 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 175.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -113.26 123.94 51.34 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.117 -0.989 . . . . 0.0 111.651 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.426 ' HB2' ' CD ' ' A' ' 146' ' ' PRO . 16.4 p -78.13 177.97 2.46 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 145' ' ' CYS . 47.2 Cg_endo -62.0 173.98 2.76 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 O-C-N 123.516 1.272 . . . . 0.0 110.326 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 59.23 24.77 13.25 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.396 -0.815 . . . . 0.0 110.5 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 68.1 -144.38 42.92 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.6 m170 58.03 111.15 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.85 -0.794 . . . . 0.0 111.333 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.92 142.24 57.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.545 -0.722 . . . . 0.0 109.305 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 1.0 OUTLIER -100.58 -41.07 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.665 -0.647 . . . . 0.0 109.723 -179.385 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.401 ' N ' HG12 ' A' ' 172' ' ' VAL . . . -179.62 -177.58 47.93 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.432 HG12 ' CE ' ' A' ' 175' ' ' MET . 1.2 pt -117.23 157.12 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.14 -1.212 . . . . 0.0 111.329 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 7.7 t80 -69.26 109.4 4.09 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.314 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -44.73 6.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.383 -0.823 . . . . 0.0 109.717 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' A' ' 168' ' ' ASP . . . -149.42 170.59 18.21 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -128.23 117.15 21.0 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.887 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.73 99.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.5 p -127.21 143.65 51.21 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 162' ' ' GLY . 2.2 p -77.37 -173.51 2.91 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -48.21 85.21 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 121.667 0.746 . . . . 0.0 112.912 -178.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 84.01 -28.48 4.1 Favored Glycine 0 N--CA 1.5 2.94 0 O-C-N 120.803 -1.186 . . . . 0.0 112.038 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.5 t -94.62 137.93 21.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 119.264 1.532 . . . . 0.0 109.086 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.26 127.36 47.89 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.016 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -109.72 -42.27 4.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.706 -0.621 . . . . 0.0 110.688 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -121.2 176.54 5.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.16 -0.962 . . . . 0.0 110.221 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.76 154.26 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-O 121.786 0.803 . . . . 0.0 111.095 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.405 ' HB3' ' CB ' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -118.76 102.16 8.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 177.137 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.497 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 1.1 p90 -132.87 150.4 52.16 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.823 -1.151 . . . . 0.0 112.435 -175.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.2 p -101.25 133.56 20.86 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 47.2 Cg_endo -60.88 158.42 33.63 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.91 1.479 . . . . 0.0 111.469 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 152' ' ' GLY . 31.3 m -82.55 3.43 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.381 -0.824 . . . . 0.0 110.688 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -90.54 -37.78 13.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 108.731 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.9 t -63.85 -36.45 83.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.935 -0.478 . . . . 0.0 110.05 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.432 ' CE ' HG12 ' A' ' 153' ' ' ILE . 0.5 OUTLIER -48.75 -39.55 25.38 Favored 'General case' 0 N--CA 1.518 2.954 0 CA-C-O 121.643 0.735 . . . . 0.0 109.375 -179.428 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -53.14 -38.06 62.37 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.882 0.848 . . . . 0.0 109.711 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 m -54.22 -39.0 66.31 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.606 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.478 HG23 ' CZ3' ' A' ' 53' ' ' TRP . 9.6 t -59.0 -35.94 74.09 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.093 -1.004 . . . . 0.0 111.644 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.44 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -53.14 -39.63 63.66 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.707 -1.246 . . . . 0.0 110.716 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -38.46 83.43 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.076 0.941 . . . . 0.0 109.179 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -71.47 -39.14 71.11 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.737 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 94.4 p -69.22 82.3 0.35 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.525 -0.734 . . . . 0.0 110.357 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.95 128.5 35.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.442 -0.787 . . . . 0.0 110.26 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.14 155.95 36.46 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.371 -0.83 . . . . 0.0 109.954 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -105.85 -48.78 3.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.453 -0.779 . . . . 0.0 110.42 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.119 -179.772 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.958 0.409 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.68 -148.62 7.56 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -142.94 70.1 1.32 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.59 -0.947 . . . . 0.0 110.123 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -77.78 175.55 9.86 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.312 -0.867 . . . . 0.0 110.64 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt 52.35 72.37 0.41 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.465 -0.772 . . . . 0.0 111.305 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -101.02 93.3 5.42 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.392 -0.817 . . . . 0.0 110.246 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -159.8 77.38 0.67 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.984 0.897 . . . . 0.0 110.496 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.22 -164.69 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.57 -0.706 . . . . 0.0 109.677 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 57.05 78.82 0.21 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.31 -0.869 . . . . 0.0 109.652 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -161.27 -121.46 0.58 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -150.98 -39.74 0.12 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.668 -0.901 . . . . 0.0 110.681 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.7 t -111.58 156.28 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.45 -0.781 . . . . 0.0 110.49 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.67 174.0 10.98 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.427 ' CG1' ' HD2' ' A' ' 109' ' ' ARG . 5.2 p -161.93 150.48 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.353 -0.842 . . . . 0.0 110.487 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.484 ' CG1' ' CH2' ' A' ' 85' ' ' TRP . 0.9 OUTLIER -131.6 175.08 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.2 p -127.61 143.55 51.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.613 -0.679 . . . . 0.0 110.337 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 40' ' ' THR . 7.6 t -142.58 -179.7 6.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.634 -0.666 . . . . 0.0 109.349 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.65 76.8 0.29 Allowed 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.106 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.1 m 174.72 -61.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 174.71 -165.44 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.0 p -108.58 143.49 37.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.409 -0.807 . . . . 0.0 109.369 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 59' ' ' ALA . 11.9 p90 -115.01 -177.42 3.12 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.379 -0.826 . . . . 0.0 111.637 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.413 ' CD2' ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -101.69 147.11 26.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.0 110.919 -178.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.24 152.97 36.87 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.791 -0.568 . . . . 0.0 109.996 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 46' ' ' THR . 14.2 t -134.47 117.47 16.29 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.273 1.035 . . . . 0.0 111.966 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 21.4 p -66.83 81.71 0.11 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.719 -0.613 . . . . 0.0 110.785 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.4 t -97.11 133.45 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.835 -1.166 . . . . 0.0 109.096 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.63 23.55 6.23 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.49 -0.756 . . . . 0.0 110.151 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.0 23.28 49.86 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.1 t -139.41 114.84 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.374 -1.074 . . . . 0.0 109.69 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.514 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 57.0 m -69.79 105.46 2.77 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.612 -0.68 . . . . 0.0 109.876 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.459 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 97.0 m95 -88.21 137.1 32.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.267 -0.896 . . . . 0.0 112.152 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.45 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 2.0 t -162.82 130.33 3.69 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.208 0.527 . . . . 0.0 109.76 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.416 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 8.4 m -48.54 145.66 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 O-C-N 121.417 -0.802 . . . . 0.0 111.547 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -78.54 -15.9 58.06 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.338 -0.851 . . . . 0.0 111.118 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.416 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 6.1 p-80 -77.33 -23.0 50.99 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.219 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.6 -23.18 7.32 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.478 ' HA ' ' CE1' ' A' ' 43' ' ' PHE . . . -69.34 -81.0 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.309 -1.112 . . . . 0.0 109.957 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.0 -144.22 15.93 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.8 -148.69 0.26 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.425 -1.044 . . . . 0.0 110.358 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.77 -178.99 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.287 -0.883 . . . . 0.0 110.842 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.86 97.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.734 -0.604 . . . . 0.0 109.94 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.408 ' HG ' HG23 ' A' ' 36' ' ' VAL . 3.4 tt -53.84 153.71 4.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.726 -0.609 . . . . 0.0 110.839 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.76 145.95 39.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.766 -0.584 . . . . 0.0 109.752 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.87 -179.07 16.14 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.65 -16.89 57.61 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.938 1.494 . . . . 0.0 110.73 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -120.4 23.22 10.98 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.117 -0.989 . . . . 0.0 111.439 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.71 -166.31 12.25 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -65.6 135.5 42.33 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.96 1.505 . . . . 0.0 110.786 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.6 mt -95.72 157.81 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.62 -0.675 . . . . 0.0 109.945 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 p -105.11 104.98 14.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.401 -0.812 . . . . 0.0 109.998 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -56.33 151.64 12.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.732 -0.605 . . . . 0.0 111.166 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 tpt -138.11 -38.88 0.55 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.66 -0.65 . . . . 0.0 110.329 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -126.22 122.86 36.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.287 -0.883 . . . . 0.0 110.032 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.414 ' HA ' HG11 ' A' ' 83' ' ' VAL . 2.5 m -146.88 121.81 10.01 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.456 -0.777 . . . . 0.0 109.589 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -146.31 77.79 1.49 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.259 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -49.97 -28.95 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.628 -0.67 . . . . 0.0 110.433 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.33 -45.19 92.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.43 -0.794 . . . . 0.0 109.485 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.83 14.17 26.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.599 -0.688 . . . . 0.0 109.694 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 52.22 56.28 7.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.283 -0.885 . . . . 0.0 111.951 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' CD1' HG13 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -159.29 137.54 10.52 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.215 -0.928 . . . . 0.0 111.651 178.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.414 HG11 ' HA ' ' A' ' 76' ' ' THR . 39.6 t -144.14 103.0 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 52' ' ' CYS . . . -102.83 94.29 1.13 Allowed Glycine 0 N--CA 1.483 1.797 0 C-N-CA 119.928 -1.13 . . . . 0.0 111.216 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.514 ' CE2' ' HB2' ' A' ' 52' ' ' CYS . 4.8 p90 -81.43 178.57 8.29 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -92.26 125.08 36.78 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.042 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.06 156.15 21.46 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.424 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.489 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 30.2 Cg_endo -62.28 -77.43 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.353 0 O-C-N 123.991 1.522 . . . . 0.0 111.822 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 88' ' ' PRO . 59.3 Cg_endo -94.16 28.54 0.28 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 115.874 -2.284 . . . . 0.0 109.287 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.52 -16.91 59.61 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 50.49 22.04 0.97 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.039 -1.271 . . . . 0.0 111.31 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 64.7 69.56 0.5 Allowed 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 m -43.27 128.68 4.78 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.04 -157.9 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 p -144.08 -179.25 0.91 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.554 -0.716 . . . . 0.0 110.263 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -86.51 170.18 7.93 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 O-C-N 123.841 1.443 . . . . 0.0 110.318 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 9.4 t -82.81 -91.35 0.07 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.611 -0.681 . . . . 0.0 109.694 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.2 m 51.83 21.42 1.42 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.909 -1.12 . . . . 0.0 111.348 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 13.3 p -141.42 -25.5 0.71 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.284 -0.885 . . . . 0.0 112.482 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -102.06 128.71 9.64 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.0 p -66.63 -46.88 74.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.753 -0.851 . . . . 0.0 110.058 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 t -162.57 -156.45 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.576 -0.702 . . . . 0.0 110.504 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 55.41 100.69 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.549 -0.719 . . . . 0.0 110.493 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.22 -170.18 1.98 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.36 -0.837 . . . . 0.0 110.124 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 105' ' ' TYR . 11.7 p90 -160.88 98.02 1.18 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 pp -67.29 123.3 19.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.843 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.23 99.63 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.452 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.9 p -61.92 155.38 23.68 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HD2' ' CG1' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -78.95 0.56 26.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.301 -0.875 . . . . 0.0 110.764 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.1 OUTLIER -114.87 35.76 4.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.096 -1.003 . . . . 0.0 109.678 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.35 76.74 0.32 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.52 -0.738 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -167.46 97.25 0.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.534 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.72 145.05 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.425 HD13 ' CZ ' ' A' ' 134' ' ' TYR . 39.7 mt -133.21 111.39 12.96 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -58.47 145.27 95.1 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.655 1.345 . . . . 0.0 111.396 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.1 t -140.46 150.8 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.609 -0.682 . . . . 0.0 109.886 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -109.34 116.14 31.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -48.68 125.35 9.88 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.363 -0.836 . . . . 0.0 111.015 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -108.32 -44.22 4.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.95 -0.469 . . . . 0.0 110.479 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -159.2 63.93 0.3 Allowed Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.947 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.457 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER 60.9 -75.56 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.625 -0.927 . . . . 0.0 111.109 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 120' ' ' GLY . 41.2 p -89.69 38.24 0.91 Allowed 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.85 -0.531 . . . . 0.0 110.3 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.466 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 18.6 ttm180 -168.43 149.12 4.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.371 -0.83 . . . . 0.0 110.312 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.17 -179.26 19.7 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.16 117.21 24.12 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 122.097 -0.649 . . . . 0.0 111.415 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.29 142.22 32.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.637 -0.664 . . . . 0.0 110.158 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.5 mt -112.42 55.21 0.69 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.57 118.8 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.027 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.254 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -59.79 101.01 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 O-C-N 123.483 1.254 . . . . 0.0 109.568 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -120.51 169.26 8.98 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.22 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -85.73 129.3 3.52 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 124.148 1.604 . . . . 0.0 110.303 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.68 -35.35 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.796 -0.565 . . . . 0.0 110.076 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.9 m -48.94 -36.34 17.15 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.299 -0.876 . . . . 0.0 110.41 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.425 ' CZ ' HD13 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -66.03 -38.25 87.92 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 17.5 mt -70.21 -37.04 74.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -55.57 124.82 18.59 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.022 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.33 -29.62 12.11 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.2 m -82.71 1.11 40.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.694 -0.886 . . . . 0.0 111.028 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.41 123.95 14.55 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.922 -1.111 . . . . 0.0 110.394 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.58 -11.85 12.31 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.41 140.07 46.08 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -82.85 124.27 3.88 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.594 1.312 . . . . 0.0 113.171 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.463 HD23 ' CD1' ' A' ' 169' ' ' PHE . 1.2 mp -76.0 141.3 42.2 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.416 ' O ' ' CE1' ' A' ' 105' ' ' TYR . 0.9 OUTLIER -137.57 136.58 37.71 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 120.009 1.277 . . . . 0.0 112.355 -177.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.434 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 15.2 p -84.16 -174.16 0.5 Allowed Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 49.6 Cg_endo -60.1 164.84 11.61 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 117.328 -1.314 . . . . 0.0 110.08 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.36 163.15 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.344 -0.847 . . . . 0.0 109.588 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 149' ' ' HIS . . . -69.59 102.81 1.01 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.41 ' CG ' ' O ' ' A' ' 148' ' ' GLY . 1.5 m170 -166.46 106.84 0.66 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.588 -0.948 . . . . 0.0 110.38 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.17 142.36 54.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.642 . . . . 0.0 110.448 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.452 HG13 ' CE2' ' A' ' 169' ' ' PHE . 3.4 t -107.88 -44.38 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.414 ' N ' HG12 ' A' ' 172' ' ' VAL . . . -178.86 -178.33 48.07 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.431 HG12 ' CE ' ' A' ' 175' ' ' MET . 1.1 pt -116.44 143.77 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.129 -1.218 . . . . 0.0 111.21 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 5.8 t80 -60.53 116.55 4.42 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.048 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -103.68 -44.62 5.04 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.371 -0.83 . . . . 0.0 109.062 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.5 169.92 21.42 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.58 115.58 19.72 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.066 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.41 100.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.4 p -128.88 142.48 50.94 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -174.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 162' ' ' GLY . 69.9 p -73.79 -174.61 1.84 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.9 84.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 86.89 -27.77 5.81 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 121.146 -0.971 . . . . 0.0 111.92 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -94.07 137.16 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.026 1.413 . . . . 0.0 109.089 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.03 126.08 47.69 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.843 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -110.35 -38.68 5.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.78 -0.575 . . . . 0.0 110.384 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -126.32 170.56 11.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 110.164 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.2 153.85 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.642 0.734 . . . . 0.0 111.261 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.03 96.49 5.12 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CE1' ' N ' ' A' ' 123' ' ' ARG . 3.7 p90 -130.41 161.39 31.46 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.596 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.405 HG13 ' CD1' ' A' ' 82' ' ' LEU . 1.1 p -111.28 123.21 35.64 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.1 Cg_endo -50.56 157.13 3.64 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.861 1.453 . . . . 0.0 112.359 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 152' ' ' GLY . 27.8 m -83.22 3.08 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.799 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -87.79 -36.32 17.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -36.05 78.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 110.592 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.436 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -47.3 -39.18 14.1 Favored 'General case' 0 N--CA 1.524 3.27 0 CA-C-O 121.789 0.804 . . . . 0.0 109.302 -179.159 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -53.78 -38.46 64.51 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.915 0.864 . . . . 0.0 109.197 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.1 m -55.81 -39.6 71.56 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.374 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -58.11 -42.64 86.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.522 -0.736 . . . . 0.0 110.32 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.459 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -54.79 -40.16 69.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.405 -0.809 . . . . 0.0 111.056 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -51.28 -38.22 51.62 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.94 0.876 . . . . 0.0 110.408 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -80.84 -41.18 23.66 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.7 m 53.21 99.23 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.626 -0.671 . . . . 0.0 110.595 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 55.08 -167.32 0.09 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.276 -0.89 . . . . 0.0 110.28 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -69.08 -169.88 0.21 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.589 -0.694 . . . . 0.0 109.986 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -62.22 157.19 19.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.566 -0.709 . . . . 0.0 110.196 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.156 -179.938 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.903 0.383 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -176.8 -60.18 0.06 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.14 54.88 1.32 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.441 -1.034 . . . . 0.0 111.224 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -85.76 112.05 20.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.424 -0.798 . . . . 0.0 109.952 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -90.47 91.69 8.56 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.452 -0.78 . . . . 0.0 110.204 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -79.99 -179.19 6.86 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.562 -0.711 . . . . 0.0 109.766 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -161.63 77.49 0.53 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.471 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -85.84 173.05 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -156.28 76.84 0.92 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.64 0.733 . . . . 0.0 109.565 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.35 57.45 8.17 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -154.83 -85.26 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.57 -0.959 . . . . 0.0 111.795 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.9 t -149.8 152.11 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.964 -1.085 . . . . 0.0 111.581 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.22 144.11 48.24 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.413 ' CG1' ' HB2' ' A' ' 109' ' ' ARG . 34.5 m -103.57 178.81 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.207 -0.933 . . . . 0.0 111.934 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.407 HG12 ' CH2' ' A' ' 85' ' ' TRP . 33.1 m -136.31 -179.4 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.0 m -157.5 135.59 10.96 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.634 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 p -141.36 -179.07 5.92 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.09 75.44 0.67 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.949 -1.101 . . . . 0.0 108.621 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m 179.25 -63.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.7 -163.36 0.14 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.664 -0.647 . . . . 0.0 109.342 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -120.63 136.5 54.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.435 -0.791 . . . . 0.0 109.902 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 52.4 m-85 -101.87 -177.55 3.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.609 -0.682 . . . . 0.0 110.518 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.426 ' CG ' ' HB3' ' A' ' 109' ' ' ARG . 7.6 tt -113.37 153.72 28.07 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.363 -0.836 . . . . 0.0 109.37 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.413 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -156.85 130.94 8.42 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.029 -1.044 . . . . 0.0 109.973 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -97.84 129.98 44.78 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.201 -0.937 . . . . 0.0 111.883 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 80.1 m -80.81 84.39 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.292 -0.88 . . . . 0.0 110.289 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.451 ' HB ' ' CD1' ' A' ' 53' ' ' TRP . 54.7 t -98.4 138.01 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 58.26 19.61 6.4 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.207 -0.933 . . . . 0.0 109.818 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.28 24.33 54.68 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -138.24 106.85 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.38 -1.071 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.94 115.57 2.94 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.62 -0.675 . . . . 0.0 109.182 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.47 ' CH2' ' HE2' ' A' ' 179' ' ' MET . 97.7 m95 -96.49 142.44 28.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 111.326 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.8 t -161.42 -177.59 6.08 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 m -109.8 150.27 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.449 -0.782 . . . . 0.0 110.457 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.412 ' CB ' ' HB ' ' A' ' 78' ' ' VAL . 33.7 t80 -71.2 -0.91 10.88 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.826 -1.171 . . . . 0.0 112.073 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -48.44 -27.65 2.78 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.171 -0.956 . . . . 0.0 110.608 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.9 41.27 0.11 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -156.95 113.73 3.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.661 -0.905 . . . . 0.0 110.328 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.07 -49.0 0.89 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.09 178.28 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.546 -0.973 . . . . 0.0 110.514 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 50.7 -170.93 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.39 -0.819 . . . . 0.0 110.889 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.63 106.88 19.26 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.652 0.739 . . . . 0.0 109.768 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 169.98 2.32 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.502 0.667 . . . . 0.0 111.275 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -115.99 136.3 53.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.869 -0.519 . . . . 0.0 109.691 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.18 -178.48 15.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -53.46 96.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.826 0 O-C-N 123.653 1.344 . . . . 0.0 110.855 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt 54.2 28.28 8.9 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.445 -0.784 . . . . 0.0 110.629 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.07 139.09 5.0 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.14 163.06 24.07 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.861 1.453 . . . . 0.0 110.3 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.9 mt -97.94 99.2 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.569 -0.707 . . . . 0.0 109.684 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.2 t -55.81 123.47 14.3 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.623 -0.673 . . . . 0.0 110.874 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -55.4 130.73 43.73 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.631 -0.668 . . . . 0.0 111.007 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.2 mmt -128.75 -50.07 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.494 -0.753 . . . . 0.0 109.82 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.426 ' CE1' ' HB2' ' A' ' 179' ' ' MET . 10.7 m-85 -125.93 111.67 15.05 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.538 -0.726 . . . . 0.0 110.014 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.4 HG21 ' CG1' ' A' ' 83' ' ' VAL . 12.8 m -144.67 112.36 6.22 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.601 -0.687 . . . . 0.0 110.723 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -139.53 76.01 1.54 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.921 -1.112 . . . . 0.0 111.886 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.412 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.4 p -52.35 -25.18 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.36 -0.838 . . . . 0.0 109.512 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -32.82 73.61 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -96.75 22.48 8.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.76 41.9 31.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.498 -0.751 . . . . 0.0 111.469 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 175' ' ' MET . 0.3 OUTLIER -169.09 153.23 5.42 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.061 -1.055 . . . . 0.0 113.158 178.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.4 ' CG1' HG21 ' A' ' 76' ' ' THR . 35.0 m -155.34 130.48 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.45 148.71 20.32 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.615 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.407 ' CH2' HG12 ' A' ' 36' ' ' VAL . 1.1 m-90 -116.32 172.02 7.45 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -75.11 141.94 43.69 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.126 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -111.2 101.69 50.99 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.111 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.4 Cg_endo -115.63 10.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.11 0 O-C-N 123.75 1.395 . . . . 0.0 112.768 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 52.1 Cg_endo -63.7 -100.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 116.702 -1.732 . . . . 0.0 108.686 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.44 34.21 5.83 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 105.49 -3.044 . . . . 0.0 105.49 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.61 157.97 37.01 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.945 -0.738 . . . . 0.0 111.214 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.19 20.48 6.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.846 -0.534 . . . . 0.0 109.926 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.9 p 45.63 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.628 -0.67 . . . . 0.0 112.431 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.7 -151.52 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 109.763 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -161.04 171.23 7.26 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.394 -0.816 . . . . 0.0 110.611 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 172' ' ' VAL . 49.1 Cg_endo -83.12 159.46 15.44 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 O-C-N 123.935 1.492 . . . . 0.0 110.575 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.1 t -92.99 136.77 32.96 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.561 -0.712 . . . . 0.0 109.555 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.9 m -108.05 -37.12 6.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.603 -0.685 . . . . 0.0 110.121 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.6 p -64.67 -22.31 66.95 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.675 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.87 -94.57 0.04 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.6 t 51.82 -174.5 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.389 -1.065 . . . . 0.0 110.436 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.2 p -107.23 -162.0 0.82 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.433 -0.792 . . . . 0.0 110.33 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 55.36 97.21 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.529 -0.732 . . . . 0.0 110.467 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 116' ' ' VAL . 3.0 mt -114.18 -176.38 2.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.598 -0.689 . . . . 0.0 110.159 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -132.08 84.77 2.18 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.9 tp -67.52 97.0 0.56 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.6 t -82.96 113.9 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.616 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.432 ' HB ' ' NE2' ' A' ' 110' ' ' HIS . 67.3 p -70.21 178.5 2.79 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.426 ' HB3' ' CG ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -99.73 42.44 1.11 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.008 -1.058 . . . . 0.0 110.64 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.432 ' NE2' ' HB ' ' A' ' 108' ' ' THR . 2.8 p80 -164.97 46.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.717 0.77 . . . . 0.0 109.703 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.29 70.0 0.61 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.353 0.597 . . . . 0.0 111.206 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.49 78.18 0.29 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.479 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.7 p -68.1 152.72 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.615 -0.678 . . . . 0.0 110.209 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 114' ' ' ILE . 46.9 mt -131.37 111.63 15.31 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.353 -0.842 . . . . 0.0 108.783 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -56.89 141.6 93.18 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 O-C-N 123.66 1.348 . . . . 0.0 111.913 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 41.9 t -135.95 148.72 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.525 -0.735 . . . . 0.0 109.767 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.2 115.96 29.05 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -49.3 125.24 10.56 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.299 -0.875 . . . . 0.0 110.882 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.402 ' HG2' ' HB2' ' A' ' 125' ' ' SER . 0.0 OUTLIER -104.75 -47.34 4.07 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.278 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.73 -164.91 13.1 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.12 137.66 57.2 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.457 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 58.1 p 46.03 47.71 12.69 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.062 0.458 . . . . 0.0 111.892 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.441 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.4 OUTLIER -168.59 144.81 3.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.41 -0.806 . . . . 0.0 110.779 179.279 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -137.98 -178.44 16.1 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.402 ' HB2' ' HG2' ' A' ' 119' ' ' ARG . 0.3 OUTLIER -130.3 102.93 6.41 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.004 -178.242 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 pp -49.63 146.91 3.88 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.597 -0.69 . . . . 0.0 110.404 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.8 mt -109.08 54.74 0.65 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.02 0.914 . . . . 0.0 108.841 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.5 117.77 0.17 Allowed Pre-proline 0 N--CA 1.497 1.902 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -59.12 99.13 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 O-C-N 123.742 1.391 . . . . 0.0 109.447 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -114.46 144.9 32.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.019 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 44.3 Cg_endo -62.25 123.84 13.23 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 124.042 1.549 . . . . 0.0 109.993 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 p -51.0 -36.57 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.593 -0.692 . . . . 0.0 110.901 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.4 t -49.56 -35.36 20.23 Favored 'General case' 0 N--CA 1.506 2.353 0 CA-C-O 122.042 0.925 . . . . 0.0 110.099 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 34.8 t80 -63.38 -38.56 91.62 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 10.7 mt -68.8 -35.9 77.6 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.113 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -59.99 121.85 12.85 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.555 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 112.66 -30.21 7.66 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.3 m -88.78 10.53 20.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.74 -0.859 . . . . 0.0 111.12 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.5 p -51.46 127.6 20.47 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.049 -1.032 . . . . 0.0 109.755 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 115.71 -11.91 18.27 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -44.51 114.99 1.18 Allowed Glycine 0 N--CA 1.504 3.225 0 O-C-N 121.556 -0.967 . . . . 0.0 111.454 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.62 119.87 6.84 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.927 1.488 . . . . 0.0 111.356 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.402 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 4.0 mp -87.6 90.94 8.56 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.31 124.1 34.63 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.304 -0.872 . . . . 0.0 111.395 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.408 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 26.6 p -74.86 172.31 9.34 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.776 -0.578 . . . . 0.0 109.892 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 49.3 Cg_endo -71.05 90.43 0.65 Allowed 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.637 1.335 . . . . 0.0 110.973 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.72 -41.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.431 -0.793 . . . . 0.0 110.149 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.97 28.9 1.6 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -141.29 143.27 33.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.377 -1.072 . . . . 0.0 109.469 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.51 131.95 46.14 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.54 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 0.8 OUTLIER -94.14 -27.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.451 ' HA2' ' CG1' ' A' ' 172' ' ' VAL . . . 177.91 -177.85 48.4 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.408 ' CD1' HD13 ' A' ' 82' ' ' LEU . 1.8 pp -128.51 153.69 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 CA-C-N 119.013 1.406 . . . . 0.0 111.828 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 4.2 t80 -64.26 103.52 0.64 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.777 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -90.95 -42.66 10.44 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -154.46 177.88 10.68 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -133.35 118.56 18.62 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.657 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.99 102.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.424 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 28.0 p -129.1 153.25 47.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 122.162 0.982 . . . . 0.0 113.618 -174.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -86.77 -174.84 5.16 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.61 85.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.657 -0.652 . . . . 0.0 112.442 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 85.15 -23.59 7.93 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.23 -0.919 . . . . 0.0 111.718 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -98.41 142.42 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 119.125 1.462 . . . . 0.0 109.123 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.424 ' HA ' ' CB ' ' A' ' 159' ' ' CYS . . . -102.05 133.09 47.43 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.151 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.6 mtpt -114.17 -36.13 4.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.562 -0.711 . . . . 0.0 110.965 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.37 172.75 12.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.402 -0.811 . . . . 0.0 109.979 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.431 HG11 ' CE1' ' A' ' 154' ' ' PHE . 0.7 OUTLIER -115.19 152.62 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 111.178 -178.557 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.03 93.21 4.1 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.441 ' CE1' ' N ' ' A' ' 123' ' ' ARG . 2.6 p90 -128.35 148.65 50.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.408 -0.808 . . . . 0.0 110.838 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.412 ' CG2' ' SD ' ' A' ' 175' ' ' MET . 1.0 OUTLIER -103.51 148.78 36.27 Favored Pre-proline 0 N--CA 1.497 1.916 0 C-N-CA 118.621 -1.232 . . . . 0.0 108.596 179.054 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 175' ' ' MET . 47.0 Cg_endo -63.03 137.91 64.7 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.103 1.581 . . . . 0.0 110.496 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.451 ' CG1' ' HA2' ' A' ' 152' ' ' GLY . 25.6 m -75.94 -0.99 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -77.27 -37.01 53.8 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.1 m -84.13 -38.42 20.74 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.781 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.511 ' HG3' ' O ' ' A' ' 171' ' ' PRO . 11.3 mtm -49.54 -41.05 40.22 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.313 -0.867 . . . . 0.0 110.039 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.446 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 44.8 mm-40 -54.15 -39.49 66.57 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.569 0.7 . . . . 0.0 110.323 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.4 m -50.26 -35.75 28.35 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.933 -0.479 . . . . 0.0 112.266 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.3 t -48.69 -40.81 29.53 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.213 -0.93 . . . . 0.0 113.174 -177.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.47 ' HE2' ' CH2' ' A' ' 53' ' ' TRP . 3.3 ptp -61.0 -38.59 86.57 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.611 -1.306 . . . . 0.0 110.003 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.34 -38.55 53.69 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.871 0.843 . . . . 0.0 109.903 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -78.53 -39.7 37.18 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.4 t 53.1 33.91 16.1 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.382 -0.824 . . . . 0.0 111.042 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm -60.88 88.52 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.463 -0.773 . . . . 0.0 110.165 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -107.05 -164.23 0.97 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.443 -0.786 . . . . 0.0 110.233 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -156.01 93.31 1.43 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.571 -0.706 . . . . 0.0 109.91 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 8.4 tttm . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.267 -179.606 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 83.9 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.092 0.472 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.5 -39.86 1.71 Allowed Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 62.8 131.86 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.41 -1.053 . . . . 0.0 111.029 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.9 t0 53.24 39.74 30.19 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.379 -0.825 . . . . 0.0 111.102 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -3.79 40.82 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.502 -0.749 . . . . 0.0 111.177 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -113.99 -178.33 3.35 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.487 -0.758 . . . . 0.0 109.853 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -160.77 77.82 0.6 Allowed 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.1 p -70.04 152.52 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.706 -0.621 . . . . 0.0 110.607 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.83 79.37 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.625 -0.672 . . . . 0.0 109.22 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.89 -86.75 0.12 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.67 -35.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.495 -1.003 . . . . 0.0 111.008 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.56 153.29 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.32 -0.862 . . . . 0.0 110.303 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -139.3 135.33 33.7 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.411 -0.806 . . . . 0.0 110.438 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -108.97 161.58 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.544 -0.723 . . . . 0.0 111.583 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.0 p -144.87 145.28 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 p -117.7 143.54 46.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.748 . . . . 0.0 111.03 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.418 HG23 ' CE1' ' A' ' 43' ' ' PHE . 7.4 t -128.74 -179.61 5.17 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.06 76.63 0.23 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.354 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.2 m 177.9 -59.76 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -175.95 -166.38 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.677 -0.64 . . . . 0.0 109.443 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.7 p -119.83 137.91 53.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.354 -0.842 . . . . 0.0 110.436 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -108.96 -176.2 2.97 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.462 ' HG ' ' HG3' ' A' ' 109' ' ' ARG . 8.3 tt -125.74 147.86 49.24 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.92 135.98 19.97 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.858 -1.151 . . . . 0.0 111.467 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 46' ' ' THR . 7.3 t -106.32 126.37 52.15 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.471 -0.768 . . . . 0.0 111.88 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.6 t -76.34 85.01 3.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.475 -0.766 . . . . 0.0 109.766 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.8 t -102.14 138.03 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.4 t30 58.18 18.83 5.62 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.434 -0.791 . . . . 0.0 110.143 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.97 23.97 43.25 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.1 t -143.0 112.62 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -1.117 . . . . 0.0 110.358 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.7 p -61.56 126.37 27.11 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.47 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 85.2 m95 -105.5 139.46 40.08 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.233 -0.917 . . . . 0.0 112.621 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.4 HG23 ' CZ2' ' A' ' 85' ' ' TRP . 5.7 t -160.73 150.81 17.73 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.598 -0.688 . . . . 0.0 110.235 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.417 ' HB ' ' CD2' ' A' ' 57' ' ' HIS . 16.0 t -72.67 149.45 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 121.242 -0.911 . . . . 0.0 109.888 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.433 ' CD1' HG22 ' A' ' 76' ' ' THR . 9.0 t80 -82.44 5.26 21.11 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.856 -1.153 . . . . 0.0 112.328 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.417 ' CD2' ' HB ' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -76.68 5.91 6.82 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.059 -1.025 . . . . 0.0 112.013 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.57 -43.21 0.03 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HB3' ' CD2' ' A' ' 43' ' ' PHE . . . -91.55 146.19 23.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.593 -0.945 . . . . 0.0 110.147 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.44 -45.8 1.42 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.5 t -60.19 174.36 0.53 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.519 -0.989 . . . . 0.0 109.803 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.32 -176.24 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.304 -0.873 . . . . 0.0 110.489 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 m -88.87 94.72 10.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.539 -0.725 . . . . 0.0 110.18 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.448 ' CD1' ' CH2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -61.23 174.78 0.63 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.637 -0.664 . . . . 0.0 110.046 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.53 137.14 41.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.46 -0.775 . . . . 0.0 110.68 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.96 -179.46 16.04 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.4 -8.48 23.71 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.914 1.481 . . . . 0.0 111.035 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -139.01 30.87 2.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.034 -1.041 . . . . 0.0 110.999 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.67 175.13 13.98 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.73 148.02 76.66 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 124.016 1.535 . . . . 0.0 110.13 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.444 HG23 ' CG ' ' A' ' 85' ' ' TRP . 84.1 mt -91.62 151.06 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 110.04 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.2 m -159.49 -62.81 0.07 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.479 -0.763 . . . . 0.0 110.401 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.19 -156.48 0.24 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.409 -0.807 . . . . 0.0 110.183 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.3 ttt -142.7 28.04 1.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.764 . . . . 0.0 110.164 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CE1' ' CB ' ' A' ' 179' ' ' MET . 13.4 m-30 -106.94 100.32 9.83 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.433 HG22 ' CD1' ' A' ' 56' ' ' TYR . 66.3 m -159.93 137.36 9.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 110.742 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -159.95 79.66 0.7 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.561 -0.856 . . . . 0.0 112.142 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.9 m -44.63 -26.44 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.437 -0.79 . . . . 0.0 111.812 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -55.65 -62.66 1.54 Allowed 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.004 -1.06 . . . . 0.0 108.596 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -81.48 -1.19 45.02 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.143 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.447 ' HB3' ' HG3' ' A' ' 155' ' ' ARG . 1.0 OUTLIER 60.77 66.49 0.91 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.563 -0.711 . . . . 0.0 111.076 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.496 ' CD2' ' CB ' ' A' ' 175' ' ' MET . 0.2 OUTLIER -164.44 145.9 8.35 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.254 -0.978 . . . . 0.0 112.868 178.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 m -142.81 159.39 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.1 101.83 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 118.486 -1.816 . . . . 0.0 111.782 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.448 ' CH2' ' CD1' ' A' ' 64' ' ' LEU . 0.6 OUTLIER -85.62 166.28 16.34 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 177.382 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -90.44 131.13 36.38 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.904 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.71 139.17 80.34 Favored Pre-proline 0 C--N 1.297 -1.686 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.829 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.453 ' CD ' ' CD ' ' A' ' 89' ' ' PRO . 36.3 Cg_endo -115.23 -41.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 117.389 -1.274 . . . . 0.0 115.116 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.453 ' CD ' ' CD ' ' A' ' 88' ' ' PRO . 55.8 Cg_endo -63.27 -152.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 116.994 -1.537 . . . . 0.0 109.454 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.79 34.11 2.56 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.25 126.85 26.63 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.059 -1.26 . . . . 0.0 111.014 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.81 154.7 41.53 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.3 p -112.91 117.94 33.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.363 -0.836 . . . . 0.0 110.619 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.7 mt -86.71 -164.39 1.06 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.623 -0.673 . . . . 0.0 109.288 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.52 -170.04 0.23 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.631 -0.668 . . . . 0.0 109.48 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -89.19 156.71 5.64 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 O-C-N 123.528 1.278 . . . . 0.0 111.308 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -105.14 143.44 33.31 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.568 -0.708 . . . . 0.0 110.204 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 m -156.81 37.18 0.31 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.622 -0.674 . . . . 0.0 110.439 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 31.6 p -93.57 -171.27 2.57 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.28 -0.888 . . . . 0.0 110.579 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.79 94.81 0.87 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.7 p -165.47 -164.09 0.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.963 . . . . 0.0 109.893 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.07 -40.32 0.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.432 -0.793 . . . . 0.0 110.789 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -64.5 123.49 19.36 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.414 -0.803 . . . . 0.0 110.087 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mt -115.85 179.15 4.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.453 -0.78 . . . . 0.0 109.97 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -132.92 79.49 1.84 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.427 ' HB3' ' HB ' ' A' ' 114' ' ' ILE . 1.4 tp -58.79 101.81 0.1 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.6 t -90.55 114.89 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.563 -0.711 . . . . 0.0 111.727 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.2 p -74.71 178.71 5.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.462 ' HG3' ' HG ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -98.31 29.51 3.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.857 -1.152 . . . . 0.0 110.288 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -128.58 33.41 4.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.51 69.31 0.74 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.455 -0.778 . . . . 0.0 110.908 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -172.06 108.64 0.23 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.594 -0.691 . . . . 0.0 110.256 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.3 m -84.81 158.39 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.929 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 106' ' ' LEU . 28.3 mm -127.98 111.56 20.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -60.88 133.12 45.84 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 O-C-N 123.752 1.396 . . . . 0.0 111.259 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.2 t -135.09 149.08 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.643 -0.66 . . . . 0.0 109.841 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -104.29 111.15 23.66 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -48.71 122.54 5.72 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.641 0.734 . . . . 0.0 111.351 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.85 -36.95 5.77 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.31 171.82 32.21 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.04 -21.95 35.18 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.502 -0.999 . . . . 0.0 110.703 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.6 p -130.91 40.02 3.52 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.807 -0.558 . . . . 0.0 111.104 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.487 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -171.05 153.5 3.8 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.142 -0.974 . . . . 0.0 111.021 179.08 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.39 -178.39 25.23 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.38 115.75 18.0 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.912 -0.758 . . . . 0.0 111.907 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.43 148.08 12.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.328 -0.857 . . . . 0.0 109.881 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.6 mt -112.27 54.02 0.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 164.5 142.73 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.311 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.31 112.15 2.02 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.79 1.416 . . . . 0.0 109.576 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.08 127.99 25.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.474 -0.766 . . . . 0.0 108.945 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -54.72 131.11 44.02 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.775 1.408 . . . . 0.0 111.467 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.79 -36.03 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 121.253 0.549 . . . . 0.0 109.999 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -48.74 -36.54 16.61 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.08 -1.013 . . . . 0.0 110.611 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.405 ' CD2' HD22 ' A' ' 135' ' ' LEU . 26.8 t80 -65.8 -38.62 89.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.1 mt -65.09 -36.01 82.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -63.08 124.78 22.0 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.704 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.52 -25.55 27.21 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.3 m -90.32 6.79 41.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.994 . . . . 0.0 111.283 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 p -53.15 121.4 7.4 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.021 -1.049 . . . . 0.0 109.747 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 120.91 -10.33 10.27 Favored Glycine 0 CA--C 1.542 1.725 0 N-CA-C 107.664 -2.174 . . . . 0.0 107.664 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -54.97 116.41 6.72 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.41 118.82 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.813 1.428 . . . . 0.0 111.805 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.44 HD21 ' CD1' ' A' ' 169' ' ' PHE . 2.7 mp -74.87 138.58 42.57 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 176.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mt -134.8 120.57 19.53 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.845 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.432 ' HB3' HG22 ' A' ' 151' ' ' VAL . 16.9 p -71.81 -178.3 0.59 Allowed Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.1 Cg_endo -60.62 -179.57 0.28 Allowed 'Trans proline' 0 N--CA 1.491 1.343 0 O-C-N 123.288 1.151 . . . . 0.0 110.833 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.01 -79.16 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.449 -0.782 . . . . 0.0 110.286 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 177.46 -142.28 5.64 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 62.4 m170 57.99 118.14 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.839 -0.801 . . . . 0.0 111.308 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.02 137.68 58.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.489 -0.757 . . . . 0.0 109.913 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 145' ' ' CYS . 3.1 t -92.04 -44.92 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.42 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -173.62 -177.78 43.09 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.0 142.06 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.515 -0.991 . . . . 0.0 110.541 178.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 10.1 t80 -58.2 116.58 3.66 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.447 ' HG3' ' HB3' ' A' ' 81' ' ' ASP . 5.4 ttt180 -103.37 -43.06 5.53 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.406 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -160.4 179.6 8.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.413 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -141.67 128.9 21.02 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.036 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.66 102.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 76.7 m -120.9 172.42 7.93 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.587 1.184 . . . . 0.0 113.401 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.4 OUTLIER -110.92 -174.42 2.47 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.422 ' O ' ' CG ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -49.47 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.37 -0.831 . . . . 0.0 112.798 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 84.4 -25.21 5.76 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.668 -1.27 . . . . 0.0 111.896 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.18 136.1 31.62 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.222 0 O-C-N 120.756 -1.438 . . . . 0.0 109.256 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -96.57 139.62 32.4 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.732 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -114.61 -47.84 2.89 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.529 -0.732 . . . . 0.0 110.887 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -123.05 -178.93 4.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.788 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.59 162.38 12.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.501 0.667 . . . . 0.0 110.104 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.97 88.26 2.38 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.487 ' CE1' ' N ' ' A' ' 123' ' ' ARG . 4.7 p90 -128.42 166.59 18.42 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.006 -1.078 . . . . 0.0 112.694 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -112.82 131.03 22.93 Favored Pre-proline 0 N--CA 1.491 1.58 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -60.27 157.15 36.7 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.985 1.519 . . . . 0.0 111.02 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.418 ' N ' ' HA2' ' A' ' 152' ' ' GLY . 26.8 m -82.05 5.05 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.381 -0.825 . . . . 0.0 110.744 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -85.87 -37.08 19.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.32 -38.74 49.81 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.765 -0.584 . . . . 0.0 111.024 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.496 ' CB ' ' CD2' ' A' ' 82' ' ' LEU . 9.2 ptp -49.91 -36.47 27.63 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.141 -0.974 . . . . 0.0 110.184 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.462 ' N ' ' HG3' ' A' ' 175' ' ' MET . 27.4 mm-40 -57.23 -37.86 72.91 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.485 -0.76 . . . . 0.0 109.731 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.5 m -60.3 -36.03 76.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.245 0.545 . . . . 0.0 110.343 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -49.56 -52.83 27.24 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.581 -0.699 . . . . 0.0 112.421 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.47 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 3.9 ptp -65.03 -40.94 95.57 Favored 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.041 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -54.94 -38.13 67.31 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 122.053 0.93 . . . . 0.0 109.25 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.5 -38.98 67.99 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.369 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.6 m -69.53 93.34 0.68 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.083 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -80.95 159.24 24.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.639 -0.663 . . . . 0.0 110.151 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 15.2 pttt -127.1 34.14 4.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.626 -0.672 . . . . 0.0 110.003 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -150.93 -155.37 0.62 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.677 -0.639 . . . . 0.0 110.209 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.0 tttt . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.2 -179.869 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 p . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.942 0.401 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.02 105.08 0.18 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.0 ttm105 -129.27 -67.09 0.79 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.445 -1.033 . . . . 0.0 110.65 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 50.38 94.6 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.817 -0.552 . . . . 0.0 110.507 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -83.44 1.66 40.48 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.352 -0.842 . . . . 0.0 112.352 -178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -144.79 78.83 1.58 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.225 -0.922 . . . . 0.0 110.442 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -162.46 77.84 0.48 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.586 -0.696 . . . . 0.0 109.233 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.2 m -67.77 175.72 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.33 -0.856 . . . . 0.0 110.256 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -170.96 79.28 0.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.368 0.604 . . . . 0.0 109.502 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.74 -19.17 58.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -79.54 -68.92 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.353 -1.087 . . . . 0.0 110.685 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.6 t -137.5 146.62 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.031 0.919 . . . . 0.0 111.497 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.97 173.94 11.16 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.1 m -143.03 161.43 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 118.963 -1.095 . . . . 0.0 111.613 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.488 ' CG2' ' CD2' ' A' ' 43' ' ' PHE . 26.4 m -120.94 -178.42 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 m -153.84 139.83 18.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.296 -0.878 . . . . 0.0 111.422 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -139.24 -178.38 5.34 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.411 ' O ' ' CG2' ' A' ' 40' ' ' THR . . . -69.19 75.67 0.35 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.131 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER 170.75 -61.24 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -174.73 -170.48 0.49 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.322 -0.861 . . . . 0.0 111.083 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.7 p -116.6 145.37 43.43 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.625 -0.672 . . . . 0.0 110.425 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.493 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -106.74 -172.85 2.16 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.173 -0.955 . . . . 0.0 109.766 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 45' ' ' ALA 0.25 5.7 tt -111.1 149.1 31.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.466 -0.771 . . . . 0.0 109.937 -178.001 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.412 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -155.35 137.35 14.58 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.974 -1.079 . . . . 0.0 110.809 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 t -105.49 125.0 50.48 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.995 -1.066 . . . . 0.0 113.137 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 89.9 m -77.18 86.06 3.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.44 -0.787 . . . . 0.0 110.458 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -107.15 141.84 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.338 -0.851 . . . . 0.0 108.731 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 57.3 19.04 4.69 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.363 -0.835 . . . . 0.0 110.082 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.59 23.71 49.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.1 t -142.42 113.84 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.268 -1.137 . . . . 0.0 110.493 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.31 114.04 4.47 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.483 ' CZ3' HG23 ' A' ' 178' ' ' THR . 96.0 m95 -97.83 140.53 32.07 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.588 -0.695 . . . . 0.0 111.614 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.405 HG21 HG21 ' A' ' 83' ' ' VAL . 4.3 t -161.64 177.8 9.63 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.421 HG12 ' CE1' ' A' ' 57' ' ' HIS . 21.2 t -97.86 146.87 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.274 -0.891 . . . . 0.0 109.927 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.44 ' CE1' ' O ' ' A' ' 59' ' ' ALA . 37.1 t80 -63.33 -4.52 2.67 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.659 -1.276 . . . . 0.0 112.08 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.421 ' CE1' HG12 ' A' ' 55' ' ' VAL . 30.3 m170 -39.64 -39.89 0.82 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.313 -0.867 . . . . 0.0 111.816 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.86 -44.79 0.44 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.486 ' N ' ' CE2' ' A' ' 43' ' ' PHE . . . -51.51 97.75 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.433 -1.04 . . . . 0.0 109.818 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.67 25.42 21.28 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.67 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.15 28.34 5.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.244 -1.151 . . . . 0.0 110.891 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -98.1 -156.41 0.54 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.49 -0.756 . . . . 0.0 109.881 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 m -59.21 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.336 -0.853 . . . . 0.0 110.386 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.34 136.35 42.52 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.2 143.19 49.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.432 -0.792 . . . . 0.0 110.789 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.97 -179.44 17.06 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.82 -11.56 31.34 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.92 1.484 . . . . 0.0 110.844 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -114.55 19.63 15.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.982 -1.074 . . . . 0.0 110.858 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.25 -152.64 17.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.14 143.7 54.74 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 124.064 1.56 . . . . 0.0 111.216 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.3 mt -107.28 105.09 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -55.16 149.65 12.03 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.306 -0.871 . . . . 0.0 110.892 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.59 165.36 19.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 0.0 110.087 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -166.21 -47.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.359 -0.838 . . . . 0.0 111.338 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.452 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 19.1 m-85 -123.27 126.54 47.1 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.2 m -158.29 111.76 2.43 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.293 -0.879 . . . . 0.0 112.333 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -137.46 75.18 1.51 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 111.117 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.414 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.5 p -55.56 -21.97 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.433 -0.792 . . . . 0.0 111.012 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.2 77.97 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.467 -0.77 . . . . 0.0 111.324 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 49.24 25.23 1.16 Allowed 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.277 -0.889 . . . . 0.0 111.238 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.96 -95.36 0.49 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.403 -0.811 . . . . 0.0 110.943 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 175' ' ' MET . 5.1 tp -179.13 163.19 1.28 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.518 -1.364 . . . . 0.0 111.021 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 56' ' ' TYR . 26.9 m -139.82 137.61 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.42 137.93 5.26 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.019 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.437 ' CH2' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -98.32 150.36 21.65 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -64.78 141.16 58.87 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.22 89.95 4.28 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.834 -0.541 . . . . 0.0 110.769 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.567 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -97.46 0.65 1.56 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 O-C-N 123.679 1.358 . . . . 0.0 113.455 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 49.8 Cg_endo -74.73 74.76 3.76 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 115.75 -2.367 . . . . 0.0 109.915 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.64 25.8 22.57 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.32 140.3 39.92 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.471 -1.017 . . . . 0.0 110.63 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -84.93 3.88 36.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.352 -0.842 . . . . 0.0 111.437 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.5 t 45.36 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.415 -0.803 . . . . 0.0 112.558 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -161.39 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.7 p -148.74 177.92 1.64 Allowed Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.662 -0.649 . . . . 0.0 110.956 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -86.51 155.36 9.17 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.95 1.5 . . . . 0.0 110.262 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.98 114.63 21.84 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.313 -0.867 . . . . 0.0 110.016 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 66.9 p -75.11 -28.51 60.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.636 -0.665 . . . . 0.0 110.095 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.1 p -100.41 109.84 22.02 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.62 0.724 . . . . 0.0 110.253 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.7 63.39 2.32 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 m -91.51 157.94 16.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.518 -0.99 . . . . 0.0 109.563 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.5 p -85.54 -157.98 0.35 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.444 -0.785 . . . . 0.0 110.809 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 t70 52.84 83.89 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.466 -0.771 . . . . 0.0 110.761 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.88 -174.51 2.53 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.4 -0.813 . . . . 0.0 109.39 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -134.05 91.51 2.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.757 -0.59 . . . . 0.0 109.837 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.414 ' CD1' ' CD1' ' A' ' 143' ' ' LEU . 8.8 tp -56.36 98.89 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.413 -0.804 . . . . 0.0 110.268 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.6 t -74.07 118.99 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.587 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.7 p -86.53 166.98 15.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.557 -0.714 . . . . 0.0 109.418 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.408 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 34.5 ttp180 -77.16 -1.35 28.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.611 -0.681 . . . . 0.0 111.098 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.485 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -120.7 40.77 3.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.221 -0.925 . . . . 0.0 109.993 -178.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.39 64.4 1.86 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.543 -0.723 . . . . 0.0 111.56 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -152.62 89.96 1.45 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.1 m -87.83 136.0 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.457 -0.777 . . . . 0.0 110.071 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.3 pt -124.36 146.76 53.0 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.527 -0.733 . . . . 0.0 109.59 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.65 148.13 82.69 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 124.066 1.561 . . . . 0.0 111.746 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.7 t -138.63 141.11 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -106.7 113.46 26.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -48.93 124.29 8.43 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.613 -0.679 . . . . 0.0 110.307 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -110.66 -25.78 9.77 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.539 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -173.14 -176.11 41.43 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.94 122.74 15.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.758 -0.848 . . . . 0.0 109.515 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 169' ' ' PHE . 0.9 OUTLIER 60.95 44.32 10.66 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.214 0.53 . . . . 0.0 110.721 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.498 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 8.7 ttm180 -162.65 151.83 15.26 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.413 -0.805 . . . . 0.0 110.228 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.54 -178.42 21.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.34 130.82 53.27 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.948 -0.737 . . . . 0.0 111.308 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.37 123.24 25.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.655 -0.653 . . . . 0.0 109.475 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mt -100.01 53.84 0.91 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 177.41 91.55 0.13 Allowed Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -52.87 108.69 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 O-C-N 123.588 1.31 . . . . 0.0 110.626 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -130.64 162.18 56.51 Favored Pre-proline 0 N--CA 1.493 1.696 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.028 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.37 130.9 28.19 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.939 1.494 . . . . 0.0 111.274 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 p -59.84 -35.23 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.487 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.96 -34.81 9.75 Favored 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 122.139 0.971 . . . . 0.0 110.535 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -64.66 -38.51 91.24 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 13.4 mt -65.33 -36.24 83.44 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -62.55 129.51 40.91 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.489 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.59 -28.01 17.89 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.8 m -93.45 16.18 14.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.556 -0.967 . . . . 0.0 110.566 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 56.3 m -62.0 122.32 15.2 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.3 -0.875 . . . . 0.0 109.003 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 122.12 -10.77 9.37 Favored Glycine 0 CA--C 1.543 1.781 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.409 ' HA2' HD23 ' A' ' 44' ' ' LEU . . . -55.72 108.82 1.17 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 153' ' ' ILE . 43.1 Cg_endo -66.25 126.38 15.59 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.074 1.565 . . . . 0.0 112.458 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.414 ' CD1' ' CD1' ' A' ' 106' ' ' LEU . 6.6 mp -79.6 128.83 33.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 176.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -124.21 123.61 40.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 111.662 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 32.0 p -77.82 162.63 67.08 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.798 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -62.89 87.07 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 O-C-N 123.763 1.401 . . . . 0.0 110.726 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t -172.73 -40.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.62 -0.675 . . . . 0.0 110.18 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.03 -30.57 4.77 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -73.21 154.93 40.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.638 -0.919 . . . . 0.0 109.915 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -85.39 141.32 30.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.098 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 2.1 t -97.65 -36.62 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.823 -0.548 . . . . 0.0 109.743 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.443 ' HA2' ' N ' ' A' ' 172' ' ' VAL . . . 176.49 -178.91 47.76 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.431 HG13 ' CG1' ' A' ' 170' ' ' VAL . 1.2 pt -116.8 158.19 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 118.504 1.152 . . . . 0.0 110.953 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 12.2 t80 -75.99 103.41 6.04 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.701 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -92.0 -39.1 11.85 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.413 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -159.39 -179.66 8.14 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.401 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -140.76 125.98 18.58 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.762 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.67 102.08 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 71.0 m -115.67 159.4 21.4 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 122.451 1.119 . . . . 0.0 113.722 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.8 OUTLIER -97.63 -174.06 2.8 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.75 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 O-C-N 121.314 -0.866 . . . . 0.0 112.69 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 82.83 -35.59 2.7 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.014 -1.053 . . . . 0.0 111.382 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.75 134.47 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 120.713 -1.463 . . . . 0.0 109.145 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.4 140.64 29.57 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.336 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -120.9 -44.25 2.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.468 -0.77 . . . . 0.0 110.866 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.94 -179.77 4.12 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.311 -0.868 . . . . 0.0 110.612 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -119.42 151.46 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.8 0.81 . . . . 0.0 111.022 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.16 94.25 4.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.498 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 1.1 p90 -127.89 148.52 50.49 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.922 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.431 ' CG1' HG13 ' A' ' 153' ' ' ILE . 3.9 p -98.9 136.55 20.59 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 52.2 Cg_endo -64.91 152.91 80.58 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.814 1.428 . . . . 0.0 110.476 -178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.448 ' HA ' ' HG2' ' A' ' 175' ' ' MET . 30.6 m -79.8 1.04 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.395 -0.816 . . . . 0.0 110.597 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -89.14 -38.56 14.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.314 -0.866 . . . . 0.0 109.8 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.6 t -74.14 -40.73 62.42 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.603 -0.686 . . . . 0.0 110.791 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.473 ' HB3' HD23 ' A' ' 82' ' ' LEU . 8.3 ptp -51.78 -36.2 46.7 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.096 -1.003 . . . . 0.0 110.48 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.98 -38.02 69.85 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.192 -0.943 . . . . 0.0 109.068 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.6 m -57.53 -37.47 73.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.945 -0.472 . . . . 0.0 110.64 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.483 HG23 ' CZ3' ' A' ' 53' ' ' TRP . 1.4 t -48.54 -36.42 15.39 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.431 -0.793 . . . . 0.0 111.96 -178.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.471 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -51.08 -39.49 56.16 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.815 -1.178 . . . . 0.0 110.685 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.7 ttt85 -52.2 -37.43 54.83 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.916 0.865 . . . . 0.0 110.194 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -81.25 -44.31 17.94 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.891 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.9 t 54.01 -175.77 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.072 -1.018 . . . . 0.0 110.439 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -106.37 44.63 1.03 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.422 -0.799 . . . . 0.0 110.373 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -97.58 49.73 1.04 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.615 -0.678 . . . . 0.0 109.765 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -125.15 -64.2 1.1 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.684 -0.635 . . . . 0.0 110.063 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.0 tttp . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.833 -1.079 . . . . 0.0 110.142 179.827 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.3 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.246 0.546 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.36 69.75 0.18 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -101.23 52.75 0.84 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.638 -0.919 . . . . 0.0 110.259 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.22 175.22 0.76 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.654 -0.654 . . . . 0.0 109.726 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.65 -158.88 0.7 Allowed 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.518 -0.739 . . . . 0.0 109.541 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -87.17 90.97 8.55 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.276 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -161.61 76.88 0.52 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.599 -0.688 . . . . 0.0 110.019 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 t -104.08 172.93 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.284 -0.885 . . . . 0.0 109.588 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -167.8 79.29 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.02 -170.98 38.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -117.89 22.98 11.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.501 -1.0 . . . . 0.0 110.531 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 44.6 t -145.15 143.58 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.734 . . . . 0.0 110.431 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -138.97 140.62 38.28 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.465 -0.772 . . . . 0.0 109.718 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.1 p -108.97 150.37 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.448 -0.783 . . . . 0.0 111.481 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.453 HG11 ' CE2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -131.33 124.38 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.589 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 p -101.16 143.85 30.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.369 -0.832 . . . . 0.0 109.455 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 40' ' ' THR . 5.6 t -149.61 -178.84 6.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.556 -0.715 . . . . 0.0 109.083 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.418 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -69.21 75.53 0.35 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.062 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 39' ' ' ALA . 2.3 m -177.44 -61.14 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.77 -163.95 0.05 Allowed 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 t -122.06 119.46 31.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.292 -0.88 . . . . 0.0 109.297 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.453 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -111.52 166.46 11.12 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.614 -0.679 . . . . 0.0 109.718 -179.488 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 109' ' ' ARG . 13.3 mt -105.31 174.31 5.93 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.174 -0.954 . . . . 0.0 111.133 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -157.08 128.74 7.05 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.981 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -103.1 118.89 37.82 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.966 0.888 . . . . 0.0 111.643 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.2 t -70.2 89.63 0.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.821 -0.549 . . . . 0.0 110.161 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.7 t -109.16 136.27 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.8 19.18 6.69 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.404 -0.81 . . . . 0.0 110.18 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.85 24.88 40.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.9 t -145.98 108.82 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -1.136 . . . . 0.0 110.668 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.1 p -61.57 129.11 39.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.248 -0.907 . . . . 0.0 109.304 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.476 ' CZ2' ' HE3' ' A' ' 179' ' ' MET . 56.1 m95 -108.13 139.25 43.06 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.502 -0.749 . . . . 0.0 111.66 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.451 ' O ' HG21 ' A' ' 83' ' ' VAL . 7.6 t -161.13 128.08 4.06 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.64 0.734 . . . . 0.0 110.315 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 57' ' ' HIS . 28.3 m -48.92 141.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.47 0 O-C-N 120.855 -1.153 . . . . 0.0 112.16 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -83.08 -13.65 55.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.062 -1.024 . . . . 0.0 111.357 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.461 ' CE1' ' CG2' ' A' ' 55' ' ' VAL . 2.1 p-80 -63.23 -22.9 67.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.957 . . . . 0.0 110.061 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.45 ' N ' ' CD2' ' A' ' 57' ' ' HIS . . . -119.03 -30.27 1.64 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HA ' ' CE2' ' A' ' 43' ' ' PHE . . . -55.34 174.75 0.08 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.357 -1.084 . . . . 0.0 111.203 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.97 150.62 19.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 m -101.79 -32.25 10.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.794 -0.827 . . . . 0.0 109.635 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -59.31 -169.49 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.639 -0.663 . . . . 0.0 109.933 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.8 m -68.24 97.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.543 -0.723 . . . . 0.0 109.424 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.412 ' CG ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -55.21 165.9 0.65 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.663 -0.648 . . . . 0.0 110.962 -179.446 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.82 145.37 50.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.836 -0.54 . . . . 0.0 110.491 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -140.29 177.18 20.88 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.49 -12.66 36.5 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 O-C-N 123.915 1.482 . . . . 0.0 111.278 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.63 21.36 11.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 111.044 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.88 -168.3 13.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.51 144.14 65.77 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 124.033 1.544 . . . . 0.0 110.511 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.41 HD11 HD21 ' A' ' 64' ' ' LEU . 56.0 mt -92.88 101.93 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -63.0 117.53 6.56 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.964 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -59.02 102.5 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.299 0.571 . . . . 0.0 110.31 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpt -87.46 -42.0 13.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.777 . . . . 0.0 109.468 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.409 ' CD1' ' HG3' ' A' ' 179' ' ' MET . 23.5 m-85 -125.7 130.51 51.69 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m -149.77 126.56 11.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.533 -0.729 . . . . 0.0 110.435 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.12 77.82 1.37 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.518 -0.739 . . . . 0.0 110.845 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -56.15 -18.62 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.407 -0.808 . . . . 0.0 109.947 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.54 -58.14 7.13 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.096 -1.002 . . . . 0.0 109.482 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.09 23.77 8.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 52.83 69.51 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.826 -0.546 . . . . 0.0 112.088 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.404 ' CD1' HG12 ' A' ' 170' ' ' VAL . 1.4 tp -162.43 141.91 9.41 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.01 -1.056 . . . . 0.0 112.638 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 54' ' ' THR . 9.4 m -145.13 125.39 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -110.94 99.99 1.19 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.931 -1.128 . . . . 0.0 111.874 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.45 ' CE2' HG22 ' A' ' 83' ' ' VAL . 1.6 m0 -90.18 169.14 11.39 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 176.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -89.24 128.9 35.87 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.041 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.76 139.24 93.39 Favored Pre-proline 0 N--CA 1.494 1.769 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.702 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.507 ' CD ' ' HD3' ' A' ' 89' ' ' PRO . 33.7 Cg_endo -105.54 -54.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 117.266 -1.356 . . . . 0.0 115.081 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.507 ' HD3' ' CD ' ' A' ' 88' ' ' PRO . 56.6 Cg_endo -66.37 -150.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.859 0 C-N-CA 116.923 -1.585 . . . . 0.0 108.822 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.85 34.19 3.21 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 107.734 -2.147 . . . . 0.0 107.734 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -48.64 130.73 17.58 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.105 -1.232 . . . . 0.0 110.923 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.6 142.21 58.5 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.76 -0.588 . . . . 0.0 110.44 -179.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 m -112.82 110.52 20.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 110.628 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 mt -93.3 -158.74 0.63 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.623 -0.673 . . . . 0.0 109.669 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.68 176.5 2.23 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.784 -0.573 . . . . 0.0 109.676 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.52 162.28 42.58 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 O-C-N 123.671 1.353 . . . . 0.0 111.18 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.6 t -81.95 -76.35 0.26 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.67 -0.644 . . . . 0.0 110.491 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.2 m 55.31 52.81 10.84 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.34 -0.85 . . . . 0.0 110.198 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.6 p -139.34 -149.59 0.29 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.488 -0.757 . . . . 0.0 110.304 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.33 -128.94 4.49 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.9 m 49.75 -157.59 0.08 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.371 -1.076 . . . . 0.0 111.031 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 p -171.4 -34.71 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.538 -0.726 . . . . 0.0 110.684 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.8 128.09 35.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.563 -0.711 . . . . 0.0 110.314 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.84 -168.01 1.58 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.416 -0.803 . . . . 0.0 109.345 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -141.11 87.15 2.07 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.433 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 12.3 tp -56.98 96.66 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.155 -0.966 . . . . 0.0 108.494 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.7 t -89.77 101.94 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.662 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.38 179.99 0.69 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.428 ' HB2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -100.92 29.16 4.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.015 -1.053 . . . . 0.0 109.464 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.83 30.17 4.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.338 -0.851 . . . . 0.0 109.679 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 59.36 70.6 0.63 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.46 -0.775 . . . . 0.0 110.551 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -171.56 93.88 0.16 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.344 0.593 . . . . 0.0 109.874 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.7 m -98.87 149.0 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.424 -0.797 . . . . 0.0 110.593 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.433 ' CG1' ' HB3' ' A' ' 106' ' ' LEU . 33.2 pt -131.33 147.55 66.61 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.631 -0.668 . . . . 0.0 109.316 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.88 138.67 29.04 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 O-C-N 123.909 1.479 . . . . 0.0 112.222 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.5 t -129.59 137.94 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.8 mmm-85 -102.64 121.28 42.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.862 . . . . 0.0 108.979 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -49.15 126.82 13.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.395 -0.816 . . . . 0.0 110.994 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -103.97 -55.0 2.45 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.53 -166.71 13.1 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -62.64 127.67 32.38 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.735 -0.862 . . . . 0.0 109.908 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.02 50.81 15.86 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.491 0.663 . . . . 0.0 109.901 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.463 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -166.77 151.37 7.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.767 -0.583 . . . . 0.0 110.391 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.62 -177.73 18.8 Favored Glycine 0 N--CA 1.498 2.828 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.27 103.94 6.23 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.769 -0.842 . . . . 0.0 112.291 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 165' ' ' LYS . 2.7 pp -50.91 150.91 2.74 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.361 -0.837 . . . . 0.0 110.537 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.4 mt -114.88 54.47 0.78 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.27 99.06 0.1 Allowed Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -52.38 99.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.805 0 O-C-N 123.417 1.219 . . . . 0.0 110.92 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -116.03 164.59 17.27 Favored Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.006 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.79 124.41 12.28 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.99 1.521 . . . . 0.0 111.064 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.4 p -57.82 -34.15 47.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.501 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -48.53 -36.21 14.89 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.245 -0.909 . . . . 0.0 110.256 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -62.24 -39.14 91.86 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.0 mt -67.39 -36.61 81.67 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 126.36 27.09 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.615 -0.834 . . . . 0.0 108.884 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.47 -20.64 49.51 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.0 m -93.91 11.6 28.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -1.09 . . . . 0.0 110.847 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.7 p -54.85 143.51 25.62 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.848 -1.158 . . . . 0.0 110.255 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.9 -14.32 58.77 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.54 115.6 4.99 Favored Glycine 0 N--CA 1.503 3.13 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.35 128.37 16.3 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 O-C-N 123.707 1.372 . . . . 0.0 112.683 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.56 120.26 25.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.77 124.91 50.75 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.693 -177.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.473 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 31.1 p -68.59 172.14 5.08 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.8 Cg_endo -64.73 165.52 20.65 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 O-C-N 123.38 1.2 . . . . 0.0 110.116 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.72 39.46 20.92 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.165 -0.959 . . . . 0.0 110.479 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.12 -138.02 30.48 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.7 m170 56.44 111.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.718 -0.872 . . . . 0.0 111.446 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.3 147.55 42.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 109.053 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 1.4 t -108.48 -34.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.636 -0.665 . . . . 0.0 109.638 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.439 ' HA2' HG21 ' A' ' 172' ' ' VAL . . . 174.1 179.22 44.58 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.409 HG12 ' CE ' ' A' ' 175' ' ' MET . 0.9 OUTLIER -115.05 163.32 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 CA-C-N 118.871 1.336 . . . . 0.0 110.903 178.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 3.2 t80 -70.76 114.82 9.23 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.017 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -101.18 -45.71 5.28 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 168' ' ' ASP . . . -153.44 168.36 26.38 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -124.02 116.59 23.07 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.985 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.3 t -68.63 103.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.5 p -127.32 158.41 37.32 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.121 0.963 . . . . 0.0 113.51 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 162' ' ' GLY . 24.0 p -95.13 -173.54 2.97 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 175.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.22 82.53 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 86.02 -25.56 6.76 Favored Glycine 0 N--CA 1.502 3.063 0 O-C-N 120.7 -1.25 . . . . 0.0 111.916 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.45 140.69 17.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 120.962 -1.317 . . . . 0.0 108.949 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -93.46 138.21 31.98 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.962 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.411 ' HA ' HD12 ' A' ' 126' ' ' LEU . 0.7 OUTLIER -119.16 -28.26 5.49 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.635 -0.665 . . . . 0.0 110.38 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -144.01 178.14 8.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.875 . . . . 0.0 109.444 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.03 154.54 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.878 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.411 ' HB3' ' CB ' ' A' ' 156' ' ' ALA . 1.7 t70 -119.94 99.62 6.73 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.463 ' CE1' ' N ' ' A' ' 123' ' ' ARG . 1.6 p90 -130.38 153.88 48.26 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.83 -1.148 . . . . 0.0 112.798 -175.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.404 HG12 ' CD1' ' A' ' 82' ' ' LEU . 2.7 p -103.0 127.47 29.81 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 45.9 Cg_endo -56.56 163.69 6.58 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 124.024 1.539 . . . . 0.0 111.636 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.439 HG21 ' HA2' ' A' ' 152' ' ' GLY . 70.8 t -81.24 1.14 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.378 -0.827 . . . . 0.0 110.039 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -92.92 -37.69 12.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.844 . . . . 0.0 108.95 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.3 t -63.93 -38.14 90.0 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.434 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 7.9 mtt -48.14 -35.28 11.26 Favored 'General case' 0 N--CA 1.518 2.941 0 O-C-N 121.853 -0.529 . . . . 0.0 109.871 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -48.22 -38.34 18.21 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.131 -0.98 . . . . 0.0 111.177 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.6 t -54.21 -34.67 61.16 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.213 -0.93 . . . . 0.0 109.529 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.404 ' CB ' ' O ' ' A' ' 175' ' ' MET . 32.1 m -48.12 -61.94 1.73 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.898 -0.501 . . . . 0.0 110.949 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.476 ' HE3' ' CZ2' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -54.57 -51.3 65.68 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.385 -0.822 . . . . 0.0 110.887 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -52.87 -37.68 60.71 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.154 -0.966 . . . . 0.0 109.994 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -73.33 -39.23 65.4 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.993 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.4 t -76.47 98.78 4.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.635 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -86.97 98.11 11.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.421 -0.799 . . . . 0.0 109.822 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -124.24 62.68 1.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.654 0.74 . . . . 0.0 109.642 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -100.44 113.91 27.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.882 -0.512 . . . . 0.0 110.214 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.884 -1.055 . . . . 0.0 109.769 179.877 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.091 0.472 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.31 -98.6 0.13 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.83 29.09 11.31 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.319 -1.106 . . . . 0.0 110.435 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -143.56 69.28 1.29 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.658 -0.651 . . . . 0.0 110.39 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -153.37 56.8 0.76 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.572 -0.705 . . . . 0.0 109.971 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -80.0 88.15 5.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.441 -0.787 . . . . 0.0 110.24 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -161.54 78.0 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.4 m -51.79 -38.4 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-O 121.608 0.718 . . . . 0.0 111.439 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 54.89 80.2 0.13 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.408 0.623 . . . . 0.0 110.98 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.22 63.9 1.34 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -175.35 -73.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.438 ' CG1' ' CD1' ' A' ' 44' ' ' LEU . 62.4 t -124.62 138.26 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.63 -0.669 . . . . 0.0 110.263 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -125.05 178.94 5.26 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.414 ' CG2' ' O ' ' A' ' 43' ' ' PHE . 2.9 p -154.46 143.19 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.542 -0.724 . . . . 0.0 109.533 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.457 ' CG1' ' CH2' ' A' ' 85' ' ' TRP . 33.9 m -104.18 176.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.7 p -131.28 137.71 48.96 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.566 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.3 p -131.49 -176.42 4.02 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.57 103.09 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.206 -0.934 . . . . 0.0 110.389 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 62.1 p 47.0 53.71 10.21 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.275 0.559 . . . . 0.0 111.473 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.79 164.39 16.5 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.507 0.67 . . . . 0.0 110.554 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.6 p -155.51 132.8 10.92 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.414 ' O ' ' CG2' ' A' ' 35' ' ' VAL . 92.8 m-85 -105.76 175.03 5.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.193 -0.942 . . . . 0.0 111.612 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.438 ' CD1' ' CG1' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -101.89 152.76 20.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 0.0 111.899 -177.794 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.43 161.24 32.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.896 -0.503 . . . . 0.0 110.283 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.411 HG21 ' O ' ' A' ' 46' ' ' THR . 14.6 t -137.82 125.18 21.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.098 -1.001 . . . . 0.0 111.981 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.8 m -74.04 79.24 1.71 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.378 -0.826 . . . . 0.0 109.408 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.89 138.1 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.965 -1.084 . . . . 0.0 108.586 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.53 18.46 3.58 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.307 -0.871 . . . . 0.0 110.219 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.405 ' N ' ' CB ' ' A' ' 93' ' ' SER . . . 85.6 27.33 32.75 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.2 t -143.12 116.16 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.41 -1.053 . . . . 0.0 110.506 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 58.8 m -66.59 117.15 8.38 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.474 ' CH2' ' CE ' ' A' ' 179' ' ' MET . 21.4 m95 -102.29 137.1 40.99 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 121.042 -1.036 . . . . 0.0 112.442 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.447 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 1.0 OUTLIER -162.74 131.51 4.07 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.518 -0.739 . . . . 0.0 110.443 177.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.469 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 30.4 m -52.91 147.98 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.334 -0.854 . . . . 0.0 111.497 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.452 ' CD1' HG12 ' A' ' 83' ' ' VAL . 19.9 t80 -68.26 -11.06 58.77 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.118 -0.988 . . . . 0.0 112.052 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.469 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 12.9 p-80 -94.99 36.97 1.16 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.981 -1.074 . . . . 0.0 109.952 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.414 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . -149.95 -67.16 0.01 OUTLIER Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.029 -2.029 . . . . 0.0 108.029 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.37 141.85 40.4 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.476 -1.014 . . . . 0.0 109.885 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.7 -5.23 73.38 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 120.266 -0.968 . . . . 0.0 111.029 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 p 51.76 178.72 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.171 -1.194 . . . . 0.0 111.6 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.3 mttp 53.74 -94.43 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 111.338 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m -85.06 90.41 7.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 110.541 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.424 HD12 ' CZ3' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -103.41 143.61 32.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.637 -0.664 . . . . 0.0 109.903 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.64 149.54 25.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.49 -0.756 . . . . 0.0 110.022 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.1 -179.46 15.88 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.87 -5.19 16.57 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 O-C-N 124.044 1.549 . . . . 0.0 111.268 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -139.59 22.27 2.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.072 -1.017 . . . . 0.0 110.582 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.5 -178.92 17.29 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.51 149.78 87.4 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.07 1.563 . . . . 0.0 111.143 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.407 HG22 ' CD1' ' A' ' 85' ' ' TRP . 59.1 mt -108.33 165.09 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.2 t -102.11 -166.7 1.32 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.435 -0.79 . . . . 0.0 110.057 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -119.62 120.07 35.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.557 -0.714 . . . . 0.0 110.147 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.413 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 3.6 mmt -116.03 -36.68 4.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 110.308 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.447 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 24.6 m-85 -133.44 129.93 37.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.497 -0.752 . . . . 0.0 110.367 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -152.69 115.37 4.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.385 -0.822 . . . . 0.0 110.464 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -145.93 75.15 1.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.853 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.43 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.4 p -54.0 -25.96 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.36 -41.83 76.78 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.392 -0.817 . . . . 0.0 109.347 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -97.48 22.5 8.79 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 53.95 52.34 13.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.512 -0.743 . . . . 0.0 111.667 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.415 ' CD2' ' HB3' ' A' ' 175' ' ' MET . 1.3 tp -166.43 136.12 3.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.089 -1.007 . . . . 0.0 112.596 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.452 HG12 ' CD1' ' A' ' 56' ' ' TYR . 30.0 m -148.23 140.39 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 176.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.28 176.17 36.98 Favored Glycine 0 C--N 1.298 -1.566 0 C-N-CA 118.426 -1.845 . . . . 0.0 111.663 -178.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.457 ' CH2' ' CG1' ' A' ' 36' ' ' VAL . 37.1 p90 -130.07 134.78 47.6 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -51.26 139.46 18.82 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.484 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.3 88.18 1.58 Allowed Pre-proline 0 C--N 1.297 -1.702 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.263 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.54 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.1 Cg_endo -94.79 -12.97 0.86 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.867 1.456 . . . . 0.0 112.271 177.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 43.1 Cg_endo -70.93 71.95 2.06 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 115.738 -2.374 . . . . 0.0 111.046 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.75 24.91 20.66 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.48 125.43 30.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.488 -1.007 . . . . 0.0 110.488 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -66.31 154.32 40.3 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.405 ' CB ' ' N ' ' A' ' 50' ' ' GLY . 4.9 p -113.69 103.91 11.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.625 -0.672 . . . . 0.0 110.351 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.44 -162.08 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.535 -0.728 . . . . 0.0 109.475 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 96' ' ' PRO . 0.6 OUTLIER -145.6 -172.06 0.3 Allowed Pre-proline 0 C--N 1.299 -1.589 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.333 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.41 ' N ' HG22 ' A' ' 95' ' ' THR . 51.2 Cg_endo -90.93 162.68 3.97 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.772 1.406 . . . . 0.0 110.991 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 80.29 1.29 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.377 -0.827 . . . . 0.0 110.845 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.2 p -77.46 62.63 2.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.437 -0.789 . . . . 0.0 109.234 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.2 p -129.9 169.14 15.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.48 -0.762 . . . . 0.0 111.191 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.51 -156.17 26.64 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.82 -158.45 0.2 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.448 -1.031 . . . . 0.0 110.434 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.01 -88.76 0.39 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.547 -0.721 . . . . 0.0 110.121 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 44.81 55.13 6.23 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.167 -0.958 . . . . 0.0 111.769 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.441 ' CB ' ' HB ' ' A' ' 116' ' ' VAL . 16.8 mt -88.85 168.65 12.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -149.79 86.87 1.46 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.405 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 40.6 tp -58.48 103.21 0.14 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.632 -0.667 . . . . 0.0 109.237 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.44 101.06 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.326 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 48.7 p -66.4 158.45 29.31 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.417 ' CB ' ' CD2' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -80.56 2.14 26.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.001 -1.062 . . . . 0.0 110.974 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.435 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -97.73 30.09 3.11 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.054 -1.029 . . . . 0.0 109.465 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.73 62.42 1.93 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.458 -0.776 . . . . 0.0 110.805 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.34 104.1 0.45 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.225 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.4 m -102.32 155.34 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.519 -0.738 . . . . 0.0 110.751 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.405 ' CG1' ' HB3' ' A' ' 106' ' ' LEU . 42.2 pt -133.09 140.19 36.7 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.477 -0.765 . . . . 0.0 109.636 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.1 129.04 16.57 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.861 1.453 . . . . 0.0 111.988 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 104' ' ' LEU . 63.9 t -116.95 158.69 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.57 109.42 18.23 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -46.6 129.31 11.04 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.494 -0.754 . . . . 0.0 111.418 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.7 -46.37 3.38 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.943 -0.473 . . . . 0.0 111.482 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -155.35 57.88 0.39 Allowed Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.27 -1.443 . . . . 0.0 111.1 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.419 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.5 OUTLIER 65.48 -66.72 0.14 Allowed 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.486 -1.008 . . . . 0.0 111.06 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 120' ' ' GLY . 25.8 p -98.96 41.68 1.13 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 121.467 0.651 . . . . 0.0 110.019 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.459 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 13.7 ttm180 -171.65 150.02 2.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 109.689 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.37 -178.99 18.18 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.65 113.34 16.58 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 122.181 -0.6 . . . . 0.0 111.161 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.38 133.15 45.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.623 -0.673 . . . . 0.0 109.705 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.3 mt -106.91 54.35 0.67 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.107 0.956 . . . . 0.0 108.587 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 170.44 123.52 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.15 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -56.02 112.11 0.97 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 O-C-N 123.495 1.261 . . . . 0.0 110.043 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -127.72 150.58 73.57 Favored Pre-proline 0 N--CA 1.487 1.375 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.646 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.14 130.18 18.44 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 124.107 1.583 . . . . 0.0 110.342 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.91 -35.98 73.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.416 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -49.23 -37.82 24.36 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -61.84 -38.24 87.47 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.1 mt -69.54 -36.65 76.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.6 103.64 0.7 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.461 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.36 -33.48 3.45 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.7 p -83.65 5.35 24.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.654 -0.909 . . . . 0.0 110.955 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.4 m -54.3 124.32 15.55 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.134 -0.979 . . . . 0.0 110.797 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.05 -13.67 12.67 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.64 134.44 44.39 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -79.23 132.56 10.36 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.717 1.377 . . . . 0.0 113.254 -177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.435 HD23 ' CD1' ' A' ' 169' ' ' PHE . 4.6 mp -82.53 139.22 34.0 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 175.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.67 121.81 19.08 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 120.099 1.318 . . . . 0.0 111.593 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.436 ' N ' ' CD ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -69.56 -21.18 0.55 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.862 -0.524 . . . . 0.0 110.255 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 145' ' ' CYS . 46.0 Cg_endo -140.9 -162.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.876 0 O-C-N 123.461 1.243 . . . . 0.0 110.438 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.45 -55.59 29.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.387 -0.821 . . . . 0.0 110.185 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -107.7 -158.55 20.41 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.4 m170 53.06 100.7 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.395 -1.062 . . . . 0.0 111.095 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.42 154.64 36.98 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.512 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 2.1 t -103.9 -35.32 3.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 171' ' ' PRO . . . 176.23 -178.36 47.64 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.436 ' CG1' ' CE ' ' A' ' 175' ' ' MET . 1.6 pp -118.61 146.45 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 CA-C-N 118.837 1.319 . . . . 0.0 110.98 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 6.6 t80 -59.01 113.55 2.15 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.632 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.4 -46.94 5.33 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -150.45 171.39 17.12 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.67 116.66 21.33 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.019 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.402 ' HB ' ' CB ' ' A' ' 166' ' ' ALA . 7.0 t -67.34 99.73 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 177.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.1 p -127.73 165.04 20.81 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.555 1.169 . . . . 0.0 113.78 -175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.6 OUTLIER -105.31 -174.18 2.47 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.398 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.427 ' O ' ' CG ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -48.77 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.087 0.946 . . . . 0.0 112.544 -179.31 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 82.17 -26.69 3.78 Favored Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.644 -1.285 . . . . 0.0 112.43 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.5 t -100.58 134.82 39.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 119.223 1.512 . . . . 0.0 110.025 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -95.75 131.15 42.33 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.421 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -109.12 -43.21 4.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.746 . . . . 0.0 110.344 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.402 ' CB ' ' HB ' ' A' ' 158' ' ' VAL . . . -128.43 163.86 23.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.49 -0.756 . . . . 0.0 110.088 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.55 154.28 9.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.533 0.683 . . . . 0.0 110.26 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.01 101.62 7.33 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.459 ' CE1' ' N ' ' A' ' 123' ' ' ARG . 4.9 p90 -135.22 164.34 27.92 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.676 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.402 HG11 HG13 ' A' ' 153' ' ' ILE . 3.2 p -108.57 132.39 21.16 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 40.6 Cg_endo -61.73 161.52 24.72 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.794 1.418 . . . . 0.0 111.364 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.439 ' HA ' ' HG3' ' A' ' 175' ' ' MET . 19.0 m -83.93 3.54 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 121.238 -0.914 . . . . 0.0 111.341 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.67 -38.15 13.28 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.6 t -72.69 -37.2 67.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.933 -0.48 . . . . 0.0 110.642 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.439 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 28.5 mtt -48.89 -38.74 23.51 Favored 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.429 -0.795 . . . . 0.0 109.252 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -55.87 -39.13 71.08 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.629 0.728 . . . . 0.0 109.695 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.1 m -54.62 -38.1 66.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.774 -0.579 . . . . 0.0 110.472 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.65 -41.01 63.4 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.444 -0.785 . . . . 0.0 110.548 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.474 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -52.34 -40.47 61.98 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.19 -0.944 . . . . 0.0 111.629 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.13 -37.62 64.55 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.246 -0.909 . . . . 0.0 110.149 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.28 -39.19 54.91 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.37 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.32 -4.4 36.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.459 -0.776 . . . . 0.0 111.301 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.28 120.25 32.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.168 -0.958 . . . . 0.0 109.96 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -96.48 -75.17 0.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.585 -0.697 . . . . 0.0 110.487 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.15 117.43 1.65 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.579 -0.701 . . . . 0.0 110.447 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt . . . . . 0 N--CA 1.501 2.081 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.813 179.692 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.144 0.497 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.63 89.82 0.04 OUTLIER Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.42 -156.42 0.62 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.674 -0.897 . . . . 0.0 109.886 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -91.41 81.29 5.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.602 -0.686 . . . . 0.0 109.897 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -92.26 86.51 5.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.649 -0.657 . . . . 0.0 110.276 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -91.17 89.88 7.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 109.856 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.34 78.05 0.56 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.76 -0.588 . . . . 0.0 109.582 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.8 p -89.17 150.97 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.743 -0.598 . . . . 0.0 110.109 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -173.92 79.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.371 -0.831 . . . . 0.0 109.766 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.65 151.5 5.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -67.98 -14.6 63.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.705 -0.879 . . . . 0.0 110.771 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.4 t -111.78 141.82 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 0.0 110.188 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -125.33 171.22 10.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.703 -0.623 . . . . 0.0 109.351 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.5 m -143.63 177.28 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.774 . . . . 0.0 110.748 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.07 179.48 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 p -137.09 135.88 37.85 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.073 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.2 p -132.52 -177.45 4.48 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.76 95.66 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.459 -0.776 . . . . 0.0 110.986 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.6 m 58.25 44.95 17.97 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.483 -0.761 . . . . 0.0 110.994 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -164.92 156.95 15.64 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.204 -0.935 . . . . 0.0 111.262 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 p -146.5 132.61 19.33 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.476 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 46.9 m-85 -100.59 -179.29 4.05 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.199 -0.938 . . . . 0.0 110.401 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.487 ' CD1' ' HA ' ' A' ' 138' ' ' SER . 0.0 OUTLIER -111.97 152.47 28.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 0.0 110.881 -178.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.0 136.56 9.01 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.554 -0.717 . . . . 0.0 109.609 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.413 HG23 ' CG2' ' A' ' 153' ' ' ILE . 13.6 t -110.52 119.22 38.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.222 -0.924 . . . . 0.0 112.636 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 52.5 t -71.38 83.36 0.79 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.4 t -102.63 138.43 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 t30 56.07 21.35 5.02 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.405 -0.809 . . . . 0.0 110.208 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.13 24.94 53.64 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.432 ' O ' ' CD1' ' A' ' 53' ' ' TRP . 61.6 t -141.44 106.34 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.37 -1.077 . . . . 0.0 109.875 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.9 OUTLIER -64.24 108.86 1.69 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.291 -0.88 . . . . 0.0 109.913 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.459 ' CZ2' ' CE ' ' A' ' 179' ' ' MET . 97.7 m95 -93.79 148.54 22.03 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.486 -0.759 . . . . 0.0 111.157 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.6 t -161.26 179.91 7.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.845 -0.535 . . . . 0.0 109.725 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -94.85 143.57 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.581 -0.699 . . . . 0.0 110.54 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.441 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 45.7 t80 -76.05 -0.92 23.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.098 -1.001 . . . . 0.0 111.889 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -51.76 -30.63 23.55 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.073 -1.017 . . . . 0.0 109.648 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.86 -147.8 5.25 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.41 ' HB1' ' CG ' ' A' ' 43' ' ' PHE . . . 53.0 22.07 2.31 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.12 -1.223 . . . . 0.0 111.406 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.98 -136.39 2.16 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.92 20.67 4.35 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.505 -0.997 . . . . 0.0 110.964 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -171.61 -161.18 0.19 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.21 -0.931 . . . . 0.0 110.65 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -78.2 96.31 5.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.715 -0.616 . . . . 0.0 110.397 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.464 ' CD1' ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -64.78 177.56 0.93 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.714 -0.616 . . . . 0.0 110.234 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.88 136.34 48.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.59 -0.694 . . . . 0.0 110.108 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.46 178.76 17.87 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -64.71 -16.97 58.03 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.997 1.525 . . . . 0.0 110.673 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -147.45 42.26 1.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.224 -0.923 . . . . 0.0 110.082 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.74 164.16 11.19 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -57.3 157.88 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 O-C-N 123.747 1.393 . . . . 0.0 110.877 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 92.0 mt -98.5 162.49 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.557 -0.715 . . . . 0.0 110.297 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 p -97.11 -169.68 1.9 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.565 -0.71 . . . . 0.0 110.495 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -141.56 116.4 9.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.696 . . . . 0.0 110.021 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 tpt -113.96 -31.84 6.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.559 -0.713 . . . . 0.0 110.331 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.416 ' CD1' ' HA ' ' A' ' 179' ' ' MET . 15.8 m-85 -129.47 104.34 7.41 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.582 -0.699 . . . . 0.0 109.658 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.75 109.69 4.68 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.349 -0.941 . . . . 0.0 112.117 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -161.82 74.86 0.46 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.36 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 5.9 p -67.77 -23.18 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.229 -0.919 . . . . 0.0 110.224 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -50.95 -26.35 5.83 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.301 -0.874 . . . . 0.0 110.653 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -172.68 36.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.585 -0.697 . . . . 0.0 110.511 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.82 -86.19 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.138 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.409 ' CD1' ' CG2' ' A' ' 170' ' ' VAL . 0.2 OUTLIER 175.55 175.97 0.23 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.58 -1.325 . . . . 0.0 110.343 -178.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 83' ' ' VAL . 27.7 m -143.56 121.6 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.648 0.737 . . . . 0.0 109.354 177.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.19 149.34 18.7 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.464 ' CZ2' ' CD1' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -110.46 151.37 27.61 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -63.55 137.19 58.02 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.168 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 135.8 34.62 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.736 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.458 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 38.0 Cg_endo -114.46 -38.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.463 0 O-C-N 123.56 1.295 . . . . 0.0 114.911 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 54.9 Cg_endo -61.34 -155.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 117.063 -1.492 . . . . 0.0 109.966 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -78.63 32.45 1.89 Allowed Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 89' ' ' PRO . . . -58.33 126.52 27.89 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.021 -1.282 . . . . 0.0 110.549 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 147.68 52.29 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.62 116.83 32.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.456 -0.778 . . . . 0.0 110.895 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -159.23 0.61 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.73 -0.607 . . . . 0.0 109.528 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.06 -173.64 0.39 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.601 -0.687 . . . . 0.0 109.742 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -87.97 156.16 7.21 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 O-C-N 123.77 1.405 . . . . 0.0 110.311 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.46 -67.81 0.82 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.443 -0.785 . . . . 0.0 110.275 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.1 m 50.57 26.79 2.58 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.193 -0.942 . . . . 0.0 110.721 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -147.06 174.28 11.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.513 -0.742 . . . . 0.0 110.86 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.46 -167.1 48.41 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.9 m -121.11 -55.41 1.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.726 -0.867 . . . . 0.0 109.772 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.62 -152.84 0.21 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.713 -0.617 . . . . 0.0 109.944 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 t0 57.3 101.87 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.335 -0.853 . . . . 0.0 110.266 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.4 mt -120.3 -168.99 1.72 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.505 -0.747 . . . . 0.0 109.751 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -140.45 83.68 1.92 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 24.6 tp -60.01 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.67 102.88 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.063 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.3 p -65.14 170.17 4.8 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.454 ' HB2' ' CG ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -95.55 25.8 4.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.911 -1.118 . . . . 0.0 110.363 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.463 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -124.62 29.83 6.15 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 62.08 70.68 0.57 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.543 -0.723 . . . . 0.0 111.088 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -175.0 102.69 0.09 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.645 -0.659 . . . . 0.0 110.223 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.8 m -101.79 153.81 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.446 -0.784 . . . . 0.0 110.222 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.2 pt -135.94 139.34 30.17 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.474 -0.766 . . . . 0.0 109.559 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.85 145.48 74.84 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 123.929 1.489 . . . . 0.0 111.503 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.33 142.9 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.93 117.32 34.35 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.84 128.52 15.79 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.527 -0.733 . . . . 0.0 110.119 -178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -112.97 -25.41 8.99 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.173 -177.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -172.93 53.35 0.16 Allowed Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.57 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.411 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER 65.9 -70.19 0.1 Allowed 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.633 -0.922 . . . . 0.0 110.06 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 120' ' ' GLY . 77.7 p -92.94 35.7 1.05 Allowed 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.342 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.456 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -167.91 150.75 5.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.336 -0.852 . . . . 0.0 110.216 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.42 -178.21 20.78 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.1 t -127.86 117.0 21.01 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.607 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.53 139.27 55.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.45 -0.782 . . . . 0.0 109.475 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.7 mt -105.26 53.92 0.71 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.237 1.018 . . . . 0.0 108.267 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 167.48 152.64 0.1 Allowed Pre-proline 0 N--CA 1.503 2.184 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.19 115.65 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.782 1.412 . . . . 0.0 110.044 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.62 131.8 24.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.488 -0.758 . . . . 0.0 109.035 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -58.2 130.84 39.85 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.793 1.418 . . . . 0.0 110.898 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.79 -37.3 79.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.584 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -49.97 -37.08 30.74 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 122.042 0.925 . . . . 0.0 110.458 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.46 ' CD2' HD22 ' A' ' 135' ' ' LEU . 15.5 t80 -66.91 -38.37 86.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.46 HD22 ' CD2' ' A' ' 134' ' ' TYR . 15.4 mt -66.95 -36.43 82.21 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -61.02 123.29 17.19 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.949 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.17 -25.89 26.56 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.487 ' HA ' ' CD1' ' A' ' 44' ' ' LEU . 7.4 m -81.09 0.96 33.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.547 -0.972 . . . . 0.0 111.427 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 60.1 m -55.83 126.2 24.61 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.216 -0.928 . . . . 0.0 111.569 -178.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 123.66 -22.66 6.86 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.42 ' CA ' ' CD2' ' A' ' 44' ' ' LEU . . . -53.75 126.37 35.02 Favored Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.33 125.67 9.85 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.763 1.402 . . . . 0.0 112.977 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.446 HD23 ' CG ' ' A' ' 169' ' ' PHE . 1.1 mp -76.86 135.22 38.86 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 175.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mt -132.91 127.73 34.98 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 118.924 -1.11 . . . . 0.0 111.962 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.415 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 14.2 p -74.98 -174.72 0.39 Allowed Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.1 Cg_endo -71.1 68.21 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.419 1.22 . . . . 0.0 110.643 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.78 -175.28 1.76 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.559 -0.713 . . . . 0.0 109.75 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.42 27.11 20.98 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -116.81 135.97 53.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.535 -0.979 . . . . 0.0 109.753 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.05 141.01 49.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.662 -0.649 . . . . 0.0 110.241 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 1.4 t -96.85 -37.64 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.419 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . 177.29 -177.9 48.28 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.422 ' O ' ' HB2' ' A' ' 169' ' ' PHE . 1.1 pt -117.02 140.32 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.112 -1.228 . . . . 0.0 110.435 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 135' ' ' LEU . 9.1 t80 -58.44 115.94 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.268 0.556 . . . . 0.0 110.541 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.68 -46.09 4.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.662 -0.649 . . . . 0.0 109.662 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.29 171.99 16.59 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -132.09 118.11 19.2 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.674 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.96 102.44 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.403 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 27.9 p -128.08 159.55 34.73 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.301 1.048 . . . . 0.0 113.642 -175.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 162' ' ' GLY . 1.6 m -94.05 -174.17 3.32 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.421 ' O ' ' CG ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -48.85 84.96 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 121.74 0.781 . . . . 0.0 112.76 -178.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 84.78 -27.59 4.79 Favored Glycine 0 N--CA 1.5 2.967 0 O-C-N 120.713 -1.242 . . . . 0.0 111.775 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -96.21 131.75 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.773 -1.428 . . . . 0.0 109.604 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.403 ' HA ' ' CB ' ' A' ' 159' ' ' CYS . . . -95.62 134.47 38.47 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.772 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -115.24 -39.98 3.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.729 -0.607 . . . . 0.0 110.961 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.61 177.95 5.68 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.255 -0.903 . . . . 0.0 109.841 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.33 155.55 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.608 0.718 . . . . 0.0 110.685 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.28 96.02 4.46 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.456 ' CE1' ' N ' ' A' ' 123' ' ' ARG . 3.7 p90 -132.54 165.86 23.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.824 -1.173 . . . . 0.0 112.946 -176.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.409 ' CG2' ' CD1' ' A' ' 82' ' ' LEU . 1.3 p -108.81 127.46 27.32 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 44.2 Cg_endo -59.05 160.58 18.26 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.963 1.507 . . . . 0.0 111.954 -177.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 152' ' ' GLY . 40.0 t -84.23 2.98 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.515 -0.741 . . . . 0.0 109.798 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.41 -37.17 21.8 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -36.34 83.92 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.585 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.451 ' O ' ' HB ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -49.89 -36.37 27.09 Favored 'General case' 0 N--CA 1.521 3.09 0 O-C-N 121.426 -0.796 . . . . 0.0 108.885 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -57.77 -37.48 73.74 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.121 -0.987 . . . . 0.0 108.708 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.1 m -76.27 -36.84 58.22 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.633 0.73 . . . . 0.0 109.42 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 175' ' ' MET . 1.3 m -48.82 -52.99 21.12 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.673 -0.642 . . . . 0.0 111.193 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.459 ' CE ' ' CZ2' ' A' ' 53' ' ' TRP . 2.2 ptp -59.85 -40.85 89.92 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.066 -1.021 . . . . 0.0 109.94 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -57.67 -38.36 74.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.038 0.923 . . . . 0.0 109.449 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.58 78.22 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.624 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.3 p -92.5 40.43 1.05 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.59 -0.693 . . . . 0.0 110.714 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -66.1 164.23 15.91 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.457 -0.777 . . . . 0.0 110.02 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -137.77 42.76 2.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.569 -0.707 . . . . 0.0 110.747 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -93.79 103.42 15.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.51 -0.744 . . . . 0.0 110.129 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.079 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.443 HG11 ' HG2' ' A' ' 89' ' ' PRO . 35.2 m . . . . . 0 N--CA 1.499 1.978 0 CA-C-O 120.947 0.403 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 59.92 79.64 0.23 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.173 -0.954 . . . . 0.0 109.831 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.03 -89.72 0.08 OUTLIER Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -171.15 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.633 -0.922 . . . . 0.0 110.762 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 45' ' ' ALA . 7.3 p -117.34 158.8 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.59 0.71 . . . . 0.0 111.705 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 1.5 tt0 -142.35 140.2 32.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.53 HG12 ' HD2' ' A' ' 109' ' ' ARG . 27.7 m -106.22 173.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.967 0.889 . . . . 0.0 112.233 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.465 HG11 ' CH2' ' A' ' 85' ' ' TRP . 33.6 m -129.68 179.75 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.5 p -152.95 139.4 18.62 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.147 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.0 p -146.09 -178.92 6.38 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.42 75.34 0.76 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.762 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 m 178.7 -58.32 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -179.72 -156.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.391 -0.818 . . . . 0.0 109.717 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 p -128.34 139.35 52.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.548 -0.72 . . . . 0.0 109.962 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 67.9 m-85 -99.67 -178.71 3.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.477 -0.764 . . . . 0.0 110.284 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 44' ' ' LEU . 6.8 tt -116.48 146.76 42.33 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.217 -0.927 . . . . 0.0 108.883 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.596 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -148.96 137.51 21.12 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.909 -1.119 . . . . 0.0 110.714 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.697 HG23 HG23 ' A' ' 48' ' ' VAL . 14.8 t -106.39 129.89 54.3 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.283 -0.886 . . . . 0.0 113.381 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.564 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 42.2 t -75.46 87.85 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 109.883 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.697 HG23 HG23 ' A' ' 46' ' ' THR . 59.2 t -103.33 135.01 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m120 57.8 18.97 5.26 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.346 -0.846 . . . . 0.0 110.137 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.19 20.36 52.91 Favored Glycine 0 N--CA 1.498 2.775 0 O-C-N 121.215 -0.928 . . . . 0.0 111.015 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 85' ' ' TRP . 59.0 t -137.91 107.78 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.211 -1.17 . . . . 0.0 110.119 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.0 p -60.17 107.38 0.63 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.528 -0.733 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.918 ' CE3' HD23 ' A' ' 82' ' ' LEU . 96.2 m95 -88.19 146.68 25.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.032 -1.042 . . . . 0.0 111.956 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.601 HG21 ' CH2' ' A' ' 85' ' ' TRP . 8.6 t -162.76 171.25 17.05 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.865 HG11 ' CE1' ' A' ' 57' ' ' HIS . 16.3 t -94.5 151.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.451 -0.78 . . . . 0.0 109.655 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.416 ' CD2' HG12 ' A' ' 78' ' ' VAL . 18.2 t80 -76.93 4.46 9.88 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.178 -0.951 . . . . 0.0 111.709 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.865 ' CE1' HG11 ' A' ' 55' ' ' VAL . 26.3 m170 -40.72 -39.45 1.09 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.379 -0.826 . . . . 0.0 112.392 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.34 40.74 0.24 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.91 -5.6 59.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.445 -1.032 . . . . 0.0 110.864 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.49 133.58 3.07 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -92.32 -20.96 20.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.556 -0.967 . . . . 0.0 110.364 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.0 mtpp -77.7 -165.59 0.65 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.775 . . . . 0.0 110.374 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.594 HG22 ' HB2' ' A' ' 70' ' ' PRO . 1.2 m -64.93 100.09 0.39 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.594 -0.691 . . . . 0.0 111.147 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.711 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -52.24 171.39 0.05 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.626 -0.671 . . . . 0.0 110.261 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.37 142.89 46.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.269 -0.895 . . . . 0.0 111.312 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.99 -179.02 17.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -64.88 -23.0 62.62 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 O-C-N 123.9 1.474 . . . . 0.0 110.752 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -152.27 41.45 0.64 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.356 -0.84 . . . . 0.0 110.062 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.69 156.1 7.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.594 ' HB2' HG22 ' A' ' 63' ' ' THR . 52.1 Cg_endo -61.52 158.71 35.2 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.778 1.409 . . . . 0.0 110.112 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.711 HD12 ' CD2' ' A' ' 64' ' ' LEU . 80.5 mt -99.3 118.57 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.514 -0.741 . . . . 0.0 109.563 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 m -59.22 124.64 20.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.772 -0.58 . . . . 0.0 110.41 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -73.59 136.02 43.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.656 -0.653 . . . . 0.0 110.072 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.402 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -135.1 -44.9 0.71 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.631 -0.668 . . . . 0.0 110.304 -179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.467 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 14.8 m-85 -130.6 118.44 21.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.599 -0.688 . . . . 0.0 110.055 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.846 HG23 ' CG1' ' A' ' 83' ' ' VAL . 11.7 m -158.27 108.91 2.13 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.558 -0.714 . . . . 0.0 111.196 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 3.0 m120 -138.67 76.65 1.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.021 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.416 HG12 ' CD2' ' A' ' 56' ' ' TYR . 30.2 m 11.77 -133.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.88 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.49 177.99 8.62 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.733 -1.23 . . . . 0.0 110.106 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 52.31 23.08 2.25 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.523 -0.736 . . . . 0.0 110.871 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 1.8 m-20 -163.59 -114.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 109.081 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.918 HD23 ' CE3' ' A' ' 53' ' ' TRP . 3.0 tp 173.47 176.53 0.12 Allowed 'General case' 0 N--CA 1.516 2.847 0 CA-C-N 120.908 1.686 . . . . 0.0 111.319 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.846 ' CG1' HG23 ' A' ' 76' ' ' THR . 13.3 t -144.8 104.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 53' ' ' TRP . . . -123.06 109.87 1.43 Allowed Glycine 0 N--CA 1.487 2.049 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.879 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.601 ' CH2' HG21 ' A' ' 54' ' ' THR . 1.7 m0 -86.72 171.19 11.13 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -83.11 131.73 35.13 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.338 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -108.0 85.38 2.55 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.144 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.551 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -95.55 -10.71 1.0 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.745 1.392 . . . . 0.0 113.218 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 47.7 Cg_endo -72.32 73.57 2.69 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 115.715 -2.39 . . . . 0.0 110.767 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 51.87 25.8 16.82 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.564 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -67.56 138.73 56.71 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.458 -1.025 . . . . 0.0 110.963 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -84.18 120.4 26.15 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.3 p -93.17 119.73 32.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.632 -0.667 . . . . 0.0 110.7 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mt -77.66 -147.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.485 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 0.6 OUTLIER -159.2 -174.7 0.45 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 109.084 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.412 ' HD2' ' OG1' ' A' ' 95' ' ' THR . 51.8 Cg_endo -80.22 149.24 19.46 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 O-C-N 123.339 1.178 . . . . 0.0 111.138 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.731 ' O ' HG23 ' A' ' 98' ' ' THR . 1.8 t -68.15 156.23 37.94 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.158 0.98 . . . . 0.0 110.65 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 97' ' ' CYS . 0.6 OUTLIER -170.98 38.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 11.8 m -82.33 -172.56 4.07 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.625 0.726 . . . . 0.0 110.842 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -110.59 -32.76 2.62 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 m -99.02 -155.38 0.5 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.537 -0.978 . . . . 0.0 109.858 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.76 19.92 0.91 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.383 -0.823 . . . . 0.0 111.094 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 46.9 m-20 -78.85 106.82 11.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.69 HD13 HD23 ' A' ' 143' ' ' LEU . 0.3 OUTLIER -107.54 -178.39 3.61 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.778 -178.227 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.46 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.3 m-85 -141.49 92.97 2.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.686 -0.634 . . . . 0.0 109.32 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.48 HD11 HD11 ' A' ' 143' ' ' LEU . 6.2 tp -51.33 100.45 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.412 -0.805 . . . . 0.0 110.201 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.575 ' HA ' HG12 ' A' ' 113' ' ' VAL . 45.2 t -82.79 124.64 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.106 -1.037 . . . . 0.0 110.858 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 112' ' ' ASP . 47.6 p -89.91 179.73 5.91 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.656 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -96.38 52.99 1.28 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.047 -1.033 . . . . 0.0 111.404 -178.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.427 ' NE2' ' HB ' ' A' ' 108' ' ' THR . 4.9 p80 -177.09 44.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.44 -0.788 . . . . 0.0 109.996 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.57 65.11 1.61 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.643 -0.661 . . . . 0.0 111.237 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.492 ' O ' HG23 ' A' ' 108' ' ' THR . 0.8 OUTLIER -155.58 96.56 1.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 107' ' ' VAL . 17.0 m -109.26 150.71 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.607 -0.683 . . . . 0.0 110.948 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.8 pt -133.22 134.61 24.34 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.379 -0.825 . . . . 0.0 109.797 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.93 142.3 92.55 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 123.831 1.437 . . . . 0.0 112.13 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.45 152.89 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.763 -0.586 . . . . 0.0 109.683 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.89 110.84 18.24 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -48.35 127.12 12.46 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.354 -0.841 . . . . 0.0 110.725 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -111.88 -24.7 9.83 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.384 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.44 -169.66 36.75 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -63.31 128.33 35.33 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.843 0.83 . . . . 0.0 109.96 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.78 46.86 24.93 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.139 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.46 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 1.2 ttp180 -166.44 151.16 7.81 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.493 -0.754 . . . . 0.0 110.649 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.84 -178.34 18.65 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -123.64 134.45 53.77 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 122.008 -0.701 . . . . 0.0 111.88 -178.622 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.98 133.47 40.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.608 -0.683 . . . . 0.0 109.194 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 33.2 mt -107.27 54.16 0.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.001 0.905 . . . . 0.0 108.642 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.34 126.6 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.175 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -58.35 110.12 0.6 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 O-C-N 123.568 1.299 . . . . 0.0 110.33 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -123.03 137.77 28.71 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 47.1 Cg_endo -66.58 131.69 26.86 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.854 1.45 . . . . 0.0 110.505 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.597 HG21 ' SG ' ' A' ' 159' ' ' CYS . 7.8 p -60.14 -36.83 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.658 -0.651 . . . . 0.0 109.674 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 t -49.39 -36.51 22.07 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 122.035 0.922 . . . . 0.0 110.654 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.408 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 30.0 t80 -66.68 -37.49 84.86 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.527 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.3 mt -66.46 -36.23 82.24 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -61.18 121.62 13.0 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.746 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 113.82 -31.99 6.26 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.5 m -91.39 13.2 18.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.975 . . . . 0.0 110.881 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 p -51.52 128.74 23.82 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.174 -0.954 . . . . 0.0 110.379 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.535 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 116.26 -13.75 16.13 Favored Glycine 0 CA--C 1.542 1.772 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.654 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -46.28 110.22 0.47 Allowed Glycine 0 N--CA 1.504 3.21 0 O-C-N 121.504 -0.997 . . . . 0.0 111.174 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -67.84 126.97 15.38 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 124.066 1.561 . . . . 0.0 110.927 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.69 HD23 HD13 ' A' ' 104' ' ' LEU . 6.2 mp -80.24 130.87 35.51 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.64 120.37 22.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 109.472 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.595 ' CB ' ' HD3' ' A' ' 146' ' ' PRO . 43.1 m -49.9 -92.17 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.653 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.595 ' HD3' ' CB ' ' A' ' 145' ' ' CYS . 49.3 Cg_endo -92.3 -81.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 114.764 -3.024 . . . . 0.0 111.15 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.7 t -136.95 78.96 1.73 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.19 -0.944 . . . . 0.0 109.714 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 127.09 -166.53 19.85 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.9 m170 54.46 98.53 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.266 -1.138 . . . . 0.0 110.382 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.762 ' HB1' HG11 ' A' ' 172' ' ' VAL . . . -71.68 141.33 49.87 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.206 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.687 HG21 ' CD2' ' A' ' 104' ' ' LEU . 33.4 t -107.04 -43.39 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.69 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 175.81 179.33 46.24 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.451 HG13 HG12 ' A' ' 170' ' ' VAL . 1.4 pt -111.8 170.47 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 CA-C-N 119.589 1.695 . . . . 0.0 111.212 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.843 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 10.3 t80 -83.71 89.17 7.1 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.089 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -74.75 -41.04 60.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.503 -0.748 . . . . 0.0 109.153 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -159.74 -179.46 7.88 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.843 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -137.98 113.91 9.91 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.452 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.871 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 4.5 t -60.21 101.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.597 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.9 p -123.01 156.94 33.77 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.363 1.078 . . . . 0.0 113.603 -175.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 163' ' ' VAL . 6.1 p -96.38 -171.79 2.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -46.0 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.396 -0.815 . . . . 0.0 111.905 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.577 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 73.01 -19.24 1.28 Allowed Glycine 0 N--CA 1.499 2.865 0 O-C-N 121.168 -0.958 . . . . 0.0 112.795 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.8 t -101.98 136.05 35.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 119.39 1.595 . . . . 0.0 109.199 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.527 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -94.53 135.59 35.8 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.063 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -116.23 -38.48 3.57 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.611 -0.681 . . . . 0.0 111.047 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.871 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -129.36 178.78 6.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.496 -0.753 . . . . 0.0 109.685 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.2 t -121.11 144.82 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.671 0.748 . . . . 0.0 111.595 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.654 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -107.6 97.34 7.09 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 176.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.506 ' CE1' HG12 ' A' ' 151' ' ' VAL . 0.2 OUTLIER -126.97 142.91 51.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.881 -1.128 . . . . 0.0 112.468 -175.757 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.562 HG11 HD11 ' A' ' 82' ' ' LEU . 3.7 p -98.19 130.43 28.5 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 50.5 Cg_endo -58.68 152.69 54.46 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.667 1.351 . . . . 0.0 111.484 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.762 HG11 ' HB1' ' A' ' 150' ' ' ALA . 17.8 m -77.57 -2.53 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.417 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -85.32 -38.67 18.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 109.032 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.4 m -60.68 -36.42 78.7 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.525 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 3.3 mtt -49.25 -37.13 22.38 Favored 'General case' 0 N--CA 1.515 2.796 0 CA-C-O 121.715 0.769 . . . . 0.0 109.075 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -61.0 -40.53 93.87 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.7 m -65.55 -39.74 92.06 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.718 0.771 . . . . 0.0 109.205 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 175' ' ' MET . 0.9 OUTLIER -50.62 -41.22 54.76 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.819 -0.551 . . . . 0.0 110.798 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.467 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -53.88 -41.45 67.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.943 -1.098 . . . . 0.0 111.193 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -53.39 -36.7 61.73 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.301 -0.874 . . . . 0.0 109.61 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 178' ' ' THR . . . -67.82 -43.54 79.35 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.449 -0.782 . . . . 0.0 110.656 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 91' ' ' ALA . 9.4 p . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.329 0.585 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -170.82 81.04 0.08 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.72 169.53 11.77 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.481 ' HB2' HD12 ' A' ' 94' ' ' LEU . 1.1 pt-20 -98.4 -6.12 31.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.587 -0.949 . . . . 0.0 111.308 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.601 HG12 ' HG3' ' A' ' 109' ' ' ARG . 63.0 t -120.23 142.38 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.122 -0.986 . . . . 0.0 110.749 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.605 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 40.1 tt0 -135.47 144.81 46.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.826 -0.546 . . . . 0.0 109.873 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.593 HG12 HD22 ' A' ' 44' ' ' LEU . 26.8 m -117.8 174.01 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.38 -0.825 . . . . 0.0 110.815 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.512 HG11 ' CH2' ' A' ' 85' ' ' TRP . 36.0 m -128.57 -179.07 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -138.66 133.97 33.06 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.731 -1.187 . . . . 0.0 112.296 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.3 p -126.48 -177.81 4.12 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.18 96.69 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.164 -0.96 . . . . 0.0 111.145 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 m 59.54 47.55 10.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.644 -0.66 . . . . 0.0 110.622 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -165.13 169.31 16.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.248 -0.907 . . . . 0.0 110.984 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.5 p -158.45 132.99 8.14 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . 91.8 m-85 -99.65 -178.94 4.04 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.111 -0.993 . . . . 0.0 111.235 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.593 HD22 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -113.1 152.49 29.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 34' ' ' GLN . . . -162.18 159.39 25.82 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.596 -0.69 . . . . 0.0 110.368 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.695 HG23 HG23 ' A' ' 48' ' ' VAL . 14.2 t -138.05 128.83 26.86 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.457 -0.777 . . . . 0.0 111.612 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 79.5 m -77.97 82.22 4.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.551 -0.718 . . . . 0.0 109.727 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.695 HG23 HG23 ' A' ' 46' ' ' THR . 57.9 t -97.95 137.84 24.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 57.18 21.0 6.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.801 -0.562 . . . . 0.0 110.248 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.63 23.62 38.79 Favored Glycine 0 N--CA 1.494 2.524 0 O-C-N 121.414 -0.804 . . . . 0.0 111.822 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 85' ' ' TRP . 46.3 t -143.3 116.18 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-N 118.939 1.37 . . . . 0.0 110.388 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.519 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 13.1 t -64.29 105.64 0.95 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.955 ' CE3' HD23 ' A' ' 82' ' ' LEU . 98.3 m95 -86.41 149.84 24.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.388 -0.82 . . . . 0.0 112.146 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.86 HG21 ' CZ2' ' A' ' 85' ' ' TRP . 7.5 t -164.45 171.93 14.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.584 -0.698 . . . . 0.0 110.519 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.556 HG11 ' CD2' ' A' ' 57' ' ' HIS . 2.8 t -92.98 150.05 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.604 -0.685 . . . . 0.0 109.922 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.536 ' HB3' ' HA ' ' A' ' 78' ' ' VAL . 27.0 t80 -82.95 -2.43 55.08 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.219 -0.926 . . . . 0.0 112.112 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.556 ' CD2' HG11 ' A' ' 55' ' ' VAL . 1.2 p80 -67.47 -10.72 54.19 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.206 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.12 -50.58 0.02 OUTLIER Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.833 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HB3' ' OG1' ' A' ' 54' ' ' THR . . . -83.08 112.63 19.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.012 -1.287 . . . . 0.0 109.899 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.27 10.45 27.61 Favored Glycine 0 N--CA 1.499 2.847 0 O-C-N 121.169 -0.957 . . . . 0.0 110.85 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.4 t -103.66 -38.57 7.05 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.86 -1.377 . . . . 0.0 110.193 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.53 -165.17 1.09 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.494 -0.754 . . . . 0.0 110.577 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -72.05 90.57 1.18 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.669 -0.645 . . . . 0.0 109.855 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.864 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -56.22 177.77 0.06 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.869 -0.519 . . . . 0.0 110.414 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.3 126.82 32.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -127.99 -178.63 15.43 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.78 -18.04 52.69 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 124.036 1.545 . . . . 0.0 109.649 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -122.89 25.55 8.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 111.008 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 66' ' ' GLY . . . 108.7 -157.71 15.07 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -55.49 145.81 66.82 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.692 1.364 . . . . 0.0 111.523 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.864 HD12 ' CD2' ' A' ' 64' ' ' LEU . 88.1 mt -93.14 16.57 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.519 -0.738 . . . . 0.0 110.506 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 p 43.17 -153.8 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.302 -0.874 . . . . 0.0 111.501 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.66 118.75 2.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.68 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -30.49 9.98 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.374 -0.828 . . . . 0.0 109.967 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.433 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 15.5 m-85 -129.58 121.71 27.66 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.699 HG23 ' CG1' ' A' ' 83' ' ' VAL . 3.7 m -160.44 113.52 2.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.287 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.45 ' C ' HG22 ' A' ' 78' ' ' VAL . 6.3 t-20 -143.59 73.15 1.38 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.504 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.536 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 14.2 m 36.01 -162.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.93 -31.61 34.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.406 ' HB2' HG23 ' A' ' 78' ' ' VAL . 54.3 mt-30 -52.2 -30.6 27.9 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.682 0.753 . . . . 0.0 109.255 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.416 ' CB ' ' HB3' ' A' ' 77' ' ' ASN . 0.5 OUTLIER -126.97 -102.26 0.35 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.484 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.955 HD23 ' CE3' ' A' ' 53' ' ' TRP . 0.8 OUTLIER 179.22 168.42 1.01 Allowed 'General case' 0 N--CA 1.512 2.628 0 O-C-N 120.299 -1.501 . . . . 0.0 112.27 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.699 ' CG1' HG23 ' A' ' 76' ' ' THR . 20.0 t -128.5 150.54 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.38 111.31 0.47 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.319 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.86 ' CZ2' HG21 ' A' ' 54' ' ' THR . 1.1 m-90 -87.04 172.58 9.87 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -87.31 131.33 34.29 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.688 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 91' ' ' ALA . . . -58.66 167.73 1.7 Allowed Pre-proline 0 N--CA 1.494 1.773 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.554 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 33.2 Cg_endo -67.29 -79.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.555 1.546 0 O-C-N 123.879 1.463 . . . . 0.0 110.581 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 88' ' ' PRO . 56.0 Cg_endo -97.65 36.04 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 115.731 -2.379 . . . . 0.0 108.606 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.28 -10.34 73.53 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.659 ' HA ' HG23 ' A' ' 29' ' ' VAL . . . 50.15 -178.39 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.207 -1.173 . . . . 0.0 111.855 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -73.19 72.43 1.22 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 t -41.74 95.88 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.755 -0.591 . . . . 0.0 111.968 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.481 HD12 ' HB2' ' A' ' 32' ' ' GLU . 1.0 OUTLIER -68.88 -157.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.596 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.695 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 0.9 OUTLIER -153.29 175.14 3.16 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 121.245 -0.91 . . . . 0.0 111.179 -179.431 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.62 163.95 26.26 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 O-C-N 123.845 1.445 . . . . 0.0 111.545 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 18.5 t -79.56 -72.78 0.38 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.705 -0.622 . . . . 0.0 109.811 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.0 m 49.77 74.48 0.2 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.419 -0.801 . . . . 0.0 110.612 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 77.2 m -138.14 -64.92 0.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.261 -0.899 . . . . 0.0 110.601 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 116.33 33.69 1.43 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.4 m -134.32 -163.84 1.42 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.655 -0.909 . . . . 0.0 109.725 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.6 p -135.64 -151.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.578 -0.701 . . . . 0.0 109.546 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 30.2 t70 62.23 109.79 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.331 -0.856 . . . . 0.0 109.893 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.604 HD13 HD23 ' A' ' 143' ' ' LEU . 1.1 mt -128.2 -171.4 2.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.545 -0.722 . . . . 0.0 109.434 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.635 ' O ' HG23 ' A' ' 107' ' ' VAL . 16.4 m-85 -139.5 90.5 2.41 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.553 HD12 ' HG ' ' A' ' 143' ' ' LEU . 11.6 tp -59.44 93.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 105' ' ' TYR . 84.6 t -82.56 101.57 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.356 -177.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.525 HG21 ' OH ' ' A' ' 134' ' ' TYR . 38.5 p -65.66 168.48 7.57 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.601 ' HG3' HG12 ' A' ' 33' ' ' VAL . 1.1 tmt_? -93.35 24.03 4.15 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.728 -1.232 . . . . 0.0 110.727 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.96 31.27 5.88 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 56.46 71.73 0.55 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.63 0.729 . . . . 0.0 110.516 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -171.99 91.88 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.57 ' CG1' HG22 ' A' ' 107' ' ' VAL . 11.8 m -94.57 151.24 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.421 ' CG1' ' HB3' ' A' ' 106' ' ' LEU . 30.9 pt -129.96 142.43 45.34 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.29 -0.881 . . . . 0.0 109.031 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.58 132.85 24.5 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.811 1.427 . . . . 0.0 112.09 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 103' ' ' ASP . 91.4 t -121.45 153.71 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -116.06 111.85 20.9 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.92 124.13 8.15 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.626 -0.672 . . . . 0.0 110.15 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 125' ' ' SER . 1.6 mmm180 -104.97 -49.45 3.48 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.842 -0.536 . . . . 0.0 110.701 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -151.93 -158.43 8.41 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.712 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -70.58 125.05 25.73 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.147 0.975 . . . . 0.0 109.262 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.83 50.13 16.36 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.042 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.521 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 19.2 ttm180 -166.12 156.53 12.64 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.589 -0.694 . . . . 0.0 110.787 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.95 -178.61 23.28 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.475 ' HB2' ' HG3' ' A' ' 119' ' ' ARG . 1.4 t -135.37 100.84 4.64 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.086 -0.655 . . . . 0.0 111.559 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 126' ' ' LEU . 2.4 pp -48.19 162.64 0.08 Allowed 'General case' 0 N--CA 1.51 2.552 0 O-C-N 121.466 -0.771 . . . . 0.0 110.713 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.7 mt -127.41 67.51 1.3 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 164.3 134.96 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.058 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.691 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.0 100.49 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.803 1.423 . . . . 0.0 109.566 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.36 128.21 25.74 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.539 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -56.0 127.13 24.81 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.917 1.483 . . . . 0.0 110.85 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.712 HG21 ' SG ' ' A' ' 159' ' ' CYS . 7.3 p -60.61 -36.56 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.44 -37.03 24.29 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.546 -0.722 . . . . 0.0 110.807 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.525 ' OH ' HG21 ' A' ' 108' ' ' THR . 17.0 t80 -67.8 -39.49 84.01 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.3 mt -63.05 -34.8 78.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 123.81 17.1 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.651 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.31 -31.22 8.88 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.464 ' HA ' HD23 ' A' ' 44' ' ' LEU . 57.6 m -79.34 -0.62 33.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.915 -0.756 . . . . 0.0 111.104 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 2.0 m -57.53 119.84 7.24 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 120.9 -1.125 . . . . 0.0 109.738 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 122.8 -17.24 8.22 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.4 137.88 49.71 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.51 ' CD ' HG22 ' A' ' 33' ' ' VAL . 49.5 Cg_endo -85.16 129.12 3.78 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 O-C-N 123.522 1.275 . . . . 0.0 113.476 -177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.604 HD23 HD13 ' A' ' 104' ' ' LEU . 4.4 mp -81.6 130.79 35.18 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 150' ' ' ALA . 1.1 mt -129.92 123.74 31.46 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 119.778 1.172 . . . . 0.0 112.474 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.428 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 4.2 p -67.44 -173.6 0.16 Allowed Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 40.8 Cg_endo -66.94 169.25 15.24 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.674 1.355 . . . . 0.0 110.214 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m 53.35 29.89 9.4 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.638 -0.664 . . . . 0.0 111.43 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 73.63 -134.01 18.43 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 59.61 106.19 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.26 -1.141 . . . . 0.0 110.278 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -65.81 143.94 57.17 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.69 -0.631 . . . . 0.0 110.798 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 2.1 t -107.01 -42.94 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.759 -0.588 . . . . 0.0 110.326 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.701 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 177.71 -178.62 48.42 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.66 HG13 HG13 ' A' ' 170' ' ' VAL . 1.0 OUTLIER -116.72 153.48 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 118.59 1.195 . . . . 0.0 111.718 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.78 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 7.4 t80 -65.38 117.24 7.62 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.505 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -107.26 -35.01 6.93 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.234 -0.916 . . . . 0.0 109.171 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.717 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -159.17 169.83 23.28 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.78 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -129.84 116.89 19.36 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.41 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.802 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.0 t -63.39 100.55 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.712 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.8 p -129.03 167.29 17.71 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.512 1.148 . . . . 0.0 113.971 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 162' ' ' GLY . 14.9 p -105.47 -173.51 2.32 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.12 82.9 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.635 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 86.09 -27.25 5.63 Favored Glycine 0 N--CA 1.501 2.968 0 O-C-N 121.098 -1.001 . . . . 0.0 112.52 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.27 139.73 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-N 119.188 1.494 . . . . 0.0 108.288 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.605 ' C ' HD21 ' A' ' 126' ' ' LEU . . . -99.52 139.32 35.35 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.371 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.517 ' HA ' HD11 ' A' ' 126' ' ' LEU . 5.7 mtpt -112.98 -31.36 6.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.697 -0.627 . . . . 0.0 110.62 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.802 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -141.58 178.65 7.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.888 . . . . 0.0 110.324 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.34 150.4 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.662 0.744 . . . . 0.0 110.857 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.717 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -119.92 103.24 9.16 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 177.279 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.521 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 1.7 p90 -128.44 174.32 9.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 118.966 -1.094 . . . . 0.0 112.23 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.662 HG11 ' CD1' ' A' ' 82' ' ' LEU . 1.4 p -125.96 122.26 24.35 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 41.1 Cg_endo -47.92 152.84 2.89 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 O-C-N 123.651 1.343 . . . . 0.0 113.11 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.701 HG13 ' HA2' ' A' ' 152' ' ' GLY . 18.2 m -82.38 -1.85 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.343 -0.848 . . . . 0.0 109.832 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -87.42 -43.69 11.9 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.547 -0.72 . . . . 0.0 109.187 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.7 t -60.7 -42.74 97.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.737 -0.602 . . . . 0.0 109.716 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.903 ' HB3' HD22 ' A' ' 82' ' ' LEU . 8.2 ptp -58.9 -36.54 74.85 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.914 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.85 -38.05 69.57 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.387 -1.445 . . . . 0.0 108.822 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.7 m -63.62 -36.89 85.3 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.325 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.899 HG22 ' O ' ' A' ' 175' ' ' MET . 3.1 t -48.71 -35.5 14.15 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.12 -0.987 . . . . 0.0 111.645 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.471 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -58.19 -41.25 83.51 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.866 -1.146 . . . . 0.0 110.447 179.012 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -48.61 -36.68 16.27 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.967 0.889 . . . . 0.0 110.604 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -91.3 -42.74 10.2 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.502 2.155 0 O-C-N 121.296 -0.877 . . . . 0.0 110.962 179.705 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 89' ' ' PRO . 33.6 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.049 0.452 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 58.51 79.07 0.22 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.333 -0.855 . . . . 0.0 109.869 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.0 -108.92 0.21 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -168.43 -35.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.549 -0.971 . . . . 0.0 111.437 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.755 HG22 ' OG1' ' A' ' 46' ' ' THR . 54.1 t -131.32 140.6 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.119 -0.988 . . . . 0.0 111.723 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.84 156.41 48.95 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.657 HG11 ' HB3' ' A' ' 109' ' ' ARG . 33.7 m -123.27 174.87 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.307 -0.87 . . . . 0.0 111.885 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.72 HG13 ' CZ ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -144.6 163.73 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.056 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.3 p -119.91 142.89 48.29 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.387 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 p -123.85 -176.87 3.58 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.27 98.36 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.395 -0.815 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 p 51.92 31.98 9.27 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.828 -0.545 . . . . 0.0 110.794 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -146.87 154.99 41.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.552 -0.717 . . . . 0.0 110.449 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.2 t -150.0 165.72 31.83 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.568 -0.707 . . . . 0.0 109.318 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.72 ' CZ ' HG13 ' A' ' 36' ' ' VAL . 11.0 p90 -153.6 -177.38 6.33 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.254 -0.904 . . . . 0.0 110.598 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.778 HD12 ' HG3' ' A' ' 109' ' ' ARG . 7.0 tt -110.43 146.1 36.46 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.509 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -146.12 128.86 16.23 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.681 -1.262 . . . . 0.0 110.287 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.755 ' OG1' HG22 ' A' ' 33' ' ' VAL . 99.9 m -110.31 128.13 55.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.435 -0.791 . . . . 0.0 111.479 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 79.2 m -78.07 85.95 4.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.806 -0.559 . . . . 0.0 109.816 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 94' ' ' LEU . 21.8 t -98.26 136.44 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.99 19.3 5.78 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.397 -0.815 . . . . 0.0 109.993 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.98 24.35 45.31 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 85' ' ' TRP . 42.9 t -139.85 105.44 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 121.261 -1.141 . . . . 0.0 110.378 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.423 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -58.04 97.34 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.464 -0.772 . . . . 0.0 109.942 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.991 ' CE3' HD23 ' A' ' 82' ' ' LEU . 81.2 m95 -78.53 141.35 38.23 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.341 -0.849 . . . . 0.0 110.668 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.477 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 10.2 t -163.33 126.77 2.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.564 -0.71 . . . . 0.0 109.707 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.476 HG11 ' HA ' ' A' ' 155' ' ' ARG . 21.4 m -49.3 143.7 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 O-C-N 121.274 -0.891 . . . . 0.0 110.902 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.528 ' HB2' HG21 ' A' ' 83' ' ' VAL . 4.8 t80 -74.62 -1.72 22.85 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.123 -0.986 . . . . 0.0 110.902 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -48.79 -27.31 2.89 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.26 -0.9 . . . . 0.0 110.689 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.03 76.7 0.09 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.583 ' HB1' ' HZ2' ' A' ' 85' ' ' TRP . . . -105.09 -51.16 3.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.447 -1.031 . . . . 0.0 110.101 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 151.08 -40.6 0.79 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 p 51.68 23.94 2.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.551 -0.97 . . . . 0.0 111.201 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.24 -158.47 0.91 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.426 -0.797 . . . . 0.0 110.509 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.4 m -60.3 91.02 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.573 -0.704 . . . . 0.0 110.534 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.855 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -76.16 164.82 25.72 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.675 -0.641 . . . . 0.0 110.233 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.31 135.48 55.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.205 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.23 -179.02 19.87 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.3 -29.19 88.37 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.872 1.459 . . . . 0.0 111.098 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -147.32 38.6 0.96 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.407 -0.808 . . . . 0.0 110.096 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.06 158.08 8.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -63.63 163.7 23.52 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 O-C-N 123.92 1.484 . . . . 0.0 110.493 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.855 HD12 ' CD2' ' A' ' 64' ' ' LEU . 93.4 mt -106.81 108.75 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.653 -0.654 . . . . 0.0 109.494 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -62.0 137.09 58.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.717 -0.615 . . . . 0.0 110.51 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -73.55 163.47 27.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.566 -0.708 . . . . 0.0 109.806 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -43.81 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.448 -0.783 . . . . 0.0 110.486 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.458 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 14.3 m-85 -126.68 124.36 39.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.492 -0.755 . . . . 0.0 110.075 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.633 HG23 ' CG1' ' A' ' 83' ' ' VAL . 6.3 m -158.85 106.41 1.84 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.705 -0.622 . . . . 0.0 111.009 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.417 ' CB ' ' HB2' ' A' ' 81' ' ' ASP . 18.7 m120 -152.44 76.57 1.16 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.554 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.5 p -72.31 -21.26 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.641 -0.662 . . . . 0.0 110.828 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.73 -32.17 29.32 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.045 -1.034 . . . . 0.0 110.401 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -173.85 34.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.595 -0.691 . . . . 0.0 110.337 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.417 ' HB2' ' CB ' ' A' ' 77' ' ' ASN . 6.7 m-20 -153.95 -99.92 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.313 -0.867 . . . . 0.0 111.811 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.991 HD23 ' CE3' ' A' ' 53' ' ' TRP . 6.2 tp 178.19 176.35 0.47 Allowed 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.548 -1.345 . . . . 0.0 110.274 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.633 ' CG1' HG23 ' A' ' 76' ' ' THR . 16.1 t -132.83 115.57 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.31 110.79 0.82 Allowed Glycine 0 N--CA 1.485 1.908 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.42 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.583 ' HZ2' ' HB1' ' A' ' 59' ' ' ALA . 1.9 m0 -79.38 166.43 22.07 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -86.39 130.29 34.56 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.304 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.707 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -108.17 92.13 9.04 Favored Pre-proline 0 C--N 1.294 -1.846 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.344 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.578 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.8 Cg_endo -104.48 -3.5 0.2 Allowed 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.747 1.393 . . . . 0.0 112.967 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 52.4 Cg_endo -72.94 72.29 3.28 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 115.714 -2.391 . . . . 0.0 109.683 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 57.21 24.24 50.58 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 87' ' ' ALA . . . -74.39 138.56 43.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.546 -0.973 . . . . 0.0 110.732 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.0 135.95 43.16 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.474 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.3 p -104.59 97.93 7.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.563 -0.71 . . . . 0.0 109.563 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.59 ' HB3' HG13 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -65.49 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.543 -0.723 . . . . 0.0 109.161 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.788 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 5.6 p -155.48 173.77 4.56 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.573 -0.705 . . . . 0.0 110.339 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.34 177.61 8.55 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.839 1.441 . . . . 0.0 110.198 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 t -98.69 -77.3 0.52 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.539 -0.725 . . . . 0.0 110.119 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m 55.11 49.81 16.64 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.223 -0.923 . . . . 0.0 110.008 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 78.3 m -112.5 -46.69 3.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.671 -0.643 . . . . 0.0 110.302 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.98 28.8 6.38 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.31 -164.56 1.22 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.609 -0.936 . . . . 0.0 109.987 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.2 p -140.88 -150.33 0.31 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.369 -0.832 . . . . 0.0 110.541 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.73 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.137 -0.977 . . . . 0.0 109.973 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.8 HD13 HD23 ' A' ' 143' ' ' LEU . 0.6 OUTLIER -117.94 -178.8 3.58 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.503 -0.748 . . . . 0.0 110.097 -179.203 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -133.56 84.74 2.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.669 -0.644 . . . . 0.0 109.618 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 154' ' ' PHE . 21.5 tp -60.87 106.38 0.57 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.629 -0.669 . . . . 0.0 109.39 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.712 HG22 HG12 ' A' ' 113' ' ' VAL . 25.1 t -84.43 133.65 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.657 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.3 p -89.34 -177.86 5.47 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.778 ' HG3' HD12 ' A' ' 44' ' ' LEU . 14.5 mtm180 -87.73 18.9 3.73 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.0 -1.063 . . . . 0.0 110.505 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.48 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.9 OUTLIER -151.19 47.49 0.83 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.051 -1.03 . . . . 0.0 111.99 -177.503 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.06 73.03 0.44 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.294 -0.879 . . . . 0.0 111.457 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.82 90.16 0.69 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.791 -0.568 . . . . 0.0 109.818 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.712 HG12 HG22 ' A' ' 107' ' ' VAL . 26.3 m -94.78 149.55 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 110.252 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.638 HG22 HH21 ' A' ' 130' ' ' ARG . 34.1 pt -131.48 141.77 42.94 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.512 -0.742 . . . . 0.0 109.723 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.33 137.38 36.55 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.918 1.483 . . . . 0.0 111.772 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.9 t -130.97 140.31 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.04 118.26 36.16 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -48.75 127.3 13.51 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.401 -0.812 . . . . 0.0 110.203 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.42 ' CG ' ' HB2' ' A' ' 125' ' ' SER . 3.7 mmt180 -107.13 -25.23 11.64 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.257 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 121' ' ' ASP . . . 173.04 56.52 0.05 OUTLIER Glycine 0 N--CA 1.498 2.773 0 C-N-CA 118.834 -1.65 . . . . 0.0 110.59 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 120' ' ' GLY . 0.6 OUTLIER 59.23 142.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.831 -0.806 . . . . 0.0 110.132 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.5 p 45.57 27.78 0.45 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.544 0.688 . . . . 0.0 111.554 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.518 ' HD2' HG21 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -166.88 148.05 5.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.522 -0.736 . . . . 0.0 109.427 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.37 -178.09 18.04 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.6 t -124.31 122.25 37.22 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.245 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.4 149.53 33.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.743 -0.598 . . . . 0.0 109.582 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 128' ' ' SER . 90.2 mt -126.01 69.4 1.2 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER 158.16 123.05 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.368 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -58.95 106.81 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 O-C-N 123.588 1.31 . . . . 0.0 109.745 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.638 HH21 HG22 ' A' ' 114' ' ' ILE . 9.9 mtt-85 -122.39 151.18 59.0 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.95 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 49.2 Cg_endo -75.3 130.02 12.6 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.178 1.62 . . . . 0.0 109.807 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.7 p -57.92 -36.53 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.73 -0.606 . . . . 0.0 110.093 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 t -49.58 -36.55 24.35 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 122.127 0.965 . . . . 0.0 110.227 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.417 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 57.7 t80 -60.85 -38.04 84.18 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 11.5 mt -69.21 -35.28 76.05 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.712 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -56.95 117.07 3.6 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.746 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 108.29 -24.47 22.57 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.44 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -86.43 4.29 40.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.506 -0.997 . . . . 0.0 111.273 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 80.1 p -51.93 128.85 25.4 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.964 -1.085 . . . . 0.0 109.609 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.519 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 114.96 -18.28 16.64 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.731 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -48.28 117.46 3.79 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.516 ' HG3' HG21 ' A' ' 46' ' ' THR . 53.7 Cg_endo -74.11 124.71 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 124.022 1.538 . . . . 0.0 111.343 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.8 HD23 HD13 ' A' ' 104' ' ' LEU . 6.0 mp -82.9 105.07 13.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 176.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.577 HD21 ' CD1' ' A' ' 94' ' ' LEU . 1.5 mt -105.24 119.72 39.75 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.131 -0.981 . . . . 0.0 112.385 -176.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.451 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 0.9 OUTLIER -59.63 -167.34 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 41.2 Cg_endo -69.4 167.06 25.06 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 117.092 -1.472 . . . . 0.0 109.472 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.2 t 56.77 -155.04 0.32 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.27 -0.894 . . . . 0.0 110.115 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 149' ' ' HIS . . . -102.76 100.53 1.97 Allowed Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.426 ' CG ' ' O ' ' A' ' 148' ' ' GLY . 0.4 OUTLIER -170.65 95.95 0.22 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.692 -0.887 . . . . 0.0 109.853 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.788 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -63.23 142.32 58.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.573 -0.704 . . . . 0.0 109.256 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 0.9 OUTLIER -103.39 -36.99 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.451 -0.781 . . . . 0.0 109.575 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.661 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 176.15 -178.89 47.49 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.804 HG23 ' HE1' ' A' ' 175' ' ' MET . 1.1 pp -114.7 168.75 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-N 118.906 1.353 . . . . 0.0 111.392 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.749 ' HB2' HD11 ' A' ' 106' ' ' LEU . 5.9 t80 -76.96 114.57 15.89 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.29 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.476 ' HA ' HG11 ' A' ' 55' ' ' VAL . 26.5 ttt-85 -100.97 -38.97 7.97 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.698 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -159.89 173.61 15.68 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.743 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -129.69 119.84 24.16 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.772 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.839 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.5 t -69.95 100.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.67 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.6 p -127.3 158.07 38.19 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 122.253 1.025 . . . . 0.0 113.354 -175.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' GLY . 16.5 p -91.25 -175.01 4.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.92 85.65 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.692 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 86.51 -25.0 7.62 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 121.063 -1.023 . . . . 0.0 112.214 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -101.7 140.61 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 119.177 1.489 . . . . 0.0 109.214 -179.485 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -103.26 129.63 50.29 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.047 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt -111.51 -33.79 6.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.652 -0.655 . . . . 0.0 110.548 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.839 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -129.6 -179.7 5.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.275 -0.891 . . . . 0.0 110.219 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -126.89 147.47 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.615 0.722 . . . . 0.0 111.683 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.698 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -111.45 96.33 6.04 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 177.006 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.61 ' CD2' HD22 ' A' ' 143' ' ' LEU . 0.3 OUTLIER -124.13 160.42 27.83 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.252 -0.979 . . . . 0.0 112.694 -175.882 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 153' ' ' ILE . 2.7 p -116.21 126.22 27.82 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 47.0 Cg_endo -56.53 156.36 22.46 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 O-C-N 123.872 1.459 . . . . 0.0 112.311 -177.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.661 HG23 ' HA2' ' A' ' 152' ' ' GLY . 57.5 t -80.76 -2.96 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.05 -37.78 28.5 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.9 t -72.42 -36.01 68.49 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.949 ' O ' HG22 ' A' ' 178' ' ' THR . 36.7 mtt -48.24 -39.07 20.13 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.621 -0.674 . . . . 0.0 110.426 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -54.82 -37.27 65.93 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.883 0.849 . . . . 0.0 109.283 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.7 m -52.9 -41.71 64.65 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.236 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.949 HG22 ' O ' ' A' ' 175' ' ' MET . 14.6 t -56.56 -36.47 69.34 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.94 -1.1 . . . . 0.0 111.635 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.482 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -56.2 -44.2 79.23 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.645 -1.284 . . . . 0.0 110.56 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -51.45 -37.91 51.07 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.944 0.878 . . . . 0.0 110.054 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -74.11 -48.47 29.39 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.697 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.503 2.22 0 O-C-N 121.509 -0.744 . . . . 0.0 110.992 179.701 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.43 HG22 ' N ' ' A' ' 30' ' ' GLU . 3.5 p . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 121.401 0.62 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.43 ' N ' HG22 ' A' ' 29' ' ' VAL . 2.6 mm-40 -156.06 79.38 0.98 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.32 -26.39 3.4 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.39 -79.72 0.07 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.508 -0.995 . . . . 0.0 109.243 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 45' ' ' ALA . 9.6 p -150.43 148.71 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 111.385 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -131.84 150.2 52.22 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.587 HG12 HD23 ' A' ' 44' ' ' LEU . 31.6 m -108.98 164.09 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.218 -0.926 . . . . 0.0 112.311 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.717 HG11 ' CH2' ' A' ' 85' ' ' TRP . 21.9 m -122.53 179.7 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -149.93 137.87 20.23 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.447 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.4 p -144.65 -178.67 6.12 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 40' ' ' THR . . . -68.87 76.74 0.31 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.027 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER 175.51 -59.51 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.584 -0.697 . . . . 0.0 109.323 -179.537 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 178.21 -171.3 0.11 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.538 -0.726 . . . . 0.0 109.075 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.3 p -112.68 138.06 50.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.513 -0.742 . . . . 0.0 109.923 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 43.9 m-85 -106.3 173.07 6.48 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.537 -0.727 . . . . 0.0 110.607 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.776 HD22 ' HB2' ' A' ' 109' ' ' ARG . 12.7 mt -100.67 159.85 14.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.521 -0.737 . . . . 0.0 110.713 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -158.45 126.71 5.3 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.073 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.587 HG23 HG23 ' A' ' 48' ' ' VAL . 8.6 t -104.95 127.43 52.79 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.375 -0.828 . . . . 0.0 112.288 -178.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 97.2 m -80.15 85.41 5.71 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.762 -0.586 . . . . 0.0 109.951 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.587 HG23 HG23 ' A' ' 46' ' ' THR . 67.7 t -105.13 139.43 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.41 17.97 5.23 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.246 -0.909 . . . . 0.0 110.259 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.23 43.12 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.4 t -141.59 112.04 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.313 -1.11 . . . . 0.0 110.546 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.43 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 1.8 t -67.38 105.65 1.85 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.932 ' CE3' HD23 ' A' ' 82' ' ' LEU . 82.2 m95 -87.3 145.54 26.31 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.235 -0.916 . . . . 0.0 111.097 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 83' ' ' VAL . 9.0 t -162.2 178.35 8.83 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.269 -0.894 . . . . 0.0 110.293 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 55' ' ' VAL . 31.4 m -101.35 143.12 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.636 -0.665 . . . . 0.0 109.948 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.606 ' HB2' HG11 ' A' ' 83' ' ' VAL . 36.9 t80 -78.25 2.53 18.03 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.063 -1.023 . . . . 0.0 111.923 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -48.73 -26.77 2.51 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.178 -0.951 . . . . 0.0 110.868 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.414 ' HA3' ' CZ ' ' A' ' 43' ' ' PHE . . . -177.75 35.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.531 ' HB1' ' CZ2' ' A' ' 85' ' ' TRP . . . -81.29 0.39 37.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.188 -1.184 . . . . 0.0 111.194 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.05 -171.28 22.37 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.0 t -160.65 -43.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.677 -0.896 . . . . 0.0 110.033 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -165.99 0.06 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.726 -0.608 . . . . 0.0 110.513 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -59.7 97.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.663 -0.648 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.666 HD22 HD12 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -60.46 176.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.668 -0.645 . . . . 0.0 109.928 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -118.18 135.68 54.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.417 -0.802 . . . . 0.0 110.669 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.3 179.61 23.81 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -63.57 -23.15 70.54 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.876 1.461 . . . . 0.0 110.483 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -153.28 40.47 0.53 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.326 -0.859 . . . . 0.0 110.425 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 150.11 170.07 16.99 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -64.74 147.7 89.85 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.892 1.469 . . . . 0.0 110.333 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.666 HD12 HD22 ' A' ' 64' ' ' LEU . 91.4 mt -79.22 168.87 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.581 -0.699 . . . . 0.0 109.369 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.456 ' N ' HG22 ' A' ' 71' ' ' ILE . 7.2 m -80.75 -45.58 16.82 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.21 -0.931 . . . . 0.0 111.608 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 55.5 90.05 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.457 -0.777 . . . . 0.0 109.775 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.6 ttt -126.81 -10.02 6.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.546 -0.722 . . . . 0.0 111.444 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 15.5 m-85 -128.25 113.65 15.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.091 -1.006 . . . . 0.0 109.655 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.624 HG22 HG12 ' A' ' 83' ' ' VAL . 0.7 OUTLIER -151.06 112.51 4.4 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.888 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -159.8 74.63 0.6 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.592 HG11 ' HB3' ' A' ' 56' ' ' TYR . 6.6 p -68.05 -10.8 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.361 -0.837 . . . . 0.0 111.302 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.79 85.75 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.349 -0.844 . . . . 0.0 108.976 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 78' ' ' VAL . 3.9 tt0 60.1 39.09 20.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.544 -0.723 . . . . 0.0 109.653 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.79 -93.89 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.969 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.932 HD23 ' CE3' ' A' ' 53' ' ' TRP . 10.2 tp 177.68 168.61 0.68 Allowed 'General case' 0 N--CA 1.508 2.425 0 O-C-N 120.329 -1.482 . . . . 0.0 110.943 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.624 HG12 HG22 ' A' ' 76' ' ' THR . 9.8 m -141.98 122.67 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.69 142.83 10.29 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.717 ' CH2' HG11 ' A' ' 36' ' ' VAL . 2.4 m-90 -99.08 169.52 9.35 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.32 140.31 31.7 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.727 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.57 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -102.81 94.73 5.52 Favored Pre-proline 0 C--N 1.3 -1.553 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.041 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.576 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.5 Cg_endo -101.39 -12.3 0.17 Allowed 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.644 1.339 . . . . 0.0 113.321 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 49.5 Cg_endo -72.03 69.1 3.14 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 116.175 -2.083 . . . . 0.0 111.203 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.12 14.48 25.31 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.57 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -57.01 131.7 50.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.107 -1.231 . . . . 0.0 110.73 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -85.16 97.73 10.06 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.5 m -52.17 112.95 0.89 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.737 -0.602 . . . . 0.0 111.394 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -75.64 -152.62 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.52 -0.737 . . . . 0.0 109.133 179.234 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 94' ' ' LEU . 1.7 p -152.67 179.44 1.27 Allowed Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.346 -0.846 . . . . 0.0 111.303 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -86.03 164.19 10.14 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 O-C-N 123.916 1.482 . . . . 0.0 111.535 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.469 ' SG ' HG23 ' A' ' 151' ' ' VAL . 0.8 OUTLIER -96.76 86.58 4.09 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.592 -0.693 . . . . 0.0 110.605 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.1 p -61.11 -39.07 88.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.421 -0.799 . . . . 0.0 109.647 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.3 p -64.6 -37.91 89.18 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.48 -0.763 . . . . 0.0 109.764 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 48.2 29.29 6.76 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.86 159.02 14.68 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.498 -1.001 . . . . 0.0 110.281 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 118' ' ' ARG . 5.1 t -66.02 -170.1 0.08 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.524 -0.735 . . . . 0.0 110.049 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.77 100.66 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.507 -0.745 . . . . 0.0 110.34 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.68 HD13 HD23 ' A' ' 143' ' ' LEU . 2.6 mt -117.33 -173.59 2.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.398 -0.814 . . . . 0.0 109.936 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -140.7 84.98 1.97 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.817 -0.552 . . . . 0.0 109.699 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.777 HD23 HD11 ' A' ' 114' ' ' ILE . 28.5 tp -71.89 100.96 2.54 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.798 HG22 HG12 ' A' ' 113' ' ' VAL . 32.2 t -90.72 123.21 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.123 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 138' ' ' SER . 24.9 p -88.37 145.84 25.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.776 ' HB2' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -61.82 -15.14 39.46 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.837 -1.165 . . . . 0.0 109.744 179.168 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.591 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 13.4 m170 -55.23 -79.29 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 110' ' ' HIS . . . 169.72 47.83 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.25 -0.906 . . . . 0.0 110.305 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -169.56 127.15 0.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.734 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.798 HG12 HG22 ' A' ' 107' ' ' VAL . 10.6 m -95.6 156.49 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.777 HD11 HD23 ' A' ' 106' ' ' LEU . 39.3 pt -131.68 127.76 21.51 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.442 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -66.04 145.9 80.72 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.876 1.461 . . . . 0.0 110.786 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.8 t -137.74 152.22 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.24 107.5 18.35 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -48.57 122.76 5.83 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.584 -0.697 . . . . 0.0 110.566 -178.59 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.18 -24.33 9.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.824 -0.547 . . . . 0.0 110.188 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.96 177.92 36.24 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -61.42 -22.8 65.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.959 -0.73 . . . . 0.0 110.204 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.3 p -135.76 41.09 2.73 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.834 -0.541 . . . . 0.0 111.463 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.499 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -169.8 151.88 4.34 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.174 -0.954 . . . . 0.0 111.397 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.86 -178.73 22.42 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.7 OUTLIER -128.09 116.08 19.43 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.896 -0.767 . . . . 0.0 111.773 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.509 HD21 HD12 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -52.66 142.71 17.71 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.43 -0.794 . . . . 0.0 110.514 179.397 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.9 mt -111.03 54.27 0.68 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 164.38 125.28 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.252 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -56.82 115.94 2.85 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 O-C-N 123.543 1.286 . . . . 0.0 110.72 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.404 ' HB2' HD22 ' A' ' 126' ' ' LEU . 0.8 OUTLIER -122.31 141.63 35.09 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.752 . . . . 0.0 109.27 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -64.52 128.19 20.68 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.813 1.428 . . . . 0.0 110.383 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 162' ' ' GLY . 12.1 p -62.84 -35.06 69.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.157 0.503 . . . . 0.0 110.061 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 m -48.71 -37.24 18.13 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.122 -0.986 . . . . 0.0 110.487 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -67.26 -38.34 84.97 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.9 mt -64.99 -36.13 83.4 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -63.85 123.18 18.28 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.97 -26.01 24.52 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.566 ' O ' HD12 ' A' ' 44' ' ' LEU . 16.9 m -92.38 14.41 16.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.481 -1.011 . . . . 0.0 110.694 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.59 127.67 32.38 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.102 -0.999 . . . . 0.0 109.63 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.51 -7.12 26.38 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.45 136.2 50.81 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.07 123.59 5.72 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.745 1.392 . . . . 0.0 112.698 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.68 HD23 HD13 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -82.74 124.69 30.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.179 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.3 mt -124.34 116.19 22.2 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.955 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.598 ' HB3' HG21 ' A' ' 151' ' ' VAL . 19.9 p -73.41 177.76 1.85 Allowed Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 48.7 Cg_endo -62.36 179.73 0.6 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.297 1.156 . . . . 0.0 109.952 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.5 m 56.01 29.1 13.78 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.312 -0.867 . . . . 0.0 110.789 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 60.5 -145.09 47.43 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 21.1 m170 61.68 127.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.895 -0.768 . . . . 0.0 110.44 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.47 ' O ' HG21 ' A' ' 172' ' ' VAL . . . -76.34 140.89 41.64 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.347 -0.846 . . . . 0.0 110.461 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.712 HG12 ' CE2' ' A' ' 169' ' ' PHE . 1.1 t -97.14 -43.41 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.778 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 178.53 -178.56 48.69 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.634 HD11 HD11 ' A' ' 82' ' ' LEU . 1.3 pp -116.93 150.31 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.063 -1.257 . . . . 0.0 111.397 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.776 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.3 t80 -63.0 115.13 4.14 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.014 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -102.05 -38.58 7.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.679 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -160.74 176.13 11.84 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.776 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -133.17 117.06 17.0 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.473 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.795 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.4 t -65.9 97.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.606 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.6 p -120.93 159.51 25.41 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 122.399 1.095 . . . . 0.0 113.888 -175.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.537 HG22 ' H ' ' A' ' 161' ' ' ARG . 2.1 m -95.5 -173.78 2.99 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.537 ' H ' HG22 ' A' ' 160' ' ' THR . 0.1 OUTLIER -48.65 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.438 -0.789 . . . . 0.0 112.567 -178.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.747 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 82.8 -31.83 3.0 Favored Glycine 0 N--CA 1.499 2.888 0 O-C-N 121.205 -0.934 . . . . 0.0 111.748 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.25 131.64 39.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 119.144 1.472 . . . . 0.0 109.328 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.418 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -92.13 135.14 34.22 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.035 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -113.31 -44.19 3.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.555 -0.716 . . . . 0.0 111.135 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.795 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -121.84 179.45 4.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.129 -0.982 . . . . 0.0 109.868 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.58 151.17 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.421 -0.799 . . . . 0.0 110.818 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.679 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -119.68 91.04 3.45 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.27 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.712 ' CE2' HG12 ' A' ' 151' ' ' VAL . 3.1 p90 -127.42 160.24 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.862 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.495 HG11 HD13 ' A' ' 82' ' ' LEU . 2.1 p -107.63 130.3 23.01 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.2 Cg_endo -60.67 154.05 57.59 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 124.14 1.6 . . . . 0.0 111.394 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.778 HG13 ' HA2' ' A' ' 152' ' ' GLY . 25.2 m -79.47 1.05 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.6 -0.688 . . . . 0.0 110.789 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.22 -37.46 14.12 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.717 ' O ' HG22 ' A' ' 177' ' ' THR . 35.4 t -72.07 -36.25 69.49 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.119 0.485 . . . . 0.0 110.272 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.928 ' O ' HG22 ' A' ' 178' ' ' THR . 32.3 mtt -47.32 -36.94 10.07 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.69 -0.631 . . . . 0.0 111.08 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -48.02 -36.59 13.13 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.694 -0.629 . . . . 0.0 111.915 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 174' ' ' SER . 9.0 t -48.64 -39.07 22.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.542 -0.724 . . . . 0.0 112.841 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.928 HG22 ' O ' ' A' ' 175' ' ' MET . 6.4 t -56.92 -38.49 72.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.116 -0.99 . . . . 0.0 112.213 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.453 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -57.5 -40.07 77.88 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.596 -1.315 . . . . 0.0 110.362 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -38.4 91.01 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.956 0.884 . . . . 0.0 108.905 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.76 66.1 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.909 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.518 -0.739 . . . . 0.0 109.913 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 89' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -168.73 78.84 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.8 . . . . 0.0 109.375 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.55 -68.77 0.07 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.544 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.5 pt-20 -164.92 -48.78 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.963 . . . . 0.0 110.832 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.852 HG11 ' N ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -164.09 -161.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.929 -1.107 . . . . 0.0 112.738 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -143.08 167.1 22.89 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.462 0.649 . . . . 0.0 110.117 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.858 HG12 HD22 ' A' ' 44' ' ' LEU . 27.2 m -114.98 147.03 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.657 HG11 HD21 ' A' ' 64' ' ' LEU . 28.0 m -98.48 -179.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 m -134.69 138.88 44.8 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.968 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 p -132.99 -175.99 3.97 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.1 102.99 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.357 -0.84 . . . . 0.0 110.551 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.5 p 47.47 43.76 16.04 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.202 0.525 . . . . 0.0 111.554 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.47 153.13 21.01 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.709 -0.619 . . . . 0.0 111.128 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 p -139.85 139.48 36.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.504 -0.748 . . . . 0.0 109.25 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' A' ' 36' ' ' VAL . 37.2 m-85 -105.02 -179.26 3.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.164 -0.96 . . . . 0.0 111.802 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.858 HD22 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -120.34 140.64 50.98 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.605 -0.684 . . . . 0.0 110.445 -179.206 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.743 ' C ' HG11 ' A' ' 33' ' ' VAL . . . -119.45 -177.56 3.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.41 -0.806 . . . . 0.0 109.747 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.906 HG21 ' CG2' ' A' ' 153' ' ' ILE . 3.4 t -157.85 113.91 2.82 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.185 -0.947 . . . . 0.0 111.513 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.3 p -70.62 105.73 3.24 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.947 -1.095 . . . . 0.0 111.434 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.722 HG11 ' CG1' ' A' ' 172' ' ' VAL . 17.6 t -124.39 127.93 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t30 60.48 17.83 7.66 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.365 -0.834 . . . . 0.0 109.722 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.05 19.79 52.05 Favored Glycine 0 N--CA 1.499 2.894 0 O-C-N 121.109 -0.994 . . . . 0.0 111.088 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 85' ' ' TRP . 47.3 t -136.18 105.84 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.114 -1.227 . . . . 0.0 109.638 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.4 p -59.75 103.37 0.2 Allowed 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.309 -0.87 . . . . 0.0 109.794 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.526 ' CH2' ' HE1' ' A' ' 179' ' ' MET . 95.9 m95 -82.75 150.96 26.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.998 -1.064 . . . . 0.0 111.416 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.786 HG21 ' CZ2' ' A' ' 85' ' ' TRP . 7.7 t -158.61 155.23 27.87 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.617 HG11 ' ND1' ' A' ' 57' ' ' HIS . 20.7 t -80.83 144.57 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.232 -0.917 . . . . 0.0 109.676 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 28.8 t80 -78.08 4.75 11.58 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.049 -1.032 . . . . 0.0 112.134 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.617 ' ND1' HG11 ' A' ' 55' ' ' VAL . 16.2 m170 -45.51 -39.63 7.59 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.292 -0.88 . . . . 0.0 111.54 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.415 ' O ' ' CE1' ' A' ' 43' ' ' PHE . . . -167.68 28.18 0.16 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.57 -166.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.262 -1.14 . . . . 0.0 109.632 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.45 ' O ' HD12 ' A' ' 64' ' ' LEU . . . -75.22 90.77 0.81 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.6 p -71.2 -10.09 59.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.497 -1.002 . . . . 0.0 110.082 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -118.79 -153.39 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 110.506 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 63' ' ' THR . 8.5 t -59.69 90.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.477 -0.764 . . . . 0.0 110.937 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.657 HD21 HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.21 173.15 0.9 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.322 -0.861 . . . . 0.0 109.392 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.743 ' O ' HD11 ' A' ' 71' ' ' ILE . . . -112.43 132.21 55.16 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.206 -0.934 . . . . 0.0 110.314 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.88 -178.82 24.26 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -57.9 -20.38 44.09 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.78 1.41 . . . . 0.0 110.507 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 24.71 12.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.534 -0.729 . . . . 0.0 109.809 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.6 -106.51 2.43 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -76.35 120.39 5.62 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.753 1.396 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.743 HD11 ' O ' ' A' ' 65' ' ' ALA . 75.5 mt -75.19 146.15 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 m -90.64 92.95 9.06 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.442 -0.786 . . . . 0.0 111.06 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -61.63 107.92 0.89 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.675 -0.641 . . . . 0.0 109.406 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 mmt -113.9 -26.81 7.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.576 -0.702 . . . . 0.0 111.042 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.526 ' O ' HG13 ' A' ' 83' ' ' VAL . 7.5 m-85 -122.57 118.31 27.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.417 -0.802 . . . . 0.0 109.738 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.657 HG23 ' CG2' ' A' ' 83' ' ' VAL . 5.4 m -155.29 122.99 5.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.635 -0.666 . . . . 0.0 110.779 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -142.11 76.65 1.55 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.28 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.437 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.4 p -49.5 -32.62 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.595 -0.691 . . . . 0.0 109.69 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.59 -47.72 73.01 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.7 -0.625 . . . . 0.0 109.671 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -93.06 17.27 11.11 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.981 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 52.29 52.47 14.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.214 -0.929 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.558 HD21 ' HE2' ' A' ' 175' ' ' MET . 1.5 mt -161.44 151.69 17.42 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.031 0.919 . . . . 0.0 112.343 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.657 ' CG2' HG23 ' A' ' 76' ' ' THR . 58.1 t -156.76 146.03 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 53' ' ' TRP . . . -142.45 115.28 0.94 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.008 -1.568 . . . . 0.0 112.18 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.786 ' CZ2' HG21 ' A' ' 54' ' ' THR . 1.5 m0 -97.98 167.2 11.05 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -81.22 134.71 35.66 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.387 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -104.05 91.17 3.5 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.214 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 53.5 Cg_endo -101.9 -10.24 0.2 Allowed 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.595 1.313 . . . . 0.0 112.726 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 46.5 Cg_endo -72.84 67.52 3.92 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 115.735 -2.377 . . . . 0.0 110.678 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 53.79 23.24 21.24 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.61 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -73.4 135.79 44.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -1.005 . . . . 0.0 110.736 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -61.35 -168.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.771 -0.581 . . . . 0.0 109.68 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 t -147.0 103.97 3.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.54 -0.725 . . . . 0.0 109.386 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.442 HD13 ' HB2' ' A' ' 150' ' ' ALA . 2.3 mt -79.66 -160.77 0.28 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.618 -0.676 . . . . 0.0 109.907 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.2 t -161.01 153.46 17.16 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.754 -0.591 . . . . 0.0 109.452 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.79 143.43 73.71 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 O-C-N 123.517 1.272 . . . . 0.0 111.727 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 25.0 t -64.94 159.45 22.86 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.432 0.634 . . . . 0.0 110.416 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 t -159.19 33.95 0.2 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.448 0.642 . . . . 0.0 109.339 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.2 p -117.85 -167.73 1.39 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.664 -0.648 . . . . 0.0 110.336 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -124.49 29.88 4.87 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.405 ' HB3' ' CG ' ' A' ' 146' ' ' PRO . 75.3 m -91.94 171.87 8.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.587 -0.949 . . . . 0.0 109.998 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 118' ' ' ARG . 40.8 m -127.4 -35.2 2.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.51 -0.743 . . . . 0.0 111.634 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.85 119.07 9.3 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.347 -0.846 . . . . 0.0 110.593 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.749 HD13 HD23 ' A' ' 143' ' ' LEU . 1.5 mt -115.37 -174.46 2.51 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.211 -0.931 . . . . 0.0 110.42 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.676 ' HB3' HG13 ' A' ' 113' ' ' VAL . 85.3 m-85 -139.85 87.25 2.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.724 HD23 HD11 ' A' ' 114' ' ' ILE . 36.0 tp -64.62 99.39 0.31 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.945 HG22 HG22 ' A' ' 113' ' ' VAL . 61.6 t -90.47 114.48 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.833 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.3 p -71.86 -179.82 2.86 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.775 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -93.33 16.28 13.69 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.072 -1.017 . . . . 0.0 110.67 179.367 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -124.78 41.4 3.52 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.216 -0.927 . . . . 0.0 109.754 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.62 68.15 0.9 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.486 -0.758 . . . . 0.0 111.499 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -155.1 109.17 2.9 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.654 -0.654 . . . . 0.0 110.589 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.945 HG22 HG22 ' A' ' 107' ' ' VAL . 24.4 t -106.14 137.52 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.772 -0.58 . . . . 0.0 109.69 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.724 HD11 HD23 ' A' ' 106' ' ' LEU . 29.3 pt -131.74 131.15 22.56 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 109.126 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.499 ' HB2' HD12 ' A' ' 127' ' ' LEU . 48.8 Cg_endo -66.07 140.51 60.1 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.835 1.439 . . . . 0.0 111.779 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 167' ' ' VAL . 25.0 t -136.03 144.59 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.12 119.43 38.73 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.439 ' HB2' ' HA ' ' A' ' 102' ' ' SER . 23.3 ttt180 -49.73 126.96 14.95 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.263 -0.898 . . . . 0.0 110.032 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.96 -33.14 7.0 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.013 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -169.08 58.52 0.2 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.415 -1.374 . . . . 0.0 110.414 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.1 OUTLIER 64.35 -72.82 0.06 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.728 -0.866 . . . . 0.0 110.056 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 120' ' ' GLY . 3.8 p -92.44 40.02 1.04 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 121.162 0.506 . . . . 0.0 110.39 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.435 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 13.8 ttm180 -168.33 154.79 7.34 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.42 -0.8 . . . . 0.0 110.252 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.49 -178.62 23.76 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -128.55 118.33 22.82 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 122.048 -0.678 . . . . 0.0 111.819 -178.026 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 145.31 52.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.695 -0.628 . . . . 0.0 109.794 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.499 HD12 ' HB2' ' A' ' 115' ' ' PRO . 17.2 mt -115.38 55.23 0.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 170.32 125.33 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -63.67 103.49 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.757 1.399 . . . . 0.0 109.843 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.91 149.59 42.71 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.407 -0.808 . . . . 0.0 109.207 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.406 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 50.4 Cg_endo -68.07 127.33 15.79 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.819 1.431 . . . . 0.0 110.604 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.2 p -62.01 -37.08 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.829 -0.544 . . . . 0.0 110.166 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.33 -35.73 19.23 Favored 'General case' 0 N--CA 1.506 2.36 0 CA-C-O 122.082 0.944 . . . . 0.0 110.535 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 21.2 t80 -67.66 -38.93 84.47 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.479 HD11 ' CB ' ' A' ' 164' ' ' ALA . 14.3 mt -64.02 -35.79 81.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -57.9 131.31 50.01 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.71 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.8 -25.74 26.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.9 m -90.0 4.17 50.96 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -1.081 . . . . 0.0 111.486 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 13.5 p -56.87 121.91 10.99 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.967 -1.083 . . . . 0.0 111.025 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.83 -15.15 9.02 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.27 139.22 48.31 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.714 -1.755 . . . . 0.0 108.714 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.87 123.14 6.65 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.921 1.485 . . . . 0.0 113.691 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.749 HD23 HD13 ' A' ' 104' ' ' LEU . 1.7 mp -79.03 116.91 19.62 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.35 117.75 33.34 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.82 -1.152 . . . . 0.0 113.081 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.435 ' HB3' HG21 ' A' ' 151' ' ' VAL . 27.0 p -56.99 173.69 0.31 Allowed Pre-proline 0 N--CA 1.5 2.064 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.809 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 44.9 Cg_endo -76.66 72.44 5.64 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.714 1.376 . . . . 0.0 109.907 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.37 -46.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.62 -0.675 . . . . 0.0 110.26 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 135.36 -28.27 3.03 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.99 129.61 37.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.523 -0.986 . . . . 0.0 110.194 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.516 ' HB1' HG21 ' A' ' 172' ' ' VAL . . . -59.07 138.75 57.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.669 -0.644 . . . . 0.0 110.112 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.684 HG12 ' CE2' ' A' ' 169' ' ' PHE . 0.9 OUTLIER -99.61 -33.1 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.839 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 176.92 -178.44 48.13 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.906 ' CG2' HG21 ' A' ' 46' ' ' THR . 1.1 pt -120.19 139.93 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.354 -1.086 . . . . 0.0 111.016 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.759 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.3 t80 -53.34 118.58 3.93 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.92 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -107.59 -41.06 5.14 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.439 -0.788 . . . . 0.0 109.6 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -154.08 167.59 29.3 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.759 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -124.95 116.46 22.22 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.659 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.802 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.9 t -67.56 100.75 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.636 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.5 p -125.25 154.91 40.93 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.648 1.213 . . . . 0.0 114.119 -175.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.519 HG22 ' H ' ' A' ' 161' ' ' ARG . 2.0 m -92.2 -172.3 3.08 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.519 ' H ' HG22 ' A' ' 160' ' ' THR . 1.6 ttt180 -45.94 88.91 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.402 -0.811 . . . . 0.0 111.727 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.654 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 72.63 -15.08 2.28 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.101 -1.0 . . . . 0.0 112.509 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.7 t -101.14 135.85 35.55 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.351 0 CA-C-N 118.948 1.374 . . . . 0.0 109.286 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.479 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -97.59 124.78 41.99 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.747 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -108.2 -41.28 4.94 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.607 -0.683 . . . . 0.0 110.545 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.802 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -126.48 166.78 16.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 109.358 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.436 HG21 HG11 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -112.42 162.01 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.839 0.828 . . . . 0.0 111.28 -178.084 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.758 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -130.65 99.28 4.91 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.354 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.684 ' CE2' HG12 ' A' ' 151' ' ' VAL . 5.1 p90 -135.9 159.63 41.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.007 -1.058 . . . . 0.0 111.567 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 82' ' ' LEU . 1.2 m -103.75 144.68 29.16 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 37.1 Cg_endo -61.9 155.17 56.52 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.092 1.575 . . . . 0.0 111.917 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.839 HG23 ' HA2' ' A' ' 152' ' ' GLY . 4.3 t -82.75 -2.11 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.504 -0.747 . . . . 0.0 109.709 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -81.96 -38.43 25.19 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.6 t -57.64 -36.79 72.32 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.806 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.599 ' HE1' HG23 ' A' ' 153' ' ' ILE . 8.4 mtt -49.93 -39.2 39.46 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.563 -0.71 . . . . 0.0 109.348 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.47 ' O ' ' HB3' ' A' ' 179' ' ' MET . 2.0 mt-10 -66.18 -38.11 87.27 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.8 m -64.98 -38.75 91.99 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -37.08 81.36 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.526 ' HE1' ' CH2' ' A' ' 53' ' ' TRP . 34.5 tpp -61.79 -53.44 55.87 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.723 -0.611 . . . . 0.0 110.329 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.12 -38.77 62.92 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.366 -0.834 . . . . 0.0 110.915 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -55.94 -38.11 69.87 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.431 -0.793 . . . . 0.0 110.926 -179.754 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 89' ' ' PRO . 28.7 m . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 120.992 0.425 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.92 78.41 0.29 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.248 -0.907 . . . . 0.0 109.384 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.59 14.29 0.05 OUTLIER Glycine 0 N--CA 1.498 2.805 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.427 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.453 ' C ' HG23 ' A' ' 33' ' ' VAL . 21.5 mt-10 55.98 6.73 0.24 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.858 -1.378 . . . . 0.0 113.433 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.453 HG23 ' C ' ' A' ' 32' ' ' GLU . 60.4 t -152.23 151.98 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 120.455 -1.403 . . . . 0.0 110.151 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 2.9 tt0 -150.44 143.26 24.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.734 -0.604 . . . . 0.0 110.05 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.737 HG12 HD22 ' A' ' 44' ' ' LEU . 27.2 m -110.15 174.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.482 0.658 . . . . 0.0 110.712 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.562 HG11 ' CH2' ' A' ' 85' ' ' TRP . 31.9 m -131.76 -178.18 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -147.84 136.05 21.37 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.0 p -143.78 -179.11 6.26 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.67 76.11 0.6 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.911 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m 177.31 -61.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -179.39 -159.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.612 -0.68 . . . . 0.0 109.262 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 13.3 t -117.58 139.72 50.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.503 -0.748 . . . . 0.0 109.928 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 59' ' ' ALA . 98.7 m-85 -102.18 -178.54 3.73 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.569 -0.707 . . . . 0.0 111.617 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.836 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -111.69 151.7 28.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.608 -0.683 . . . . 0.0 111.351 -178.313 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.529 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -159.55 145.01 15.74 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.654 -0.654 . . . . 0.0 109.351 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.512 HG23 HG23 ' A' ' 48' ' ' VAL . 13.2 t -117.86 127.38 53.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.162 -0.961 . . . . 0.0 112.036 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 87.4 m -78.77 82.78 4.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.531 -0.73 . . . . 0.0 110.467 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.828 HG11 HG11 ' A' ' 172' ' ' VAL . 57.8 t -98.59 139.2 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 56.12 20.41 4.41 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.343 -0.848 . . . . 0.0 110.027 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.6 24.49 53.43 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.9 t -138.81 103.97 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -1.212 . . . . 0.0 110.612 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.7 t -58.2 96.61 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.538 -0.726 . . . . 0.0 110.022 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.937 ' CE3' HD23 ' A' ' 82' ' ' LEU . 79.5 m95 -76.07 145.34 40.17 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.325 -0.859 . . . . 0.0 110.331 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.539 HG23 HG23 ' A' ' 83' ' ' VAL . 2.7 t -163.08 176.43 10.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.574 -0.704 . . . . 0.0 109.787 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.464 HG11 ' HG2' ' A' ' 155' ' ' ARG . 13.6 m -104.42 138.19 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.563 -0.711 . . . . 0.0 109.986 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.606 ' HB2' HG11 ' A' ' 83' ' ' VAL . 1.6 t80 -73.79 -12.07 60.58 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.007 -1.058 . . . . 0.0 111.357 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.431 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 4.7 p-80 -83.63 -0.95 52.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.151 -0.968 . . . . 0.0 110.229 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.53 74.84 0.21 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.408 ' HA ' ' CD2' ' A' ' 43' ' ' PHE . . . -164.35 -72.1 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.466 -1.02 . . . . 0.0 110.123 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.85 -161.96 32.25 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.4 p -167.15 -163.52 0.54 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.725 -0.867 . . . . 0.0 109.702 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt 51.5 -164.2 0.06 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.421 -0.8 . . . . 0.0 110.72 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -56.7 90.35 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.512 -0.742 . . . . 0.0 110.615 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.879 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -63.9 162.26 14.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.705 -0.622 . . . . 0.0 110.295 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.23 142.74 48.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.632 -0.667 . . . . 0.0 110.313 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -124.83 -179.4 15.7 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.84 -6.91 20.19 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.972 1.512 . . . . 0.0 111.493 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.66 29.57 1.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.045 . . . . 0.0 110.382 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.61 176.51 14.44 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.25 155.79 68.15 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.852 1.449 . . . . 0.0 109.9 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.879 HD12 ' CD2' ' A' ' 64' ' ' LEU . 77.8 mt -100.79 119.54 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.558 -0.714 . . . . 0.0 109.786 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -61.4 135.14 57.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.609 -0.682 . . . . 0.0 110.703 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -94.51 115.11 27.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 109.415 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.3 mmm -124.81 -34.88 2.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.525 -0.735 . . . . 0.0 110.866 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.468 ' CD2' ' CE ' ' A' ' 179' ' ' MET . 15.5 m-85 -118.35 108.45 15.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.389 -0.819 . . . . 0.0 109.661 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.606 ' CG2' HG12 ' A' ' 83' ' ' VAL . 1.6 m -149.1 114.46 5.54 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.544 -0.862 . . . . 0.0 112.407 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -148.03 75.66 1.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.872 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.485 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 8.2 p -54.97 -22.48 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.465 -0.772 . . . . 0.0 111.098 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -60.67 83.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.732 -0.605 . . . . 0.0 110.962 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 49.45 26.39 1.65 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.515 -0.741 . . . . 0.0 111.461 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -126.12 -95.32 0.45 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.937 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.937 HD23 ' CE3' ' A' ' 53' ' ' TRP . 8.4 tp 177.72 164.21 0.62 Allowed 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.548 -1.345 . . . . 0.0 110.824 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' A' ' 56' ' ' TYR . 16.4 m -135.02 122.99 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.12 133.93 4.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.562 ' CH2' HG11 ' A' ' 36' ' ' VAL . 1.3 m-90 -100.55 168.91 9.42 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -80.23 136.52 36.48 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.586 -0.845 . . . . 0.0 109.844 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.494 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -108.94 92.94 11.52 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.874 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.568 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.5 Cg_endo -102.35 -11.69 0.16 Allowed 'Trans proline' 0 CA--C 1.551 1.354 0 O-C-N 123.911 1.48 . . . . 0.0 112.847 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 51.2 Cg_endo -71.2 75.8 1.79 Allowed 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 116.058 -2.162 . . . . 0.0 111.104 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.83 25.13 21.95 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.494 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -74.71 139.44 43.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.942 . . . . 0.0 110.574 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.3 tpt85 -75.34 140.3 42.97 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.7 p -104.66 103.15 12.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.348 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -158.37 0.25 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.446 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -151.55 -169.44 0.22 Allowed Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.567 -0.708 . . . . 0.0 109.878 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -93.81 159.48 2.28 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 O-C-N 123.69 1.363 . . . . 0.0 111.521 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 0.5 OUTLIER -108.65 133.51 52.66 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.667 -0.646 . . . . 0.0 109.94 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 m -139.56 91.33 2.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.612 -0.68 . . . . 0.0 109.953 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 29.7 m -132.95 -162.28 1.22 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.47 -0.769 . . . . 0.0 109.927 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.73 31.42 2.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.88 -151.1 0.47 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.685 -0.891 . . . . 0.0 110.168 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.8 p -149.78 -147.97 0.25 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 0.0 109.881 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 7.6 t0 58.06 105.24 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.126 -0.984 . . . . 0.0 110.794 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.664 HD13 HD23 ' A' ' 143' ' ' LEU . 0.8 OUTLIER -123.18 -168.45 1.77 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.167 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.736 ' HB3' HG13 ' A' ' 113' ' ' VAL . 79.7 m-85 -142.3 93.04 2.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.492 -0.755 . . . . 0.0 110.728 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.458 HD12 ' HG ' ' A' ' 143' ' ' LEU . 7.0 tp -60.09 92.59 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 105' ' ' TYR . 89.7 t -84.5 101.95 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.331 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.422 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 21.8 p -67.4 155.86 37.95 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.836 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -78.18 3.9 13.99 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.028 -1.045 . . . . 0.0 111.126 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.447 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -101.91 31.52 3.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.972 -1.08 . . . . 0.0 109.055 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 61.42 74.55 0.44 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.519 -0.738 . . . . 0.0 110.67 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.61 119.47 0.88 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.606 -0.684 . . . . 0.0 110.528 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 105' ' ' TYR . 71.5 t -98.13 143.34 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.537 -0.727 . . . . 0.0 109.768 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.439 ' HB ' ' HB3' ' A' ' 106' ' ' LEU . 14.4 mt -130.68 109.89 15.93 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -58.05 134.16 60.31 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 O-C-N 123.655 1.345 . . . . 0.0 111.929 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 103' ' ' ASP . 35.1 t -127.78 142.98 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.644 -0.66 . . . . 0.0 109.525 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.58 121.29 43.21 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -48.68 130.41 17.41 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.38 -0.825 . . . . 0.0 110.917 -178.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -102.95 -49.43 3.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.804 -0.56 . . . . 0.0 110.654 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.84 60.23 0.11 Allowed Glycine 0 N--CA 1.498 2.796 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.757 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.37 145.35 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.787 -0.831 . . . . 0.0 109.222 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.427 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 17.5 p 44.63 27.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.737 -0.602 . . . . 0.0 112.122 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.47 ' N ' ' CD2' ' A' ' 169' ' ' PHE . 0.4 OUTLIER -170.37 144.26 2.47 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.125 -0.984 . . . . 0.0 110.219 178.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.26 -177.79 16.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -123.21 123.14 40.12 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 122.045 -0.679 . . . . 0.0 111.743 -178.265 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.09 130.7 45.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.565 -0.709 . . . . 0.0 109.492 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.5 mt -101.06 53.62 0.84 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.86 118.45 0.14 Allowed Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.333 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -60.31 106.86 0.37 Allowed 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.61 1.321 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.6 mtt-85 -125.75 146.41 54.99 Favored Pre-proline 0 N--CA 1.49 1.54 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.089 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.411 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 47.8 Cg_endo -64.24 129.31 23.8 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 124.098 1.578 . . . . 0.0 110.604 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 162' ' ' GLY . 6.1 p -56.96 -36.01 49.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.848 -0.532 . . . . 0.0 110.163 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -49.14 -36.85 20.27 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.232 -0.918 . . . . 0.0 110.603 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 7.4 t80 -64.43 -38.9 92.65 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.469 HD11 ' CB ' ' A' ' 164' ' ' ALA . 8.7 mt -67.4 -35.92 80.26 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -56.39 111.87 1.1 Allowed 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.939 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.27 -34.37 4.73 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.7 m -79.86 -2.72 44.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.676 -0.896 . . . . 0.0 110.808 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.1 m -57.37 126.6 28.02 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.181 -0.95 . . . . 0.0 110.447 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.12 -9.22 31.37 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.723 ' HA2' HD12 ' A' ' 44' ' ' LEU . . . -56.88 -175.98 0.31 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -114.57 124.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.489 1.258 . . . . 0.0 112.527 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.664 HD23 HD13 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -83.34 126.35 32.61 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 176.444 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.16 121.06 31.74 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.709 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 14.7 p -69.29 -173.27 0.2 Allowed Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.44 ' CD ' ' HB2' ' A' ' 145' ' ' CYS . 49.9 Cg_endo -71.65 66.92 3.01 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.562 1.296 . . . . 0.0 110.422 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.86 -165.7 0.38 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.551 -0.718 . . . . 0.0 110.123 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -110.24 48.57 0.92 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -136.41 128.69 30.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.606 -0.937 . . . . 0.0 109.927 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.555 ' CB ' HG21 ' A' ' 172' ' ' VAL . . . -66.34 121.83 16.15 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.496 -0.752 . . . . 0.0 109.918 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.537 HG11 HD22 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -78.24 -44.5 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.696 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . -179.6 -178.31 48.34 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.627 HG12 ' HE2' ' A' ' 175' ' ' MET . 1.0 OUTLIER -111.73 154.79 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-N 118.838 1.319 . . . . 0.0 111.988 179.601 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.85 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 7.6 t80 -69.17 83.3 0.35 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.8 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.464 ' HG2' HG11 ' A' ' 55' ' ' VAL . 2.6 ttt180 -64.06 -49.91 70.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.618 -0.676 . . . . 0.0 109.595 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.612 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -155.78 -179.19 7.88 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.85 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -134.04 121.82 22.1 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.874 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.7 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.5 t -70.69 104.49 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 177.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.63 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.3 p -129.43 142.58 50.76 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -175.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.662 HG22 HG12 ' A' ' 163' ' ' VAL . 5.9 t -76.26 -174.58 2.85 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.54 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.325 -0.859 . . . . 0.0 112.937 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.779 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 85.99 -27.32 5.54 Favored Glycine 0 N--CA 1.498 2.771 0 O-C-N 121.204 -0.935 . . . . 0.0 112.316 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.662 HG12 HG22 ' A' ' 160' ' ' THR . 1.0 OUTLIER -96.55 136.91 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 119.108 1.454 . . . . 0.0 109.82 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.469 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -103.57 125.65 50.23 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.604 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -111.62 -34.37 6.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.654 -0.653 . . . . 0.0 111.224 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.7 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -124.8 176.77 6.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.077 -1.014 . . . . 0.0 110.946 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.52 140.92 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 111.596 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 3.2 t0 -106.48 100.24 9.77 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.47 ' CD2' ' N ' ' A' ' 123' ' ' ARG . 0.5 OUTLIER -129.8 157.87 41.02 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.071 -1.052 . . . . 0.0 113.748 -176.04 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.407 ' CG1' HG13 ' A' ' 153' ' ' ILE . 2.9 p -111.87 128.09 25.93 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 45.0 Cg_endo -57.68 156.37 27.72 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 O-C-N 123.775 1.408 . . . . 0.0 111.752 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.828 HG11 HG11 ' A' ' 48' ' ' VAL . 97.9 t -79.37 -1.66 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.611 -0.681 . . . . 0.0 110.08 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -86.08 -37.66 18.61 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.1 m -72.08 -38.61 69.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.861 -0.525 . . . . 0.0 110.021 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.627 ' HE2' HG12 ' A' ' 153' ' ' ILE . 14.8 mtt -50.93 -38.79 52.37 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.542 -0.724 . . . . 0.0 109.711 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -62.87 -39.99 96.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 35.1 m -57.86 -38.51 75.84 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.606 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 0.3 OUTLIER -51.31 -35.01 35.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.844 -0.535 . . . . 0.0 109.739 178.772 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.579 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 9.5 mmt -48.04 -53.63 15.69 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.46 -0.775 . . . . 0.0 110.847 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.02 -37.45 45.32 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.989 0.899 . . . . 0.0 109.846 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 178' ' ' THR . . . -63.73 -39.77 95.11 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.013 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.407 ' CB ' ' HA ' ' A' ' 75' ' ' TYR . 10.8 m . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.47 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -154.6 76.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.636 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 44.58 66.56 1.37 Allowed Glycine 0 N--CA 1.5 2.911 0 O-C-N 121.933 -0.48 . . . . 0.0 111.911 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.494 ' C ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -164.08 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.418 -1.048 . . . . 0.0 111.432 179.73 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.494 HG23 ' C ' ' A' ' 32' ' ' GLU . 70.1 t -150.91 153.83 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.227 -0.92 . . . . 0.0 111.724 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.419 ' OE1' ' HG3' ' A' ' 89' ' ' PRO . 12.5 tt0 -144.84 136.37 25.41 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.45 HG11 ' HG3' ' A' ' 109' ' ' ARG . 33.7 m -98.81 168.68 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.82 0.819 . . . . 0.0 111.632 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.545 HG11 ' CH2' ' A' ' 85' ' ' TRP . 28.2 m -125.91 -179.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -145.43 135.99 24.27 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.251 -0.905 . . . . 0.0 110.95 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.5 p -142.74 177.79 8.08 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.42 75.87 0.55 Allowed 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.254 -0.979 . . . . 0.0 108.684 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 173.69 -57.16 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.57 -170.13 0.1 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.42 -0.8 . . . . 0.0 109.65 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 86.0 p -111.22 140.75 45.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.706 -0.621 . . . . 0.0 110.431 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 27.4 m-85 -102.08 175.51 5.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.467 -0.771 . . . . 0.0 109.944 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.695 ' C ' HD23 ' A' ' 44' ' ' LEU . 5.5 tt -109.96 143.92 39.21 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.644 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -147.21 131.53 17.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.927 -1.108 . . . . 0.0 110.311 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 46' ' ' THR . 8.4 t -100.02 127.81 46.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.254 -0.904 . . . . 0.0 112.462 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.419 ' HG ' ' HG ' ' A' ' 52' ' ' CYS . 85.8 m -82.89 95.07 7.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.375 -0.828 . . . . 0.0 110.747 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.889 HG11 ' CG1' ' A' ' 172' ' ' VAL . 93.5 t -103.86 133.09 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t30 62.22 11.4 4.41 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.422 -0.799 . . . . 0.0 110.681 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.62 30.61 8.91 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.023 -1.048 . . . . 0.0 111.167 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.4 t -147.2 105.81 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -1.187 . . . . 0.0 109.257 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.419 ' HG ' ' HG ' ' A' ' 47' ' ' CYS . 0.7 OUTLIER -56.17 109.56 0.61 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.498 -0.751 . . . . 0.0 109.485 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 1.004 ' CE3' HD23 ' A' ' 82' ' ' LEU . 92.7 m95 -91.23 141.8 28.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.671 -0.643 . . . . 0.0 110.435 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.461 HG21 ' CH2' ' A' ' 85' ' ' TRP . 5.2 t -161.27 -179.78 7.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.457 -0.777 . . . . 0.0 110.319 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.524 HG11 ' HA ' ' A' ' 155' ' ' ARG . 11.6 m -102.18 145.12 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.596 -0.69 . . . . 0.0 110.497 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.656 ' HB2' HG11 ' A' ' 83' ' ' VAL . 42.9 t80 -78.02 1.72 20.01 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.113 -0.992 . . . . 0.0 112.301 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -49.78 -24.85 2.59 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 121.163 -0.961 . . . . 0.0 110.684 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.448 ' O ' ' CE1' ' A' ' 43' ' ' PHE . . . -177.89 39.83 0.09 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.41 25.96 4.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.331 -1.099 . . . . 0.0 111.009 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.56 -164.39 41.47 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.1 t -136.84 -80.38 0.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.762 -0.846 . . . . 0.0 110.074 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -118.47 -33.46 4.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.198 -0.939 . . . . 0.0 111.305 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -93.31 89.57 6.43 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.116 0.484 . . . . 0.0 111.721 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.534 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -101.28 172.8 6.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.51 -0.744 . . . . 0.0 109.751 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.6 130.97 57.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.681 -0.637 . . . . 0.0 110.136 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.59 179.24 16.73 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -55.17 103.82 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 O-C-N 123.652 1.343 . . . . 0.0 110.628 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.1 tttp 54.37 30.05 11.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.505 -0.747 . . . . 0.0 111.22 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.43 134.87 2.1 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -58.85 169.8 3.16 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 O-C-N 123.729 1.383 . . . . 0.0 110.82 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.534 HD12 ' CD2' ' A' ' 64' ' ' LEU . 63.2 mt -106.93 134.5 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.395 -0.816 . . . . 0.0 108.976 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.5 p -74.69 -174.61 2.18 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.278 -0.889 . . . . 0.0 111.032 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -123.15 166.43 15.21 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.606 -0.684 . . . . 0.0 109.973 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.435 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 6.4 tpt -169.54 -37.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.156 -0.965 . . . . 0.0 111.453 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 74' ' ' MET . 14.4 m-85 -131.84 111.53 11.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.472 -0.768 . . . . 0.0 109.103 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.613 ' CG2' HG12 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -152.49 114.2 4.34 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.035 -1.066 . . . . 0.0 113.013 -178.822 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -160.54 76.52 0.59 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.729 -0.607 . . . . 0.0 110.45 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.61 HG11 ' HB3' ' A' ' 56' ' ' TYR . 7.3 p -74.74 -17.3 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.1 -1.0 . . . . 0.0 111.128 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.73 -25.17 17.45 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.129 -0.982 . . . . 0.0 110.244 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -176.11 34.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.748 -0.595 . . . . 0.0 110.144 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -156.03 -89.44 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.997 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.004 HD23 ' CE3' ' A' ' 53' ' ' TRP . 6.8 tp 179.14 177.29 0.53 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.718 -1.239 . . . . 0.0 110.125 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.656 HG11 ' HB2' ' A' ' 56' ' ' TYR . 21.6 m -146.58 121.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -154.09 144.08 10.82 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.545 ' CH2' HG11 ' A' ' 36' ' ' VAL . 1.1 m-90 -108.2 167.83 9.73 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -69.5 137.52 52.62 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.879 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.55 97.0 15.26 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.721 -0.612 . . . . 0.0 111.144 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.7 Cg_endo -111.21 10.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 117.178 -1.415 . . . . 0.0 113.061 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 55.7 Cg_endo -67.58 -108.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 116.587 -1.809 . . . . 0.0 107.75 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.79 32.47 7.39 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 106.559 -2.616 . . . . 0.0 106.559 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.62 152.69 45.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.383 -1.069 . . . . 0.0 111.058 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -125.14 17.16 8.43 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.784 -0.572 . . . . 0.0 110.735 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.8 t 49.98 97.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.288 -0.883 . . . . 0.0 112.536 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.421 HD23 ' HB2' ' A' ' 150' ' ' ALA . 0.3 OUTLIER -74.19 -143.16 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.555 -0.715 . . . . 0.0 110.13 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 t -169.61 153.3 5.04 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 120.897 -1.127 . . . . 0.0 110.657 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.45 160.37 46.95 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.741 1.39 . . . . 0.0 111.173 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.9 t -95.6 112.12 23.9 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.1 p -75.1 -44.05 49.53 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.4 p -65.48 149.42 50.07 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.325 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -111.2 40.43 2.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.99 146.13 51.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.687 -0.89 . . . . 0.0 109.703 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 m -77.69 -159.17 0.14 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.664 -0.648 . . . . 0.0 110.929 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.7 t70 52.43 95.08 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.652 -0.655 . . . . 0.0 111.171 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.889 HD13 HD23 ' A' ' 143' ' ' LEU . 0.8 OUTLIER -113.6 168.81 9.45 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.371 -0.83 . . . . 0.0 110.025 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 107' ' ' VAL . 70.9 m-85 -117.4 86.43 2.51 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.644 -0.66 . . . . 0.0 109.571 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.444 ' CD1' HD11 ' A' ' 143' ' ' LEU . 9.5 tp -54.45 98.85 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.445 -0.785 . . . . 0.0 109.838 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 105' ' ' TYR . 37.4 t -81.68 109.65 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.239 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.459 ' HB ' ' NE2' ' A' ' 110' ' ' HIS . 18.7 p -74.58 177.52 6.0 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.605 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -95.06 28.1 2.93 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.913 -1.117 . . . . 0.0 110.819 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.463 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 1.4 p80 -150.31 46.17 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.916 0.865 . . . . 0.0 109.537 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 49.08 63.47 2.12 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.425 0.631 . . . . 0.0 111.674 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.46 92.37 2.08 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.416 HG13 ' HB3' ' A' ' 105' ' ' TYR . 59.1 t -81.0 144.04 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.176 -0.952 . . . . 0.0 110.123 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.2 mt -128.97 114.99 18.89 Favored Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -59.35 134.42 58.63 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.781 1.411 . . . . 0.0 111.516 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 60.5 t -125.5 149.33 30.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -114.25 111.7 21.94 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -48.12 121.61 4.44 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.749 0.785 . . . . 0.0 110.276 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.9 -37.51 5.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.963 -0.46 . . . . 0.0 110.406 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.81 -170.07 26.03 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -62.56 140.9 58.65 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.831 -0.806 . . . . 0.0 109.568 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.0 p 44.46 42.55 5.57 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.275 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.441 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 3.9 ttp85 -164.32 153.75 13.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.337 -0.852 . . . . 0.0 111.392 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.88 -179.58 21.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -119.39 130.9 55.54 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 122.072 -0.663 . . . . 0.0 111.116 -178.364 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.47 HD22 ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -72.75 128.9 36.9 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.355 -0.84 . . . . 0.0 109.383 179.23 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 mt -103.71 54.57 0.74 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.47 ' O ' HD22 ' A' ' 126' ' ' LEU . 2.4 p 174.95 107.09 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -57.56 103.63 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 O-C-N 123.598 1.315 . . . . 0.0 109.168 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -124.63 159.03 59.94 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.986 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 50.1 Cg_endo -72.54 129.58 14.89 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 124.077 1.567 . . . . 0.0 109.255 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.635 HG21 ' SG ' ' A' ' 159' ' ' CYS . 10.1 p -55.7 -35.71 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.387 -0.82 . . . . 0.0 109.879 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.3 t -48.85 -36.67 17.47 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.401 -0.812 . . . . 0.0 110.504 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 19.8 t80 -63.4 -39.24 93.98 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.521 HD11 ' CB ' ' A' ' 164' ' ' ALA . 15.9 mt -66.2 -34.78 78.81 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.58 126.3 24.73 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.858 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.26 -31.8 8.31 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.448 ' O ' HD13 ' A' ' 44' ' ' LEU . 74.1 m -84.04 3.14 35.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.822 -0.811 . . . . 0.0 110.525 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.2 m -49.77 127.04 15.19 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.289 -0.882 . . . . 0.0 109.731 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.607 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 116.22 -17.24 14.75 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 107.031 -2.428 . . . . 0.0 107.031 -176.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.688 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -45.66 110.24 0.43 Allowed Glycine 0 N--CA 1.501 2.987 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.416 ' O ' HD12 ' A' ' 144' ' ' LEU . 46.9 Cg_endo -68.16 126.62 14.64 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.933 1.491 . . . . 0.0 111.9 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.889 HD23 HD13 ' A' ' 104' ' ' LEU . 9.0 mp -80.56 135.43 36.08 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 142' ' ' PRO . 1.2 mt -131.89 111.91 11.99 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.389 -0.924 . . . . 0.0 112.172 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.497 ' HB3' HG21 ' A' ' 151' ' ' VAL . 27.7 p -69.9 163.53 59.78 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.933 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 46.9 Cg_endo -62.72 86.31 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.769 1.405 . . . . 0.0 110.136 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.9 -48.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.637 -0.664 . . . . 0.0 109.47 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.04 23.43 3.27 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -131.44 147.09 52.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.401 -1.058 . . . . 0.0 109.554 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.816 ' HB1' HG21 ' A' ' 172' ' ' VAL . . . -66.43 122.14 16.87 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.497 -0.752 . . . . 0.0 110.723 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 145' ' ' CYS . 2.1 t -84.47 -37.88 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.836 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 178.43 -179.09 48.72 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.606 HD11 HD11 ' A' ' 82' ' ' LEU . 1.5 pt -117.12 156.77 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 CA-C-N 118.923 1.362 . . . . 0.0 111.841 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.892 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 9.9 t80 -75.56 85.78 2.64 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.602 0.715 . . . . 0.0 111.203 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.524 ' HA ' HG11 ' A' ' 55' ' ' VAL . 19.2 ttm180 -70.91 -49.29 47.35 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -147.78 177.65 9.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.892 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -131.67 119.86 21.97 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.967 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.849 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.1 t -66.4 99.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.635 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.7 p -126.08 140.57 52.48 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 161' ' ' ARG . 0.9 OUTLIER -74.34 -174.77 2.1 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.479 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -48.78 82.93 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 86.01 -26.95 5.73 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.033 -1.042 . . . . 0.0 110.91 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -93.83 135.99 26.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 118.981 1.391 . . . . 0.0 108.631 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -97.53 129.78 44.65 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.876 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -113.09 -44.87 3.22 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.452 -0.78 . . . . 0.0 111.174 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.849 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -123.82 -178.95 4.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.451 -0.78 . . . . 0.0 109.766 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -120.32 164.07 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.45 -0.781 . . . . 0.0 110.647 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.676 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 1.2 t0 -128.69 94.8 3.94 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.716 ' CG ' HD22 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -126.53 146.1 50.26 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.718 -174.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.477 HG11 ' CD1' ' A' ' 82' ' ' LEU . 2.7 p -99.81 131.69 24.16 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 42.9 Cg_endo -56.42 154.98 27.23 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 O-C-N 123.756 1.398 . . . . 0.0 111.412 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.889 ' CG1' HG11 ' A' ' 48' ' ' VAL . 42.6 t -84.44 2.78 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.366 -0.833 . . . . 0.0 109.748 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -91.75 -39.06 12.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.592 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.6 t -72.13 -44.33 63.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.809 -0.557 . . . . 0.0 110.75 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.86 ' HB3' HD22 ' A' ' 82' ' ' LEU . 2.8 ptp -53.76 -37.86 63.84 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.233 -0.917 . . . . 0.0 110.536 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -56.39 -37.84 70.69 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.999 0.904 . . . . 0.0 108.961 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.4 m -62.37 -35.01 77.81 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.96 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 175' ' ' MET . 0.7 OUTLIER -47.22 -37.52 10.5 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.41 -0.806 . . . . 0.0 111.455 -178.644 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.472 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -51.83 -46.12 64.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.234 -0.916 . . . . 0.0 110.323 178.646 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.45 -38.22 58.76 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.096 0.95 . . . . 0.0 110.018 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.87 65.38 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.087 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.7 t . . . . . 0 N--CA 1.5 2.065 0 O-C-N 121.517 -0.74 . . . . 0.0 111.166 179.492 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.726 HG11 ' O ' ' A' ' 89' ' ' PRO . 24.5 m . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 121.554 0.693 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 174.1 77.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 25.68 53.19 0.06 OUTLIER Glycine 0 N--CA 1.51 3.589 0 C-N-CA 123.548 0.594 . . . . 0.0 113.529 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -164.21 -67.36 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.485 1.143 . . . . 0.0 112.669 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.4 t -138.04 158.77 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 122.25 1.024 . . . . 0.0 112.971 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.648 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 2.8 tm0? -143.93 137.85 28.09 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.435 ' CG1' ' CD ' ' A' ' 109' ' ' ARG . 32.6 m -108.41 -179.78 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 122.152 0.977 . . . . 0.0 112.664 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.463 HG11 ' CZ3' ' A' ' 85' ' ' TRP . 21.3 m -139.29 -179.36 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.2 p -149.91 138.09 20.43 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.541 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.435 HG21 ' O ' ' A' ' 59' ' ' ALA . 46.2 p -139.45 179.16 6.71 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -73.43 72.42 1.34 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.815 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.734 HG22 ' HG2' ' A' ' 41' ' ' GLN . 72.1 m -175.4 -59.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.734 ' HG2' HG22 ' A' ' 40' ' ' THR . 3.7 pt20 179.77 -163.22 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.72 -0.612 . . . . 0.0 109.525 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 p -117.99 143.66 46.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.258 -0.901 . . . . 0.0 110.151 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 42.7 m-85 -99.81 -178.47 3.87 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.268 -0.895 . . . . 0.0 110.855 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 109' ' ' ARG . 5.5 tt -114.32 142.44 46.31 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 34' ' ' GLN . . . -147.45 131.22 16.99 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.804 -1.185 . . . . 0.0 110.805 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.645 HG23 HG23 ' A' ' 48' ' ' VAL . 5.3 t -97.84 123.48 41.82 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.34 -0.85 . . . . 0.0 111.865 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.4 p -78.98 83.63 5.06 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.796 0.808 . . . . 0.0 110.368 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.762 HG11 HG11 ' A' ' 172' ' ' VAL . 86.3 t -102.02 145.65 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 54.56 23.69 4.81 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.76 31.1 56.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 85' ' ' TRP . 38.2 t -147.02 111.38 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.176 -1.191 . . . . 0.0 110.483 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 49.3 m -60.83 115.62 3.82 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.474 -0.766 . . . . 0.0 109.294 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.61 ' CZ3' HD23 ' A' ' 82' ' ' LEU . 76.2 m95 -94.49 140.82 29.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.354 -0.841 . . . . 0.0 111.206 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.924 HG21 ' CH2' ' A' ' 85' ' ' TRP . 4.5 t -161.95 -178.58 6.54 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 12.5 t -104.0 144.82 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.426 -0.796 . . . . 0.0 109.671 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -74.34 -1.0 18.93 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.882 -1.137 . . . . 0.0 112.597 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.46 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 1.5 p-80 -70.08 -8.69 51.48 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.912 -1.118 . . . . 0.0 111.169 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.449 ' HA3' ' CE2' ' A' ' 43' ' ' PHE . . . -137.63 -134.08 3.2 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.435 ' O ' HG21 ' A' ' 38' ' ' THR . . . 54.51 174.6 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.481 -1.011 . . . . 0.0 111.01 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.09 112.4 4.46 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.0 p -56.09 173.28 0.16 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.442 -1.034 . . . . 0.0 110.388 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 tttp 58.17 -161.5 0.24 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.317 -0.864 . . . . 0.0 110.482 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -55.24 97.3 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.506 -0.747 . . . . 0.0 110.954 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.426 HD22 HD12 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -52.99 174.65 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.724 -0.61 . . . . 0.0 110.613 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . . . -120.2 137.29 54.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.49 -0.756 . . . . 0.0 110.613 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.12 179.38 20.47 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.0 -21.82 73.09 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.815 1.429 . . . . 0.0 110.957 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -154.31 36.57 0.43 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.361 -0.837 . . . . 0.0 109.937 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 156.62 150.4 5.65 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 47.3 Cg_endo -65.1 158.43 51.97 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.889 1.468 . . . . 0.0 110.483 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.426 HD12 HD22 ' A' ' 64' ' ' LEU . 69.6 mt -99.94 117.51 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.705 -0.622 . . . . 0.0 109.392 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 72' ' ' THR . 9.7 t -59.95 119.83 8.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.5 -0.75 . . . . 0.0 110.372 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 140.97 54.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.65 -0.656 . . . . 0.0 109.973 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.431 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 6.5 tpt -131.01 -41.16 1.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.641 -0.662 . . . . 0.0 110.395 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.471 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 20.7 m-85 -133.15 126.42 31.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.569 -0.707 . . . . 0.0 110.126 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.445 HG23 ' HB ' ' A' ' 83' ' ' VAL . 1.2 m -151.2 113.92 4.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.717 . . . . 0.0 110.407 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.9 76.92 1.53 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.479 -0.889 . . . . 0.0 111.018 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.42 -26.86 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -42.6 80.28 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -96.18 20.15 10.73 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.34 46.88 24.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.406 -0.809 . . . . 0.0 111.842 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.76 HD13 HG11 ' A' ' 170' ' ' VAL . 1.9 tp -161.87 141.68 10.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.359 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.71 ' CG2' HG23 ' A' ' 54' ' ' THR . 33.4 m -143.58 111.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -105.69 102.53 1.99 Allowed Glycine 0 N--CA 1.486 2.014 0 C-N-CA 119.613 -1.279 . . . . 0.0 111.431 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.924 ' CH2' HG21 ' A' ' 54' ' ' THR . 1.8 m-90 -82.0 167.01 19.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.4 ' O ' ' CD ' ' A' ' 88' ' ' PRO . 8.0 mt-30 -80.58 140.45 35.76 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.441 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -102.75 89.94 2.05 Favored Pre-proline 0 C--N 1.301 -1.539 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.545 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.588 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 46.5 Cg_endo -96.62 -14.83 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.731 1.385 . . . . 0.0 112.618 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.726 ' O ' HG11 ' A' ' 29' ' ' VAL . 46.9 Cg_endo -71.29 87.97 0.74 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 116.216 -2.056 . . . . 0.0 111.281 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 49.07 21.44 2.53 Favored Glycine 0 N--CA 1.5 2.944 0 O-C-N 121.402 -0.812 . . . . 0.0 111.368 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 87' ' ' ALA . . . -63.52 148.3 49.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.304 -1.115 . . . . 0.0 109.734 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -106.48 12.07 30.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.454 -0.779 . . . . 0.0 111.576 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 t 46.7 103.58 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.486 -0.759 . . . . 0.0 112.906 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -86.56 -150.21 0.15 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.267 -0.896 . . . . 0.0 109.855 178.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 94' ' ' LEU . 1.6 p -156.06 177.91 1.88 Allowed Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.206 -0.934 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -90.6 169.77 3.79 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 O-C-N 123.79 1.416 . . . . 0.0 111.014 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.541 ' SG ' HG22 ' A' ' 151' ' ' VAL . 39.3 t -93.06 -73.64 0.55 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.69 -0.631 . . . . 0.0 110.023 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m 56.1 42.82 27.88 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.385 -0.822 . . . . 0.0 109.071 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.0 p -126.42 -163.55 1.24 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.899 -0.5 . . . . 0.0 110.596 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.97 70.13 0.39 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t -128.37 -8.11 5.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.541 -0.976 . . . . 0.0 111.677 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 118' ' ' ARG . 23.6 m 53.78 -162.68 0.11 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.012 -1.055 . . . . 0.0 111.029 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.79 100.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.617 -0.677 . . . . 0.0 110.605 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.866 HD13 HD23 ' A' ' 143' ' ' LEU . 1.7 mt -115.86 153.99 30.52 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.02 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 107' ' ' VAL . 53.9 m-85 -105.17 94.35 5.19 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.523 HD23 HD11 ' A' ' 114' ' ' ILE . 8.8 tp -62.98 93.66 0.06 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.684 HG22 HG22 ' A' ' 113' ' ' VAL . 96.4 t -80.94 112.8 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.892 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.421 HG23 ' HB3' ' A' ' 138' ' ' SER . 8.7 m -78.38 172.89 12.96 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.733 ' N ' HD12 ' A' ' 44' ' ' LEU . 19.1 tpt180 -85.51 -8.85 58.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 111.021 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.493 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -107.55 41.42 1.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 110.046 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.48 71.44 0.52 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.376 -0.827 . . . . 0.0 110.676 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -156.4 98.37 1.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.777 -0.577 . . . . 0.0 110.284 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.684 HG22 HG22 ' A' ' 107' ' ' VAL . 54.6 t -99.71 135.57 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.489 -0.757 . . . . 0.0 110.121 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.523 HD11 HD23 ' A' ' 106' ' ' LEU . 32.4 pt -127.07 140.52 38.06 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.85 142.3 51.68 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 O-C-N 123.687 1.362 . . . . 0.0 112.044 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.26 151.36 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -106.2 105.6 15.71 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 102' ' ' SER . 9.9 ttp180 -48.89 123.02 6.36 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 122.036 0.922 . . . . 0.0 111.81 -177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -115.72 -26.79 7.29 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.72 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.21 161.06 32.7 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -51.49 -26.87 9.07 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.311 -1.111 . . . . 0.0 110.776 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -124.41 38.81 4.11 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.046 0.45 . . . . 0.0 110.364 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.468 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 4.1 ttt180 -166.82 156.82 11.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.343 -0.848 . . . . 0.0 110.528 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.47 -178.43 28.82 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.96 113.68 18.14 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.857 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.494 HD21 HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -57.92 130.99 49.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.535 -0.728 . . . . 0.0 109.463 178.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.6 mt -105.6 54.66 0.7 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.7 t 177.83 114.03 0.16 Allowed Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.095 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -58.27 102.98 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.731 0 O-C-N 123.478 1.251 . . . . 0.0 109.979 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 mtt-85 -119.01 160.73 39.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.233 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 43.3 Cg_endo -73.93 127.66 11.66 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 124.058 1.557 . . . . 0.0 109.956 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.2 p -58.82 -37.5 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.806 -0.559 . . . . 0.0 110.571 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -48.87 -36.46 17.08 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 122.038 0.923 . . . . 0.0 110.783 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.417 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 25.3 t80 -66.13 -38.41 88.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.614 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.0 mt -65.34 -35.96 82.57 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -63.67 -21.4 66.36 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.559 -0.856 . . . . 0.0 110.649 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.04 30.37 10.23 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.421 ' HB3' HG23 ' A' ' 108' ' ' THR . 85.2 p -150.7 21.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.566 -0.961 . . . . 0.0 111.453 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.7 p -56.07 132.91 51.42 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.152 -0.968 . . . . 0.0 109.04 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.551 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 109.9 -19.2 28.22 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.69 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -43.85 100.79 0.02 OUTLIER Glycine 0 N--CA 1.504 3.207 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 153' ' ' ILE . 44.2 Cg_endo -63.76 128.23 21.61 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.996 1.524 . . . . 0.0 112.243 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.866 HD23 HD13 ' A' ' 104' ' ' LEU . 9.8 mp -84.26 119.76 25.43 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.5 130.26 56.82 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.686 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 31.6 p -74.05 168.27 27.78 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.235 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 44.2 Cg_endo -69.63 76.66 1.07 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 O-C-N 123.739 1.389 . . . . 0.0 110.751 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.6 t -173.4 -57.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.326 -0.858 . . . . 0.0 110.345 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.57 -42.75 0.63 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER -59.27 123.5 16.94 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.729 -0.865 . . . . 0.0 110.083 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.34 145.33 55.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.66 . . . . 0.0 110.064 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.652 HG12 ' CE2' ' A' ' 169' ' ' PHE . 2.4 t -94.8 -37.23 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.644 -0.66 . . . . 0.0 109.478 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.677 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 177.13 -178.08 48.24 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 82' ' ' LEU . 1.8 pp -117.06 157.15 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.363 -1.081 . . . . 0.0 110.983 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.709 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 6.1 t80 -68.85 119.26 12.92 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.73 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -107.01 -41.13 5.26 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -161.28 179.98 7.89 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.709 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -141.65 128.29 20.29 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.492 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.946 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.2 t -68.32 99.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.471 ' SG ' HG23 ' A' ' 132' ' ' VAL . 72.8 m -115.9 159.86 20.98 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.461 1.124 . . . . 0.0 113.351 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 162' ' ' GLY . 1.8 m -98.3 -174.83 2.94 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.46 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -47.88 83.8 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.456 -0.778 . . . . 0.0 112.708 -179.138 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.717 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 83.06 -32.31 3.02 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.846 -1.159 . . . . 0.0 111.443 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.97 131.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 119.098 1.449 . . . . 0.0 108.944 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.614 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -91.68 132.71 36.17 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.713 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -113.86 -46.78 3.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.649 -0.657 . . . . 0.0 111.045 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.946 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -117.46 179.08 4.16 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.259 -0.901 . . . . 0.0 110.405 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 t -115.47 162.24 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.464 -0.772 . . . . 0.0 110.599 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.66 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -136.27 84.45 2.08 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.765 ' CD1' HD22 ' A' ' 143' ' ' LEU . 2.6 p90 -119.97 163.19 17.97 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.054 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.76 HG11 HD13 ' A' ' 82' ' ' LEU . 2.6 p -111.14 130.52 22.91 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 40.5 Cg_endo -60.57 159.41 28.06 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 124.063 1.559 . . . . 0.0 111.468 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.762 HG11 HG11 ' A' ' 48' ' ' VAL . 96.3 t -77.36 -3.88 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -84.57 -37.75 20.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 0.0 108.692 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.9 t -70.3 -38.12 74.92 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.76 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.723 ' HE1' HG23 ' A' ' 153' ' ' ILE . 19.4 mtt -49.91 -38.83 37.76 Favored 'General case' 0 N--CA 1.516 2.866 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -52.94 -38.73 62.26 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.497 0.665 . . . . 0.0 109.854 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.2 m -51.82 -38.07 54.29 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.405 0.621 . . . . 0.0 109.767 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.09 -42.37 80.6 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.65 -0.656 . . . . 0.0 110.02 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.471 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -56.19 -49.69 73.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.458 -0.776 . . . . 0.0 110.585 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -37.35 61.72 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.93 0.871 . . . . 0.0 109.804 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -78.54 -39.65 37.26 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.919 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.218 0 O-C-N 121.35 -0.844 . . . . 0.0 110.647 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 7.7 p . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -161.65 78.58 0.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.124 0.964 . . . . 0.0 110.618 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 45.46 -93.66 0.01 OUTLIER Glycine 0 N--CA 1.496 2.685 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.363 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -90.42 -29.8 17.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.73 -0.865 . . . . 0.0 112.729 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 34' ' ' GLN . 47.3 t -125.97 162.38 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 120.942 -1.099 . . . . 0.0 112.554 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.447 ' N ' HG12 ' A' ' 33' ' ' VAL . 6.4 tt0 -153.46 135.67 14.87 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.568 HG12 ' HB2' ' A' ' 109' ' ' ARG . 11.2 m -91.89 177.7 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 120.932 -1.105 . . . . 0.0 112.53 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.614 HG21 ' CD2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -135.97 172.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.55 -179.139 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -160.7 138.36 9.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.453 -0.779 . . . . 0.0 111.008 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 40' ' ' THR . 6.2 t -153.42 179.55 8.68 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -71.01 72.72 0.59 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.815 -1.154 . . . . 0.0 108.772 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 39' ' ' ALA . 23.3 m -175.24 -61.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -177.24 -168.16 0.19 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.839 -0.538 . . . . 0.0 109.867 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.5 p -125.05 128.01 47.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.658 -0.651 . . . . 0.0 109.251 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.614 ' CD2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -108.12 -177.43 3.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.143 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.843 HD12 ' N ' ' A' ' 109' ' ' ARG . 6.1 tt -107.9 149.94 27.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.343 -0.848 . . . . 0.0 109.687 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.614 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -139.77 136.01 33.66 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.217 -0.927 . . . . 0.0 109.391 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.746 HG21 ' CG2' ' A' ' 153' ' ' ILE . 4.6 t -107.29 116.7 32.39 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.3 -0.875 . . . . 0.0 112.522 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.43 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 84.3 m -72.11 83.0 0.99 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.319 -0.863 . . . . 0.0 110.175 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.464 HG11 ' CG1' ' A' ' 172' ' ' VAL . 60.5 t -107.28 139.5 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.0 t30 57.44 19.96 5.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.575 -0.703 . . . . 0.0 109.811 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.76 54.68 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 85' ' ' TRP . 57.0 t -144.52 109.67 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.424 -1.045 . . . . 0.0 110.089 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 46' ' ' THR . 15.0 p -61.4 97.03 0.06 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.702 -0.624 . . . . 0.0 110.136 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.914 ' CE3' HD23 ' A' ' 82' ' ' LEU . 98.4 m95 -76.43 150.29 36.76 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.089 -1.007 . . . . 0.0 110.302 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.606 ' O ' HG22 ' A' ' 83' ' ' VAL . 7.9 t -164.03 -178.59 5.7 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.972 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 55' ' ' VAL . 12.0 m -97.25 139.16 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.562 -0.712 . . . . 0.0 110.076 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.547 ' HB3' HG11 ' A' ' 78' ' ' VAL . 31.9 t80 -76.33 0.05 20.82 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.306 -0.871 . . . . 0.0 111.313 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -49.2 -33.33 12.19 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.415 -0.803 . . . . 0.0 110.871 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.81 -14.0 1.93 Allowed Glycine 0 N--CA 1.496 2.667 0 C-N-CA 119.754 -1.213 . . . . 0.0 111.875 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 43' ' ' PHE . . . -52.32 -34.38 46.75 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.787 -1.42 . . . . 0.0 110.983 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.84 168.81 4.41 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.6 t -96.94 -19.65 18.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.521 -0.987 . . . . 0.0 110.19 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -57.33 179.0 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.56 0.695 . . . . 0.0 110.768 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.47 103.91 2.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.678 -0.639 . . . . 0.0 110.094 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.722 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -53.43 160.98 1.07 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.694 -0.629 . . . . 0.0 110.192 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.1 133.09 50.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.804 . . . . 0.0 110.602 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.87 -177.5 14.9 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -59.05 96.17 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 O-C-N 123.77 1.405 . . . . 0.0 110.279 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.63 37.86 29.13 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.367 -0.833 . . . . 0.0 110.443 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.97 136.5 2.44 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.035 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.58 153.22 78.77 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 124.081 1.569 . . . . 0.0 109.685 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.722 HD12 ' CD2' ' A' ' 64' ' ' LEU . 65.7 mt -100.45 116.76 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.336 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -59.92 126.79 28.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.565 -0.709 . . . . 0.0 111.034 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -79.76 105.24 10.91 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 tpt -101.56 -32.17 10.5 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.23 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.45 ' CZ ' ' HG3' ' A' ' 179' ' ' MET . 14.2 m-85 -130.15 115.63 17.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.696 -0.628 . . . . 0.0 110.084 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.83 HG23 ' CG1' ' A' ' 83' ' ' VAL . 18.4 m -161.06 107.5 1.43 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.146 -0.971 . . . . 0.0 112.839 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.45 ' CB ' ' HB3' ' A' ' 81' ' ' ASP . 5.0 m-80 -163.84 78.17 0.4 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.694 . . . . 0.0 109.917 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 56' ' ' TYR . 34.9 m -51.39 -21.92 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.731 -1.231 . . . . 0.0 111.852 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.85 78.69 0.63 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.052 -1.03 . . . . 0.0 108.721 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 60.32 46.57 9.94 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.644 -0.66 . . . . 0.0 110.753 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -156.33 -33.21 0.09 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.217 -0.927 . . . . 0.0 111.859 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.914 HD23 ' CE3' ' A' ' 53' ' ' TRP . 5.7 tp 72.75 165.62 0.3 Allowed 'General case' 0 N--CA 1.526 3.343 0 CA-C-N 120.217 1.371 . . . . 0.0 111.075 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.83 ' CG1' HG23 ' A' ' 76' ' ' THR . 1.4 m -122.21 147.79 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.94 110.04 0.42 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.527 ' CH2' HG21 ' A' ' 54' ' ' THR . 1.2 m-90 -86.6 169.62 12.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -81.98 138.45 34.92 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.482 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -107.0 82.52 1.12 Allowed Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.401 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.566 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 48.0 Cg_endo -98.81 -6.8 0.63 Allowed 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.575 1.303 . . . . 0.0 112.977 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 40.4 Cg_endo -73.24 63.23 4.32 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 115.592 -2.472 . . . . 0.0 111.269 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.96 52.91 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.43 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -72.19 129.48 38.57 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.247 -1.149 . . . . 0.0 111.206 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -68.46 136.15 52.79 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.223 -0.991 . . . . 0.0 108.619 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -103.21 115.43 30.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.49 -0.757 . . . . 0.0 110.292 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mp -85.92 -164.1 0.98 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.495 0.664 . . . . 0.0 110.513 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.64 173.83 4.13 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.778 -0.576 . . . . 0.0 110.343 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.415 ' HB2' HG23 ' A' ' 98' ' ' THR . 50.4 Cg_endo -72.91 166.16 30.8 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 O-C-N 123.657 1.346 . . . . 0.0 110.551 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.452 ' HB2' HG23 ' A' ' 151' ' ' VAL . 6.8 t -84.68 -49.99 8.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.727 -0.608 . . . . 0.0 109.656 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.415 HG23 ' HB2' ' A' ' 96' ' ' PRO . 61.8 p 45.06 37.33 2.45 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.813 -0.554 . . . . 0.0 111.041 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.6 p -122.78 -162.03 0.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.492 -0.755 . . . . 0.0 110.172 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.27 74.55 0.37 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m -150.72 165.11 34.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.719 -0.871 . . . . 0.0 110.184 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.8 t -112.31 -154.89 0.55 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.52 -0.737 . . . . 0.0 110.588 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 57.86 99.35 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.207 -0.933 . . . . 0.0 110.508 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.774 HD13 HD23 ' A' ' 143' ' ' LEU . 2.3 mt -116.11 -176.27 2.91 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.301 -0.874 . . . . 0.0 109.963 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.458 ' O ' HG23 ' A' ' 107' ' ' VAL . 28.7 m-85 -131.53 85.06 2.22 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 154' ' ' PHE . 19.2 tp -61.13 89.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.457 -0.777 . . . . 0.0 109.039 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.609 HG13 HG12 ' A' ' 113' ' ' VAL . 21.8 t -75.41 101.37 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.186 -1.006 . . . . 0.0 109.638 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.889 HG22 ' O ' ' A' ' 112' ' ' ASP . 7.4 t -75.73 179.7 5.27 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.843 ' N ' HD12 ' A' ' 44' ' ' LEU . 16.4 ptt85 -95.3 17.07 15.11 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.12 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.54 ' H ' HG23 ' A' ' 108' ' ' THR . 0.8 OUTLIER -103.36 21.17 16.43 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 59.12 56.36 3.95 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.363 -0.836 . . . . 0.0 109.816 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.889 ' O ' HG22 ' A' ' 108' ' ' THR . 11.6 t70 -166.86 121.88 1.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.688 -0.632 . . . . 0.0 109.881 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.609 HG12 HG13 ' A' ' 107' ' ' VAL . 8.4 m -104.1 145.36 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.993 -1.067 . . . . 0.0 109.608 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.443 HD11 HD23 ' A' ' 106' ' ' LEU . 44.0 pt -125.98 138.6 32.41 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.077 -1.015 . . . . 0.0 110.091 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.591 ' HB2' HD12 ' A' ' 127' ' ' LEU . 54.5 Cg_endo -66.18 141.47 63.31 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 O-C-N 123.796 1.419 . . . . 0.0 112.201 -177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 58.4 t -132.59 138.47 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.679 -0.638 . . . . 0.0 109.65 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.58 117.71 35.26 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 -48.96 129.5 17.4 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.488 -0.757 . . . . 0.0 110.702 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.428 ' CG ' ' HB2' ' A' ' 125' ' ' SER . 5.5 mmm180 -109.8 -27.26 9.39 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.736 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.19 -150.05 7.43 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -77.16 127.58 32.88 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.734 -0.862 . . . . 0.0 108.822 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.38 45.39 28.6 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.127 0.489 . . . . 0.0 111.217 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.485 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -160.89 151.59 18.33 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.332 -0.855 . . . . 0.0 110.754 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.0 -177.05 17.64 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.0 OUTLIER -129.46 120.65 25.81 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.803 -0.822 . . . . 0.0 112.041 -178.588 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.404 HD22 ' HB2' ' A' ' 130' ' ' ARG . 0.2 OUTLIER -58.48 141.25 52.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.436 -0.79 . . . . 0.0 109.001 178.194 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' ' 115' ' ' PRO . 20.7 mt -108.44 52.99 0.7 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.3 p 166.19 136.79 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.2 113.96 2.84 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.802 1.422 . . . . 0.0 109.81 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.404 ' HB2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -121.66 147.32 47.76 Favored Pre-proline 0 N--CA 1.49 1.531 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.68 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 43.3 Cg_endo -68.15 125.11 12.54 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 124.14 1.6 . . . . 0.0 110.055 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.45 HG21 ' SG ' ' A' ' 159' ' ' CYS . 10.8 p -58.86 -36.84 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.624 0.726 . . . . 0.0 109.684 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.1 m -49.13 -35.63 16.97 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 122.031 0.919 . . . . 0.0 110.936 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.738 ' OH ' HG21 ' A' ' 108' ' ' THR . 43.4 t80 -70.07 -36.93 75.31 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.567 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.9 mt -63.58 -37.2 86.41 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -57.83 122.93 14.09 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.576 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.45 -31.64 8.48 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.9 m -79.96 0.19 32.54 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.487 -1.008 . . . . 0.0 111.152 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.402 ' CB ' HG21 ' A' ' 55' ' ' VAL . 78.8 p -48.42 134.04 15.55 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.225 -0.922 . . . . 0.0 110.714 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.593 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 110.74 -20.59 24.48 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 107.376 -2.29 . . . . 0.0 107.376 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.76 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -47.09 113.66 1.31 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.41 122.62 9.64 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 124.05 1.552 . . . . 0.0 111.726 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.774 HD23 HD13 ' A' ' 104' ' ' LEU . 6.4 mp -79.11 114.08 17.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.618 HD23 ' HA ' ' A' ' 150' ' ' ALA . 1.8 mt -110.15 121.85 46.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 111.492 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.488 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 29.5 p -60.81 178.32 0.27 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.93 -0.481 . . . . 0.0 109.932 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 55.1 Cg_endo -83.63 51.01 3.37 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.514 1.271 . . . . 0.0 111.227 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.84 43.75 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.182 -0.949 . . . . 0.0 110.456 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 61.14 -167.01 12.53 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 56.48 106.02 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.567 -0.96 . . . . 0.0 110.671 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.618 ' HA ' HD23 ' A' ' 144' ' ' LEU . . . -57.44 153.63 12.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.192 -0.943 . . . . 0.0 109.982 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -105.07 -30.72 2.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.707 ' CA ' HG23 ' A' ' 172' ' ' VAL . . . 173.55 -177.15 46.03 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.769 HD11 HD11 ' A' ' 82' ' ' LEU . 1.2 pt -121.59 164.22 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 CA-C-N 119.24 1.52 . . . . 0.0 111.541 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.837 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.5 t80 -75.41 99.83 4.28 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.447 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -37.9 15.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -161.35 176.63 10.95 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.837 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -135.37 120.75 19.14 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.371 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.857 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 4.1 t -68.61 103.62 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.45 ' SG ' HG21 ' A' ' 132' ' ' VAL . 30.0 p -124.02 162.92 22.46 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.733 1.254 . . . . 0.0 114.06 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 161' ' ' ARG . 1.3 m -103.67 -172.56 2.13 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.469 ' H ' HG22 ' A' ' 160' ' ' THR . 7.1 ttt180 -46.38 90.07 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.677 0 O-C-N 121.396 -0.815 . . . . 0.0 111.623 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 72.25 -18.2 1.27 Allowed Glycine 0 N--CA 1.499 2.889 0 O-C-N 121.245 -0.91 . . . . 0.0 112.984 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.12 127.87 60.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 119.484 1.642 . . . . 0.0 109.527 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.567 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -89.66 137.82 32.0 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.052 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -117.94 -43.74 2.75 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.461 -0.775 . . . . 0.0 110.77 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.857 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -119.4 171.84 8.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.411 -0.806 . . . . 0.0 109.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.8 t -118.24 145.83 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.543 0.687 . . . . 0.0 110.865 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.668 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.5 OUTLIER -109.94 100.28 9.27 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 177.165 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.666 ' CG ' HD22 ' A' ' 143' ' ' LEU . 0.4 OUTLIER -131.89 142.97 49.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.803 -1.159 . . . . 0.0 113.194 -175.357 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.578 HG11 HD13 ' A' ' 82' ' ' LEU . 2.9 p -94.09 133.45 27.46 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 49.4 Cg_endo -61.17 160.74 25.34 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.812 1.427 . . . . 0.0 110.859 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.707 HG23 ' CA ' ' A' ' 152' ' ' GLY . 40.1 t -82.41 1.56 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.294 -0.879 . . . . 0.0 109.602 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -93.08 -39.38 11.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.046 -1.034 . . . . 0.0 110.228 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.9 t -75.33 -40.05 58.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.72 -0.613 . . . . 0.0 110.305 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.951 ' O ' HG22 ' A' ' 178' ' ' THR . 4.0 ptp -55.75 -36.32 67.16 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.315 -0.866 . . . . 0.0 110.349 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -37.95 65.41 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.219 -0.926 . . . . 0.0 109.862 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.4 m -48.92 -38.96 24.35 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.951 HG22 ' O ' ' A' ' 175' ' ' MET . 7.6 t -49.91 -38.73 37.28 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 120.752 -1.217 . . . . 0.0 112.267 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.486 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -57.69 -35.14 70.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.814 -1.179 . . . . 0.0 111.462 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -47.41 -37.28 11.13 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.272 -0.892 . . . . 0.0 110.634 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.85 -45.55 10.2 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.103 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.504 2.247 0 O-C-N 121.096 -1.002 . . . . 0.0 111.176 179.515 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.613 HG11 ' HB2' ' A' ' 89' ' ' PRO . 33.9 m . . . . . 0 N--CA 1.501 2.099 0 CA-C-O 120.641 0.258 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 62.69 80.06 0.24 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.984 -1.072 . . . . 0.0 109.364 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.58 164.61 29.73 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.489 ' CD ' HD11 ' A' ' 94' ' ' LEU . 8.6 mt-10 -90.9 -28.1 18.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.669 -0.901 . . . . 0.0 110.94 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.404 HG11 HD11 ' A' ' 44' ' ' LEU . 39.4 t -115.5 143.86 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.476 -0.765 . . . . 0.0 111.248 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.457 ' C ' HG13 ' A' ' 35' ' ' VAL . 2.7 tt0 -137.13 175.74 9.34 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 44' ' ' LEU . 34.3 m -148.56 177.96 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.23 -0.919 . . . . 0.0 111.173 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.471 HG11 HD11 ' A' ' 64' ' ' LEU . 10.6 m -130.75 -179.4 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 p -136.88 133.75 36.11 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.48 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.3 p -128.46 -176.42 3.82 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.94 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.201 -0.937 . . . . 0.0 110.959 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.0 p 49.1 39.95 16.3 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.842 -0.536 . . . . 0.0 111.005 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -155.03 137.87 15.36 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.661 -0.649 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.9 t -130.71 135.03 47.42 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.464 -0.773 . . . . 0.0 109.098 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -100.9 178.29 4.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.261 -0.899 . . . . 0.0 110.824 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.691 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -113.13 149.39 33.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.427 -0.796 . . . . 0.0 109.729 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.431 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -158.07 152.52 24.63 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.55 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.617 HG23 HG23 ' A' ' 48' ' ' VAL . 11.8 t -125.55 127.19 46.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.327 -0.858 . . . . 0.0 111.155 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.4 m -78.27 80.89 4.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.333 -0.854 . . . . 0.0 110.325 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.617 HG23 HG23 ' A' ' 46' ' ' THR . 95.3 t -100.04 139.17 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.75 20.31 6.35 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.327 -0.858 . . . . 0.0 108.945 -177.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 23.13 60.07 Favored Glycine 0 N--CA 1.491 2.332 0 O-C-N 121.392 -0.817 . . . . 0.0 111.361 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -136.88 105.12 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 118.79 1.295 . . . . 0.0 110.557 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.5 t -58.4 101.44 0.08 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.68 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.615 ' CZ3' HG21 ' A' ' 178' ' ' THR . 52.8 m95 -82.19 144.98 30.33 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.479 -0.763 . . . . 0.0 112.177 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.906 HG21 ' CH2' ' A' ' 85' ' ' TRP . 3.4 t -165.23 128.66 2.28 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 81' ' ' ASP . 13.4 m -49.61 153.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 O-C-N 121.26 -0.9 . . . . 0.0 111.349 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.465 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 57.1 t80 -76.4 1.31 16.72 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.159 -0.963 . . . . 0.0 111.643 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -49.24 -25.12 2.1 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.129 -0.982 . . . . 0.0 110.883 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.95 73.1 0.06 OUTLIER Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.749 ' O ' HD12 ' A' ' 64' ' ' LEU . . . -156.01 -54.45 0.09 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.592 -0.946 . . . . 0.0 110.264 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.68 -1.6 90.24 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 p -74.16 144.88 44.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.191 -1.182 . . . . 0.0 110.242 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.0 tttm 55.04 -171.6 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.477 -0.765 . . . . 0.0 110.65 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m -86.92 101.95 13.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.611 -0.68 . . . . 0.0 110.287 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.749 HD12 ' O ' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -55.46 156.13 4.79 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.625 -0.672 . . . . 0.0 110.646 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.21 141.4 47.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.673 -0.642 . . . . 0.0 110.465 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.97 -178.44 15.41 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -56.14 95.76 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.766 1.403 . . . . 0.0 110.59 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.9 tttt 56.66 33.44 22.83 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.535 -0.728 . . . . 0.0 110.503 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.35 137.33 3.42 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.98 162.21 42.62 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 O-C-N 123.836 1.44 . . . . 0.0 109.769 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.627 ' HB ' HD22 ' A' ' 64' ' ' LEU . 73.6 mt -118.9 93.54 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.375 -0.828 . . . . 0.0 110.098 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 m -110.02 141.19 43.17 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.222 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -146.87 -144.92 0.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.794 -0.566 . . . . 0.0 109.799 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.8 ttp -145.65 22.82 1.45 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.985 -1.072 . . . . 0.0 111.179 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.473 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 11.3 m-30 -115.85 101.85 9.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.328 -0.857 . . . . 0.0 110.139 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.609 HG23 ' CG1' ' A' ' 83' ' ' VAL . 3.0 m -150.88 121.33 7.37 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -142.83 78.09 1.6 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.344 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.441 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.7 p -52.76 -29.36 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.352 -0.842 . . . . 0.0 110.03 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.03 -50.65 69.85 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -86.59 5.98 33.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.772 -0.58 . . . . 0.0 109.786 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.54 ' O ' HG12 ' A' ' 55' ' ' VAL . 58.3 m-20 56.72 54.17 7.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.254 -0.904 . . . . 0.0 112.601 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.93 HD13 HG11 ' A' ' 170' ' ' VAL . 1.2 tp -160.87 138.02 9.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.922 -1.112 . . . . 0.0 112.559 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.609 ' CG1' HG23 ' A' ' 76' ' ' THR . 21.9 t -143.67 139.26 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -145.09 123.61 1.96 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 118.14 -1.981 . . . . 0.0 112.585 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.906 ' CH2' HG21 ' A' ' 54' ' ' THR . 1.2 m-90 -99.75 137.51 38.12 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -58.45 131.3 50.31 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.69 0.757 . . . . 0.0 111.757 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.508 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -104.65 93.28 5.86 Favored Pre-proline 0 C--N 1.296 -1.753 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.09 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.2 Cg_endo -99.89 -14.95 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.863 1.454 . . . . 0.0 112.473 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.613 ' HB2' HG11 ' A' ' 29' ' ' VAL . 47.9 Cg_endo -69.42 78.7 0.88 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 116.235 -2.043 . . . . 0.0 111.062 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 50.09 26.47 8.96 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.508 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -79.08 138.46 37.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.618 -0.931 . . . . 0.0 110.229 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -68.93 145.58 53.52 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.412 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -111.67 92.62 4.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.611 -0.681 . . . . 0.0 109.513 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.489 HD11 ' CD ' ' A' ' 32' ' ' GLU . 0.6 OUTLIER -71.14 -161.37 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.593 -0.692 . . . . 0.0 109.621 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -152.96 -176.28 0.57 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.718 -0.614 . . . . 0.0 109.959 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 95' ' ' THR . 41.1 Cg_endo -85.61 158.12 10.64 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 O-C-N 123.814 1.429 . . . . 0.0 109.944 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.83 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 0.1 OUTLIER -109.81 86.71 2.35 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.509 -0.745 . . . . 0.0 110.709 -179.381 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.1 p -91.85 79.59 5.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.41 -0.806 . . . . 0.0 109.549 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 31.1 p -138.2 -151.51 0.39 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.64 -128.98 3.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m 54.67 -164.16 0.11 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.252 -1.146 . . . . 0.0 110.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.9 m -160.19 -35.3 0.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.355 -0.84 . . . . 0.0 111.779 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 3.5 p30 -60.68 134.31 56.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.21 -0.931 . . . . 0.0 110.787 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.756 HD13 HD23 ' A' ' 143' ' ' LEU . 1.3 mt -128.08 -166.87 1.68 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.03 -1.043 . . . . 0.0 109.884 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.484 ' O ' HG23 ' A' ' 107' ' ' VAL . 72.7 m-85 -144.74 85.59 1.77 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.709 HD23 HD11 ' A' ' 114' ' ' ILE . 38.0 tp -65.84 109.66 2.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.315 -0.866 . . . . 0.0 109.279 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 105' ' ' TYR . 38.1 t -100.69 128.27 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 111.582 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.527 HG21 ' CE1' ' A' ' 134' ' ' TYR . 33.2 p -94.55 166.49 12.01 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.691 ' CB ' HD21 ' A' ' 44' ' ' LEU . 27.2 tpt85 -79.97 -7.52 58.84 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.199 -0.938 . . . . 0.0 110.724 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.39 41.53 1.3 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.979 -1.075 . . . . 0.0 110.037 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 50.63 63.52 2.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.558 -0.714 . . . . 0.0 111.329 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.36 82.61 1.42 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.643 -0.66 . . . . 0.0 110.021 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.43 HG23 HG22 ' A' ' 107' ' ' VAL . 9.7 p -92.94 149.96 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.493 -0.754 . . . . 0.0 110.93 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.709 HD11 HD23 ' A' ' 106' ' ' LEU . 40.6 pt -145.16 144.72 24.41 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.226 -0.921 . . . . 0.0 110.018 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.52 ' HB2' HD12 ' A' ' 127' ' ' LEU . 52.5 Cg_endo -78.07 135.41 13.82 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.805 1.424 . . . . 0.0 110.909 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 103' ' ' ASP . 46.4 t -122.01 146.28 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.552 -0.718 . . . . 0.0 109.38 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.17 115.05 29.72 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.01 129.21 17.27 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.505 -0.747 . . . . 0.0 111.047 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -114.73 -25.85 8.09 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.51 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -171.03 61.22 0.17 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.825 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.456 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.4 OUTLIER 60.13 -75.17 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.663 -0.904 . . . . 0.0 111.66 179.051 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 120' ' ' GLY . 9.4 p -91.97 39.82 1.03 Allowed 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.283 0.563 . . . . 0.0 111.579 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.05 151.22 2.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.423 ' HA3' HG12 ' A' ' 116' ' ' VAL . . . -143.25 -177.2 18.0 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -125.04 118.39 26.08 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.917 -178.328 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.587 HD21 HD12 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -55.35 141.78 34.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.591 -0.693 . . . . 0.0 110.112 179.104 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.52 HD12 ' HB2' ' A' ' 115' ' ' PRO . 49.2 mt -109.75 53.94 0.68 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 168.08 128.82 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.05 112.45 2.05 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.775 1.408 . . . . 0.0 110.022 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -125.72 143.81 46.26 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.254 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.49 128.46 23.64 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.987 1.52 . . . . 0.0 110.907 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.695 HG21 ' SG ' ' A' ' 159' ' ' CYS . 7.4 p -60.28 -36.73 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.482 0.658 . . . . 0.0 109.499 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.8 m -48.44 -36.53 15.08 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.372 -0.83 . . . . 0.0 110.979 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.527 ' CE1' HG21 ' A' ' 108' ' ' THR . 0.1 OUTLIER -65.87 -38.58 89.19 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.8 mt -63.91 -35.49 80.82 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.08 121.7 10.63 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.584 -0.847 . . . . 0.0 109.788 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.34 -30.83 9.42 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.429 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 8.9 m -80.83 2.23 27.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.533 -0.981 . . . . 0.0 111.263 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 p -52.96 122.84 10.1 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.133 -0.979 . . . . 0.0 110.618 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 115.37 -9.71 19.98 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -59.86 152.35 35.9 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -93.82 129.64 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.697 1.367 . . . . 0.0 112.784 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.756 HD23 HD13 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -88.05 123.35 32.65 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 176.141 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.61 123.87 42.17 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.673 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.83 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 31.3 p -58.54 -170.95 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 48.6 Cg_endo -81.13 57.51 6.54 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 117.699 -1.068 . . . . 0.0 111.149 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.2 p -175.7 -158.13 0.06 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 149' ' ' HIS . . . -83.32 -160.18 29.12 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 148' ' ' GLY . 0.6 OUTLIER 57.73 133.17 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 117.789 0.795 . . . . 0.0 112.034 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.639 ' HB3' HG21 ' A' ' 172' ' ' VAL . . . -80.85 137.5 36.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.101 -0.999 . . . . 0.0 109.811 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.668 HG12 ' CE2' ' A' ' 169' ' ' PHE . 0.9 OUTLIER -81.83 -38.51 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.497 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.628 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 177.16 -178.29 48.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.773 HD11 ' CD1' ' A' ' 82' ' ' LEU . 1.7 pp -118.76 150.8 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 118.67 1.235 . . . . 0.0 111.346 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.745 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.9 t80 -60.63 112.33 1.96 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.39 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -46.75 5.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -149.32 172.99 14.0 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.745 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -128.73 115.6 18.23 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.555 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.796 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.4 t -67.67 94.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.695 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.2 p -123.87 148.68 46.59 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.876 0.846 . . . . 0.0 113.279 -175.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.585 HG22 ' H ' ' A' ' 161' ' ' ARG . 2.3 m -88.59 -173.49 4.17 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.585 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -46.56 85.99 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.99 0.9 . . . . 0.0 112.829 -178.531 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.613 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 80.42 -26.1 3.12 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.994 -1.066 . . . . 0.0 112.321 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.35 129.91 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.088 1.444 . . . . 0.0 109.271 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.442 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -91.98 126.69 37.16 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.961 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -109.0 -35.87 6.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.483 -0.761 . . . . 0.0 110.638 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.796 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -134.3 176.36 8.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.816 . . . . 0.0 109.921 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.01 153.11 26.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-O 121.663 0.745 . . . . 0.0 110.85 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.73 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 3.2 t70 -120.53 93.93 4.2 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.668 ' CE2' HG12 ' A' ' 151' ' ' VAL . 3.5 p90 -124.85 156.38 37.94 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.954 -1.098 . . . . 0.0 113.099 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.93 HG11 HD13 ' A' ' 82' ' ' LEU . 4.7 p -100.15 130.62 25.69 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 39.2 Cg_endo -62.06 159.59 33.67 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.778 1.41 . . . . 0.0 110.97 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.639 HG21 ' HB3' ' A' ' 150' ' ' ALA . 92.6 t -78.37 0.32 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.458 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -87.48 -37.65 16.77 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.838 0.828 . . . . 0.0 108.789 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 t -70.31 -37.21 74.71 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.28 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.603 ' HE1' HG23 ' A' ' 153' ' ' ILE . 14.9 mtt -49.12 -38.3 24.57 Favored 'General case' 0 N--CA 1.516 2.844 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -53.15 -38.34 62.63 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.29 -0.881 . . . . 0.0 108.968 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 m -55.47 -35.14 65.19 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.525 0.678 . . . . 0.0 109.452 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.615 HG21 ' CZ3' ' A' ' 53' ' ' TRP . 31.0 m -48.02 -61.02 2.18 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.859 -0.526 . . . . 0.0 110.535 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.473 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -55.04 -38.13 67.57 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.628 -0.67 . . . . 0.0 110.763 179.526 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -48.94 -37.04 18.82 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.982 0.896 . . . . 0.0 110.337 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.03 36.76 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.239 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.503 2.177 0 O-C-N 121.218 -0.926 . . . . 0.0 110.649 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 89' ' ' PRO . 25.4 m . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 121.382 0.611 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.84 79.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.91 53.82 4.7 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -164.47 -82.1 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.516 -0.99 . . . . 0.0 109.764 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.664 HG22 ' CD ' ' A' ' 142' ' ' PRO . 72.2 t -129.5 147.38 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.322 -0.861 . . . . 0.0 110.726 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -134.56 178.85 6.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.68 -0.637 . . . . 0.0 110.033 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 43' ' ' PHE . 2.6 p -159.89 144.64 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.861 0.839 . . . . 0.0 110.01 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.58 ' CG1' HD21 ' A' ' 64' ' ' LEU . 12.8 m -116.74 -178.96 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.1 m -146.37 137.54 24.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.38 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.9 p -136.65 -178.88 5.37 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.53 74.27 0.77 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.68 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.583 HG22 ' HG2' ' A' ' 41' ' ' GLN . 1.1 m 174.55 -63.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.583 ' HG2' HG22 ' A' ' 40' ' ' THR . 1.6 pt20 -173.15 -173.64 0.95 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.507 -0.746 . . . . 0.0 110.564 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.5 p -107.61 146.34 32.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.713 -0.617 . . . . 0.0 110.302 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.823 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . 93.1 m-85 -105.85 -177.48 3.37 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.316 -0.865 . . . . 0.0 111.855 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.718 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -114.19 146.88 39.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.616 -0.678 . . . . 0.0 110.382 -178.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.442 ' HB1' ' SG ' ' A' ' 52' ' ' CYS . . . -152.33 166.73 30.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.58 -0.7 . . . . 0.0 110.685 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 46' ' ' THR . 8.8 t -141.93 115.34 8.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.722 . . . . 0.0 111.685 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 81.8 m -66.88 85.5 0.12 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.361 -0.837 . . . . 0.0 110.247 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.591 HG11 ' HB ' ' A' ' 172' ' ' VAL . 53.3 t -104.35 139.75 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 55.39 20.2 3.49 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.485 -0.76 . . . . 0.0 110.331 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.442 ' C ' HG23 ' A' ' 51' ' ' VAL . . . 83.13 26.63 43.61 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 50' ' ' GLY . 91.2 t -146.9 106.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.448 -1.031 . . . . 0.0 109.865 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.442 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -61.8 119.98 9.81 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.484 -0.76 . . . . 0.0 109.259 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.994 ' CE3' HD23 ' A' ' 82' ' ' LEU . 95.7 m95 -99.75 153.62 18.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.44 -0.788 . . . . 0.0 111.807 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.833 HG23 HG23 ' A' ' 83' ' ' VAL . 6.9 t -162.89 -176.53 4.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.492 ' HB ' ' CD2' ' A' ' 57' ' ' HIS . 15.5 m -104.96 139.13 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.615 ' HB2' HG11 ' A' ' 83' ' ' VAL . 13.1 t80 -65.99 -7.14 15.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.182 -0.948 . . . . 0.0 113.022 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.492 ' CD2' ' HB ' ' A' ' 55' ' ' VAL . 32.3 p80 -95.84 36.36 1.3 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.024 -1.048 . . . . 0.0 110.161 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.506 ' CA ' ' CE1' ' A' ' 43' ' ' PHE . . . -173.93 -81.41 0.05 OUTLIER Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.823 ' HB2' ' CB ' ' A' ' 43' ' ' PHE . . . -88.43 116.48 26.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.585 -0.95 . . . . 0.0 109.13 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.93 -60.22 0.49 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.8 t -55.16 170.69 0.19 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.232 -1.158 . . . . 0.0 110.597 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 58.91 168.74 0.06 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.479 -0.763 . . . . 0.0 110.053 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.652 ' O ' HG23 ' A' ' 63' ' ' THR . 9.0 t -78.03 101.06 6.75 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.699 0.762 . . . . 0.0 110.759 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.768 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -61.91 168.49 3.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.362 -0.836 . . . . 0.0 109.496 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.69 130.16 50.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.46 -0.775 . . . . 0.0 110.739 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.88 179.86 19.29 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.12 -26.83 65.17 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.982 1.517 . . . . 0.0 110.994 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -143.48 27.49 1.54 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.386 -0.821 . . . . 0.0 111.082 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.23 154.85 8.03 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -64.23 168.64 12.18 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.957 1.504 . . . . 0.0 110.186 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.768 HD12 ' CD2' ' A' ' 64' ' ' LEU . 16.5 mt -127.25 98.27 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 O-C-N 121.392 -0.817 . . . . 0.0 110.371 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 72' ' ' THR . 21.0 m -161.86 51.52 0.22 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.264 -0.898 . . . . 0.0 111.064 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -168.18 66.66 0.07 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.047 -1.033 . . . . 0.0 111.473 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.413 ' HG2' ' HG3' ' A' ' 86' ' ' GLN . 0.5 OUTLIER -143.03 -72.82 0.3 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.225 -0.922 . . . . 0.0 109.799 179.084 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.482 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 22.5 m-85 -137.77 119.83 15.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.564 -0.71 . . . . 0.0 109.479 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.582 ' CG2' HG12 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -151.87 112.58 4.19 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.375 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.518 HD22 ' HB1' ' A' ' 181' ' ' ALA . 41.4 t-20 -147.29 75.63 1.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.637 0.732 . . . . 0.0 110.018 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.526 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.3 p -44.99 168.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.497 -0.752 . . . . 0.0 112.166 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.471 ' N ' HG22 ' A' ' 78' ' ' VAL . 6.9 m-20 57.51 114.48 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.679 0.752 . . . . 0.0 111.336 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 66.33 -66.73 0.17 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.593 -0.692 . . . . 0.0 111.999 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' A' ' 77' ' ' ASN . 21.1 m-20 -63.99 -114.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 111.689 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.994 HD23 ' CE3' ' A' ' 53' ' ' TRP . 4.5 tp 176.94 174.09 0.42 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.182 -1.574 . . . . 0.0 111.286 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.833 HG23 HG23 ' A' ' 54' ' ' THR . 27.5 m -135.54 133.78 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.6 131.63 2.69 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.302 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.521 ' HH2' ' HB1' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -95.42 161.2 14.18 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.413 ' HG3' ' HG2' ' A' ' 74' ' ' MET . 13.8 mt-30 -79.52 135.27 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.812 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.55 93.38 4.93 Favored Pre-proline 0 C--N 1.298 -1.672 0 O-C-N 122.003 -0.436 . . . . 0.0 110.404 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.527 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 52.1 Cg_endo -92.44 -12.82 1.65 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 123.779 1.41 . . . . 0.0 113.782 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.703 ' O ' HG12 ' A' ' 29' ' ' VAL . 43.0 Cg_endo -68.83 80.51 0.64 Allowed 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 115.931 -2.246 . . . . 0.0 111.738 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 49.49 24.6 5.6 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -53.63 133.32 41.59 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.315 -1.109 . . . . 0.0 110.133 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -94.87 -5.28 45.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.632 -0.668 . . . . 0.0 112.056 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 t 59.68 129.42 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 121.708 0.766 . . . . 0.0 110.813 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.973 HD21 HD21 ' A' ' 144' ' ' LEU . 12.7 tp -95.54 14.92 21.24 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.302 -0.874 . . . . 0.0 111.05 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 63.4 p 44.35 -169.26 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.853 -0.53 . . . . 0.0 112.176 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -112.86 -164.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 O-C-N 123.439 1.231 . . . . 0.0 111.179 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 1.268 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 43.4 t -110.66 -50.37 2.96 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.446 -0.784 . . . . 0.0 110.083 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.492 HG22 ' C ' ' A' ' 97' ' ' CYS . 9.6 t 38.45 30.46 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 1.268 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 28.0 p -116.32 -177.73 3.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 109.642 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.27 -18.93 27.28 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.6 t -51.18 138.99 19.32 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.221 -1.164 . . . . 0.0 111.363 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.3 m -109.78 -11.11 14.75 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.436 -0.79 . . . . 0.0 111.403 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 4.0 t70 -61.28 112.77 2.28 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.875 -1.141 . . . . 0.0 109.072 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.839 HD13 HD23 ' A' ' 143' ' ' LEU . 33.9 mt -112.31 170.29 8.27 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.558 0.694 . . . . 0.0 111.427 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.413 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.7 m-85 -148.23 89.45 1.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 154' ' ' PHE . 20.3 tp -59.56 111.46 1.42 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.487 -0.758 . . . . 0.0 109.123 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 113' ' ' VAL . 97.8 t -92.99 97.1 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.551 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.434 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 80.6 p -65.59 152.38 44.25 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.718 ' CB ' HD21 ' A' ' 44' ' ' LEU . 1.6 tpm_? -74.25 -2.0 23.05 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.17 -0.956 . . . . 0.0 111.037 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.441 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -103.62 34.76 2.84 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.027 -1.046 . . . . 0.0 109.252 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.71 75.35 0.3 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.446 -0.783 . . . . 0.0 110.746 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.3 102.96 0.96 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.887 -0.508 . . . . 0.0 110.406 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 107' ' ' VAL . 2.5 t -98.38 139.05 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.604 HD11 HD23 ' A' ' 106' ' ' LEU . 42.7 pt -129.55 131.4 23.56 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.473 ' HB2' HD12 ' A' ' 127' ' ' LEU . 47.0 Cg_endo -67.01 137.19 43.67 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 O-C-N 123.581 1.306 . . . . 0.0 112.436 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 62.1 t -127.14 148.25 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.586 ' HG2' HD11 ' A' ' 127' ' ' LEU . 17.2 mmt180 -113.72 120.91 42.45 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -48.7 128.27 15.05 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.676 -0.64 . . . . 0.0 110.429 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.444 ' HG3' ' HB2' ' A' ' 125' ' ' SER . 8.0 mmm180 -109.02 -29.08 8.74 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.8 -0.562 . . . . 0.0 110.221 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.39 -159.45 22.96 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.36 127.81 33.72 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.701 -0.882 . . . . 0.0 109.373 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.444 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 0.0 OUTLIER 49.94 55.95 8.64 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 121.221 0.534 . . . . 0.0 111.492 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -172.84 149.75 2.0 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.438 -0.789 . . . . 0.0 111.061 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.95 -178.24 17.85 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.4 OUTLIER -136.27 104.7 5.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.729 -178.561 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.58 HD21 ' C ' ' A' ' 164' ' ' ALA . 3.2 pp -49.37 151.32 1.54 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.817 -0.552 . . . . 0.0 110.319 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.586 HD11 ' HG2' ' A' ' 117' ' ' ARG . 36.8 mt -110.91 54.2 0.68 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.53 106.51 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -55.71 106.76 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 O-C-N 123.396 1.208 . . . . 0.0 110.283 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -109.76 175.61 1.87 Allowed Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.781 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.421 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 51.5 Cg_endo -79.9 124.99 5.8 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 124.139 1.599 . . . . 0.0 109.294 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.818 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.2 p -62.39 -35.41 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.558 -0.714 . . . . 0.0 109.4 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.75 -36.77 17.16 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 122.111 0.958 . . . . 0.0 110.27 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.421 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 21.9 t80 -66.34 -38.73 88.31 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 17.9 mt -64.88 -35.84 82.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.37 119.2 4.86 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.704 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.5 -32.98 6.37 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.6 m -78.72 -4.68 50.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.625 -0.926 . . . . 0.0 111.454 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 2.4 m -50.39 125.28 12.31 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.003 -1.061 . . . . 0.0 111.045 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 113.83 -15.69 21.37 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.543 ' HA2' HD12 ' A' ' 44' ' ' LEU . . . -58.69 135.09 52.21 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.664 ' CD ' HG22 ' A' ' 33' ' ' VAL . 51.6 Cg_endo -79.75 131.18 9.06 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.8 1.421 . . . . 0.0 113.011 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.839 HD23 HD13 ' A' ' 104' ' ' LEU . 5.1 mp -79.11 138.13 37.8 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.973 HD21 HD21 ' A' ' 94' ' ' LEU . 0.9 OUTLIER -129.81 128.06 41.58 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.003 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 1.076 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 1.1 p -58.58 -109.25 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.104 0 CA-C-O 117.337 -1.316 . . . . 0.0 110.907 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 145' ' ' CYS . 47.2 Cg_endo -68.99 -84.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 114.35 -3.3 . . . . 0.0 110.307 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.9 m -153.79 99.86 2.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.797 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.1 -61.34 0.65 Allowed Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -58.9 124.41 19.76 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.699 -0.883 . . . . 0.0 111.24 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -78.27 140.88 38.84 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.581 HG11 HD21 ' A' ' 104' ' ' LEU . 2.5 t -108.62 -37.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.522 -0.736 . . . . 0.0 109.54 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.747 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 174.19 -177.91 46.23 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.467 HD11 HD11 ' A' ' 82' ' ' LEU . 3.2 pt -112.76 156.07 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 120.96 -1.318 . . . . 0.0 111.428 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.843 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 9.8 t80 -73.58 84.5 1.56 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.219 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -66.05 -52.25 50.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.584 -0.698 . . . . 0.0 109.901 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -150.13 178.81 8.62 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.843 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -131.01 115.91 17.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.136 -0.978 . . . . 0.0 110.313 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.814 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 4.2 t -63.46 101.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.679 ' SG ' HG21 ' A' ' 132' ' ' VAL . 26.3 p -129.57 139.53 51.46 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.6 OUTLIER -73.83 -173.79 1.63 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 176.143 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.57 84.16 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.333 -0.854 . . . . 0.0 112.801 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.818 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 87.42 -28.27 5.86 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 120.809 -1.182 . . . . 0.0 111.447 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.0 OUTLIER -92.49 133.92 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.86 -1.377 . . . . 0.0 110.022 -179.245 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.58 ' C ' HD21 ' A' ' 126' ' ' LEU . . . -92.8 129.2 38.79 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.221 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.53 ' HA ' HD11 ' A' ' 126' ' ' LEU . 3.2 mtpt -114.09 -21.5 10.5 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.474 -0.766 . . . . 0.0 111.318 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.814 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -151.27 -178.47 6.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.878 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.23 144.29 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 111.59 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -109.98 101.28 10.11 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.429 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.661 ' CG ' HD22 ' A' ' 143' ' ' LEU . 0.6 OUTLIER -130.63 148.15 52.39 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.33 -0.948 . . . . 0.0 113.019 -175.427 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.491 HG11 HD11 ' A' ' 82' ' ' LEU . 3.0 p -103.17 132.98 20.59 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 54.7 Cg_endo -60.38 153.66 58.56 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.796 1.419 . . . . 0.0 111.357 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.747 HG13 ' HA2' ' A' ' 152' ' ' GLY . 35.9 m -80.3 0.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.452 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -89.9 -38.93 13.36 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.311 -0.868 . . . . 0.0 108.776 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 88.3 p -61.12 -36.37 79.54 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.565 ' HG2' HD22 ' A' ' 82' ' ' LEU . 19.7 mtt -48.13 -38.18 17.25 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-O 121.519 0.676 . . . . 0.0 109.649 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -56.11 -38.09 70.29 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -67.5 -39.73 85.18 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.738 0.78 . . . . 0.0 109.031 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.432 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 0.7 OUTLIER -52.31 -41.5 63.01 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.807 -0.558 . . . . 0.0 110.543 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.482 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -49.56 -41.6 42.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.206 -0.934 . . . . 0.0 111.167 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -38.71 72.99 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.133 0.968 . . . . 0.0 109.322 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.518 ' HB1' HD22 ' A' ' 77' ' ' ASN . . . -67.87 -38.37 82.98 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.512 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.333 -0.854 . . . . 0.0 111.142 179.664 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.259 0.552 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 62.37 78.58 0.29 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.063 -1.023 . . . . 0.0 108.859 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.95 -95.81 0.11 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.785 ' HG3' HG23 ' A' ' 33' ' ' VAL . 5.2 pt-20 -173.12 -36.01 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.275 -1.133 . . . . 0.0 111.629 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.785 HG23 ' HG3' ' A' ' 32' ' ' GLU . 97.0 t -113.52 155.34 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.187 -0.946 . . . . 0.0 110.92 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.575 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 18.7 tp60 -141.16 148.78 40.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.592 -0.693 . . . . 0.0 110.231 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' A' ' 109' ' ' ARG . 31.4 m -106.78 -179.3 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.42 -0.8 . . . . 0.0 112.034 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.784 HG21 ' CE2' ' A' ' 43' ' ' PHE . 27.6 m -139.1 -178.33 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.5 p -156.2 136.62 13.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.582 -0.699 . . . . 0.0 110.054 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.638 HG23 ' OG1' ' A' ' 40' ' ' THR . 8.0 t -152.83 -178.7 7.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.672 ' O ' HG23 ' A' ' 40' ' ' THR . . . -68.41 76.85 0.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.349 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER 174.03 -58.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 175.4 -176.41 0.1 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.269 -0.894 . . . . 0.0 109.948 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.8 t -112.49 127.87 56.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 109.358 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.784 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -107.37 -176.26 3.02 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.144 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 45' ' ' ALA . 6.6 tt -103.85 154.47 19.57 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.668 -0.645 . . . . 0.0 109.738 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.801 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -150.77 129.13 12.05 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.261 -0.899 . . . . 0.0 109.689 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.636 HG23 HG23 ' A' ' 48' ' ' VAL . 12.6 t -97.58 124.74 41.95 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.241 -0.912 . . . . 0.0 112.004 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.71 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 41.3 t -75.22 90.71 2.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.65 -0.656 . . . . 0.0 109.793 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.636 HG23 HG23 ' A' ' 46' ' ' THR . 65.1 t -104.14 133.43 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.4 t30 57.34 20.61 6.01 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.471 -0.768 . . . . 0.0 110.032 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.97 25.08 38.85 Favored Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.225 -0.922 . . . . 0.0 110.887 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.674 HG22 ' HG2' ' A' ' 86' ' ' GLN . 94.3 t -139.44 106.69 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.54 -0.977 . . . . 0.0 110.06 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.4 ' O ' ' HA2' ' A' ' 84' ' ' GLY . 5.4 m -62.51 114.67 3.67 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.262 -0.899 . . . . 0.0 108.854 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.911 ' CE3' HD23 ' A' ' 82' ' ' LEU . 98.8 m95 -96.8 146.89 24.49 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.409 -0.807 . . . . 0.0 112.682 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.808 HG21 ' CH2' ' A' ' 85' ' ' TRP . 4.5 t -164.31 141.71 6.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 155' ' ' ARG . 12.8 m -57.71 148.12 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.029 -1.045 . . . . 0.0 109.812 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 47.3 t80 -72.99 -1.07 15.64 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.008 -1.057 . . . . 0.0 111.715 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -49.8 -28.1 5.87 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.209 -0.932 . . . . 0.0 110.397 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.31 -46.83 0.16 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' CE1' ' A' ' 56' ' ' TYR . . . -49.49 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.404 -1.057 . . . . 0.0 110.831 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.66 175.36 22.25 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.2 p -93.57 -7.51 43.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.702 -0.881 . . . . 0.0 110.783 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -59.53 -167.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.152 -0.967 . . . . 0.0 110.856 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.3 m -83.97 101.77 11.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.742 -0.598 . . . . 0.0 109.705 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.711 HD22 HD12 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -57.72 173.51 0.29 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.579 -0.701 . . . . 0.0 110.139 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.94 132.75 53.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.524 -0.735 . . . . 0.0 110.876 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.03 -179.46 37.2 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.15 -18.39 64.76 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.767 1.404 . . . . 0.0 110.797 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -159.86 31.47 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 110.235 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.01 161.43 12.35 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.53 159.37 36.71 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.957 1.504 . . . . 0.0 110.403 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.711 HD12 HD22 ' A' ' 64' ' ' LEU . 96.1 mt -91.54 153.96 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 110.351 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.5 p -89.45 167.29 13.12 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.497 -0.752 . . . . 0.0 110.698 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 53.0 -179.21 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.381 -0.824 . . . . 0.0 110.359 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.6 ttp -176.37 51.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.332 -0.855 . . . . 0.0 109.902 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.482 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.2 m-85 -55.9 131.7 47.77 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.267 -0.896 . . . . 0.0 109.108 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.582 HG23 ' CG1' ' A' ' 83' ' ' VAL . 3.7 m -156.91 118.13 3.72 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.458 -0.897 . . . . 0.0 112.323 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 49.3 m-20 -145.64 76.66 1.48 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.829 0.823 . . . . 0.0 109.076 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.9 p -48.67 152.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.485 0.66 . . . . 0.0 111.372 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 t70 61.61 127.01 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.887 0.851 . . . . 0.0 112.446 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 46.56 24.48 0.32 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 3.2 m-20 -156.2 -126.71 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -0.987 . . . . 0.0 109.777 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.911 HD23 ' CE3' ' A' ' 53' ' ' TRP . 1.7 tp -178.65 174.98 1.13 Allowed 'General case' 0 N--CA 1.511 2.615 0 CA-C-N 121.089 1.768 . . . . 0.0 112.739 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.582 ' CG1' HG23 ' A' ' 76' ' ' THR . 13.6 t -134.03 138.55 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 52' ' ' CYS . . . -158.25 117.57 0.78 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 118.738 -1.696 . . . . 0.0 110.596 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.808 ' CH2' HG21 ' A' ' 54' ' ' THR . 0.1 OUTLIER -95.42 135.81 36.58 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.674 ' HG2' HG22 ' A' ' 51' ' ' VAL . 29.9 mt-30 -57.55 133.89 55.65 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.835 0.826 . . . . 0.0 111.482 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -112.85 98.29 44.56 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.135 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.58 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 46.6 Cg_endo -113.95 8.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.781 1.411 . . . . 0.0 113.264 178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 55.2 Cg_endo -68.46 -106.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 115.832 -2.312 . . . . 0.0 108.083 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.91 39.46 2.85 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 105.535 -3.026 . . . . 0.0 105.535 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.71 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -81.85 140.4 34.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.582 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -92.6 100.42 12.95 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.8 t -55.41 104.04 0.11 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.366 -0.834 . . . . 0.0 110.832 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.66 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -78.77 -156.03 0.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.687 -0.633 . . . . 0.0 109.603 179.795 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -159.96 -171.03 0.26 Allowed Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.489 -0.757 . . . . 0.0 110.612 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 95' ' ' THR . 44.9 Cg_endo -92.97 170.72 2.25 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 O-C-N 123.567 1.299 . . . . 0.0 111.137 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 18.2 t -90.4 148.76 22.6 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.526 -0.734 . . . . 0.0 109.742 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 t -146.33 43.64 1.21 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 1.304 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 26.3 p -125.74 174.1 8.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.677 -0.64 . . . . 0.0 110.618 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -113.57 33.95 5.26 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 p -108.2 -179.35 3.86 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.534 -0.98 . . . . 0.0 110.403 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.5 p -136.26 19.71 3.18 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.585 -0.697 . . . . 0.0 110.809 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 73.8 m-20 -81.65 90.52 6.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.369 -0.832 . . . . 0.0 109.564 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.768 HD13 HD23 ' A' ' 143' ' ' LEU . 88.5 mt -97.09 156.63 16.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -0.825 . . . . 0.0 111.402 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.56 ' O ' HG23 ' A' ' 107' ' ' VAL . 84.4 m-85 -132.12 84.49 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.959 -0.463 . . . . 0.0 109.797 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 106' ' ' LEU . 14.4 tp -55.36 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.328 -0.857 . . . . 0.0 109.539 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 113' ' ' VAL . 58.4 t -80.29 119.57 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.008 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.649 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 37.9 p -82.15 -179.88 7.56 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.763 ' N ' HD12 ' A' ' 44' ' ' LEU . 51.9 ptt85 -99.96 51.41 0.91 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.026 -1.046 . . . . 0.0 110.447 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.649 ' CE1' ' HB ' ' A' ' 108' ' ' THR . 7.1 p-80 -175.17 44.06 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.532 0.682 . . . . 0.0 110.024 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.62 67.2 1.04 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.524 -0.735 . . . . 0.0 111.005 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.99 83.65 0.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.619 -0.676 . . . . 0.0 110.08 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 107' ' ' VAL . 53.9 t -77.91 154.44 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.573 -0.705 . . . . 0.0 109.534 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.8 mt -136.79 107.88 9.08 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -53.4 141.51 61.07 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 O-C-N 123.63 1.332 . . . . 0.0 112.695 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.533 ' CG1' HG21 ' A' ' 167' ' ' VAL . 21.7 t -133.97 150.23 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -111.81 118.56 35.9 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -47.88 127.85 12.55 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.374 -0.829 . . . . 0.0 110.207 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 125' ' ' SER . 1.3 mmp_? -107.79 -36.85 6.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.598 -0.689 . . . . 0.0 111.603 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.95 64.03 0.06 OUTLIER Glycine 0 N--CA 1.497 2.738 0 C-N-CA 118.892 -1.623 . . . . 0.0 110.604 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.81 140.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.89 0.852 . . . . 0.0 110.242 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.404 ' CA ' ' O ' ' A' ' 169' ' ' PHE . 69.1 p 44.12 28.56 0.28 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.792 -0.567 . . . . 0.0 112.278 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.502 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 8.4 ttm180 -165.36 151.5 9.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.274 -0.891 . . . . 0.0 110.457 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.16 -177.99 22.12 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 119' ' ' ARG . 0.5 OUTLIER -121.43 127.63 51.33 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.696 -178.451 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.56 132.14 43.4 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.3 mt -103.09 53.55 0.77 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.2 t 175.47 133.5 0.16 Allowed Pre-proline 0 N--CA 1.5 2.044 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.829 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -62.64 104.94 0.39 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 O-C-N 123.721 1.38 . . . . 0.0 108.813 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.61 128.24 25.49 Favored Pre-proline 0 N--CA 1.488 1.458 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.632 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 43.6 Cg_endo -60.76 131.18 36.29 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.982 1.517 . . . . 0.0 110.129 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.599 HG21 ' SG ' ' A' ' 159' ' ' CYS . 11.7 p -57.63 -36.84 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.728 -0.608 . . . . 0.0 110.266 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.8 t -49.09 -36.59 19.04 Favored 'General case' 0 N--CA 1.507 2.393 0 CA-C-O 122.064 0.935 . . . . 0.0 110.728 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 34.7 t80 -69.09 -38.21 78.84 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.56 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.7 mt -65.5 -35.37 80.68 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.153 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -57.14 -21.03 29.57 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.001 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -97.87 30.2 9.79 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 99.0 p -150.89 23.39 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.516 -0.99 . . . . 0.0 110.734 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -59.36 126.94 29.69 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.256 -0.902 . . . . 0.0 108.691 179.227 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.659 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 108.43 -13.38 36.26 Favored Glycine 0 CA--C 1.541 1.663 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -176.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.654 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -46.34 109.06 0.31 Allowed Glycine 0 N--CA 1.503 3.166 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.81 125.67 12.39 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.997 1.525 . . . . 0.0 111.753 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.768 HD23 HD13 ' A' ' 104' ' ' LEU . 6.3 mp -82.52 116.28 21.88 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.519 HD22 ' O ' ' A' ' 147' ' ' SER . 1.1 mt -114.36 119.01 35.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.108 -0.995 . . . . 0.0 111.194 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 1.304 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER -60.4 -20.68 0.65 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.839 -0.538 . . . . 0.0 110.507 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 145' ' ' CYS . 40.7 Cg_endo -137.44 -77.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.322 -0.833 0 O-C-N 123.535 1.282 . . . . 0.0 110.326 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.519 ' O ' HD22 ' A' ' 144' ' ' LEU . 9.1 p -164.18 -54.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.406 -0.809 . . . . 0.0 110.0 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.68 -51.39 3.45 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -66.98 117.37 8.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.599 -0.942 . . . . 0.0 110.297 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.602 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -88.99 150.58 22.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 110.075 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 97' ' ' CYS . 0.9 OUTLIER -107.3 -31.77 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.603 -0.685 . . . . 0.0 109.913 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.831 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 177.28 -179.67 47.97 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.822 HD11 HD11 ' A' ' 82' ' ' LEU . 1.1 pt -117.2 162.71 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.317 -1.107 . . . . 0.0 110.858 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.786 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 6.5 t80 -79.91 98.58 7.19 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.585 0.707 . . . . 0.0 110.9 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.582 ' HA ' HG11 ' A' ' 55' ' ' VAL . 2.6 ttt-85 -82.69 -42.91 17.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -160.69 -179.68 7.82 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.786 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -134.42 120.96 20.46 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.569 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.781 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.3 t -65.82 102.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.599 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.2 p -129.18 142.88 50.74 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -175.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 161' ' ' ARG . 1.9 m -75.74 -174.25 2.5 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.513 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -47.85 86.07 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.734 0.778 . . . . 0.0 112.884 -178.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 82.53 -25.25 4.54 Favored Glycine 0 N--CA 1.499 2.896 0 O-C-N 120.879 -1.138 . . . . 0.0 112.186 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -95.48 133.54 36.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 119.217 1.508 . . . . 0.0 109.345 -179.48 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.56 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -100.35 132.82 45.51 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.1 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -117.71 -37.27 3.48 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.571 -0.706 . . . . 0.0 110.775 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.781 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -122.27 -179.36 4.15 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.202 -0.936 . . . . 0.0 109.994 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.533 HG21 ' CG1' ' A' ' 116' ' ' VAL . 1.3 t -125.6 145.85 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.46 -0.775 . . . . 0.0 111.878 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -109.3 101.46 10.46 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 177.052 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.541 ' CD2' HD22 ' A' ' 143' ' ' LEU . 0.2 OUTLIER -132.56 154.42 50.02 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.891 -175.857 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.608 HG21 HD13 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -108.12 144.46 29.46 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.4 Cg_endo -64.39 148.59 90.84 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.916 1.482 . . . . 0.0 110.675 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.831 HG13 ' HA2' ' A' ' 152' ' ' GLY . 18.1 m -82.21 2.95 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.068 -1.02 . . . . 0.0 110.618 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -83.55 -38.15 22.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.0 t -74.02 -40.18 63.08 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.69 -0.631 . . . . 0.0 110.872 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.854 ' O ' HG22 ' A' ' 178' ' ' THR . 12.4 ptp -51.07 -36.18 38.66 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.307 -0.871 . . . . 0.0 110.012 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.422 ' N ' ' HG3' ' A' ' 175' ' ' MET . 19.0 tt0 -58.1 -36.33 72.72 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.194 -0.941 . . . . 0.0 108.847 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.7 m -70.6 -36.07 73.32 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.418 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.854 HG22 ' O ' ' A' ' 175' ' ' MET . 2.8 t -48.44 -37.52 17.42 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.095 -1.003 . . . . 0.0 112.699 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.452 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 2.3 ptp -63.22 -39.65 95.22 Favored 'General case' 0 N--CA 1.513 2.678 0 O-C-N 120.418 -1.426 . . . . 0.0 110.253 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -38.25 41.0 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.769 0.795 . . . . 0.0 110.512 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -79.81 -44.65 20.19 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.47 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.506 2.343 0 O-C-N 121.6 -0.688 . . . . 0.0 111.678 179.51 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -171.95 80.72 0.06 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.395 -0.815 . . . . 0.0 110.417 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.11 -68.15 0.1 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -172.63 -46.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.947 . . . . 0.0 110.091 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.84 HG11 ' C ' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -158.78 -163.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 122.318 1.056 . . . . 0.0 112.337 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.442 ' H ' HG12 ' A' ' 33' ' ' VAL . 1.7 tt0 -148.99 171.89 15.62 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.89 HG12 HD22 ' A' ' 44' ' ' LEU . 34.0 m -108.96 169.56 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.722 -0.611 . . . . 0.0 109.969 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.93 -179.16 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.41 ' C ' HG23 ' A' ' 38' ' ' THR . 1.3 m -149.79 138.92 21.21 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.655 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 37' ' ' SER . 70.0 p -146.72 -179.76 7.01 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.81 75.45 0.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.651 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m 175.84 -61.22 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.74 -171.04 0.29 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.468 -0.77 . . . . 0.0 109.655 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.7 p -110.74 142.25 42.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.34 -0.85 . . . . 0.0 110.146 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.447 ' CE2' ' HA3' ' A' ' 58' ' ' GLY . 80.2 m-85 -105.53 -178.39 3.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.473 -0.767 . . . . 0.0 111.201 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.89 HD22 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -118.49 141.27 48.73 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.547 -0.721 . . . . 0.0 111.173 -178.147 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.84 ' C ' HG11 ' A' ' 33' ' ' VAL . . . -121.93 -177.71 3.65 Favored 'General case' 0 N--CA 1.507 2.417 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.525 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 1.05 HG21 HG21 ' A' ' 153' ' ' ILE . 4.6 t -154.94 109.19 2.94 Favored 'General case' 0 N--CA 1.51 2.537 0 O-C-N 121.102 -0.999 . . . . 0.0 112.449 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.464 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 42.9 t -69.49 85.89 0.44 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.319 -0.863 . . . . 0.0 110.18 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.4 t -108.57 128.17 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.6 t30 64.4 12.74 7.55 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.396 -0.815 . . . . 0.0 110.558 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.07 14.55 48.39 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.161 -0.962 . . . . 0.0 111.88 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 85' ' ' TRP . 63.3 t -137.46 109.54 6.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.212 -1.169 . . . . 0.0 109.428 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 12.8 m -58.6 99.71 0.05 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.806 -0.559 . . . . 0.0 110.148 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.648 ' HZ3' HG21 ' A' ' 178' ' ' THR . 97.7 m95 -80.47 144.87 32.22 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.197 -0.939 . . . . 0.0 110.588 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.847 HG21 ' CH2' ' A' ' 85' ' ' TRP . 7.2 t -162.64 131.89 4.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.795 -0.565 . . . . 0.0 110.204 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 81' ' ' ASP . 9.8 m -48.69 154.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.646 0 O-C-N 121.349 -0.844 . . . . 0.0 111.384 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.464 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 2.6 t80 -99.97 -12.61 19.62 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.096 -1.003 . . . . 0.0 111.933 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -57.82 -20.37 35.46 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.936 -1.103 . . . . 0.0 110.05 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.447 ' HA3' ' CE2' ' A' ' 43' ' ' PHE . . . -128.46 -137.2 4.33 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 52.26 -172.18 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.243 -1.151 . . . . 0.0 110.811 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.89 122.32 5.98 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 89.8 p -79.9 -13.26 59.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.639 -0.919 . . . . 0.0 111.022 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -148.09 -58.96 0.25 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.234 -0.916 . . . . 0.0 110.439 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -96.61 95.29 7.86 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.113 0.482 . . . . 0.0 111.192 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.892 HD22 HD12 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -101.45 172.99 6.64 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.499 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.465 ' H ' HD23 ' A' ' 64' ' ' LEU . . . -116.79 129.67 56.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.287 -0.883 . . . . 0.0 110.85 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.72 -178.24 15.52 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -53.39 93.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 O-C-N 123.776 1.409 . . . . 0.0 111.128 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.6 tttp 52.65 42.36 31.56 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.475 -0.766 . . . . 0.0 110.947 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.98 131.93 1.5 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -60.65 156.44 42.5 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 O-C-N 123.779 1.41 . . . . 0.0 110.931 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.892 HD12 HD22 ' A' ' 64' ' ' LEU . 64.7 mt -102.12 127.06 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.565 -0.71 . . . . 0.0 110.106 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 m -119.49 -61.37 1.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.429 -0.794 . . . . 0.0 109.721 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 54.43 -159.02 0.18 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.348 -0.845 . . . . 0.0 111.015 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.8 ttm -149.49 22.97 0.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.147 -0.971 . . . . 0.0 111.139 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.499 ' O ' HG13 ' A' ' 83' ' ' VAL . 16.7 m-30 -115.25 103.67 11.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.461 -0.774 . . . . 0.0 109.216 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.599 HG23 ' CG2' ' A' ' 83' ' ' VAL . 2.3 m -152.7 133.89 14.25 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.735 -0.603 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.63 78.01 1.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.639 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 p -48.46 -28.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.49 -0.756 . . . . 0.0 110.387 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -51.2 60.26 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -83.93 2.52 38.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.998 -0.439 . . . . 0.0 109.969 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.554 ' O ' HD12 ' A' ' 82' ' ' LEU . 68.4 m-20 57.09 52.15 9.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.879 . . . . 0.0 111.228 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.576 HD13 HG11 ' A' ' 170' ' ' VAL . 1.4 tp -158.0 143.75 17.1 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.424 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.599 ' CG2' HG23 ' A' ' 76' ' ' THR . 22.0 t -145.4 119.38 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.42 ' CA ' HG12 ' A' ' 51' ' ' VAL . . . -99.79 97.1 1.73 Allowed Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.514 -1.327 . . . . 0.0 112.213 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.847 ' CH2' HG21 ' A' ' 54' ' ' THR . 24.1 m0 -76.8 172.92 12.33 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.52 134.46 38.34 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.907 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.55 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -109.79 87.67 5.83 Favored Pre-proline 0 C--N 1.295 -1.771 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.803 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.558 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -100.24 -8.59 0.36 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.844 1.444 . . . . 0.0 113.401 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 46.5 Cg_endo -73.16 65.11 4.3 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 115.982 -2.212 . . . . 0.0 110.689 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.46 24.94 18.88 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.55 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -66.13 136.18 55.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.692 -0.887 . . . . 0.0 110.962 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -75.85 129.25 36.7 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 p -98.65 103.94 15.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.544 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.479 ' O ' HG23 ' A' ' 95' ' ' THR . 19.9 mt -65.33 -156.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.635 -0.666 . . . . 0.0 109.562 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -154.3 175.41 3.08 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.575 -0.703 . . . . 0.0 110.538 -179.181 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.421 ' HA ' HG23 ' A' ' 172' ' ' VAL . 44.6 Cg_endo -74.98 151.53 39.74 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 O-C-N 123.815 1.429 . . . . 0.0 110.604 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.652 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 1.6 t -106.3 85.99 2.28 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.424 -0.798 . . . . 0.0 110.211 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -66.62 -32.46 73.81 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.044 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.652 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 11.9 p -60.53 111.88 1.76 Allowed 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.268 0.556 . . . . 0.0 110.459 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.99 80.03 1.4 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.7 m -122.76 139.92 53.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.587 -0.949 . . . . 0.0 109.955 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -76.2 -165.86 0.54 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.545 -0.722 . . . . 0.0 110.437 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 t70 57.93 102.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.501 -0.75 . . . . 0.0 110.008 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.798 HD13 HD23 ' A' ' 143' ' ' LEU . 3.7 mt -116.01 -167.53 1.28 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.565 -0.709 . . . . 0.0 110.004 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -140.26 92.21 2.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.814 -0.554 . . . . 0.0 109.576 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 154' ' ' PHE . 58.0 tp -77.53 95.17 4.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.1 t -89.93 111.6 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.377 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.443 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 20.7 p -69.42 178.83 2.26 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.798 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.72 29.51 5.29 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.766 -1.209 . . . . 0.0 110.348 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -133.4 34.46 3.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.451 -0.78 . . . . 0.0 109.214 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.48 68.35 0.84 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.838 -0.539 . . . . 0.0 111.257 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -167.57 90.8 0.34 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.781 -0.575 . . . . 0.0 109.678 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 113' ' ' VAL . 10.5 p -77.52 152.62 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.491 -0.756 . . . . 0.0 110.686 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.468 HD11 ' CE2' ' A' ' 134' ' ' TYR . 22.5 mt -131.58 111.5 15.01 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -62.35 133.4 43.06 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 O-C-N 123.604 1.318 . . . . 0.0 111.239 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 20.0 t -124.05 151.1 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.624 -0.672 . . . . 0.0 109.362 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.464 ' HB2' HD11 ' A' ' 127' ' ' LEU . 11.5 tpt180 -111.85 114.81 27.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -48.67 124.54 8.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.575 -0.703 . . . . 0.0 111.022 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -109.53 -48.9 3.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.791 -0.568 . . . . 0.0 110.096 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.23 -169.71 16.06 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.5 135.45 54.23 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 169' ' ' PHE . 10.4 p 53.52 43.31 31.42 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.439 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.497 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 2.2 ttp180 -167.43 151.15 6.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.417 -0.802 . . . . 0.0 110.889 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.9 -178.83 19.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -122.23 120.41 34.06 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 122.019 -0.695 . . . . 0.0 111.688 -178.288 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.419 HD21 HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -63.72 132.93 52.54 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.721 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 117' ' ' ARG . 12.4 mt -106.13 54.37 0.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.074 0.94 . . . . 0.0 108.502 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.9 t 176.1 116.46 0.13 Allowed Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -57.72 100.24 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.502 1.264 . . . . 0.0 109.467 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 -118.32 147.07 40.93 Favored Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.29 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.414 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 46.3 Cg_endo -65.9 127.42 17.74 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 124.018 1.536 . . . . 0.0 109.838 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.859 HG12 ' O ' ' A' ' 162' ' ' GLY . 6.7 p -55.29 -36.14 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.78 -0.575 . . . . 0.0 110.4 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -48.35 -36.37 14.33 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.28 -0.888 . . . . 0.0 110.789 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.468 ' CE2' HD11 ' A' ' 114' ' ' ILE . 9.1 t80 -65.39 -38.5 90.19 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.474 HD11 ' CB ' ' A' ' 164' ' ' ALA . 11.8 mt -66.62 -35.93 81.37 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.87 120.59 9.31 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.56 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.11 -33.39 6.17 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.9 m -82.06 3.1 28.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.642 -0.917 . . . . 0.0 111.208 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 28.4 p -57.67 127.47 32.2 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.136 -0.978 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.12 -8.83 29.16 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.491 ' O ' HG22 ' A' ' 153' ' ' ILE . . . -56.71 -177.28 0.36 Allowed Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -112.99 121.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.103 0 O-C-N 123.494 1.26 . . . . 0.0 113.276 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.798 HD23 HD13 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -86.53 110.39 19.75 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 175.704 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 150' ' ' ALA . 1.2 mt -113.26 123.94 51.34 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.117 -0.989 . . . . 0.0 111.651 -177.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.599 ' HB3' HG21 ' A' ' 151' ' ' VAL . 16.4 p -78.13 177.97 2.46 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.2 Cg_endo -62.0 173.98 2.76 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 O-C-N 123.516 1.272 . . . . 0.0 110.326 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 59.23 24.77 13.25 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.396 -0.815 . . . . 0.0 110.5 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 68.1 -144.38 42.92 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.6 m170 58.03 111.15 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.85 -0.794 . . . . 0.0 111.333 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.517 ' HA ' HD23 ' A' ' 144' ' ' LEU . . . -61.92 142.24 57.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.545 -0.722 . . . . 0.0 109.305 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.599 HG21 ' HB3' ' A' ' 145' ' ' CYS . 1.0 OUTLIER -100.58 -41.07 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.665 -0.647 . . . . 0.0 109.723 -179.385 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.751 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . -179.62 -177.58 47.93 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 1.05 HG21 HG21 ' A' ' 46' ' ' THR . 1.2 pt -117.23 157.12 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.14 -1.212 . . . . 0.0 111.329 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.731 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 7.7 t80 -69.26 109.4 4.09 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.314 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -44.73 6.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.383 -0.823 . . . . 0.0 109.717 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -149.42 170.59 18.21 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.731 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -128.23 117.15 21.0 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.887 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.831 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 4.1 t -67.73 99.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.482 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.5 p -127.21 143.65 51.21 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 162' ' ' GLY . 2.2 p -77.37 -173.51 2.91 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -48.21 85.21 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 121.667 0.746 . . . . 0.0 112.912 -178.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.859 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 84.01 -28.48 4.1 Favored Glycine 0 N--CA 1.5 2.94 0 O-C-N 120.803 -1.186 . . . . 0.0 112.038 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.5 t -94.62 137.93 21.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 119.264 1.532 . . . . 0.0 109.086 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.474 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -101.26 127.36 47.89 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.016 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -109.72 -42.27 4.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.706 -0.621 . . . . 0.0 110.688 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.831 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -121.2 176.54 5.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.16 -0.962 . . . . 0.0 110.221 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.76 154.26 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-O 121.786 0.803 . . . . 0.0 111.095 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.713 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -118.76 102.16 8.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 177.137 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.524 ' HB2' HD13 ' A' ' 143' ' ' LEU . 1.1 p90 -132.87 150.4 52.16 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.823 -1.151 . . . . 0.0 112.435 -175.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.576 HG11 HD13 ' A' ' 82' ' ' LEU . 3.2 p -101.25 133.56 20.86 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 47.2 Cg_endo -60.88 158.42 33.63 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.91 1.479 . . . . 0.0 111.469 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.751 HG13 ' HA2' ' A' ' 152' ' ' GLY . 31.3 m -82.55 3.43 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.381 -0.824 . . . . 0.0 110.688 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.41 ' HG2' ' HB3' ' A' ' 96' ' ' PRO . 24.6 mt-10 -90.54 -37.78 13.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 108.731 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.9 t -63.85 -36.45 83.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.935 -0.478 . . . . 0.0 110.05 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.943 ' O ' HG22 ' A' ' 178' ' ' THR . 0.5 OUTLIER -48.75 -39.55 25.38 Favored 'General case' 0 N--CA 1.518 2.954 0 CA-C-O 121.643 0.735 . . . . 0.0 109.375 -179.428 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -53.14 -38.06 62.37 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.882 0.848 . . . . 0.0 109.711 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 m -54.22 -39.0 66.31 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.606 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.943 HG22 ' O ' ' A' ' 175' ' ' MET . 9.6 t -59.0 -35.94 74.09 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.093 -1.004 . . . . 0.0 111.644 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.44 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -53.14 -39.63 63.66 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.707 -1.246 . . . . 0.0 110.716 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -38.46 83.43 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.076 0.941 . . . . 0.0 109.179 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -71.47 -39.14 71.11 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.737 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 94.4 p . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.525 -0.734 . . . . 0.0 110.357 -179.834 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.565 HG21 ' HG3' ' A' ' 89' ' ' PRO . 27.0 m . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 57.05 78.82 0.21 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.31 -0.869 . . . . 0.0 109.652 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -161.27 -121.46 0.58 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.558 ' OE1' HD11 ' A' ' 94' ' ' LEU . 24.7 mt-10 -150.98 -39.74 0.12 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.668 -0.901 . . . . 0.0 110.681 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 44' ' ' LEU . 97.7 t -111.58 156.28 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.45 -0.781 . . . . 0.0 110.49 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.67 174.0 10.98 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 43' ' ' PHE . 5.2 p -161.93 150.48 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.353 -0.842 . . . . 0.0 110.487 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.666 HG13 ' CZ ' ' A' ' 43' ' ' PHE . 0.9 OUTLIER -131.6 175.08 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.171 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.426 ' N ' HG23 ' A' ' 36' ' ' VAL . 5.2 p -127.61 143.55 51.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.613 -0.679 . . . . 0.0 110.337 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 40' ' ' THR . 7.6 t -142.58 -179.7 6.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.634 -0.666 . . . . 0.0 109.349 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.65 76.8 0.29 Allowed 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.106 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.1 m 174.72 -61.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 174.71 -165.44 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.0 p -108.58 143.49 37.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.409 -0.807 . . . . 0.0 109.369 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.806 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.9 p90 -115.01 -177.42 3.12 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.379 -0.826 . . . . 0.0 111.637 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.687 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -101.69 147.11 26.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.0 110.919 -178.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.451 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -149.24 152.97 36.87 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.791 -0.568 . . . . 0.0 109.996 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.615 HG23 HG23 ' A' ' 48' ' ' VAL . 14.2 t -134.47 117.47 16.29 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.273 1.035 . . . . 0.0 111.966 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.475 ' CB ' ' HB3' ' A' ' 91' ' ' ALA . 21.4 p -66.83 81.71 0.11 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.719 -0.613 . . . . 0.0 110.785 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.615 HG23 HG23 ' A' ' 46' ' ' THR . 59.4 t -97.11 133.45 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.835 -1.166 . . . . 0.0 109.096 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.63 23.55 6.23 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.49 -0.756 . . . . 0.0 110.151 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.0 23.28 49.86 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.42 HG12 ' CA ' ' A' ' 84' ' ' GLY . 39.1 t -139.41 114.84 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.374 -1.074 . . . . 0.0 109.69 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 57.0 m -69.79 105.46 2.77 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.612 -0.68 . . . . 0.0 109.876 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.675 ' CZ3' HD23 ' A' ' 82' ' ' LEU . 97.0 m95 -88.21 137.1 32.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.267 -0.896 . . . . 0.0 112.152 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.638 HG21 ' CZ3' ' A' ' 85' ' ' TRP . 2.0 t -162.82 130.33 3.69 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.208 0.527 . . . . 0.0 109.76 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.542 ' HB ' ' CD2' ' A' ' 57' ' ' HIS . 8.4 m -48.54 145.66 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 O-C-N 121.417 -0.802 . . . . 0.0 111.547 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.408 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 61.9 t80 -78.54 -15.9 58.06 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.338 -0.851 . . . . 0.0 111.118 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.542 ' CD2' ' HB ' ' A' ' 55' ' ' VAL . 15.8 p80 -77.33 -23.0 50.99 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.219 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.6 -23.18 7.32 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.534 ' HA ' ' CE1' ' A' ' 43' ' ' PHE . . . -69.34 -81.0 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.309 -1.112 . . . . 0.0 109.957 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.0 -144.22 15.93 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.8 -148.69 0.26 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.425 -1.044 . . . . 0.0 110.358 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.77 -178.99 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.287 -0.883 . . . . 0.0 110.842 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.86 97.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.734 -0.604 . . . . 0.0 109.94 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.914 ' CD2' HD12 ' A' ' 71' ' ' ILE . 3.4 tt -53.84 153.71 4.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.726 -0.609 . . . . 0.0 110.839 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.76 145.95 39.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.766 -0.584 . . . . 0.0 109.752 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.436 ' HA3' HD11 ' A' ' 71' ' ' ILE . . . -134.87 -179.07 16.14 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.65 -16.89 57.61 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.938 1.494 . . . . 0.0 110.73 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -120.4 23.22 10.98 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.117 -0.989 . . . . 0.0 111.439 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.71 -166.31 12.25 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 45.9 Cg_endo -65.6 135.5 42.33 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.96 1.505 . . . . 0.0 110.786 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.914 HD12 ' CD2' ' A' ' 64' ' ' LEU . 71.6 mt -95.72 157.81 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.62 -0.675 . . . . 0.0 109.945 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 p -105.11 104.98 14.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.401 -0.812 . . . . 0.0 109.998 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -56.33 151.64 12.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.732 -0.605 . . . . 0.0 111.166 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 tpt -138.11 -38.88 0.55 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.66 -0.65 . . . . 0.0 110.329 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 20.7 m-85 -126.22 122.86 36.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.287 -0.883 . . . . 0.0 110.032 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.733 HG23 ' CG1' ' A' ' 83' ' ' VAL . 2.5 m -146.88 121.81 10.01 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.456 -0.777 . . . . 0.0 109.589 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -146.31 77.79 1.49 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.259 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' A' ' 56' ' ' TYR . 7.5 p -49.97 -28.95 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.628 -0.67 . . . . 0.0 110.433 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.33 -45.19 92.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.43 -0.794 . . . . 0.0 109.485 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.83 14.17 26.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.599 -0.688 . . . . 0.0 109.694 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.635 ' O ' HD12 ' A' ' 82' ' ' LEU . 24.9 m-20 52.22 56.28 7.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.283 -0.885 . . . . 0.0 111.951 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.675 HD23 ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -159.29 137.54 10.52 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.215 -0.928 . . . . 0.0 111.651 178.391 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.733 ' CG1' HG23 ' A' ' 76' ' ' THR . 39.6 t -144.14 103.0 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 52' ' ' CYS . . . -102.83 94.29 1.13 Allowed Glycine 0 N--CA 1.483 1.797 0 C-N-CA 119.928 -1.13 . . . . 0.0 111.216 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.638 ' CZ3' HG21 ' A' ' 54' ' ' THR . 4.8 p90 -81.43 178.57 8.29 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -92.26 125.08 36.78 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.042 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' A' ' 91' ' ' ALA . . . -58.06 156.15 21.46 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.424 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.515 ' HG2' ' HD3' ' A' ' 89' ' ' PRO . 30.2 Cg_endo -62.28 -77.43 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.353 0 O-C-N 123.991 1.522 . . . . 0.0 111.822 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.565 ' HG3' HG21 ' A' ' 29' ' ' VAL . 59.3 Cg_endo -94.16 28.54 0.28 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 115.874 -2.284 . . . . 0.0 109.287 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.52 -16.91 59.61 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.475 ' HB3' ' CB ' ' A' ' 47' ' ' CYS . . . 50.49 22.04 0.97 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.039 -1.271 . . . . 0.0 111.31 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 64.7 69.56 0.5 Allowed 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -177.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 m -43.27 128.68 4.78 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.582 HD23 ' HB2' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -85.04 -157.9 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.685 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 1.3 p -144.08 -179.25 0.91 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.554 -0.716 . . . . 0.0 110.263 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -86.51 170.18 7.93 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 O-C-N 123.841 1.443 . . . . 0.0 110.318 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' A' ' 151' ' ' VAL . 9.4 t -82.81 -91.35 0.07 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.611 -0.681 . . . . 0.0 109.694 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 98' ' ' THR . 26.2 m 51.83 21.42 1.42 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.909 -1.12 . . . . 0.0 111.348 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 13.3 p -141.42 -25.5 0.71 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.284 -0.885 . . . . 0.0 112.482 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.406 ' HA3' ' HD2' ' A' ' 146' ' ' PRO . . . -102.06 128.71 9.64 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.0 p -66.63 -46.88 74.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.753 -0.851 . . . . 0.0 110.058 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 t -162.57 -156.45 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.576 -0.702 . . . . 0.0 110.504 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 55.41 100.69 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.549 -0.719 . . . . 0.0 110.493 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.829 HD13 HD23 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -121.22 -170.18 1.98 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.36 -0.837 . . . . 0.0 110.124 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.753 ' HB2' HG13 ' A' ' 113' ' ' VAL . 11.7 p90 -160.88 98.02 1.18 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.893 HD11 HD12 ' A' ' 114' ' ' ILE . 3.3 pp -67.29 123.3 19.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.843 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.23 99.63 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.452 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.9 p -61.92 155.38 23.68 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.687 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -78.95 0.56 26.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.301 -0.875 . . . . 0.0 110.764 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.1 OUTLIER -114.87 35.76 4.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.096 -1.003 . . . . 0.0 109.678 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.35 76.74 0.32 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.52 -0.738 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -167.46 97.25 0.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.534 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.753 HG13 ' HB2' ' A' ' 105' ' ' TYR . 2.1 t -82.72 145.05 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.893 HD12 HD11 ' A' ' 106' ' ' LEU . 39.7 mt -133.21 111.39 12.96 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 46.7 Cg_endo -58.47 145.27 95.1 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.655 1.345 . . . . 0.0 111.396 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 114' ' ' ILE . 33.1 t -140.46 150.8 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.609 -0.682 . . . . 0.0 109.886 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -109.34 116.14 31.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -48.68 125.35 9.88 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.363 -0.836 . . . . 0.0 111.015 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -108.32 -44.22 4.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.95 -0.469 . . . . 0.0 110.479 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -159.2 63.93 0.3 Allowed Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.947 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.457 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER 60.9 -75.56 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.625 -0.927 . . . . 0.0 111.109 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 120' ' ' GLY . 41.2 p -89.69 38.24 0.91 Allowed 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.85 -0.531 . . . . 0.0 110.3 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.466 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 18.6 ttm180 -168.43 149.12 4.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.371 -0.83 . . . . 0.0 110.312 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.17 -179.26 19.7 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -124.16 117.21 24.12 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 122.097 -0.649 . . . . 0.0 111.415 -178.535 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.448 HD22 ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -55.29 142.22 32.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.637 -0.664 . . . . 0.0 110.158 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.5 mt -112.42 55.21 0.69 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.448 ' O ' HD22 ' A' ' 126' ' ' LEU . 0.5 OUTLIER 172.57 118.8 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.027 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.254 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -59.79 101.01 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 O-C-N 123.483 1.254 . . . . 0.0 109.568 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -120.51 169.26 8.98 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.22 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.411 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 44.7 Cg_endo -85.73 129.3 3.52 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 124.148 1.604 . . . . 0.0 110.303 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.7 p -59.68 -35.35 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.796 -0.565 . . . . 0.0 110.076 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.9 m -48.94 -36.34 17.15 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.299 -0.876 . . . . 0.0 110.41 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.558 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -66.03 -38.25 87.92 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 17.5 mt -70.21 -37.04 74.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -55.57 124.82 18.59 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.022 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.33 -29.62 12.11 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.425 ' HA ' HD23 ' A' ' 44' ' ' LEU . 57.2 m -82.71 1.11 40.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.694 -0.886 . . . . 0.0 111.028 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.41 123.95 14.55 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.922 -1.111 . . . . 0.0 110.394 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.58 -11.85 12.31 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 44' ' ' LEU . . . -62.41 140.07 46.08 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.585 ' O ' HD12 ' A' ' 144' ' ' LEU . 52.3 Cg_endo -82.85 124.27 3.88 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.594 1.312 . . . . 0.0 113.171 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.829 HD23 HD13 ' A' ' 104' ' ' LEU . 1.2 mp -76.0 141.3 42.2 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 142' ' ' PRO . 0.9 OUTLIER -137.57 136.58 37.71 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 120.009 1.277 . . . . 0.0 112.355 -177.638 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.49 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 15.2 p -84.16 -174.16 0.5 Allowed Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 49.6 Cg_endo -60.1 164.84 11.61 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 117.328 -1.314 . . . . 0.0 110.08 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.36 163.15 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.344 -0.847 . . . . 0.0 109.588 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 149' ' ' HIS . . . -69.59 102.81 1.01 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.41 ' CG ' ' O ' ' A' ' 148' ' ' GLY . 1.5 m170 -166.46 106.84 0.66 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.588 -0.948 . . . . 0.0 110.38 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -60.17 142.36 54.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.642 . . . . 0.0 110.448 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.657 HG12 ' CE2' ' A' ' 169' ' ' PHE . 3.4 t -107.88 -44.38 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.713 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . -178.86 -178.33 48.07 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.523 HD11 HD12 ' A' ' 82' ' ' LEU . 1.1 pt -116.44 143.77 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.129 -1.218 . . . . 0.0 111.21 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.733 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.8 t80 -60.53 116.55 4.42 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.048 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -103.68 -44.62 5.04 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.371 -0.83 . . . . 0.0 109.062 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -152.5 169.92 21.42 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.733 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -126.58 115.58 19.72 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.066 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.778 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.4 t -66.41 100.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.59 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.4 p -128.88 142.48 50.94 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -174.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 162' ' ' GLY . 69.9 p -73.79 -174.61 1.84 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.9 84.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.741 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 86.89 -27.77 5.81 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 121.146 -0.971 . . . . 0.0 111.92 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -94.07 137.16 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.026 1.413 . . . . 0.0 109.089 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.03 126.08 47.69 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.843 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -110.35 -38.68 5.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.78 -0.575 . . . . 0.0 110.384 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.778 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -126.32 170.56 11.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 110.164 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.2 153.85 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.642 0.734 . . . . 0.0 111.261 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.645 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 11.8 t0 -121.03 96.49 5.12 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.657 ' CE2' HG12 ' A' ' 151' ' ' VAL . 3.7 p90 -130.41 161.39 31.46 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.596 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.461 HG11 ' CD1' ' A' ' 82' ' ' LEU . 1.1 p -111.28 123.21 35.64 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.1 Cg_endo -50.56 157.13 3.64 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.861 1.453 . . . . 0.0 112.359 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.713 HG13 ' HA2' ' A' ' 152' ' ' GLY . 27.8 m -83.22 3.08 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.799 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -87.79 -36.32 17.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -36.05 78.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 110.592 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.52 ' HG2' HD21 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -47.3 -39.18 14.1 Favored 'General case' 0 N--CA 1.524 3.27 0 CA-C-O 121.789 0.804 . . . . 0.0 109.302 -179.159 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -53.78 -38.46 64.51 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.915 0.864 . . . . 0.0 109.197 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.1 m -55.81 -39.6 71.56 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.374 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -58.11 -42.64 86.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.522 -0.736 . . . . 0.0 110.32 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.459 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -54.79 -40.16 69.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.405 -0.809 . . . . 0.0 111.056 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -51.28 -38.22 51.62 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.94 0.876 . . . . 0.0 110.408 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -80.84 -41.18 23.66 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.5 2.056 0 O-C-N 121.626 -0.671 . . . . 0.0 110.595 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.568 HG21 ' HG3' ' A' ' 34' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -156.28 76.84 0.92 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.64 0.733 . . . . 0.0 109.565 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.35 57.45 8.17 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.451 ' C ' HG23 ' A' ' 33' ' ' VAL . 11.8 mt-10 -154.83 -85.26 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.57 -0.959 . . . . 0.0 111.795 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 45' ' ' ALA . 59.9 t -149.8 152.11 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.964 -1.085 . . . . 0.0 111.581 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.568 ' HG3' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -134.22 144.11 48.24 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.095 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.501 HG12 ' HD2' ' A' ' 109' ' ' ARG . 34.5 m -103.57 178.81 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.207 -0.933 . . . . 0.0 111.934 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.463 ' CG1' HD21 ' A' ' 64' ' ' LEU . 33.1 m -136.31 -179.4 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.0 m -157.5 135.59 10.96 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.634 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 p -141.36 -179.07 5.92 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.09 75.44 0.67 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.949 -1.101 . . . . 0.0 108.621 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m 179.25 -63.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.7 -163.36 0.14 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.664 -0.647 . . . . 0.0 109.342 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -120.63 136.5 54.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.435 -0.791 . . . . 0.0 109.902 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 52.4 m-85 -101.87 -177.55 3.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.609 -0.682 . . . . 0.0 110.518 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.764 HD23 ' N ' ' A' ' 45' ' ' ALA . 7.6 tt -113.37 153.72 28.07 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.363 -0.836 . . . . 0.0 109.37 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.764 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -156.85 130.94 8.42 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.029 -1.044 . . . . 0.0 109.973 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.576 HG23 HG23 ' A' ' 48' ' ' VAL . 15.2 t -97.84 129.98 44.78 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.201 -0.937 . . . . 0.0 111.883 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 80.1 m -80.81 84.39 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.292 -0.88 . . . . 0.0 110.289 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.576 HG23 HG23 ' A' ' 46' ' ' THR . 54.7 t -98.4 138.01 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.26 19.61 6.4 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.207 -0.933 . . . . 0.0 109.818 -178.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.28 24.33 54.68 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -138.24 106.85 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.38 -1.071 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.94 115.57 2.94 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.62 -0.675 . . . . 0.0 109.182 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.505 ' CH2' ' HE3' ' A' ' 179' ' ' MET . 97.7 m95 -96.49 142.44 28.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 111.326 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.6 HG23 HG23 ' A' ' 83' ' ' VAL . 10.8 t -161.42 -177.59 6.08 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.407 ' C ' HG22 ' A' ' 83' ' ' VAL . 12.3 m -109.8 150.27 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.449 -0.782 . . . . 0.0 110.457 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.567 ' HB2' HG11 ' A' ' 83' ' ' VAL . 33.7 t80 -71.2 -0.91 10.88 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.826 -1.171 . . . . 0.0 112.073 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -48.44 -27.65 2.78 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.171 -0.956 . . . . 0.0 110.608 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.9 41.27 0.11 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -156.95 113.73 3.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.661 -0.905 . . . . 0.0 110.328 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.07 -49.0 0.89 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.09 178.28 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.546 -0.973 . . . . 0.0 110.514 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 50.7 -170.93 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.39 -0.819 . . . . 0.0 110.889 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.63 106.88 19.26 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.652 0.739 . . . . 0.0 109.768 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.463 HD21 ' CG1' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.91 169.98 2.32 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.502 0.667 . . . . 0.0 111.275 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -115.99 136.3 53.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.869 -0.519 . . . . 0.0 109.691 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.18 -178.48 15.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -53.46 96.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.826 0 O-C-N 123.653 1.344 . . . . 0.0 110.855 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt 54.2 28.28 8.9 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.445 -0.784 . . . . 0.0 110.629 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.07 139.09 5.0 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.14 163.06 24.07 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.861 1.453 . . . . 0.0 110.3 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.9 mt -97.94 99.2 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.569 -0.707 . . . . 0.0 109.684 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 72' ' ' THR . 9.2 t -55.81 123.47 14.3 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.623 -0.673 . . . . 0.0 110.874 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -55.4 130.73 43.73 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.631 -0.668 . . . . 0.0 111.007 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.2 mmt -128.75 -50.07 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.494 -0.753 . . . . 0.0 109.82 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 179' ' ' MET . 10.7 m-85 -125.93 111.67 15.05 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.538 -0.726 . . . . 0.0 110.014 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.602 HG23 ' HB ' ' A' ' 83' ' ' VAL . 12.8 m -144.67 112.36 6.22 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.601 -0.687 . . . . 0.0 110.723 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -139.53 76.01 1.54 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.921 -1.112 . . . . 0.0 111.886 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.429 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.4 p -52.35 -25.18 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.36 -0.838 . . . . 0.0 109.512 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -32.82 73.61 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -96.75 22.48 8.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.76 41.9 31.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.498 -0.751 . . . . 0.0 111.469 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.842 HD11 HD11 ' A' ' 153' ' ' ILE . 0.3 OUTLIER -169.09 153.23 5.42 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.061 -1.055 . . . . 0.0 113.158 178.486 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.602 ' HB ' HG23 ' A' ' 76' ' ' THR . 35.0 m -155.34 130.48 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.45 148.71 20.32 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.615 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.462 ' CZ2' HD11 ' A' ' 64' ' ' LEU . 1.1 m-90 -116.32 172.02 7.45 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -75.11 141.94 43.69 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.126 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -111.2 101.69 50.99 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.111 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.4 Cg_endo -115.63 10.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.11 0 O-C-N 123.75 1.395 . . . . 0.0 112.768 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 52.1 Cg_endo -63.7 -100.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 116.702 -1.732 . . . . 0.0 108.686 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.44 34.21 5.83 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 105.49 -3.044 . . . . 0.0 105.49 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.61 157.97 37.01 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.945 -0.738 . . . . 0.0 111.214 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.19 20.48 6.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.846 -0.534 . . . . 0.0 109.926 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.9 p 45.63 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.628 -0.67 . . . . 0.0 112.431 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.69 ' O ' HG23 ' A' ' 95' ' ' THR . 0.3 OUTLIER -76.7 -151.52 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 109.763 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -161.04 171.23 7.26 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.394 -0.816 . . . . 0.0 110.611 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -83.12 159.46 15.44 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 O-C-N 123.935 1.492 . . . . 0.0 110.575 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.654 ' CB ' HG23 ' A' ' 151' ' ' VAL . 2.1 t -92.99 136.77 32.96 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.561 -0.712 . . . . 0.0 109.555 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.9 m -108.05 -37.12 6.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.603 -0.685 . . . . 0.0 110.121 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.473 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 26.6 p -64.67 -22.31 66.95 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.675 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.87 -94.57 0.04 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.6 t 51.82 -174.5 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.389 -1.065 . . . . 0.0 110.436 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.2 p -107.23 -162.0 0.82 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.433 -0.792 . . . . 0.0 110.33 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 55.2 m-20 55.36 97.21 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.529 -0.732 . . . . 0.0 110.467 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.843 HD13 HD23 ' A' ' 143' ' ' LEU . 3.0 mt -114.18 -176.38 2.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.598 -0.689 . . . . 0.0 110.159 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 107' ' ' VAL . 64.2 m-85 -132.08 84.77 2.18 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.9 tp -67.52 97.0 0.56 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 105' ' ' TYR . 47.6 t -82.96 113.9 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.616 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.448 ' HB ' ' NE2' ' A' ' 110' ' ' HIS . 67.3 p -70.21 178.5 2.79 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.625 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -99.73 42.44 1.11 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.008 -1.058 . . . . 0.0 110.64 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.448 ' NE2' ' HB ' ' A' ' 108' ' ' THR . 2.8 p80 -164.97 46.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.717 0.77 . . . . 0.0 109.703 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.29 70.0 0.61 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.353 0.597 . . . . 0.0 111.206 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 108' ' ' THR . 0.8 OUTLIER -165.49 78.18 0.29 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.479 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.7 p -68.1 152.72 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.615 -0.678 . . . . 0.0 110.209 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 116' ' ' VAL . 46.9 mt -131.37 111.63 15.31 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.353 -0.842 . . . . 0.0 108.783 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -56.89 141.6 93.18 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 O-C-N 123.66 1.348 . . . . 0.0 111.913 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 41.9 t -135.95 148.72 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.525 -0.735 . . . . 0.0 109.767 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.2 115.96 29.05 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -49.3 125.24 10.56 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.299 -0.875 . . . . 0.0 110.882 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.423 ' HG2' ' HB2' ' A' ' 125' ' ' SER . 0.0 OUTLIER -104.75 -47.34 4.07 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.278 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.73 -164.91 13.1 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.12 137.66 57.2 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.504 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 58.1 p 46.03 47.71 12.69 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.062 0.458 . . . . 0.0 111.892 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.509 ' HD2' HG21 ' A' ' 158' ' ' VAL . 0.4 OUTLIER -168.59 144.81 3.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.41 -0.806 . . . . 0.0 110.779 179.279 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -137.98 -178.44 16.1 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.423 ' HB2' ' HG2' ' A' ' 119' ' ' ARG . 0.3 OUTLIER -130.3 102.93 6.41 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.004 -178.242 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.854 ' O ' HD12 ' A' ' 126' ' ' LEU . 1.8 pp -49.63 146.91 3.88 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.597 -0.69 . . . . 0.0 110.404 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.8 mt -109.08 54.74 0.65 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.02 0.914 . . . . 0.0 108.841 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.5 117.77 0.17 Allowed Pre-proline 0 N--CA 1.497 1.902 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -59.12 99.13 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 O-C-N 123.742 1.391 . . . . 0.0 109.447 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -114.46 144.9 32.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.019 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.487 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 44.3 Cg_endo -62.25 123.84 13.23 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 124.042 1.549 . . . . 0.0 109.993 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 162' ' ' GLY . 6.7 p -51.0 -36.57 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.593 -0.692 . . . . 0.0 110.901 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.4 t -49.56 -35.36 20.23 Favored 'General case' 0 N--CA 1.506 2.353 0 CA-C-O 122.042 0.925 . . . . 0.0 110.099 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.487 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 34.8 t80 -63.38 -38.56 91.62 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.52 HD11 ' CB ' ' A' ' 164' ' ' ALA . 10.7 mt -68.8 -35.9 77.6 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.113 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -59.99 121.85 12.85 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.555 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 112.66 -30.21 7.66 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.3 m -88.78 10.53 20.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.74 -0.859 . . . . 0.0 111.12 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.5 p -51.46 127.6 20.47 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.049 -1.032 . . . . 0.0 109.755 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.588 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 115.71 -11.91 18.27 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -176.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.637 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -44.51 114.99 1.18 Allowed Glycine 0 N--CA 1.504 3.225 0 O-C-N 121.556 -0.967 . . . . 0.0 111.454 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.62 119.87 6.84 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.927 1.488 . . . . 0.0 111.356 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.843 HD23 HD13 ' A' ' 104' ' ' LEU . 4.0 mp -87.6 90.94 8.56 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.31 124.1 34.63 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.304 -0.872 . . . . 0.0 111.395 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.473 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 26.6 p -74.86 172.31 9.34 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.776 -0.578 . . . . 0.0 109.892 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 49.3 Cg_endo -71.05 90.43 0.65 Allowed 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.637 1.335 . . . . 0.0 110.973 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.72 -41.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.431 -0.793 . . . . 0.0 110.149 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.97 28.9 1.6 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -141.29 143.27 33.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.377 -1.072 . . . . 0.0 109.469 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.446 ' O ' HG21 ' A' ' 172' ' ' VAL . . . -68.51 131.95 46.14 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.54 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.654 HG23 ' CB ' ' A' ' 97' ' ' CYS . 0.8 OUTLIER -94.14 -27.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.901 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 177.91 -177.85 48.4 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.842 HD11 HD11 ' A' ' 82' ' ' LEU . 1.8 pp -128.51 153.69 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 CA-C-N 119.013 1.406 . . . . 0.0 111.828 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.85 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 4.2 t80 -64.26 103.52 0.64 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.777 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -90.95 -42.66 10.44 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.601 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -154.46 177.88 10.68 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.85 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -133.35 118.56 18.62 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.657 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.843 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.1 t -65.99 102.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.507 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.0 p -129.1 153.25 47.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 122.162 0.982 . . . . 0.0 113.618 -174.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -86.77 -174.84 5.16 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.61 85.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.657 -0.652 . . . . 0.0 112.442 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.78 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 85.15 -23.59 7.93 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.23 -0.919 . . . . 0.0 111.718 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -98.41 142.42 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 119.125 1.462 . . . . 0.0 109.123 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.697 ' C ' HD21 ' A' ' 126' ' ' LEU . . . -102.05 133.09 47.43 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.151 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.674 ' HA ' HD11 ' A' ' 126' ' ' LEU . 20.6 mtpt -114.17 -36.13 4.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.562 -0.711 . . . . 0.0 110.965 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.843 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -135.37 172.75 12.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.402 -0.811 . . . . 0.0 109.979 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.19 152.62 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 111.178 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -117.03 93.21 4.1 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.435 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.837 ' CG ' HD22 ' A' ' 143' ' ' LEU . 2.6 p90 -128.35 148.65 50.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.408 -0.808 . . . . 0.0 110.838 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.412 ' CG2' ' SD ' ' A' ' 175' ' ' MET . 1.0 OUTLIER -103.51 148.78 36.27 Favored Pre-proline 0 N--CA 1.497 1.916 0 C-N-CA 118.621 -1.232 . . . . 0.0 108.596 179.054 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.544 ' O ' ' HG3' ' A' ' 175' ' ' MET . 47.0 Cg_endo -63.03 137.91 64.7 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.103 1.581 . . . . 0.0 110.496 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.901 HG13 ' HA2' ' A' ' 152' ' ' GLY . 25.6 m -75.94 -0.99 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -77.27 -37.01 53.8 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.1 m -84.13 -38.42 20.74 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.781 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.544 ' HG3' ' O ' ' A' ' 171' ' ' PRO . 11.3 mtm -49.54 -41.05 40.22 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.313 -0.867 . . . . 0.0 110.039 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.459 ' HA ' ' HE3' ' A' ' 179' ' ' MET . 44.8 mm-40 -54.15 -39.49 66.57 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.569 0.7 . . . . 0.0 110.323 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.4 m -50.26 -35.75 28.35 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.933 -0.479 . . . . 0.0 112.266 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.3 t -48.69 -40.81 29.53 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.213 -0.93 . . . . 0.0 113.174 -177.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.505 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 3.3 ptp -61.0 -38.59 86.57 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.611 -1.306 . . . . 0.0 110.003 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.34 -38.55 53.69 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.871 0.843 . . . . 0.0 109.903 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -78.53 -39.7 37.18 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.502 2.128 0 O-C-N 121.382 -0.824 . . . . 0.0 111.042 179.72 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.731 HG21 ' HA ' ' A' ' 91' ' ' ALA . 14.1 p . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.249 0.547 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.83 79.37 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.625 -0.672 . . . . 0.0 109.22 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.89 -86.75 0.12 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.606 ' OE2' HD21 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -173.67 -35.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.495 -1.003 . . . . 0.0 111.008 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.553 HG11 HD21 ' A' ' 44' ' ' LEU . 21.2 t -104.56 153.29 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.32 -0.862 . . . . 0.0 110.303 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.439 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 18.7 pt20 -139.3 135.33 33.7 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.411 -0.806 . . . . 0.0 110.438 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 44' ' ' LEU . 36.0 m -108.97 161.58 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.544 -0.723 . . . . 0.0 111.583 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.792 HG11 HD21 ' A' ' 64' ' ' LEU . 2.0 p -144.87 145.28 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 p -117.7 143.54 46.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.748 . . . . 0.0 111.03 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 40' ' ' THR . 7.4 t -128.74 -179.61 5.17 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.06 76.63 0.23 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.354 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.2 m 177.9 -59.76 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -175.95 -166.38 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.677 -0.64 . . . . 0.0 109.443 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.7 p -119.83 137.91 53.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.354 -0.842 . . . . 0.0 110.436 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.685 ' CE2' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -108.96 -176.2 2.97 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.752 HD23 ' N ' ' A' ' 45' ' ' ALA . 8.3 tt -125.74 147.86 49.24 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.752 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -148.92 135.98 19.97 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.858 -1.151 . . . . 0.0 111.467 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.707 HG23 HG23 ' A' ' 48' ' ' VAL . 7.3 t -106.32 126.37 52.15 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.471 -0.768 . . . . 0.0 111.88 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.6 t -76.34 85.01 3.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.475 -0.766 . . . . 0.0 109.766 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.707 HG23 HG23 ' A' ' 46' ' ' THR . 95.8 t -102.14 138.03 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.4 t30 58.18 18.83 5.62 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.434 -0.791 . . . . 0.0 110.143 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.97 23.97 43.25 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 85' ' ' TRP . 85.1 t -143.0 112.62 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -1.117 . . . . 0.0 110.358 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.405 ' O ' ' HA2' ' A' ' 84' ' ' GLY . 25.7 p -61.56 126.37 27.11 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.688 ' CE3' HD23 ' A' ' 82' ' ' LEU . 85.2 m95 -105.5 139.46 40.08 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.233 -0.917 . . . . 0.0 112.621 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.872 ' O ' HG22 ' A' ' 83' ' ' VAL . 5.7 t -160.73 150.81 17.73 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.598 -0.688 . . . . 0.0 110.235 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.607 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 16.0 t -72.67 149.45 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 121.242 -0.911 . . . . 0.0 109.888 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.706 ' HB3' HG12 ' A' ' 78' ' ' VAL . 9.0 t80 -82.44 5.26 21.11 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.856 -1.153 . . . . 0.0 112.328 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -76.68 5.91 6.82 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.059 -1.025 . . . . 0.0 112.013 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.57 -43.21 0.03 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . . . -91.55 146.19 23.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.593 -0.945 . . . . 0.0 110.147 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.44 -45.8 1.42 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.5 t -60.19 174.36 0.53 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.519 -0.989 . . . . 0.0 109.803 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.32 -176.24 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.304 -0.873 . . . . 0.0 110.489 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 m -88.87 94.72 10.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.539 -0.725 . . . . 0.0 110.18 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.898 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -61.23 174.78 0.63 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.637 -0.664 . . . . 0.0 110.046 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.53 137.14 41.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.46 -0.775 . . . . 0.0 110.68 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.96 -179.46 16.04 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.4 -8.48 23.71 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.914 1.481 . . . . 0.0 111.035 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -139.01 30.87 2.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.034 -1.041 . . . . 0.0 110.999 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.67 175.13 13.98 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.73 148.02 76.66 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 124.016 1.535 . . . . 0.0 110.13 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.898 HD12 ' CD2' ' A' ' 64' ' ' LEU . 84.1 mt -91.62 151.06 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 110.04 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.427 ' HG1' ' C ' ' A' ' 71' ' ' ILE . 24.2 m -159.49 -62.81 0.07 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.479 -0.763 . . . . 0.0 110.401 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.541 ' NE2' ' CD2' ' A' ' 75' ' ' TYR . 0.0 OUTLIER 55.19 -156.48 0.24 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.409 -0.807 . . . . 0.0 110.183 -179.711 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.3 ttt -142.7 28.04 1.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.764 . . . . 0.0 110.164 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.541 ' CD2' ' NE2' ' A' ' 73' ' ' GLN . 13.4 m-30 -106.94 100.32 9.83 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.8 HG23 ' CG1' ' A' ' 83' ' ' VAL . 66.3 m -159.93 137.36 9.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 110.742 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -159.95 79.66 0.7 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.561 -0.856 . . . . 0.0 112.142 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.706 HG12 ' HB3' ' A' ' 56' ' ' TYR . 33.9 m -44.63 -26.44 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.437 -0.79 . . . . 0.0 111.812 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -55.65 -62.66 1.54 Allowed 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.004 -1.06 . . . . 0.0 108.596 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -81.48 -1.19 45.02 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.143 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.546 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.0 OUTLIER 60.77 66.49 0.91 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.563 -0.711 . . . . 0.0 111.076 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.002 HD11 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -164.44 145.9 8.35 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.254 -0.978 . . . . 0.0 112.868 178.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 54' ' ' THR . 2.5 m -142.81 159.39 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 52' ' ' CYS . . . -149.1 101.83 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 118.486 -1.816 . . . . 0.0 111.782 -178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.574 ' CH2' HD11 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -85.62 166.28 16.34 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 177.382 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -90.44 131.13 36.38 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.904 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -72.71 139.17 80.34 Favored Pre-proline 0 C--N 1.297 -1.686 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.829 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.466 ' HG2' ' HD3' ' A' ' 89' ' ' PRO . 36.3 Cg_endo -115.23 -41.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 117.389 -1.274 . . . . 0.0 115.116 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.585 ' HB2' HG12 ' A' ' 29' ' ' VAL . 55.8 Cg_endo -63.27 -152.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 116.994 -1.537 . . . . 0.0 109.454 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.79 34.11 2.56 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.731 ' HA ' HG21 ' A' ' 29' ' ' VAL . . . -55.25 126.85 26.63 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.059 -1.26 . . . . 0.0 111.014 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.81 154.7 41.53 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.3 p -112.91 117.94 33.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.363 -0.836 . . . . 0.0 110.619 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 ' OE2' ' A' ' 32' ' ' GLU . 16.7 mt -86.71 -164.39 1.06 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.623 -0.673 . . . . 0.0 109.288 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.428 HG23 ' N ' ' A' ' 96' ' ' PRO . 0.6 OUTLIER -150.52 -170.04 0.23 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.631 -0.668 . . . . 0.0 109.48 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.428 ' N ' HG23 ' A' ' 95' ' ' THR . 50.1 Cg_endo -89.19 156.71 5.64 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 O-C-N 123.528 1.278 . . . . 0.0 111.308 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -105.14 143.44 33.31 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.568 -0.708 . . . . 0.0 110.204 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 m -156.81 37.18 0.31 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.622 -0.674 . . . . 0.0 110.439 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 31.6 p -93.57 -171.27 2.57 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.28 -0.888 . . . . 0.0 110.579 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.79 94.81 0.87 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.7 p -165.47 -164.09 0.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.963 . . . . 0.0 109.893 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.07 -40.32 0.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.432 -0.793 . . . . 0.0 110.789 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 2.7 t0 -64.5 123.49 19.36 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.414 -0.803 . . . . 0.0 110.087 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.661 HD13 HD23 ' A' ' 143' ' ' LEU . 1.6 mt -115.85 179.15 4.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.453 -0.78 . . . . 0.0 109.97 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.66 ' O ' HG23 ' A' ' 107' ' ' VAL . 12.2 m-85 -132.92 79.49 1.84 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.622 HD23 ' HB ' ' A' ' 114' ' ' ILE . 1.4 tp -58.79 101.81 0.1 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.992 HG22 HG12 ' A' ' 113' ' ' VAL . 75.6 t -90.55 114.89 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.563 -0.711 . . . . 0.0 111.727 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.522 HG21 ' CZ ' ' A' ' 134' ' ' TYR . 10.2 p -74.71 178.71 5.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.517 ' HD3' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -98.31 29.51 3.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.857 -1.152 . . . . 0.0 110.288 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.403 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -128.58 33.41 4.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.601 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 58.51 69.31 0.74 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.455 -0.778 . . . . 0.0 110.908 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -172.06 108.64 0.23 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.594 -0.691 . . . . 0.0 110.256 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.992 HG12 HG22 ' A' ' 107' ' ' VAL . 33.3 m -84.81 158.39 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.929 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.622 ' HB ' HD23 ' A' ' 106' ' ' LEU . 28.3 mm -127.98 111.56 20.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -60.88 133.12 45.84 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 O-C-N 123.752 1.396 . . . . 0.0 111.259 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 114' ' ' ILE . 20.2 t -135.09 149.08 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.643 -0.66 . . . . 0.0 109.841 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -104.29 111.15 23.66 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.445 HH12 HG13 ' A' ' 151' ' ' VAL . 17.2 ttt180 -48.71 122.54 5.72 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.641 0.734 . . . . 0.0 111.351 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.85 -36.95 5.77 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.31 171.82 32.21 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.04 -21.95 35.18 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.502 -0.999 . . . . 0.0 110.703 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.401 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 4.6 p -130.91 40.02 3.52 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.807 -0.558 . . . . 0.0 111.104 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.487 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -171.05 153.5 3.8 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.142 -0.974 . . . . 0.0 111.021 179.08 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.39 -178.39 25.23 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -129.38 115.75 18.0 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.912 -0.758 . . . . 0.0 111.907 -178.23 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' A' ' 130' ' ' ARG . 0.1 OUTLIER -54.43 148.08 12.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.328 -0.857 . . . . 0.0 109.881 178.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.6 mt -112.27 54.02 0.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 164.5 142.73 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.311 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.31 112.15 2.02 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.79 1.416 . . . . 0.0 109.576 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.426 ' HB3' HD22 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -121.08 127.99 25.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.474 -0.766 . . . . 0.0 108.945 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -54.72 131.11 44.02 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.775 1.408 . . . . 0.0 111.467 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.8 p -63.79 -36.03 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 121.253 0.549 . . . . 0.0 109.999 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -48.74 -36.54 16.61 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.08 -1.013 . . . . 0.0 110.611 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.522 ' CZ ' HG21 ' A' ' 108' ' ' THR . 26.8 t80 -65.8 -38.62 89.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.1 mt -65.09 -36.01 82.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -63.08 124.78 22.0 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.704 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.52 -25.55 27.21 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.3 m -90.32 6.79 41.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.994 . . . . 0.0 111.283 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 p -53.15 121.4 7.4 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.021 -1.049 . . . . 0.0 109.747 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.573 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 120.91 -10.33 10.27 Favored Glycine 0 CA--C 1.542 1.725 0 N-CA-C 107.664 -2.174 . . . . 0.0 107.664 -176.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.605 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -54.97 116.41 6.72 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.5 ' O ' HD12 ' A' ' 144' ' ' LEU . 51.6 Cg_endo -68.41 118.82 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.813 1.428 . . . . 0.0 111.805 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.661 HD23 HD13 ' A' ' 104' ' ' LEU . 2.7 mp -74.87 138.58 42.57 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 176.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 142' ' ' PRO . 1.1 mt -134.8 120.57 19.53 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.845 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 16.9 p -71.81 -178.3 0.59 Allowed Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.1 Cg_endo -60.62 -179.57 0.28 Allowed 'Trans proline' 0 N--CA 1.491 1.343 0 O-C-N 123.288 1.151 . . . . 0.0 110.833 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.01 -79.16 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.449 -0.782 . . . . 0.0 110.286 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 177.46 -142.28 5.64 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 62.4 m170 57.99 118.14 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.839 -0.801 . . . . 0.0 111.308 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.521 ' O ' HG21 ' A' ' 172' ' ' VAL . . . -63.02 137.68 58.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.489 -0.757 . . . . 0.0 109.913 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.578 HG12 ' CE2' ' A' ' 169' ' ' PHE . 3.1 t -92.04 -44.92 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.809 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . -173.62 -177.78 43.09 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 1.002 HD11 HD11 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -120.0 142.06 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.515 -0.991 . . . . 0.0 110.541 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.719 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 10.1 t80 -58.2 116.58 3.66 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.495 ' HG3' ' HB3' ' A' ' 81' ' ' ASP . 5.4 ttt180 -103.37 -43.06 5.53 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.622 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -160.4 179.6 8.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.719 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -141.67 128.9 21.02 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.036 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.78 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.3 t -69.66 102.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 76.7 m -120.9 172.42 7.93 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.587 1.184 . . . . 0.0 113.401 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.4 OUTLIER -110.92 -174.42 2.47 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.571 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -49.47 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.37 -0.831 . . . . 0.0 112.798 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.717 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 84.4 -25.21 5.76 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.668 -1.27 . . . . 0.0 111.896 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.18 136.1 31.62 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.222 0 O-C-N 120.756 -1.438 . . . . 0.0 109.256 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.441 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -96.57 139.62 32.4 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.732 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -114.61 -47.84 2.89 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.529 -0.732 . . . . 0.0 110.887 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.78 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -123.05 -178.93 4.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.788 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.473 HG21 ' CG1' ' A' ' 116' ' ' VAL . 3.0 t -114.59 162.38 12.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.501 0.667 . . . . 0.0 110.104 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.622 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -135.97 88.26 2.38 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 178.312 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CE2' HG12 ' A' ' 151' ' ' VAL . 4.7 p90 -128.42 166.59 18.42 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.006 -1.078 . . . . 0.0 112.694 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.68 HG21 HD13 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -112.82 131.03 22.93 Favored Pre-proline 0 N--CA 1.491 1.58 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.755 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.453 ' HA ' ' HA3' ' A' ' 152' ' ' GLY . 40.4 Cg_endo -60.27 157.15 36.7 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.985 1.519 . . . . 0.0 111.02 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.809 HG13 ' HA2' ' A' ' 152' ' ' GLY . 26.8 m -82.05 5.05 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.381 -0.825 . . . . 0.0 110.744 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -85.87 -37.08 19.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.32 -38.74 49.81 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.765 -0.584 . . . . 0.0 111.024 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.502 ' HB3' ' CD2' ' A' ' 82' ' ' LEU . 9.2 ptp -49.91 -36.47 27.63 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.141 -0.974 . . . . 0.0 110.184 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.478 ' N ' ' HG3' ' A' ' 175' ' ' MET . 27.4 mm-40 -57.23 -37.86 72.91 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.485 -0.76 . . . . 0.0 109.731 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.5 m -60.3 -36.03 76.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.245 0.545 . . . . 0.0 110.343 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -49.56 -52.83 27.24 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.581 -0.699 . . . . 0.0 112.421 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.47 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 3.9 ptp -65.03 -40.94 95.57 Favored 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.041 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -54.94 -38.13 67.31 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 122.053 0.93 . . . . 0.0 109.25 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.5 -38.98 67.99 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.369 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.495 1.797 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.083 179.829 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 89' ' ' PRO . 15.2 m . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 121.191 0.519 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -170.96 79.28 0.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.368 0.604 . . . . 0.0 109.502 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.74 -19.17 58.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.434 ' OE2' HD11 ' A' ' 94' ' ' LEU . 1.5 tp10 -79.54 -68.92 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.353 -1.087 . . . . 0.0 110.685 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.6 t -137.5 146.62 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.031 0.919 . . . . 0.0 111.497 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.97 173.94 11.16 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.445 HG12 ' HG3' ' A' ' 109' ' ' ARG . 8.1 m -143.03 161.43 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 118.963 -1.095 . . . . 0.0 111.613 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.693 HG11 ' CH2' ' A' ' 85' ' ' TRP . 26.4 m -120.94 -178.42 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 m -153.84 139.83 18.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.296 -0.878 . . . . 0.0 111.422 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -139.24 -178.38 5.34 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 40' ' ' THR . . . -69.19 75.67 0.35 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.131 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER 170.75 -61.24 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -174.73 -170.48 0.49 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.322 -0.861 . . . . 0.0 111.083 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.7 p -116.6 145.37 43.43 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.625 -0.672 . . . . 0.0 110.425 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -106.74 -172.85 2.16 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.173 -0.955 . . . . 0.0 109.766 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.911 HD23 ' N ' ' A' ' 45' ' ' ALA 0.25 5.7 tt -111.1 149.1 31.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.466 -0.771 . . . . 0.0 109.937 -178.001 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.911 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -155.35 137.35 14.58 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.974 -1.079 . . . . 0.0 110.809 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 46' ' ' THR . 13.4 t -105.49 125.0 50.48 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.995 -1.066 . . . . 0.0 113.137 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 89.9 m -77.18 86.06 3.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.44 -0.787 . . . . 0.0 110.458 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.432 HG23 HG23 ' A' ' 46' ' ' THR . 59.6 t -107.15 141.84 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.338 -0.851 . . . . 0.0 108.731 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 57.3 19.04 4.69 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.363 -0.835 . . . . 0.0 110.082 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.59 23.71 49.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.1 t -142.42 113.84 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.268 -1.137 . . . . 0.0 110.493 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.31 114.04 4.47 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.931 ' CE3' HD23 ' A' ' 82' ' ' LEU . 96.0 m95 -97.83 140.53 32.07 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.588 -0.695 . . . . 0.0 111.614 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.87 HG21 ' CH2' ' A' ' 85' ' ' TRP . 4.3 t -161.64 177.8 9.63 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.821 HG11 ' CE1' ' A' ' 57' ' ' HIS . 21.2 t -97.86 146.87 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.274 -0.891 . . . . 0.0 109.927 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.509 ' HB2' HG11 ' A' ' 83' ' ' VAL . 37.1 t80 -63.33 -4.52 2.67 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.659 -1.276 . . . . 0.0 112.08 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.821 ' CE1' HG11 ' A' ' 55' ' ' VAL . 30.3 m170 -39.64 -39.89 0.82 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.313 -0.867 . . . . 0.0 111.816 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.86 -44.79 0.44 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.486 ' N ' ' CE2' ' A' ' 43' ' ' PHE . . . -51.51 97.75 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.433 -1.04 . . . . 0.0 109.818 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.67 25.42 21.28 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.67 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.15 28.34 5.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.244 -1.151 . . . . 0.0 110.891 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -98.1 -156.41 0.54 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.49 -0.756 . . . . 0.0 109.881 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 m -59.21 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.336 -0.853 . . . . 0.0 110.386 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.725 HD12 ' HB ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -74.34 136.35 42.52 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.2 143.19 49.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.432 -0.792 . . . . 0.0 110.789 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.564 ' HA3' HD11 ' A' ' 71' ' ' ILE . . . -137.97 -179.44 17.06 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.82 -11.56 31.34 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.92 1.484 . . . . 0.0 110.844 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -114.55 19.63 15.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.982 -1.074 . . . . 0.0 110.858 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.25 -152.64 17.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.14 143.7 54.74 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 124.064 1.56 . . . . 0.0 111.216 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.725 ' HB ' HD12 ' A' ' 64' ' ' LEU . 87.3 mt -107.28 105.09 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -55.16 149.65 12.03 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.306 -0.871 . . . . 0.0 110.892 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.59 165.36 19.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 0.0 110.087 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -166.21 -47.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.359 -0.838 . . . . 0.0 111.338 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.452 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 19.1 m-85 -123.27 126.54 47.1 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.411 ' HA ' HG12 ' A' ' 83' ' ' VAL . 2.2 m -158.29 111.76 2.43 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.293 -0.879 . . . . 0.0 112.333 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -137.46 75.18 1.51 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 111.117 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' A' ' 56' ' ' TYR . 7.5 p -55.56 -21.97 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.433 -0.792 . . . . 0.0 111.012 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.2 77.97 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.467 -0.77 . . . . 0.0 111.324 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 49.24 25.23 1.16 Allowed 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.277 -0.889 . . . . 0.0 111.238 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.96 -95.36 0.49 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.403 -0.811 . . . . 0.0 110.943 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.931 HD23 ' CE3' ' A' ' 53' ' ' TRP . 5.1 tp -179.13 163.19 1.28 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.518 -1.364 . . . . 0.0 111.021 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.509 HG11 ' HB2' ' A' ' 56' ' ' TYR . 26.9 m -139.82 137.61 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.42 137.93 5.26 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.019 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.87 ' CH2' HG21 ' A' ' 54' ' ' THR . 0.4 OUTLIER -98.32 150.36 21.65 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.542 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -64.78 141.16 58.87 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.22 89.95 4.28 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.834 -0.541 . . . . 0.0 110.769 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.567 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -97.46 0.65 1.56 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 O-C-N 123.679 1.358 . . . . 0.0 113.455 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 49.8 Cg_endo -74.73 74.76 3.76 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 115.75 -2.367 . . . . 0.0 109.915 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.64 25.8 22.57 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.32 140.3 39.92 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.471 -1.017 . . . . 0.0 110.63 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -84.93 3.88 36.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.352 -0.842 . . . . 0.0 111.437 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.5 t 45.36 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.415 -0.803 . . . . 0.0 112.558 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -69.81 -161.39 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.607 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.7 p -148.74 177.92 1.64 Allowed Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.662 -0.649 . . . . 0.0 110.956 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -86.51 155.36 9.17 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.95 1.5 . . . . 0.0 110.262 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.483 ' SG ' HG23 ' A' ' 151' ' ' VAL . 0.3 OUTLIER -83.98 114.63 21.84 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.313 -0.867 . . . . 0.0 110.016 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 66.9 p -75.11 -28.51 60.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.636 -0.665 . . . . 0.0 110.095 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.1 p -100.41 109.84 22.02 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.62 0.724 . . . . 0.0 110.253 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.7 63.39 2.32 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 m -91.51 157.94 16.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.518 -0.99 . . . . 0.0 109.563 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.5 p -85.54 -157.98 0.35 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.444 -0.785 . . . . 0.0 110.809 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 t70 52.84 83.89 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.466 -0.771 . . . . 0.0 110.761 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.805 HD13 HD23 ' A' ' 143' ' ' LEU . 0.4 OUTLIER -108.88 -174.51 2.53 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.4 -0.813 . . . . 0.0 109.39 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 94.8 m-85 -134.05 91.51 2.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.757 -0.59 . . . . 0.0 109.837 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.445 ' CD1' HD11 ' A' ' 143' ' ' LEU . 8.8 tp -56.36 98.89 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.413 -0.804 . . . . 0.0 110.268 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.446 ' HA ' HG12 ' A' ' 113' ' ' VAL . 60.6 t -74.07 118.99 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.587 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.7 p -86.53 166.98 15.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.557 -0.714 . . . . 0.0 109.418 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.587 ' N ' HD12 ' A' ' 44' ' ' LEU . 34.5 ttp180 -77.16 -1.35 28.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.611 -0.681 . . . . 0.0 111.098 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.7 40.77 3.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.221 -0.925 . . . . 0.0 109.993 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.39 64.4 1.86 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.543 -0.723 . . . . 0.0 111.56 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -152.62 89.96 1.45 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 107' ' ' VAL . 16.1 m -87.83 136.0 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.457 -0.777 . . . . 0.0 110.071 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 106' ' ' LEU . 26.3 pt -124.36 146.76 53.0 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.527 -0.733 . . . . 0.0 109.59 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 53.7 Cg_endo -66.65 148.13 82.69 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 124.066 1.561 . . . . 0.0 111.746 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.7 t -138.63 141.11 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -106.7 113.46 26.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -48.93 124.29 8.43 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.613 -0.679 . . . . 0.0 110.307 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -110.66 -25.78 9.77 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.539 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -173.14 -176.11 41.43 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.94 122.74 15.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.758 -0.848 . . . . 0.0 109.515 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 169' ' ' PHE . 0.9 OUTLIER 60.95 44.32 10.66 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.214 0.53 . . . . 0.0 110.721 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.498 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 8.7 ttm180 -162.65 151.83 15.26 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.413 -0.805 . . . . 0.0 110.228 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.54 -178.42 21.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.34 130.82 53.27 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.948 -0.737 . . . . 0.0 111.308 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.521 HD21 ' NE ' ' A' ' 130' ' ' ARG . 0.2 OUTLIER -76.37 123.24 25.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.655 -0.653 . . . . 0.0 109.475 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mt -100.01 53.84 0.91 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.456 ' O ' HD22 ' A' ' 126' ' ' LEU . 0.4 OUTLIER 177.41 91.55 0.13 Allowed Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -52.87 108.69 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 O-C-N 123.588 1.31 . . . . 0.0 110.626 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.521 ' NE ' HD21 ' A' ' 126' ' ' LEU . 15.3 ptp180 -130.64 162.18 56.51 Favored Pre-proline 0 N--CA 1.493 1.696 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.028 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.37 130.9 28.19 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.939 1.494 . . . . 0.0 111.274 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.886 HG12 ' O ' ' A' ' 162' ' ' GLY . 4.0 p -59.84 -35.23 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.487 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.96 -34.81 9.75 Favored 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 122.139 0.971 . . . . 0.0 110.535 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -64.66 -38.51 91.24 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.583 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.4 mt -65.33 -36.24 83.44 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -62.55 129.51 40.91 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.489 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.59 -28.01 17.89 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.542 ' O ' HD13 ' A' ' 44' ' ' LEU . 30.8 m -93.45 16.18 14.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.556 -0.967 . . . . 0.0 110.566 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.419 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 56.3 m -62.0 122.32 15.2 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.3 -0.875 . . . . 0.0 109.003 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.735 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 122.12 -10.77 9.37 Favored Glycine 0 CA--C 1.543 1.781 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.567 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -55.72 108.82 1.17 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 153' ' ' ILE . 43.1 Cg_endo -66.25 126.38 15.59 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.074 1.565 . . . . 0.0 112.458 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.805 HD23 HD13 ' A' ' 104' ' ' LEU . 6.6 mp -79.6 128.83 33.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 176.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -124.21 123.61 40.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 111.662 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.549 ' HB3' HG21 ' A' ' 151' ' ' VAL . 32.0 p -77.82 162.63 67.08 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.798 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 45.6 Cg_endo -62.89 87.07 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 O-C-N 123.763 1.401 . . . . 0.0 110.726 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t -172.73 -40.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.62 -0.675 . . . . 0.0 110.18 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.03 -30.57 4.77 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -73.21 154.93 40.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.638 -0.919 . . . . 0.0 109.915 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.509 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -85.39 141.32 30.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.098 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 145' ' ' CYS . 2.1 t -97.65 -36.62 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.823 -0.548 . . . . 0.0 109.743 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.81 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 176.49 -178.91 47.76 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 82' ' ' LEU . 1.2 pt -116.8 158.19 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 118.504 1.152 . . . . 0.0 110.953 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.769 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 12.2 t80 -75.99 103.41 6.04 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.701 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.415 ' HA ' HG21 ' A' ' 55' ' ' VAL . 7.4 ttp180 -92.0 -39.1 11.85 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -159.39 -179.66 8.14 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.769 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -140.76 125.98 18.58 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.762 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.904 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.6 t -67.67 102.08 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 71.0 m -115.67 159.4 21.4 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 122.451 1.119 . . . . 0.0 113.722 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.8 OUTLIER -97.63 -174.06 2.8 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.289 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.75 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 O-C-N 121.314 -0.866 . . . . 0.0 112.69 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.886 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 82.83 -35.59 2.7 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.014 -1.053 . . . . 0.0 111.382 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.75 134.47 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 120.713 -1.463 . . . . 0.0 109.145 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.583 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -91.4 140.64 29.57 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.336 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -120.9 -44.25 2.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.468 -0.77 . . . . 0.0 110.866 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.904 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -120.94 -179.77 4.12 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.311 -0.868 . . . . 0.0 110.612 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -119.42 151.46 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.8 0.81 . . . . 0.0 111.022 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.712 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -120.16 94.25 4.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.332 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.619 ' CD2' HD22 ' A' ' 143' ' ' LEU . 1.1 p90 -127.89 148.52 50.49 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.922 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.473 HG11 ' CD1' ' A' ' 82' ' ' LEU . 3.9 p -98.9 136.55 20.59 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 52.2 Cg_endo -64.91 152.91 80.58 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.814 1.428 . . . . 0.0 110.476 -178.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.81 HG13 ' HA2' ' A' ' 152' ' ' GLY . 30.6 m -79.8 1.04 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.395 -0.816 . . . . 0.0 110.597 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -89.14 -38.56 14.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.314 -0.866 . . . . 0.0 109.8 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.6 t -74.14 -40.73 62.42 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.603 -0.686 . . . . 0.0 110.791 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.789 ' HB3' HD22 ' A' ' 82' ' ' LEU . 8.3 ptp -51.78 -36.2 46.7 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.096 -1.003 . . . . 0.0 110.48 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.98 -38.02 69.85 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.192 -0.943 . . . . 0.0 109.068 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.6 m -57.53 -37.47 73.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.945 -0.472 . . . . 0.0 110.64 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.745 HG22 ' O ' ' A' ' 175' ' ' MET . 1.4 t -48.54 -36.42 15.39 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.431 -0.793 . . . . 0.0 111.96 -178.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.471 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -51.08 -39.49 56.16 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.815 -1.178 . . . . 0.0 110.685 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.7 ttt85 -52.2 -37.43 54.83 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.916 0.865 . . . . 0.0 110.194 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -81.25 -44.31 17.94 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.891 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.504 2.258 0 O-C-N 121.072 -1.018 . . . . 0.0 110.439 -179.344 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.472 0.653 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -167.8 79.29 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.02 -170.98 38.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.591 ' HB3' HD11 ' A' ' 94' ' ' LEU . 7.9 mt-10 -117.89 22.98 11.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.501 -1.0 . . . . 0.0 110.531 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.627 HG12 ' CG ' ' A' ' 109' ' ' ARG . 44.6 t -145.15 143.58 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.734 . . . . 0.0 110.431 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -138.97 140.62 38.28 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.465 -0.772 . . . . 0.0 109.718 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 43' ' ' PHE . 11.1 p -108.97 150.37 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.448 -0.783 . . . . 0.0 111.481 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.714 HG13 ' CE2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -131.33 124.38 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.589 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 p -101.16 143.85 30.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.369 -0.832 . . . . 0.0 109.455 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 40' ' ' THR . 5.6 t -149.61 -178.84 6.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.556 -0.715 . . . . 0.0 109.083 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.21 75.53 0.35 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.062 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.674 HG22 ' HG2' ' A' ' 41' ' ' GLN . 2.3 m -177.44 -61.14 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.674 ' HG2' HG22 ' A' ' 40' ' ' THR . 0.1 OUTLIER 179.77 -163.95 0.05 Allowed 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 t -122.06 119.46 31.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.292 -0.88 . . . . 0.0 109.297 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.759 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -111.52 166.46 11.12 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.614 -0.679 . . . . 0.0 109.718 -179.488 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.818 HD22 ' CB ' ' A' ' 109' ' ' ARG . 13.3 mt -105.31 174.31 5.93 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.174 -0.954 . . . . 0.0 111.133 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 52' ' ' CYS . . . -157.08 128.74 7.05 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.981 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 46' ' ' THR . 12.3 t -103.1 118.89 37.82 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.966 0.888 . . . . 0.0 111.643 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 49.2 t -70.2 89.63 0.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.821 -0.549 . . . . 0.0 110.161 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.526 HG11 HG11 ' A' ' 172' ' ' VAL . 98.7 t -109.16 136.27 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.8 19.18 6.69 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.404 -0.81 . . . . 0.0 110.18 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.85 24.88 40.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 85' ' ' TRP . 19.9 t -145.98 108.82 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -1.136 . . . . 0.0 110.668 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.511 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 24.1 p -61.57 129.11 39.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.248 -0.907 . . . . 0.0 109.304 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.726 ' HZ3' HG21 ' A' ' 178' ' ' THR . 56.1 m95 -108.13 139.25 43.06 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.502 -0.749 . . . . 0.0 111.66 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.938 ' O ' HG22 ' A' ' 83' ' ' VAL . 7.6 t -161.13 128.08 4.06 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.64 0.734 . . . . 0.0 110.315 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 81' ' ' ASP . 28.3 m -48.92 141.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.47 0 O-C-N 120.855 -1.153 . . . . 0.0 112.16 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 51.9 t80 -83.08 -13.65 55.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.062 -1.024 . . . . 0.0 111.357 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.615 ' CE1' HG21 ' A' ' 55' ' ' VAL . 3.5 p80 -63.23 -22.9 67.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.957 . . . . 0.0 110.061 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.03 -30.27 1.64 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.465 ' HA ' ' CE2' ' A' ' 43' ' ' PHE . . . -55.34 174.75 0.08 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.357 -1.084 . . . . 0.0 111.203 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.97 150.62 19.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 m -101.79 -32.25 10.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.794 -0.827 . . . . 0.0 109.635 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -59.31 -169.49 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.639 -0.663 . . . . 0.0 109.933 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.8 m -68.24 97.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.543 -0.723 . . . . 0.0 109.424 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.9 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -55.21 165.9 0.65 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.663 -0.648 . . . . 0.0 110.962 -179.446 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.82 145.37 50.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.836 -0.54 . . . . 0.0 110.491 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -140.29 177.18 20.88 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.49 -12.66 36.5 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 O-C-N 123.915 1.482 . . . . 0.0 111.278 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.63 21.36 11.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 111.044 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.88 -168.3 13.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.51 144.14 65.77 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 124.033 1.544 . . . . 0.0 110.511 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.9 HD12 ' CD2' ' A' ' 64' ' ' LEU . 56.0 mt -92.88 101.93 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -63.0 117.53 6.56 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.964 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -59.02 102.5 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.299 0.571 . . . . 0.0 110.31 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpt -87.46 -42.0 13.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.777 . . . . 0.0 109.468 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.435 ' CD1' ' HG3' ' A' ' 179' ' ' MET . 23.5 m-85 -125.7 130.51 51.69 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.477 HG23 ' CG1' ' A' ' 83' ' ' VAL . 3.2 m -149.77 126.56 11.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.533 -0.729 . . . . 0.0 110.435 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.12 77.82 1.37 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.518 -0.739 . . . . 0.0 110.845 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -56.15 -18.62 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.407 -0.808 . . . . 0.0 109.947 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.54 -58.14 7.13 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.096 -1.002 . . . . 0.0 109.482 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.09 23.77 8.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.668 ' O ' HG12 ' A' ' 55' ' ' VAL . 31.5 m-20 52.83 69.51 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.826 -0.546 . . . . 0.0 112.088 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.668 ' CD1' HD11 ' A' ' 153' ' ' ILE . 1.4 tp -162.43 141.91 9.41 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.01 -1.056 . . . . 0.0 112.638 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.938 HG22 ' O ' ' A' ' 54' ' ' THR . 9.4 m -145.13 125.39 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -110.94 99.99 1.19 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.931 -1.128 . . . . 0.0 111.874 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.503 ' O ' HG13 ' A' ' 51' ' ' VAL . 1.6 m0 -90.18 169.14 11.39 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 176.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -89.24 128.9 35.87 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.041 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.677 ' HB1' ' HB3' ' A' ' 91' ' ' ALA . . . -60.76 139.24 93.39 Favored Pre-proline 0 N--CA 1.494 1.769 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.702 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.545 ' CD ' ' HD3' ' A' ' 89' ' ' PRO . 33.7 Cg_endo -105.54 -54.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 117.266 -1.356 . . . . 0.0 115.081 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.545 ' HD3' ' CD ' ' A' ' 88' ' ' PRO . 56.6 Cg_endo -66.37 -150.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.859 0 C-N-CA 116.923 -1.585 . . . . 0.0 108.822 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.85 34.19 3.21 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 107.734 -2.147 . . . . 0.0 107.734 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.677 ' HB3' ' HB1' ' A' ' 87' ' ' ALA . . . -48.64 130.73 17.58 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.105 -1.232 . . . . 0.0 110.923 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.6 142.21 58.5 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.76 -0.588 . . . . 0.0 110.44 -179.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 m -112.82 110.52 20.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 110.628 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' A' ' 32' ' ' GLU . 5.2 mt -93.3 -158.74 0.63 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.623 -0.673 . . . . 0.0 109.669 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.68 176.5 2.23 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.784 -0.573 . . . . 0.0 109.676 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.52 162.28 42.58 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 O-C-N 123.671 1.353 . . . . 0.0 111.18 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 1.093 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 43.6 t -81.95 -76.35 0.26 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.67 -0.644 . . . . 0.0 110.491 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.2 m 55.31 52.81 10.84 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.34 -0.85 . . . . 0.0 110.198 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 1.093 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 30.6 p -139.34 -149.59 0.29 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.488 -0.757 . . . . 0.0 110.304 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.33 -128.94 4.49 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.9 m 49.75 -157.59 0.08 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.371 -1.076 . . . . 0.0 111.031 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 p -171.4 -34.71 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.538 -0.726 . . . . 0.0 110.684 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 0.9 OUTLIER -58.8 128.09 35.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.563 -0.711 . . . . 0.0 110.314 179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.893 HD13 HD23 ' A' ' 143' ' ' LEU . 1.2 mt -120.84 -168.01 1.58 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.416 -0.803 . . . . 0.0 109.345 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.772 ' O ' HG23 ' A' ' 107' ' ' VAL . 29.4 m-85 -141.11 87.15 2.07 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.465 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 12.3 tp -56.98 96.66 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.155 -0.966 . . . . 0.0 108.494 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 105' ' ' TYR . 41.7 t -89.77 101.94 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.662 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.664 HG22 ' HB3' ' A' ' 138' ' ' SER . 0.8 OUTLIER -65.38 179.99 0.69 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.61 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.818 ' CB ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -100.92 29.16 4.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.015 -1.053 . . . . 0.0 109.464 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.413 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -130.83 30.17 4.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.338 -0.851 . . . . 0.0 109.679 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 59.36 70.6 0.63 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.46 -0.775 . . . . 0.0 110.551 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -171.56 93.88 0.16 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.344 0.593 . . . . 0.0 109.874 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.68 HG12 HG13 ' A' ' 107' ' ' VAL . 10.7 m -98.87 149.0 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.424 -0.797 . . . . 0.0 110.593 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.465 ' CG1' ' HB3' ' A' ' 106' ' ' LEU . 33.2 pt -131.33 147.55 66.61 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.631 -0.668 . . . . 0.0 109.316 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.546 ' HB2' HD12 ' A' ' 127' ' ' LEU . 44.3 Cg_endo -72.88 138.67 29.04 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 O-C-N 123.909 1.479 . . . . 0.0 112.222 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 103' ' ' ASP . 67.5 t -129.59 137.94 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.8 mmm-85 -102.64 121.28 42.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.862 . . . . 0.0 108.979 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -49.15 126.82 13.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.395 -0.816 . . . . 0.0 110.994 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -103.97 -55.0 2.45 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.53 -166.71 13.1 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -62.64 127.67 32.38 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.735 -0.862 . . . . 0.0 109.908 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.417 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 0.3 OUTLIER 54.02 50.81 15.86 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.491 0.663 . . . . 0.0 109.901 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.463 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -166.77 151.37 7.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.767 -0.583 . . . . 0.0 110.391 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.62 -177.73 18.8 Favored Glycine 0 N--CA 1.498 2.828 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -133.27 103.94 6.23 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.769 -0.842 . . . . 0.0 112.291 -178.069 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.737 HD11 ' HA ' ' A' ' 165' ' ' LYS . 2.7 pp -50.91 150.91 2.74 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.361 -0.837 . . . . 0.0 110.537 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.546 HD12 ' HB2' ' A' ' 115' ' ' PRO . 6.4 mt -114.88 54.47 0.78 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.27 99.06 0.1 Allowed Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -52.38 99.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.805 0 O-C-N 123.417 1.219 . . . . 0.0 110.92 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.559 ' HD2' HD21 ' A' ' 135' ' ' LEU . 8.4 ptp180 -116.03 164.59 17.27 Favored Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.006 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.79 124.41 12.28 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.99 1.521 . . . . 0.0 111.064 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.841 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.4 p -57.82 -34.15 47.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.501 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -48.53 -36.21 14.89 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.245 -0.909 . . . . 0.0 110.256 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -62.24 -39.14 91.86 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.559 HD21 ' HD2' ' A' ' 130' ' ' ARG . 14.0 mt -67.39 -36.61 81.67 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 126.36 27.09 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.615 -0.834 . . . . 0.0 108.884 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.47 -20.64 49.51 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.664 ' HB3' HG22 ' A' ' 108' ' ' THR . 6.0 m -93.91 11.6 28.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -1.09 . . . . 0.0 110.847 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.7 p -54.85 143.51 25.62 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.848 -1.158 . . . . 0.0 110.255 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.9 -14.32 58.77 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.54 115.6 4.99 Favored Glycine 0 N--CA 1.503 3.13 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.435 ' O ' HD12 ' A' ' 144' ' ' LEU . 54.2 Cg_endo -69.35 128.37 16.3 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 O-C-N 123.707 1.372 . . . . 0.0 112.683 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.893 HD23 HD13 ' A' ' 104' ' ' LEU . 5.7 mp -83.56 120.26 25.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 142' ' ' PRO . 0.8 OUTLIER -116.77 124.91 50.75 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.693 -177.024 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.507 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 31.1 p -68.59 172.14 5.08 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.8 Cg_endo -64.73 165.52 20.65 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 O-C-N 123.38 1.2 . . . . 0.0 110.116 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.72 39.46 20.92 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.165 -0.959 . . . . 0.0 110.479 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.12 -138.02 30.48 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.7 m170 56.44 111.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.718 -0.872 . . . . 0.0 111.446 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.403 ' CB ' HG21 ' A' ' 172' ' ' VAL . . . -74.3 147.55 42.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 109.053 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.646 HG12 ' CE2' ' A' ' 169' ' ' PHE . 1.4 t -108.48 -34.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.636 -0.665 . . . . 0.0 109.638 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.642 ' N ' HG23 ' A' ' 172' ' ' VAL . . . 174.1 179.22 44.58 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.668 HD11 ' CD1' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -115.05 163.32 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 CA-C-N 118.871 1.336 . . . . 0.0 110.903 178.726 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.763 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 3.2 t80 -70.76 114.82 9.23 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.017 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.405 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 15.9 ttp180 -101.18 -45.71 5.28 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.688 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -153.44 168.36 26.38 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.763 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -124.02 116.59 23.07 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.985 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.805 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 16.3 t -68.63 103.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.5 p -127.32 158.41 37.32 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.121 0.963 . . . . 0.0 113.51 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 162' ' ' GLY . 24.0 p -95.13 -173.54 2.97 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 175.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.22 82.53 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.841 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 86.02 -25.56 6.76 Favored Glycine 0 N--CA 1.502 3.063 0 O-C-N 120.7 -1.25 . . . . 0.0 111.916 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -98.45 140.69 17.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 120.962 -1.317 . . . . 0.0 108.949 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.713 ' C ' HD21 ' A' ' 126' ' ' LEU . . . -93.46 138.21 31.98 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.962 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.737 ' HA ' HD11 ' A' ' 126' ' ' LEU . 0.7 OUTLIER -119.16 -28.26 5.49 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.635 -0.665 . . . . 0.0 110.38 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.805 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -144.01 178.14 8.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.875 . . . . 0.0 109.444 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.03 154.54 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.878 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.688 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 1.7 t70 -119.94 99.62 6.73 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.646 ' CE2' HG12 ' A' ' 151' ' ' VAL . 1.6 p90 -130.38 153.88 48.26 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.83 -1.148 . . . . 0.0 112.798 -175.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.62 HG11 HD13 ' A' ' 82' ' ' LEU . 2.7 p -103.0 127.47 29.81 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 45.9 Cg_endo -56.56 163.69 6.58 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 124.024 1.539 . . . . 0.0 111.636 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.642 HG23 ' N ' ' A' ' 152' ' ' GLY . 70.8 t -81.24 1.14 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.378 -0.827 . . . . 0.0 110.039 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -92.92 -37.69 12.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.844 . . . . 0.0 108.95 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.762 ' O ' HG22 ' A' ' 177' ' ' THR . 7.3 t -63.93 -38.14 90.0 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.572 ' HE1' HG23 ' A' ' 153' ' ' ILE . 7.9 mtt -48.14 -35.28 11.26 Favored 'General case' 0 N--CA 1.518 2.941 0 O-C-N 121.853 -0.529 . . . . 0.0 109.871 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -48.22 -38.34 18.21 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.131 -0.98 . . . . 0.0 111.177 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.762 HG22 ' O ' ' A' ' 174' ' ' SER . 14.6 t -54.21 -34.67 61.16 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.213 -0.93 . . . . 0.0 109.529 178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.726 HG21 ' HZ3' ' A' ' 53' ' ' TRP . 32.1 m -48.12 -61.94 1.73 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.898 -0.501 . . . . 0.0 110.949 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.447 ' HE1' ' CZ2' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -54.57 -51.3 65.68 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.385 -0.822 . . . . 0.0 110.887 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -52.87 -37.68 60.71 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.154 -0.966 . . . . 0.0 109.994 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -73.33 -39.23 65.4 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.993 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.635 179.627 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 89' ' ' PRO . 34.4 m . . . . . 0 N--CA 1.503 2.205 0 CA-C-O 121.608 0.718 . . . . 0.0 111.439 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' N ' HG23 ' A' ' 29' ' ' VAL . 0.3 OUTLIER 54.89 80.2 0.13 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.408 0.623 . . . . 0.0 110.98 179.722 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 92' ' ' ARG . . . -72.22 63.9 1.34 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -175.35 -73.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.557 HG22 ' CD ' ' A' ' 142' ' ' PRO . 62.4 t -124.62 138.26 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.63 -0.669 . . . . 0.0 110.263 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -125.05 178.94 5.26 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 43' ' ' PHE . 2.9 p -154.46 143.19 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.542 -0.724 . . . . 0.0 109.533 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.715 HG12 HD21 ' A' ' 64' ' ' LEU . 33.9 m -104.18 176.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.7 p -131.28 137.71 48.96 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.566 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.3 p -131.49 -176.42 4.02 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.57 103.09 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.206 -0.934 . . . . 0.0 110.389 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 62.1 p 47.0 53.71 10.21 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.275 0.559 . . . . 0.0 111.473 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.79 164.39 16.5 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.507 0.67 . . . . 0.0 110.554 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.6 p -155.51 132.8 10.92 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.867 ' O ' HG23 ' A' ' 35' ' ' VAL . 92.8 m-85 -105.76 175.03 5.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.193 -0.942 . . . . 0.0 111.612 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.758 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -101.89 152.76 20.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 0.0 111.899 -177.794 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.588 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -160.43 161.24 32.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.896 -0.503 . . . . 0.0 110.283 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.623 HG23 HG23 ' A' ' 48' ' ' VAL . 14.6 t -137.82 125.18 21.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.098 -1.001 . . . . 0.0 111.981 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.8 m -74.04 79.24 1.71 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.378 -0.826 . . . . 0.0 109.408 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.623 HG23 HG23 ' A' ' 46' ' ' THR . 58.0 t -98.89 138.1 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.965 -1.084 . . . . 0.0 108.586 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.53 18.46 3.58 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.307 -0.871 . . . . 0.0 110.219 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.405 ' N ' ' CB ' ' A' ' 93' ' ' SER . . . 85.6 27.33 32.75 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.2 t -143.12 116.16 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.41 -1.053 . . . . 0.0 110.506 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.726 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 58.8 m -66.59 117.15 8.38 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.58 ' CE3' HD23 ' A' ' 82' ' ' LEU . 21.4 m95 -102.29 137.1 40.99 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 121.042 -1.036 . . . . 0.0 112.442 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.509 ' O ' HG22 ' A' ' 83' ' ' VAL . 1.0 OUTLIER -162.74 131.51 4.07 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.518 -0.739 . . . . 0.0 110.443 177.57 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.508 HG21 ' NE2' ' A' ' 57' ' ' HIS . 30.4 m -52.91 147.98 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.334 -0.854 . . . . 0.0 111.497 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.513 ' HA ' HG21 ' A' ' 83' ' ' VAL . 19.9 t80 -68.26 -11.06 58.77 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.118 -0.988 . . . . 0.0 112.052 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.508 ' NE2' HG21 ' A' ' 55' ' ' VAL . 12.9 p-80 -94.99 36.97 1.16 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.981 -1.074 . . . . 0.0 109.952 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.414 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . -149.95 -67.16 0.01 OUTLIER Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.029 -2.029 . . . . 0.0 108.029 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.37 141.85 40.4 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.476 -1.014 . . . . 0.0 109.885 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.7 -5.23 73.38 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 120.266 -0.968 . . . . 0.0 111.029 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 p 51.76 178.72 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.171 -1.194 . . . . 0.0 111.6 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.3 mttp 53.74 -94.43 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 111.338 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m -85.06 90.41 7.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 110.541 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.775 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -103.41 143.61 32.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.637 -0.664 . . . . 0.0 109.903 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.64 149.54 25.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.49 -0.756 . . . . 0.0 110.022 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.1 -179.46 15.88 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.87 -5.19 16.57 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 O-C-N 124.044 1.549 . . . . 0.0 111.268 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -139.59 22.27 2.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.072 -1.017 . . . . 0.0 110.582 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.5 -178.92 17.29 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.51 149.78 87.4 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.07 1.563 . . . . 0.0 111.143 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.775 HD12 ' CD2' ' A' ' 64' ' ' LEU . 59.1 mt -108.33 165.09 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.443 ' N ' HG22 ' A' ' 71' ' ' ILE . 7.2 t -102.11 -166.7 1.32 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.435 -0.79 . . . . 0.0 110.057 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -119.62 120.07 35.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.557 -0.714 . . . . 0.0 110.147 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.413 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 3.6 mmt -116.03 -36.68 4.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 110.308 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.485 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 24.6 m-85 -133.44 129.93 37.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.497 -0.752 . . . . 0.0 110.367 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.1 m -152.69 115.37 4.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.385 -0.822 . . . . 0.0 110.464 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -145.93 75.15 1.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.853 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.435 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.4 p -54.0 -25.96 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.36 -41.83 76.78 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.392 -0.817 . . . . 0.0 109.347 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -97.48 22.5 8.79 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.468 ' O ' HD12 ' A' ' 82' ' ' LEU . 71.2 m-20 53.95 52.34 13.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.512 -0.743 . . . . 0.0 111.667 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.772 HD13 HG11 ' A' ' 170' ' ' VAL . 1.3 tp -166.43 136.12 3.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.089 -1.007 . . . . 0.0 112.596 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.513 HG21 ' HA ' ' A' ' 56' ' ' TYR . 30.0 m -148.23 140.39 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 176.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 52' ' ' CYS . . . -160.28 176.17 36.98 Favored Glycine 0 C--N 1.298 -1.566 0 C-N-CA 118.426 -1.845 . . . . 0.0 111.663 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.544 ' CD1' HG21 ' A' ' 71' ' ' ILE . 37.1 p90 -130.07 134.78 47.6 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -51.26 139.46 18.82 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.484 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.726 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . . . -103.3 88.18 1.58 Allowed Pre-proline 0 C--N 1.297 -1.702 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.263 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.54 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.1 Cg_endo -94.79 -12.97 0.86 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.867 1.456 . . . . 0.0 112.271 177.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 43.1 Cg_endo -70.93 71.95 2.06 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 115.738 -2.374 . . . . 0.0 111.046 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 88' ' ' PRO . . . 52.75 24.91 20.66 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.625 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -81.48 125.43 30.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.488 -1.007 . . . . 0.0 110.488 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.408 ' CB ' ' HA3' ' A' ' 31' ' ' GLY . 26.3 ttt180 -66.31 154.32 40.3 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.405 ' CB ' ' N ' ' A' ' 50' ' ' GLY . 4.9 p -113.69 103.91 11.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.625 -0.672 . . . . 0.0 110.351 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.654 HD23 ' HB2' ' A' ' 150' ' ' ALA . 1.5 mp -64.44 -162.08 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.535 -0.728 . . . . 0.0 109.475 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.445 HG23 ' N ' ' A' ' 96' ' ' PRO . 0.6 OUTLIER -145.6 -172.06 0.3 Allowed Pre-proline 0 C--N 1.299 -1.589 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.333 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.445 ' N ' HG23 ' A' ' 95' ' ' THR . 51.2 Cg_endo -90.93 162.68 3.97 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.772 1.406 . . . . 0.0 110.991 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 80.29 1.29 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.377 -0.827 . . . . 0.0 110.845 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.2 p -77.46 62.63 2.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.437 -0.789 . . . . 0.0 109.234 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.494 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 27.2 p -129.9 169.14 15.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.48 -0.762 . . . . 0.0 111.191 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.51 -156.17 26.64 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.82 -158.45 0.2 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.448 -1.031 . . . . 0.0 110.434 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.01 -88.76 0.39 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.547 -0.721 . . . . 0.0 110.121 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 62.8 m-20 44.81 55.13 6.23 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.167 -0.958 . . . . 0.0 111.769 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.748 HD13 HD23 ' A' ' 143' ' ' LEU . 16.8 mt -88.85 168.65 12.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.494 ' O ' HG23 ' A' ' 107' ' ' VAL . 75.2 m-85 -149.79 86.87 1.46 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.586 HD13 ' CD1' ' A' ' 143' ' ' LEU . 40.6 tp -58.48 103.21 0.14 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.632 -0.667 . . . . 0.0 109.237 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.748 HG13 HG12 ' A' ' 113' ' ' VAL . 41.4 t -87.44 101.06 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.326 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.759 HG21 ' OH ' ' A' ' 134' ' ' TYR . 48.7 p -66.4 158.45 29.31 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.758 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -80.56 2.14 26.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.001 -1.062 . . . . 0.0 110.974 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.408 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -97.73 30.09 3.11 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.054 -1.029 . . . . 0.0 109.465 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 58.73 62.42 1.93 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.458 -0.776 . . . . 0.0 110.805 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.34 104.1 0.45 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.225 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.748 HG12 HG13 ' A' ' 107' ' ' VAL . 3.4 m -102.32 155.34 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.519 -0.738 . . . . 0.0 110.751 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.46 HD11 HD23 ' A' ' 106' ' ' LEU . 42.2 pt -133.09 140.19 36.7 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.477 -0.765 . . . . 0.0 109.636 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.1 129.04 16.57 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.861 1.453 . . . . 0.0 111.988 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.463 ' HB ' ' CB ' ' A' ' 104' ' ' LEU . 63.9 t -116.95 158.69 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.738 ' HG3' HD21 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -114.57 109.42 18.23 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.728 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -46.6 129.31 11.04 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.494 -0.754 . . . . 0.0 111.418 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.7 -46.37 3.38 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.943 -0.473 . . . . 0.0 111.482 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -155.35 57.88 0.39 Allowed Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.27 -1.443 . . . . 0.0 111.1 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.419 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.5 OUTLIER 65.48 -66.72 0.14 Allowed 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.486 -1.008 . . . . 0.0 111.06 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 120' ' ' GLY . 25.8 p -98.96 41.68 1.13 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 121.467 0.651 . . . . 0.0 110.019 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.459 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 13.7 ttm180 -171.65 150.02 2.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 109.689 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.37 -178.99 18.18 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.65 113.34 16.58 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 122.181 -0.6 . . . . 0.0 111.161 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.38 133.15 45.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.623 -0.673 . . . . 0.0 109.705 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.738 HD21 ' HG3' ' A' ' 117' ' ' ARG . 7.3 mt -106.91 54.35 0.67 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.107 0.956 . . . . 0.0 108.587 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 170.44 123.52 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.15 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -56.02 112.11 0.97 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 O-C-N 123.495 1.261 . . . . 0.0 110.043 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -127.72 150.58 73.57 Favored Pre-proline 0 N--CA 1.487 1.375 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.646 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.14 130.18 18.44 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 124.107 1.583 . . . . 0.0 110.342 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.689 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.1 p -62.91 -35.98 73.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.416 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -49.23 -37.82 24.36 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.759 ' OH ' HG21 ' A' ' 108' ' ' THR . 30.7 t80 -61.84 -38.24 87.47 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.476 HD11 ' CB ' ' A' ' 164' ' ' ALA . 14.1 mt -69.54 -36.65 76.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.6 103.64 0.7 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.461 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.36 -33.48 3.45 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.7 p -83.65 5.35 24.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.654 -0.909 . . . . 0.0 110.955 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.4 m -54.3 124.32 15.55 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.134 -0.979 . . . . 0.0 110.797 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.05 -13.67 12.67 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.462 ' HA2' HD12 ' A' ' 44' ' ' LEU . . . -62.64 134.44 44.39 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.557 ' CD ' HG22 ' A' ' 33' ' ' VAL . 54.5 Cg_endo -79.23 132.56 10.36 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.717 1.377 . . . . 0.0 113.254 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.748 HD23 HD13 ' A' ' 104' ' ' LEU . 4.6 mp -82.53 139.22 34.0 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 175.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 142' ' ' PRO . 1.1 mp -136.67 121.81 19.08 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 120.099 1.318 . . . . 0.0 111.593 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.494 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -69.56 -21.18 0.55 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.862 -0.524 . . . . 0.0 110.255 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 145' ' ' CYS . 46.0 Cg_endo -140.9 -162.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.876 0 O-C-N 123.461 1.243 . . . . 0.0 110.438 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.45 -55.59 29.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.387 -0.821 . . . . 0.0 110.185 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -107.7 -158.55 20.41 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 53.06 100.7 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.395 -1.062 . . . . 0.0 111.095 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.654 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -75.42 154.64 36.98 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.512 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.626 HG12 ' CE2' ' A' ' 169' ' ' PHE . 2.1 t -103.9 -35.32 3.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.702 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 176.23 -178.36 47.64 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.673 HD11 ' CD1' ' A' ' 82' ' ' LEU . 1.6 pp -118.61 146.45 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 CA-C-N 118.837 1.319 . . . . 0.0 110.98 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.807 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 6.6 t80 -59.01 113.55 2.15 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.632 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.437 ' HA ' HG11 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -99.4 -46.94 5.33 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.726 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -150.45 171.39 17.12 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.807 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -126.67 116.66 21.33 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.019 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.817 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 7.0 t -67.34 99.73 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 177.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.591 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.1 p -127.73 165.04 20.81 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.555 1.169 . . . . 0.0 113.78 -175.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.6 OUTLIER -105.31 -174.18 2.47 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.398 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -48.77 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.087 0.946 . . . . 0.0 112.544 -179.31 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.689 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 82.17 -26.69 3.78 Favored Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.644 -1.285 . . . . 0.0 112.43 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.5 t -100.58 134.82 39.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 119.223 1.512 . . . . 0.0 110.025 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.476 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -95.75 131.15 42.33 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.421 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -109.12 -43.21 4.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.746 . . . . 0.0 110.344 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.817 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -128.43 163.86 23.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.49 -0.756 . . . . 0.0 110.088 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.55 154.28 9.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.533 0.683 . . . . 0.0 110.26 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.726 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -124.01 101.62 7.33 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.195 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.626 ' CE2' HG12 ' A' ' 151' ' ' VAL . 4.9 p90 -135.22 164.34 27.92 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.676 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.772 HG11 HD13 ' A' ' 82' ' ' LEU . 3.2 p -108.57 132.39 21.16 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 40.6 Cg_endo -61.73 161.52 24.72 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.794 1.418 . . . . 0.0 111.364 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.702 HG13 ' HA2' ' A' ' 152' ' ' GLY . 19.0 m -83.93 3.54 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 121.238 -0.914 . . . . 0.0 111.341 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.67 -38.15 13.28 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.6 t -72.69 -37.2 67.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.933 -0.48 . . . . 0.0 110.642 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.625 ' HE1' HG23 ' A' ' 153' ' ' ILE . 28.5 mtt -48.89 -38.74 23.51 Favored 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.429 -0.795 . . . . 0.0 109.252 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -55.87 -39.13 71.08 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.629 0.728 . . . . 0.0 109.695 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.1 m -54.62 -38.1 66.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.774 -0.579 . . . . 0.0 110.472 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.65 -41.01 63.4 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.444 -0.785 . . . . 0.0 110.548 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.485 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -52.34 -40.47 61.98 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.19 -0.944 . . . . 0.0 111.629 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.13 -37.62 64.55 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.246 -0.909 . . . . 0.0 110.149 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.28 -39.19 54.91 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.37 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 O-C-N 121.459 -0.776 . . . . 0.0 111.301 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.572 HG11 ' N ' ' A' ' 90' ' ' GLY . 7.8 p . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.19 0.519 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -173.92 79.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.371 -0.831 . . . . 0.0 109.766 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.65 151.5 5.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.561 ' HB2' HD12 ' A' ' 94' ' ' LEU . 1.3 pm0 -67.98 -14.6 63.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.705 -0.879 . . . . 0.0 110.771 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.53 HG23 ' HG2' ' A' ' 32' ' ' GLU . 98.4 t -111.78 141.82 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 0.0 110.188 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -125.33 171.22 10.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.703 -0.623 . . . . 0.0 109.351 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 44' ' ' LEU . 34.5 m -143.63 177.28 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.774 . . . . 0.0 110.748 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.07 179.48 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 p -137.09 135.88 37.85 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.073 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.2 p -132.52 -177.45 4.48 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.76 95.66 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.459 -0.776 . . . . 0.0 110.986 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 40' ' ' THR . 16.6 m 58.25 44.95 17.97 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.483 -0.761 . . . . 0.0 110.994 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -164.92 156.95 15.64 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.204 -0.935 . . . . 0.0 111.262 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 p -146.5 132.61 19.33 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.795 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . 46.9 m-85 -100.59 -179.29 4.05 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.199 -0.938 . . . . 0.0 110.401 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.655 HD13 ' HA ' ' A' ' 138' ' ' SER . 0.0 OUTLIER -111.97 152.47 28.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 0.0 110.881 -178.838 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.0 136.56 9.01 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.554 -0.717 . . . . 0.0 109.609 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.546 HG23 HG23 ' A' ' 48' ' ' VAL . 13.6 t -110.52 119.22 38.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.222 -0.924 . . . . 0.0 112.636 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.5 t -71.38 83.36 0.79 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.762 HG11 ' CG1' ' A' ' 172' ' ' VAL . 87.4 t -102.63 138.43 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 t30 56.07 21.35 5.02 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.405 -0.809 . . . . 0.0 110.208 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.13 24.94 53.64 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.566 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 61.6 t -141.44 106.34 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.37 -1.077 . . . . 0.0 109.875 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.24 108.86 1.69 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.291 -0.88 . . . . 0.0 109.913 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.593 ' CZ3' HG21 ' A' ' 178' ' ' THR . 97.7 m95 -93.79 148.54 22.03 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.486 -0.759 . . . . 0.0 111.157 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.404 HG23 HG23 ' A' ' 83' ' ' VAL . 5.6 t -161.26 179.91 7.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.845 -0.535 . . . . 0.0 109.725 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.696 HG11 ' HA ' ' A' ' 155' ' ' ARG . 27.1 m -94.85 143.57 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.581 -0.699 . . . . 0.0 110.54 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.706 ' HB2' HG11 ' A' ' 83' ' ' VAL . 45.7 t80 -76.05 -0.92 23.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.098 -1.001 . . . . 0.0 111.889 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -51.76 -30.63 23.55 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.073 -1.017 . . . . 0.0 109.648 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.86 -147.8 5.25 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.795 ' HB2' ' CB ' ' A' ' 43' ' ' PHE . . . 53.0 22.07 2.31 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.12 -1.223 . . . . 0.0 111.406 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.98 -136.39 2.16 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.92 20.67 4.35 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.505 -0.997 . . . . 0.0 110.964 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -171.61 -161.18 0.19 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.21 -0.931 . . . . 0.0 110.65 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -78.2 96.31 5.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.715 -0.616 . . . . 0.0 110.397 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.882 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -64.78 177.56 0.93 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.714 -0.616 . . . . 0.0 110.234 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.457 ' H ' HD23 ' A' ' 64' ' ' LEU . . . -130.88 136.34 48.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.59 -0.694 . . . . 0.0 110.108 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.46 178.76 17.87 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -64.71 -16.97 58.03 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.997 1.525 . . . . 0.0 110.673 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -147.45 42.26 1.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.224 -0.923 . . . . 0.0 110.082 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.74 164.16 11.19 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -57.3 157.88 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 O-C-N 123.747 1.393 . . . . 0.0 110.877 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.882 HD12 ' CD2' ' A' ' 64' ' ' LEU . 92.0 mt -98.5 162.49 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.557 -0.715 . . . . 0.0 110.297 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 p -97.11 -169.68 1.9 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.565 -0.71 . . . . 0.0 110.495 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -141.56 116.4 9.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.696 . . . . 0.0 110.021 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 tpt -113.96 -31.84 6.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.559 -0.713 . . . . 0.0 110.331 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.421 ' CD1' ' HA ' ' A' ' 179' ' ' MET . 15.8 m-85 -129.47 104.34 7.41 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.582 -0.699 . . . . 0.0 109.658 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.616 HG22 HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -146.75 109.69 4.68 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.349 -0.941 . . . . 0.0 112.117 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -161.82 74.86 0.46 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.36 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.656 HG11 ' HB3' ' A' ' 56' ' ' TYR . 5.9 p -67.77 -23.18 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.229 -0.919 . . . . 0.0 110.224 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -50.95 -26.35 5.83 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.301 -0.874 . . . . 0.0 110.653 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -172.68 36.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.585 -0.697 . . . . 0.0 110.511 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.507 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -161.82 -86.19 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.138 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.724 ' CD1' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER 175.55 175.97 0.23 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.58 -1.325 . . . . 0.0 110.343 -178.745 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.706 HG11 ' HB2' ' A' ' 56' ' ' TYR . 27.7 m -143.56 121.6 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.648 0.737 . . . . 0.0 109.354 177.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.19 149.34 18.7 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.529 ' CZ2' HD11 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -110.46 151.37 27.61 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -63.55 137.19 58.02 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.168 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 135.8 34.62 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.736 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.458 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 38.0 Cg_endo -114.46 -38.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.463 0 O-C-N 123.56 1.295 . . . . 0.0 114.911 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 54.9 Cg_endo -61.34 -155.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 117.063 -1.492 . . . . 0.0 109.966 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.572 ' N ' HG11 ' A' ' 29' ' ' VAL . . . -78.63 32.45 1.89 Allowed Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.5 ' HA ' HG21 ' A' ' 29' ' ' VAL . . . -58.33 126.52 27.89 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.021 -1.282 . . . . 0.0 110.549 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 147.68 52.29 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.62 116.83 32.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.456 -0.778 . . . . 0.0 110.895 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.561 HD12 ' HB2' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -90.96 -159.23 0.61 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.73 -0.607 . . . . 0.0 109.528 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.536 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -156.06 -173.64 0.39 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.601 -0.687 . . . . 0.0 109.742 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -87.97 156.16 7.21 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 O-C-N 123.77 1.405 . . . . 0.0 110.311 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.448 ' SG ' HG23 ' A' ' 151' ' ' VAL . 0.5 OUTLIER -90.46 -67.81 0.82 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.443 -0.785 . . . . 0.0 110.275 179.681 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.1 m 50.57 26.79 2.58 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.193 -0.942 . . . . 0.0 110.721 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -147.06 174.28 11.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.513 -0.742 . . . . 0.0 110.86 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.46 -167.1 48.41 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.9 m -121.11 -55.41 1.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.726 -0.867 . . . . 0.0 109.772 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.62 -152.84 0.21 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.713 -0.617 . . . . 0.0 109.944 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 t0 57.3 101.87 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.335 -0.853 . . . . 0.0 110.266 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.77 HD13 HD23 ' A' ' 143' ' ' LEU . 1.4 mt -120.3 -168.99 1.72 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.505 -0.747 . . . . 0.0 109.751 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.676 ' O ' HG23 ' A' ' 107' ' ' VAL . 20.6 m-85 -140.45 83.68 1.92 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.759 HD23 HD11 ' A' ' 114' ' ' ILE . 24.6 tp -60.01 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 105' ' ' TYR . 48.6 t -84.67 102.88 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.063 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.3 p -65.14 170.17 4.8 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HB2' ' CG ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -95.55 25.8 4.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.911 -1.118 . . . . 0.0 110.363 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -124.62 29.83 6.15 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 62.08 70.68 0.57 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.543 -0.723 . . . . 0.0 111.088 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -175.0 102.69 0.09 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.645 -0.659 . . . . 0.0 110.223 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.626 ' CG1' HG22 ' A' ' 107' ' ' VAL . 7.8 m -101.79 153.81 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.446 -0.784 . . . . 0.0 110.222 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.759 HD11 HD23 ' A' ' 106' ' ' LEU . 30.2 pt -135.94 139.34 30.17 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.474 -0.766 . . . . 0.0 109.559 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.63 ' HB2' HD12 ' A' ' 127' ' ' LEU . 47.1 Cg_endo -66.85 145.48 74.84 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 123.929 1.489 . . . . 0.0 111.503 -178.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.33 142.9 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.93 117.32 34.35 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.84 128.52 15.79 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.527 -0.733 . . . . 0.0 110.119 -178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -112.97 -25.41 8.99 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.173 -177.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -172.93 53.35 0.16 Allowed Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.57 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.411 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER 65.9 -70.19 0.1 Allowed 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.633 -0.922 . . . . 0.0 110.06 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 120' ' ' GLY . 77.7 p -92.94 35.7 1.05 Allowed 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.342 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.456 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -167.91 150.75 5.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.336 -0.852 . . . . 0.0 110.216 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.42 -178.21 20.78 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 4.1 t -127.86 117.0 21.01 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.607 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.693 HD21 HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -58.53 139.27 55.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.45 -0.782 . . . . 0.0 109.475 178.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 115' ' ' PRO . 38.7 mt -105.26 53.92 0.71 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.237 1.018 . . . . 0.0 108.267 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 167.48 152.64 0.1 Allowed Pre-proline 0 N--CA 1.503 2.184 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.19 115.65 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.782 1.412 . . . . 0.0 110.044 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.606 ' HB2' HD22 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -123.62 131.8 24.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.488 -0.758 . . . . 0.0 109.035 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -58.2 130.84 39.85 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.793 1.418 . . . . 0.0 110.898 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.729 HG21 ' SG ' ' A' ' 159' ' ' CYS . 10.9 p -65.79 -37.3 79.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.584 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -49.97 -37.08 30.74 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 122.042 0.925 . . . . 0.0 110.458 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -66.91 -38.37 86.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.517 HD11 ' CB ' ' A' ' 164' ' ' ALA . 15.4 mt -66.95 -36.43 82.21 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -61.02 123.29 17.19 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.949 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.17 -25.89 26.56 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.655 ' HA ' HD13 ' A' ' 44' ' ' LEU . 7.4 m -81.09 0.96 33.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.547 -0.972 . . . . 0.0 111.427 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 60.1 m -55.83 126.2 24.61 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.216 -0.928 . . . . 0.0 111.569 -178.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 123.66 -22.66 6.86 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.624 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -53.75 126.37 35.02 Favored Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.478 ' O ' HD12 ' A' ' 144' ' ' LEU . 49.2 Cg_endo -74.33 125.67 9.85 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.763 1.402 . . . . 0.0 112.977 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.77 HD23 HD13 ' A' ' 104' ' ' LEU . 1.1 mp -76.86 135.22 38.86 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 175.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 142' ' ' PRO . 1.1 mt -132.91 127.73 34.98 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 118.924 -1.11 . . . . 0.0 111.962 -178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.506 ' HB3' HG21 ' A' ' 151' ' ' VAL . 14.2 p -74.98 -174.72 0.39 Allowed Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.1 Cg_endo -71.1 68.21 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.419 1.22 . . . . 0.0 110.643 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.78 -175.28 1.76 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.559 -0.713 . . . . 0.0 109.75 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.42 27.11 20.98 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -116.81 135.97 53.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.535 -0.979 . . . . 0.0 109.753 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -72.05 141.01 49.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.662 -0.649 . . . . 0.0 110.241 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.653 HG12 ' CE2' ' A' ' 169' ' ' PHE . 1.4 t -96.85 -37.64 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.822 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 177.29 -177.9 48.28 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.484 HG13 HG13 ' A' ' 170' ' ' VAL . 1.1 pt -117.02 140.32 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.112 -1.228 . . . . 0.0 110.435 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.756 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 9.1 t80 -58.44 115.94 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.268 0.556 . . . . 0.0 110.541 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.696 ' HA ' HG11 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -103.68 -46.09 4.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.662 -0.649 . . . . 0.0 109.662 -179.829 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.731 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -151.29 171.99 16.59 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.756 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -132.09 118.11 19.2 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.674 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.859 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.4 t -65.96 102.44 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.729 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.9 p -128.08 159.55 34.73 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.301 1.048 . . . . 0.0 113.642 -175.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 161' ' ' ARG . 1.6 m -94.05 -174.17 3.32 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.506 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -48.85 84.96 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 121.74 0.781 . . . . 0.0 112.76 -178.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.665 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 84.78 -27.59 4.79 Favored Glycine 0 N--CA 1.5 2.967 0 O-C-N 120.713 -1.242 . . . . 0.0 111.775 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -96.21 131.75 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.773 -1.428 . . . . 0.0 109.604 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.517 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -95.62 134.47 38.47 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.772 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -115.24 -39.98 3.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.729 -0.607 . . . . 0.0 110.961 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.859 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -124.61 177.95 5.68 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.255 -0.903 . . . . 0.0 109.841 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.33 155.55 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.608 0.718 . . . . 0.0 110.685 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.731 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -127.28 96.02 4.46 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.653 ' CE2' HG12 ' A' ' 151' ' ' VAL . 3.7 p90 -132.54 165.86 23.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.824 -1.173 . . . . 0.0 112.946 -176.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.724 HG21 ' CD1' ' A' ' 82' ' ' LEU . 1.3 p -108.81 127.46 27.32 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 44.2 Cg_endo -59.05 160.58 18.26 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.963 1.507 . . . . 0.0 111.954 -177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.822 HG23 ' HA2' ' A' ' 152' ' ' GLY . 40.0 t -84.23 2.98 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.515 -0.741 . . . . 0.0 109.798 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.41 -37.17 21.8 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -36.34 83.92 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.585 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.578 ' SD ' HD22 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -49.89 -36.37 27.09 Favored 'General case' 0 N--CA 1.521 3.09 0 O-C-N 121.426 -0.796 . . . . 0.0 108.885 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -57.77 -37.48 73.74 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.121 -0.987 . . . . 0.0 108.708 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.1 m -76.27 -36.84 58.22 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.633 0.73 . . . . 0.0 109.42 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.593 HG21 ' CZ3' ' A' ' 53' ' ' TRP . 1.3 m -48.82 -52.99 21.12 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.673 -0.642 . . . . 0.0 111.193 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.459 ' CE ' ' CZ2' ' A' ' 53' ' ' TRP . 2.2 ptp -59.85 -40.85 89.92 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.066 -1.021 . . . . 0.0 109.94 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -57.67 -38.36 74.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.038 0.923 . . . . 0.0 109.449 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.58 78.22 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.624 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.59 -0.693 . . . . 0.0 110.714 -179.738 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.11 0.481 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.85 78.88 0.16 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.2 71.69 0.96 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.539 -0.977 . . . . 0.0 109.495 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -72.71 141.03 48.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.766 -0.584 . . . . 0.0 110.211 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.99 90.91 1.99 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.586 -0.696 . . . . 0.0 110.398 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -84.87 -177.33 6.55 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -153.43 77.84 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.41 0.624 . . . . 0.0 110.184 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.443 HG11 ' HG2' ' A' ' 89' ' ' PRO . 35.2 m -64.14 -158.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.749 -0.594 . . . . 0.0 110.278 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 59.92 79.64 0.23 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.173 -0.954 . . . . 0.0 109.831 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.03 -89.72 0.08 OUTLIER Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -171.15 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.633 -0.922 . . . . 0.0 110.762 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 45' ' ' ALA . 7.3 p -117.34 158.8 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.59 0.71 . . . . 0.0 111.705 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 1.5 tt0 -142.35 140.2 32.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.53 HG12 ' HD2' ' A' ' 109' ' ' ARG . 27.7 m -106.22 173.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.967 0.889 . . . . 0.0 112.233 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.465 HG11 ' CH2' ' A' ' 85' ' ' TRP . 33.6 m -129.68 179.75 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.5 p -152.95 139.4 18.62 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.147 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.0 p -146.09 -178.92 6.38 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.42 75.34 0.76 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.762 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 m 178.7 -58.32 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -179.72 -156.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.391 -0.818 . . . . 0.0 109.717 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 p -128.34 139.35 52.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.548 -0.72 . . . . 0.0 109.962 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 67.9 m-85 -99.67 -178.71 3.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.477 -0.764 . . . . 0.0 110.284 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 44' ' ' LEU . 6.8 tt -116.48 146.76 42.33 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.217 -0.927 . . . . 0.0 108.883 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.596 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -148.96 137.51 21.12 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.909 -1.119 . . . . 0.0 110.714 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.697 HG23 HG23 ' A' ' 48' ' ' VAL . 14.8 t -106.39 129.89 54.3 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.283 -0.886 . . . . 0.0 113.381 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.564 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 42.2 t -75.46 87.85 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 109.883 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.697 HG23 HG23 ' A' ' 46' ' ' THR . 59.2 t -103.33 135.01 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m120 57.8 18.97 5.26 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.346 -0.846 . . . . 0.0 110.137 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.19 20.36 52.91 Favored Glycine 0 N--CA 1.498 2.775 0 O-C-N 121.215 -0.928 . . . . 0.0 111.015 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 85' ' ' TRP . 59.0 t -137.91 107.78 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.211 -1.17 . . . . 0.0 110.119 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.0 p -60.17 107.38 0.63 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.528 -0.733 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.918 ' CE3' HD23 ' A' ' 82' ' ' LEU . 96.2 m95 -88.19 146.68 25.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.032 -1.042 . . . . 0.0 111.956 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.601 HG21 ' CH2' ' A' ' 85' ' ' TRP . 8.6 t -162.76 171.25 17.05 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.865 HG11 ' CE1' ' A' ' 57' ' ' HIS . 16.3 t -94.5 151.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.451 -0.78 . . . . 0.0 109.655 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.416 ' CD2' HG12 ' A' ' 78' ' ' VAL . 18.2 t80 -76.93 4.46 9.88 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.178 -0.951 . . . . 0.0 111.709 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.865 ' CE1' HG11 ' A' ' 55' ' ' VAL . 26.3 m170 -40.72 -39.45 1.09 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.379 -0.826 . . . . 0.0 112.392 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.34 40.74 0.24 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.91 -5.6 59.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.445 -1.032 . . . . 0.0 110.864 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.49 133.58 3.07 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -92.32 -20.96 20.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.556 -0.967 . . . . 0.0 110.364 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.0 mtpp -77.7 -165.59 0.65 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.775 . . . . 0.0 110.374 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.594 HG22 ' HB2' ' A' ' 70' ' ' PRO . 1.2 m -64.93 100.09 0.39 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.594 -0.691 . . . . 0.0 111.147 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.711 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -52.24 171.39 0.05 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.626 -0.671 . . . . 0.0 110.261 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.37 142.89 46.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.269 -0.895 . . . . 0.0 111.312 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.99 -179.02 17.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -64.88 -23.0 62.62 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 O-C-N 123.9 1.474 . . . . 0.0 110.752 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -152.27 41.45 0.64 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.356 -0.84 . . . . 0.0 110.062 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.69 156.1 7.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.594 ' HB2' HG22 ' A' ' 63' ' ' THR . 52.1 Cg_endo -61.52 158.71 35.2 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.778 1.409 . . . . 0.0 110.112 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.711 HD12 ' CD2' ' A' ' 64' ' ' LEU . 80.5 mt -99.3 118.57 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.514 -0.741 . . . . 0.0 109.563 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 m -59.22 124.64 20.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.772 -0.58 . . . . 0.0 110.41 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -73.59 136.02 43.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.656 -0.653 . . . . 0.0 110.072 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.402 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -135.1 -44.9 0.71 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.631 -0.668 . . . . 0.0 110.304 -179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.467 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 14.8 m-85 -130.6 118.44 21.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.599 -0.688 . . . . 0.0 110.055 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.846 HG23 ' CG1' ' A' ' 83' ' ' VAL . 11.7 m -158.27 108.91 2.13 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.558 -0.714 . . . . 0.0 111.196 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 3.0 m120 -138.67 76.65 1.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.021 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.416 HG12 ' CD2' ' A' ' 56' ' ' TYR . 30.2 m 11.77 -133.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.88 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.49 177.99 8.62 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.733 -1.23 . . . . 0.0 110.106 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 52.31 23.08 2.25 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.523 -0.736 . . . . 0.0 110.871 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 1.8 m-20 -163.59 -114.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 109.081 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.918 HD23 ' CE3' ' A' ' 53' ' ' TRP . 3.0 tp 173.47 176.53 0.12 Allowed 'General case' 0 N--CA 1.516 2.847 0 CA-C-N 120.908 1.686 . . . . 0.0 111.319 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.846 ' CG1' HG23 ' A' ' 76' ' ' THR . 13.3 t -144.8 104.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 53' ' ' TRP . . . -123.06 109.87 1.43 Allowed Glycine 0 N--CA 1.487 2.049 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.879 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.601 ' CH2' HG21 ' A' ' 54' ' ' THR . 1.7 m0 -86.72 171.19 11.13 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -83.11 131.73 35.13 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.338 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -108.0 85.38 2.55 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.144 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.551 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -95.55 -10.71 1.0 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.745 1.392 . . . . 0.0 113.218 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 47.7 Cg_endo -72.32 73.57 2.69 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 115.715 -2.39 . . . . 0.0 110.767 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 51.87 25.8 16.82 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.564 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -67.56 138.73 56.71 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.458 -1.025 . . . . 0.0 110.963 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -84.18 120.4 26.15 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.3 p -93.17 119.73 32.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.632 -0.667 . . . . 0.0 110.7 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mt -77.66 -147.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.485 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 0.6 OUTLIER -159.2 -174.7 0.45 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 109.084 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.412 ' HD2' ' OG1' ' A' ' 95' ' ' THR . 51.8 Cg_endo -80.22 149.24 19.46 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 O-C-N 123.339 1.178 . . . . 0.0 111.138 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.731 ' O ' HG23 ' A' ' 98' ' ' THR . 1.8 t -68.15 156.23 37.94 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.158 0.98 . . . . 0.0 110.65 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 97' ' ' CYS . 0.6 OUTLIER -170.98 38.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 11.8 m -82.33 -172.56 4.07 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.625 0.726 . . . . 0.0 110.842 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -110.59 -32.76 2.62 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 m -99.02 -155.38 0.5 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.537 -0.978 . . . . 0.0 109.858 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.76 19.92 0.91 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.383 -0.823 . . . . 0.0 111.094 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 46.9 m-20 -78.85 106.82 11.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.69 HD13 HD23 ' A' ' 143' ' ' LEU . 0.3 OUTLIER -107.54 -178.39 3.61 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.778 -178.227 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.46 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.3 m-85 -141.49 92.97 2.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.686 -0.634 . . . . 0.0 109.32 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.48 HD11 HD11 ' A' ' 143' ' ' LEU . 6.2 tp -51.33 100.45 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.412 -0.805 . . . . 0.0 110.201 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.575 ' HA ' HG12 ' A' ' 113' ' ' VAL . 45.2 t -82.79 124.64 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.106 -1.037 . . . . 0.0 110.858 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 112' ' ' ASP . 47.6 p -89.91 179.73 5.91 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.656 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -96.38 52.99 1.28 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.047 -1.033 . . . . 0.0 111.404 -178.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.427 ' NE2' ' HB ' ' A' ' 108' ' ' THR . 4.9 p80 -177.09 44.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.44 -0.788 . . . . 0.0 109.996 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.57 65.11 1.61 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.643 -0.661 . . . . 0.0 111.237 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.492 ' O ' HG23 ' A' ' 108' ' ' THR . 0.8 OUTLIER -155.58 96.56 1.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 107' ' ' VAL . 17.0 m -109.26 150.71 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.607 -0.683 . . . . 0.0 110.948 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.8 pt -133.22 134.61 24.34 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.379 -0.825 . . . . 0.0 109.797 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.93 142.3 92.55 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 123.831 1.437 . . . . 0.0 112.13 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.45 152.89 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.763 -0.586 . . . . 0.0 109.683 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.89 110.84 18.24 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -48.35 127.12 12.46 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.354 -0.841 . . . . 0.0 110.725 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -111.88 -24.7 9.83 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.384 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.44 -169.66 36.75 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -63.31 128.33 35.33 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.843 0.83 . . . . 0.0 109.96 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.78 46.86 24.93 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.139 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.46 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 1.2 ttp180 -166.44 151.16 7.81 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.493 -0.754 . . . . 0.0 110.649 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.84 -178.34 18.65 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -123.64 134.45 53.77 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 122.008 -0.701 . . . . 0.0 111.88 -178.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.98 133.47 40.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.608 -0.683 . . . . 0.0 109.194 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 33.2 mt -107.27 54.16 0.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.001 0.905 . . . . 0.0 108.642 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.34 126.6 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.175 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -58.35 110.12 0.6 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 O-C-N 123.568 1.299 . . . . 0.0 110.33 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -123.03 137.77 28.71 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 47.1 Cg_endo -66.58 131.69 26.86 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.854 1.45 . . . . 0.0 110.505 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.597 HG21 ' SG ' ' A' ' 159' ' ' CYS . 7.8 p -60.14 -36.83 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.658 -0.651 . . . . 0.0 109.674 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 t -49.39 -36.51 22.07 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 122.035 0.922 . . . . 0.0 110.654 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.408 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 30.0 t80 -66.68 -37.49 84.86 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.527 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.3 mt -66.46 -36.23 82.24 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -61.18 121.62 13.0 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.746 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 113.82 -31.99 6.26 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.5 m -91.39 13.2 18.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.975 . . . . 0.0 110.881 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 p -51.52 128.74 23.82 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.174 -0.954 . . . . 0.0 110.379 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.535 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 116.26 -13.75 16.13 Favored Glycine 0 CA--C 1.542 1.772 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.654 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -46.28 110.22 0.47 Allowed Glycine 0 N--CA 1.504 3.21 0 O-C-N 121.504 -0.997 . . . . 0.0 111.174 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -67.84 126.97 15.38 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 124.066 1.561 . . . . 0.0 110.927 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.69 HD23 HD13 ' A' ' 104' ' ' LEU . 6.2 mp -80.24 130.87 35.51 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.64 120.37 22.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 109.472 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.595 ' CB ' ' HD3' ' A' ' 146' ' ' PRO . 43.1 m -49.9 -92.17 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.653 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.595 ' HD3' ' CB ' ' A' ' 145' ' ' CYS . 49.3 Cg_endo -92.3 -81.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 114.764 -3.024 . . . . 0.0 111.15 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.7 t -136.95 78.96 1.73 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.19 -0.944 . . . . 0.0 109.714 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 127.09 -166.53 19.85 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.9 m170 54.46 98.53 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.266 -1.138 . . . . 0.0 110.382 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.762 ' HB1' HG11 ' A' ' 172' ' ' VAL . . . -71.68 141.33 49.87 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.206 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.687 HG21 ' CD2' ' A' ' 104' ' ' LEU . 33.4 t -107.04 -43.39 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.69 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 175.81 179.33 46.24 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.451 HG13 HG12 ' A' ' 170' ' ' VAL . 1.4 pt -111.8 170.47 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 CA-C-N 119.589 1.695 . . . . 0.0 111.212 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.843 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 10.3 t80 -83.71 89.17 7.1 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.089 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -74.75 -41.04 60.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.503 -0.748 . . . . 0.0 109.153 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -159.74 -179.46 7.88 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.843 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -137.98 113.91 9.91 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.452 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.871 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 4.5 t -60.21 101.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.597 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.9 p -123.01 156.94 33.77 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.363 1.078 . . . . 0.0 113.603 -175.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 163' ' ' VAL . 6.1 p -96.38 -171.79 2.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -46.0 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.396 -0.815 . . . . 0.0 111.905 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.577 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 73.01 -19.24 1.28 Allowed Glycine 0 N--CA 1.499 2.865 0 O-C-N 121.168 -0.958 . . . . 0.0 112.795 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.8 t -101.98 136.05 35.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 119.39 1.595 . . . . 0.0 109.199 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.527 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -94.53 135.59 35.8 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.063 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -116.23 -38.48 3.57 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.611 -0.681 . . . . 0.0 111.047 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.871 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -129.36 178.78 6.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.496 -0.753 . . . . 0.0 109.685 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.2 t -121.11 144.82 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.671 0.748 . . . . 0.0 111.595 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.654 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -107.6 97.34 7.09 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 176.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.506 ' CE1' HG12 ' A' ' 151' ' ' VAL . 0.2 OUTLIER -126.97 142.91 51.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.881 -1.128 . . . . 0.0 112.468 -175.757 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.562 HG11 HD11 ' A' ' 82' ' ' LEU . 3.7 p -98.19 130.43 28.5 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 50.5 Cg_endo -58.68 152.69 54.46 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.667 1.351 . . . . 0.0 111.484 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.762 HG11 ' HB1' ' A' ' 150' ' ' ALA . 17.8 m -77.57 -2.53 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.417 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -85.32 -38.67 18.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 109.032 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.4 m -60.68 -36.42 78.7 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.525 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 3.3 mtt -49.25 -37.13 22.38 Favored 'General case' 0 N--CA 1.515 2.796 0 CA-C-O 121.715 0.769 . . . . 0.0 109.075 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -61.0 -40.53 93.87 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.7 m -65.55 -39.74 92.06 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.718 0.771 . . . . 0.0 109.205 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 175' ' ' MET . 0.9 OUTLIER -50.62 -41.22 54.76 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.819 -0.551 . . . . 0.0 110.798 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.467 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -53.88 -41.45 67.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.943 -1.098 . . . . 0.0 111.193 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -53.39 -36.7 61.73 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.301 -0.874 . . . . 0.0 109.61 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 178' ' ' THR . . . -67.82 -43.54 79.35 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 t -100.93 107.45 18.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.449 -0.782 . . . . 0.0 110.656 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -118.75 -62.17 1.56 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.436 -0.79 . . . . 0.0 110.326 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt 52.96 26.07 4.45 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.393 -0.817 . . . . 0.0 110.743 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -86.7 -80.93 0.23 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.57 -0.706 . . . . 0.0 110.019 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.183 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.953 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.261 0.553 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -151.99 -105.46 0.29 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 57.74 107.18 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.55 -0.971 . . . . 0.0 111.154 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.4 t0 55.69 40.3 30.88 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.466 -0.772 . . . . 0.0 110.201 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.79 21.44 4.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.516 -0.74 . . . . 0.0 111.195 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -108.21 -179.49 3.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 110.011 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.73 80.09 0.64 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 91' ' ' ALA . 9.4 p -52.27 115.87 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.642 -0.661 . . . . 0.0 111.239 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -170.82 81.04 0.08 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.72 169.53 11.77 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.481 ' HB2' HD12 ' A' ' 94' ' ' LEU . 1.1 pt-20 -98.4 -6.12 31.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.587 -0.949 . . . . 0.0 111.308 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.601 HG12 ' HG3' ' A' ' 109' ' ' ARG . 63.0 t -120.23 142.38 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.122 -0.986 . . . . 0.0 110.749 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.605 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 40.1 tt0 -135.47 144.81 46.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.826 -0.546 . . . . 0.0 109.873 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.593 HG12 HD22 ' A' ' 44' ' ' LEU . 26.8 m -117.8 174.01 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.38 -0.825 . . . . 0.0 110.815 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.512 HG11 ' CH2' ' A' ' 85' ' ' TRP . 36.0 m -128.57 -179.07 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -138.66 133.97 33.06 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.731 -1.187 . . . . 0.0 112.296 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.3 p -126.48 -177.81 4.12 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.18 96.69 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.164 -0.96 . . . . 0.0 111.145 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 m 59.54 47.55 10.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.644 -0.66 . . . . 0.0 110.622 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -165.13 169.31 16.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.248 -0.907 . . . . 0.0 110.984 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.5 p -158.45 132.99 8.14 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . 91.8 m-85 -99.65 -178.94 4.04 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.111 -0.993 . . . . 0.0 111.235 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.593 HD22 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -113.1 152.49 29.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 34' ' ' GLN . . . -162.18 159.39 25.82 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.596 -0.69 . . . . 0.0 110.368 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.695 HG23 HG23 ' A' ' 48' ' ' VAL . 14.2 t -138.05 128.83 26.86 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.457 -0.777 . . . . 0.0 111.612 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 79.5 m -77.97 82.22 4.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.551 -0.718 . . . . 0.0 109.727 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.695 HG23 HG23 ' A' ' 46' ' ' THR . 57.9 t -97.95 137.84 24.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 57.18 21.0 6.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.801 -0.562 . . . . 0.0 110.248 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.63 23.62 38.79 Favored Glycine 0 N--CA 1.494 2.524 0 O-C-N 121.414 -0.804 . . . . 0.0 111.822 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 85' ' ' TRP . 46.3 t -143.3 116.18 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-N 118.939 1.37 . . . . 0.0 110.388 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.519 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 13.1 t -64.29 105.64 0.95 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.955 ' CE3' HD23 ' A' ' 82' ' ' LEU . 98.3 m95 -86.41 149.84 24.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.388 -0.82 . . . . 0.0 112.146 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.86 HG21 ' CZ2' ' A' ' 85' ' ' TRP . 7.5 t -164.45 171.93 14.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.584 -0.698 . . . . 0.0 110.519 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.556 HG11 ' CD2' ' A' ' 57' ' ' HIS . 2.8 t -92.98 150.05 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.604 -0.685 . . . . 0.0 109.922 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.536 ' HB3' ' HA ' ' A' ' 78' ' ' VAL . 27.0 t80 -82.95 -2.43 55.08 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.219 -0.926 . . . . 0.0 112.112 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.556 ' CD2' HG11 ' A' ' 55' ' ' VAL . 1.2 p80 -67.47 -10.72 54.19 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.206 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.12 -50.58 0.02 OUTLIER Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.833 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HB3' ' OG1' ' A' ' 54' ' ' THR . . . -83.08 112.63 19.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.012 -1.287 . . . . 0.0 109.899 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.27 10.45 27.61 Favored Glycine 0 N--CA 1.499 2.847 0 O-C-N 121.169 -0.957 . . . . 0.0 110.85 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.4 t -103.66 -38.57 7.05 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.86 -1.377 . . . . 0.0 110.193 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.53 -165.17 1.09 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.494 -0.754 . . . . 0.0 110.577 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -72.05 90.57 1.18 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.669 -0.645 . . . . 0.0 109.855 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.864 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -56.22 177.77 0.06 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.869 -0.519 . . . . 0.0 110.414 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.3 126.82 32.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -127.99 -178.63 15.43 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.78 -18.04 52.69 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 124.036 1.545 . . . . 0.0 109.649 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -122.89 25.55 8.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 111.008 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 66' ' ' GLY . . . 108.7 -157.71 15.07 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -55.49 145.81 66.82 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.692 1.364 . . . . 0.0 111.523 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.864 HD12 ' CD2' ' A' ' 64' ' ' LEU . 88.1 mt -93.14 16.57 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.519 -0.738 . . . . 0.0 110.506 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 p 43.17 -153.8 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.302 -0.874 . . . . 0.0 111.501 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.66 118.75 2.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.68 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -30.49 9.98 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.374 -0.828 . . . . 0.0 109.967 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.433 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 15.5 m-85 -129.58 121.71 27.66 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.699 HG23 ' CG1' ' A' ' 83' ' ' VAL . 3.7 m -160.44 113.52 2.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.287 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.45 ' C ' HG22 ' A' ' 78' ' ' VAL . 6.3 t-20 -143.59 73.15 1.38 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.504 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.536 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 14.2 m 36.01 -162.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.93 -31.61 34.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.406 ' HB2' HG23 ' A' ' 78' ' ' VAL . 54.3 mt-30 -52.2 -30.6 27.9 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.682 0.753 . . . . 0.0 109.255 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.416 ' CB ' ' HB3' ' A' ' 77' ' ' ASN . 0.5 OUTLIER -126.97 -102.26 0.35 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.484 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.955 HD23 ' CE3' ' A' ' 53' ' ' TRP . 0.8 OUTLIER 179.22 168.42 1.01 Allowed 'General case' 0 N--CA 1.512 2.628 0 O-C-N 120.299 -1.501 . . . . 0.0 112.27 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.699 ' CG1' HG23 ' A' ' 76' ' ' THR . 20.0 t -128.5 150.54 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.38 111.31 0.47 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.319 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.86 ' CZ2' HG21 ' A' ' 54' ' ' THR . 1.1 m-90 -87.04 172.58 9.87 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -87.31 131.33 34.29 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.688 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 91' ' ' ALA . . . -58.66 167.73 1.7 Allowed Pre-proline 0 N--CA 1.494 1.773 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.554 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 33.2 Cg_endo -67.29 -79.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.555 1.546 0 O-C-N 123.879 1.463 . . . . 0.0 110.581 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 88' ' ' PRO . 56.0 Cg_endo -97.65 36.04 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 115.731 -2.379 . . . . 0.0 108.606 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.28 -10.34 73.53 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.659 ' HA ' HG23 ' A' ' 29' ' ' VAL . . . 50.15 -178.39 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.207 -1.173 . . . . 0.0 111.855 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -73.19 72.43 1.22 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 t -41.74 95.88 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.755 -0.591 . . . . 0.0 111.968 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.481 HD12 ' HB2' ' A' ' 32' ' ' GLU . 1.0 OUTLIER -68.88 -157.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.596 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.695 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 0.9 OUTLIER -153.29 175.14 3.16 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 121.245 -0.91 . . . . 0.0 111.179 -179.431 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.62 163.95 26.26 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 O-C-N 123.845 1.445 . . . . 0.0 111.545 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 18.5 t -79.56 -72.78 0.38 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.705 -0.622 . . . . 0.0 109.811 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.0 m 49.77 74.48 0.2 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.419 -0.801 . . . . 0.0 110.612 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 77.2 m -138.14 -64.92 0.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.261 -0.899 . . . . 0.0 110.601 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 116.33 33.69 1.43 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.4 m -134.32 -163.84 1.42 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.655 -0.909 . . . . 0.0 109.725 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.6 p -135.64 -151.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.578 -0.701 . . . . 0.0 109.546 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 30.2 t70 62.23 109.79 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.331 -0.856 . . . . 0.0 109.893 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.604 HD13 HD23 ' A' ' 143' ' ' LEU . 1.1 mt -128.2 -171.4 2.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.545 -0.722 . . . . 0.0 109.434 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.635 ' O ' HG23 ' A' ' 107' ' ' VAL . 16.4 m-85 -139.5 90.5 2.41 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.553 HD12 ' HG ' ' A' ' 143' ' ' LEU . 11.6 tp -59.44 93.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 105' ' ' TYR . 84.6 t -82.56 101.57 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.356 -177.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.525 HG21 ' OH ' ' A' ' 134' ' ' TYR . 38.5 p -65.66 168.48 7.57 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.601 ' HG3' HG12 ' A' ' 33' ' ' VAL . 1.1 tmt_? -93.35 24.03 4.15 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.728 -1.232 . . . . 0.0 110.727 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.96 31.27 5.88 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 56.46 71.73 0.55 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.63 0.729 . . . . 0.0 110.516 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -171.99 91.88 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.57 ' CG1' HG22 ' A' ' 107' ' ' VAL . 11.8 m -94.57 151.24 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.421 ' CG1' ' HB3' ' A' ' 106' ' ' LEU . 30.9 pt -129.96 142.43 45.34 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.29 -0.881 . . . . 0.0 109.031 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.58 132.85 24.5 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.811 1.427 . . . . 0.0 112.09 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 103' ' ' ASP . 91.4 t -121.45 153.71 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -116.06 111.85 20.9 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.92 124.13 8.15 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.626 -0.672 . . . . 0.0 110.15 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 125' ' ' SER . 1.6 mmm180 -104.97 -49.45 3.48 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.842 -0.536 . . . . 0.0 110.701 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -151.93 -158.43 8.41 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.712 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -70.58 125.05 25.73 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.147 0.975 . . . . 0.0 109.262 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.83 50.13 16.36 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.042 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.521 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 19.2 ttm180 -166.12 156.53 12.64 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.589 -0.694 . . . . 0.0 110.787 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.95 -178.61 23.28 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.475 ' HB2' ' HG3' ' A' ' 119' ' ' ARG . 1.4 t -135.37 100.84 4.64 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.086 -0.655 . . . . 0.0 111.559 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 126' ' ' LEU . 2.4 pp -48.19 162.64 0.08 Allowed 'General case' 0 N--CA 1.51 2.552 0 O-C-N 121.466 -0.771 . . . . 0.0 110.713 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.7 mt -127.41 67.51 1.3 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 164.3 134.96 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.058 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.691 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.0 100.49 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.803 1.423 . . . . 0.0 109.566 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.36 128.21 25.74 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.539 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -56.0 127.13 24.81 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.917 1.483 . . . . 0.0 110.85 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.712 HG21 ' SG ' ' A' ' 159' ' ' CYS . 7.3 p -60.61 -36.56 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.44 -37.03 24.29 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.546 -0.722 . . . . 0.0 110.807 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.525 ' OH ' HG21 ' A' ' 108' ' ' THR . 17.0 t80 -67.8 -39.49 84.01 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.3 mt -63.05 -34.8 78.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 123.81 17.1 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.651 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.31 -31.22 8.88 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.464 ' HA ' HD23 ' A' ' 44' ' ' LEU . 57.6 m -79.34 -0.62 33.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.915 -0.756 . . . . 0.0 111.104 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 2.0 m -57.53 119.84 7.24 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 120.9 -1.125 . . . . 0.0 109.738 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 122.8 -17.24 8.22 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.4 137.88 49.71 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.51 ' CD ' HG22 ' A' ' 33' ' ' VAL . 49.5 Cg_endo -85.16 129.12 3.78 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 O-C-N 123.522 1.275 . . . . 0.0 113.476 -177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.604 HD23 HD13 ' A' ' 104' ' ' LEU . 4.4 mp -81.6 130.79 35.18 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 150' ' ' ALA . 1.1 mt -129.92 123.74 31.46 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 119.778 1.172 . . . . 0.0 112.474 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.428 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 4.2 p -67.44 -173.6 0.16 Allowed Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 40.8 Cg_endo -66.94 169.25 15.24 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.674 1.355 . . . . 0.0 110.214 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m 53.35 29.89 9.4 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.638 -0.664 . . . . 0.0 111.43 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 73.63 -134.01 18.43 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 59.61 106.19 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.26 -1.141 . . . . 0.0 110.278 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -65.81 143.94 57.17 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.69 -0.631 . . . . 0.0 110.798 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 2.1 t -107.01 -42.94 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.759 -0.588 . . . . 0.0 110.326 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.701 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 177.71 -178.62 48.42 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.66 HG13 HG13 ' A' ' 170' ' ' VAL . 1.0 OUTLIER -116.72 153.48 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 118.59 1.195 . . . . 0.0 111.718 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.78 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 7.4 t80 -65.38 117.24 7.62 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.505 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -107.26 -35.01 6.93 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.234 -0.916 . . . . 0.0 109.171 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.717 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -159.17 169.83 23.28 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.78 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -129.84 116.89 19.36 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.41 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.802 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.0 t -63.39 100.55 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.712 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.8 p -129.03 167.29 17.71 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.512 1.148 . . . . 0.0 113.971 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 162' ' ' GLY . 14.9 p -105.47 -173.51 2.32 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.12 82.9 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.635 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 86.09 -27.25 5.63 Favored Glycine 0 N--CA 1.501 2.968 0 O-C-N 121.098 -1.001 . . . . 0.0 112.52 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.27 139.73 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-N 119.188 1.494 . . . . 0.0 108.288 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.605 ' C ' HD21 ' A' ' 126' ' ' LEU . . . -99.52 139.32 35.35 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.371 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.517 ' HA ' HD11 ' A' ' 126' ' ' LEU . 5.7 mtpt -112.98 -31.36 6.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.697 -0.627 . . . . 0.0 110.62 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.802 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -141.58 178.65 7.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.888 . . . . 0.0 110.324 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.34 150.4 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.662 0.744 . . . . 0.0 110.857 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.717 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -119.92 103.24 9.16 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 177.279 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.521 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 1.7 p90 -128.44 174.32 9.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 118.966 -1.094 . . . . 0.0 112.23 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.662 HG11 ' CD1' ' A' ' 82' ' ' LEU . 1.4 p -125.96 122.26 24.35 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 41.1 Cg_endo -47.92 152.84 2.89 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 O-C-N 123.651 1.343 . . . . 0.0 113.11 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.701 HG13 ' HA2' ' A' ' 152' ' ' GLY . 18.2 m -82.38 -1.85 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.343 -0.848 . . . . 0.0 109.832 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -87.42 -43.69 11.9 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.547 -0.72 . . . . 0.0 109.187 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.7 t -60.7 -42.74 97.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.737 -0.602 . . . . 0.0 109.716 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.903 ' HB3' HD22 ' A' ' 82' ' ' LEU . 8.2 ptp -58.9 -36.54 74.85 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.914 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.85 -38.05 69.57 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.387 -1.445 . . . . 0.0 108.822 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.7 m -63.62 -36.89 85.3 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.325 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.899 HG22 ' O ' ' A' ' 175' ' ' MET . 3.1 t -48.71 -35.5 14.15 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.12 -0.987 . . . . 0.0 111.645 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.471 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -58.19 -41.25 83.51 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.866 -1.146 . . . . 0.0 110.447 179.012 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -48.61 -36.68 16.27 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.967 0.889 . . . . 0.0 110.604 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -91.3 -42.74 10.2 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.2 t 51.72 -176.57 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.296 -0.877 . . . . 0.0 110.962 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt -101.62 -67.64 0.86 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.741 0.781 . . . . 0.0 109.941 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.63 144.53 30.24 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.778 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -149.04 53.44 0.97 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.526 -0.734 . . . . 0.0 110.46 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.29 179.721 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.181 0.515 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.11 71.32 0.6 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -124.0 54.76 1.31 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.604 -0.939 . . . . 0.0 109.331 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -147.27 42.3 1.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.633 -0.667 . . . . 0.0 110.453 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -91.47 52.54 2.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.47 -0.769 . . . . 0.0 110.489 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -65.22 86.82 0.07 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.534 -0.729 . . . . 0.0 109.305 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.85 77.94 0.76 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.543 -0.723 . . . . 0.0 109.592 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 89' ' ' PRO . 33.6 m -100.31 -164.48 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.816 -0.553 . . . . 0.0 109.91 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 58.51 79.07 0.22 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.333 -0.855 . . . . 0.0 109.869 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.0 -108.92 0.21 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -168.43 -35.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.549 -0.971 . . . . 0.0 111.437 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.755 HG22 ' OG1' ' A' ' 46' ' ' THR . 54.1 t -131.32 140.6 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.119 -0.988 . . . . 0.0 111.723 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.84 156.41 48.95 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.657 HG11 ' HB3' ' A' ' 109' ' ' ARG . 33.7 m -123.27 174.87 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.307 -0.87 . . . . 0.0 111.885 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.72 HG13 ' CZ ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -144.6 163.73 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.056 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.3 p -119.91 142.89 48.29 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.387 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 p -123.85 -176.87 3.58 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.27 98.36 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.395 -0.815 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 p 51.92 31.98 9.27 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.828 -0.545 . . . . 0.0 110.794 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -146.87 154.99 41.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.552 -0.717 . . . . 0.0 110.449 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.2 t -150.0 165.72 31.83 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.568 -0.707 . . . . 0.0 109.318 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.72 ' CZ ' HG13 ' A' ' 36' ' ' VAL . 11.0 p90 -153.6 -177.38 6.33 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.254 -0.904 . . . . 0.0 110.598 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.778 HD12 ' HG3' ' A' ' 109' ' ' ARG . 7.0 tt -110.43 146.1 36.46 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.509 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -146.12 128.86 16.23 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.681 -1.262 . . . . 0.0 110.287 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.755 ' OG1' HG22 ' A' ' 33' ' ' VAL . 99.9 m -110.31 128.13 55.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.435 -0.791 . . . . 0.0 111.479 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 79.2 m -78.07 85.95 4.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.806 -0.559 . . . . 0.0 109.816 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 94' ' ' LEU . 21.8 t -98.26 136.44 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.99 19.3 5.78 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.397 -0.815 . . . . 0.0 109.993 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.98 24.35 45.31 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 85' ' ' TRP . 42.9 t -139.85 105.44 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 121.261 -1.141 . . . . 0.0 110.378 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.423 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -58.04 97.34 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.464 -0.772 . . . . 0.0 109.942 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.991 ' CE3' HD23 ' A' ' 82' ' ' LEU . 81.2 m95 -78.53 141.35 38.23 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.341 -0.849 . . . . 0.0 110.668 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.477 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 10.2 t -163.33 126.77 2.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.564 -0.71 . . . . 0.0 109.707 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.476 HG11 ' HA ' ' A' ' 155' ' ' ARG . 21.4 m -49.3 143.7 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 O-C-N 121.274 -0.891 . . . . 0.0 110.902 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.528 ' HB2' HG21 ' A' ' 83' ' ' VAL . 4.8 t80 -74.62 -1.72 22.85 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.123 -0.986 . . . . 0.0 110.902 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -48.79 -27.31 2.89 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.26 -0.9 . . . . 0.0 110.689 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.03 76.7 0.09 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.583 ' HB1' ' HZ2' ' A' ' 85' ' ' TRP . . . -105.09 -51.16 3.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.447 -1.031 . . . . 0.0 110.101 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 151.08 -40.6 0.79 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 p 51.68 23.94 2.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.551 -0.97 . . . . 0.0 111.201 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.24 -158.47 0.91 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.426 -0.797 . . . . 0.0 110.509 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.4 m -60.3 91.02 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.573 -0.704 . . . . 0.0 110.534 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.855 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -76.16 164.82 25.72 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.675 -0.641 . . . . 0.0 110.233 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.31 135.48 55.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.205 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.23 -179.02 19.87 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.3 -29.19 88.37 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.872 1.459 . . . . 0.0 111.098 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -147.32 38.6 0.96 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.407 -0.808 . . . . 0.0 110.096 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.06 158.08 8.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -63.63 163.7 23.52 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 O-C-N 123.92 1.484 . . . . 0.0 110.493 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.855 HD12 ' CD2' ' A' ' 64' ' ' LEU . 93.4 mt -106.81 108.75 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.653 -0.654 . . . . 0.0 109.494 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -62.0 137.09 58.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.717 -0.615 . . . . 0.0 110.51 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -73.55 163.47 27.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.566 -0.708 . . . . 0.0 109.806 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -43.81 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.448 -0.783 . . . . 0.0 110.486 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.458 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 14.3 m-85 -126.68 124.36 39.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.492 -0.755 . . . . 0.0 110.075 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.633 HG23 ' CG1' ' A' ' 83' ' ' VAL . 6.3 m -158.85 106.41 1.84 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.705 -0.622 . . . . 0.0 111.009 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.417 ' CB ' ' HB2' ' A' ' 81' ' ' ASP . 18.7 m120 -152.44 76.57 1.16 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.554 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.5 p -72.31 -21.26 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.641 -0.662 . . . . 0.0 110.828 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.73 -32.17 29.32 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.045 -1.034 . . . . 0.0 110.401 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -173.85 34.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.595 -0.691 . . . . 0.0 110.337 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.417 ' HB2' ' CB ' ' A' ' 77' ' ' ASN . 6.7 m-20 -153.95 -99.92 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.313 -0.867 . . . . 0.0 111.811 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.991 HD23 ' CE3' ' A' ' 53' ' ' TRP . 6.2 tp 178.19 176.35 0.47 Allowed 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.548 -1.345 . . . . 0.0 110.274 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.633 ' CG1' HG23 ' A' ' 76' ' ' THR . 16.1 t -132.83 115.57 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.31 110.79 0.82 Allowed Glycine 0 N--CA 1.485 1.908 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.42 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.583 ' HZ2' ' HB1' ' A' ' 59' ' ' ALA . 1.9 m0 -79.38 166.43 22.07 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -86.39 130.29 34.56 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.304 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.707 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -108.17 92.13 9.04 Favored Pre-proline 0 C--N 1.294 -1.846 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.344 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.578 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.8 Cg_endo -104.48 -3.5 0.2 Allowed 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.747 1.393 . . . . 0.0 112.967 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 52.4 Cg_endo -72.94 72.29 3.28 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 115.714 -2.391 . . . . 0.0 109.683 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 57.21 24.24 50.58 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 87' ' ' ALA . . . -74.39 138.56 43.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.546 -0.973 . . . . 0.0 110.732 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.0 135.95 43.16 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.474 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.3 p -104.59 97.93 7.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.563 -0.71 . . . . 0.0 109.563 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.59 ' HB3' HG13 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -65.49 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.543 -0.723 . . . . 0.0 109.161 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.788 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 5.6 p -155.48 173.77 4.56 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.573 -0.705 . . . . 0.0 110.339 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.34 177.61 8.55 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.839 1.441 . . . . 0.0 110.198 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 t -98.69 -77.3 0.52 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.539 -0.725 . . . . 0.0 110.119 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m 55.11 49.81 16.64 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.223 -0.923 . . . . 0.0 110.008 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 78.3 m -112.5 -46.69 3.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.671 -0.643 . . . . 0.0 110.302 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.98 28.8 6.38 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.31 -164.56 1.22 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.609 -0.936 . . . . 0.0 109.987 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.2 p -140.88 -150.33 0.31 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.369 -0.832 . . . . 0.0 110.541 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.73 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.137 -0.977 . . . . 0.0 109.973 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.8 HD13 HD23 ' A' ' 143' ' ' LEU . 0.6 OUTLIER -117.94 -178.8 3.58 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.503 -0.748 . . . . 0.0 110.097 -179.203 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -133.56 84.74 2.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.669 -0.644 . . . . 0.0 109.618 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 154' ' ' PHE . 21.5 tp -60.87 106.38 0.57 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.629 -0.669 . . . . 0.0 109.39 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.712 HG22 HG12 ' A' ' 113' ' ' VAL . 25.1 t -84.43 133.65 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.657 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.3 p -89.34 -177.86 5.47 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.778 ' HG3' HD12 ' A' ' 44' ' ' LEU . 14.5 mtm180 -87.73 18.9 3.73 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.0 -1.063 . . . . 0.0 110.505 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.48 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.9 OUTLIER -151.19 47.49 0.83 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.051 -1.03 . . . . 0.0 111.99 -177.503 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.06 73.03 0.44 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.294 -0.879 . . . . 0.0 111.457 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.82 90.16 0.69 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.791 -0.568 . . . . 0.0 109.818 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.712 HG12 HG22 ' A' ' 107' ' ' VAL . 26.3 m -94.78 149.55 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 110.252 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.638 HG22 HH21 ' A' ' 130' ' ' ARG . 34.1 pt -131.48 141.77 42.94 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.512 -0.742 . . . . 0.0 109.723 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.33 137.38 36.55 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.918 1.483 . . . . 0.0 111.772 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.9 t -130.97 140.31 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.04 118.26 36.16 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -48.75 127.3 13.51 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.401 -0.812 . . . . 0.0 110.203 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.42 ' CG ' ' HB2' ' A' ' 125' ' ' SER . 3.7 mmt180 -107.13 -25.23 11.64 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.257 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 121' ' ' ASP . . . 173.04 56.52 0.05 OUTLIER Glycine 0 N--CA 1.498 2.773 0 C-N-CA 118.834 -1.65 . . . . 0.0 110.59 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 120' ' ' GLY . 0.6 OUTLIER 59.23 142.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.831 -0.806 . . . . 0.0 110.132 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.5 p 45.57 27.78 0.45 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.544 0.688 . . . . 0.0 111.554 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.518 ' HD2' HG21 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -166.88 148.05 5.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.522 -0.736 . . . . 0.0 109.427 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.37 -178.09 18.04 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.6 t -124.31 122.25 37.22 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.245 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.4 149.53 33.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.743 -0.598 . . . . 0.0 109.582 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 128' ' ' SER . 90.2 mt -126.01 69.4 1.2 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER 158.16 123.05 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.368 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -58.95 106.81 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 O-C-N 123.588 1.31 . . . . 0.0 109.745 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.638 HH21 HG22 ' A' ' 114' ' ' ILE . 9.9 mtt-85 -122.39 151.18 59.0 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.95 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 49.2 Cg_endo -75.3 130.02 12.6 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.178 1.62 . . . . 0.0 109.807 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.7 p -57.92 -36.53 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.73 -0.606 . . . . 0.0 110.093 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 t -49.58 -36.55 24.35 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 122.127 0.965 . . . . 0.0 110.227 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.417 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 57.7 t80 -60.85 -38.04 84.18 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 11.5 mt -69.21 -35.28 76.05 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.712 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -56.95 117.07 3.6 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.746 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 108.29 -24.47 22.57 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.44 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -86.43 4.29 40.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.506 -0.997 . . . . 0.0 111.273 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 80.1 p -51.93 128.85 25.4 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.964 -1.085 . . . . 0.0 109.609 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.519 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 114.96 -18.28 16.64 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.731 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -48.28 117.46 3.79 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.516 ' HG3' HG21 ' A' ' 46' ' ' THR . 53.7 Cg_endo -74.11 124.71 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 124.022 1.538 . . . . 0.0 111.343 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.8 HD23 HD13 ' A' ' 104' ' ' LEU . 6.0 mp -82.9 105.07 13.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 176.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.577 HD21 ' CD1' ' A' ' 94' ' ' LEU . 1.5 mt -105.24 119.72 39.75 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.131 -0.981 . . . . 0.0 112.385 -176.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.451 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 0.9 OUTLIER -59.63 -167.34 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 41.2 Cg_endo -69.4 167.06 25.06 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 117.092 -1.472 . . . . 0.0 109.472 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.2 t 56.77 -155.04 0.32 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.27 -0.894 . . . . 0.0 110.115 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 149' ' ' HIS . . . -102.76 100.53 1.97 Allowed Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.426 ' CG ' ' O ' ' A' ' 148' ' ' GLY . 0.4 OUTLIER -170.65 95.95 0.22 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.692 -0.887 . . . . 0.0 109.853 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.788 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -63.23 142.32 58.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.573 -0.704 . . . . 0.0 109.256 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 0.9 OUTLIER -103.39 -36.99 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.451 -0.781 . . . . 0.0 109.575 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.661 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 176.15 -178.89 47.49 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.804 HG23 ' HE1' ' A' ' 175' ' ' MET . 1.1 pp -114.7 168.75 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-N 118.906 1.353 . . . . 0.0 111.392 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.749 ' HB2' HD11 ' A' ' 106' ' ' LEU . 5.9 t80 -76.96 114.57 15.89 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.29 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.476 ' HA ' HG11 ' A' ' 55' ' ' VAL . 26.5 ttt-85 -100.97 -38.97 7.97 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.698 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -159.89 173.61 15.68 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.743 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -129.69 119.84 24.16 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.772 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.839 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.5 t -69.95 100.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.67 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.6 p -127.3 158.07 38.19 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 122.253 1.025 . . . . 0.0 113.354 -175.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' GLY . 16.5 p -91.25 -175.01 4.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.92 85.65 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.692 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 86.51 -25.0 7.62 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 121.063 -1.023 . . . . 0.0 112.214 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -101.7 140.61 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 119.177 1.489 . . . . 0.0 109.214 -179.485 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -103.26 129.63 50.29 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.047 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt -111.51 -33.79 6.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.652 -0.655 . . . . 0.0 110.548 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.839 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -129.6 -179.7 5.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.275 -0.891 . . . . 0.0 110.219 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -126.89 147.47 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.615 0.722 . . . . 0.0 111.683 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.698 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -111.45 96.33 6.04 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 177.006 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.61 ' CD2' HD22 ' A' ' 143' ' ' LEU . 0.3 OUTLIER -124.13 160.42 27.83 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.252 -0.979 . . . . 0.0 112.694 -175.882 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 153' ' ' ILE . 2.7 p -116.21 126.22 27.82 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 47.0 Cg_endo -56.53 156.36 22.46 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 O-C-N 123.872 1.459 . . . . 0.0 112.311 -177.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.661 HG23 ' HA2' ' A' ' 152' ' ' GLY . 57.5 t -80.76 -2.96 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.05 -37.78 28.5 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.9 t -72.42 -36.01 68.49 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.949 ' O ' HG22 ' A' ' 178' ' ' THR . 36.7 mtt -48.24 -39.07 20.13 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.621 -0.674 . . . . 0.0 110.426 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -54.82 -37.27 65.93 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.883 0.849 . . . . 0.0 109.283 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.7 m -52.9 -41.71 64.65 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.236 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.949 HG22 ' O ' ' A' ' 175' ' ' MET . 14.6 t -56.56 -36.47 69.34 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.94 -1.1 . . . . 0.0 111.635 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.482 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -56.2 -44.2 79.23 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.645 -1.284 . . . . 0.0 110.56 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -51.45 -37.91 51.07 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.944 0.878 . . . . 0.0 110.054 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -74.11 -48.47 29.39 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.697 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.3 t 49.88 41.45 22.68 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.509 -0.744 . . . . 0.0 110.992 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt 54.22 -177.19 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.471 -0.768 . . . . 0.0 110.784 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -67.01 151.54 47.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.579 -0.701 . . . . 0.0 109.916 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -154.68 29.07 0.43 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.561 -0.712 . . . . 0.0 110.518 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.7 tptt . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.289 179.957 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.204 0.526 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.13 -37.46 0.07 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.18 85.39 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.385 -1.068 . . . . 0.0 110.508 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -125.13 45.75 2.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.732 -0.605 . . . . 0.0 110.304 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -95.01 47.37 1.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.633 -0.667 . . . . 0.0 110.454 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -62.58 83.91 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.629 -0.669 . . . . 0.0 110.155 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -160.84 77.81 0.59 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.639 -0.663 . . . . 0.0 109.351 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.43 HG22 ' N ' ' A' ' 30' ' ' GLU . 3.5 p -51.36 162.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.468 -0.77 . . . . 0.0 110.476 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.43 ' N ' HG22 ' A' ' 29' ' ' VAL . 2.6 mm-40 -156.06 79.38 0.98 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.32 -26.39 3.4 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.39 -79.72 0.07 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.508 -0.995 . . . . 0.0 109.243 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 45' ' ' ALA . 9.6 p -150.43 148.71 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 111.385 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -131.84 150.2 52.22 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.587 HG12 HD23 ' A' ' 44' ' ' LEU . 31.6 m -108.98 164.09 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.218 -0.926 . . . . 0.0 112.311 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.717 HG11 ' CH2' ' A' ' 85' ' ' TRP . 21.9 m -122.53 179.7 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -149.93 137.87 20.23 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.447 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.4 p -144.65 -178.67 6.12 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 40' ' ' THR . . . -68.87 76.74 0.31 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.027 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER 175.51 -59.51 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.584 -0.697 . . . . 0.0 109.323 -179.537 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 178.21 -171.3 0.11 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.538 -0.726 . . . . 0.0 109.075 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.3 p -112.68 138.06 50.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.513 -0.742 . . . . 0.0 109.923 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 43.9 m-85 -106.3 173.07 6.48 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.537 -0.727 . . . . 0.0 110.607 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.776 HD22 ' HB2' ' A' ' 109' ' ' ARG . 12.7 mt -100.67 159.85 14.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.521 -0.737 . . . . 0.0 110.713 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -158.45 126.71 5.3 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.073 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.587 HG23 HG23 ' A' ' 48' ' ' VAL . 8.6 t -104.95 127.43 52.79 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.375 -0.828 . . . . 0.0 112.288 -178.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 97.2 m -80.15 85.41 5.71 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.762 -0.586 . . . . 0.0 109.951 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.587 HG23 HG23 ' A' ' 46' ' ' THR . 67.7 t -105.13 139.43 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.41 17.97 5.23 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.246 -0.909 . . . . 0.0 110.259 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.23 43.12 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.4 t -141.59 112.04 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.313 -1.11 . . . . 0.0 110.546 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.43 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 1.8 t -67.38 105.65 1.85 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.932 ' CE3' HD23 ' A' ' 82' ' ' LEU . 82.2 m95 -87.3 145.54 26.31 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.235 -0.916 . . . . 0.0 111.097 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 83' ' ' VAL . 9.0 t -162.2 178.35 8.83 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.269 -0.894 . . . . 0.0 110.293 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 55' ' ' VAL . 31.4 m -101.35 143.12 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.636 -0.665 . . . . 0.0 109.948 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.606 ' HB2' HG11 ' A' ' 83' ' ' VAL . 36.9 t80 -78.25 2.53 18.03 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.063 -1.023 . . . . 0.0 111.923 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -48.73 -26.77 2.51 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.178 -0.951 . . . . 0.0 110.868 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.414 ' HA3' ' CZ ' ' A' ' 43' ' ' PHE . . . -177.75 35.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.531 ' HB1' ' CZ2' ' A' ' 85' ' ' TRP . . . -81.29 0.39 37.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.188 -1.184 . . . . 0.0 111.194 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.05 -171.28 22.37 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.0 t -160.65 -43.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.677 -0.896 . . . . 0.0 110.033 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -165.99 0.06 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.726 -0.608 . . . . 0.0 110.513 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -59.7 97.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.663 -0.648 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.666 HD22 HD12 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -60.46 176.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.668 -0.645 . . . . 0.0 109.928 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -118.18 135.68 54.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.417 -0.802 . . . . 0.0 110.669 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.3 179.61 23.81 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -63.57 -23.15 70.54 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.876 1.461 . . . . 0.0 110.483 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -153.28 40.47 0.53 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.326 -0.859 . . . . 0.0 110.425 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 150.11 170.07 16.99 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -64.74 147.7 89.85 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.892 1.469 . . . . 0.0 110.333 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.666 HD12 HD22 ' A' ' 64' ' ' LEU . 91.4 mt -79.22 168.87 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.581 -0.699 . . . . 0.0 109.369 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.456 ' N ' HG22 ' A' ' 71' ' ' ILE . 7.2 m -80.75 -45.58 16.82 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.21 -0.931 . . . . 0.0 111.608 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 55.5 90.05 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.457 -0.777 . . . . 0.0 109.775 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.6 ttt -126.81 -10.02 6.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.546 -0.722 . . . . 0.0 111.444 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 15.5 m-85 -128.25 113.65 15.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.091 -1.006 . . . . 0.0 109.655 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.624 HG22 HG12 ' A' ' 83' ' ' VAL . 0.7 OUTLIER -151.06 112.51 4.4 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.888 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -159.8 74.63 0.6 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.592 HG11 ' HB3' ' A' ' 56' ' ' TYR . 6.6 p -68.05 -10.8 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.361 -0.837 . . . . 0.0 111.302 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.79 85.75 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.349 -0.844 . . . . 0.0 108.976 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 78' ' ' VAL . 3.9 tt0 60.1 39.09 20.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.544 -0.723 . . . . 0.0 109.653 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.79 -93.89 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.969 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.932 HD23 ' CE3' ' A' ' 53' ' ' TRP . 10.2 tp 177.68 168.61 0.68 Allowed 'General case' 0 N--CA 1.508 2.425 0 O-C-N 120.329 -1.482 . . . . 0.0 110.943 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.624 HG12 HG22 ' A' ' 76' ' ' THR . 9.8 m -141.98 122.67 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.69 142.83 10.29 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.717 ' CH2' HG11 ' A' ' 36' ' ' VAL . 2.4 m-90 -99.08 169.52 9.35 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.32 140.31 31.7 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.727 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.57 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -102.81 94.73 5.52 Favored Pre-proline 0 C--N 1.3 -1.553 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.041 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.576 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.5 Cg_endo -101.39 -12.3 0.17 Allowed 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.644 1.339 . . . . 0.0 113.321 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 49.5 Cg_endo -72.03 69.1 3.14 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 116.175 -2.083 . . . . 0.0 111.203 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.12 14.48 25.31 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.57 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -57.01 131.7 50.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.107 -1.231 . . . . 0.0 110.73 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -85.16 97.73 10.06 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.5 m -52.17 112.95 0.89 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.737 -0.602 . . . . 0.0 111.394 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -75.64 -152.62 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.52 -0.737 . . . . 0.0 109.133 179.234 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 94' ' ' LEU . 1.7 p -152.67 179.44 1.27 Allowed Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.346 -0.846 . . . . 0.0 111.303 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -86.03 164.19 10.14 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 O-C-N 123.916 1.482 . . . . 0.0 111.535 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.469 ' SG ' HG23 ' A' ' 151' ' ' VAL . 0.8 OUTLIER -96.76 86.58 4.09 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.592 -0.693 . . . . 0.0 110.605 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.1 p -61.11 -39.07 88.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.421 -0.799 . . . . 0.0 109.647 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.3 p -64.6 -37.91 89.18 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.48 -0.763 . . . . 0.0 109.764 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 48.2 29.29 6.76 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.86 159.02 14.68 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.498 -1.001 . . . . 0.0 110.281 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 118' ' ' ARG . 5.1 t -66.02 -170.1 0.08 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.524 -0.735 . . . . 0.0 110.049 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.77 100.66 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.507 -0.745 . . . . 0.0 110.34 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.68 HD13 HD23 ' A' ' 143' ' ' LEU . 2.6 mt -117.33 -173.59 2.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.398 -0.814 . . . . 0.0 109.936 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -140.7 84.98 1.97 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.817 -0.552 . . . . 0.0 109.699 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.777 HD23 HD11 ' A' ' 114' ' ' ILE . 28.5 tp -71.89 100.96 2.54 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.798 HG22 HG12 ' A' ' 113' ' ' VAL . 32.2 t -90.72 123.21 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.123 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 138' ' ' SER . 24.9 p -88.37 145.84 25.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.776 ' HB2' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -61.82 -15.14 39.46 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.837 -1.165 . . . . 0.0 109.744 179.168 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.591 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 13.4 m170 -55.23 -79.29 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 110' ' ' HIS . . . 169.72 47.83 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.25 -0.906 . . . . 0.0 110.305 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -169.56 127.15 0.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.734 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.798 HG12 HG22 ' A' ' 107' ' ' VAL . 10.6 m -95.6 156.49 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.777 HD11 HD23 ' A' ' 106' ' ' LEU . 39.3 pt -131.68 127.76 21.51 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.442 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -66.04 145.9 80.72 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.876 1.461 . . . . 0.0 110.786 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.8 t -137.74 152.22 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.24 107.5 18.35 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -48.57 122.76 5.83 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.584 -0.697 . . . . 0.0 110.566 -178.59 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.18 -24.33 9.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.824 -0.547 . . . . 0.0 110.188 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.96 177.92 36.24 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -61.42 -22.8 65.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.959 -0.73 . . . . 0.0 110.204 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.3 p -135.76 41.09 2.73 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.834 -0.541 . . . . 0.0 111.463 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.499 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -169.8 151.88 4.34 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.174 -0.954 . . . . 0.0 111.397 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.86 -178.73 22.42 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.7 OUTLIER -128.09 116.08 19.43 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.896 -0.767 . . . . 0.0 111.773 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.509 HD21 HD12 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -52.66 142.71 17.71 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.43 -0.794 . . . . 0.0 110.514 179.397 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.9 mt -111.03 54.27 0.68 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 164.38 125.28 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.252 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -56.82 115.94 2.85 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 O-C-N 123.543 1.286 . . . . 0.0 110.72 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.404 ' HB2' HD22 ' A' ' 126' ' ' LEU . 0.8 OUTLIER -122.31 141.63 35.09 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.752 . . . . 0.0 109.27 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -64.52 128.19 20.68 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.813 1.428 . . . . 0.0 110.383 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 162' ' ' GLY . 12.1 p -62.84 -35.06 69.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.157 0.503 . . . . 0.0 110.061 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 m -48.71 -37.24 18.13 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.122 -0.986 . . . . 0.0 110.487 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -67.26 -38.34 84.97 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.9 mt -64.99 -36.13 83.4 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -63.85 123.18 18.28 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.97 -26.01 24.52 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.566 ' O ' HD12 ' A' ' 44' ' ' LEU . 16.9 m -92.38 14.41 16.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.481 -1.011 . . . . 0.0 110.694 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.59 127.67 32.38 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.102 -0.999 . . . . 0.0 109.63 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.51 -7.12 26.38 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.45 136.2 50.81 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.07 123.59 5.72 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.745 1.392 . . . . 0.0 112.698 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.68 HD23 HD13 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -82.74 124.69 30.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.179 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.3 mt -124.34 116.19 22.2 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.955 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.598 ' HB3' HG21 ' A' ' 151' ' ' VAL . 19.9 p -73.41 177.76 1.85 Allowed Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 48.7 Cg_endo -62.36 179.73 0.6 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.297 1.156 . . . . 0.0 109.952 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.5 m 56.01 29.1 13.78 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.312 -0.867 . . . . 0.0 110.789 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 60.5 -145.09 47.43 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 21.1 m170 61.68 127.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.895 -0.768 . . . . 0.0 110.44 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.47 ' O ' HG21 ' A' ' 172' ' ' VAL . . . -76.34 140.89 41.64 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.347 -0.846 . . . . 0.0 110.461 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.712 HG12 ' CE2' ' A' ' 169' ' ' PHE . 1.1 t -97.14 -43.41 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.778 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 178.53 -178.56 48.69 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.634 HD11 HD11 ' A' ' 82' ' ' LEU . 1.3 pp -116.93 150.31 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.063 -1.257 . . . . 0.0 111.397 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.776 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.3 t80 -63.0 115.13 4.14 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.014 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -102.05 -38.58 7.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.679 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -160.74 176.13 11.84 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.776 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -133.17 117.06 17.0 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.473 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.795 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.4 t -65.9 97.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.606 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.6 p -120.93 159.51 25.41 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 122.399 1.095 . . . . 0.0 113.888 -175.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.537 HG22 ' H ' ' A' ' 161' ' ' ARG . 2.1 m -95.5 -173.78 2.99 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.537 ' H ' HG22 ' A' ' 160' ' ' THR . 0.1 OUTLIER -48.65 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.438 -0.789 . . . . 0.0 112.567 -178.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.747 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 82.8 -31.83 3.0 Favored Glycine 0 N--CA 1.499 2.888 0 O-C-N 121.205 -0.934 . . . . 0.0 111.748 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.25 131.64 39.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 119.144 1.472 . . . . 0.0 109.328 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.418 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -92.13 135.14 34.22 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.035 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -113.31 -44.19 3.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.555 -0.716 . . . . 0.0 111.135 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.795 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -121.84 179.45 4.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.129 -0.982 . . . . 0.0 109.868 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.58 151.17 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.421 -0.799 . . . . 0.0 110.818 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.679 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -119.68 91.04 3.45 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.27 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.712 ' CE2' HG12 ' A' ' 151' ' ' VAL . 3.1 p90 -127.42 160.24 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.862 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.495 HG11 HD13 ' A' ' 82' ' ' LEU . 2.1 p -107.63 130.3 23.01 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.2 Cg_endo -60.67 154.05 57.59 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 124.14 1.6 . . . . 0.0 111.394 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.778 HG13 ' HA2' ' A' ' 152' ' ' GLY . 25.2 m -79.47 1.05 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.6 -0.688 . . . . 0.0 110.789 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.22 -37.46 14.12 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.717 ' O ' HG22 ' A' ' 177' ' ' THR . 35.4 t -72.07 -36.25 69.49 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.119 0.485 . . . . 0.0 110.272 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.928 ' O ' HG22 ' A' ' 178' ' ' THR . 32.3 mtt -47.32 -36.94 10.07 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.69 -0.631 . . . . 0.0 111.08 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -48.02 -36.59 13.13 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.694 -0.629 . . . . 0.0 111.915 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 174' ' ' SER . 9.0 t -48.64 -39.07 22.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.542 -0.724 . . . . 0.0 112.841 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.928 HG22 ' O ' ' A' ' 175' ' ' MET . 6.4 t -56.92 -38.49 72.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.116 -0.99 . . . . 0.0 112.213 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.453 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -57.5 -40.07 77.88 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.596 -1.315 . . . . 0.0 110.362 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -38.4 91.01 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.956 0.884 . . . . 0.0 108.905 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.76 66.1 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.909 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.5 m -77.64 103.04 7.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.518 -0.739 . . . . 0.0 109.913 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -121.04 63.98 0.87 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.463 -0.773 . . . . 0.0 110.749 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -87.82 66.12 8.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.402 -0.811 . . . . 0.0 109.45 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -65.31 152.35 44.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.703 -0.623 . . . . 0.0 109.94 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.644 -179.704 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.057 0.456 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -129.9 35.93 2.44 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -86.83 95.7 9.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.601 -0.941 . . . . 0.0 110.152 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.54 -45.7 3.1 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -145.67 86.88 1.75 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.328 0.585 . . . . 0.0 109.979 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -80.01 -178.14 6.36 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.702 -0.624 . . . . 0.0 109.425 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -160.71 78.61 0.62 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.248 0.547 . . . . 0.0 110.159 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 89' ' ' PRO . 0.5 OUTLIER -62.53 163.41 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -168.73 78.84 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.8 . . . . 0.0 109.375 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.55 -68.77 0.07 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.544 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.5 pt-20 -164.92 -48.78 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.963 . . . . 0.0 110.832 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.852 HG11 ' N ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -164.09 -161.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.929 -1.107 . . . . 0.0 112.738 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -143.08 167.1 22.89 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.462 0.649 . . . . 0.0 110.117 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.858 HG12 HD22 ' A' ' 44' ' ' LEU . 27.2 m -114.98 147.03 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.657 HG11 HD21 ' A' ' 64' ' ' LEU . 28.0 m -98.48 -179.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 m -134.69 138.88 44.8 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.968 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 p -132.99 -175.99 3.97 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.1 102.99 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.357 -0.84 . . . . 0.0 110.551 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.5 p 47.47 43.76 16.04 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.202 0.525 . . . . 0.0 111.554 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.47 153.13 21.01 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.709 -0.619 . . . . 0.0 111.128 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 p -139.85 139.48 36.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.504 -0.748 . . . . 0.0 109.25 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' A' ' 36' ' ' VAL . 37.2 m-85 -105.02 -179.26 3.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.164 -0.96 . . . . 0.0 111.802 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.858 HD22 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -120.34 140.64 50.98 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.605 -0.684 . . . . 0.0 110.445 -179.206 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.743 ' C ' HG11 ' A' ' 33' ' ' VAL . . . -119.45 -177.56 3.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.41 -0.806 . . . . 0.0 109.747 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.906 HG21 ' CG2' ' A' ' 153' ' ' ILE . 3.4 t -157.85 113.91 2.82 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.185 -0.947 . . . . 0.0 111.513 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.3 p -70.62 105.73 3.24 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.947 -1.095 . . . . 0.0 111.434 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.722 HG11 ' CG1' ' A' ' 172' ' ' VAL . 17.6 t -124.39 127.93 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t30 60.48 17.83 7.66 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.365 -0.834 . . . . 0.0 109.722 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.05 19.79 52.05 Favored Glycine 0 N--CA 1.499 2.894 0 O-C-N 121.109 -0.994 . . . . 0.0 111.088 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 85' ' ' TRP . 47.3 t -136.18 105.84 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.114 -1.227 . . . . 0.0 109.638 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.4 p -59.75 103.37 0.2 Allowed 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.309 -0.87 . . . . 0.0 109.794 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.526 ' CH2' ' HE1' ' A' ' 179' ' ' MET . 95.9 m95 -82.75 150.96 26.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.998 -1.064 . . . . 0.0 111.416 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.786 HG21 ' CZ2' ' A' ' 85' ' ' TRP . 7.7 t -158.61 155.23 27.87 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.617 HG11 ' ND1' ' A' ' 57' ' ' HIS . 20.7 t -80.83 144.57 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.232 -0.917 . . . . 0.0 109.676 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 28.8 t80 -78.08 4.75 11.58 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.049 -1.032 . . . . 0.0 112.134 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.617 ' ND1' HG11 ' A' ' 55' ' ' VAL . 16.2 m170 -45.51 -39.63 7.59 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.292 -0.88 . . . . 0.0 111.54 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.415 ' O ' ' CE1' ' A' ' 43' ' ' PHE . . . -167.68 28.18 0.16 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.57 -166.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.262 -1.14 . . . . 0.0 109.632 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.45 ' O ' HD12 ' A' ' 64' ' ' LEU . . . -75.22 90.77 0.81 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.6 p -71.2 -10.09 59.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.497 -1.002 . . . . 0.0 110.082 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -118.79 -153.39 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 110.506 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 63' ' ' THR . 8.5 t -59.69 90.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.477 -0.764 . . . . 0.0 110.937 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.657 HD21 HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.21 173.15 0.9 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.322 -0.861 . . . . 0.0 109.392 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.743 ' O ' HD11 ' A' ' 71' ' ' ILE . . . -112.43 132.21 55.16 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.206 -0.934 . . . . 0.0 110.314 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.88 -178.82 24.26 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -57.9 -20.38 44.09 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.78 1.41 . . . . 0.0 110.507 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 24.71 12.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.534 -0.729 . . . . 0.0 109.809 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.6 -106.51 2.43 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -76.35 120.39 5.62 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.753 1.396 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.743 HD11 ' O ' ' A' ' 65' ' ' ALA . 75.5 mt -75.19 146.15 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 m -90.64 92.95 9.06 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.442 -0.786 . . . . 0.0 111.06 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -61.63 107.92 0.89 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.675 -0.641 . . . . 0.0 109.406 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 mmt -113.9 -26.81 7.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.576 -0.702 . . . . 0.0 111.042 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.526 ' O ' HG13 ' A' ' 83' ' ' VAL . 7.5 m-85 -122.57 118.31 27.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.417 -0.802 . . . . 0.0 109.738 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.657 HG23 ' CG2' ' A' ' 83' ' ' VAL . 5.4 m -155.29 122.99 5.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.635 -0.666 . . . . 0.0 110.779 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -142.11 76.65 1.55 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.28 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.437 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.4 p -49.5 -32.62 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.595 -0.691 . . . . 0.0 109.69 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.59 -47.72 73.01 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.7 -0.625 . . . . 0.0 109.671 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -93.06 17.27 11.11 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.981 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 52.29 52.47 14.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.214 -0.929 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.558 HD21 ' HE2' ' A' ' 175' ' ' MET . 1.5 mt -161.44 151.69 17.42 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.031 0.919 . . . . 0.0 112.343 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.657 ' CG2' HG23 ' A' ' 76' ' ' THR . 58.1 t -156.76 146.03 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 53' ' ' TRP . . . -142.45 115.28 0.94 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.008 -1.568 . . . . 0.0 112.18 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.786 ' CZ2' HG21 ' A' ' 54' ' ' THR . 1.5 m0 -97.98 167.2 11.05 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -81.22 134.71 35.66 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.387 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -104.05 91.17 3.5 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.214 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 53.5 Cg_endo -101.9 -10.24 0.2 Allowed 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.595 1.313 . . . . 0.0 112.726 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 46.5 Cg_endo -72.84 67.52 3.92 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 115.735 -2.377 . . . . 0.0 110.678 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 53.79 23.24 21.24 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.61 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -73.4 135.79 44.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -1.005 . . . . 0.0 110.736 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -61.35 -168.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.771 -0.581 . . . . 0.0 109.68 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 t -147.0 103.97 3.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.54 -0.725 . . . . 0.0 109.386 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.442 HD13 ' HB2' ' A' ' 150' ' ' ALA . 2.3 mt -79.66 -160.77 0.28 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.618 -0.676 . . . . 0.0 109.907 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.2 t -161.01 153.46 17.16 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.754 -0.591 . . . . 0.0 109.452 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.79 143.43 73.71 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 O-C-N 123.517 1.272 . . . . 0.0 111.727 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 25.0 t -64.94 159.45 22.86 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.432 0.634 . . . . 0.0 110.416 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 t -159.19 33.95 0.2 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.448 0.642 . . . . 0.0 109.339 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.2 p -117.85 -167.73 1.39 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.664 -0.648 . . . . 0.0 110.336 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -124.49 29.88 4.87 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.405 ' HB3' ' CG ' ' A' ' 146' ' ' PRO . 75.3 m -91.94 171.87 8.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.587 -0.949 . . . . 0.0 109.998 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 118' ' ' ARG . 40.8 m -127.4 -35.2 2.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.51 -0.743 . . . . 0.0 111.634 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.85 119.07 9.3 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.347 -0.846 . . . . 0.0 110.593 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.749 HD13 HD23 ' A' ' 143' ' ' LEU . 1.5 mt -115.37 -174.46 2.51 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.211 -0.931 . . . . 0.0 110.42 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.676 ' HB3' HG13 ' A' ' 113' ' ' VAL . 85.3 m-85 -139.85 87.25 2.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.724 HD23 HD11 ' A' ' 114' ' ' ILE . 36.0 tp -64.62 99.39 0.31 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.945 HG22 HG22 ' A' ' 113' ' ' VAL . 61.6 t -90.47 114.48 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.833 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.3 p -71.86 -179.82 2.86 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.775 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -93.33 16.28 13.69 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.072 -1.017 . . . . 0.0 110.67 179.367 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -124.78 41.4 3.52 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.216 -0.927 . . . . 0.0 109.754 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.62 68.15 0.9 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.486 -0.758 . . . . 0.0 111.499 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -155.1 109.17 2.9 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.654 -0.654 . . . . 0.0 110.589 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.945 HG22 HG22 ' A' ' 107' ' ' VAL . 24.4 t -106.14 137.52 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.772 -0.58 . . . . 0.0 109.69 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.724 HD11 HD23 ' A' ' 106' ' ' LEU . 29.3 pt -131.74 131.15 22.56 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 109.126 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.499 ' HB2' HD12 ' A' ' 127' ' ' LEU . 48.8 Cg_endo -66.07 140.51 60.1 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.835 1.439 . . . . 0.0 111.779 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 167' ' ' VAL . 25.0 t -136.03 144.59 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.12 119.43 38.73 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.439 ' HB2' ' HA ' ' A' ' 102' ' ' SER . 23.3 ttt180 -49.73 126.96 14.95 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.263 -0.898 . . . . 0.0 110.032 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.96 -33.14 7.0 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.013 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -169.08 58.52 0.2 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.415 -1.374 . . . . 0.0 110.414 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.1 OUTLIER 64.35 -72.82 0.06 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.728 -0.866 . . . . 0.0 110.056 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 120' ' ' GLY . 3.8 p -92.44 40.02 1.04 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 121.162 0.506 . . . . 0.0 110.39 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.435 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 13.8 ttm180 -168.33 154.79 7.34 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.42 -0.8 . . . . 0.0 110.252 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.49 -178.62 23.76 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -128.55 118.33 22.82 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 122.048 -0.678 . . . . 0.0 111.819 -178.026 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 145.31 52.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.695 -0.628 . . . . 0.0 109.794 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.499 HD12 ' HB2' ' A' ' 115' ' ' PRO . 17.2 mt -115.38 55.23 0.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 170.32 125.33 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -63.67 103.49 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.757 1.399 . . . . 0.0 109.843 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.91 149.59 42.71 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.407 -0.808 . . . . 0.0 109.207 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.406 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 50.4 Cg_endo -68.07 127.33 15.79 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.819 1.431 . . . . 0.0 110.604 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.2 p -62.01 -37.08 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.829 -0.544 . . . . 0.0 110.166 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.33 -35.73 19.23 Favored 'General case' 0 N--CA 1.506 2.36 0 CA-C-O 122.082 0.944 . . . . 0.0 110.535 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 21.2 t80 -67.66 -38.93 84.47 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.479 HD11 ' CB ' ' A' ' 164' ' ' ALA . 14.3 mt -64.02 -35.79 81.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -57.9 131.31 50.01 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.71 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.8 -25.74 26.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.9 m -90.0 4.17 50.96 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -1.081 . . . . 0.0 111.486 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 13.5 p -56.87 121.91 10.99 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.967 -1.083 . . . . 0.0 111.025 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.83 -15.15 9.02 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.27 139.22 48.31 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.714 -1.755 . . . . 0.0 108.714 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.87 123.14 6.65 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.921 1.485 . . . . 0.0 113.691 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.749 HD23 HD13 ' A' ' 104' ' ' LEU . 1.7 mp -79.03 116.91 19.62 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.35 117.75 33.34 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.82 -1.152 . . . . 0.0 113.081 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.435 ' HB3' HG21 ' A' ' 151' ' ' VAL . 27.0 p -56.99 173.69 0.31 Allowed Pre-proline 0 N--CA 1.5 2.064 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.809 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 44.9 Cg_endo -76.66 72.44 5.64 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.714 1.376 . . . . 0.0 109.907 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.37 -46.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.62 -0.675 . . . . 0.0 110.26 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 135.36 -28.27 3.03 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.99 129.61 37.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.523 -0.986 . . . . 0.0 110.194 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.516 ' HB1' HG21 ' A' ' 172' ' ' VAL . . . -59.07 138.75 57.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.669 -0.644 . . . . 0.0 110.112 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.684 HG12 ' CE2' ' A' ' 169' ' ' PHE . 0.9 OUTLIER -99.61 -33.1 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.839 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 176.92 -178.44 48.13 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.906 ' CG2' HG21 ' A' ' 46' ' ' THR . 1.1 pt -120.19 139.93 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.354 -1.086 . . . . 0.0 111.016 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.759 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.3 t80 -53.34 118.58 3.93 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.92 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -107.59 -41.06 5.14 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.439 -0.788 . . . . 0.0 109.6 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -154.08 167.59 29.3 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.759 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -124.95 116.46 22.22 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.659 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.802 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.9 t -67.56 100.75 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.636 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.5 p -125.25 154.91 40.93 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.648 1.213 . . . . 0.0 114.119 -175.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.519 HG22 ' H ' ' A' ' 161' ' ' ARG . 2.0 m -92.2 -172.3 3.08 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.519 ' H ' HG22 ' A' ' 160' ' ' THR . 1.6 ttt180 -45.94 88.91 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.402 -0.811 . . . . 0.0 111.727 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.654 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 72.63 -15.08 2.28 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.101 -1.0 . . . . 0.0 112.509 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.7 t -101.14 135.85 35.55 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.351 0 CA-C-N 118.948 1.374 . . . . 0.0 109.286 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.479 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -97.59 124.78 41.99 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.747 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -108.2 -41.28 4.94 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.607 -0.683 . . . . 0.0 110.545 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.802 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -126.48 166.78 16.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 109.358 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.436 HG21 HG11 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -112.42 162.01 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.839 0.828 . . . . 0.0 111.28 -178.084 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.758 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -130.65 99.28 4.91 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.684 ' CE2' HG12 ' A' ' 151' ' ' VAL . 5.1 p90 -135.9 159.63 41.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.007 -1.058 . . . . 0.0 111.567 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 82' ' ' LEU . 1.2 m -103.75 144.68 29.16 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 37.1 Cg_endo -61.9 155.17 56.52 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.092 1.575 . . . . 0.0 111.917 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.839 HG23 ' HA2' ' A' ' 152' ' ' GLY . 4.3 t -82.75 -2.11 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.504 -0.747 . . . . 0.0 109.709 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -81.96 -38.43 25.19 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.6 t -57.64 -36.79 72.32 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.806 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.599 ' HE1' HG23 ' A' ' 153' ' ' ILE . 8.4 mtt -49.93 -39.2 39.46 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.563 -0.71 . . . . 0.0 109.348 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.47 ' O ' ' HB3' ' A' ' 179' ' ' MET . 2.0 mt-10 -66.18 -38.11 87.27 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.8 m -64.98 -38.75 91.99 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -37.08 81.36 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.526 ' HE1' ' CH2' ' A' ' 53' ' ' TRP . 34.5 tpp -61.79 -53.44 55.87 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.723 -0.611 . . . . 0.0 110.329 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.12 -38.77 62.92 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.366 -0.834 . . . . 0.0 110.915 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -55.94 -38.11 69.87 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 59.7 p -75.17 112.1 11.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.431 -0.793 . . . . 0.0 110.926 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -98.01 141.85 30.45 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.494 -0.754 . . . . 0.0 110.34 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -66.34 115.28 6.11 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.513 -0.742 . . . . 0.0 110.392 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -111.53 -76.03 0.61 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.352 -0.843 . . . . 0.0 110.334 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 11.5 mptt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.132 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.166 0.507 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.65 -111.75 1.98 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 57.66 -85.74 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.538 -0.978 . . . . 0.0 110.872 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.5 96.14 1.48 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.532 -0.73 . . . . 0.0 110.281 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 94.91 8.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.484 -0.76 . . . . 0.0 109.792 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -66.01 84.15 0.08 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.599 -0.688 . . . . 0.0 110.497 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.63 77.62 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.633 -0.667 . . . . 0.0 109.254 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 89' ' ' PRO . 28.7 m -122.38 -158.72 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.737 -0.602 . . . . 0.0 109.886 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.92 78.41 0.29 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.248 -0.907 . . . . 0.0 109.384 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.59 14.29 0.05 OUTLIER Glycine 0 N--CA 1.498 2.805 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.427 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.453 ' C ' HG23 ' A' ' 33' ' ' VAL . 21.5 mt-10 55.98 6.73 0.24 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.858 -1.378 . . . . 0.0 113.433 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.453 HG23 ' C ' ' A' ' 32' ' ' GLU . 60.4 t -152.23 151.98 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 120.455 -1.403 . . . . 0.0 110.151 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 2.9 tt0 -150.44 143.26 24.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.734 -0.604 . . . . 0.0 110.05 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.737 HG12 HD22 ' A' ' 44' ' ' LEU . 27.2 m -110.15 174.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.482 0.658 . . . . 0.0 110.712 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.562 HG11 ' CH2' ' A' ' 85' ' ' TRP . 31.9 m -131.76 -178.18 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -147.84 136.05 21.37 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.0 p -143.78 -179.11 6.26 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.67 76.11 0.6 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.911 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m 177.31 -61.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -179.39 -159.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.612 -0.68 . . . . 0.0 109.262 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 13.3 t -117.58 139.72 50.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.503 -0.748 . . . . 0.0 109.928 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 59' ' ' ALA . 98.7 m-85 -102.18 -178.54 3.73 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.569 -0.707 . . . . 0.0 111.617 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.836 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -111.69 151.7 28.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.608 -0.683 . . . . 0.0 111.351 -178.313 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.529 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -159.55 145.01 15.74 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.654 -0.654 . . . . 0.0 109.351 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.512 HG23 HG23 ' A' ' 48' ' ' VAL . 13.2 t -117.86 127.38 53.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.162 -0.961 . . . . 0.0 112.036 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 87.4 m -78.77 82.78 4.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.531 -0.73 . . . . 0.0 110.467 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.828 HG11 HG11 ' A' ' 172' ' ' VAL . 57.8 t -98.59 139.2 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 56.12 20.41 4.41 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.343 -0.848 . . . . 0.0 110.027 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.6 24.49 53.43 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.9 t -138.81 103.97 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -1.212 . . . . 0.0 110.612 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.7 t -58.2 96.61 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.538 -0.726 . . . . 0.0 110.022 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.937 ' CE3' HD23 ' A' ' 82' ' ' LEU . 79.5 m95 -76.07 145.34 40.17 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.325 -0.859 . . . . 0.0 110.331 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.539 HG23 HG23 ' A' ' 83' ' ' VAL . 2.7 t -163.08 176.43 10.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.574 -0.704 . . . . 0.0 109.787 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.464 HG11 ' HG2' ' A' ' 155' ' ' ARG . 13.6 m -104.42 138.19 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.563 -0.711 . . . . 0.0 109.986 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.606 ' HB2' HG11 ' A' ' 83' ' ' VAL . 1.6 t80 -73.79 -12.07 60.58 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.007 -1.058 . . . . 0.0 111.357 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.431 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 4.7 p-80 -83.63 -0.95 52.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.151 -0.968 . . . . 0.0 110.229 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.53 74.84 0.21 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.408 ' HA ' ' CD2' ' A' ' 43' ' ' PHE . . . -164.35 -72.1 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.466 -1.02 . . . . 0.0 110.123 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.85 -161.96 32.25 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.4 p -167.15 -163.52 0.54 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.725 -0.867 . . . . 0.0 109.702 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt 51.5 -164.2 0.06 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.421 -0.8 . . . . 0.0 110.72 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -56.7 90.35 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.512 -0.742 . . . . 0.0 110.615 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.879 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -63.9 162.26 14.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.705 -0.622 . . . . 0.0 110.295 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.23 142.74 48.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.632 -0.667 . . . . 0.0 110.313 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -124.83 -179.4 15.7 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.84 -6.91 20.19 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.972 1.512 . . . . 0.0 111.493 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.66 29.57 1.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.045 . . . . 0.0 110.382 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.61 176.51 14.44 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.25 155.79 68.15 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.852 1.449 . . . . 0.0 109.9 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.879 HD12 ' CD2' ' A' ' 64' ' ' LEU . 77.8 mt -100.79 119.54 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.558 -0.714 . . . . 0.0 109.786 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -61.4 135.14 57.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.609 -0.682 . . . . 0.0 110.703 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -94.51 115.11 27.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 109.415 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.3 mmm -124.81 -34.88 2.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.525 -0.735 . . . . 0.0 110.866 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.468 ' CD2' ' CE ' ' A' ' 179' ' ' MET . 15.5 m-85 -118.35 108.45 15.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.389 -0.819 . . . . 0.0 109.661 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.606 ' CG2' HG12 ' A' ' 83' ' ' VAL . 1.6 m -149.1 114.46 5.54 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.544 -0.862 . . . . 0.0 112.407 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -148.03 75.66 1.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.872 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.485 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 8.2 p -54.97 -22.48 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.465 -0.772 . . . . 0.0 111.098 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -60.67 83.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.732 -0.605 . . . . 0.0 110.962 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 49.45 26.39 1.65 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.515 -0.741 . . . . 0.0 111.461 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -126.12 -95.32 0.45 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.937 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.937 HD23 ' CE3' ' A' ' 53' ' ' TRP . 8.4 tp 177.72 164.21 0.62 Allowed 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.548 -1.345 . . . . 0.0 110.824 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' A' ' 56' ' ' TYR . 16.4 m -135.02 122.99 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.12 133.93 4.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.562 ' CH2' HG11 ' A' ' 36' ' ' VAL . 1.3 m-90 -100.55 168.91 9.42 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -80.23 136.52 36.48 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.586 -0.845 . . . . 0.0 109.844 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.494 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -108.94 92.94 11.52 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.874 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.568 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.5 Cg_endo -102.35 -11.69 0.16 Allowed 'Trans proline' 0 CA--C 1.551 1.354 0 O-C-N 123.911 1.48 . . . . 0.0 112.847 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 51.2 Cg_endo -71.2 75.8 1.79 Allowed 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 116.058 -2.162 . . . . 0.0 111.104 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.83 25.13 21.95 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.494 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -74.71 139.44 43.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.942 . . . . 0.0 110.574 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.3 tpt85 -75.34 140.3 42.97 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.7 p -104.66 103.15 12.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.348 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -158.37 0.25 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.446 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -151.55 -169.44 0.22 Allowed Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.567 -0.708 . . . . 0.0 109.878 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -93.81 159.48 2.28 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 O-C-N 123.69 1.363 . . . . 0.0 111.521 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.65 133.51 52.66 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.667 -0.646 . . . . 0.0 109.94 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 m -139.56 91.33 2.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.612 -0.68 . . . . 0.0 109.953 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 29.7 m -132.95 -162.28 1.22 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.47 -0.769 . . . . 0.0 109.927 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.73 31.42 2.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.88 -151.1 0.47 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.685 -0.891 . . . . 0.0 110.168 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.8 p -149.78 -147.97 0.25 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 0.0 109.881 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 7.6 t0 58.06 105.24 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.126 -0.984 . . . . 0.0 110.794 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.664 HD13 HD23 ' A' ' 143' ' ' LEU . 0.8 OUTLIER -123.18 -168.45 1.77 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.167 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.736 ' HB3' HG13 ' A' ' 113' ' ' VAL . 79.7 m-85 -142.3 93.04 2.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.492 -0.755 . . . . 0.0 110.728 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.458 HD12 ' HG ' ' A' ' 143' ' ' LEU . 7.0 tp -60.09 92.59 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 105' ' ' TYR . 89.7 t -84.5 101.95 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.331 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.422 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 21.8 p -67.4 155.86 37.95 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.836 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -78.18 3.9 13.99 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.028 -1.045 . . . . 0.0 111.126 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.447 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -101.91 31.52 3.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.972 -1.08 . . . . 0.0 109.055 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 61.42 74.55 0.44 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.519 -0.738 . . . . 0.0 110.67 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.61 119.47 0.88 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.606 -0.684 . . . . 0.0 110.528 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 105' ' ' TYR . 71.5 t -98.13 143.34 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.537 -0.727 . . . . 0.0 109.768 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.439 ' HB ' ' HB3' ' A' ' 106' ' ' LEU . 14.4 mt -130.68 109.89 15.93 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -58.05 134.16 60.31 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 O-C-N 123.655 1.345 . . . . 0.0 111.929 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 103' ' ' ASP . 35.1 t -127.78 142.98 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.644 -0.66 . . . . 0.0 109.525 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.58 121.29 43.21 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -48.68 130.41 17.41 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.38 -0.825 . . . . 0.0 110.917 -178.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -102.95 -49.43 3.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.804 -0.56 . . . . 0.0 110.654 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.84 60.23 0.11 Allowed Glycine 0 N--CA 1.498 2.796 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.757 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.37 145.35 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.787 -0.831 . . . . 0.0 109.222 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.427 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 17.5 p 44.63 27.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.737 -0.602 . . . . 0.0 112.122 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.47 ' N ' ' CD2' ' A' ' 169' ' ' PHE . 0.4 OUTLIER -170.37 144.26 2.47 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.125 -0.984 . . . . 0.0 110.219 178.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.26 -177.79 16.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -123.21 123.14 40.12 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 122.045 -0.679 . . . . 0.0 111.743 -178.265 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.09 130.7 45.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.565 -0.709 . . . . 0.0 109.492 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.5 mt -101.06 53.62 0.84 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.86 118.45 0.14 Allowed Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.333 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -60.31 106.86 0.37 Allowed 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.61 1.321 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.6 mtt-85 -125.75 146.41 54.99 Favored Pre-proline 0 N--CA 1.49 1.54 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.089 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.411 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 47.8 Cg_endo -64.24 129.31 23.8 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 124.098 1.578 . . . . 0.0 110.604 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 162' ' ' GLY . 6.1 p -56.96 -36.01 49.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.848 -0.532 . . . . 0.0 110.163 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -49.14 -36.85 20.27 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.232 -0.918 . . . . 0.0 110.603 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 7.4 t80 -64.43 -38.9 92.65 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.469 HD11 ' CB ' ' A' ' 164' ' ' ALA . 8.7 mt -67.4 -35.92 80.26 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -56.39 111.87 1.1 Allowed 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.939 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.27 -34.37 4.73 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.7 m -79.86 -2.72 44.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.676 -0.896 . . . . 0.0 110.808 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.1 m -57.37 126.6 28.02 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.181 -0.95 . . . . 0.0 110.447 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.12 -9.22 31.37 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.723 ' HA2' HD12 ' A' ' 44' ' ' LEU . . . -56.88 -175.98 0.31 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -114.57 124.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.489 1.258 . . . . 0.0 112.527 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.664 HD23 HD13 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -83.34 126.35 32.61 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 176.444 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.16 121.06 31.74 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.709 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.498 ' HB3' HG21 ' A' ' 151' ' ' VAL . 14.7 p -69.29 -173.27 0.2 Allowed Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.44 ' CD ' ' HB2' ' A' ' 145' ' ' CYS . 49.9 Cg_endo -71.65 66.92 3.01 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.562 1.296 . . . . 0.0 110.422 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.86 -165.7 0.38 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.551 -0.718 . . . . 0.0 110.123 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -110.24 48.57 0.92 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -136.41 128.69 30.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.606 -0.937 . . . . 0.0 109.927 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.555 ' CB ' HG21 ' A' ' 172' ' ' VAL . . . -66.34 121.83 16.15 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.496 -0.752 . . . . 0.0 109.918 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.537 HG11 HD22 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -78.24 -44.5 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.696 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . -179.6 -178.31 48.34 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.627 HG12 ' HE2' ' A' ' 175' ' ' MET . 1.0 OUTLIER -111.73 154.79 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-N 118.838 1.319 . . . . 0.0 111.988 179.601 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.85 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 7.6 t80 -69.17 83.3 0.35 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.8 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.464 ' HG2' HG11 ' A' ' 55' ' ' VAL . 2.6 ttt180 -64.06 -49.91 70.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.618 -0.676 . . . . 0.0 109.595 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.612 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -155.78 -179.19 7.88 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.85 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -134.04 121.82 22.1 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.874 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.7 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.5 t -70.69 104.49 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 177.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.63 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.3 p -129.43 142.58 50.76 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -175.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.662 HG22 HG12 ' A' ' 163' ' ' VAL . 5.9 t -76.26 -174.58 2.85 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.54 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.325 -0.859 . . . . 0.0 112.937 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.779 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 85.99 -27.32 5.54 Favored Glycine 0 N--CA 1.498 2.771 0 O-C-N 121.204 -0.935 . . . . 0.0 112.316 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.662 HG12 HG22 ' A' ' 160' ' ' THR . 1.0 OUTLIER -96.55 136.91 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 119.108 1.454 . . . . 0.0 109.82 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.469 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -103.57 125.65 50.23 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.604 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -111.62 -34.37 6.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.654 -0.653 . . . . 0.0 111.224 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.7 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -124.8 176.77 6.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.077 -1.014 . . . . 0.0 110.946 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.52 140.92 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 111.596 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 3.2 t0 -106.48 100.24 9.77 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.47 ' CD2' ' N ' ' A' ' 123' ' ' ARG . 0.5 OUTLIER -129.8 157.87 41.02 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.071 -1.052 . . . . 0.0 113.748 -176.04 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.407 ' CG1' HG13 ' A' ' 153' ' ' ILE . 2.9 p -111.87 128.09 25.93 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 45.0 Cg_endo -57.68 156.37 27.72 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 O-C-N 123.775 1.408 . . . . 0.0 111.752 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.828 HG11 HG11 ' A' ' 48' ' ' VAL . 97.9 t -79.37 -1.66 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.611 -0.681 . . . . 0.0 110.08 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -86.08 -37.66 18.61 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.1 m -72.08 -38.61 69.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.861 -0.525 . . . . 0.0 110.021 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.627 ' HE2' HG12 ' A' ' 153' ' ' ILE . 14.8 mtt -50.93 -38.79 52.37 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.542 -0.724 . . . . 0.0 109.711 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -62.87 -39.99 96.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 35.1 m -57.86 -38.51 75.84 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.606 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 0.3 OUTLIER -51.31 -35.01 35.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.844 -0.535 . . . . 0.0 109.739 178.772 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.579 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 9.5 mmt -48.04 -53.63 15.69 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.46 -0.775 . . . . 0.0 110.847 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.02 -37.45 45.32 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.989 0.899 . . . . 0.0 109.846 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 178' ' ' THR . . . -63.73 -39.77 95.11 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.013 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.407 ' CB ' ' HA ' ' A' ' 75' ' ' TYR . 10.8 m -91.57 74.82 5.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.47 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -135.6 47.8 2.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.667 -0.646 . . . . 0.0 109.547 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -108.83 32.23 5.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.728 . . . . 0.0 110.861 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.2 ttmt -148.77 82.78 1.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.548 -0.72 . . . . 0.0 110.276 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.035 179.85 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.324 0.583 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.67 -39.54 1.27 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -91.31 96.1 10.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.938 -0.742 . . . . 0.0 110.491 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -155.44 -160.36 1.03 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.596 -0.69 . . . . 0.0 110.537 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -100.21 93.67 5.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.665 -0.647 . . . . 0.0 111.071 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.44 -179.14 6.64 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.401 -0.812 . . . . 0.0 109.308 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -161.64 77.96 0.54 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.247 0.546 . . . . 0.0 110.304 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.25 176.73 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -154.6 76.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.636 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 44.58 66.56 1.37 Allowed Glycine 0 N--CA 1.5 2.911 0 O-C-N 121.933 -0.48 . . . . 0.0 111.911 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.494 ' C ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -164.08 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.418 -1.048 . . . . 0.0 111.432 179.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.494 HG23 ' C ' ' A' ' 32' ' ' GLU . 70.1 t -150.91 153.83 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.227 -0.92 . . . . 0.0 111.724 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.419 ' OE1' ' HG3' ' A' ' 89' ' ' PRO . 12.5 tt0 -144.84 136.37 25.41 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.45 HG11 ' HG3' ' A' ' 109' ' ' ARG . 33.7 m -98.81 168.68 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.82 0.819 . . . . 0.0 111.632 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.545 HG11 ' CH2' ' A' ' 85' ' ' TRP . 28.2 m -125.91 -179.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -145.43 135.99 24.27 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.251 -0.905 . . . . 0.0 110.95 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.5 p -142.74 177.79 8.08 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.42 75.87 0.55 Allowed 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.254 -0.979 . . . . 0.0 108.684 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 173.69 -57.16 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.57 -170.13 0.1 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.42 -0.8 . . . . 0.0 109.65 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 86.0 p -111.22 140.75 45.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.706 -0.621 . . . . 0.0 110.431 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 27.4 m-85 -102.08 175.51 5.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.467 -0.771 . . . . 0.0 109.944 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.695 ' C ' HD23 ' A' ' 44' ' ' LEU . 5.5 tt -109.96 143.92 39.21 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.644 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -147.21 131.53 17.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.927 -1.108 . . . . 0.0 110.311 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 46' ' ' THR . 8.4 t -100.02 127.81 46.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.254 -0.904 . . . . 0.0 112.462 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.419 ' HG ' ' HG ' ' A' ' 52' ' ' CYS . 85.8 m -82.89 95.07 7.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.375 -0.828 . . . . 0.0 110.747 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.889 HG11 ' CG1' ' A' ' 172' ' ' VAL . 93.5 t -103.86 133.09 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t30 62.22 11.4 4.41 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.422 -0.799 . . . . 0.0 110.681 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.62 30.61 8.91 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.023 -1.048 . . . . 0.0 111.167 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.4 t -147.2 105.81 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -1.187 . . . . 0.0 109.257 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.419 ' HG ' ' HG ' ' A' ' 47' ' ' CYS . 0.7 OUTLIER -56.17 109.56 0.61 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.498 -0.751 . . . . 0.0 109.485 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 1.004 ' CE3' HD23 ' A' ' 82' ' ' LEU . 92.7 m95 -91.23 141.8 28.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.671 -0.643 . . . . 0.0 110.435 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.461 HG21 ' CH2' ' A' ' 85' ' ' TRP . 5.2 t -161.27 -179.78 7.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.457 -0.777 . . . . 0.0 110.319 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.524 HG11 ' HA ' ' A' ' 155' ' ' ARG . 11.6 m -102.18 145.12 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.596 -0.69 . . . . 0.0 110.497 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.656 ' HB2' HG11 ' A' ' 83' ' ' VAL . 42.9 t80 -78.02 1.72 20.01 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.113 -0.992 . . . . 0.0 112.301 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -49.78 -24.85 2.59 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 121.163 -0.961 . . . . 0.0 110.684 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.448 ' O ' ' CE1' ' A' ' 43' ' ' PHE . . . -177.89 39.83 0.09 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.41 25.96 4.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.331 -1.099 . . . . 0.0 111.009 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.56 -164.39 41.47 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.1 t -136.84 -80.38 0.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.762 -0.846 . . . . 0.0 110.074 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -118.47 -33.46 4.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.198 -0.939 . . . . 0.0 111.305 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -93.31 89.57 6.43 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.116 0.484 . . . . 0.0 111.721 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.534 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -101.28 172.8 6.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.51 -0.744 . . . . 0.0 109.751 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.6 130.97 57.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.681 -0.637 . . . . 0.0 110.136 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.59 179.24 16.73 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -55.17 103.82 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 O-C-N 123.652 1.343 . . . . 0.0 110.628 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.1 tttp 54.37 30.05 11.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.505 -0.747 . . . . 0.0 111.22 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.43 134.87 2.1 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -58.85 169.8 3.16 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 O-C-N 123.729 1.383 . . . . 0.0 110.82 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.534 HD12 ' CD2' ' A' ' 64' ' ' LEU . 63.2 mt -106.93 134.5 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.395 -0.816 . . . . 0.0 108.976 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.5 p -74.69 -174.61 2.18 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.278 -0.889 . . . . 0.0 111.032 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -123.15 166.43 15.21 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.606 -0.684 . . . . 0.0 109.973 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.435 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 6.4 tpt -169.54 -37.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.156 -0.965 . . . . 0.0 111.453 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 74' ' ' MET . 14.4 m-85 -131.84 111.53 11.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.472 -0.768 . . . . 0.0 109.103 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.613 ' CG2' HG12 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -152.49 114.2 4.34 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.035 -1.066 . . . . 0.0 113.013 -178.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -160.54 76.52 0.59 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.729 -0.607 . . . . 0.0 110.45 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.61 HG11 ' HB3' ' A' ' 56' ' ' TYR . 7.3 p -74.74 -17.3 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.1 -1.0 . . . . 0.0 111.128 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.73 -25.17 17.45 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.129 -0.982 . . . . 0.0 110.244 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -176.11 34.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.748 -0.595 . . . . 0.0 110.144 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -156.03 -89.44 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.997 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.004 HD23 ' CE3' ' A' ' 53' ' ' TRP . 6.8 tp 179.14 177.29 0.53 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.718 -1.239 . . . . 0.0 110.125 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.656 HG11 ' HB2' ' A' ' 56' ' ' TYR . 21.6 m -146.58 121.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -154.09 144.08 10.82 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.545 ' CH2' HG11 ' A' ' 36' ' ' VAL . 1.1 m-90 -108.2 167.83 9.73 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -69.5 137.52 52.62 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.879 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.55 97.0 15.26 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.721 -0.612 . . . . 0.0 111.144 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.7 Cg_endo -111.21 10.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 117.178 -1.415 . . . . 0.0 113.061 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 55.7 Cg_endo -67.58 -108.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 116.587 -1.809 . . . . 0.0 107.75 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.79 32.47 7.39 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 106.559 -2.616 . . . . 0.0 106.559 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.62 152.69 45.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.383 -1.069 . . . . 0.0 111.058 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -125.14 17.16 8.43 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.784 -0.572 . . . . 0.0 110.735 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.8 t 49.98 97.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.288 -0.883 . . . . 0.0 112.536 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.421 HD23 ' HB2' ' A' ' 150' ' ' ALA . 0.3 OUTLIER -74.19 -143.16 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.555 -0.715 . . . . 0.0 110.13 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 t -169.61 153.3 5.04 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 120.897 -1.127 . . . . 0.0 110.657 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.45 160.37 46.95 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.741 1.39 . . . . 0.0 111.173 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.9 t -95.6 112.12 23.9 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.1 p -75.1 -44.05 49.53 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.4 p -65.48 149.42 50.07 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.325 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -111.2 40.43 2.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.99 146.13 51.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.687 -0.89 . . . . 0.0 109.703 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 m -77.69 -159.17 0.14 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.664 -0.648 . . . . 0.0 110.929 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.7 t70 52.43 95.08 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.652 -0.655 . . . . 0.0 111.171 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.889 HD13 HD23 ' A' ' 143' ' ' LEU . 0.8 OUTLIER -113.6 168.81 9.45 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.371 -0.83 . . . . 0.0 110.025 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 107' ' ' VAL . 70.9 m-85 -117.4 86.43 2.51 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.644 -0.66 . . . . 0.0 109.571 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.444 ' CD1' HD11 ' A' ' 143' ' ' LEU . 9.5 tp -54.45 98.85 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.445 -0.785 . . . . 0.0 109.838 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 105' ' ' TYR . 37.4 t -81.68 109.65 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.239 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.459 ' HB ' ' NE2' ' A' ' 110' ' ' HIS . 18.7 p -74.58 177.52 6.0 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.605 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -95.06 28.1 2.93 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.913 -1.117 . . . . 0.0 110.819 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.463 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 1.4 p80 -150.31 46.17 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.916 0.865 . . . . 0.0 109.537 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 49.08 63.47 2.12 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.425 0.631 . . . . 0.0 111.674 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.46 92.37 2.08 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.416 HG13 ' HB3' ' A' ' 105' ' ' TYR . 59.1 t -81.0 144.04 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.176 -0.952 . . . . 0.0 110.123 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.2 mt -128.97 114.99 18.89 Favored Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -59.35 134.42 58.63 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.781 1.411 . . . . 0.0 111.516 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 60.5 t -125.5 149.33 30.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -114.25 111.7 21.94 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -48.12 121.61 4.44 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.749 0.785 . . . . 0.0 110.276 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.9 -37.51 5.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.963 -0.46 . . . . 0.0 110.406 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.81 -170.07 26.03 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -62.56 140.9 58.65 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.831 -0.806 . . . . 0.0 109.568 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.0 p 44.46 42.55 5.57 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.275 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.441 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 3.9 ttp85 -164.32 153.75 13.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.337 -0.852 . . . . 0.0 111.392 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.88 -179.58 21.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -119.39 130.9 55.54 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 122.072 -0.663 . . . . 0.0 111.116 -178.364 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.47 HD22 ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -72.75 128.9 36.9 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.355 -0.84 . . . . 0.0 109.383 179.23 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 mt -103.71 54.57 0.74 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.47 ' O ' HD22 ' A' ' 126' ' ' LEU . 2.4 p 174.95 107.09 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -57.56 103.63 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 O-C-N 123.598 1.315 . . . . 0.0 109.168 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -124.63 159.03 59.94 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.986 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 50.1 Cg_endo -72.54 129.58 14.89 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 124.077 1.567 . . . . 0.0 109.255 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.635 HG21 ' SG ' ' A' ' 159' ' ' CYS . 10.1 p -55.7 -35.71 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.387 -0.82 . . . . 0.0 109.879 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.3 t -48.85 -36.67 17.47 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.401 -0.812 . . . . 0.0 110.504 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 19.8 t80 -63.4 -39.24 93.98 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.521 HD11 ' CB ' ' A' ' 164' ' ' ALA . 15.9 mt -66.2 -34.78 78.81 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.58 126.3 24.73 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.858 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.26 -31.8 8.31 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.448 ' O ' HD13 ' A' ' 44' ' ' LEU . 74.1 m -84.04 3.14 35.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.822 -0.811 . . . . 0.0 110.525 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.2 m -49.77 127.04 15.19 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.289 -0.882 . . . . 0.0 109.731 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.607 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 116.22 -17.24 14.75 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 107.031 -2.428 . . . . 0.0 107.031 -176.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.688 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -45.66 110.24 0.43 Allowed Glycine 0 N--CA 1.501 2.987 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.416 ' O ' HD12 ' A' ' 144' ' ' LEU . 46.9 Cg_endo -68.16 126.62 14.64 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.933 1.491 . . . . 0.0 111.9 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.889 HD23 HD13 ' A' ' 104' ' ' LEU . 9.0 mp -80.56 135.43 36.08 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 142' ' ' PRO . 1.2 mt -131.89 111.91 11.99 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.389 -0.924 . . . . 0.0 112.172 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.497 ' HB3' HG21 ' A' ' 151' ' ' VAL . 27.7 p -69.9 163.53 59.78 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.933 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 46.9 Cg_endo -62.72 86.31 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.769 1.405 . . . . 0.0 110.136 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.9 -48.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.637 -0.664 . . . . 0.0 109.47 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.04 23.43 3.27 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -131.44 147.09 52.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.401 -1.058 . . . . 0.0 109.554 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.816 ' HB1' HG21 ' A' ' 172' ' ' VAL . . . -66.43 122.14 16.87 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.497 -0.752 . . . . 0.0 110.723 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 145' ' ' CYS . 2.1 t -84.47 -37.88 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.836 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 178.43 -179.09 48.72 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.606 HD11 HD11 ' A' ' 82' ' ' LEU . 1.5 pt -117.12 156.77 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 CA-C-N 118.923 1.362 . . . . 0.0 111.841 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.892 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 9.9 t80 -75.56 85.78 2.64 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.602 0.715 . . . . 0.0 111.203 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.524 ' HA ' HG11 ' A' ' 55' ' ' VAL . 19.2 ttm180 -70.91 -49.29 47.35 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -147.78 177.65 9.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.892 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -131.67 119.86 21.97 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.967 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.849 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.1 t -66.4 99.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.635 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.7 p -126.08 140.57 52.48 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 161' ' ' ARG . 0.9 OUTLIER -74.34 -174.77 2.1 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.479 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -48.78 82.93 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 86.01 -26.95 5.73 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.033 -1.042 . . . . 0.0 110.91 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -93.83 135.99 26.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 118.981 1.391 . . . . 0.0 108.631 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -97.53 129.78 44.65 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.876 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -113.09 -44.87 3.22 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.452 -0.78 . . . . 0.0 111.174 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.849 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -123.82 -178.95 4.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.451 -0.78 . . . . 0.0 109.766 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -120.32 164.07 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.45 -0.781 . . . . 0.0 110.647 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.676 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 1.2 t0 -128.69 94.8 3.94 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.716 ' CG ' HD22 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -126.53 146.1 50.26 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.718 -174.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.477 HG11 ' CD1' ' A' ' 82' ' ' LEU . 2.7 p -99.81 131.69 24.16 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 42.9 Cg_endo -56.42 154.98 27.23 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 O-C-N 123.756 1.398 . . . . 0.0 111.412 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.889 ' CG1' HG11 ' A' ' 48' ' ' VAL . 42.6 t -84.44 2.78 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.366 -0.833 . . . . 0.0 109.748 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -91.75 -39.06 12.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.592 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.6 t -72.13 -44.33 63.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.809 -0.557 . . . . 0.0 110.75 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.86 ' HB3' HD22 ' A' ' 82' ' ' LEU . 2.8 ptp -53.76 -37.86 63.84 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.233 -0.917 . . . . 0.0 110.536 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -56.39 -37.84 70.69 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.999 0.904 . . . . 0.0 108.961 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.4 m -62.37 -35.01 77.81 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.96 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 175' ' ' MET . 0.7 OUTLIER -47.22 -37.52 10.5 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.41 -0.806 . . . . 0.0 111.455 -178.644 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.472 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -51.83 -46.12 64.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.234 -0.916 . . . . 0.0 110.323 178.646 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.45 -38.22 58.76 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.096 0.95 . . . . 0.0 110.018 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.87 65.38 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.087 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.7 t -75.64 -2.96 31.83 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.517 -0.74 . . . . 0.0 111.166 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.45 160.2 24.06 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.141 -0.974 . . . . 0.0 110.64 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 2.1 ptmt -68.78 80.83 0.29 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.302 -0.874 . . . . 0.0 109.917 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.35 100.1 11.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.288 -0.883 . . . . 0.0 109.619 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.4 mttt . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.652 -179.492 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.057 0.456 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.35 115.38 4.0 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.11 79.86 0.11 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.378 -1.072 . . . . 0.0 110.645 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -107.88 2.87 23.73 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.595 -0.691 . . . . 0.0 111.11 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 53.13 95.18 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.07 -1.019 . . . . 0.0 111.104 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -96.14 -177.7 4.08 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.639 -0.663 . . . . 0.0 109.303 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -148.12 77.32 1.4 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.554 0.692 . . . . 0.0 109.287 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.726 HG11 ' O ' ' A' ' 89' ' ' PRO . 24.5 m -58.66 175.66 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 121.554 0.693 . . . . 0.0 110.474 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 174.1 77.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 25.68 53.19 0.06 OUTLIER Glycine 0 N--CA 1.51 3.589 0 C-N-CA 123.548 0.594 . . . . 0.0 113.529 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -164.21 -67.36 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.485 1.143 . . . . 0.0 112.669 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.4 t -138.04 158.77 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 122.25 1.024 . . . . 0.0 112.971 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.648 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 2.8 tm0? -143.93 137.85 28.09 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.435 ' CG1' ' CD ' ' A' ' 109' ' ' ARG . 32.6 m -108.41 -179.78 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 122.152 0.977 . . . . 0.0 112.664 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.463 HG11 ' CZ3' ' A' ' 85' ' ' TRP . 21.3 m -139.29 -179.36 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.2 p -149.91 138.09 20.43 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.541 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.435 HG21 ' O ' ' A' ' 59' ' ' ALA . 46.2 p -139.45 179.16 6.71 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -73.43 72.42 1.34 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.815 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.734 HG22 ' HG2' ' A' ' 41' ' ' GLN . 72.1 m -175.4 -59.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.734 ' HG2' HG22 ' A' ' 40' ' ' THR . 3.7 pt20 179.77 -163.22 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.72 -0.612 . . . . 0.0 109.525 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 p -117.99 143.66 46.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.258 -0.901 . . . . 0.0 110.151 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 42.7 m-85 -99.81 -178.47 3.87 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.268 -0.895 . . . . 0.0 110.855 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 109' ' ' ARG . 5.5 tt -114.32 142.44 46.31 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 34' ' ' GLN . . . -147.45 131.22 16.99 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.804 -1.185 . . . . 0.0 110.805 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.645 HG23 HG23 ' A' ' 48' ' ' VAL . 5.3 t -97.84 123.48 41.82 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.34 -0.85 . . . . 0.0 111.865 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.4 p -78.98 83.63 5.06 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.796 0.808 . . . . 0.0 110.368 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.762 HG11 HG11 ' A' ' 172' ' ' VAL . 86.3 t -102.02 145.65 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 54.56 23.69 4.81 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.76 31.1 56.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 85' ' ' TRP . 38.2 t -147.02 111.38 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.176 -1.191 . . . . 0.0 110.483 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 49.3 m -60.83 115.62 3.82 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.474 -0.766 . . . . 0.0 109.294 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.61 ' CZ3' HD23 ' A' ' 82' ' ' LEU . 76.2 m95 -94.49 140.82 29.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.354 -0.841 . . . . 0.0 111.206 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.924 HG21 ' CH2' ' A' ' 85' ' ' TRP . 4.5 t -161.95 -178.58 6.54 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 12.5 t -104.0 144.82 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.426 -0.796 . . . . 0.0 109.671 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -74.34 -1.0 18.93 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.882 -1.137 . . . . 0.0 112.597 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.46 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 1.5 p-80 -70.08 -8.69 51.48 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.912 -1.118 . . . . 0.0 111.169 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.449 ' HA3' ' CE2' ' A' ' 43' ' ' PHE . . . -137.63 -134.08 3.2 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.435 ' O ' HG21 ' A' ' 38' ' ' THR . . . 54.51 174.6 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.481 -1.011 . . . . 0.0 111.01 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.09 112.4 4.46 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.0 p -56.09 173.28 0.16 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.442 -1.034 . . . . 0.0 110.388 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 tttp 58.17 -161.5 0.24 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.317 -0.864 . . . . 0.0 110.482 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -55.24 97.3 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.506 -0.747 . . . . 0.0 110.954 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.426 HD22 HD12 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -52.99 174.65 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.724 -0.61 . . . . 0.0 110.613 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . . . -120.2 137.29 54.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.49 -0.756 . . . . 0.0 110.613 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.12 179.38 20.47 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.0 -21.82 73.09 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.815 1.429 . . . . 0.0 110.957 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -154.31 36.57 0.43 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.361 -0.837 . . . . 0.0 109.937 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 156.62 150.4 5.65 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 47.3 Cg_endo -65.1 158.43 51.97 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.889 1.468 . . . . 0.0 110.483 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.426 HD12 HD22 ' A' ' 64' ' ' LEU . 69.6 mt -99.94 117.51 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.705 -0.622 . . . . 0.0 109.392 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 72' ' ' THR . 9.7 t -59.95 119.83 8.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.5 -0.75 . . . . 0.0 110.372 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 140.97 54.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.65 -0.656 . . . . 0.0 109.973 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.431 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 6.5 tpt -131.01 -41.16 1.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.641 -0.662 . . . . 0.0 110.395 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.471 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 20.7 m-85 -133.15 126.42 31.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.569 -0.707 . . . . 0.0 110.126 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.445 HG23 ' HB ' ' A' ' 83' ' ' VAL . 1.2 m -151.2 113.92 4.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.717 . . . . 0.0 110.407 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.9 76.92 1.53 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.479 -0.889 . . . . 0.0 111.018 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.42 -26.86 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -42.6 80.28 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -96.18 20.15 10.73 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.34 46.88 24.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.406 -0.809 . . . . 0.0 111.842 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.76 HD13 HG11 ' A' ' 170' ' ' VAL . 1.9 tp -161.87 141.68 10.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.359 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.71 ' CG2' HG23 ' A' ' 54' ' ' THR . 33.4 m -143.58 111.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -105.69 102.53 1.99 Allowed Glycine 0 N--CA 1.486 2.014 0 C-N-CA 119.613 -1.279 . . . . 0.0 111.431 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.924 ' CH2' HG21 ' A' ' 54' ' ' THR . 1.8 m-90 -82.0 167.01 19.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.4 ' O ' ' CD ' ' A' ' 88' ' ' PRO . 8.0 mt-30 -80.58 140.45 35.76 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.441 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -102.75 89.94 2.05 Favored Pre-proline 0 C--N 1.301 -1.539 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.545 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.588 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 46.5 Cg_endo -96.62 -14.83 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.731 1.385 . . . . 0.0 112.618 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.726 ' O ' HG11 ' A' ' 29' ' ' VAL . 46.9 Cg_endo -71.29 87.97 0.74 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 116.216 -2.056 . . . . 0.0 111.281 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 49.07 21.44 2.53 Favored Glycine 0 N--CA 1.5 2.944 0 O-C-N 121.402 -0.812 . . . . 0.0 111.368 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 87' ' ' ALA . . . -63.52 148.3 49.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.304 -1.115 . . . . 0.0 109.734 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -106.48 12.07 30.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.454 -0.779 . . . . 0.0 111.576 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 t 46.7 103.58 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.486 -0.759 . . . . 0.0 112.906 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -86.56 -150.21 0.15 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.267 -0.896 . . . . 0.0 109.855 178.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 94' ' ' LEU . 1.6 p -156.06 177.91 1.88 Allowed Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.206 -0.934 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -90.6 169.77 3.79 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 O-C-N 123.79 1.416 . . . . 0.0 111.014 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.541 ' SG ' HG22 ' A' ' 151' ' ' VAL . 39.3 t -93.06 -73.64 0.55 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.69 -0.631 . . . . 0.0 110.023 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m 56.1 42.82 27.88 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.385 -0.822 . . . . 0.0 109.071 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.0 p -126.42 -163.55 1.24 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.899 -0.5 . . . . 0.0 110.596 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.97 70.13 0.39 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t -128.37 -8.11 5.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.541 -0.976 . . . . 0.0 111.677 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 118' ' ' ARG . 23.6 m 53.78 -162.68 0.11 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.012 -1.055 . . . . 0.0 111.029 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.79 100.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.617 -0.677 . . . . 0.0 110.605 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.866 HD13 HD23 ' A' ' 143' ' ' LEU . 1.7 mt -115.86 153.99 30.52 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.02 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 107' ' ' VAL . 53.9 m-85 -105.17 94.35 5.19 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.523 HD23 HD11 ' A' ' 114' ' ' ILE . 8.8 tp -62.98 93.66 0.06 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.684 HG22 HG22 ' A' ' 113' ' ' VAL . 96.4 t -80.94 112.8 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.892 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.421 HG23 ' HB3' ' A' ' 138' ' ' SER . 8.7 m -78.38 172.89 12.96 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.733 ' N ' HD12 ' A' ' 44' ' ' LEU . 19.1 tpt180 -85.51 -8.85 58.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 111.021 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.493 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -107.55 41.42 1.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 110.046 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.48 71.44 0.52 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.376 -0.827 . . . . 0.0 110.676 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -156.4 98.37 1.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.777 -0.577 . . . . 0.0 110.284 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.684 HG22 HG22 ' A' ' 107' ' ' VAL . 54.6 t -99.71 135.57 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.489 -0.757 . . . . 0.0 110.121 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.523 HD11 HD23 ' A' ' 106' ' ' LEU . 32.4 pt -127.07 140.52 38.06 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.85 142.3 51.68 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 O-C-N 123.687 1.362 . . . . 0.0 112.044 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.26 151.36 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -106.2 105.6 15.71 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 102' ' ' SER . 9.9 ttp180 -48.89 123.02 6.36 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 122.036 0.922 . . . . 0.0 111.81 -177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -115.72 -26.79 7.29 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.72 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.21 161.06 32.7 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -51.49 -26.87 9.07 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.311 -1.111 . . . . 0.0 110.776 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -124.41 38.81 4.11 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.046 0.45 . . . . 0.0 110.364 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.468 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 4.1 ttt180 -166.82 156.82 11.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.343 -0.848 . . . . 0.0 110.528 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.47 -178.43 28.82 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.96 113.68 18.14 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.857 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.494 HD21 HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -57.92 130.99 49.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.535 -0.728 . . . . 0.0 109.463 178.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.6 mt -105.6 54.66 0.7 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.7 t 177.83 114.03 0.16 Allowed Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.095 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -58.27 102.98 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.731 0 O-C-N 123.478 1.251 . . . . 0.0 109.979 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 mtt-85 -119.01 160.73 39.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.233 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 43.3 Cg_endo -73.93 127.66 11.66 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 124.058 1.557 . . . . 0.0 109.956 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.2 p -58.82 -37.5 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.806 -0.559 . . . . 0.0 110.571 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -48.87 -36.46 17.08 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 122.038 0.923 . . . . 0.0 110.783 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.417 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 25.3 t80 -66.13 -38.41 88.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.614 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.0 mt -65.34 -35.96 82.57 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -63.67 -21.4 66.36 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.559 -0.856 . . . . 0.0 110.649 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.04 30.37 10.23 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.421 ' HB3' HG23 ' A' ' 108' ' ' THR . 85.2 p -150.7 21.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.566 -0.961 . . . . 0.0 111.453 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.7 p -56.07 132.91 51.42 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.152 -0.968 . . . . 0.0 109.04 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.551 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 109.9 -19.2 28.22 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.69 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -43.85 100.79 0.02 OUTLIER Glycine 0 N--CA 1.504 3.207 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 153' ' ' ILE . 44.2 Cg_endo -63.76 128.23 21.61 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.996 1.524 . . . . 0.0 112.243 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.866 HD23 HD13 ' A' ' 104' ' ' LEU . 9.8 mp -84.26 119.76 25.43 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.5 130.26 56.82 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.686 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 31.6 p -74.05 168.27 27.78 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.235 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 44.2 Cg_endo -69.63 76.66 1.07 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 O-C-N 123.739 1.389 . . . . 0.0 110.751 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.6 t -173.4 -57.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.326 -0.858 . . . . 0.0 110.345 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.57 -42.75 0.63 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER -59.27 123.5 16.94 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.729 -0.865 . . . . 0.0 110.083 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.34 145.33 55.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.66 . . . . 0.0 110.064 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.652 HG12 ' CE2' ' A' ' 169' ' ' PHE . 2.4 t -94.8 -37.23 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.644 -0.66 . . . . 0.0 109.478 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.677 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 177.13 -178.08 48.24 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 82' ' ' LEU . 1.8 pp -117.06 157.15 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.363 -1.081 . . . . 0.0 110.983 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.709 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 6.1 t80 -68.85 119.26 12.92 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.73 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -107.01 -41.13 5.26 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -161.28 179.98 7.89 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.709 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -141.65 128.29 20.29 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.492 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.946 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.2 t -68.32 99.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.471 ' SG ' HG23 ' A' ' 132' ' ' VAL . 72.8 m -115.9 159.86 20.98 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.461 1.124 . . . . 0.0 113.351 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 162' ' ' GLY . 1.8 m -98.3 -174.83 2.94 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.46 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -47.88 83.8 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.456 -0.778 . . . . 0.0 112.708 -179.138 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.717 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 83.06 -32.31 3.02 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.846 -1.159 . . . . 0.0 111.443 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.97 131.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 119.098 1.449 . . . . 0.0 108.944 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.614 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -91.68 132.71 36.17 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.713 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -113.86 -46.78 3.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.649 -0.657 . . . . 0.0 111.045 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.946 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -117.46 179.08 4.16 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.259 -0.901 . . . . 0.0 110.405 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 t -115.47 162.24 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.464 -0.772 . . . . 0.0 110.599 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.66 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -136.27 84.45 2.08 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.765 ' CD1' HD22 ' A' ' 143' ' ' LEU . 2.6 p90 -119.97 163.19 17.97 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.054 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.76 HG11 HD13 ' A' ' 82' ' ' LEU . 2.6 p -111.14 130.52 22.91 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 40.5 Cg_endo -60.57 159.41 28.06 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 124.063 1.559 . . . . 0.0 111.468 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.762 HG11 HG11 ' A' ' 48' ' ' VAL . 96.3 t -77.36 -3.88 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -84.57 -37.75 20.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 0.0 108.692 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.9 t -70.3 -38.12 74.92 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.76 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.723 ' HE1' HG23 ' A' ' 153' ' ' ILE . 19.4 mtt -49.91 -38.83 37.76 Favored 'General case' 0 N--CA 1.516 2.866 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -52.94 -38.73 62.26 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.497 0.665 . . . . 0.0 109.854 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.2 m -51.82 -38.07 54.29 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.405 0.621 . . . . 0.0 109.767 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.09 -42.37 80.6 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.65 -0.656 . . . . 0.0 110.02 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.471 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -56.19 -49.69 73.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.458 -0.776 . . . . 0.0 110.585 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -37.35 61.72 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.93 0.871 . . . . 0.0 109.804 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -78.54 -39.65 37.26 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.919 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.7 -172.06 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.35 -0.844 . . . . 0.0 110.647 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.86 71.06 0.51 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.488 -0.758 . . . . 0.0 109.906 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.29 127.68 33.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.696 -0.627 . . . . 0.0 110.593 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -88.4 152.3 22.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.541 -0.724 . . . . 0.0 109.852 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 2.4 tptp . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.247 -179.873 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.33 0.586 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.38 -83.18 0.05 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -95.59 28.89 2.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.503 -0.998 . . . . 0.0 110.783 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -65.39 -175.59 0.26 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.411 -0.806 . . . . 0.0 109.091 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.3 44.32 2.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.622 -0.674 . . . . 0.0 110.317 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 p-10 -157.37 117.22 3.41 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.482 -0.761 . . . . 0.0 110.656 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.11 76.87 1.3 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.542 -0.724 . . . . 0.0 109.198 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 7.7 p -160.47 154.98 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.712 -0.617 . . . . 0.0 109.626 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -161.65 78.58 0.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.124 0.964 . . . . 0.0 110.618 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 45.46 -93.66 0.01 OUTLIER Glycine 0 N--CA 1.496 2.685 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.363 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -90.42 -29.8 17.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.73 -0.865 . . . . 0.0 112.729 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 34' ' ' GLN . 47.3 t -125.97 162.38 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 120.942 -1.099 . . . . 0.0 112.554 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.447 ' N ' HG12 ' A' ' 33' ' ' VAL . 6.4 tt0 -153.46 135.67 14.87 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.568 HG12 ' HB2' ' A' ' 109' ' ' ARG . 11.2 m -91.89 177.7 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 120.932 -1.105 . . . . 0.0 112.53 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.614 HG21 ' CD2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -135.97 172.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.55 -179.139 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -160.7 138.36 9.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.453 -0.779 . . . . 0.0 111.008 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 40' ' ' THR . 6.2 t -153.42 179.55 8.68 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -71.01 72.72 0.59 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.815 -1.154 . . . . 0.0 108.772 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 39' ' ' ALA . 23.3 m -175.24 -61.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -177.24 -168.16 0.19 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.839 -0.538 . . . . 0.0 109.867 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.5 p -125.05 128.01 47.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.658 -0.651 . . . . 0.0 109.251 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.614 ' CD2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -108.12 -177.43 3.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.143 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.843 HD12 ' N ' ' A' ' 109' ' ' ARG . 6.1 tt -107.9 149.94 27.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.343 -0.848 . . . . 0.0 109.687 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.614 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -139.77 136.01 33.66 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.217 -0.927 . . . . 0.0 109.391 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.746 HG21 ' CG2' ' A' ' 153' ' ' ILE . 4.6 t -107.29 116.7 32.39 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.3 -0.875 . . . . 0.0 112.522 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.43 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 84.3 m -72.11 83.0 0.99 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.319 -0.863 . . . . 0.0 110.175 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.464 HG11 ' CG1' ' A' ' 172' ' ' VAL . 60.5 t -107.28 139.5 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.0 t30 57.44 19.96 5.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.575 -0.703 . . . . 0.0 109.811 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.76 54.68 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 85' ' ' TRP . 57.0 t -144.52 109.67 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.424 -1.045 . . . . 0.0 110.089 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 46' ' ' THR . 15.0 p -61.4 97.03 0.06 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.702 -0.624 . . . . 0.0 110.136 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.914 ' CE3' HD23 ' A' ' 82' ' ' LEU . 98.4 m95 -76.43 150.29 36.76 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.089 -1.007 . . . . 0.0 110.302 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.606 ' O ' HG22 ' A' ' 83' ' ' VAL . 7.9 t -164.03 -178.59 5.7 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.972 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 55' ' ' VAL . 12.0 m -97.25 139.16 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.562 -0.712 . . . . 0.0 110.076 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.547 ' HB3' HG11 ' A' ' 78' ' ' VAL . 31.9 t80 -76.33 0.05 20.82 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.306 -0.871 . . . . 0.0 111.313 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -49.2 -33.33 12.19 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.415 -0.803 . . . . 0.0 110.871 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.81 -14.0 1.93 Allowed Glycine 0 N--CA 1.496 2.667 0 C-N-CA 119.754 -1.213 . . . . 0.0 111.875 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 43' ' ' PHE . . . -52.32 -34.38 46.75 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.787 -1.42 . . . . 0.0 110.983 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.84 168.81 4.41 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.6 t -96.94 -19.65 18.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.521 -0.987 . . . . 0.0 110.19 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -57.33 179.0 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.56 0.695 . . . . 0.0 110.768 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.47 103.91 2.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.678 -0.639 . . . . 0.0 110.094 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.722 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -53.43 160.98 1.07 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.694 -0.629 . . . . 0.0 110.192 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.1 133.09 50.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.804 . . . . 0.0 110.602 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.87 -177.5 14.9 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -59.05 96.17 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 O-C-N 123.77 1.405 . . . . 0.0 110.279 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.63 37.86 29.13 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.367 -0.833 . . . . 0.0 110.443 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.97 136.5 2.44 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.035 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.58 153.22 78.77 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 124.081 1.569 . . . . 0.0 109.685 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.722 HD12 ' CD2' ' A' ' 64' ' ' LEU . 65.7 mt -100.45 116.76 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.336 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -59.92 126.79 28.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.565 -0.709 . . . . 0.0 111.034 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -79.76 105.24 10.91 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 tpt -101.56 -32.17 10.5 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.23 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.45 ' CZ ' ' HG3' ' A' ' 179' ' ' MET . 14.2 m-85 -130.15 115.63 17.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.696 -0.628 . . . . 0.0 110.084 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.83 HG23 ' CG1' ' A' ' 83' ' ' VAL . 18.4 m -161.06 107.5 1.43 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.146 -0.971 . . . . 0.0 112.839 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.45 ' CB ' ' HB3' ' A' ' 81' ' ' ASP . 5.0 m-80 -163.84 78.17 0.4 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.694 . . . . 0.0 109.917 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 56' ' ' TYR . 34.9 m -51.39 -21.92 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.731 -1.231 . . . . 0.0 111.852 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.85 78.69 0.63 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.052 -1.03 . . . . 0.0 108.721 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 60.32 46.57 9.94 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.644 -0.66 . . . . 0.0 110.753 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -156.33 -33.21 0.09 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.217 -0.927 . . . . 0.0 111.859 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.914 HD23 ' CE3' ' A' ' 53' ' ' TRP . 5.7 tp 72.75 165.62 0.3 Allowed 'General case' 0 N--CA 1.526 3.343 0 CA-C-N 120.217 1.371 . . . . 0.0 111.075 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.83 ' CG1' HG23 ' A' ' 76' ' ' THR . 1.4 m -122.21 147.79 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.94 110.04 0.42 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.527 ' CH2' HG21 ' A' ' 54' ' ' THR . 1.2 m-90 -86.6 169.62 12.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -81.98 138.45 34.92 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.482 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -107.0 82.52 1.12 Allowed Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.401 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.566 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 48.0 Cg_endo -98.81 -6.8 0.63 Allowed 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.575 1.303 . . . . 0.0 112.977 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 40.4 Cg_endo -73.24 63.23 4.32 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 115.592 -2.472 . . . . 0.0 111.269 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.96 52.91 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.43 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -72.19 129.48 38.57 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.247 -1.149 . . . . 0.0 111.206 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -68.46 136.15 52.79 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.223 -0.991 . . . . 0.0 108.619 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -103.21 115.43 30.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.49 -0.757 . . . . 0.0 110.292 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mp -85.92 -164.1 0.98 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.495 0.664 . . . . 0.0 110.513 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.64 173.83 4.13 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.778 -0.576 . . . . 0.0 110.343 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.415 ' HB2' HG23 ' A' ' 98' ' ' THR . 50.4 Cg_endo -72.91 166.16 30.8 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 O-C-N 123.657 1.346 . . . . 0.0 110.551 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.452 ' HB2' HG23 ' A' ' 151' ' ' VAL . 6.8 t -84.68 -49.99 8.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.727 -0.608 . . . . 0.0 109.656 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.415 HG23 ' HB2' ' A' ' 96' ' ' PRO . 61.8 p 45.06 37.33 2.45 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.813 -0.554 . . . . 0.0 111.041 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.6 p -122.78 -162.03 0.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.492 -0.755 . . . . 0.0 110.172 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.27 74.55 0.37 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m -150.72 165.11 34.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.719 -0.871 . . . . 0.0 110.184 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.8 t -112.31 -154.89 0.55 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.52 -0.737 . . . . 0.0 110.588 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 57.86 99.35 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.207 -0.933 . . . . 0.0 110.508 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.774 HD13 HD23 ' A' ' 143' ' ' LEU . 2.3 mt -116.11 -176.27 2.91 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.301 -0.874 . . . . 0.0 109.963 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.458 ' O ' HG23 ' A' ' 107' ' ' VAL . 28.7 m-85 -131.53 85.06 2.22 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 154' ' ' PHE . 19.2 tp -61.13 89.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.457 -0.777 . . . . 0.0 109.039 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.609 HG13 HG12 ' A' ' 113' ' ' VAL . 21.8 t -75.41 101.37 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.186 -1.006 . . . . 0.0 109.638 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.889 HG22 ' O ' ' A' ' 112' ' ' ASP . 7.4 t -75.73 179.7 5.27 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.843 ' N ' HD12 ' A' ' 44' ' ' LEU . 16.4 ptt85 -95.3 17.07 15.11 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.12 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.54 ' H ' HG23 ' A' ' 108' ' ' THR . 0.8 OUTLIER -103.36 21.17 16.43 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 59.12 56.36 3.95 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.363 -0.836 . . . . 0.0 109.816 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.889 ' O ' HG22 ' A' ' 108' ' ' THR . 11.6 t70 -166.86 121.88 1.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.688 -0.632 . . . . 0.0 109.881 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.609 HG12 HG13 ' A' ' 107' ' ' VAL . 8.4 m -104.1 145.36 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.993 -1.067 . . . . 0.0 109.608 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.443 HD11 HD23 ' A' ' 106' ' ' LEU . 44.0 pt -125.98 138.6 32.41 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.077 -1.015 . . . . 0.0 110.091 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.591 ' HB2' HD12 ' A' ' 127' ' ' LEU . 54.5 Cg_endo -66.18 141.47 63.31 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 O-C-N 123.796 1.419 . . . . 0.0 112.201 -177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 58.4 t -132.59 138.47 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.679 -0.638 . . . . 0.0 109.65 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.58 117.71 35.26 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 -48.96 129.5 17.4 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.488 -0.757 . . . . 0.0 110.702 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.428 ' CG ' ' HB2' ' A' ' 125' ' ' SER . 5.5 mmm180 -109.8 -27.26 9.39 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.736 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.19 -150.05 7.43 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -77.16 127.58 32.88 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.734 -0.862 . . . . 0.0 108.822 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.38 45.39 28.6 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.127 0.489 . . . . 0.0 111.217 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.485 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -160.89 151.59 18.33 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.332 -0.855 . . . . 0.0 110.754 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.0 -177.05 17.64 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.0 OUTLIER -129.46 120.65 25.81 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.803 -0.822 . . . . 0.0 112.041 -178.588 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.404 HD22 ' HB2' ' A' ' 130' ' ' ARG . 0.2 OUTLIER -58.48 141.25 52.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.436 -0.79 . . . . 0.0 109.001 178.194 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' ' 115' ' ' PRO . 20.7 mt -108.44 52.99 0.7 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.3 p 166.19 136.79 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.2 113.96 2.84 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.802 1.422 . . . . 0.0 109.81 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.404 ' HB2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -121.66 147.32 47.76 Favored Pre-proline 0 N--CA 1.49 1.531 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.68 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 43.3 Cg_endo -68.15 125.11 12.54 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 124.14 1.6 . . . . 0.0 110.055 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.45 HG21 ' SG ' ' A' ' 159' ' ' CYS . 10.8 p -58.86 -36.84 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.624 0.726 . . . . 0.0 109.684 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.1 m -49.13 -35.63 16.97 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 122.031 0.919 . . . . 0.0 110.936 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.738 ' OH ' HG21 ' A' ' 108' ' ' THR . 43.4 t80 -70.07 -36.93 75.31 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.567 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.9 mt -63.58 -37.2 86.41 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -57.83 122.93 14.09 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.576 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.45 -31.64 8.48 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.9 m -79.96 0.19 32.54 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.487 -1.008 . . . . 0.0 111.152 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.402 ' CB ' HG21 ' A' ' 55' ' ' VAL . 78.8 p -48.42 134.04 15.55 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.225 -0.922 . . . . 0.0 110.714 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.593 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 110.74 -20.59 24.48 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 107.376 -2.29 . . . . 0.0 107.376 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.76 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -47.09 113.66 1.31 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.41 122.62 9.64 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 124.05 1.552 . . . . 0.0 111.726 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.774 HD23 HD13 ' A' ' 104' ' ' LEU . 6.4 mp -79.11 114.08 17.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.618 HD23 ' HA ' ' A' ' 150' ' ' ALA . 1.8 mt -110.15 121.85 46.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 111.492 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.488 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 29.5 p -60.81 178.32 0.27 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.93 -0.481 . . . . 0.0 109.932 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 55.1 Cg_endo -83.63 51.01 3.37 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.514 1.271 . . . . 0.0 111.227 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.84 43.75 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.182 -0.949 . . . . 0.0 110.456 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 61.14 -167.01 12.53 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 56.48 106.02 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.567 -0.96 . . . . 0.0 110.671 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.618 ' HA ' HD23 ' A' ' 144' ' ' LEU . . . -57.44 153.63 12.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.192 -0.943 . . . . 0.0 109.982 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -105.07 -30.72 2.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.707 ' CA ' HG23 ' A' ' 172' ' ' VAL . . . 173.55 -177.15 46.03 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.769 HD11 HD11 ' A' ' 82' ' ' LEU . 1.2 pt -121.59 164.22 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 CA-C-N 119.24 1.52 . . . . 0.0 111.541 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.837 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.5 t80 -75.41 99.83 4.28 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.447 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -37.9 15.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -161.35 176.63 10.95 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.837 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -135.37 120.75 19.14 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.371 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.857 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 4.1 t -68.61 103.62 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.45 ' SG ' HG21 ' A' ' 132' ' ' VAL . 30.0 p -124.02 162.92 22.46 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.733 1.254 . . . . 0.0 114.06 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 161' ' ' ARG . 1.3 m -103.67 -172.56 2.13 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.469 ' H ' HG22 ' A' ' 160' ' ' THR . 7.1 ttt180 -46.38 90.07 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.677 0 O-C-N 121.396 -0.815 . . . . 0.0 111.623 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 72.25 -18.2 1.27 Allowed Glycine 0 N--CA 1.499 2.889 0 O-C-N 121.245 -0.91 . . . . 0.0 112.984 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.12 127.87 60.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 119.484 1.642 . . . . 0.0 109.527 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.567 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -89.66 137.82 32.0 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.052 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -117.94 -43.74 2.75 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.461 -0.775 . . . . 0.0 110.77 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.857 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -119.4 171.84 8.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.411 -0.806 . . . . 0.0 109.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.8 t -118.24 145.83 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.543 0.687 . . . . 0.0 110.865 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.668 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.5 OUTLIER -109.94 100.28 9.27 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 177.165 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.666 ' CG ' HD22 ' A' ' 143' ' ' LEU . 0.4 OUTLIER -131.89 142.97 49.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.803 -1.159 . . . . 0.0 113.194 -175.357 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.578 HG11 HD13 ' A' ' 82' ' ' LEU . 2.9 p -94.09 133.45 27.46 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 49.4 Cg_endo -61.17 160.74 25.34 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.812 1.427 . . . . 0.0 110.859 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.707 HG23 ' CA ' ' A' ' 152' ' ' GLY . 40.1 t -82.41 1.56 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.294 -0.879 . . . . 0.0 109.602 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -93.08 -39.38 11.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.046 -1.034 . . . . 0.0 110.228 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.9 t -75.33 -40.05 58.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.72 -0.613 . . . . 0.0 110.305 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.951 ' O ' HG22 ' A' ' 178' ' ' THR . 4.0 ptp -55.75 -36.32 67.16 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.315 -0.866 . . . . 0.0 110.349 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -37.95 65.41 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.219 -0.926 . . . . 0.0 109.862 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.4 m -48.92 -38.96 24.35 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.951 HG22 ' O ' ' A' ' 175' ' ' MET . 7.6 t -49.91 -38.73 37.28 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 120.752 -1.217 . . . . 0.0 112.267 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.486 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -57.69 -35.14 70.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.814 -1.179 . . . . 0.0 111.462 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -47.41 -37.28 11.13 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.272 -0.892 . . . . 0.0 110.634 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.85 -45.55 10.2 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.103 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.3 t 50.28 31.56 5.36 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.096 -1.002 . . . . 0.0 111.176 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 43.8 mttt 52.97 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.22 -0.925 . . . . 0.0 110.661 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -139.1 -40.95 0.47 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.409 -0.807 . . . . 0.0 111.127 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -64.95 153.33 40.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.406 -0.809 . . . . 0.0 110.11 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.061 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.978 0.418 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.25 -74.26 0.28 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.95 -88.79 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.658 -0.907 . . . . 0.0 111.295 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t0 57.49 -167.22 0.13 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.148 -0.97 . . . . 0.0 109.924 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -144.78 -162.81 1.56 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.472 -0.767 . . . . 0.0 110.055 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -99.24 109.46 22.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.814 -0.554 . . . . 0.0 109.895 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.2 77.71 1.41 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.387 0.613 . . . . 0.0 110.03 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.613 HG11 ' HB2' ' A' ' 89' ' ' PRO . 33.9 m -99.72 -148.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.658 -0.651 . . . . 0.0 110.402 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 62.69 80.06 0.24 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.984 -1.072 . . . . 0.0 109.364 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.58 164.61 29.73 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.489 ' CD ' HD11 ' A' ' 94' ' ' LEU . 8.6 mt-10 -90.9 -28.1 18.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.669 -0.901 . . . . 0.0 110.94 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.404 HG11 HD11 ' A' ' 44' ' ' LEU . 39.4 t -115.5 143.86 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.476 -0.765 . . . . 0.0 111.248 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.457 ' C ' HG13 ' A' ' 35' ' ' VAL . 2.7 tt0 -137.13 175.74 9.34 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 44' ' ' LEU . 34.3 m -148.56 177.96 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.23 -0.919 . . . . 0.0 111.173 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.471 HG11 HD11 ' A' ' 64' ' ' LEU . 10.6 m -130.75 -179.4 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 p -136.88 133.75 36.11 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.48 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.3 p -128.46 -176.42 3.82 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.94 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.201 -0.937 . . . . 0.0 110.959 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.0 p 49.1 39.95 16.3 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.842 -0.536 . . . . 0.0 111.005 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -155.03 137.87 15.36 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.661 -0.649 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.9 t -130.71 135.03 47.42 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.464 -0.773 . . . . 0.0 109.098 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -100.9 178.29 4.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.261 -0.899 . . . . 0.0 110.824 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.691 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -113.13 149.39 33.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.427 -0.796 . . . . 0.0 109.729 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.431 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -158.07 152.52 24.63 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.55 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.617 HG23 HG23 ' A' ' 48' ' ' VAL . 11.8 t -125.55 127.19 46.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.327 -0.858 . . . . 0.0 111.155 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.4 m -78.27 80.89 4.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.333 -0.854 . . . . 0.0 110.325 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.617 HG23 HG23 ' A' ' 46' ' ' THR . 95.3 t -100.04 139.17 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.75 20.31 6.35 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.327 -0.858 . . . . 0.0 108.945 -177.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 23.13 60.07 Favored Glycine 0 N--CA 1.491 2.332 0 O-C-N 121.392 -0.817 . . . . 0.0 111.361 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -136.88 105.12 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 118.79 1.295 . . . . 0.0 110.557 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.5 t -58.4 101.44 0.08 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.68 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.615 ' CZ3' HG21 ' A' ' 178' ' ' THR . 52.8 m95 -82.19 144.98 30.33 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.479 -0.763 . . . . 0.0 112.177 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.906 HG21 ' CH2' ' A' ' 85' ' ' TRP . 3.4 t -165.23 128.66 2.28 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 81' ' ' ASP . 13.4 m -49.61 153.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 O-C-N 121.26 -0.9 . . . . 0.0 111.349 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.465 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 57.1 t80 -76.4 1.31 16.72 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.159 -0.963 . . . . 0.0 111.643 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -49.24 -25.12 2.1 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.129 -0.982 . . . . 0.0 110.883 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.95 73.1 0.06 OUTLIER Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.749 ' O ' HD12 ' A' ' 64' ' ' LEU . . . -156.01 -54.45 0.09 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.592 -0.946 . . . . 0.0 110.264 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.68 -1.6 90.24 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 p -74.16 144.88 44.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.191 -1.182 . . . . 0.0 110.242 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.0 tttm 55.04 -171.6 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.477 -0.765 . . . . 0.0 110.65 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m -86.92 101.95 13.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.611 -0.68 . . . . 0.0 110.287 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.749 HD12 ' O ' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -55.46 156.13 4.79 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.625 -0.672 . . . . 0.0 110.646 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.21 141.4 47.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.673 -0.642 . . . . 0.0 110.465 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.97 -178.44 15.41 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -56.14 95.76 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.766 1.403 . . . . 0.0 110.59 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.9 tttt 56.66 33.44 22.83 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.535 -0.728 . . . . 0.0 110.503 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.35 137.33 3.42 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.98 162.21 42.62 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 O-C-N 123.836 1.44 . . . . 0.0 109.769 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.627 ' HB ' HD22 ' A' ' 64' ' ' LEU . 73.6 mt -118.9 93.54 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.375 -0.828 . . . . 0.0 110.098 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 m -110.02 141.19 43.17 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.222 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -146.87 -144.92 0.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.794 -0.566 . . . . 0.0 109.799 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.8 ttp -145.65 22.82 1.45 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.985 -1.072 . . . . 0.0 111.179 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.473 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 11.3 m-30 -115.85 101.85 9.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.328 -0.857 . . . . 0.0 110.139 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.609 HG23 ' CG1' ' A' ' 83' ' ' VAL . 3.0 m -150.88 121.33 7.37 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -142.83 78.09 1.6 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.344 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.441 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.7 p -52.76 -29.36 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.352 -0.842 . . . . 0.0 110.03 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.03 -50.65 69.85 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -86.59 5.98 33.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.772 -0.58 . . . . 0.0 109.786 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.54 ' O ' HG12 ' A' ' 55' ' ' VAL . 58.3 m-20 56.72 54.17 7.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.254 -0.904 . . . . 0.0 112.601 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.93 HD13 HG11 ' A' ' 170' ' ' VAL . 1.2 tp -160.87 138.02 9.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.922 -1.112 . . . . 0.0 112.559 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.609 ' CG1' HG23 ' A' ' 76' ' ' THR . 21.9 t -143.67 139.26 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -145.09 123.61 1.96 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 118.14 -1.981 . . . . 0.0 112.585 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.906 ' CH2' HG21 ' A' ' 54' ' ' THR . 1.2 m-90 -99.75 137.51 38.12 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -58.45 131.3 50.31 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.69 0.757 . . . . 0.0 111.757 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.508 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -104.65 93.28 5.86 Favored Pre-proline 0 C--N 1.296 -1.753 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.09 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.2 Cg_endo -99.89 -14.95 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.863 1.454 . . . . 0.0 112.473 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.613 ' HB2' HG11 ' A' ' 29' ' ' VAL . 47.9 Cg_endo -69.42 78.7 0.88 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 116.235 -2.043 . . . . 0.0 111.062 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 50.09 26.47 8.96 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.508 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -79.08 138.46 37.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.618 -0.931 . . . . 0.0 110.229 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -68.93 145.58 53.52 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.412 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -111.67 92.62 4.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.611 -0.681 . . . . 0.0 109.513 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.489 HD11 ' CD ' ' A' ' 32' ' ' GLU . 0.6 OUTLIER -71.14 -161.37 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.593 -0.692 . . . . 0.0 109.621 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -152.96 -176.28 0.57 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.718 -0.614 . . . . 0.0 109.959 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 95' ' ' THR . 41.1 Cg_endo -85.61 158.12 10.64 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 O-C-N 123.814 1.429 . . . . 0.0 109.944 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.81 86.71 2.35 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.509 -0.745 . . . . 0.0 110.709 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.1 p -91.85 79.59 5.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.41 -0.806 . . . . 0.0 109.549 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 31.1 p -138.2 -151.51 0.39 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.64 -128.98 3.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m 54.67 -164.16 0.11 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.252 -1.146 . . . . 0.0 110.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.9 m -160.19 -35.3 0.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.355 -0.84 . . . . 0.0 111.779 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 3.5 p30 -60.68 134.31 56.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.21 -0.931 . . . . 0.0 110.787 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.756 HD13 HD23 ' A' ' 143' ' ' LEU . 1.3 mt -128.08 -166.87 1.68 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.03 -1.043 . . . . 0.0 109.884 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.484 ' O ' HG23 ' A' ' 107' ' ' VAL . 72.7 m-85 -144.74 85.59 1.77 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.709 HD23 HD11 ' A' ' 114' ' ' ILE . 38.0 tp -65.84 109.66 2.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.315 -0.866 . . . . 0.0 109.279 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 105' ' ' TYR . 38.1 t -100.69 128.27 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 111.582 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.527 HG21 ' CE1' ' A' ' 134' ' ' TYR . 33.2 p -94.55 166.49 12.01 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.691 ' CB ' HD21 ' A' ' 44' ' ' LEU . 27.2 tpt85 -79.97 -7.52 58.84 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.199 -0.938 . . . . 0.0 110.724 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.39 41.53 1.3 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.979 -1.075 . . . . 0.0 110.037 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 50.63 63.52 2.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.558 -0.714 . . . . 0.0 111.329 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.36 82.61 1.42 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.643 -0.66 . . . . 0.0 110.021 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.43 HG23 HG22 ' A' ' 107' ' ' VAL . 9.7 p -92.94 149.96 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.493 -0.754 . . . . 0.0 110.93 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.709 HD11 HD23 ' A' ' 106' ' ' LEU . 40.6 pt -145.16 144.72 24.41 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.226 -0.921 . . . . 0.0 110.018 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.52 ' HB2' HD12 ' A' ' 127' ' ' LEU . 52.5 Cg_endo -78.07 135.41 13.82 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.805 1.424 . . . . 0.0 110.909 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 103' ' ' ASP . 46.4 t -122.01 146.28 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.552 -0.718 . . . . 0.0 109.38 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.17 115.05 29.72 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.01 129.21 17.27 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.505 -0.747 . . . . 0.0 111.047 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -114.73 -25.85 8.09 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.51 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -171.03 61.22 0.17 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.825 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.456 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.4 OUTLIER 60.13 -75.17 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.663 -0.904 . . . . 0.0 111.66 179.051 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 120' ' ' GLY . 9.4 p -91.97 39.82 1.03 Allowed 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.283 0.563 . . . . 0.0 111.579 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.05 151.22 2.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.423 ' HA3' HG12 ' A' ' 116' ' ' VAL . . . -143.25 -177.2 18.0 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -125.04 118.39 26.08 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.917 -178.328 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.587 HD21 HD12 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -55.35 141.78 34.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.591 -0.693 . . . . 0.0 110.112 179.104 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.52 HD12 ' HB2' ' A' ' 115' ' ' PRO . 49.2 mt -109.75 53.94 0.68 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 168.08 128.82 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.05 112.45 2.05 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.775 1.408 . . . . 0.0 110.022 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -125.72 143.81 46.26 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.254 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.49 128.46 23.64 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.987 1.52 . . . . 0.0 110.907 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.695 HG21 ' SG ' ' A' ' 159' ' ' CYS . 7.4 p -60.28 -36.73 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.482 0.658 . . . . 0.0 109.499 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.8 m -48.44 -36.53 15.08 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.372 -0.83 . . . . 0.0 110.979 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.527 ' CE1' HG21 ' A' ' 108' ' ' THR . 0.1 OUTLIER -65.87 -38.58 89.19 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.8 mt -63.91 -35.49 80.82 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.08 121.7 10.63 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.584 -0.847 . . . . 0.0 109.788 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.34 -30.83 9.42 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.429 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 8.9 m -80.83 2.23 27.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.533 -0.981 . . . . 0.0 111.263 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 p -52.96 122.84 10.1 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.133 -0.979 . . . . 0.0 110.618 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 115.37 -9.71 19.98 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -59.86 152.35 35.9 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -93.82 129.64 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.697 1.367 . . . . 0.0 112.784 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.756 HD23 HD13 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -88.05 123.35 32.65 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 176.141 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.61 123.87 42.17 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.673 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.539 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 31.3 p -58.54 -170.95 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 48.6 Cg_endo -81.13 57.51 6.54 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 117.699 -1.068 . . . . 0.0 111.149 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.2 p -175.7 -158.13 0.06 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 149' ' ' HIS . . . -83.32 -160.18 29.12 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 148' ' ' GLY . 0.6 OUTLIER 57.73 133.17 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 117.789 0.795 . . . . 0.0 112.034 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.639 ' HB3' HG21 ' A' ' 172' ' ' VAL . . . -80.85 137.5 36.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.101 -0.999 . . . . 0.0 109.811 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.668 HG12 ' CE2' ' A' ' 169' ' ' PHE . 0.9 OUTLIER -81.83 -38.51 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.497 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.628 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 177.16 -178.29 48.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.773 HD11 ' CD1' ' A' ' 82' ' ' LEU . 1.7 pp -118.76 150.8 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 118.67 1.235 . . . . 0.0 111.346 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.745 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.9 t80 -60.63 112.33 1.96 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.39 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -46.75 5.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -149.32 172.99 14.0 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.745 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -128.73 115.6 18.23 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.555 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.796 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.4 t -67.67 94.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.695 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.2 p -123.87 148.68 46.59 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.876 0.846 . . . . 0.0 113.279 -175.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.585 HG22 ' H ' ' A' ' 161' ' ' ARG . 2.3 m -88.59 -173.49 4.17 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.585 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -46.56 85.99 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.99 0.9 . . . . 0.0 112.829 -178.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.613 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 80.42 -26.1 3.12 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.994 -1.066 . . . . 0.0 112.321 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.35 129.91 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.088 1.444 . . . . 0.0 109.271 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.442 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -91.98 126.69 37.16 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.961 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -109.0 -35.87 6.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.483 -0.761 . . . . 0.0 110.638 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.796 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -134.3 176.36 8.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.816 . . . . 0.0 109.921 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.01 153.11 26.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-O 121.663 0.745 . . . . 0.0 110.85 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.73 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 3.2 t70 -120.53 93.93 4.2 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.668 ' CE2' HG12 ' A' ' 151' ' ' VAL . 3.5 p90 -124.85 156.38 37.94 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.954 -1.098 . . . . 0.0 113.099 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.93 HG11 HD13 ' A' ' 82' ' ' LEU . 4.7 p -100.15 130.62 25.69 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 39.2 Cg_endo -62.06 159.59 33.67 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.778 1.41 . . . . 0.0 110.97 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.639 HG21 ' HB3' ' A' ' 150' ' ' ALA . 92.6 t -78.37 0.32 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.458 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -87.48 -37.65 16.77 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.838 0.828 . . . . 0.0 108.789 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 t -70.31 -37.21 74.71 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.28 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.603 ' HE1' HG23 ' A' ' 153' ' ' ILE . 14.9 mtt -49.12 -38.3 24.57 Favored 'General case' 0 N--CA 1.516 2.844 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -53.15 -38.34 62.63 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.29 -0.881 . . . . 0.0 108.968 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 m -55.47 -35.14 65.19 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.525 0.678 . . . . 0.0 109.452 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.615 HG21 ' CZ3' ' A' ' 53' ' ' TRP . 31.0 m -48.02 -61.02 2.18 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.859 -0.526 . . . . 0.0 110.535 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.473 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -55.04 -38.13 67.57 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.628 -0.67 . . . . 0.0 110.763 179.526 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -48.94 -37.04 18.82 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.982 0.896 . . . . 0.0 110.337 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.03 36.76 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.239 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.28 30.27 7.75 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.218 -0.926 . . . . 0.0 110.649 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -51.92 118.81 3.7 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.488 -0.757 . . . . 0.0 111.271 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -81.96 178.88 8.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.595 -0.69 . . . . 0.0 110.267 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -119.07 45.42 2.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.538 -0.726 . . . . 0.0 110.713 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.181 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.257 0.551 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.49 -94.64 0.48 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -86.47 92.45 8.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.493 -1.004 . . . . 0.0 109.76 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.38 175.45 0.76 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.636 -0.665 . . . . 0.0 110.692 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -124.23 -142.53 0.31 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.604 -0.685 . . . . 0.0 109.393 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -65.42 99.57 0.42 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.739 -1.226 . . . . 0.0 110.245 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -159.62 78.91 0.71 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 89' ' ' PRO . 25.4 m -57.58 -176.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.382 0.611 . . . . 0.0 111.012 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.84 79.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.91 53.82 4.7 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -164.47 -82.1 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.516 -0.99 . . . . 0.0 109.764 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.664 HG22 ' CD ' ' A' ' 142' ' ' PRO . 72.2 t -129.5 147.38 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.322 -0.861 . . . . 0.0 110.726 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -134.56 178.85 6.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.68 -0.637 . . . . 0.0 110.033 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 43' ' ' PHE . 2.6 p -159.89 144.64 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.861 0.839 . . . . 0.0 110.01 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.58 ' CG1' HD21 ' A' ' 64' ' ' LEU . 12.8 m -116.74 -178.96 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.1 m -146.37 137.54 24.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.38 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.9 p -136.65 -178.88 5.37 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.53 74.27 0.77 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.68 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.583 HG22 ' HG2' ' A' ' 41' ' ' GLN . 1.1 m 174.55 -63.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.583 ' HG2' HG22 ' A' ' 40' ' ' THR . 1.6 pt20 -173.15 -173.64 0.95 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.507 -0.746 . . . . 0.0 110.564 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.5 p -107.61 146.34 32.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.713 -0.617 . . . . 0.0 110.302 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.823 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . 93.1 m-85 -105.85 -177.48 3.37 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.316 -0.865 . . . . 0.0 111.855 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.718 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -114.19 146.88 39.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.616 -0.678 . . . . 0.0 110.382 -178.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.442 ' HB1' ' SG ' ' A' ' 52' ' ' CYS . . . -152.33 166.73 30.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.58 -0.7 . . . . 0.0 110.685 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 46' ' ' THR . 8.8 t -141.93 115.34 8.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.722 . . . . 0.0 111.685 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 81.8 m -66.88 85.5 0.12 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.361 -0.837 . . . . 0.0 110.247 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.591 HG11 ' HB ' ' A' ' 172' ' ' VAL . 53.3 t -104.35 139.75 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 55.39 20.2 3.49 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.485 -0.76 . . . . 0.0 110.331 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.442 ' C ' HG23 ' A' ' 51' ' ' VAL . . . 83.13 26.63 43.61 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 50' ' ' GLY . 91.2 t -146.9 106.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.448 -1.031 . . . . 0.0 109.865 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.442 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -61.8 119.98 9.81 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.484 -0.76 . . . . 0.0 109.259 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.994 ' CE3' HD23 ' A' ' 82' ' ' LEU . 95.7 m95 -99.75 153.62 18.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.44 -0.788 . . . . 0.0 111.807 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.833 HG23 HG23 ' A' ' 83' ' ' VAL . 6.9 t -162.89 -176.53 4.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.492 ' HB ' ' CD2' ' A' ' 57' ' ' HIS . 15.5 m -104.96 139.13 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.615 ' HB2' HG11 ' A' ' 83' ' ' VAL . 13.1 t80 -65.99 -7.14 15.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.182 -0.948 . . . . 0.0 113.022 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.492 ' CD2' ' HB ' ' A' ' 55' ' ' VAL . 32.3 p80 -95.84 36.36 1.3 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.024 -1.048 . . . . 0.0 110.161 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.506 ' CA ' ' CE1' ' A' ' 43' ' ' PHE . . . -173.93 -81.41 0.05 OUTLIER Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.823 ' HB2' ' CB ' ' A' ' 43' ' ' PHE . . . -88.43 116.48 26.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.585 -0.95 . . . . 0.0 109.13 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.93 -60.22 0.49 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.8 t -55.16 170.69 0.19 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.232 -1.158 . . . . 0.0 110.597 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 58.91 168.74 0.06 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.479 -0.763 . . . . 0.0 110.053 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.652 ' O ' HG23 ' A' ' 63' ' ' THR . 9.0 t -78.03 101.06 6.75 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.699 0.762 . . . . 0.0 110.759 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.768 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -61.91 168.49 3.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.362 -0.836 . . . . 0.0 109.496 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.69 130.16 50.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.46 -0.775 . . . . 0.0 110.739 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.88 179.86 19.29 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.12 -26.83 65.17 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.982 1.517 . . . . 0.0 110.994 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -143.48 27.49 1.54 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.386 -0.821 . . . . 0.0 111.082 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.23 154.85 8.03 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -64.23 168.64 12.18 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.957 1.504 . . . . 0.0 110.186 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.768 HD12 ' CD2' ' A' ' 64' ' ' LEU . 16.5 mt -127.25 98.27 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 O-C-N 121.392 -0.817 . . . . 0.0 110.371 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 72' ' ' THR . 21.0 m -161.86 51.52 0.22 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.264 -0.898 . . . . 0.0 111.064 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -168.18 66.66 0.07 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.047 -1.033 . . . . 0.0 111.473 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.413 ' HG2' ' HG3' ' A' ' 86' ' ' GLN . 0.5 OUTLIER -143.03 -72.82 0.3 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.225 -0.922 . . . . 0.0 109.799 179.084 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.482 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 22.5 m-85 -137.77 119.83 15.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.564 -0.71 . . . . 0.0 109.479 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.582 ' CG2' HG12 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -151.87 112.58 4.19 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.375 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.518 HD22 ' HB1' ' A' ' 181' ' ' ALA . 41.4 t-20 -147.29 75.63 1.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.637 0.732 . . . . 0.0 110.018 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.526 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.3 p -44.99 168.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.497 -0.752 . . . . 0.0 112.166 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.471 ' N ' HG22 ' A' ' 78' ' ' VAL . 6.9 m-20 57.51 114.48 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.679 0.752 . . . . 0.0 111.336 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 66.33 -66.73 0.17 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.593 -0.692 . . . . 0.0 111.999 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' A' ' 77' ' ' ASN . 21.1 m-20 -63.99 -114.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 111.689 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.994 HD23 ' CE3' ' A' ' 53' ' ' TRP . 4.5 tp 176.94 174.09 0.42 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.182 -1.574 . . . . 0.0 111.286 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.833 HG23 HG23 ' A' ' 54' ' ' THR . 27.5 m -135.54 133.78 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.6 131.63 2.69 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.302 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.521 ' HH2' ' HB1' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -95.42 161.2 14.18 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.413 ' HG3' ' HG2' ' A' ' 74' ' ' MET . 13.8 mt-30 -79.52 135.27 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.812 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.55 93.38 4.93 Favored Pre-proline 0 C--N 1.298 -1.672 0 O-C-N 122.003 -0.436 . . . . 0.0 110.404 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.527 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 52.1 Cg_endo -92.44 -12.82 1.65 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 123.779 1.41 . . . . 0.0 113.782 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.703 ' O ' HG12 ' A' ' 29' ' ' VAL . 43.0 Cg_endo -68.83 80.51 0.64 Allowed 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 115.931 -2.246 . . . . 0.0 111.738 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 49.49 24.6 5.6 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -53.63 133.32 41.59 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.315 -1.109 . . . . 0.0 110.133 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -94.87 -5.28 45.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.632 -0.668 . . . . 0.0 112.056 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 t 59.68 129.42 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 121.708 0.766 . . . . 0.0 110.813 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.973 HD21 HD21 ' A' ' 144' ' ' LEU . 12.7 tp -95.54 14.92 21.24 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.302 -0.874 . . . . 0.0 111.05 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 63.4 p 44.35 -169.26 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.853 -0.53 . . . . 0.0 112.176 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -112.86 -164.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 O-C-N 123.439 1.231 . . . . 0.0 111.179 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.492 ' C ' HG22 ' A' ' 98' ' ' THR . 43.4 t -110.66 -50.37 2.96 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.446 -0.784 . . . . 0.0 110.083 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.492 HG22 ' C ' ' A' ' 97' ' ' CYS . 9.6 t 38.45 30.46 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.0 p -116.32 -177.73 3.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 109.642 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.27 -18.93 27.28 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.6 t -51.18 138.99 19.32 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.221 -1.164 . . . . 0.0 111.363 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.3 m -109.78 -11.11 14.75 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.436 -0.79 . . . . 0.0 111.403 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 4.0 t70 -61.28 112.77 2.28 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.875 -1.141 . . . . 0.0 109.072 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.839 HD13 HD23 ' A' ' 143' ' ' LEU . 33.9 mt -112.31 170.29 8.27 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.558 0.694 . . . . 0.0 111.427 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.413 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.7 m-85 -148.23 89.45 1.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 154' ' ' PHE . 20.3 tp -59.56 111.46 1.42 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.487 -0.758 . . . . 0.0 109.123 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 113' ' ' VAL . 97.8 t -92.99 97.1 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.551 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.434 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 80.6 p -65.59 152.38 44.25 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.718 ' CB ' HD21 ' A' ' 44' ' ' LEU . 1.6 tpm_? -74.25 -2.0 23.05 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.17 -0.956 . . . . 0.0 111.037 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.441 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -103.62 34.76 2.84 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.027 -1.046 . . . . 0.0 109.252 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.71 75.35 0.3 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.446 -0.783 . . . . 0.0 110.746 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.3 102.96 0.96 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.887 -0.508 . . . . 0.0 110.406 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 107' ' ' VAL . 2.5 t -98.38 139.05 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.604 HD11 HD23 ' A' ' 106' ' ' LEU . 42.7 pt -129.55 131.4 23.56 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.473 ' HB2' HD12 ' A' ' 127' ' ' LEU . 47.0 Cg_endo -67.01 137.19 43.67 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 O-C-N 123.581 1.306 . . . . 0.0 112.436 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 62.1 t -127.14 148.25 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.586 ' HG2' HD11 ' A' ' 127' ' ' LEU . 17.2 mmt180 -113.72 120.91 42.45 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -48.7 128.27 15.05 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.676 -0.64 . . . . 0.0 110.429 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.444 ' HG3' ' HB2' ' A' ' 125' ' ' SER . 8.0 mmm180 -109.02 -29.08 8.74 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.8 -0.562 . . . . 0.0 110.221 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.39 -159.45 22.96 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.36 127.81 33.72 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.701 -0.882 . . . . 0.0 109.373 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.444 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 0.0 OUTLIER 49.94 55.95 8.64 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 121.221 0.534 . . . . 0.0 111.492 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -172.84 149.75 2.0 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.438 -0.789 . . . . 0.0 111.061 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.95 -178.24 17.85 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.4 OUTLIER -136.27 104.7 5.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.729 -178.561 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.58 HD21 ' C ' ' A' ' 164' ' ' ALA . 3.2 pp -49.37 151.32 1.54 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.817 -0.552 . . . . 0.0 110.319 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.586 HD11 ' HG2' ' A' ' 117' ' ' ARG . 36.8 mt -110.91 54.2 0.68 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.53 106.51 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -55.71 106.76 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 O-C-N 123.396 1.208 . . . . 0.0 110.283 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -109.76 175.61 1.87 Allowed Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.781 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.421 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 51.5 Cg_endo -79.9 124.99 5.8 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 124.139 1.599 . . . . 0.0 109.294 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.818 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.2 p -62.39 -35.41 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.558 -0.714 . . . . 0.0 109.4 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.75 -36.77 17.16 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 122.111 0.958 . . . . 0.0 110.27 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.421 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 21.9 t80 -66.34 -38.73 88.31 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 17.9 mt -64.88 -35.84 82.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.37 119.2 4.86 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.704 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.5 -32.98 6.37 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.6 m -78.72 -4.68 50.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.625 -0.926 . . . . 0.0 111.454 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 2.4 m -50.39 125.28 12.31 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.003 -1.061 . . . . 0.0 111.045 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 113.83 -15.69 21.37 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.543 ' HA2' HD12 ' A' ' 44' ' ' LEU . . . -58.69 135.09 52.21 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.664 ' CD ' HG22 ' A' ' 33' ' ' VAL . 51.6 Cg_endo -79.75 131.18 9.06 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.8 1.421 . . . . 0.0 113.011 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.839 HD23 HD13 ' A' ' 104' ' ' LEU . 5.1 mp -79.11 138.13 37.8 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.973 HD21 HD21 ' A' ' 94' ' ' LEU . 0.9 OUTLIER -129.81 128.06 41.58 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.003 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.523 ' HB2' ' HD3' ' A' ' 146' ' ' PRO . 1.1 p -58.58 -109.25 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.104 0 CA-C-O 117.337 -1.316 . . . . 0.0 110.907 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 145' ' ' CYS . 47.2 Cg_endo -68.99 -84.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 114.35 -3.3 . . . . 0.0 110.307 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.9 m -153.79 99.86 2.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.797 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.1 -61.34 0.65 Allowed Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -58.9 124.41 19.76 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.699 -0.883 . . . . 0.0 111.24 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -78.27 140.88 38.84 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.581 HG11 HD21 ' A' ' 104' ' ' LEU . 2.5 t -108.62 -37.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.522 -0.736 . . . . 0.0 109.54 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.747 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 174.19 -177.91 46.23 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.467 HD11 HD11 ' A' ' 82' ' ' LEU . 3.2 pt -112.76 156.07 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 120.96 -1.318 . . . . 0.0 111.428 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.843 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 9.8 t80 -73.58 84.5 1.56 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.219 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -66.05 -52.25 50.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.584 -0.698 . . . . 0.0 109.901 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -150.13 178.81 8.62 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.843 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -131.01 115.91 17.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.136 -0.978 . . . . 0.0 110.313 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.814 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 4.2 t -63.46 101.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.679 ' SG ' HG21 ' A' ' 132' ' ' VAL . 26.3 p -129.57 139.53 51.46 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.6 OUTLIER -73.83 -173.79 1.63 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 176.143 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.57 84.16 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.333 -0.854 . . . . 0.0 112.801 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.818 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 87.42 -28.27 5.86 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 120.809 -1.182 . . . . 0.0 111.447 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.0 OUTLIER -92.49 133.92 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.86 -1.377 . . . . 0.0 110.022 -179.245 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.58 ' C ' HD21 ' A' ' 126' ' ' LEU . . . -92.8 129.2 38.79 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.221 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.53 ' HA ' HD11 ' A' ' 126' ' ' LEU . 3.2 mtpt -114.09 -21.5 10.5 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.474 -0.766 . . . . 0.0 111.318 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.814 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -151.27 -178.47 6.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.878 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.23 144.29 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 111.59 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -109.98 101.28 10.11 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.429 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.661 ' CG ' HD22 ' A' ' 143' ' ' LEU . 0.6 OUTLIER -130.63 148.15 52.39 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.33 -0.948 . . . . 0.0 113.019 -175.427 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.491 HG11 HD11 ' A' ' 82' ' ' LEU . 3.0 p -103.17 132.98 20.59 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 54.7 Cg_endo -60.38 153.66 58.56 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.796 1.419 . . . . 0.0 111.357 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.747 HG13 ' HA2' ' A' ' 152' ' ' GLY . 35.9 m -80.3 0.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.452 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -89.9 -38.93 13.36 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.311 -0.868 . . . . 0.0 108.776 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 88.3 p -61.12 -36.37 79.54 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.565 ' HG2' HD22 ' A' ' 82' ' ' LEU . 19.7 mtt -48.13 -38.18 17.25 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-O 121.519 0.676 . . . . 0.0 109.649 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -56.11 -38.09 70.29 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -67.5 -39.73 85.18 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.738 0.78 . . . . 0.0 109.031 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.432 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 0.7 OUTLIER -52.31 -41.5 63.01 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.807 -0.558 . . . . 0.0 110.543 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.482 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -49.56 -41.6 42.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.206 -0.934 . . . . 0.0 111.167 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -38.71 72.99 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.133 0.968 . . . . 0.0 109.322 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.518 ' HB1' HD22 ' A' ' 77' ' ' ASN . . . -67.87 -38.37 82.98 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.512 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.8 t -77.69 -8.09 57.43 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.333 -0.854 . . . . 0.0 111.142 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -102.41 99.54 9.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.943 -1.098 . . . . 0.0 110.104 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -100.04 32.54 2.91 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.528 -0.733 . . . . 0.0 110.862 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -91.31 98.39 11.68 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.447 -0.783 . . . . 0.0 109.606 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 18.9 mttp . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.594 -179.673 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.8 m . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.19 0.519 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.53 71.33 0.12 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.27 91.35 3.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.64 -0.918 . . . . 0.0 110.097 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.59 135.82 42.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.672 -0.642 . . . . 0.0 109.826 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.86 85.32 7.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.561 -0.712 . . . . 0.0 109.758 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -81.25 -178.21 6.81 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.621 0.724 . . . . 0.0 109.529 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -149.79 77.79 1.34 Allowed 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -59.93 -157.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.259 0.552 . . . . 0.0 110.727 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 62.37 78.58 0.29 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.063 -1.023 . . . . 0.0 108.859 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.95 -95.81 0.11 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.785 ' HG3' HG23 ' A' ' 33' ' ' VAL . 5.2 pt-20 -173.12 -36.01 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.275 -1.133 . . . . 0.0 111.629 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.785 HG23 ' HG3' ' A' ' 32' ' ' GLU . 97.0 t -113.52 155.34 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.187 -0.946 . . . . 0.0 110.92 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.575 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 18.7 tp60 -141.16 148.78 40.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.592 -0.693 . . . . 0.0 110.231 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' A' ' 109' ' ' ARG . 31.4 m -106.78 -179.3 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.42 -0.8 . . . . 0.0 112.034 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.784 HG21 ' CE2' ' A' ' 43' ' ' PHE . 27.6 m -139.1 -178.33 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.5 p -156.2 136.62 13.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.582 -0.699 . . . . 0.0 110.054 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.638 HG23 ' OG1' ' A' ' 40' ' ' THR . 8.0 t -152.83 -178.7 7.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.672 ' O ' HG23 ' A' ' 40' ' ' THR . . . -68.41 76.85 0.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.349 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER 174.03 -58.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 175.4 -176.41 0.1 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.269 -0.894 . . . . 0.0 109.948 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.8 t -112.49 127.87 56.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 109.358 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.784 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -107.37 -176.26 3.02 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.144 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 45' ' ' ALA . 6.6 tt -103.85 154.47 19.57 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.668 -0.645 . . . . 0.0 109.738 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.801 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -150.77 129.13 12.05 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.261 -0.899 . . . . 0.0 109.689 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.636 HG23 HG23 ' A' ' 48' ' ' VAL . 12.6 t -97.58 124.74 41.95 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.241 -0.912 . . . . 0.0 112.004 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.71 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 41.3 t -75.22 90.71 2.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.65 -0.656 . . . . 0.0 109.793 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.636 HG23 HG23 ' A' ' 46' ' ' THR . 65.1 t -104.14 133.43 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.4 t30 57.34 20.61 6.01 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.471 -0.768 . . . . 0.0 110.032 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.97 25.08 38.85 Favored Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.225 -0.922 . . . . 0.0 110.887 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.674 HG22 ' HG2' ' A' ' 86' ' ' GLN . 94.3 t -139.44 106.69 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.54 -0.977 . . . . 0.0 110.06 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.4 ' O ' ' HA2' ' A' ' 84' ' ' GLY . 5.4 m -62.51 114.67 3.67 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.262 -0.899 . . . . 0.0 108.854 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.911 ' CE3' HD23 ' A' ' 82' ' ' LEU . 98.8 m95 -96.8 146.89 24.49 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.409 -0.807 . . . . 0.0 112.682 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.808 HG21 ' CH2' ' A' ' 85' ' ' TRP . 4.5 t -164.31 141.71 6.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 155' ' ' ARG . 12.8 m -57.71 148.12 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.029 -1.045 . . . . 0.0 109.812 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 47.3 t80 -72.99 -1.07 15.64 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.008 -1.057 . . . . 0.0 111.715 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -49.8 -28.1 5.87 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.209 -0.932 . . . . 0.0 110.397 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.31 -46.83 0.16 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' CE1' ' A' ' 56' ' ' TYR . . . -49.49 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.404 -1.057 . . . . 0.0 110.831 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.66 175.36 22.25 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.2 p -93.57 -7.51 43.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.702 -0.881 . . . . 0.0 110.783 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -59.53 -167.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.152 -0.967 . . . . 0.0 110.856 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.3 m -83.97 101.77 11.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.742 -0.598 . . . . 0.0 109.705 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.711 HD22 HD12 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -57.72 173.51 0.29 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.579 -0.701 . . . . 0.0 110.139 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.94 132.75 53.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.524 -0.735 . . . . 0.0 110.876 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.03 -179.46 37.2 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.15 -18.39 64.76 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.767 1.404 . . . . 0.0 110.797 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -159.86 31.47 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 110.235 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.01 161.43 12.35 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.53 159.37 36.71 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.957 1.504 . . . . 0.0 110.403 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.711 HD12 HD22 ' A' ' 64' ' ' LEU . 96.1 mt -91.54 153.96 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 110.351 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.5 p -89.45 167.29 13.12 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.497 -0.752 . . . . 0.0 110.698 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 53.0 -179.21 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.381 -0.824 . . . . 0.0 110.359 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.6 ttp -176.37 51.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.332 -0.855 . . . . 0.0 109.902 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.482 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.2 m-85 -55.9 131.7 47.77 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.267 -0.896 . . . . 0.0 109.108 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.582 HG23 ' CG1' ' A' ' 83' ' ' VAL . 3.7 m -156.91 118.13 3.72 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.458 -0.897 . . . . 0.0 112.323 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 5.5 m120 -145.64 76.66 1.48 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.829 0.823 . . . . 0.0 109.076 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.9 p -48.67 152.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.485 0.66 . . . . 0.0 111.372 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 t70 61.61 127.01 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.887 0.851 . . . . 0.0 112.446 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 46.56 24.48 0.32 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 3.2 m-20 -156.2 -126.71 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -0.987 . . . . 0.0 109.777 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.911 HD23 ' CE3' ' A' ' 53' ' ' TRP . 1.7 tp -178.65 174.98 1.13 Allowed 'General case' 0 N--CA 1.511 2.615 0 CA-C-N 121.089 1.768 . . . . 0.0 112.739 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.582 ' CG1' HG23 ' A' ' 76' ' ' THR . 13.6 t -134.03 138.55 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 52' ' ' CYS . . . -158.25 117.57 0.78 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 118.738 -1.696 . . . . 0.0 110.596 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.808 ' CH2' HG21 ' A' ' 54' ' ' THR . 0.1 OUTLIER -95.42 135.81 36.58 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.674 ' HG2' HG22 ' A' ' 51' ' ' VAL . 29.9 mt-30 -57.55 133.89 55.65 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.835 0.826 . . . . 0.0 111.482 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -112.85 98.29 44.56 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.135 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.58 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 46.6 Cg_endo -113.95 8.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.781 1.411 . . . . 0.0 113.264 178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 55.2 Cg_endo -68.46 -106.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 115.832 -2.312 . . . . 0.0 108.083 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.91 39.46 2.85 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 105.535 -3.026 . . . . 0.0 105.535 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.71 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -81.85 140.4 34.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.582 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -92.6 100.42 12.95 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.8 t -55.41 104.04 0.11 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.366 -0.834 . . . . 0.0 110.832 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.66 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -78.77 -156.03 0.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.687 -0.633 . . . . 0.0 109.603 179.795 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -159.96 -171.03 0.26 Allowed Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.489 -0.757 . . . . 0.0 110.612 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 95' ' ' THR . 44.9 Cg_endo -92.97 170.72 2.25 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 O-C-N 123.567 1.299 . . . . 0.0 111.137 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.494 ' HB2' HG23 ' A' ' 151' ' ' VAL . 18.2 t -90.4 148.76 22.6 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.526 -0.734 . . . . 0.0 109.742 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 t -146.33 43.64 1.21 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -125.74 174.1 8.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.677 -0.64 . . . . 0.0 110.618 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -113.57 33.95 5.26 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 p -108.2 -179.35 3.86 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.534 -0.98 . . . . 0.0 110.403 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.5 p -136.26 19.71 3.18 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.585 -0.697 . . . . 0.0 110.809 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 73.8 m-20 -81.65 90.52 6.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.369 -0.832 . . . . 0.0 109.564 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.768 HD13 HD23 ' A' ' 143' ' ' LEU . 88.5 mt -97.09 156.63 16.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -0.825 . . . . 0.0 111.402 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.56 ' O ' HG23 ' A' ' 107' ' ' VAL . 84.4 m-85 -132.12 84.49 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.959 -0.463 . . . . 0.0 109.797 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 106' ' ' LEU . 14.4 tp -55.36 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.328 -0.857 . . . . 0.0 109.539 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 113' ' ' VAL . 58.4 t -80.29 119.57 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.008 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.649 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 37.9 p -82.15 -179.88 7.56 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.763 ' N ' HD12 ' A' ' 44' ' ' LEU . 51.9 ptt85 -99.96 51.41 0.91 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.026 -1.046 . . . . 0.0 110.447 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.649 ' CE1' ' HB ' ' A' ' 108' ' ' THR . 7.1 p-80 -175.17 44.06 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.532 0.682 . . . . 0.0 110.024 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.62 67.2 1.04 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.524 -0.735 . . . . 0.0 111.005 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.99 83.65 0.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.619 -0.676 . . . . 0.0 110.08 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 107' ' ' VAL . 53.9 t -77.91 154.44 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.573 -0.705 . . . . 0.0 109.534 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.8 mt -136.79 107.88 9.08 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -53.4 141.51 61.07 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 O-C-N 123.63 1.332 . . . . 0.0 112.695 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.533 ' CG1' HG21 ' A' ' 167' ' ' VAL . 21.7 t -133.97 150.23 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -111.81 118.56 35.9 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -47.88 127.85 12.55 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.374 -0.829 . . . . 0.0 110.207 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 125' ' ' SER . 1.3 mmp_? -107.79 -36.85 6.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.598 -0.689 . . . . 0.0 111.603 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.95 64.03 0.06 OUTLIER Glycine 0 N--CA 1.497 2.738 0 C-N-CA 118.892 -1.623 . . . . 0.0 110.604 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.81 140.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.89 0.852 . . . . 0.0 110.242 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.404 ' CA ' ' O ' ' A' ' 169' ' ' PHE . 69.1 p 44.12 28.56 0.28 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.792 -0.567 . . . . 0.0 112.278 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.502 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 8.4 ttm180 -165.36 151.5 9.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.274 -0.891 . . . . 0.0 110.457 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.16 -177.99 22.12 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 119' ' ' ARG . 0.5 OUTLIER -121.43 127.63 51.33 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.696 -178.451 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.56 132.14 43.4 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.3 mt -103.09 53.55 0.77 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.2 t 175.47 133.5 0.16 Allowed Pre-proline 0 N--CA 1.5 2.044 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.829 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -62.64 104.94 0.39 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 O-C-N 123.721 1.38 . . . . 0.0 108.813 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.61 128.24 25.49 Favored Pre-proline 0 N--CA 1.488 1.458 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.632 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 43.6 Cg_endo -60.76 131.18 36.29 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.982 1.517 . . . . 0.0 110.129 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.599 HG21 ' SG ' ' A' ' 159' ' ' CYS . 11.7 p -57.63 -36.84 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.728 -0.608 . . . . 0.0 110.266 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.8 t -49.09 -36.59 19.04 Favored 'General case' 0 N--CA 1.507 2.393 0 CA-C-O 122.064 0.935 . . . . 0.0 110.728 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 34.7 t80 -69.09 -38.21 78.84 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.56 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.7 mt -65.5 -35.37 80.68 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.153 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -57.14 -21.03 29.57 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.001 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -97.87 30.2 9.79 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 99.0 p -150.89 23.39 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.516 -0.99 . . . . 0.0 110.734 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -59.36 126.94 29.69 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.256 -0.902 . . . . 0.0 108.691 179.227 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.659 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 108.43 -13.38 36.26 Favored Glycine 0 CA--C 1.541 1.663 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -176.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.654 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -46.34 109.06 0.31 Allowed Glycine 0 N--CA 1.503 3.166 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.81 125.67 12.39 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.997 1.525 . . . . 0.0 111.753 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.768 HD23 HD13 ' A' ' 104' ' ' LEU . 6.3 mp -82.52 116.28 21.88 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.519 HD22 ' O ' ' A' ' 147' ' ' SER . 1.1 mt -114.36 119.01 35.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.108 -0.995 . . . . 0.0 111.194 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -60.4 -20.68 0.65 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.839 -0.538 . . . . 0.0 110.507 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 145' ' ' CYS . 40.7 Cg_endo -137.44 -77.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.322 -0.833 0 O-C-N 123.535 1.282 . . . . 0.0 110.326 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.519 ' O ' HD22 ' A' ' 144' ' ' LEU . 9.1 p -164.18 -54.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.406 -0.809 . . . . 0.0 110.0 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.68 -51.39 3.45 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -66.98 117.37 8.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.599 -0.942 . . . . 0.0 110.297 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.602 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -88.99 150.58 22.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 110.075 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 97' ' ' CYS . 0.9 OUTLIER -107.3 -31.77 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.603 -0.685 . . . . 0.0 109.913 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.831 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 177.28 -179.67 47.97 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.822 HD11 HD11 ' A' ' 82' ' ' LEU . 1.1 pt -117.2 162.71 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.317 -1.107 . . . . 0.0 110.858 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.786 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 6.5 t80 -79.91 98.58 7.19 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.585 0.707 . . . . 0.0 110.9 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.582 ' HA ' HG11 ' A' ' 55' ' ' VAL . 2.6 ttt-85 -82.69 -42.91 17.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -160.69 -179.68 7.82 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.786 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -134.42 120.96 20.46 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.569 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.781 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.3 t -65.82 102.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.599 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.2 p -129.18 142.88 50.74 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -175.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 161' ' ' ARG . 1.9 m -75.74 -174.25 2.5 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.513 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -47.85 86.07 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.734 0.778 . . . . 0.0 112.884 -178.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 82.53 -25.25 4.54 Favored Glycine 0 N--CA 1.499 2.896 0 O-C-N 120.879 -1.138 . . . . 0.0 112.186 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -95.48 133.54 36.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 119.217 1.508 . . . . 0.0 109.345 -179.48 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.56 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -100.35 132.82 45.51 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.1 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -117.71 -37.27 3.48 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.571 -0.706 . . . . 0.0 110.775 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.781 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -122.27 -179.36 4.15 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.202 -0.936 . . . . 0.0 109.994 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.533 HG21 ' CG1' ' A' ' 116' ' ' VAL . 1.3 t -125.6 145.85 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.46 -0.775 . . . . 0.0 111.878 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -109.3 101.46 10.46 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 177.052 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.541 ' CD2' HD22 ' A' ' 143' ' ' LEU . 0.2 OUTLIER -132.56 154.42 50.02 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.891 -175.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.608 HG21 HD13 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -108.12 144.46 29.46 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.4 Cg_endo -64.39 148.59 90.84 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.916 1.482 . . . . 0.0 110.675 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.831 HG13 ' HA2' ' A' ' 152' ' ' GLY . 18.1 m -82.21 2.95 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.068 -1.02 . . . . 0.0 110.618 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -83.55 -38.15 22.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.0 t -74.02 -40.18 63.08 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.69 -0.631 . . . . 0.0 110.872 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.854 ' O ' HG22 ' A' ' 178' ' ' THR . 12.4 ptp -51.07 -36.18 38.66 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.307 -0.871 . . . . 0.0 110.012 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.422 ' N ' ' HG3' ' A' ' 175' ' ' MET . 19.0 tt0 -58.1 -36.33 72.72 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.194 -0.941 . . . . 0.0 108.847 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.7 m -70.6 -36.07 73.32 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.418 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.854 HG22 ' O ' ' A' ' 175' ' ' MET . 2.8 t -48.44 -37.52 17.42 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.095 -1.003 . . . . 0.0 112.699 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.452 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 2.3 ptp -63.22 -39.65 95.22 Favored 'General case' 0 N--CA 1.513 2.678 0 O-C-N 120.418 -1.426 . . . . 0.0 110.253 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -38.25 41.0 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.769 0.795 . . . . 0.0 110.512 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -79.81 -44.65 20.19 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.47 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.2 p 46.16 29.21 0.77 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.6 -0.688 . . . . 0.0 111.678 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -80.57 130.79 35.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.528 -0.733 . . . . 0.0 110.548 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -133.76 -39.0 0.89 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.615 -0.678 . . . . 0.0 110.534 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.31 113.45 19.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.286 -0.883 . . . . 0.0 110.13 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 69.5 tttt . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.297 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.144 0.497 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.89 99.13 1.98 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -82.05 97.57 8.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.965 . . . . 0.0 109.949 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.41 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . 3.9 t0 -95.23 -17.07 22.02 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.643 -0.66 . . . . 0.0 110.761 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.422 ' CB ' ' HA ' ' A' ' 67' ' ' PRO . 4.3 mttt -98.44 28.32 4.22 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.264 -0.898 . . . . 0.0 110.045 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -93.17 89.92 6.64 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.726 -0.609 . . . . 0.0 109.935 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -161.91 78.09 0.52 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.296 -0.877 . . . . 0.0 110.215 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -98.0 166.59 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -171.95 80.72 0.06 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.395 -0.815 . . . . 0.0 110.417 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.11 -68.15 0.1 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -172.63 -46.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.947 . . . . 0.0 110.091 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.84 HG11 ' C ' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -158.78 -163.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 122.318 1.056 . . . . 0.0 112.337 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.442 ' H ' HG12 ' A' ' 33' ' ' VAL . 1.7 tt0 -148.99 171.89 15.62 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.89 HG12 HD22 ' A' ' 44' ' ' LEU . 34.0 m -108.96 169.56 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.722 -0.611 . . . . 0.0 109.969 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.93 -179.16 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.41 ' C ' HG23 ' A' ' 38' ' ' THR . 1.3 m -149.79 138.92 21.21 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.655 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 37' ' ' SER . 70.0 p -146.72 -179.76 7.01 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.81 75.45 0.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.651 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m 175.84 -61.22 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.74 -171.04 0.29 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.468 -0.77 . . . . 0.0 109.655 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.7 p -110.74 142.25 42.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.34 -0.85 . . . . 0.0 110.146 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.447 ' CE2' ' HA3' ' A' ' 58' ' ' GLY . 80.2 m-85 -105.53 -178.39 3.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.473 -0.767 . . . . 0.0 111.201 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.89 HD22 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -118.49 141.27 48.73 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.547 -0.721 . . . . 0.0 111.173 -178.147 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.84 ' C ' HG11 ' A' ' 33' ' ' VAL . . . -121.93 -177.71 3.65 Favored 'General case' 0 N--CA 1.507 2.417 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.525 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 1.05 HG21 HG21 ' A' ' 153' ' ' ILE . 4.6 t -154.94 109.19 2.94 Favored 'General case' 0 N--CA 1.51 2.537 0 O-C-N 121.102 -0.999 . . . . 0.0 112.449 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.464 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 42.9 t -69.49 85.89 0.44 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.319 -0.863 . . . . 0.0 110.18 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.4 t -108.57 128.17 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.6 t30 64.4 12.74 7.55 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.396 -0.815 . . . . 0.0 110.558 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.07 14.55 48.39 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.161 -0.962 . . . . 0.0 111.88 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 85' ' ' TRP . 63.3 t -137.46 109.54 6.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.212 -1.169 . . . . 0.0 109.428 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 12.8 m -58.6 99.71 0.05 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.806 -0.559 . . . . 0.0 110.148 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.648 ' HZ3' HG21 ' A' ' 178' ' ' THR . 97.7 m95 -80.47 144.87 32.22 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.197 -0.939 . . . . 0.0 110.588 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.847 HG21 ' CH2' ' A' ' 85' ' ' TRP . 7.2 t -162.64 131.89 4.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.795 -0.565 . . . . 0.0 110.204 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 81' ' ' ASP . 9.8 m -48.69 154.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.646 0 O-C-N 121.349 -0.844 . . . . 0.0 111.384 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.464 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 2.6 t80 -99.97 -12.61 19.62 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.096 -1.003 . . . . 0.0 111.933 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -57.82 -20.37 35.46 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.936 -1.103 . . . . 0.0 110.05 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.447 ' HA3' ' CE2' ' A' ' 43' ' ' PHE . . . -128.46 -137.2 4.33 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 52.26 -172.18 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.243 -1.151 . . . . 0.0 110.811 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.89 122.32 5.98 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 89.8 p -79.9 -13.26 59.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.639 -0.919 . . . . 0.0 111.022 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -148.09 -58.96 0.25 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.234 -0.916 . . . . 0.0 110.439 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -96.61 95.29 7.86 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.113 0.482 . . . . 0.0 111.192 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.892 HD22 HD12 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -101.45 172.99 6.64 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.499 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.465 ' H ' HD23 ' A' ' 64' ' ' LEU . . . -116.79 129.67 56.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.287 -0.883 . . . . 0.0 110.85 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.72 -178.24 15.52 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 26' ' ' LYS . 46.7 Cg_endo -53.39 93.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 O-C-N 123.776 1.409 . . . . 0.0 111.128 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.41 ' HD3' ' HB2' ' A' ' 25' ' ' ASP . 9.6 tttp 52.65 42.36 31.56 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.475 -0.766 . . . . 0.0 110.947 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.98 131.93 1.5 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -60.65 156.44 42.5 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 O-C-N 123.779 1.41 . . . . 0.0 110.931 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.892 HD12 HD22 ' A' ' 64' ' ' LEU . 64.7 mt -102.12 127.06 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.565 -0.71 . . . . 0.0 110.106 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 m -119.49 -61.37 1.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.429 -0.794 . . . . 0.0 109.721 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 54.43 -159.02 0.18 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.348 -0.845 . . . . 0.0 111.015 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.8 ttm -149.49 22.97 0.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.147 -0.971 . . . . 0.0 111.139 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.499 ' O ' HG13 ' A' ' 83' ' ' VAL . 16.7 m-30 -115.25 103.67 11.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.461 -0.774 . . . . 0.0 109.216 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.599 HG23 ' CG2' ' A' ' 83' ' ' VAL . 2.3 m -152.7 133.89 14.25 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.735 -0.603 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.63 78.01 1.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.639 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 p -48.46 -28.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.49 -0.756 . . . . 0.0 110.387 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -51.2 60.26 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -83.93 2.52 38.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.998 -0.439 . . . . 0.0 109.969 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.554 ' O ' HD12 ' A' ' 82' ' ' LEU . 68.4 m-20 57.09 52.15 9.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.879 . . . . 0.0 111.228 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.576 HD13 HG11 ' A' ' 170' ' ' VAL . 1.4 tp -158.0 143.75 17.1 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.424 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.599 ' CG2' HG23 ' A' ' 76' ' ' THR . 22.0 t -145.4 119.38 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.42 ' CA ' HG12 ' A' ' 51' ' ' VAL . . . -99.79 97.1 1.73 Allowed Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.514 -1.327 . . . . 0.0 112.213 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.847 ' CH2' HG21 ' A' ' 54' ' ' THR . 24.1 m0 -76.8 172.92 12.33 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.52 134.46 38.34 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.907 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.55 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -109.79 87.67 5.83 Favored Pre-proline 0 C--N 1.295 -1.771 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.803 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.558 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -100.24 -8.59 0.36 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.844 1.444 . . . . 0.0 113.401 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 46.5 Cg_endo -73.16 65.11 4.3 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 115.982 -2.212 . . . . 0.0 110.689 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.46 24.94 18.88 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.55 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -66.13 136.18 55.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.692 -0.887 . . . . 0.0 110.962 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -75.85 129.25 36.7 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 p -98.65 103.94 15.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.544 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.479 ' O ' HG23 ' A' ' 95' ' ' THR . 19.9 mt -65.33 -156.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.635 -0.666 . . . . 0.0 109.562 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -154.3 175.41 3.08 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.575 -0.703 . . . . 0.0 110.538 -179.181 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.421 ' HA ' HG23 ' A' ' 172' ' ' VAL . 44.6 Cg_endo -74.98 151.53 39.74 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 O-C-N 123.815 1.429 . . . . 0.0 110.604 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.466 ' CB ' HG23 ' A' ' 151' ' ' VAL . 1.6 t -106.3 85.99 2.28 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.424 -0.798 . . . . 0.0 110.211 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -66.62 -32.46 73.81 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.044 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 11.9 p -60.53 111.88 1.76 Allowed 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.268 0.556 . . . . 0.0 110.459 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.99 80.03 1.4 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.7 m -122.76 139.92 53.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.587 -0.949 . . . . 0.0 109.955 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -76.2 -165.86 0.54 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.545 -0.722 . . . . 0.0 110.437 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 t70 57.93 102.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.501 -0.75 . . . . 0.0 110.008 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.798 HD13 HD23 ' A' ' 143' ' ' LEU . 3.7 mt -116.01 -167.53 1.28 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.565 -0.709 . . . . 0.0 110.004 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -140.26 92.21 2.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.814 -0.554 . . . . 0.0 109.576 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 154' ' ' PHE . 58.0 tp -77.53 95.17 4.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.1 t -89.93 111.6 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.377 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.443 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 20.7 p -69.42 178.83 2.26 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.798 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.72 29.51 5.29 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.766 -1.209 . . . . 0.0 110.348 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -133.4 34.46 3.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.451 -0.78 . . . . 0.0 109.214 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.48 68.35 0.84 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.838 -0.539 . . . . 0.0 111.257 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -167.57 90.8 0.34 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.781 -0.575 . . . . 0.0 109.678 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 113' ' ' VAL . 10.5 p -77.52 152.62 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.491 -0.756 . . . . 0.0 110.686 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.468 HD11 ' CE2' ' A' ' 134' ' ' TYR . 22.5 mt -131.58 111.5 15.01 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -62.35 133.4 43.06 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 O-C-N 123.604 1.318 . . . . 0.0 111.239 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 20.0 t -124.05 151.1 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.624 -0.672 . . . . 0.0 109.362 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.464 ' HB2' HD11 ' A' ' 127' ' ' LEU . 11.5 tpt180 -111.85 114.81 27.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -48.67 124.54 8.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.575 -0.703 . . . . 0.0 111.022 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -109.53 -48.9 3.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.791 -0.568 . . . . 0.0 110.096 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.23 -169.71 16.06 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.5 135.45 54.23 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 169' ' ' PHE . 10.4 p 53.52 43.31 31.42 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.439 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.497 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 2.2 ttp180 -167.43 151.15 6.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.417 -0.802 . . . . 0.0 110.889 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.9 -178.83 19.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -122.23 120.41 34.06 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 122.019 -0.695 . . . . 0.0 111.688 -178.288 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.419 HD21 HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -63.72 132.93 52.54 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.721 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 117' ' ' ARG . 12.4 mt -106.13 54.37 0.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.074 0.94 . . . . 0.0 108.502 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.9 t 176.1 116.46 0.13 Allowed Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -57.72 100.24 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.502 1.264 . . . . 0.0 109.467 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 -118.32 147.07 40.93 Favored Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.29 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.414 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 46.3 Cg_endo -65.9 127.42 17.74 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 124.018 1.536 . . . . 0.0 109.838 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.859 HG12 ' O ' ' A' ' 162' ' ' GLY . 6.7 p -55.29 -36.14 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.78 -0.575 . . . . 0.0 110.4 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -48.35 -36.37 14.33 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.28 -0.888 . . . . 0.0 110.789 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.468 ' CE2' HD11 ' A' ' 114' ' ' ILE . 9.1 t80 -65.39 -38.5 90.19 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.474 HD11 ' CB ' ' A' ' 164' ' ' ALA . 11.8 mt -66.62 -35.93 81.37 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.87 120.59 9.31 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.56 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.11 -33.39 6.17 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.9 m -82.06 3.1 28.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.642 -0.917 . . . . 0.0 111.208 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 28.4 p -57.67 127.47 32.2 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.136 -0.978 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.12 -8.83 29.16 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.491 ' O ' HG22 ' A' ' 153' ' ' ILE . . . -56.71 -177.28 0.36 Allowed Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -112.99 121.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.103 0 O-C-N 123.494 1.26 . . . . 0.0 113.276 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.798 HD23 HD13 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -86.53 110.39 19.75 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 175.704 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 150' ' ' ALA . 1.2 mt -113.26 123.94 51.34 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.117 -0.989 . . . . 0.0 111.651 -177.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.599 ' HB3' HG21 ' A' ' 151' ' ' VAL . 16.4 p -78.13 177.97 2.46 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.2 Cg_endo -62.0 173.98 2.76 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 O-C-N 123.516 1.272 . . . . 0.0 110.326 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 59.23 24.77 13.25 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.396 -0.815 . . . . 0.0 110.5 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 68.1 -144.38 42.92 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.6 m170 58.03 111.15 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.85 -0.794 . . . . 0.0 111.333 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.517 ' HA ' HD23 ' A' ' 144' ' ' LEU . . . -61.92 142.24 57.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.545 -0.722 . . . . 0.0 109.305 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.599 HG21 ' HB3' ' A' ' 145' ' ' CYS . 1.0 OUTLIER -100.58 -41.07 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.665 -0.647 . . . . 0.0 109.723 -179.385 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.751 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . -179.62 -177.58 47.93 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 1.05 HG21 HG21 ' A' ' 46' ' ' THR . 1.2 pt -117.23 157.12 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.14 -1.212 . . . . 0.0 111.329 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.731 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 7.7 t80 -69.26 109.4 4.09 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.314 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -44.73 6.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.383 -0.823 . . . . 0.0 109.717 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -149.42 170.59 18.21 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.731 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -128.23 117.15 21.0 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.887 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.831 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 4.1 t -67.73 99.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.482 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.5 p -127.21 143.65 51.21 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 162' ' ' GLY . 2.2 p -77.37 -173.51 2.91 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -48.21 85.21 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 121.667 0.746 . . . . 0.0 112.912 -178.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.859 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 84.01 -28.48 4.1 Favored Glycine 0 N--CA 1.5 2.94 0 O-C-N 120.803 -1.186 . . . . 0.0 112.038 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.5 t -94.62 137.93 21.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 119.264 1.532 . . . . 0.0 109.086 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.474 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -101.26 127.36 47.89 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.016 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -109.72 -42.27 4.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.706 -0.621 . . . . 0.0 110.688 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.831 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -121.2 176.54 5.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.16 -0.962 . . . . 0.0 110.221 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.76 154.26 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-O 121.786 0.803 . . . . 0.0 111.095 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.713 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -118.76 102.16 8.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 177.137 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.524 ' HB2' HD13 ' A' ' 143' ' ' LEU . 1.1 p90 -132.87 150.4 52.16 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.823 -1.151 . . . . 0.0 112.435 -175.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.576 HG11 HD13 ' A' ' 82' ' ' LEU . 3.2 p -101.25 133.56 20.86 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 47.2 Cg_endo -60.88 158.42 33.63 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.91 1.479 . . . . 0.0 111.469 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.751 HG13 ' HA2' ' A' ' 152' ' ' GLY . 31.3 m -82.55 3.43 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.381 -0.824 . . . . 0.0 110.688 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.41 ' HG2' ' HB3' ' A' ' 96' ' ' PRO . 24.6 mt-10 -90.54 -37.78 13.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 108.731 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.9 t -63.85 -36.45 83.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.935 -0.478 . . . . 0.0 110.05 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.943 ' O ' HG22 ' A' ' 178' ' ' THR . 0.5 OUTLIER -48.75 -39.55 25.38 Favored 'General case' 0 N--CA 1.518 2.954 0 CA-C-O 121.643 0.735 . . . . 0.0 109.375 -179.428 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -53.14 -38.06 62.37 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.882 0.848 . . . . 0.0 109.711 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 m -54.22 -39.0 66.31 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.606 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.943 HG22 ' O ' ' A' ' 175' ' ' MET . 9.6 t -59.0 -35.94 74.09 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.093 -1.004 . . . . 0.0 111.644 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.44 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -53.14 -39.63 63.66 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.707 -1.246 . . . . 0.0 110.716 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -38.46 83.43 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.076 0.941 . . . . 0.0 109.179 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -71.47 -39.14 71.11 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.737 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 94.4 p -69.22 82.3 0.35 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.525 -0.734 . . . . 0.0 110.357 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.95 128.5 35.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.442 -0.787 . . . . 0.0 110.26 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.14 155.95 36.46 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.371 -0.83 . . . . 0.0 109.954 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -105.85 -48.78 3.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.453 -0.779 . . . . 0.0 110.42 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.119 -179.772 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.958 0.409 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.68 -148.62 7.56 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -142.94 70.1 1.32 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.59 -0.947 . . . . 0.0 110.123 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -77.78 175.55 9.86 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.312 -0.867 . . . . 0.0 110.64 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt 52.35 72.37 0.41 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.465 -0.772 . . . . 0.0 111.305 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -101.02 93.3 5.42 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.392 -0.817 . . . . 0.0 110.246 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -159.8 77.38 0.67 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.984 0.897 . . . . 0.0 110.496 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.565 HG21 ' HG3' ' A' ' 89' ' ' PRO . 27.0 m -106.22 -164.69 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.57 -0.706 . . . . 0.0 109.677 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 57.05 78.82 0.21 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.31 -0.869 . . . . 0.0 109.652 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -161.27 -121.46 0.58 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.558 ' OE1' HD11 ' A' ' 94' ' ' LEU . 24.7 mt-10 -150.98 -39.74 0.12 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.668 -0.901 . . . . 0.0 110.681 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 44' ' ' LEU . 97.7 t -111.58 156.28 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.45 -0.781 . . . . 0.0 110.49 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.67 174.0 10.98 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 43' ' ' PHE . 5.2 p -161.93 150.48 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.353 -0.842 . . . . 0.0 110.487 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.666 HG13 ' CZ ' ' A' ' 43' ' ' PHE . 0.9 OUTLIER -131.6 175.08 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.171 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.426 ' N ' HG23 ' A' ' 36' ' ' VAL . 5.2 p -127.61 143.55 51.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.613 -0.679 . . . . 0.0 110.337 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 40' ' ' THR . 7.6 t -142.58 -179.7 6.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.634 -0.666 . . . . 0.0 109.349 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.65 76.8 0.29 Allowed 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.106 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.1 m 174.72 -61.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 174.71 -165.44 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.0 p -108.58 143.49 37.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.409 -0.807 . . . . 0.0 109.369 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.806 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.9 p90 -115.01 -177.42 3.12 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.379 -0.826 . . . . 0.0 111.637 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.687 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -101.69 147.11 26.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.0 110.919 -178.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.451 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -149.24 152.97 36.87 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.791 -0.568 . . . . 0.0 109.996 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.615 HG23 HG23 ' A' ' 48' ' ' VAL . 14.2 t -134.47 117.47 16.29 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.273 1.035 . . . . 0.0 111.966 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.475 ' CB ' ' HB3' ' A' ' 91' ' ' ALA . 21.4 p -66.83 81.71 0.11 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.719 -0.613 . . . . 0.0 110.785 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.615 HG23 HG23 ' A' ' 46' ' ' THR . 59.4 t -97.11 133.45 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.835 -1.166 . . . . 0.0 109.096 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.63 23.55 6.23 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.49 -0.756 . . . . 0.0 110.151 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.0 23.28 49.86 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.42 HG12 ' CA ' ' A' ' 84' ' ' GLY . 39.1 t -139.41 114.84 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.374 -1.074 . . . . 0.0 109.69 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 57.0 m -69.79 105.46 2.77 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.612 -0.68 . . . . 0.0 109.876 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.675 ' CZ3' HD23 ' A' ' 82' ' ' LEU . 97.0 m95 -88.21 137.1 32.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.267 -0.896 . . . . 0.0 112.152 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.638 HG21 ' CZ3' ' A' ' 85' ' ' TRP . 2.0 t -162.82 130.33 3.69 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.208 0.527 . . . . 0.0 109.76 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.542 ' HB ' ' CD2' ' A' ' 57' ' ' HIS . 8.4 m -48.54 145.66 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 O-C-N 121.417 -0.802 . . . . 0.0 111.547 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.408 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 61.9 t80 -78.54 -15.9 58.06 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.338 -0.851 . . . . 0.0 111.118 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.542 ' CD2' ' HB ' ' A' ' 55' ' ' VAL . 15.8 p80 -77.33 -23.0 50.99 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.219 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.6 -23.18 7.32 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.534 ' HA ' ' CE1' ' A' ' 43' ' ' PHE . . . -69.34 -81.0 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.309 -1.112 . . . . 0.0 109.957 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.0 -144.22 15.93 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.8 -148.69 0.26 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.425 -1.044 . . . . 0.0 110.358 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.77 -178.99 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.287 -0.883 . . . . 0.0 110.842 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.86 97.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.734 -0.604 . . . . 0.0 109.94 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.914 ' CD2' HD12 ' A' ' 71' ' ' ILE . 3.4 tt -53.84 153.71 4.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.726 -0.609 . . . . 0.0 110.839 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.76 145.95 39.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.766 -0.584 . . . . 0.0 109.752 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.436 ' HA3' HD11 ' A' ' 71' ' ' ILE . . . -134.87 -179.07 16.14 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.65 -16.89 57.61 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.938 1.494 . . . . 0.0 110.73 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -120.4 23.22 10.98 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.117 -0.989 . . . . 0.0 111.439 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.71 -166.31 12.25 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 45.9 Cg_endo -65.6 135.5 42.33 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.96 1.505 . . . . 0.0 110.786 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.914 HD12 ' CD2' ' A' ' 64' ' ' LEU . 71.6 mt -95.72 157.81 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.62 -0.675 . . . . 0.0 109.945 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 p -105.11 104.98 14.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.401 -0.812 . . . . 0.0 109.998 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -56.33 151.64 12.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.732 -0.605 . . . . 0.0 111.166 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 tpt -138.11 -38.88 0.55 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.66 -0.65 . . . . 0.0 110.329 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 20.7 m-85 -126.22 122.86 36.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.287 -0.883 . . . . 0.0 110.032 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.733 HG23 ' CG1' ' A' ' 83' ' ' VAL . 2.5 m -146.88 121.81 10.01 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.456 -0.777 . . . . 0.0 109.589 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -146.31 77.79 1.49 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.259 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' A' ' 56' ' ' TYR . 7.5 p -49.97 -28.95 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.628 -0.67 . . . . 0.0 110.433 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.33 -45.19 92.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.43 -0.794 . . . . 0.0 109.485 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.83 14.17 26.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.599 -0.688 . . . . 0.0 109.694 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.635 ' O ' HD12 ' A' ' 82' ' ' LEU . 24.9 m-20 52.22 56.28 7.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.283 -0.885 . . . . 0.0 111.951 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.675 HD23 ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -159.29 137.54 10.52 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.215 -0.928 . . . . 0.0 111.651 178.391 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.733 ' CG1' HG23 ' A' ' 76' ' ' THR . 39.6 t -144.14 103.0 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 52' ' ' CYS . . . -102.83 94.29 1.13 Allowed Glycine 0 N--CA 1.483 1.797 0 C-N-CA 119.928 -1.13 . . . . 0.0 111.216 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.638 ' CZ3' HG21 ' A' ' 54' ' ' THR . 4.8 p90 -81.43 178.57 8.29 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -92.26 125.08 36.78 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.042 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' A' ' 91' ' ' ALA . . . -58.06 156.15 21.46 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.424 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.515 ' HG2' ' HD3' ' A' ' 89' ' ' PRO . 30.2 Cg_endo -62.28 -77.43 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.353 0 O-C-N 123.991 1.522 . . . . 0.0 111.822 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.565 ' HG3' HG21 ' A' ' 29' ' ' VAL . 59.3 Cg_endo -94.16 28.54 0.28 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 115.874 -2.284 . . . . 0.0 109.287 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.52 -16.91 59.61 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.475 ' HB3' ' CB ' ' A' ' 47' ' ' CYS . . . 50.49 22.04 0.97 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.039 -1.271 . . . . 0.0 111.31 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 64.7 69.56 0.5 Allowed 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -177.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 m -43.27 128.68 4.78 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.582 HD23 ' HB2' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -85.04 -157.9 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.685 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 1.3 p -144.08 -179.25 0.91 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.554 -0.716 . . . . 0.0 110.263 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -86.51 170.18 7.93 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 O-C-N 123.841 1.443 . . . . 0.0 110.318 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' A' ' 151' ' ' VAL . 9.4 t -82.81 -91.35 0.07 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.611 -0.681 . . . . 0.0 109.694 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 98' ' ' THR . 26.2 m 51.83 21.42 1.42 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.909 -1.12 . . . . 0.0 111.348 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.524 ' SG ' ' CD2' ' A' ' 149' ' ' HIS . 13.3 p -141.42 -25.5 0.71 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.284 -0.885 . . . . 0.0 112.482 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.406 ' HA3' ' HD2' ' A' ' 146' ' ' PRO . . . -102.06 128.71 9.64 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.0 p -66.63 -46.88 74.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.753 -0.851 . . . . 0.0 110.058 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 t -162.57 -156.45 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.576 -0.702 . . . . 0.0 110.504 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 55.41 100.69 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.549 -0.719 . . . . 0.0 110.493 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.829 HD13 HD23 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -121.22 -170.18 1.98 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.36 -0.837 . . . . 0.0 110.124 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.753 ' HB2' HG13 ' A' ' 113' ' ' VAL . 11.7 p90 -160.88 98.02 1.18 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.893 HD11 HD12 ' A' ' 114' ' ' ILE . 3.3 pp -67.29 123.3 19.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.843 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.23 99.63 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.452 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.9 p -61.92 155.38 23.68 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.687 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -78.95 0.56 26.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.301 -0.875 . . . . 0.0 110.764 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.1 OUTLIER -114.87 35.76 4.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.096 -1.003 . . . . 0.0 109.678 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.35 76.74 0.32 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.52 -0.738 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -167.46 97.25 0.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.534 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.753 HG13 ' HB2' ' A' ' 105' ' ' TYR . 2.1 t -82.72 145.05 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.893 HD12 HD11 ' A' ' 106' ' ' LEU . 39.7 mt -133.21 111.39 12.96 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 46.7 Cg_endo -58.47 145.27 95.1 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.655 1.345 . . . . 0.0 111.396 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 114' ' ' ILE . 33.1 t -140.46 150.8 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.609 -0.682 . . . . 0.0 109.886 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -109.34 116.14 31.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -48.68 125.35 9.88 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.363 -0.836 . . . . 0.0 111.015 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -108.32 -44.22 4.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.95 -0.469 . . . . 0.0 110.479 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -159.2 63.93 0.3 Allowed Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.947 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.457 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER 60.9 -75.56 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.625 -0.927 . . . . 0.0 111.109 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 120' ' ' GLY . 41.2 p -89.69 38.24 0.91 Allowed 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.85 -0.531 . . . . 0.0 110.3 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.466 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 18.6 ttm180 -168.43 149.12 4.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.371 -0.83 . . . . 0.0 110.312 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.17 -179.26 19.7 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -124.16 117.21 24.12 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 122.097 -0.649 . . . . 0.0 111.415 -178.535 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.448 HD22 ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -55.29 142.22 32.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.637 -0.664 . . . . 0.0 110.158 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.5 mt -112.42 55.21 0.69 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.448 ' O ' HD22 ' A' ' 126' ' ' LEU . 0.5 OUTLIER 172.57 118.8 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.027 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.254 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -59.79 101.01 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 O-C-N 123.483 1.254 . . . . 0.0 109.568 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -120.51 169.26 8.98 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.22 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.411 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 44.7 Cg_endo -85.73 129.3 3.52 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 124.148 1.604 . . . . 0.0 110.303 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.7 p -59.68 -35.35 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.796 -0.565 . . . . 0.0 110.076 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.9 m -48.94 -36.34 17.15 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.299 -0.876 . . . . 0.0 110.41 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.558 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -66.03 -38.25 87.92 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 17.5 mt -70.21 -37.04 74.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -55.57 124.82 18.59 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.022 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.33 -29.62 12.11 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.425 ' HA ' HD23 ' A' ' 44' ' ' LEU . 57.2 m -82.71 1.11 40.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.694 -0.886 . . . . 0.0 111.028 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.41 123.95 14.55 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.922 -1.111 . . . . 0.0 110.394 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.58 -11.85 12.31 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 44' ' ' LEU . . . -62.41 140.07 46.08 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.585 ' O ' HD12 ' A' ' 144' ' ' LEU . 52.3 Cg_endo -82.85 124.27 3.88 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.594 1.312 . . . . 0.0 113.171 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.829 HD23 HD13 ' A' ' 104' ' ' LEU . 1.2 mp -76.0 141.3 42.2 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 142' ' ' PRO . 0.9 OUTLIER -137.57 136.58 37.71 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 120.009 1.277 . . . . 0.0 112.355 -177.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.49 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 15.2 p -84.16 -174.16 0.5 Allowed Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 49.6 Cg_endo -60.1 164.84 11.61 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 117.328 -1.314 . . . . 0.0 110.08 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.36 163.15 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.344 -0.847 . . . . 0.0 109.588 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 149' ' ' HIS . . . -69.59 102.81 1.01 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.524 ' CD2' ' SG ' ' A' ' 99' ' ' CYS . 1.8 m-70 -166.46 106.84 0.66 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.588 -0.948 . . . . 0.0 110.38 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -60.17 142.36 54.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.642 . . . . 0.0 110.448 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.657 HG12 ' CE2' ' A' ' 169' ' ' PHE . 3.4 t -107.88 -44.38 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.713 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . -178.86 -178.33 48.07 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.523 HD11 HD12 ' A' ' 82' ' ' LEU . 1.1 pt -116.44 143.77 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.129 -1.218 . . . . 0.0 111.21 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.733 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.8 t80 -60.53 116.55 4.42 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.048 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -103.68 -44.62 5.04 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.371 -0.83 . . . . 0.0 109.062 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -152.5 169.92 21.42 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.733 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -126.58 115.58 19.72 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.066 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.778 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.4 t -66.41 100.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.59 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.4 p -128.88 142.48 50.94 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -174.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 162' ' ' GLY . 69.9 p -73.79 -174.61 1.84 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.9 84.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.741 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 86.89 -27.77 5.81 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 121.146 -0.971 . . . . 0.0 111.92 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -94.07 137.16 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.026 1.413 . . . . 0.0 109.089 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.03 126.08 47.69 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.843 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -110.35 -38.68 5.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.78 -0.575 . . . . 0.0 110.384 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.778 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -126.32 170.56 11.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 110.164 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.2 153.85 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.642 0.734 . . . . 0.0 111.261 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.645 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 11.8 t0 -121.03 96.49 5.12 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.657 ' CE2' HG12 ' A' ' 151' ' ' VAL . 3.7 p90 -130.41 161.39 31.46 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.596 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.461 HG11 ' CD1' ' A' ' 82' ' ' LEU . 1.1 p -111.28 123.21 35.64 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.1 Cg_endo -50.56 157.13 3.64 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.861 1.453 . . . . 0.0 112.359 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.713 HG13 ' HA2' ' A' ' 152' ' ' GLY . 27.8 m -83.22 3.08 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.799 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -87.79 -36.32 17.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -36.05 78.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 110.592 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.52 ' HG2' HD21 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -47.3 -39.18 14.1 Favored 'General case' 0 N--CA 1.524 3.27 0 CA-C-O 121.789 0.804 . . . . 0.0 109.302 -179.159 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -53.78 -38.46 64.51 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.915 0.864 . . . . 0.0 109.197 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.1 m -55.81 -39.6 71.56 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.374 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -58.11 -42.64 86.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.522 -0.736 . . . . 0.0 110.32 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.459 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -54.79 -40.16 69.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.405 -0.809 . . . . 0.0 111.056 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -51.28 -38.22 51.62 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.94 0.876 . . . . 0.0 110.408 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -80.84 -41.18 23.66 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.7 m 53.21 99.23 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.626 -0.671 . . . . 0.0 110.595 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 55.08 -167.32 0.09 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.276 -0.89 . . . . 0.0 110.28 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -69.08 -169.88 0.21 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.589 -0.694 . . . . 0.0 109.986 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -62.22 157.19 19.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.566 -0.709 . . . . 0.0 110.196 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.156 -179.938 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.903 0.383 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -176.8 -60.18 0.06 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.14 54.88 1.32 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.441 -1.034 . . . . 0.0 111.224 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -85.76 112.05 20.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.424 -0.798 . . . . 0.0 109.952 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -90.47 91.69 8.56 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.452 -0.78 . . . . 0.0 110.204 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -79.99 -179.19 6.86 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.562 -0.711 . . . . 0.0 109.766 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -161.63 77.49 0.53 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.471 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.568 HG21 ' HG3' ' A' ' 34' ' ' GLN . 0.9 OUTLIER -85.84 173.05 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.032 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -156.28 76.84 0.92 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.64 0.733 . . . . 0.0 109.565 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.35 57.45 8.17 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.451 ' C ' HG23 ' A' ' 33' ' ' VAL . 11.8 mt-10 -154.83 -85.26 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.57 -0.959 . . . . 0.0 111.795 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 45' ' ' ALA . 59.9 t -149.8 152.11 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.964 -1.085 . . . . 0.0 111.581 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.568 ' HG3' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -134.22 144.11 48.24 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.095 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.501 HG12 ' HD2' ' A' ' 109' ' ' ARG . 34.5 m -103.57 178.81 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.207 -0.933 . . . . 0.0 111.934 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.463 ' CG1' HD21 ' A' ' 64' ' ' LEU . 33.1 m -136.31 -179.4 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.0 m -157.5 135.59 10.96 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.634 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 p -141.36 -179.07 5.92 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.09 75.44 0.67 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.949 -1.101 . . . . 0.0 108.621 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m 179.25 -63.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.7 -163.36 0.14 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.664 -0.647 . . . . 0.0 109.342 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -120.63 136.5 54.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.435 -0.791 . . . . 0.0 109.902 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 52.4 m-85 -101.87 -177.55 3.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.609 -0.682 . . . . 0.0 110.518 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.764 HD23 ' N ' ' A' ' 45' ' ' ALA . 7.6 tt -113.37 153.72 28.07 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.363 -0.836 . . . . 0.0 109.37 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.764 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -156.85 130.94 8.42 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.029 -1.044 . . . . 0.0 109.973 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.576 HG23 HG23 ' A' ' 48' ' ' VAL . 15.2 t -97.84 129.98 44.78 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.201 -0.937 . . . . 0.0 111.883 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 80.1 m -80.81 84.39 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.292 -0.88 . . . . 0.0 110.289 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.576 HG23 HG23 ' A' ' 46' ' ' THR . 54.7 t -98.4 138.01 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.26 19.61 6.4 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.207 -0.933 . . . . 0.0 109.818 -178.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.28 24.33 54.68 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -138.24 106.85 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.38 -1.071 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.94 115.57 2.94 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.62 -0.675 . . . . 0.0 109.182 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.505 ' CH2' ' HE3' ' A' ' 179' ' ' MET . 97.7 m95 -96.49 142.44 28.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 111.326 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.6 HG23 HG23 ' A' ' 83' ' ' VAL . 10.8 t -161.42 -177.59 6.08 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.407 ' C ' HG22 ' A' ' 83' ' ' VAL . 12.3 m -109.8 150.27 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.449 -0.782 . . . . 0.0 110.457 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.567 ' HB2' HG11 ' A' ' 83' ' ' VAL . 33.7 t80 -71.2 -0.91 10.88 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.826 -1.171 . . . . 0.0 112.073 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -48.44 -27.65 2.78 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.171 -0.956 . . . . 0.0 110.608 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.9 41.27 0.11 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -156.95 113.73 3.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.661 -0.905 . . . . 0.0 110.328 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.07 -49.0 0.89 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.09 178.28 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.546 -0.973 . . . . 0.0 110.514 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 50.7 -170.93 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.39 -0.819 . . . . 0.0 110.889 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.63 106.88 19.26 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.652 0.739 . . . . 0.0 109.768 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.463 HD21 ' CG1' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.91 169.98 2.32 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.502 0.667 . . . . 0.0 111.275 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -115.99 136.3 53.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.869 -0.519 . . . . 0.0 109.691 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.18 -178.48 15.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -53.46 96.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.826 0 O-C-N 123.653 1.344 . . . . 0.0 110.855 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt 54.2 28.28 8.9 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.445 -0.784 . . . . 0.0 110.629 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.07 139.09 5.0 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.14 163.06 24.07 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.861 1.453 . . . . 0.0 110.3 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.9 mt -97.94 99.2 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.569 -0.707 . . . . 0.0 109.684 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 72' ' ' THR . 9.2 t -55.81 123.47 14.3 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.623 -0.673 . . . . 0.0 110.874 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -55.4 130.73 43.73 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.631 -0.668 . . . . 0.0 111.007 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.2 mmt -128.75 -50.07 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.494 -0.753 . . . . 0.0 109.82 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 179' ' ' MET . 10.7 m-85 -125.93 111.67 15.05 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.538 -0.726 . . . . 0.0 110.014 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.602 HG23 ' HB ' ' A' ' 83' ' ' VAL . 12.8 m -144.67 112.36 6.22 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.601 -0.687 . . . . 0.0 110.723 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 183' ' ' LYS . 1.9 t-20 -139.53 76.01 1.54 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.921 -1.112 . . . . 0.0 111.886 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.429 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.4 p -52.35 -25.18 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.36 -0.838 . . . . 0.0 109.512 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -32.82 73.61 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -96.75 22.48 8.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.76 41.9 31.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.498 -0.751 . . . . 0.0 111.469 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.842 HD11 HD11 ' A' ' 153' ' ' ILE . 0.3 OUTLIER -169.09 153.23 5.42 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.061 -1.055 . . . . 0.0 113.158 178.486 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.602 ' HB ' HG23 ' A' ' 76' ' ' THR . 35.0 m -155.34 130.48 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.45 148.71 20.32 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.615 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.462 ' CZ2' HD11 ' A' ' 64' ' ' LEU . 1.1 m-90 -116.32 172.02 7.45 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -75.11 141.94 43.69 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.126 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -111.2 101.69 50.99 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.111 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.4 Cg_endo -115.63 10.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.11 0 O-C-N 123.75 1.395 . . . . 0.0 112.768 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 52.1 Cg_endo -63.7 -100.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 116.702 -1.732 . . . . 0.0 108.686 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.44 34.21 5.83 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 105.49 -3.044 . . . . 0.0 105.49 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.61 157.97 37.01 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.945 -0.738 . . . . 0.0 111.214 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.19 20.48 6.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.846 -0.534 . . . . 0.0 109.926 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.9 p 45.63 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.628 -0.67 . . . . 0.0 112.431 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.69 ' O ' HG23 ' A' ' 95' ' ' THR . 0.3 OUTLIER -76.7 -151.52 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 109.763 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -161.04 171.23 7.26 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.394 -0.816 . . . . 0.0 110.611 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -83.12 159.46 15.44 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 O-C-N 123.935 1.492 . . . . 0.0 110.575 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.654 ' CB ' HG23 ' A' ' 151' ' ' VAL . 2.1 t -92.99 136.77 32.96 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.561 -0.712 . . . . 0.0 109.555 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.9 m -108.05 -37.12 6.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.603 -0.685 . . . . 0.0 110.121 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.6 p -64.67 -22.31 66.95 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.675 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.87 -94.57 0.04 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.6 t 51.82 -174.5 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.389 -1.065 . . . . 0.0 110.436 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.2 p -107.23 -162.0 0.82 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.433 -0.792 . . . . 0.0 110.33 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 55.2 m-20 55.36 97.21 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.529 -0.732 . . . . 0.0 110.467 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.843 HD13 HD23 ' A' ' 143' ' ' LEU . 3.0 mt -114.18 -176.38 2.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.598 -0.689 . . . . 0.0 110.159 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 107' ' ' VAL . 64.2 m-85 -132.08 84.77 2.18 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.9 tp -67.52 97.0 0.56 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 105' ' ' TYR . 47.6 t -82.96 113.9 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.616 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.448 ' HB ' ' NE2' ' A' ' 110' ' ' HIS . 67.3 p -70.21 178.5 2.79 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.625 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -99.73 42.44 1.11 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.008 -1.058 . . . . 0.0 110.64 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.448 ' NE2' ' HB ' ' A' ' 108' ' ' THR . 2.8 p80 -164.97 46.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.717 0.77 . . . . 0.0 109.703 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.29 70.0 0.61 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.353 0.597 . . . . 0.0 111.206 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 108' ' ' THR . 0.8 OUTLIER -165.49 78.18 0.29 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.479 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.7 p -68.1 152.72 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.615 -0.678 . . . . 0.0 110.209 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 116' ' ' VAL . 46.9 mt -131.37 111.63 15.31 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.353 -0.842 . . . . 0.0 108.783 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -56.89 141.6 93.18 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 O-C-N 123.66 1.348 . . . . 0.0 111.913 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 41.9 t -135.95 148.72 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.525 -0.735 . . . . 0.0 109.767 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.2 115.96 29.05 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -49.3 125.24 10.56 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.299 -0.875 . . . . 0.0 110.882 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.423 ' HG2' ' HB2' ' A' ' 125' ' ' SER . 0.0 OUTLIER -104.75 -47.34 4.07 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.278 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.73 -164.91 13.1 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.12 137.66 57.2 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.504 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 58.1 p 46.03 47.71 12.69 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.062 0.458 . . . . 0.0 111.892 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.509 ' HD2' HG21 ' A' ' 158' ' ' VAL . 0.4 OUTLIER -168.59 144.81 3.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.41 -0.806 . . . . 0.0 110.779 179.279 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -137.98 -178.44 16.1 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.423 ' HB2' ' HG2' ' A' ' 119' ' ' ARG . 0.3 OUTLIER -130.3 102.93 6.41 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.004 -178.242 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.854 ' O ' HD12 ' A' ' 126' ' ' LEU . 1.8 pp -49.63 146.91 3.88 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.597 -0.69 . . . . 0.0 110.404 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.8 mt -109.08 54.74 0.65 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.02 0.914 . . . . 0.0 108.841 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.5 117.77 0.17 Allowed Pre-proline 0 N--CA 1.497 1.902 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -59.12 99.13 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 O-C-N 123.742 1.391 . . . . 0.0 109.447 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -114.46 144.9 32.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.019 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.487 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 44.3 Cg_endo -62.25 123.84 13.23 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 124.042 1.549 . . . . 0.0 109.993 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 162' ' ' GLY . 6.7 p -51.0 -36.57 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.593 -0.692 . . . . 0.0 110.901 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.4 t -49.56 -35.36 20.23 Favored 'General case' 0 N--CA 1.506 2.353 0 CA-C-O 122.042 0.925 . . . . 0.0 110.099 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.487 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 34.8 t80 -63.38 -38.56 91.62 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.52 HD11 ' CB ' ' A' ' 164' ' ' ALA . 10.7 mt -68.8 -35.9 77.6 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.113 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -59.99 121.85 12.85 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.555 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 112.66 -30.21 7.66 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.3 m -88.78 10.53 20.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.74 -0.859 . . . . 0.0 111.12 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.5 p -51.46 127.6 20.47 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.049 -1.032 . . . . 0.0 109.755 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.588 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 115.71 -11.91 18.27 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -176.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.637 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -44.51 114.99 1.18 Allowed Glycine 0 N--CA 1.504 3.225 0 O-C-N 121.556 -0.967 . . . . 0.0 111.454 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.62 119.87 6.84 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.927 1.488 . . . . 0.0 111.356 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.843 HD23 HD13 ' A' ' 104' ' ' LEU . 4.0 mp -87.6 90.94 8.56 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.31 124.1 34.63 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.304 -0.872 . . . . 0.0 111.395 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.446 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 26.6 p -74.86 172.31 9.34 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.776 -0.578 . . . . 0.0 109.892 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 49.3 Cg_endo -71.05 90.43 0.65 Allowed 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.637 1.335 . . . . 0.0 110.973 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.72 -41.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.431 -0.793 . . . . 0.0 110.149 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.97 28.9 1.6 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -141.29 143.27 33.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.377 -1.072 . . . . 0.0 109.469 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.446 ' O ' HG21 ' A' ' 172' ' ' VAL . . . -68.51 131.95 46.14 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.54 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.654 HG23 ' CB ' ' A' ' 97' ' ' CYS . 0.8 OUTLIER -94.14 -27.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.901 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 177.91 -177.85 48.4 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.842 HD11 HD11 ' A' ' 82' ' ' LEU . 1.8 pp -128.51 153.69 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 CA-C-N 119.013 1.406 . . . . 0.0 111.828 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.85 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 4.2 t80 -64.26 103.52 0.64 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.777 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -90.95 -42.66 10.44 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.601 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -154.46 177.88 10.68 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.85 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -133.35 118.56 18.62 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.657 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.843 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.1 t -65.99 102.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.507 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.0 p -129.1 153.25 47.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 122.162 0.982 . . . . 0.0 113.618 -174.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -86.77 -174.84 5.16 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.61 85.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.657 -0.652 . . . . 0.0 112.442 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.78 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 85.15 -23.59 7.93 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.23 -0.919 . . . . 0.0 111.718 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -98.41 142.42 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 119.125 1.462 . . . . 0.0 109.123 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.697 ' C ' HD21 ' A' ' 126' ' ' LEU . . . -102.05 133.09 47.43 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.151 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.674 ' HA ' HD11 ' A' ' 126' ' ' LEU . 20.6 mtpt -114.17 -36.13 4.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.562 -0.711 . . . . 0.0 110.965 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.843 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -135.37 172.75 12.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.402 -0.811 . . . . 0.0 109.979 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.19 152.62 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 111.178 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -117.03 93.21 4.1 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.435 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.837 ' CG ' HD22 ' A' ' 143' ' ' LEU . 2.6 p90 -128.35 148.65 50.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.408 -0.808 . . . . 0.0 110.838 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.412 ' CG2' ' SD ' ' A' ' 175' ' ' MET . 1.0 OUTLIER -103.51 148.78 36.27 Favored Pre-proline 0 N--CA 1.497 1.916 0 C-N-CA 118.621 -1.232 . . . . 0.0 108.596 179.054 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.544 ' O ' ' HG3' ' A' ' 175' ' ' MET . 47.0 Cg_endo -63.03 137.91 64.7 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.103 1.581 . . . . 0.0 110.496 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.901 HG13 ' HA2' ' A' ' 152' ' ' GLY . 25.6 m -75.94 -0.99 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -77.27 -37.01 53.8 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.1 m -84.13 -38.42 20.74 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.781 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.544 ' HG3' ' O ' ' A' ' 171' ' ' PRO . 11.3 mtm -49.54 -41.05 40.22 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.313 -0.867 . . . . 0.0 110.039 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.459 ' HA ' ' HE3' ' A' ' 179' ' ' MET . 44.8 mm-40 -54.15 -39.49 66.57 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.569 0.7 . . . . 0.0 110.323 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.4 m -50.26 -35.75 28.35 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.933 -0.479 . . . . 0.0 112.266 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.3 t -48.69 -40.81 29.53 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.213 -0.93 . . . . 0.0 113.174 -177.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.505 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 3.3 ptp -61.0 -38.59 86.57 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.611 -1.306 . . . . 0.0 110.003 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.34 -38.55 53.69 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.871 0.843 . . . . 0.0 109.903 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -78.53 -39.7 37.18 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.4 t 53.1 33.91 16.1 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.382 -0.824 . . . . 0.0 111.042 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.402 ' HB2' ' ND2' ' A' ' 77' ' ' ASN . 16.0 mmtm -60.88 88.52 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.463 -0.773 . . . . 0.0 110.165 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -107.05 -164.23 0.97 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.443 -0.786 . . . . 0.0 110.233 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -156.01 93.31 1.43 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.571 -0.706 . . . . 0.0 109.91 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 8.4 tttm . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.267 -179.606 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 83.9 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.092 0.472 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.5 -39.86 1.71 Allowed Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 62.8 131.86 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.41 -1.053 . . . . 0.0 111.029 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.9 t0 53.24 39.74 30.19 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.379 -0.825 . . . . 0.0 111.102 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -3.79 40.82 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.502 -0.749 . . . . 0.0 111.177 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -113.99 -178.33 3.35 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.487 -0.758 . . . . 0.0 109.853 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -160.77 77.82 0.6 Allowed 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.731 HG21 ' HA ' ' A' ' 91' ' ' ALA . 14.1 p -70.04 152.52 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.706 -0.621 . . . . 0.0 110.607 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.83 79.37 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.625 -0.672 . . . . 0.0 109.22 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.89 -86.75 0.12 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.606 ' OE2' HD21 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -173.67 -35.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.495 -1.003 . . . . 0.0 111.008 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.553 HG11 HD21 ' A' ' 44' ' ' LEU . 21.2 t -104.56 153.29 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.32 -0.862 . . . . 0.0 110.303 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.439 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 18.7 pt20 -139.3 135.33 33.7 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.411 -0.806 . . . . 0.0 110.438 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 44' ' ' LEU . 36.0 m -108.97 161.58 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.544 -0.723 . . . . 0.0 111.583 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.792 HG11 HD21 ' A' ' 64' ' ' LEU . 2.0 p -144.87 145.28 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 p -117.7 143.54 46.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.748 . . . . 0.0 111.03 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 40' ' ' THR . 7.4 t -128.74 -179.61 5.17 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.06 76.63 0.23 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.354 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.2 m 177.9 -59.76 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -175.95 -166.38 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.677 -0.64 . . . . 0.0 109.443 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.7 p -119.83 137.91 53.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.354 -0.842 . . . . 0.0 110.436 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.685 ' CE2' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -108.96 -176.2 2.97 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.752 HD23 ' N ' ' A' ' 45' ' ' ALA . 8.3 tt -125.74 147.86 49.24 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.752 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -148.92 135.98 19.97 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.858 -1.151 . . . . 0.0 111.467 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.707 HG23 HG23 ' A' ' 48' ' ' VAL . 7.3 t -106.32 126.37 52.15 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.471 -0.768 . . . . 0.0 111.88 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.6 t -76.34 85.01 3.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.475 -0.766 . . . . 0.0 109.766 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.707 HG23 HG23 ' A' ' 46' ' ' THR . 95.8 t -102.14 138.03 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.4 t30 58.18 18.83 5.62 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.434 -0.791 . . . . 0.0 110.143 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.97 23.97 43.25 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 85' ' ' TRP . 85.1 t -143.0 112.62 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -1.117 . . . . 0.0 110.358 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.405 ' O ' ' HA2' ' A' ' 84' ' ' GLY . 25.7 p -61.56 126.37 27.11 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.688 ' CE3' HD23 ' A' ' 82' ' ' LEU . 85.2 m95 -105.5 139.46 40.08 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.233 -0.917 . . . . 0.0 112.621 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.872 ' O ' HG22 ' A' ' 83' ' ' VAL . 5.7 t -160.73 150.81 17.73 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.598 -0.688 . . . . 0.0 110.235 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.607 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 16.0 t -72.67 149.45 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 121.242 -0.911 . . . . 0.0 109.888 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.706 ' HB3' HG12 ' A' ' 78' ' ' VAL . 9.0 t80 -82.44 5.26 21.11 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.856 -1.153 . . . . 0.0 112.328 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -76.68 5.91 6.82 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.059 -1.025 . . . . 0.0 112.013 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.57 -43.21 0.03 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . . . -91.55 146.19 23.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.593 -0.945 . . . . 0.0 110.147 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.44 -45.8 1.42 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.5 t -60.19 174.36 0.53 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.519 -0.989 . . . . 0.0 109.803 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.32 -176.24 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.304 -0.873 . . . . 0.0 110.489 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 m -88.87 94.72 10.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.539 -0.725 . . . . 0.0 110.18 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.898 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -61.23 174.78 0.63 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.637 -0.664 . . . . 0.0 110.046 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.53 137.14 41.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.46 -0.775 . . . . 0.0 110.68 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.96 -179.46 16.04 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.4 -8.48 23.71 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.914 1.481 . . . . 0.0 111.035 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -139.01 30.87 2.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.034 -1.041 . . . . 0.0 110.999 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.67 175.13 13.98 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.73 148.02 76.66 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 124.016 1.535 . . . . 0.0 110.13 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.898 HD12 ' CD2' ' A' ' 64' ' ' LEU . 84.1 mt -91.62 151.06 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 110.04 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.427 ' HG1' ' C ' ' A' ' 71' ' ' ILE . 24.2 m -159.49 -62.81 0.07 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.479 -0.763 . . . . 0.0 110.401 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.541 ' NE2' ' CD2' ' A' ' 75' ' ' TYR . 0.0 OUTLIER 55.19 -156.48 0.24 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.409 -0.807 . . . . 0.0 110.183 -179.711 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.3 ttt -142.7 28.04 1.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.764 . . . . 0.0 110.164 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.541 ' CD2' ' NE2' ' A' ' 73' ' ' GLN . 13.4 m-30 -106.94 100.32 9.83 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.8 HG23 ' CG1' ' A' ' 83' ' ' VAL . 66.3 m -159.93 137.36 9.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 110.742 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -159.95 79.66 0.7 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.561 -0.856 . . . . 0.0 112.142 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.706 HG12 ' HB3' ' A' ' 56' ' ' TYR . 33.9 m -44.63 -26.44 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.437 -0.79 . . . . 0.0 111.812 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -55.65 -62.66 1.54 Allowed 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.004 -1.06 . . . . 0.0 108.596 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -81.48 -1.19 45.02 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.143 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.546 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.0 OUTLIER 60.77 66.49 0.91 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.563 -0.711 . . . . 0.0 111.076 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.002 HD11 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -164.44 145.9 8.35 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.254 -0.978 . . . . 0.0 112.868 178.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 54' ' ' THR . 2.5 m -142.81 159.39 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 52' ' ' CYS . . . -149.1 101.83 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 118.486 -1.816 . . . . 0.0 111.782 -178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.574 ' CH2' HD11 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -85.62 166.28 16.34 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 177.382 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -90.44 131.13 36.38 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.904 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -72.71 139.17 80.34 Favored Pre-proline 0 C--N 1.297 -1.686 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.829 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.466 ' HG2' ' HD3' ' A' ' 89' ' ' PRO . 36.3 Cg_endo -115.23 -41.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 117.389 -1.274 . . . . 0.0 115.116 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.585 ' HB2' HG12 ' A' ' 29' ' ' VAL . 55.8 Cg_endo -63.27 -152.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 116.994 -1.537 . . . . 0.0 109.454 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.79 34.11 2.56 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.731 ' HA ' HG21 ' A' ' 29' ' ' VAL . . . -55.25 126.85 26.63 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.059 -1.26 . . . . 0.0 111.014 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.81 154.7 41.53 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.3 p -112.91 117.94 33.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.363 -0.836 . . . . 0.0 110.619 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 ' OE2' ' A' ' 32' ' ' GLU . 16.7 mt -86.71 -164.39 1.06 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.623 -0.673 . . . . 0.0 109.288 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.428 HG23 ' N ' ' A' ' 96' ' ' PRO . 0.6 OUTLIER -150.52 -170.04 0.23 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.631 -0.668 . . . . 0.0 109.48 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.428 ' N ' HG23 ' A' ' 95' ' ' THR . 50.1 Cg_endo -89.19 156.71 5.64 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 O-C-N 123.528 1.278 . . . . 0.0 111.308 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -105.14 143.44 33.31 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.568 -0.708 . . . . 0.0 110.204 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 m -156.81 37.18 0.31 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.622 -0.674 . . . . 0.0 110.439 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 31.6 p -93.57 -171.27 2.57 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.28 -0.888 . . . . 0.0 110.579 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.79 94.81 0.87 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.7 p -165.47 -164.09 0.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.963 . . . . 0.0 109.893 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.07 -40.32 0.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.432 -0.793 . . . . 0.0 110.789 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 2.7 t0 -64.5 123.49 19.36 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.414 -0.803 . . . . 0.0 110.087 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.661 HD13 HD23 ' A' ' 143' ' ' LEU . 1.6 mt -115.85 179.15 4.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.453 -0.78 . . . . 0.0 109.97 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.66 ' O ' HG23 ' A' ' 107' ' ' VAL . 12.2 m-85 -132.92 79.49 1.84 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.622 HD23 ' HB ' ' A' ' 114' ' ' ILE . 1.4 tp -58.79 101.81 0.1 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.992 HG22 HG12 ' A' ' 113' ' ' VAL . 75.6 t -90.55 114.89 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.563 -0.711 . . . . 0.0 111.727 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.522 HG21 ' CZ ' ' A' ' 134' ' ' TYR . 10.2 p -74.71 178.71 5.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.517 ' HD3' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -98.31 29.51 3.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.857 -1.152 . . . . 0.0 110.288 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.403 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -128.58 33.41 4.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.601 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 58.51 69.31 0.74 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.455 -0.778 . . . . 0.0 110.908 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -172.06 108.64 0.23 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.594 -0.691 . . . . 0.0 110.256 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.992 HG12 HG22 ' A' ' 107' ' ' VAL . 33.3 m -84.81 158.39 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.929 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.622 ' HB ' HD23 ' A' ' 106' ' ' LEU . 28.3 mm -127.98 111.56 20.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -60.88 133.12 45.84 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 O-C-N 123.752 1.396 . . . . 0.0 111.259 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 114' ' ' ILE . 20.2 t -135.09 149.08 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.643 -0.66 . . . . 0.0 109.841 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -104.29 111.15 23.66 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.445 HH12 HG13 ' A' ' 151' ' ' VAL . 17.2 ttt180 -48.71 122.54 5.72 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.641 0.734 . . . . 0.0 111.351 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.85 -36.95 5.77 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.31 171.82 32.21 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.04 -21.95 35.18 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.502 -0.999 . . . . 0.0 110.703 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.401 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 4.6 p -130.91 40.02 3.52 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.807 -0.558 . . . . 0.0 111.104 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.487 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -171.05 153.5 3.8 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.142 -0.974 . . . . 0.0 111.021 179.08 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.39 -178.39 25.23 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -129.38 115.75 18.0 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.912 -0.758 . . . . 0.0 111.907 -178.23 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' A' ' 130' ' ' ARG . 0.1 OUTLIER -54.43 148.08 12.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.328 -0.857 . . . . 0.0 109.881 178.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.6 mt -112.27 54.02 0.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 164.5 142.73 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.311 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.31 112.15 2.02 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.79 1.416 . . . . 0.0 109.576 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.426 ' HB3' HD22 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -121.08 127.99 25.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.474 -0.766 . . . . 0.0 108.945 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -54.72 131.11 44.02 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.775 1.408 . . . . 0.0 111.467 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.8 p -63.79 -36.03 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 121.253 0.549 . . . . 0.0 109.999 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -48.74 -36.54 16.61 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.08 -1.013 . . . . 0.0 110.611 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.522 ' CZ ' HG21 ' A' ' 108' ' ' THR . 26.8 t80 -65.8 -38.62 89.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.1 mt -65.09 -36.01 82.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -63.08 124.78 22.0 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.704 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.52 -25.55 27.21 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.3 m -90.32 6.79 41.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.994 . . . . 0.0 111.283 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 p -53.15 121.4 7.4 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.021 -1.049 . . . . 0.0 109.747 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.573 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 120.91 -10.33 10.27 Favored Glycine 0 CA--C 1.542 1.725 0 N-CA-C 107.664 -2.174 . . . . 0.0 107.664 -176.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.605 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -54.97 116.41 6.72 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.5 ' O ' HD12 ' A' ' 144' ' ' LEU . 51.6 Cg_endo -68.41 118.82 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.813 1.428 . . . . 0.0 111.805 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.661 HD23 HD13 ' A' ' 104' ' ' LEU . 2.7 mp -74.87 138.58 42.57 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 176.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 142' ' ' PRO . 1.1 mt -134.8 120.57 19.53 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.845 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.482 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 16.9 p -71.81 -178.3 0.59 Allowed Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.1 Cg_endo -60.62 -179.57 0.28 Allowed 'Trans proline' 0 N--CA 1.491 1.343 0 O-C-N 123.288 1.151 . . . . 0.0 110.833 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.01 -79.16 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.449 -0.782 . . . . 0.0 110.286 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 177.46 -142.28 5.64 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 62.4 m170 57.99 118.14 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.839 -0.801 . . . . 0.0 111.308 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.521 ' O ' HG21 ' A' ' 172' ' ' VAL . . . -63.02 137.68 58.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.489 -0.757 . . . . 0.0 109.913 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.578 HG12 ' CE2' ' A' ' 169' ' ' PHE . 3.1 t -92.04 -44.92 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.809 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . -173.62 -177.78 43.09 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 1.002 HD11 HD11 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -120.0 142.06 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.515 -0.991 . . . . 0.0 110.541 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.719 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 10.1 t80 -58.2 116.58 3.66 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.495 ' HG3' ' HB3' ' A' ' 81' ' ' ASP . 5.4 ttt180 -103.37 -43.06 5.53 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.622 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -160.4 179.6 8.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.719 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -141.67 128.9 21.02 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.036 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.78 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.3 t -69.66 102.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 76.7 m -120.9 172.42 7.93 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.587 1.184 . . . . 0.0 113.401 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.4 OUTLIER -110.92 -174.42 2.47 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.571 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -49.47 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.37 -0.831 . . . . 0.0 112.798 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.717 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 84.4 -25.21 5.76 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.668 -1.27 . . . . 0.0 111.896 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.18 136.1 31.62 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.222 0 O-C-N 120.756 -1.438 . . . . 0.0 109.256 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.441 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -96.57 139.62 32.4 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.732 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -114.61 -47.84 2.89 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.529 -0.732 . . . . 0.0 110.887 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.78 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -123.05 -178.93 4.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.788 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.473 HG21 ' CG1' ' A' ' 116' ' ' VAL . 3.0 t -114.59 162.38 12.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.501 0.667 . . . . 0.0 110.104 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.622 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -135.97 88.26 2.38 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 178.312 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CE2' HG12 ' A' ' 151' ' ' VAL . 4.7 p90 -128.42 166.59 18.42 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.006 -1.078 . . . . 0.0 112.694 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.68 HG21 HD13 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -112.82 131.03 22.93 Favored Pre-proline 0 N--CA 1.491 1.58 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.755 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.453 ' HA ' ' HA3' ' A' ' 152' ' ' GLY . 40.4 Cg_endo -60.27 157.15 36.7 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.985 1.519 . . . . 0.0 111.02 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.809 HG13 ' HA2' ' A' ' 152' ' ' GLY . 26.8 m -82.05 5.05 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.381 -0.825 . . . . 0.0 110.744 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -85.87 -37.08 19.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.32 -38.74 49.81 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.765 -0.584 . . . . 0.0 111.024 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.502 ' HB3' ' CD2' ' A' ' 82' ' ' LEU . 9.2 ptp -49.91 -36.47 27.63 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.141 -0.974 . . . . 0.0 110.184 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.478 ' N ' ' HG3' ' A' ' 175' ' ' MET . 27.4 mm-40 -57.23 -37.86 72.91 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.485 -0.76 . . . . 0.0 109.731 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.5 m -60.3 -36.03 76.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.245 0.545 . . . . 0.0 110.343 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -49.56 -52.83 27.24 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.581 -0.699 . . . . 0.0 112.421 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.47 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 3.9 ptp -65.03 -40.94 95.57 Favored 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.041 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -54.94 -38.13 67.31 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 122.053 0.93 . . . . 0.0 109.25 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.5 -38.98 67.99 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.369 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.6 m -69.53 93.34 0.68 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.083 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -80.95 159.24 24.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.639 -0.663 . . . . 0.0 110.151 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 15.2 pttt -127.1 34.14 4.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.626 -0.672 . . . . 0.0 110.003 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -150.93 -155.37 0.62 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.677 -0.639 . . . . 0.0 110.209 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.0 tttt . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.2 -179.869 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 p . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.942 0.401 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.02 105.08 0.18 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.0 ttm105 -129.27 -67.09 0.79 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.445 -1.033 . . . . 0.0 110.65 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 50.38 94.6 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.817 -0.552 . . . . 0.0 110.507 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 12.8 tttt -83.44 1.66 40.48 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.352 -0.842 . . . . 0.0 112.352 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -144.79 78.83 1.58 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.225 -0.922 . . . . 0.0 110.442 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -162.46 77.84 0.48 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.586 -0.696 . . . . 0.0 109.233 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 89' ' ' PRO . 15.2 m -67.77 175.72 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.33 -0.856 . . . . 0.0 110.256 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -170.96 79.28 0.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.368 0.604 . . . . 0.0 109.502 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.74 -19.17 58.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.434 ' OE2' HD11 ' A' ' 94' ' ' LEU . 1.5 tp10 -79.54 -68.92 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.353 -1.087 . . . . 0.0 110.685 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.6 t -137.5 146.62 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.031 0.919 . . . . 0.0 111.497 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.97 173.94 11.16 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.445 HG12 ' HG3' ' A' ' 109' ' ' ARG . 8.1 m -143.03 161.43 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 118.963 -1.095 . . . . 0.0 111.613 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.693 HG11 ' CH2' ' A' ' 85' ' ' TRP . 26.4 m -120.94 -178.42 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 m -153.84 139.83 18.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.296 -0.878 . . . . 0.0 111.422 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -139.24 -178.38 5.34 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 40' ' ' THR . . . -69.19 75.67 0.35 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.131 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER 170.75 -61.24 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -174.73 -170.48 0.49 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.322 -0.861 . . . . 0.0 111.083 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.7 p -116.6 145.37 43.43 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.625 -0.672 . . . . 0.0 110.425 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -106.74 -172.85 2.16 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.173 -0.955 . . . . 0.0 109.766 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.911 HD23 ' N ' ' A' ' 45' ' ' ALA 0.25 5.7 tt -111.1 149.1 31.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.466 -0.771 . . . . 0.0 109.937 -178.001 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.911 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -155.35 137.35 14.58 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.974 -1.079 . . . . 0.0 110.809 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 46' ' ' THR . 13.4 t -105.49 125.0 50.48 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.995 -1.066 . . . . 0.0 113.137 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 89.9 m -77.18 86.06 3.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.44 -0.787 . . . . 0.0 110.458 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.432 HG23 HG23 ' A' ' 46' ' ' THR . 59.6 t -107.15 141.84 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.338 -0.851 . . . . 0.0 108.731 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 57.3 19.04 4.69 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.363 -0.835 . . . . 0.0 110.082 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.59 23.71 49.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.1 t -142.42 113.84 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.268 -1.137 . . . . 0.0 110.493 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.31 114.04 4.47 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.931 ' CE3' HD23 ' A' ' 82' ' ' LEU . 96.0 m95 -97.83 140.53 32.07 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.588 -0.695 . . . . 0.0 111.614 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.87 HG21 ' CH2' ' A' ' 85' ' ' TRP . 4.3 t -161.64 177.8 9.63 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.821 HG11 ' CE1' ' A' ' 57' ' ' HIS . 21.2 t -97.86 146.87 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.274 -0.891 . . . . 0.0 109.927 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.509 ' HB2' HG11 ' A' ' 83' ' ' VAL . 37.1 t80 -63.33 -4.52 2.67 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.659 -1.276 . . . . 0.0 112.08 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.821 ' CE1' HG11 ' A' ' 55' ' ' VAL . 30.3 m170 -39.64 -39.89 0.82 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.313 -0.867 . . . . 0.0 111.816 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.86 -44.79 0.44 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.486 ' N ' ' CE2' ' A' ' 43' ' ' PHE . . . -51.51 97.75 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.433 -1.04 . . . . 0.0 109.818 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.67 25.42 21.28 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.67 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.15 28.34 5.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.244 -1.151 . . . . 0.0 110.891 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -98.1 -156.41 0.54 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.49 -0.756 . . . . 0.0 109.881 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 m -59.21 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.336 -0.853 . . . . 0.0 110.386 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.725 HD12 ' HB ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -74.34 136.35 42.52 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.2 143.19 49.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.432 -0.792 . . . . 0.0 110.789 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.564 ' HA3' HD11 ' A' ' 71' ' ' ILE . . . -137.97 -179.44 17.06 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.441 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 43.4 Cg_endo -65.82 -11.56 31.34 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.92 1.484 . . . . 0.0 110.844 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -114.55 19.63 15.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.982 -1.074 . . . . 0.0 110.858 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.25 -152.64 17.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.14 143.7 54.74 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 124.064 1.56 . . . . 0.0 111.216 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.725 ' HB ' HD12 ' A' ' 64' ' ' LEU . 87.3 mt -107.28 105.09 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -55.16 149.65 12.03 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.306 -0.871 . . . . 0.0 110.892 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.59 165.36 19.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 0.0 110.087 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -166.21 -47.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.359 -0.838 . . . . 0.0 111.338 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.452 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 19.1 m-85 -123.27 126.54 47.1 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.411 ' HA ' HG12 ' A' ' 83' ' ' VAL . 2.2 m -158.29 111.76 2.43 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.293 -0.879 . . . . 0.0 112.333 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -137.46 75.18 1.51 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 111.117 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' A' ' 56' ' ' TYR . 7.5 p -55.56 -21.97 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.433 -0.792 . . . . 0.0 111.012 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.2 77.97 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.467 -0.77 . . . . 0.0 111.324 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 49.24 25.23 1.16 Allowed 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.277 -0.889 . . . . 0.0 111.238 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.96 -95.36 0.49 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.403 -0.811 . . . . 0.0 110.943 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.931 HD23 ' CE3' ' A' ' 53' ' ' TRP . 5.1 tp -179.13 163.19 1.28 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.518 -1.364 . . . . 0.0 111.021 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.509 HG11 ' HB2' ' A' ' 56' ' ' TYR . 26.9 m -139.82 137.61 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.42 137.93 5.26 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.019 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.87 ' CH2' HG21 ' A' ' 54' ' ' THR . 0.4 OUTLIER -98.32 150.36 21.65 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.542 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -64.78 141.16 58.87 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.22 89.95 4.28 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.834 -0.541 . . . . 0.0 110.769 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.567 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -97.46 0.65 1.56 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 O-C-N 123.679 1.358 . . . . 0.0 113.455 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 49.8 Cg_endo -74.73 74.76 3.76 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 115.75 -2.367 . . . . 0.0 109.915 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.64 25.8 22.57 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.32 140.3 39.92 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.471 -1.017 . . . . 0.0 110.63 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -84.93 3.88 36.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.352 -0.842 . . . . 0.0 111.437 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.5 t 45.36 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.415 -0.803 . . . . 0.0 112.558 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -69.81 -161.39 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.607 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.7 p -148.74 177.92 1.64 Allowed Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.662 -0.649 . . . . 0.0 110.956 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -86.51 155.36 9.17 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.95 1.5 . . . . 0.0 110.262 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.483 ' SG ' HG23 ' A' ' 151' ' ' VAL . 0.3 OUTLIER -83.98 114.63 21.84 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.313 -0.867 . . . . 0.0 110.016 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 66.9 p -75.11 -28.51 60.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.636 -0.665 . . . . 0.0 110.095 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.1 p -100.41 109.84 22.02 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.62 0.724 . . . . 0.0 110.253 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.7 63.39 2.32 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 m -91.51 157.94 16.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.518 -0.99 . . . . 0.0 109.563 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.5 p -85.54 -157.98 0.35 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.444 -0.785 . . . . 0.0 110.809 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 t70 52.84 83.89 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.466 -0.771 . . . . 0.0 110.761 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.805 HD13 HD23 ' A' ' 143' ' ' LEU . 0.4 OUTLIER -108.88 -174.51 2.53 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.4 -0.813 . . . . 0.0 109.39 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 94.8 m-85 -134.05 91.51 2.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.757 -0.59 . . . . 0.0 109.837 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.445 ' CD1' HD11 ' A' ' 143' ' ' LEU . 8.8 tp -56.36 98.89 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.413 -0.804 . . . . 0.0 110.268 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.446 ' HA ' HG12 ' A' ' 113' ' ' VAL . 60.6 t -74.07 118.99 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.587 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.7 p -86.53 166.98 15.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.557 -0.714 . . . . 0.0 109.418 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.587 ' N ' HD12 ' A' ' 44' ' ' LEU . 34.5 ttp180 -77.16 -1.35 28.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.611 -0.681 . . . . 0.0 111.098 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.7 40.77 3.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.221 -0.925 . . . . 0.0 109.993 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.39 64.4 1.86 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.543 -0.723 . . . . 0.0 111.56 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -152.62 89.96 1.45 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 107' ' ' VAL . 16.1 m -87.83 136.0 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.457 -0.777 . . . . 0.0 110.071 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 106' ' ' LEU . 26.3 pt -124.36 146.76 53.0 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.527 -0.733 . . . . 0.0 109.59 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 53.7 Cg_endo -66.65 148.13 82.69 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 124.066 1.561 . . . . 0.0 111.746 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.7 t -138.63 141.11 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -106.7 113.46 26.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -48.93 124.29 8.43 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.613 -0.679 . . . . 0.0 110.307 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -110.66 -25.78 9.77 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.539 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -173.14 -176.11 41.43 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.94 122.74 15.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.758 -0.848 . . . . 0.0 109.515 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 169' ' ' PHE . 0.9 OUTLIER 60.95 44.32 10.66 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.214 0.53 . . . . 0.0 110.721 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.498 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 8.7 ttm180 -162.65 151.83 15.26 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.413 -0.805 . . . . 0.0 110.228 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.54 -178.42 21.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.34 130.82 53.27 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.948 -0.737 . . . . 0.0 111.308 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.521 HD21 ' NE ' ' A' ' 130' ' ' ARG . 0.2 OUTLIER -76.37 123.24 25.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.655 -0.653 . . . . 0.0 109.475 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mt -100.01 53.84 0.91 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.456 ' O ' HD22 ' A' ' 126' ' ' LEU . 0.4 OUTLIER 177.41 91.55 0.13 Allowed Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -52.87 108.69 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 O-C-N 123.588 1.31 . . . . 0.0 110.626 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.521 ' NE ' HD21 ' A' ' 126' ' ' LEU . 15.3 ptp180 -130.64 162.18 56.51 Favored Pre-proline 0 N--CA 1.493 1.696 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.028 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.37 130.9 28.19 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.939 1.494 . . . . 0.0 111.274 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.886 HG12 ' O ' ' A' ' 162' ' ' GLY . 4.0 p -59.84 -35.23 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.487 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.96 -34.81 9.75 Favored 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 122.139 0.971 . . . . 0.0 110.535 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -64.66 -38.51 91.24 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.583 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.4 mt -65.33 -36.24 83.44 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -62.55 129.51 40.91 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.489 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.59 -28.01 17.89 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.542 ' O ' HD13 ' A' ' 44' ' ' LEU . 30.8 m -93.45 16.18 14.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.556 -0.967 . . . . 0.0 110.566 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.419 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 56.3 m -62.0 122.32 15.2 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.3 -0.875 . . . . 0.0 109.003 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.735 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 122.12 -10.77 9.37 Favored Glycine 0 CA--C 1.543 1.781 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.567 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -55.72 108.82 1.17 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 153' ' ' ILE . 43.1 Cg_endo -66.25 126.38 15.59 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.074 1.565 . . . . 0.0 112.458 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.805 HD23 HD13 ' A' ' 104' ' ' LEU . 6.6 mp -79.6 128.83 33.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 176.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -124.21 123.61 40.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 111.662 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.549 ' HB3' HG21 ' A' ' 151' ' ' VAL . 32.0 p -77.82 162.63 67.08 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.798 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 45.6 Cg_endo -62.89 87.07 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 O-C-N 123.763 1.401 . . . . 0.0 110.726 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t -172.73 -40.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.62 -0.675 . . . . 0.0 110.18 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.03 -30.57 4.77 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -73.21 154.93 40.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.638 -0.919 . . . . 0.0 109.915 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.509 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -85.39 141.32 30.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.098 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 145' ' ' CYS . 2.1 t -97.65 -36.62 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.823 -0.548 . . . . 0.0 109.743 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.81 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 176.49 -178.91 47.76 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 82' ' ' LEU . 1.2 pt -116.8 158.19 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 118.504 1.152 . . . . 0.0 110.953 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.769 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 12.2 t80 -75.99 103.41 6.04 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.701 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.415 ' HA ' HG21 ' A' ' 55' ' ' VAL . 7.4 ttp180 -92.0 -39.1 11.85 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -159.39 -179.66 8.14 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.769 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -140.76 125.98 18.58 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.762 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.904 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.6 t -67.67 102.08 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 71.0 m -115.67 159.4 21.4 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 122.451 1.119 . . . . 0.0 113.722 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.8 OUTLIER -97.63 -174.06 2.8 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.289 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.75 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 O-C-N 121.314 -0.866 . . . . 0.0 112.69 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.886 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 82.83 -35.59 2.7 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.014 -1.053 . . . . 0.0 111.382 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.75 134.47 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 120.713 -1.463 . . . . 0.0 109.145 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.583 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -91.4 140.64 29.57 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.336 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -120.9 -44.25 2.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.468 -0.77 . . . . 0.0 110.866 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.904 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -120.94 -179.77 4.12 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.311 -0.868 . . . . 0.0 110.612 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -119.42 151.46 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.8 0.81 . . . . 0.0 111.022 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.712 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -120.16 94.25 4.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.332 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.619 ' CD2' HD22 ' A' ' 143' ' ' LEU . 1.1 p90 -127.89 148.52 50.49 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.922 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.473 HG11 ' CD1' ' A' ' 82' ' ' LEU . 3.9 p -98.9 136.55 20.59 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 52.2 Cg_endo -64.91 152.91 80.58 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.814 1.428 . . . . 0.0 110.476 -178.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.81 HG13 ' HA2' ' A' ' 152' ' ' GLY . 30.6 m -79.8 1.04 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.395 -0.816 . . . . 0.0 110.597 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -89.14 -38.56 14.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.314 -0.866 . . . . 0.0 109.8 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.6 t -74.14 -40.73 62.42 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.603 -0.686 . . . . 0.0 110.791 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.789 ' HB3' HD22 ' A' ' 82' ' ' LEU . 8.3 ptp -51.78 -36.2 46.7 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.096 -1.003 . . . . 0.0 110.48 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.98 -38.02 69.85 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.192 -0.943 . . . . 0.0 109.068 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.6 m -57.53 -37.47 73.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.945 -0.472 . . . . 0.0 110.64 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.745 HG22 ' O ' ' A' ' 175' ' ' MET . 1.4 t -48.54 -36.42 15.39 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.431 -0.793 . . . . 0.0 111.96 -178.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.471 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -51.08 -39.49 56.16 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.815 -1.178 . . . . 0.0 110.685 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.7 ttt85 -52.2 -37.43 54.83 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.916 0.865 . . . . 0.0 110.194 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -81.25 -44.31 17.94 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.891 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.9 t 54.01 -175.77 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.072 -1.018 . . . . 0.0 110.439 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -106.37 44.63 1.03 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.422 -0.799 . . . . 0.0 110.373 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -97.58 49.73 1.04 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.615 -0.678 . . . . 0.0 109.765 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -125.15 -64.2 1.1 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.684 -0.635 . . . . 0.0 110.063 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.0 tttp . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.833 -1.079 . . . . 0.0 110.142 179.827 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.3 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.246 0.546 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.36 69.75 0.18 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -101.23 52.75 0.84 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.638 -0.919 . . . . 0.0 110.259 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.22 175.22 0.76 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.654 -0.654 . . . . 0.0 109.726 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.65 -158.88 0.7 Allowed 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.518 -0.739 . . . . 0.0 109.541 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -87.17 90.97 8.55 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.276 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -161.61 76.88 0.52 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.599 -0.688 . . . . 0.0 110.019 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 t -104.08 172.93 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.284 -0.885 . . . . 0.0 109.588 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -167.8 79.29 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.02 -170.98 38.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.591 ' HB3' HD11 ' A' ' 94' ' ' LEU . 7.9 mt-10 -117.89 22.98 11.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.501 -1.0 . . . . 0.0 110.531 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.627 HG12 ' CG ' ' A' ' 109' ' ' ARG . 44.6 t -145.15 143.58 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.734 . . . . 0.0 110.431 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -138.97 140.62 38.28 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.465 -0.772 . . . . 0.0 109.718 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 43' ' ' PHE . 11.1 p -108.97 150.37 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.448 -0.783 . . . . 0.0 111.481 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.714 HG13 ' CE2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -131.33 124.38 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.589 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 p -101.16 143.85 30.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.369 -0.832 . . . . 0.0 109.455 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 40' ' ' THR . 5.6 t -149.61 -178.84 6.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.556 -0.715 . . . . 0.0 109.083 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.21 75.53 0.35 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.062 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.674 HG22 ' HG2' ' A' ' 41' ' ' GLN . 2.3 m -177.44 -61.14 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.674 ' HG2' HG22 ' A' ' 40' ' ' THR . 0.1 OUTLIER 179.77 -163.95 0.05 Allowed 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 t -122.06 119.46 31.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.292 -0.88 . . . . 0.0 109.297 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.759 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -111.52 166.46 11.12 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.614 -0.679 . . . . 0.0 109.718 -179.488 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.818 HD22 ' CB ' ' A' ' 109' ' ' ARG . 13.3 mt -105.31 174.31 5.93 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.174 -0.954 . . . . 0.0 111.133 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 52' ' ' CYS . . . -157.08 128.74 7.05 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.981 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 46' ' ' THR . 12.3 t -103.1 118.89 37.82 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.966 0.888 . . . . 0.0 111.643 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 49.2 t -70.2 89.63 0.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.821 -0.549 . . . . 0.0 110.161 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.526 HG11 HG11 ' A' ' 172' ' ' VAL . 98.7 t -109.16 136.27 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.8 19.18 6.69 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.404 -0.81 . . . . 0.0 110.18 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.85 24.88 40.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 85' ' ' TRP . 19.9 t -145.98 108.82 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -1.136 . . . . 0.0 110.668 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.511 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 24.1 p -61.57 129.11 39.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.248 -0.907 . . . . 0.0 109.304 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.726 ' HZ3' HG21 ' A' ' 178' ' ' THR . 56.1 m95 -108.13 139.25 43.06 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.502 -0.749 . . . . 0.0 111.66 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.938 ' O ' HG22 ' A' ' 83' ' ' VAL . 7.6 t -161.13 128.08 4.06 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.64 0.734 . . . . 0.0 110.315 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 81' ' ' ASP . 28.3 m -48.92 141.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.47 0 O-C-N 120.855 -1.153 . . . . 0.0 112.16 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 51.9 t80 -83.08 -13.65 55.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.062 -1.024 . . . . 0.0 111.357 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.615 ' CE1' HG21 ' A' ' 55' ' ' VAL . 3.5 p80 -63.23 -22.9 67.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.957 . . . . 0.0 110.061 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.03 -30.27 1.64 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.465 ' HA ' ' CE2' ' A' ' 43' ' ' PHE . . . -55.34 174.75 0.08 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.357 -1.084 . . . . 0.0 111.203 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.97 150.62 19.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 m -101.79 -32.25 10.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.794 -0.827 . . . . 0.0 109.635 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -59.31 -169.49 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.639 -0.663 . . . . 0.0 109.933 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.8 m -68.24 97.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.543 -0.723 . . . . 0.0 109.424 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.9 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -55.21 165.9 0.65 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.663 -0.648 . . . . 0.0 110.962 -179.446 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.82 145.37 50.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.836 -0.54 . . . . 0.0 110.491 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -140.29 177.18 20.88 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.49 -12.66 36.5 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 O-C-N 123.915 1.482 . . . . 0.0 111.278 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.63 21.36 11.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 111.044 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.88 -168.3 13.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.51 144.14 65.77 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 124.033 1.544 . . . . 0.0 110.511 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.9 HD12 ' CD2' ' A' ' 64' ' ' LEU . 56.0 mt -92.88 101.93 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -63.0 117.53 6.56 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.964 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -59.02 102.5 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.299 0.571 . . . . 0.0 110.31 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpt -87.46 -42.0 13.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.777 . . . . 0.0 109.468 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.435 ' CD1' ' HG3' ' A' ' 179' ' ' MET . 23.5 m-85 -125.7 130.51 51.69 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.477 HG23 ' CG1' ' A' ' 83' ' ' VAL . 3.2 m -149.77 126.56 11.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.533 -0.729 . . . . 0.0 110.435 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.12 77.82 1.37 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.518 -0.739 . . . . 0.0 110.845 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -56.15 -18.62 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.407 -0.808 . . . . 0.0 109.947 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.54 -58.14 7.13 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.096 -1.002 . . . . 0.0 109.482 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.09 23.77 8.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.668 ' O ' HG12 ' A' ' 55' ' ' VAL . 31.5 m-20 52.83 69.51 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.826 -0.546 . . . . 0.0 112.088 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.668 ' CD1' HD11 ' A' ' 153' ' ' ILE . 1.4 tp -162.43 141.91 9.41 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.01 -1.056 . . . . 0.0 112.638 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.938 HG22 ' O ' ' A' ' 54' ' ' THR . 9.4 m -145.13 125.39 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -110.94 99.99 1.19 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.931 -1.128 . . . . 0.0 111.874 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.503 ' O ' HG13 ' A' ' 51' ' ' VAL . 1.6 m0 -90.18 169.14 11.39 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 176.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -89.24 128.9 35.87 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.041 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.677 ' HB1' ' HB3' ' A' ' 91' ' ' ALA . . . -60.76 139.24 93.39 Favored Pre-proline 0 N--CA 1.494 1.769 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.702 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.545 ' CD ' ' HD3' ' A' ' 89' ' ' PRO . 33.7 Cg_endo -105.54 -54.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 117.266 -1.356 . . . . 0.0 115.081 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.545 ' HD3' ' CD ' ' A' ' 88' ' ' PRO . 56.6 Cg_endo -66.37 -150.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.859 0 C-N-CA 116.923 -1.585 . . . . 0.0 108.822 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.85 34.19 3.21 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 107.734 -2.147 . . . . 0.0 107.734 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.677 ' HB3' ' HB1' ' A' ' 87' ' ' ALA . . . -48.64 130.73 17.58 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.105 -1.232 . . . . 0.0 110.923 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.6 142.21 58.5 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.76 -0.588 . . . . 0.0 110.44 -179.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 m -112.82 110.52 20.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 110.628 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' A' ' 32' ' ' GLU . 5.2 mt -93.3 -158.74 0.63 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.623 -0.673 . . . . 0.0 109.669 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.68 176.5 2.23 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.784 -0.573 . . . . 0.0 109.676 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.52 162.28 42.58 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 O-C-N 123.671 1.353 . . . . 0.0 111.18 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.6 t -81.95 -76.35 0.26 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.67 -0.644 . . . . 0.0 110.491 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.2 m 55.31 52.81 10.84 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.34 -0.85 . . . . 0.0 110.198 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.6 p -139.34 -149.59 0.29 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.488 -0.757 . . . . 0.0 110.304 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.33 -128.94 4.49 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.9 m 49.75 -157.59 0.08 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.371 -1.076 . . . . 0.0 111.031 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 p -171.4 -34.71 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.538 -0.726 . . . . 0.0 110.684 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 0.9 OUTLIER -58.8 128.09 35.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.563 -0.711 . . . . 0.0 110.314 179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.893 HD13 HD23 ' A' ' 143' ' ' LEU . 1.2 mt -120.84 -168.01 1.58 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.416 -0.803 . . . . 0.0 109.345 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.772 ' O ' HG23 ' A' ' 107' ' ' VAL . 29.4 m-85 -141.11 87.15 2.07 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.465 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 12.3 tp -56.98 96.66 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.155 -0.966 . . . . 0.0 108.494 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 105' ' ' TYR . 41.7 t -89.77 101.94 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.662 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.664 HG22 ' HB3' ' A' ' 138' ' ' SER . 0.8 OUTLIER -65.38 179.99 0.69 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.61 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.818 ' CB ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -100.92 29.16 4.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.015 -1.053 . . . . 0.0 109.464 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.413 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -130.83 30.17 4.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.338 -0.851 . . . . 0.0 109.679 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 59.36 70.6 0.63 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.46 -0.775 . . . . 0.0 110.551 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -171.56 93.88 0.16 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.344 0.593 . . . . 0.0 109.874 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.68 HG12 HG13 ' A' ' 107' ' ' VAL . 10.7 m -98.87 149.0 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.424 -0.797 . . . . 0.0 110.593 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.465 ' CG1' ' HB3' ' A' ' 106' ' ' LEU . 33.2 pt -131.33 147.55 66.61 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.631 -0.668 . . . . 0.0 109.316 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.546 ' HB2' HD12 ' A' ' 127' ' ' LEU . 44.3 Cg_endo -72.88 138.67 29.04 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 O-C-N 123.909 1.479 . . . . 0.0 112.222 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 103' ' ' ASP . 67.5 t -129.59 137.94 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.8 mmm-85 -102.64 121.28 42.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.862 . . . . 0.0 108.979 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -49.15 126.82 13.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.395 -0.816 . . . . 0.0 110.994 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -103.97 -55.0 2.45 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.53 -166.71 13.1 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -62.64 127.67 32.38 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.735 -0.862 . . . . 0.0 109.908 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.417 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 0.3 OUTLIER 54.02 50.81 15.86 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.491 0.663 . . . . 0.0 109.901 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.463 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -166.77 151.37 7.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.767 -0.583 . . . . 0.0 110.391 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.62 -177.73 18.8 Favored Glycine 0 N--CA 1.498 2.828 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -133.27 103.94 6.23 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.769 -0.842 . . . . 0.0 112.291 -178.069 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.737 HD11 ' HA ' ' A' ' 165' ' ' LYS . 2.7 pp -50.91 150.91 2.74 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.361 -0.837 . . . . 0.0 110.537 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.546 HD12 ' HB2' ' A' ' 115' ' ' PRO . 6.4 mt -114.88 54.47 0.78 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.27 99.06 0.1 Allowed Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -52.38 99.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.805 0 O-C-N 123.417 1.219 . . . . 0.0 110.92 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.559 ' HD2' HD21 ' A' ' 135' ' ' LEU . 8.4 ptp180 -116.03 164.59 17.27 Favored Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.006 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.79 124.41 12.28 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.99 1.521 . . . . 0.0 111.064 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.841 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.4 p -57.82 -34.15 47.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.501 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -48.53 -36.21 14.89 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.245 -0.909 . . . . 0.0 110.256 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -62.24 -39.14 91.86 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.559 HD21 ' HD2' ' A' ' 130' ' ' ARG . 14.0 mt -67.39 -36.61 81.67 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 126.36 27.09 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.615 -0.834 . . . . 0.0 108.884 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.47 -20.64 49.51 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.664 ' HB3' HG22 ' A' ' 108' ' ' THR . 6.0 m -93.91 11.6 28.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -1.09 . . . . 0.0 110.847 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.7 p -54.85 143.51 25.62 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.848 -1.158 . . . . 0.0 110.255 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.9 -14.32 58.77 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.54 115.6 4.99 Favored Glycine 0 N--CA 1.503 3.13 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.435 ' O ' HD12 ' A' ' 144' ' ' LEU . 54.2 Cg_endo -69.35 128.37 16.3 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 O-C-N 123.707 1.372 . . . . 0.0 112.683 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.893 HD23 HD13 ' A' ' 104' ' ' LEU . 5.7 mp -83.56 120.26 25.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 142' ' ' PRO . 0.8 OUTLIER -116.77 124.91 50.75 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.693 -177.024 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.507 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 31.1 p -68.59 172.14 5.08 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.8 Cg_endo -64.73 165.52 20.65 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 O-C-N 123.38 1.2 . . . . 0.0 110.116 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.72 39.46 20.92 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.165 -0.959 . . . . 0.0 110.479 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.12 -138.02 30.48 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.7 m170 56.44 111.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.718 -0.872 . . . . 0.0 111.446 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.403 ' CB ' HG21 ' A' ' 172' ' ' VAL . . . -74.3 147.55 42.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 109.053 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.646 HG12 ' CE2' ' A' ' 169' ' ' PHE . 1.4 t -108.48 -34.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.636 -0.665 . . . . 0.0 109.638 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.642 ' N ' HG23 ' A' ' 172' ' ' VAL . . . 174.1 179.22 44.58 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.668 HD11 ' CD1' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -115.05 163.32 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 CA-C-N 118.871 1.336 . . . . 0.0 110.903 178.726 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.763 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 3.2 t80 -70.76 114.82 9.23 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.017 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.405 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 15.9 ttp180 -101.18 -45.71 5.28 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.688 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -153.44 168.36 26.38 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.763 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -124.02 116.59 23.07 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.985 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.805 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 16.3 t -68.63 103.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.5 p -127.32 158.41 37.32 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.121 0.963 . . . . 0.0 113.51 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 162' ' ' GLY . 24.0 p -95.13 -173.54 2.97 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 175.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.22 82.53 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.841 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 86.02 -25.56 6.76 Favored Glycine 0 N--CA 1.502 3.063 0 O-C-N 120.7 -1.25 . . . . 0.0 111.916 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -98.45 140.69 17.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 120.962 -1.317 . . . . 0.0 108.949 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.713 ' C ' HD21 ' A' ' 126' ' ' LEU . . . -93.46 138.21 31.98 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.962 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.737 ' HA ' HD11 ' A' ' 126' ' ' LEU . 0.7 OUTLIER -119.16 -28.26 5.49 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.635 -0.665 . . . . 0.0 110.38 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.805 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -144.01 178.14 8.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.875 . . . . 0.0 109.444 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.03 154.54 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.878 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.688 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 1.7 t70 -119.94 99.62 6.73 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.646 ' CE2' HG12 ' A' ' 151' ' ' VAL . 1.6 p90 -130.38 153.88 48.26 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.83 -1.148 . . . . 0.0 112.798 -175.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.62 HG11 HD13 ' A' ' 82' ' ' LEU . 2.7 p -103.0 127.47 29.81 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 45.9 Cg_endo -56.56 163.69 6.58 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 124.024 1.539 . . . . 0.0 111.636 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.642 HG23 ' N ' ' A' ' 152' ' ' GLY . 70.8 t -81.24 1.14 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.378 -0.827 . . . . 0.0 110.039 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -92.92 -37.69 12.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.844 . . . . 0.0 108.95 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.762 ' O ' HG22 ' A' ' 177' ' ' THR . 7.3 t -63.93 -38.14 90.0 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.572 ' HE1' HG23 ' A' ' 153' ' ' ILE . 7.9 mtt -48.14 -35.28 11.26 Favored 'General case' 0 N--CA 1.518 2.941 0 O-C-N 121.853 -0.529 . . . . 0.0 109.871 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -48.22 -38.34 18.21 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.131 -0.98 . . . . 0.0 111.177 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.762 HG22 ' O ' ' A' ' 174' ' ' SER . 14.6 t -54.21 -34.67 61.16 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.213 -0.93 . . . . 0.0 109.529 178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.726 HG21 ' HZ3' ' A' ' 53' ' ' TRP . 32.1 m -48.12 -61.94 1.73 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.898 -0.501 . . . . 0.0 110.949 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.447 ' HE1' ' CZ2' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -54.57 -51.3 65.68 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.385 -0.822 . . . . 0.0 110.887 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -52.87 -37.68 60.71 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.154 -0.966 . . . . 0.0 109.994 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -73.33 -39.23 65.4 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.993 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.4 t -76.47 98.78 4.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.635 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -86.97 98.11 11.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.421 -0.799 . . . . 0.0 109.822 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -124.24 62.68 1.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.654 0.74 . . . . 0.0 109.642 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -100.44 113.91 27.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.882 -0.512 . . . . 0.0 110.214 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.884 -1.055 . . . . 0.0 109.769 179.877 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.091 0.472 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.31 -98.6 0.13 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.83 29.09 11.31 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.319 -1.106 . . . . 0.0 110.435 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -143.56 69.28 1.29 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.658 -0.651 . . . . 0.0 110.39 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.447 ' HB3' ' HA ' ' A' ' 67' ' ' PRO . 2.8 tptt -153.37 56.8 0.76 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.572 -0.705 . . . . 0.0 109.971 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -80.0 88.15 5.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.441 -0.787 . . . . 0.0 110.24 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -161.54 78.0 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 89' ' ' PRO . 34.4 m -51.79 -38.4 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-O 121.608 0.718 . . . . 0.0 111.439 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' N ' HG23 ' A' ' 29' ' ' VAL . 0.3 OUTLIER 54.89 80.2 0.13 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.408 0.623 . . . . 0.0 110.98 179.722 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 92' ' ' ARG . . . -72.22 63.9 1.34 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -175.35 -73.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.557 HG22 ' CD ' ' A' ' 142' ' ' PRO . 62.4 t -124.62 138.26 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.63 -0.669 . . . . 0.0 110.263 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -125.05 178.94 5.26 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 43' ' ' PHE . 2.9 p -154.46 143.19 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.542 -0.724 . . . . 0.0 109.533 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.715 HG12 HD21 ' A' ' 64' ' ' LEU . 33.9 m -104.18 176.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.7 p -131.28 137.71 48.96 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.566 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.3 p -131.49 -176.42 4.02 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.57 103.09 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.206 -0.934 . . . . 0.0 110.389 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 62.1 p 47.0 53.71 10.21 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.275 0.559 . . . . 0.0 111.473 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.79 164.39 16.5 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.507 0.67 . . . . 0.0 110.554 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.6 p -155.51 132.8 10.92 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.867 ' O ' HG23 ' A' ' 35' ' ' VAL . 92.8 m-85 -105.76 175.03 5.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.193 -0.942 . . . . 0.0 111.612 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.758 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -101.89 152.76 20.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 0.0 111.899 -177.794 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.588 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -160.43 161.24 32.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.896 -0.503 . . . . 0.0 110.283 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.623 HG23 HG23 ' A' ' 48' ' ' VAL . 14.6 t -137.82 125.18 21.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.098 -1.001 . . . . 0.0 111.981 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.8 m -74.04 79.24 1.71 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.378 -0.826 . . . . 0.0 109.408 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.623 HG23 HG23 ' A' ' 46' ' ' THR . 58.0 t -98.89 138.1 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.965 -1.084 . . . . 0.0 108.586 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.53 18.46 3.58 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.307 -0.871 . . . . 0.0 110.219 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.405 ' N ' ' CB ' ' A' ' 93' ' ' SER . . . 85.6 27.33 32.75 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.2 t -143.12 116.16 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.41 -1.053 . . . . 0.0 110.506 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.726 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 58.8 m -66.59 117.15 8.38 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.58 ' CE3' HD23 ' A' ' 82' ' ' LEU . 21.4 m95 -102.29 137.1 40.99 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 121.042 -1.036 . . . . 0.0 112.442 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.509 ' O ' HG22 ' A' ' 83' ' ' VAL . 1.0 OUTLIER -162.74 131.51 4.07 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.518 -0.739 . . . . 0.0 110.443 177.57 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.508 HG21 ' NE2' ' A' ' 57' ' ' HIS . 30.4 m -52.91 147.98 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.334 -0.854 . . . . 0.0 111.497 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.513 ' HA ' HG21 ' A' ' 83' ' ' VAL . 19.9 t80 -68.26 -11.06 58.77 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.118 -0.988 . . . . 0.0 112.052 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.508 ' NE2' HG21 ' A' ' 55' ' ' VAL . 12.9 p-80 -94.99 36.97 1.16 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.981 -1.074 . . . . 0.0 109.952 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.414 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . -149.95 -67.16 0.01 OUTLIER Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.029 -2.029 . . . . 0.0 108.029 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.37 141.85 40.4 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.476 -1.014 . . . . 0.0 109.885 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.7 -5.23 73.38 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 120.266 -0.968 . . . . 0.0 111.029 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 p 51.76 178.72 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.171 -1.194 . . . . 0.0 111.6 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.3 mttp 53.74 -94.43 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 111.338 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m -85.06 90.41 7.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 110.541 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.775 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -103.41 143.61 32.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.637 -0.664 . . . . 0.0 109.903 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.64 149.54 25.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.49 -0.756 . . . . 0.0 110.022 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.1 -179.46 15.88 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 43.9 Cg_endo -71.87 -5.19 16.57 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 O-C-N 124.044 1.549 . . . . 0.0 111.268 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -139.59 22.27 2.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.072 -1.017 . . . . 0.0 110.582 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.5 -178.92 17.29 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.51 149.78 87.4 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.07 1.563 . . . . 0.0 111.143 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.775 HD12 ' CD2' ' A' ' 64' ' ' LEU . 59.1 mt -108.33 165.09 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.443 ' N ' HG22 ' A' ' 71' ' ' ILE . 7.2 t -102.11 -166.7 1.32 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.435 -0.79 . . . . 0.0 110.057 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -119.62 120.07 35.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.557 -0.714 . . . . 0.0 110.147 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.413 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 3.6 mmt -116.03 -36.68 4.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 110.308 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.485 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 24.6 m-85 -133.44 129.93 37.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.497 -0.752 . . . . 0.0 110.367 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.1 m -152.69 115.37 4.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.385 -0.822 . . . . 0.0 110.464 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -145.93 75.15 1.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.853 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.435 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.4 p -54.0 -25.96 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.36 -41.83 76.78 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.392 -0.817 . . . . 0.0 109.347 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -97.48 22.5 8.79 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.468 ' O ' HD12 ' A' ' 82' ' ' LEU . 71.2 m-20 53.95 52.34 13.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.512 -0.743 . . . . 0.0 111.667 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.772 HD13 HG11 ' A' ' 170' ' ' VAL . 1.3 tp -166.43 136.12 3.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.089 -1.007 . . . . 0.0 112.596 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.513 HG21 ' HA ' ' A' ' 56' ' ' TYR . 30.0 m -148.23 140.39 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 176.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 52' ' ' CYS . . . -160.28 176.17 36.98 Favored Glycine 0 C--N 1.298 -1.566 0 C-N-CA 118.426 -1.845 . . . . 0.0 111.663 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.544 ' CD1' HG21 ' A' ' 71' ' ' ILE . 37.1 p90 -130.07 134.78 47.6 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -51.26 139.46 18.82 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.484 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.726 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . . . -103.3 88.18 1.58 Allowed Pre-proline 0 C--N 1.297 -1.702 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.263 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.54 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.1 Cg_endo -94.79 -12.97 0.86 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.867 1.456 . . . . 0.0 112.271 177.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 43.1 Cg_endo -70.93 71.95 2.06 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 115.738 -2.374 . . . . 0.0 111.046 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 88' ' ' PRO . . . 52.75 24.91 20.66 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.625 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -81.48 125.43 30.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.488 -1.007 . . . . 0.0 110.488 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.408 ' CB ' ' HA3' ' A' ' 31' ' ' GLY . 26.3 ttt180 -66.31 154.32 40.3 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.405 ' CB ' ' N ' ' A' ' 50' ' ' GLY . 4.9 p -113.69 103.91 11.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.625 -0.672 . . . . 0.0 110.351 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.654 HD23 ' HB2' ' A' ' 150' ' ' ALA . 1.5 mp -64.44 -162.08 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.535 -0.728 . . . . 0.0 109.475 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.445 HG23 ' N ' ' A' ' 96' ' ' PRO . 0.6 OUTLIER -145.6 -172.06 0.3 Allowed Pre-proline 0 C--N 1.299 -1.589 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.333 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.445 ' N ' HG23 ' A' ' 95' ' ' THR . 51.2 Cg_endo -90.93 162.68 3.97 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.772 1.406 . . . . 0.0 110.991 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 80.29 1.29 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.377 -0.827 . . . . 0.0 110.845 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.2 p -77.46 62.63 2.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.437 -0.789 . . . . 0.0 109.234 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.2 p -129.9 169.14 15.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.48 -0.762 . . . . 0.0 111.191 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.51 -156.17 26.64 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.82 -158.45 0.2 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.448 -1.031 . . . . 0.0 110.434 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.01 -88.76 0.39 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.547 -0.721 . . . . 0.0 110.121 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 62.8 m-20 44.81 55.13 6.23 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.167 -0.958 . . . . 0.0 111.769 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.748 HD13 HD23 ' A' ' 143' ' ' LEU . 16.8 mt -88.85 168.65 12.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.494 ' O ' HG23 ' A' ' 107' ' ' VAL . 75.2 m-85 -149.79 86.87 1.46 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.586 HD13 ' CD1' ' A' ' 143' ' ' LEU . 40.6 tp -58.48 103.21 0.14 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.632 -0.667 . . . . 0.0 109.237 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.748 HG13 HG12 ' A' ' 113' ' ' VAL . 41.4 t -87.44 101.06 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.326 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.759 HG21 ' OH ' ' A' ' 134' ' ' TYR . 48.7 p -66.4 158.45 29.31 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.758 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -80.56 2.14 26.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.001 -1.062 . . . . 0.0 110.974 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.408 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -97.73 30.09 3.11 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.054 -1.029 . . . . 0.0 109.465 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 58.73 62.42 1.93 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.458 -0.776 . . . . 0.0 110.805 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.34 104.1 0.45 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.225 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.748 HG12 HG13 ' A' ' 107' ' ' VAL . 3.4 m -102.32 155.34 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.519 -0.738 . . . . 0.0 110.751 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.46 HD11 HD23 ' A' ' 106' ' ' LEU . 42.2 pt -133.09 140.19 36.7 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.477 -0.765 . . . . 0.0 109.636 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.1 129.04 16.57 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.861 1.453 . . . . 0.0 111.988 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.463 ' HB ' ' CB ' ' A' ' 104' ' ' LEU . 63.9 t -116.95 158.69 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.738 ' HG3' HD21 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -114.57 109.42 18.23 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.728 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -46.6 129.31 11.04 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.494 -0.754 . . . . 0.0 111.418 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.7 -46.37 3.38 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.943 -0.473 . . . . 0.0 111.482 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -155.35 57.88 0.39 Allowed Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.27 -1.443 . . . . 0.0 111.1 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.419 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.5 OUTLIER 65.48 -66.72 0.14 Allowed 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.486 -1.008 . . . . 0.0 111.06 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 120' ' ' GLY . 25.8 p -98.96 41.68 1.13 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 121.467 0.651 . . . . 0.0 110.019 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.459 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 13.7 ttm180 -171.65 150.02 2.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 109.689 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.37 -178.99 18.18 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.65 113.34 16.58 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 122.181 -0.6 . . . . 0.0 111.161 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.38 133.15 45.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.623 -0.673 . . . . 0.0 109.705 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.738 HD21 ' HG3' ' A' ' 117' ' ' ARG . 7.3 mt -106.91 54.35 0.67 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.107 0.956 . . . . 0.0 108.587 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 170.44 123.52 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.15 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -56.02 112.11 0.97 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 O-C-N 123.495 1.261 . . . . 0.0 110.043 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -127.72 150.58 73.57 Favored Pre-proline 0 N--CA 1.487 1.375 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.646 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.14 130.18 18.44 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 124.107 1.583 . . . . 0.0 110.342 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.689 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.1 p -62.91 -35.98 73.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.416 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -49.23 -37.82 24.36 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.759 ' OH ' HG21 ' A' ' 108' ' ' THR . 30.7 t80 -61.84 -38.24 87.47 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.476 HD11 ' CB ' ' A' ' 164' ' ' ALA . 14.1 mt -69.54 -36.65 76.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.6 103.64 0.7 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.461 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.36 -33.48 3.45 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.7 p -83.65 5.35 24.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.654 -0.909 . . . . 0.0 110.955 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.4 m -54.3 124.32 15.55 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.134 -0.979 . . . . 0.0 110.797 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.05 -13.67 12.67 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.462 ' HA2' HD12 ' A' ' 44' ' ' LEU . . . -62.64 134.44 44.39 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.557 ' CD ' HG22 ' A' ' 33' ' ' VAL . 54.5 Cg_endo -79.23 132.56 10.36 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.717 1.377 . . . . 0.0 113.254 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.748 HD23 HD13 ' A' ' 104' ' ' LEU . 4.6 mp -82.53 139.22 34.0 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 175.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 142' ' ' PRO . 1.1 mp -136.67 121.81 19.08 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 120.099 1.318 . . . . 0.0 111.593 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -69.56 -21.18 0.55 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.862 -0.524 . . . . 0.0 110.255 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 145' ' ' CYS . 46.0 Cg_endo -140.9 -162.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.876 0 O-C-N 123.461 1.243 . . . . 0.0 110.438 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.45 -55.59 29.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.387 -0.821 . . . . 0.0 110.185 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -107.7 -158.55 20.41 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 53.06 100.7 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.395 -1.062 . . . . 0.0 111.095 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.654 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -75.42 154.64 36.98 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.512 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.626 HG12 ' CE2' ' A' ' 169' ' ' PHE . 2.1 t -103.9 -35.32 3.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.702 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 176.23 -178.36 47.64 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.673 HD11 ' CD1' ' A' ' 82' ' ' LEU . 1.6 pp -118.61 146.45 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 CA-C-N 118.837 1.319 . . . . 0.0 110.98 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.807 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 6.6 t80 -59.01 113.55 2.15 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.632 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.437 ' HA ' HG11 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -99.4 -46.94 5.33 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.726 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -150.45 171.39 17.12 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.807 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -126.67 116.66 21.33 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.019 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.817 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 7.0 t -67.34 99.73 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 177.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.591 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.1 p -127.73 165.04 20.81 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.555 1.169 . . . . 0.0 113.78 -175.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.6 OUTLIER -105.31 -174.18 2.47 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.398 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -48.77 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.087 0.946 . . . . 0.0 112.544 -179.31 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.689 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 82.17 -26.69 3.78 Favored Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.644 -1.285 . . . . 0.0 112.43 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.5 t -100.58 134.82 39.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 119.223 1.512 . . . . 0.0 110.025 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.476 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -95.75 131.15 42.33 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.421 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -109.12 -43.21 4.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.746 . . . . 0.0 110.344 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.817 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -128.43 163.86 23.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.49 -0.756 . . . . 0.0 110.088 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.55 154.28 9.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.533 0.683 . . . . 0.0 110.26 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.726 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -124.01 101.62 7.33 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.195 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.626 ' CE2' HG12 ' A' ' 151' ' ' VAL . 4.9 p90 -135.22 164.34 27.92 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.676 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.772 HG11 HD13 ' A' ' 82' ' ' LEU . 3.2 p -108.57 132.39 21.16 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 40.6 Cg_endo -61.73 161.52 24.72 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.794 1.418 . . . . 0.0 111.364 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.702 HG13 ' HA2' ' A' ' 152' ' ' GLY . 19.0 m -83.93 3.54 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 121.238 -0.914 . . . . 0.0 111.341 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.67 -38.15 13.28 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.6 t -72.69 -37.2 67.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.933 -0.48 . . . . 0.0 110.642 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.625 ' HE1' HG23 ' A' ' 153' ' ' ILE . 28.5 mtt -48.89 -38.74 23.51 Favored 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.429 -0.795 . . . . 0.0 109.252 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -55.87 -39.13 71.08 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.629 0.728 . . . . 0.0 109.695 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.1 m -54.62 -38.1 66.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.774 -0.579 . . . . 0.0 110.472 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.65 -41.01 63.4 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.444 -0.785 . . . . 0.0 110.548 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.485 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -52.34 -40.47 61.98 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.19 -0.944 . . . . 0.0 111.629 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.13 -37.62 64.55 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.246 -0.909 . . . . 0.0 110.149 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.28 -39.19 54.91 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.37 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.32 -4.4 36.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.459 -0.776 . . . . 0.0 111.301 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.28 120.25 32.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.168 -0.958 . . . . 0.0 109.96 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -96.48 -75.17 0.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.585 -0.697 . . . . 0.0 110.487 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.15 117.43 1.65 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.579 -0.701 . . . . 0.0 110.447 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt . . . . . 0 N--CA 1.501 2.081 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.813 179.692 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.144 0.497 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.63 89.82 0.04 OUTLIER Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.42 -156.42 0.62 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.674 -0.897 . . . . 0.0 109.886 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -91.41 81.29 5.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.602 -0.686 . . . . 0.0 109.897 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -92.26 86.51 5.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.649 -0.657 . . . . 0.0 110.276 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -91.17 89.88 7.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 109.856 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.34 78.05 0.56 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.76 -0.588 . . . . 0.0 109.582 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.572 HG11 ' N ' ' A' ' 90' ' ' GLY . 7.8 p -89.17 150.97 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.743 -0.598 . . . . 0.0 110.109 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -173.92 79.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.371 -0.831 . . . . 0.0 109.766 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.65 151.5 5.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.561 ' HB2' HD12 ' A' ' 94' ' ' LEU . 1.3 pm0 -67.98 -14.6 63.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.705 -0.879 . . . . 0.0 110.771 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.53 HG23 ' HG2' ' A' ' 32' ' ' GLU . 98.4 t -111.78 141.82 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 0.0 110.188 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -125.33 171.22 10.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.703 -0.623 . . . . 0.0 109.351 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 44' ' ' LEU . 34.5 m -143.63 177.28 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.774 . . . . 0.0 110.748 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.07 179.48 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 p -137.09 135.88 37.85 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.073 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.2 p -132.52 -177.45 4.48 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.76 95.66 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.459 -0.776 . . . . 0.0 110.986 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 40' ' ' THR . 16.6 m 58.25 44.95 17.97 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.483 -0.761 . . . . 0.0 110.994 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -164.92 156.95 15.64 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.204 -0.935 . . . . 0.0 111.262 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 p -146.5 132.61 19.33 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.795 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . 46.9 m-85 -100.59 -179.29 4.05 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.199 -0.938 . . . . 0.0 110.401 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.655 HD13 ' HA ' ' A' ' 138' ' ' SER . 0.0 OUTLIER -111.97 152.47 28.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 0.0 110.881 -178.838 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.0 136.56 9.01 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.554 -0.717 . . . . 0.0 109.609 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.546 HG23 HG23 ' A' ' 48' ' ' VAL . 13.6 t -110.52 119.22 38.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.222 -0.924 . . . . 0.0 112.636 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.5 t -71.38 83.36 0.79 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.762 HG11 ' CG1' ' A' ' 172' ' ' VAL . 87.4 t -102.63 138.43 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 t30 56.07 21.35 5.02 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.405 -0.809 . . . . 0.0 110.208 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.13 24.94 53.64 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.566 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 61.6 t -141.44 106.34 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.37 -1.077 . . . . 0.0 109.875 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.24 108.86 1.69 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.291 -0.88 . . . . 0.0 109.913 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.593 ' CZ3' HG21 ' A' ' 178' ' ' THR . 97.7 m95 -93.79 148.54 22.03 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.486 -0.759 . . . . 0.0 111.157 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.404 HG23 HG23 ' A' ' 83' ' ' VAL . 5.6 t -161.26 179.91 7.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.845 -0.535 . . . . 0.0 109.725 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.696 HG11 ' HA ' ' A' ' 155' ' ' ARG . 27.1 m -94.85 143.57 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.581 -0.699 . . . . 0.0 110.54 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.706 ' HB2' HG11 ' A' ' 83' ' ' VAL . 45.7 t80 -76.05 -0.92 23.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.098 -1.001 . . . . 0.0 111.889 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -51.76 -30.63 23.55 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.073 -1.017 . . . . 0.0 109.648 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.86 -147.8 5.25 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.795 ' HB2' ' CB ' ' A' ' 43' ' ' PHE . . . 53.0 22.07 2.31 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.12 -1.223 . . . . 0.0 111.406 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.98 -136.39 2.16 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.92 20.67 4.35 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.505 -0.997 . . . . 0.0 110.964 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -171.61 -161.18 0.19 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.21 -0.931 . . . . 0.0 110.65 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -78.2 96.31 5.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.715 -0.616 . . . . 0.0 110.397 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.882 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -64.78 177.56 0.93 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.714 -0.616 . . . . 0.0 110.234 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.457 ' H ' HD23 ' A' ' 64' ' ' LEU . . . -130.88 136.34 48.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.59 -0.694 . . . . 0.0 110.108 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.46 178.76 17.87 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -64.71 -16.97 58.03 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.997 1.525 . . . . 0.0 110.673 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -147.45 42.26 1.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.224 -0.923 . . . . 0.0 110.082 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.74 164.16 11.19 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -57.3 157.88 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 O-C-N 123.747 1.393 . . . . 0.0 110.877 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.882 HD12 ' CD2' ' A' ' 64' ' ' LEU . 92.0 mt -98.5 162.49 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.557 -0.715 . . . . 0.0 110.297 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 p -97.11 -169.68 1.9 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.565 -0.71 . . . . 0.0 110.495 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -141.56 116.4 9.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.696 . . . . 0.0 110.021 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 tpt -113.96 -31.84 6.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.559 -0.713 . . . . 0.0 110.331 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.421 ' CD1' ' HA ' ' A' ' 179' ' ' MET . 15.8 m-85 -129.47 104.34 7.41 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.582 -0.699 . . . . 0.0 109.658 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.616 HG22 HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -146.75 109.69 4.68 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.349 -0.941 . . . . 0.0 112.117 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -161.82 74.86 0.46 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.36 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.656 HG11 ' HB3' ' A' ' 56' ' ' TYR . 5.9 p -67.77 -23.18 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.229 -0.919 . . . . 0.0 110.224 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -50.95 -26.35 5.83 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.301 -0.874 . . . . 0.0 110.653 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -172.68 36.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.585 -0.697 . . . . 0.0 110.511 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.507 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -161.82 -86.19 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.138 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.724 ' CD1' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER 175.55 175.97 0.23 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.58 -1.325 . . . . 0.0 110.343 -178.745 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.706 HG11 ' HB2' ' A' ' 56' ' ' TYR . 27.7 m -143.56 121.6 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.648 0.737 . . . . 0.0 109.354 177.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.19 149.34 18.7 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.529 ' CZ2' HD11 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -110.46 151.37 27.61 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -63.55 137.19 58.02 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.168 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 135.8 34.62 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.736 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.458 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 38.0 Cg_endo -114.46 -38.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.463 0 O-C-N 123.56 1.295 . . . . 0.0 114.911 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 54.9 Cg_endo -61.34 -155.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 117.063 -1.492 . . . . 0.0 109.966 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.572 ' N ' HG11 ' A' ' 29' ' ' VAL . . . -78.63 32.45 1.89 Allowed Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.5 ' HA ' HG21 ' A' ' 29' ' ' VAL . . . -58.33 126.52 27.89 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.021 -1.282 . . . . 0.0 110.549 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 147.68 52.29 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.62 116.83 32.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.456 -0.778 . . . . 0.0 110.895 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.561 HD12 ' HB2' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -90.96 -159.23 0.61 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.73 -0.607 . . . . 0.0 109.528 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.536 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -156.06 -173.64 0.39 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.601 -0.687 . . . . 0.0 109.742 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -87.97 156.16 7.21 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 O-C-N 123.77 1.405 . . . . 0.0 110.311 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.448 ' SG ' HG23 ' A' ' 151' ' ' VAL . 0.5 OUTLIER -90.46 -67.81 0.82 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.443 -0.785 . . . . 0.0 110.275 179.681 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.1 m 50.57 26.79 2.58 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.193 -0.942 . . . . 0.0 110.721 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -147.06 174.28 11.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.513 -0.742 . . . . 0.0 110.86 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.46 -167.1 48.41 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.9 m -121.11 -55.41 1.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.726 -0.867 . . . . 0.0 109.772 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.62 -152.84 0.21 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.713 -0.617 . . . . 0.0 109.944 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 t0 57.3 101.87 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.335 -0.853 . . . . 0.0 110.266 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.77 HD13 HD23 ' A' ' 143' ' ' LEU . 1.4 mt -120.3 -168.99 1.72 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.505 -0.747 . . . . 0.0 109.751 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.676 ' O ' HG23 ' A' ' 107' ' ' VAL . 20.6 m-85 -140.45 83.68 1.92 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.759 HD23 HD11 ' A' ' 114' ' ' ILE . 24.6 tp -60.01 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 105' ' ' TYR . 48.6 t -84.67 102.88 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.063 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.3 p -65.14 170.17 4.8 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HB2' ' CG ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -95.55 25.8 4.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.911 -1.118 . . . . 0.0 110.363 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -124.62 29.83 6.15 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 62.08 70.68 0.57 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.543 -0.723 . . . . 0.0 111.088 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -175.0 102.69 0.09 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.645 -0.659 . . . . 0.0 110.223 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.626 ' CG1' HG22 ' A' ' 107' ' ' VAL . 7.8 m -101.79 153.81 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.446 -0.784 . . . . 0.0 110.222 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.759 HD11 HD23 ' A' ' 106' ' ' LEU . 30.2 pt -135.94 139.34 30.17 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.474 -0.766 . . . . 0.0 109.559 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.63 ' HB2' HD12 ' A' ' 127' ' ' LEU . 47.1 Cg_endo -66.85 145.48 74.84 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 123.929 1.489 . . . . 0.0 111.503 -178.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.33 142.9 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.93 117.32 34.35 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.84 128.52 15.79 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.527 -0.733 . . . . 0.0 110.119 -178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -112.97 -25.41 8.99 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.173 -177.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -172.93 53.35 0.16 Allowed Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.57 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.411 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER 65.9 -70.19 0.1 Allowed 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.633 -0.922 . . . . 0.0 110.06 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 120' ' ' GLY . 77.7 p -92.94 35.7 1.05 Allowed 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.342 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.456 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -167.91 150.75 5.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.336 -0.852 . . . . 0.0 110.216 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.42 -178.21 20.78 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 4.1 t -127.86 117.0 21.01 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.607 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.693 HD21 HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -58.53 139.27 55.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.45 -0.782 . . . . 0.0 109.475 178.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 115' ' ' PRO . 38.7 mt -105.26 53.92 0.71 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.237 1.018 . . . . 0.0 108.267 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 167.48 152.64 0.1 Allowed Pre-proline 0 N--CA 1.503 2.184 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.19 115.65 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.782 1.412 . . . . 0.0 110.044 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.606 ' HB2' HD22 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -123.62 131.8 24.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.488 -0.758 . . . . 0.0 109.035 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -58.2 130.84 39.85 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.793 1.418 . . . . 0.0 110.898 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.729 HG21 ' SG ' ' A' ' 159' ' ' CYS . 10.9 p -65.79 -37.3 79.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.584 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -49.97 -37.08 30.74 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 122.042 0.925 . . . . 0.0 110.458 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -66.91 -38.37 86.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.517 HD11 ' CB ' ' A' ' 164' ' ' ALA . 15.4 mt -66.95 -36.43 82.21 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -61.02 123.29 17.19 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.949 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.17 -25.89 26.56 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.655 ' HA ' HD13 ' A' ' 44' ' ' LEU . 7.4 m -81.09 0.96 33.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.547 -0.972 . . . . 0.0 111.427 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 60.1 m -55.83 126.2 24.61 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.216 -0.928 . . . . 0.0 111.569 -178.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 123.66 -22.66 6.86 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.624 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -53.75 126.37 35.02 Favored Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.478 ' O ' HD12 ' A' ' 144' ' ' LEU . 49.2 Cg_endo -74.33 125.67 9.85 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.763 1.402 . . . . 0.0 112.977 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.77 HD23 HD13 ' A' ' 104' ' ' LEU . 1.1 mp -76.86 135.22 38.86 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 175.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 142' ' ' PRO . 1.1 mt -132.91 127.73 34.98 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 118.924 -1.11 . . . . 0.0 111.962 -178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.506 ' HB3' HG21 ' A' ' 151' ' ' VAL . 14.2 p -74.98 -174.72 0.39 Allowed Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.1 Cg_endo -71.1 68.21 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.419 1.22 . . . . 0.0 110.643 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.78 -175.28 1.76 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.559 -0.713 . . . . 0.0 109.75 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.42 27.11 20.98 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -116.81 135.97 53.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.535 -0.979 . . . . 0.0 109.753 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -72.05 141.01 49.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.662 -0.649 . . . . 0.0 110.241 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.653 HG12 ' CE2' ' A' ' 169' ' ' PHE . 1.4 t -96.85 -37.64 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.822 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 177.29 -177.9 48.28 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.484 HG13 HG13 ' A' ' 170' ' ' VAL . 1.1 pt -117.02 140.32 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.112 -1.228 . . . . 0.0 110.435 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.756 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 9.1 t80 -58.44 115.94 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.268 0.556 . . . . 0.0 110.541 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.696 ' HA ' HG11 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -103.68 -46.09 4.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.662 -0.649 . . . . 0.0 109.662 -179.829 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.731 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -151.29 171.99 16.59 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.756 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -132.09 118.11 19.2 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.674 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.859 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.4 t -65.96 102.44 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.729 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.9 p -128.08 159.55 34.73 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.301 1.048 . . . . 0.0 113.642 -175.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 161' ' ' ARG . 1.6 m -94.05 -174.17 3.32 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.506 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -48.85 84.96 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 121.74 0.781 . . . . 0.0 112.76 -178.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.665 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 84.78 -27.59 4.79 Favored Glycine 0 N--CA 1.5 2.967 0 O-C-N 120.713 -1.242 . . . . 0.0 111.775 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -96.21 131.75 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.773 -1.428 . . . . 0.0 109.604 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.517 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -95.62 134.47 38.47 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.772 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -115.24 -39.98 3.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.729 -0.607 . . . . 0.0 110.961 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.859 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -124.61 177.95 5.68 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.255 -0.903 . . . . 0.0 109.841 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.33 155.55 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.608 0.718 . . . . 0.0 110.685 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.731 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -127.28 96.02 4.46 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.653 ' CE2' HG12 ' A' ' 151' ' ' VAL . 3.7 p90 -132.54 165.86 23.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.824 -1.173 . . . . 0.0 112.946 -176.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.724 HG21 ' CD1' ' A' ' 82' ' ' LEU . 1.3 p -108.81 127.46 27.32 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 44.2 Cg_endo -59.05 160.58 18.26 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.963 1.507 . . . . 0.0 111.954 -177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.822 HG23 ' HA2' ' A' ' 152' ' ' GLY . 40.0 t -84.23 2.98 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.515 -0.741 . . . . 0.0 109.798 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.41 -37.17 21.8 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -36.34 83.92 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.585 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.578 ' SD ' HD22 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -49.89 -36.37 27.09 Favored 'General case' 0 N--CA 1.521 3.09 0 O-C-N 121.426 -0.796 . . . . 0.0 108.885 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -57.77 -37.48 73.74 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.121 -0.987 . . . . 0.0 108.708 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.1 m -76.27 -36.84 58.22 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.633 0.73 . . . . 0.0 109.42 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.593 HG21 ' CZ3' ' A' ' 53' ' ' TRP . 1.3 m -48.82 -52.99 21.12 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.673 -0.642 . . . . 0.0 111.193 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.459 ' CE ' ' CZ2' ' A' ' 53' ' ' TRP . 2.2 ptp -59.85 -40.85 89.92 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.066 -1.021 . . . . 0.0 109.94 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -57.67 -38.36 74.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.038 0.923 . . . . 0.0 109.449 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.58 78.22 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.624 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.3 p -92.5 40.43 1.05 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.59 -0.693 . . . . 0.0 110.714 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -66.1 164.23 15.91 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.457 -0.777 . . . . 0.0 110.02 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -137.77 42.76 2.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.569 -0.707 . . . . 0.0 110.747 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -93.79 103.42 15.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.51 -0.744 . . . . 0.0 110.129 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.079 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.443 HG11 ' HG2' ' A' ' 89' ' ' PRO . 35.2 m . . . . . 0 N--CA 1.499 1.978 0 CA-C-O 120.947 0.403 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 59.92 79.64 0.23 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.173 -0.954 . . . . 0.0 109.831 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.03 -89.72 0.08 OUTLIER Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -171.15 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.633 -0.922 . . . . 0.0 110.762 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 45' ' ' ALA . 7.3 p -117.34 158.8 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.59 0.71 . . . . 0.0 111.705 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 1.5 tt0 -142.35 140.2 32.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.53 HG12 ' HD2' ' A' ' 109' ' ' ARG . 27.7 m -106.22 173.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.967 0.889 . . . . 0.0 112.233 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.465 HG11 ' CH2' ' A' ' 85' ' ' TRP . 33.6 m -129.68 179.75 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.5 p -152.95 139.4 18.62 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.147 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.0 p -146.09 -178.92 6.38 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.42 75.34 0.76 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.762 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 m 178.7 -58.32 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -179.72 -156.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.391 -0.818 . . . . 0.0 109.717 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 p -128.34 139.35 52.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.548 -0.72 . . . . 0.0 109.962 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 67.9 m-85 -99.67 -178.71 3.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.477 -0.764 . . . . 0.0 110.284 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 44' ' ' LEU . 6.8 tt -116.48 146.76 42.33 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.217 -0.927 . . . . 0.0 108.883 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.596 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -148.96 137.51 21.12 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.909 -1.119 . . . . 0.0 110.714 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.697 HG23 HG23 ' A' ' 48' ' ' VAL . 14.8 t -106.39 129.89 54.3 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.283 -0.886 . . . . 0.0 113.381 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.564 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 42.2 t -75.46 87.85 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 109.883 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.697 HG23 HG23 ' A' ' 46' ' ' THR . 59.2 t -103.33 135.01 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m120 57.8 18.97 5.26 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.346 -0.846 . . . . 0.0 110.137 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.19 20.36 52.91 Favored Glycine 0 N--CA 1.498 2.775 0 O-C-N 121.215 -0.928 . . . . 0.0 111.015 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 85' ' ' TRP . 59.0 t -137.91 107.78 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.211 -1.17 . . . . 0.0 110.119 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.0 p -60.17 107.38 0.63 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.528 -0.733 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.918 ' CE3' HD23 ' A' ' 82' ' ' LEU . 96.2 m95 -88.19 146.68 25.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.032 -1.042 . . . . 0.0 111.956 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.601 HG21 ' CH2' ' A' ' 85' ' ' TRP . 8.6 t -162.76 171.25 17.05 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.865 HG11 ' CE1' ' A' ' 57' ' ' HIS . 16.3 t -94.5 151.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.451 -0.78 . . . . 0.0 109.655 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.416 ' CD2' HG12 ' A' ' 78' ' ' VAL . 18.2 t80 -76.93 4.46 9.88 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.178 -0.951 . . . . 0.0 111.709 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.865 ' CE1' HG11 ' A' ' 55' ' ' VAL . 26.3 m170 -40.72 -39.45 1.09 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.379 -0.826 . . . . 0.0 112.392 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.34 40.74 0.24 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.91 -5.6 59.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.445 -1.032 . . . . 0.0 110.864 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.49 133.58 3.07 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -92.32 -20.96 20.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.556 -0.967 . . . . 0.0 110.364 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.0 mtpp -77.7 -165.59 0.65 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.775 . . . . 0.0 110.374 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.594 HG22 ' HB2' ' A' ' 70' ' ' PRO . 1.2 m -64.93 100.09 0.39 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.594 -0.691 . . . . 0.0 111.147 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.711 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -52.24 171.39 0.05 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.626 -0.671 . . . . 0.0 110.261 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.37 142.89 46.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.269 -0.895 . . . . 0.0 111.312 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.99 -179.02 17.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -64.88 -23.0 62.62 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 O-C-N 123.9 1.474 . . . . 0.0 110.752 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -152.27 41.45 0.64 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.356 -0.84 . . . . 0.0 110.062 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.69 156.1 7.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.594 ' HB2' HG22 ' A' ' 63' ' ' THR . 52.1 Cg_endo -61.52 158.71 35.2 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.778 1.409 . . . . 0.0 110.112 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.711 HD12 ' CD2' ' A' ' 64' ' ' LEU . 80.5 mt -99.3 118.57 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.514 -0.741 . . . . 0.0 109.563 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 m -59.22 124.64 20.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.772 -0.58 . . . . 0.0 110.41 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -73.59 136.02 43.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.656 -0.653 . . . . 0.0 110.072 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.402 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -135.1 -44.9 0.71 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.631 -0.668 . . . . 0.0 110.304 -179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.467 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 14.8 m-85 -130.6 118.44 21.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.599 -0.688 . . . . 0.0 110.055 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.846 HG23 ' CG1' ' A' ' 83' ' ' VAL . 11.7 m -158.27 108.91 2.13 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.558 -0.714 . . . . 0.0 111.196 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 3.0 m120 -138.67 76.65 1.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.021 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.416 HG12 ' CD2' ' A' ' 56' ' ' TYR . 30.2 m 11.77 -133.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.88 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.49 177.99 8.62 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.733 -1.23 . . . . 0.0 110.106 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 52.31 23.08 2.25 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.523 -0.736 . . . . 0.0 110.871 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 1.8 m-20 -163.59 -114.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 109.081 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.918 HD23 ' CE3' ' A' ' 53' ' ' TRP . 3.0 tp 173.47 176.53 0.12 Allowed 'General case' 0 N--CA 1.516 2.847 0 CA-C-N 120.908 1.686 . . . . 0.0 111.319 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.846 ' CG1' HG23 ' A' ' 76' ' ' THR . 13.3 t -144.8 104.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 53' ' ' TRP . . . -123.06 109.87 1.43 Allowed Glycine 0 N--CA 1.487 2.049 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.879 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.601 ' CH2' HG21 ' A' ' 54' ' ' THR . 1.7 m0 -86.72 171.19 11.13 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -83.11 131.73 35.13 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.338 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -108.0 85.38 2.55 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.144 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.551 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -95.55 -10.71 1.0 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.745 1.392 . . . . 0.0 113.218 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 47.7 Cg_endo -72.32 73.57 2.69 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 115.715 -2.39 . . . . 0.0 110.767 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 51.87 25.8 16.82 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.564 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -67.56 138.73 56.71 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.458 -1.025 . . . . 0.0 110.963 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -84.18 120.4 26.15 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.3 p -93.17 119.73 32.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.632 -0.667 . . . . 0.0 110.7 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mt -77.66 -147.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.485 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 0.6 OUTLIER -159.2 -174.7 0.45 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 109.084 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.412 ' HD2' ' OG1' ' A' ' 95' ' ' THR . 51.8 Cg_endo -80.22 149.24 19.46 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 O-C-N 123.339 1.178 . . . . 0.0 111.138 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.731 ' O ' HG23 ' A' ' 98' ' ' THR . 1.8 t -68.15 156.23 37.94 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.158 0.98 . . . . 0.0 110.65 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 97' ' ' CYS . 0.6 OUTLIER -170.98 38.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 11.8 m -82.33 -172.56 4.07 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.625 0.726 . . . . 0.0 110.842 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -110.59 -32.76 2.62 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 m -99.02 -155.38 0.5 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.537 -0.978 . . . . 0.0 109.858 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.76 19.92 0.91 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.383 -0.823 . . . . 0.0 111.094 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 46.9 m-20 -78.85 106.82 11.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.69 HD13 HD23 ' A' ' 143' ' ' LEU . 0.3 OUTLIER -107.54 -178.39 3.61 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.778 -178.227 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.46 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.3 m-85 -141.49 92.97 2.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.686 -0.634 . . . . 0.0 109.32 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.48 HD11 HD11 ' A' ' 143' ' ' LEU . 6.2 tp -51.33 100.45 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.412 -0.805 . . . . 0.0 110.201 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.575 ' HA ' HG12 ' A' ' 113' ' ' VAL . 45.2 t -82.79 124.64 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.106 -1.037 . . . . 0.0 110.858 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 112' ' ' ASP . 47.6 p -89.91 179.73 5.91 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.656 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -96.38 52.99 1.28 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.047 -1.033 . . . . 0.0 111.404 -178.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.427 ' NE2' ' HB ' ' A' ' 108' ' ' THR . 4.9 p80 -177.09 44.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.44 -0.788 . . . . 0.0 109.996 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.57 65.11 1.61 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.643 -0.661 . . . . 0.0 111.237 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.492 ' O ' HG23 ' A' ' 108' ' ' THR . 0.8 OUTLIER -155.58 96.56 1.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 107' ' ' VAL . 17.0 m -109.26 150.71 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.607 -0.683 . . . . 0.0 110.948 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.8 pt -133.22 134.61 24.34 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.379 -0.825 . . . . 0.0 109.797 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.93 142.3 92.55 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 123.831 1.437 . . . . 0.0 112.13 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.45 152.89 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.763 -0.586 . . . . 0.0 109.683 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.89 110.84 18.24 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -48.35 127.12 12.46 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.354 -0.841 . . . . 0.0 110.725 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -111.88 -24.7 9.83 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.384 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.44 -169.66 36.75 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -63.31 128.33 35.33 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.843 0.83 . . . . 0.0 109.96 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.78 46.86 24.93 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.139 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.46 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 1.2 ttp180 -166.44 151.16 7.81 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.493 -0.754 . . . . 0.0 110.649 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.84 -178.34 18.65 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -123.64 134.45 53.77 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 122.008 -0.701 . . . . 0.0 111.88 -178.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.98 133.47 40.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.608 -0.683 . . . . 0.0 109.194 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 33.2 mt -107.27 54.16 0.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.001 0.905 . . . . 0.0 108.642 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.34 126.6 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.175 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -58.35 110.12 0.6 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 O-C-N 123.568 1.299 . . . . 0.0 110.33 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -123.03 137.77 28.71 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 47.1 Cg_endo -66.58 131.69 26.86 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.854 1.45 . . . . 0.0 110.505 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.597 HG21 ' SG ' ' A' ' 159' ' ' CYS . 7.8 p -60.14 -36.83 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.658 -0.651 . . . . 0.0 109.674 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 t -49.39 -36.51 22.07 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 122.035 0.922 . . . . 0.0 110.654 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.408 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 30.0 t80 -66.68 -37.49 84.86 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.527 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.3 mt -66.46 -36.23 82.24 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -61.18 121.62 13.0 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.746 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 113.82 -31.99 6.26 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.5 m -91.39 13.2 18.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.975 . . . . 0.0 110.881 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 p -51.52 128.74 23.82 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.174 -0.954 . . . . 0.0 110.379 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.535 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 116.26 -13.75 16.13 Favored Glycine 0 CA--C 1.542 1.772 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.654 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -46.28 110.22 0.47 Allowed Glycine 0 N--CA 1.504 3.21 0 O-C-N 121.504 -0.997 . . . . 0.0 111.174 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -67.84 126.97 15.38 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 124.066 1.561 . . . . 0.0 110.927 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.69 HD23 HD13 ' A' ' 104' ' ' LEU . 6.2 mp -80.24 130.87 35.51 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.64 120.37 22.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 109.472 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.595 ' CB ' ' HD3' ' A' ' 146' ' ' PRO . 43.1 m -49.9 -92.17 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.653 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.595 ' HD3' ' CB ' ' A' ' 145' ' ' CYS . 49.3 Cg_endo -92.3 -81.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 114.764 -3.024 . . . . 0.0 111.15 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.7 t -136.95 78.96 1.73 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.19 -0.944 . . . . 0.0 109.714 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 127.09 -166.53 19.85 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.9 m170 54.46 98.53 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.266 -1.138 . . . . 0.0 110.382 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.762 ' HB1' HG11 ' A' ' 172' ' ' VAL . . . -71.68 141.33 49.87 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.206 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.687 HG21 ' CD2' ' A' ' 104' ' ' LEU . 33.4 t -107.04 -43.39 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.69 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 175.81 179.33 46.24 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.451 HG13 HG12 ' A' ' 170' ' ' VAL . 1.4 pt -111.8 170.47 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 CA-C-N 119.589 1.695 . . . . 0.0 111.212 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.843 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 10.3 t80 -83.71 89.17 7.1 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.089 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -74.75 -41.04 60.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.503 -0.748 . . . . 0.0 109.153 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -159.74 -179.46 7.88 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.843 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -137.98 113.91 9.91 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.452 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.871 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 4.5 t -60.21 101.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.597 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.9 p -123.01 156.94 33.77 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.363 1.078 . . . . 0.0 113.603 -175.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 163' ' ' VAL . 6.1 p -96.38 -171.79 2.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -46.0 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.396 -0.815 . . . . 0.0 111.905 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.577 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 73.01 -19.24 1.28 Allowed Glycine 0 N--CA 1.499 2.865 0 O-C-N 121.168 -0.958 . . . . 0.0 112.795 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.8 t -101.98 136.05 35.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 119.39 1.595 . . . . 0.0 109.199 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.527 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -94.53 135.59 35.8 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.063 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -116.23 -38.48 3.57 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.611 -0.681 . . . . 0.0 111.047 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.871 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -129.36 178.78 6.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.496 -0.753 . . . . 0.0 109.685 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.2 t -121.11 144.82 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.671 0.748 . . . . 0.0 111.595 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.654 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -107.6 97.34 7.09 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 176.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.506 ' CE1' HG12 ' A' ' 151' ' ' VAL . 0.2 OUTLIER -126.97 142.91 51.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.881 -1.128 . . . . 0.0 112.468 -175.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.562 HG11 HD11 ' A' ' 82' ' ' LEU . 3.7 p -98.19 130.43 28.5 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 50.5 Cg_endo -58.68 152.69 54.46 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.667 1.351 . . . . 0.0 111.484 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.762 HG11 ' HB1' ' A' ' 150' ' ' ALA . 17.8 m -77.57 -2.53 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.417 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -85.32 -38.67 18.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 109.032 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.4 m -60.68 -36.42 78.7 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.525 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 3.3 mtt -49.25 -37.13 22.38 Favored 'General case' 0 N--CA 1.515 2.796 0 CA-C-O 121.715 0.769 . . . . 0.0 109.075 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -61.0 -40.53 93.87 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.7 m -65.55 -39.74 92.06 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.718 0.771 . . . . 0.0 109.205 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 175' ' ' MET . 0.9 OUTLIER -50.62 -41.22 54.76 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.819 -0.551 . . . . 0.0 110.798 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.467 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -53.88 -41.45 67.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.943 -1.098 . . . . 0.0 111.193 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -53.39 -36.7 61.73 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.301 -0.874 . . . . 0.0 109.61 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 178' ' ' THR . . . -67.82 -43.54 79.35 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.449 -0.782 . . . . 0.0 110.656 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 91' ' ' ALA . 9.4 p . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.329 0.585 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -170.82 81.04 0.08 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.72 169.53 11.77 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.481 ' HB2' HD12 ' A' ' 94' ' ' LEU . 1.1 pt-20 -98.4 -6.12 31.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.587 -0.949 . . . . 0.0 111.308 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.601 HG12 ' HG3' ' A' ' 109' ' ' ARG . 63.0 t -120.23 142.38 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.122 -0.986 . . . . 0.0 110.749 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.605 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 40.1 tt0 -135.47 144.81 46.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.826 -0.546 . . . . 0.0 109.873 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.593 HG12 HD22 ' A' ' 44' ' ' LEU . 26.8 m -117.8 174.01 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.38 -0.825 . . . . 0.0 110.815 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.512 HG11 ' CH2' ' A' ' 85' ' ' TRP . 36.0 m -128.57 -179.07 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -138.66 133.97 33.06 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.731 -1.187 . . . . 0.0 112.296 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.3 p -126.48 -177.81 4.12 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.18 96.69 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.164 -0.96 . . . . 0.0 111.145 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 m 59.54 47.55 10.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.644 -0.66 . . . . 0.0 110.622 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -165.13 169.31 16.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.248 -0.907 . . . . 0.0 110.984 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.5 p -158.45 132.99 8.14 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . 91.8 m-85 -99.65 -178.94 4.04 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.111 -0.993 . . . . 0.0 111.235 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.593 HD22 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -113.1 152.49 29.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 34' ' ' GLN . . . -162.18 159.39 25.82 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.596 -0.69 . . . . 0.0 110.368 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.695 HG23 HG23 ' A' ' 48' ' ' VAL . 14.2 t -138.05 128.83 26.86 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.457 -0.777 . . . . 0.0 111.612 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 79.5 m -77.97 82.22 4.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.551 -0.718 . . . . 0.0 109.727 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.695 HG23 HG23 ' A' ' 46' ' ' THR . 57.9 t -97.95 137.84 24.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 57.18 21.0 6.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.801 -0.562 . . . . 0.0 110.248 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.63 23.62 38.79 Favored Glycine 0 N--CA 1.494 2.524 0 O-C-N 121.414 -0.804 . . . . 0.0 111.822 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 85' ' ' TRP . 46.3 t -143.3 116.18 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-N 118.939 1.37 . . . . 0.0 110.388 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.519 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 13.1 t -64.29 105.64 0.95 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.955 ' CE3' HD23 ' A' ' 82' ' ' LEU . 98.3 m95 -86.41 149.84 24.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.388 -0.82 . . . . 0.0 112.146 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.86 HG21 ' CZ2' ' A' ' 85' ' ' TRP . 7.5 t -164.45 171.93 14.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.584 -0.698 . . . . 0.0 110.519 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -92.98 150.05 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.604 -0.685 . . . . 0.0 109.922 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.536 ' HB3' ' HA ' ' A' ' 78' ' ' VAL . 27.0 t80 -82.95 -2.43 55.08 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.219 -0.926 . . . . 0.0 112.112 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -67.47 -10.72 54.19 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.206 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.12 -50.58 0.02 OUTLIER Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.833 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HB3' ' OG1' ' A' ' 54' ' ' THR . . . -83.08 112.63 19.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.012 -1.287 . . . . 0.0 109.899 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.27 10.45 27.61 Favored Glycine 0 N--CA 1.499 2.847 0 O-C-N 121.169 -0.957 . . . . 0.0 110.85 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.4 t -103.66 -38.57 7.05 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.86 -1.377 . . . . 0.0 110.193 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.53 -165.17 1.09 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.494 -0.754 . . . . 0.0 110.577 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -72.05 90.57 1.18 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.669 -0.645 . . . . 0.0 109.855 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.864 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -56.22 177.77 0.06 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.869 -0.519 . . . . 0.0 110.414 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.3 126.82 32.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -127.99 -178.63 15.43 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.78 -18.04 52.69 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 124.036 1.545 . . . . 0.0 109.649 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -122.89 25.55 8.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 111.008 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 66' ' ' GLY . . . 108.7 -157.71 15.07 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -55.49 145.81 66.82 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.692 1.364 . . . . 0.0 111.523 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.864 HD12 ' CD2' ' A' ' 64' ' ' LEU . 88.1 mt -93.14 16.57 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.519 -0.738 . . . . 0.0 110.506 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 p 43.17 -153.8 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.302 -0.874 . . . . 0.0 111.501 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.66 118.75 2.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.68 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -30.49 9.98 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.374 -0.828 . . . . 0.0 109.967 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.433 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 15.5 m-85 -129.58 121.71 27.66 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.699 HG23 ' CG1' ' A' ' 83' ' ' VAL . 3.7 m -160.44 113.52 2.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.287 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.45 ' C ' HG22 ' A' ' 78' ' ' VAL . 6.3 t-20 -143.59 73.15 1.38 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.504 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.536 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 14.2 m 36.01 -162.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.93 -31.61 34.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.406 ' HB2' HG23 ' A' ' 78' ' ' VAL . 54.3 mt-30 -52.2 -30.6 27.9 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.682 0.753 . . . . 0.0 109.255 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.416 ' CB ' ' HB3' ' A' ' 77' ' ' ASN . 0.5 OUTLIER -126.97 -102.26 0.35 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.955 HD23 ' CE3' ' A' ' 53' ' ' TRP . 0.8 OUTLIER 179.22 168.42 1.01 Allowed 'General case' 0 N--CA 1.512 2.628 0 O-C-N 120.299 -1.501 . . . . 0.0 112.27 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.699 ' CG1' HG23 ' A' ' 76' ' ' THR . 20.0 t -128.5 150.54 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.38 111.31 0.47 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.319 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.86 ' CZ2' HG21 ' A' ' 54' ' ' THR . 1.1 m-90 -87.04 172.58 9.87 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -87.31 131.33 34.29 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.688 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 91' ' ' ALA . . . -58.66 167.73 1.7 Allowed Pre-proline 0 N--CA 1.494 1.773 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.554 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 33.2 Cg_endo -67.29 -79.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.555 1.546 0 O-C-N 123.879 1.463 . . . . 0.0 110.581 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 88' ' ' PRO . 56.0 Cg_endo -97.65 36.04 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 115.731 -2.379 . . . . 0.0 108.606 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.28 -10.34 73.53 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.659 ' HA ' HG23 ' A' ' 29' ' ' VAL . . . 50.15 -178.39 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.207 -1.173 . . . . 0.0 111.855 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -73.19 72.43 1.22 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 t -41.74 95.88 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.755 -0.591 . . . . 0.0 111.968 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.481 HD12 ' HB2' ' A' ' 32' ' ' GLU . 1.0 OUTLIER -68.88 -157.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.695 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 0.9 OUTLIER -153.29 175.14 3.16 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 121.245 -0.91 . . . . 0.0 111.179 -179.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.62 163.95 26.26 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 O-C-N 123.845 1.445 . . . . 0.0 111.545 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 18.5 t -79.56 -72.78 0.38 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.705 -0.622 . . . . 0.0 109.811 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.0 m 49.77 74.48 0.2 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.419 -0.801 . . . . 0.0 110.612 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 77.2 m -138.14 -64.92 0.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.261 -0.899 . . . . 0.0 110.601 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 116.33 33.69 1.43 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.4 m -134.32 -163.84 1.42 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.655 -0.909 . . . . 0.0 109.725 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.6 p -135.64 -151.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.578 -0.701 . . . . 0.0 109.546 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 30.2 t70 62.23 109.79 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.331 -0.856 . . . . 0.0 109.893 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.604 HD13 HD23 ' A' ' 143' ' ' LEU . 1.1 mt -128.2 -171.4 2.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.545 -0.722 . . . . 0.0 109.434 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.635 ' O ' HG23 ' A' ' 107' ' ' VAL . 16.4 m-85 -139.5 90.5 2.41 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.553 HD12 ' HG ' ' A' ' 143' ' ' LEU . 11.6 tp -59.44 93.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 105' ' ' TYR . 84.6 t -82.56 101.57 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.356 -177.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.525 HG21 ' OH ' ' A' ' 134' ' ' TYR . 38.5 p -65.66 168.48 7.57 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.601 ' HG3' HG12 ' A' ' 33' ' ' VAL . 1.1 tmt_? -93.35 24.03 4.15 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.728 -1.232 . . . . 0.0 110.727 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.96 31.27 5.88 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 56.46 71.73 0.55 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.63 0.729 . . . . 0.0 110.516 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -171.99 91.88 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.57 ' CG1' HG22 ' A' ' 107' ' ' VAL . 11.8 m -94.57 151.24 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.421 ' CG1' ' HB3' ' A' ' 106' ' ' LEU . 30.9 pt -129.96 142.43 45.34 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.29 -0.881 . . . . 0.0 109.031 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.58 132.85 24.5 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.811 1.427 . . . . 0.0 112.09 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 103' ' ' ASP . 91.4 t -121.45 153.71 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -116.06 111.85 20.9 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.92 124.13 8.15 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.626 -0.672 . . . . 0.0 110.15 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 125' ' ' SER . 1.6 mmm180 -104.97 -49.45 3.48 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.842 -0.536 . . . . 0.0 110.701 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -151.93 -158.43 8.41 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.712 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -70.58 125.05 25.73 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.147 0.975 . . . . 0.0 109.262 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.83 50.13 16.36 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.042 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.521 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 19.2 ttm180 -166.12 156.53 12.64 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.589 -0.694 . . . . 0.0 110.787 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.95 -178.61 23.28 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.475 ' HB2' ' HG3' ' A' ' 119' ' ' ARG . 1.4 t -135.37 100.84 4.64 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.086 -0.655 . . . . 0.0 111.559 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 126' ' ' LEU . 2.4 pp -48.19 162.64 0.08 Allowed 'General case' 0 N--CA 1.51 2.552 0 O-C-N 121.466 -0.771 . . . . 0.0 110.713 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.7 mt -127.41 67.51 1.3 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 164.3 134.96 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.058 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.691 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.0 100.49 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.803 1.423 . . . . 0.0 109.566 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.36 128.21 25.74 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.539 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -56.0 127.13 24.81 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.917 1.483 . . . . 0.0 110.85 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.712 HG21 ' SG ' ' A' ' 159' ' ' CYS . 7.3 p -60.61 -36.56 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.44 -37.03 24.29 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.546 -0.722 . . . . 0.0 110.807 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.525 ' OH ' HG21 ' A' ' 108' ' ' THR . 17.0 t80 -67.8 -39.49 84.01 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.3 mt -63.05 -34.8 78.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 123.81 17.1 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.651 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.31 -31.22 8.88 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.464 ' HA ' HD23 ' A' ' 44' ' ' LEU . 57.6 m -79.34 -0.62 33.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.915 -0.756 . . . . 0.0 111.104 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 2.0 m -57.53 119.84 7.24 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 120.9 -1.125 . . . . 0.0 109.738 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 122.8 -17.24 8.22 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.4 137.88 49.71 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.51 ' CD ' HG22 ' A' ' 33' ' ' VAL . 49.5 Cg_endo -85.16 129.12 3.78 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 O-C-N 123.522 1.275 . . . . 0.0 113.476 -177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.604 HD23 HD13 ' A' ' 104' ' ' LEU . 4.4 mp -81.6 130.79 35.18 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 150' ' ' ALA . 1.1 mt -129.92 123.74 31.46 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 119.778 1.172 . . . . 0.0 112.474 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.428 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 4.2 p -67.44 -173.6 0.16 Allowed Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 40.8 Cg_endo -66.94 169.25 15.24 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.674 1.355 . . . . 0.0 110.214 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m 53.35 29.89 9.4 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.638 -0.664 . . . . 0.0 111.43 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 73.63 -134.01 18.43 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 59.61 106.19 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.26 -1.141 . . . . 0.0 110.278 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -65.81 143.94 57.17 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.69 -0.631 . . . . 0.0 110.798 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 2.1 t -107.01 -42.94 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.759 -0.588 . . . . 0.0 110.326 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.701 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 177.71 -178.62 48.42 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.66 HG13 HG13 ' A' ' 170' ' ' VAL . 1.0 OUTLIER -116.72 153.48 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 118.59 1.195 . . . . 0.0 111.718 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.78 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 7.4 t80 -65.38 117.24 7.62 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.505 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -107.26 -35.01 6.93 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.234 -0.916 . . . . 0.0 109.171 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.717 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -159.17 169.83 23.28 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.78 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -129.84 116.89 19.36 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.41 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.802 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.0 t -63.39 100.55 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.712 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.8 p -129.03 167.29 17.71 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.512 1.148 . . . . 0.0 113.971 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 162' ' ' GLY . 14.9 p -105.47 -173.51 2.32 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.12 82.9 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.635 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 86.09 -27.25 5.63 Favored Glycine 0 N--CA 1.501 2.968 0 O-C-N 121.098 -1.001 . . . . 0.0 112.52 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.27 139.73 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-N 119.188 1.494 . . . . 0.0 108.288 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.605 ' C ' HD21 ' A' ' 126' ' ' LEU . . . -99.52 139.32 35.35 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.371 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.517 ' HA ' HD11 ' A' ' 126' ' ' LEU . 5.7 mtpt -112.98 -31.36 6.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.697 -0.627 . . . . 0.0 110.62 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.802 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -141.58 178.65 7.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.888 . . . . 0.0 110.324 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.34 150.4 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.662 0.744 . . . . 0.0 110.857 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.717 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -119.92 103.24 9.16 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 177.279 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.521 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 1.7 p90 -128.44 174.32 9.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 118.966 -1.094 . . . . 0.0 112.23 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.662 HG11 ' CD1' ' A' ' 82' ' ' LEU . 1.4 p -125.96 122.26 24.35 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 41.1 Cg_endo -47.92 152.84 2.89 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 O-C-N 123.651 1.343 . . . . 0.0 113.11 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.701 HG13 ' HA2' ' A' ' 152' ' ' GLY . 18.2 m -82.38 -1.85 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.343 -0.848 . . . . 0.0 109.832 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -87.42 -43.69 11.9 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.547 -0.72 . . . . 0.0 109.187 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.7 t -60.7 -42.74 97.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.737 -0.602 . . . . 0.0 109.716 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.903 ' HB3' HD22 ' A' ' 82' ' ' LEU . 8.2 ptp -58.9 -36.54 74.85 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.914 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.85 -38.05 69.57 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.387 -1.445 . . . . 0.0 108.822 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.7 m -63.62 -36.89 85.3 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.325 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.899 HG22 ' O ' ' A' ' 175' ' ' MET . 3.1 t -48.71 -35.5 14.15 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.12 -0.987 . . . . 0.0 111.645 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.471 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -58.19 -41.25 83.51 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.866 -1.146 . . . . 0.0 110.447 179.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -48.61 -36.68 16.27 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.967 0.889 . . . . 0.0 110.604 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -91.3 -42.74 10.2 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.502 2.155 0 O-C-N 121.296 -0.877 . . . . 0.0 110.962 179.705 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 89' ' ' PRO . 33.6 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.049 0.452 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 58.51 79.07 0.22 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.333 -0.855 . . . . 0.0 109.869 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.0 -108.92 0.21 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -168.43 -35.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.549 -0.971 . . . . 0.0 111.437 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.755 HG22 ' OG1' ' A' ' 46' ' ' THR . 54.1 t -131.32 140.6 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.119 -0.988 . . . . 0.0 111.723 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.84 156.41 48.95 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.657 HG11 ' HB3' ' A' ' 109' ' ' ARG . 33.7 m -123.27 174.87 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.307 -0.87 . . . . 0.0 111.885 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.72 HG13 ' CZ ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -144.6 163.73 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.3 p -119.91 142.89 48.29 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.387 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 p -123.85 -176.87 3.58 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.27 98.36 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.395 -0.815 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 p 51.92 31.98 9.27 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.828 -0.545 . . . . 0.0 110.794 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -146.87 154.99 41.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.552 -0.717 . . . . 0.0 110.449 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.2 t -150.0 165.72 31.83 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.568 -0.707 . . . . 0.0 109.318 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.72 ' CZ ' HG13 ' A' ' 36' ' ' VAL . 11.0 p90 -153.6 -177.38 6.33 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.254 -0.904 . . . . 0.0 110.598 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.778 HD12 ' HG3' ' A' ' 109' ' ' ARG . 7.0 tt -110.43 146.1 36.46 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.509 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -146.12 128.86 16.23 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.681 -1.262 . . . . 0.0 110.287 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.755 ' OG1' HG22 ' A' ' 33' ' ' VAL . 99.9 m -110.31 128.13 55.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.435 -0.791 . . . . 0.0 111.479 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 79.2 m -78.07 85.95 4.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.806 -0.559 . . . . 0.0 109.816 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 94' ' ' LEU . 21.8 t -98.26 136.44 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.99 19.3 5.78 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.397 -0.815 . . . . 0.0 109.993 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.98 24.35 45.31 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 85' ' ' TRP . 42.9 t -139.85 105.44 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 121.261 -1.141 . . . . 0.0 110.378 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.423 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -58.04 97.34 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.464 -0.772 . . . . 0.0 109.942 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.991 ' CE3' HD23 ' A' ' 82' ' ' LEU . 81.2 m95 -78.53 141.35 38.23 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.341 -0.849 . . . . 0.0 110.668 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.477 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 10.2 t -163.33 126.77 2.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.564 -0.71 . . . . 0.0 109.707 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.476 HG11 ' HA ' ' A' ' 155' ' ' ARG . 21.4 m -49.3 143.7 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 O-C-N 121.274 -0.891 . . . . 0.0 110.902 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.528 ' HB2' HG21 ' A' ' 83' ' ' VAL . 4.8 t80 -74.62 -1.72 22.85 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.123 -0.986 . . . . 0.0 110.902 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -48.79 -27.31 2.89 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.26 -0.9 . . . . 0.0 110.689 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.03 76.7 0.09 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.583 ' HB1' ' HZ2' ' A' ' 85' ' ' TRP . . . -105.09 -51.16 3.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.447 -1.031 . . . . 0.0 110.101 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 151.08 -40.6 0.79 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 p 51.68 23.94 2.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.551 -0.97 . . . . 0.0 111.201 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.24 -158.47 0.91 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.426 -0.797 . . . . 0.0 110.509 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.4 m -60.3 91.02 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.573 -0.704 . . . . 0.0 110.534 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.855 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -76.16 164.82 25.72 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.675 -0.641 . . . . 0.0 110.233 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.31 135.48 55.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.205 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.23 -179.02 19.87 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.3 -29.19 88.37 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.872 1.459 . . . . 0.0 111.098 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -147.32 38.6 0.96 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.407 -0.808 . . . . 0.0 110.096 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.06 158.08 8.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -63.63 163.7 23.52 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 O-C-N 123.92 1.484 . . . . 0.0 110.493 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.855 HD12 ' CD2' ' A' ' 64' ' ' LEU . 93.4 mt -106.81 108.75 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.653 -0.654 . . . . 0.0 109.494 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -62.0 137.09 58.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.717 -0.615 . . . . 0.0 110.51 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -73.55 163.47 27.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.566 -0.708 . . . . 0.0 109.806 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -43.81 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.448 -0.783 . . . . 0.0 110.486 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.458 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 14.3 m-85 -126.68 124.36 39.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.492 -0.755 . . . . 0.0 110.075 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.633 HG23 ' CG1' ' A' ' 83' ' ' VAL . 6.3 m -158.85 106.41 1.84 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.705 -0.622 . . . . 0.0 111.009 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.417 ' CB ' ' HB2' ' A' ' 81' ' ' ASP . 18.7 m120 -152.44 76.57 1.16 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.554 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.5 p -72.31 -21.26 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.641 -0.662 . . . . 0.0 110.828 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.73 -32.17 29.32 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.045 -1.034 . . . . 0.0 110.401 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -173.85 34.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.595 -0.691 . . . . 0.0 110.337 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.417 ' HB2' ' CB ' ' A' ' 77' ' ' ASN . 6.7 m-20 -153.95 -99.92 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.313 -0.867 . . . . 0.0 111.811 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.991 HD23 ' CE3' ' A' ' 53' ' ' TRP . 6.2 tp 178.19 176.35 0.47 Allowed 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.548 -1.345 . . . . 0.0 110.274 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.633 ' CG1' HG23 ' A' ' 76' ' ' THR . 16.1 t -132.83 115.57 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.31 110.79 0.82 Allowed Glycine 0 N--CA 1.485 1.908 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.42 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.583 ' HZ2' ' HB1' ' A' ' 59' ' ' ALA . 1.9 m0 -79.38 166.43 22.07 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -86.39 130.29 34.56 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.304 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.707 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -108.17 92.13 9.04 Favored Pre-proline 0 C--N 1.294 -1.846 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.344 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.578 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.8 Cg_endo -104.48 -3.5 0.2 Allowed 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.747 1.393 . . . . 0.0 112.967 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 52.4 Cg_endo -72.94 72.29 3.28 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 115.714 -2.391 . . . . 0.0 109.683 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 57.21 24.24 50.58 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 87' ' ' ALA . . . -74.39 138.56 43.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.546 -0.973 . . . . 0.0 110.732 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.0 135.95 43.16 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.474 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.3 p -104.59 97.93 7.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.563 -0.71 . . . . 0.0 109.563 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.59 ' HB3' HG13 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -65.49 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.543 -0.723 . . . . 0.0 109.161 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.788 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 5.6 p -155.48 173.77 4.56 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.573 -0.705 . . . . 0.0 110.339 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.34 177.61 8.55 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.839 1.441 . . . . 0.0 110.198 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 t -98.69 -77.3 0.52 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.539 -0.725 . . . . 0.0 110.119 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m 55.11 49.81 16.64 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.223 -0.923 . . . . 0.0 110.008 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 78.3 m -112.5 -46.69 3.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.671 -0.643 . . . . 0.0 110.302 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.98 28.8 6.38 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.31 -164.56 1.22 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.609 -0.936 . . . . 0.0 109.987 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.2 p -140.88 -150.33 0.31 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.369 -0.832 . . . . 0.0 110.541 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.73 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.137 -0.977 . . . . 0.0 109.973 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.8 HD13 HD23 ' A' ' 143' ' ' LEU . 0.6 OUTLIER -117.94 -178.8 3.58 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.503 -0.748 . . . . 0.0 110.097 -179.203 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -133.56 84.74 2.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.669 -0.644 . . . . 0.0 109.618 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 154' ' ' PHE . 21.5 tp -60.87 106.38 0.57 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.629 -0.669 . . . . 0.0 109.39 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.712 HG22 HG12 ' A' ' 113' ' ' VAL . 25.1 t -84.43 133.65 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.657 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.3 p -89.34 -177.86 5.47 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.778 ' HG3' HD12 ' A' ' 44' ' ' LEU . 14.5 mtm180 -87.73 18.9 3.73 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.0 -1.063 . . . . 0.0 110.505 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.48 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.9 OUTLIER -151.19 47.49 0.83 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.051 -1.03 . . . . 0.0 111.99 -177.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.06 73.03 0.44 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.294 -0.879 . . . . 0.0 111.457 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.82 90.16 0.69 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.791 -0.568 . . . . 0.0 109.818 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.712 HG12 HG22 ' A' ' 107' ' ' VAL . 26.3 m -94.78 149.55 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 110.252 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.638 HG22 HH21 ' A' ' 130' ' ' ARG . 34.1 pt -131.48 141.77 42.94 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.512 -0.742 . . . . 0.0 109.723 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.33 137.38 36.55 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.918 1.483 . . . . 0.0 111.772 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.9 t -130.97 140.31 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.04 118.26 36.16 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -48.75 127.3 13.51 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.401 -0.812 . . . . 0.0 110.203 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.42 ' CG ' ' HB2' ' A' ' 125' ' ' SER . 3.7 mmt180 -107.13 -25.23 11.64 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.257 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 121' ' ' ASP . . . 173.04 56.52 0.05 OUTLIER Glycine 0 N--CA 1.498 2.773 0 C-N-CA 118.834 -1.65 . . . . 0.0 110.59 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 120' ' ' GLY . 0.6 OUTLIER 59.23 142.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.831 -0.806 . . . . 0.0 110.132 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.5 p 45.57 27.78 0.45 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.544 0.688 . . . . 0.0 111.554 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.518 ' HD2' HG21 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -166.88 148.05 5.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.522 -0.736 . . . . 0.0 109.427 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.37 -178.09 18.04 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.6 t -124.31 122.25 37.22 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.245 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.4 149.53 33.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.743 -0.598 . . . . 0.0 109.582 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 128' ' ' SER . 90.2 mt -126.01 69.4 1.2 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER 158.16 123.05 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.368 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -58.95 106.81 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 O-C-N 123.588 1.31 . . . . 0.0 109.745 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.638 HH21 HG22 ' A' ' 114' ' ' ILE . 9.9 mtt-85 -122.39 151.18 59.0 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.95 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 49.2 Cg_endo -75.3 130.02 12.6 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.178 1.62 . . . . 0.0 109.807 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.7 p -57.92 -36.53 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.73 -0.606 . . . . 0.0 110.093 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 t -49.58 -36.55 24.35 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 122.127 0.965 . . . . 0.0 110.227 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.417 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 57.7 t80 -60.85 -38.04 84.18 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 11.5 mt -69.21 -35.28 76.05 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.712 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -56.95 117.07 3.6 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.746 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 108.29 -24.47 22.57 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.44 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -86.43 4.29 40.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.506 -0.997 . . . . 0.0 111.273 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 80.1 p -51.93 128.85 25.4 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.964 -1.085 . . . . 0.0 109.609 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.519 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 114.96 -18.28 16.64 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.731 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -48.28 117.46 3.79 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.516 ' HG3' HG21 ' A' ' 46' ' ' THR . 53.7 Cg_endo -74.11 124.71 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 124.022 1.538 . . . . 0.0 111.343 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.8 HD23 HD13 ' A' ' 104' ' ' LEU . 6.0 mp -82.9 105.07 13.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 176.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.577 HD21 ' CD1' ' A' ' 94' ' ' LEU . 1.5 mt -105.24 119.72 39.75 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.131 -0.981 . . . . 0.0 112.385 -176.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.451 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 0.9 OUTLIER -59.63 -167.34 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 41.2 Cg_endo -69.4 167.06 25.06 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 117.092 -1.472 . . . . 0.0 109.472 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.2 t 56.77 -155.04 0.32 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.27 -0.894 . . . . 0.0 110.115 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 149' ' ' HIS . . . -102.76 100.53 1.97 Allowed Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.426 ' CG ' ' O ' ' A' ' 148' ' ' GLY . 1.1 m170 -170.65 95.95 0.22 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.692 -0.887 . . . . 0.0 109.853 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.788 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -63.23 142.32 58.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.573 -0.704 . . . . 0.0 109.256 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 0.9 OUTLIER -103.39 -36.99 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.451 -0.781 . . . . 0.0 109.575 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.661 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 176.15 -178.89 47.49 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.804 HG23 ' HE1' ' A' ' 175' ' ' MET . 1.1 pp -114.7 168.75 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-N 118.906 1.353 . . . . 0.0 111.392 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.749 ' HB2' HD11 ' A' ' 106' ' ' LEU . 5.9 t80 -76.96 114.57 15.89 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.29 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.476 ' HA ' HG11 ' A' ' 55' ' ' VAL . 26.5 ttt-85 -100.97 -38.97 7.97 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.698 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -159.89 173.61 15.68 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.743 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -129.69 119.84 24.16 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.772 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.839 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.5 t -69.95 100.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.67 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.6 p -127.3 158.07 38.19 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 122.253 1.025 . . . . 0.0 113.354 -175.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' GLY . 16.5 p -91.25 -175.01 4.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.92 85.65 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.692 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 86.51 -25.0 7.62 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 121.063 -1.023 . . . . 0.0 112.214 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -101.7 140.61 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 119.177 1.489 . . . . 0.0 109.214 -179.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -103.26 129.63 50.29 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.047 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt -111.51 -33.79 6.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.652 -0.655 . . . . 0.0 110.548 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.839 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -129.6 -179.7 5.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.275 -0.891 . . . . 0.0 110.219 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -126.89 147.47 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.615 0.722 . . . . 0.0 111.683 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.698 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -111.45 96.33 6.04 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 177.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.61 ' CD2' HD22 ' A' ' 143' ' ' LEU . 0.3 OUTLIER -124.13 160.42 27.83 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.252 -0.979 . . . . 0.0 112.694 -175.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 153' ' ' ILE . 2.7 p -116.21 126.22 27.82 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 47.0 Cg_endo -56.53 156.36 22.46 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 O-C-N 123.872 1.459 . . . . 0.0 112.311 -177.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.661 HG23 ' HA2' ' A' ' 152' ' ' GLY . 57.5 t -80.76 -2.96 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.05 -37.78 28.5 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.9 t -72.42 -36.01 68.49 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.949 ' O ' HG22 ' A' ' 178' ' ' THR . 36.7 mtt -48.24 -39.07 20.13 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.621 -0.674 . . . . 0.0 110.426 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -54.82 -37.27 65.93 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.883 0.849 . . . . 0.0 109.283 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.7 m -52.9 -41.71 64.65 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.236 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.949 HG22 ' O ' ' A' ' 175' ' ' MET . 14.6 t -56.56 -36.47 69.34 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.94 -1.1 . . . . 0.0 111.635 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.482 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -56.2 -44.2 79.23 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.645 -1.284 . . . . 0.0 110.56 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -51.45 -37.91 51.07 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.944 0.878 . . . . 0.0 110.054 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -74.11 -48.47 29.39 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.697 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.503 2.22 0 O-C-N 121.509 -0.744 . . . . 0.0 110.992 179.701 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.43 HG22 ' N ' ' A' ' 30' ' ' GLU . 3.5 p . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 121.401 0.62 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.43 ' N ' HG22 ' A' ' 29' ' ' VAL . 2.6 mm-40 -156.06 79.38 0.98 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.32 -26.39 3.4 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.39 -79.72 0.07 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.508 -0.995 . . . . 0.0 109.243 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 45' ' ' ALA . 9.6 p -150.43 148.71 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 111.385 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -131.84 150.2 52.22 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.587 HG12 HD23 ' A' ' 44' ' ' LEU . 31.6 m -108.98 164.09 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.218 -0.926 . . . . 0.0 112.311 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.717 HG11 ' CH2' ' A' ' 85' ' ' TRP . 21.9 m -122.53 179.7 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -149.93 137.87 20.23 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.447 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.4 p -144.65 -178.67 6.12 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 40' ' ' THR . . . -68.87 76.74 0.31 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.027 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER 175.51 -59.51 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.584 -0.697 . . . . 0.0 109.323 -179.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 178.21 -171.3 0.11 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.538 -0.726 . . . . 0.0 109.075 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.3 p -112.68 138.06 50.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.513 -0.742 . . . . 0.0 109.923 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 43.9 m-85 -106.3 173.07 6.48 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.537 -0.727 . . . . 0.0 110.607 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.776 HD22 ' HB2' ' A' ' 109' ' ' ARG . 12.7 mt -100.67 159.85 14.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.521 -0.737 . . . . 0.0 110.713 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -158.45 126.71 5.3 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.073 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.587 HG23 HG23 ' A' ' 48' ' ' VAL . 8.6 t -104.95 127.43 52.79 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.375 -0.828 . . . . 0.0 112.288 -178.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 97.2 m -80.15 85.41 5.71 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.762 -0.586 . . . . 0.0 109.951 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.587 HG23 HG23 ' A' ' 46' ' ' THR . 67.7 t -105.13 139.43 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.41 17.97 5.23 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.246 -0.909 . . . . 0.0 110.259 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.23 43.12 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.4 t -141.59 112.04 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.313 -1.11 . . . . 0.0 110.546 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.43 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 1.8 t -67.38 105.65 1.85 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.932 ' CE3' HD23 ' A' ' 82' ' ' LEU . 82.2 m95 -87.3 145.54 26.31 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.235 -0.916 . . . . 0.0 111.097 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 83' ' ' VAL . 9.0 t -162.2 178.35 8.83 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.269 -0.894 . . . . 0.0 110.293 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 55' ' ' VAL . 31.4 m -101.35 143.12 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.636 -0.665 . . . . 0.0 109.948 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.606 ' HB2' HG11 ' A' ' 83' ' ' VAL . 36.9 t80 -78.25 2.53 18.03 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.063 -1.023 . . . . 0.0 111.923 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -48.73 -26.77 2.51 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.178 -0.951 . . . . 0.0 110.868 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.414 ' HA3' ' CZ ' ' A' ' 43' ' ' PHE . . . -177.75 35.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.531 ' HB1' ' CZ2' ' A' ' 85' ' ' TRP . . . -81.29 0.39 37.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.188 -1.184 . . . . 0.0 111.194 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.05 -171.28 22.37 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.0 t -160.65 -43.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.677 -0.896 . . . . 0.0 110.033 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -165.99 0.06 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.726 -0.608 . . . . 0.0 110.513 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -59.7 97.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.663 -0.648 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.666 HD22 HD12 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -60.46 176.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.668 -0.645 . . . . 0.0 109.928 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -118.18 135.68 54.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.417 -0.802 . . . . 0.0 110.669 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.3 179.61 23.81 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -63.57 -23.15 70.54 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.876 1.461 . . . . 0.0 110.483 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -153.28 40.47 0.53 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.326 -0.859 . . . . 0.0 110.425 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 150.11 170.07 16.99 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -64.74 147.7 89.85 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.892 1.469 . . . . 0.0 110.333 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.666 HD12 HD22 ' A' ' 64' ' ' LEU . 91.4 mt -79.22 168.87 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.581 -0.699 . . . . 0.0 109.369 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.456 ' N ' HG22 ' A' ' 71' ' ' ILE . 7.2 m -80.75 -45.58 16.82 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.21 -0.931 . . . . 0.0 111.608 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 55.5 90.05 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.457 -0.777 . . . . 0.0 109.775 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.6 ttt -126.81 -10.02 6.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.546 -0.722 . . . . 0.0 111.444 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 15.5 m-85 -128.25 113.65 15.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.091 -1.006 . . . . 0.0 109.655 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.624 HG22 HG12 ' A' ' 83' ' ' VAL . 0.7 OUTLIER -151.06 112.51 4.4 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.888 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -159.8 74.63 0.6 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.592 HG11 ' HB3' ' A' ' 56' ' ' TYR . 6.6 p -68.05 -10.8 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.361 -0.837 . . . . 0.0 111.302 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.79 85.75 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.349 -0.844 . . . . 0.0 108.976 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 78' ' ' VAL . 3.9 tt0 60.1 39.09 20.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.544 -0.723 . . . . 0.0 109.653 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.79 -93.89 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.969 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.932 HD23 ' CE3' ' A' ' 53' ' ' TRP . 10.2 tp 177.68 168.61 0.68 Allowed 'General case' 0 N--CA 1.508 2.425 0 O-C-N 120.329 -1.482 . . . . 0.0 110.943 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.624 HG12 HG22 ' A' ' 76' ' ' THR . 9.8 m -141.98 122.67 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.69 142.83 10.29 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.717 ' CH2' HG11 ' A' ' 36' ' ' VAL . 2.4 m-90 -99.08 169.52 9.35 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.32 140.31 31.7 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.727 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.57 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -102.81 94.73 5.52 Favored Pre-proline 0 C--N 1.3 -1.553 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.041 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.576 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.5 Cg_endo -101.39 -12.3 0.17 Allowed 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.644 1.339 . . . . 0.0 113.321 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 49.5 Cg_endo -72.03 69.1 3.14 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 116.175 -2.083 . . . . 0.0 111.203 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.12 14.48 25.31 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.57 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -57.01 131.7 50.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.107 -1.231 . . . . 0.0 110.73 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -85.16 97.73 10.06 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.5 m -52.17 112.95 0.89 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.737 -0.602 . . . . 0.0 111.394 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -75.64 -152.62 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.52 -0.737 . . . . 0.0 109.133 179.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 94' ' ' LEU . 1.7 p -152.67 179.44 1.27 Allowed Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.346 -0.846 . . . . 0.0 111.303 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -86.03 164.19 10.14 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 O-C-N 123.916 1.482 . . . . 0.0 111.535 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.469 ' SG ' HG23 ' A' ' 151' ' ' VAL . 0.8 OUTLIER -96.76 86.58 4.09 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.592 -0.693 . . . . 0.0 110.605 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.1 p -61.11 -39.07 88.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.421 -0.799 . . . . 0.0 109.647 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.3 p -64.6 -37.91 89.18 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.48 -0.763 . . . . 0.0 109.764 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 48.2 29.29 6.76 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.86 159.02 14.68 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.498 -1.001 . . . . 0.0 110.281 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 118' ' ' ARG . 5.1 t -66.02 -170.1 0.08 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.524 -0.735 . . . . 0.0 110.049 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.77 100.66 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.507 -0.745 . . . . 0.0 110.34 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.68 HD13 HD23 ' A' ' 143' ' ' LEU . 2.6 mt -117.33 -173.59 2.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.398 -0.814 . . . . 0.0 109.936 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -140.7 84.98 1.97 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.817 -0.552 . . . . 0.0 109.699 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.777 HD23 HD11 ' A' ' 114' ' ' ILE . 28.5 tp -71.89 100.96 2.54 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.798 HG22 HG12 ' A' ' 113' ' ' VAL . 32.2 t -90.72 123.21 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.123 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 138' ' ' SER . 24.9 p -88.37 145.84 25.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.776 ' HB2' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -61.82 -15.14 39.46 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.837 -1.165 . . . . 0.0 109.744 179.168 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.591 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 13.4 m170 -55.23 -79.29 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 110' ' ' HIS . . . 169.72 47.83 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.25 -0.906 . . . . 0.0 110.305 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -169.56 127.15 0.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.734 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.798 HG12 HG22 ' A' ' 107' ' ' VAL . 10.6 m -95.6 156.49 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.777 HD11 HD23 ' A' ' 106' ' ' LEU . 39.3 pt -131.68 127.76 21.51 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.442 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -66.04 145.9 80.72 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.876 1.461 . . . . 0.0 110.786 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.8 t -137.74 152.22 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.24 107.5 18.35 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -48.57 122.76 5.83 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.584 -0.697 . . . . 0.0 110.566 -178.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.18 -24.33 9.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.824 -0.547 . . . . 0.0 110.188 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.96 177.92 36.24 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -61.42 -22.8 65.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.959 -0.73 . . . . 0.0 110.204 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.3 p -135.76 41.09 2.73 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.834 -0.541 . . . . 0.0 111.463 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.499 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -169.8 151.88 4.34 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.174 -0.954 . . . . 0.0 111.397 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.86 -178.73 22.42 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.7 OUTLIER -128.09 116.08 19.43 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.896 -0.767 . . . . 0.0 111.773 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.509 HD21 HD12 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -52.66 142.71 17.71 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.43 -0.794 . . . . 0.0 110.514 179.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.9 mt -111.03 54.27 0.68 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 164.38 125.28 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.252 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -56.82 115.94 2.85 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 O-C-N 123.543 1.286 . . . . 0.0 110.72 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.404 ' HB2' HD22 ' A' ' 126' ' ' LEU . 0.8 OUTLIER -122.31 141.63 35.09 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.752 . . . . 0.0 109.27 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -64.52 128.19 20.68 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.813 1.428 . . . . 0.0 110.383 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 162' ' ' GLY . 12.1 p -62.84 -35.06 69.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.157 0.503 . . . . 0.0 110.061 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 m -48.71 -37.24 18.13 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.122 -0.986 . . . . 0.0 110.487 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -67.26 -38.34 84.97 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.9 mt -64.99 -36.13 83.4 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -63.85 123.18 18.28 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.97 -26.01 24.52 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.566 ' O ' HD12 ' A' ' 44' ' ' LEU . 16.9 m -92.38 14.41 16.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.481 -1.011 . . . . 0.0 110.694 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.59 127.67 32.38 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.102 -0.999 . . . . 0.0 109.63 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.51 -7.12 26.38 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.45 136.2 50.81 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.07 123.59 5.72 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.745 1.392 . . . . 0.0 112.698 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.68 HD23 HD13 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -82.74 124.69 30.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.179 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.3 mt -124.34 116.19 22.2 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.955 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.598 ' HB3' HG21 ' A' ' 151' ' ' VAL . 19.9 p -73.41 177.76 1.85 Allowed Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 48.7 Cg_endo -62.36 179.73 0.6 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.297 1.156 . . . . 0.0 109.952 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.5 m 56.01 29.1 13.78 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.312 -0.867 . . . . 0.0 110.789 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 60.5 -145.09 47.43 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 21.1 m170 61.68 127.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.895 -0.768 . . . . 0.0 110.44 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.47 ' O ' HG21 ' A' ' 172' ' ' VAL . . . -76.34 140.89 41.64 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.347 -0.846 . . . . 0.0 110.461 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.712 HG12 ' CE2' ' A' ' 169' ' ' PHE . 1.1 t -97.14 -43.41 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.778 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 178.53 -178.56 48.69 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.634 HD11 HD11 ' A' ' 82' ' ' LEU . 1.3 pp -116.93 150.31 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.063 -1.257 . . . . 0.0 111.397 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.776 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.3 t80 -63.0 115.13 4.14 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.014 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -102.05 -38.58 7.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.679 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -160.74 176.13 11.84 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.776 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -133.17 117.06 17.0 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.473 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.795 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.4 t -65.9 97.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.606 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.6 p -120.93 159.51 25.41 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 122.399 1.095 . . . . 0.0 113.888 -175.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.537 HG22 ' H ' ' A' ' 161' ' ' ARG . 2.1 m -95.5 -173.78 2.99 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.537 ' H ' HG22 ' A' ' 160' ' ' THR . 0.1 OUTLIER -48.65 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.438 -0.789 . . . . 0.0 112.567 -178.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.747 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 82.8 -31.83 3.0 Favored Glycine 0 N--CA 1.499 2.888 0 O-C-N 121.205 -0.934 . . . . 0.0 111.748 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.25 131.64 39.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 119.144 1.472 . . . . 0.0 109.328 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.418 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -92.13 135.14 34.22 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.035 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -113.31 -44.19 3.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.555 -0.716 . . . . 0.0 111.135 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.795 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -121.84 179.45 4.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.129 -0.982 . . . . 0.0 109.868 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.58 151.17 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.421 -0.799 . . . . 0.0 110.818 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.679 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -119.68 91.04 3.45 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.712 ' CE2' HG12 ' A' ' 151' ' ' VAL . 3.1 p90 -127.42 160.24 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.862 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.495 HG11 HD13 ' A' ' 82' ' ' LEU . 2.1 p -107.63 130.3 23.01 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.2 Cg_endo -60.67 154.05 57.59 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 124.14 1.6 . . . . 0.0 111.394 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.778 HG13 ' HA2' ' A' ' 152' ' ' GLY . 25.2 m -79.47 1.05 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.6 -0.688 . . . . 0.0 110.789 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.22 -37.46 14.12 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.717 ' O ' HG22 ' A' ' 177' ' ' THR . 35.4 t -72.07 -36.25 69.49 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.119 0.485 . . . . 0.0 110.272 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.928 ' O ' HG22 ' A' ' 178' ' ' THR . 32.3 mtt -47.32 -36.94 10.07 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.69 -0.631 . . . . 0.0 111.08 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -48.02 -36.59 13.13 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.694 -0.629 . . . . 0.0 111.915 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 174' ' ' SER . 9.0 t -48.64 -39.07 22.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.542 -0.724 . . . . 0.0 112.841 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.928 HG22 ' O ' ' A' ' 175' ' ' MET . 6.4 t -56.92 -38.49 72.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.116 -0.99 . . . . 0.0 112.213 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.453 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -57.5 -40.07 77.88 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.596 -1.315 . . . . 0.0 110.362 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -38.4 91.01 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.956 0.884 . . . . 0.0 108.905 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.76 66.1 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.909 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.518 -0.739 . . . . 0.0 109.913 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 89' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -168.73 78.84 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.8 . . . . 0.0 109.375 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.55 -68.77 0.07 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.544 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.5 pt-20 -164.92 -48.78 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.963 . . . . 0.0 110.832 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.852 HG11 ' N ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -164.09 -161.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.929 -1.107 . . . . 0.0 112.738 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -143.08 167.1 22.89 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.462 0.649 . . . . 0.0 110.117 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.858 HG12 HD22 ' A' ' 44' ' ' LEU . 27.2 m -114.98 147.03 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.657 HG11 HD21 ' A' ' 64' ' ' LEU . 28.0 m -98.48 -179.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 m -134.69 138.88 44.8 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.968 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 p -132.99 -175.99 3.97 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.1 102.99 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.357 -0.84 . . . . 0.0 110.551 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.5 p 47.47 43.76 16.04 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.202 0.525 . . . . 0.0 111.554 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.47 153.13 21.01 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.709 -0.619 . . . . 0.0 111.128 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 p -139.85 139.48 36.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.504 -0.748 . . . . 0.0 109.25 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' A' ' 36' ' ' VAL . 37.2 m-85 -105.02 -179.26 3.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.164 -0.96 . . . . 0.0 111.802 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.858 HD22 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -120.34 140.64 50.98 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.605 -0.684 . . . . 0.0 110.445 -179.206 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.743 ' C ' HG11 ' A' ' 33' ' ' VAL . . . -119.45 -177.56 3.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.41 -0.806 . . . . 0.0 109.747 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.906 HG21 ' CG2' ' A' ' 153' ' ' ILE . 3.4 t -157.85 113.91 2.82 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.185 -0.947 . . . . 0.0 111.513 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.3 p -70.62 105.73 3.24 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.947 -1.095 . . . . 0.0 111.434 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.722 HG11 ' CG1' ' A' ' 172' ' ' VAL . 17.6 t -124.39 127.93 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t30 60.48 17.83 7.66 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.365 -0.834 . . . . 0.0 109.722 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.05 19.79 52.05 Favored Glycine 0 N--CA 1.499 2.894 0 O-C-N 121.109 -0.994 . . . . 0.0 111.088 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 85' ' ' TRP . 47.3 t -136.18 105.84 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.114 -1.227 . . . . 0.0 109.638 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.4 p -59.75 103.37 0.2 Allowed 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.309 -0.87 . . . . 0.0 109.794 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.526 ' CH2' ' HE1' ' A' ' 179' ' ' MET . 95.9 m95 -82.75 150.96 26.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.998 -1.064 . . . . 0.0 111.416 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.786 HG21 ' CZ2' ' A' ' 85' ' ' TRP . 7.7 t -158.61 155.23 27.87 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.617 HG11 ' ND1' ' A' ' 57' ' ' HIS . 20.7 t -80.83 144.57 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.232 -0.917 . . . . 0.0 109.676 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 28.8 t80 -78.08 4.75 11.58 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.049 -1.032 . . . . 0.0 112.134 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.617 ' ND1' HG11 ' A' ' 55' ' ' VAL . 16.2 m170 -45.51 -39.63 7.59 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.292 -0.88 . . . . 0.0 111.54 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.415 ' O ' ' CE1' ' A' ' 43' ' ' PHE . . . -167.68 28.18 0.16 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.57 -166.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.262 -1.14 . . . . 0.0 109.632 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.45 ' O ' HD12 ' A' ' 64' ' ' LEU . . . -75.22 90.77 0.81 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.6 p -71.2 -10.09 59.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.497 -1.002 . . . . 0.0 110.082 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -118.79 -153.39 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 110.506 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 63' ' ' THR . 8.5 t -59.69 90.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.477 -0.764 . . . . 0.0 110.937 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.657 HD21 HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.21 173.15 0.9 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.322 -0.861 . . . . 0.0 109.392 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.743 ' O ' HD11 ' A' ' 71' ' ' ILE . . . -112.43 132.21 55.16 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.206 -0.934 . . . . 0.0 110.314 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.88 -178.82 24.26 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -57.9 -20.38 44.09 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.78 1.41 . . . . 0.0 110.507 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 24.71 12.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.534 -0.729 . . . . 0.0 109.809 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.6 -106.51 2.43 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -76.35 120.39 5.62 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.753 1.396 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.743 HD11 ' O ' ' A' ' 65' ' ' ALA . 75.5 mt -75.19 146.15 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 m -90.64 92.95 9.06 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.442 -0.786 . . . . 0.0 111.06 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -61.63 107.92 0.89 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.675 -0.641 . . . . 0.0 109.406 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 mmt -113.9 -26.81 7.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.576 -0.702 . . . . 0.0 111.042 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.526 ' O ' HG13 ' A' ' 83' ' ' VAL . 7.5 m-85 -122.57 118.31 27.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.417 -0.802 . . . . 0.0 109.738 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.657 HG23 ' CG2' ' A' ' 83' ' ' VAL . 5.4 m -155.29 122.99 5.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.635 -0.666 . . . . 0.0 110.779 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -142.11 76.65 1.55 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.28 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.437 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.4 p -49.5 -32.62 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.595 -0.691 . . . . 0.0 109.69 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.59 -47.72 73.01 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.7 -0.625 . . . . 0.0 109.671 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -93.06 17.27 11.11 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.981 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 52.29 52.47 14.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.214 -0.929 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.558 HD21 ' HE2' ' A' ' 175' ' ' MET . 1.5 mt -161.44 151.69 17.42 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.031 0.919 . . . . 0.0 112.343 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.657 ' CG2' HG23 ' A' ' 76' ' ' THR . 58.1 t -156.76 146.03 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 53' ' ' TRP . . . -142.45 115.28 0.94 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.008 -1.568 . . . . 0.0 112.18 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.786 ' CZ2' HG21 ' A' ' 54' ' ' THR . 1.5 m0 -97.98 167.2 11.05 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -81.22 134.71 35.66 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.387 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -104.05 91.17 3.5 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.214 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 53.5 Cg_endo -101.9 -10.24 0.2 Allowed 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.595 1.313 . . . . 0.0 112.726 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 46.5 Cg_endo -72.84 67.52 3.92 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 115.735 -2.377 . . . . 0.0 110.678 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 53.79 23.24 21.24 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.61 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -73.4 135.79 44.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -1.005 . . . . 0.0 110.736 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -61.35 -168.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.771 -0.581 . . . . 0.0 109.68 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 t -147.0 103.97 3.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.54 -0.725 . . . . 0.0 109.386 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.442 HD13 ' HB2' ' A' ' 150' ' ' ALA . 2.3 mt -79.66 -160.77 0.28 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.618 -0.676 . . . . 0.0 109.907 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.2 t -161.01 153.46 17.16 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.754 -0.591 . . . . 0.0 109.452 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.79 143.43 73.71 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 O-C-N 123.517 1.272 . . . . 0.0 111.727 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 25.0 t -64.94 159.45 22.86 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.432 0.634 . . . . 0.0 110.416 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 t -159.19 33.95 0.2 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.448 0.642 . . . . 0.0 109.339 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.2 p -117.85 -167.73 1.39 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.664 -0.648 . . . . 0.0 110.336 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -124.49 29.88 4.87 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.405 ' HB3' ' CG ' ' A' ' 146' ' ' PRO . 75.3 m -91.94 171.87 8.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.587 -0.949 . . . . 0.0 109.998 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 118' ' ' ARG . 40.8 m -127.4 -35.2 2.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.51 -0.743 . . . . 0.0 111.634 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.85 119.07 9.3 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.347 -0.846 . . . . 0.0 110.593 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.749 HD13 HD23 ' A' ' 143' ' ' LEU . 1.5 mt -115.37 -174.46 2.51 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.211 -0.931 . . . . 0.0 110.42 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.676 ' HB3' HG13 ' A' ' 113' ' ' VAL . 85.3 m-85 -139.85 87.25 2.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.724 HD23 HD11 ' A' ' 114' ' ' ILE . 36.0 tp -64.62 99.39 0.31 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.945 HG22 HG22 ' A' ' 113' ' ' VAL . 61.6 t -90.47 114.48 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.833 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.3 p -71.86 -179.82 2.86 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.775 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -93.33 16.28 13.69 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.072 -1.017 . . . . 0.0 110.67 179.367 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -124.78 41.4 3.52 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.216 -0.927 . . . . 0.0 109.754 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.62 68.15 0.9 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.486 -0.758 . . . . 0.0 111.499 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -155.1 109.17 2.9 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.654 -0.654 . . . . 0.0 110.589 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.945 HG22 HG22 ' A' ' 107' ' ' VAL . 24.4 t -106.14 137.52 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.772 -0.58 . . . . 0.0 109.69 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.724 HD11 HD23 ' A' ' 106' ' ' LEU . 29.3 pt -131.74 131.15 22.56 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 109.126 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.499 ' HB2' HD12 ' A' ' 127' ' ' LEU . 48.8 Cg_endo -66.07 140.51 60.1 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.835 1.439 . . . . 0.0 111.779 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 167' ' ' VAL . 25.0 t -136.03 144.59 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.12 119.43 38.73 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.439 ' HB2' ' HA ' ' A' ' 102' ' ' SER . 23.3 ttt180 -49.73 126.96 14.95 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.263 -0.898 . . . . 0.0 110.032 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.96 -33.14 7.0 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.013 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -169.08 58.52 0.2 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.415 -1.374 . . . . 0.0 110.414 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.1 OUTLIER 64.35 -72.82 0.06 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.728 -0.866 . . . . 0.0 110.056 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 120' ' ' GLY . 3.8 p -92.44 40.02 1.04 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 121.162 0.506 . . . . 0.0 110.39 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.435 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 13.8 ttm180 -168.33 154.79 7.34 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.42 -0.8 . . . . 0.0 110.252 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.49 -178.62 23.76 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -128.55 118.33 22.82 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 122.048 -0.678 . . . . 0.0 111.819 -178.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 145.31 52.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.695 -0.628 . . . . 0.0 109.794 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.499 HD12 ' HB2' ' A' ' 115' ' ' PRO . 17.2 mt -115.38 55.23 0.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 170.32 125.33 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -63.67 103.49 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.757 1.399 . . . . 0.0 109.843 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.91 149.59 42.71 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.407 -0.808 . . . . 0.0 109.207 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.406 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 50.4 Cg_endo -68.07 127.33 15.79 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.819 1.431 . . . . 0.0 110.604 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.2 p -62.01 -37.08 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.829 -0.544 . . . . 0.0 110.166 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.33 -35.73 19.23 Favored 'General case' 0 N--CA 1.506 2.36 0 CA-C-O 122.082 0.944 . . . . 0.0 110.535 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 21.2 t80 -67.66 -38.93 84.47 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.479 HD11 ' CB ' ' A' ' 164' ' ' ALA . 14.3 mt -64.02 -35.79 81.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -57.9 131.31 50.01 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.71 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.8 -25.74 26.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.9 m -90.0 4.17 50.96 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -1.081 . . . . 0.0 111.486 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 13.5 p -56.87 121.91 10.99 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.967 -1.083 . . . . 0.0 111.025 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.83 -15.15 9.02 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.27 139.22 48.31 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.714 -1.755 . . . . 0.0 108.714 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.87 123.14 6.65 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.921 1.485 . . . . 0.0 113.691 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.749 HD23 HD13 ' A' ' 104' ' ' LEU . 1.7 mp -79.03 116.91 19.62 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.35 117.75 33.34 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.82 -1.152 . . . . 0.0 113.081 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.435 ' HB3' HG21 ' A' ' 151' ' ' VAL . 27.0 p -56.99 173.69 0.31 Allowed Pre-proline 0 N--CA 1.5 2.064 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.809 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 44.9 Cg_endo -76.66 72.44 5.64 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.714 1.376 . . . . 0.0 109.907 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.37 -46.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.62 -0.675 . . . . 0.0 110.26 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 135.36 -28.27 3.03 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.99 129.61 37.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.523 -0.986 . . . . 0.0 110.194 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.516 ' HB1' HG21 ' A' ' 172' ' ' VAL . . . -59.07 138.75 57.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.669 -0.644 . . . . 0.0 110.112 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.684 HG12 ' CE2' ' A' ' 169' ' ' PHE . 0.9 OUTLIER -99.61 -33.1 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.839 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 176.92 -178.44 48.13 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.906 ' CG2' HG21 ' A' ' 46' ' ' THR . 1.1 pt -120.19 139.93 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.354 -1.086 . . . . 0.0 111.016 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.759 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.3 t80 -53.34 118.58 3.93 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.92 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -107.59 -41.06 5.14 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.439 -0.788 . . . . 0.0 109.6 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -154.08 167.59 29.3 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.759 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -124.95 116.46 22.22 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.659 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.802 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.9 t -67.56 100.75 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.636 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.5 p -125.25 154.91 40.93 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.648 1.213 . . . . 0.0 114.119 -175.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.519 HG22 ' H ' ' A' ' 161' ' ' ARG . 2.0 m -92.2 -172.3 3.08 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.519 ' H ' HG22 ' A' ' 160' ' ' THR . 1.6 ttt180 -45.94 88.91 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.402 -0.811 . . . . 0.0 111.727 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.654 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 72.63 -15.08 2.28 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.101 -1.0 . . . . 0.0 112.509 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.7 t -101.14 135.85 35.55 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.351 0 CA-C-N 118.948 1.374 . . . . 0.0 109.286 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.479 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -97.59 124.78 41.99 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.747 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -108.2 -41.28 4.94 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.607 -0.683 . . . . 0.0 110.545 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.802 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -126.48 166.78 16.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 109.358 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.436 HG21 HG11 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -112.42 162.01 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.839 0.828 . . . . 0.0 111.28 -178.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.758 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -130.65 99.28 4.91 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.684 ' CE2' HG12 ' A' ' 151' ' ' VAL . 5.1 p90 -135.9 159.63 41.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.007 -1.058 . . . . 0.0 111.567 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 82' ' ' LEU . 1.2 m -103.75 144.68 29.16 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 37.1 Cg_endo -61.9 155.17 56.52 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.092 1.575 . . . . 0.0 111.917 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.839 HG23 ' HA2' ' A' ' 152' ' ' GLY . 4.3 t -82.75 -2.11 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.504 -0.747 . . . . 0.0 109.709 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -81.96 -38.43 25.19 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.6 t -57.64 -36.79 72.32 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.806 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.599 ' HE1' HG23 ' A' ' 153' ' ' ILE . 8.4 mtt -49.93 -39.2 39.46 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.563 -0.71 . . . . 0.0 109.348 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.47 ' O ' ' HB3' ' A' ' 179' ' ' MET . 2.0 mt-10 -66.18 -38.11 87.27 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.8 m -64.98 -38.75 91.99 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -37.08 81.36 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.526 ' HE1' ' CH2' ' A' ' 53' ' ' TRP . 34.5 tpp -61.79 -53.44 55.87 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.723 -0.611 . . . . 0.0 110.329 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.12 -38.77 62.92 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.366 -0.834 . . . . 0.0 110.915 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -55.94 -38.11 69.87 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.431 -0.793 . . . . 0.0 110.926 -179.754 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 89' ' ' PRO . 28.7 m . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 120.992 0.425 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.92 78.41 0.29 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.248 -0.907 . . . . 0.0 109.384 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.59 14.29 0.05 OUTLIER Glycine 0 N--CA 1.498 2.805 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.427 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.453 ' C ' HG23 ' A' ' 33' ' ' VAL . 21.5 mt-10 55.98 6.73 0.24 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.858 -1.378 . . . . 0.0 113.433 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.453 HG23 ' C ' ' A' ' 32' ' ' GLU . 60.4 t -152.23 151.98 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 120.455 -1.403 . . . . 0.0 110.151 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 2.9 tt0 -150.44 143.26 24.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.734 -0.604 . . . . 0.0 110.05 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.737 HG12 HD22 ' A' ' 44' ' ' LEU . 27.2 m -110.15 174.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.482 0.658 . . . . 0.0 110.712 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.562 HG11 ' CH2' ' A' ' 85' ' ' TRP . 31.9 m -131.76 -178.18 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -147.84 136.05 21.37 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.0 p -143.78 -179.11 6.26 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.67 76.11 0.6 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.911 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m 177.31 -61.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -179.39 -159.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.612 -0.68 . . . . 0.0 109.262 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 13.3 t -117.58 139.72 50.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.503 -0.748 . . . . 0.0 109.928 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 59' ' ' ALA . 98.7 m-85 -102.18 -178.54 3.73 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.569 -0.707 . . . . 0.0 111.617 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.836 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -111.69 151.7 28.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.608 -0.683 . . . . 0.0 111.351 -178.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.529 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -159.55 145.01 15.74 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.654 -0.654 . . . . 0.0 109.351 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.512 HG23 HG23 ' A' ' 48' ' ' VAL . 13.2 t -117.86 127.38 53.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.162 -0.961 . . . . 0.0 112.036 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 87.4 m -78.77 82.78 4.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.531 -0.73 . . . . 0.0 110.467 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.828 HG11 HG11 ' A' ' 172' ' ' VAL . 57.8 t -98.59 139.2 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 56.12 20.41 4.41 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.343 -0.848 . . . . 0.0 110.027 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.6 24.49 53.43 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.9 t -138.81 103.97 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -1.212 . . . . 0.0 110.612 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.7 t -58.2 96.61 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.538 -0.726 . . . . 0.0 110.022 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.937 ' CE3' HD23 ' A' ' 82' ' ' LEU . 79.5 m95 -76.07 145.34 40.17 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.325 -0.859 . . . . 0.0 110.331 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.539 HG23 HG23 ' A' ' 83' ' ' VAL . 2.7 t -163.08 176.43 10.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.574 -0.704 . . . . 0.0 109.787 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.464 HG11 ' HG2' ' A' ' 155' ' ' ARG . 13.6 m -104.42 138.19 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.563 -0.711 . . . . 0.0 109.986 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.606 ' HB2' HG11 ' A' ' 83' ' ' VAL . 1.6 t80 -73.79 -12.07 60.58 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.007 -1.058 . . . . 0.0 111.357 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.431 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 4.7 p-80 -83.63 -0.95 52.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.151 -0.968 . . . . 0.0 110.229 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.53 74.84 0.21 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.408 ' HA ' ' CD2' ' A' ' 43' ' ' PHE . . . -164.35 -72.1 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.466 -1.02 . . . . 0.0 110.123 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.85 -161.96 32.25 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.4 p -167.15 -163.52 0.54 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.725 -0.867 . . . . 0.0 109.702 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt 51.5 -164.2 0.06 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.421 -0.8 . . . . 0.0 110.72 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -56.7 90.35 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.512 -0.742 . . . . 0.0 110.615 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.879 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -63.9 162.26 14.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.705 -0.622 . . . . 0.0 110.295 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.23 142.74 48.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.632 -0.667 . . . . 0.0 110.313 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -124.83 -179.4 15.7 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.84 -6.91 20.19 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.972 1.512 . . . . 0.0 111.493 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.66 29.57 1.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.045 . . . . 0.0 110.382 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.61 176.51 14.44 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.25 155.79 68.15 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.852 1.449 . . . . 0.0 109.9 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.879 HD12 ' CD2' ' A' ' 64' ' ' LEU . 77.8 mt -100.79 119.54 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.558 -0.714 . . . . 0.0 109.786 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -61.4 135.14 57.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.609 -0.682 . . . . 0.0 110.703 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -94.51 115.11 27.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 109.415 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.3 mmm -124.81 -34.88 2.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.525 -0.735 . . . . 0.0 110.866 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.468 ' CD2' ' CE ' ' A' ' 179' ' ' MET . 15.5 m-85 -118.35 108.45 15.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.389 -0.819 . . . . 0.0 109.661 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.606 ' CG2' HG12 ' A' ' 83' ' ' VAL . 1.6 m -149.1 114.46 5.54 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.544 -0.862 . . . . 0.0 112.407 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -148.03 75.66 1.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.872 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.485 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 8.2 p -54.97 -22.48 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.465 -0.772 . . . . 0.0 111.098 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -60.67 83.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.732 -0.605 . . . . 0.0 110.962 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 49.45 26.39 1.65 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.515 -0.741 . . . . 0.0 111.461 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -126.12 -95.32 0.45 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.937 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.937 HD23 ' CE3' ' A' ' 53' ' ' TRP . 8.4 tp 177.72 164.21 0.62 Allowed 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.548 -1.345 . . . . 0.0 110.824 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' A' ' 56' ' ' TYR . 16.4 m -135.02 122.99 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.12 133.93 4.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.562 ' CH2' HG11 ' A' ' 36' ' ' VAL . 1.3 m-90 -100.55 168.91 9.42 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -80.23 136.52 36.48 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.586 -0.845 . . . . 0.0 109.844 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.494 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -108.94 92.94 11.52 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.874 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.568 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.5 Cg_endo -102.35 -11.69 0.16 Allowed 'Trans proline' 0 CA--C 1.551 1.354 0 O-C-N 123.911 1.48 . . . . 0.0 112.847 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 51.2 Cg_endo -71.2 75.8 1.79 Allowed 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 116.058 -2.162 . . . . 0.0 111.104 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.83 25.13 21.95 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.494 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -74.71 139.44 43.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.942 . . . . 0.0 110.574 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.3 tpt85 -75.34 140.3 42.97 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.7 p -104.66 103.15 12.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.348 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -158.37 0.25 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.446 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -151.55 -169.44 0.22 Allowed Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.567 -0.708 . . . . 0.0 109.878 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -93.81 159.48 2.28 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 O-C-N 123.69 1.363 . . . . 0.0 111.521 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 0.5 OUTLIER -108.65 133.51 52.66 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.667 -0.646 . . . . 0.0 109.94 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 m -139.56 91.33 2.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.612 -0.68 . . . . 0.0 109.953 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 29.7 m -132.95 -162.28 1.22 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.47 -0.769 . . . . 0.0 109.927 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.73 31.42 2.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.88 -151.1 0.47 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.685 -0.891 . . . . 0.0 110.168 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.8 p -149.78 -147.97 0.25 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 0.0 109.881 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 7.6 t0 58.06 105.24 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.126 -0.984 . . . . 0.0 110.794 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.664 HD13 HD23 ' A' ' 143' ' ' LEU . 0.8 OUTLIER -123.18 -168.45 1.77 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.167 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.736 ' HB3' HG13 ' A' ' 113' ' ' VAL . 79.7 m-85 -142.3 93.04 2.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.492 -0.755 . . . . 0.0 110.728 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.458 HD12 ' HG ' ' A' ' 143' ' ' LEU . 7.0 tp -60.09 92.59 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 105' ' ' TYR . 89.7 t -84.5 101.95 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.331 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.422 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 21.8 p -67.4 155.86 37.95 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.836 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -78.18 3.9 13.99 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.028 -1.045 . . . . 0.0 111.126 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.447 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -101.91 31.52 3.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.972 -1.08 . . . . 0.0 109.055 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 61.42 74.55 0.44 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.519 -0.738 . . . . 0.0 110.67 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.61 119.47 0.88 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.606 -0.684 . . . . 0.0 110.528 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 105' ' ' TYR . 71.5 t -98.13 143.34 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.537 -0.727 . . . . 0.0 109.768 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.439 ' HB ' ' HB3' ' A' ' 106' ' ' LEU . 14.4 mt -130.68 109.89 15.93 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -58.05 134.16 60.31 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 O-C-N 123.655 1.345 . . . . 0.0 111.929 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 103' ' ' ASP . 35.1 t -127.78 142.98 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.644 -0.66 . . . . 0.0 109.525 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.58 121.29 43.21 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -48.68 130.41 17.41 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.38 -0.825 . . . . 0.0 110.917 -178.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -102.95 -49.43 3.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.804 -0.56 . . . . 0.0 110.654 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.84 60.23 0.11 Allowed Glycine 0 N--CA 1.498 2.796 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.757 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.37 145.35 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.787 -0.831 . . . . 0.0 109.222 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.427 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 17.5 p 44.63 27.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.737 -0.602 . . . . 0.0 112.122 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.47 ' N ' ' CD2' ' A' ' 169' ' ' PHE . 0.4 OUTLIER -170.37 144.26 2.47 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.125 -0.984 . . . . 0.0 110.219 178.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.26 -177.79 16.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -123.21 123.14 40.12 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 122.045 -0.679 . . . . 0.0 111.743 -178.265 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.09 130.7 45.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.565 -0.709 . . . . 0.0 109.492 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.5 mt -101.06 53.62 0.84 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.86 118.45 0.14 Allowed Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.333 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -60.31 106.86 0.37 Allowed 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.61 1.321 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.6 mtt-85 -125.75 146.41 54.99 Favored Pre-proline 0 N--CA 1.49 1.54 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.089 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.411 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 47.8 Cg_endo -64.24 129.31 23.8 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 124.098 1.578 . . . . 0.0 110.604 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 162' ' ' GLY . 6.1 p -56.96 -36.01 49.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.848 -0.532 . . . . 0.0 110.163 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -49.14 -36.85 20.27 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.232 -0.918 . . . . 0.0 110.603 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 7.4 t80 -64.43 -38.9 92.65 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.469 HD11 ' CB ' ' A' ' 164' ' ' ALA . 8.7 mt -67.4 -35.92 80.26 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -56.39 111.87 1.1 Allowed 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.939 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.27 -34.37 4.73 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.7 m -79.86 -2.72 44.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.676 -0.896 . . . . 0.0 110.808 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.1 m -57.37 126.6 28.02 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.181 -0.95 . . . . 0.0 110.447 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.12 -9.22 31.37 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.723 ' HA2' HD12 ' A' ' 44' ' ' LEU . . . -56.88 -175.98 0.31 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -114.57 124.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.489 1.258 . . . . 0.0 112.527 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.664 HD23 HD13 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -83.34 126.35 32.61 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 176.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.16 121.06 31.74 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.709 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 14.7 p -69.29 -173.27 0.2 Allowed Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.44 ' CD ' ' HB2' ' A' ' 145' ' ' CYS . 49.9 Cg_endo -71.65 66.92 3.01 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.562 1.296 . . . . 0.0 110.422 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.86 -165.7 0.38 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.551 -0.718 . . . . 0.0 110.123 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -110.24 48.57 0.92 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -136.41 128.69 30.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.606 -0.937 . . . . 0.0 109.927 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.555 ' CB ' HG21 ' A' ' 172' ' ' VAL . . . -66.34 121.83 16.15 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.496 -0.752 . . . . 0.0 109.918 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.537 HG11 HD22 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -78.24 -44.5 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.696 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . -179.6 -178.31 48.34 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.627 HG12 ' HE2' ' A' ' 175' ' ' MET . 1.0 OUTLIER -111.73 154.79 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-N 118.838 1.319 . . . . 0.0 111.988 179.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.85 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 7.6 t80 -69.17 83.3 0.35 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.8 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.464 ' HG2' HG11 ' A' ' 55' ' ' VAL . 2.6 ttt180 -64.06 -49.91 70.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.618 -0.676 . . . . 0.0 109.595 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.612 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -155.78 -179.19 7.88 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.85 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -134.04 121.82 22.1 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.874 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.7 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.5 t -70.69 104.49 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 177.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.63 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.3 p -129.43 142.58 50.76 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -175.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.662 HG22 HG12 ' A' ' 163' ' ' VAL . 5.9 t -76.26 -174.58 2.85 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.54 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.325 -0.859 . . . . 0.0 112.937 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.779 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 85.99 -27.32 5.54 Favored Glycine 0 N--CA 1.498 2.771 0 O-C-N 121.204 -0.935 . . . . 0.0 112.316 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.662 HG12 HG22 ' A' ' 160' ' ' THR . 1.0 OUTLIER -96.55 136.91 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 119.108 1.454 . . . . 0.0 109.82 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.469 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -103.57 125.65 50.23 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.604 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -111.62 -34.37 6.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.654 -0.653 . . . . 0.0 111.224 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.7 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -124.8 176.77 6.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.077 -1.014 . . . . 0.0 110.946 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.52 140.92 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 111.596 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 3.2 t0 -106.48 100.24 9.77 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.47 ' CD2' ' N ' ' A' ' 123' ' ' ARG . 0.5 OUTLIER -129.8 157.87 41.02 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.071 -1.052 . . . . 0.0 113.748 -176.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.407 ' CG1' HG13 ' A' ' 153' ' ' ILE . 2.9 p -111.87 128.09 25.93 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 45.0 Cg_endo -57.68 156.37 27.72 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 O-C-N 123.775 1.408 . . . . 0.0 111.752 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.828 HG11 HG11 ' A' ' 48' ' ' VAL . 97.9 t -79.37 -1.66 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.611 -0.681 . . . . 0.0 110.08 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -86.08 -37.66 18.61 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.1 m -72.08 -38.61 69.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.861 -0.525 . . . . 0.0 110.021 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.627 ' HE2' HG12 ' A' ' 153' ' ' ILE . 14.8 mtt -50.93 -38.79 52.37 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.542 -0.724 . . . . 0.0 109.711 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -62.87 -39.99 96.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 35.1 m -57.86 -38.51 75.84 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.606 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 0.3 OUTLIER -51.31 -35.01 35.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.844 -0.535 . . . . 0.0 109.739 178.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.579 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 9.5 mmt -48.04 -53.63 15.69 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.46 -0.775 . . . . 0.0 110.847 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.02 -37.45 45.32 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.989 0.899 . . . . 0.0 109.846 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 178' ' ' THR . . . -63.73 -39.77 95.11 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.013 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.407 ' CB ' ' HA ' ' A' ' 75' ' ' TYR . 10.8 m . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.47 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -154.6 76.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.636 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 44.58 66.56 1.37 Allowed Glycine 0 N--CA 1.5 2.911 0 O-C-N 121.933 -0.48 . . . . 0.0 111.911 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.494 ' C ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -164.08 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.418 -1.048 . . . . 0.0 111.432 179.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.494 HG23 ' C ' ' A' ' 32' ' ' GLU . 70.1 t -150.91 153.83 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.227 -0.92 . . . . 0.0 111.724 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.419 ' OE1' ' HG3' ' A' ' 89' ' ' PRO . 12.5 tt0 -144.84 136.37 25.41 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.45 HG11 ' HG3' ' A' ' 109' ' ' ARG . 33.7 m -98.81 168.68 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.82 0.819 . . . . 0.0 111.632 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.545 HG11 ' CH2' ' A' ' 85' ' ' TRP . 28.2 m -125.91 -179.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -145.43 135.99 24.27 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.251 -0.905 . . . . 0.0 110.95 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.5 p -142.74 177.79 8.08 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.42 75.87 0.55 Allowed 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.254 -0.979 . . . . 0.0 108.684 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 173.69 -57.16 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.57 -170.13 0.1 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.42 -0.8 . . . . 0.0 109.65 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 86.0 p -111.22 140.75 45.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.706 -0.621 . . . . 0.0 110.431 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 27.4 m-85 -102.08 175.51 5.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.467 -0.771 . . . . 0.0 109.944 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.695 ' C ' HD23 ' A' ' 44' ' ' LEU . 5.5 tt -109.96 143.92 39.21 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.644 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -147.21 131.53 17.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.927 -1.108 . . . . 0.0 110.311 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 46' ' ' THR . 8.4 t -100.02 127.81 46.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.254 -0.904 . . . . 0.0 112.462 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.419 ' HG ' ' HG ' ' A' ' 52' ' ' CYS . 85.8 m -82.89 95.07 7.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.375 -0.828 . . . . 0.0 110.747 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.889 HG11 ' CG1' ' A' ' 172' ' ' VAL . 93.5 t -103.86 133.09 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t30 62.22 11.4 4.41 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.422 -0.799 . . . . 0.0 110.681 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.62 30.61 8.91 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.023 -1.048 . . . . 0.0 111.167 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.4 t -147.2 105.81 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -1.187 . . . . 0.0 109.257 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.419 ' HG ' ' HG ' ' A' ' 47' ' ' CYS . 0.7 OUTLIER -56.17 109.56 0.61 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.498 -0.751 . . . . 0.0 109.485 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 1.004 ' CE3' HD23 ' A' ' 82' ' ' LEU . 92.7 m95 -91.23 141.8 28.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.671 -0.643 . . . . 0.0 110.435 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.461 HG21 ' CH2' ' A' ' 85' ' ' TRP . 5.2 t -161.27 -179.78 7.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.457 -0.777 . . . . 0.0 110.319 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.524 HG11 ' HA ' ' A' ' 155' ' ' ARG . 11.6 m -102.18 145.12 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.596 -0.69 . . . . 0.0 110.497 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.656 ' HB2' HG11 ' A' ' 83' ' ' VAL . 42.9 t80 -78.02 1.72 20.01 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.113 -0.992 . . . . 0.0 112.301 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -49.78 -24.85 2.59 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 121.163 -0.961 . . . . 0.0 110.684 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.448 ' O ' ' CE1' ' A' ' 43' ' ' PHE . . . -177.89 39.83 0.09 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.41 25.96 4.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.331 -1.099 . . . . 0.0 111.009 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.56 -164.39 41.47 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.1 t -136.84 -80.38 0.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.762 -0.846 . . . . 0.0 110.074 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -118.47 -33.46 4.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.198 -0.939 . . . . 0.0 111.305 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -93.31 89.57 6.43 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.116 0.484 . . . . 0.0 111.721 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.534 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -101.28 172.8 6.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.51 -0.744 . . . . 0.0 109.751 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.6 130.97 57.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.681 -0.637 . . . . 0.0 110.136 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.59 179.24 16.73 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -55.17 103.82 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 O-C-N 123.652 1.343 . . . . 0.0 110.628 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.1 tttp 54.37 30.05 11.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.505 -0.747 . . . . 0.0 111.22 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.43 134.87 2.1 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -58.85 169.8 3.16 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 O-C-N 123.729 1.383 . . . . 0.0 110.82 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.534 HD12 ' CD2' ' A' ' 64' ' ' LEU . 63.2 mt -106.93 134.5 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.395 -0.816 . . . . 0.0 108.976 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.5 p -74.69 -174.61 2.18 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.278 -0.889 . . . . 0.0 111.032 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -123.15 166.43 15.21 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.606 -0.684 . . . . 0.0 109.973 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.435 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 6.4 tpt -169.54 -37.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.156 -0.965 . . . . 0.0 111.453 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 74' ' ' MET . 14.4 m-85 -131.84 111.53 11.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.472 -0.768 . . . . 0.0 109.103 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.613 ' CG2' HG12 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -152.49 114.2 4.34 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.035 -1.066 . . . . 0.0 113.013 -178.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -160.54 76.52 0.59 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.729 -0.607 . . . . 0.0 110.45 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.61 HG11 ' HB3' ' A' ' 56' ' ' TYR . 7.3 p -74.74 -17.3 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.1 -1.0 . . . . 0.0 111.128 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.73 -25.17 17.45 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.129 -0.982 . . . . 0.0 110.244 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -176.11 34.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.748 -0.595 . . . . 0.0 110.144 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -156.03 -89.44 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.997 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.004 HD23 ' CE3' ' A' ' 53' ' ' TRP . 6.8 tp 179.14 177.29 0.53 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.718 -1.239 . . . . 0.0 110.125 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.656 HG11 ' HB2' ' A' ' 56' ' ' TYR . 21.6 m -146.58 121.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -154.09 144.08 10.82 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.545 ' CH2' HG11 ' A' ' 36' ' ' VAL . 1.1 m-90 -108.2 167.83 9.73 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -69.5 137.52 52.62 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.879 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.55 97.0 15.26 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.721 -0.612 . . . . 0.0 111.144 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.7 Cg_endo -111.21 10.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 117.178 -1.415 . . . . 0.0 113.061 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 55.7 Cg_endo -67.58 -108.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 116.587 -1.809 . . . . 0.0 107.75 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.79 32.47 7.39 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 106.559 -2.616 . . . . 0.0 106.559 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.62 152.69 45.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.383 -1.069 . . . . 0.0 111.058 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -125.14 17.16 8.43 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.784 -0.572 . . . . 0.0 110.735 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.8 t 49.98 97.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.288 -0.883 . . . . 0.0 112.536 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.421 HD23 ' HB2' ' A' ' 150' ' ' ALA . 0.3 OUTLIER -74.19 -143.16 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.555 -0.715 . . . . 0.0 110.13 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 t -169.61 153.3 5.04 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 120.897 -1.127 . . . . 0.0 110.657 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.45 160.37 46.95 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.741 1.39 . . . . 0.0 111.173 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.9 t -95.6 112.12 23.9 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.1 p -75.1 -44.05 49.53 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.4 p -65.48 149.42 50.07 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.325 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -111.2 40.43 2.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.99 146.13 51.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.687 -0.89 . . . . 0.0 109.703 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 m -77.69 -159.17 0.14 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.664 -0.648 . . . . 0.0 110.929 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.7 t70 52.43 95.08 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.652 -0.655 . . . . 0.0 111.171 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.889 HD13 HD23 ' A' ' 143' ' ' LEU . 0.8 OUTLIER -113.6 168.81 9.45 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.371 -0.83 . . . . 0.0 110.025 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 107' ' ' VAL . 70.9 m-85 -117.4 86.43 2.51 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.644 -0.66 . . . . 0.0 109.571 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.444 ' CD1' HD11 ' A' ' 143' ' ' LEU . 9.5 tp -54.45 98.85 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.445 -0.785 . . . . 0.0 109.838 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 105' ' ' TYR . 37.4 t -81.68 109.65 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.239 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.459 ' HB ' ' NE2' ' A' ' 110' ' ' HIS . 18.7 p -74.58 177.52 6.0 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.605 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -95.06 28.1 2.93 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.913 -1.117 . . . . 0.0 110.819 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.463 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 1.4 p80 -150.31 46.17 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.916 0.865 . . . . 0.0 109.537 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 49.08 63.47 2.12 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.425 0.631 . . . . 0.0 111.674 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.46 92.37 2.08 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.416 HG13 ' HB3' ' A' ' 105' ' ' TYR . 59.1 t -81.0 144.04 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.176 -0.952 . . . . 0.0 110.123 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.2 mt -128.97 114.99 18.89 Favored Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -59.35 134.42 58.63 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.781 1.411 . . . . 0.0 111.516 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 60.5 t -125.5 149.33 30.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -114.25 111.7 21.94 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -48.12 121.61 4.44 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.749 0.785 . . . . 0.0 110.276 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.9 -37.51 5.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.963 -0.46 . . . . 0.0 110.406 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.81 -170.07 26.03 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -62.56 140.9 58.65 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.831 -0.806 . . . . 0.0 109.568 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.0 p 44.46 42.55 5.57 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.275 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.441 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 3.9 ttp85 -164.32 153.75 13.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.337 -0.852 . . . . 0.0 111.392 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.88 -179.58 21.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -119.39 130.9 55.54 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 122.072 -0.663 . . . . 0.0 111.116 -178.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.47 HD22 ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -72.75 128.9 36.9 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.355 -0.84 . . . . 0.0 109.383 179.23 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 mt -103.71 54.57 0.74 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.47 ' O ' HD22 ' A' ' 126' ' ' LEU . 2.4 p 174.95 107.09 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -57.56 103.63 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 O-C-N 123.598 1.315 . . . . 0.0 109.168 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -124.63 159.03 59.94 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.986 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 50.1 Cg_endo -72.54 129.58 14.89 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 124.077 1.567 . . . . 0.0 109.255 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.635 HG21 ' SG ' ' A' ' 159' ' ' CYS . 10.1 p -55.7 -35.71 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.387 -0.82 . . . . 0.0 109.879 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.3 t -48.85 -36.67 17.47 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.401 -0.812 . . . . 0.0 110.504 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 19.8 t80 -63.4 -39.24 93.98 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.521 HD11 ' CB ' ' A' ' 164' ' ' ALA . 15.9 mt -66.2 -34.78 78.81 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.58 126.3 24.73 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.858 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.26 -31.8 8.31 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.448 ' O ' HD13 ' A' ' 44' ' ' LEU . 74.1 m -84.04 3.14 35.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.822 -0.811 . . . . 0.0 110.525 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.2 m -49.77 127.04 15.19 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.289 -0.882 . . . . 0.0 109.731 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.607 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 116.22 -17.24 14.75 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 107.031 -2.428 . . . . 0.0 107.031 -176.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.688 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -45.66 110.24 0.43 Allowed Glycine 0 N--CA 1.501 2.987 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.416 ' O ' HD12 ' A' ' 144' ' ' LEU . 46.9 Cg_endo -68.16 126.62 14.64 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.933 1.491 . . . . 0.0 111.9 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.889 HD23 HD13 ' A' ' 104' ' ' LEU . 9.0 mp -80.56 135.43 36.08 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 142' ' ' PRO . 1.2 mt -131.89 111.91 11.99 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.389 -0.924 . . . . 0.0 112.172 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.497 ' HB3' HG21 ' A' ' 151' ' ' VAL . 27.7 p -69.9 163.53 59.78 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.933 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 46.9 Cg_endo -62.72 86.31 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.769 1.405 . . . . 0.0 110.136 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.9 -48.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.637 -0.664 . . . . 0.0 109.47 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.04 23.43 3.27 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -131.44 147.09 52.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.401 -1.058 . . . . 0.0 109.554 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.816 ' HB1' HG21 ' A' ' 172' ' ' VAL . . . -66.43 122.14 16.87 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.497 -0.752 . . . . 0.0 110.723 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 145' ' ' CYS . 2.1 t -84.47 -37.88 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.836 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 178.43 -179.09 48.72 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.606 HD11 HD11 ' A' ' 82' ' ' LEU . 1.5 pt -117.12 156.77 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 CA-C-N 118.923 1.362 . . . . 0.0 111.841 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.892 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 9.9 t80 -75.56 85.78 2.64 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.602 0.715 . . . . 0.0 111.203 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.524 ' HA ' HG11 ' A' ' 55' ' ' VAL . 19.2 ttm180 -70.91 -49.29 47.35 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -147.78 177.65 9.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.892 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -131.67 119.86 21.97 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.967 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.849 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.1 t -66.4 99.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.635 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.7 p -126.08 140.57 52.48 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 161' ' ' ARG . 0.9 OUTLIER -74.34 -174.77 2.1 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.479 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -48.78 82.93 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 86.01 -26.95 5.73 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.033 -1.042 . . . . 0.0 110.91 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -93.83 135.99 26.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 118.981 1.391 . . . . 0.0 108.631 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -97.53 129.78 44.65 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.876 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -113.09 -44.87 3.22 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.452 -0.78 . . . . 0.0 111.174 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.849 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -123.82 -178.95 4.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.451 -0.78 . . . . 0.0 109.766 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -120.32 164.07 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.45 -0.781 . . . . 0.0 110.647 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.676 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 1.2 t0 -128.69 94.8 3.94 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.716 ' CG ' HD22 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -126.53 146.1 50.26 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.718 -174.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.477 HG11 ' CD1' ' A' ' 82' ' ' LEU . 2.7 p -99.81 131.69 24.16 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 42.9 Cg_endo -56.42 154.98 27.23 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 O-C-N 123.756 1.398 . . . . 0.0 111.412 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.889 ' CG1' HG11 ' A' ' 48' ' ' VAL . 42.6 t -84.44 2.78 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.366 -0.833 . . . . 0.0 109.748 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -91.75 -39.06 12.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.592 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.6 t -72.13 -44.33 63.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.809 -0.557 . . . . 0.0 110.75 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.86 ' HB3' HD22 ' A' ' 82' ' ' LEU . 2.8 ptp -53.76 -37.86 63.84 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.233 -0.917 . . . . 0.0 110.536 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -56.39 -37.84 70.69 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.999 0.904 . . . . 0.0 108.961 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.4 m -62.37 -35.01 77.81 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.96 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 175' ' ' MET . 0.7 OUTLIER -47.22 -37.52 10.5 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.41 -0.806 . . . . 0.0 111.455 -178.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.472 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -51.83 -46.12 64.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.234 -0.916 . . . . 0.0 110.323 178.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.45 -38.22 58.76 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.096 0.95 . . . . 0.0 110.018 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.87 65.38 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.087 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.7 t . . . . . 0 N--CA 1.5 2.065 0 O-C-N 121.517 -0.74 . . . . 0.0 111.166 179.492 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.726 HG11 ' O ' ' A' ' 89' ' ' PRO . 24.5 m . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 121.554 0.693 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 174.1 77.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 25.68 53.19 0.06 OUTLIER Glycine 0 N--CA 1.51 3.589 0 C-N-CA 123.548 0.594 . . . . 0.0 113.529 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -164.21 -67.36 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.485 1.143 . . . . 0.0 112.669 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.4 t -138.04 158.77 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 122.25 1.024 . . . . 0.0 112.971 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.648 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 2.8 tm0? -143.93 137.85 28.09 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.435 ' CG1' ' CD ' ' A' ' 109' ' ' ARG . 32.6 m -108.41 -179.78 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 122.152 0.977 . . . . 0.0 112.664 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.463 HG11 ' CZ3' ' A' ' 85' ' ' TRP . 21.3 m -139.29 -179.36 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.2 p -149.91 138.09 20.43 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.541 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.435 HG21 ' O ' ' A' ' 59' ' ' ALA . 46.2 p -139.45 179.16 6.71 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -73.43 72.42 1.34 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.815 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.734 HG22 ' HG2' ' A' ' 41' ' ' GLN . 72.1 m -175.4 -59.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.734 ' HG2' HG22 ' A' ' 40' ' ' THR . 3.7 pt20 179.77 -163.22 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.72 -0.612 . . . . 0.0 109.525 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 p -117.99 143.66 46.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.258 -0.901 . . . . 0.0 110.151 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 42.7 m-85 -99.81 -178.47 3.87 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.268 -0.895 . . . . 0.0 110.855 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 109' ' ' ARG . 5.5 tt -114.32 142.44 46.31 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 34' ' ' GLN . . . -147.45 131.22 16.99 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.804 -1.185 . . . . 0.0 110.805 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.645 HG23 HG23 ' A' ' 48' ' ' VAL . 5.3 t -97.84 123.48 41.82 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.34 -0.85 . . . . 0.0 111.865 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.4 p -78.98 83.63 5.06 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.796 0.808 . . . . 0.0 110.368 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.762 HG11 HG11 ' A' ' 172' ' ' VAL . 86.3 t -102.02 145.65 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 54.56 23.69 4.81 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.76 31.1 56.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 85' ' ' TRP . 38.2 t -147.02 111.38 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.176 -1.191 . . . . 0.0 110.483 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 49.3 m -60.83 115.62 3.82 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.474 -0.766 . . . . 0.0 109.294 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.61 ' CZ3' HD23 ' A' ' 82' ' ' LEU . 76.2 m95 -94.49 140.82 29.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.354 -0.841 . . . . 0.0 111.206 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.924 HG21 ' CH2' ' A' ' 85' ' ' TRP . 4.5 t -161.95 -178.58 6.54 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 12.5 t -104.0 144.82 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.426 -0.796 . . . . 0.0 109.671 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -74.34 -1.0 18.93 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.882 -1.137 . . . . 0.0 112.597 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.46 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 1.5 p-80 -70.08 -8.69 51.48 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.912 -1.118 . . . . 0.0 111.169 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.449 ' HA3' ' CE2' ' A' ' 43' ' ' PHE . . . -137.63 -134.08 3.2 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.435 ' O ' HG21 ' A' ' 38' ' ' THR . . . 54.51 174.6 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.481 -1.011 . . . . 0.0 111.01 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.09 112.4 4.46 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.0 p -56.09 173.28 0.16 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.442 -1.034 . . . . 0.0 110.388 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 tttp 58.17 -161.5 0.24 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.317 -0.864 . . . . 0.0 110.482 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -55.24 97.3 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.506 -0.747 . . . . 0.0 110.954 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.426 HD22 HD12 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -52.99 174.65 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.724 -0.61 . . . . 0.0 110.613 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . . . -120.2 137.29 54.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.49 -0.756 . . . . 0.0 110.613 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.12 179.38 20.47 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.0 -21.82 73.09 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.815 1.429 . . . . 0.0 110.957 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -154.31 36.57 0.43 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.361 -0.837 . . . . 0.0 109.937 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 156.62 150.4 5.65 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 47.3 Cg_endo -65.1 158.43 51.97 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.889 1.468 . . . . 0.0 110.483 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.426 HD12 HD22 ' A' ' 64' ' ' LEU . 69.6 mt -99.94 117.51 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.705 -0.622 . . . . 0.0 109.392 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 72' ' ' THR . 9.7 t -59.95 119.83 8.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.5 -0.75 . . . . 0.0 110.372 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 140.97 54.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.65 -0.656 . . . . 0.0 109.973 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.431 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 6.5 tpt -131.01 -41.16 1.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.641 -0.662 . . . . 0.0 110.395 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.471 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 20.7 m-85 -133.15 126.42 31.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.569 -0.707 . . . . 0.0 110.126 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.445 HG23 ' HB ' ' A' ' 83' ' ' VAL . 1.2 m -151.2 113.92 4.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.717 . . . . 0.0 110.407 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.9 76.92 1.53 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.479 -0.889 . . . . 0.0 111.018 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.42 -26.86 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -42.6 80.28 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -96.18 20.15 10.73 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.34 46.88 24.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.406 -0.809 . . . . 0.0 111.842 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.76 HD13 HG11 ' A' ' 170' ' ' VAL . 1.9 tp -161.87 141.68 10.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.359 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.71 ' CG2' HG23 ' A' ' 54' ' ' THR . 33.4 m -143.58 111.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -105.69 102.53 1.99 Allowed Glycine 0 N--CA 1.486 2.014 0 C-N-CA 119.613 -1.279 . . . . 0.0 111.431 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.924 ' CH2' HG21 ' A' ' 54' ' ' THR . 1.8 m-90 -82.0 167.01 19.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.4 ' O ' ' CD ' ' A' ' 88' ' ' PRO . 8.0 mt-30 -80.58 140.45 35.76 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.441 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -102.75 89.94 2.05 Favored Pre-proline 0 C--N 1.301 -1.539 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.545 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.588 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 46.5 Cg_endo -96.62 -14.83 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.731 1.385 . . . . 0.0 112.618 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.726 ' O ' HG11 ' A' ' 29' ' ' VAL . 46.9 Cg_endo -71.29 87.97 0.74 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 116.216 -2.056 . . . . 0.0 111.281 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 49.07 21.44 2.53 Favored Glycine 0 N--CA 1.5 2.944 0 O-C-N 121.402 -0.812 . . . . 0.0 111.368 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 87' ' ' ALA . . . -63.52 148.3 49.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.304 -1.115 . . . . 0.0 109.734 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -106.48 12.07 30.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.454 -0.779 . . . . 0.0 111.576 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 t 46.7 103.58 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.486 -0.759 . . . . 0.0 112.906 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -86.56 -150.21 0.15 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.267 -0.896 . . . . 0.0 109.855 178.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 94' ' ' LEU . 1.6 p -156.06 177.91 1.88 Allowed Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.206 -0.934 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -90.6 169.77 3.79 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 O-C-N 123.79 1.416 . . . . 0.0 111.014 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.541 ' SG ' HG22 ' A' ' 151' ' ' VAL . 39.3 t -93.06 -73.64 0.55 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.69 -0.631 . . . . 0.0 110.023 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m 56.1 42.82 27.88 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.385 -0.822 . . . . 0.0 109.071 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.0 p -126.42 -163.55 1.24 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.899 -0.5 . . . . 0.0 110.596 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.97 70.13 0.39 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t -128.37 -8.11 5.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.541 -0.976 . . . . 0.0 111.677 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 118' ' ' ARG . 23.6 m 53.78 -162.68 0.11 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.012 -1.055 . . . . 0.0 111.029 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.79 100.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.617 -0.677 . . . . 0.0 110.605 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.866 HD13 HD23 ' A' ' 143' ' ' LEU . 1.7 mt -115.86 153.99 30.52 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.02 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 107' ' ' VAL . 53.9 m-85 -105.17 94.35 5.19 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.523 HD23 HD11 ' A' ' 114' ' ' ILE . 8.8 tp -62.98 93.66 0.06 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.684 HG22 HG22 ' A' ' 113' ' ' VAL . 96.4 t -80.94 112.8 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.892 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.421 HG23 ' HB3' ' A' ' 138' ' ' SER . 8.7 m -78.38 172.89 12.96 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.733 ' N ' HD12 ' A' ' 44' ' ' LEU . 19.1 tpt180 -85.51 -8.85 58.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 111.021 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.493 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -107.55 41.42 1.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 110.046 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.48 71.44 0.52 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.376 -0.827 . . . . 0.0 110.676 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -156.4 98.37 1.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.777 -0.577 . . . . 0.0 110.284 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.684 HG22 HG22 ' A' ' 107' ' ' VAL . 54.6 t -99.71 135.57 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.489 -0.757 . . . . 0.0 110.121 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.523 HD11 HD23 ' A' ' 106' ' ' LEU . 32.4 pt -127.07 140.52 38.06 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.85 142.3 51.68 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 O-C-N 123.687 1.362 . . . . 0.0 112.044 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.26 151.36 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -106.2 105.6 15.71 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 102' ' ' SER . 9.9 ttp180 -48.89 123.02 6.36 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 122.036 0.922 . . . . 0.0 111.81 -177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -115.72 -26.79 7.29 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.72 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.21 161.06 32.7 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -51.49 -26.87 9.07 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.311 -1.111 . . . . 0.0 110.776 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -124.41 38.81 4.11 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.046 0.45 . . . . 0.0 110.364 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.468 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 4.1 ttt180 -166.82 156.82 11.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.343 -0.848 . . . . 0.0 110.528 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.47 -178.43 28.82 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.96 113.68 18.14 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.857 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.494 HD21 HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -57.92 130.99 49.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.535 -0.728 . . . . 0.0 109.463 178.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.6 mt -105.6 54.66 0.7 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.7 t 177.83 114.03 0.16 Allowed Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.095 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -58.27 102.98 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.731 0 O-C-N 123.478 1.251 . . . . 0.0 109.979 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 mtt-85 -119.01 160.73 39.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.233 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 43.3 Cg_endo -73.93 127.66 11.66 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 124.058 1.557 . . . . 0.0 109.956 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.2 p -58.82 -37.5 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.806 -0.559 . . . . 0.0 110.571 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -48.87 -36.46 17.08 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 122.038 0.923 . . . . 0.0 110.783 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.417 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 25.3 t80 -66.13 -38.41 88.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.614 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.0 mt -65.34 -35.96 82.57 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -63.67 -21.4 66.36 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.559 -0.856 . . . . 0.0 110.649 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.04 30.37 10.23 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.421 ' HB3' HG23 ' A' ' 108' ' ' THR . 85.2 p -150.7 21.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.566 -0.961 . . . . 0.0 111.453 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.7 p -56.07 132.91 51.42 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.152 -0.968 . . . . 0.0 109.04 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.551 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 109.9 -19.2 28.22 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.69 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -43.85 100.79 0.02 OUTLIER Glycine 0 N--CA 1.504 3.207 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 153' ' ' ILE . 44.2 Cg_endo -63.76 128.23 21.61 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.996 1.524 . . . . 0.0 112.243 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.866 HD23 HD13 ' A' ' 104' ' ' LEU . 9.8 mp -84.26 119.76 25.43 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.5 130.26 56.82 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.686 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 31.6 p -74.05 168.27 27.78 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.235 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 44.2 Cg_endo -69.63 76.66 1.07 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 O-C-N 123.739 1.389 . . . . 0.0 110.751 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.6 t -173.4 -57.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.326 -0.858 . . . . 0.0 110.345 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.57 -42.75 0.63 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER -59.27 123.5 16.94 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.729 -0.865 . . . . 0.0 110.083 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.34 145.33 55.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.66 . . . . 0.0 110.064 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.652 HG12 ' CE2' ' A' ' 169' ' ' PHE . 2.4 t -94.8 -37.23 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.644 -0.66 . . . . 0.0 109.478 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.677 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 177.13 -178.08 48.24 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 82' ' ' LEU . 1.8 pp -117.06 157.15 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.363 -1.081 . . . . 0.0 110.983 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.709 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 6.1 t80 -68.85 119.26 12.92 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.73 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -107.01 -41.13 5.26 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -161.28 179.98 7.89 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.709 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -141.65 128.29 20.29 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.492 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.946 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.2 t -68.32 99.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.471 ' SG ' HG23 ' A' ' 132' ' ' VAL . 72.8 m -115.9 159.86 20.98 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.461 1.124 . . . . 0.0 113.351 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 162' ' ' GLY . 1.8 m -98.3 -174.83 2.94 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.46 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -47.88 83.8 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.456 -0.778 . . . . 0.0 112.708 -179.138 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.717 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 83.06 -32.31 3.02 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.846 -1.159 . . . . 0.0 111.443 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.97 131.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 119.098 1.449 . . . . 0.0 108.944 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.614 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -91.68 132.71 36.17 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.713 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -113.86 -46.78 3.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.649 -0.657 . . . . 0.0 111.045 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.946 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -117.46 179.08 4.16 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.259 -0.901 . . . . 0.0 110.405 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 t -115.47 162.24 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.464 -0.772 . . . . 0.0 110.599 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.66 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -136.27 84.45 2.08 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.765 ' CD1' HD22 ' A' ' 143' ' ' LEU . 2.6 p90 -119.97 163.19 17.97 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.054 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.76 HG11 HD13 ' A' ' 82' ' ' LEU . 2.6 p -111.14 130.52 22.91 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 40.5 Cg_endo -60.57 159.41 28.06 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 124.063 1.559 . . . . 0.0 111.468 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.762 HG11 HG11 ' A' ' 48' ' ' VAL . 96.3 t -77.36 -3.88 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -84.57 -37.75 20.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 0.0 108.692 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.9 t -70.3 -38.12 74.92 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.76 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.723 ' HE1' HG23 ' A' ' 153' ' ' ILE . 19.4 mtt -49.91 -38.83 37.76 Favored 'General case' 0 N--CA 1.516 2.866 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -52.94 -38.73 62.26 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.497 0.665 . . . . 0.0 109.854 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.2 m -51.82 -38.07 54.29 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.405 0.621 . . . . 0.0 109.767 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.09 -42.37 80.6 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.65 -0.656 . . . . 0.0 110.02 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.471 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -56.19 -49.69 73.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.458 -0.776 . . . . 0.0 110.585 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -37.35 61.72 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.93 0.871 . . . . 0.0 109.804 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -78.54 -39.65 37.26 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.919 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.218 0 O-C-N 121.35 -0.844 . . . . 0.0 110.647 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 7.7 p . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -161.65 78.58 0.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.124 0.964 . . . . 0.0 110.618 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 45.46 -93.66 0.01 OUTLIER Glycine 0 N--CA 1.496 2.685 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.363 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -90.42 -29.8 17.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.73 -0.865 . . . . 0.0 112.729 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 34' ' ' GLN . 47.3 t -125.97 162.38 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 120.942 -1.099 . . . . 0.0 112.554 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.447 ' N ' HG12 ' A' ' 33' ' ' VAL . 6.4 tt0 -153.46 135.67 14.87 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.568 HG12 ' HB2' ' A' ' 109' ' ' ARG . 11.2 m -91.89 177.7 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 120.932 -1.105 . . . . 0.0 112.53 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.614 HG21 ' CD2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -135.97 172.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.55 -179.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -160.7 138.36 9.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.453 -0.779 . . . . 0.0 111.008 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 40' ' ' THR . 6.2 t -153.42 179.55 8.68 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -71.01 72.72 0.59 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.815 -1.154 . . . . 0.0 108.772 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 39' ' ' ALA . 23.3 m -175.24 -61.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -177.24 -168.16 0.19 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.839 -0.538 . . . . 0.0 109.867 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.5 p -125.05 128.01 47.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.658 -0.651 . . . . 0.0 109.251 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.614 ' CD2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -108.12 -177.43 3.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.143 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.843 HD12 ' N ' ' A' ' 109' ' ' ARG . 6.1 tt -107.9 149.94 27.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.343 -0.848 . . . . 0.0 109.687 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.614 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -139.77 136.01 33.66 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.217 -0.927 . . . . 0.0 109.391 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.746 HG21 ' CG2' ' A' ' 153' ' ' ILE . 4.6 t -107.29 116.7 32.39 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.3 -0.875 . . . . 0.0 112.522 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.43 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 84.3 m -72.11 83.0 0.99 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.319 -0.863 . . . . 0.0 110.175 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.464 HG11 ' CG1' ' A' ' 172' ' ' VAL . 60.5 t -107.28 139.5 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.0 t30 57.44 19.96 5.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.575 -0.703 . . . . 0.0 109.811 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.76 54.68 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 85' ' ' TRP . 57.0 t -144.52 109.67 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.424 -1.045 . . . . 0.0 110.089 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 46' ' ' THR . 15.0 p -61.4 97.03 0.06 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.702 -0.624 . . . . 0.0 110.136 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.914 ' CE3' HD23 ' A' ' 82' ' ' LEU . 98.4 m95 -76.43 150.29 36.76 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.089 -1.007 . . . . 0.0 110.302 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.606 ' O ' HG22 ' A' ' 83' ' ' VAL . 7.9 t -164.03 -178.59 5.7 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.972 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 55' ' ' VAL . 12.0 m -97.25 139.16 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.562 -0.712 . . . . 0.0 110.076 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.547 ' HB3' HG11 ' A' ' 78' ' ' VAL . 31.9 t80 -76.33 0.05 20.82 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.306 -0.871 . . . . 0.0 111.313 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -49.2 -33.33 12.19 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.415 -0.803 . . . . 0.0 110.871 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.81 -14.0 1.93 Allowed Glycine 0 N--CA 1.496 2.667 0 C-N-CA 119.754 -1.213 . . . . 0.0 111.875 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 43' ' ' PHE . . . -52.32 -34.38 46.75 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.787 -1.42 . . . . 0.0 110.983 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.84 168.81 4.41 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.6 t -96.94 -19.65 18.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.521 -0.987 . . . . 0.0 110.19 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -57.33 179.0 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.56 0.695 . . . . 0.0 110.768 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.47 103.91 2.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.678 -0.639 . . . . 0.0 110.094 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.722 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -53.43 160.98 1.07 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.694 -0.629 . . . . 0.0 110.192 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.1 133.09 50.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.804 . . . . 0.0 110.602 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.87 -177.5 14.9 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -59.05 96.17 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 O-C-N 123.77 1.405 . . . . 0.0 110.279 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.63 37.86 29.13 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.367 -0.833 . . . . 0.0 110.443 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.97 136.5 2.44 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.035 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.58 153.22 78.77 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 124.081 1.569 . . . . 0.0 109.685 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.722 HD12 ' CD2' ' A' ' 64' ' ' LEU . 65.7 mt -100.45 116.76 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.336 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -59.92 126.79 28.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.565 -0.709 . . . . 0.0 111.034 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -79.76 105.24 10.91 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 tpt -101.56 -32.17 10.5 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.23 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.45 ' CZ ' ' HG3' ' A' ' 179' ' ' MET . 14.2 m-85 -130.15 115.63 17.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.696 -0.628 . . . . 0.0 110.084 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.83 HG23 ' CG1' ' A' ' 83' ' ' VAL . 18.4 m -161.06 107.5 1.43 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.146 -0.971 . . . . 0.0 112.839 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.45 ' CB ' ' HB3' ' A' ' 81' ' ' ASP . 5.0 m-80 -163.84 78.17 0.4 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.694 . . . . 0.0 109.917 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 56' ' ' TYR . 34.9 m -51.39 -21.92 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.731 -1.231 . . . . 0.0 111.852 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.85 78.69 0.63 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.052 -1.03 . . . . 0.0 108.721 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 60.32 46.57 9.94 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.644 -0.66 . . . . 0.0 110.753 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -156.33 -33.21 0.09 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.217 -0.927 . . . . 0.0 111.859 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.914 HD23 ' CE3' ' A' ' 53' ' ' TRP . 5.7 tp 72.75 165.62 0.3 Allowed 'General case' 0 N--CA 1.526 3.343 0 CA-C-N 120.217 1.371 . . . . 0.0 111.075 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.83 ' CG1' HG23 ' A' ' 76' ' ' THR . 1.4 m -122.21 147.79 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.94 110.04 0.42 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.527 ' CH2' HG21 ' A' ' 54' ' ' THR . 1.2 m-90 -86.6 169.62 12.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -81.98 138.45 34.92 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.482 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -107.0 82.52 1.12 Allowed Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.401 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.566 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 48.0 Cg_endo -98.81 -6.8 0.63 Allowed 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.575 1.303 . . . . 0.0 112.977 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 40.4 Cg_endo -73.24 63.23 4.32 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 115.592 -2.472 . . . . 0.0 111.269 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.96 52.91 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.43 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -72.19 129.48 38.57 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.247 -1.149 . . . . 0.0 111.206 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -68.46 136.15 52.79 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.223 -0.991 . . . . 0.0 108.619 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -103.21 115.43 30.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.49 -0.757 . . . . 0.0 110.292 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mp -85.92 -164.1 0.98 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.495 0.664 . . . . 0.0 110.513 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.64 173.83 4.13 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.778 -0.576 . . . . 0.0 110.343 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.415 ' HB2' HG23 ' A' ' 98' ' ' THR . 50.4 Cg_endo -72.91 166.16 30.8 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 O-C-N 123.657 1.346 . . . . 0.0 110.551 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.452 ' HB2' HG23 ' A' ' 151' ' ' VAL . 6.8 t -84.68 -49.99 8.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.727 -0.608 . . . . 0.0 109.656 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.415 HG23 ' HB2' ' A' ' 96' ' ' PRO . 61.8 p 45.06 37.33 2.45 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.813 -0.554 . . . . 0.0 111.041 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.6 p -122.78 -162.03 0.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.492 -0.755 . . . . 0.0 110.172 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.27 74.55 0.37 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m -150.72 165.11 34.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.719 -0.871 . . . . 0.0 110.184 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.8 t -112.31 -154.89 0.55 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.52 -0.737 . . . . 0.0 110.588 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 57.86 99.35 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.207 -0.933 . . . . 0.0 110.508 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.774 HD13 HD23 ' A' ' 143' ' ' LEU . 2.3 mt -116.11 -176.27 2.91 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.301 -0.874 . . . . 0.0 109.963 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.458 ' O ' HG23 ' A' ' 107' ' ' VAL . 28.7 m-85 -131.53 85.06 2.22 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 154' ' ' PHE . 19.2 tp -61.13 89.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.457 -0.777 . . . . 0.0 109.039 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.609 HG13 HG12 ' A' ' 113' ' ' VAL . 21.8 t -75.41 101.37 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.186 -1.006 . . . . 0.0 109.638 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.889 HG22 ' O ' ' A' ' 112' ' ' ASP . 7.4 t -75.73 179.7 5.27 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.843 ' N ' HD12 ' A' ' 44' ' ' LEU . 16.4 ptt85 -95.3 17.07 15.11 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.12 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.54 ' H ' HG23 ' A' ' 108' ' ' THR . 6.3 m170 -103.36 21.17 16.43 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 59.12 56.36 3.95 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.363 -0.836 . . . . 0.0 109.816 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.889 ' O ' HG22 ' A' ' 108' ' ' THR . 11.6 t70 -166.86 121.88 1.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.688 -0.632 . . . . 0.0 109.881 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.609 HG12 HG13 ' A' ' 107' ' ' VAL . 8.4 m -104.1 145.36 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.993 -1.067 . . . . 0.0 109.608 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.443 HD11 HD23 ' A' ' 106' ' ' LEU . 44.0 pt -125.98 138.6 32.41 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.077 -1.015 . . . . 0.0 110.091 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.591 ' HB2' HD12 ' A' ' 127' ' ' LEU . 54.5 Cg_endo -66.18 141.47 63.31 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 O-C-N 123.796 1.419 . . . . 0.0 112.201 -177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 58.4 t -132.59 138.47 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.679 -0.638 . . . . 0.0 109.65 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.58 117.71 35.26 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 -48.96 129.5 17.4 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.488 -0.757 . . . . 0.0 110.702 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.428 ' CG ' ' HB2' ' A' ' 125' ' ' SER . 5.5 mmm180 -109.8 -27.26 9.39 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.736 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.19 -150.05 7.43 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -77.16 127.58 32.88 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.734 -0.862 . . . . 0.0 108.822 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.38 45.39 28.6 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.127 0.489 . . . . 0.0 111.217 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.485 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -160.89 151.59 18.33 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.332 -0.855 . . . . 0.0 110.754 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.0 -177.05 17.64 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.0 OUTLIER -129.46 120.65 25.81 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.803 -0.822 . . . . 0.0 112.041 -178.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.404 HD22 ' HB2' ' A' ' 130' ' ' ARG . 0.2 OUTLIER -58.48 141.25 52.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.436 -0.79 . . . . 0.0 109.001 178.194 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' ' 115' ' ' PRO . 20.7 mt -108.44 52.99 0.7 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.3 p 166.19 136.79 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.2 113.96 2.84 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.802 1.422 . . . . 0.0 109.81 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.404 ' HB2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -121.66 147.32 47.76 Favored Pre-proline 0 N--CA 1.49 1.531 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.68 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 43.3 Cg_endo -68.15 125.11 12.54 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 124.14 1.6 . . . . 0.0 110.055 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.45 HG21 ' SG ' ' A' ' 159' ' ' CYS . 10.8 p -58.86 -36.84 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.624 0.726 . . . . 0.0 109.684 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.1 m -49.13 -35.63 16.97 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 122.031 0.919 . . . . 0.0 110.936 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.738 ' OH ' HG21 ' A' ' 108' ' ' THR . 43.4 t80 -70.07 -36.93 75.31 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.567 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.9 mt -63.58 -37.2 86.41 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -57.83 122.93 14.09 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.576 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.45 -31.64 8.48 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.9 m -79.96 0.19 32.54 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.487 -1.008 . . . . 0.0 111.152 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.402 ' CB ' HG21 ' A' ' 55' ' ' VAL . 78.8 p -48.42 134.04 15.55 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.225 -0.922 . . . . 0.0 110.714 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.593 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 110.74 -20.59 24.48 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 107.376 -2.29 . . . . 0.0 107.376 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.76 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -47.09 113.66 1.31 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.41 122.62 9.64 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 124.05 1.552 . . . . 0.0 111.726 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.774 HD23 HD13 ' A' ' 104' ' ' LEU . 6.4 mp -79.11 114.08 17.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.618 HD23 ' HA ' ' A' ' 150' ' ' ALA . 1.8 mt -110.15 121.85 46.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 111.492 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.488 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 29.5 p -60.81 178.32 0.27 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.93 -0.481 . . . . 0.0 109.932 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 55.1 Cg_endo -83.63 51.01 3.37 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.514 1.271 . . . . 0.0 111.227 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.84 43.75 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.182 -0.949 . . . . 0.0 110.456 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 61.14 -167.01 12.53 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.4 m170 56.48 106.02 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.567 -0.96 . . . . 0.0 110.671 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.618 ' HA ' HD23 ' A' ' 144' ' ' LEU . . . -57.44 153.63 12.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.192 -0.943 . . . . 0.0 109.982 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -105.07 -30.72 2.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.707 ' CA ' HG23 ' A' ' 172' ' ' VAL . . . 173.55 -177.15 46.03 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.769 HD11 HD11 ' A' ' 82' ' ' LEU . 1.2 pt -121.59 164.22 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 CA-C-N 119.24 1.52 . . . . 0.0 111.541 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.837 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.5 t80 -75.41 99.83 4.28 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.447 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -37.9 15.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -161.35 176.63 10.95 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.837 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -135.37 120.75 19.14 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.371 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.857 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 4.1 t -68.61 103.62 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.45 ' SG ' HG21 ' A' ' 132' ' ' VAL . 30.0 p -124.02 162.92 22.46 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.733 1.254 . . . . 0.0 114.06 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 161' ' ' ARG . 1.3 m -103.67 -172.56 2.13 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.469 ' H ' HG22 ' A' ' 160' ' ' THR . 7.1 ttt180 -46.38 90.07 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.677 0 O-C-N 121.396 -0.815 . . . . 0.0 111.623 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 72.25 -18.2 1.27 Allowed Glycine 0 N--CA 1.499 2.889 0 O-C-N 121.245 -0.91 . . . . 0.0 112.984 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.12 127.87 60.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 119.484 1.642 . . . . 0.0 109.527 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.567 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -89.66 137.82 32.0 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.052 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -117.94 -43.74 2.75 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.461 -0.775 . . . . 0.0 110.77 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.857 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -119.4 171.84 8.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.411 -0.806 . . . . 0.0 109.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.8 t -118.24 145.83 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.543 0.687 . . . . 0.0 110.865 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.668 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.5 OUTLIER -109.94 100.28 9.27 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 177.165 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.666 ' CG ' HD22 ' A' ' 143' ' ' LEU . 0.4 OUTLIER -131.89 142.97 49.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.803 -1.159 . . . . 0.0 113.194 -175.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.578 HG11 HD13 ' A' ' 82' ' ' LEU . 2.9 p -94.09 133.45 27.46 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 49.4 Cg_endo -61.17 160.74 25.34 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.812 1.427 . . . . 0.0 110.859 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.707 HG23 ' CA ' ' A' ' 152' ' ' GLY . 40.1 t -82.41 1.56 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.294 -0.879 . . . . 0.0 109.602 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -93.08 -39.38 11.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.046 -1.034 . . . . 0.0 110.228 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.9 t -75.33 -40.05 58.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.72 -0.613 . . . . 0.0 110.305 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.951 ' O ' HG22 ' A' ' 178' ' ' THR . 4.0 ptp -55.75 -36.32 67.16 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.315 -0.866 . . . . 0.0 110.349 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -37.95 65.41 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.219 -0.926 . . . . 0.0 109.862 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.4 m -48.92 -38.96 24.35 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.951 HG22 ' O ' ' A' ' 175' ' ' MET . 7.6 t -49.91 -38.73 37.28 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 120.752 -1.217 . . . . 0.0 112.267 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.486 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -57.69 -35.14 70.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.814 -1.179 . . . . 0.0 111.462 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -47.41 -37.28 11.13 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.272 -0.892 . . . . 0.0 110.634 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.85 -45.55 10.2 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.103 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.504 2.247 0 O-C-N 121.096 -1.002 . . . . 0.0 111.176 179.515 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.613 HG11 ' HB2' ' A' ' 89' ' ' PRO . 33.9 m . . . . . 0 N--CA 1.501 2.099 0 CA-C-O 120.641 0.258 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 62.69 80.06 0.24 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.984 -1.072 . . . . 0.0 109.364 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.58 164.61 29.73 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.489 ' CD ' HD11 ' A' ' 94' ' ' LEU . 8.6 mt-10 -90.9 -28.1 18.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.669 -0.901 . . . . 0.0 110.94 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.404 HG11 HD11 ' A' ' 44' ' ' LEU . 39.4 t -115.5 143.86 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.476 -0.765 . . . . 0.0 111.248 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.457 ' C ' HG13 ' A' ' 35' ' ' VAL . 2.7 tt0 -137.13 175.74 9.34 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 44' ' ' LEU . 34.3 m -148.56 177.96 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.23 -0.919 . . . . 0.0 111.173 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.471 HG11 HD11 ' A' ' 64' ' ' LEU . 10.6 m -130.75 -179.4 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 p -136.88 133.75 36.11 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.48 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.3 p -128.46 -176.42 3.82 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.94 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.201 -0.937 . . . . 0.0 110.959 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.0 p 49.1 39.95 16.3 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.842 -0.536 . . . . 0.0 111.005 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -155.03 137.87 15.36 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.661 -0.649 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.9 t -130.71 135.03 47.42 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.464 -0.773 . . . . 0.0 109.098 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -100.9 178.29 4.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.261 -0.899 . . . . 0.0 110.824 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.691 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -113.13 149.39 33.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.427 -0.796 . . . . 0.0 109.729 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.431 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -158.07 152.52 24.63 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.55 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.617 HG23 HG23 ' A' ' 48' ' ' VAL . 11.8 t -125.55 127.19 46.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.327 -0.858 . . . . 0.0 111.155 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.4 m -78.27 80.89 4.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.333 -0.854 . . . . 0.0 110.325 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.617 HG23 HG23 ' A' ' 46' ' ' THR . 95.3 t -100.04 139.17 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.75 20.31 6.35 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.327 -0.858 . . . . 0.0 108.945 -177.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 23.13 60.07 Favored Glycine 0 N--CA 1.491 2.332 0 O-C-N 121.392 -0.817 . . . . 0.0 111.361 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -136.88 105.12 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 118.79 1.295 . . . . 0.0 110.557 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.5 t -58.4 101.44 0.08 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.68 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.615 ' CZ3' HG21 ' A' ' 178' ' ' THR . 52.8 m95 -82.19 144.98 30.33 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.479 -0.763 . . . . 0.0 112.177 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.906 HG21 ' CH2' ' A' ' 85' ' ' TRP . 3.4 t -165.23 128.66 2.28 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 81' ' ' ASP . 13.4 m -49.61 153.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 O-C-N 121.26 -0.9 . . . . 0.0 111.349 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.465 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 57.1 t80 -76.4 1.31 16.72 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.159 -0.963 . . . . 0.0 111.643 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -49.24 -25.12 2.1 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.129 -0.982 . . . . 0.0 110.883 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.95 73.1 0.06 OUTLIER Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.749 ' O ' HD12 ' A' ' 64' ' ' LEU . . . -156.01 -54.45 0.09 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.592 -0.946 . . . . 0.0 110.264 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.68 -1.6 90.24 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 p -74.16 144.88 44.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.191 -1.182 . . . . 0.0 110.242 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.0 tttm 55.04 -171.6 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.477 -0.765 . . . . 0.0 110.65 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m -86.92 101.95 13.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.611 -0.68 . . . . 0.0 110.287 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.749 HD12 ' O ' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -55.46 156.13 4.79 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.625 -0.672 . . . . 0.0 110.646 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.21 141.4 47.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.673 -0.642 . . . . 0.0 110.465 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.97 -178.44 15.41 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -56.14 95.76 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.766 1.403 . . . . 0.0 110.59 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.9 tttt 56.66 33.44 22.83 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.535 -0.728 . . . . 0.0 110.503 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.35 137.33 3.42 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.98 162.21 42.62 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 O-C-N 123.836 1.44 . . . . 0.0 109.769 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.627 ' HB ' HD22 ' A' ' 64' ' ' LEU . 73.6 mt -118.9 93.54 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.375 -0.828 . . . . 0.0 110.098 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 m -110.02 141.19 43.17 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.222 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -146.87 -144.92 0.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.794 -0.566 . . . . 0.0 109.799 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.8 ttp -145.65 22.82 1.45 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.985 -1.072 . . . . 0.0 111.179 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.473 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 11.3 m-30 -115.85 101.85 9.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.328 -0.857 . . . . 0.0 110.139 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.609 HG23 ' CG1' ' A' ' 83' ' ' VAL . 3.0 m -150.88 121.33 7.37 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -142.83 78.09 1.6 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.344 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.441 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.7 p -52.76 -29.36 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.352 -0.842 . . . . 0.0 110.03 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.03 -50.65 69.85 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -86.59 5.98 33.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.772 -0.58 . . . . 0.0 109.786 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.54 ' O ' HG12 ' A' ' 55' ' ' VAL . 58.3 m-20 56.72 54.17 7.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.254 -0.904 . . . . 0.0 112.601 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.93 HD13 HG11 ' A' ' 170' ' ' VAL . 1.2 tp -160.87 138.02 9.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.922 -1.112 . . . . 0.0 112.559 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.609 ' CG1' HG23 ' A' ' 76' ' ' THR . 21.9 t -143.67 139.26 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -145.09 123.61 1.96 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 118.14 -1.981 . . . . 0.0 112.585 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.906 ' CH2' HG21 ' A' ' 54' ' ' THR . 1.2 m-90 -99.75 137.51 38.12 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -58.45 131.3 50.31 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.69 0.757 . . . . 0.0 111.757 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.508 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -104.65 93.28 5.86 Favored Pre-proline 0 C--N 1.296 -1.753 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.09 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.2 Cg_endo -99.89 -14.95 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.863 1.454 . . . . 0.0 112.473 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.613 ' HB2' HG11 ' A' ' 29' ' ' VAL . 47.9 Cg_endo -69.42 78.7 0.88 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 116.235 -2.043 . . . . 0.0 111.062 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 50.09 26.47 8.96 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.508 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -79.08 138.46 37.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.618 -0.931 . . . . 0.0 110.229 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -68.93 145.58 53.52 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.412 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -111.67 92.62 4.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.611 -0.681 . . . . 0.0 109.513 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.489 HD11 ' CD ' ' A' ' 32' ' ' GLU . 0.6 OUTLIER -71.14 -161.37 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.593 -0.692 . . . . 0.0 109.621 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -152.96 -176.28 0.57 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.718 -0.614 . . . . 0.0 109.959 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 95' ' ' THR . 41.1 Cg_endo -85.61 158.12 10.64 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 O-C-N 123.814 1.429 . . . . 0.0 109.944 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.83 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 0.1 OUTLIER -109.81 86.71 2.35 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.509 -0.745 . . . . 0.0 110.709 -179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.1 p -91.85 79.59 5.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.41 -0.806 . . . . 0.0 109.549 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 31.1 p -138.2 -151.51 0.39 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.64 -128.98 3.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m 54.67 -164.16 0.11 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.252 -1.146 . . . . 0.0 110.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.9 m -160.19 -35.3 0.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.355 -0.84 . . . . 0.0 111.779 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 3.5 p30 -60.68 134.31 56.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.21 -0.931 . . . . 0.0 110.787 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.756 HD13 HD23 ' A' ' 143' ' ' LEU . 1.3 mt -128.08 -166.87 1.68 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.03 -1.043 . . . . 0.0 109.884 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.484 ' O ' HG23 ' A' ' 107' ' ' VAL . 72.7 m-85 -144.74 85.59 1.77 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.709 HD23 HD11 ' A' ' 114' ' ' ILE . 38.0 tp -65.84 109.66 2.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.315 -0.866 . . . . 0.0 109.279 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 105' ' ' TYR . 38.1 t -100.69 128.27 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 111.582 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.527 HG21 ' CE1' ' A' ' 134' ' ' TYR . 33.2 p -94.55 166.49 12.01 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.691 ' CB ' HD21 ' A' ' 44' ' ' LEU . 27.2 tpt85 -79.97 -7.52 58.84 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.199 -0.938 . . . . 0.0 110.724 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.39 41.53 1.3 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.979 -1.075 . . . . 0.0 110.037 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 50.63 63.52 2.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.558 -0.714 . . . . 0.0 111.329 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.36 82.61 1.42 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.643 -0.66 . . . . 0.0 110.021 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.43 HG23 HG22 ' A' ' 107' ' ' VAL . 9.7 p -92.94 149.96 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.493 -0.754 . . . . 0.0 110.93 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.709 HD11 HD23 ' A' ' 106' ' ' LEU . 40.6 pt -145.16 144.72 24.41 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.226 -0.921 . . . . 0.0 110.018 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.52 ' HB2' HD12 ' A' ' 127' ' ' LEU . 52.5 Cg_endo -78.07 135.41 13.82 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.805 1.424 . . . . 0.0 110.909 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 103' ' ' ASP . 46.4 t -122.01 146.28 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.552 -0.718 . . . . 0.0 109.38 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.17 115.05 29.72 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.01 129.21 17.27 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.505 -0.747 . . . . 0.0 111.047 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -114.73 -25.85 8.09 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.51 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -171.03 61.22 0.17 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.825 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.456 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.4 OUTLIER 60.13 -75.17 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.663 -0.904 . . . . 0.0 111.66 179.051 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 120' ' ' GLY . 9.4 p -91.97 39.82 1.03 Allowed 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.283 0.563 . . . . 0.0 111.579 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.05 151.22 2.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.423 ' HA3' HG12 ' A' ' 116' ' ' VAL . . . -143.25 -177.2 18.0 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -125.04 118.39 26.08 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.917 -178.328 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.587 HD21 HD12 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -55.35 141.78 34.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.591 -0.693 . . . . 0.0 110.112 179.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.52 HD12 ' HB2' ' A' ' 115' ' ' PRO . 49.2 mt -109.75 53.94 0.68 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 168.08 128.82 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.05 112.45 2.05 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.775 1.408 . . . . 0.0 110.022 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -125.72 143.81 46.26 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.254 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.49 128.46 23.64 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.987 1.52 . . . . 0.0 110.907 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.695 HG21 ' SG ' ' A' ' 159' ' ' CYS . 7.4 p -60.28 -36.73 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.482 0.658 . . . . 0.0 109.499 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.8 m -48.44 -36.53 15.08 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.372 -0.83 . . . . 0.0 110.979 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.527 ' CE1' HG21 ' A' ' 108' ' ' THR . 0.1 OUTLIER -65.87 -38.58 89.19 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.8 mt -63.91 -35.49 80.82 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.08 121.7 10.63 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.584 -0.847 . . . . 0.0 109.788 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.34 -30.83 9.42 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.429 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 8.9 m -80.83 2.23 27.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.533 -0.981 . . . . 0.0 111.263 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 p -52.96 122.84 10.1 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.133 -0.979 . . . . 0.0 110.618 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 115.37 -9.71 19.98 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -59.86 152.35 35.9 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -93.82 129.64 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.697 1.367 . . . . 0.0 112.784 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.756 HD23 HD13 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -88.05 123.35 32.65 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 176.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.61 123.87 42.17 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.673 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.83 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 31.3 p -58.54 -170.95 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 48.6 Cg_endo -81.13 57.51 6.54 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 117.699 -1.068 . . . . 0.0 111.149 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.2 p -175.7 -158.13 0.06 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 149' ' ' HIS . . . -83.32 -160.18 29.12 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 148' ' ' GLY . 27.2 m170 57.73 133.17 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 117.789 0.795 . . . . 0.0 112.034 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.639 ' HB3' HG21 ' A' ' 172' ' ' VAL . . . -80.85 137.5 36.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.101 -0.999 . . . . 0.0 109.811 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.668 HG12 ' CE2' ' A' ' 169' ' ' PHE . 0.9 OUTLIER -81.83 -38.51 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.628 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 177.16 -178.29 48.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.773 HD11 ' CD1' ' A' ' 82' ' ' LEU . 1.7 pp -118.76 150.8 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 118.67 1.235 . . . . 0.0 111.346 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.745 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.9 t80 -60.63 112.33 1.96 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.39 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -46.75 5.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -149.32 172.99 14.0 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.745 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -128.73 115.6 18.23 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.555 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.796 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.4 t -67.67 94.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.695 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.2 p -123.87 148.68 46.59 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.876 0.846 . . . . 0.0 113.279 -175.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.585 HG22 ' H ' ' A' ' 161' ' ' ARG . 2.3 m -88.59 -173.49 4.17 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.585 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -46.56 85.99 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.99 0.9 . . . . 0.0 112.829 -178.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.613 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 80.42 -26.1 3.12 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.994 -1.066 . . . . 0.0 112.321 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.35 129.91 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.088 1.444 . . . . 0.0 109.271 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.442 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -91.98 126.69 37.16 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.961 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -109.0 -35.87 6.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.483 -0.761 . . . . 0.0 110.638 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.796 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -134.3 176.36 8.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.816 . . . . 0.0 109.921 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.01 153.11 26.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-O 121.663 0.745 . . . . 0.0 110.85 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.73 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 3.2 t70 -120.53 93.93 4.2 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.668 ' CE2' HG12 ' A' ' 151' ' ' VAL . 3.5 p90 -124.85 156.38 37.94 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.954 -1.098 . . . . 0.0 113.099 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.93 HG11 HD13 ' A' ' 82' ' ' LEU . 4.7 p -100.15 130.62 25.69 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 39.2 Cg_endo -62.06 159.59 33.67 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.778 1.41 . . . . 0.0 110.97 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.639 HG21 ' HB3' ' A' ' 150' ' ' ALA . 92.6 t -78.37 0.32 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.458 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -87.48 -37.65 16.77 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.838 0.828 . . . . 0.0 108.789 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 t -70.31 -37.21 74.71 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.28 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.603 ' HE1' HG23 ' A' ' 153' ' ' ILE . 14.9 mtt -49.12 -38.3 24.57 Favored 'General case' 0 N--CA 1.516 2.844 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -53.15 -38.34 62.63 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.29 -0.881 . . . . 0.0 108.968 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 m -55.47 -35.14 65.19 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.525 0.678 . . . . 0.0 109.452 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.615 HG21 ' CZ3' ' A' ' 53' ' ' TRP . 31.0 m -48.02 -61.02 2.18 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.859 -0.526 . . . . 0.0 110.535 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.473 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -55.04 -38.13 67.57 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.628 -0.67 . . . . 0.0 110.763 179.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -48.94 -37.04 18.82 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.982 0.896 . . . . 0.0 110.337 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.03 36.76 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.239 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.503 2.177 0 O-C-N 121.218 -0.926 . . . . 0.0 110.649 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 89' ' ' PRO . 25.4 m . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 121.382 0.611 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.84 79.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.91 53.82 4.7 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -164.47 -82.1 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.516 -0.99 . . . . 0.0 109.764 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.664 HG22 ' CD ' ' A' ' 142' ' ' PRO . 72.2 t -129.5 147.38 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.322 -0.861 . . . . 0.0 110.726 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -134.56 178.85 6.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.68 -0.637 . . . . 0.0 110.033 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 43' ' ' PHE . 2.6 p -159.89 144.64 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.861 0.839 . . . . 0.0 110.01 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.58 ' CG1' HD21 ' A' ' 64' ' ' LEU . 12.8 m -116.74 -178.96 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.1 m -146.37 137.54 24.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.38 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.9 p -136.65 -178.88 5.37 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.53 74.27 0.77 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.68 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.583 HG22 ' HG2' ' A' ' 41' ' ' GLN . 1.1 m 174.55 -63.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.583 ' HG2' HG22 ' A' ' 40' ' ' THR . 1.6 pt20 -173.15 -173.64 0.95 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.507 -0.746 . . . . 0.0 110.564 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.5 p -107.61 146.34 32.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.713 -0.617 . . . . 0.0 110.302 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.823 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . 93.1 m-85 -105.85 -177.48 3.37 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.316 -0.865 . . . . 0.0 111.855 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.718 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -114.19 146.88 39.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.616 -0.678 . . . . 0.0 110.382 -178.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.442 ' HB1' ' SG ' ' A' ' 52' ' ' CYS . . . -152.33 166.73 30.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.58 -0.7 . . . . 0.0 110.685 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 46' ' ' THR . 8.8 t -141.93 115.34 8.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.722 . . . . 0.0 111.685 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 81.8 m -66.88 85.5 0.12 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.361 -0.837 . . . . 0.0 110.247 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.591 HG11 ' HB ' ' A' ' 172' ' ' VAL . 53.3 t -104.35 139.75 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 55.39 20.2 3.49 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.485 -0.76 . . . . 0.0 110.331 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.442 ' C ' HG23 ' A' ' 51' ' ' VAL . . . 83.13 26.63 43.61 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 50' ' ' GLY . 91.2 t -146.9 106.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.448 -1.031 . . . . 0.0 109.865 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.442 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -61.8 119.98 9.81 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.484 -0.76 . . . . 0.0 109.259 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.994 ' CE3' HD23 ' A' ' 82' ' ' LEU . 95.7 m95 -99.75 153.62 18.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.44 -0.788 . . . . 0.0 111.807 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.833 HG23 HG23 ' A' ' 83' ' ' VAL . 6.9 t -162.89 -176.53 4.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.446 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 15.5 m -104.96 139.13 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.615 ' HB2' HG11 ' A' ' 83' ' ' VAL . 13.1 t80 -65.99 -7.14 15.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.182 -0.948 . . . . 0.0 113.022 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.446 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 14.6 p-80 -95.84 36.36 1.3 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.024 -1.048 . . . . 0.0 110.161 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.506 ' CA ' ' CE1' ' A' ' 43' ' ' PHE . . . -173.93 -81.41 0.05 OUTLIER Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.823 ' HB2' ' CB ' ' A' ' 43' ' ' PHE . . . -88.43 116.48 26.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.585 -0.95 . . . . 0.0 109.13 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.93 -60.22 0.49 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.8 t -55.16 170.69 0.19 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.232 -1.158 . . . . 0.0 110.597 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 58.91 168.74 0.06 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.479 -0.763 . . . . 0.0 110.053 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.652 ' O ' HG23 ' A' ' 63' ' ' THR . 9.0 t -78.03 101.06 6.75 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.699 0.762 . . . . 0.0 110.759 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.768 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -61.91 168.49 3.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.362 -0.836 . . . . 0.0 109.496 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.69 130.16 50.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.46 -0.775 . . . . 0.0 110.739 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.88 179.86 19.29 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.12 -26.83 65.17 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.982 1.517 . . . . 0.0 110.994 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -143.48 27.49 1.54 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.386 -0.821 . . . . 0.0 111.082 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.23 154.85 8.03 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -64.23 168.64 12.18 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.957 1.504 . . . . 0.0 110.186 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.768 HD12 ' CD2' ' A' ' 64' ' ' LEU . 16.5 mt -127.25 98.27 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 O-C-N 121.392 -0.817 . . . . 0.0 110.371 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 72' ' ' THR . 21.0 m -161.86 51.52 0.22 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.264 -0.898 . . . . 0.0 111.064 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -168.18 66.66 0.07 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.047 -1.033 . . . . 0.0 111.473 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.413 ' HG2' ' HG3' ' A' ' 86' ' ' GLN . 0.5 OUTLIER -143.03 -72.82 0.3 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.225 -0.922 . . . . 0.0 109.799 179.084 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.482 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 22.5 m-85 -137.77 119.83 15.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.564 -0.71 . . . . 0.0 109.479 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.582 ' CG2' HG12 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -151.87 112.58 4.19 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.375 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.518 HD22 ' HB1' ' A' ' 181' ' ' ALA . 41.4 t-20 -147.29 75.63 1.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.637 0.732 . . . . 0.0 110.018 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.526 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.3 p -44.99 168.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.497 -0.752 . . . . 0.0 112.166 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.471 ' N ' HG22 ' A' ' 78' ' ' VAL . 6.9 m-20 57.51 114.48 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.679 0.752 . . . . 0.0 111.336 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 66.33 -66.73 0.17 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.593 -0.692 . . . . 0.0 111.999 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' A' ' 77' ' ' ASN . 21.1 m-20 -63.99 -114.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 111.689 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.994 HD23 ' CE3' ' A' ' 53' ' ' TRP . 4.5 tp 176.94 174.09 0.42 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.182 -1.574 . . . . 0.0 111.286 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.833 HG23 HG23 ' A' ' 54' ' ' THR . 27.5 m -135.54 133.78 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.6 131.63 2.69 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.302 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.521 ' HH2' ' HB1' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -95.42 161.2 14.18 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.413 ' HG3' ' HG2' ' A' ' 74' ' ' MET . 13.8 mt-30 -79.52 135.27 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.812 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.55 93.38 4.93 Favored Pre-proline 0 C--N 1.298 -1.672 0 O-C-N 122.003 -0.436 . . . . 0.0 110.404 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.527 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 52.1 Cg_endo -92.44 -12.82 1.65 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 123.779 1.41 . . . . 0.0 113.782 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.703 ' O ' HG12 ' A' ' 29' ' ' VAL . 43.0 Cg_endo -68.83 80.51 0.64 Allowed 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 115.931 -2.246 . . . . 0.0 111.738 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 49.49 24.6 5.6 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -53.63 133.32 41.59 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.315 -1.109 . . . . 0.0 110.133 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -94.87 -5.28 45.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.632 -0.668 . . . . 0.0 112.056 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 t 59.68 129.42 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 121.708 0.766 . . . . 0.0 110.813 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.973 HD21 HD21 ' A' ' 144' ' ' LEU . 12.7 tp -95.54 14.92 21.24 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.302 -0.874 . . . . 0.0 111.05 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 63.4 p 44.35 -169.26 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.853 -0.53 . . . . 0.0 112.176 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -112.86 -164.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 O-C-N 123.439 1.231 . . . . 0.0 111.179 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 1.268 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 43.4 t -110.66 -50.37 2.96 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.446 -0.784 . . . . 0.0 110.083 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.492 HG22 ' C ' ' A' ' 97' ' ' CYS . 9.6 t 38.45 30.46 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 1.268 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 28.0 p -116.32 -177.73 3.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 109.642 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.27 -18.93 27.28 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.6 t -51.18 138.99 19.32 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.221 -1.164 . . . . 0.0 111.363 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.3 m -109.78 -11.11 14.75 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.436 -0.79 . . . . 0.0 111.403 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 4.0 t70 -61.28 112.77 2.28 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.875 -1.141 . . . . 0.0 109.072 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.839 HD13 HD23 ' A' ' 143' ' ' LEU . 33.9 mt -112.31 170.29 8.27 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.558 0.694 . . . . 0.0 111.427 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.413 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.7 m-85 -148.23 89.45 1.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 154' ' ' PHE . 20.3 tp -59.56 111.46 1.42 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.487 -0.758 . . . . 0.0 109.123 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 113' ' ' VAL . 97.8 t -92.99 97.1 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.551 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.434 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 80.6 p -65.59 152.38 44.25 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.718 ' CB ' HD21 ' A' ' 44' ' ' LEU . 1.6 tpm_? -74.25 -2.0 23.05 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.17 -0.956 . . . . 0.0 111.037 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.441 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -103.62 34.76 2.84 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.027 -1.046 . . . . 0.0 109.252 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.71 75.35 0.3 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.446 -0.783 . . . . 0.0 110.746 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.3 102.96 0.96 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.887 -0.508 . . . . 0.0 110.406 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 107' ' ' VAL . 2.5 t -98.38 139.05 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.604 HD11 HD23 ' A' ' 106' ' ' LEU . 42.7 pt -129.55 131.4 23.56 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.473 ' HB2' HD12 ' A' ' 127' ' ' LEU . 47.0 Cg_endo -67.01 137.19 43.67 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 O-C-N 123.581 1.306 . . . . 0.0 112.436 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 62.1 t -127.14 148.25 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.586 ' HG2' HD11 ' A' ' 127' ' ' LEU . 17.2 mmt180 -113.72 120.91 42.45 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -48.7 128.27 15.05 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.676 -0.64 . . . . 0.0 110.429 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.444 ' HG3' ' HB2' ' A' ' 125' ' ' SER . 8.0 mmm180 -109.02 -29.08 8.74 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.8 -0.562 . . . . 0.0 110.221 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.39 -159.45 22.96 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.36 127.81 33.72 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.701 -0.882 . . . . 0.0 109.373 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.444 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 0.0 OUTLIER 49.94 55.95 8.64 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 121.221 0.534 . . . . 0.0 111.492 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -172.84 149.75 2.0 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.438 -0.789 . . . . 0.0 111.061 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.95 -178.24 17.85 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.4 OUTLIER -136.27 104.7 5.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.729 -178.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.58 HD21 ' C ' ' A' ' 164' ' ' ALA . 3.2 pp -49.37 151.32 1.54 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.817 -0.552 . . . . 0.0 110.319 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.586 HD11 ' HG2' ' A' ' 117' ' ' ARG . 36.8 mt -110.91 54.2 0.68 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.53 106.51 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -55.71 106.76 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 O-C-N 123.396 1.208 . . . . 0.0 110.283 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -109.76 175.61 1.87 Allowed Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.781 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.421 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 51.5 Cg_endo -79.9 124.99 5.8 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 124.139 1.599 . . . . 0.0 109.294 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.818 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.2 p -62.39 -35.41 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.558 -0.714 . . . . 0.0 109.4 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.75 -36.77 17.16 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 122.111 0.958 . . . . 0.0 110.27 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.421 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 21.9 t80 -66.34 -38.73 88.31 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 17.9 mt -64.88 -35.84 82.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.37 119.2 4.86 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.704 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.5 -32.98 6.37 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.6 m -78.72 -4.68 50.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.625 -0.926 . . . . 0.0 111.454 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 2.4 m -50.39 125.28 12.31 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.003 -1.061 . . . . 0.0 111.045 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 113.83 -15.69 21.37 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.543 ' HA2' HD12 ' A' ' 44' ' ' LEU . . . -58.69 135.09 52.21 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.664 ' CD ' HG22 ' A' ' 33' ' ' VAL . 51.6 Cg_endo -79.75 131.18 9.06 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.8 1.421 . . . . 0.0 113.011 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.839 HD23 HD13 ' A' ' 104' ' ' LEU . 5.1 mp -79.11 138.13 37.8 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.973 HD21 HD21 ' A' ' 94' ' ' LEU . 0.9 OUTLIER -129.81 128.06 41.58 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.003 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 1.076 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 1.1 p -58.58 -109.25 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.104 0 CA-C-O 117.337 -1.316 . . . . 0.0 110.907 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 145' ' ' CYS . 47.2 Cg_endo -68.99 -84.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 114.35 -3.3 . . . . 0.0 110.307 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.9 m -153.79 99.86 2.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.797 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.1 -61.34 0.65 Allowed Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -58.9 124.41 19.76 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.699 -0.883 . . . . 0.0 111.24 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -78.27 140.88 38.84 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.581 HG11 HD21 ' A' ' 104' ' ' LEU . 2.5 t -108.62 -37.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.522 -0.736 . . . . 0.0 109.54 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.747 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 174.19 -177.91 46.23 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.467 HD11 HD11 ' A' ' 82' ' ' LEU . 3.2 pt -112.76 156.07 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 120.96 -1.318 . . . . 0.0 111.428 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.843 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 9.8 t80 -73.58 84.5 1.56 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.219 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -66.05 -52.25 50.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.584 -0.698 . . . . 0.0 109.901 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -150.13 178.81 8.62 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.843 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -131.01 115.91 17.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.136 -0.978 . . . . 0.0 110.313 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.814 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 4.2 t -63.46 101.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.679 ' SG ' HG21 ' A' ' 132' ' ' VAL . 26.3 p -129.57 139.53 51.46 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.6 OUTLIER -73.83 -173.79 1.63 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 176.143 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.57 84.16 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.333 -0.854 . . . . 0.0 112.801 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.818 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 87.42 -28.27 5.86 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 120.809 -1.182 . . . . 0.0 111.447 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.0 OUTLIER -92.49 133.92 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.86 -1.377 . . . . 0.0 110.022 -179.245 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.58 ' C ' HD21 ' A' ' 126' ' ' LEU . . . -92.8 129.2 38.79 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.221 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.53 ' HA ' HD11 ' A' ' 126' ' ' LEU . 3.2 mtpt -114.09 -21.5 10.5 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.474 -0.766 . . . . 0.0 111.318 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.814 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -151.27 -178.47 6.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.878 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.23 144.29 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 111.59 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -109.98 101.28 10.11 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.661 ' CG ' HD22 ' A' ' 143' ' ' LEU . 0.6 OUTLIER -130.63 148.15 52.39 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.33 -0.948 . . . . 0.0 113.019 -175.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.491 HG11 HD11 ' A' ' 82' ' ' LEU . 3.0 p -103.17 132.98 20.59 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 54.7 Cg_endo -60.38 153.66 58.56 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.796 1.419 . . . . 0.0 111.357 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.747 HG13 ' HA2' ' A' ' 152' ' ' GLY . 35.9 m -80.3 0.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.452 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -89.9 -38.93 13.36 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.311 -0.868 . . . . 0.0 108.776 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 88.3 p -61.12 -36.37 79.54 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.565 ' HG2' HD22 ' A' ' 82' ' ' LEU . 19.7 mtt -48.13 -38.18 17.25 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-O 121.519 0.676 . . . . 0.0 109.649 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -56.11 -38.09 70.29 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -67.5 -39.73 85.18 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.738 0.78 . . . . 0.0 109.031 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.432 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 0.7 OUTLIER -52.31 -41.5 63.01 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.807 -0.558 . . . . 0.0 110.543 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.482 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -49.56 -41.6 42.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.206 -0.934 . . . . 0.0 111.167 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -38.71 72.99 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.133 0.968 . . . . 0.0 109.322 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.518 ' HB1' HD22 ' A' ' 77' ' ' ASN . . . -67.87 -38.37 82.98 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.512 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.333 -0.854 . . . . 0.0 111.142 179.664 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.259 0.552 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 62.37 78.58 0.29 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.063 -1.023 . . . . 0.0 108.859 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.95 -95.81 0.11 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.785 ' HG3' HG23 ' A' ' 33' ' ' VAL . 5.2 pt-20 -173.12 -36.01 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.275 -1.133 . . . . 0.0 111.629 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.785 HG23 ' HG3' ' A' ' 32' ' ' GLU . 97.0 t -113.52 155.34 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.187 -0.946 . . . . 0.0 110.92 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.575 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 18.7 tp60 -141.16 148.78 40.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.592 -0.693 . . . . 0.0 110.231 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' A' ' 109' ' ' ARG . 31.4 m -106.78 -179.3 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.42 -0.8 . . . . 0.0 112.034 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.784 HG21 ' CE2' ' A' ' 43' ' ' PHE . 27.6 m -139.1 -178.33 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.5 p -156.2 136.62 13.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.582 -0.699 . . . . 0.0 110.054 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.638 HG23 ' OG1' ' A' ' 40' ' ' THR . 8.0 t -152.83 -178.7 7.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.672 ' O ' HG23 ' A' ' 40' ' ' THR . . . -68.41 76.85 0.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.349 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER 174.03 -58.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 175.4 -176.41 0.1 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.269 -0.894 . . . . 0.0 109.948 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.8 t -112.49 127.87 56.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 109.358 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.784 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -107.37 -176.26 3.02 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.144 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 45' ' ' ALA . 6.6 tt -103.85 154.47 19.57 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.668 -0.645 . . . . 0.0 109.738 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.801 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -150.77 129.13 12.05 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.261 -0.899 . . . . 0.0 109.689 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.636 HG23 HG23 ' A' ' 48' ' ' VAL . 12.6 t -97.58 124.74 41.95 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.241 -0.912 . . . . 0.0 112.004 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.71 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 41.3 t -75.22 90.71 2.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.65 -0.656 . . . . 0.0 109.793 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.636 HG23 HG23 ' A' ' 46' ' ' THR . 65.1 t -104.14 133.43 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.4 t30 57.34 20.61 6.01 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.471 -0.768 . . . . 0.0 110.032 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.97 25.08 38.85 Favored Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.225 -0.922 . . . . 0.0 110.887 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.674 HG22 ' HG2' ' A' ' 86' ' ' GLN . 94.3 t -139.44 106.69 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.54 -0.977 . . . . 0.0 110.06 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.4 ' O ' ' HA2' ' A' ' 84' ' ' GLY . 5.4 m -62.51 114.67 3.67 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.262 -0.899 . . . . 0.0 108.854 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.911 ' CE3' HD23 ' A' ' 82' ' ' LEU . 98.8 m95 -96.8 146.89 24.49 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.409 -0.807 . . . . 0.0 112.682 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.808 HG21 ' CH2' ' A' ' 85' ' ' TRP . 4.5 t -164.31 141.71 6.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 155' ' ' ARG . 12.8 m -57.71 148.12 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.029 -1.045 . . . . 0.0 109.812 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 47.3 t80 -72.99 -1.07 15.64 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.008 -1.057 . . . . 0.0 111.715 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -49.8 -28.1 5.87 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.209 -0.932 . . . . 0.0 110.397 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.31 -46.83 0.16 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' CE1' ' A' ' 56' ' ' TYR . . . -49.49 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.404 -1.057 . . . . 0.0 110.831 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.66 175.36 22.25 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.2 p -93.57 -7.51 43.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.702 -0.881 . . . . 0.0 110.783 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -59.53 -167.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.152 -0.967 . . . . 0.0 110.856 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.3 m -83.97 101.77 11.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.742 -0.598 . . . . 0.0 109.705 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.711 HD22 HD12 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -57.72 173.51 0.29 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.579 -0.701 . . . . 0.0 110.139 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.94 132.75 53.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.524 -0.735 . . . . 0.0 110.876 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.03 -179.46 37.2 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.15 -18.39 64.76 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.767 1.404 . . . . 0.0 110.797 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -159.86 31.47 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 110.235 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.01 161.43 12.35 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.53 159.37 36.71 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.957 1.504 . . . . 0.0 110.403 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.711 HD12 HD22 ' A' ' 64' ' ' LEU . 96.1 mt -91.54 153.96 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 110.351 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.5 p -89.45 167.29 13.12 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.497 -0.752 . . . . 0.0 110.698 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 53.0 -179.21 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.381 -0.824 . . . . 0.0 110.359 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.6 ttp -176.37 51.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.332 -0.855 . . . . 0.0 109.902 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.482 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.2 m-85 -55.9 131.7 47.77 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.267 -0.896 . . . . 0.0 109.108 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.582 HG23 ' CG1' ' A' ' 83' ' ' VAL . 3.7 m -156.91 118.13 3.72 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.458 -0.897 . . . . 0.0 112.323 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 49.3 m-20 -145.64 76.66 1.48 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.829 0.823 . . . . 0.0 109.076 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.9 p -48.67 152.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.485 0.66 . . . . 0.0 111.372 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 t70 61.61 127.01 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.887 0.851 . . . . 0.0 112.446 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 46.56 24.48 0.32 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 3.2 m-20 -156.2 -126.71 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -0.987 . . . . 0.0 109.777 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.911 HD23 ' CE3' ' A' ' 53' ' ' TRP . 1.7 tp -178.65 174.98 1.13 Allowed 'General case' 0 N--CA 1.511 2.615 0 CA-C-N 121.089 1.768 . . . . 0.0 112.739 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.582 ' CG1' HG23 ' A' ' 76' ' ' THR . 13.6 t -134.03 138.55 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 52' ' ' CYS . . . -158.25 117.57 0.78 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 118.738 -1.696 . . . . 0.0 110.596 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.808 ' CH2' HG21 ' A' ' 54' ' ' THR . 0.1 OUTLIER -95.42 135.81 36.58 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.674 ' HG2' HG22 ' A' ' 51' ' ' VAL . 29.9 mt-30 -57.55 133.89 55.65 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.835 0.826 . . . . 0.0 111.482 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -112.85 98.29 44.56 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.135 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.58 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 46.6 Cg_endo -113.95 8.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.781 1.411 . . . . 0.0 113.264 178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 55.2 Cg_endo -68.46 -106.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 115.832 -2.312 . . . . 0.0 108.083 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.91 39.46 2.85 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 105.535 -3.026 . . . . 0.0 105.535 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.71 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -81.85 140.4 34.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.582 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -92.6 100.42 12.95 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.8 t -55.41 104.04 0.11 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.366 -0.834 . . . . 0.0 110.832 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.66 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -78.77 -156.03 0.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.687 -0.633 . . . . 0.0 109.603 179.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -159.96 -171.03 0.26 Allowed Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.489 -0.757 . . . . 0.0 110.612 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 95' ' ' THR . 44.9 Cg_endo -92.97 170.72 2.25 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 O-C-N 123.567 1.299 . . . . 0.0 111.137 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 18.2 t -90.4 148.76 22.6 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.526 -0.734 . . . . 0.0 109.742 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 t -146.33 43.64 1.21 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 1.304 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 26.3 p -125.74 174.1 8.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.677 -0.64 . . . . 0.0 110.618 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -113.57 33.95 5.26 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 p -108.2 -179.35 3.86 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.534 -0.98 . . . . 0.0 110.403 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.5 p -136.26 19.71 3.18 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.585 -0.697 . . . . 0.0 110.809 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 73.8 m-20 -81.65 90.52 6.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.369 -0.832 . . . . 0.0 109.564 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.768 HD13 HD23 ' A' ' 143' ' ' LEU . 88.5 mt -97.09 156.63 16.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -0.825 . . . . 0.0 111.402 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.56 ' O ' HG23 ' A' ' 107' ' ' VAL . 84.4 m-85 -132.12 84.49 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.959 -0.463 . . . . 0.0 109.797 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 106' ' ' LEU . 14.4 tp -55.36 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.328 -0.857 . . . . 0.0 109.539 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 113' ' ' VAL . 58.4 t -80.29 119.57 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.008 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.466 ' C ' HD12 ' A' ' 44' ' ' LEU . 37.9 p -82.15 -179.88 7.56 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.763 ' N ' HD12 ' A' ' 44' ' ' LEU . 51.9 ptt85 -99.96 51.41 0.91 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.026 -1.046 . . . . 0.0 110.447 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.449 ' NE2' ' HB ' ' A' ' 108' ' ' THR . 3.9 p80 -175.17 44.06 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.532 0.682 . . . . 0.0 110.024 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.62 67.2 1.04 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.524 -0.735 . . . . 0.0 111.005 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.99 83.65 0.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.619 -0.676 . . . . 0.0 110.08 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 107' ' ' VAL . 53.9 t -77.91 154.44 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.573 -0.705 . . . . 0.0 109.534 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.8 mt -136.79 107.88 9.08 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -53.4 141.51 61.07 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 O-C-N 123.63 1.332 . . . . 0.0 112.695 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.533 ' CG1' HG21 ' A' ' 167' ' ' VAL . 21.7 t -133.97 150.23 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -111.81 118.56 35.9 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -47.88 127.85 12.55 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.374 -0.829 . . . . 0.0 110.207 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 125' ' ' SER . 1.3 mmp_? -107.79 -36.85 6.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.598 -0.689 . . . . 0.0 111.603 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.95 64.03 0.06 OUTLIER Glycine 0 N--CA 1.497 2.738 0 C-N-CA 118.892 -1.623 . . . . 0.0 110.604 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.81 140.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.89 0.852 . . . . 0.0 110.242 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.404 ' CA ' ' O ' ' A' ' 169' ' ' PHE . 69.1 p 44.12 28.56 0.28 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.792 -0.567 . . . . 0.0 112.278 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.502 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 8.4 ttm180 -165.36 151.5 9.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.274 -0.891 . . . . 0.0 110.457 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.16 -177.99 22.12 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 119' ' ' ARG . 0.5 OUTLIER -121.43 127.63 51.33 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.696 -178.451 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.56 132.14 43.4 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.3 mt -103.09 53.55 0.77 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.2 t 175.47 133.5 0.16 Allowed Pre-proline 0 N--CA 1.5 2.044 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.829 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -62.64 104.94 0.39 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 O-C-N 123.721 1.38 . . . . 0.0 108.813 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.61 128.24 25.49 Favored Pre-proline 0 N--CA 1.488 1.458 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.632 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 43.6 Cg_endo -60.76 131.18 36.29 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.982 1.517 . . . . 0.0 110.129 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.599 HG21 ' SG ' ' A' ' 159' ' ' CYS . 11.7 p -57.63 -36.84 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.728 -0.608 . . . . 0.0 110.266 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.8 t -49.09 -36.59 19.04 Favored 'General case' 0 N--CA 1.507 2.393 0 CA-C-O 122.064 0.935 . . . . 0.0 110.728 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 34.7 t80 -69.09 -38.21 78.84 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.56 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.7 mt -65.5 -35.37 80.68 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.153 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -57.14 -21.03 29.57 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.001 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -97.87 30.2 9.79 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 99.0 p -150.89 23.39 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.516 -0.99 . . . . 0.0 110.734 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -59.36 126.94 29.69 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.256 -0.902 . . . . 0.0 108.691 179.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.659 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 108.43 -13.38 36.26 Favored Glycine 0 CA--C 1.541 1.663 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -176.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.654 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -46.34 109.06 0.31 Allowed Glycine 0 N--CA 1.503 3.166 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.81 125.67 12.39 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.997 1.525 . . . . 0.0 111.753 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.768 HD23 HD13 ' A' ' 104' ' ' LEU . 6.3 mp -82.52 116.28 21.88 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.519 HD22 ' O ' ' A' ' 147' ' ' SER . 1.1 mt -114.36 119.01 35.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.108 -0.995 . . . . 0.0 111.194 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 1.304 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER -60.4 -20.68 0.65 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.839 -0.538 . . . . 0.0 110.507 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 145' ' ' CYS . 40.7 Cg_endo -137.44 -77.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.322 -0.833 0 O-C-N 123.535 1.282 . . . . 0.0 110.326 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.519 ' O ' HD22 ' A' ' 144' ' ' LEU . 9.1 p -164.18 -54.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.406 -0.809 . . . . 0.0 110.0 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.68 -51.39 3.45 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -66.98 117.37 8.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.599 -0.942 . . . . 0.0 110.297 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.602 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -88.99 150.58 22.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 110.075 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 97' ' ' CYS . 0.9 OUTLIER -107.3 -31.77 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.603 -0.685 . . . . 0.0 109.913 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.831 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 177.28 -179.67 47.97 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.822 HD11 HD11 ' A' ' 82' ' ' LEU . 1.1 pt -117.2 162.71 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.317 -1.107 . . . . 0.0 110.858 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.786 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 6.5 t80 -79.91 98.58 7.19 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.585 0.707 . . . . 0.0 110.9 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.582 ' HA ' HG11 ' A' ' 55' ' ' VAL . 2.6 ttt-85 -82.69 -42.91 17.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -160.69 -179.68 7.82 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.786 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -134.42 120.96 20.46 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.569 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.781 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.3 t -65.82 102.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.599 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.2 p -129.18 142.88 50.74 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -175.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 161' ' ' ARG . 1.9 m -75.74 -174.25 2.5 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.513 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -47.85 86.07 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.734 0.778 . . . . 0.0 112.884 -178.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 82.53 -25.25 4.54 Favored Glycine 0 N--CA 1.499 2.896 0 O-C-N 120.879 -1.138 . . . . 0.0 112.186 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -95.48 133.54 36.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 119.217 1.508 . . . . 0.0 109.345 -179.48 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.56 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -100.35 132.82 45.51 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.1 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -117.71 -37.27 3.48 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.571 -0.706 . . . . 0.0 110.775 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.781 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -122.27 -179.36 4.15 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.202 -0.936 . . . . 0.0 109.994 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.533 HG21 ' CG1' ' A' ' 116' ' ' VAL . 1.3 t -125.6 145.85 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.46 -0.775 . . . . 0.0 111.878 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -109.3 101.46 10.46 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 177.052 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.541 ' CD2' HD22 ' A' ' 143' ' ' LEU . 0.2 OUTLIER -132.56 154.42 50.02 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.891 -175.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.608 HG21 HD13 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -108.12 144.46 29.46 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.4 Cg_endo -64.39 148.59 90.84 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.916 1.482 . . . . 0.0 110.675 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.831 HG13 ' HA2' ' A' ' 152' ' ' GLY . 18.1 m -82.21 2.95 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.068 -1.02 . . . . 0.0 110.618 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -83.55 -38.15 22.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.0 t -74.02 -40.18 63.08 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.69 -0.631 . . . . 0.0 110.872 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.854 ' O ' HG22 ' A' ' 178' ' ' THR . 12.4 ptp -51.07 -36.18 38.66 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.307 -0.871 . . . . 0.0 110.012 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.422 ' N ' ' HG3' ' A' ' 175' ' ' MET . 19.0 tt0 -58.1 -36.33 72.72 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.194 -0.941 . . . . 0.0 108.847 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.7 m -70.6 -36.07 73.32 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.418 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.854 HG22 ' O ' ' A' ' 175' ' ' MET . 2.8 t -48.44 -37.52 17.42 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.095 -1.003 . . . . 0.0 112.699 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.452 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 2.3 ptp -63.22 -39.65 95.22 Favored 'General case' 0 N--CA 1.513 2.678 0 O-C-N 120.418 -1.426 . . . . 0.0 110.253 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -38.25 41.0 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.769 0.795 . . . . 0.0 110.512 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -79.81 -44.65 20.19 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.47 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.506 2.343 0 O-C-N 121.6 -0.688 . . . . 0.0 111.678 179.51 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -171.95 80.72 0.06 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.395 -0.815 . . . . 0.0 110.417 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.11 -68.15 0.1 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -172.63 -46.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.947 . . . . 0.0 110.091 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.84 HG11 ' C ' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -158.78 -163.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 122.318 1.056 . . . . 0.0 112.337 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.442 ' H ' HG12 ' A' ' 33' ' ' VAL . 1.7 tt0 -148.99 171.89 15.62 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.89 HG12 HD22 ' A' ' 44' ' ' LEU . 34.0 m -108.96 169.56 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.722 -0.611 . . . . 0.0 109.969 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.93 -179.16 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.41 ' C ' HG23 ' A' ' 38' ' ' THR . 1.3 m -149.79 138.92 21.21 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.655 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 37' ' ' SER . 70.0 p -146.72 -179.76 7.01 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.81 75.45 0.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.651 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m 175.84 -61.22 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.74 -171.04 0.29 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.468 -0.77 . . . . 0.0 109.655 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.7 p -110.74 142.25 42.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.34 -0.85 . . . . 0.0 110.146 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.447 ' CE2' ' HA3' ' A' ' 58' ' ' GLY . 80.2 m-85 -105.53 -178.39 3.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.473 -0.767 . . . . 0.0 111.201 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.89 HD22 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -118.49 141.27 48.73 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.547 -0.721 . . . . 0.0 111.173 -178.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.84 ' C ' HG11 ' A' ' 33' ' ' VAL . . . -121.93 -177.71 3.65 Favored 'General case' 0 N--CA 1.507 2.417 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.525 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 1.05 HG21 HG21 ' A' ' 153' ' ' ILE . 4.6 t -154.94 109.19 2.94 Favored 'General case' 0 N--CA 1.51 2.537 0 O-C-N 121.102 -0.999 . . . . 0.0 112.449 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.464 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 42.9 t -69.49 85.89 0.44 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.319 -0.863 . . . . 0.0 110.18 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.4 t -108.57 128.17 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.6 t30 64.4 12.74 7.55 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.396 -0.815 . . . . 0.0 110.558 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.07 14.55 48.39 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.161 -0.962 . . . . 0.0 111.88 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 85' ' ' TRP . 63.3 t -137.46 109.54 6.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.212 -1.169 . . . . 0.0 109.428 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 12.8 m -58.6 99.71 0.05 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.806 -0.559 . . . . 0.0 110.148 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.648 ' HZ3' HG21 ' A' ' 178' ' ' THR . 97.7 m95 -80.47 144.87 32.22 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.197 -0.939 . . . . 0.0 110.588 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.847 HG21 ' CH2' ' A' ' 85' ' ' TRP . 7.2 t -162.64 131.89 4.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.795 -0.565 . . . . 0.0 110.204 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.451 HG21 ' CE1' ' A' ' 57' ' ' HIS . 9.8 m -48.69 154.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.646 0 O-C-N 121.349 -0.844 . . . . 0.0 111.384 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.464 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 2.6 t80 -99.97 -12.61 19.62 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.096 -1.003 . . . . 0.0 111.933 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.451 ' CE1' HG21 ' A' ' 55' ' ' VAL . 2.4 p-80 -57.82 -20.37 35.46 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.936 -1.103 . . . . 0.0 110.05 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.447 ' HA3' ' CE2' ' A' ' 43' ' ' PHE . . . -128.46 -137.2 4.33 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 52.26 -172.18 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.243 -1.151 . . . . 0.0 110.811 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.89 122.32 5.98 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 89.8 p -79.9 -13.26 59.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.639 -0.919 . . . . 0.0 111.022 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -148.09 -58.96 0.25 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.234 -0.916 . . . . 0.0 110.439 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -96.61 95.29 7.86 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.113 0.482 . . . . 0.0 111.192 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.892 HD22 HD12 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -101.45 172.99 6.64 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.499 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.465 ' H ' HD23 ' A' ' 64' ' ' LEU . . . -116.79 129.67 56.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.287 -0.883 . . . . 0.0 110.85 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.72 -178.24 15.52 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -53.39 93.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 O-C-N 123.776 1.409 . . . . 0.0 111.128 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.6 tttp 52.65 42.36 31.56 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.475 -0.766 . . . . 0.0 110.947 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.98 131.93 1.5 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -60.65 156.44 42.5 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 O-C-N 123.779 1.41 . . . . 0.0 110.931 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.892 HD12 HD22 ' A' ' 64' ' ' LEU . 64.7 mt -102.12 127.06 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.565 -0.71 . . . . 0.0 110.106 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 m -119.49 -61.37 1.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.429 -0.794 . . . . 0.0 109.721 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 54.43 -159.02 0.18 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.348 -0.845 . . . . 0.0 111.015 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.8 ttm -149.49 22.97 0.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.147 -0.971 . . . . 0.0 111.139 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.499 ' O ' HG13 ' A' ' 83' ' ' VAL . 16.7 m-30 -115.25 103.67 11.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.461 -0.774 . . . . 0.0 109.216 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.599 HG23 ' CG2' ' A' ' 83' ' ' VAL . 2.3 m -152.7 133.89 14.25 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.735 -0.603 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.63 78.01 1.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.639 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 p -48.46 -28.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.49 -0.756 . . . . 0.0 110.387 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -51.2 60.26 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -83.93 2.52 38.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.998 -0.439 . . . . 0.0 109.969 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.554 ' O ' HD12 ' A' ' 82' ' ' LEU . 68.4 m-20 57.09 52.15 9.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.879 . . . . 0.0 111.228 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.576 HD13 HG11 ' A' ' 170' ' ' VAL . 1.4 tp -158.0 143.75 17.1 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.424 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.599 ' CG2' HG23 ' A' ' 76' ' ' THR . 22.0 t -145.4 119.38 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.42 ' CA ' HG12 ' A' ' 51' ' ' VAL . . . -99.79 97.1 1.73 Allowed Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.514 -1.327 . . . . 0.0 112.213 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.847 ' CH2' HG21 ' A' ' 54' ' ' THR . 24.1 m0 -76.8 172.92 12.33 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.52 134.46 38.34 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.907 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.55 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -109.79 87.67 5.83 Favored Pre-proline 0 C--N 1.295 -1.771 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.803 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.558 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -100.24 -8.59 0.36 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.844 1.444 . . . . 0.0 113.401 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 46.5 Cg_endo -73.16 65.11 4.3 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 115.982 -2.212 . . . . 0.0 110.689 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.46 24.94 18.88 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.55 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -66.13 136.18 55.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.692 -0.887 . . . . 0.0 110.962 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -75.85 129.25 36.7 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 p -98.65 103.94 15.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.544 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.479 ' O ' HG23 ' A' ' 95' ' ' THR . 19.9 mt -65.33 -156.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.635 -0.666 . . . . 0.0 109.562 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -154.3 175.41 3.08 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.575 -0.703 . . . . 0.0 110.538 -179.181 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.421 ' HA ' HG23 ' A' ' 172' ' ' VAL . 44.6 Cg_endo -74.98 151.53 39.74 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 O-C-N 123.815 1.429 . . . . 0.0 110.604 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.652 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 1.6 t -106.3 85.99 2.28 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.424 -0.798 . . . . 0.0 110.211 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -66.62 -32.46 73.81 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.044 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.652 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 11.9 p -60.53 111.88 1.76 Allowed 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.268 0.556 . . . . 0.0 110.459 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.99 80.03 1.4 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.7 m -122.76 139.92 53.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.587 -0.949 . . . . 0.0 109.955 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -76.2 -165.86 0.54 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.545 -0.722 . . . . 0.0 110.437 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 t70 57.93 102.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.501 -0.75 . . . . 0.0 110.008 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.798 HD13 HD23 ' A' ' 143' ' ' LEU . 3.7 mt -116.01 -167.53 1.28 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.565 -0.709 . . . . 0.0 110.004 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -140.26 92.21 2.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.814 -0.554 . . . . 0.0 109.576 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 154' ' ' PHE . 58.0 tp -77.53 95.17 4.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.1 t -89.93 111.6 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.377 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.443 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 20.7 p -69.42 178.83 2.26 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.798 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.72 29.51 5.29 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.766 -1.209 . . . . 0.0 110.348 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -133.4 34.46 3.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.451 -0.78 . . . . 0.0 109.214 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.48 68.35 0.84 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.838 -0.539 . . . . 0.0 111.257 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -167.57 90.8 0.34 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.781 -0.575 . . . . 0.0 109.678 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 113' ' ' VAL . 10.5 p -77.52 152.62 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.491 -0.756 . . . . 0.0 110.686 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.468 HD11 ' CE2' ' A' ' 134' ' ' TYR . 22.5 mt -131.58 111.5 15.01 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -62.35 133.4 43.06 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 O-C-N 123.604 1.318 . . . . 0.0 111.239 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 20.0 t -124.05 151.1 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.624 -0.672 . . . . 0.0 109.362 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.464 ' HB2' HD11 ' A' ' 127' ' ' LEU . 11.5 tpt180 -111.85 114.81 27.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -48.67 124.54 8.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.575 -0.703 . . . . 0.0 111.022 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -109.53 -48.9 3.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.791 -0.568 . . . . 0.0 110.096 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.23 -169.71 16.06 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.5 135.45 54.23 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 169' ' ' PHE . 10.4 p 53.52 43.31 31.42 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.439 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.497 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 2.2 ttp180 -167.43 151.15 6.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.417 -0.802 . . . . 0.0 110.889 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.9 -178.83 19.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -122.23 120.41 34.06 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 122.019 -0.695 . . . . 0.0 111.688 -178.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.419 HD21 HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -63.72 132.93 52.54 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 117' ' ' ARG . 12.4 mt -106.13 54.37 0.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.074 0.94 . . . . 0.0 108.502 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.9 t 176.1 116.46 0.13 Allowed Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -57.72 100.24 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.502 1.264 . . . . 0.0 109.467 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 -118.32 147.07 40.93 Favored Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.29 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.414 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 46.3 Cg_endo -65.9 127.42 17.74 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 124.018 1.536 . . . . 0.0 109.838 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.859 HG12 ' O ' ' A' ' 162' ' ' GLY . 6.7 p -55.29 -36.14 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.78 -0.575 . . . . 0.0 110.4 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -48.35 -36.37 14.33 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.28 -0.888 . . . . 0.0 110.789 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.468 ' CE2' HD11 ' A' ' 114' ' ' ILE . 9.1 t80 -65.39 -38.5 90.19 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.474 HD11 ' CB ' ' A' ' 164' ' ' ALA . 11.8 mt -66.62 -35.93 81.37 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.87 120.59 9.31 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.56 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.11 -33.39 6.17 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.9 m -82.06 3.1 28.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.642 -0.917 . . . . 0.0 111.208 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 28.4 p -57.67 127.47 32.2 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.136 -0.978 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.12 -8.83 29.16 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.491 ' O ' HG22 ' A' ' 153' ' ' ILE . . . -56.71 -177.28 0.36 Allowed Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -112.99 121.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.103 0 O-C-N 123.494 1.26 . . . . 0.0 113.276 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.798 HD23 HD13 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -86.53 110.39 19.75 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 175.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 150' ' ' ALA . 1.2 mt -113.26 123.94 51.34 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.117 -0.989 . . . . 0.0 111.651 -177.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.599 ' HB3' HG21 ' A' ' 151' ' ' VAL . 16.4 p -78.13 177.97 2.46 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.2 Cg_endo -62.0 173.98 2.76 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 O-C-N 123.516 1.272 . . . . 0.0 110.326 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 59.23 24.77 13.25 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.396 -0.815 . . . . 0.0 110.5 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 68.1 -144.38 42.92 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.6 m170 58.03 111.15 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.85 -0.794 . . . . 0.0 111.333 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.517 ' HA ' HD23 ' A' ' 144' ' ' LEU . . . -61.92 142.24 57.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.545 -0.722 . . . . 0.0 109.305 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.599 HG21 ' HB3' ' A' ' 145' ' ' CYS . 1.0 OUTLIER -100.58 -41.07 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.665 -0.647 . . . . 0.0 109.723 -179.385 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.751 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . -179.62 -177.58 47.93 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 1.05 HG21 HG21 ' A' ' 46' ' ' THR . 1.2 pt -117.23 157.12 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.14 -1.212 . . . . 0.0 111.329 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.731 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 7.7 t80 -69.26 109.4 4.09 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.314 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -44.73 6.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.383 -0.823 . . . . 0.0 109.717 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -149.42 170.59 18.21 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.731 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -128.23 117.15 21.0 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.887 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.831 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 4.1 t -67.73 99.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.482 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.5 p -127.21 143.65 51.21 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 162' ' ' GLY . 2.2 p -77.37 -173.51 2.91 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -48.21 85.21 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 121.667 0.746 . . . . 0.0 112.912 -178.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.859 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 84.01 -28.48 4.1 Favored Glycine 0 N--CA 1.5 2.94 0 O-C-N 120.803 -1.186 . . . . 0.0 112.038 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.5 t -94.62 137.93 21.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 119.264 1.532 . . . . 0.0 109.086 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.474 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -101.26 127.36 47.89 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.016 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -109.72 -42.27 4.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.706 -0.621 . . . . 0.0 110.688 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.831 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -121.2 176.54 5.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.16 -0.962 . . . . 0.0 110.221 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.76 154.26 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-O 121.786 0.803 . . . . 0.0 111.095 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.713 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -118.76 102.16 8.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 177.137 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.524 ' HB2' HD13 ' A' ' 143' ' ' LEU . 1.1 p90 -132.87 150.4 52.16 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.823 -1.151 . . . . 0.0 112.435 -175.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.576 HG11 HD13 ' A' ' 82' ' ' LEU . 3.2 p -101.25 133.56 20.86 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 47.2 Cg_endo -60.88 158.42 33.63 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.91 1.479 . . . . 0.0 111.469 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.751 HG13 ' HA2' ' A' ' 152' ' ' GLY . 31.3 m -82.55 3.43 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.381 -0.824 . . . . 0.0 110.688 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.41 ' HG2' ' HB3' ' A' ' 96' ' ' PRO . 24.6 mt-10 -90.54 -37.78 13.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 108.731 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.9 t -63.85 -36.45 83.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.935 -0.478 . . . . 0.0 110.05 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.943 ' O ' HG22 ' A' ' 178' ' ' THR . 0.5 OUTLIER -48.75 -39.55 25.38 Favored 'General case' 0 N--CA 1.518 2.954 0 CA-C-O 121.643 0.735 . . . . 0.0 109.375 -179.428 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -53.14 -38.06 62.37 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.882 0.848 . . . . 0.0 109.711 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 m -54.22 -39.0 66.31 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.606 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.943 HG22 ' O ' ' A' ' 175' ' ' MET . 9.6 t -59.0 -35.94 74.09 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.093 -1.004 . . . . 0.0 111.644 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.44 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -53.14 -39.63 63.66 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.707 -1.246 . . . . 0.0 110.716 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -38.46 83.43 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.076 0.941 . . . . 0.0 109.179 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -71.47 -39.14 71.11 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.737 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 94.4 p . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.525 -0.734 . . . . 0.0 110.357 -179.834 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.565 HG21 ' HG3' ' A' ' 89' ' ' PRO . 27.0 m . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 57.05 78.82 0.21 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.31 -0.869 . . . . 0.0 109.652 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -161.27 -121.46 0.58 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.558 ' OE1' HD11 ' A' ' 94' ' ' LEU . 24.7 mt-10 -150.98 -39.74 0.12 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.668 -0.901 . . . . 0.0 110.681 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 44' ' ' LEU . 97.7 t -111.58 156.28 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.45 -0.781 . . . . 0.0 110.49 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.67 174.0 10.98 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 43' ' ' PHE . 5.2 p -161.93 150.48 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.353 -0.842 . . . . 0.0 110.487 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.666 HG13 ' CZ ' ' A' ' 43' ' ' PHE . 0.9 OUTLIER -131.6 175.08 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.426 ' N ' HG23 ' A' ' 36' ' ' VAL . 5.2 p -127.61 143.55 51.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.613 -0.679 . . . . 0.0 110.337 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 40' ' ' THR . 7.6 t -142.58 -179.7 6.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.634 -0.666 . . . . 0.0 109.349 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.65 76.8 0.29 Allowed 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.106 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.1 m 174.72 -61.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 174.71 -165.44 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.0 p -108.58 143.49 37.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.409 -0.807 . . . . 0.0 109.369 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.806 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.9 p90 -115.01 -177.42 3.12 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.379 -0.826 . . . . 0.0 111.637 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.687 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -101.69 147.11 26.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.0 110.919 -178.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.451 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -149.24 152.97 36.87 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.791 -0.568 . . . . 0.0 109.996 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.615 HG23 HG23 ' A' ' 48' ' ' VAL . 14.2 t -134.47 117.47 16.29 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.273 1.035 . . . . 0.0 111.966 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.475 ' CB ' ' HB3' ' A' ' 91' ' ' ALA . 21.4 p -66.83 81.71 0.11 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.719 -0.613 . . . . 0.0 110.785 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.615 HG23 HG23 ' A' ' 46' ' ' THR . 59.4 t -97.11 133.45 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.835 -1.166 . . . . 0.0 109.096 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.63 23.55 6.23 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.49 -0.756 . . . . 0.0 110.151 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.0 23.28 49.86 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.42 HG12 ' CA ' ' A' ' 84' ' ' GLY . 39.1 t -139.41 114.84 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.374 -1.074 . . . . 0.0 109.69 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 57.0 m -69.79 105.46 2.77 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.612 -0.68 . . . . 0.0 109.876 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.675 ' CZ3' HD23 ' A' ' 82' ' ' LEU . 97.0 m95 -88.21 137.1 32.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.267 -0.896 . . . . 0.0 112.152 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.638 HG21 ' CZ3' ' A' ' 85' ' ' TRP . 2.0 t -162.82 130.33 3.69 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.208 0.527 . . . . 0.0 109.76 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.415 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 8.4 m -48.54 145.66 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 O-C-N 121.417 -0.802 . . . . 0.0 111.547 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.408 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 61.9 t80 -78.54 -15.9 58.06 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.338 -0.851 . . . . 0.0 111.118 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.415 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 6.1 p-80 -77.33 -23.0 50.99 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.219 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.6 -23.18 7.32 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.534 ' HA ' ' CE1' ' A' ' 43' ' ' PHE . . . -69.34 -81.0 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.309 -1.112 . . . . 0.0 109.957 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.0 -144.22 15.93 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.8 -148.69 0.26 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.425 -1.044 . . . . 0.0 110.358 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.77 -178.99 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.287 -0.883 . . . . 0.0 110.842 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.86 97.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.734 -0.604 . . . . 0.0 109.94 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.914 ' CD2' HD12 ' A' ' 71' ' ' ILE . 3.4 tt -53.84 153.71 4.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.726 -0.609 . . . . 0.0 110.839 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.76 145.95 39.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.766 -0.584 . . . . 0.0 109.752 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.436 ' HA3' HD11 ' A' ' 71' ' ' ILE . . . -134.87 -179.07 16.14 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.65 -16.89 57.61 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.938 1.494 . . . . 0.0 110.73 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -120.4 23.22 10.98 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.117 -0.989 . . . . 0.0 111.439 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.71 -166.31 12.25 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 45.9 Cg_endo -65.6 135.5 42.33 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.96 1.505 . . . . 0.0 110.786 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.914 HD12 ' CD2' ' A' ' 64' ' ' LEU . 71.6 mt -95.72 157.81 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.62 -0.675 . . . . 0.0 109.945 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 p -105.11 104.98 14.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.401 -0.812 . . . . 0.0 109.998 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -56.33 151.64 12.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.732 -0.605 . . . . 0.0 111.166 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 tpt -138.11 -38.88 0.55 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.66 -0.65 . . . . 0.0 110.329 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 20.7 m-85 -126.22 122.86 36.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.287 -0.883 . . . . 0.0 110.032 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.733 HG23 ' CG1' ' A' ' 83' ' ' VAL . 2.5 m -146.88 121.81 10.01 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.456 -0.777 . . . . 0.0 109.589 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -146.31 77.79 1.49 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.259 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' A' ' 56' ' ' TYR . 7.5 p -49.97 -28.95 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.628 -0.67 . . . . 0.0 110.433 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.33 -45.19 92.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.43 -0.794 . . . . 0.0 109.485 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.83 14.17 26.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.599 -0.688 . . . . 0.0 109.694 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.635 ' O ' HD12 ' A' ' 82' ' ' LEU . 24.9 m-20 52.22 56.28 7.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.283 -0.885 . . . . 0.0 111.951 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.675 HD23 ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -159.29 137.54 10.52 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.215 -0.928 . . . . 0.0 111.651 178.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.733 ' CG1' HG23 ' A' ' 76' ' ' THR . 39.6 t -144.14 103.0 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 52' ' ' CYS . . . -102.83 94.29 1.13 Allowed Glycine 0 N--CA 1.483 1.797 0 C-N-CA 119.928 -1.13 . . . . 0.0 111.216 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.638 ' CZ3' HG21 ' A' ' 54' ' ' THR . 4.8 p90 -81.43 178.57 8.29 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -92.26 125.08 36.78 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.042 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' A' ' 91' ' ' ALA . . . -58.06 156.15 21.46 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.424 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.515 ' HG2' ' HD3' ' A' ' 89' ' ' PRO . 30.2 Cg_endo -62.28 -77.43 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.353 0 O-C-N 123.991 1.522 . . . . 0.0 111.822 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.565 ' HG3' HG21 ' A' ' 29' ' ' VAL . 59.3 Cg_endo -94.16 28.54 0.28 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 115.874 -2.284 . . . . 0.0 109.287 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.52 -16.91 59.61 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.475 ' HB3' ' CB ' ' A' ' 47' ' ' CYS . . . 50.49 22.04 0.97 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.039 -1.271 . . . . 0.0 111.31 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 64.7 69.56 0.5 Allowed 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -177.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 m -43.27 128.68 4.78 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.582 HD23 ' HB2' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -85.04 -157.9 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.685 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 1.3 p -144.08 -179.25 0.91 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.554 -0.716 . . . . 0.0 110.263 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -86.51 170.18 7.93 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 O-C-N 123.841 1.443 . . . . 0.0 110.318 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' A' ' 151' ' ' VAL . 9.4 t -82.81 -91.35 0.07 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.611 -0.681 . . . . 0.0 109.694 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 98' ' ' THR . 26.2 m 51.83 21.42 1.42 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.909 -1.12 . . . . 0.0 111.348 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 13.3 p -141.42 -25.5 0.71 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.284 -0.885 . . . . 0.0 112.482 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.406 ' HA3' ' HD2' ' A' ' 146' ' ' PRO . . . -102.06 128.71 9.64 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.0 p -66.63 -46.88 74.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.753 -0.851 . . . . 0.0 110.058 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 t -162.57 -156.45 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.576 -0.702 . . . . 0.0 110.504 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 55.41 100.69 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.549 -0.719 . . . . 0.0 110.493 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.829 HD13 HD23 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -121.22 -170.18 1.98 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.36 -0.837 . . . . 0.0 110.124 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.753 ' HB2' HG13 ' A' ' 113' ' ' VAL . 11.7 p90 -160.88 98.02 1.18 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.893 HD11 HD12 ' A' ' 114' ' ' ILE . 3.3 pp -67.29 123.3 19.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.843 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.23 99.63 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.452 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.9 p -61.92 155.38 23.68 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.687 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -78.95 0.56 26.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.301 -0.875 . . . . 0.0 110.764 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.1 OUTLIER -114.87 35.76 4.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.096 -1.003 . . . . 0.0 109.678 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.35 76.74 0.32 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.52 -0.738 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -167.46 97.25 0.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.534 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.753 HG13 ' HB2' ' A' ' 105' ' ' TYR . 2.1 t -82.72 145.05 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.893 HD12 HD11 ' A' ' 106' ' ' LEU . 39.7 mt -133.21 111.39 12.96 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 46.7 Cg_endo -58.47 145.27 95.1 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.655 1.345 . . . . 0.0 111.396 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 114' ' ' ILE . 33.1 t -140.46 150.8 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.609 -0.682 . . . . 0.0 109.886 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -109.34 116.14 31.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -48.68 125.35 9.88 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.363 -0.836 . . . . 0.0 111.015 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -108.32 -44.22 4.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.95 -0.469 . . . . 0.0 110.479 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -159.2 63.93 0.3 Allowed Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.947 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.457 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER 60.9 -75.56 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.625 -0.927 . . . . 0.0 111.109 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 120' ' ' GLY . 41.2 p -89.69 38.24 0.91 Allowed 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.85 -0.531 . . . . 0.0 110.3 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.466 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 18.6 ttm180 -168.43 149.12 4.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.371 -0.83 . . . . 0.0 110.312 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.17 -179.26 19.7 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -124.16 117.21 24.12 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 122.097 -0.649 . . . . 0.0 111.415 -178.535 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.448 HD22 ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -55.29 142.22 32.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.637 -0.664 . . . . 0.0 110.158 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.5 mt -112.42 55.21 0.69 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.448 ' O ' HD22 ' A' ' 126' ' ' LEU . 0.5 OUTLIER 172.57 118.8 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.027 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.254 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -59.79 101.01 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 O-C-N 123.483 1.254 . . . . 0.0 109.568 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -120.51 169.26 8.98 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.22 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.411 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 44.7 Cg_endo -85.73 129.3 3.52 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 124.148 1.604 . . . . 0.0 110.303 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.7 p -59.68 -35.35 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.796 -0.565 . . . . 0.0 110.076 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.9 m -48.94 -36.34 17.15 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.299 -0.876 . . . . 0.0 110.41 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.558 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -66.03 -38.25 87.92 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 17.5 mt -70.21 -37.04 74.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -55.57 124.82 18.59 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.022 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.33 -29.62 12.11 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.425 ' HA ' HD23 ' A' ' 44' ' ' LEU . 57.2 m -82.71 1.11 40.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.694 -0.886 . . . . 0.0 111.028 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.41 123.95 14.55 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.922 -1.111 . . . . 0.0 110.394 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.58 -11.85 12.31 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 44' ' ' LEU . . . -62.41 140.07 46.08 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.585 ' O ' HD12 ' A' ' 144' ' ' LEU . 52.3 Cg_endo -82.85 124.27 3.88 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.594 1.312 . . . . 0.0 113.171 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.829 HD23 HD13 ' A' ' 104' ' ' LEU . 1.2 mp -76.0 141.3 42.2 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 142' ' ' PRO . 0.9 OUTLIER -137.57 136.58 37.71 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 120.009 1.277 . . . . 0.0 112.355 -177.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.49 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 15.2 p -84.16 -174.16 0.5 Allowed Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 49.6 Cg_endo -60.1 164.84 11.61 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 117.328 -1.314 . . . . 0.0 110.08 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.36 163.15 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.344 -0.847 . . . . 0.0 109.588 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 149' ' ' HIS . . . -69.59 102.81 1.01 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.41 ' CG ' ' O ' ' A' ' 148' ' ' GLY . 1.5 m170 -166.46 106.84 0.66 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.588 -0.948 . . . . 0.0 110.38 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -60.17 142.36 54.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.642 . . . . 0.0 110.448 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.657 HG12 ' CE2' ' A' ' 169' ' ' PHE . 3.4 t -107.88 -44.38 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.713 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . -178.86 -178.33 48.07 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.523 HD11 HD12 ' A' ' 82' ' ' LEU . 1.1 pt -116.44 143.77 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.129 -1.218 . . . . 0.0 111.21 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.733 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.8 t80 -60.53 116.55 4.42 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.048 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -103.68 -44.62 5.04 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.371 -0.83 . . . . 0.0 109.062 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -152.5 169.92 21.42 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.733 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -126.58 115.58 19.72 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.066 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.778 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.4 t -66.41 100.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.59 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.4 p -128.88 142.48 50.94 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -174.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 162' ' ' GLY . 69.9 p -73.79 -174.61 1.84 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.9 84.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.741 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 86.89 -27.77 5.81 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 121.146 -0.971 . . . . 0.0 111.92 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -94.07 137.16 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.026 1.413 . . . . 0.0 109.089 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.03 126.08 47.69 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.843 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -110.35 -38.68 5.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.78 -0.575 . . . . 0.0 110.384 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.778 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -126.32 170.56 11.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 110.164 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.2 153.85 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.642 0.734 . . . . 0.0 111.261 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.645 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 11.8 t0 -121.03 96.49 5.12 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.657 ' CE2' HG12 ' A' ' 151' ' ' VAL . 3.7 p90 -130.41 161.39 31.46 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.596 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.461 HG11 ' CD1' ' A' ' 82' ' ' LEU . 1.1 p -111.28 123.21 35.64 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.1 Cg_endo -50.56 157.13 3.64 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.861 1.453 . . . . 0.0 112.359 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.713 HG13 ' HA2' ' A' ' 152' ' ' GLY . 27.8 m -83.22 3.08 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.799 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -87.79 -36.32 17.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -36.05 78.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 110.592 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.52 ' HG2' HD21 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -47.3 -39.18 14.1 Favored 'General case' 0 N--CA 1.524 3.27 0 CA-C-O 121.789 0.804 . . . . 0.0 109.302 -179.159 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -53.78 -38.46 64.51 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.915 0.864 . . . . 0.0 109.197 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.1 m -55.81 -39.6 71.56 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.374 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -58.11 -42.64 86.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.522 -0.736 . . . . 0.0 110.32 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.459 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -54.79 -40.16 69.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.405 -0.809 . . . . 0.0 111.056 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -51.28 -38.22 51.62 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.94 0.876 . . . . 0.0 110.408 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -80.84 -41.18 23.66 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.5 2.056 0 O-C-N 121.626 -0.671 . . . . 0.0 110.595 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.568 HG21 ' HG3' ' A' ' 34' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -156.28 76.84 0.92 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.64 0.733 . . . . 0.0 109.565 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.35 57.45 8.17 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.451 ' C ' HG23 ' A' ' 33' ' ' VAL . 11.8 mt-10 -154.83 -85.26 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.57 -0.959 . . . . 0.0 111.795 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 45' ' ' ALA . 59.9 t -149.8 152.11 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.964 -1.085 . . . . 0.0 111.581 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.568 ' HG3' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -134.22 144.11 48.24 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.095 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.501 HG12 ' HD2' ' A' ' 109' ' ' ARG . 34.5 m -103.57 178.81 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.207 -0.933 . . . . 0.0 111.934 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.463 ' CG1' HD21 ' A' ' 64' ' ' LEU . 33.1 m -136.31 -179.4 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.0 m -157.5 135.59 10.96 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.634 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 p -141.36 -179.07 5.92 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.09 75.44 0.67 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.949 -1.101 . . . . 0.0 108.621 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m 179.25 -63.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.7 -163.36 0.14 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.664 -0.647 . . . . 0.0 109.342 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -120.63 136.5 54.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.435 -0.791 . . . . 0.0 109.902 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 52.4 m-85 -101.87 -177.55 3.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.609 -0.682 . . . . 0.0 110.518 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.764 HD23 ' N ' ' A' ' 45' ' ' ALA . 7.6 tt -113.37 153.72 28.07 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.363 -0.836 . . . . 0.0 109.37 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.764 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -156.85 130.94 8.42 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.029 -1.044 . . . . 0.0 109.973 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.576 HG23 HG23 ' A' ' 48' ' ' VAL . 15.2 t -97.84 129.98 44.78 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.201 -0.937 . . . . 0.0 111.883 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 80.1 m -80.81 84.39 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.292 -0.88 . . . . 0.0 110.289 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.576 HG23 HG23 ' A' ' 46' ' ' THR . 54.7 t -98.4 138.01 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 58.26 19.61 6.4 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.207 -0.933 . . . . 0.0 109.818 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.28 24.33 54.68 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -138.24 106.85 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.38 -1.071 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.94 115.57 2.94 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.62 -0.675 . . . . 0.0 109.182 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.505 ' CH2' ' HE3' ' A' ' 179' ' ' MET . 97.7 m95 -96.49 142.44 28.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 111.326 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.6 HG23 HG23 ' A' ' 83' ' ' VAL . 10.8 t -161.42 -177.59 6.08 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.407 ' C ' HG22 ' A' ' 83' ' ' VAL . 12.3 m -109.8 150.27 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.449 -0.782 . . . . 0.0 110.457 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.567 ' HB2' HG11 ' A' ' 83' ' ' VAL . 33.7 t80 -71.2 -0.91 10.88 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.826 -1.171 . . . . 0.0 112.073 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -48.44 -27.65 2.78 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.171 -0.956 . . . . 0.0 110.608 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.9 41.27 0.11 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -156.95 113.73 3.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.661 -0.905 . . . . 0.0 110.328 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.07 -49.0 0.89 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.09 178.28 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.546 -0.973 . . . . 0.0 110.514 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 50.7 -170.93 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.39 -0.819 . . . . 0.0 110.889 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.63 106.88 19.26 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.652 0.739 . . . . 0.0 109.768 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.463 HD21 ' CG1' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.91 169.98 2.32 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.502 0.667 . . . . 0.0 111.275 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -115.99 136.3 53.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.869 -0.519 . . . . 0.0 109.691 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.18 -178.48 15.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -53.46 96.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.826 0 O-C-N 123.653 1.344 . . . . 0.0 110.855 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt 54.2 28.28 8.9 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.445 -0.784 . . . . 0.0 110.629 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.07 139.09 5.0 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.14 163.06 24.07 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.861 1.453 . . . . 0.0 110.3 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.9 mt -97.94 99.2 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.569 -0.707 . . . . 0.0 109.684 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 72' ' ' THR . 9.2 t -55.81 123.47 14.3 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.623 -0.673 . . . . 0.0 110.874 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -55.4 130.73 43.73 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.631 -0.668 . . . . 0.0 111.007 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.2 mmt -128.75 -50.07 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.494 -0.753 . . . . 0.0 109.82 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 179' ' ' MET . 10.7 m-85 -125.93 111.67 15.05 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.538 -0.726 . . . . 0.0 110.014 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.602 HG23 ' HB ' ' A' ' 83' ' ' VAL . 12.8 m -144.67 112.36 6.22 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.601 -0.687 . . . . 0.0 110.723 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -139.53 76.01 1.54 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.921 -1.112 . . . . 0.0 111.886 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.429 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.4 p -52.35 -25.18 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.36 -0.838 . . . . 0.0 109.512 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -32.82 73.61 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -96.75 22.48 8.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.76 41.9 31.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.498 -0.751 . . . . 0.0 111.469 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.842 HD11 HD11 ' A' ' 153' ' ' ILE . 0.3 OUTLIER -169.09 153.23 5.42 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.061 -1.055 . . . . 0.0 113.158 178.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.602 ' HB ' HG23 ' A' ' 76' ' ' THR . 35.0 m -155.34 130.48 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.45 148.71 20.32 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.615 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.462 ' CZ2' HD11 ' A' ' 64' ' ' LEU . 1.1 m-90 -116.32 172.02 7.45 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -75.11 141.94 43.69 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.126 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -111.2 101.69 50.99 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.111 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.4 Cg_endo -115.63 10.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.11 0 O-C-N 123.75 1.395 . . . . 0.0 112.768 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 52.1 Cg_endo -63.7 -100.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 116.702 -1.732 . . . . 0.0 108.686 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.44 34.21 5.83 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 105.49 -3.044 . . . . 0.0 105.49 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.61 157.97 37.01 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.945 -0.738 . . . . 0.0 111.214 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.19 20.48 6.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.846 -0.534 . . . . 0.0 109.926 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.9 p 45.63 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.628 -0.67 . . . . 0.0 112.431 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.69 ' O ' HG23 ' A' ' 95' ' ' THR . 0.3 OUTLIER -76.7 -151.52 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 109.763 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -161.04 171.23 7.26 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.394 -0.816 . . . . 0.0 110.611 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -83.12 159.46 15.44 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 O-C-N 123.935 1.492 . . . . 0.0 110.575 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.654 ' CB ' HG23 ' A' ' 151' ' ' VAL . 2.1 t -92.99 136.77 32.96 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.561 -0.712 . . . . 0.0 109.555 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.9 m -108.05 -37.12 6.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.603 -0.685 . . . . 0.0 110.121 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.473 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 26.6 p -64.67 -22.31 66.95 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.675 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.87 -94.57 0.04 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.6 t 51.82 -174.5 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.389 -1.065 . . . . 0.0 110.436 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.2 p -107.23 -162.0 0.82 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.433 -0.792 . . . . 0.0 110.33 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 55.2 m-20 55.36 97.21 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.529 -0.732 . . . . 0.0 110.467 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.843 HD13 HD23 ' A' ' 143' ' ' LEU . 3.0 mt -114.18 -176.38 2.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.598 -0.689 . . . . 0.0 110.159 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 107' ' ' VAL . 64.2 m-85 -132.08 84.77 2.18 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.9 tp -67.52 97.0 0.56 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 105' ' ' TYR . 47.6 t -82.96 113.9 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.616 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.448 ' HB ' ' NE2' ' A' ' 110' ' ' HIS . 67.3 p -70.21 178.5 2.79 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.625 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -99.73 42.44 1.11 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.008 -1.058 . . . . 0.0 110.64 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.448 ' NE2' ' HB ' ' A' ' 108' ' ' THR . 2.8 p80 -164.97 46.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.717 0.77 . . . . 0.0 109.703 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.29 70.0 0.61 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.353 0.597 . . . . 0.0 111.206 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 108' ' ' THR . 0.8 OUTLIER -165.49 78.18 0.29 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.479 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.7 p -68.1 152.72 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.615 -0.678 . . . . 0.0 110.209 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 116' ' ' VAL . 46.9 mt -131.37 111.63 15.31 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.353 -0.842 . . . . 0.0 108.783 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -56.89 141.6 93.18 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 O-C-N 123.66 1.348 . . . . 0.0 111.913 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 41.9 t -135.95 148.72 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.525 -0.735 . . . . 0.0 109.767 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.2 115.96 29.05 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -49.3 125.24 10.56 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.299 -0.875 . . . . 0.0 110.882 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.423 ' HG2' ' HB2' ' A' ' 125' ' ' SER . 0.0 OUTLIER -104.75 -47.34 4.07 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.278 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.73 -164.91 13.1 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.12 137.66 57.2 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.504 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 58.1 p 46.03 47.71 12.69 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.062 0.458 . . . . 0.0 111.892 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.509 ' HD2' HG21 ' A' ' 158' ' ' VAL . 0.4 OUTLIER -168.59 144.81 3.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.41 -0.806 . . . . 0.0 110.779 179.279 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -137.98 -178.44 16.1 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.423 ' HB2' ' HG2' ' A' ' 119' ' ' ARG . 0.3 OUTLIER -130.3 102.93 6.41 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.004 -178.242 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.854 ' O ' HD12 ' A' ' 126' ' ' LEU . 1.8 pp -49.63 146.91 3.88 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.597 -0.69 . . . . 0.0 110.404 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.8 mt -109.08 54.74 0.65 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.02 0.914 . . . . 0.0 108.841 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.5 117.77 0.17 Allowed Pre-proline 0 N--CA 1.497 1.902 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -59.12 99.13 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 O-C-N 123.742 1.391 . . . . 0.0 109.447 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -114.46 144.9 32.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.019 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.487 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 44.3 Cg_endo -62.25 123.84 13.23 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 124.042 1.549 . . . . 0.0 109.993 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 162' ' ' GLY . 6.7 p -51.0 -36.57 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.593 -0.692 . . . . 0.0 110.901 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.4 t -49.56 -35.36 20.23 Favored 'General case' 0 N--CA 1.506 2.353 0 CA-C-O 122.042 0.925 . . . . 0.0 110.099 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.487 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 34.8 t80 -63.38 -38.56 91.62 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.52 HD11 ' CB ' ' A' ' 164' ' ' ALA . 10.7 mt -68.8 -35.9 77.6 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.113 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -59.99 121.85 12.85 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.555 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 112.66 -30.21 7.66 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.3 m -88.78 10.53 20.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.74 -0.859 . . . . 0.0 111.12 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.5 p -51.46 127.6 20.47 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.049 -1.032 . . . . 0.0 109.755 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.588 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 115.71 -11.91 18.27 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -176.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.637 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -44.51 114.99 1.18 Allowed Glycine 0 N--CA 1.504 3.225 0 O-C-N 121.556 -0.967 . . . . 0.0 111.454 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.62 119.87 6.84 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.927 1.488 . . . . 0.0 111.356 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.843 HD23 HD13 ' A' ' 104' ' ' LEU . 4.0 mp -87.6 90.94 8.56 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.31 124.1 34.63 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.304 -0.872 . . . . 0.0 111.395 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.473 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 26.6 p -74.86 172.31 9.34 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.776 -0.578 . . . . 0.0 109.892 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 49.3 Cg_endo -71.05 90.43 0.65 Allowed 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.637 1.335 . . . . 0.0 110.973 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.72 -41.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.431 -0.793 . . . . 0.0 110.149 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.97 28.9 1.6 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -141.29 143.27 33.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.377 -1.072 . . . . 0.0 109.469 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.446 ' O ' HG21 ' A' ' 172' ' ' VAL . . . -68.51 131.95 46.14 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.54 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.654 HG23 ' CB ' ' A' ' 97' ' ' CYS . 0.8 OUTLIER -94.14 -27.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.901 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 177.91 -177.85 48.4 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.842 HD11 HD11 ' A' ' 82' ' ' LEU . 1.8 pp -128.51 153.69 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 CA-C-N 119.013 1.406 . . . . 0.0 111.828 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.85 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 4.2 t80 -64.26 103.52 0.64 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.777 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -90.95 -42.66 10.44 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.601 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -154.46 177.88 10.68 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.85 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -133.35 118.56 18.62 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.657 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.843 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.1 t -65.99 102.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.507 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.0 p -129.1 153.25 47.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 122.162 0.982 . . . . 0.0 113.618 -174.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -86.77 -174.84 5.16 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.61 85.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.657 -0.652 . . . . 0.0 112.442 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.78 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 85.15 -23.59 7.93 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.23 -0.919 . . . . 0.0 111.718 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -98.41 142.42 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 119.125 1.462 . . . . 0.0 109.123 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.697 ' C ' HD21 ' A' ' 126' ' ' LEU . . . -102.05 133.09 47.43 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.151 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.674 ' HA ' HD11 ' A' ' 126' ' ' LEU . 20.6 mtpt -114.17 -36.13 4.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.562 -0.711 . . . . 0.0 110.965 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.843 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -135.37 172.75 12.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.402 -0.811 . . . . 0.0 109.979 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.19 152.62 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 111.178 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -117.03 93.21 4.1 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.435 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.837 ' CG ' HD22 ' A' ' 143' ' ' LEU . 2.6 p90 -128.35 148.65 50.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.408 -0.808 . . . . 0.0 110.838 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.412 ' CG2' ' SD ' ' A' ' 175' ' ' MET . 1.0 OUTLIER -103.51 148.78 36.27 Favored Pre-proline 0 N--CA 1.497 1.916 0 C-N-CA 118.621 -1.232 . . . . 0.0 108.596 179.054 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.544 ' O ' ' HG3' ' A' ' 175' ' ' MET . 47.0 Cg_endo -63.03 137.91 64.7 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.103 1.581 . . . . 0.0 110.496 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.901 HG13 ' HA2' ' A' ' 152' ' ' GLY . 25.6 m -75.94 -0.99 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -77.27 -37.01 53.8 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.1 m -84.13 -38.42 20.74 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.781 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.544 ' HG3' ' O ' ' A' ' 171' ' ' PRO . 11.3 mtm -49.54 -41.05 40.22 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.313 -0.867 . . . . 0.0 110.039 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.459 ' HA ' ' HE3' ' A' ' 179' ' ' MET . 44.8 mm-40 -54.15 -39.49 66.57 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.569 0.7 . . . . 0.0 110.323 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.4 m -50.26 -35.75 28.35 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.933 -0.479 . . . . 0.0 112.266 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.3 t -48.69 -40.81 29.53 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.213 -0.93 . . . . 0.0 113.174 -177.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.505 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 3.3 ptp -61.0 -38.59 86.57 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.611 -1.306 . . . . 0.0 110.003 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.34 -38.55 53.69 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.871 0.843 . . . . 0.0 109.903 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -78.53 -39.7 37.18 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.502 2.128 0 O-C-N 121.382 -0.824 . . . . 0.0 111.042 179.72 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.731 HG21 ' HA ' ' A' ' 91' ' ' ALA . 14.1 p . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.249 0.547 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.83 79.37 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.625 -0.672 . . . . 0.0 109.22 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.89 -86.75 0.12 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.606 ' OE2' HD21 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -173.67 -35.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.495 -1.003 . . . . 0.0 111.008 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.553 HG11 HD21 ' A' ' 44' ' ' LEU . 21.2 t -104.56 153.29 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.32 -0.862 . . . . 0.0 110.303 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.439 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 18.7 pt20 -139.3 135.33 33.7 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.411 -0.806 . . . . 0.0 110.438 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 44' ' ' LEU . 36.0 m -108.97 161.58 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.544 -0.723 . . . . 0.0 111.583 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.792 HG11 HD21 ' A' ' 64' ' ' LEU . 2.0 p -144.87 145.28 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 p -117.7 143.54 46.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.748 . . . . 0.0 111.03 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 40' ' ' THR . 7.4 t -128.74 -179.61 5.17 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.06 76.63 0.23 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.354 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.2 m 177.9 -59.76 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -175.95 -166.38 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.677 -0.64 . . . . 0.0 109.443 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.7 p -119.83 137.91 53.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.354 -0.842 . . . . 0.0 110.436 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.685 ' CE2' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -108.96 -176.2 2.97 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.752 HD23 ' N ' ' A' ' 45' ' ' ALA . 8.3 tt -125.74 147.86 49.24 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.752 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -148.92 135.98 19.97 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.858 -1.151 . . . . 0.0 111.467 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.707 HG23 HG23 ' A' ' 48' ' ' VAL . 7.3 t -106.32 126.37 52.15 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.471 -0.768 . . . . 0.0 111.88 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.6 t -76.34 85.01 3.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.475 -0.766 . . . . 0.0 109.766 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.707 HG23 HG23 ' A' ' 46' ' ' THR . 95.8 t -102.14 138.03 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.4 t30 58.18 18.83 5.62 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.434 -0.791 . . . . 0.0 110.143 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.97 23.97 43.25 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 85' ' ' TRP . 85.1 t -143.0 112.62 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -1.117 . . . . 0.0 110.358 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.405 ' O ' ' HA2' ' A' ' 84' ' ' GLY . 25.7 p -61.56 126.37 27.11 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.688 ' CE3' HD23 ' A' ' 82' ' ' LEU . 85.2 m95 -105.5 139.46 40.08 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.233 -0.917 . . . . 0.0 112.621 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.872 ' O ' HG22 ' A' ' 83' ' ' VAL . 5.7 t -160.73 150.81 17.73 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.598 -0.688 . . . . 0.0 110.235 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.419 ' HB ' ' CD2' ' A' ' 57' ' ' HIS . 16.0 t -72.67 149.45 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 121.242 -0.911 . . . . 0.0 109.888 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.706 ' HB3' HG12 ' A' ' 78' ' ' VAL . 9.0 t80 -82.44 5.26 21.11 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.856 -1.153 . . . . 0.0 112.328 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.419 ' CD2' ' HB ' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -76.68 5.91 6.82 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.059 -1.025 . . . . 0.0 112.013 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.57 -43.21 0.03 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . . . -91.55 146.19 23.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.593 -0.945 . . . . 0.0 110.147 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.44 -45.8 1.42 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.5 t -60.19 174.36 0.53 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.519 -0.989 . . . . 0.0 109.803 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.32 -176.24 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.304 -0.873 . . . . 0.0 110.489 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 m -88.87 94.72 10.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.539 -0.725 . . . . 0.0 110.18 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.898 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -61.23 174.78 0.63 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.637 -0.664 . . . . 0.0 110.046 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.53 137.14 41.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.46 -0.775 . . . . 0.0 110.68 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.96 -179.46 16.04 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.4 -8.48 23.71 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.914 1.481 . . . . 0.0 111.035 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -139.01 30.87 2.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.034 -1.041 . . . . 0.0 110.999 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.67 175.13 13.98 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.73 148.02 76.66 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 124.016 1.535 . . . . 0.0 110.13 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.898 HD12 ' CD2' ' A' ' 64' ' ' LEU . 84.1 mt -91.62 151.06 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 110.04 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.427 ' HG1' ' C ' ' A' ' 71' ' ' ILE . 24.2 m -159.49 -62.81 0.07 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.479 -0.763 . . . . 0.0 110.401 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.19 -156.48 0.24 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.409 -0.807 . . . . 0.0 110.183 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.3 ttt -142.7 28.04 1.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.764 . . . . 0.0 110.164 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CE1' ' CB ' ' A' ' 179' ' ' MET . 13.4 m-30 -106.94 100.32 9.83 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.8 HG23 ' CG1' ' A' ' 83' ' ' VAL . 66.3 m -159.93 137.36 9.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 110.742 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -159.95 79.66 0.7 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.561 -0.856 . . . . 0.0 112.142 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.706 HG12 ' HB3' ' A' ' 56' ' ' TYR . 33.9 m -44.63 -26.44 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.437 -0.79 . . . . 0.0 111.812 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -55.65 -62.66 1.54 Allowed 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.004 -1.06 . . . . 0.0 108.596 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -81.48 -1.19 45.02 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.143 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.546 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.0 OUTLIER 60.77 66.49 0.91 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.563 -0.711 . . . . 0.0 111.076 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.002 HD11 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -164.44 145.9 8.35 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.254 -0.978 . . . . 0.0 112.868 178.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 54' ' ' THR . 2.5 m -142.81 159.39 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 52' ' ' CYS . . . -149.1 101.83 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 118.486 -1.816 . . . . 0.0 111.782 -178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.574 ' CH2' HD11 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -85.62 166.28 16.34 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 177.382 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -90.44 131.13 36.38 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.904 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -72.71 139.17 80.34 Favored Pre-proline 0 C--N 1.297 -1.686 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.829 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.466 ' HG2' ' HD3' ' A' ' 89' ' ' PRO . 36.3 Cg_endo -115.23 -41.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 117.389 -1.274 . . . . 0.0 115.116 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.585 ' HB2' HG12 ' A' ' 29' ' ' VAL . 55.8 Cg_endo -63.27 -152.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 116.994 -1.537 . . . . 0.0 109.454 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.79 34.11 2.56 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.731 ' HA ' HG21 ' A' ' 29' ' ' VAL . . . -55.25 126.85 26.63 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.059 -1.26 . . . . 0.0 111.014 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.81 154.7 41.53 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.3 p -112.91 117.94 33.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.363 -0.836 . . . . 0.0 110.619 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 ' OE2' ' A' ' 32' ' ' GLU . 16.7 mt -86.71 -164.39 1.06 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.623 -0.673 . . . . 0.0 109.288 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.428 HG23 ' N ' ' A' ' 96' ' ' PRO . 0.6 OUTLIER -150.52 -170.04 0.23 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.631 -0.668 . . . . 0.0 109.48 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.428 ' N ' HG23 ' A' ' 95' ' ' THR . 50.1 Cg_endo -89.19 156.71 5.64 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 O-C-N 123.528 1.278 . . . . 0.0 111.308 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -105.14 143.44 33.31 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.568 -0.708 . . . . 0.0 110.204 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 m -156.81 37.18 0.31 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.622 -0.674 . . . . 0.0 110.439 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 31.6 p -93.57 -171.27 2.57 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.28 -0.888 . . . . 0.0 110.579 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.79 94.81 0.87 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.7 p -165.47 -164.09 0.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.963 . . . . 0.0 109.893 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.07 -40.32 0.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.432 -0.793 . . . . 0.0 110.789 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 2.7 t0 -64.5 123.49 19.36 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.414 -0.803 . . . . 0.0 110.087 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.661 HD13 HD23 ' A' ' 143' ' ' LEU . 1.6 mt -115.85 179.15 4.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.453 -0.78 . . . . 0.0 109.97 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.66 ' O ' HG23 ' A' ' 107' ' ' VAL . 12.2 m-85 -132.92 79.49 1.84 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.622 HD23 ' HB ' ' A' ' 114' ' ' ILE . 1.4 tp -58.79 101.81 0.1 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.992 HG22 HG12 ' A' ' 113' ' ' VAL . 75.6 t -90.55 114.89 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.563 -0.711 . . . . 0.0 111.727 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.522 HG21 ' CZ ' ' A' ' 134' ' ' TYR . 10.2 p -74.71 178.71 5.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.517 ' HD3' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -98.31 29.51 3.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.857 -1.152 . . . . 0.0 110.288 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -128.58 33.41 4.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 58.51 69.31 0.74 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.455 -0.778 . . . . 0.0 110.908 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -172.06 108.64 0.23 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.594 -0.691 . . . . 0.0 110.256 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.992 HG12 HG22 ' A' ' 107' ' ' VAL . 33.3 m -84.81 158.39 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.929 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.622 ' HB ' HD23 ' A' ' 106' ' ' LEU . 28.3 mm -127.98 111.56 20.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -60.88 133.12 45.84 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 O-C-N 123.752 1.396 . . . . 0.0 111.259 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 114' ' ' ILE . 20.2 t -135.09 149.08 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.643 -0.66 . . . . 0.0 109.841 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -104.29 111.15 23.66 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.445 HH12 HG13 ' A' ' 151' ' ' VAL . 17.2 ttt180 -48.71 122.54 5.72 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.641 0.734 . . . . 0.0 111.351 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.85 -36.95 5.77 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.31 171.82 32.21 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.04 -21.95 35.18 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.502 -0.999 . . . . 0.0 110.703 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.401 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 4.6 p -130.91 40.02 3.52 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.807 -0.558 . . . . 0.0 111.104 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.487 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -171.05 153.5 3.8 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.142 -0.974 . . . . 0.0 111.021 179.08 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.39 -178.39 25.23 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -129.38 115.75 18.0 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.912 -0.758 . . . . 0.0 111.907 -178.23 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' A' ' 130' ' ' ARG . 0.1 OUTLIER -54.43 148.08 12.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.328 -0.857 . . . . 0.0 109.881 178.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.6 mt -112.27 54.02 0.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 164.5 142.73 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.311 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.31 112.15 2.02 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.79 1.416 . . . . 0.0 109.576 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.426 ' HB3' HD22 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -121.08 127.99 25.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.474 -0.766 . . . . 0.0 108.945 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -54.72 131.11 44.02 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.775 1.408 . . . . 0.0 111.467 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.8 p -63.79 -36.03 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 121.253 0.549 . . . . 0.0 109.999 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -48.74 -36.54 16.61 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.08 -1.013 . . . . 0.0 110.611 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.522 ' CZ ' HG21 ' A' ' 108' ' ' THR . 26.8 t80 -65.8 -38.62 89.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.1 mt -65.09 -36.01 82.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -63.08 124.78 22.0 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.704 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.52 -25.55 27.21 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.3 m -90.32 6.79 41.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.994 . . . . 0.0 111.283 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 p -53.15 121.4 7.4 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.021 -1.049 . . . . 0.0 109.747 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.573 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 120.91 -10.33 10.27 Favored Glycine 0 CA--C 1.542 1.725 0 N-CA-C 107.664 -2.174 . . . . 0.0 107.664 -176.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.605 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -54.97 116.41 6.72 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.5 ' O ' HD12 ' A' ' 144' ' ' LEU . 51.6 Cg_endo -68.41 118.82 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.813 1.428 . . . . 0.0 111.805 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.661 HD23 HD13 ' A' ' 104' ' ' LEU . 2.7 mp -74.87 138.58 42.57 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 176.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 142' ' ' PRO . 1.1 mt -134.8 120.57 19.53 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.845 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 16.9 p -71.81 -178.3 0.59 Allowed Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.1 Cg_endo -60.62 -179.57 0.28 Allowed 'Trans proline' 0 N--CA 1.491 1.343 0 O-C-N 123.288 1.151 . . . . 0.0 110.833 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.01 -79.16 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.449 -0.782 . . . . 0.0 110.286 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 177.46 -142.28 5.64 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 62.4 m170 57.99 118.14 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.839 -0.801 . . . . 0.0 111.308 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.521 ' O ' HG21 ' A' ' 172' ' ' VAL . . . -63.02 137.68 58.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.489 -0.757 . . . . 0.0 109.913 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.578 HG12 ' CE2' ' A' ' 169' ' ' PHE . 3.1 t -92.04 -44.92 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.809 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . -173.62 -177.78 43.09 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 1.002 HD11 HD11 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -120.0 142.06 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.515 -0.991 . . . . 0.0 110.541 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.719 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 10.1 t80 -58.2 116.58 3.66 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.495 ' HG3' ' HB3' ' A' ' 81' ' ' ASP . 5.4 ttt180 -103.37 -43.06 5.53 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.622 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -160.4 179.6 8.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.719 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -141.67 128.9 21.02 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.036 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.78 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.3 t -69.66 102.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 76.7 m -120.9 172.42 7.93 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.587 1.184 . . . . 0.0 113.401 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.4 OUTLIER -110.92 -174.42 2.47 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -49.47 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.37 -0.831 . . . . 0.0 112.798 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.717 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 84.4 -25.21 5.76 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.668 -1.27 . . . . 0.0 111.896 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.18 136.1 31.62 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.222 0 O-C-N 120.756 -1.438 . . . . 0.0 109.256 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.441 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -96.57 139.62 32.4 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.732 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -114.61 -47.84 2.89 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.529 -0.732 . . . . 0.0 110.887 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.78 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -123.05 -178.93 4.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.788 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.473 HG21 ' CG1' ' A' ' 116' ' ' VAL . 3.0 t -114.59 162.38 12.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.501 0.667 . . . . 0.0 110.104 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.622 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -135.97 88.26 2.38 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 178.312 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CE2' HG12 ' A' ' 151' ' ' VAL . 4.7 p90 -128.42 166.59 18.42 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.006 -1.078 . . . . 0.0 112.694 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.68 HG21 HD13 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -112.82 131.03 22.93 Favored Pre-proline 0 N--CA 1.491 1.58 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.453 ' HA ' ' HA3' ' A' ' 152' ' ' GLY . 40.4 Cg_endo -60.27 157.15 36.7 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.985 1.519 . . . . 0.0 111.02 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.809 HG13 ' HA2' ' A' ' 152' ' ' GLY . 26.8 m -82.05 5.05 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.381 -0.825 . . . . 0.0 110.744 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -85.87 -37.08 19.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.32 -38.74 49.81 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.765 -0.584 . . . . 0.0 111.024 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.502 ' HB3' ' CD2' ' A' ' 82' ' ' LEU . 9.2 ptp -49.91 -36.47 27.63 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.141 -0.974 . . . . 0.0 110.184 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.478 ' N ' ' HG3' ' A' ' 175' ' ' MET . 27.4 mm-40 -57.23 -37.86 72.91 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.485 -0.76 . . . . 0.0 109.731 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.5 m -60.3 -36.03 76.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.245 0.545 . . . . 0.0 110.343 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -49.56 -52.83 27.24 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.581 -0.699 . . . . 0.0 112.421 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.47 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 3.9 ptp -65.03 -40.94 95.57 Favored 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.041 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -54.94 -38.13 67.31 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 122.053 0.93 . . . . 0.0 109.25 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.5 -38.98 67.99 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.369 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.495 1.797 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.083 179.829 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 89' ' ' PRO . 15.2 m . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 121.191 0.519 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -170.96 79.28 0.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.368 0.604 . . . . 0.0 109.502 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.74 -19.17 58.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.434 ' OE2' HD11 ' A' ' 94' ' ' LEU . 1.5 tp10 -79.54 -68.92 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.353 -1.087 . . . . 0.0 110.685 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.6 t -137.5 146.62 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.031 0.919 . . . . 0.0 111.497 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.97 173.94 11.16 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.445 HG12 ' HG3' ' A' ' 109' ' ' ARG . 8.1 m -143.03 161.43 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 118.963 -1.095 . . . . 0.0 111.613 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.693 HG11 ' CH2' ' A' ' 85' ' ' TRP . 26.4 m -120.94 -178.42 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 m -153.84 139.83 18.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.296 -0.878 . . . . 0.0 111.422 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -139.24 -178.38 5.34 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 40' ' ' THR . . . -69.19 75.67 0.35 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.131 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER 170.75 -61.24 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -174.73 -170.48 0.49 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.322 -0.861 . . . . 0.0 111.083 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.7 p -116.6 145.37 43.43 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.625 -0.672 . . . . 0.0 110.425 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -106.74 -172.85 2.16 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.173 -0.955 . . . . 0.0 109.766 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.911 HD23 ' N ' ' A' ' 45' ' ' ALA 0.25 5.7 tt -111.1 149.1 31.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.466 -0.771 . . . . 0.0 109.937 -178.001 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.911 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -155.35 137.35 14.58 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.974 -1.079 . . . . 0.0 110.809 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 46' ' ' THR . 13.4 t -105.49 125.0 50.48 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.995 -1.066 . . . . 0.0 113.137 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 89.9 m -77.18 86.06 3.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.44 -0.787 . . . . 0.0 110.458 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.432 HG23 HG23 ' A' ' 46' ' ' THR . 59.6 t -107.15 141.84 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.338 -0.851 . . . . 0.0 108.731 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 57.3 19.04 4.69 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.363 -0.835 . . . . 0.0 110.082 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.59 23.71 49.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.1 t -142.42 113.84 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.268 -1.137 . . . . 0.0 110.493 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.31 114.04 4.47 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.931 ' CE3' HD23 ' A' ' 82' ' ' LEU . 96.0 m95 -97.83 140.53 32.07 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.588 -0.695 . . . . 0.0 111.614 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.87 HG21 ' CH2' ' A' ' 85' ' ' TRP . 4.3 t -161.64 177.8 9.63 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.821 HG11 ' CE1' ' A' ' 57' ' ' HIS . 21.2 t -97.86 146.87 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.274 -0.891 . . . . 0.0 109.927 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.509 ' HB2' HG11 ' A' ' 83' ' ' VAL . 37.1 t80 -63.33 -4.52 2.67 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.659 -1.276 . . . . 0.0 112.08 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.821 ' CE1' HG11 ' A' ' 55' ' ' VAL . 30.3 m170 -39.64 -39.89 0.82 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.313 -0.867 . . . . 0.0 111.816 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.86 -44.79 0.44 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.486 ' N ' ' CE2' ' A' ' 43' ' ' PHE . . . -51.51 97.75 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.433 -1.04 . . . . 0.0 109.818 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.67 25.42 21.28 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.67 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.15 28.34 5.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.244 -1.151 . . . . 0.0 110.891 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -98.1 -156.41 0.54 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.49 -0.756 . . . . 0.0 109.881 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 m -59.21 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.336 -0.853 . . . . 0.0 110.386 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.725 HD12 ' HB ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -74.34 136.35 42.52 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.2 143.19 49.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.432 -0.792 . . . . 0.0 110.789 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.564 ' HA3' HD11 ' A' ' 71' ' ' ILE . . . -137.97 -179.44 17.06 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.82 -11.56 31.34 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.92 1.484 . . . . 0.0 110.844 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -114.55 19.63 15.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.982 -1.074 . . . . 0.0 110.858 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.25 -152.64 17.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.14 143.7 54.74 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 124.064 1.56 . . . . 0.0 111.216 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.725 ' HB ' HD12 ' A' ' 64' ' ' LEU . 87.3 mt -107.28 105.09 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -55.16 149.65 12.03 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.306 -0.871 . . . . 0.0 110.892 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.59 165.36 19.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 0.0 110.087 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -166.21 -47.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.359 -0.838 . . . . 0.0 111.338 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.452 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 19.1 m-85 -123.27 126.54 47.1 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.411 ' HA ' HG12 ' A' ' 83' ' ' VAL . 2.2 m -158.29 111.76 2.43 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.293 -0.879 . . . . 0.0 112.333 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -137.46 75.18 1.51 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 111.117 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' A' ' 56' ' ' TYR . 7.5 p -55.56 -21.97 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.433 -0.792 . . . . 0.0 111.012 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.2 77.97 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.467 -0.77 . . . . 0.0 111.324 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 49.24 25.23 1.16 Allowed 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.277 -0.889 . . . . 0.0 111.238 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.96 -95.36 0.49 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.403 -0.811 . . . . 0.0 110.943 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.931 HD23 ' CE3' ' A' ' 53' ' ' TRP . 5.1 tp -179.13 163.19 1.28 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.518 -1.364 . . . . 0.0 111.021 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.509 HG11 ' HB2' ' A' ' 56' ' ' TYR . 26.9 m -139.82 137.61 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.42 137.93 5.26 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.019 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.87 ' CH2' HG21 ' A' ' 54' ' ' THR . 0.4 OUTLIER -98.32 150.36 21.65 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -64.78 141.16 58.87 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.22 89.95 4.28 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.834 -0.541 . . . . 0.0 110.769 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.567 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -97.46 0.65 1.56 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 O-C-N 123.679 1.358 . . . . 0.0 113.455 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 49.8 Cg_endo -74.73 74.76 3.76 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 115.75 -2.367 . . . . 0.0 109.915 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.64 25.8 22.57 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.32 140.3 39.92 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.471 -1.017 . . . . 0.0 110.63 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -84.93 3.88 36.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.352 -0.842 . . . . 0.0 111.437 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.5 t 45.36 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.415 -0.803 . . . . 0.0 112.558 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -69.81 -161.39 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.7 p -148.74 177.92 1.64 Allowed Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.662 -0.649 . . . . 0.0 110.956 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -86.51 155.36 9.17 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.95 1.5 . . . . 0.0 110.262 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.483 ' SG ' HG23 ' A' ' 151' ' ' VAL . 0.3 OUTLIER -83.98 114.63 21.84 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.313 -0.867 . . . . 0.0 110.016 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 66.9 p -75.11 -28.51 60.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.636 -0.665 . . . . 0.0 110.095 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.1 p -100.41 109.84 22.02 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.62 0.724 . . . . 0.0 110.253 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.7 63.39 2.32 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 m -91.51 157.94 16.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.518 -0.99 . . . . 0.0 109.563 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.5 p -85.54 -157.98 0.35 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.444 -0.785 . . . . 0.0 110.809 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 t70 52.84 83.89 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.466 -0.771 . . . . 0.0 110.761 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.805 HD13 HD23 ' A' ' 143' ' ' LEU . 0.4 OUTLIER -108.88 -174.51 2.53 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.4 -0.813 . . . . 0.0 109.39 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 94.8 m-85 -134.05 91.51 2.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.757 -0.59 . . . . 0.0 109.837 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.445 ' CD1' HD11 ' A' ' 143' ' ' LEU . 8.8 tp -56.36 98.89 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.413 -0.804 . . . . 0.0 110.268 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.446 ' HA ' HG12 ' A' ' 113' ' ' VAL . 60.6 t -74.07 118.99 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.587 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.7 p -86.53 166.98 15.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.557 -0.714 . . . . 0.0 109.418 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.587 ' N ' HD12 ' A' ' 44' ' ' LEU . 34.5 ttp180 -77.16 -1.35 28.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.611 -0.681 . . . . 0.0 111.098 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.485 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -120.7 40.77 3.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.221 -0.925 . . . . 0.0 109.993 -178.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.39 64.4 1.86 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.543 -0.723 . . . . 0.0 111.56 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -152.62 89.96 1.45 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 107' ' ' VAL . 16.1 m -87.83 136.0 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.457 -0.777 . . . . 0.0 110.071 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 106' ' ' LEU . 26.3 pt -124.36 146.76 53.0 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.527 -0.733 . . . . 0.0 109.59 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 53.7 Cg_endo -66.65 148.13 82.69 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 124.066 1.561 . . . . 0.0 111.746 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.7 t -138.63 141.11 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -106.7 113.46 26.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -48.93 124.29 8.43 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.613 -0.679 . . . . 0.0 110.307 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -110.66 -25.78 9.77 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.539 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -173.14 -176.11 41.43 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.94 122.74 15.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.758 -0.848 . . . . 0.0 109.515 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 169' ' ' PHE . 0.9 OUTLIER 60.95 44.32 10.66 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.214 0.53 . . . . 0.0 110.721 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.498 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 8.7 ttm180 -162.65 151.83 15.26 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.413 -0.805 . . . . 0.0 110.228 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.54 -178.42 21.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.34 130.82 53.27 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.948 -0.737 . . . . 0.0 111.308 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.521 HD21 ' NE ' ' A' ' 130' ' ' ARG . 0.2 OUTLIER -76.37 123.24 25.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.655 -0.653 . . . . 0.0 109.475 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mt -100.01 53.84 0.91 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.456 ' O ' HD22 ' A' ' 126' ' ' LEU . 0.4 OUTLIER 177.41 91.55 0.13 Allowed Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -52.87 108.69 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 O-C-N 123.588 1.31 . . . . 0.0 110.626 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.521 ' NE ' HD21 ' A' ' 126' ' ' LEU . 15.3 ptp180 -130.64 162.18 56.51 Favored Pre-proline 0 N--CA 1.493 1.696 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.028 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.37 130.9 28.19 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.939 1.494 . . . . 0.0 111.274 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.886 HG12 ' O ' ' A' ' 162' ' ' GLY . 4.0 p -59.84 -35.23 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.487 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.96 -34.81 9.75 Favored 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 122.139 0.971 . . . . 0.0 110.535 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -64.66 -38.51 91.24 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.583 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.4 mt -65.33 -36.24 83.44 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -62.55 129.51 40.91 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.489 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.59 -28.01 17.89 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.542 ' O ' HD13 ' A' ' 44' ' ' LEU . 30.8 m -93.45 16.18 14.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.556 -0.967 . . . . 0.0 110.566 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.419 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 56.3 m -62.0 122.32 15.2 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.3 -0.875 . . . . 0.0 109.003 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.735 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 122.12 -10.77 9.37 Favored Glycine 0 CA--C 1.543 1.781 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.567 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -55.72 108.82 1.17 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 153' ' ' ILE . 43.1 Cg_endo -66.25 126.38 15.59 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.074 1.565 . . . . 0.0 112.458 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.805 HD23 HD13 ' A' ' 104' ' ' LEU . 6.6 mp -79.6 128.83 33.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 176.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -124.21 123.61 40.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 111.662 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.549 ' HB3' HG21 ' A' ' 151' ' ' VAL . 32.0 p -77.82 162.63 67.08 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.798 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 45.6 Cg_endo -62.89 87.07 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 O-C-N 123.763 1.401 . . . . 0.0 110.726 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t -172.73 -40.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.62 -0.675 . . . . 0.0 110.18 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.03 -30.57 4.77 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -73.21 154.93 40.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.638 -0.919 . . . . 0.0 109.915 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.509 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -85.39 141.32 30.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.098 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 145' ' ' CYS . 2.1 t -97.65 -36.62 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.823 -0.548 . . . . 0.0 109.743 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.81 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 176.49 -178.91 47.76 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 82' ' ' LEU . 1.2 pt -116.8 158.19 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 118.504 1.152 . . . . 0.0 110.953 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.769 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 12.2 t80 -75.99 103.41 6.04 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.701 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.415 ' HA ' HG21 ' A' ' 55' ' ' VAL . 7.4 ttp180 -92.0 -39.1 11.85 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -159.39 -179.66 8.14 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.769 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -140.76 125.98 18.58 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.762 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.904 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.6 t -67.67 102.08 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 71.0 m -115.67 159.4 21.4 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 122.451 1.119 . . . . 0.0 113.722 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.8 OUTLIER -97.63 -174.06 2.8 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.75 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 O-C-N 121.314 -0.866 . . . . 0.0 112.69 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.886 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 82.83 -35.59 2.7 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.014 -1.053 . . . . 0.0 111.382 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.75 134.47 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 120.713 -1.463 . . . . 0.0 109.145 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.583 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -91.4 140.64 29.57 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.336 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -120.9 -44.25 2.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.468 -0.77 . . . . 0.0 110.866 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.904 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -120.94 -179.77 4.12 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.311 -0.868 . . . . 0.0 110.612 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -119.42 151.46 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.8 0.81 . . . . 0.0 111.022 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.712 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -120.16 94.25 4.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.332 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.619 ' CD2' HD22 ' A' ' 143' ' ' LEU . 1.1 p90 -127.89 148.52 50.49 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.922 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.473 HG11 ' CD1' ' A' ' 82' ' ' LEU . 3.9 p -98.9 136.55 20.59 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 52.2 Cg_endo -64.91 152.91 80.58 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.814 1.428 . . . . 0.0 110.476 -178.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.81 HG13 ' HA2' ' A' ' 152' ' ' GLY . 30.6 m -79.8 1.04 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.395 -0.816 . . . . 0.0 110.597 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -89.14 -38.56 14.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.314 -0.866 . . . . 0.0 109.8 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.6 t -74.14 -40.73 62.42 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.603 -0.686 . . . . 0.0 110.791 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.789 ' HB3' HD22 ' A' ' 82' ' ' LEU . 8.3 ptp -51.78 -36.2 46.7 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.096 -1.003 . . . . 0.0 110.48 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.98 -38.02 69.85 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.192 -0.943 . . . . 0.0 109.068 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.6 m -57.53 -37.47 73.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.945 -0.472 . . . . 0.0 110.64 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.745 HG22 ' O ' ' A' ' 175' ' ' MET . 1.4 t -48.54 -36.42 15.39 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.431 -0.793 . . . . 0.0 111.96 -178.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.471 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -51.08 -39.49 56.16 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.815 -1.178 . . . . 0.0 110.685 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.7 ttt85 -52.2 -37.43 54.83 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.916 0.865 . . . . 0.0 110.194 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -81.25 -44.31 17.94 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.891 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.504 2.258 0 O-C-N 121.072 -1.018 . . . . 0.0 110.439 -179.344 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.472 0.653 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -167.8 79.29 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.02 -170.98 38.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.591 ' HB3' HD11 ' A' ' 94' ' ' LEU . 7.9 mt-10 -117.89 22.98 11.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.501 -1.0 . . . . 0.0 110.531 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.627 HG12 ' CG ' ' A' ' 109' ' ' ARG . 44.6 t -145.15 143.58 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.734 . . . . 0.0 110.431 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -138.97 140.62 38.28 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.465 -0.772 . . . . 0.0 109.718 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 43' ' ' PHE . 11.1 p -108.97 150.37 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.448 -0.783 . . . . 0.0 111.481 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.714 HG13 ' CE2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -131.33 124.38 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 p -101.16 143.85 30.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.369 -0.832 . . . . 0.0 109.455 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 40' ' ' THR . 5.6 t -149.61 -178.84 6.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.556 -0.715 . . . . 0.0 109.083 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.21 75.53 0.35 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.062 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.674 HG22 ' HG2' ' A' ' 41' ' ' GLN . 2.3 m -177.44 -61.14 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.674 ' HG2' HG22 ' A' ' 40' ' ' THR . 0.1 OUTLIER 179.77 -163.95 0.05 Allowed 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 t -122.06 119.46 31.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.292 -0.88 . . . . 0.0 109.297 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.759 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -111.52 166.46 11.12 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.614 -0.679 . . . . 0.0 109.718 -179.488 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.818 HD22 ' CB ' ' A' ' 109' ' ' ARG . 13.3 mt -105.31 174.31 5.93 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.174 -0.954 . . . . 0.0 111.133 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 52' ' ' CYS . . . -157.08 128.74 7.05 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.981 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 46' ' ' THR . 12.3 t -103.1 118.89 37.82 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.966 0.888 . . . . 0.0 111.643 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 49.2 t -70.2 89.63 0.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.821 -0.549 . . . . 0.0 110.161 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.526 HG11 HG11 ' A' ' 172' ' ' VAL . 98.7 t -109.16 136.27 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.8 19.18 6.69 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.404 -0.81 . . . . 0.0 110.18 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.85 24.88 40.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 85' ' ' TRP . 19.9 t -145.98 108.82 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -1.136 . . . . 0.0 110.668 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.511 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 24.1 p -61.57 129.11 39.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.248 -0.907 . . . . 0.0 109.304 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.726 ' HZ3' HG21 ' A' ' 178' ' ' THR . 56.1 m95 -108.13 139.25 43.06 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.502 -0.749 . . . . 0.0 111.66 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.938 ' O ' HG22 ' A' ' 83' ' ' VAL . 7.6 t -161.13 128.08 4.06 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.64 0.734 . . . . 0.0 110.315 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.672 HG21 ' CE1' ' A' ' 57' ' ' HIS . 28.3 m -48.92 141.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.47 0 O-C-N 120.855 -1.153 . . . . 0.0 112.16 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 51.9 t80 -83.08 -13.65 55.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.062 -1.024 . . . . 0.0 111.357 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.672 ' CE1' HG21 ' A' ' 55' ' ' VAL . 2.1 p-80 -63.23 -22.9 67.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.957 . . . . 0.0 110.061 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.45 ' N ' ' CD2' ' A' ' 57' ' ' HIS . . . -119.03 -30.27 1.64 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.465 ' HA ' ' CE2' ' A' ' 43' ' ' PHE . . . -55.34 174.75 0.08 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.357 -1.084 . . . . 0.0 111.203 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.97 150.62 19.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 m -101.79 -32.25 10.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.794 -0.827 . . . . 0.0 109.635 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -59.31 -169.49 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.639 -0.663 . . . . 0.0 109.933 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.8 m -68.24 97.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.543 -0.723 . . . . 0.0 109.424 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.9 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -55.21 165.9 0.65 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.663 -0.648 . . . . 0.0 110.962 -179.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.82 145.37 50.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.836 -0.54 . . . . 0.0 110.491 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -140.29 177.18 20.88 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.49 -12.66 36.5 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 O-C-N 123.915 1.482 . . . . 0.0 111.278 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.63 21.36 11.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 111.044 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.88 -168.3 13.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.51 144.14 65.77 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 124.033 1.544 . . . . 0.0 110.511 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.9 HD12 ' CD2' ' A' ' 64' ' ' LEU . 56.0 mt -92.88 101.93 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -63.0 117.53 6.56 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.964 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -59.02 102.5 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.299 0.571 . . . . 0.0 110.31 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpt -87.46 -42.0 13.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.777 . . . . 0.0 109.468 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.435 ' CD1' ' HG3' ' A' ' 179' ' ' MET . 23.5 m-85 -125.7 130.51 51.69 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.477 HG23 ' CG1' ' A' ' 83' ' ' VAL . 3.2 m -149.77 126.56 11.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.533 -0.729 . . . . 0.0 110.435 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.12 77.82 1.37 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.518 -0.739 . . . . 0.0 110.845 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -56.15 -18.62 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.407 -0.808 . . . . 0.0 109.947 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.54 -58.14 7.13 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.096 -1.002 . . . . 0.0 109.482 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.09 23.77 8.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.668 ' O ' HG12 ' A' ' 55' ' ' VAL . 31.5 m-20 52.83 69.51 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.826 -0.546 . . . . 0.0 112.088 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.668 ' CD1' HD11 ' A' ' 153' ' ' ILE . 1.4 tp -162.43 141.91 9.41 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.01 -1.056 . . . . 0.0 112.638 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.938 HG22 ' O ' ' A' ' 54' ' ' THR . 9.4 m -145.13 125.39 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -110.94 99.99 1.19 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.931 -1.128 . . . . 0.0 111.874 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.503 ' O ' HG13 ' A' ' 51' ' ' VAL . 1.6 m0 -90.18 169.14 11.39 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 176.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -89.24 128.9 35.87 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.041 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.677 ' HB1' ' HB3' ' A' ' 91' ' ' ALA . . . -60.76 139.24 93.39 Favored Pre-proline 0 N--CA 1.494 1.769 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.702 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.545 ' CD ' ' HD3' ' A' ' 89' ' ' PRO . 33.7 Cg_endo -105.54 -54.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 117.266 -1.356 . . . . 0.0 115.081 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.545 ' HD3' ' CD ' ' A' ' 88' ' ' PRO . 56.6 Cg_endo -66.37 -150.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.859 0 C-N-CA 116.923 -1.585 . . . . 0.0 108.822 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.85 34.19 3.21 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 107.734 -2.147 . . . . 0.0 107.734 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.677 ' HB3' ' HB1' ' A' ' 87' ' ' ALA . . . -48.64 130.73 17.58 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.105 -1.232 . . . . 0.0 110.923 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.6 142.21 58.5 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.76 -0.588 . . . . 0.0 110.44 -179.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 m -112.82 110.52 20.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 110.628 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' A' ' 32' ' ' GLU . 5.2 mt -93.3 -158.74 0.63 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.623 -0.673 . . . . 0.0 109.669 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.68 176.5 2.23 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.784 -0.573 . . . . 0.0 109.676 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.52 162.28 42.58 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 O-C-N 123.671 1.353 . . . . 0.0 111.18 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 1.093 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 43.6 t -81.95 -76.35 0.26 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.67 -0.644 . . . . 0.0 110.491 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.2 m 55.31 52.81 10.84 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.34 -0.85 . . . . 0.0 110.198 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 1.093 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 30.6 p -139.34 -149.59 0.29 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.488 -0.757 . . . . 0.0 110.304 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.33 -128.94 4.49 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.9 m 49.75 -157.59 0.08 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.371 -1.076 . . . . 0.0 111.031 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 p -171.4 -34.71 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.538 -0.726 . . . . 0.0 110.684 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 0.9 OUTLIER -58.8 128.09 35.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.563 -0.711 . . . . 0.0 110.314 179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.893 HD13 HD23 ' A' ' 143' ' ' LEU . 1.2 mt -120.84 -168.01 1.58 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.416 -0.803 . . . . 0.0 109.345 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.772 ' O ' HG23 ' A' ' 107' ' ' VAL . 29.4 m-85 -141.11 87.15 2.07 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.465 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 12.3 tp -56.98 96.66 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.155 -0.966 . . . . 0.0 108.494 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 105' ' ' TYR . 41.7 t -89.77 101.94 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.662 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.664 HG22 ' HB3' ' A' ' 138' ' ' SER . 0.8 OUTLIER -65.38 179.99 0.69 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.818 ' CB ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -100.92 29.16 4.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.015 -1.053 . . . . 0.0 109.464 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.413 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -130.83 30.17 4.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.338 -0.851 . . . . 0.0 109.679 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 59.36 70.6 0.63 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.46 -0.775 . . . . 0.0 110.551 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -171.56 93.88 0.16 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.344 0.593 . . . . 0.0 109.874 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.68 HG12 HG13 ' A' ' 107' ' ' VAL . 10.7 m -98.87 149.0 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.424 -0.797 . . . . 0.0 110.593 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.465 ' CG1' ' HB3' ' A' ' 106' ' ' LEU . 33.2 pt -131.33 147.55 66.61 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.631 -0.668 . . . . 0.0 109.316 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.546 ' HB2' HD12 ' A' ' 127' ' ' LEU . 44.3 Cg_endo -72.88 138.67 29.04 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 O-C-N 123.909 1.479 . . . . 0.0 112.222 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 103' ' ' ASP . 67.5 t -129.59 137.94 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.8 mmm-85 -102.64 121.28 42.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.862 . . . . 0.0 108.979 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -49.15 126.82 13.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.395 -0.816 . . . . 0.0 110.994 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -103.97 -55.0 2.45 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.53 -166.71 13.1 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -62.64 127.67 32.38 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.735 -0.862 . . . . 0.0 109.908 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.417 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 0.3 OUTLIER 54.02 50.81 15.86 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.491 0.663 . . . . 0.0 109.901 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.463 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -166.77 151.37 7.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.767 -0.583 . . . . 0.0 110.391 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.62 -177.73 18.8 Favored Glycine 0 N--CA 1.498 2.828 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -133.27 103.94 6.23 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.769 -0.842 . . . . 0.0 112.291 -178.069 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.737 HD11 ' HA ' ' A' ' 165' ' ' LYS . 2.7 pp -50.91 150.91 2.74 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.361 -0.837 . . . . 0.0 110.537 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.546 HD12 ' HB2' ' A' ' 115' ' ' PRO . 6.4 mt -114.88 54.47 0.78 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.27 99.06 0.1 Allowed Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -52.38 99.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.805 0 O-C-N 123.417 1.219 . . . . 0.0 110.92 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.559 ' HD2' HD21 ' A' ' 135' ' ' LEU . 8.4 ptp180 -116.03 164.59 17.27 Favored Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.006 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.79 124.41 12.28 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.99 1.521 . . . . 0.0 111.064 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.841 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.4 p -57.82 -34.15 47.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.501 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -48.53 -36.21 14.89 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.245 -0.909 . . . . 0.0 110.256 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -62.24 -39.14 91.86 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.559 HD21 ' HD2' ' A' ' 130' ' ' ARG . 14.0 mt -67.39 -36.61 81.67 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 126.36 27.09 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.615 -0.834 . . . . 0.0 108.884 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.47 -20.64 49.51 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.664 ' HB3' HG22 ' A' ' 108' ' ' THR . 6.0 m -93.91 11.6 28.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -1.09 . . . . 0.0 110.847 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.7 p -54.85 143.51 25.62 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.848 -1.158 . . . . 0.0 110.255 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.9 -14.32 58.77 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.54 115.6 4.99 Favored Glycine 0 N--CA 1.503 3.13 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.435 ' O ' HD12 ' A' ' 144' ' ' LEU . 54.2 Cg_endo -69.35 128.37 16.3 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 O-C-N 123.707 1.372 . . . . 0.0 112.683 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.893 HD23 HD13 ' A' ' 104' ' ' LEU . 5.7 mp -83.56 120.26 25.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 142' ' ' PRO . 0.8 OUTLIER -116.77 124.91 50.75 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.693 -177.024 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.507 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 31.1 p -68.59 172.14 5.08 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.8 Cg_endo -64.73 165.52 20.65 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 O-C-N 123.38 1.2 . . . . 0.0 110.116 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.72 39.46 20.92 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.165 -0.959 . . . . 0.0 110.479 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.12 -138.02 30.48 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.7 m170 56.44 111.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.718 -0.872 . . . . 0.0 111.446 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.403 ' CB ' HG21 ' A' ' 172' ' ' VAL . . . -74.3 147.55 42.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 109.053 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.646 HG12 ' CE2' ' A' ' 169' ' ' PHE . 1.4 t -108.48 -34.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.636 -0.665 . . . . 0.0 109.638 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.642 ' N ' HG23 ' A' ' 172' ' ' VAL . . . 174.1 179.22 44.58 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.668 HD11 ' CD1' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -115.05 163.32 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 CA-C-N 118.871 1.336 . . . . 0.0 110.903 178.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.763 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 3.2 t80 -70.76 114.82 9.23 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.017 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.405 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 15.9 ttp180 -101.18 -45.71 5.28 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.688 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -153.44 168.36 26.38 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.763 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -124.02 116.59 23.07 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.985 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.805 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 16.3 t -68.63 103.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.5 p -127.32 158.41 37.32 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.121 0.963 . . . . 0.0 113.51 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 162' ' ' GLY . 24.0 p -95.13 -173.54 2.97 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 175.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.22 82.53 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.841 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 86.02 -25.56 6.76 Favored Glycine 0 N--CA 1.502 3.063 0 O-C-N 120.7 -1.25 . . . . 0.0 111.916 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -98.45 140.69 17.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 120.962 -1.317 . . . . 0.0 108.949 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.713 ' C ' HD21 ' A' ' 126' ' ' LEU . . . -93.46 138.21 31.98 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.962 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.737 ' HA ' HD11 ' A' ' 126' ' ' LEU . 0.7 OUTLIER -119.16 -28.26 5.49 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.635 -0.665 . . . . 0.0 110.38 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.805 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -144.01 178.14 8.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.875 . . . . 0.0 109.444 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.03 154.54 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.878 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.688 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 1.7 t70 -119.94 99.62 6.73 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.646 ' CE2' HG12 ' A' ' 151' ' ' VAL . 1.6 p90 -130.38 153.88 48.26 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.83 -1.148 . . . . 0.0 112.798 -175.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.62 HG11 HD13 ' A' ' 82' ' ' LEU . 2.7 p -103.0 127.47 29.81 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 45.9 Cg_endo -56.56 163.69 6.58 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 124.024 1.539 . . . . 0.0 111.636 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.642 HG23 ' N ' ' A' ' 152' ' ' GLY . 70.8 t -81.24 1.14 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.378 -0.827 . . . . 0.0 110.039 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -92.92 -37.69 12.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.844 . . . . 0.0 108.95 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.762 ' O ' HG22 ' A' ' 177' ' ' THR . 7.3 t -63.93 -38.14 90.0 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.572 ' HE1' HG23 ' A' ' 153' ' ' ILE . 7.9 mtt -48.14 -35.28 11.26 Favored 'General case' 0 N--CA 1.518 2.941 0 O-C-N 121.853 -0.529 . . . . 0.0 109.871 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -48.22 -38.34 18.21 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.131 -0.98 . . . . 0.0 111.177 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.762 HG22 ' O ' ' A' ' 174' ' ' SER . 14.6 t -54.21 -34.67 61.16 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.213 -0.93 . . . . 0.0 109.529 178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.726 HG21 ' HZ3' ' A' ' 53' ' ' TRP . 32.1 m -48.12 -61.94 1.73 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.898 -0.501 . . . . 0.0 110.949 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.447 ' HE1' ' CZ2' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -54.57 -51.3 65.68 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.385 -0.822 . . . . 0.0 110.887 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -52.87 -37.68 60.71 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.154 -0.966 . . . . 0.0 109.994 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -73.33 -39.23 65.4 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.993 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.635 179.627 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 89' ' ' PRO . 34.4 m . . . . . 0 N--CA 1.503 2.205 0 CA-C-O 121.608 0.718 . . . . 0.0 111.439 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' N ' HG23 ' A' ' 29' ' ' VAL . 0.3 OUTLIER 54.89 80.2 0.13 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.408 0.623 . . . . 0.0 110.98 179.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 92' ' ' ARG . . . -72.22 63.9 1.34 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -175.35 -73.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.557 HG22 ' CD ' ' A' ' 142' ' ' PRO . 62.4 t -124.62 138.26 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.63 -0.669 . . . . 0.0 110.263 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -125.05 178.94 5.26 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 43' ' ' PHE . 2.9 p -154.46 143.19 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.542 -0.724 . . . . 0.0 109.533 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.715 HG12 HD21 ' A' ' 64' ' ' LEU . 33.9 m -104.18 176.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.7 p -131.28 137.71 48.96 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.566 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.3 p -131.49 -176.42 4.02 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.57 103.09 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.206 -0.934 . . . . 0.0 110.389 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 62.1 p 47.0 53.71 10.21 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.275 0.559 . . . . 0.0 111.473 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.79 164.39 16.5 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.507 0.67 . . . . 0.0 110.554 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.6 p -155.51 132.8 10.92 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.867 ' O ' HG23 ' A' ' 35' ' ' VAL . 92.8 m-85 -105.76 175.03 5.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.193 -0.942 . . . . 0.0 111.612 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.758 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -101.89 152.76 20.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 0.0 111.899 -177.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.588 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -160.43 161.24 32.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.896 -0.503 . . . . 0.0 110.283 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.623 HG23 HG23 ' A' ' 48' ' ' VAL . 14.6 t -137.82 125.18 21.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.098 -1.001 . . . . 0.0 111.981 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.8 m -74.04 79.24 1.71 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.378 -0.826 . . . . 0.0 109.408 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.623 HG23 HG23 ' A' ' 46' ' ' THR . 58.0 t -98.89 138.1 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.965 -1.084 . . . . 0.0 108.586 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.53 18.46 3.58 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.307 -0.871 . . . . 0.0 110.219 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.405 ' N ' ' CB ' ' A' ' 93' ' ' SER . . . 85.6 27.33 32.75 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.2 t -143.12 116.16 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.41 -1.053 . . . . 0.0 110.506 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.726 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 58.8 m -66.59 117.15 8.38 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.58 ' CE3' HD23 ' A' ' 82' ' ' LEU . 21.4 m95 -102.29 137.1 40.99 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 121.042 -1.036 . . . . 0.0 112.442 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.509 ' O ' HG22 ' A' ' 83' ' ' VAL . 1.0 OUTLIER -162.74 131.51 4.07 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.518 -0.739 . . . . 0.0 110.443 177.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.508 HG21 ' NE2' ' A' ' 57' ' ' HIS . 30.4 m -52.91 147.98 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.334 -0.854 . . . . 0.0 111.497 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.513 ' HA ' HG21 ' A' ' 83' ' ' VAL . 19.9 t80 -68.26 -11.06 58.77 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.118 -0.988 . . . . 0.0 112.052 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.508 ' NE2' HG21 ' A' ' 55' ' ' VAL . 12.9 p-80 -94.99 36.97 1.16 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.981 -1.074 . . . . 0.0 109.952 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.414 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . -149.95 -67.16 0.01 OUTLIER Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.029 -2.029 . . . . 0.0 108.029 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.37 141.85 40.4 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.476 -1.014 . . . . 0.0 109.885 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.7 -5.23 73.38 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 120.266 -0.968 . . . . 0.0 111.029 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 p 51.76 178.72 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.171 -1.194 . . . . 0.0 111.6 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.3 mttp 53.74 -94.43 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 111.338 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m -85.06 90.41 7.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 110.541 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.775 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -103.41 143.61 32.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.637 -0.664 . . . . 0.0 109.903 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.64 149.54 25.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.49 -0.756 . . . . 0.0 110.022 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.1 -179.46 15.88 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.87 -5.19 16.57 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 O-C-N 124.044 1.549 . . . . 0.0 111.268 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -139.59 22.27 2.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.072 -1.017 . . . . 0.0 110.582 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.5 -178.92 17.29 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.51 149.78 87.4 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.07 1.563 . . . . 0.0 111.143 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.775 HD12 ' CD2' ' A' ' 64' ' ' LEU . 59.1 mt -108.33 165.09 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.443 ' N ' HG22 ' A' ' 71' ' ' ILE . 7.2 t -102.11 -166.7 1.32 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.435 -0.79 . . . . 0.0 110.057 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -119.62 120.07 35.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.557 -0.714 . . . . 0.0 110.147 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.413 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 3.6 mmt -116.03 -36.68 4.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 110.308 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.485 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 24.6 m-85 -133.44 129.93 37.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.497 -0.752 . . . . 0.0 110.367 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.1 m -152.69 115.37 4.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.385 -0.822 . . . . 0.0 110.464 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -145.93 75.15 1.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.853 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.435 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.4 p -54.0 -25.96 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.36 -41.83 76.78 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.392 -0.817 . . . . 0.0 109.347 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -97.48 22.5 8.79 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.468 ' O ' HD12 ' A' ' 82' ' ' LEU . 71.2 m-20 53.95 52.34 13.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.512 -0.743 . . . . 0.0 111.667 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.772 HD13 HG11 ' A' ' 170' ' ' VAL . 1.3 tp -166.43 136.12 3.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.089 -1.007 . . . . 0.0 112.596 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.513 HG21 ' HA ' ' A' ' 56' ' ' TYR . 30.0 m -148.23 140.39 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 176.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 52' ' ' CYS . . . -160.28 176.17 36.98 Favored Glycine 0 C--N 1.298 -1.566 0 C-N-CA 118.426 -1.845 . . . . 0.0 111.663 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.544 ' CD1' HG21 ' A' ' 71' ' ' ILE . 37.1 p90 -130.07 134.78 47.6 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -51.26 139.46 18.82 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.484 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.726 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . . . -103.3 88.18 1.58 Allowed Pre-proline 0 C--N 1.297 -1.702 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.263 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.54 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.1 Cg_endo -94.79 -12.97 0.86 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.867 1.456 . . . . 0.0 112.271 177.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 43.1 Cg_endo -70.93 71.95 2.06 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 115.738 -2.374 . . . . 0.0 111.046 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 88' ' ' PRO . . . 52.75 24.91 20.66 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.625 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -81.48 125.43 30.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.488 -1.007 . . . . 0.0 110.488 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.408 ' CB ' ' HA3' ' A' ' 31' ' ' GLY . 26.3 ttt180 -66.31 154.32 40.3 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.405 ' CB ' ' N ' ' A' ' 50' ' ' GLY . 4.9 p -113.69 103.91 11.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.625 -0.672 . . . . 0.0 110.351 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.654 HD23 ' HB2' ' A' ' 150' ' ' ALA . 1.5 mp -64.44 -162.08 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.535 -0.728 . . . . 0.0 109.475 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.445 HG23 ' N ' ' A' ' 96' ' ' PRO . 0.6 OUTLIER -145.6 -172.06 0.3 Allowed Pre-proline 0 C--N 1.299 -1.589 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.333 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.445 ' N ' HG23 ' A' ' 95' ' ' THR . 51.2 Cg_endo -90.93 162.68 3.97 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.772 1.406 . . . . 0.0 110.991 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 80.29 1.29 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.377 -0.827 . . . . 0.0 110.845 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.2 p -77.46 62.63 2.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.437 -0.789 . . . . 0.0 109.234 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.494 ' SG ' ' SG ' ' A' ' 145' ' ' CYS . 27.2 p -129.9 169.14 15.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.48 -0.762 . . . . 0.0 111.191 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.51 -156.17 26.64 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.82 -158.45 0.2 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.448 -1.031 . . . . 0.0 110.434 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.01 -88.76 0.39 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.547 -0.721 . . . . 0.0 110.121 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 62.8 m-20 44.81 55.13 6.23 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.167 -0.958 . . . . 0.0 111.769 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.748 HD13 HD23 ' A' ' 143' ' ' LEU . 16.8 mt -88.85 168.65 12.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.494 ' O ' HG23 ' A' ' 107' ' ' VAL . 75.2 m-85 -149.79 86.87 1.46 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.586 HD13 ' CD1' ' A' ' 143' ' ' LEU . 40.6 tp -58.48 103.21 0.14 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.632 -0.667 . . . . 0.0 109.237 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.748 HG13 HG12 ' A' ' 113' ' ' VAL . 41.4 t -87.44 101.06 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.326 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.759 HG21 ' OH ' ' A' ' 134' ' ' TYR . 48.7 p -66.4 158.45 29.31 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.758 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -80.56 2.14 26.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.001 -1.062 . . . . 0.0 110.974 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.435 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -97.73 30.09 3.11 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.054 -1.029 . . . . 0.0 109.465 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 58.73 62.42 1.93 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.458 -0.776 . . . . 0.0 110.805 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.34 104.1 0.45 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.225 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.748 HG12 HG13 ' A' ' 107' ' ' VAL . 3.4 m -102.32 155.34 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.519 -0.738 . . . . 0.0 110.751 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.46 HD11 HD23 ' A' ' 106' ' ' LEU . 42.2 pt -133.09 140.19 36.7 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.477 -0.765 . . . . 0.0 109.636 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.1 129.04 16.57 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.861 1.453 . . . . 0.0 111.988 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.463 ' HB ' ' CB ' ' A' ' 104' ' ' LEU . 63.9 t -116.95 158.69 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.738 ' HG3' HD21 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -114.57 109.42 18.23 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -46.6 129.31 11.04 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.494 -0.754 . . . . 0.0 111.418 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.7 -46.37 3.38 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.943 -0.473 . . . . 0.0 111.482 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -155.35 57.88 0.39 Allowed Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.27 -1.443 . . . . 0.0 111.1 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.419 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.5 OUTLIER 65.48 -66.72 0.14 Allowed 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.486 -1.008 . . . . 0.0 111.06 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 120' ' ' GLY . 25.8 p -98.96 41.68 1.13 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 121.467 0.651 . . . . 0.0 110.019 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.459 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 13.7 ttm180 -171.65 150.02 2.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 109.689 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.37 -178.99 18.18 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.65 113.34 16.58 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 122.181 -0.6 . . . . 0.0 111.161 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.38 133.15 45.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.623 -0.673 . . . . 0.0 109.705 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.738 HD21 ' HG3' ' A' ' 117' ' ' ARG . 7.3 mt -106.91 54.35 0.67 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.107 0.956 . . . . 0.0 108.587 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 170.44 123.52 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.15 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -56.02 112.11 0.97 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 O-C-N 123.495 1.261 . . . . 0.0 110.043 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -127.72 150.58 73.57 Favored Pre-proline 0 N--CA 1.487 1.375 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.646 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.14 130.18 18.44 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 124.107 1.583 . . . . 0.0 110.342 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.689 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.1 p -62.91 -35.98 73.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.416 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -49.23 -37.82 24.36 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.759 ' OH ' HG21 ' A' ' 108' ' ' THR . 30.7 t80 -61.84 -38.24 87.47 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.476 HD11 ' CB ' ' A' ' 164' ' ' ALA . 14.1 mt -69.54 -36.65 76.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.6 103.64 0.7 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.461 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.36 -33.48 3.45 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.7 p -83.65 5.35 24.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.654 -0.909 . . . . 0.0 110.955 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.4 m -54.3 124.32 15.55 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.134 -0.979 . . . . 0.0 110.797 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.05 -13.67 12.67 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.462 ' HA2' HD12 ' A' ' 44' ' ' LEU . . . -62.64 134.44 44.39 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.557 ' CD ' HG22 ' A' ' 33' ' ' VAL . 54.5 Cg_endo -79.23 132.56 10.36 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.717 1.377 . . . . 0.0 113.254 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.748 HD23 HD13 ' A' ' 104' ' ' LEU . 4.6 mp -82.53 139.22 34.0 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 175.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 142' ' ' PRO . 1.1 mp -136.67 121.81 19.08 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 120.099 1.318 . . . . 0.0 111.593 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.494 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -69.56 -21.18 0.55 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.862 -0.524 . . . . 0.0 110.255 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 145' ' ' CYS . 46.0 Cg_endo -140.9 -162.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.876 0 O-C-N 123.461 1.243 . . . . 0.0 110.438 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.45 -55.59 29.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.387 -0.821 . . . . 0.0 110.185 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -107.7 -158.55 20.41 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.4 m170 53.06 100.7 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.395 -1.062 . . . . 0.0 111.095 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.654 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -75.42 154.64 36.98 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.512 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.626 HG12 ' CE2' ' A' ' 169' ' ' PHE . 2.1 t -103.9 -35.32 3.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.702 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 176.23 -178.36 47.64 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.673 HD11 ' CD1' ' A' ' 82' ' ' LEU . 1.6 pp -118.61 146.45 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 CA-C-N 118.837 1.319 . . . . 0.0 110.98 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.807 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 6.6 t80 -59.01 113.55 2.15 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.632 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.437 ' HA ' HG11 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -99.4 -46.94 5.33 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.726 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -150.45 171.39 17.12 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.807 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -126.67 116.66 21.33 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.019 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.817 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 7.0 t -67.34 99.73 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 177.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.591 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.1 p -127.73 165.04 20.81 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.555 1.169 . . . . 0.0 113.78 -175.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.6 OUTLIER -105.31 -174.18 2.47 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.398 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -48.77 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.087 0.946 . . . . 0.0 112.544 -179.31 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.689 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 82.17 -26.69 3.78 Favored Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.644 -1.285 . . . . 0.0 112.43 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.5 t -100.58 134.82 39.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 119.223 1.512 . . . . 0.0 110.025 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.476 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -95.75 131.15 42.33 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.421 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -109.12 -43.21 4.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.746 . . . . 0.0 110.344 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.817 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -128.43 163.86 23.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.49 -0.756 . . . . 0.0 110.088 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.55 154.28 9.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.533 0.683 . . . . 0.0 110.26 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.726 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -124.01 101.62 7.33 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.195 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.626 ' CE2' HG12 ' A' ' 151' ' ' VAL . 4.9 p90 -135.22 164.34 27.92 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.676 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.772 HG11 HD13 ' A' ' 82' ' ' LEU . 3.2 p -108.57 132.39 21.16 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 40.6 Cg_endo -61.73 161.52 24.72 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.794 1.418 . . . . 0.0 111.364 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.702 HG13 ' HA2' ' A' ' 152' ' ' GLY . 19.0 m -83.93 3.54 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 121.238 -0.914 . . . . 0.0 111.341 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.67 -38.15 13.28 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.6 t -72.69 -37.2 67.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.933 -0.48 . . . . 0.0 110.642 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.625 ' HE1' HG23 ' A' ' 153' ' ' ILE . 28.5 mtt -48.89 -38.74 23.51 Favored 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.429 -0.795 . . . . 0.0 109.252 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -55.87 -39.13 71.08 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.629 0.728 . . . . 0.0 109.695 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.1 m -54.62 -38.1 66.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.774 -0.579 . . . . 0.0 110.472 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.65 -41.01 63.4 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.444 -0.785 . . . . 0.0 110.548 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.485 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -52.34 -40.47 61.98 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.19 -0.944 . . . . 0.0 111.629 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.13 -37.62 64.55 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.246 -0.909 . . . . 0.0 110.149 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.28 -39.19 54.91 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.37 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 O-C-N 121.459 -0.776 . . . . 0.0 111.301 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.572 HG11 ' N ' ' A' ' 90' ' ' GLY . 7.8 p . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.19 0.519 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -173.92 79.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.371 -0.831 . . . . 0.0 109.766 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.65 151.5 5.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.561 ' HB2' HD12 ' A' ' 94' ' ' LEU . 1.3 pm0 -67.98 -14.6 63.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.705 -0.879 . . . . 0.0 110.771 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.53 HG23 ' HG2' ' A' ' 32' ' ' GLU . 98.4 t -111.78 141.82 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 0.0 110.188 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -125.33 171.22 10.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.703 -0.623 . . . . 0.0 109.351 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 44' ' ' LEU . 34.5 m -143.63 177.28 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.774 . . . . 0.0 110.748 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.07 179.48 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 p -137.09 135.88 37.85 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.073 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.2 p -132.52 -177.45 4.48 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.76 95.66 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.459 -0.776 . . . . 0.0 110.986 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 40' ' ' THR . 16.6 m 58.25 44.95 17.97 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.483 -0.761 . . . . 0.0 110.994 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -164.92 156.95 15.64 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.204 -0.935 . . . . 0.0 111.262 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 p -146.5 132.61 19.33 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.795 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . 46.9 m-85 -100.59 -179.29 4.05 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.199 -0.938 . . . . 0.0 110.401 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.655 HD13 ' HA ' ' A' ' 138' ' ' SER . 0.0 OUTLIER -111.97 152.47 28.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 0.0 110.881 -178.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.0 136.56 9.01 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.554 -0.717 . . . . 0.0 109.609 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.546 HG23 HG23 ' A' ' 48' ' ' VAL . 13.6 t -110.52 119.22 38.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.222 -0.924 . . . . 0.0 112.636 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.5 t -71.38 83.36 0.79 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.762 HG11 ' CG1' ' A' ' 172' ' ' VAL . 87.4 t -102.63 138.43 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 t30 56.07 21.35 5.02 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.405 -0.809 . . . . 0.0 110.208 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.13 24.94 53.64 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.566 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 61.6 t -141.44 106.34 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.37 -1.077 . . . . 0.0 109.875 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.24 108.86 1.69 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.291 -0.88 . . . . 0.0 109.913 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.593 ' CZ3' HG21 ' A' ' 178' ' ' THR . 97.7 m95 -93.79 148.54 22.03 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.486 -0.759 . . . . 0.0 111.157 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.404 HG23 HG23 ' A' ' 83' ' ' VAL . 5.6 t -161.26 179.91 7.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.845 -0.535 . . . . 0.0 109.725 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.696 HG11 ' HA ' ' A' ' 155' ' ' ARG . 27.1 m -94.85 143.57 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.581 -0.699 . . . . 0.0 110.54 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.706 ' HB2' HG11 ' A' ' 83' ' ' VAL . 45.7 t80 -76.05 -0.92 23.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.098 -1.001 . . . . 0.0 111.889 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -51.76 -30.63 23.55 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.073 -1.017 . . . . 0.0 109.648 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.86 -147.8 5.25 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.795 ' HB2' ' CB ' ' A' ' 43' ' ' PHE . . . 53.0 22.07 2.31 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.12 -1.223 . . . . 0.0 111.406 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.98 -136.39 2.16 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.92 20.67 4.35 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.505 -0.997 . . . . 0.0 110.964 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -171.61 -161.18 0.19 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.21 -0.931 . . . . 0.0 110.65 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -78.2 96.31 5.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.715 -0.616 . . . . 0.0 110.397 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.882 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -64.78 177.56 0.93 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.714 -0.616 . . . . 0.0 110.234 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.457 ' H ' HD23 ' A' ' 64' ' ' LEU . . . -130.88 136.34 48.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.59 -0.694 . . . . 0.0 110.108 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.46 178.76 17.87 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -64.71 -16.97 58.03 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.997 1.525 . . . . 0.0 110.673 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -147.45 42.26 1.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.224 -0.923 . . . . 0.0 110.082 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.74 164.16 11.19 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -57.3 157.88 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 O-C-N 123.747 1.393 . . . . 0.0 110.877 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.882 HD12 ' CD2' ' A' ' 64' ' ' LEU . 92.0 mt -98.5 162.49 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.557 -0.715 . . . . 0.0 110.297 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 p -97.11 -169.68 1.9 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.565 -0.71 . . . . 0.0 110.495 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -141.56 116.4 9.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.696 . . . . 0.0 110.021 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 tpt -113.96 -31.84 6.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.559 -0.713 . . . . 0.0 110.331 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.421 ' CD1' ' HA ' ' A' ' 179' ' ' MET . 15.8 m-85 -129.47 104.34 7.41 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.582 -0.699 . . . . 0.0 109.658 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.616 HG22 HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -146.75 109.69 4.68 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.349 -0.941 . . . . 0.0 112.117 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -161.82 74.86 0.46 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.36 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.656 HG11 ' HB3' ' A' ' 56' ' ' TYR . 5.9 p -67.77 -23.18 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.229 -0.919 . . . . 0.0 110.224 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -50.95 -26.35 5.83 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.301 -0.874 . . . . 0.0 110.653 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -172.68 36.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.585 -0.697 . . . . 0.0 110.511 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.507 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -161.82 -86.19 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.138 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.724 ' CD1' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER 175.55 175.97 0.23 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.58 -1.325 . . . . 0.0 110.343 -178.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.706 HG11 ' HB2' ' A' ' 56' ' ' TYR . 27.7 m -143.56 121.6 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.648 0.737 . . . . 0.0 109.354 177.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.19 149.34 18.7 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.529 ' CZ2' HD11 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -110.46 151.37 27.61 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -63.55 137.19 58.02 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.168 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 135.8 34.62 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.736 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.458 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 38.0 Cg_endo -114.46 -38.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.463 0 O-C-N 123.56 1.295 . . . . 0.0 114.911 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 54.9 Cg_endo -61.34 -155.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 117.063 -1.492 . . . . 0.0 109.966 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.572 ' N ' HG11 ' A' ' 29' ' ' VAL . . . -78.63 32.45 1.89 Allowed Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.5 ' HA ' HG21 ' A' ' 29' ' ' VAL . . . -58.33 126.52 27.89 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.021 -1.282 . . . . 0.0 110.549 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 147.68 52.29 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.62 116.83 32.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.456 -0.778 . . . . 0.0 110.895 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.561 HD12 ' HB2' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -90.96 -159.23 0.61 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.73 -0.607 . . . . 0.0 109.528 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.536 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -156.06 -173.64 0.39 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.601 -0.687 . . . . 0.0 109.742 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -87.97 156.16 7.21 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 O-C-N 123.77 1.405 . . . . 0.0 110.311 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.448 ' SG ' HG23 ' A' ' 151' ' ' VAL . 0.5 OUTLIER -90.46 -67.81 0.82 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.443 -0.785 . . . . 0.0 110.275 179.681 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.1 m 50.57 26.79 2.58 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.193 -0.942 . . . . 0.0 110.721 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -147.06 174.28 11.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.513 -0.742 . . . . 0.0 110.86 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.46 -167.1 48.41 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.9 m -121.11 -55.41 1.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.726 -0.867 . . . . 0.0 109.772 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.62 -152.84 0.21 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.713 -0.617 . . . . 0.0 109.944 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 t0 57.3 101.87 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.335 -0.853 . . . . 0.0 110.266 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.77 HD13 HD23 ' A' ' 143' ' ' LEU . 1.4 mt -120.3 -168.99 1.72 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.505 -0.747 . . . . 0.0 109.751 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.676 ' O ' HG23 ' A' ' 107' ' ' VAL . 20.6 m-85 -140.45 83.68 1.92 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.759 HD23 HD11 ' A' ' 114' ' ' ILE . 24.6 tp -60.01 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 105' ' ' TYR . 48.6 t -84.67 102.88 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.063 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.3 p -65.14 170.17 4.8 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HB2' ' CG ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -95.55 25.8 4.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.911 -1.118 . . . . 0.0 110.363 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.463 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -124.62 29.83 6.15 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 62.08 70.68 0.57 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.543 -0.723 . . . . 0.0 111.088 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -175.0 102.69 0.09 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.645 -0.659 . . . . 0.0 110.223 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.626 ' CG1' HG22 ' A' ' 107' ' ' VAL . 7.8 m -101.79 153.81 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.446 -0.784 . . . . 0.0 110.222 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.759 HD11 HD23 ' A' ' 106' ' ' LEU . 30.2 pt -135.94 139.34 30.17 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.474 -0.766 . . . . 0.0 109.559 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.63 ' HB2' HD12 ' A' ' 127' ' ' LEU . 47.1 Cg_endo -66.85 145.48 74.84 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 123.929 1.489 . . . . 0.0 111.503 -178.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.33 142.9 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.93 117.32 34.35 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.84 128.52 15.79 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.527 -0.733 . . . . 0.0 110.119 -178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -112.97 -25.41 8.99 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.173 -177.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -172.93 53.35 0.16 Allowed Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.57 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.411 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER 65.9 -70.19 0.1 Allowed 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.633 -0.922 . . . . 0.0 110.06 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 120' ' ' GLY . 77.7 p -92.94 35.7 1.05 Allowed 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.342 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.456 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -167.91 150.75 5.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.336 -0.852 . . . . 0.0 110.216 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.42 -178.21 20.78 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 4.1 t -127.86 117.0 21.01 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.607 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.693 HD21 HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -58.53 139.27 55.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.45 -0.782 . . . . 0.0 109.475 178.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 115' ' ' PRO . 38.7 mt -105.26 53.92 0.71 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.237 1.018 . . . . 0.0 108.267 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 167.48 152.64 0.1 Allowed Pre-proline 0 N--CA 1.503 2.184 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.19 115.65 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.782 1.412 . . . . 0.0 110.044 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.606 ' HB2' HD22 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -123.62 131.8 24.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.488 -0.758 . . . . 0.0 109.035 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -58.2 130.84 39.85 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.793 1.418 . . . . 0.0 110.898 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.729 HG21 ' SG ' ' A' ' 159' ' ' CYS . 10.9 p -65.79 -37.3 79.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.584 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -49.97 -37.08 30.74 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 122.042 0.925 . . . . 0.0 110.458 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -66.91 -38.37 86.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.517 HD11 ' CB ' ' A' ' 164' ' ' ALA . 15.4 mt -66.95 -36.43 82.21 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -61.02 123.29 17.19 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.949 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.17 -25.89 26.56 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.655 ' HA ' HD13 ' A' ' 44' ' ' LEU . 7.4 m -81.09 0.96 33.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.547 -0.972 . . . . 0.0 111.427 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 60.1 m -55.83 126.2 24.61 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.216 -0.928 . . . . 0.0 111.569 -178.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 123.66 -22.66 6.86 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.624 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -53.75 126.37 35.02 Favored Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.478 ' O ' HD12 ' A' ' 144' ' ' LEU . 49.2 Cg_endo -74.33 125.67 9.85 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.763 1.402 . . . . 0.0 112.977 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.77 HD23 HD13 ' A' ' 104' ' ' LEU . 1.1 mp -76.86 135.22 38.86 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 175.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 142' ' ' PRO . 1.1 mt -132.91 127.73 34.98 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 118.924 -1.11 . . . . 0.0 111.962 -178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.506 ' HB3' HG21 ' A' ' 151' ' ' VAL . 14.2 p -74.98 -174.72 0.39 Allowed Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.1 Cg_endo -71.1 68.21 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.419 1.22 . . . . 0.0 110.643 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.78 -175.28 1.76 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.559 -0.713 . . . . 0.0 109.75 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.42 27.11 20.98 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -116.81 135.97 53.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.535 -0.979 . . . . 0.0 109.753 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -72.05 141.01 49.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.662 -0.649 . . . . 0.0 110.241 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.653 HG12 ' CE2' ' A' ' 169' ' ' PHE . 1.4 t -96.85 -37.64 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.822 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 177.29 -177.9 48.28 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.484 HG13 HG13 ' A' ' 170' ' ' VAL . 1.1 pt -117.02 140.32 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.112 -1.228 . . . . 0.0 110.435 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.756 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 9.1 t80 -58.44 115.94 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.268 0.556 . . . . 0.0 110.541 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.696 ' HA ' HG11 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -103.68 -46.09 4.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.662 -0.649 . . . . 0.0 109.662 -179.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.731 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -151.29 171.99 16.59 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.756 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -132.09 118.11 19.2 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.674 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.859 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.4 t -65.96 102.44 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.729 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.9 p -128.08 159.55 34.73 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.301 1.048 . . . . 0.0 113.642 -175.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 161' ' ' ARG . 1.6 m -94.05 -174.17 3.32 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.506 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -48.85 84.96 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 121.74 0.781 . . . . 0.0 112.76 -178.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.665 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 84.78 -27.59 4.79 Favored Glycine 0 N--CA 1.5 2.967 0 O-C-N 120.713 -1.242 . . . . 0.0 111.775 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -96.21 131.75 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.773 -1.428 . . . . 0.0 109.604 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.517 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -95.62 134.47 38.47 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.772 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -115.24 -39.98 3.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.729 -0.607 . . . . 0.0 110.961 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.859 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -124.61 177.95 5.68 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.255 -0.903 . . . . 0.0 109.841 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.33 155.55 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.608 0.718 . . . . 0.0 110.685 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.731 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -127.28 96.02 4.46 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.653 ' CE2' HG12 ' A' ' 151' ' ' VAL . 3.7 p90 -132.54 165.86 23.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.824 -1.173 . . . . 0.0 112.946 -176.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.724 HG21 ' CD1' ' A' ' 82' ' ' LEU . 1.3 p -108.81 127.46 27.32 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 44.2 Cg_endo -59.05 160.58 18.26 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.963 1.507 . . . . 0.0 111.954 -177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.822 HG23 ' HA2' ' A' ' 152' ' ' GLY . 40.0 t -84.23 2.98 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.515 -0.741 . . . . 0.0 109.798 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.41 -37.17 21.8 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -36.34 83.92 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.585 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.578 ' SD ' HD22 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -49.89 -36.37 27.09 Favored 'General case' 0 N--CA 1.521 3.09 0 O-C-N 121.426 -0.796 . . . . 0.0 108.885 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -57.77 -37.48 73.74 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.121 -0.987 . . . . 0.0 108.708 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.1 m -76.27 -36.84 58.22 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.633 0.73 . . . . 0.0 109.42 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.593 HG21 ' CZ3' ' A' ' 53' ' ' TRP . 1.3 m -48.82 -52.99 21.12 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.673 -0.642 . . . . 0.0 111.193 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.459 ' CE ' ' CZ2' ' A' ' 53' ' ' TRP . 2.2 ptp -59.85 -40.85 89.92 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.066 -1.021 . . . . 0.0 109.94 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -57.67 -38.36 74.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.038 0.923 . . . . 0.0 109.449 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.58 78.22 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.624 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.59 -0.693 . . . . 0.0 110.714 -179.738 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.11 0.481 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.85 78.88 0.16 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.2 71.69 0.96 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.539 -0.977 . . . . 0.0 109.495 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -72.71 141.03 48.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.766 -0.584 . . . . 0.0 110.211 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.99 90.91 1.99 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.586 -0.696 . . . . 0.0 110.398 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -84.87 -177.33 6.55 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -153.43 77.84 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.41 0.624 . . . . 0.0 110.184 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.443 HG11 ' HG2' ' A' ' 89' ' ' PRO . 35.2 m -64.14 -158.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.749 -0.594 . . . . 0.0 110.278 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 59.92 79.64 0.23 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.173 -0.954 . . . . 0.0 109.831 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.03 -89.72 0.08 OUTLIER Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -171.15 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.633 -0.922 . . . . 0.0 110.762 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 45' ' ' ALA . 7.3 p -117.34 158.8 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.59 0.71 . . . . 0.0 111.705 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 1.5 tt0 -142.35 140.2 32.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.53 HG12 ' HD2' ' A' ' 109' ' ' ARG . 27.7 m -106.22 173.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.967 0.889 . . . . 0.0 112.233 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.465 HG11 ' CH2' ' A' ' 85' ' ' TRP . 33.6 m -129.68 179.75 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.5 p -152.95 139.4 18.62 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.147 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.0 p -146.09 -178.92 6.38 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.42 75.34 0.76 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.762 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 m 178.7 -58.32 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -179.72 -156.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.391 -0.818 . . . . 0.0 109.717 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 p -128.34 139.35 52.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.548 -0.72 . . . . 0.0 109.962 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 67.9 m-85 -99.67 -178.71 3.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.477 -0.764 . . . . 0.0 110.284 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 44' ' ' LEU . 6.8 tt -116.48 146.76 42.33 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.217 -0.927 . . . . 0.0 108.883 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.596 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -148.96 137.51 21.12 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.909 -1.119 . . . . 0.0 110.714 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.697 HG23 HG23 ' A' ' 48' ' ' VAL . 14.8 t -106.39 129.89 54.3 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.283 -0.886 . . . . 0.0 113.381 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.564 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 42.2 t -75.46 87.85 2.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 109.883 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.697 HG23 HG23 ' A' ' 46' ' ' THR . 59.2 t -103.33 135.01 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m120 57.8 18.97 5.26 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.346 -0.846 . . . . 0.0 110.137 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.19 20.36 52.91 Favored Glycine 0 N--CA 1.498 2.775 0 O-C-N 121.215 -0.928 . . . . 0.0 111.015 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 85' ' ' TRP . 59.0 t -137.91 107.78 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.211 -1.17 . . . . 0.0 110.119 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.0 p -60.17 107.38 0.63 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.528 -0.733 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.918 ' CE3' HD23 ' A' ' 82' ' ' LEU . 96.2 m95 -88.19 146.68 25.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.032 -1.042 . . . . 0.0 111.956 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.601 HG21 ' CH2' ' A' ' 85' ' ' TRP . 8.6 t -162.76 171.25 17.05 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.865 HG11 ' CE1' ' A' ' 57' ' ' HIS . 16.3 t -94.5 151.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.451 -0.78 . . . . 0.0 109.655 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.416 ' CD2' HG12 ' A' ' 78' ' ' VAL . 18.2 t80 -76.93 4.46 9.88 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.178 -0.951 . . . . 0.0 111.709 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.865 ' CE1' HG11 ' A' ' 55' ' ' VAL . 26.3 m170 -40.72 -39.45 1.09 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.379 -0.826 . . . . 0.0 112.392 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.34 40.74 0.24 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.91 -5.6 59.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.445 -1.032 . . . . 0.0 110.864 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.49 133.58 3.07 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -92.32 -20.96 20.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.556 -0.967 . . . . 0.0 110.364 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.0 mtpp -77.7 -165.59 0.65 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.775 . . . . 0.0 110.374 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.594 HG22 ' HB2' ' A' ' 70' ' ' PRO . 1.2 m -64.93 100.09 0.39 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.594 -0.691 . . . . 0.0 111.147 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.711 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -52.24 171.39 0.05 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.626 -0.671 . . . . 0.0 110.261 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.37 142.89 46.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.269 -0.895 . . . . 0.0 111.312 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.99 -179.02 17.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -64.88 -23.0 62.62 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 O-C-N 123.9 1.474 . . . . 0.0 110.752 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -152.27 41.45 0.64 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.356 -0.84 . . . . 0.0 110.062 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.69 156.1 7.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.594 ' HB2' HG22 ' A' ' 63' ' ' THR . 52.1 Cg_endo -61.52 158.71 35.2 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.778 1.409 . . . . 0.0 110.112 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.711 HD12 ' CD2' ' A' ' 64' ' ' LEU . 80.5 mt -99.3 118.57 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.514 -0.741 . . . . 0.0 109.563 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 m -59.22 124.64 20.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.772 -0.58 . . . . 0.0 110.41 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -73.59 136.02 43.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.656 -0.653 . . . . 0.0 110.072 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.402 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -135.1 -44.9 0.71 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.631 -0.668 . . . . 0.0 110.304 -179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.467 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 14.8 m-85 -130.6 118.44 21.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.599 -0.688 . . . . 0.0 110.055 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.846 HG23 ' CG1' ' A' ' 83' ' ' VAL . 11.7 m -158.27 108.91 2.13 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.558 -0.714 . . . . 0.0 111.196 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 3.0 m120 -138.67 76.65 1.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.021 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.416 HG12 ' CD2' ' A' ' 56' ' ' TYR . 30.2 m 11.77 -133.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.88 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.49 177.99 8.62 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.733 -1.23 . . . . 0.0 110.106 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 52.31 23.08 2.25 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.523 -0.736 . . . . 0.0 110.871 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 1.8 m-20 -163.59 -114.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 109.081 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.918 HD23 ' CE3' ' A' ' 53' ' ' TRP . 3.0 tp 173.47 176.53 0.12 Allowed 'General case' 0 N--CA 1.516 2.847 0 CA-C-N 120.908 1.686 . . . . 0.0 111.319 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.846 ' CG1' HG23 ' A' ' 76' ' ' THR . 13.3 t -144.8 104.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 53' ' ' TRP . . . -123.06 109.87 1.43 Allowed Glycine 0 N--CA 1.487 2.049 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.879 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.601 ' CH2' HG21 ' A' ' 54' ' ' THR . 1.7 m0 -86.72 171.19 11.13 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -83.11 131.73 35.13 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.338 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -108.0 85.38 2.55 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.144 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.551 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -95.55 -10.71 1.0 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.745 1.392 . . . . 0.0 113.218 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 47.7 Cg_endo -72.32 73.57 2.69 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 115.715 -2.39 . . . . 0.0 110.767 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 51.87 25.8 16.82 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.564 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -67.56 138.73 56.71 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.458 -1.025 . . . . 0.0 110.963 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -84.18 120.4 26.15 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.3 p -93.17 119.73 32.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.632 -0.667 . . . . 0.0 110.7 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mt -77.66 -147.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.485 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 0.6 OUTLIER -159.2 -174.7 0.45 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 109.084 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.412 ' HD2' ' OG1' ' A' ' 95' ' ' THR . 51.8 Cg_endo -80.22 149.24 19.46 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 O-C-N 123.339 1.178 . . . . 0.0 111.138 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.731 ' O ' HG23 ' A' ' 98' ' ' THR . 1.8 t -68.15 156.23 37.94 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.158 0.98 . . . . 0.0 110.65 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 97' ' ' CYS . 0.6 OUTLIER -170.98 38.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 11.8 m -82.33 -172.56 4.07 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.625 0.726 . . . . 0.0 110.842 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -110.59 -32.76 2.62 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 m -99.02 -155.38 0.5 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.537 -0.978 . . . . 0.0 109.858 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.76 19.92 0.91 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.383 -0.823 . . . . 0.0 111.094 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 46.9 m-20 -78.85 106.82 11.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.69 HD13 HD23 ' A' ' 143' ' ' LEU . 0.3 OUTLIER -107.54 -178.39 3.61 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.778 -178.227 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.46 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.3 m-85 -141.49 92.97 2.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.686 -0.634 . . . . 0.0 109.32 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.48 HD11 HD11 ' A' ' 143' ' ' LEU . 6.2 tp -51.33 100.45 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.412 -0.805 . . . . 0.0 110.201 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.575 ' HA ' HG12 ' A' ' 113' ' ' VAL . 45.2 t -82.79 124.64 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.106 -1.037 . . . . 0.0 110.858 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 112' ' ' ASP . 47.6 p -89.91 179.73 5.91 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.656 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -96.38 52.99 1.28 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.047 -1.033 . . . . 0.0 111.404 -178.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.427 ' NE2' ' HB ' ' A' ' 108' ' ' THR . 4.9 p80 -177.09 44.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.44 -0.788 . . . . 0.0 109.996 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.57 65.11 1.61 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.643 -0.661 . . . . 0.0 111.237 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.492 ' O ' HG23 ' A' ' 108' ' ' THR . 0.8 OUTLIER -155.58 96.56 1.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 107' ' ' VAL . 17.0 m -109.26 150.71 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.607 -0.683 . . . . 0.0 110.948 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.8 pt -133.22 134.61 24.34 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.379 -0.825 . . . . 0.0 109.797 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.93 142.3 92.55 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 123.831 1.437 . . . . 0.0 112.13 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.45 152.89 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.763 -0.586 . . . . 0.0 109.683 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.89 110.84 18.24 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -48.35 127.12 12.46 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.354 -0.841 . . . . 0.0 110.725 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -111.88 -24.7 9.83 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.384 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.44 -169.66 36.75 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -63.31 128.33 35.33 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.843 0.83 . . . . 0.0 109.96 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.78 46.86 24.93 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.139 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.46 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 1.2 ttp180 -166.44 151.16 7.81 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.493 -0.754 . . . . 0.0 110.649 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.84 -178.34 18.65 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -123.64 134.45 53.77 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 122.008 -0.701 . . . . 0.0 111.88 -178.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.98 133.47 40.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.608 -0.683 . . . . 0.0 109.194 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 33.2 mt -107.27 54.16 0.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.001 0.905 . . . . 0.0 108.642 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.34 126.6 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.175 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -58.35 110.12 0.6 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 O-C-N 123.568 1.299 . . . . 0.0 110.33 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -123.03 137.77 28.71 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 47.1 Cg_endo -66.58 131.69 26.86 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.854 1.45 . . . . 0.0 110.505 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.597 HG21 ' SG ' ' A' ' 159' ' ' CYS . 7.8 p -60.14 -36.83 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.658 -0.651 . . . . 0.0 109.674 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 t -49.39 -36.51 22.07 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 122.035 0.922 . . . . 0.0 110.654 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.408 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 30.0 t80 -66.68 -37.49 84.86 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.527 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.3 mt -66.46 -36.23 82.24 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -61.18 121.62 13.0 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.746 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 113.82 -31.99 6.26 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.5 m -91.39 13.2 18.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.975 . . . . 0.0 110.881 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 p -51.52 128.74 23.82 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.174 -0.954 . . . . 0.0 110.379 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.535 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 116.26 -13.75 16.13 Favored Glycine 0 CA--C 1.542 1.772 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.654 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -46.28 110.22 0.47 Allowed Glycine 0 N--CA 1.504 3.21 0 O-C-N 121.504 -0.997 . . . . 0.0 111.174 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -67.84 126.97 15.38 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 124.066 1.561 . . . . 0.0 110.927 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.69 HD23 HD13 ' A' ' 104' ' ' LEU . 6.2 mp -80.24 130.87 35.51 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.64 120.37 22.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 109.472 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.595 ' CB ' ' HD3' ' A' ' 146' ' ' PRO . 43.1 m -49.9 -92.17 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.653 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.595 ' HD3' ' CB ' ' A' ' 145' ' ' CYS . 49.3 Cg_endo -92.3 -81.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 114.764 -3.024 . . . . 0.0 111.15 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.7 t -136.95 78.96 1.73 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.19 -0.944 . . . . 0.0 109.714 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 127.09 -166.53 19.85 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.9 m170 54.46 98.53 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.266 -1.138 . . . . 0.0 110.382 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.762 ' HB1' HG11 ' A' ' 172' ' ' VAL . . . -71.68 141.33 49.87 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.206 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.687 HG21 ' CD2' ' A' ' 104' ' ' LEU . 33.4 t -107.04 -43.39 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.69 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 175.81 179.33 46.24 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.451 HG13 HG12 ' A' ' 170' ' ' VAL . 1.4 pt -111.8 170.47 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 CA-C-N 119.589 1.695 . . . . 0.0 111.212 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.843 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 10.3 t80 -83.71 89.17 7.1 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.089 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -74.75 -41.04 60.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.503 -0.748 . . . . 0.0 109.153 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -159.74 -179.46 7.88 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.843 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -137.98 113.91 9.91 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.452 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.871 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 4.5 t -60.21 101.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.597 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.9 p -123.01 156.94 33.77 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.363 1.078 . . . . 0.0 113.603 -175.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 163' ' ' VAL . 6.1 p -96.38 -171.79 2.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -46.0 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.396 -0.815 . . . . 0.0 111.905 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.577 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 73.01 -19.24 1.28 Allowed Glycine 0 N--CA 1.499 2.865 0 O-C-N 121.168 -0.958 . . . . 0.0 112.795 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.8 t -101.98 136.05 35.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 119.39 1.595 . . . . 0.0 109.199 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.527 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -94.53 135.59 35.8 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.063 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -116.23 -38.48 3.57 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.611 -0.681 . . . . 0.0 111.047 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.871 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -129.36 178.78 6.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.496 -0.753 . . . . 0.0 109.685 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.2 t -121.11 144.82 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.671 0.748 . . . . 0.0 111.595 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.654 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -107.6 97.34 7.09 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 176.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.506 ' CE1' HG12 ' A' ' 151' ' ' VAL . 0.2 OUTLIER -126.97 142.91 51.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.881 -1.128 . . . . 0.0 112.468 -175.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.562 HG11 HD11 ' A' ' 82' ' ' LEU . 3.7 p -98.19 130.43 28.5 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 50.5 Cg_endo -58.68 152.69 54.46 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.667 1.351 . . . . 0.0 111.484 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.762 HG11 ' HB1' ' A' ' 150' ' ' ALA . 17.8 m -77.57 -2.53 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.417 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -85.32 -38.67 18.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 109.032 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.4 m -60.68 -36.42 78.7 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.525 ' HG3' ' HA ' ' A' ' 172' ' ' VAL . 3.3 mtt -49.25 -37.13 22.38 Favored 'General case' 0 N--CA 1.515 2.796 0 CA-C-O 121.715 0.769 . . . . 0.0 109.075 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -61.0 -40.53 93.87 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.7 m -65.55 -39.74 92.06 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.718 0.771 . . . . 0.0 109.205 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 175' ' ' MET . 0.9 OUTLIER -50.62 -41.22 54.76 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.819 -0.551 . . . . 0.0 110.798 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.467 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -53.88 -41.45 67.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.943 -1.098 . . . . 0.0 111.193 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -53.39 -36.7 61.73 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.301 -0.874 . . . . 0.0 109.61 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 178' ' ' THR . . . -67.82 -43.54 79.35 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 t -100.93 107.45 18.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.449 -0.782 . . . . 0.0 110.656 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -118.75 -62.17 1.56 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.436 -0.79 . . . . 0.0 110.326 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt 52.96 26.07 4.45 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.393 -0.817 . . . . 0.0 110.743 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -86.7 -80.93 0.23 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.57 -0.706 . . . . 0.0 110.019 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.183 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.953 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.261 0.553 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -151.99 -105.46 0.29 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 57.74 107.18 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.55 -0.971 . . . . 0.0 111.154 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.4 t0 55.69 40.3 30.88 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.466 -0.772 . . . . 0.0 110.201 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.79 21.44 4.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.516 -0.74 . . . . 0.0 111.195 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -108.21 -179.49 3.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 110.011 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.73 80.09 0.64 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 91' ' ' ALA . 9.4 p -52.27 115.87 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.642 -0.661 . . . . 0.0 111.239 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -170.82 81.04 0.08 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.72 169.53 11.77 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.481 ' HB2' HD12 ' A' ' 94' ' ' LEU . 1.1 pt-20 -98.4 -6.12 31.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.587 -0.949 . . . . 0.0 111.308 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.601 HG12 ' HG3' ' A' ' 109' ' ' ARG . 63.0 t -120.23 142.38 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.122 -0.986 . . . . 0.0 110.749 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.605 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 40.1 tt0 -135.47 144.81 46.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.826 -0.546 . . . . 0.0 109.873 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.593 HG12 HD22 ' A' ' 44' ' ' LEU . 26.8 m -117.8 174.01 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.38 -0.825 . . . . 0.0 110.815 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.512 HG11 ' CH2' ' A' ' 85' ' ' TRP . 36.0 m -128.57 -179.07 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -138.66 133.97 33.06 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.731 -1.187 . . . . 0.0 112.296 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.3 p -126.48 -177.81 4.12 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.18 96.69 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.164 -0.96 . . . . 0.0 111.145 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 m 59.54 47.55 10.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.644 -0.66 . . . . 0.0 110.622 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -165.13 169.31 16.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.248 -0.907 . . . . 0.0 110.984 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.5 p -158.45 132.99 8.14 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . 91.8 m-85 -99.65 -178.94 4.04 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.111 -0.993 . . . . 0.0 111.235 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.593 HD22 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -113.1 152.49 29.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.248 -0.907 . . . . 0.0 110.301 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 34' ' ' GLN . . . -162.18 159.39 25.82 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.596 -0.69 . . . . 0.0 110.368 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.695 HG23 HG23 ' A' ' 48' ' ' VAL . 14.2 t -138.05 128.83 26.86 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.457 -0.777 . . . . 0.0 111.612 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 79.5 m -77.97 82.22 4.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.551 -0.718 . . . . 0.0 109.727 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.695 HG23 HG23 ' A' ' 46' ' ' THR . 57.9 t -97.95 137.84 24.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 57.18 21.0 6.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.801 -0.562 . . . . 0.0 110.248 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.63 23.62 38.79 Favored Glycine 0 N--CA 1.494 2.524 0 O-C-N 121.414 -0.804 . . . . 0.0 111.822 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 85' ' ' TRP . 46.3 t -143.3 116.18 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-N 118.939 1.37 . . . . 0.0 110.388 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.519 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 13.1 t -64.29 105.64 0.95 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.955 ' CE3' HD23 ' A' ' 82' ' ' LEU . 98.3 m95 -86.41 149.84 24.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.388 -0.82 . . . . 0.0 112.146 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.86 HG21 ' CZ2' ' A' ' 85' ' ' TRP . 7.5 t -164.45 171.93 14.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.584 -0.698 . . . . 0.0 110.519 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -92.98 150.05 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.604 -0.685 . . . . 0.0 109.922 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.536 ' HB3' ' HA ' ' A' ' 78' ' ' VAL . 27.0 t80 -82.95 -2.43 55.08 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.219 -0.926 . . . . 0.0 112.112 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -67.47 -10.72 54.19 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.206 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.12 -50.58 0.02 OUTLIER Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.833 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HB3' ' OG1' ' A' ' 54' ' ' THR . . . -83.08 112.63 19.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.012 -1.287 . . . . 0.0 109.899 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.27 10.45 27.61 Favored Glycine 0 N--CA 1.499 2.847 0 O-C-N 121.169 -0.957 . . . . 0.0 110.85 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.4 t -103.66 -38.57 7.05 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.86 -1.377 . . . . 0.0 110.193 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.53 -165.17 1.09 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.494 -0.754 . . . . 0.0 110.577 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -72.05 90.57 1.18 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.669 -0.645 . . . . 0.0 109.855 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.864 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -56.22 177.77 0.06 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.869 -0.519 . . . . 0.0 110.414 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.3 126.82 32.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -127.99 -178.63 15.43 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.78 -18.04 52.69 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 124.036 1.545 . . . . 0.0 109.649 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -122.89 25.55 8.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 111.008 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 66' ' ' GLY . . . 108.7 -157.71 15.07 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -55.49 145.81 66.82 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.692 1.364 . . . . 0.0 111.523 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.864 HD12 ' CD2' ' A' ' 64' ' ' LEU . 88.1 mt -93.14 16.57 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.519 -0.738 . . . . 0.0 110.506 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 p 43.17 -153.8 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.302 -0.874 . . . . 0.0 111.501 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.66 118.75 2.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.68 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -30.49 9.98 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.374 -0.828 . . . . 0.0 109.967 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.433 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 15.5 m-85 -129.58 121.71 27.66 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.699 HG23 ' CG1' ' A' ' 83' ' ' VAL . 3.7 m -160.44 113.52 2.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.287 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.45 ' C ' HG22 ' A' ' 78' ' ' VAL . 6.3 t-20 -143.59 73.15 1.38 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.504 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.536 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 14.2 m 36.01 -162.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.93 -31.61 34.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.406 ' HB2' HG23 ' A' ' 78' ' ' VAL . 54.3 mt-30 -52.2 -30.6 27.9 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.682 0.753 . . . . 0.0 109.255 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.416 ' CB ' ' HB3' ' A' ' 77' ' ' ASN . 0.5 OUTLIER -126.97 -102.26 0.35 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.955 HD23 ' CE3' ' A' ' 53' ' ' TRP . 0.8 OUTLIER 179.22 168.42 1.01 Allowed 'General case' 0 N--CA 1.512 2.628 0 O-C-N 120.299 -1.501 . . . . 0.0 112.27 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.699 ' CG1' HG23 ' A' ' 76' ' ' THR . 20.0 t -128.5 150.54 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.38 111.31 0.47 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.319 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.86 ' CZ2' HG21 ' A' ' 54' ' ' THR . 1.1 m-90 -87.04 172.58 9.87 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -87.31 131.33 34.29 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.688 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 91' ' ' ALA . . . -58.66 167.73 1.7 Allowed Pre-proline 0 N--CA 1.494 1.773 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.554 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 33.2 Cg_endo -67.29 -79.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.555 1.546 0 O-C-N 123.879 1.463 . . . . 0.0 110.581 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 88' ' ' PRO . 56.0 Cg_endo -97.65 36.04 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 115.731 -2.379 . . . . 0.0 108.606 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.28 -10.34 73.53 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.659 ' HA ' HG23 ' A' ' 29' ' ' VAL . . . 50.15 -178.39 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.207 -1.173 . . . . 0.0 111.855 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -73.19 72.43 1.22 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 t -41.74 95.88 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.755 -0.591 . . . . 0.0 111.968 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.481 HD12 ' HB2' ' A' ' 32' ' ' GLU . 1.0 OUTLIER -68.88 -157.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.695 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 0.9 OUTLIER -153.29 175.14 3.16 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 121.245 -0.91 . . . . 0.0 111.179 -179.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.62 163.95 26.26 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 O-C-N 123.845 1.445 . . . . 0.0 111.545 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 18.5 t -79.56 -72.78 0.38 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.705 -0.622 . . . . 0.0 109.811 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.0 m 49.77 74.48 0.2 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.419 -0.801 . . . . 0.0 110.612 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 77.2 m -138.14 -64.92 0.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.261 -0.899 . . . . 0.0 110.601 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 116.33 33.69 1.43 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.4 m -134.32 -163.84 1.42 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.655 -0.909 . . . . 0.0 109.725 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.6 p -135.64 -151.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.578 -0.701 . . . . 0.0 109.546 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 30.2 t70 62.23 109.79 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.331 -0.856 . . . . 0.0 109.893 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.604 HD13 HD23 ' A' ' 143' ' ' LEU . 1.1 mt -128.2 -171.4 2.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.545 -0.722 . . . . 0.0 109.434 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.635 ' O ' HG23 ' A' ' 107' ' ' VAL . 16.4 m-85 -139.5 90.5 2.41 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.553 HD12 ' HG ' ' A' ' 143' ' ' LEU . 11.6 tp -59.44 93.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 105' ' ' TYR . 84.6 t -82.56 101.57 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.356 -177.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.525 HG21 ' OH ' ' A' ' 134' ' ' TYR . 38.5 p -65.66 168.48 7.57 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.601 ' HG3' HG12 ' A' ' 33' ' ' VAL . 1.1 tmt_? -93.35 24.03 4.15 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.728 -1.232 . . . . 0.0 110.727 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.96 31.27 5.88 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 56.46 71.73 0.55 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.63 0.729 . . . . 0.0 110.516 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -171.99 91.88 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.57 ' CG1' HG22 ' A' ' 107' ' ' VAL . 11.8 m -94.57 151.24 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.421 ' CG1' ' HB3' ' A' ' 106' ' ' LEU . 30.9 pt -129.96 142.43 45.34 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.29 -0.881 . . . . 0.0 109.031 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.58 132.85 24.5 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.811 1.427 . . . . 0.0 112.09 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 103' ' ' ASP . 91.4 t -121.45 153.71 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -116.06 111.85 20.9 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.92 124.13 8.15 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.626 -0.672 . . . . 0.0 110.15 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 125' ' ' SER . 1.6 mmm180 -104.97 -49.45 3.48 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.842 -0.536 . . . . 0.0 110.701 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -151.93 -158.43 8.41 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.712 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -70.58 125.05 25.73 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.147 0.975 . . . . 0.0 109.262 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.83 50.13 16.36 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.042 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.521 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 19.2 ttm180 -166.12 156.53 12.64 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.589 -0.694 . . . . 0.0 110.787 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.95 -178.61 23.28 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.475 ' HB2' ' HG3' ' A' ' 119' ' ' ARG . 1.4 t -135.37 100.84 4.64 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.086 -0.655 . . . . 0.0 111.559 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 126' ' ' LEU . 2.4 pp -48.19 162.64 0.08 Allowed 'General case' 0 N--CA 1.51 2.552 0 O-C-N 121.466 -0.771 . . . . 0.0 110.713 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.7 mt -127.41 67.51 1.3 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 164.3 134.96 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.058 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.691 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.0 100.49 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.803 1.423 . . . . 0.0 109.566 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.36 128.21 25.74 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.539 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -56.0 127.13 24.81 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.917 1.483 . . . . 0.0 110.85 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.712 HG21 ' SG ' ' A' ' 159' ' ' CYS . 7.3 p -60.61 -36.56 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.44 -37.03 24.29 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.546 -0.722 . . . . 0.0 110.807 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.525 ' OH ' HG21 ' A' ' 108' ' ' THR . 17.0 t80 -67.8 -39.49 84.01 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.3 mt -63.05 -34.8 78.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 123.81 17.1 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.651 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.31 -31.22 8.88 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.464 ' HA ' HD23 ' A' ' 44' ' ' LEU . 57.6 m -79.34 -0.62 33.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.915 -0.756 . . . . 0.0 111.104 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 2.0 m -57.53 119.84 7.24 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 120.9 -1.125 . . . . 0.0 109.738 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 122.8 -17.24 8.22 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.4 137.88 49.71 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.51 ' CD ' HG22 ' A' ' 33' ' ' VAL . 49.5 Cg_endo -85.16 129.12 3.78 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 O-C-N 123.522 1.275 . . . . 0.0 113.476 -177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.604 HD23 HD13 ' A' ' 104' ' ' LEU . 4.4 mp -81.6 130.79 35.18 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 150' ' ' ALA . 1.1 mt -129.92 123.74 31.46 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 119.778 1.172 . . . . 0.0 112.474 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.428 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 4.2 p -67.44 -173.6 0.16 Allowed Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 40.8 Cg_endo -66.94 169.25 15.24 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.674 1.355 . . . . 0.0 110.214 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m 53.35 29.89 9.4 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.638 -0.664 . . . . 0.0 111.43 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 73.63 -134.01 18.43 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 59.61 106.19 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.26 -1.141 . . . . 0.0 110.278 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -65.81 143.94 57.17 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.69 -0.631 . . . . 0.0 110.798 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 2.1 t -107.01 -42.94 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.759 -0.588 . . . . 0.0 110.326 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.701 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 177.71 -178.62 48.42 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.66 HG13 HG13 ' A' ' 170' ' ' VAL . 1.0 OUTLIER -116.72 153.48 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 118.59 1.195 . . . . 0.0 111.718 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.78 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 7.4 t80 -65.38 117.24 7.62 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.505 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -107.26 -35.01 6.93 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.234 -0.916 . . . . 0.0 109.171 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.717 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -159.17 169.83 23.28 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.78 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -129.84 116.89 19.36 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.41 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.802 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.0 t -63.39 100.55 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.712 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.8 p -129.03 167.29 17.71 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.512 1.148 . . . . 0.0 113.971 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 162' ' ' GLY . 14.9 p -105.47 -173.51 2.32 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.12 82.9 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.635 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 86.09 -27.25 5.63 Favored Glycine 0 N--CA 1.501 2.968 0 O-C-N 121.098 -1.001 . . . . 0.0 112.52 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.27 139.73 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-N 119.188 1.494 . . . . 0.0 108.288 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.605 ' C ' HD21 ' A' ' 126' ' ' LEU . . . -99.52 139.32 35.35 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.371 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.517 ' HA ' HD11 ' A' ' 126' ' ' LEU . 5.7 mtpt -112.98 -31.36 6.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.697 -0.627 . . . . 0.0 110.62 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.802 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -141.58 178.65 7.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.888 . . . . 0.0 110.324 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.34 150.4 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.662 0.744 . . . . 0.0 110.857 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.717 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -119.92 103.24 9.16 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 177.279 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.521 ' CE2' ' N ' ' A' ' 123' ' ' ARG . 1.7 p90 -128.44 174.32 9.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 118.966 -1.094 . . . . 0.0 112.23 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.662 HG11 ' CD1' ' A' ' 82' ' ' LEU . 1.4 p -125.96 122.26 24.35 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 41.1 Cg_endo -47.92 152.84 2.89 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 O-C-N 123.651 1.343 . . . . 0.0 113.11 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.701 HG13 ' HA2' ' A' ' 152' ' ' GLY . 18.2 m -82.38 -1.85 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.343 -0.848 . . . . 0.0 109.832 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -87.42 -43.69 11.9 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.547 -0.72 . . . . 0.0 109.187 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.7 t -60.7 -42.74 97.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.737 -0.602 . . . . 0.0 109.716 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.903 ' HB3' HD22 ' A' ' 82' ' ' LEU . 8.2 ptp -58.9 -36.54 74.85 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.914 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.85 -38.05 69.57 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.387 -1.445 . . . . 0.0 108.822 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.7 m -63.62 -36.89 85.3 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.325 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.899 HG22 ' O ' ' A' ' 175' ' ' MET . 3.1 t -48.71 -35.5 14.15 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.12 -0.987 . . . . 0.0 111.645 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.471 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -58.19 -41.25 83.51 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.866 -1.146 . . . . 0.0 110.447 179.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -48.61 -36.68 16.27 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.967 0.889 . . . . 0.0 110.604 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -91.3 -42.74 10.2 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.2 t 51.72 -176.57 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.296 -0.877 . . . . 0.0 110.962 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt -101.62 -67.64 0.86 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.741 0.781 . . . . 0.0 109.941 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.63 144.53 30.24 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.778 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -149.04 53.44 0.97 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.526 -0.734 . . . . 0.0 110.46 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.29 179.721 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.181 0.515 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.11 71.32 0.6 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -124.0 54.76 1.31 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.604 -0.939 . . . . 0.0 109.331 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -147.27 42.3 1.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.633 -0.667 . . . . 0.0 110.453 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -91.47 52.54 2.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.47 -0.769 . . . . 0.0 110.489 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -65.22 86.82 0.07 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.534 -0.729 . . . . 0.0 109.305 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.85 77.94 0.76 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.543 -0.723 . . . . 0.0 109.592 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 89' ' ' PRO . 33.6 m -100.31 -164.48 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.816 -0.553 . . . . 0.0 109.91 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 58.51 79.07 0.22 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.333 -0.855 . . . . 0.0 109.869 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.0 -108.92 0.21 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -168.43 -35.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.549 -0.971 . . . . 0.0 111.437 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.755 HG22 ' OG1' ' A' ' 46' ' ' THR . 54.1 t -131.32 140.6 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.119 -0.988 . . . . 0.0 111.723 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.84 156.41 48.95 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.657 HG11 ' HB3' ' A' ' 109' ' ' ARG . 33.7 m -123.27 174.87 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.307 -0.87 . . . . 0.0 111.885 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.72 HG13 ' CZ ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -144.6 163.73 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.3 p -119.91 142.89 48.29 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.387 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 p -123.85 -176.87 3.58 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.27 98.36 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.395 -0.815 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 p 51.92 31.98 9.27 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.828 -0.545 . . . . 0.0 110.794 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -146.87 154.99 41.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.552 -0.717 . . . . 0.0 110.449 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.2 t -150.0 165.72 31.83 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.568 -0.707 . . . . 0.0 109.318 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.72 ' CZ ' HG13 ' A' ' 36' ' ' VAL . 11.0 p90 -153.6 -177.38 6.33 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.254 -0.904 . . . . 0.0 110.598 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.778 HD12 ' HG3' ' A' ' 109' ' ' ARG . 7.0 tt -110.43 146.1 36.46 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.509 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -146.12 128.86 16.23 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.681 -1.262 . . . . 0.0 110.287 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.755 ' OG1' HG22 ' A' ' 33' ' ' VAL . 99.9 m -110.31 128.13 55.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.435 -0.791 . . . . 0.0 111.479 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 79.2 m -78.07 85.95 4.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.806 -0.559 . . . . 0.0 109.816 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 94' ' ' LEU . 21.8 t -98.26 136.44 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.99 19.3 5.78 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.397 -0.815 . . . . 0.0 109.993 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.98 24.35 45.31 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 85' ' ' TRP . 42.9 t -139.85 105.44 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 121.261 -1.141 . . . . 0.0 110.378 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.423 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -58.04 97.34 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.464 -0.772 . . . . 0.0 109.942 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.991 ' CE3' HD23 ' A' ' 82' ' ' LEU . 81.2 m95 -78.53 141.35 38.23 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.341 -0.849 . . . . 0.0 110.668 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.477 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 10.2 t -163.33 126.77 2.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.564 -0.71 . . . . 0.0 109.707 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.476 HG11 ' HA ' ' A' ' 155' ' ' ARG . 21.4 m -49.3 143.7 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 O-C-N 121.274 -0.891 . . . . 0.0 110.902 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.528 ' HB2' HG21 ' A' ' 83' ' ' VAL . 4.8 t80 -74.62 -1.72 22.85 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.123 -0.986 . . . . 0.0 110.902 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -48.79 -27.31 2.89 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.26 -0.9 . . . . 0.0 110.689 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.03 76.7 0.09 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.583 ' HB1' ' HZ2' ' A' ' 85' ' ' TRP . . . -105.09 -51.16 3.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.447 -1.031 . . . . 0.0 110.101 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 151.08 -40.6 0.79 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 p 51.68 23.94 2.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.551 -0.97 . . . . 0.0 111.201 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.24 -158.47 0.91 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.426 -0.797 . . . . 0.0 110.509 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.4 m -60.3 91.02 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.573 -0.704 . . . . 0.0 110.534 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.855 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -76.16 164.82 25.72 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.675 -0.641 . . . . 0.0 110.233 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.31 135.48 55.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.205 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.23 -179.02 19.87 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.3 -29.19 88.37 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.872 1.459 . . . . 0.0 111.098 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -147.32 38.6 0.96 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.407 -0.808 . . . . 0.0 110.096 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.06 158.08 8.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -63.63 163.7 23.52 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 O-C-N 123.92 1.484 . . . . 0.0 110.493 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.855 HD12 ' CD2' ' A' ' 64' ' ' LEU . 93.4 mt -106.81 108.75 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.653 -0.654 . . . . 0.0 109.494 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -62.0 137.09 58.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.717 -0.615 . . . . 0.0 110.51 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -73.55 163.47 27.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.566 -0.708 . . . . 0.0 109.806 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -43.81 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.448 -0.783 . . . . 0.0 110.486 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.458 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 14.3 m-85 -126.68 124.36 39.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.492 -0.755 . . . . 0.0 110.075 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.633 HG23 ' CG1' ' A' ' 83' ' ' VAL . 6.3 m -158.85 106.41 1.84 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.705 -0.622 . . . . 0.0 111.009 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.417 ' CB ' ' HB2' ' A' ' 81' ' ' ASP . 18.7 m120 -152.44 76.57 1.16 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.554 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.5 p -72.31 -21.26 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.641 -0.662 . . . . 0.0 110.828 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.73 -32.17 29.32 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.045 -1.034 . . . . 0.0 110.401 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -173.85 34.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.595 -0.691 . . . . 0.0 110.337 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.417 ' HB2' ' CB ' ' A' ' 77' ' ' ASN . 6.7 m-20 -153.95 -99.92 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.313 -0.867 . . . . 0.0 111.811 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.991 HD23 ' CE3' ' A' ' 53' ' ' TRP . 6.2 tp 178.19 176.35 0.47 Allowed 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.548 -1.345 . . . . 0.0 110.274 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.633 ' CG1' HG23 ' A' ' 76' ' ' THR . 16.1 t -132.83 115.57 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.31 110.79 0.82 Allowed Glycine 0 N--CA 1.485 1.908 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.42 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.583 ' HZ2' ' HB1' ' A' ' 59' ' ' ALA . 1.9 m0 -79.38 166.43 22.07 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -86.39 130.29 34.56 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.304 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.707 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -108.17 92.13 9.04 Favored Pre-proline 0 C--N 1.294 -1.846 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.344 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.578 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.8 Cg_endo -104.48 -3.5 0.2 Allowed 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.747 1.393 . . . . 0.0 112.967 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 52.4 Cg_endo -72.94 72.29 3.28 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 115.714 -2.391 . . . . 0.0 109.683 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 57.21 24.24 50.58 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 87' ' ' ALA . . . -74.39 138.56 43.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.546 -0.973 . . . . 0.0 110.732 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.0 135.95 43.16 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.474 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.3 p -104.59 97.93 7.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.563 -0.71 . . . . 0.0 109.563 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.59 ' HB3' HG13 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -65.49 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.543 -0.723 . . . . 0.0 109.161 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.788 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 5.6 p -155.48 173.77 4.56 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.573 -0.705 . . . . 0.0 110.339 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.34 177.61 8.55 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.839 1.441 . . . . 0.0 110.198 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 t -98.69 -77.3 0.52 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.539 -0.725 . . . . 0.0 110.119 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m 55.11 49.81 16.64 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.223 -0.923 . . . . 0.0 110.008 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 78.3 m -112.5 -46.69 3.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.671 -0.643 . . . . 0.0 110.302 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.98 28.8 6.38 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.31 -164.56 1.22 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.609 -0.936 . . . . 0.0 109.987 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.2 p -140.88 -150.33 0.31 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.369 -0.832 . . . . 0.0 110.541 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.73 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.137 -0.977 . . . . 0.0 109.973 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.8 HD13 HD23 ' A' ' 143' ' ' LEU . 0.6 OUTLIER -117.94 -178.8 3.58 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.503 -0.748 . . . . 0.0 110.097 -179.203 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -133.56 84.74 2.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.669 -0.644 . . . . 0.0 109.618 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 154' ' ' PHE . 21.5 tp -60.87 106.38 0.57 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.629 -0.669 . . . . 0.0 109.39 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.712 HG22 HG12 ' A' ' 113' ' ' VAL . 25.1 t -84.43 133.65 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.657 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.3 p -89.34 -177.86 5.47 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.778 ' HG3' HD12 ' A' ' 44' ' ' LEU . 14.5 mtm180 -87.73 18.9 3.73 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.0 -1.063 . . . . 0.0 110.505 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.48 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.9 OUTLIER -151.19 47.49 0.83 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.051 -1.03 . . . . 0.0 111.99 -177.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.06 73.03 0.44 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.294 -0.879 . . . . 0.0 111.457 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.82 90.16 0.69 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.791 -0.568 . . . . 0.0 109.818 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.712 HG12 HG22 ' A' ' 107' ' ' VAL . 26.3 m -94.78 149.55 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 110.252 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.638 HG22 HH21 ' A' ' 130' ' ' ARG . 34.1 pt -131.48 141.77 42.94 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.512 -0.742 . . . . 0.0 109.723 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.33 137.38 36.55 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.918 1.483 . . . . 0.0 111.772 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.9 t -130.97 140.31 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.04 118.26 36.16 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -48.75 127.3 13.51 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.401 -0.812 . . . . 0.0 110.203 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.42 ' CG ' ' HB2' ' A' ' 125' ' ' SER . 3.7 mmt180 -107.13 -25.23 11.64 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.257 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 121' ' ' ASP . . . 173.04 56.52 0.05 OUTLIER Glycine 0 N--CA 1.498 2.773 0 C-N-CA 118.834 -1.65 . . . . 0.0 110.59 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 120' ' ' GLY . 0.6 OUTLIER 59.23 142.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.831 -0.806 . . . . 0.0 110.132 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.5 p 45.57 27.78 0.45 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.544 0.688 . . . . 0.0 111.554 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.518 ' HD2' HG21 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -166.88 148.05 5.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.522 -0.736 . . . . 0.0 109.427 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.37 -178.09 18.04 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.6 t -124.31 122.25 37.22 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.245 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.4 149.53 33.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.743 -0.598 . . . . 0.0 109.582 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 128' ' ' SER . 90.2 mt -126.01 69.4 1.2 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER 158.16 123.05 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.368 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -58.95 106.81 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 O-C-N 123.588 1.31 . . . . 0.0 109.745 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.638 HH21 HG22 ' A' ' 114' ' ' ILE . 9.9 mtt-85 -122.39 151.18 59.0 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.95 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 49.2 Cg_endo -75.3 130.02 12.6 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.178 1.62 . . . . 0.0 109.807 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.7 p -57.92 -36.53 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.73 -0.606 . . . . 0.0 110.093 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 t -49.58 -36.55 24.35 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 122.127 0.965 . . . . 0.0 110.227 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.417 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 57.7 t80 -60.85 -38.04 84.18 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 11.5 mt -69.21 -35.28 76.05 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.712 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -56.95 117.07 3.6 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.746 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 108.29 -24.47 22.57 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.44 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -86.43 4.29 40.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.506 -0.997 . . . . 0.0 111.273 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 80.1 p -51.93 128.85 25.4 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.964 -1.085 . . . . 0.0 109.609 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.519 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 114.96 -18.28 16.64 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.731 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -48.28 117.46 3.79 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.516 ' HG3' HG21 ' A' ' 46' ' ' THR . 53.7 Cg_endo -74.11 124.71 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 124.022 1.538 . . . . 0.0 111.343 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.8 HD23 HD13 ' A' ' 104' ' ' LEU . 6.0 mp -82.9 105.07 13.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 176.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.577 HD21 ' CD1' ' A' ' 94' ' ' LEU . 1.5 mt -105.24 119.72 39.75 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.131 -0.981 . . . . 0.0 112.385 -176.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.451 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 0.9 OUTLIER -59.63 -167.34 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 41.2 Cg_endo -69.4 167.06 25.06 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 117.092 -1.472 . . . . 0.0 109.472 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.2 t 56.77 -155.04 0.32 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.27 -0.894 . . . . 0.0 110.115 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 149' ' ' HIS . . . -102.76 100.53 1.97 Allowed Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.426 ' CG ' ' O ' ' A' ' 148' ' ' GLY . 1.1 m170 -170.65 95.95 0.22 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.692 -0.887 . . . . 0.0 109.853 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.788 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -63.23 142.32 58.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.573 -0.704 . . . . 0.0 109.256 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 171' ' ' PRO . 0.9 OUTLIER -103.39 -36.99 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.451 -0.781 . . . . 0.0 109.575 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.661 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 176.15 -178.89 47.49 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.804 HG23 ' HE1' ' A' ' 175' ' ' MET . 1.1 pp -114.7 168.75 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-N 118.906 1.353 . . . . 0.0 111.392 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.749 ' HB2' HD11 ' A' ' 106' ' ' LEU . 5.9 t80 -76.96 114.57 15.89 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.29 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.476 ' HA ' HG11 ' A' ' 55' ' ' VAL . 26.5 ttt-85 -100.97 -38.97 7.97 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.698 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -159.89 173.61 15.68 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.743 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -129.69 119.84 24.16 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.772 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.839 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.5 t -69.95 100.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.67 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.6 p -127.3 158.07 38.19 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 122.253 1.025 . . . . 0.0 113.354 -175.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' GLY . 16.5 p -91.25 -175.01 4.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.92 85.65 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.692 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 86.51 -25.0 7.62 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 121.063 -1.023 . . . . 0.0 112.214 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -101.7 140.61 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 119.177 1.489 . . . . 0.0 109.214 -179.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -103.26 129.63 50.29 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.047 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt -111.51 -33.79 6.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.652 -0.655 . . . . 0.0 110.548 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.839 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -129.6 -179.7 5.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.275 -0.891 . . . . 0.0 110.219 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -126.89 147.47 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.615 0.722 . . . . 0.0 111.683 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.698 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -111.45 96.33 6.04 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 177.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.61 ' CD2' HD22 ' A' ' 143' ' ' LEU . 0.3 OUTLIER -124.13 160.42 27.83 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.252 -0.979 . . . . 0.0 112.694 -175.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 153' ' ' ILE . 2.7 p -116.21 126.22 27.82 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 47.0 Cg_endo -56.53 156.36 22.46 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 O-C-N 123.872 1.459 . . . . 0.0 112.311 -177.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.661 HG23 ' HA2' ' A' ' 152' ' ' GLY . 57.5 t -80.76 -2.96 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.05 -37.78 28.5 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.9 t -72.42 -36.01 68.49 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.949 ' O ' HG22 ' A' ' 178' ' ' THR . 36.7 mtt -48.24 -39.07 20.13 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.621 -0.674 . . . . 0.0 110.426 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -54.82 -37.27 65.93 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.883 0.849 . . . . 0.0 109.283 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.7 m -52.9 -41.71 64.65 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.236 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.949 HG22 ' O ' ' A' ' 175' ' ' MET . 14.6 t -56.56 -36.47 69.34 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.94 -1.1 . . . . 0.0 111.635 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.482 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -56.2 -44.2 79.23 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.645 -1.284 . . . . 0.0 110.56 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -51.45 -37.91 51.07 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.944 0.878 . . . . 0.0 110.054 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -74.11 -48.47 29.39 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.697 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.3 t 49.88 41.45 22.68 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.509 -0.744 . . . . 0.0 110.992 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt 54.22 -177.19 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.471 -0.768 . . . . 0.0 110.784 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -67.01 151.54 47.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.579 -0.701 . . . . 0.0 109.916 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -154.68 29.07 0.43 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.561 -0.712 . . . . 0.0 110.518 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.7 tptt . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.289 179.957 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.204 0.526 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.13 -37.46 0.07 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.18 85.39 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.385 -1.068 . . . . 0.0 110.508 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -125.13 45.75 2.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.732 -0.605 . . . . 0.0 110.304 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -95.01 47.37 1.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.633 -0.667 . . . . 0.0 110.454 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -62.58 83.91 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.629 -0.669 . . . . 0.0 110.155 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -160.84 77.81 0.59 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.639 -0.663 . . . . 0.0 109.351 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.43 HG22 ' N ' ' A' ' 30' ' ' GLU . 3.5 p -51.36 162.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.468 -0.77 . . . . 0.0 110.476 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.43 ' N ' HG22 ' A' ' 29' ' ' VAL . 2.6 mm-40 -156.06 79.38 0.98 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.32 -26.39 3.4 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.39 -79.72 0.07 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.508 -0.995 . . . . 0.0 109.243 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 45' ' ' ALA . 9.6 p -150.43 148.71 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 111.385 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -131.84 150.2 52.22 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.587 HG12 HD23 ' A' ' 44' ' ' LEU . 31.6 m -108.98 164.09 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.218 -0.926 . . . . 0.0 112.311 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.717 HG11 ' CH2' ' A' ' 85' ' ' TRP . 21.9 m -122.53 179.7 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -149.93 137.87 20.23 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.447 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.4 p -144.65 -178.67 6.12 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 40' ' ' THR . . . -68.87 76.74 0.31 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.027 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER 175.51 -59.51 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.584 -0.697 . . . . 0.0 109.323 -179.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 178.21 -171.3 0.11 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.538 -0.726 . . . . 0.0 109.075 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.3 p -112.68 138.06 50.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.513 -0.742 . . . . 0.0 109.923 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 43.9 m-85 -106.3 173.07 6.48 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.537 -0.727 . . . . 0.0 110.607 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.776 HD22 ' HB2' ' A' ' 109' ' ' ARG . 12.7 mt -100.67 159.85 14.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.521 -0.737 . . . . 0.0 110.713 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -158.45 126.71 5.3 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.073 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.587 HG23 HG23 ' A' ' 48' ' ' VAL . 8.6 t -104.95 127.43 52.79 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.375 -0.828 . . . . 0.0 112.288 -178.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 97.2 m -80.15 85.41 5.71 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.762 -0.586 . . . . 0.0 109.951 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.587 HG23 HG23 ' A' ' 46' ' ' THR . 67.7 t -105.13 139.43 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.41 17.97 5.23 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.246 -0.909 . . . . 0.0 110.259 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.23 43.12 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.4 t -141.59 112.04 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.313 -1.11 . . . . 0.0 110.546 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.43 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 1.8 t -67.38 105.65 1.85 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.932 ' CE3' HD23 ' A' ' 82' ' ' LEU . 82.2 m95 -87.3 145.54 26.31 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.235 -0.916 . . . . 0.0 111.097 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 83' ' ' VAL . 9.0 t -162.2 178.35 8.83 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.269 -0.894 . . . . 0.0 110.293 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 55' ' ' VAL . 31.4 m -101.35 143.12 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.636 -0.665 . . . . 0.0 109.948 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.606 ' HB2' HG11 ' A' ' 83' ' ' VAL . 36.9 t80 -78.25 2.53 18.03 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.063 -1.023 . . . . 0.0 111.923 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -48.73 -26.77 2.51 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.178 -0.951 . . . . 0.0 110.868 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.414 ' HA3' ' CZ ' ' A' ' 43' ' ' PHE . . . -177.75 35.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.531 ' HB1' ' CZ2' ' A' ' 85' ' ' TRP . . . -81.29 0.39 37.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.188 -1.184 . . . . 0.0 111.194 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.05 -171.28 22.37 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.0 t -160.65 -43.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.677 -0.896 . . . . 0.0 110.033 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -165.99 0.06 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.726 -0.608 . . . . 0.0 110.513 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -59.7 97.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.663 -0.648 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.666 HD22 HD12 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -60.46 176.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.668 -0.645 . . . . 0.0 109.928 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -118.18 135.68 54.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.417 -0.802 . . . . 0.0 110.669 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.3 179.61 23.81 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -63.57 -23.15 70.54 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.876 1.461 . . . . 0.0 110.483 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -153.28 40.47 0.53 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.326 -0.859 . . . . 0.0 110.425 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 150.11 170.07 16.99 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -64.74 147.7 89.85 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.892 1.469 . . . . 0.0 110.333 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.666 HD12 HD22 ' A' ' 64' ' ' LEU . 91.4 mt -79.22 168.87 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.581 -0.699 . . . . 0.0 109.369 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.456 ' N ' HG22 ' A' ' 71' ' ' ILE . 7.2 m -80.75 -45.58 16.82 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.21 -0.931 . . . . 0.0 111.608 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 55.5 90.05 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.457 -0.777 . . . . 0.0 109.775 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.6 ttt -126.81 -10.02 6.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.546 -0.722 . . . . 0.0 111.444 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 15.5 m-85 -128.25 113.65 15.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.091 -1.006 . . . . 0.0 109.655 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.624 HG22 HG12 ' A' ' 83' ' ' VAL . 0.7 OUTLIER -151.06 112.51 4.4 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.888 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -159.8 74.63 0.6 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.592 HG11 ' HB3' ' A' ' 56' ' ' TYR . 6.6 p -68.05 -10.8 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.361 -0.837 . . . . 0.0 111.302 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.79 85.75 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.349 -0.844 . . . . 0.0 108.976 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 78' ' ' VAL . 3.9 tt0 60.1 39.09 20.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.544 -0.723 . . . . 0.0 109.653 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.79 -93.89 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.969 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.932 HD23 ' CE3' ' A' ' 53' ' ' TRP . 10.2 tp 177.68 168.61 0.68 Allowed 'General case' 0 N--CA 1.508 2.425 0 O-C-N 120.329 -1.482 . . . . 0.0 110.943 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.624 HG12 HG22 ' A' ' 76' ' ' THR . 9.8 m -141.98 122.67 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.69 142.83 10.29 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.717 ' CH2' HG11 ' A' ' 36' ' ' VAL . 2.4 m-90 -99.08 169.52 9.35 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.32 140.31 31.7 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.727 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.57 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -102.81 94.73 5.52 Favored Pre-proline 0 C--N 1.3 -1.553 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.041 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.576 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.5 Cg_endo -101.39 -12.3 0.17 Allowed 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.644 1.339 . . . . 0.0 113.321 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 49.5 Cg_endo -72.03 69.1 3.14 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 116.175 -2.083 . . . . 0.0 111.203 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.12 14.48 25.31 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.57 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -57.01 131.7 50.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.107 -1.231 . . . . 0.0 110.73 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -85.16 97.73 10.06 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.5 m -52.17 112.95 0.89 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.737 -0.602 . . . . 0.0 111.394 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -75.64 -152.62 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.52 -0.737 . . . . 0.0 109.133 179.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 94' ' ' LEU . 1.7 p -152.67 179.44 1.27 Allowed Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.346 -0.846 . . . . 0.0 111.303 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -86.03 164.19 10.14 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 O-C-N 123.916 1.482 . . . . 0.0 111.535 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.469 ' SG ' HG23 ' A' ' 151' ' ' VAL . 0.8 OUTLIER -96.76 86.58 4.09 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.592 -0.693 . . . . 0.0 110.605 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.1 p -61.11 -39.07 88.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.421 -0.799 . . . . 0.0 109.647 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.3 p -64.6 -37.91 89.18 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.48 -0.763 . . . . 0.0 109.764 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 48.2 29.29 6.76 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.86 159.02 14.68 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.498 -1.001 . . . . 0.0 110.281 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 118' ' ' ARG . 5.1 t -66.02 -170.1 0.08 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.524 -0.735 . . . . 0.0 110.049 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.77 100.66 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.507 -0.745 . . . . 0.0 110.34 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.68 HD13 HD23 ' A' ' 143' ' ' LEU . 2.6 mt -117.33 -173.59 2.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.398 -0.814 . . . . 0.0 109.936 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -140.7 84.98 1.97 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.817 -0.552 . . . . 0.0 109.699 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.777 HD23 HD11 ' A' ' 114' ' ' ILE . 28.5 tp -71.89 100.96 2.54 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.798 HG22 HG12 ' A' ' 113' ' ' VAL . 32.2 t -90.72 123.21 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.123 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 138' ' ' SER . 24.9 p -88.37 145.84 25.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.776 ' HB2' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -61.82 -15.14 39.46 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.837 -1.165 . . . . 0.0 109.744 179.168 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.591 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 13.4 m170 -55.23 -79.29 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 110' ' ' HIS . . . 169.72 47.83 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.25 -0.906 . . . . 0.0 110.305 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -169.56 127.15 0.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.734 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.798 HG12 HG22 ' A' ' 107' ' ' VAL . 10.6 m -95.6 156.49 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.777 HD11 HD23 ' A' ' 106' ' ' LEU . 39.3 pt -131.68 127.76 21.51 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.442 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -66.04 145.9 80.72 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.876 1.461 . . . . 0.0 110.786 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.8 t -137.74 152.22 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.24 107.5 18.35 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -48.57 122.76 5.83 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.584 -0.697 . . . . 0.0 110.566 -178.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.18 -24.33 9.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.824 -0.547 . . . . 0.0 110.188 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.96 177.92 36.24 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -61.42 -22.8 65.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.959 -0.73 . . . . 0.0 110.204 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.3 p -135.76 41.09 2.73 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.834 -0.541 . . . . 0.0 111.463 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.499 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -169.8 151.88 4.34 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.174 -0.954 . . . . 0.0 111.397 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.86 -178.73 22.42 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.7 OUTLIER -128.09 116.08 19.43 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.896 -0.767 . . . . 0.0 111.773 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.509 HD21 HD12 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -52.66 142.71 17.71 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.43 -0.794 . . . . 0.0 110.514 179.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.9 mt -111.03 54.27 0.68 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 164.38 125.28 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.252 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -56.82 115.94 2.85 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 O-C-N 123.543 1.286 . . . . 0.0 110.72 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.404 ' HB2' HD22 ' A' ' 126' ' ' LEU . 0.8 OUTLIER -122.31 141.63 35.09 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.752 . . . . 0.0 109.27 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -64.52 128.19 20.68 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.813 1.428 . . . . 0.0 110.383 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 162' ' ' GLY . 12.1 p -62.84 -35.06 69.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.157 0.503 . . . . 0.0 110.061 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 m -48.71 -37.24 18.13 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.122 -0.986 . . . . 0.0 110.487 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -67.26 -38.34 84.97 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.9 mt -64.99 -36.13 83.4 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -63.85 123.18 18.28 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.97 -26.01 24.52 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.566 ' O ' HD12 ' A' ' 44' ' ' LEU . 16.9 m -92.38 14.41 16.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.481 -1.011 . . . . 0.0 110.694 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.59 127.67 32.38 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.102 -0.999 . . . . 0.0 109.63 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.51 -7.12 26.38 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.45 136.2 50.81 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.07 123.59 5.72 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.745 1.392 . . . . 0.0 112.698 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.68 HD23 HD13 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -82.74 124.69 30.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.179 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.3 mt -124.34 116.19 22.2 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.955 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.598 ' HB3' HG21 ' A' ' 151' ' ' VAL . 19.9 p -73.41 177.76 1.85 Allowed Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 48.7 Cg_endo -62.36 179.73 0.6 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.297 1.156 . . . . 0.0 109.952 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.5 m 56.01 29.1 13.78 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.312 -0.867 . . . . 0.0 110.789 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 60.5 -145.09 47.43 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 21.1 m170 61.68 127.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.895 -0.768 . . . . 0.0 110.44 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.47 ' O ' HG21 ' A' ' 172' ' ' VAL . . . -76.34 140.89 41.64 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.347 -0.846 . . . . 0.0 110.461 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.712 HG12 ' CE2' ' A' ' 169' ' ' PHE . 1.1 t -97.14 -43.41 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.778 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 178.53 -178.56 48.69 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.634 HD11 HD11 ' A' ' 82' ' ' LEU . 1.3 pp -116.93 150.31 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.063 -1.257 . . . . 0.0 111.397 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.776 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.3 t80 -63.0 115.13 4.14 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.014 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -102.05 -38.58 7.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.679 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -160.74 176.13 11.84 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.776 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -133.17 117.06 17.0 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.473 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.795 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.4 t -65.9 97.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.606 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.6 p -120.93 159.51 25.41 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 122.399 1.095 . . . . 0.0 113.888 -175.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.537 HG22 ' H ' ' A' ' 161' ' ' ARG . 2.1 m -95.5 -173.78 2.99 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.537 ' H ' HG22 ' A' ' 160' ' ' THR . 0.1 OUTLIER -48.65 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.438 -0.789 . . . . 0.0 112.567 -178.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.747 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 82.8 -31.83 3.0 Favored Glycine 0 N--CA 1.499 2.888 0 O-C-N 121.205 -0.934 . . . . 0.0 111.748 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.25 131.64 39.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 119.144 1.472 . . . . 0.0 109.328 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.418 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -92.13 135.14 34.22 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.035 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -113.31 -44.19 3.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.555 -0.716 . . . . 0.0 111.135 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.795 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -121.84 179.45 4.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.129 -0.982 . . . . 0.0 109.868 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.58 151.17 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.421 -0.799 . . . . 0.0 110.818 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.679 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -119.68 91.04 3.45 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.712 ' CE2' HG12 ' A' ' 151' ' ' VAL . 3.1 p90 -127.42 160.24 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.862 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.495 HG11 HD13 ' A' ' 82' ' ' LEU . 2.1 p -107.63 130.3 23.01 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.2 Cg_endo -60.67 154.05 57.59 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 124.14 1.6 . . . . 0.0 111.394 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.778 HG13 ' HA2' ' A' ' 152' ' ' GLY . 25.2 m -79.47 1.05 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.6 -0.688 . . . . 0.0 110.789 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.22 -37.46 14.12 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.717 ' O ' HG22 ' A' ' 177' ' ' THR . 35.4 t -72.07 -36.25 69.49 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.119 0.485 . . . . 0.0 110.272 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.928 ' O ' HG22 ' A' ' 178' ' ' THR . 32.3 mtt -47.32 -36.94 10.07 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.69 -0.631 . . . . 0.0 111.08 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -48.02 -36.59 13.13 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.694 -0.629 . . . . 0.0 111.915 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 174' ' ' SER . 9.0 t -48.64 -39.07 22.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.542 -0.724 . . . . 0.0 112.841 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.928 HG22 ' O ' ' A' ' 175' ' ' MET . 6.4 t -56.92 -38.49 72.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.116 -0.99 . . . . 0.0 112.213 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.453 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -57.5 -40.07 77.88 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.596 -1.315 . . . . 0.0 110.362 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -38.4 91.01 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.956 0.884 . . . . 0.0 108.905 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.76 66.1 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.909 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.5 m -77.64 103.04 7.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.518 -0.739 . . . . 0.0 109.913 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -121.04 63.98 0.87 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.463 -0.773 . . . . 0.0 110.749 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -87.82 66.12 8.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.402 -0.811 . . . . 0.0 109.45 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -65.31 152.35 44.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.703 -0.623 . . . . 0.0 109.94 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.644 -179.704 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.057 0.456 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -129.9 35.93 2.44 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -86.83 95.7 9.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.601 -0.941 . . . . 0.0 110.152 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.54 -45.7 3.1 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -145.67 86.88 1.75 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.328 0.585 . . . . 0.0 109.979 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -80.01 -178.14 6.36 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.702 -0.624 . . . . 0.0 109.425 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -160.71 78.61 0.62 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.248 0.547 . . . . 0.0 110.159 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 89' ' ' PRO . 0.5 OUTLIER -62.53 163.41 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -168.73 78.84 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.8 . . . . 0.0 109.375 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.55 -68.77 0.07 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.544 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.5 pt-20 -164.92 -48.78 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.963 . . . . 0.0 110.832 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.852 HG11 ' N ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -164.09 -161.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.929 -1.107 . . . . 0.0 112.738 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -143.08 167.1 22.89 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.462 0.649 . . . . 0.0 110.117 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.858 HG12 HD22 ' A' ' 44' ' ' LEU . 27.2 m -114.98 147.03 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.657 HG11 HD21 ' A' ' 64' ' ' LEU . 28.0 m -98.48 -179.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 m -134.69 138.88 44.8 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.968 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 p -132.99 -175.99 3.97 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.1 102.99 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.357 -0.84 . . . . 0.0 110.551 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.5 p 47.47 43.76 16.04 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.202 0.525 . . . . 0.0 111.554 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.47 153.13 21.01 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.709 -0.619 . . . . 0.0 111.128 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 p -139.85 139.48 36.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.504 -0.748 . . . . 0.0 109.25 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' A' ' 36' ' ' VAL . 37.2 m-85 -105.02 -179.26 3.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.164 -0.96 . . . . 0.0 111.802 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.858 HD22 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -120.34 140.64 50.98 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.605 -0.684 . . . . 0.0 110.445 -179.206 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.743 ' C ' HG11 ' A' ' 33' ' ' VAL . . . -119.45 -177.56 3.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.41 -0.806 . . . . 0.0 109.747 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.906 HG21 ' CG2' ' A' ' 153' ' ' ILE . 3.4 t -157.85 113.91 2.82 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.185 -0.947 . . . . 0.0 111.513 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.3 p -70.62 105.73 3.24 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.947 -1.095 . . . . 0.0 111.434 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.722 HG11 ' CG1' ' A' ' 172' ' ' VAL . 17.6 t -124.39 127.93 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t30 60.48 17.83 7.66 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.365 -0.834 . . . . 0.0 109.722 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.05 19.79 52.05 Favored Glycine 0 N--CA 1.499 2.894 0 O-C-N 121.109 -0.994 . . . . 0.0 111.088 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 85' ' ' TRP . 47.3 t -136.18 105.84 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.114 -1.227 . . . . 0.0 109.638 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.4 p -59.75 103.37 0.2 Allowed 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.309 -0.87 . . . . 0.0 109.794 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.526 ' CH2' ' HE1' ' A' ' 179' ' ' MET . 95.9 m95 -82.75 150.96 26.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.998 -1.064 . . . . 0.0 111.416 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.786 HG21 ' CZ2' ' A' ' 85' ' ' TRP . 7.7 t -158.61 155.23 27.87 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.617 HG11 ' ND1' ' A' ' 57' ' ' HIS . 20.7 t -80.83 144.57 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.232 -0.917 . . . . 0.0 109.676 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 28.8 t80 -78.08 4.75 11.58 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.049 -1.032 . . . . 0.0 112.134 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.617 ' ND1' HG11 ' A' ' 55' ' ' VAL . 16.2 m170 -45.51 -39.63 7.59 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.292 -0.88 . . . . 0.0 111.54 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.415 ' O ' ' CE1' ' A' ' 43' ' ' PHE . . . -167.68 28.18 0.16 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.57 -166.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.262 -1.14 . . . . 0.0 109.632 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.45 ' O ' HD12 ' A' ' 64' ' ' LEU . . . -75.22 90.77 0.81 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.6 p -71.2 -10.09 59.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.497 -1.002 . . . . 0.0 110.082 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -118.79 -153.39 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 110.506 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 63' ' ' THR . 8.5 t -59.69 90.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.477 -0.764 . . . . 0.0 110.937 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.657 HD21 HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.21 173.15 0.9 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.322 -0.861 . . . . 0.0 109.392 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.743 ' O ' HD11 ' A' ' 71' ' ' ILE . . . -112.43 132.21 55.16 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.206 -0.934 . . . . 0.0 110.314 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.88 -178.82 24.26 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -57.9 -20.38 44.09 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.78 1.41 . . . . 0.0 110.507 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 24.71 12.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.534 -0.729 . . . . 0.0 109.809 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.6 -106.51 2.43 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -76.35 120.39 5.62 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.753 1.396 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.743 HD11 ' O ' ' A' ' 65' ' ' ALA . 75.5 mt -75.19 146.15 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 m -90.64 92.95 9.06 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.442 -0.786 . . . . 0.0 111.06 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -61.63 107.92 0.89 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.675 -0.641 . . . . 0.0 109.406 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 mmt -113.9 -26.81 7.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.576 -0.702 . . . . 0.0 111.042 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.526 ' O ' HG13 ' A' ' 83' ' ' VAL . 7.5 m-85 -122.57 118.31 27.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.417 -0.802 . . . . 0.0 109.738 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.657 HG23 ' CG2' ' A' ' 83' ' ' VAL . 5.4 m -155.29 122.99 5.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.635 -0.666 . . . . 0.0 110.779 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -142.11 76.65 1.55 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.28 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.437 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.4 p -49.5 -32.62 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.595 -0.691 . . . . 0.0 109.69 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.59 -47.72 73.01 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.7 -0.625 . . . . 0.0 109.671 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -93.06 17.27 11.11 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.981 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 52.29 52.47 14.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.214 -0.929 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.558 HD21 ' HE2' ' A' ' 175' ' ' MET . 1.5 mt -161.44 151.69 17.42 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.031 0.919 . . . . 0.0 112.343 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.657 ' CG2' HG23 ' A' ' 76' ' ' THR . 58.1 t -156.76 146.03 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 53' ' ' TRP . . . -142.45 115.28 0.94 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.008 -1.568 . . . . 0.0 112.18 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.786 ' CZ2' HG21 ' A' ' 54' ' ' THR . 1.5 m0 -97.98 167.2 11.05 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -81.22 134.71 35.66 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.387 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -104.05 91.17 3.5 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.214 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 53.5 Cg_endo -101.9 -10.24 0.2 Allowed 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.595 1.313 . . . . 0.0 112.726 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 46.5 Cg_endo -72.84 67.52 3.92 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 115.735 -2.377 . . . . 0.0 110.678 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 53.79 23.24 21.24 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.61 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -73.4 135.79 44.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -1.005 . . . . 0.0 110.736 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -61.35 -168.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.771 -0.581 . . . . 0.0 109.68 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 t -147.0 103.97 3.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.54 -0.725 . . . . 0.0 109.386 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.442 HD13 ' HB2' ' A' ' 150' ' ' ALA . 2.3 mt -79.66 -160.77 0.28 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.618 -0.676 . . . . 0.0 109.907 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.2 t -161.01 153.46 17.16 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.754 -0.591 . . . . 0.0 109.452 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.79 143.43 73.71 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 O-C-N 123.517 1.272 . . . . 0.0 111.727 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 25.0 t -64.94 159.45 22.86 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.432 0.634 . . . . 0.0 110.416 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 t -159.19 33.95 0.2 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.448 0.642 . . . . 0.0 109.339 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.2 p -117.85 -167.73 1.39 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.664 -0.648 . . . . 0.0 110.336 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -124.49 29.88 4.87 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.405 ' HB3' ' CG ' ' A' ' 146' ' ' PRO . 75.3 m -91.94 171.87 8.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.587 -0.949 . . . . 0.0 109.998 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 118' ' ' ARG . 40.8 m -127.4 -35.2 2.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.51 -0.743 . . . . 0.0 111.634 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.85 119.07 9.3 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.347 -0.846 . . . . 0.0 110.593 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.749 HD13 HD23 ' A' ' 143' ' ' LEU . 1.5 mt -115.37 -174.46 2.51 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.211 -0.931 . . . . 0.0 110.42 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.676 ' HB3' HG13 ' A' ' 113' ' ' VAL . 85.3 m-85 -139.85 87.25 2.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.724 HD23 HD11 ' A' ' 114' ' ' ILE . 36.0 tp -64.62 99.39 0.31 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.945 HG22 HG22 ' A' ' 113' ' ' VAL . 61.6 t -90.47 114.48 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.833 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.3 p -71.86 -179.82 2.86 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.775 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -93.33 16.28 13.69 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.072 -1.017 . . . . 0.0 110.67 179.367 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -124.78 41.4 3.52 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.216 -0.927 . . . . 0.0 109.754 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.62 68.15 0.9 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.486 -0.758 . . . . 0.0 111.499 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -155.1 109.17 2.9 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.654 -0.654 . . . . 0.0 110.589 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.945 HG22 HG22 ' A' ' 107' ' ' VAL . 24.4 t -106.14 137.52 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.772 -0.58 . . . . 0.0 109.69 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.724 HD11 HD23 ' A' ' 106' ' ' LEU . 29.3 pt -131.74 131.15 22.56 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 109.126 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.499 ' HB2' HD12 ' A' ' 127' ' ' LEU . 48.8 Cg_endo -66.07 140.51 60.1 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.835 1.439 . . . . 0.0 111.779 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 167' ' ' VAL . 25.0 t -136.03 144.59 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.12 119.43 38.73 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.439 ' HB2' ' HA ' ' A' ' 102' ' ' SER . 23.3 ttt180 -49.73 126.96 14.95 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.263 -0.898 . . . . 0.0 110.032 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.96 -33.14 7.0 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.013 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -169.08 58.52 0.2 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.415 -1.374 . . . . 0.0 110.414 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.1 OUTLIER 64.35 -72.82 0.06 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.728 -0.866 . . . . 0.0 110.056 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 120' ' ' GLY . 3.8 p -92.44 40.02 1.04 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 121.162 0.506 . . . . 0.0 110.39 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.435 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 13.8 ttm180 -168.33 154.79 7.34 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.42 -0.8 . . . . 0.0 110.252 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.49 -178.62 23.76 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -128.55 118.33 22.82 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 122.048 -0.678 . . . . 0.0 111.819 -178.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 145.31 52.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.695 -0.628 . . . . 0.0 109.794 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.499 HD12 ' HB2' ' A' ' 115' ' ' PRO . 17.2 mt -115.38 55.23 0.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 170.32 125.33 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -63.67 103.49 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.757 1.399 . . . . 0.0 109.843 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.91 149.59 42.71 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.407 -0.808 . . . . 0.0 109.207 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.406 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 50.4 Cg_endo -68.07 127.33 15.79 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.819 1.431 . . . . 0.0 110.604 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.2 p -62.01 -37.08 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.829 -0.544 . . . . 0.0 110.166 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.33 -35.73 19.23 Favored 'General case' 0 N--CA 1.506 2.36 0 CA-C-O 122.082 0.944 . . . . 0.0 110.535 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 21.2 t80 -67.66 -38.93 84.47 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.479 HD11 ' CB ' ' A' ' 164' ' ' ALA . 14.3 mt -64.02 -35.79 81.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -57.9 131.31 50.01 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.71 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.8 -25.74 26.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.9 m -90.0 4.17 50.96 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -1.081 . . . . 0.0 111.486 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 13.5 p -56.87 121.91 10.99 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.967 -1.083 . . . . 0.0 111.025 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.83 -15.15 9.02 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.27 139.22 48.31 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.714 -1.755 . . . . 0.0 108.714 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.87 123.14 6.65 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.921 1.485 . . . . 0.0 113.691 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.749 HD23 HD13 ' A' ' 104' ' ' LEU . 1.7 mp -79.03 116.91 19.62 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.35 117.75 33.34 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.82 -1.152 . . . . 0.0 113.081 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.435 ' HB3' HG21 ' A' ' 151' ' ' VAL . 27.0 p -56.99 173.69 0.31 Allowed Pre-proline 0 N--CA 1.5 2.064 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.809 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 44.9 Cg_endo -76.66 72.44 5.64 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.714 1.376 . . . . 0.0 109.907 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.37 -46.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.62 -0.675 . . . . 0.0 110.26 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 135.36 -28.27 3.03 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.99 129.61 37.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.523 -0.986 . . . . 0.0 110.194 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.516 ' HB1' HG21 ' A' ' 172' ' ' VAL . . . -59.07 138.75 57.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.669 -0.644 . . . . 0.0 110.112 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.684 HG12 ' CE2' ' A' ' 169' ' ' PHE . 0.9 OUTLIER -99.61 -33.1 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.839 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 176.92 -178.44 48.13 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.906 ' CG2' HG21 ' A' ' 46' ' ' THR . 1.1 pt -120.19 139.93 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.354 -1.086 . . . . 0.0 111.016 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.759 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.3 t80 -53.34 118.58 3.93 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.92 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -107.59 -41.06 5.14 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.439 -0.788 . . . . 0.0 109.6 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -154.08 167.59 29.3 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.759 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -124.95 116.46 22.22 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.659 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.802 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.9 t -67.56 100.75 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.636 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.5 p -125.25 154.91 40.93 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.648 1.213 . . . . 0.0 114.119 -175.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.519 HG22 ' H ' ' A' ' 161' ' ' ARG . 2.0 m -92.2 -172.3 3.08 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.519 ' H ' HG22 ' A' ' 160' ' ' THR . 1.6 ttt180 -45.94 88.91 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.402 -0.811 . . . . 0.0 111.727 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.654 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 72.63 -15.08 2.28 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.101 -1.0 . . . . 0.0 112.509 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.7 t -101.14 135.85 35.55 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.351 0 CA-C-N 118.948 1.374 . . . . 0.0 109.286 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.479 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -97.59 124.78 41.99 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.747 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -108.2 -41.28 4.94 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.607 -0.683 . . . . 0.0 110.545 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.802 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -126.48 166.78 16.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 109.358 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.436 HG21 HG11 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -112.42 162.01 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.839 0.828 . . . . 0.0 111.28 -178.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.758 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -130.65 99.28 4.91 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.684 ' CE2' HG12 ' A' ' 151' ' ' VAL . 5.1 p90 -135.9 159.63 41.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.007 -1.058 . . . . 0.0 111.567 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 82' ' ' LEU . 1.2 m -103.75 144.68 29.16 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 37.1 Cg_endo -61.9 155.17 56.52 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.092 1.575 . . . . 0.0 111.917 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.839 HG23 ' HA2' ' A' ' 152' ' ' GLY . 4.3 t -82.75 -2.11 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.504 -0.747 . . . . 0.0 109.709 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -81.96 -38.43 25.19 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.6 t -57.64 -36.79 72.32 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.806 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.599 ' HE1' HG23 ' A' ' 153' ' ' ILE . 8.4 mtt -49.93 -39.2 39.46 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.563 -0.71 . . . . 0.0 109.348 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.47 ' O ' ' HB3' ' A' ' 179' ' ' MET . 2.0 mt-10 -66.18 -38.11 87.27 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.8 m -64.98 -38.75 91.99 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -37.08 81.36 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.526 ' HE1' ' CH2' ' A' ' 53' ' ' TRP . 34.5 tpp -61.79 -53.44 55.87 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.723 -0.611 . . . . 0.0 110.329 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.12 -38.77 62.92 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.366 -0.834 . . . . 0.0 110.915 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -55.94 -38.11 69.87 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 59.7 p -75.17 112.1 11.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.431 -0.793 . . . . 0.0 110.926 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -98.01 141.85 30.45 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.494 -0.754 . . . . 0.0 110.34 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -66.34 115.28 6.11 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.513 -0.742 . . . . 0.0 110.392 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -111.53 -76.03 0.61 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.352 -0.843 . . . . 0.0 110.334 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 11.5 mptt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.132 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.166 0.507 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.65 -111.75 1.98 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 57.66 -85.74 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.538 -0.978 . . . . 0.0 110.872 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.5 96.14 1.48 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.532 -0.73 . . . . 0.0 110.281 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 94.91 8.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.484 -0.76 . . . . 0.0 109.792 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -66.01 84.15 0.08 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.599 -0.688 . . . . 0.0 110.497 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.63 77.62 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.633 -0.667 . . . . 0.0 109.254 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 89' ' ' PRO . 28.7 m -122.38 -158.72 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.737 -0.602 . . . . 0.0 109.886 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.92 78.41 0.29 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.248 -0.907 . . . . 0.0 109.384 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.59 14.29 0.05 OUTLIER Glycine 0 N--CA 1.498 2.805 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.427 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.453 ' C ' HG23 ' A' ' 33' ' ' VAL . 21.5 mt-10 55.98 6.73 0.24 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.858 -1.378 . . . . 0.0 113.433 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.453 HG23 ' C ' ' A' ' 32' ' ' GLU . 60.4 t -152.23 151.98 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 120.455 -1.403 . . . . 0.0 110.151 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 2.9 tt0 -150.44 143.26 24.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.734 -0.604 . . . . 0.0 110.05 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.737 HG12 HD22 ' A' ' 44' ' ' LEU . 27.2 m -110.15 174.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.482 0.658 . . . . 0.0 110.712 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.562 HG11 ' CH2' ' A' ' 85' ' ' TRP . 31.9 m -131.76 -178.18 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -147.84 136.05 21.37 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.0 p -143.78 -179.11 6.26 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.67 76.11 0.6 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.911 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m 177.31 -61.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -179.39 -159.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.612 -0.68 . . . . 0.0 109.262 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 13.3 t -117.58 139.72 50.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.503 -0.748 . . . . 0.0 109.928 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 59' ' ' ALA . 98.7 m-85 -102.18 -178.54 3.73 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.569 -0.707 . . . . 0.0 111.617 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.836 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -111.69 151.7 28.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.608 -0.683 . . . . 0.0 111.351 -178.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.529 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -159.55 145.01 15.74 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.654 -0.654 . . . . 0.0 109.351 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.512 HG23 HG23 ' A' ' 48' ' ' VAL . 13.2 t -117.86 127.38 53.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.162 -0.961 . . . . 0.0 112.036 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 87.4 m -78.77 82.78 4.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.531 -0.73 . . . . 0.0 110.467 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.828 HG11 HG11 ' A' ' 172' ' ' VAL . 57.8 t -98.59 139.2 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 56.12 20.41 4.41 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.343 -0.848 . . . . 0.0 110.027 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.6 24.49 53.43 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.9 t -138.81 103.97 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -1.212 . . . . 0.0 110.612 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.7 t -58.2 96.61 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.538 -0.726 . . . . 0.0 110.022 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.937 ' CE3' HD23 ' A' ' 82' ' ' LEU . 79.5 m95 -76.07 145.34 40.17 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.325 -0.859 . . . . 0.0 110.331 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.539 HG23 HG23 ' A' ' 83' ' ' VAL . 2.7 t -163.08 176.43 10.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.574 -0.704 . . . . 0.0 109.787 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.464 HG11 ' HG2' ' A' ' 155' ' ' ARG . 13.6 m -104.42 138.19 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.563 -0.711 . . . . 0.0 109.986 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.606 ' HB2' HG11 ' A' ' 83' ' ' VAL . 1.6 t80 -73.79 -12.07 60.58 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.007 -1.058 . . . . 0.0 111.357 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.431 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 4.7 p-80 -83.63 -0.95 52.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.151 -0.968 . . . . 0.0 110.229 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.53 74.84 0.21 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.408 ' HA ' ' CD2' ' A' ' 43' ' ' PHE . . . -164.35 -72.1 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.466 -1.02 . . . . 0.0 110.123 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.85 -161.96 32.25 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.4 p -167.15 -163.52 0.54 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.725 -0.867 . . . . 0.0 109.702 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt 51.5 -164.2 0.06 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.421 -0.8 . . . . 0.0 110.72 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -56.7 90.35 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.512 -0.742 . . . . 0.0 110.615 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.879 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -63.9 162.26 14.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.705 -0.622 . . . . 0.0 110.295 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.23 142.74 48.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.632 -0.667 . . . . 0.0 110.313 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -124.83 -179.4 15.7 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.84 -6.91 20.19 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.972 1.512 . . . . 0.0 111.493 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.66 29.57 1.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.045 . . . . 0.0 110.382 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.61 176.51 14.44 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.25 155.79 68.15 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.852 1.449 . . . . 0.0 109.9 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.879 HD12 ' CD2' ' A' ' 64' ' ' LEU . 77.8 mt -100.79 119.54 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.558 -0.714 . . . . 0.0 109.786 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -61.4 135.14 57.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.609 -0.682 . . . . 0.0 110.703 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -94.51 115.11 27.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 109.415 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.3 mmm -124.81 -34.88 2.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.525 -0.735 . . . . 0.0 110.866 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.468 ' CD2' ' CE ' ' A' ' 179' ' ' MET . 15.5 m-85 -118.35 108.45 15.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.389 -0.819 . . . . 0.0 109.661 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.606 ' CG2' HG12 ' A' ' 83' ' ' VAL . 1.6 m -149.1 114.46 5.54 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.544 -0.862 . . . . 0.0 112.407 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -148.03 75.66 1.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.872 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.485 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 8.2 p -54.97 -22.48 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.465 -0.772 . . . . 0.0 111.098 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -60.67 83.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.732 -0.605 . . . . 0.0 110.962 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 49.45 26.39 1.65 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.515 -0.741 . . . . 0.0 111.461 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -126.12 -95.32 0.45 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.937 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.937 HD23 ' CE3' ' A' ' 53' ' ' TRP . 8.4 tp 177.72 164.21 0.62 Allowed 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.548 -1.345 . . . . 0.0 110.824 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' A' ' 56' ' ' TYR . 16.4 m -135.02 122.99 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.12 133.93 4.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.562 ' CH2' HG11 ' A' ' 36' ' ' VAL . 1.3 m-90 -100.55 168.91 9.42 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -80.23 136.52 36.48 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.586 -0.845 . . . . 0.0 109.844 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.494 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -108.94 92.94 11.52 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.874 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.568 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.5 Cg_endo -102.35 -11.69 0.16 Allowed 'Trans proline' 0 CA--C 1.551 1.354 0 O-C-N 123.911 1.48 . . . . 0.0 112.847 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 51.2 Cg_endo -71.2 75.8 1.79 Allowed 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 116.058 -2.162 . . . . 0.0 111.104 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.83 25.13 21.95 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.494 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -74.71 139.44 43.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.942 . . . . 0.0 110.574 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.3 tpt85 -75.34 140.3 42.97 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.7 p -104.66 103.15 12.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.348 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -158.37 0.25 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.446 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -151.55 -169.44 0.22 Allowed Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.567 -0.708 . . . . 0.0 109.878 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -93.81 159.48 2.28 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 O-C-N 123.69 1.363 . . . . 0.0 111.521 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.65 133.51 52.66 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.667 -0.646 . . . . 0.0 109.94 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 m -139.56 91.33 2.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.612 -0.68 . . . . 0.0 109.953 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 29.7 m -132.95 -162.28 1.22 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.47 -0.769 . . . . 0.0 109.927 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.73 31.42 2.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.88 -151.1 0.47 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.685 -0.891 . . . . 0.0 110.168 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.8 p -149.78 -147.97 0.25 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 0.0 109.881 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 7.6 t0 58.06 105.24 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.126 -0.984 . . . . 0.0 110.794 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.664 HD13 HD23 ' A' ' 143' ' ' LEU . 0.8 OUTLIER -123.18 -168.45 1.77 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.167 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.736 ' HB3' HG13 ' A' ' 113' ' ' VAL . 79.7 m-85 -142.3 93.04 2.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.492 -0.755 . . . . 0.0 110.728 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.458 HD12 ' HG ' ' A' ' 143' ' ' LEU . 7.0 tp -60.09 92.59 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 105' ' ' TYR . 89.7 t -84.5 101.95 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.331 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.422 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 21.8 p -67.4 155.86 37.95 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.836 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -78.18 3.9 13.99 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.028 -1.045 . . . . 0.0 111.126 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.447 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -101.91 31.52 3.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.972 -1.08 . . . . 0.0 109.055 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 61.42 74.55 0.44 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.519 -0.738 . . . . 0.0 110.67 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.61 119.47 0.88 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.606 -0.684 . . . . 0.0 110.528 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 105' ' ' TYR . 71.5 t -98.13 143.34 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.537 -0.727 . . . . 0.0 109.768 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.439 ' HB ' ' HB3' ' A' ' 106' ' ' LEU . 14.4 mt -130.68 109.89 15.93 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -58.05 134.16 60.31 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 O-C-N 123.655 1.345 . . . . 0.0 111.929 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 103' ' ' ASP . 35.1 t -127.78 142.98 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.644 -0.66 . . . . 0.0 109.525 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.58 121.29 43.21 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -48.68 130.41 17.41 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.38 -0.825 . . . . 0.0 110.917 -178.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -102.95 -49.43 3.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.804 -0.56 . . . . 0.0 110.654 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.84 60.23 0.11 Allowed Glycine 0 N--CA 1.498 2.796 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.757 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.37 145.35 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.787 -0.831 . . . . 0.0 109.222 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.427 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 17.5 p 44.63 27.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.737 -0.602 . . . . 0.0 112.122 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.47 ' N ' ' CD2' ' A' ' 169' ' ' PHE . 0.4 OUTLIER -170.37 144.26 2.47 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.125 -0.984 . . . . 0.0 110.219 178.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.26 -177.79 16.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -123.21 123.14 40.12 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 122.045 -0.679 . . . . 0.0 111.743 -178.265 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.09 130.7 45.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.565 -0.709 . . . . 0.0 109.492 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.5 mt -101.06 53.62 0.84 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.86 118.45 0.14 Allowed Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.333 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -60.31 106.86 0.37 Allowed 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.61 1.321 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.6 mtt-85 -125.75 146.41 54.99 Favored Pre-proline 0 N--CA 1.49 1.54 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.089 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.411 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 47.8 Cg_endo -64.24 129.31 23.8 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 124.098 1.578 . . . . 0.0 110.604 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 162' ' ' GLY . 6.1 p -56.96 -36.01 49.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.848 -0.532 . . . . 0.0 110.163 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -49.14 -36.85 20.27 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.232 -0.918 . . . . 0.0 110.603 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 7.4 t80 -64.43 -38.9 92.65 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.469 HD11 ' CB ' ' A' ' 164' ' ' ALA . 8.7 mt -67.4 -35.92 80.26 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -56.39 111.87 1.1 Allowed 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.939 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.27 -34.37 4.73 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.7 m -79.86 -2.72 44.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.676 -0.896 . . . . 0.0 110.808 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.1 m -57.37 126.6 28.02 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.181 -0.95 . . . . 0.0 110.447 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.12 -9.22 31.37 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.723 ' HA2' HD12 ' A' ' 44' ' ' LEU . . . -56.88 -175.98 0.31 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -114.57 124.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.489 1.258 . . . . 0.0 112.527 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.664 HD23 HD13 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -83.34 126.35 32.61 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 176.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.16 121.06 31.74 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.709 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.498 ' HB3' HG21 ' A' ' 151' ' ' VAL . 14.7 p -69.29 -173.27 0.2 Allowed Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.44 ' CD ' ' HB2' ' A' ' 145' ' ' CYS . 49.9 Cg_endo -71.65 66.92 3.01 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.562 1.296 . . . . 0.0 110.422 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.86 -165.7 0.38 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.551 -0.718 . . . . 0.0 110.123 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -110.24 48.57 0.92 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -136.41 128.69 30.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.606 -0.937 . . . . 0.0 109.927 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.555 ' CB ' HG21 ' A' ' 172' ' ' VAL . . . -66.34 121.83 16.15 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.496 -0.752 . . . . 0.0 109.918 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.537 HG11 HD22 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -78.24 -44.5 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.696 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . -179.6 -178.31 48.34 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.627 HG12 ' HE2' ' A' ' 175' ' ' MET . 1.0 OUTLIER -111.73 154.79 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-N 118.838 1.319 . . . . 0.0 111.988 179.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.85 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 7.6 t80 -69.17 83.3 0.35 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.8 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.464 ' HG2' HG11 ' A' ' 55' ' ' VAL . 2.6 ttt180 -64.06 -49.91 70.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.618 -0.676 . . . . 0.0 109.595 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.612 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -155.78 -179.19 7.88 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.85 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -134.04 121.82 22.1 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.874 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.7 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.5 t -70.69 104.49 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 177.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.63 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.3 p -129.43 142.58 50.76 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -175.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.662 HG22 HG12 ' A' ' 163' ' ' VAL . 5.9 t -76.26 -174.58 2.85 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.54 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.325 -0.859 . . . . 0.0 112.937 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.779 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 85.99 -27.32 5.54 Favored Glycine 0 N--CA 1.498 2.771 0 O-C-N 121.204 -0.935 . . . . 0.0 112.316 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.662 HG12 HG22 ' A' ' 160' ' ' THR . 1.0 OUTLIER -96.55 136.91 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 119.108 1.454 . . . . 0.0 109.82 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.469 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -103.57 125.65 50.23 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.604 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -111.62 -34.37 6.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.654 -0.653 . . . . 0.0 111.224 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.7 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -124.8 176.77 6.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.077 -1.014 . . . . 0.0 110.946 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.52 140.92 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 111.596 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 3.2 t0 -106.48 100.24 9.77 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.47 ' CD2' ' N ' ' A' ' 123' ' ' ARG . 0.5 OUTLIER -129.8 157.87 41.02 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.071 -1.052 . . . . 0.0 113.748 -176.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.407 ' CG1' HG13 ' A' ' 153' ' ' ILE . 2.9 p -111.87 128.09 25.93 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 45.0 Cg_endo -57.68 156.37 27.72 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 O-C-N 123.775 1.408 . . . . 0.0 111.752 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.828 HG11 HG11 ' A' ' 48' ' ' VAL . 97.9 t -79.37 -1.66 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.611 -0.681 . . . . 0.0 110.08 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -86.08 -37.66 18.61 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.1 m -72.08 -38.61 69.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.861 -0.525 . . . . 0.0 110.021 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.627 ' HE2' HG12 ' A' ' 153' ' ' ILE . 14.8 mtt -50.93 -38.79 52.37 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.542 -0.724 . . . . 0.0 109.711 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -62.87 -39.99 96.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 35.1 m -57.86 -38.51 75.84 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.606 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 0.3 OUTLIER -51.31 -35.01 35.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.844 -0.535 . . . . 0.0 109.739 178.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.579 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 9.5 mmt -48.04 -53.63 15.69 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.46 -0.775 . . . . 0.0 110.847 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.02 -37.45 45.32 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.989 0.899 . . . . 0.0 109.846 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 178' ' ' THR . . . -63.73 -39.77 95.11 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.013 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.407 ' CB ' ' HA ' ' A' ' 75' ' ' TYR . 10.8 m -91.57 74.82 5.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.47 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -135.6 47.8 2.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.667 -0.646 . . . . 0.0 109.547 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -108.83 32.23 5.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.728 . . . . 0.0 110.861 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.2 ttmt -148.77 82.78 1.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.548 -0.72 . . . . 0.0 110.276 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.035 179.85 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.324 0.583 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.67 -39.54 1.27 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -91.31 96.1 10.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.938 -0.742 . . . . 0.0 110.491 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -155.44 -160.36 1.03 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.596 -0.69 . . . . 0.0 110.537 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -100.21 93.67 5.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.665 -0.647 . . . . 0.0 111.071 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.44 -179.14 6.64 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.401 -0.812 . . . . 0.0 109.308 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -161.64 77.96 0.54 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.247 0.546 . . . . 0.0 110.304 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.25 176.73 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -154.6 76.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.636 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 44.58 66.56 1.37 Allowed Glycine 0 N--CA 1.5 2.911 0 O-C-N 121.933 -0.48 . . . . 0.0 111.911 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.494 ' C ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -164.08 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.418 -1.048 . . . . 0.0 111.432 179.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.494 HG23 ' C ' ' A' ' 32' ' ' GLU . 70.1 t -150.91 153.83 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.227 -0.92 . . . . 0.0 111.724 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.419 ' OE1' ' HG3' ' A' ' 89' ' ' PRO . 12.5 tt0 -144.84 136.37 25.41 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.45 HG11 ' HG3' ' A' ' 109' ' ' ARG . 33.7 m -98.81 168.68 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.82 0.819 . . . . 0.0 111.632 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.545 HG11 ' CH2' ' A' ' 85' ' ' TRP . 28.2 m -125.91 -179.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -145.43 135.99 24.27 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.251 -0.905 . . . . 0.0 110.95 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.5 p -142.74 177.79 8.08 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.42 75.87 0.55 Allowed 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.254 -0.979 . . . . 0.0 108.684 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 173.69 -57.16 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.57 -170.13 0.1 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.42 -0.8 . . . . 0.0 109.65 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 86.0 p -111.22 140.75 45.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.706 -0.621 . . . . 0.0 110.431 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 27.4 m-85 -102.08 175.51 5.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.467 -0.771 . . . . 0.0 109.944 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.695 ' C ' HD23 ' A' ' 44' ' ' LEU . 5.5 tt -109.96 143.92 39.21 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.644 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -147.21 131.53 17.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.927 -1.108 . . . . 0.0 110.311 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 46' ' ' THR . 8.4 t -100.02 127.81 46.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.254 -0.904 . . . . 0.0 112.462 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.419 ' HG ' ' HG ' ' A' ' 52' ' ' CYS . 85.8 m -82.89 95.07 7.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.375 -0.828 . . . . 0.0 110.747 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.889 HG11 ' CG1' ' A' ' 172' ' ' VAL . 93.5 t -103.86 133.09 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t30 62.22 11.4 4.41 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.422 -0.799 . . . . 0.0 110.681 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.62 30.61 8.91 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.023 -1.048 . . . . 0.0 111.167 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.4 t -147.2 105.81 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -1.187 . . . . 0.0 109.257 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.419 ' HG ' ' HG ' ' A' ' 47' ' ' CYS . 0.7 OUTLIER -56.17 109.56 0.61 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.498 -0.751 . . . . 0.0 109.485 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 1.004 ' CE3' HD23 ' A' ' 82' ' ' LEU . 92.7 m95 -91.23 141.8 28.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.671 -0.643 . . . . 0.0 110.435 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.461 HG21 ' CH2' ' A' ' 85' ' ' TRP . 5.2 t -161.27 -179.78 7.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.457 -0.777 . . . . 0.0 110.319 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.524 HG11 ' HA ' ' A' ' 155' ' ' ARG . 11.6 m -102.18 145.12 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.596 -0.69 . . . . 0.0 110.497 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.656 ' HB2' HG11 ' A' ' 83' ' ' VAL . 42.9 t80 -78.02 1.72 20.01 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.113 -0.992 . . . . 0.0 112.301 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -49.78 -24.85 2.59 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 121.163 -0.961 . . . . 0.0 110.684 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.448 ' O ' ' CE1' ' A' ' 43' ' ' PHE . . . -177.89 39.83 0.09 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.41 25.96 4.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.331 -1.099 . . . . 0.0 111.009 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.56 -164.39 41.47 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.1 t -136.84 -80.38 0.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.762 -0.846 . . . . 0.0 110.074 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -118.47 -33.46 4.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.198 -0.939 . . . . 0.0 111.305 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -93.31 89.57 6.43 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.116 0.484 . . . . 0.0 111.721 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.534 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -101.28 172.8 6.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.51 -0.744 . . . . 0.0 109.751 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.6 130.97 57.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.681 -0.637 . . . . 0.0 110.136 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.59 179.24 16.73 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -55.17 103.82 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 O-C-N 123.652 1.343 . . . . 0.0 110.628 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.1 tttp 54.37 30.05 11.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.505 -0.747 . . . . 0.0 111.22 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.43 134.87 2.1 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -58.85 169.8 3.16 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 O-C-N 123.729 1.383 . . . . 0.0 110.82 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.534 HD12 ' CD2' ' A' ' 64' ' ' LEU . 63.2 mt -106.93 134.5 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.395 -0.816 . . . . 0.0 108.976 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.5 p -74.69 -174.61 2.18 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.278 -0.889 . . . . 0.0 111.032 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -123.15 166.43 15.21 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.606 -0.684 . . . . 0.0 109.973 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.435 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 6.4 tpt -169.54 -37.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.156 -0.965 . . . . 0.0 111.453 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 74' ' ' MET . 14.4 m-85 -131.84 111.53 11.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.472 -0.768 . . . . 0.0 109.103 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.613 ' CG2' HG12 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -152.49 114.2 4.34 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.035 -1.066 . . . . 0.0 113.013 -178.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -160.54 76.52 0.59 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.729 -0.607 . . . . 0.0 110.45 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.61 HG11 ' HB3' ' A' ' 56' ' ' TYR . 7.3 p -74.74 -17.3 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.1 -1.0 . . . . 0.0 111.128 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.73 -25.17 17.45 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.129 -0.982 . . . . 0.0 110.244 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -176.11 34.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.748 -0.595 . . . . 0.0 110.144 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -156.03 -89.44 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.997 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.004 HD23 ' CE3' ' A' ' 53' ' ' TRP . 6.8 tp 179.14 177.29 0.53 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.718 -1.239 . . . . 0.0 110.125 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.656 HG11 ' HB2' ' A' ' 56' ' ' TYR . 21.6 m -146.58 121.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -154.09 144.08 10.82 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.545 ' CH2' HG11 ' A' ' 36' ' ' VAL . 1.1 m-90 -108.2 167.83 9.73 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -69.5 137.52 52.62 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.879 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.55 97.0 15.26 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.721 -0.612 . . . . 0.0 111.144 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.7 Cg_endo -111.21 10.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 117.178 -1.415 . . . . 0.0 113.061 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 55.7 Cg_endo -67.58 -108.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 116.587 -1.809 . . . . 0.0 107.75 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.79 32.47 7.39 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 106.559 -2.616 . . . . 0.0 106.559 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.62 152.69 45.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.383 -1.069 . . . . 0.0 111.058 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -125.14 17.16 8.43 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.784 -0.572 . . . . 0.0 110.735 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.8 t 49.98 97.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.288 -0.883 . . . . 0.0 112.536 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.421 HD23 ' HB2' ' A' ' 150' ' ' ALA . 0.3 OUTLIER -74.19 -143.16 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.555 -0.715 . . . . 0.0 110.13 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 t -169.61 153.3 5.04 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 120.897 -1.127 . . . . 0.0 110.657 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.45 160.37 46.95 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.741 1.39 . . . . 0.0 111.173 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.9 t -95.6 112.12 23.9 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.1 p -75.1 -44.05 49.53 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.4 p -65.48 149.42 50.07 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.325 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -111.2 40.43 2.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.99 146.13 51.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.687 -0.89 . . . . 0.0 109.703 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 m -77.69 -159.17 0.14 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.664 -0.648 . . . . 0.0 110.929 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.7 t70 52.43 95.08 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.652 -0.655 . . . . 0.0 111.171 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.889 HD13 HD23 ' A' ' 143' ' ' LEU . 0.8 OUTLIER -113.6 168.81 9.45 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.371 -0.83 . . . . 0.0 110.025 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 107' ' ' VAL . 70.9 m-85 -117.4 86.43 2.51 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.644 -0.66 . . . . 0.0 109.571 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.444 ' CD1' HD11 ' A' ' 143' ' ' LEU . 9.5 tp -54.45 98.85 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.445 -0.785 . . . . 0.0 109.838 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 105' ' ' TYR . 37.4 t -81.68 109.65 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.239 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.459 ' HB ' ' NE2' ' A' ' 110' ' ' HIS . 18.7 p -74.58 177.52 6.0 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.605 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -95.06 28.1 2.93 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.913 -1.117 . . . . 0.0 110.819 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.463 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 1.4 p80 -150.31 46.17 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.916 0.865 . . . . 0.0 109.537 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 49.08 63.47 2.12 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.425 0.631 . . . . 0.0 111.674 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.46 92.37 2.08 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.416 HG13 ' HB3' ' A' ' 105' ' ' TYR . 59.1 t -81.0 144.04 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.176 -0.952 . . . . 0.0 110.123 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.2 mt -128.97 114.99 18.89 Favored Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -59.35 134.42 58.63 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.781 1.411 . . . . 0.0 111.516 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 60.5 t -125.5 149.33 30.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -114.25 111.7 21.94 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -48.12 121.61 4.44 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.749 0.785 . . . . 0.0 110.276 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.9 -37.51 5.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.963 -0.46 . . . . 0.0 110.406 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.81 -170.07 26.03 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -62.56 140.9 58.65 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.831 -0.806 . . . . 0.0 109.568 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.0 p 44.46 42.55 5.57 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.275 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.441 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 3.9 ttp85 -164.32 153.75 13.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.337 -0.852 . . . . 0.0 111.392 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.88 -179.58 21.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -119.39 130.9 55.54 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 122.072 -0.663 . . . . 0.0 111.116 -178.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.47 HD22 ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -72.75 128.9 36.9 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.355 -0.84 . . . . 0.0 109.383 179.23 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 mt -103.71 54.57 0.74 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.47 ' O ' HD22 ' A' ' 126' ' ' LEU . 2.4 p 174.95 107.09 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -57.56 103.63 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 O-C-N 123.598 1.315 . . . . 0.0 109.168 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -124.63 159.03 59.94 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.986 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 50.1 Cg_endo -72.54 129.58 14.89 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 124.077 1.567 . . . . 0.0 109.255 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.635 HG21 ' SG ' ' A' ' 159' ' ' CYS . 10.1 p -55.7 -35.71 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.387 -0.82 . . . . 0.0 109.879 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.3 t -48.85 -36.67 17.47 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.401 -0.812 . . . . 0.0 110.504 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 19.8 t80 -63.4 -39.24 93.98 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.521 HD11 ' CB ' ' A' ' 164' ' ' ALA . 15.9 mt -66.2 -34.78 78.81 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.58 126.3 24.73 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.858 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.26 -31.8 8.31 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.448 ' O ' HD13 ' A' ' 44' ' ' LEU . 74.1 m -84.04 3.14 35.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.822 -0.811 . . . . 0.0 110.525 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.2 m -49.77 127.04 15.19 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.289 -0.882 . . . . 0.0 109.731 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.607 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 116.22 -17.24 14.75 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 107.031 -2.428 . . . . 0.0 107.031 -176.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.688 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -45.66 110.24 0.43 Allowed Glycine 0 N--CA 1.501 2.987 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.416 ' O ' HD12 ' A' ' 144' ' ' LEU . 46.9 Cg_endo -68.16 126.62 14.64 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.933 1.491 . . . . 0.0 111.9 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.889 HD23 HD13 ' A' ' 104' ' ' LEU . 9.0 mp -80.56 135.43 36.08 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 142' ' ' PRO . 1.2 mt -131.89 111.91 11.99 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.389 -0.924 . . . . 0.0 112.172 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.497 ' HB3' HG21 ' A' ' 151' ' ' VAL . 27.7 p -69.9 163.53 59.78 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.933 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 46.9 Cg_endo -62.72 86.31 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.769 1.405 . . . . 0.0 110.136 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.9 -48.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.637 -0.664 . . . . 0.0 109.47 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.04 23.43 3.27 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -131.44 147.09 52.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.401 -1.058 . . . . 0.0 109.554 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.816 ' HB1' HG21 ' A' ' 172' ' ' VAL . . . -66.43 122.14 16.87 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.497 -0.752 . . . . 0.0 110.723 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 145' ' ' CYS . 2.1 t -84.47 -37.88 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.836 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 178.43 -179.09 48.72 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.606 HD11 HD11 ' A' ' 82' ' ' LEU . 1.5 pt -117.12 156.77 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 CA-C-N 118.923 1.362 . . . . 0.0 111.841 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.892 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 9.9 t80 -75.56 85.78 2.64 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.602 0.715 . . . . 0.0 111.203 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.524 ' HA ' HG11 ' A' ' 55' ' ' VAL . 19.2 ttm180 -70.91 -49.29 47.35 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -147.78 177.65 9.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.892 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -131.67 119.86 21.97 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.967 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.849 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.1 t -66.4 99.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.635 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.7 p -126.08 140.57 52.48 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 161' ' ' ARG . 0.9 OUTLIER -74.34 -174.77 2.1 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.479 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -48.78 82.93 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 86.01 -26.95 5.73 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.033 -1.042 . . . . 0.0 110.91 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -93.83 135.99 26.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 118.981 1.391 . . . . 0.0 108.631 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -97.53 129.78 44.65 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.876 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -113.09 -44.87 3.22 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.452 -0.78 . . . . 0.0 111.174 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.849 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -123.82 -178.95 4.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.451 -0.78 . . . . 0.0 109.766 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -120.32 164.07 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.45 -0.781 . . . . 0.0 110.647 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.676 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 1.2 t0 -128.69 94.8 3.94 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.716 ' CG ' HD22 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -126.53 146.1 50.26 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.718 -174.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.477 HG11 ' CD1' ' A' ' 82' ' ' LEU . 2.7 p -99.81 131.69 24.16 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 42.9 Cg_endo -56.42 154.98 27.23 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 O-C-N 123.756 1.398 . . . . 0.0 111.412 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.889 ' CG1' HG11 ' A' ' 48' ' ' VAL . 42.6 t -84.44 2.78 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.366 -0.833 . . . . 0.0 109.748 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -91.75 -39.06 12.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.592 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.6 t -72.13 -44.33 63.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.809 -0.557 . . . . 0.0 110.75 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.86 ' HB3' HD22 ' A' ' 82' ' ' LEU . 2.8 ptp -53.76 -37.86 63.84 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.233 -0.917 . . . . 0.0 110.536 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -56.39 -37.84 70.69 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.999 0.904 . . . . 0.0 108.961 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.4 m -62.37 -35.01 77.81 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.96 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 175' ' ' MET . 0.7 OUTLIER -47.22 -37.52 10.5 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.41 -0.806 . . . . 0.0 111.455 -178.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.472 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -51.83 -46.12 64.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.234 -0.916 . . . . 0.0 110.323 178.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.45 -38.22 58.76 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.096 0.95 . . . . 0.0 110.018 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.87 65.38 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.087 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.7 t -75.64 -2.96 31.83 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.517 -0.74 . . . . 0.0 111.166 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.45 160.2 24.06 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.141 -0.974 . . . . 0.0 110.64 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 2.1 ptmt -68.78 80.83 0.29 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.302 -0.874 . . . . 0.0 109.917 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.35 100.1 11.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.288 -0.883 . . . . 0.0 109.619 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.4 mttt . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.652 -179.492 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.057 0.456 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.35 115.38 4.0 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.11 79.86 0.11 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.378 -1.072 . . . . 0.0 110.645 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -107.88 2.87 23.73 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.595 -0.691 . . . . 0.0 111.11 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 53.13 95.18 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.07 -1.019 . . . . 0.0 111.104 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -96.14 -177.7 4.08 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.639 -0.663 . . . . 0.0 109.303 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -148.12 77.32 1.4 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.554 0.692 . . . . 0.0 109.287 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.726 HG11 ' O ' ' A' ' 89' ' ' PRO . 24.5 m -58.66 175.66 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 121.554 0.693 . . . . 0.0 110.474 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 174.1 77.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 25.68 53.19 0.06 OUTLIER Glycine 0 N--CA 1.51 3.589 0 C-N-CA 123.548 0.594 . . . . 0.0 113.529 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -164.21 -67.36 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.485 1.143 . . . . 0.0 112.669 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.4 t -138.04 158.77 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 122.25 1.024 . . . . 0.0 112.971 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.648 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 2.8 tm0? -143.93 137.85 28.09 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.435 ' CG1' ' CD ' ' A' ' 109' ' ' ARG . 32.6 m -108.41 -179.78 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 122.152 0.977 . . . . 0.0 112.664 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.463 HG11 ' CZ3' ' A' ' 85' ' ' TRP . 21.3 m -139.29 -179.36 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.2 p -149.91 138.09 20.43 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.541 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.435 HG21 ' O ' ' A' ' 59' ' ' ALA . 46.2 p -139.45 179.16 6.71 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -73.43 72.42 1.34 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.815 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.734 HG22 ' HG2' ' A' ' 41' ' ' GLN . 72.1 m -175.4 -59.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.734 ' HG2' HG22 ' A' ' 40' ' ' THR . 3.7 pt20 179.77 -163.22 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.72 -0.612 . . . . 0.0 109.525 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 p -117.99 143.66 46.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.258 -0.901 . . . . 0.0 110.151 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 42.7 m-85 -99.81 -178.47 3.87 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.268 -0.895 . . . . 0.0 110.855 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 109' ' ' ARG . 5.5 tt -114.32 142.44 46.31 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 34' ' ' GLN . . . -147.45 131.22 16.99 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.804 -1.185 . . . . 0.0 110.805 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.645 HG23 HG23 ' A' ' 48' ' ' VAL . 5.3 t -97.84 123.48 41.82 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.34 -0.85 . . . . 0.0 111.865 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.4 p -78.98 83.63 5.06 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.796 0.808 . . . . 0.0 110.368 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.762 HG11 HG11 ' A' ' 172' ' ' VAL . 86.3 t -102.02 145.65 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 54.56 23.69 4.81 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.76 31.1 56.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 85' ' ' TRP . 38.2 t -147.02 111.38 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.176 -1.191 . . . . 0.0 110.483 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 49.3 m -60.83 115.62 3.82 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.474 -0.766 . . . . 0.0 109.294 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.61 ' CZ3' HD23 ' A' ' 82' ' ' LEU . 76.2 m95 -94.49 140.82 29.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.354 -0.841 . . . . 0.0 111.206 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.924 HG21 ' CH2' ' A' ' 85' ' ' TRP . 4.5 t -161.95 -178.58 6.54 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 12.5 t -104.0 144.82 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.426 -0.796 . . . . 0.0 109.671 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -74.34 -1.0 18.93 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.882 -1.137 . . . . 0.0 112.597 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.46 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 1.5 p-80 -70.08 -8.69 51.48 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.912 -1.118 . . . . 0.0 111.169 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.449 ' HA3' ' CE2' ' A' ' 43' ' ' PHE . . . -137.63 -134.08 3.2 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.435 ' O ' HG21 ' A' ' 38' ' ' THR . . . 54.51 174.6 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.481 -1.011 . . . . 0.0 111.01 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.09 112.4 4.46 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.0 p -56.09 173.28 0.16 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.442 -1.034 . . . . 0.0 110.388 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 tttp 58.17 -161.5 0.24 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.317 -0.864 . . . . 0.0 110.482 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -55.24 97.3 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.506 -0.747 . . . . 0.0 110.954 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.426 HD22 HD12 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -52.99 174.65 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.724 -0.61 . . . . 0.0 110.613 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . . . -120.2 137.29 54.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.49 -0.756 . . . . 0.0 110.613 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.12 179.38 20.47 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.0 -21.82 73.09 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.815 1.429 . . . . 0.0 110.957 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -154.31 36.57 0.43 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.361 -0.837 . . . . 0.0 109.937 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 156.62 150.4 5.65 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 47.3 Cg_endo -65.1 158.43 51.97 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.889 1.468 . . . . 0.0 110.483 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.426 HD12 HD22 ' A' ' 64' ' ' LEU . 69.6 mt -99.94 117.51 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.705 -0.622 . . . . 0.0 109.392 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 72' ' ' THR . 9.7 t -59.95 119.83 8.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.5 -0.75 . . . . 0.0 110.372 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 140.97 54.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.65 -0.656 . . . . 0.0 109.973 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.431 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 6.5 tpt -131.01 -41.16 1.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.641 -0.662 . . . . 0.0 110.395 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.471 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 20.7 m-85 -133.15 126.42 31.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.569 -0.707 . . . . 0.0 110.126 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.445 HG23 ' HB ' ' A' ' 83' ' ' VAL . 1.2 m -151.2 113.92 4.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.717 . . . . 0.0 110.407 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.9 76.92 1.53 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.479 -0.889 . . . . 0.0 111.018 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.42 -26.86 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -42.6 80.28 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -96.18 20.15 10.73 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.34 46.88 24.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.406 -0.809 . . . . 0.0 111.842 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.76 HD13 HG11 ' A' ' 170' ' ' VAL . 1.9 tp -161.87 141.68 10.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.359 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.71 ' CG2' HG23 ' A' ' 54' ' ' THR . 33.4 m -143.58 111.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -105.69 102.53 1.99 Allowed Glycine 0 N--CA 1.486 2.014 0 C-N-CA 119.613 -1.279 . . . . 0.0 111.431 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.924 ' CH2' HG21 ' A' ' 54' ' ' THR . 1.8 m-90 -82.0 167.01 19.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.4 ' O ' ' CD ' ' A' ' 88' ' ' PRO . 8.0 mt-30 -80.58 140.45 35.76 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.441 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -102.75 89.94 2.05 Favored Pre-proline 0 C--N 1.301 -1.539 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.545 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.588 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 46.5 Cg_endo -96.62 -14.83 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.731 1.385 . . . . 0.0 112.618 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.726 ' O ' HG11 ' A' ' 29' ' ' VAL . 46.9 Cg_endo -71.29 87.97 0.74 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 116.216 -2.056 . . . . 0.0 111.281 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 49.07 21.44 2.53 Favored Glycine 0 N--CA 1.5 2.944 0 O-C-N 121.402 -0.812 . . . . 0.0 111.368 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 87' ' ' ALA . . . -63.52 148.3 49.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.304 -1.115 . . . . 0.0 109.734 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -106.48 12.07 30.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.454 -0.779 . . . . 0.0 111.576 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 t 46.7 103.58 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.486 -0.759 . . . . 0.0 112.906 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -86.56 -150.21 0.15 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.267 -0.896 . . . . 0.0 109.855 178.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 94' ' ' LEU . 1.6 p -156.06 177.91 1.88 Allowed Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.206 -0.934 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -90.6 169.77 3.79 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 O-C-N 123.79 1.416 . . . . 0.0 111.014 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.541 ' SG ' HG22 ' A' ' 151' ' ' VAL . 39.3 t -93.06 -73.64 0.55 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.69 -0.631 . . . . 0.0 110.023 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m 56.1 42.82 27.88 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.385 -0.822 . . . . 0.0 109.071 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.0 p -126.42 -163.55 1.24 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.899 -0.5 . . . . 0.0 110.596 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.97 70.13 0.39 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t -128.37 -8.11 5.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.541 -0.976 . . . . 0.0 111.677 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 118' ' ' ARG . 23.6 m 53.78 -162.68 0.11 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.012 -1.055 . . . . 0.0 111.029 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.79 100.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.617 -0.677 . . . . 0.0 110.605 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.866 HD13 HD23 ' A' ' 143' ' ' LEU . 1.7 mt -115.86 153.99 30.52 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.02 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 107' ' ' VAL . 53.9 m-85 -105.17 94.35 5.19 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.523 HD23 HD11 ' A' ' 114' ' ' ILE . 8.8 tp -62.98 93.66 0.06 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.684 HG22 HG22 ' A' ' 113' ' ' VAL . 96.4 t -80.94 112.8 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.892 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.421 HG23 ' HB3' ' A' ' 138' ' ' SER . 8.7 m -78.38 172.89 12.96 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.733 ' N ' HD12 ' A' ' 44' ' ' LEU . 19.1 tpt180 -85.51 -8.85 58.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 111.021 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.493 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -107.55 41.42 1.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 110.046 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.48 71.44 0.52 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.376 -0.827 . . . . 0.0 110.676 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -156.4 98.37 1.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.777 -0.577 . . . . 0.0 110.284 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.684 HG22 HG22 ' A' ' 107' ' ' VAL . 54.6 t -99.71 135.57 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.489 -0.757 . . . . 0.0 110.121 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.523 HD11 HD23 ' A' ' 106' ' ' LEU . 32.4 pt -127.07 140.52 38.06 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.85 142.3 51.68 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 O-C-N 123.687 1.362 . . . . 0.0 112.044 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.26 151.36 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -106.2 105.6 15.71 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 102' ' ' SER . 9.9 ttp180 -48.89 123.02 6.36 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 122.036 0.922 . . . . 0.0 111.81 -177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -115.72 -26.79 7.29 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.72 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.21 161.06 32.7 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -51.49 -26.87 9.07 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.311 -1.111 . . . . 0.0 110.776 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -124.41 38.81 4.11 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.046 0.45 . . . . 0.0 110.364 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.468 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 4.1 ttt180 -166.82 156.82 11.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.343 -0.848 . . . . 0.0 110.528 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.47 -178.43 28.82 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.96 113.68 18.14 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.857 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.494 HD21 HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -57.92 130.99 49.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.535 -0.728 . . . . 0.0 109.463 178.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.6 mt -105.6 54.66 0.7 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.7 t 177.83 114.03 0.16 Allowed Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.095 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -58.27 102.98 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.731 0 O-C-N 123.478 1.251 . . . . 0.0 109.979 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 mtt-85 -119.01 160.73 39.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.233 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 43.3 Cg_endo -73.93 127.66 11.66 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 124.058 1.557 . . . . 0.0 109.956 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.2 p -58.82 -37.5 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.806 -0.559 . . . . 0.0 110.571 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -48.87 -36.46 17.08 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 122.038 0.923 . . . . 0.0 110.783 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.417 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 25.3 t80 -66.13 -38.41 88.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.614 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.0 mt -65.34 -35.96 82.57 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -63.67 -21.4 66.36 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.559 -0.856 . . . . 0.0 110.649 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.04 30.37 10.23 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.421 ' HB3' HG23 ' A' ' 108' ' ' THR . 85.2 p -150.7 21.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.566 -0.961 . . . . 0.0 111.453 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.7 p -56.07 132.91 51.42 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.152 -0.968 . . . . 0.0 109.04 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.551 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 109.9 -19.2 28.22 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.69 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -43.85 100.79 0.02 OUTLIER Glycine 0 N--CA 1.504 3.207 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 153' ' ' ILE . 44.2 Cg_endo -63.76 128.23 21.61 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.996 1.524 . . . . 0.0 112.243 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.866 HD23 HD13 ' A' ' 104' ' ' LEU . 9.8 mp -84.26 119.76 25.43 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.5 130.26 56.82 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.686 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 31.6 p -74.05 168.27 27.78 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.235 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 44.2 Cg_endo -69.63 76.66 1.07 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 O-C-N 123.739 1.389 . . . . 0.0 110.751 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.6 t -173.4 -57.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.326 -0.858 . . . . 0.0 110.345 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.57 -42.75 0.63 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER -59.27 123.5 16.94 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.729 -0.865 . . . . 0.0 110.083 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.34 145.33 55.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.66 . . . . 0.0 110.064 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.652 HG12 ' CE2' ' A' ' 169' ' ' PHE . 2.4 t -94.8 -37.23 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.644 -0.66 . . . . 0.0 109.478 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.677 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 177.13 -178.08 48.24 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 82' ' ' LEU . 1.8 pp -117.06 157.15 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.363 -1.081 . . . . 0.0 110.983 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.709 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 6.1 t80 -68.85 119.26 12.92 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.73 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -107.01 -41.13 5.26 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -161.28 179.98 7.89 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.709 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -141.65 128.29 20.29 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.492 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.946 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.2 t -68.32 99.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.471 ' SG ' HG23 ' A' ' 132' ' ' VAL . 72.8 m -115.9 159.86 20.98 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.461 1.124 . . . . 0.0 113.351 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 162' ' ' GLY . 1.8 m -98.3 -174.83 2.94 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.46 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -47.88 83.8 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.456 -0.778 . . . . 0.0 112.708 -179.138 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.717 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 83.06 -32.31 3.02 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.846 -1.159 . . . . 0.0 111.443 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.97 131.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 119.098 1.449 . . . . 0.0 108.944 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.614 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -91.68 132.71 36.17 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.713 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -113.86 -46.78 3.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.649 -0.657 . . . . 0.0 111.045 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.946 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -117.46 179.08 4.16 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.259 -0.901 . . . . 0.0 110.405 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 t -115.47 162.24 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.464 -0.772 . . . . 0.0 110.599 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.66 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -136.27 84.45 2.08 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.765 ' CD1' HD22 ' A' ' 143' ' ' LEU . 2.6 p90 -119.97 163.19 17.97 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.054 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.76 HG11 HD13 ' A' ' 82' ' ' LEU . 2.6 p -111.14 130.52 22.91 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 40.5 Cg_endo -60.57 159.41 28.06 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 124.063 1.559 . . . . 0.0 111.468 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.762 HG11 HG11 ' A' ' 48' ' ' VAL . 96.3 t -77.36 -3.88 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -84.57 -37.75 20.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 0.0 108.692 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.9 t -70.3 -38.12 74.92 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.76 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.723 ' HE1' HG23 ' A' ' 153' ' ' ILE . 19.4 mtt -49.91 -38.83 37.76 Favored 'General case' 0 N--CA 1.516 2.866 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -52.94 -38.73 62.26 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.497 0.665 . . . . 0.0 109.854 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.2 m -51.82 -38.07 54.29 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.405 0.621 . . . . 0.0 109.767 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.09 -42.37 80.6 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.65 -0.656 . . . . 0.0 110.02 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.471 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -56.19 -49.69 73.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.458 -0.776 . . . . 0.0 110.585 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -37.35 61.72 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.93 0.871 . . . . 0.0 109.804 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -78.54 -39.65 37.26 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.919 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.7 -172.06 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.35 -0.844 . . . . 0.0 110.647 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.86 71.06 0.51 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.488 -0.758 . . . . 0.0 109.906 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.29 127.68 33.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.696 -0.627 . . . . 0.0 110.593 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -88.4 152.3 22.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.541 -0.724 . . . . 0.0 109.852 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 2.4 tptp . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.247 -179.873 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.33 0.586 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.38 -83.18 0.05 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -95.59 28.89 2.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.503 -0.998 . . . . 0.0 110.783 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -65.39 -175.59 0.26 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.411 -0.806 . . . . 0.0 109.091 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.3 44.32 2.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.622 -0.674 . . . . 0.0 110.317 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 p-10 -157.37 117.22 3.41 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.482 -0.761 . . . . 0.0 110.656 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.11 76.87 1.3 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.542 -0.724 . . . . 0.0 109.198 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 7.7 p -160.47 154.98 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.712 -0.617 . . . . 0.0 109.626 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -161.65 78.58 0.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.124 0.964 . . . . 0.0 110.618 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 45.46 -93.66 0.01 OUTLIER Glycine 0 N--CA 1.496 2.685 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.363 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -90.42 -29.8 17.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.73 -0.865 . . . . 0.0 112.729 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 34' ' ' GLN . 47.3 t -125.97 162.38 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 120.942 -1.099 . . . . 0.0 112.554 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.447 ' N ' HG12 ' A' ' 33' ' ' VAL . 6.4 tt0 -153.46 135.67 14.87 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.568 HG12 ' HB2' ' A' ' 109' ' ' ARG . 11.2 m -91.89 177.7 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 120.932 -1.105 . . . . 0.0 112.53 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.614 HG21 ' CD2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -135.97 172.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.55 -179.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -160.7 138.36 9.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.453 -0.779 . . . . 0.0 111.008 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 40' ' ' THR . 6.2 t -153.42 179.55 8.68 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . -71.01 72.72 0.59 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.815 -1.154 . . . . 0.0 108.772 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 39' ' ' ALA . 23.3 m -175.24 -61.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -177.24 -168.16 0.19 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.839 -0.538 . . . . 0.0 109.867 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.5 p -125.05 128.01 47.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.658 -0.651 . . . . 0.0 109.251 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.614 ' CD2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -108.12 -177.43 3.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.143 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.843 HD12 ' N ' ' A' ' 109' ' ' ARG . 6.1 tt -107.9 149.94 27.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.343 -0.848 . . . . 0.0 109.687 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.614 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -139.77 136.01 33.66 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.217 -0.927 . . . . 0.0 109.391 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.746 HG21 ' CG2' ' A' ' 153' ' ' ILE . 4.6 t -107.29 116.7 32.39 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.3 -0.875 . . . . 0.0 112.522 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.43 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 84.3 m -72.11 83.0 0.99 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.319 -0.863 . . . . 0.0 110.175 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.464 HG11 ' CG1' ' A' ' 172' ' ' VAL . 60.5 t -107.28 139.5 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.0 t30 57.44 19.96 5.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.575 -0.703 . . . . 0.0 109.811 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.76 54.68 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 85' ' ' TRP . 57.0 t -144.52 109.67 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.424 -1.045 . . . . 0.0 110.089 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 46' ' ' THR . 15.0 p -61.4 97.03 0.06 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.702 -0.624 . . . . 0.0 110.136 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.914 ' CE3' HD23 ' A' ' 82' ' ' LEU . 98.4 m95 -76.43 150.29 36.76 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.089 -1.007 . . . . 0.0 110.302 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.606 ' O ' HG22 ' A' ' 83' ' ' VAL . 7.9 t -164.03 -178.59 5.7 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.972 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 55' ' ' VAL . 12.0 m -97.25 139.16 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.562 -0.712 . . . . 0.0 110.076 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.547 ' HB3' HG11 ' A' ' 78' ' ' VAL . 31.9 t80 -76.33 0.05 20.82 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.306 -0.871 . . . . 0.0 111.313 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -49.2 -33.33 12.19 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.415 -0.803 . . . . 0.0 110.871 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.81 -14.0 1.93 Allowed Glycine 0 N--CA 1.496 2.667 0 C-N-CA 119.754 -1.213 . . . . 0.0 111.875 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 43' ' ' PHE . . . -52.32 -34.38 46.75 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.787 -1.42 . . . . 0.0 110.983 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.84 168.81 4.41 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.6 t -96.94 -19.65 18.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.521 -0.987 . . . . 0.0 110.19 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -57.33 179.0 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.56 0.695 . . . . 0.0 110.768 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.47 103.91 2.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.678 -0.639 . . . . 0.0 110.094 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.722 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -53.43 160.98 1.07 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.694 -0.629 . . . . 0.0 110.192 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.1 133.09 50.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.804 . . . . 0.0 110.602 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.87 -177.5 14.9 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -59.05 96.17 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 O-C-N 123.77 1.405 . . . . 0.0 110.279 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.63 37.86 29.13 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.367 -0.833 . . . . 0.0 110.443 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.97 136.5 2.44 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.035 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.58 153.22 78.77 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 124.081 1.569 . . . . 0.0 109.685 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.722 HD12 ' CD2' ' A' ' 64' ' ' LEU . 65.7 mt -100.45 116.76 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.336 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -59.92 126.79 28.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.565 -0.709 . . . . 0.0 111.034 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -79.76 105.24 10.91 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 tpt -101.56 -32.17 10.5 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.23 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.45 ' CZ ' ' HG3' ' A' ' 179' ' ' MET . 14.2 m-85 -130.15 115.63 17.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.696 -0.628 . . . . 0.0 110.084 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.83 HG23 ' CG1' ' A' ' 83' ' ' VAL . 18.4 m -161.06 107.5 1.43 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.146 -0.971 . . . . 0.0 112.839 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.45 ' CB ' ' HB3' ' A' ' 81' ' ' ASP . 5.0 m-80 -163.84 78.17 0.4 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.694 . . . . 0.0 109.917 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 56' ' ' TYR . 34.9 m -51.39 -21.92 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.731 -1.231 . . . . 0.0 111.852 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.85 78.69 0.63 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.052 -1.03 . . . . 0.0 108.721 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 60.32 46.57 9.94 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.644 -0.66 . . . . 0.0 110.753 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -156.33 -33.21 0.09 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.217 -0.927 . . . . 0.0 111.859 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.914 HD23 ' CE3' ' A' ' 53' ' ' TRP . 5.7 tp 72.75 165.62 0.3 Allowed 'General case' 0 N--CA 1.526 3.343 0 CA-C-N 120.217 1.371 . . . . 0.0 111.075 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.83 ' CG1' HG23 ' A' ' 76' ' ' THR . 1.4 m -122.21 147.79 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.94 110.04 0.42 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.527 ' CH2' HG21 ' A' ' 54' ' ' THR . 1.2 m-90 -86.6 169.62 12.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -81.98 138.45 34.92 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.482 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -107.0 82.52 1.12 Allowed Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.401 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.566 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 48.0 Cg_endo -98.81 -6.8 0.63 Allowed 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.575 1.303 . . . . 0.0 112.977 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 40.4 Cg_endo -73.24 63.23 4.32 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 115.592 -2.472 . . . . 0.0 111.269 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.96 52.91 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.43 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -72.19 129.48 38.57 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.247 -1.149 . . . . 0.0 111.206 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -68.46 136.15 52.79 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.223 -0.991 . . . . 0.0 108.619 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -103.21 115.43 30.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.49 -0.757 . . . . 0.0 110.292 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mp -85.92 -164.1 0.98 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.495 0.664 . . . . 0.0 110.513 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.64 173.83 4.13 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.778 -0.576 . . . . 0.0 110.343 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.415 ' HB2' HG23 ' A' ' 98' ' ' THR . 50.4 Cg_endo -72.91 166.16 30.8 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 O-C-N 123.657 1.346 . . . . 0.0 110.551 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.452 ' HB2' HG23 ' A' ' 151' ' ' VAL . 6.8 t -84.68 -49.99 8.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.727 -0.608 . . . . 0.0 109.656 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.415 HG23 ' HB2' ' A' ' 96' ' ' PRO . 61.8 p 45.06 37.33 2.45 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.813 -0.554 . . . . 0.0 111.041 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.6 p -122.78 -162.03 0.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.492 -0.755 . . . . 0.0 110.172 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.27 74.55 0.37 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m -150.72 165.11 34.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.719 -0.871 . . . . 0.0 110.184 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.8 t -112.31 -154.89 0.55 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.52 -0.737 . . . . 0.0 110.588 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 57.86 99.35 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.207 -0.933 . . . . 0.0 110.508 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.774 HD13 HD23 ' A' ' 143' ' ' LEU . 2.3 mt -116.11 -176.27 2.91 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.301 -0.874 . . . . 0.0 109.963 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.458 ' O ' HG23 ' A' ' 107' ' ' VAL . 28.7 m-85 -131.53 85.06 2.22 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 154' ' ' PHE . 19.2 tp -61.13 89.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.457 -0.777 . . . . 0.0 109.039 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.609 HG13 HG12 ' A' ' 113' ' ' VAL . 21.8 t -75.41 101.37 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.186 -1.006 . . . . 0.0 109.638 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.889 HG22 ' O ' ' A' ' 112' ' ' ASP . 7.4 t -75.73 179.7 5.27 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.843 ' N ' HD12 ' A' ' 44' ' ' LEU . 16.4 ptt85 -95.3 17.07 15.11 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.12 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.54 ' H ' HG23 ' A' ' 108' ' ' THR . 6.3 m170 -103.36 21.17 16.43 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 59.12 56.36 3.95 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.363 -0.836 . . . . 0.0 109.816 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.889 ' O ' HG22 ' A' ' 108' ' ' THR . 11.6 t70 -166.86 121.88 1.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.688 -0.632 . . . . 0.0 109.881 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.609 HG12 HG13 ' A' ' 107' ' ' VAL . 8.4 m -104.1 145.36 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.993 -1.067 . . . . 0.0 109.608 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.443 HD11 HD23 ' A' ' 106' ' ' LEU . 44.0 pt -125.98 138.6 32.41 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.077 -1.015 . . . . 0.0 110.091 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.591 ' HB2' HD12 ' A' ' 127' ' ' LEU . 54.5 Cg_endo -66.18 141.47 63.31 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 O-C-N 123.796 1.419 . . . . 0.0 112.201 -177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 58.4 t -132.59 138.47 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.679 -0.638 . . . . 0.0 109.65 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.58 117.71 35.26 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 -48.96 129.5 17.4 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.488 -0.757 . . . . 0.0 110.702 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.428 ' CG ' ' HB2' ' A' ' 125' ' ' SER . 5.5 mmm180 -109.8 -27.26 9.39 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.736 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.19 -150.05 7.43 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -77.16 127.58 32.88 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.734 -0.862 . . . . 0.0 108.822 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.38 45.39 28.6 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.127 0.489 . . . . 0.0 111.217 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.485 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -160.89 151.59 18.33 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.332 -0.855 . . . . 0.0 110.754 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.0 -177.05 17.64 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.0 OUTLIER -129.46 120.65 25.81 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.803 -0.822 . . . . 0.0 112.041 -178.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.404 HD22 ' HB2' ' A' ' 130' ' ' ARG . 0.2 OUTLIER -58.48 141.25 52.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.436 -0.79 . . . . 0.0 109.001 178.194 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' ' 115' ' ' PRO . 20.7 mt -108.44 52.99 0.7 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.3 p 166.19 136.79 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.2 113.96 2.84 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.802 1.422 . . . . 0.0 109.81 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.404 ' HB2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -121.66 147.32 47.76 Favored Pre-proline 0 N--CA 1.49 1.531 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.68 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 43.3 Cg_endo -68.15 125.11 12.54 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 124.14 1.6 . . . . 0.0 110.055 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.45 HG21 ' SG ' ' A' ' 159' ' ' CYS . 10.8 p -58.86 -36.84 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.624 0.726 . . . . 0.0 109.684 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.1 m -49.13 -35.63 16.97 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 122.031 0.919 . . . . 0.0 110.936 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.738 ' OH ' HG21 ' A' ' 108' ' ' THR . 43.4 t80 -70.07 -36.93 75.31 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.567 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.9 mt -63.58 -37.2 86.41 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -57.83 122.93 14.09 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.576 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.45 -31.64 8.48 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.9 m -79.96 0.19 32.54 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.487 -1.008 . . . . 0.0 111.152 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.402 ' CB ' HG21 ' A' ' 55' ' ' VAL . 78.8 p -48.42 134.04 15.55 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.225 -0.922 . . . . 0.0 110.714 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.593 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 110.74 -20.59 24.48 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 107.376 -2.29 . . . . 0.0 107.376 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.76 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -47.09 113.66 1.31 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.41 122.62 9.64 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 124.05 1.552 . . . . 0.0 111.726 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.774 HD23 HD13 ' A' ' 104' ' ' LEU . 6.4 mp -79.11 114.08 17.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.618 HD23 ' HA ' ' A' ' 150' ' ' ALA . 1.8 mt -110.15 121.85 46.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 111.492 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.488 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 29.5 p -60.81 178.32 0.27 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.93 -0.481 . . . . 0.0 109.932 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 55.1 Cg_endo -83.63 51.01 3.37 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.514 1.271 . . . . 0.0 111.227 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.84 43.75 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.182 -0.949 . . . . 0.0 110.456 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 61.14 -167.01 12.53 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.4 m170 56.48 106.02 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.567 -0.96 . . . . 0.0 110.671 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.618 ' HA ' HD23 ' A' ' 144' ' ' LEU . . . -57.44 153.63 12.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.192 -0.943 . . . . 0.0 109.982 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -105.07 -30.72 2.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.707 ' CA ' HG23 ' A' ' 172' ' ' VAL . . . 173.55 -177.15 46.03 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.769 HD11 HD11 ' A' ' 82' ' ' LEU . 1.2 pt -121.59 164.22 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 CA-C-N 119.24 1.52 . . . . 0.0 111.541 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.837 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.5 t80 -75.41 99.83 4.28 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.447 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -37.9 15.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -161.35 176.63 10.95 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.837 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -135.37 120.75 19.14 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.371 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.857 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 4.1 t -68.61 103.62 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.45 ' SG ' HG21 ' A' ' 132' ' ' VAL . 30.0 p -124.02 162.92 22.46 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.733 1.254 . . . . 0.0 114.06 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 161' ' ' ARG . 1.3 m -103.67 -172.56 2.13 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.469 ' H ' HG22 ' A' ' 160' ' ' THR . 7.1 ttt180 -46.38 90.07 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.677 0 O-C-N 121.396 -0.815 . . . . 0.0 111.623 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 72.25 -18.2 1.27 Allowed Glycine 0 N--CA 1.499 2.889 0 O-C-N 121.245 -0.91 . . . . 0.0 112.984 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.12 127.87 60.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 119.484 1.642 . . . . 0.0 109.527 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.567 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -89.66 137.82 32.0 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.052 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -117.94 -43.74 2.75 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.461 -0.775 . . . . 0.0 110.77 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.857 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -119.4 171.84 8.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.411 -0.806 . . . . 0.0 109.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.8 t -118.24 145.83 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.543 0.687 . . . . 0.0 110.865 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.668 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.5 OUTLIER -109.94 100.28 9.27 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 177.165 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.666 ' CG ' HD22 ' A' ' 143' ' ' LEU . 0.4 OUTLIER -131.89 142.97 49.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.803 -1.159 . . . . 0.0 113.194 -175.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.578 HG11 HD13 ' A' ' 82' ' ' LEU . 2.9 p -94.09 133.45 27.46 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 49.4 Cg_endo -61.17 160.74 25.34 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.812 1.427 . . . . 0.0 110.859 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.707 HG23 ' CA ' ' A' ' 152' ' ' GLY . 40.1 t -82.41 1.56 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.294 -0.879 . . . . 0.0 109.602 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -93.08 -39.38 11.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.046 -1.034 . . . . 0.0 110.228 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.9 t -75.33 -40.05 58.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.72 -0.613 . . . . 0.0 110.305 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.951 ' O ' HG22 ' A' ' 178' ' ' THR . 4.0 ptp -55.75 -36.32 67.16 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.315 -0.866 . . . . 0.0 110.349 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -37.95 65.41 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.219 -0.926 . . . . 0.0 109.862 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.4 m -48.92 -38.96 24.35 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.951 HG22 ' O ' ' A' ' 175' ' ' MET . 7.6 t -49.91 -38.73 37.28 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 120.752 -1.217 . . . . 0.0 112.267 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.486 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -57.69 -35.14 70.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.814 -1.179 . . . . 0.0 111.462 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -47.41 -37.28 11.13 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.272 -0.892 . . . . 0.0 110.634 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.85 -45.55 10.2 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.103 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.3 t 50.28 31.56 5.36 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.096 -1.002 . . . . 0.0 111.176 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 43.8 mttt 52.97 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.22 -0.925 . . . . 0.0 110.661 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -139.1 -40.95 0.47 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.409 -0.807 . . . . 0.0 111.127 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -64.95 153.33 40.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.406 -0.809 . . . . 0.0 110.11 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.061 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.978 0.418 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.25 -74.26 0.28 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.95 -88.79 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.658 -0.907 . . . . 0.0 111.295 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t0 57.49 -167.22 0.13 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.148 -0.97 . . . . 0.0 109.924 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -144.78 -162.81 1.56 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.472 -0.767 . . . . 0.0 110.055 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -99.24 109.46 22.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.814 -0.554 . . . . 0.0 109.895 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.2 77.71 1.41 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.387 0.613 . . . . 0.0 110.03 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.613 HG11 ' HB2' ' A' ' 89' ' ' PRO . 33.9 m -99.72 -148.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.658 -0.651 . . . . 0.0 110.402 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 62.69 80.06 0.24 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.984 -1.072 . . . . 0.0 109.364 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.58 164.61 29.73 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.489 ' CD ' HD11 ' A' ' 94' ' ' LEU . 8.6 mt-10 -90.9 -28.1 18.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.669 -0.901 . . . . 0.0 110.94 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.404 HG11 HD11 ' A' ' 44' ' ' LEU . 39.4 t -115.5 143.86 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.476 -0.765 . . . . 0.0 111.248 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.457 ' C ' HG13 ' A' ' 35' ' ' VAL . 2.7 tt0 -137.13 175.74 9.34 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 44' ' ' LEU . 34.3 m -148.56 177.96 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.23 -0.919 . . . . 0.0 111.173 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.471 HG11 HD11 ' A' ' 64' ' ' LEU . 10.6 m -130.75 -179.4 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 p -136.88 133.75 36.11 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.48 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.3 p -128.46 -176.42 3.82 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.94 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.201 -0.937 . . . . 0.0 110.959 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.0 p 49.1 39.95 16.3 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.842 -0.536 . . . . 0.0 111.005 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -155.03 137.87 15.36 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.661 -0.649 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.9 t -130.71 135.03 47.42 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.464 -0.773 . . . . 0.0 109.098 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -100.9 178.29 4.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.261 -0.899 . . . . 0.0 110.824 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.691 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -113.13 149.39 33.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.427 -0.796 . . . . 0.0 109.729 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.431 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -158.07 152.52 24.63 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.55 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.617 HG23 HG23 ' A' ' 48' ' ' VAL . 11.8 t -125.55 127.19 46.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.327 -0.858 . . . . 0.0 111.155 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.4 m -78.27 80.89 4.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.333 -0.854 . . . . 0.0 110.325 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.617 HG23 HG23 ' A' ' 46' ' ' THR . 95.3 t -100.04 139.17 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.75 20.31 6.35 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.327 -0.858 . . . . 0.0 108.945 -177.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 23.13 60.07 Favored Glycine 0 N--CA 1.491 2.332 0 O-C-N 121.392 -0.817 . . . . 0.0 111.361 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -136.88 105.12 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 118.79 1.295 . . . . 0.0 110.557 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.5 t -58.4 101.44 0.08 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.68 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.615 ' CZ3' HG21 ' A' ' 178' ' ' THR . 52.8 m95 -82.19 144.98 30.33 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.479 -0.763 . . . . 0.0 112.177 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.906 HG21 ' CH2' ' A' ' 85' ' ' TRP . 3.4 t -165.23 128.66 2.28 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 81' ' ' ASP . 13.4 m -49.61 153.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 O-C-N 121.26 -0.9 . . . . 0.0 111.349 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.465 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 57.1 t80 -76.4 1.31 16.72 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.159 -0.963 . . . . 0.0 111.643 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -49.24 -25.12 2.1 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.129 -0.982 . . . . 0.0 110.883 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.95 73.1 0.06 OUTLIER Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.749 ' O ' HD12 ' A' ' 64' ' ' LEU . . . -156.01 -54.45 0.09 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.592 -0.946 . . . . 0.0 110.264 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.68 -1.6 90.24 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 p -74.16 144.88 44.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.191 -1.182 . . . . 0.0 110.242 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.0 tttm 55.04 -171.6 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.477 -0.765 . . . . 0.0 110.65 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m -86.92 101.95 13.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.611 -0.68 . . . . 0.0 110.287 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.749 HD12 ' O ' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -55.46 156.13 4.79 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.625 -0.672 . . . . 0.0 110.646 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.21 141.4 47.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.673 -0.642 . . . . 0.0 110.465 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.97 -178.44 15.41 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -56.14 95.76 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.766 1.403 . . . . 0.0 110.59 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.9 tttt 56.66 33.44 22.83 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.535 -0.728 . . . . 0.0 110.503 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.35 137.33 3.42 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.98 162.21 42.62 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 O-C-N 123.836 1.44 . . . . 0.0 109.769 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.627 ' HB ' HD22 ' A' ' 64' ' ' LEU . 73.6 mt -118.9 93.54 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.375 -0.828 . . . . 0.0 110.098 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 m -110.02 141.19 43.17 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.222 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -146.87 -144.92 0.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.794 -0.566 . . . . 0.0 109.799 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.8 ttp -145.65 22.82 1.45 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.985 -1.072 . . . . 0.0 111.179 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.473 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 11.3 m-30 -115.85 101.85 9.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.328 -0.857 . . . . 0.0 110.139 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.609 HG23 ' CG1' ' A' ' 83' ' ' VAL . 3.0 m -150.88 121.33 7.37 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -142.83 78.09 1.6 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.344 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.441 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.7 p -52.76 -29.36 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.352 -0.842 . . . . 0.0 110.03 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.03 -50.65 69.85 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -86.59 5.98 33.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.772 -0.58 . . . . 0.0 109.786 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.54 ' O ' HG12 ' A' ' 55' ' ' VAL . 58.3 m-20 56.72 54.17 7.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.254 -0.904 . . . . 0.0 112.601 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.93 HD13 HG11 ' A' ' 170' ' ' VAL . 1.2 tp -160.87 138.02 9.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.922 -1.112 . . . . 0.0 112.559 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.609 ' CG1' HG23 ' A' ' 76' ' ' THR . 21.9 t -143.67 139.26 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -145.09 123.61 1.96 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 118.14 -1.981 . . . . 0.0 112.585 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.906 ' CH2' HG21 ' A' ' 54' ' ' THR . 1.2 m-90 -99.75 137.51 38.12 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -58.45 131.3 50.31 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.69 0.757 . . . . 0.0 111.757 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.508 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -104.65 93.28 5.86 Favored Pre-proline 0 C--N 1.296 -1.753 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.09 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 51.2 Cg_endo -99.89 -14.95 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.863 1.454 . . . . 0.0 112.473 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.613 ' HB2' HG11 ' A' ' 29' ' ' VAL . 47.9 Cg_endo -69.42 78.7 0.88 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 116.235 -2.043 . . . . 0.0 111.062 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 50.09 26.47 8.96 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.508 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -79.08 138.46 37.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.618 -0.931 . . . . 0.0 110.229 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -68.93 145.58 53.52 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.412 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -111.67 92.62 4.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.611 -0.681 . . . . 0.0 109.513 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.489 HD11 ' CD ' ' A' ' 32' ' ' GLU . 0.6 OUTLIER -71.14 -161.37 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.593 -0.692 . . . . 0.0 109.621 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -152.96 -176.28 0.57 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.718 -0.614 . . . . 0.0 109.959 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 95' ' ' THR . 41.1 Cg_endo -85.61 158.12 10.64 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 O-C-N 123.814 1.429 . . . . 0.0 109.944 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.81 86.71 2.35 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.509 -0.745 . . . . 0.0 110.709 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.1 p -91.85 79.59 5.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.41 -0.806 . . . . 0.0 109.549 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 31.1 p -138.2 -151.51 0.39 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.64 -128.98 3.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m 54.67 -164.16 0.11 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.252 -1.146 . . . . 0.0 110.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.9 m -160.19 -35.3 0.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.355 -0.84 . . . . 0.0 111.779 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 3.5 p30 -60.68 134.31 56.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.21 -0.931 . . . . 0.0 110.787 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.756 HD13 HD23 ' A' ' 143' ' ' LEU . 1.3 mt -128.08 -166.87 1.68 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.03 -1.043 . . . . 0.0 109.884 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.484 ' O ' HG23 ' A' ' 107' ' ' VAL . 72.7 m-85 -144.74 85.59 1.77 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.709 HD23 HD11 ' A' ' 114' ' ' ILE . 38.0 tp -65.84 109.66 2.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.315 -0.866 . . . . 0.0 109.279 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 105' ' ' TYR . 38.1 t -100.69 128.27 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 111.582 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.527 HG21 ' CE1' ' A' ' 134' ' ' TYR . 33.2 p -94.55 166.49 12.01 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.691 ' CB ' HD21 ' A' ' 44' ' ' LEU . 27.2 tpt85 -79.97 -7.52 58.84 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.199 -0.938 . . . . 0.0 110.724 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.39 41.53 1.3 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.979 -1.075 . . . . 0.0 110.037 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 50.63 63.52 2.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.558 -0.714 . . . . 0.0 111.329 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.36 82.61 1.42 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.643 -0.66 . . . . 0.0 110.021 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.43 HG23 HG22 ' A' ' 107' ' ' VAL . 9.7 p -92.94 149.96 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.493 -0.754 . . . . 0.0 110.93 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.709 HD11 HD23 ' A' ' 106' ' ' LEU . 40.6 pt -145.16 144.72 24.41 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.226 -0.921 . . . . 0.0 110.018 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.52 ' HB2' HD12 ' A' ' 127' ' ' LEU . 52.5 Cg_endo -78.07 135.41 13.82 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.805 1.424 . . . . 0.0 110.909 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 103' ' ' ASP . 46.4 t -122.01 146.28 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.552 -0.718 . . . . 0.0 109.38 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.17 115.05 29.72 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.01 129.21 17.27 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.505 -0.747 . . . . 0.0 111.047 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -114.73 -25.85 8.09 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.51 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -171.03 61.22 0.17 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.825 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.456 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.4 OUTLIER 60.13 -75.17 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.663 -0.904 . . . . 0.0 111.66 179.051 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 120' ' ' GLY . 9.4 p -91.97 39.82 1.03 Allowed 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.283 0.563 . . . . 0.0 111.579 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.05 151.22 2.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.423 ' HA3' HG12 ' A' ' 116' ' ' VAL . . . -143.25 -177.2 18.0 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -125.04 118.39 26.08 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.917 -178.328 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.587 HD21 HD12 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -55.35 141.78 34.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.591 -0.693 . . . . 0.0 110.112 179.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.52 HD12 ' HB2' ' A' ' 115' ' ' PRO . 49.2 mt -109.75 53.94 0.68 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 168.08 128.82 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.05 112.45 2.05 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.775 1.408 . . . . 0.0 110.022 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -125.72 143.81 46.26 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.254 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.49 128.46 23.64 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.987 1.52 . . . . 0.0 110.907 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.695 HG21 ' SG ' ' A' ' 159' ' ' CYS . 7.4 p -60.28 -36.73 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.482 0.658 . . . . 0.0 109.499 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.8 m -48.44 -36.53 15.08 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.372 -0.83 . . . . 0.0 110.979 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.527 ' CE1' HG21 ' A' ' 108' ' ' THR . 0.1 OUTLIER -65.87 -38.58 89.19 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.8 mt -63.91 -35.49 80.82 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.08 121.7 10.63 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.584 -0.847 . . . . 0.0 109.788 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.34 -30.83 9.42 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.429 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 8.9 m -80.83 2.23 27.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.533 -0.981 . . . . 0.0 111.263 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 p -52.96 122.84 10.1 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.133 -0.979 . . . . 0.0 110.618 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 115.37 -9.71 19.98 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -59.86 152.35 35.9 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -93.82 129.64 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.697 1.367 . . . . 0.0 112.784 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.756 HD23 HD13 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -88.05 123.35 32.65 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 176.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.61 123.87 42.17 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.673 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.539 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 31.3 p -58.54 -170.95 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 48.6 Cg_endo -81.13 57.51 6.54 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 117.699 -1.068 . . . . 0.0 111.149 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.2 p -175.7 -158.13 0.06 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 149' ' ' HIS . . . -83.32 -160.18 29.12 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 148' ' ' GLY . 27.2 m170 57.73 133.17 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 117.789 0.795 . . . . 0.0 112.034 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.639 ' HB3' HG21 ' A' ' 172' ' ' VAL . . . -80.85 137.5 36.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.101 -0.999 . . . . 0.0 109.811 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.668 HG12 ' CE2' ' A' ' 169' ' ' PHE . 0.9 OUTLIER -81.83 -38.51 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.628 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 177.16 -178.29 48.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.773 HD11 ' CD1' ' A' ' 82' ' ' LEU . 1.7 pp -118.76 150.8 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 118.67 1.235 . . . . 0.0 111.346 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.745 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.9 t80 -60.63 112.33 1.96 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.39 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -46.75 5.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -149.32 172.99 14.0 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.745 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -128.73 115.6 18.23 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.555 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.796 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.4 t -67.67 94.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.695 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.2 p -123.87 148.68 46.59 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.876 0.846 . . . . 0.0 113.279 -175.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.585 HG22 ' H ' ' A' ' 161' ' ' ARG . 2.3 m -88.59 -173.49 4.17 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.585 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -46.56 85.99 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.99 0.9 . . . . 0.0 112.829 -178.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.613 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 80.42 -26.1 3.12 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.994 -1.066 . . . . 0.0 112.321 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.35 129.91 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.088 1.444 . . . . 0.0 109.271 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.442 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -91.98 126.69 37.16 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.961 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -109.0 -35.87 6.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.483 -0.761 . . . . 0.0 110.638 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.796 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -134.3 176.36 8.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.816 . . . . 0.0 109.921 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.01 153.11 26.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-O 121.663 0.745 . . . . 0.0 110.85 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.73 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 3.2 t70 -120.53 93.93 4.2 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.668 ' CE2' HG12 ' A' ' 151' ' ' VAL . 3.5 p90 -124.85 156.38 37.94 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.954 -1.098 . . . . 0.0 113.099 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.93 HG11 HD13 ' A' ' 82' ' ' LEU . 4.7 p -100.15 130.62 25.69 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 39.2 Cg_endo -62.06 159.59 33.67 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.778 1.41 . . . . 0.0 110.97 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.639 HG21 ' HB3' ' A' ' 150' ' ' ALA . 92.6 t -78.37 0.32 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.458 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -87.48 -37.65 16.77 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.838 0.828 . . . . 0.0 108.789 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 t -70.31 -37.21 74.71 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.28 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.603 ' HE1' HG23 ' A' ' 153' ' ' ILE . 14.9 mtt -49.12 -38.3 24.57 Favored 'General case' 0 N--CA 1.516 2.844 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -53.15 -38.34 62.63 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.29 -0.881 . . . . 0.0 108.968 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 m -55.47 -35.14 65.19 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.525 0.678 . . . . 0.0 109.452 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.615 HG21 ' CZ3' ' A' ' 53' ' ' TRP . 31.0 m -48.02 -61.02 2.18 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.859 -0.526 . . . . 0.0 110.535 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.473 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -55.04 -38.13 67.57 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.628 -0.67 . . . . 0.0 110.763 179.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -48.94 -37.04 18.82 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.982 0.896 . . . . 0.0 110.337 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.03 36.76 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.239 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.28 30.27 7.75 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.218 -0.926 . . . . 0.0 110.649 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -51.92 118.81 3.7 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.488 -0.757 . . . . 0.0 111.271 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -81.96 178.88 8.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.595 -0.69 . . . . 0.0 110.267 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -119.07 45.42 2.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.538 -0.726 . . . . 0.0 110.713 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.181 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.257 0.551 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.49 -94.64 0.48 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -86.47 92.45 8.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.493 -1.004 . . . . 0.0 109.76 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.38 175.45 0.76 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.636 -0.665 . . . . 0.0 110.692 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -124.23 -142.53 0.31 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.604 -0.685 . . . . 0.0 109.393 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -65.42 99.57 0.42 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.739 -1.226 . . . . 0.0 110.245 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -159.62 78.91 0.71 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 89' ' ' PRO . 25.4 m -57.58 -176.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.382 0.611 . . . . 0.0 111.012 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.84 79.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.91 53.82 4.7 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -164.47 -82.1 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.516 -0.99 . . . . 0.0 109.764 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.664 HG22 ' CD ' ' A' ' 142' ' ' PRO . 72.2 t -129.5 147.38 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.322 -0.861 . . . . 0.0 110.726 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -134.56 178.85 6.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.68 -0.637 . . . . 0.0 110.033 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 43' ' ' PHE . 2.6 p -159.89 144.64 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.861 0.839 . . . . 0.0 110.01 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.58 ' CG1' HD21 ' A' ' 64' ' ' LEU . 12.8 m -116.74 -178.96 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.1 m -146.37 137.54 24.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.38 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.9 p -136.65 -178.88 5.37 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.53 74.27 0.77 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.68 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.583 HG22 ' HG2' ' A' ' 41' ' ' GLN . 1.1 m 174.55 -63.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.583 ' HG2' HG22 ' A' ' 40' ' ' THR . 1.6 pt20 -173.15 -173.64 0.95 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.507 -0.746 . . . . 0.0 110.564 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.5 p -107.61 146.34 32.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.713 -0.617 . . . . 0.0 110.302 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.823 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . 93.1 m-85 -105.85 -177.48 3.37 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.316 -0.865 . . . . 0.0 111.855 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.718 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -114.19 146.88 39.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.616 -0.678 . . . . 0.0 110.382 -178.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.442 ' HB1' ' SG ' ' A' ' 52' ' ' CYS . . . -152.33 166.73 30.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.58 -0.7 . . . . 0.0 110.685 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 46' ' ' THR . 8.8 t -141.93 115.34 8.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.722 . . . . 0.0 111.685 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 81.8 m -66.88 85.5 0.12 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.361 -0.837 . . . . 0.0 110.247 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.591 HG11 ' HB ' ' A' ' 172' ' ' VAL . 53.3 t -104.35 139.75 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 55.39 20.2 3.49 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.485 -0.76 . . . . 0.0 110.331 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.442 ' C ' HG23 ' A' ' 51' ' ' VAL . . . 83.13 26.63 43.61 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 50' ' ' GLY . 91.2 t -146.9 106.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.448 -1.031 . . . . 0.0 109.865 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.442 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -61.8 119.98 9.81 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.484 -0.76 . . . . 0.0 109.259 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.994 ' CE3' HD23 ' A' ' 82' ' ' LEU . 95.7 m95 -99.75 153.62 18.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.44 -0.788 . . . . 0.0 111.807 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.833 HG23 HG23 ' A' ' 83' ' ' VAL . 6.9 t -162.89 -176.53 4.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.446 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 15.5 m -104.96 139.13 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.615 ' HB2' HG11 ' A' ' 83' ' ' VAL . 13.1 t80 -65.99 -7.14 15.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.182 -0.948 . . . . 0.0 113.022 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.446 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 14.6 p-80 -95.84 36.36 1.3 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.024 -1.048 . . . . 0.0 110.161 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.506 ' CA ' ' CE1' ' A' ' 43' ' ' PHE . . . -173.93 -81.41 0.05 OUTLIER Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.823 ' HB2' ' CB ' ' A' ' 43' ' ' PHE . . . -88.43 116.48 26.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.585 -0.95 . . . . 0.0 109.13 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.93 -60.22 0.49 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.8 t -55.16 170.69 0.19 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.232 -1.158 . . . . 0.0 110.597 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 58.91 168.74 0.06 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.479 -0.763 . . . . 0.0 110.053 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.652 ' O ' HG23 ' A' ' 63' ' ' THR . 9.0 t -78.03 101.06 6.75 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.699 0.762 . . . . 0.0 110.759 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.768 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -61.91 168.49 3.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.362 -0.836 . . . . 0.0 109.496 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.69 130.16 50.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.46 -0.775 . . . . 0.0 110.739 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.88 179.86 19.29 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.12 -26.83 65.17 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.982 1.517 . . . . 0.0 110.994 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -143.48 27.49 1.54 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.386 -0.821 . . . . 0.0 111.082 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.23 154.85 8.03 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -64.23 168.64 12.18 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.957 1.504 . . . . 0.0 110.186 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.768 HD12 ' CD2' ' A' ' 64' ' ' LEU . 16.5 mt -127.25 98.27 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 O-C-N 121.392 -0.817 . . . . 0.0 110.371 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 72' ' ' THR . 21.0 m -161.86 51.52 0.22 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.264 -0.898 . . . . 0.0 111.064 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -168.18 66.66 0.07 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.047 -1.033 . . . . 0.0 111.473 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.413 ' HG2' ' HG3' ' A' ' 86' ' ' GLN . 0.5 OUTLIER -143.03 -72.82 0.3 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.225 -0.922 . . . . 0.0 109.799 179.084 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.482 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 22.5 m-85 -137.77 119.83 15.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.564 -0.71 . . . . 0.0 109.479 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.582 ' CG2' HG12 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -151.87 112.58 4.19 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.375 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.518 HD22 ' HB1' ' A' ' 181' ' ' ALA . 41.4 t-20 -147.29 75.63 1.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.637 0.732 . . . . 0.0 110.018 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.526 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.3 p -44.99 168.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.497 -0.752 . . . . 0.0 112.166 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.471 ' N ' HG22 ' A' ' 78' ' ' VAL . 6.9 m-20 57.51 114.48 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.679 0.752 . . . . 0.0 111.336 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 66.33 -66.73 0.17 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.593 -0.692 . . . . 0.0 111.999 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' A' ' 77' ' ' ASN . 21.1 m-20 -63.99 -114.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 111.689 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.994 HD23 ' CE3' ' A' ' 53' ' ' TRP . 4.5 tp 176.94 174.09 0.42 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.182 -1.574 . . . . 0.0 111.286 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.833 HG23 HG23 ' A' ' 54' ' ' THR . 27.5 m -135.54 133.78 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.6 131.63 2.69 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.302 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.521 ' HH2' ' HB1' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -95.42 161.2 14.18 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.413 ' HG3' ' HG2' ' A' ' 74' ' ' MET . 13.8 mt-30 -79.52 135.27 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.812 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.55 93.38 4.93 Favored Pre-proline 0 C--N 1.298 -1.672 0 O-C-N 122.003 -0.436 . . . . 0.0 110.404 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.527 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 52.1 Cg_endo -92.44 -12.82 1.65 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 123.779 1.41 . . . . 0.0 113.782 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.703 ' O ' HG12 ' A' ' 29' ' ' VAL . 43.0 Cg_endo -68.83 80.51 0.64 Allowed 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 115.931 -2.246 . . . . 0.0 111.738 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 49.49 24.6 5.6 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -53.63 133.32 41.59 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.315 -1.109 . . . . 0.0 110.133 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -94.87 -5.28 45.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.632 -0.668 . . . . 0.0 112.056 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 t 59.68 129.42 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 121.708 0.766 . . . . 0.0 110.813 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.973 HD21 HD21 ' A' ' 144' ' ' LEU . 12.7 tp -95.54 14.92 21.24 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.302 -0.874 . . . . 0.0 111.05 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 63.4 p 44.35 -169.26 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.853 -0.53 . . . . 0.0 112.176 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -112.86 -164.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 O-C-N 123.439 1.231 . . . . 0.0 111.179 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.492 ' C ' HG22 ' A' ' 98' ' ' THR . 43.4 t -110.66 -50.37 2.96 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.446 -0.784 . . . . 0.0 110.083 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.492 HG22 ' C ' ' A' ' 97' ' ' CYS . 9.6 t 38.45 30.46 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.0 p -116.32 -177.73 3.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 109.642 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.27 -18.93 27.28 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.6 t -51.18 138.99 19.32 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.221 -1.164 . . . . 0.0 111.363 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.3 m -109.78 -11.11 14.75 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.436 -0.79 . . . . 0.0 111.403 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 4.0 t70 -61.28 112.77 2.28 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.875 -1.141 . . . . 0.0 109.072 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.839 HD13 HD23 ' A' ' 143' ' ' LEU . 33.9 mt -112.31 170.29 8.27 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.558 0.694 . . . . 0.0 111.427 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.413 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.7 m-85 -148.23 89.45 1.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 154' ' ' PHE . 20.3 tp -59.56 111.46 1.42 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.487 -0.758 . . . . 0.0 109.123 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 113' ' ' VAL . 97.8 t -92.99 97.1 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.551 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.434 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 80.6 p -65.59 152.38 44.25 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.718 ' CB ' HD21 ' A' ' 44' ' ' LEU . 1.6 tpm_? -74.25 -2.0 23.05 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.17 -0.956 . . . . 0.0 111.037 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.441 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -103.62 34.76 2.84 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.027 -1.046 . . . . 0.0 109.252 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.71 75.35 0.3 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.446 -0.783 . . . . 0.0 110.746 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.3 102.96 0.96 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.887 -0.508 . . . . 0.0 110.406 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 107' ' ' VAL . 2.5 t -98.38 139.05 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.604 HD11 HD23 ' A' ' 106' ' ' LEU . 42.7 pt -129.55 131.4 23.56 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.473 ' HB2' HD12 ' A' ' 127' ' ' LEU . 47.0 Cg_endo -67.01 137.19 43.67 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 O-C-N 123.581 1.306 . . . . 0.0 112.436 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 62.1 t -127.14 148.25 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.586 ' HG2' HD11 ' A' ' 127' ' ' LEU . 17.2 mmt180 -113.72 120.91 42.45 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -48.7 128.27 15.05 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.676 -0.64 . . . . 0.0 110.429 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.444 ' HG3' ' HB2' ' A' ' 125' ' ' SER . 8.0 mmm180 -109.02 -29.08 8.74 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.8 -0.562 . . . . 0.0 110.221 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.39 -159.45 22.96 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.36 127.81 33.72 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.701 -0.882 . . . . 0.0 109.373 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.444 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 0.0 OUTLIER 49.94 55.95 8.64 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 121.221 0.534 . . . . 0.0 111.492 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -172.84 149.75 2.0 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.438 -0.789 . . . . 0.0 111.061 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.95 -178.24 17.85 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.4 OUTLIER -136.27 104.7 5.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.729 -178.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.58 HD21 ' C ' ' A' ' 164' ' ' ALA . 3.2 pp -49.37 151.32 1.54 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.817 -0.552 . . . . 0.0 110.319 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.586 HD11 ' HG2' ' A' ' 117' ' ' ARG . 36.8 mt -110.91 54.2 0.68 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.53 106.51 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -55.71 106.76 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 O-C-N 123.396 1.208 . . . . 0.0 110.283 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -109.76 175.61 1.87 Allowed Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.781 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.421 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 51.5 Cg_endo -79.9 124.99 5.8 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 124.139 1.599 . . . . 0.0 109.294 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.818 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.2 p -62.39 -35.41 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.558 -0.714 . . . . 0.0 109.4 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.75 -36.77 17.16 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 122.111 0.958 . . . . 0.0 110.27 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.421 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 21.9 t80 -66.34 -38.73 88.31 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 17.9 mt -64.88 -35.84 82.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.37 119.2 4.86 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.704 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.5 -32.98 6.37 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.6 m -78.72 -4.68 50.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.625 -0.926 . . . . 0.0 111.454 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 2.4 m -50.39 125.28 12.31 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.003 -1.061 . . . . 0.0 111.045 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 113.83 -15.69 21.37 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.543 ' HA2' HD12 ' A' ' 44' ' ' LEU . . . -58.69 135.09 52.21 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.664 ' CD ' HG22 ' A' ' 33' ' ' VAL . 51.6 Cg_endo -79.75 131.18 9.06 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.8 1.421 . . . . 0.0 113.011 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.839 HD23 HD13 ' A' ' 104' ' ' LEU . 5.1 mp -79.11 138.13 37.8 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.973 HD21 HD21 ' A' ' 94' ' ' LEU . 0.9 OUTLIER -129.81 128.06 41.58 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.003 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.523 ' HB2' ' HD3' ' A' ' 146' ' ' PRO . 1.1 p -58.58 -109.25 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.104 0 CA-C-O 117.337 -1.316 . . . . 0.0 110.907 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 145' ' ' CYS . 47.2 Cg_endo -68.99 -84.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 114.35 -3.3 . . . . 0.0 110.307 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.9 m -153.79 99.86 2.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.797 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.1 -61.34 0.65 Allowed Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -58.9 124.41 19.76 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.699 -0.883 . . . . 0.0 111.24 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -78.27 140.88 38.84 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.581 HG11 HD21 ' A' ' 104' ' ' LEU . 2.5 t -108.62 -37.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.522 -0.736 . . . . 0.0 109.54 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.747 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 174.19 -177.91 46.23 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.467 HD11 HD11 ' A' ' 82' ' ' LEU . 3.2 pt -112.76 156.07 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 120.96 -1.318 . . . . 0.0 111.428 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.843 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 9.8 t80 -73.58 84.5 1.56 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.219 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -66.05 -52.25 50.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.584 -0.698 . . . . 0.0 109.901 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -150.13 178.81 8.62 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.843 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -131.01 115.91 17.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.136 -0.978 . . . . 0.0 110.313 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.814 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 4.2 t -63.46 101.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.679 ' SG ' HG21 ' A' ' 132' ' ' VAL . 26.3 p -129.57 139.53 51.46 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.6 OUTLIER -73.83 -173.79 1.63 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 176.143 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.57 84.16 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.333 -0.854 . . . . 0.0 112.801 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.818 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 87.42 -28.27 5.86 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 120.809 -1.182 . . . . 0.0 111.447 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.0 OUTLIER -92.49 133.92 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.86 -1.377 . . . . 0.0 110.022 -179.245 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.58 ' C ' HD21 ' A' ' 126' ' ' LEU . . . -92.8 129.2 38.79 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.221 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.53 ' HA ' HD11 ' A' ' 126' ' ' LEU . 3.2 mtpt -114.09 -21.5 10.5 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.474 -0.766 . . . . 0.0 111.318 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.814 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -151.27 -178.47 6.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.878 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.23 144.29 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 111.59 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -109.98 101.28 10.11 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.661 ' CG ' HD22 ' A' ' 143' ' ' LEU . 0.6 OUTLIER -130.63 148.15 52.39 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.33 -0.948 . . . . 0.0 113.019 -175.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.491 HG11 HD11 ' A' ' 82' ' ' LEU . 3.0 p -103.17 132.98 20.59 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 54.7 Cg_endo -60.38 153.66 58.56 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.796 1.419 . . . . 0.0 111.357 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.747 HG13 ' HA2' ' A' ' 152' ' ' GLY . 35.9 m -80.3 0.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.452 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -89.9 -38.93 13.36 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.311 -0.868 . . . . 0.0 108.776 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 88.3 p -61.12 -36.37 79.54 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.565 ' HG2' HD22 ' A' ' 82' ' ' LEU . 19.7 mtt -48.13 -38.18 17.25 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-O 121.519 0.676 . . . . 0.0 109.649 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -56.11 -38.09 70.29 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -67.5 -39.73 85.18 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.738 0.78 . . . . 0.0 109.031 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.432 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 0.7 OUTLIER -52.31 -41.5 63.01 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.807 -0.558 . . . . 0.0 110.543 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.482 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -49.56 -41.6 42.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.206 -0.934 . . . . 0.0 111.167 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -38.71 72.99 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.133 0.968 . . . . 0.0 109.322 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.518 ' HB1' HD22 ' A' ' 77' ' ' ASN . . . -67.87 -38.37 82.98 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.512 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.8 t -77.69 -8.09 57.43 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.333 -0.854 . . . . 0.0 111.142 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -102.41 99.54 9.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.943 -1.098 . . . . 0.0 110.104 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -100.04 32.54 2.91 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.528 -0.733 . . . . 0.0 110.862 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -91.31 98.39 11.68 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.447 -0.783 . . . . 0.0 109.606 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 18.9 mttp . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.594 -179.673 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.8 m . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.19 0.519 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.53 71.33 0.12 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.27 91.35 3.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.64 -0.918 . . . . 0.0 110.097 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.59 135.82 42.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.672 -0.642 . . . . 0.0 109.826 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.86 85.32 7.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.561 -0.712 . . . . 0.0 109.758 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -81.25 -178.21 6.81 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.621 0.724 . . . . 0.0 109.529 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -149.79 77.79 1.34 Allowed 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -59.93 -157.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.259 0.552 . . . . 0.0 110.727 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 62.37 78.58 0.29 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.063 -1.023 . . . . 0.0 108.859 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.95 -95.81 0.11 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.785 ' HG3' HG23 ' A' ' 33' ' ' VAL . 5.2 pt-20 -173.12 -36.01 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.275 -1.133 . . . . 0.0 111.629 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.785 HG23 ' HG3' ' A' ' 32' ' ' GLU . 97.0 t -113.52 155.34 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.187 -0.946 . . . . 0.0 110.92 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.575 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 18.7 tp60 -141.16 148.78 40.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.592 -0.693 . . . . 0.0 110.231 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' A' ' 109' ' ' ARG . 31.4 m -106.78 -179.3 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.42 -0.8 . . . . 0.0 112.034 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.784 HG21 ' CE2' ' A' ' 43' ' ' PHE . 27.6 m -139.1 -178.33 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.5 p -156.2 136.62 13.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.582 -0.699 . . . . 0.0 110.054 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.638 HG23 ' OG1' ' A' ' 40' ' ' THR . 8.0 t -152.83 -178.7 7.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.672 ' O ' HG23 ' A' ' 40' ' ' THR . . . -68.41 76.85 0.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.349 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER 174.03 -58.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 175.4 -176.41 0.1 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.269 -0.894 . . . . 0.0 109.948 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.8 t -112.49 127.87 56.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 109.358 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.784 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -107.37 -176.26 3.02 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.144 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 45' ' ' ALA . 6.6 tt -103.85 154.47 19.57 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.668 -0.645 . . . . 0.0 109.738 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.801 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -150.77 129.13 12.05 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.261 -0.899 . . . . 0.0 109.689 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.636 HG23 HG23 ' A' ' 48' ' ' VAL . 12.6 t -97.58 124.74 41.95 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.241 -0.912 . . . . 0.0 112.004 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.71 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 41.3 t -75.22 90.71 2.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.65 -0.656 . . . . 0.0 109.793 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.636 HG23 HG23 ' A' ' 46' ' ' THR . 65.1 t -104.14 133.43 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.4 t30 57.34 20.61 6.01 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.471 -0.768 . . . . 0.0 110.032 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.97 25.08 38.85 Favored Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.225 -0.922 . . . . 0.0 110.887 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.674 HG22 ' HG2' ' A' ' 86' ' ' GLN . 94.3 t -139.44 106.69 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.54 -0.977 . . . . 0.0 110.06 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.4 ' O ' ' HA2' ' A' ' 84' ' ' GLY . 5.4 m -62.51 114.67 3.67 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.262 -0.899 . . . . 0.0 108.854 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.911 ' CE3' HD23 ' A' ' 82' ' ' LEU . 98.8 m95 -96.8 146.89 24.49 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.409 -0.807 . . . . 0.0 112.682 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.808 HG21 ' CH2' ' A' ' 85' ' ' TRP . 4.5 t -164.31 141.71 6.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 155' ' ' ARG . 12.8 m -57.71 148.12 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.029 -1.045 . . . . 0.0 109.812 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 47.3 t80 -72.99 -1.07 15.64 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.008 -1.057 . . . . 0.0 111.715 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -49.8 -28.1 5.87 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.209 -0.932 . . . . 0.0 110.397 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.31 -46.83 0.16 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' CE1' ' A' ' 56' ' ' TYR . . . -49.49 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.404 -1.057 . . . . 0.0 110.831 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.66 175.36 22.25 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.2 p -93.57 -7.51 43.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.702 -0.881 . . . . 0.0 110.783 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -59.53 -167.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.152 -0.967 . . . . 0.0 110.856 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.3 m -83.97 101.77 11.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.742 -0.598 . . . . 0.0 109.705 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.711 HD22 HD12 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -57.72 173.51 0.29 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.579 -0.701 . . . . 0.0 110.139 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.94 132.75 53.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.524 -0.735 . . . . 0.0 110.876 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.03 -179.46 37.2 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.15 -18.39 64.76 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.767 1.404 . . . . 0.0 110.797 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -159.86 31.47 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 110.235 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.01 161.43 12.35 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.53 159.37 36.71 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.957 1.504 . . . . 0.0 110.403 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.711 HD12 HD22 ' A' ' 64' ' ' LEU . 96.1 mt -91.54 153.96 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 110.351 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.5 p -89.45 167.29 13.12 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.497 -0.752 . . . . 0.0 110.698 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 53.0 -179.21 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.381 -0.824 . . . . 0.0 110.359 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.6 ttp -176.37 51.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.332 -0.855 . . . . 0.0 109.902 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.482 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.2 m-85 -55.9 131.7 47.77 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.267 -0.896 . . . . 0.0 109.108 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.582 HG23 ' CG1' ' A' ' 83' ' ' VAL . 3.7 m -156.91 118.13 3.72 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.458 -0.897 . . . . 0.0 112.323 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 49.3 m-20 -145.64 76.66 1.48 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.829 0.823 . . . . 0.0 109.076 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.9 p -48.67 152.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.485 0.66 . . . . 0.0 111.372 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 t70 61.61 127.01 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.887 0.851 . . . . 0.0 112.446 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 46.56 24.48 0.32 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 3.2 m-20 -156.2 -126.71 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -0.987 . . . . 0.0 109.777 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.911 HD23 ' CE3' ' A' ' 53' ' ' TRP . 1.7 tp -178.65 174.98 1.13 Allowed 'General case' 0 N--CA 1.511 2.615 0 CA-C-N 121.089 1.768 . . . . 0.0 112.739 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.582 ' CG1' HG23 ' A' ' 76' ' ' THR . 13.6 t -134.03 138.55 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 52' ' ' CYS . . . -158.25 117.57 0.78 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 118.738 -1.696 . . . . 0.0 110.596 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.808 ' CH2' HG21 ' A' ' 54' ' ' THR . 0.1 OUTLIER -95.42 135.81 36.58 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.674 ' HG2' HG22 ' A' ' 51' ' ' VAL . 29.9 mt-30 -57.55 133.89 55.65 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.835 0.826 . . . . 0.0 111.482 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -112.85 98.29 44.56 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.135 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.58 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 46.6 Cg_endo -113.95 8.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.781 1.411 . . . . 0.0 113.264 178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 55.2 Cg_endo -68.46 -106.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 115.832 -2.312 . . . . 0.0 108.083 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.91 39.46 2.85 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 105.535 -3.026 . . . . 0.0 105.535 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.71 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -81.85 140.4 34.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.582 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -92.6 100.42 12.95 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.8 t -55.41 104.04 0.11 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.366 -0.834 . . . . 0.0 110.832 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.66 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -78.77 -156.03 0.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.687 -0.633 . . . . 0.0 109.603 179.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -159.96 -171.03 0.26 Allowed Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.489 -0.757 . . . . 0.0 110.612 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 95' ' ' THR . 44.9 Cg_endo -92.97 170.72 2.25 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 O-C-N 123.567 1.299 . . . . 0.0 111.137 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.494 ' HB2' HG23 ' A' ' 151' ' ' VAL . 18.2 t -90.4 148.76 22.6 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.526 -0.734 . . . . 0.0 109.742 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 t -146.33 43.64 1.21 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -125.74 174.1 8.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.677 -0.64 . . . . 0.0 110.618 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -113.57 33.95 5.26 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 p -108.2 -179.35 3.86 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.534 -0.98 . . . . 0.0 110.403 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.5 p -136.26 19.71 3.18 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.585 -0.697 . . . . 0.0 110.809 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 73.8 m-20 -81.65 90.52 6.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.369 -0.832 . . . . 0.0 109.564 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.768 HD13 HD23 ' A' ' 143' ' ' LEU . 88.5 mt -97.09 156.63 16.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -0.825 . . . . 0.0 111.402 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.56 ' O ' HG23 ' A' ' 107' ' ' VAL . 84.4 m-85 -132.12 84.49 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.959 -0.463 . . . . 0.0 109.797 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 106' ' ' LEU . 14.4 tp -55.36 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.328 -0.857 . . . . 0.0 109.539 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 113' ' ' VAL . 58.4 t -80.29 119.57 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.008 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.466 ' C ' HD12 ' A' ' 44' ' ' LEU . 37.9 p -82.15 -179.88 7.56 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.763 ' N ' HD12 ' A' ' 44' ' ' LEU . 51.9 ptt85 -99.96 51.41 0.91 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.026 -1.046 . . . . 0.0 110.447 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.449 ' NE2' ' HB ' ' A' ' 108' ' ' THR . 3.9 p80 -175.17 44.06 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.532 0.682 . . . . 0.0 110.024 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.62 67.2 1.04 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.524 -0.735 . . . . 0.0 111.005 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.99 83.65 0.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.619 -0.676 . . . . 0.0 110.08 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 107' ' ' VAL . 53.9 t -77.91 154.44 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.573 -0.705 . . . . 0.0 109.534 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.8 mt -136.79 107.88 9.08 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -53.4 141.51 61.07 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 O-C-N 123.63 1.332 . . . . 0.0 112.695 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.533 ' CG1' HG21 ' A' ' 167' ' ' VAL . 21.7 t -133.97 150.23 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -111.81 118.56 35.9 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -47.88 127.85 12.55 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.374 -0.829 . . . . 0.0 110.207 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 125' ' ' SER . 1.3 mmp_? -107.79 -36.85 6.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.598 -0.689 . . . . 0.0 111.603 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.95 64.03 0.06 OUTLIER Glycine 0 N--CA 1.497 2.738 0 C-N-CA 118.892 -1.623 . . . . 0.0 110.604 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.81 140.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.89 0.852 . . . . 0.0 110.242 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.404 ' CA ' ' O ' ' A' ' 169' ' ' PHE . 69.1 p 44.12 28.56 0.28 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.792 -0.567 . . . . 0.0 112.278 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.502 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 8.4 ttm180 -165.36 151.5 9.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.274 -0.891 . . . . 0.0 110.457 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.16 -177.99 22.12 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 119' ' ' ARG . 0.5 OUTLIER -121.43 127.63 51.33 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.696 -178.451 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.56 132.14 43.4 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.3 mt -103.09 53.55 0.77 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.2 t 175.47 133.5 0.16 Allowed Pre-proline 0 N--CA 1.5 2.044 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.829 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -62.64 104.94 0.39 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 O-C-N 123.721 1.38 . . . . 0.0 108.813 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.61 128.24 25.49 Favored Pre-proline 0 N--CA 1.488 1.458 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.632 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 43.6 Cg_endo -60.76 131.18 36.29 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.982 1.517 . . . . 0.0 110.129 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.599 HG21 ' SG ' ' A' ' 159' ' ' CYS . 11.7 p -57.63 -36.84 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.728 -0.608 . . . . 0.0 110.266 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.8 t -49.09 -36.59 19.04 Favored 'General case' 0 N--CA 1.507 2.393 0 CA-C-O 122.064 0.935 . . . . 0.0 110.728 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 34.7 t80 -69.09 -38.21 78.84 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.56 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.7 mt -65.5 -35.37 80.68 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.153 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -57.14 -21.03 29.57 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.001 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -97.87 30.2 9.79 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 99.0 p -150.89 23.39 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.516 -0.99 . . . . 0.0 110.734 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -59.36 126.94 29.69 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.256 -0.902 . . . . 0.0 108.691 179.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.659 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 108.43 -13.38 36.26 Favored Glycine 0 CA--C 1.541 1.663 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -176.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.654 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -46.34 109.06 0.31 Allowed Glycine 0 N--CA 1.503 3.166 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.81 125.67 12.39 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.997 1.525 . . . . 0.0 111.753 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.768 HD23 HD13 ' A' ' 104' ' ' LEU . 6.3 mp -82.52 116.28 21.88 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.519 HD22 ' O ' ' A' ' 147' ' ' SER . 1.1 mt -114.36 119.01 35.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.108 -0.995 . . . . 0.0 111.194 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -60.4 -20.68 0.65 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.839 -0.538 . . . . 0.0 110.507 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 145' ' ' CYS . 40.7 Cg_endo -137.44 -77.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.322 -0.833 0 O-C-N 123.535 1.282 . . . . 0.0 110.326 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.519 ' O ' HD22 ' A' ' 144' ' ' LEU . 9.1 p -164.18 -54.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.406 -0.809 . . . . 0.0 110.0 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.68 -51.39 3.45 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -66.98 117.37 8.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.599 -0.942 . . . . 0.0 110.297 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.602 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -88.99 150.58 22.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 110.075 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 97' ' ' CYS . 0.9 OUTLIER -107.3 -31.77 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.603 -0.685 . . . . 0.0 109.913 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.831 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 177.28 -179.67 47.97 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.822 HD11 HD11 ' A' ' 82' ' ' LEU . 1.1 pt -117.2 162.71 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.317 -1.107 . . . . 0.0 110.858 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.786 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 6.5 t80 -79.91 98.58 7.19 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.585 0.707 . . . . 0.0 110.9 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.582 ' HA ' HG11 ' A' ' 55' ' ' VAL . 2.6 ttt-85 -82.69 -42.91 17.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -160.69 -179.68 7.82 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.786 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -134.42 120.96 20.46 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.569 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.781 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.3 t -65.82 102.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.599 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.2 p -129.18 142.88 50.74 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -175.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 161' ' ' ARG . 1.9 m -75.74 -174.25 2.5 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.513 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -47.85 86.07 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.734 0.778 . . . . 0.0 112.884 -178.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 160' ' ' THR . . . 82.53 -25.25 4.54 Favored Glycine 0 N--CA 1.499 2.896 0 O-C-N 120.879 -1.138 . . . . 0.0 112.186 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -95.48 133.54 36.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 119.217 1.508 . . . . 0.0 109.345 -179.48 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.56 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -100.35 132.82 45.51 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.1 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -117.71 -37.27 3.48 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.571 -0.706 . . . . 0.0 110.775 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.781 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -122.27 -179.36 4.15 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.202 -0.936 . . . . 0.0 109.994 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.533 HG21 ' CG1' ' A' ' 116' ' ' VAL . 1.3 t -125.6 145.85 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.46 -0.775 . . . . 0.0 111.878 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -109.3 101.46 10.46 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 177.052 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.541 ' CD2' HD22 ' A' ' 143' ' ' LEU . 0.2 OUTLIER -132.56 154.42 50.02 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.891 -175.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.608 HG21 HD13 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -108.12 144.46 29.46 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.4 Cg_endo -64.39 148.59 90.84 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.916 1.482 . . . . 0.0 110.675 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.831 HG13 ' HA2' ' A' ' 152' ' ' GLY . 18.1 m -82.21 2.95 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.068 -1.02 . . . . 0.0 110.618 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -83.55 -38.15 22.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.0 t -74.02 -40.18 63.08 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.69 -0.631 . . . . 0.0 110.872 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.854 ' O ' HG22 ' A' ' 178' ' ' THR . 12.4 ptp -51.07 -36.18 38.66 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.307 -0.871 . . . . 0.0 110.012 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.422 ' N ' ' HG3' ' A' ' 175' ' ' MET . 19.0 tt0 -58.1 -36.33 72.72 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.194 -0.941 . . . . 0.0 108.847 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.7 m -70.6 -36.07 73.32 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.418 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.854 HG22 ' O ' ' A' ' 175' ' ' MET . 2.8 t -48.44 -37.52 17.42 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.095 -1.003 . . . . 0.0 112.699 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.452 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 2.3 ptp -63.22 -39.65 95.22 Favored 'General case' 0 N--CA 1.513 2.678 0 O-C-N 120.418 -1.426 . . . . 0.0 110.253 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -38.25 41.0 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.769 0.795 . . . . 0.0 110.512 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -79.81 -44.65 20.19 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.47 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.2 p 46.16 29.21 0.77 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.6 -0.688 . . . . 0.0 111.678 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -80.57 130.79 35.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.528 -0.733 . . . . 0.0 110.548 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -133.76 -39.0 0.89 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.615 -0.678 . . . . 0.0 110.534 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.31 113.45 19.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.286 -0.883 . . . . 0.0 110.13 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 69.5 tttt . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.297 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.144 0.497 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.89 99.13 1.98 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -82.05 97.57 8.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.965 . . . . 0.0 109.949 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.41 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . 3.9 t0 -95.23 -17.07 22.02 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.643 -0.66 . . . . 0.0 110.761 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.422 ' CB ' ' HA ' ' A' ' 67' ' ' PRO . 4.3 mttt -98.44 28.32 4.22 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.264 -0.898 . . . . 0.0 110.045 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -93.17 89.92 6.64 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.726 -0.609 . . . . 0.0 109.935 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -161.91 78.09 0.52 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.296 -0.877 . . . . 0.0 110.215 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -98.0 166.59 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -171.95 80.72 0.06 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.395 -0.815 . . . . 0.0 110.417 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.11 -68.15 0.1 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -172.63 -46.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.947 . . . . 0.0 110.091 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.84 HG11 ' C ' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -158.78 -163.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 122.318 1.056 . . . . 0.0 112.337 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.442 ' H ' HG12 ' A' ' 33' ' ' VAL . 1.7 tt0 -148.99 171.89 15.62 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.89 HG12 HD22 ' A' ' 44' ' ' LEU . 34.0 m -108.96 169.56 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.722 -0.611 . . . . 0.0 109.969 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.93 -179.16 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.41 ' C ' HG23 ' A' ' 38' ' ' THR . 1.3 m -149.79 138.92 21.21 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.655 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 37' ' ' SER . 70.0 p -146.72 -179.76 7.01 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.81 75.45 0.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.651 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m 175.84 -61.22 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.74 -171.04 0.29 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.468 -0.77 . . . . 0.0 109.655 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.7 p -110.74 142.25 42.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.34 -0.85 . . . . 0.0 110.146 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.447 ' CE2' ' HA3' ' A' ' 58' ' ' GLY . 80.2 m-85 -105.53 -178.39 3.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.473 -0.767 . . . . 0.0 111.201 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.89 HD22 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -118.49 141.27 48.73 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.547 -0.721 . . . . 0.0 111.173 -178.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.84 ' C ' HG11 ' A' ' 33' ' ' VAL . . . -121.93 -177.71 3.65 Favored 'General case' 0 N--CA 1.507 2.417 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.525 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 1.05 HG21 HG21 ' A' ' 153' ' ' ILE . 4.6 t -154.94 109.19 2.94 Favored 'General case' 0 N--CA 1.51 2.537 0 O-C-N 121.102 -0.999 . . . . 0.0 112.449 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.464 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 42.9 t -69.49 85.89 0.44 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.319 -0.863 . . . . 0.0 110.18 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.4 t -108.57 128.17 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.6 t30 64.4 12.74 7.55 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.396 -0.815 . . . . 0.0 110.558 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.07 14.55 48.39 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.161 -0.962 . . . . 0.0 111.88 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 85' ' ' TRP . 63.3 t -137.46 109.54 6.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.212 -1.169 . . . . 0.0 109.428 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 12.8 m -58.6 99.71 0.05 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.806 -0.559 . . . . 0.0 110.148 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.648 ' HZ3' HG21 ' A' ' 178' ' ' THR . 97.7 m95 -80.47 144.87 32.22 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.197 -0.939 . . . . 0.0 110.588 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.847 HG21 ' CH2' ' A' ' 85' ' ' TRP . 7.2 t -162.64 131.89 4.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.795 -0.565 . . . . 0.0 110.204 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.451 HG21 ' CE1' ' A' ' 57' ' ' HIS . 9.8 m -48.69 154.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.646 0 O-C-N 121.349 -0.844 . . . . 0.0 111.384 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.464 ' CD1' ' CG2' ' A' ' 76' ' ' THR . 2.6 t80 -99.97 -12.61 19.62 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.096 -1.003 . . . . 0.0 111.933 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.451 ' CE1' HG21 ' A' ' 55' ' ' VAL . 2.4 p-80 -57.82 -20.37 35.46 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.936 -1.103 . . . . 0.0 110.05 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.447 ' HA3' ' CE2' ' A' ' 43' ' ' PHE . . . -128.46 -137.2 4.33 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 52.26 -172.18 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.243 -1.151 . . . . 0.0 110.811 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.89 122.32 5.98 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 89.8 p -79.9 -13.26 59.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.639 -0.919 . . . . 0.0 111.022 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -148.09 -58.96 0.25 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.234 -0.916 . . . . 0.0 110.439 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -96.61 95.29 7.86 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.113 0.482 . . . . 0.0 111.192 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.892 HD22 HD12 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -101.45 172.99 6.64 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.499 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.465 ' H ' HD23 ' A' ' 64' ' ' LEU . . . -116.79 129.67 56.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.287 -0.883 . . . . 0.0 110.85 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.72 -178.24 15.52 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 26' ' ' LYS . 46.7 Cg_endo -53.39 93.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 O-C-N 123.776 1.409 . . . . 0.0 111.128 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.41 ' HD3' ' HB2' ' A' ' 25' ' ' ASP . 9.6 tttp 52.65 42.36 31.56 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.475 -0.766 . . . . 0.0 110.947 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.98 131.93 1.5 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -60.65 156.44 42.5 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 O-C-N 123.779 1.41 . . . . 0.0 110.931 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.892 HD12 HD22 ' A' ' 64' ' ' LEU . 64.7 mt -102.12 127.06 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.565 -0.71 . . . . 0.0 110.106 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 m -119.49 -61.37 1.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.429 -0.794 . . . . 0.0 109.721 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 54.43 -159.02 0.18 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.348 -0.845 . . . . 0.0 111.015 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.8 ttm -149.49 22.97 0.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.147 -0.971 . . . . 0.0 111.139 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.499 ' O ' HG13 ' A' ' 83' ' ' VAL . 16.7 m-30 -115.25 103.67 11.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.461 -0.774 . . . . 0.0 109.216 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.599 HG23 ' CG2' ' A' ' 83' ' ' VAL . 2.3 m -152.7 133.89 14.25 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.735 -0.603 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.63 78.01 1.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.639 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 p -48.46 -28.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.49 -0.756 . . . . 0.0 110.387 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -51.2 60.26 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -83.93 2.52 38.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.998 -0.439 . . . . 0.0 109.969 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.554 ' O ' HD12 ' A' ' 82' ' ' LEU . 68.4 m-20 57.09 52.15 9.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.879 . . . . 0.0 111.228 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.576 HD13 HG11 ' A' ' 170' ' ' VAL . 1.4 tp -158.0 143.75 17.1 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.424 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.599 ' CG2' HG23 ' A' ' 76' ' ' THR . 22.0 t -145.4 119.38 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.42 ' CA ' HG12 ' A' ' 51' ' ' VAL . . . -99.79 97.1 1.73 Allowed Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.514 -1.327 . . . . 0.0 112.213 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.847 ' CH2' HG21 ' A' ' 54' ' ' THR . 24.1 m0 -76.8 172.92 12.33 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.52 134.46 38.34 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.907 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.55 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -109.79 87.67 5.83 Favored Pre-proline 0 C--N 1.295 -1.771 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.803 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.558 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -100.24 -8.59 0.36 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.844 1.444 . . . . 0.0 113.401 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 46.5 Cg_endo -73.16 65.11 4.3 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 115.982 -2.212 . . . . 0.0 110.689 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.46 24.94 18.88 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.55 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -66.13 136.18 55.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.692 -0.887 . . . . 0.0 110.962 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -75.85 129.25 36.7 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 p -98.65 103.94 15.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.544 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.479 ' O ' HG23 ' A' ' 95' ' ' THR . 19.9 mt -65.33 -156.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.635 -0.666 . . . . 0.0 109.562 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -154.3 175.41 3.08 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.575 -0.703 . . . . 0.0 110.538 -179.181 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.421 ' HA ' HG23 ' A' ' 172' ' ' VAL . 44.6 Cg_endo -74.98 151.53 39.74 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 O-C-N 123.815 1.429 . . . . 0.0 110.604 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.466 ' CB ' HG23 ' A' ' 151' ' ' VAL . 1.6 t -106.3 85.99 2.28 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.424 -0.798 . . . . 0.0 110.211 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -66.62 -32.46 73.81 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.044 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 11.9 p -60.53 111.88 1.76 Allowed 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.268 0.556 . . . . 0.0 110.459 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.99 80.03 1.4 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.7 m -122.76 139.92 53.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.587 -0.949 . . . . 0.0 109.955 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -76.2 -165.86 0.54 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.545 -0.722 . . . . 0.0 110.437 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 t70 57.93 102.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.501 -0.75 . . . . 0.0 110.008 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.798 HD13 HD23 ' A' ' 143' ' ' LEU . 3.7 mt -116.01 -167.53 1.28 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.565 -0.709 . . . . 0.0 110.004 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -140.26 92.21 2.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.814 -0.554 . . . . 0.0 109.576 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 154' ' ' PHE . 58.0 tp -77.53 95.17 4.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.1 t -89.93 111.6 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.377 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.443 ' HB ' ' CE1' ' A' ' 110' ' ' HIS . 20.7 p -69.42 178.83 2.26 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.798 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.72 29.51 5.29 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.766 -1.209 . . . . 0.0 110.348 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -133.4 34.46 3.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.451 -0.78 . . . . 0.0 109.214 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.48 68.35 0.84 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.838 -0.539 . . . . 0.0 111.257 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -167.57 90.8 0.34 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.781 -0.575 . . . . 0.0 109.678 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 113' ' ' VAL . 10.5 p -77.52 152.62 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.491 -0.756 . . . . 0.0 110.686 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.468 HD11 ' CE2' ' A' ' 134' ' ' TYR . 22.5 mt -131.58 111.5 15.01 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -62.35 133.4 43.06 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 O-C-N 123.604 1.318 . . . . 0.0 111.239 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 20.0 t -124.05 151.1 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.624 -0.672 . . . . 0.0 109.362 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.464 ' HB2' HD11 ' A' ' 127' ' ' LEU . 11.5 tpt180 -111.85 114.81 27.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -48.67 124.54 8.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.575 -0.703 . . . . 0.0 111.022 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -109.53 -48.9 3.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.791 -0.568 . . . . 0.0 110.096 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.23 -169.71 16.06 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.5 135.45 54.23 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 169' ' ' PHE . 10.4 p 53.52 43.31 31.42 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.439 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.497 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 2.2 ttp180 -167.43 151.15 6.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.417 -0.802 . . . . 0.0 110.889 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.9 -178.83 19.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -122.23 120.41 34.06 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 122.019 -0.695 . . . . 0.0 111.688 -178.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.419 HD21 HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -63.72 132.93 52.54 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 117' ' ' ARG . 12.4 mt -106.13 54.37 0.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.074 0.94 . . . . 0.0 108.502 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.9 t 176.1 116.46 0.13 Allowed Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -57.72 100.24 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.502 1.264 . . . . 0.0 109.467 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 -118.32 147.07 40.93 Favored Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.29 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.414 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 46.3 Cg_endo -65.9 127.42 17.74 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 124.018 1.536 . . . . 0.0 109.838 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.859 HG12 ' O ' ' A' ' 162' ' ' GLY . 6.7 p -55.29 -36.14 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.78 -0.575 . . . . 0.0 110.4 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -48.35 -36.37 14.33 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.28 -0.888 . . . . 0.0 110.789 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.468 ' CE2' HD11 ' A' ' 114' ' ' ILE . 9.1 t80 -65.39 -38.5 90.19 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.474 HD11 ' CB ' ' A' ' 164' ' ' ALA . 11.8 mt -66.62 -35.93 81.37 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.87 120.59 9.31 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.56 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.11 -33.39 6.17 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.9 m -82.06 3.1 28.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.642 -0.917 . . . . 0.0 111.208 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 28.4 p -57.67 127.47 32.2 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.136 -0.978 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.12 -8.83 29.16 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.491 ' O ' HG22 ' A' ' 153' ' ' ILE . . . -56.71 -177.28 0.36 Allowed Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -112.99 121.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.103 0 O-C-N 123.494 1.26 . . . . 0.0 113.276 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.798 HD23 HD13 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -86.53 110.39 19.75 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 175.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 150' ' ' ALA . 1.2 mt -113.26 123.94 51.34 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.117 -0.989 . . . . 0.0 111.651 -177.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.599 ' HB3' HG21 ' A' ' 151' ' ' VAL . 16.4 p -78.13 177.97 2.46 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.2 Cg_endo -62.0 173.98 2.76 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 O-C-N 123.516 1.272 . . . . 0.0 110.326 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 59.23 24.77 13.25 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.396 -0.815 . . . . 0.0 110.5 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 68.1 -144.38 42.92 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.6 m170 58.03 111.15 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.85 -0.794 . . . . 0.0 111.333 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.517 ' HA ' HD23 ' A' ' 144' ' ' LEU . . . -61.92 142.24 57.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.545 -0.722 . . . . 0.0 109.305 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.599 HG21 ' HB3' ' A' ' 145' ' ' CYS . 1.0 OUTLIER -100.58 -41.07 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.665 -0.647 . . . . 0.0 109.723 -179.385 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.751 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . -179.62 -177.58 47.93 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 1.05 HG21 HG21 ' A' ' 46' ' ' THR . 1.2 pt -117.23 157.12 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.14 -1.212 . . . . 0.0 111.329 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.731 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 7.7 t80 -69.26 109.4 4.09 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.314 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -44.73 6.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.383 -0.823 . . . . 0.0 109.717 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -149.42 170.59 18.21 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.731 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -128.23 117.15 21.0 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.887 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.831 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 4.1 t -67.73 99.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.482 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.5 p -127.21 143.65 51.21 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 162' ' ' GLY . 2.2 p -77.37 -173.51 2.91 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -48.21 85.21 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 121.667 0.746 . . . . 0.0 112.912 -178.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.859 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 84.01 -28.48 4.1 Favored Glycine 0 N--CA 1.5 2.94 0 O-C-N 120.803 -1.186 . . . . 0.0 112.038 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 160' ' ' THR . 1.5 t -94.62 137.93 21.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 119.264 1.532 . . . . 0.0 109.086 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.474 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -101.26 127.36 47.89 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.016 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -109.72 -42.27 4.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.706 -0.621 . . . . 0.0 110.688 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.831 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -121.2 176.54 5.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.16 -0.962 . . . . 0.0 110.221 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.76 154.26 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-O 121.786 0.803 . . . . 0.0 111.095 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.713 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -118.76 102.16 8.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 177.137 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.524 ' HB2' HD13 ' A' ' 143' ' ' LEU . 1.1 p90 -132.87 150.4 52.16 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.823 -1.151 . . . . 0.0 112.435 -175.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.576 HG11 HD13 ' A' ' 82' ' ' LEU . 3.2 p -101.25 133.56 20.86 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 47.2 Cg_endo -60.88 158.42 33.63 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.91 1.479 . . . . 0.0 111.469 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.751 HG13 ' HA2' ' A' ' 152' ' ' GLY . 31.3 m -82.55 3.43 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.381 -0.824 . . . . 0.0 110.688 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.41 ' HG2' ' HB3' ' A' ' 96' ' ' PRO . 24.6 mt-10 -90.54 -37.78 13.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 108.731 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.9 t -63.85 -36.45 83.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.935 -0.478 . . . . 0.0 110.05 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.943 ' O ' HG22 ' A' ' 178' ' ' THR . 0.5 OUTLIER -48.75 -39.55 25.38 Favored 'General case' 0 N--CA 1.518 2.954 0 CA-C-O 121.643 0.735 . . . . 0.0 109.375 -179.428 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -53.14 -38.06 62.37 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.882 0.848 . . . . 0.0 109.711 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 m -54.22 -39.0 66.31 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.606 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.943 HG22 ' O ' ' A' ' 175' ' ' MET . 9.6 t -59.0 -35.94 74.09 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.093 -1.004 . . . . 0.0 111.644 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.44 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -53.14 -39.63 63.66 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.707 -1.246 . . . . 0.0 110.716 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -38.46 83.43 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.076 0.941 . . . . 0.0 109.179 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -71.47 -39.14 71.11 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.737 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 94.4 p -69.22 82.3 0.35 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.525 -0.734 . . . . 0.0 110.357 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.95 128.5 35.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.442 -0.787 . . . . 0.0 110.26 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.14 155.95 36.46 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.371 -0.83 . . . . 0.0 109.954 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -105.85 -48.78 3.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.453 -0.779 . . . . 0.0 110.42 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.119 -179.772 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.958 0.409 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.68 -148.62 7.56 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -142.94 70.1 1.32 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.59 -0.947 . . . . 0.0 110.123 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -77.78 175.55 9.86 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.312 -0.867 . . . . 0.0 110.64 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt 52.35 72.37 0.41 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.465 -0.772 . . . . 0.0 111.305 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -101.02 93.3 5.42 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.392 -0.817 . . . . 0.0 110.246 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -159.8 77.38 0.67 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.984 0.897 . . . . 0.0 110.496 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.565 HG21 ' HG3' ' A' ' 89' ' ' PRO . 27.0 m -106.22 -164.69 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.57 -0.706 . . . . 0.0 109.677 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 57.05 78.82 0.21 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.31 -0.869 . . . . 0.0 109.652 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -161.27 -121.46 0.58 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.558 ' OE1' HD11 ' A' ' 94' ' ' LEU . 24.7 mt-10 -150.98 -39.74 0.12 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.668 -0.901 . . . . 0.0 110.681 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 44' ' ' LEU . 97.7 t -111.58 156.28 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.45 -0.781 . . . . 0.0 110.49 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.67 174.0 10.98 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 43' ' ' PHE . 5.2 p -161.93 150.48 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.353 -0.842 . . . . 0.0 110.487 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.666 HG13 ' CZ ' ' A' ' 43' ' ' PHE . 0.9 OUTLIER -131.6 175.08 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.426 ' N ' HG23 ' A' ' 36' ' ' VAL . 5.2 p -127.61 143.55 51.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.613 -0.679 . . . . 0.0 110.337 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 40' ' ' THR . 7.6 t -142.58 -179.7 6.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.634 -0.666 . . . . 0.0 109.349 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.65 76.8 0.29 Allowed 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.106 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.1 m 174.72 -61.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 174.71 -165.44 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.0 p -108.58 143.49 37.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.409 -0.807 . . . . 0.0 109.369 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.806 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.9 p90 -115.01 -177.42 3.12 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.379 -0.826 . . . . 0.0 111.637 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.687 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -101.69 147.11 26.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.0 110.919 -178.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.451 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -149.24 152.97 36.87 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.791 -0.568 . . . . 0.0 109.996 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.615 HG23 HG23 ' A' ' 48' ' ' VAL . 14.2 t -134.47 117.47 16.29 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.273 1.035 . . . . 0.0 111.966 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.475 ' CB ' ' HB3' ' A' ' 91' ' ' ALA . 21.4 p -66.83 81.71 0.11 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.719 -0.613 . . . . 0.0 110.785 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.615 HG23 HG23 ' A' ' 46' ' ' THR . 59.4 t -97.11 133.45 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.835 -1.166 . . . . 0.0 109.096 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.63 23.55 6.23 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.49 -0.756 . . . . 0.0 110.151 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.0 23.28 49.86 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.42 HG12 ' CA ' ' A' ' 84' ' ' GLY . 39.1 t -139.41 114.84 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.374 -1.074 . . . . 0.0 109.69 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 57.0 m -69.79 105.46 2.77 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.612 -0.68 . . . . 0.0 109.876 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.675 ' CZ3' HD23 ' A' ' 82' ' ' LEU . 97.0 m95 -88.21 137.1 32.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.267 -0.896 . . . . 0.0 112.152 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.638 HG21 ' CZ3' ' A' ' 85' ' ' TRP . 2.0 t -162.82 130.33 3.69 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.208 0.527 . . . . 0.0 109.76 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 8.4 m -48.54 145.66 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 O-C-N 121.417 -0.802 . . . . 0.0 111.547 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.408 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 61.9 t80 -78.54 -15.9 58.06 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.338 -0.851 . . . . 0.0 111.118 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.415 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 6.1 p-80 -77.33 -23.0 50.99 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.219 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.6 -23.18 7.32 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.534 ' HA ' ' CE1' ' A' ' 43' ' ' PHE . . . -69.34 -81.0 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.309 -1.112 . . . . 0.0 109.957 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.0 -144.22 15.93 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.8 -148.69 0.26 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.425 -1.044 . . . . 0.0 110.358 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.77 -178.99 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.287 -0.883 . . . . 0.0 110.842 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.86 97.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.734 -0.604 . . . . 0.0 109.94 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.914 ' CD2' HD12 ' A' ' 71' ' ' ILE . 3.4 tt -53.84 153.71 4.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.726 -0.609 . . . . 0.0 110.839 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.76 145.95 39.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.766 -0.584 . . . . 0.0 109.752 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.436 ' HA3' HD11 ' A' ' 71' ' ' ILE . . . -134.87 -179.07 16.14 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.65 -16.89 57.61 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.938 1.494 . . . . 0.0 110.73 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -120.4 23.22 10.98 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.117 -0.989 . . . . 0.0 111.439 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.71 -166.31 12.25 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 45.9 Cg_endo -65.6 135.5 42.33 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.96 1.505 . . . . 0.0 110.786 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.914 HD12 ' CD2' ' A' ' 64' ' ' LEU . 71.6 mt -95.72 157.81 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.62 -0.675 . . . . 0.0 109.945 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 p -105.11 104.98 14.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.401 -0.812 . . . . 0.0 109.998 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -56.33 151.64 12.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.732 -0.605 . . . . 0.0 111.166 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 tpt -138.11 -38.88 0.55 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.66 -0.65 . . . . 0.0 110.329 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 20.7 m-85 -126.22 122.86 36.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.287 -0.883 . . . . 0.0 110.032 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.733 HG23 ' CG1' ' A' ' 83' ' ' VAL . 2.5 m -146.88 121.81 10.01 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.456 -0.777 . . . . 0.0 109.589 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -146.31 77.79 1.49 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.259 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' A' ' 56' ' ' TYR . 7.5 p -49.97 -28.95 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.628 -0.67 . . . . 0.0 110.433 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.33 -45.19 92.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.43 -0.794 . . . . 0.0 109.485 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.83 14.17 26.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.599 -0.688 . . . . 0.0 109.694 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.635 ' O ' HD12 ' A' ' 82' ' ' LEU . 24.9 m-20 52.22 56.28 7.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.283 -0.885 . . . . 0.0 111.951 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.675 HD23 ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -159.29 137.54 10.52 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.215 -0.928 . . . . 0.0 111.651 178.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.733 ' CG1' HG23 ' A' ' 76' ' ' THR . 39.6 t -144.14 103.0 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 52' ' ' CYS . . . -102.83 94.29 1.13 Allowed Glycine 0 N--CA 1.483 1.797 0 C-N-CA 119.928 -1.13 . . . . 0.0 111.216 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.638 ' CZ3' HG21 ' A' ' 54' ' ' THR . 4.8 p90 -81.43 178.57 8.29 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -92.26 125.08 36.78 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.042 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' A' ' 91' ' ' ALA . . . -58.06 156.15 21.46 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.424 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.515 ' HG2' ' HD3' ' A' ' 89' ' ' PRO . 30.2 Cg_endo -62.28 -77.43 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.353 0 O-C-N 123.991 1.522 . . . . 0.0 111.822 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.565 ' HG3' HG21 ' A' ' 29' ' ' VAL . 59.3 Cg_endo -94.16 28.54 0.28 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 115.874 -2.284 . . . . 0.0 109.287 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.52 -16.91 59.61 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.475 ' HB3' ' CB ' ' A' ' 47' ' ' CYS . . . 50.49 22.04 0.97 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.039 -1.271 . . . . 0.0 111.31 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 64.7 69.56 0.5 Allowed 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -177.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 m -43.27 128.68 4.78 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.582 HD23 ' HB2' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -85.04 -157.9 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.685 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 1.3 p -144.08 -179.25 0.91 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.554 -0.716 . . . . 0.0 110.263 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -86.51 170.18 7.93 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 O-C-N 123.841 1.443 . . . . 0.0 110.318 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' A' ' 151' ' ' VAL . 9.4 t -82.81 -91.35 0.07 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.611 -0.681 . . . . 0.0 109.694 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 98' ' ' THR . 26.2 m 51.83 21.42 1.42 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.909 -1.12 . . . . 0.0 111.348 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 13.3 p -141.42 -25.5 0.71 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.284 -0.885 . . . . 0.0 112.482 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.406 ' HA3' ' HD2' ' A' ' 146' ' ' PRO . . . -102.06 128.71 9.64 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.0 p -66.63 -46.88 74.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.753 -0.851 . . . . 0.0 110.058 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 t -162.57 -156.45 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.576 -0.702 . . . . 0.0 110.504 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 55.41 100.69 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.549 -0.719 . . . . 0.0 110.493 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.829 HD13 HD23 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -121.22 -170.18 1.98 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.36 -0.837 . . . . 0.0 110.124 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.753 ' HB2' HG13 ' A' ' 113' ' ' VAL . 11.7 p90 -160.88 98.02 1.18 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.893 HD11 HD12 ' A' ' 114' ' ' ILE . 3.3 pp -67.29 123.3 19.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.843 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.23 99.63 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.452 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.9 p -61.92 155.38 23.68 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.687 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -78.95 0.56 26.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.301 -0.875 . . . . 0.0 110.764 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.1 OUTLIER -114.87 35.76 4.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.096 -1.003 . . . . 0.0 109.678 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.35 76.74 0.32 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.52 -0.738 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -167.46 97.25 0.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.534 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.753 HG13 ' HB2' ' A' ' 105' ' ' TYR . 2.1 t -82.72 145.05 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.893 HD12 HD11 ' A' ' 106' ' ' LEU . 39.7 mt -133.21 111.39 12.96 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 46.7 Cg_endo -58.47 145.27 95.1 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.655 1.345 . . . . 0.0 111.396 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 114' ' ' ILE . 33.1 t -140.46 150.8 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.609 -0.682 . . . . 0.0 109.886 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -109.34 116.14 31.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -48.68 125.35 9.88 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.363 -0.836 . . . . 0.0 111.015 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -108.32 -44.22 4.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.95 -0.469 . . . . 0.0 110.479 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -159.2 63.93 0.3 Allowed Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.947 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.457 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER 60.9 -75.56 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.625 -0.927 . . . . 0.0 111.109 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 120' ' ' GLY . 41.2 p -89.69 38.24 0.91 Allowed 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.85 -0.531 . . . . 0.0 110.3 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.466 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 18.6 ttm180 -168.43 149.12 4.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.371 -0.83 . . . . 0.0 110.312 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.17 -179.26 19.7 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -124.16 117.21 24.12 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 122.097 -0.649 . . . . 0.0 111.415 -178.535 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.448 HD22 ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -55.29 142.22 32.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.637 -0.664 . . . . 0.0 110.158 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.5 mt -112.42 55.21 0.69 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.448 ' O ' HD22 ' A' ' 126' ' ' LEU . 0.5 OUTLIER 172.57 118.8 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.027 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.254 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -59.79 101.01 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 O-C-N 123.483 1.254 . . . . 0.0 109.568 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -120.51 169.26 8.98 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.22 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.411 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 44.7 Cg_endo -85.73 129.3 3.52 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 124.148 1.604 . . . . 0.0 110.303 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.7 p -59.68 -35.35 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.796 -0.565 . . . . 0.0 110.076 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.9 m -48.94 -36.34 17.15 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.299 -0.876 . . . . 0.0 110.41 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.558 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -66.03 -38.25 87.92 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 17.5 mt -70.21 -37.04 74.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -55.57 124.82 18.59 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.022 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.33 -29.62 12.11 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.425 ' HA ' HD23 ' A' ' 44' ' ' LEU . 57.2 m -82.71 1.11 40.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.694 -0.886 . . . . 0.0 111.028 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.41 123.95 14.55 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.922 -1.111 . . . . 0.0 110.394 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.58 -11.85 12.31 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 44' ' ' LEU . . . -62.41 140.07 46.08 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.585 ' O ' HD12 ' A' ' 144' ' ' LEU . 52.3 Cg_endo -82.85 124.27 3.88 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.594 1.312 . . . . 0.0 113.171 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.829 HD23 HD13 ' A' ' 104' ' ' LEU . 1.2 mp -76.0 141.3 42.2 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 142' ' ' PRO . 0.9 OUTLIER -137.57 136.58 37.71 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 120.009 1.277 . . . . 0.0 112.355 -177.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.49 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 15.2 p -84.16 -174.16 0.5 Allowed Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 49.6 Cg_endo -60.1 164.84 11.61 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 117.328 -1.314 . . . . 0.0 110.08 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.36 163.15 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.344 -0.847 . . . . 0.0 109.588 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 149' ' ' HIS . . . -69.59 102.81 1.01 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.41 ' CG ' ' O ' ' A' ' 148' ' ' GLY . 1.5 m170 -166.46 106.84 0.66 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.588 -0.948 . . . . 0.0 110.38 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -60.17 142.36 54.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.642 . . . . 0.0 110.448 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.657 HG12 ' CE2' ' A' ' 169' ' ' PHE . 3.4 t -107.88 -44.38 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.713 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . -178.86 -178.33 48.07 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.523 HD11 HD12 ' A' ' 82' ' ' LEU . 1.1 pt -116.44 143.77 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.129 -1.218 . . . . 0.0 111.21 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.733 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 5.8 t80 -60.53 116.55 4.42 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.048 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -103.68 -44.62 5.04 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.371 -0.83 . . . . 0.0 109.062 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -152.5 169.92 21.42 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.733 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -126.58 115.58 19.72 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.066 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.778 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.4 t -66.41 100.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.59 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.4 p -128.88 142.48 50.94 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -174.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 162' ' ' GLY . 69.9 p -73.79 -174.61 1.84 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.9 84.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.741 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 86.89 -27.77 5.81 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 121.146 -0.971 . . . . 0.0 111.92 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -94.07 137.16 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.026 1.413 . . . . 0.0 109.089 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.03 126.08 47.69 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.843 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -110.35 -38.68 5.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.78 -0.575 . . . . 0.0 110.384 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.778 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -126.32 170.56 11.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 110.164 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.2 153.85 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.642 0.734 . . . . 0.0 111.261 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.645 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 11.8 t0 -121.03 96.49 5.12 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.657 ' CE2' HG12 ' A' ' 151' ' ' VAL . 3.7 p90 -130.41 161.39 31.46 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.596 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.461 HG11 ' CD1' ' A' ' 82' ' ' LEU . 1.1 p -111.28 123.21 35.64 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 43.1 Cg_endo -50.56 157.13 3.64 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.861 1.453 . . . . 0.0 112.359 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.713 HG13 ' HA2' ' A' ' 152' ' ' GLY . 27.8 m -83.22 3.08 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.799 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -87.79 -36.32 17.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -36.05 78.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 110.592 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.52 ' HG2' HD21 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -47.3 -39.18 14.1 Favored 'General case' 0 N--CA 1.524 3.27 0 CA-C-O 121.789 0.804 . . . . 0.0 109.302 -179.159 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -53.78 -38.46 64.51 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.915 0.864 . . . . 0.0 109.197 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.1 m -55.81 -39.6 71.56 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.374 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -58.11 -42.64 86.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.522 -0.736 . . . . 0.0 110.32 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.459 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -54.79 -40.16 69.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.405 -0.809 . . . . 0.0 111.056 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -51.28 -38.22 51.62 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.94 0.876 . . . . 0.0 110.408 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -80.84 -41.18 23.66 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.7 m 53.21 99.23 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.626 -0.671 . . . . 0.0 110.595 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 55.08 -167.32 0.09 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.276 -0.89 . . . . 0.0 110.28 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -69.08 -169.88 0.21 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.589 -0.694 . . . . 0.0 109.986 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -62.22 157.19 19.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.566 -0.709 . . . . 0.0 110.196 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.156 -179.938 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.903 0.383 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -176.8 -60.18 0.06 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.14 54.88 1.32 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.441 -1.034 . . . . 0.0 111.224 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -85.76 112.05 20.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.424 -0.798 . . . . 0.0 109.952 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -90.47 91.69 8.56 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.452 -0.78 . . . . 0.0 110.204 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -79.99 -179.19 6.86 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.562 -0.711 . . . . 0.0 109.766 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -161.63 77.49 0.53 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.471 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.568 HG21 ' HG3' ' A' ' 34' ' ' GLN . 0.9 OUTLIER -85.84 173.05 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.032 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -156.28 76.84 0.92 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.64 0.733 . . . . 0.0 109.565 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.35 57.45 8.17 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.451 ' C ' HG23 ' A' ' 33' ' ' VAL . 11.8 mt-10 -154.83 -85.26 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.57 -0.959 . . . . 0.0 111.795 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 45' ' ' ALA . 59.9 t -149.8 152.11 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.964 -1.085 . . . . 0.0 111.581 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.568 ' HG3' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -134.22 144.11 48.24 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.095 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.501 HG12 ' HD2' ' A' ' 109' ' ' ARG . 34.5 m -103.57 178.81 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.207 -0.933 . . . . 0.0 111.934 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.463 ' CG1' HD21 ' A' ' 64' ' ' LEU . 33.1 m -136.31 -179.4 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.0 m -157.5 135.59 10.96 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.634 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 p -141.36 -179.07 5.92 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.09 75.44 0.67 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.949 -1.101 . . . . 0.0 108.621 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m 179.25 -63.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.7 -163.36 0.14 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.664 -0.647 . . . . 0.0 109.342 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -120.63 136.5 54.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.435 -0.791 . . . . 0.0 109.902 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 52.4 m-85 -101.87 -177.55 3.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.609 -0.682 . . . . 0.0 110.518 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.764 HD23 ' N ' ' A' ' 45' ' ' ALA . 7.6 tt -113.37 153.72 28.07 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.363 -0.836 . . . . 0.0 109.37 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.764 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -156.85 130.94 8.42 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.029 -1.044 . . . . 0.0 109.973 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.576 HG23 HG23 ' A' ' 48' ' ' VAL . 15.2 t -97.84 129.98 44.78 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.201 -0.937 . . . . 0.0 111.883 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 80.1 m -80.81 84.39 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.292 -0.88 . . . . 0.0 110.289 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.576 HG23 HG23 ' A' ' 46' ' ' THR . 54.7 t -98.4 138.01 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 58.26 19.61 6.4 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.207 -0.933 . . . . 0.0 109.818 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.28 24.33 54.68 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -138.24 106.85 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.38 -1.071 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.94 115.57 2.94 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.62 -0.675 . . . . 0.0 109.182 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.505 ' CH2' ' HE3' ' A' ' 179' ' ' MET . 97.7 m95 -96.49 142.44 28.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 111.326 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.6 HG23 HG23 ' A' ' 83' ' ' VAL . 10.8 t -161.42 -177.59 6.08 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.407 ' C ' HG22 ' A' ' 83' ' ' VAL . 12.3 m -109.8 150.27 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.449 -0.782 . . . . 0.0 110.457 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.567 ' HB2' HG11 ' A' ' 83' ' ' VAL . 33.7 t80 -71.2 -0.91 10.88 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.826 -1.171 . . . . 0.0 112.073 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -48.44 -27.65 2.78 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.171 -0.956 . . . . 0.0 110.608 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.9 41.27 0.11 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -156.95 113.73 3.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.661 -0.905 . . . . 0.0 110.328 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.07 -49.0 0.89 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.09 178.28 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.546 -0.973 . . . . 0.0 110.514 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 50.7 -170.93 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.39 -0.819 . . . . 0.0 110.889 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.63 106.88 19.26 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.652 0.739 . . . . 0.0 109.768 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.463 HD21 ' CG1' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.91 169.98 2.32 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.502 0.667 . . . . 0.0 111.275 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -115.99 136.3 53.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.869 -0.519 . . . . 0.0 109.691 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.18 -178.48 15.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -53.46 96.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.826 0 O-C-N 123.653 1.344 . . . . 0.0 110.855 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt 54.2 28.28 8.9 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.445 -0.784 . . . . 0.0 110.629 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.07 139.09 5.0 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.14 163.06 24.07 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.861 1.453 . . . . 0.0 110.3 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.9 mt -97.94 99.2 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.569 -0.707 . . . . 0.0 109.684 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 72' ' ' THR . 9.2 t -55.81 123.47 14.3 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.623 -0.673 . . . . 0.0 110.874 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -55.4 130.73 43.73 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.631 -0.668 . . . . 0.0 111.007 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.2 mmt -128.75 -50.07 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.494 -0.753 . . . . 0.0 109.82 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 179' ' ' MET . 10.7 m-85 -125.93 111.67 15.05 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.538 -0.726 . . . . 0.0 110.014 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.602 HG23 ' HB ' ' A' ' 83' ' ' VAL . 12.8 m -144.67 112.36 6.22 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.601 -0.687 . . . . 0.0 110.723 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 183' ' ' LYS . 1.9 t-20 -139.53 76.01 1.54 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.921 -1.112 . . . . 0.0 111.886 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.429 ' HB ' ' CB ' ' A' ' 56' ' ' TYR . 7.4 p -52.35 -25.18 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.36 -0.838 . . . . 0.0 109.512 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -32.82 73.61 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -96.75 22.48 8.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.76 41.9 31.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.498 -0.751 . . . . 0.0 111.469 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.842 HD11 HD11 ' A' ' 153' ' ' ILE . 0.3 OUTLIER -169.09 153.23 5.42 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.061 -1.055 . . . . 0.0 113.158 178.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.602 ' HB ' HG23 ' A' ' 76' ' ' THR . 35.0 m -155.34 130.48 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.45 148.71 20.32 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.615 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.462 ' CZ2' HD11 ' A' ' 64' ' ' LEU . 1.1 m-90 -116.32 172.02 7.45 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -75.11 141.94 43.69 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.126 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -111.2 101.69 50.99 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.111 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.4 Cg_endo -115.63 10.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.11 0 O-C-N 123.75 1.395 . . . . 0.0 112.768 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 52.1 Cg_endo -63.7 -100.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 116.702 -1.732 . . . . 0.0 108.686 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.44 34.21 5.83 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 105.49 -3.044 . . . . 0.0 105.49 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.61 157.97 37.01 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.945 -0.738 . . . . 0.0 111.214 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.19 20.48 6.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.846 -0.534 . . . . 0.0 109.926 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.9 p 45.63 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.628 -0.67 . . . . 0.0 112.431 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.69 ' O ' HG23 ' A' ' 95' ' ' THR . 0.3 OUTLIER -76.7 -151.52 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 109.763 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -161.04 171.23 7.26 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.394 -0.816 . . . . 0.0 110.611 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -83.12 159.46 15.44 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 O-C-N 123.935 1.492 . . . . 0.0 110.575 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.654 ' CB ' HG23 ' A' ' 151' ' ' VAL . 2.1 t -92.99 136.77 32.96 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.561 -0.712 . . . . 0.0 109.555 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.9 m -108.05 -37.12 6.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.603 -0.685 . . . . 0.0 110.121 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.6 p -64.67 -22.31 66.95 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.675 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.87 -94.57 0.04 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.6 t 51.82 -174.5 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.389 -1.065 . . . . 0.0 110.436 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.2 p -107.23 -162.0 0.82 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.433 -0.792 . . . . 0.0 110.33 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 55.2 m-20 55.36 97.21 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.529 -0.732 . . . . 0.0 110.467 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.843 HD13 HD23 ' A' ' 143' ' ' LEU . 3.0 mt -114.18 -176.38 2.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.598 -0.689 . . . . 0.0 110.159 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 107' ' ' VAL . 64.2 m-85 -132.08 84.77 2.18 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.9 tp -67.52 97.0 0.56 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 105' ' ' TYR . 47.6 t -82.96 113.9 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.616 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.448 ' HB ' ' NE2' ' A' ' 110' ' ' HIS . 67.3 p -70.21 178.5 2.79 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.625 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -99.73 42.44 1.11 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.008 -1.058 . . . . 0.0 110.64 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.448 ' NE2' ' HB ' ' A' ' 108' ' ' THR . 2.8 p80 -164.97 46.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.717 0.77 . . . . 0.0 109.703 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.29 70.0 0.61 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.353 0.597 . . . . 0.0 111.206 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 108' ' ' THR . 0.8 OUTLIER -165.49 78.18 0.29 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.479 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.7 p -68.1 152.72 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.615 -0.678 . . . . 0.0 110.209 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 116' ' ' VAL . 46.9 mt -131.37 111.63 15.31 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.353 -0.842 . . . . 0.0 108.783 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -56.89 141.6 93.18 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 O-C-N 123.66 1.348 . . . . 0.0 111.913 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 41.9 t -135.95 148.72 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.525 -0.735 . . . . 0.0 109.767 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.2 115.96 29.05 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -49.3 125.24 10.56 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.299 -0.875 . . . . 0.0 110.882 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.423 ' HG2' ' HB2' ' A' ' 125' ' ' SER . 0.0 OUTLIER -104.75 -47.34 4.07 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.278 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.73 -164.91 13.1 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.12 137.66 57.2 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.504 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 58.1 p 46.03 47.71 12.69 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.062 0.458 . . . . 0.0 111.892 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.509 ' HD2' HG21 ' A' ' 158' ' ' VAL . 0.4 OUTLIER -168.59 144.81 3.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.41 -0.806 . . . . 0.0 110.779 179.279 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -137.98 -178.44 16.1 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.423 ' HB2' ' HG2' ' A' ' 119' ' ' ARG . 0.3 OUTLIER -130.3 102.93 6.41 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.004 -178.242 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.854 ' O ' HD12 ' A' ' 126' ' ' LEU . 1.8 pp -49.63 146.91 3.88 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.597 -0.69 . . . . 0.0 110.404 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.8 mt -109.08 54.74 0.65 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.02 0.914 . . . . 0.0 108.841 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.5 117.77 0.17 Allowed Pre-proline 0 N--CA 1.497 1.902 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -59.12 99.13 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 O-C-N 123.742 1.391 . . . . 0.0 109.447 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -114.46 144.9 32.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.019 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.487 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 44.3 Cg_endo -62.25 123.84 13.23 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 124.042 1.549 . . . . 0.0 109.993 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 162' ' ' GLY . 6.7 p -51.0 -36.57 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.593 -0.692 . . . . 0.0 110.901 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.4 t -49.56 -35.36 20.23 Favored 'General case' 0 N--CA 1.506 2.353 0 CA-C-O 122.042 0.925 . . . . 0.0 110.099 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.487 ' HB3' ' O ' ' A' ' 131' ' ' PRO . 34.8 t80 -63.38 -38.56 91.62 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.52 HD11 ' CB ' ' A' ' 164' ' ' ALA . 10.7 mt -68.8 -35.9 77.6 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.113 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -59.99 121.85 12.85 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.555 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 112.66 -30.21 7.66 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.3 m -88.78 10.53 20.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.74 -0.859 . . . . 0.0 111.12 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.5 p -51.46 127.6 20.47 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.049 -1.032 . . . . 0.0 109.755 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.588 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 115.71 -11.91 18.27 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -176.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.637 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -44.51 114.99 1.18 Allowed Glycine 0 N--CA 1.504 3.225 0 O-C-N 121.556 -0.967 . . . . 0.0 111.454 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.62 119.87 6.84 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.927 1.488 . . . . 0.0 111.356 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.843 HD23 HD13 ' A' ' 104' ' ' LEU . 4.0 mp -87.6 90.94 8.56 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.31 124.1 34.63 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.304 -0.872 . . . . 0.0 111.395 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.446 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 26.6 p -74.86 172.31 9.34 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.776 -0.578 . . . . 0.0 109.892 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 49.3 Cg_endo -71.05 90.43 0.65 Allowed 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.637 1.335 . . . . 0.0 110.973 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.72 -41.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.431 -0.793 . . . . 0.0 110.149 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.97 28.9 1.6 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -141.29 143.27 33.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.377 -1.072 . . . . 0.0 109.469 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.446 ' O ' HG21 ' A' ' 172' ' ' VAL . . . -68.51 131.95 46.14 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.54 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.654 HG23 ' CB ' ' A' ' 97' ' ' CYS . 0.8 OUTLIER -94.14 -27.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.901 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 177.91 -177.85 48.4 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.842 HD11 HD11 ' A' ' 82' ' ' LEU . 1.8 pp -128.51 153.69 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 CA-C-N 119.013 1.406 . . . . 0.0 111.828 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.85 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 4.2 t80 -64.26 103.52 0.64 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.777 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -90.95 -42.66 10.44 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.601 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -154.46 177.88 10.68 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.85 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -133.35 118.56 18.62 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.657 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.843 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.1 t -65.99 102.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.507 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.0 p -129.1 153.25 47.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 122.162 0.982 . . . . 0.0 113.618 -174.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -86.77 -174.84 5.16 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.61 85.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.657 -0.652 . . . . 0.0 112.442 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.78 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 85.15 -23.59 7.93 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.23 -0.919 . . . . 0.0 111.718 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -98.41 142.42 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 119.125 1.462 . . . . 0.0 109.123 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.697 ' C ' HD21 ' A' ' 126' ' ' LEU . . . -102.05 133.09 47.43 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.151 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.674 ' HA ' HD11 ' A' ' 126' ' ' LEU . 20.6 mtpt -114.17 -36.13 4.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.562 -0.711 . . . . 0.0 110.965 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.843 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -135.37 172.75 12.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.402 -0.811 . . . . 0.0 109.979 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.19 152.62 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 111.178 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -117.03 93.21 4.1 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.435 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.837 ' CG ' HD22 ' A' ' 143' ' ' LEU . 2.6 p90 -128.35 148.65 50.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.408 -0.808 . . . . 0.0 110.838 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.412 ' CG2' ' SD ' ' A' ' 175' ' ' MET . 1.0 OUTLIER -103.51 148.78 36.27 Favored Pre-proline 0 N--CA 1.497 1.916 0 C-N-CA 118.621 -1.232 . . . . 0.0 108.596 179.054 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.544 ' O ' ' HG3' ' A' ' 175' ' ' MET . 47.0 Cg_endo -63.03 137.91 64.7 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.103 1.581 . . . . 0.0 110.496 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.901 HG13 ' HA2' ' A' ' 152' ' ' GLY . 25.6 m -75.94 -0.99 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -77.27 -37.01 53.8 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.1 m -84.13 -38.42 20.74 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.781 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.544 ' HG3' ' O ' ' A' ' 171' ' ' PRO . 11.3 mtm -49.54 -41.05 40.22 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.313 -0.867 . . . . 0.0 110.039 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.459 ' HA ' ' HE3' ' A' ' 179' ' ' MET . 44.8 mm-40 -54.15 -39.49 66.57 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.569 0.7 . . . . 0.0 110.323 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.4 m -50.26 -35.75 28.35 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.933 -0.479 . . . . 0.0 112.266 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.3 t -48.69 -40.81 29.53 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.213 -0.93 . . . . 0.0 113.174 -177.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.505 ' HE3' ' CH2' ' A' ' 53' ' ' TRP . 3.3 ptp -61.0 -38.59 86.57 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.611 -1.306 . . . . 0.0 110.003 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.34 -38.55 53.69 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.871 0.843 . . . . 0.0 109.903 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -78.53 -39.7 37.18 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.4 t 53.1 33.91 16.1 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.382 -0.824 . . . . 0.0 111.042 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.402 ' HB2' ' ND2' ' A' ' 77' ' ' ASN . 16.0 mmtm -60.88 88.52 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.463 -0.773 . . . . 0.0 110.165 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -107.05 -164.23 0.97 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.443 -0.786 . . . . 0.0 110.233 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -156.01 93.31 1.43 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.571 -0.706 . . . . 0.0 109.91 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 8.4 tttm . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.267 -179.606 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 83.9 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.092 0.472 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.5 -39.86 1.71 Allowed Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 62.8 131.86 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.41 -1.053 . . . . 0.0 111.029 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.9 t0 53.24 39.74 30.19 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.379 -0.825 . . . . 0.0 111.102 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -3.79 40.82 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.502 -0.749 . . . . 0.0 111.177 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -113.99 -178.33 3.35 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.487 -0.758 . . . . 0.0 109.853 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -160.77 77.82 0.6 Allowed 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.731 HG21 ' HA ' ' A' ' 91' ' ' ALA . 14.1 p -70.04 152.52 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.706 -0.621 . . . . 0.0 110.607 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.83 79.37 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.625 -0.672 . . . . 0.0 109.22 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.89 -86.75 0.12 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.606 ' OE2' HD21 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -173.67 -35.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.495 -1.003 . . . . 0.0 111.008 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.553 HG11 HD21 ' A' ' 44' ' ' LEU . 21.2 t -104.56 153.29 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.32 -0.862 . . . . 0.0 110.303 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.439 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 18.7 pt20 -139.3 135.33 33.7 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.411 -0.806 . . . . 0.0 110.438 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 44' ' ' LEU . 36.0 m -108.97 161.58 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.544 -0.723 . . . . 0.0 111.583 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.792 HG11 HD21 ' A' ' 64' ' ' LEU . 2.0 p -144.87 145.28 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 p -117.7 143.54 46.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.748 . . . . 0.0 111.03 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 40' ' ' THR . 7.4 t -128.74 -179.61 5.17 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.06 76.63 0.23 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.354 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.2 m 177.9 -59.76 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -175.95 -166.38 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.677 -0.64 . . . . 0.0 109.443 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.7 p -119.83 137.91 53.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.354 -0.842 . . . . 0.0 110.436 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.685 ' CE2' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -108.96 -176.2 2.97 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.752 HD23 ' N ' ' A' ' 45' ' ' ALA . 8.3 tt -125.74 147.86 49.24 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.752 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -148.92 135.98 19.97 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.858 -1.151 . . . . 0.0 111.467 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.707 HG23 HG23 ' A' ' 48' ' ' VAL . 7.3 t -106.32 126.37 52.15 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.471 -0.768 . . . . 0.0 111.88 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.6 t -76.34 85.01 3.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.475 -0.766 . . . . 0.0 109.766 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.707 HG23 HG23 ' A' ' 46' ' ' THR . 95.8 t -102.14 138.03 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.4 t30 58.18 18.83 5.62 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.434 -0.791 . . . . 0.0 110.143 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.97 23.97 43.25 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 85' ' ' TRP . 85.1 t -143.0 112.62 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -1.117 . . . . 0.0 110.358 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.405 ' O ' ' HA2' ' A' ' 84' ' ' GLY . 25.7 p -61.56 126.37 27.11 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.688 ' CE3' HD23 ' A' ' 82' ' ' LEU . 85.2 m95 -105.5 139.46 40.08 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.233 -0.917 . . . . 0.0 112.621 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.872 ' O ' HG22 ' A' ' 83' ' ' VAL . 5.7 t -160.73 150.81 17.73 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.598 -0.688 . . . . 0.0 110.235 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.419 ' HB ' ' CD2' ' A' ' 57' ' ' HIS . 16.0 t -72.67 149.45 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 121.242 -0.911 . . . . 0.0 109.888 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.706 ' HB3' HG12 ' A' ' 78' ' ' VAL . 9.0 t80 -82.44 5.26 21.11 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.856 -1.153 . . . . 0.0 112.328 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.419 ' CD2' ' HB ' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -76.68 5.91 6.82 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.059 -1.025 . . . . 0.0 112.013 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.57 -43.21 0.03 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . . . -91.55 146.19 23.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.593 -0.945 . . . . 0.0 110.147 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.44 -45.8 1.42 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.5 t -60.19 174.36 0.53 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.519 -0.989 . . . . 0.0 109.803 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.32 -176.24 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.304 -0.873 . . . . 0.0 110.489 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 m -88.87 94.72 10.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.539 -0.725 . . . . 0.0 110.18 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.898 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -61.23 174.78 0.63 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.637 -0.664 . . . . 0.0 110.046 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.53 137.14 41.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.46 -0.775 . . . . 0.0 110.68 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.96 -179.46 16.04 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.4 -8.48 23.71 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.914 1.481 . . . . 0.0 111.035 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -139.01 30.87 2.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.034 -1.041 . . . . 0.0 110.999 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.67 175.13 13.98 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.73 148.02 76.66 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 124.016 1.535 . . . . 0.0 110.13 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.898 HD12 ' CD2' ' A' ' 64' ' ' LEU . 84.1 mt -91.62 151.06 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 110.04 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.427 ' HG1' ' C ' ' A' ' 71' ' ' ILE . 24.2 m -159.49 -62.81 0.07 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.479 -0.763 . . . . 0.0 110.401 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.19 -156.48 0.24 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.409 -0.807 . . . . 0.0 110.183 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.3 ttt -142.7 28.04 1.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.764 . . . . 0.0 110.164 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CE1' ' CB ' ' A' ' 179' ' ' MET . 13.4 m-30 -106.94 100.32 9.83 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.8 HG23 ' CG1' ' A' ' 83' ' ' VAL . 66.3 m -159.93 137.36 9.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 110.742 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -159.95 79.66 0.7 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.561 -0.856 . . . . 0.0 112.142 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.706 HG12 ' HB3' ' A' ' 56' ' ' TYR . 33.9 m -44.63 -26.44 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.437 -0.79 . . . . 0.0 111.812 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -55.65 -62.66 1.54 Allowed 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.004 -1.06 . . . . 0.0 108.596 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -81.48 -1.19 45.02 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.143 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.546 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.0 OUTLIER 60.77 66.49 0.91 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.563 -0.711 . . . . 0.0 111.076 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.002 HD11 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -164.44 145.9 8.35 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.254 -0.978 . . . . 0.0 112.868 178.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 54' ' ' THR . 2.5 m -142.81 159.39 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 52' ' ' CYS . . . -149.1 101.83 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 118.486 -1.816 . . . . 0.0 111.782 -178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.574 ' CH2' HD11 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -85.62 166.28 16.34 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 177.382 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -90.44 131.13 36.38 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.904 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB1' ' CB ' ' A' ' 91' ' ' ALA . . . -72.71 139.17 80.34 Favored Pre-proline 0 C--N 1.297 -1.686 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.829 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.466 ' HG2' ' HD3' ' A' ' 89' ' ' PRO . 36.3 Cg_endo -115.23 -41.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 117.389 -1.274 . . . . 0.0 115.116 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.585 ' HB2' HG12 ' A' ' 29' ' ' VAL . 55.8 Cg_endo -63.27 -152.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 116.994 -1.537 . . . . 0.0 109.454 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.79 34.11 2.56 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.731 ' HA ' HG21 ' A' ' 29' ' ' VAL . . . -55.25 126.85 26.63 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.059 -1.26 . . . . 0.0 111.014 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.81 154.7 41.53 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.3 p -112.91 117.94 33.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.363 -0.836 . . . . 0.0 110.619 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 ' OE2' ' A' ' 32' ' ' GLU . 16.7 mt -86.71 -164.39 1.06 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.623 -0.673 . . . . 0.0 109.288 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.428 HG23 ' N ' ' A' ' 96' ' ' PRO . 0.6 OUTLIER -150.52 -170.04 0.23 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.631 -0.668 . . . . 0.0 109.48 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.428 ' N ' HG23 ' A' ' 95' ' ' THR . 50.1 Cg_endo -89.19 156.71 5.64 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 O-C-N 123.528 1.278 . . . . 0.0 111.308 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -105.14 143.44 33.31 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.568 -0.708 . . . . 0.0 110.204 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 m -156.81 37.18 0.31 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.622 -0.674 . . . . 0.0 110.439 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 31.6 p -93.57 -171.27 2.57 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.28 -0.888 . . . . 0.0 110.579 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.79 94.81 0.87 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.7 p -165.47 -164.09 0.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.963 . . . . 0.0 109.893 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.07 -40.32 0.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.432 -0.793 . . . . 0.0 110.789 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 2.7 t0 -64.5 123.49 19.36 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.414 -0.803 . . . . 0.0 110.087 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.661 HD13 HD23 ' A' ' 143' ' ' LEU . 1.6 mt -115.85 179.15 4.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.453 -0.78 . . . . 0.0 109.97 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.66 ' O ' HG23 ' A' ' 107' ' ' VAL . 12.2 m-85 -132.92 79.49 1.84 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.622 HD23 ' HB ' ' A' ' 114' ' ' ILE . 1.4 tp -58.79 101.81 0.1 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.992 HG22 HG12 ' A' ' 113' ' ' VAL . 75.6 t -90.55 114.89 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.563 -0.711 . . . . 0.0 111.727 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.522 HG21 ' CZ ' ' A' ' 134' ' ' TYR . 10.2 p -74.71 178.71 5.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.517 ' HD3' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -98.31 29.51 3.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.857 -1.152 . . . . 0.0 110.288 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -128.58 33.41 4.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 58.51 69.31 0.74 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.455 -0.778 . . . . 0.0 110.908 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -172.06 108.64 0.23 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.594 -0.691 . . . . 0.0 110.256 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.992 HG12 HG22 ' A' ' 107' ' ' VAL . 33.3 m -84.81 158.39 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.929 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.622 ' HB ' HD23 ' A' ' 106' ' ' LEU . 28.3 mm -127.98 111.56 20.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -60.88 133.12 45.84 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 O-C-N 123.752 1.396 . . . . 0.0 111.259 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 114' ' ' ILE . 20.2 t -135.09 149.08 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.643 -0.66 . . . . 0.0 109.841 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -104.29 111.15 23.66 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.445 HH12 HG13 ' A' ' 151' ' ' VAL . 17.2 ttt180 -48.71 122.54 5.72 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.641 0.734 . . . . 0.0 111.351 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.85 -36.95 5.77 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.31 171.82 32.21 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.04 -21.95 35.18 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.502 -0.999 . . . . 0.0 110.703 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.401 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 4.6 p -130.91 40.02 3.52 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.807 -0.558 . . . . 0.0 111.104 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.487 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -171.05 153.5 3.8 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.142 -0.974 . . . . 0.0 111.021 179.08 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.39 -178.39 25.23 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -129.38 115.75 18.0 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.912 -0.758 . . . . 0.0 111.907 -178.23 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' A' ' 130' ' ' ARG . 0.1 OUTLIER -54.43 148.08 12.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.328 -0.857 . . . . 0.0 109.881 178.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.6 mt -112.27 54.02 0.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 164.5 142.73 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.311 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.31 112.15 2.02 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.79 1.416 . . . . 0.0 109.576 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.426 ' HB3' HD22 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -121.08 127.99 25.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.474 -0.766 . . . . 0.0 108.945 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -54.72 131.11 44.02 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 O-C-N 123.775 1.408 . . . . 0.0 111.467 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.8 p -63.79 -36.03 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 121.253 0.549 . . . . 0.0 109.999 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -48.74 -36.54 16.61 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.08 -1.013 . . . . 0.0 110.611 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.522 ' CZ ' HG21 ' A' ' 108' ' ' THR . 26.8 t80 -65.8 -38.62 89.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 14.1 mt -65.09 -36.01 82.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -63.08 124.78 22.0 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.704 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.52 -25.55 27.21 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.3 m -90.32 6.79 41.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.994 . . . . 0.0 111.283 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 p -53.15 121.4 7.4 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.021 -1.049 . . . . 0.0 109.747 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.573 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 120.91 -10.33 10.27 Favored Glycine 0 CA--C 1.542 1.725 0 N-CA-C 107.664 -2.174 . . . . 0.0 107.664 -176.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.605 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -54.97 116.41 6.72 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.5 ' O ' HD12 ' A' ' 144' ' ' LEU . 51.6 Cg_endo -68.41 118.82 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.813 1.428 . . . . 0.0 111.805 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.661 HD23 HD13 ' A' ' 104' ' ' LEU . 2.7 mp -74.87 138.58 42.57 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 176.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 142' ' ' PRO . 1.1 mt -134.8 120.57 19.53 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.845 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.482 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 16.9 p -71.81 -178.3 0.59 Allowed Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.1 Cg_endo -60.62 -179.57 0.28 Allowed 'Trans proline' 0 N--CA 1.491 1.343 0 O-C-N 123.288 1.151 . . . . 0.0 110.833 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.01 -79.16 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.449 -0.782 . . . . 0.0 110.286 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 177.46 -142.28 5.64 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 62.4 m170 57.99 118.14 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.839 -0.801 . . . . 0.0 111.308 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.521 ' O ' HG21 ' A' ' 172' ' ' VAL . . . -63.02 137.68 58.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.489 -0.757 . . . . 0.0 109.913 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.578 HG12 ' CE2' ' A' ' 169' ' ' PHE . 3.1 t -92.04 -44.92 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.809 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . -173.62 -177.78 43.09 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 1.002 HD11 HD11 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -120.0 142.06 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.515 -0.991 . . . . 0.0 110.541 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.719 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 10.1 t80 -58.2 116.58 3.66 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.495 ' HG3' ' HB3' ' A' ' 81' ' ' ASP . 5.4 ttt180 -103.37 -43.06 5.53 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.622 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -160.4 179.6 8.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.719 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -141.67 128.9 21.02 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.036 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.78 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.3 t -69.66 102.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 76.7 m -120.9 172.42 7.93 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.587 1.184 . . . . 0.0 113.401 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.4 OUTLIER -110.92 -174.42 2.47 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -49.47 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.37 -0.831 . . . . 0.0 112.798 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.717 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 84.4 -25.21 5.76 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.668 -1.27 . . . . 0.0 111.896 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.18 136.1 31.62 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.222 0 O-C-N 120.756 -1.438 . . . . 0.0 109.256 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.441 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -96.57 139.62 32.4 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.732 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -114.61 -47.84 2.89 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.529 -0.732 . . . . 0.0 110.887 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.78 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -123.05 -178.93 4.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.788 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.473 HG21 ' CG1' ' A' ' 116' ' ' VAL . 3.0 t -114.59 162.38 12.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.501 0.667 . . . . 0.0 110.104 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.622 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -135.97 88.26 2.38 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 178.312 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CE2' HG12 ' A' ' 151' ' ' VAL . 4.7 p90 -128.42 166.59 18.42 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.006 -1.078 . . . . 0.0 112.694 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.68 HG21 HD13 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -112.82 131.03 22.93 Favored Pre-proline 0 N--CA 1.491 1.58 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.453 ' HA ' ' HA3' ' A' ' 152' ' ' GLY . 40.4 Cg_endo -60.27 157.15 36.7 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.985 1.519 . . . . 0.0 111.02 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.809 HG13 ' HA2' ' A' ' 152' ' ' GLY . 26.8 m -82.05 5.05 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.381 -0.825 . . . . 0.0 110.744 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -85.87 -37.08 19.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.32 -38.74 49.81 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.765 -0.584 . . . . 0.0 111.024 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.502 ' HB3' ' CD2' ' A' ' 82' ' ' LEU . 9.2 ptp -49.91 -36.47 27.63 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.141 -0.974 . . . . 0.0 110.184 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.478 ' N ' ' HG3' ' A' ' 175' ' ' MET . 27.4 mm-40 -57.23 -37.86 72.91 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.485 -0.76 . . . . 0.0 109.731 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.5 m -60.3 -36.03 76.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.245 0.545 . . . . 0.0 110.343 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -49.56 -52.83 27.24 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.581 -0.699 . . . . 0.0 112.421 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.47 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 3.9 ptp -65.03 -40.94 95.57 Favored 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.041 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -54.94 -38.13 67.31 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 122.053 0.93 . . . . 0.0 109.25 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.5 -38.98 67.99 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.369 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.6 m -69.53 93.34 0.68 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.083 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -80.95 159.24 24.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.639 -0.663 . . . . 0.0 110.151 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 15.2 pttt -127.1 34.14 4.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.626 -0.672 . . . . 0.0 110.003 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -150.93 -155.37 0.62 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.677 -0.639 . . . . 0.0 110.209 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.0 tttt . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.2 -179.869 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 p . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.942 0.401 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.02 105.08 0.18 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.0 ttm105 -129.27 -67.09 0.79 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.445 -1.033 . . . . 0.0 110.65 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 50.38 94.6 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.817 -0.552 . . . . 0.0 110.507 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 12.8 tttt -83.44 1.66 40.48 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.352 -0.842 . . . . 0.0 112.352 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -144.79 78.83 1.58 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.225 -0.922 . . . . 0.0 110.442 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -162.46 77.84 0.48 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.586 -0.696 . . . . 0.0 109.233 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 89' ' ' PRO . 15.2 m -67.77 175.72 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.33 -0.856 . . . . 0.0 110.256 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -170.96 79.28 0.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.368 0.604 . . . . 0.0 109.502 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.74 -19.17 58.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.434 ' OE2' HD11 ' A' ' 94' ' ' LEU . 1.5 tp10 -79.54 -68.92 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.353 -1.087 . . . . 0.0 110.685 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.6 t -137.5 146.62 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.031 0.919 . . . . 0.0 111.497 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.97 173.94 11.16 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.445 HG12 ' HG3' ' A' ' 109' ' ' ARG . 8.1 m -143.03 161.43 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 118.963 -1.095 . . . . 0.0 111.613 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.693 HG11 ' CH2' ' A' ' 85' ' ' TRP . 26.4 m -120.94 -178.42 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 m -153.84 139.83 18.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.296 -0.878 . . . . 0.0 111.422 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -139.24 -178.38 5.34 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 40' ' ' THR . . . -69.19 75.67 0.35 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.131 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER 170.75 -61.24 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -174.73 -170.48 0.49 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.322 -0.861 . . . . 0.0 111.083 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.7 p -116.6 145.37 43.43 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.625 -0.672 . . . . 0.0 110.425 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -106.74 -172.85 2.16 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.173 -0.955 . . . . 0.0 109.766 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.911 HD23 ' N ' ' A' ' 45' ' ' ALA 0.25 5.7 tt -111.1 149.1 31.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.466 -0.771 . . . . 0.0 109.937 -178.001 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.911 ' N ' HD23 ' A' ' 44' ' ' LEU . . . -155.35 137.35 14.58 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.974 -1.079 . . . . 0.0 110.809 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 46' ' ' THR . 13.4 t -105.49 125.0 50.48 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.995 -1.066 . . . . 0.0 113.137 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 89.9 m -77.18 86.06 3.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.44 -0.787 . . . . 0.0 110.458 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.432 HG23 HG23 ' A' ' 46' ' ' THR . 59.6 t -107.15 141.84 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.338 -0.851 . . . . 0.0 108.731 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 57.3 19.04 4.69 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.363 -0.835 . . . . 0.0 110.082 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.59 23.71 49.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.1 t -142.42 113.84 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.268 -1.137 . . . . 0.0 110.493 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.31 114.04 4.47 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.931 ' CE3' HD23 ' A' ' 82' ' ' LEU . 96.0 m95 -97.83 140.53 32.07 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.588 -0.695 . . . . 0.0 111.614 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.87 HG21 ' CH2' ' A' ' 85' ' ' TRP . 4.3 t -161.64 177.8 9.63 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.821 HG11 ' CE1' ' A' ' 57' ' ' HIS . 21.2 t -97.86 146.87 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.274 -0.891 . . . . 0.0 109.927 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.509 ' HB2' HG11 ' A' ' 83' ' ' VAL . 37.1 t80 -63.33 -4.52 2.67 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.659 -1.276 . . . . 0.0 112.08 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.821 ' CE1' HG11 ' A' ' 55' ' ' VAL . 30.3 m170 -39.64 -39.89 0.82 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.313 -0.867 . . . . 0.0 111.816 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.86 -44.79 0.44 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.486 ' N ' ' CE2' ' A' ' 43' ' ' PHE . . . -51.51 97.75 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.433 -1.04 . . . . 0.0 109.818 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.67 25.42 21.28 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.67 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.15 28.34 5.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.244 -1.151 . . . . 0.0 110.891 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -98.1 -156.41 0.54 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.49 -0.756 . . . . 0.0 109.881 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 m -59.21 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.336 -0.853 . . . . 0.0 110.386 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.725 HD12 ' HB ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -74.34 136.35 42.52 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.2 143.19 49.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.432 -0.792 . . . . 0.0 110.789 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.564 ' HA3' HD11 ' A' ' 71' ' ' ILE . . . -137.97 -179.44 17.06 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.441 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 43.4 Cg_endo -65.82 -11.56 31.34 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.92 1.484 . . . . 0.0 110.844 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -114.55 19.63 15.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.982 -1.074 . . . . 0.0 110.858 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.25 -152.64 17.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.14 143.7 54.74 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 124.064 1.56 . . . . 0.0 111.216 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.725 ' HB ' HD12 ' A' ' 64' ' ' LEU . 87.3 mt -107.28 105.09 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -55.16 149.65 12.03 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.306 -0.871 . . . . 0.0 110.892 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.59 165.36 19.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 0.0 110.087 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -166.21 -47.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.359 -0.838 . . . . 0.0 111.338 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.452 ' CZ ' ' CG ' ' A' ' 179' ' ' MET . 19.1 m-85 -123.27 126.54 47.1 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.411 ' HA ' HG12 ' A' ' 83' ' ' VAL . 2.2 m -158.29 111.76 2.43 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.293 -0.879 . . . . 0.0 112.333 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -137.46 75.18 1.51 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 111.117 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' A' ' 56' ' ' TYR . 7.5 p -55.56 -21.97 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.433 -0.792 . . . . 0.0 111.012 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.2 77.97 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.467 -0.77 . . . . 0.0 111.324 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 49.24 25.23 1.16 Allowed 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.277 -0.889 . . . . 0.0 111.238 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.96 -95.36 0.49 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.403 -0.811 . . . . 0.0 110.943 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.931 HD23 ' CE3' ' A' ' 53' ' ' TRP . 5.1 tp -179.13 163.19 1.28 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.518 -1.364 . . . . 0.0 111.021 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.509 HG11 ' HB2' ' A' ' 56' ' ' TYR . 26.9 m -139.82 137.61 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.42 137.93 5.26 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.019 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.87 ' CH2' HG21 ' A' ' 54' ' ' THR . 0.4 OUTLIER -98.32 150.36 21.65 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -64.78 141.16 58.87 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.22 89.95 4.28 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.834 -0.541 . . . . 0.0 110.769 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.567 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 47.0 Cg_endo -97.46 0.65 1.56 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 O-C-N 123.679 1.358 . . . . 0.0 113.455 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 49.8 Cg_endo -74.73 74.76 3.76 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 115.75 -2.367 . . . . 0.0 109.915 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 52.64 25.8 22.57 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.32 140.3 39.92 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.471 -1.017 . . . . 0.0 110.63 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -84.93 3.88 36.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.352 -0.842 . . . . 0.0 111.437 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.5 t 45.36 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.415 -0.803 . . . . 0.0 112.558 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -69.81 -161.39 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.7 p -148.74 177.92 1.64 Allowed Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.662 -0.649 . . . . 0.0 110.956 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -86.51 155.36 9.17 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.95 1.5 . . . . 0.0 110.262 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.483 ' SG ' HG23 ' A' ' 151' ' ' VAL . 0.3 OUTLIER -83.98 114.63 21.84 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.313 -0.867 . . . . 0.0 110.016 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 66.9 p -75.11 -28.51 60.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.636 -0.665 . . . . 0.0 110.095 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.1 p -100.41 109.84 22.02 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.62 0.724 . . . . 0.0 110.253 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.7 63.39 2.32 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 m -91.51 157.94 16.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.518 -0.99 . . . . 0.0 109.563 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.5 p -85.54 -157.98 0.35 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.444 -0.785 . . . . 0.0 110.809 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 t70 52.84 83.89 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.466 -0.771 . . . . 0.0 110.761 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.805 HD13 HD23 ' A' ' 143' ' ' LEU . 0.4 OUTLIER -108.88 -174.51 2.53 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.4 -0.813 . . . . 0.0 109.39 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 94.8 m-85 -134.05 91.51 2.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.757 -0.59 . . . . 0.0 109.837 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.445 ' CD1' HD11 ' A' ' 143' ' ' LEU . 8.8 tp -56.36 98.89 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.413 -0.804 . . . . 0.0 110.268 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.446 ' HA ' HG12 ' A' ' 113' ' ' VAL . 60.6 t -74.07 118.99 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.587 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.7 p -86.53 166.98 15.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.557 -0.714 . . . . 0.0 109.418 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.587 ' N ' HD12 ' A' ' 44' ' ' LEU . 34.5 ttp180 -77.16 -1.35 28.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.611 -0.681 . . . . 0.0 111.098 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.485 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -120.7 40.77 3.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.221 -0.925 . . . . 0.0 109.993 -178.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.39 64.4 1.86 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.543 -0.723 . . . . 0.0 111.56 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -152.62 89.96 1.45 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 107' ' ' VAL . 16.1 m -87.83 136.0 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.457 -0.777 . . . . 0.0 110.071 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 106' ' ' LEU . 26.3 pt -124.36 146.76 53.0 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.527 -0.733 . . . . 0.0 109.59 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 53.7 Cg_endo -66.65 148.13 82.69 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 124.066 1.561 . . . . 0.0 111.746 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.7 t -138.63 141.11 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -106.7 113.46 26.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -48.93 124.29 8.43 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.613 -0.679 . . . . 0.0 110.307 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -110.66 -25.78 9.77 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.539 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -173.14 -176.11 41.43 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.94 122.74 15.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.758 -0.848 . . . . 0.0 109.515 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 169' ' ' PHE . 0.9 OUTLIER 60.95 44.32 10.66 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.214 0.53 . . . . 0.0 110.721 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.498 ' N ' ' CE2' ' A' ' 169' ' ' PHE . 8.7 ttm180 -162.65 151.83 15.26 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.413 -0.805 . . . . 0.0 110.228 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.54 -178.42 21.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.34 130.82 53.27 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.948 -0.737 . . . . 0.0 111.308 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.521 HD21 ' NE ' ' A' ' 130' ' ' ARG . 0.2 OUTLIER -76.37 123.24 25.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.655 -0.653 . . . . 0.0 109.475 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mt -100.01 53.84 0.91 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.456 ' O ' HD22 ' A' ' 126' ' ' LEU . 0.4 OUTLIER 177.41 91.55 0.13 Allowed Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -52.87 108.69 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 O-C-N 123.588 1.31 . . . . 0.0 110.626 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.521 ' NE ' HD21 ' A' ' 126' ' ' LEU . 15.3 ptp180 -130.64 162.18 56.51 Favored Pre-proline 0 N--CA 1.493 1.696 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.028 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.37 130.9 28.19 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.939 1.494 . . . . 0.0 111.274 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.886 HG12 ' O ' ' A' ' 162' ' ' GLY . 4.0 p -59.84 -35.23 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.487 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.96 -34.81 9.75 Favored 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 122.139 0.971 . . . . 0.0 110.535 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -64.66 -38.51 91.24 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.583 HD11 ' CB ' ' A' ' 164' ' ' ALA . 13.4 mt -65.33 -36.24 83.44 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -62.55 129.51 40.91 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.489 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.59 -28.01 17.89 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.542 ' O ' HD13 ' A' ' 44' ' ' LEU . 30.8 m -93.45 16.18 14.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.556 -0.967 . . . . 0.0 110.566 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.419 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 56.3 m -62.0 122.32 15.2 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.3 -0.875 . . . . 0.0 109.003 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.735 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 122.12 -10.77 9.37 Favored Glycine 0 CA--C 1.543 1.781 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.567 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -55.72 108.82 1.17 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 153' ' ' ILE . 43.1 Cg_endo -66.25 126.38 15.59 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.074 1.565 . . . . 0.0 112.458 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.805 HD23 HD13 ' A' ' 104' ' ' LEU . 6.6 mp -79.6 128.83 33.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 176.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 mt -124.21 123.61 40.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 111.662 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.549 ' HB3' HG21 ' A' ' 151' ' ' VAL . 32.0 p -77.82 162.63 67.08 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.798 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 45.6 Cg_endo -62.89 87.07 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 O-C-N 123.763 1.401 . . . . 0.0 110.726 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t -172.73 -40.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.62 -0.675 . . . . 0.0 110.18 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.03 -30.57 4.77 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -73.21 154.93 40.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.638 -0.919 . . . . 0.0 109.915 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.509 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -85.39 141.32 30.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.098 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 145' ' ' CYS . 2.1 t -97.65 -36.62 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.823 -0.548 . . . . 0.0 109.743 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.81 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 176.49 -178.91 47.76 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 82' ' ' LEU . 1.2 pt -116.8 158.19 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 118.504 1.152 . . . . 0.0 110.953 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.769 ' CZ ' ' HB2' ' A' ' 157' ' ' ALA . 12.2 t80 -75.99 103.41 6.04 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.701 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.415 ' HA ' HG21 ' A' ' 55' ' ' VAL . 7.4 ttp180 -92.0 -39.1 11.85 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -159.39 -179.66 8.14 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.769 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -140.76 125.98 18.58 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.762 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.904 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 2.6 t -67.67 102.08 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 71.0 m -115.67 159.4 21.4 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 122.451 1.119 . . . . 0.0 113.722 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.8 OUTLIER -97.63 -174.06 2.8 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.75 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 O-C-N 121.314 -0.866 . . . . 0.0 112.69 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.886 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 82.83 -35.59 2.7 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.014 -1.053 . . . . 0.0 111.382 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.75 134.47 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 120.713 -1.463 . . . . 0.0 109.145 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.583 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -91.4 140.64 29.57 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.336 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -120.9 -44.25 2.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.468 -0.77 . . . . 0.0 110.866 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.904 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -120.94 -179.77 4.12 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.311 -0.868 . . . . 0.0 110.612 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -119.42 151.46 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.8 0.81 . . . . 0.0 111.022 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.712 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -120.16 94.25 4.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.332 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.619 ' CD2' HD22 ' A' ' 143' ' ' LEU . 1.1 p90 -127.89 148.52 50.49 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.922 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.473 HG11 ' CD1' ' A' ' 82' ' ' LEU . 3.9 p -98.9 136.55 20.59 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 52.2 Cg_endo -64.91 152.91 80.58 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.814 1.428 . . . . 0.0 110.476 -178.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.81 HG13 ' HA2' ' A' ' 152' ' ' GLY . 30.6 m -79.8 1.04 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.395 -0.816 . . . . 0.0 110.597 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -89.14 -38.56 14.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.314 -0.866 . . . . 0.0 109.8 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.6 t -74.14 -40.73 62.42 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.603 -0.686 . . . . 0.0 110.791 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.789 ' HB3' HD22 ' A' ' 82' ' ' LEU . 8.3 ptp -51.78 -36.2 46.7 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.096 -1.003 . . . . 0.0 110.48 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.98 -38.02 69.85 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.192 -0.943 . . . . 0.0 109.068 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.6 m -57.53 -37.47 73.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.945 -0.472 . . . . 0.0 110.64 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.745 HG22 ' O ' ' A' ' 175' ' ' MET . 1.4 t -48.54 -36.42 15.39 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.431 -0.793 . . . . 0.0 111.96 -178.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.471 ' CE ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -51.08 -39.49 56.16 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.815 -1.178 . . . . 0.0 110.685 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.7 ttt85 -52.2 -37.43 54.83 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.916 0.865 . . . . 0.0 110.194 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -81.25 -44.31 17.94 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.891 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.9 t 54.01 -175.77 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.072 -1.018 . . . . 0.0 110.439 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -106.37 44.63 1.03 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.422 -0.799 . . . . 0.0 110.373 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -97.58 49.73 1.04 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.615 -0.678 . . . . 0.0 109.765 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -125.15 -64.2 1.1 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.684 -0.635 . . . . 0.0 110.063 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.0 tttp . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.833 -1.079 . . . . 0.0 110.142 179.827 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.3 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.246 0.546 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.36 69.75 0.18 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -101.23 52.75 0.84 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.638 -0.919 . . . . 0.0 110.259 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.22 175.22 0.76 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.654 -0.654 . . . . 0.0 109.726 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.65 -158.88 0.7 Allowed 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.518 -0.739 . . . . 0.0 109.541 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -87.17 90.97 8.55 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.276 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -161.61 76.88 0.52 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.599 -0.688 . . . . 0.0 110.019 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 t -104.08 172.93 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.284 -0.885 . . . . 0.0 109.588 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -167.8 79.29 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.02 -170.98 38.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.591 ' HB3' HD11 ' A' ' 94' ' ' LEU . 7.9 mt-10 -117.89 22.98 11.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.501 -1.0 . . . . 0.0 110.531 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.627 HG12 ' CG ' ' A' ' 109' ' ' ARG . 44.6 t -145.15 143.58 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.734 . . . . 0.0 110.431 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -138.97 140.62 38.28 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.465 -0.772 . . . . 0.0 109.718 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 43' ' ' PHE . 11.1 p -108.97 150.37 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.448 -0.783 . . . . 0.0 111.481 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.714 HG13 ' CE2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -131.33 124.38 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 p -101.16 143.85 30.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.369 -0.832 . . . . 0.0 109.455 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 40' ' ' THR . 5.6 t -149.61 -178.84 6.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.556 -0.715 . . . . 0.0 109.083 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.21 75.53 0.35 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.062 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.674 HG22 ' HG2' ' A' ' 41' ' ' GLN . 2.3 m -177.44 -61.14 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.674 ' HG2' HG22 ' A' ' 40' ' ' THR . 0.1 OUTLIER 179.77 -163.95 0.05 Allowed 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 t -122.06 119.46 31.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.292 -0.88 . . . . 0.0 109.297 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.759 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -111.52 166.46 11.12 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.614 -0.679 . . . . 0.0 109.718 -179.488 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.818 HD22 ' CB ' ' A' ' 109' ' ' ARG . 13.3 mt -105.31 174.31 5.93 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.174 -0.954 . . . . 0.0 111.133 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 52' ' ' CYS . . . -157.08 128.74 7.05 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.981 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 46' ' ' THR . 12.3 t -103.1 118.89 37.82 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.966 0.888 . . . . 0.0 111.643 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 49.2 t -70.2 89.63 0.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.821 -0.549 . . . . 0.0 110.161 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.526 HG11 HG11 ' A' ' 172' ' ' VAL . 98.7 t -109.16 136.27 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.8 19.18 6.69 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.404 -0.81 . . . . 0.0 110.18 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.85 24.88 40.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 85' ' ' TRP . 19.9 t -145.98 108.82 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -1.136 . . . . 0.0 110.668 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.511 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 24.1 p -61.57 129.11 39.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.248 -0.907 . . . . 0.0 109.304 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.726 ' HZ3' HG21 ' A' ' 178' ' ' THR . 56.1 m95 -108.13 139.25 43.06 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.502 -0.749 . . . . 0.0 111.66 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.938 ' O ' HG22 ' A' ' 83' ' ' VAL . 7.6 t -161.13 128.08 4.06 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.64 0.734 . . . . 0.0 110.315 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.672 HG21 ' CE1' ' A' ' 57' ' ' HIS . 28.3 m -48.92 141.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.47 0 O-C-N 120.855 -1.153 . . . . 0.0 112.16 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 51.9 t80 -83.08 -13.65 55.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.062 -1.024 . . . . 0.0 111.357 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.672 ' CE1' HG21 ' A' ' 55' ' ' VAL . 2.1 p-80 -63.23 -22.9 67.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.957 . . . . 0.0 110.061 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.45 ' N ' ' CD2' ' A' ' 57' ' ' HIS . . . -119.03 -30.27 1.64 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.465 ' HA ' ' CE2' ' A' ' 43' ' ' PHE . . . -55.34 174.75 0.08 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.357 -1.084 . . . . 0.0 111.203 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.97 150.62 19.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 m -101.79 -32.25 10.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.794 -0.827 . . . . 0.0 109.635 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -59.31 -169.49 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.639 -0.663 . . . . 0.0 109.933 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.8 m -68.24 97.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.543 -0.723 . . . . 0.0 109.424 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.9 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -55.21 165.9 0.65 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.663 -0.648 . . . . 0.0 110.962 -179.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.82 145.37 50.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.836 -0.54 . . . . 0.0 110.491 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -140.29 177.18 20.88 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.49 -12.66 36.5 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 O-C-N 123.915 1.482 . . . . 0.0 111.278 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.63 21.36 11.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 111.044 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.88 -168.3 13.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.51 144.14 65.77 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 124.033 1.544 . . . . 0.0 110.511 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.9 HD12 ' CD2' ' A' ' 64' ' ' LEU . 56.0 mt -92.88 101.93 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -63.0 117.53 6.56 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.964 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -59.02 102.5 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.299 0.571 . . . . 0.0 110.31 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpt -87.46 -42.0 13.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.777 . . . . 0.0 109.468 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.435 ' CD1' ' HG3' ' A' ' 179' ' ' MET . 23.5 m-85 -125.7 130.51 51.69 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.477 HG23 ' CG1' ' A' ' 83' ' ' VAL . 3.2 m -149.77 126.56 11.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.533 -0.729 . . . . 0.0 110.435 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.12 77.82 1.37 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.518 -0.739 . . . . 0.0 110.845 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -56.15 -18.62 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.407 -0.808 . . . . 0.0 109.947 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.54 -58.14 7.13 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.096 -1.002 . . . . 0.0 109.482 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.09 23.77 8.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.668 ' O ' HG12 ' A' ' 55' ' ' VAL . 31.5 m-20 52.83 69.51 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.826 -0.546 . . . . 0.0 112.088 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.668 ' CD1' HD11 ' A' ' 153' ' ' ILE . 1.4 tp -162.43 141.91 9.41 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.01 -1.056 . . . . 0.0 112.638 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.938 HG22 ' O ' ' A' ' 54' ' ' THR . 9.4 m -145.13 125.39 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -110.94 99.99 1.19 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.931 -1.128 . . . . 0.0 111.874 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.503 ' O ' HG13 ' A' ' 51' ' ' VAL . 1.6 m0 -90.18 169.14 11.39 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 176.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -89.24 128.9 35.87 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.041 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.677 ' HB1' ' HB3' ' A' ' 91' ' ' ALA . . . -60.76 139.24 93.39 Favored Pre-proline 0 N--CA 1.494 1.769 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.702 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.545 ' CD ' ' HD3' ' A' ' 89' ' ' PRO . 33.7 Cg_endo -105.54 -54.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 117.266 -1.356 . . . . 0.0 115.081 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.545 ' HD3' ' CD ' ' A' ' 88' ' ' PRO . 56.6 Cg_endo -66.37 -150.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.859 0 C-N-CA 116.923 -1.585 . . . . 0.0 108.822 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.85 34.19 3.21 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 107.734 -2.147 . . . . 0.0 107.734 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.677 ' HB3' ' HB1' ' A' ' 87' ' ' ALA . . . -48.64 130.73 17.58 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.105 -1.232 . . . . 0.0 110.923 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.6 142.21 58.5 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.76 -0.588 . . . . 0.0 110.44 -179.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 m -112.82 110.52 20.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 110.628 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' A' ' 32' ' ' GLU . 5.2 mt -93.3 -158.74 0.63 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.623 -0.673 . . . . 0.0 109.669 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.68 176.5 2.23 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.784 -0.573 . . . . 0.0 109.676 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.52 162.28 42.58 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 O-C-N 123.671 1.353 . . . . 0.0 111.18 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.6 t -81.95 -76.35 0.26 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.67 -0.644 . . . . 0.0 110.491 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.2 m 55.31 52.81 10.84 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.34 -0.85 . . . . 0.0 110.198 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.6 p -139.34 -149.59 0.29 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.488 -0.757 . . . . 0.0 110.304 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.33 -128.94 4.49 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.9 m 49.75 -157.59 0.08 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.371 -1.076 . . . . 0.0 111.031 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 p -171.4 -34.71 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.538 -0.726 . . . . 0.0 110.684 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 0.9 OUTLIER -58.8 128.09 35.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.563 -0.711 . . . . 0.0 110.314 179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.893 HD13 HD23 ' A' ' 143' ' ' LEU . 1.2 mt -120.84 -168.01 1.58 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.416 -0.803 . . . . 0.0 109.345 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.772 ' O ' HG23 ' A' ' 107' ' ' VAL . 29.4 m-85 -141.11 87.15 2.07 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.465 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 12.3 tp -56.98 96.66 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.155 -0.966 . . . . 0.0 108.494 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 105' ' ' TYR . 41.7 t -89.77 101.94 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.662 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.664 HG22 ' HB3' ' A' ' 138' ' ' SER . 0.8 OUTLIER -65.38 179.99 0.69 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.818 ' CB ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -100.92 29.16 4.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.015 -1.053 . . . . 0.0 109.464 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.413 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -130.83 30.17 4.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.338 -0.851 . . . . 0.0 109.679 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 59.36 70.6 0.63 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.46 -0.775 . . . . 0.0 110.551 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -171.56 93.88 0.16 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.344 0.593 . . . . 0.0 109.874 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.68 HG12 HG13 ' A' ' 107' ' ' VAL . 10.7 m -98.87 149.0 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.424 -0.797 . . . . 0.0 110.593 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.465 ' CG1' ' HB3' ' A' ' 106' ' ' LEU . 33.2 pt -131.33 147.55 66.61 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.631 -0.668 . . . . 0.0 109.316 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.546 ' HB2' HD12 ' A' ' 127' ' ' LEU . 44.3 Cg_endo -72.88 138.67 29.04 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 O-C-N 123.909 1.479 . . . . 0.0 112.222 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 103' ' ' ASP . 67.5 t -129.59 137.94 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.8 mmm-85 -102.64 121.28 42.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.862 . . . . 0.0 108.979 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -49.15 126.82 13.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.395 -0.816 . . . . 0.0 110.994 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -103.97 -55.0 2.45 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.53 -166.71 13.1 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -62.64 127.67 32.38 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.735 -0.862 . . . . 0.0 109.908 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.417 ' HB3' ' HD3' ' A' ' 171' ' ' PRO . 0.3 OUTLIER 54.02 50.81 15.86 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.491 0.663 . . . . 0.0 109.901 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.463 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -166.77 151.37 7.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.767 -0.583 . . . . 0.0 110.391 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.62 -177.73 18.8 Favored Glycine 0 N--CA 1.498 2.828 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -133.27 103.94 6.23 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.769 -0.842 . . . . 0.0 112.291 -178.069 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.737 HD11 ' HA ' ' A' ' 165' ' ' LYS . 2.7 pp -50.91 150.91 2.74 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.361 -0.837 . . . . 0.0 110.537 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.546 HD12 ' HB2' ' A' ' 115' ' ' PRO . 6.4 mt -114.88 54.47 0.78 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.27 99.06 0.1 Allowed Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -52.38 99.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.805 0 O-C-N 123.417 1.219 . . . . 0.0 110.92 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.559 ' HD2' HD21 ' A' ' 135' ' ' LEU . 8.4 ptp180 -116.03 164.59 17.27 Favored Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.006 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.79 124.41 12.28 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.99 1.521 . . . . 0.0 111.064 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.841 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.4 p -57.82 -34.15 47.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.501 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -48.53 -36.21 14.89 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.245 -0.909 . . . . 0.0 110.256 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -62.24 -39.14 91.86 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.559 HD21 ' HD2' ' A' ' 130' ' ' ARG . 14.0 mt -67.39 -36.61 81.67 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 126.36 27.09 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.615 -0.834 . . . . 0.0 108.884 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.47 -20.64 49.51 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.664 ' HB3' HG22 ' A' ' 108' ' ' THR . 6.0 m -93.91 11.6 28.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -1.09 . . . . 0.0 110.847 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.7 p -54.85 143.51 25.62 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.848 -1.158 . . . . 0.0 110.255 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.9 -14.32 58.77 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.54 115.6 4.99 Favored Glycine 0 N--CA 1.503 3.13 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.435 ' O ' HD12 ' A' ' 144' ' ' LEU . 54.2 Cg_endo -69.35 128.37 16.3 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 O-C-N 123.707 1.372 . . . . 0.0 112.683 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.893 HD23 HD13 ' A' ' 104' ' ' LEU . 5.7 mp -83.56 120.26 25.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 142' ' ' PRO . 0.8 OUTLIER -116.77 124.91 50.75 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.693 -177.024 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.507 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 31.1 p -68.59 172.14 5.08 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.8 Cg_endo -64.73 165.52 20.65 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 O-C-N 123.38 1.2 . . . . 0.0 110.116 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.72 39.46 20.92 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.165 -0.959 . . . . 0.0 110.479 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.12 -138.02 30.48 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.7 m170 56.44 111.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.718 -0.872 . . . . 0.0 111.446 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.403 ' CB ' HG21 ' A' ' 172' ' ' VAL . . . -74.3 147.55 42.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 109.053 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.646 HG12 ' CE2' ' A' ' 169' ' ' PHE . 1.4 t -108.48 -34.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.636 -0.665 . . . . 0.0 109.638 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.642 ' N ' HG23 ' A' ' 172' ' ' VAL . . . 174.1 179.22 44.58 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.668 HD11 ' CD1' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -115.05 163.32 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 CA-C-N 118.871 1.336 . . . . 0.0 110.903 178.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.763 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 3.2 t80 -70.76 114.82 9.23 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.017 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.405 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 15.9 ttp180 -101.18 -45.71 5.28 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.688 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -153.44 168.36 26.38 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.763 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -124.02 116.59 23.07 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.985 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.805 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 16.3 t -68.63 103.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.5 p -127.32 158.41 37.32 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.121 0.963 . . . . 0.0 113.51 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 162' ' ' GLY . 24.0 p -95.13 -173.54 2.97 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 175.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.22 82.53 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.841 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 86.02 -25.56 6.76 Favored Glycine 0 N--CA 1.502 3.063 0 O-C-N 120.7 -1.25 . . . . 0.0 111.916 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 160' ' ' THR . 0.9 OUTLIER -98.45 140.69 17.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 120.962 -1.317 . . . . 0.0 108.949 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.713 ' C ' HD21 ' A' ' 126' ' ' LEU . . . -93.46 138.21 31.98 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.962 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.737 ' HA ' HD11 ' A' ' 126' ' ' LEU . 0.7 OUTLIER -119.16 -28.26 5.49 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.635 -0.665 . . . . 0.0 110.38 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.805 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -144.01 178.14 8.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.875 . . . . 0.0 109.444 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.03 154.54 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.878 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.688 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 1.7 t70 -119.94 99.62 6.73 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.646 ' CE2' HG12 ' A' ' 151' ' ' VAL . 1.6 p90 -130.38 153.88 48.26 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.83 -1.148 . . . . 0.0 112.798 -175.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.62 HG11 HD13 ' A' ' 82' ' ' LEU . 2.7 p -103.0 127.47 29.81 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 45.9 Cg_endo -56.56 163.69 6.58 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 124.024 1.539 . . . . 0.0 111.636 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.642 HG23 ' N ' ' A' ' 152' ' ' GLY . 70.8 t -81.24 1.14 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.378 -0.827 . . . . 0.0 110.039 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -92.92 -37.69 12.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.844 . . . . 0.0 108.95 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.762 ' O ' HG22 ' A' ' 177' ' ' THR . 7.3 t -63.93 -38.14 90.0 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.572 ' HE1' HG23 ' A' ' 153' ' ' ILE . 7.9 mtt -48.14 -35.28 11.26 Favored 'General case' 0 N--CA 1.518 2.941 0 O-C-N 121.853 -0.529 . . . . 0.0 109.871 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -48.22 -38.34 18.21 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.131 -0.98 . . . . 0.0 111.177 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.762 HG22 ' O ' ' A' ' 174' ' ' SER . 14.6 t -54.21 -34.67 61.16 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.213 -0.93 . . . . 0.0 109.529 178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.726 HG21 ' HZ3' ' A' ' 53' ' ' TRP . 32.1 m -48.12 -61.94 1.73 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.898 -0.501 . . . . 0.0 110.949 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.447 ' HE1' ' CZ2' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -54.57 -51.3 65.68 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.385 -0.822 . . . . 0.0 110.887 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -52.87 -37.68 60.71 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.154 -0.966 . . . . 0.0 109.994 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -73.33 -39.23 65.4 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.993 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.4 t -76.47 98.78 4.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.635 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -86.97 98.11 11.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.421 -0.799 . . . . 0.0 109.822 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -124.24 62.68 1.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.654 0.74 . . . . 0.0 109.642 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -100.44 113.91 27.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.882 -0.512 . . . . 0.0 110.214 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.884 -1.055 . . . . 0.0 109.769 179.877 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.091 0.472 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.31 -98.6 0.13 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.83 29.09 11.31 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.319 -1.106 . . . . 0.0 110.435 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -143.56 69.28 1.29 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.658 -0.651 . . . . 0.0 110.39 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.447 ' HB3' ' HA ' ' A' ' 67' ' ' PRO . 2.8 tptt -153.37 56.8 0.76 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.572 -0.705 . . . . 0.0 109.971 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -80.0 88.15 5.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.441 -0.787 . . . . 0.0 110.24 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -161.54 78.0 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 89' ' ' PRO . 34.4 m -51.79 -38.4 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-O 121.608 0.718 . . . . 0.0 111.439 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' N ' HG23 ' A' ' 29' ' ' VAL . 0.3 OUTLIER 54.89 80.2 0.13 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.408 0.623 . . . . 0.0 110.98 179.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 92' ' ' ARG . . . -72.22 63.9 1.34 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -175.35 -73.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.557 HG22 ' CD ' ' A' ' 142' ' ' PRO . 62.4 t -124.62 138.26 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.63 -0.669 . . . . 0.0 110.263 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -125.05 178.94 5.26 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 43' ' ' PHE . 2.9 p -154.46 143.19 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.542 -0.724 . . . . 0.0 109.533 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.715 HG12 HD21 ' A' ' 64' ' ' LEU . 33.9 m -104.18 176.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.7 p -131.28 137.71 48.96 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.566 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.3 p -131.49 -176.42 4.02 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.57 103.09 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.206 -0.934 . . . . 0.0 110.389 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 62.1 p 47.0 53.71 10.21 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.275 0.559 . . . . 0.0 111.473 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.79 164.39 16.5 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.507 0.67 . . . . 0.0 110.554 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.6 p -155.51 132.8 10.92 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.867 ' O ' HG23 ' A' ' 35' ' ' VAL . 92.8 m-85 -105.76 175.03 5.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.193 -0.942 . . . . 0.0 111.612 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.758 HD21 ' CB ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -101.89 152.76 20.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 0.0 111.899 -177.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.588 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -160.43 161.24 32.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.896 -0.503 . . . . 0.0 110.283 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.623 HG23 HG23 ' A' ' 48' ' ' VAL . 14.6 t -137.82 125.18 21.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.098 -1.001 . . . . 0.0 111.981 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.8 m -74.04 79.24 1.71 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.378 -0.826 . . . . 0.0 109.408 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.623 HG23 HG23 ' A' ' 46' ' ' THR . 58.0 t -98.89 138.1 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.965 -1.084 . . . . 0.0 108.586 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.53 18.46 3.58 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.307 -0.871 . . . . 0.0 110.219 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.405 ' N ' ' CB ' ' A' ' 93' ' ' SER . . . 85.6 27.33 32.75 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.2 t -143.12 116.16 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.41 -1.053 . . . . 0.0 110.506 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.726 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 58.8 m -66.59 117.15 8.38 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.58 ' CE3' HD23 ' A' ' 82' ' ' LEU . 21.4 m95 -102.29 137.1 40.99 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 121.042 -1.036 . . . . 0.0 112.442 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.509 ' O ' HG22 ' A' ' 83' ' ' VAL . 1.0 OUTLIER -162.74 131.51 4.07 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.518 -0.739 . . . . 0.0 110.443 177.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.508 HG21 ' NE2' ' A' ' 57' ' ' HIS . 30.4 m -52.91 147.98 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.334 -0.854 . . . . 0.0 111.497 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.513 ' HA ' HG21 ' A' ' 83' ' ' VAL . 19.9 t80 -68.26 -11.06 58.77 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.118 -0.988 . . . . 0.0 112.052 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.508 ' NE2' HG21 ' A' ' 55' ' ' VAL . 12.9 p-80 -94.99 36.97 1.16 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.981 -1.074 . . . . 0.0 109.952 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.414 ' O ' ' CD2' ' A' ' 43' ' ' PHE . . . -149.95 -67.16 0.01 OUTLIER Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.029 -2.029 . . . . 0.0 108.029 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.37 141.85 40.4 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.476 -1.014 . . . . 0.0 109.885 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.7 -5.23 73.38 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 120.266 -0.968 . . . . 0.0 111.029 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 p 51.76 178.72 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.171 -1.194 . . . . 0.0 111.6 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.3 mttp 53.74 -94.43 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 111.338 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m -85.06 90.41 7.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 110.541 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.775 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -103.41 143.61 32.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.637 -0.664 . . . . 0.0 109.903 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.64 149.54 25.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.49 -0.756 . . . . 0.0 110.022 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.1 -179.46 15.88 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 43.9 Cg_endo -71.87 -5.19 16.57 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 O-C-N 124.044 1.549 . . . . 0.0 111.268 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -139.59 22.27 2.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.072 -1.017 . . . . 0.0 110.582 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.5 -178.92 17.29 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.51 149.78 87.4 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.07 1.563 . . . . 0.0 111.143 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.775 HD12 ' CD2' ' A' ' 64' ' ' LEU . 59.1 mt -108.33 165.09 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.443 ' N ' HG22 ' A' ' 71' ' ' ILE . 7.2 t -102.11 -166.7 1.32 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.435 -0.79 . . . . 0.0 110.057 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -119.62 120.07 35.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.557 -0.714 . . . . 0.0 110.147 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.413 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 3.6 mmt -116.03 -36.68 4.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 110.308 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.485 ' CE1' ' HG3' ' A' ' 179' ' ' MET . 24.6 m-85 -133.44 129.93 37.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.497 -0.752 . . . . 0.0 110.367 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.1 m -152.69 115.37 4.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.385 -0.822 . . . . 0.0 110.464 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -145.93 75.15 1.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.853 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.435 ' HB ' ' CD2' ' A' ' 56' ' ' TYR . 7.4 p -54.0 -25.96 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.36 -41.83 76.78 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.392 -0.817 . . . . 0.0 109.347 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -97.48 22.5 8.79 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.468 ' O ' HD12 ' A' ' 82' ' ' LEU . 71.2 m-20 53.95 52.34 13.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.512 -0.743 . . . . 0.0 111.667 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.772 HD13 HG11 ' A' ' 170' ' ' VAL . 1.3 tp -166.43 136.12 3.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.089 -1.007 . . . . 0.0 112.596 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.513 HG21 ' HA ' ' A' ' 56' ' ' TYR . 30.0 m -148.23 140.39 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 176.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 52' ' ' CYS . . . -160.28 176.17 36.98 Favored Glycine 0 C--N 1.298 -1.566 0 C-N-CA 118.426 -1.845 . . . . 0.0 111.663 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.544 ' CD1' HG21 ' A' ' 71' ' ' ILE . 37.1 p90 -130.07 134.78 47.6 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -51.26 139.46 18.82 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.484 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.726 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . . . -103.3 88.18 1.58 Allowed Pre-proline 0 C--N 1.297 -1.702 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.263 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.54 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 55.1 Cg_endo -94.79 -12.97 0.86 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.867 1.456 . . . . 0.0 112.271 177.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 43.1 Cg_endo -70.93 71.95 2.06 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 115.738 -2.374 . . . . 0.0 111.046 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 88' ' ' PRO . . . 52.75 24.91 20.66 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.625 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . . . -81.48 125.43 30.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.488 -1.007 . . . . 0.0 110.488 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.408 ' CB ' ' HA3' ' A' ' 31' ' ' GLY . 26.3 ttt180 -66.31 154.32 40.3 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.405 ' CB ' ' N ' ' A' ' 50' ' ' GLY . 4.9 p -113.69 103.91 11.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.625 -0.672 . . . . 0.0 110.351 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.654 HD23 ' HB2' ' A' ' 150' ' ' ALA . 1.5 mp -64.44 -162.08 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.535 -0.728 . . . . 0.0 109.475 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.445 HG23 ' N ' ' A' ' 96' ' ' PRO . 0.6 OUTLIER -145.6 -172.06 0.3 Allowed Pre-proline 0 C--N 1.299 -1.589 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.333 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.445 ' N ' HG23 ' A' ' 95' ' ' THR . 51.2 Cg_endo -90.93 162.68 3.97 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.772 1.406 . . . . 0.0 110.991 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 80.29 1.29 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.377 -0.827 . . . . 0.0 110.845 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.2 p -77.46 62.63 2.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.437 -0.789 . . . . 0.0 109.234 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.2 p -129.9 169.14 15.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.48 -0.762 . . . . 0.0 111.191 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.51 -156.17 26.64 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.82 -158.45 0.2 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.448 -1.031 . . . . 0.0 110.434 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.01 -88.76 0.39 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.547 -0.721 . . . . 0.0 110.121 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 62.8 m-20 44.81 55.13 6.23 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.167 -0.958 . . . . 0.0 111.769 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.748 HD13 HD23 ' A' ' 143' ' ' LEU . 16.8 mt -88.85 168.65 12.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.307 -0.871 . . . . 0.0 110.862 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.494 ' O ' HG23 ' A' ' 107' ' ' VAL . 75.2 m-85 -149.79 86.87 1.46 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.586 HD13 ' CD1' ' A' ' 143' ' ' LEU . 40.6 tp -58.48 103.21 0.14 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.632 -0.667 . . . . 0.0 109.237 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.748 HG13 HG12 ' A' ' 113' ' ' VAL . 41.4 t -87.44 101.06 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.326 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.759 HG21 ' OH ' ' A' ' 134' ' ' TYR . 48.7 p -66.4 158.45 29.31 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.758 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -80.56 2.14 26.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.001 -1.062 . . . . 0.0 110.974 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.435 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -97.73 30.09 3.11 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.054 -1.029 . . . . 0.0 109.465 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 58.73 62.42 1.93 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.458 -0.776 . . . . 0.0 110.805 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.34 104.1 0.45 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.225 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.748 HG12 HG13 ' A' ' 107' ' ' VAL . 3.4 m -102.32 155.34 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.519 -0.738 . . . . 0.0 110.751 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.46 HD11 HD23 ' A' ' 106' ' ' LEU . 42.2 pt -133.09 140.19 36.7 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.477 -0.765 . . . . 0.0 109.636 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.1 129.04 16.57 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.861 1.453 . . . . 0.0 111.988 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.463 ' HB ' ' CB ' ' A' ' 104' ' ' LEU . 63.9 t -116.95 158.69 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.738 ' HG3' HD21 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -114.57 109.42 18.23 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -46.6 129.31 11.04 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.494 -0.754 . . . . 0.0 111.418 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.7 -46.37 3.38 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.943 -0.473 . . . . 0.0 111.482 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -155.35 57.88 0.39 Allowed Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.27 -1.443 . . . . 0.0 111.1 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.419 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.5 OUTLIER 65.48 -66.72 0.14 Allowed 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.486 -1.008 . . . . 0.0 111.06 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 120' ' ' GLY . 25.8 p -98.96 41.68 1.13 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 121.467 0.651 . . . . 0.0 110.019 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.459 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 13.7 ttm180 -171.65 150.02 2.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 109.689 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.37 -178.99 18.18 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.65 113.34 16.58 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 122.181 -0.6 . . . . 0.0 111.161 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.38 133.15 45.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.623 -0.673 . . . . 0.0 109.705 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.738 HD21 ' HG3' ' A' ' 117' ' ' ARG . 7.3 mt -106.91 54.35 0.67 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.107 0.956 . . . . 0.0 108.587 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 170.44 123.52 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.15 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -56.02 112.11 0.97 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 O-C-N 123.495 1.261 . . . . 0.0 110.043 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -127.72 150.58 73.57 Favored Pre-proline 0 N--CA 1.487 1.375 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.646 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.14 130.18 18.44 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 124.107 1.583 . . . . 0.0 110.342 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.689 HG12 ' O ' ' A' ' 162' ' ' GLY . 7.1 p -62.91 -35.98 73.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.416 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -49.23 -37.82 24.36 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.759 ' OH ' HG21 ' A' ' 108' ' ' THR . 30.7 t80 -61.84 -38.24 87.47 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.476 HD11 ' CB ' ' A' ' 164' ' ' ALA . 14.1 mt -69.54 -36.65 76.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.6 103.64 0.7 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.461 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.36 -33.48 3.45 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.7 p -83.65 5.35 24.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.654 -0.909 . . . . 0.0 110.955 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.4 m -54.3 124.32 15.55 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.134 -0.979 . . . . 0.0 110.797 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.05 -13.67 12.67 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.462 ' HA2' HD12 ' A' ' 44' ' ' LEU . . . -62.64 134.44 44.39 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.557 ' CD ' HG22 ' A' ' 33' ' ' VAL . 54.5 Cg_endo -79.23 132.56 10.36 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.717 1.377 . . . . 0.0 113.254 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.748 HD23 HD13 ' A' ' 104' ' ' LEU . 4.6 mp -82.53 139.22 34.0 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 175.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 142' ' ' PRO . 1.1 mp -136.67 121.81 19.08 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 120.099 1.318 . . . . 0.0 111.593 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -69.56 -21.18 0.55 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.862 -0.524 . . . . 0.0 110.255 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 145' ' ' CYS . 46.0 Cg_endo -140.9 -162.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.876 0 O-C-N 123.461 1.243 . . . . 0.0 110.438 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.45 -55.59 29.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.387 -0.821 . . . . 0.0 110.185 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -107.7 -158.55 20.41 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.4 m170 53.06 100.7 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.395 -1.062 . . . . 0.0 111.095 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.654 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -75.42 154.64 36.98 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.512 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.626 HG12 ' CE2' ' A' ' 169' ' ' PHE . 2.1 t -103.9 -35.32 3.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.702 ' HA2' HG13 ' A' ' 172' ' ' VAL . . . 176.23 -178.36 47.64 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.673 HD11 ' CD1' ' A' ' 82' ' ' LEU . 1.6 pp -118.61 146.45 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 CA-C-N 118.837 1.319 . . . . 0.0 110.98 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.807 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 6.6 t80 -59.01 113.55 2.15 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.632 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.437 ' HA ' HG11 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -99.4 -46.94 5.33 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.726 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -150.45 171.39 17.12 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.807 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -126.67 116.66 21.33 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.019 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.817 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 7.0 t -67.34 99.73 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 177.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.591 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.1 p -127.73 165.04 20.81 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.555 1.169 . . . . 0.0 113.78 -175.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.6 OUTLIER -105.31 -174.18 2.47 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.398 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -48.77 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.087 0.946 . . . . 0.0 112.544 -179.31 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.689 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 82.17 -26.69 3.78 Favored Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.644 -1.285 . . . . 0.0 112.43 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.5 t -100.58 134.82 39.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 119.223 1.512 . . . . 0.0 110.025 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.476 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -95.75 131.15 42.33 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.421 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -109.12 -43.21 4.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.746 . . . . 0.0 110.344 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.817 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -128.43 163.86 23.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.49 -0.756 . . . . 0.0 110.088 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.55 154.28 9.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.533 0.683 . . . . 0.0 110.26 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.726 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -124.01 101.62 7.33 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.195 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.626 ' CE2' HG12 ' A' ' 151' ' ' VAL . 4.9 p90 -135.22 164.34 27.92 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.676 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.772 HG11 HD13 ' A' ' 82' ' ' LEU . 3.2 p -108.57 132.39 21.16 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 40.6 Cg_endo -61.73 161.52 24.72 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.794 1.418 . . . . 0.0 111.364 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.702 HG13 ' HA2' ' A' ' 152' ' ' GLY . 19.0 m -83.93 3.54 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 121.238 -0.914 . . . . 0.0 111.341 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.67 -38.15 13.28 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.6 t -72.69 -37.2 67.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.933 -0.48 . . . . 0.0 110.642 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.625 ' HE1' HG23 ' A' ' 153' ' ' ILE . 28.5 mtt -48.89 -38.74 23.51 Favored 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.429 -0.795 . . . . 0.0 109.252 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -55.87 -39.13 71.08 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.629 0.728 . . . . 0.0 109.695 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.1 m -54.62 -38.1 66.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.774 -0.579 . . . . 0.0 110.472 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.65 -41.01 63.4 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.444 -0.785 . . . . 0.0 110.548 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.485 ' HG3' ' CE1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -52.34 -40.47 61.98 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.19 -0.944 . . . . 0.0 111.629 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.13 -37.62 64.55 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.246 -0.909 . . . . 0.0 110.149 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.28 -39.19 54.91 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.37 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.32 -4.4 36.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.459 -0.776 . . . . 0.0 111.301 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.28 120.25 32.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.168 -0.958 . . . . 0.0 109.96 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -96.48 -75.17 0.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.585 -0.697 . . . . 0.0 110.487 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.15 117.43 1.65 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.579 -0.701 . . . . 0.0 110.447 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt . . . . . 0 N--CA 1.501 2.081 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.813 179.692 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.144 0.497 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.63 89.82 0.04 OUTLIER Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.42 -156.42 0.62 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.674 -0.897 . . . . 0.0 109.886 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -91.41 81.29 5.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.602 -0.686 . . . . 0.0 109.897 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -92.26 86.51 5.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.649 -0.657 . . . . 0.0 110.276 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -91.17 89.88 7.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 109.856 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.34 78.05 0.56 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.76 -0.588 . . . . 0.0 109.582 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.572 HG11 ' N ' ' A' ' 90' ' ' GLY . 7.8 p -89.17 150.97 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.743 -0.598 . . . . 0.0 110.109 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -173.92 79.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.371 -0.831 . . . . 0.0 109.766 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.65 151.5 5.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.561 ' HB2' HD12 ' A' ' 94' ' ' LEU . 1.3 pm0 -67.98 -14.6 63.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.705 -0.879 . . . . 0.0 110.771 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.53 HG23 ' HG2' ' A' ' 32' ' ' GLU . 98.4 t -111.78 141.82 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 0.0 110.188 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -125.33 171.22 10.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.703 -0.623 . . . . 0.0 109.351 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 44' ' ' LEU . 34.5 m -143.63 177.28 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.774 . . . . 0.0 110.748 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.07 179.48 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 p -137.09 135.88 37.85 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.073 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.2 p -132.52 -177.45 4.48 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.76 95.66 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.459 -0.776 . . . . 0.0 110.986 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 40' ' ' THR . 16.6 m 58.25 44.95 17.97 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.483 -0.761 . . . . 0.0 110.994 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -164.92 156.95 15.64 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.204 -0.935 . . . . 0.0 111.262 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 p -146.5 132.61 19.33 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.795 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . 46.9 m-85 -100.59 -179.29 4.05 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.199 -0.938 . . . . 0.0 110.401 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.655 HD13 ' HA ' ' A' ' 138' ' ' SER . 0.0 OUTLIER -111.97 152.47 28.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 0.0 110.881 -178.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.0 136.56 9.01 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.554 -0.717 . . . . 0.0 109.609 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.546 HG23 HG23 ' A' ' 48' ' ' VAL . 13.6 t -110.52 119.22 38.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.222 -0.924 . . . . 0.0 112.636 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.5 t -71.38 83.36 0.79 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.762 HG11 ' CG1' ' A' ' 172' ' ' VAL . 87.4 t -102.63 138.43 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 t30 56.07 21.35 5.02 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.405 -0.809 . . . . 0.0 110.208 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.13 24.94 53.64 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.566 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 61.6 t -141.44 106.34 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.37 -1.077 . . . . 0.0 109.875 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.24 108.86 1.69 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.291 -0.88 . . . . 0.0 109.913 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.593 ' CZ3' HG21 ' A' ' 178' ' ' THR . 97.7 m95 -93.79 148.54 22.03 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.486 -0.759 . . . . 0.0 111.157 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.404 HG23 HG23 ' A' ' 83' ' ' VAL . 5.6 t -161.26 179.91 7.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.845 -0.535 . . . . 0.0 109.725 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.696 HG11 ' HA ' ' A' ' 155' ' ' ARG . 27.1 m -94.85 143.57 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.581 -0.699 . . . . 0.0 110.54 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.706 ' HB2' HG11 ' A' ' 83' ' ' VAL . 45.7 t80 -76.05 -0.92 23.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.098 -1.001 . . . . 0.0 111.889 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -51.76 -30.63 23.55 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.073 -1.017 . . . . 0.0 109.648 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.86 -147.8 5.25 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.795 ' HB2' ' CB ' ' A' ' 43' ' ' PHE . . . 53.0 22.07 2.31 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.12 -1.223 . . . . 0.0 111.406 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.98 -136.39 2.16 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.92 20.67 4.35 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.505 -0.997 . . . . 0.0 110.964 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -171.61 -161.18 0.19 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.21 -0.931 . . . . 0.0 110.65 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -78.2 96.31 5.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.715 -0.616 . . . . 0.0 110.397 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.882 ' CD2' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -64.78 177.56 0.93 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.714 -0.616 . . . . 0.0 110.234 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.457 ' H ' HD23 ' A' ' 64' ' ' LEU . . . -130.88 136.34 48.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.59 -0.694 . . . . 0.0 110.108 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.46 178.76 17.87 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -64.71 -16.97 58.03 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.997 1.525 . . . . 0.0 110.673 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -147.45 42.26 1.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.224 -0.923 . . . . 0.0 110.082 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.74 164.16 11.19 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -57.3 157.88 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 O-C-N 123.747 1.393 . . . . 0.0 110.877 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.882 HD12 ' CD2' ' A' ' 64' ' ' LEU . 92.0 mt -98.5 162.49 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.557 -0.715 . . . . 0.0 110.297 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 p -97.11 -169.68 1.9 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.565 -0.71 . . . . 0.0 110.495 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -141.56 116.4 9.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.696 . . . . 0.0 110.021 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 tpt -113.96 -31.84 6.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.559 -0.713 . . . . 0.0 110.331 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.421 ' CD1' ' HA ' ' A' ' 179' ' ' MET . 15.8 m-85 -129.47 104.34 7.41 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.582 -0.699 . . . . 0.0 109.658 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.616 HG22 HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -146.75 109.69 4.68 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.349 -0.941 . . . . 0.0 112.117 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -161.82 74.86 0.46 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.36 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.656 HG11 ' HB3' ' A' ' 56' ' ' TYR . 5.9 p -67.77 -23.18 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.229 -0.919 . . . . 0.0 110.224 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -50.95 -26.35 5.83 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.301 -0.874 . . . . 0.0 110.653 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -172.68 36.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.585 -0.697 . . . . 0.0 110.511 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.507 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -161.82 -86.19 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.138 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.724 ' CD1' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER 175.55 175.97 0.23 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.58 -1.325 . . . . 0.0 110.343 -178.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.706 HG11 ' HB2' ' A' ' 56' ' ' TYR . 27.7 m -143.56 121.6 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.648 0.737 . . . . 0.0 109.354 177.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.19 149.34 18.7 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.529 ' CZ2' HD11 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -110.46 151.37 27.61 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -63.55 137.19 58.02 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.168 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 135.8 34.62 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.736 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.458 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 38.0 Cg_endo -114.46 -38.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.463 0 O-C-N 123.56 1.295 . . . . 0.0 114.911 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 54.9 Cg_endo -61.34 -155.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 117.063 -1.492 . . . . 0.0 109.966 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.572 ' N ' HG11 ' A' ' 29' ' ' VAL . . . -78.63 32.45 1.89 Allowed Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.5 ' HA ' HG21 ' A' ' 29' ' ' VAL . . . -58.33 126.52 27.89 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.021 -1.282 . . . . 0.0 110.549 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 147.68 52.29 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.62 116.83 32.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.456 -0.778 . . . . 0.0 110.895 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.561 HD12 ' HB2' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -90.96 -159.23 0.61 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.73 -0.607 . . . . 0.0 109.528 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.536 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -156.06 -173.64 0.39 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.601 -0.687 . . . . 0.0 109.742 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -87.97 156.16 7.21 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 O-C-N 123.77 1.405 . . . . 0.0 110.311 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.448 ' SG ' HG23 ' A' ' 151' ' ' VAL . 0.5 OUTLIER -90.46 -67.81 0.82 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.443 -0.785 . . . . 0.0 110.275 179.681 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.1 m 50.57 26.79 2.58 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.193 -0.942 . . . . 0.0 110.721 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -147.06 174.28 11.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.513 -0.742 . . . . 0.0 110.86 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.46 -167.1 48.41 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.9 m -121.11 -55.41 1.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.726 -0.867 . . . . 0.0 109.772 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.62 -152.84 0.21 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.713 -0.617 . . . . 0.0 109.944 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 t0 57.3 101.87 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.335 -0.853 . . . . 0.0 110.266 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.77 HD13 HD23 ' A' ' 143' ' ' LEU . 1.4 mt -120.3 -168.99 1.72 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.505 -0.747 . . . . 0.0 109.751 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.676 ' O ' HG23 ' A' ' 107' ' ' VAL . 20.6 m-85 -140.45 83.68 1.92 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.759 HD23 HD11 ' A' ' 114' ' ' ILE . 24.6 tp -60.01 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 105' ' ' TYR . 48.6 t -84.67 102.88 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.063 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.3 p -65.14 170.17 4.8 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HB2' ' CG ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -95.55 25.8 4.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.911 -1.118 . . . . 0.0 110.363 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.463 ' CD2' ' N ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -124.62 29.83 6.15 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . 62.08 70.68 0.57 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.543 -0.723 . . . . 0.0 111.088 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -175.0 102.69 0.09 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.645 -0.659 . . . . 0.0 110.223 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.626 ' CG1' HG22 ' A' ' 107' ' ' VAL . 7.8 m -101.79 153.81 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.446 -0.784 . . . . 0.0 110.222 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.759 HD11 HD23 ' A' ' 106' ' ' LEU . 30.2 pt -135.94 139.34 30.17 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.474 -0.766 . . . . 0.0 109.559 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.63 ' HB2' HD12 ' A' ' 127' ' ' LEU . 47.1 Cg_endo -66.85 145.48 74.84 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 123.929 1.489 . . . . 0.0 111.503 -178.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.33 142.9 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.93 117.32 34.35 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.84 128.52 15.79 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.527 -0.733 . . . . 0.0 110.119 -178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -112.97 -25.41 8.99 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.173 -177.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 122' ' ' SER . . . -172.93 53.35 0.16 Allowed Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.57 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.411 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER 65.9 -70.19 0.1 Allowed 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.633 -0.922 . . . . 0.0 110.06 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 120' ' ' GLY . 77.7 p -92.94 35.7 1.05 Allowed 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.342 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.456 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -167.91 150.75 5.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.336 -0.852 . . . . 0.0 110.216 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.42 -178.21 20.78 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 4.1 t -127.86 117.0 21.01 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.607 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.693 HD21 HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -58.53 139.27 55.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.45 -0.782 . . . . 0.0 109.475 178.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 115' ' ' PRO . 38.7 mt -105.26 53.92 0.71 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.237 1.018 . . . . 0.0 108.267 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 167.48 152.64 0.1 Allowed Pre-proline 0 N--CA 1.503 2.184 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.19 115.65 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.782 1.412 . . . . 0.0 110.044 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.606 ' HB2' HD22 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -123.62 131.8 24.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.488 -0.758 . . . . 0.0 109.035 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -58.2 130.84 39.85 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.793 1.418 . . . . 0.0 110.898 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.729 HG21 ' SG ' ' A' ' 159' ' ' CYS . 10.9 p -65.79 -37.3 79.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.584 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.4 m -49.97 -37.08 30.74 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 122.042 0.925 . . . . 0.0 110.458 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -66.91 -38.37 86.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.517 HD11 ' CB ' ' A' ' 164' ' ' ALA . 15.4 mt -66.95 -36.43 82.21 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -61.02 123.29 17.19 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.949 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.17 -25.89 26.56 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.655 ' HA ' HD13 ' A' ' 44' ' ' LEU . 7.4 m -81.09 0.96 33.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.547 -0.972 . . . . 0.0 111.427 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 60.1 m -55.83 126.2 24.61 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.216 -0.928 . . . . 0.0 111.569 -178.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 123.66 -22.66 6.86 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.624 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -53.75 126.37 35.02 Favored Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.478 ' O ' HD12 ' A' ' 144' ' ' LEU . 49.2 Cg_endo -74.33 125.67 9.85 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.763 1.402 . . . . 0.0 112.977 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.77 HD23 HD13 ' A' ' 104' ' ' LEU . 1.1 mp -76.86 135.22 38.86 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 175.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 142' ' ' PRO . 1.1 mt -132.91 127.73 34.98 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 118.924 -1.11 . . . . 0.0 111.962 -178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.506 ' HB3' HG21 ' A' ' 151' ' ' VAL . 14.2 p -74.98 -174.72 0.39 Allowed Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.1 Cg_endo -71.1 68.21 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.419 1.22 . . . . 0.0 110.643 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.78 -175.28 1.76 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.559 -0.713 . . . . 0.0 109.75 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.42 27.11 20.98 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -116.81 135.97 53.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.535 -0.979 . . . . 0.0 109.753 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -72.05 141.01 49.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.662 -0.649 . . . . 0.0 110.241 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.653 HG12 ' CE2' ' A' ' 169' ' ' PHE . 1.4 t -96.85 -37.64 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.822 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . 177.29 -177.9 48.28 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.484 HG13 HG13 ' A' ' 170' ' ' VAL . 1.1 pt -117.02 140.32 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.112 -1.228 . . . . 0.0 110.435 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.756 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 9.1 t80 -58.44 115.94 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.268 0.556 . . . . 0.0 110.541 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.696 ' HA ' HG11 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -103.68 -46.09 4.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.662 -0.649 . . . . 0.0 109.662 -179.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.731 ' HB3' ' HB3' ' A' ' 168' ' ' ASP . . . -151.29 171.99 16.59 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.756 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -132.09 118.11 19.2 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.674 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.859 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 3.4 t -65.96 102.44 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.729 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.9 p -128.08 159.55 34.73 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.301 1.048 . . . . 0.0 113.642 -175.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 161' ' ' ARG . 1.6 m -94.05 -174.17 3.32 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.506 ' H ' HG22 ' A' ' 160' ' ' THR . 0.0 OUTLIER -48.85 84.96 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 121.74 0.781 . . . . 0.0 112.76 -178.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.665 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 84.78 -27.59 4.79 Favored Glycine 0 N--CA 1.5 2.967 0 O-C-N 120.713 -1.242 . . . . 0.0 111.775 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -96.21 131.75 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.773 -1.428 . . . . 0.0 109.604 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.517 ' CB ' HD11 ' A' ' 135' ' ' LEU . . . -95.62 134.47 38.47 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.772 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -115.24 -39.98 3.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.729 -0.607 . . . . 0.0 110.961 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.859 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -124.61 177.95 5.68 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.255 -0.903 . . . . 0.0 109.841 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.33 155.55 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.608 0.718 . . . . 0.0 110.685 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.731 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -127.28 96.02 4.46 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.653 ' CE2' HG12 ' A' ' 151' ' ' VAL . 3.7 p90 -132.54 165.86 23.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.824 -1.173 . . . . 0.0 112.946 -176.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.724 HG21 ' CD1' ' A' ' 82' ' ' LEU . 1.3 p -108.81 127.46 27.32 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 44.2 Cg_endo -59.05 160.58 18.26 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.963 1.507 . . . . 0.0 111.954 -177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.822 HG23 ' HA2' ' A' ' 152' ' ' GLY . 40.0 t -84.23 2.98 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.515 -0.741 . . . . 0.0 109.798 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.41 -37.17 21.8 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -36.34 83.92 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.585 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.578 ' SD ' HD22 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -49.89 -36.37 27.09 Favored 'General case' 0 N--CA 1.521 3.09 0 O-C-N 121.426 -0.796 . . . . 0.0 108.885 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -57.77 -37.48 73.74 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.121 -0.987 . . . . 0.0 108.708 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.1 m -76.27 -36.84 58.22 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.633 0.73 . . . . 0.0 109.42 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.593 HG21 ' CZ3' ' A' ' 53' ' ' TRP . 1.3 m -48.82 -52.99 21.12 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.673 -0.642 . . . . 0.0 111.193 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.459 ' CE ' ' CZ2' ' A' ' 53' ' ' TRP . 2.2 ptp -59.85 -40.85 89.92 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.066 -1.021 . . . . 0.0 109.94 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -57.67 -38.36 74.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.038 0.923 . . . . 0.0 109.449 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.58 78.22 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.624 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.3 p -92.5 40.43 1.05 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.59 -0.693 . . . . 0.0 110.714 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -66.1 164.23 15.91 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.457 -0.777 . . . . 0.0 110.02 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -137.77 42.76 2.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.569 -0.707 . . . . 0.0 110.747 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -93.79 103.42 15.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.51 -0.744 . . . . 0.0 110.129 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.079 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_